PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhong, MC; Veillette, A				Zhong, Ming-Chao; Veillette, Andre			The Adaptor Molecule Signaling Lymphocytic Activation Molecule (SLAM)-associated Protein (SAP) Is Essential in Mechanisms Involving the Fyn Tyrosine Kinase for Induction and Progression of Collagen-induced Arthritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELPER T-CELLS; LINKED LYMPHOPROLIFERATIVE-DISEASE; HUMORAL IMMUNITY; GENE-PRODUCT; B-CELLS; SYSTEMIC AUTOIMMUNITY; CYTOKINE REGULATION; ANTIBODY-RESPONSES; SLAM RECEPTORS; MICE	Signaling lymphocytic activation molecule-associated protein (SAP) is an Src homology 2 domain-only adaptor involved in multiple immune cell functions. It has also been linked to immunodeficiencies and autoimmune diseases, such as systemic lupus erythematosus. Here, we examined the role and mechanism of action of SAP in autoimmunity using a mouse model of autoimmune arthritis, collagen-induced arthritis (CIA). We found that SAP was essential for development of CIA in response to collagen immunization. It was also required for production of collagen-specific antibodies, which play a key role in disease pathogenesis. These effects required SAP expression in T cells, not in B cells. In mice immunized with a high dose of collagen, the activity of SAP was nearly independent of its ability to bind the protein tyrosine kinase Fyn and correlated with the capacity of SAP to promote full differentiation of follicular T helper (T-FH) cells. However, with a lower dose of collagen, the role of SAP was more dependent on Fyn binding, suggesting that additional mechanisms other than T-FH cell differentiation were involved. Further studies suggested that this might be due to a role of the SAP-Fyn interaction in natural killer T cell development through the ability of SAP-Fyn to promote Vav-1 activation. We also found that removal of SAP expression during progression of CIA attenuated disease severity. However, it had no effect on disease when CIA was clinically established. Together, these results indicate that SAP plays an essential role in CIA because of Fyn-independent and Fyn-dependent effects on T-FH cells and, possibly, other T cell types.	[Zhong, Ming-Chao; Veillette, Andre] Clin Res Inst Montreal, Mol Oncol Lab, Montreal, PQ H2W 1R7, Canada; [Veillette, Andre] Univ Montreal, Dept Med, Montreal, PQ H3T 1J4, Canada; [Veillette, Andre] McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; McGill University	Zhong, MC (corresponding author), Clin Res Inst Montreal, Mol Oncol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	zhongmc@ircm.qc.ca; veillea@ircm.qc.ca						Barral P, 2008, P NATL ACAD SCI USA, V105, P8345, DOI 10.1073/pnas.0802968105; Brand DD, 2003, SPRINGER SEMIN IMMUN, V25, P3, DOI 10.1007/s00281-003-0127-1; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; Calpe S, 2008, ADV IMMUNOL, V97, P177, DOI 10.1016/S0065-2776(08)00004-7; Cannons JL, 2006, J EXP MED, V203, P1551, DOI 10.1084/jem.20052097; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Cannons JL, 2004, IMMUNITY, V21, P693, DOI 10.1016/j.immuni.2004.09.012; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; Chan GD, 2001, EUR J IMMUNOL, V31, P2403, DOI 10.1002/1521-4141(200108)31:8<2403::AID-IMMU2403>3.0.CO;2-O; Chen RY, 2004, MOL CELL BIOL, V24, P5144, DOI 10.1128/MCB.24.12.5144-5156.2004; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chung B, 2005, J IMMUNOL, V174, P3153, DOI 10.4049/jimmunol.174.6.3153; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Davidson D, 2004, IMMUNITY, V21, P707, DOI 10.1016/j.immuni.2004.10.005; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Dong ZJ, 2012, IMMUNITY, V36, P974, DOI 10.1016/j.immuni.2012.03.023; Dong ZJ, 2009, NAT IMMUNOL, V10, P973, DOI 10.1038/ni.1763; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Galli G, 2003, J EXP MED, V197, P1051, DOI 10.1084/jem.20021616; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Hron JD, 2004, J EXP MED, V200, P261, DOI 10.1084/jem.20040526; Kageyama R, 2012, IMMUNITY, V36, P986, DOI 10.1016/j.immuni.2012.05.016; Kim HY, 2005, J EXP MED, V201, P41, DOI 10.1084/jem.20041400; Komori H, 2006, J IMMUNOL, V176, P395, DOI 10.4049/jimmunol.176.1.395; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Latour S, 2003, NAT CELL BIOL, V5, P149, DOI 10.1038/ncb919; Leavenworth JW, 2013, J CLIN INVEST, V123, P1382, DOI 10.1172/JCI66938; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Lu KT, 2011, IMMUNITY, V35, P622, DOI 10.1016/j.immuni.2011.07.015; Ma CS, 2007, ANNU REV IMMUNOL, V25, P337, DOI 10.1146/annurev.immunol.25.022106.141651; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Ma CS, 2005, J CLIN INVEST, V115, P1049, DOI 10.1172/JCI23139; McCausland MM, 2007, J IMMUNOL, V178, P817, DOI 10.4049/jimmunol.178.2.817; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Murphy K, 2012, IMMUNOBIOLOGY; MYERS LK, 1993, J IMMUNOL, V151, P500; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; Nunez-Cruz S, 2008, J IMMUNOL, V181, P2311, DOI 10.4049/jimmunol.181.4.2311; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; Platt AM, 2010, J IMMUNOL, V185, P1558, DOI 10.4049/jimmunol.1001311; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Rosloniec E. F., 2010, CURR PROTOC IMMUNOL, P11; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Schwartzberg PL, 2009, NAT REV IMMUNOL, V9, P39, DOI 10.1038/nri2456; Simmons M, 2006, J VIROL, V80, P9577, DOI 10.1128/JVI.00284-06; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; Tangye SG, 2012, ANN NY ACAD SCI, V1250, P1, DOI 10.1111/j.1749-6632.2011.06361.x; Teige A, 2010, J IMMUNOL, V185, P345, DOI 10.4049/jimmunol.0901693; Veillette A, 2008, P NATL ACAD SCI USA, V105, P1273, DOI 10.1073/pnas.0710698105; Veillette A, 2007, IMMUNITY, V27, P698, DOI 10.1016/j.immuni.2007.11.005; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Yu D, 2010, TRENDS IMMUNOL, V31, P377, DOI 10.1016/j.it.2010.07.001; Zhao F, 2012, IMMUNITY, V36, P1003, DOI 10.1016/j.immuni.2012.05.017; Zhong MC, 2013, MOL CELL BIOL, V33, P1223, DOI 10.1128/MCB.01591-12; Zhong MC, 2008, J BIOL CHEM, V283, P19255, DOI 10.1074/jbc.M800209200; Zhu CL, 2012, J CLIN ENDOCR METAB, V97, P943, DOI 10.1210/jc.2011-2003	60	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31423	31436		10.1074/jbc.M113.473736	http://dx.doi.org/10.1074/jbc.M113.473736			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24045941	Green Published, hybrid			2022-12-25	WOS:000330596200002
J	Abdulrahim, MH; McManus, BA; Flint, SR; Coleman, DC				Abdulrahim, Mohammed H.; McManus, Brenda A.; Flint, Stephen R.; Coleman, David C.			Genotyping Candida albicans from Candida Leukoplakia and Non-Candida Leukoplakia Shows No Enrichment of Multilocus Sequence Typing Clades but Enrichment of ABC Genotype C in Candida Leukoplakia	PLOS ONE			English	Article							CHRONIC HYPERPLASTIC CANDIDIASIS; DUBLINIENSIS; IDENTIFICATION; DISORDERS; EBURST	Oral leukoplakias are histopathologically-diagnosed as Candida leukoplakia or non-Candida leukoplakia by the presence or absence of hyphae in the superficial epithelium. Candida leukoplakia lesions have significantly increased malignant potential. Candida albicans is the most prevalent fungal species associated with oral leukoplakia and may contribute to malignant transformation of Candida leukoplakia. To date, no detailed population analysis of C. albicans isolates from oral leukoplakia patients has been undertaken. This study investigated whether specific C. albicans genotypes were associated with Candida leukoplakia and non-Candida leukoplakia in a cohort of Irish patients. Patients with histopathologically-defined Candida leukoplakia (n = 31) or non-Candida leukoplakia (n = 47) were screened for Candida species by culture of oral rinse and lesional swab samples. Selected C. albicans isolates from Candida leukoplakia patients (n = 25), non-Candida leukoplakia patients (n = 19) and oral carriage isolates from age and sex matched healthy subjects without leukoplakia (n = 34) were subjected to multilocus sequence typing (MLST) and ABC genotyping. MLST revealed that the clade distribution of C. albicans from both Candida leukoplakia and non-Candida leukoplakia lesions overlapped with the corresponding clade distributions of oral carriage isolates and global reference isolates from the MLST database indicating no enrichment of leukoplakia-associated clones. Oral leukoplakia isolates were significantly enriched with ABC genotype C (12/44, 27.3%), particularly Candida leukoplakia isolates (9/25, 36%), relative to oral carriage isolates (3/34, 8.8%). Genotype C oral leukoplakia isolates were distributed in MLST clades 1,3,4,5,8,9 and 15, whereas genotype C oral carriage isolates were distributed in MLST clades 4 and 11.	[Abdulrahim, Mohammed H.; Flint, Stephen R.] Univ Dublin, Dublin Dent Univ Hosp, Div Maxillofacial Surg Oral Med & Oral Pathol, Dublin, Ireland; [McManus, Brenda A.; Coleman, David C.] Univ Dublin, Trin Coll Dublin, Dublin Dent Univ Hosp, Microbiol Res Unit,Div Oral Biosci, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin	Coleman, DC (corresponding author), Univ Dublin, Trin Coll Dublin, Dublin Dent Univ Hosp, Microbiol Res Unit,Div Oral Biosci, Dublin, Ireland.	david.coleman@dental.tcd.ie	Coleman, David C./C-2008-2009; McManus, Brenda/H-8600-2019	Coleman, David C./0000-0003-1797-2888; McManus, Brenda/0000-0003-3969-054X	Dublin Dental University Hospital Microbiology Research Unit	Dublin Dental University Hospital Microbiology Research Unit	This study was supported by the Dublin Dental University Hospital Microbiology Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartie KL, 2001, J CLIN MICROBIOL, V39, P4066, DOI 10.1128/JCM.39.11.4066-4075.2001; Bougnoux ME, 2006, J CLIN MICROBIOL, V44, P1810, DOI 10.1128/JCM.44.5.1810-1820.2006; Bougnoux ME, 2003, J CLIN MICROBIOL, V41, P5265, DOI 10.1128/JCM.41.11.5265-5266.2003; Bougnoux ME, 2002, J CLIN MICROBIOL, V40, P1290, DOI 10.1128/JCM.40.4.1290-1297.2002; CAWSON RA, 1968, BRIT J DERMATOL, V80, P9, DOI 10.1111/j.1365-2133.1968.tb11899.x; CAWSON RA, 1966, ORAL SURG ORAL MED O, V22, P582, DOI 10.1016/0030-4220(66)90161-7; Chen KW, 2006, J CLIN MICROBIOL, V44, P2172, DOI 10.1128/JCM.00320-06; Coleman DC, 1997, AIDS, V11, P557, DOI 10.1097/00002030-199705000-00002; Dalle F, 2010, CELL MICROBIOL, V12, P248, DOI 10.1111/j.1462-5822.2009.01394.x; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Gainza-Cirauqui ML, 2013, J ORAL PATHOL MED, V42, P243, DOI 10.1111/j.1600-0714.2012.01203.x; HOLMSTRUP P, 1983, ORAL SURG ORAL MED O, V56, P388, DOI 10.1016/0030-4220(83)90349-3; JEPSEN A, 1965, Acta Odontol Scand, V23, P239, DOI 10.3109/00016356509007513; KROGH P, 1987, ORAL SURG ORAL MED O, V63, P48, DOI 10.1016/0030-4220(87)90339-2; KROGH P, 1990, ACTA ODONTOL SCAND, V48, P85, DOI 10.3109/00016359009012738; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LEHNER T, 1964, Trans St Johns Hosp Dermatol Soc, V50, P8; McCullough M, 2002, ORAL ONCOL, V38, P391, DOI 10.1016/S1368-8375(01)00079-3; McCullough MJ, 1999, J CLIN MICROBIOL, V37, P417, DOI 10.1128/JCM.37.2.417-421.1999; McCullough MJ, 1999, CLIN INFECT DIS, V29, P1220, DOI 10.1086/313455; McManus BA, 2012, J CLIN MICROBIOL, V50, P3335, DOI 10.1128/JCM.01532-12; McManus BA, 2011, J CLIN MICROBIOL, V49, P1879, DOI 10.1128/JCM.00026-11; Odds FC, 2006, J CLIN MICROBIOL, V44, P3647, DOI 10.1128/JCM.00934-06; ODDS FC, 1994, J CLIN MICROBIOL, V32, P1923, DOI 10.1128/JCM.32.8.1923-1929.1994; ODDS FC, 1988, CANDIDA CANDIDOSIS, P68; Odds FC, 2008, EUKARYOT CELL, V7, P1075, DOI 10.1128/EC.00062-08; Odds FC, 2007, EUKARYOT CELL, V6, P1041, DOI 10.1128/EC.00041-07; Pincus DH, 1999, J CLIN MICROBIOL, V37, P3533, DOI 10.1128/JCM.37.11.3533-3539.1999; Sitheeque MAM, 2003, CRIT REV ORAL BIOL M, V14, P253, DOI 10.1177/154411130301400403; Spratt BG, 2004, FEMS MICROBIOL LETT, V241, P129, DOI 10.1016/j.femsle.2004.11.015; Tavanti A, 2003, J CLIN MICROBIOL, V41, P3765, DOI 10.1128/JCM.41.8.3765-3776.2003; Walker D. M., 1990, Oral candidosis., P184; Warnakulasuriya S, 2007, J ORAL PATHOL MED, V36, P575, DOI 10.1111/j.1600-0714.2007.00582.x; WILLIAMSON DM, 1969, BRIT J DERMATOL, V81, P125, DOI 10.1111/j.1365-2133.1969.tb15992.x; Wrobel L, 2008, EUKARYOT CELL, V7, P1475, DOI 10.1128/EC.00162-08	35	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73738	10.1371/journal.pone.0073738	http://dx.doi.org/10.1371/journal.pone.0073738			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058485	Green Submitted, Green Published, gold			2022-12-25	WOS:000324695900017
J	Abella, J; Valenciano, A; Perez-Ramos, A; Montoya, P; Morales, J				Abella, Juan; Valenciano, Alberto; Perez-Ramos, Alejandro; Montoya, Plinio; Morales, Jorge			On the Socio-Sexual Behaviour of the Extinct Ursid Indarctos arctoides: An Approach Based on Its Baculum Size and Morphology	PLOS ONE			English	Article							PROMEGANTEREON-OGYGIA FELIDAE; LATE MIOCENE; OS-PENIS; FUNCTIONAL-ANATOMY; COPULATORY-BEHAVIOR; MAMMALIAN BACULUM; SEXUAL-DIMORPHISM; FALSE-THUMB; CARNIVORA; EVOLUTION	The fossil bacula, or os penis, constitutes a rare subject of study due to its scarcity in the fossil record. In the present paper we describe five bacula attributed to the bear Indarctos arctoides Deperet, 1895 from the Batallones-3 site (Madrid Basin, Spain). Both the length and morphology of this fossil bacula enabled us to make interpretative approaches to a series of ecological and ethological characters of this bear. Thus, we suggest that I. arctoides could have had prolonged periods of intromission and/or maintenance of intromission during the post-ejaculatory intervals, a multi-male mating system and large home range sizes and/or lower population density. Its size might also have helped females to choose from among the available males.	[Abella, Juan] Autonomous Univ Barcelona, Inst Catala Paleontol Miquel Crusafont, Barcelona, Spain; [Abella, Juan; Morales, Jorge] CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain; [Valenciano, Alberto] UCM, CSIC, Inst Geociencias, Dept Geol Sedimentaria & Cambio Medioambiental, Madrid, Spain; [Valenciano, Alberto] UCM, Fac Ciencias Geol, Dept Paleontol, Madrid, Spain; [Perez-Ramos, Alejandro] Univ Valencia, Inst Cavanilles Biodivers & Biol Evolut, Paterna, Spain; [Montoya, Plinio] Univ Valencia, Area Paleontol, Dept Geol, E-46100 Burjassot, Spain	Autonomous University of Barcelona; Institut Catala de Paleontologia Miquel Crusafont (ICP); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UCM - Instituto de Geociencias (IGEO); Complutense University of Madrid; University of Valencia; University of Valencia	Abella, J (corresponding author), Autonomous Univ Barcelona, Inst Catala Paleontol Miquel Crusafont, Edifici ICP,Campus UAB S-N, Barcelona, Spain.	juan.abella@icp.cat	Abella, Juan/AAB-1040-2020; Morales, Jorge/L-1476-2014; Vaquero, Alberto Valenciano/N-8757-2019	Abella, Juan/0000-0002-3433-6093; Morales, Jorge/0000-0001-5170-5754; Vaquero, Alberto Valenciano/0000-0003-1633-2248; Perez-Ramos, Alejandro/0000-0003-1417-4338	Spanish Ministerio de Economia y Competitividad [CGL2011-25754, CGL2011-28681]; JAE-Predoc (CSIC program "Junta para la ampliacion de estudios''); European Social Fund;  [BSCH-UCM910607]	Spanish Ministerio de Economia y Competitividad(Spanish Government); JAE-Predoc (CSIC program "Junta para la ampliacion de estudios''); European Social Fund(European Social Fund (ESF)); 	This study was supported by the Spanish Ministerio de Economia y Competitividad (research project CGL2011-25754 and CGL2011-28681) and the research group BSCH-UCM910607. AV was supported by a JAE-Predoc 2011 (CSIC program "Junta para la ampliacion de estudios''), co-funded by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella J, 2011, PALEONTOLOGIA EVOLUC, V5, P21; Abella J., 2011, THESIS U AUTONOMA MA; Abella J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048985; Albayrak I, 2008, TURK J ZOOL, V32, P147; Amstrup SC., 2003, WILD MAMMALS N AM BI, P587; Anton M, 2004, J VERTEBR PALEONTOL, V24, P957, DOI 10.1671/0272-4634(2004)024[0957:FKCSOT]2.0.CO;2; Anton M, 2004, ZOOL J LINN SOC-LOND, V140, P207, DOI 10.1111/j.1096-3642.2003.00093.x; Anton M, 2006, J ANAT, V209, P757, DOI 10.1111/j.1469-7580.2006.00649.x; Baryshnikov GF, 2003, J MAMMAL, V84, P673, DOI 10.1644/1545-1542(2003)084<0673:MVAEOT>2.0.CO;2; BAUMGARDNER DJ, 1982, J MAMMAL, V63, P110, DOI 10.2307/1380677; Blanchard B.M., 1987, BEARS THEIR BIOL MAN, V7, P99, DOI [10.2307/3872615, DOI 10.2307/3872615]; BURT WILLIAM HENRY, 1960, MISC PUBL MUS ZOOL UNIV MICHIGAN, V113, P1; Calvo JP, 2013, SEDIMENTOLOGY, V60, P1681, DOI 10.1111/sed.12048; Dathe H, 1975, GRZIMEKS ANIMAL LIFE, P141; Davis D. D., 1964, Fieldiana Zoology Memoir, V3, P1; DEMASTER DP, 1981, MAMMALIAN SPECIES, V145, P1, DOI DOI 10.2307/3503828; Didier R, 1950, MAMMALIA, V14, P78; DIXSON AF, 1987, AM J PRIMATOL, V13, P51, DOI 10.1002/ajp.1350130107; DIXSON AF, 1995, J ZOOL, V235, P67, DOI 10.1111/j.1469-7998.1995.tb05128.x; Dixson Alan, 2004, Acta Zoologica Sinica, V50, P490; Domingo MS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2138; Dyck MG, 2004, J ZOOL, V264, P105, DOI 10.1017/S0952836904005606; Evans H.E., 2010, MILLERS GUIDE DISSEC, VFourth; Ewer, 1998, CARNIVORES; Ferguson SH, 2004, OIKOS, V105, P255; HARRISON JA, 1982, J PALEONTOL, V56, P1266; Hosken DJ, 2001, BEHAV ECOL SOCIOBIOL, V50, P450; Kelly DA, 2000, J MORPHOL, V244, P69, DOI 10.1002/(SICI)1097-4687(200004)244:1<69::AID-JMOR7>3.0.CO;2-#; KINGSLEY MCS, 1988, CAN J ZOOL, V66, P981, DOI 10.1139/z88-145; Lariviere S, 2003, J MAMMAL, V84, P937, DOI 10.1644/BME-003; Lariviere S, 2002, MAMMAL REV, V32, P283, DOI 10.1046/j.1365-2907.2002.00112.x; Laycock G, 1997, WILDERNESS LEGEND GR; LEFRANC MN, 1987, GRIZZLY BEAR COMPEND; Lindenfors P, 2002, J EVOLUTION BIOL, V15, P595, DOI 10.1046/j.1420-9101.2002.00422.x; Lindenfors P, 2002, BEHAV ECOL SOCIOBIOL, V52, P188, DOI 10.1007/s00265-002-0507-x; Lono O, 1970, NOR POLARINST SKR, V149, P1; Matthew WD, 1907, B AM MUS NAT HIST, V23, P169; Miller EH, 2000, J MAMMAL, V81, P134, DOI 10.1644/1545-1542(2000)081<0134:BSGAAI>2.0.CO;2; Miller EH, 2002, ENCY MARINE MAMMALS, P55; Mitani JC, 1996, AM NAT, V147, P966, DOI 10.1086/285888; Mohr E., 1963, Zeitschrift fuer Saugietierkunde, V28, P19; Mondolfi E, 1971, DEFENSA NATURALEZA, V1, P31; Morales J., 2004, Geogaceta, V35, P139; Morales J., 2008, Publicaciones del Seminario de Paleontologia de Zaragoza, V8, P41; Morales J., 1992, GEOGACETA, V12, P77; MOREJOHN G V, 1975, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V169, P49; MURAKAMI R, 1986, J EMBRYOL EXP MORPH, V92, P133; MURAKAMI R, 1984, DEV GROWTH DIFFER, V26, P419; OHANLON JK, 1986, J COMP PSYCHOL, V100, P178, DOI 10.1037/0735-7036.100.2.178; OLSEN SJ, 1959, J PALEONTOL, V33, P449; Oosthuizen WH, 2000, MAR MAMMAL SCI, V16, P124, DOI 10.1111/j.1748-7692.2000.tb00908.x; PATTERSON BD, 1982, J MAMMAL, V63, P1, DOI 10.2307/1380665; Peigne S, 2008, PALAEONTOLOGY, V51, P943, DOI 10.1111/j.1475-4983.2008.00788.x; Perez-Barberia FJ, 2002, EVOLUTION, V56, P1276; PEYTON B, 1980, J MAMMAL, V61, P639, DOI 10.2307/1380309; Pozo M., 2004, CUENCA MADRID GEOGAC, V35, P143; Prater S.H., 1965, BOOK INDIAN ANIMALS; Ramm SA, 2007, AM NAT, V169, P360, DOI 10.1086/510688; Romer AS., 1970, VERTEBRATE BODY; Ruth EB, 1934, ANAT REC, V60, P231, DOI 10.1002/ar.1090600209; Salesa MJ, 2008, ZOOL J LINN SOC-LOND, V152, P593, DOI 10.1111/j.1096-3642.2007.00370.x; Salesa MJ, 2012, J SYST PALAEONTOL, V10, P87, DOI 10.1080/14772019.2011.566584; Salesa MJ, 2010, J ANAT, V216, P381, DOI 10.1111/j.1469-7580.2009.01178.x; Salesa MJ, 2006, J ZOOL, V268, P243, DOI 10.1111/j.1469-7998.2005.00032.x; Salesa MJ, 2006, P NATL ACAD SCI USA, V103, P379, DOI 10.1073/pnas.0504899102; Salesa MJ, 2005, ZOOL J LINN SOC-LOND, V144, P363, DOI 10.1111/j.1096-3642.2005.00174.x; Scheffer V. B., 1963, Zeitschrift fuer Saugietierkunde, V28, P38; Schenk A, 1995, ANIM BEHAV, V50, P1483, DOI 10.1016/0003-3472(95)80005-0; Schwery Orlando, 2011, Beitraege zur Jagd- und Wildforschung, V36, P605; Servheen C, 1999, STATUS SURVEY BEARS; Siliceo G, 2011, ESTUD GEOL-MADRID, V67, P277, DOI 10.3989/egeol.40605.189; Stirling Ian, 1993, P36; TONER JP, 1987, PHYSIOL BEHAV, V39, P371, DOI 10.1016/0031-9384(87)90237-X; Valenciano A., 2012, 10 ANN M EUR ASS VER, P267; VERRELL PA, 1992, FOLIA PRIMATOL, V59, P114, DOI 10.1159/000156648; VILMANN H, 1979, ANAT ANZEIGER, V146, P483; WILLIAMSASHMAN HG, 1990, PERSPECT BIOL MED, V33, P335; WILLIAMSASHMAN HG, 1991, J STEROID BIOCHEM, V39, P873, DOI 10.1016/0960-0760(91)90344-5	78	17	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73711	10.1371/journal.pone.0073711	http://dx.doi.org/10.1371/journal.pone.0073711			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058484	Green Submitted, Green Published, gold			2022-12-25	WOS:000324695900016
J	Goplen, M; Lejeune, M; Cornick, S; Moreau, F; Chadee, K				Goplen, Michael; Lejeune, Manigandan; Cornick, Steve; Moreau, France; Chadee, Kris			Entamoeba histolytica Contains an Occludin-Like Protein That Can Alter Colonic Epithelial Barrier Function	PLOS ONE			English	Article							PERMEABILITY; PATHOGENESIS; DOMAIN	The exact mechanism by which Entamoeba histolytica disrupts the human colonic epithelium and invades the mucosa has yet to be clearly elucidated. E. histolytica produces a diverse array of putative virulent factors such as glycosidase, cysteine proteinases and amebapore that can modulate and/or disrupt epithelial barrier functions. However, it is currently thought that E. histolytica produces numerous other molecules and strategies to disrupt colonic mucosal defenses. In this study, we document a putative mechanism whereby the parasite alters the integrity of human epithelium by expressing a cognate tight junction protein of the host. We detected this protein as "occludin-like" as revealed by immunoblotting and immunoprecipitation studies and visualization by confocal microscopy using antibodies highly specific for human occludin. We propose that E. histolytica occludin-like protein might displace mucosal epithelial occludin-occludin tight junction interactions resulting in epithelial disruption analogous to sub mucosal human dendritic cells sampling luminal contents. These results indicate that E. histolytica occludin is a putative virulent component that can play a role in the pathogenesis of intestinal amebiasis.	[Goplen, Michael; Lejeune, Manigandan; Cornick, Steve; Moreau, France; Chadee, Kris] Univ Calgary, Fac Med, Dept Microbiol Immunol & Infect Dis, Gastrointestinal Res Grp,Snyder Inst Chron Dis, Calgary, AB, Canada	University of Calgary	Chadee, K (corresponding author), Univ Calgary, Fac Med, Dept Microbiol Immunol & Infect Dis, Gastrointestinal Res Grp,Snyder Inst Chron Dis, Calgary, AB, Canada.	kchadee@ucalgary.ca	Lejeune, Manigandan/AAI-9474-2021	Cornick, Steve/0000-0003-3883-6033	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Hossain Z, 2008, MOL BIOSYST, V4, P1181, DOI 10.1039/b800402a; Huston CD, 2004, TRENDS PARASITOL, V20, P23, DOI 10.1016/j.pt.2003.10.013; Lauwaet T, 2004, INT J PARASITOL, V34, P549, DOI 10.1016/j.ijpara.2003.11.013; Lejeune M, 2011, AM J PATHOL, V179, P807, DOI 10.1016/j.ajpath.2011.05.001; Lejeune M, 2009, FUTURE MICROBIOL, V4, P105, DOI 10.2217/17460913.4.1.105; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Nusrat A, 2005, MOL BIOL CELL, V16, P1725, DOI 10.1091/mbc.E04-06-0465; Nusrat A, 2000, J BIOL CHEM, V275, P29816, DOI 10.1074/jbc.M002450200; PETRI WA, 1987, J CLIN INVEST, V80, P1238, DOI 10.1172/JCI113198; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Samuel L, 1995, INFECT IMMUN, V63, P1587; WALSH JA, 1986, REV INFECT DIS, V8, P228; Wong V, 1997, J CELL BIOL, V136, P399, DOI 10.1083/jcb.136.2.399	13	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73339	10.1371/journal.pone.0073339	http://dx.doi.org/10.1371/journal.pone.0073339			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058468	gold, Green Published, Green Submitted			2022-12-25	WOS:000324408400022
J	Waminal, NE; Ryu, KH; Choi, SH; Kim, HH				Waminal, Nomar Espinosa; Ryu, Ki Hyun; Choi, Sun-Hee; Kim, Hyun Hee			Randomly Detected Genetically Modified (GM) Maize (Zea mays L.) near a Transport Route Revealed a Fragile 45S rDNA Phenotype	PLOS ONE			English	Article							COLOR FISH KARYOTYPE; RIBOSOMAL DNA; LONG-TERM; METAPHASE CHROMOSOMES; CULTIVATED FIELDS; RECOMBINANT-DNA; COPY NUMBER; GENE FLOW; INHERITANCE; POLLEN	Monitoring of genetically modified (GM) crops has been emphasized to prevent their potential effects on the environment and human health. Monitoring of the inadvertent dispersal of transgenic maize in several fields and transport routes in Korea was carried out by qualitative multiplex PCR, and molecular analyses were conducted to identify the events of the collected GM maize. Cytogenetic investigations through fluorescence in situ hybridization (FISH) of the GM maize were performed to check for possible changes in the 45S rDNA cluster because this cluster was reported to be sensitive to replication and transcription stress. Three GM maize kernels were collected from a transport route near Incheon port, Korea, and each was found to contain NK603, stacked MON863 x NK603, and stacked NK603 x MON810 inserts, respectively. Cytogenetic analysis of the GM maize containing the stacked NK603 x MON810 insert revealed two normal compact 5S rDNA signals, but the 45S rDNA showed a fragile phenotype, demonstrating a "beads-on-a-string" fragmentation pattern, which seems to be a consequence of genetic modification. Implications of the 45S rDNA cluster fragility in GM maize are also discussed.	[Waminal, Nomar Espinosa; Kim, Hyun Hee] Sahmyook Univ, Dept Life Sci, Inst Plant Biotechnol, Seoul, South Korea; [Waminal, Nomar Espinosa] Seoul Natl Univ, Coll Agr & Life Sci, Dept Plant Sci, Plant Genom & Breeding Inst, Seoul, South Korea; [Waminal, Nomar Espinosa] Seoul Natl Univ, Coll Agr & Life Sci, Res Inst Agr & Life Sci, Seoul, South Korea; [Ryu, Ki Hyun; Choi, Sun-Hee] Seoul Womens Univ, Dept Hort Biotechnol & Landscape Architecture, Seoul, South Korea	Sahmyook University; Seoul National University (SNU); Seoul National University (SNU); Seoul Women's University	Kim, HH (corresponding author), Sahmyook Univ, Dept Life Sci, Inst Plant Biotechnol, Seoul, South Korea.	kimhh@syu.ac.kr	Waminal, Nomar Espinosa/I-7620-2015	Waminal, Nomar Espinosa/0000-0001-5119-152X	Industry-Academy Cooperation Foundation, Sahmyook University [RI 2012048]	Industry-Academy Cooperation Foundation, Sahmyook University	This study was supported by the Industry-Academy Cooperation Foundation, Sahmyook University grant RI 2012048 (http://syure.syu.ac.kr/research/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert PS, 2010, CYTOGENET GENOME RES, V129, P6, DOI 10.1159/000314342; Arlt MF, 2006, DNA REPAIR, V5, P1126, DOI 10.1016/j.dnarep.2006.05.010; Arlt MF, 2003, CYTOGENET GENOME RES, V100, P92, DOI 10.1159/000072843; BENNETZEN J, 2009, HDB MAIZE GENETICS G; Brown JD, 2010, ANNU REV GENOM HUM G, V11, P291, DOI 10.1146/annurev-genom-082509-141554; Cazaux B, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-124; Cellini F, 2004, FOOD CHEM TOXICOL, V42, P1089, DOI 10.1016/j.fct.2004.02.003; CERA, 2012, GM CROP DAT; Chassy BN, 2002, J AM COLL NUTR, V21, p166S, DOI 10.1080/07315724.2002.10719261; Choi HW, 2000, PLANT SCI, V156, P85, DOI 10.1016/S0168-9452(00)00241-7; Cimprich KA, 2003, CURR BIOL, V13, pR231, DOI 10.1016/S0960-9822(03)00158-1; Coffee B, 2002, AM J HUM GENET, V71, P923, DOI 10.1086/342931; Demeke T, 2006, CAN J PLANT SCI, V86, P1, DOI 10.4141/P05-114; Domingo JL, 2011, ENVIRON INT, V37, P734, DOI 10.1016/j.envint.2011.01.003; Dona A, 2009, CRIT REV FOOD SCI, V49, P164, DOI 10.1080/10408390701855993; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; Gathmann A, 2006, MOL ECOL, V15, P2677, DOI 10.1111/j.1365-294X.2006.02962.x; Gustafson P., 2009, WHEAT SCI TRADE, P3, DOI DOI 10.1002/9780813818832.CH1; Haberer G, 2005, PLANT PHYSIOL, V139, P1612, DOI 10.1104/pp.105.068718; Hart MM, 2009, AGRON SUSTAIN DEV, V29, P497, DOI 10.1051/agro/2009020; Heck GR, 2005, CROP SCI, V45, P329, DOI 10.2135/cropsci2005.0329; Heo MS, 2004, J MICROBIOL BIOTECHN, V14, P1150; Huang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002167; Huang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035139; *ISAAA, 2012, GM CROP EV APPR S KO; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; James C, 2012, GLOBAL STATUS COMMER, P44; Kakutani T, 2002, PLANT CELL PHYSIOL, V43, P1106, DOI 10.1093/pcp/pcf131; Kalisz S, 2004, TRENDS ECOL EVOL, V19, P309, DOI 10.1016/j.tree.2004.03.034; Kim CG, 2008, J PLANT BIOL, V51, P311; Kim CG, 2006, J PLANT BIOL, V49, P218, DOI 10.1007/BF03030536; Kim HY, 2010, PURE APPL CHEM, V82, P129, DOI 10.1351/PAC-CON-09-01-21; Kojima KK, 2005, MOL BIOL EVOL, V22, P2157, DOI 10.1093/molbev/msi210; Latham JR, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/25376; Lau LT, 2004, FOOD CONTROL, V15, P471, DOI 10.1016/j.foodcont.2003.03.001; Lee B, 2009, FOOD CONTROL, V20, P250, DOI 10.1016/j.foodcont.2008.05.006; Lee Seong-Hun, 2004, Agricultural Chemistry and Biotechnology, V47, P185; Lim KY, 2000, CHROMOSOMA, V109, P161; Liu B, 2009, J GENET GENOMICS, V36, P519, DOI 10.1016/S1673-8527(08)60143-5; Losey JE, 1999, NATURE, V399, P214, DOI 10.1038/20338; Matsuoka T, 2002, J AGR FOOD CHEM, V50, P2100, DOI 10.1021/jf011157t; Matyasek R, 2007, GENETICS, V176, P2509, DOI 10.1534/genetics.107.072751; McHughen A, 2008, PLANT BIOTECHNOL J, V6, P2, DOI 10.1111/j.1467-7652.2007.00300.x; Messing J, 2006, CURR OPIN PLANT BIOL, V9, P157, DOI 10.1016/j.pbi.2006.01.009; Neves N, 2005, CYTOGENET GENOME RES, V109, P104, DOI 10.1159/000082388; Onishi M, 2005, J AGR FOOD CHEM, V53, P9713, DOI 10.1021/jf0515476; Paredes S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001376; Park KW, 2010, FOOD CONTROL, V21, P456, DOI 10.1016/j.foodcont.2009.07.006; Paszkowski J, 2011, CURR OPIN PLANT BIOL, V14, P195, DOI 10.1016/j.pbi.2011.01.002; Pikaard CS, 2000, TRENDS GENET, V16, P495, DOI 10.1016/S0168-9525(00)02113-2; Pineyro-Nelson A, 2009, MOL ECOL, V18, P750, DOI 10.1111/j.1365-294X.2008.03993.x; Prokopowich CD, 2003, GENOME, V46, P48, DOI [10.1139/g02-103, 10.1139/G02-103]; Quist D, 2001, NATURE, V414, P541, DOI 10.1038/35107068; Raskina O, 2004, CHROMOSOME RES, V12, P153, DOI 10.1023/B:CHRO.0000013168.61359.43; Richards C., 2012, PLANT GENOME DIVERSI, P257, DOI [DOI 10.1007/978-3-7091-1130-7_, DOI 10.1007/978-3-7091-1130-7_16]; RICHARDS C, 2012, DIVERSITY, V1, P257; Richards RI, 2001, TRENDS GENET, V17, P339, DOI 10.1016/S0168-9525(01)02303-4; Sadder MT, 2001, PLANT MOL BIOL REP, V19, P117, DOI 10.1007/BF02772153; Saeglitz C, 2000, MOL ECOL, V9, P2035, DOI 10.1046/j.1365-294X.2000.01109.x; Schmidt JEU, 2009, ARCH ENVIRON CON TOX, V56, P221, DOI 10.1007/s00244-008-9191-9; Sears MK, 2001, P NATL ACAD SCI USA, V98, P11937, DOI 10.1073/pnas.211329998; Secretariat of the Convention on Biological Diversity (CBD), 2005, HDB CONV BIOL DIV IN; Seralini GE, 2012, FOOD CHEM TOXICOL, V50, P4221, DOI 10.1016/j.fct.2012.08.005; Serratos-Hernandez JA, 2007, FRONT ECOL ENVIRON, V5, P247, DOI 10.1890/1540-9295(2007)5[247:TPIMIT]2.0.CO;2; Shrestha HK, 2008, J AGR FOOD CHEM, V56, P8962, DOI 10.1021/jf800501z; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Snell C, 2012, FOOD CHEM TOXICOL, V50, P1134, DOI 10.1016/j.fct.2011.11.048; Thompson Blaine K, 2011, Mob Genet Elements, V1, P29; Tizaoui K, 2012, GENET MOL BIOL, V35, P640, DOI 10.1590/S1415-47572012000400015; Verhoeven KJF, 2010, MOL ECOL, V19, P315, DOI 10.1111/j.1365-294X.2009.04460.x; WAMINAL N, 2012, CYTOGENETICS, P425; Waminal NE, 2012, HORTIC ENVIRON BIOTE, V53, P49, DOI 10.1007/s13580-012-0105-4; Waminal NE, 2011, GENES GENOM, V33, P521, DOI 10.1007/s13258-011-0046-9; Wang YH, 2006, CANCER LETT, V232, P70, DOI 10.1016/j.canlet.2005.07.040; Watrud LS, 2004, P NATL ACAD SCI USA, V101, P14533, DOI 10.1073/pnas.0405154101; Weber N, 2012, PLANT PHYSIOL, V160, P1842, DOI 10.1104/pp.112.204271; Wilson Allison K, 2006, Biotechnol Genet Eng Rev, V23, P209; Zhang D, 2008, TRANSGENIC RES, V17, P393, DOI 10.1007/s11248-007-9114-y; Zhu CF, 2010, J GENET GENOMICS, V37, P189, DOI 10.1016/S1673-8527(09)60037-0; Zolla L, 2008, J PROTEOME RES, V7, P1850, DOI 10.1021/pr0705082	80	8	10	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74060	10.1371/journal.pone.0074060	http://dx.doi.org/10.1371/journal.pone.0074060			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040165	Green Submitted, gold, Green Published			2022-12-25	WOS:000326405300154
J	Hall, MK; Weidner, DA; Chen, JM; Bernetski, CJ; Schwalbe, RA				Hall, M. Kristen; Weidner, Douglas A.; Chen, Jian Ming; Bernetski, Christopher J.; Schwalbe, Ruth A.			Glycan Structures Contain Information for the Spatial Arrangement of Glycoproteins in the Plasma Membrane	PLOS ONE			English	Article							GATED POTASSIUM CHANNELS; N-GLYCOSYLATION AFFECTS; E-CADHERIN; COMPLEX; MICE; METASTASIS; CARCINOMA; JUNCTIONS; ADHESION; PROTEIN	Glycoconjugates at the cell surface are crucial for cells to communicate with each other and the extracellular microenvironment. While it is generally accepted that glycans are vectorial biopolymers, their information content is unclear. This report provides evidence that distinct N-glycan structures influence the spatial arrangement of two integral membrane glycoproteins, Kv3.1 and E-cadherin, at the adherent membrane which in turn alter cellular properties. Distinct N-glycan structures were generated by heterologous expression of these glycoproteins in parental and glycosylation mutant Chinese hamster ovary cell lines. Unlike the N-linked glycans, the O-linked glycans of the mutant cell lines are similar to those of the parental cell line. Western and lectin blots of total membranes and GFP immunopurified samples, combined with glycosidase digestion reactions, were employed to verify the glycoproteins had predominantly complex, oligomannose, and bisecting type N-glycans from Pro(-)5, Lec1, and Lec10B cell lines, respectively. Based on total internal reflection fluorescence and differential interference contrast microscopy techniques, and cellular assays of live parental and glycosylation mutant CHO cells, we propose that glycoproteins with complex, oligomannose or bisecting type N-glycans relay information for localization of glycoproteins to various regions of the plasma membrane in both a glycan-specific and protein-specific manner, and furthermore cell-cell interactions are required for deciphering much of this information. These distinct spatial arrangements also impact cell adhesion and migration. Our findings provide direct evidence that N-glycan structures of glycoproteins contribute significantly to the information content of cells.	[Hall, M. Kristen; Chen, Jian Ming; Bernetski, Christopher J.; Schwalbe, Ruth A.] E Carolina Univ, Dept Biochem & Mol Biol, Brody Sch Med, Greenville, NC 27858 USA; [Weidner, Douglas A.] E Carolina Univ, Dept Microbiol & Immunol, Brody Sch Med, Greenville, NC USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University	Schwalbe, RA (corresponding author), E Carolina Univ, Dept Biochem & Mol Biol, Brody Sch Med, Greenville, NC 27858 USA.	schwalber@ecu.edu		Weidner, Douglas/0000-0003-1397-1757				Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Bhattacharyya R, 2002, J BIOL CHEM, V277, P26300, DOI 10.1074/jbc.M202276200; Brooks NL, 2006, FEBS J, V273, P3287, DOI 10.1111/j.1742-4658.2006.05339.x; Cartwright TA, 2007, BBA-GEN SUBJECTS, V1770, P666, DOI 10.1016/j.bbagen.2006.11.013; Cartwright TA, 2009, BIOSCIENCE REP, V29, P301, DOI 10.1042/BSR20080149; Dennis JW, 2009, TRAFFIC, V10, P1569, DOI 10.1111/j.1600-0854.2009.00981.x; Ednie AR, 2012, COMPR PHYSIOL, V2, P1269, DOI 10.1002/cphy.c110044; Granovsky M, 2000, NAT MED, V6, P306; Hall MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019317; Hall MK, 2011, FEBS LETT, V585, P3322, DOI 10.1016/j.febslet.2011.09.021; Hirabayashi S, 2003, MOL CELL BIOL, V23, P4267, DOI 10.1128/MCB.23.12.4267-4282.2003; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Jaeken J, 2010, ANN NY ACAD SCI, V1214, P190, DOI 10.1111/j.1749-6632.2010.05840.x; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Leckband D, 2012, CURR OPIN CELL BIOL, V24, P620, DOI 10.1016/j.ceb.2012.05.014; Liwosz A, 2006, J BIOL CHEM, V281, P23138, DOI 10.1074/jbc.M512621200; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; Ousingsawat J, 2007, CLIN CANCER RES, V13, P824, DOI 10.1158/1078-0432.CCR-06-1940; Paredes J, 2012, BBA-REV CANCER, V1826, P297, DOI 10.1016/j.bbcan.2012.05.002; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Patnaik SK, 2006, GLYCOBIOLOGY, V16, P305, DOI 10.1093/glycob/cwj063; Pinho SS, 2011, CELL MOL LIFE SCI, V68, P1011, DOI 10.1007/s00018-010-0595-0; Schwalbe RA, 2008, BIOCHEM CELL BIOL, V86, P21, DOI 10.1139/o07-152; Stanley P., 2009, ESSENTIALS GLYCOBIOL; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wang Y, 2001, GLYCOBIOLOGY, V11, P1051, DOI 10.1093/glycob/11.12.1051; Yoshimura M, 1996, J BIOL CHEM, V271, P13811, DOI 10.1074/jbc.271.23.13811; Zavareh RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043721; Zhao HB, 2008, J CELL BIOCHEM, V104, P162, DOI 10.1002/jcb.21608	29	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e75013	10.1371/journal.pone.0075013	http://dx.doi.org/10.1371/journal.pone.0075013			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040379	Green Published, Green Submitted, gold			2022-12-25	WOS:000324856500100
J	Harris, JL; Richards, RS; Chow, CWK; Lee, S; Kim, M; Buck, M; Teng, L; Clarke, R; Gardiner, RA; Lavin, MF				Harris, Janelle L.; Richards, Renee S.; Chow, Clement W. K.; Lee, Soon; Kim, Misook; Buck, Marion; Teng, Linda; Clarke, Raymond; Gardiner, Robert A.; Lavin, Martin F.			BMCC1 Is an AP-2 Associated Endosomal Protein in Prostate Cancer Cells	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; HOMOLOGY BCH DOMAIN; EXPRESSION; GENE; TRANSFORMATION; TRAFFICKING; MELANOMA; SEQUENCE; FUSION; BNIP-2	The prostate cancer antigen gene 3 (PCA3) is embedded in an intron of a second gene BMCC1 (Bcl2-/adenovirus E1B nineteen kDa-interacting protein 2 (BNIP-2) and Cdc42GAP homology BCH motif-containing molecule at the carboxyl terminal region 1) which is also upregulated in prostate cancer. BMCC1 was initially annotated as two genes (C9orf65/PRUNE and BNIPXL) on either side of PCA3 but our data suggest that it represents a single gene coding for a high molecular weight protein. Here we demonstrate for the first time the expression of a >300 kDa BMCC1 protein (BMCC1-1) in prostate cancer and melanoma cell lines. This protein was found exclusively in the microsomal fraction and localised to cytoplasmic vesicles. We also observed expression of BMCC1 protein in prostate cancer sections using immunohistology. GST pull down, immunoprecipitation and mass spectrometry protein interaction studies identified multiple members of the Adaptor Related Complex 2 (AP-2) as BMCC1 interactors. Consistent with a role for BMCC1 as an AP-2 interacting endosomal protein, BMCC1 co-localised with beta-adaptin at the perinuclear region of the cell. BMCC1 also showed partial co-localisation with the early endosome small GTP-ase Rab-5 as well as strong co-localisation with internalised pulse-chase labelled transferrin (Tf), providing evidence that BMCC1 is localised to functional endocytic vesicles. BMCC1 knockdown did not affect Tf uptake and AP-2 knockdown did not disperse BMCC1 vesicular distribution, excluding an essential role for BMCC1 in canonical AP-2 mediated endocytic uptake. Instead, we posit a novel role for BMCC1 in post-endocytic trafficking. This study provides fundamental characterisation of the BMCC1 complex in prostate cancer cells and for the first time implicates it in vesicle trafficking.	[Harris, Janelle L.; Richards, Renee S.; Chow, Clement W. K.; Buck, Marion; Lavin, Martin F.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Richards, Renee S.; Chow, Clement W. K.; Kim, Misook; Buck, Marion; Teng, Linda; Gardiner, Robert A.; Lavin, Martin F.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [Lee, Soon; Clarke, Raymond] Univ Western Sydney, Sch Med, Sydney, NSW, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; Western Sydney University	Harris, JL (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4006, Australia.	janelle.hancock@qimr.edu.au; martin.lavin@qimr.edu.au	Lavin, Martin F/F-5961-2014; Richards, Renee/R-8865-2016	Lavin, Martin F/0000-0002-5940-4769; Richards, Renee/0000-0002-8911-8966; Hancock, Janelle/0000-0001-6703-7228; Clarke, Raymond/0000-0002-7196-9623	Prostate Cancer Foundation of Australia	Prostate Cancer Foundation of Australia	This project was funded by the Prostate Cancer Foundation of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arama J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035488; Aschenbrenner L, 2003, MOL BIOL CELL, V14, P2728, DOI 10.1091/mbc.E02-11-0767; Bosc C, 2003, BIOCHEMISTRY-US, V42, P12125, DOI 10.1021/bi0352163; Boucrot E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010597; Boulay AC, 2013, BIOCHIMIE, V95, P799, DOI 10.1016/j.biochi.2012.11.016; Bussemakers MJG, 1999, CANCER RES, V59, P5975; Clarke RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004995; Dall'Era MA, 2008, CANCER-AM CANCER SOC, V112, P1650, DOI 10.1002/cncr.23373; Doyon JB, 2011, NAT CELL BIOL, V13, P331, DOI 10.1038/ncb2175; Govek EE, 2011, DEV NEUROBIOL, V71, P528, DOI 10.1002/dneu.20850; Harris JL, 2009, HUM MOL GENET, V18, P4102, DOI 10.1093/hmg/ddp359; Hessels D, 2010, PROSTATE, V70, P10, DOI 10.1002/pros.21032; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Iwama E, 2011, J MOL NEUROSCI, V44, P103, DOI 10.1007/s12031-010-9490-2; Lau AW, 2008, J CELL SCI, V121, P4008, DOI 10.1242/jcs.033522; Li SM, 2012, BRAIN RES, V1488, P1, DOI 10.1016/j.brainres.2012.10.001; Li SM, 2011, NEUROSCI LETT, V503, P208, DOI 10.1016/j.neulet.2011.08.037; Machida T, 2006, ONCOGENE, V25, P1931, DOI 10.1038/sj.onc.1209225; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; O'Rourke MGE, 2007, MELANOMA RES, V17, P316, DOI 10.1097/CMR.0b013e3282c3a73b; Pan CQ, 2012, FEBS LETT, V586, P2674, DOI 10.1016/j.febslet.2012.04.023; Pavey S, 2004, ONCOGENE, V23, P4060, DOI 10.1038/sj.onc.1207563; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Roberts RL, 1999, J CELL SCI, V112, P3667; Rodemer C., 2008, V186, P105, DOI 10.1007/978-3-540-72843-6_5; Salagierski M, 2010, PROSTATE, V70, P70, DOI 10.1002/pros.21040; Soh UJK, 2008, J CELL SCI, V121, P1739, DOI 10.1242/jcs.021774; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Wilson JM, 2000, MOL BIOL CELL, V11, P2657, DOI 10.1091/mbc.11.8.2657; Xing L, 2012, MOL BIOL CELL, V23, P1500, DOI 10.1091/mbc.E11-10-0867; Zhou YT, 2002, J BIOL CHEM, V277, P7483, DOI 10.1074/jbc.M109459200	35	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73880	10.1371/journal.pone.0073880	http://dx.doi.org/10.1371/journal.pone.0073880			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040105	Green Published, gold, Green Submitted			2022-12-25	WOS:000324856500064
J	Appleton, AA; Armstrong, DA; Lesseur, C; Lee, J; Padbury, JF; Lester, BM; Marsit, CJ				Appleton, Allison A.; Armstrong, David A.; Lesseur, Corina; Lee, Joyce; Padbury, James F.; Lester, Barry M.; Marsit, Carmen J.			Patterning in Placental 11-B Hydroxysteroid Dehydrogenase Methylation According to Prenatal Socioeconomic Adversity	PLOS ONE			English	Article							PSYCHOSOCIAL FACTORS; HEALTH; LIFE; CHILDHOOD; STRESS; IMPACT; GROWTH; RISK; EXPOSURE; PROMOTER	Background: Prenatal socioeconomic adversity as an intrauterine exposure is associated with a range of perinatal outcomes although the explanatory mechanisms are not well understood. The development of the fetus can be shaped by the intrauterine environment through alterations in the function of the placenta. In the placenta, the HSD11B2 gene encodes the 11-beta hydroxysteroid dehydrogenase enzyme, which is responsible for the inactivation of maternal cortisol thereby protecting the developing fetus from this exposure. This gene is regulated by DNA methylation, and this methylation and the expression it controls has been shown to be susceptible to a variety of stressors from the maternal environment. The association of prenatal socioeconomic adversity and placental HSD11B2 methylation has not been examined. Following a developmental origins of disease framework, prenatal socioeconomic adversity may alter fetal response to the postnatal environment through functional epigenetic alterations in the placenta. Therefore, we hypothesized that prenatal socioeconomic adversity would be associated with less HSD11B2 methylation. Methods and Findings: We examined the association between DNA methylation of the HSD11B2 promoter region in the placenta of 444 healthy term newborn infants and several markers of prenatal socioeconomic adversity: maternal education, poverty, dwelling crowding, tobacco use and cumulative risk. We also examined whether such associations were sex-specific. We found that infants whose mothers experienced the greatest levels of socioeconomic adversity during pregnancy had the lowest extent of placental HSD11B2 methylation, particularly for males. Associations were maintained for maternal education when adjusting for confounders (p<0.05). Conclusions: Patterns of HSD11B2 methylation suggest that environmental cues transmitted from the mother during gestation may program the developing fetus's response to an adverse postnatal environment, potentially via less exposure to cortisol during development. Less methylation of placental HSD11B2 may therefore be adaptive and promote the effective management of stress associated with social adversity in a postnatal environment.	[Appleton, Allison A.; Marsit, Carmen J.] Geisel Sch Med Dartmouth, Dept Community & Family Med, Hanover, NH USA; [Armstrong, David A.; Lesseur, Corina; Marsit, Carmen J.] Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Hanover, NH USA; [Lee, Joyce; Padbury, James F.; Lester, Barry M.] Brown Univ, Women & Infants Hosp, Dept Pediat, Providence, RI 02908 USA; [Lee, Joyce; Lester, Barry M.] Brown Univ, Women & Infants Hosp, Brown Ctr Study Children Risk, Providence, RI USA	Dartmouth College; Dartmouth College; Brown University; Women & Infants Hospital Rhode Island; Brown University; Women & Infants Hospital Rhode Island	Appleton, AA (corresponding author), Geisel Sch Med Dartmouth, Dept Community & Family Med, Hanover, NH USA.	Allison.A.Appleton@Dartmouth.edu	Lesseur, Corina/W-1034-2019	Lesseur, Corina/0000-0001-6744-6750; Marsit, Carmen/0000-0003-4566-150X	NIH-NIMH [R01MH094609]; NIH-NIGMS [P20GM103537]; NIH-NCI [R25CA134286]; NATIONAL CANCER INSTITUTE [R25CA134286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094609] Funding Source: NIH RePORTER	NIH-NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding Sources: NIH-NIMH R01MH094609, NIH-NIGMS P20GM103537, NIH-NCI R25CA134286. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; Alegra-Torres JA, 2011, EPIGENOMICS-UK, V3, P267, DOI [10.2217/EPI.11.22, 10.2217/epi.11.22]; Alikhani-Koopaei R, 2004, J CLIN INVEST, V114, P1146, DOI 10.1172/JCI200421647; Almeida ND, 2010, PSYCHOSOM MED, V72, P148, DOI 10.1097/PSY.0b013e3181c925cb; [Anonymous], 2012, FED REG, V77, P4034; Appleton AA, 2013, CIRCULATION, V127, P905, DOI 10.1161/CIRCULATIONAHA.112.115782; As I.F., 2009, FED REG, V74, P4199; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Baum A, 1999, ANN NY ACAD SCI, V896, P131, DOI 10.1111/j.1749-6632.1999.tb08111.x; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Case A, 2005, J HEALTH ECON, V24, P365, DOI 10.1016/j.jhealeco.2004.09.008; Cottrell EC, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.019.2009; Cuffe JSM, 2012, ENDOCRINOLOGY, V153, P5500, DOI 10.1210/en.2012-1479; Evans GW, 2012, PEDIATRICS, V129, pE68, DOI 10.1542/peds.2010-3647; Fenton Tanis R, 2003, BMC Pediatr, V3, P13; Friso S, 2008, ATHEROSCLEROSIS, V199, P323, DOI 10.1016/j.atherosclerosis.2007.11.029; Gilbert JS, 2008, AM J PHYSIOL-REG I, V295, pR1941, DOI 10.1152/ajpregu.90724.2008; Gluckman PD, 2007, AM J HUM BIOL, V19, P1, DOI 10.1002/ajhb.20590; Hackman DA, 2010, NAT REV NEUROSCI, V11, P651, DOI 10.1038/nrn2897; Joseph KS, 2007, CAN MED ASSOC J, V177, P583, DOI 10.1503/cmaj.061198; Kramer MS, 2000, PAEDIATR PERINAT EP, V14, P194, DOI 10.1046/j.1365-3016.2000.00266.x; Lam LL, 2012, P NATL ACAD SCI USA, V109, P17253, DOI 10.1073/pnas.1121249109; Lesage J, 2001, ENDOCRINOLOGY, V142, P1692, DOI 10.1210/en.142.5.1692; Lester BM, 2011, ANN NY ACAD SCI, V1226, P14, DOI 10.1111/j.1749-6632.2011.06037.x; Lester BM, 2009, DEV NEUROSCI, P31; Mairesse J, 2007, AM J PHYSIOL-ENDOC M, V292, pE1526, DOI 10.1152/ajpendo.00574.2006; Marsit CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033794; Matthews KA, 2010, ANN NY ACAD SCI, V1186, P146, DOI 10.1111/j.1749-6632.2009.05332.x; Meaney Michael J, 2005, Dialogues Clin Neurosci, V7, P103; Mulligan CJ, 2012, EPIGENETICS-US, V7, P853, DOI 10.4161/epi.21180; Mychasiuk R, 2011, NEUROSCIENCE, V180, P105, DOI 10.1016/j.neuroscience.2011.02.026; O'Donnell KJ, 2012, PSYCHONEUROENDOCRINO, V37, P818, DOI 10.1016/j.psyneuen.2011.09.014; Pena C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039071; Power C, 2005, AM J PUBLIC HEALTH, V95, P1396, DOI 10.2105/AJPH.2004.047340; Raat H, 2011, EARLY HUM DEV, V87, P729, DOI 10.1016/j.earlhumdev.2011.08.022; Radtke KM, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.21; Repetti RL, 2002, PSYCHOL BULL, V128, P330, DOI 10.1037/0033-2909.128.2.330; Robins Jared C, 2011, Front Biosci (Elite Ed), V3, P690, DOI 10.2741/e279; Rothman K., 1998, MODERN EPIDEMIOLOGY; Rucklidge JJ, 2010, PSYCHIAT CLIN N AM, V33, P357, DOI 10.1016/j.psc.2010.01.006; Schlotz W, 2009, BRAIN BEHAV IMMUN, V23, P905, DOI 10.1016/j.bbi.2009.02.001; Sebelius K, 2010, FED REGISTER, V75, P45628; Sebelius K, 2011, FED REGISTER, V76, P3637; Shonkoff J. P., 2000, NEURONS NEIGHBORHOOD; Staud F, 2006, PLACENTA, V27, P171, DOI 10.1016/j.placenta.2005.01.001; Tehranifar P, 2013, EPIGENETICS-US, V8, P23, DOI 10.4161/epi.22989; van den Berg G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037002; Waterland RA, 2007, ANNU REV NUTR, V27, P363, DOI 10.1146/annurev.nutr.27.061406.093705; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wyrwoll CS, 2011, FRONT NEUROENDOCRIN, V32, P265, DOI 10.1016/j.yfrne.2010.12.001	50	99	100	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74691	10.1371/journal.pone.0074691	http://dx.doi.org/10.1371/journal.pone.0074691			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219CG	24040322	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600144
J	Hamidi, M; Emberly, E				Hamidi, Mani; Emberly, Eldon			A Model for Cell Population Size Control Using Asymmetric Division	PLOS ONE			English	Article							DROSOPHILA NEUROBLASTS; DIFFERENTIATION; PATTERN	In multicellular organisms one can find examples where a growing tissue divides up until some final fixed cell number. Asymmetric division plays a prevalent feature in tissue differentiation in these organisms, where the daughters of each asymmetric division inherit unequal amounts of a fate determining molecule and as a result follow different developmental fates. In some tissues the accumulation or decrease of cell cycle regulators acts as an intrinsic timing mechanism governing proliferation. Here we present a minimal model based on asymmetric division and dilution of a cell-cycle regulator that can generate any final population size that might be needed. We show that within the model there are a variety of growth mechanisms from linear to non-linear that can lead to the same final cell count. Interestingly, when we include noise at division we find that there are special final cell population sizes that can be generated with high confidence that are flanked by population sizes that are less robust to division noise. When we include further perturbations in the division process we find that these special populations can remain relatively stable and in some cases even improve in their fidelity.	[Hamidi, Mani; Emberly, Eldon] Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Emberly, E (corresponding author), Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada.	eemberly@sfu.ca			Natural Sciences and Engineering Research Council	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	EE acknowledges the support of Natural Sciences and Engineering Research Council for funding this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2003, SCIENCE, V300, P1920, DOI 10.1126/science.1083532; Ackermann M, 2007, AGING CELL, V6, P235, DOI 10.1111/j.1474-9726.2007.00281.x; Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Chabanon Herve, 2004, Briefings in Functional Genomics & Proteomics, V3, P240; Durand B, 2000, BIOESSAYS, V22, P64; Durand B, 1997, EMBO J, V16, P306, DOI 10.1093/emboj/16.2.306; Elgjo K, 2004, CELL CYCLE, V3, P1208; Harris T. E., 2002, THEORY BRANCHING PRO; Hobert Oliver, 2005, WormBook, P1; Homem CCF, 2012, DEVELOPMENT, V139, P4297, DOI 10.1242/dev.080515; Huh D, 2011, P NATL ACAD SCI USA, V108, P15004, DOI 10.1073/pnas.1013171108; Huh D, 2011, NAT GENET, V43, P95, DOI 10.1038/ng.729; Inaba M, 2012, CELL STEM CELL, V11, P461, DOI 10.1016/j.stem.2012.09.003; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Jiang YR, 2013, ARCH BIOCHEM BIOPHYS, V534, P38, DOI 10.1016/j.abb.2012.08.003; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Lander AD, 2011, CELL, V144, P955, DOI 10.1016/j.cell.2011.03.009; Maurange C, 2005, TRENDS NEUROSCI, V28, P30, DOI 10.1016/j.tins.2004.10.009; Medioni C, 2012, DEVELOPMENT, V139, P3263, DOI 10.1242/dev.078626; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Wolpert L, 2010, PLOS BIOL, V8, DOI [10.1371/journal.pbio.1000477, DOI 10.1371/J0URNAL.PBI0.1000477]	22	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74324	10.1371/journal.pone.0074324	http://dx.doi.org/10.1371/journal.pone.0074324			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040230	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600125
J	Lafontant, PJ; Behzad, AR; Brown, E; Landry, P; Hu, N; Burns, AR				Lafontant, Pascal J.; Behzad, Ali R.; Brown, Evelyn; Landry, Paul; Hu, Norman; Burns, Alan R.			Cardiac Myocyte Diversity and a Fibroblast Network in the Junctional Region of the Zebrafish Heart Revealed by Transmission and Serial Block-Face Scanning Electron Microscopy	PLOS ONE			English	Article							CONNECTIVE-TISSUE ARCHITECTURE; FISH HEART; VENTRICULAR MYOCARDIUM; ULTRASTRUCTURE; REGENERATION; EXPRESSION; MYOFIBROBLASTS; ORGANIZATION; CRYOINJURY; ACTIVATION	The zebrafish has emerged as an important model of heart development and regeneration. While the structural characteristics of the developing and adult zebrafish ventricle have been previously studied, little attention has been paid to the nature of the interface between the compact and spongy myocardium. Here we describe how these two distinct layers are structurally and functionally integrated. We demonstrate by transmission electron microscopy that this interface is complex and composed primarily of a junctional region occupied by collagen, as well as a population of fibroblasts that form a highly complex network. We also describe a continuum of uniquely flattened transitional cardiac myocytes that form a circumferential plate upon which the radially-oriented luminal trabeculae are anchored. In addition, we have uncovered within the transitional ring a subpopulation of markedly electron dense cardiac myocytes. At discrete intervals the transitional cardiac myocytes form contact bridges across the junctional space that are stabilized through localized desmosomes and fascia adherentes junctions with adjacent compact cardiac myocytes. Finally using serial block-face scanning electron microscopy, segmentation and volume reconstruction, we confirm the three-dimensional nature of the junctional region as well as the presence of the sheet-like fibroblast network. These ultrastructural studies demonstrate the previously unrecognized complexity with which the compact and spongy layers are structurally integrated, and provide a new basis for understanding development and regeneration in the zebrafish heart.	[Lafontant, Pascal J.] Depauw Univ, Dept Biol, Greencastle, IN 46135 USA; [Behzad, Ali R.] King Abdullah Univ Sci & Technol, Imaging & Characterizat Core Lab, Thuwal, Saudi Arabia; [Brown, Evelyn; Landry, Paul; Burns, Alan R.] Univ Houston, Coll Optometry, Houston, TX USA; [Hu, Norman] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA; [Burns, Alan R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	DePauw University; King Abdullah University of Science & Technology; University of Houston System; University of Houston; Utah System of Higher Education; University of Utah; Baylor College of Medicine	Lafontant, PJ (corresponding author), Depauw Univ, Dept Biol, Greencastle, IN 46135 USA.	pascallafontant@depauw.edu	Lafontant, Pascal J/AAA-2015-2021		Fisher and Faculty Development Funds at DePauw University; National Institutes of Health/National Eye Institute [EY017120, P30EY007551]; NATIONAL EYE INSTITUTE [R01EY017120, P30EY007551] Funding Source: NIH RePORTER	Fisher and Faculty Development Funds at DePauw University; National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	PJL is supported by the Fisher and Faculty Development Funds at DePauw University. A. Burns is supported National Institutes of Health/National Eye Institute grants EY017120 and P30EY007551. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chablais F, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-21; Chilton L, 2007, J PHYSIOL-LONDON, V583, P225, DOI 10.1113/jphysiol.2007.135038; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Dobaczewski Marcin, 2009, Front Biosci (Schol Ed), V1, P391, DOI 10.2741/e33; EGHBALI M, 1992, BASIC RES CARDIOL, V87, P183; Goldsmith EC, 2004, DEV DYNAM, V230, P787, DOI 10.1002/dvdy.20095; Gupta V, 2012, NATURE, V484, P479, DOI 10.1038/nature11045; HARRISON P, 1991, CAN J ZOOL, V69, P1339, DOI 10.1139/z91-189; HAUSTEIN J, 1983, ANAT EMBRYOL, V168, P291, DOI 10.1007/BF00315823; Hu N, 2000, ANAT REC, V260, P148, DOI 10.1002/1097-0185(20001001)260:2<148::AID-AR50>3.0.CO;2-X; Hu N, 2001, ANAT REC, V264, P1, DOI 10.1002/ar.1111; Kohl P, 2007, HEART RHYTHM, V4, P233, DOI 10.1016/j.hrthm.2006.10.014; Lafontant PJ, 2012, ANAT REC, V295, P234, DOI 10.1002/ar.21492; LaFramboise WA, 2007, AM J PHYSIOL-CELL PH, V292, pC1799, DOI 10.1152/ajpcell.00166.2006; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Liu JD, 2010, DEVELOPMENT, V137, P3867, DOI 10.1242/dev.053736; MacKenna DA, 1998, J CLIN INVEST, V101, P301, DOI 10.1172/JCI1026; Gonzalez-Rosa JM, 2011, DEVELOPMENT, V138, P1663, DOI 10.1242/dev.060897; MIDTTUN B, 1983, ZOOL ANZ, V210, P271; MIDTTUN B, 1983, COMP BIOCHEM PHYS A, V76, P471, DOI 10.1016/0300-9629(83)90448-6; Miragoli M, 2007, CIRC RES, V101, P755, DOI 10.1161/CIRCRESAHA.107.160549; NISHIDA T, 1988, INVEST OPHTH VIS SCI, V29, P1887; Peshkovsky C, 2011, DEV DYNAM, V240, P446, DOI 10.1002/dvdy.22526; Pieperhoff S, 2009, J ANAT, V215, P536, DOI 10.1111/j.1469-7580.2009.01129.x; Pieperhoff S, 2008, EUR J CELL BIOL, V87, P413, DOI 10.1016/j.ejcb.2008.02.005; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; POUPA O, 1974, COMP BIOCHEM PHYSIOL, V48, P85, DOI 10.1016/0300-9629(74)90856-1; Raya A, 2003, P NATL ACAD SCI USA, V100, P11889, DOI 10.1073/pnas.1834204100; Reifers F, 2000, DEVELOPMENT, V127, P225; Rohr S, 2009, HEART RHYTHM, V6, P848, DOI 10.1016/j.hrthm.2009.02.038; SANCHEZQUINTANA D, 1995, ANN ANAT, V177, P267, DOI 10.1016/S0940-9602(11)80198-6; SanchezQuintana D, 1996, J EXP ZOOL, V275, P112, DOI 10.1002/(SICI)1097-010X(19960601/15)275:2/3<112::AID-JEZ5>3.0.CO;2-G; SANCHEZQUINTANA D, 1987, ANAT REC, V217, P263, DOI 10.1002/ar.1092170307; SANTER RM, 1980, J ZOOL, V190, P259; SANTER RM, 1985, ADV ANAT EMBRYOL CEL, V89, P1; Schnabel K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018503; STAINIER DYR, 1993, DEVELOPMENT, V119, P31; Tota B., 1978, P89; Turner NA, 2012, IUBMB LIFE, V64, P143, DOI 10.1002/iub.594; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406	42	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72388	10.1371/journal.pone.0072388	http://dx.doi.org/10.1371/journal.pone.0072388			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24058412	Green Published, gold, Green Submitted			2022-12-25	WOS:000324403200022
J	Gomez-Herreros, F; Rodriguez-Galan, O; Morillo-Huesca, M; Maya, D; Arista-Romero, M; de la Cruz, J; Chavez, S; Munoz-Centeno, MC				Gomez-Herreros, Fernando; Rodriguez-Galan, Olga; Morillo-Huesca, Macarena; Maya, Douglas; Arista-Romero, Maria; de la Cruz, Jesus; Chavez, Sebastian; Cruz Munoz-Centeno, Mari			Balanced Production of Ribosome Components Is Required for Proper G(1)/S Transition in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANT CELL-LINES; P-GLYCOPROTEIN-EGFP; HUMAN CANCER-CELLS; MULTIDRUG-RESISTANCE; SUBCELLULAR-LOCALIZATION; LYSOSOMOTROPIC AGENTS; ANTITUMOR-ACTIVITY; DRUG-RESISTANCE; IRON CHELATORS; TUMOR-CELLS	Cell cycle regulation is a very accurate process that ensures cell viability and the genomic integrity of daughter cells. A fundamental part of this regulation consists in the arrest of the cycle at particular points to ensure the completion of a previous event, to repair cellular damage, or to avoid progression in potentially risky situations. In this work, we demonstrate that a reduction in nucleotide levels or the depletion of RNA polymerase I or III subunits generates a cell cycle delay at the G(1)/S transition in Saccharomyces cerevisiae. This delay is concomitant with an imbalance between ribosomal RNAs and proteins which, among others, provokes an accumulation of free ribosomal protein L5. Consistently with a direct impact of free L5 on the G(1)/S transition, rrs1 mutants, which weaken the assembly of L5 and L11 on pre-60S ribosomal particles, enhance both the G(1)/S delay and the accumulation of free ribosomal protein L5. We propose the existence of a surveillance mechanism that couples the balanced production of yeast ribosomal components and cell cycle progression through the accumulation of free ribosomal proteins. This regulatory pathway resembles the p53-dependent nucleolar-stress checkpoint response described in human cells, which indicates that this is a general control strategy extended throughout eukaryotes.	Univ Seville, Dept Genet, E-41012 Seville, Spain; Univ Seville, CSIC, Inst Biomed Sevilla, Hosp Univ Virgen del Rocio, Seville 41012, Spain	University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	Munoz-Centeno, MC (corresponding author), Fac Biol, Dept Genet, Avda Reina Mercedes 6, Seville 41012, Spain.	mcmunoz@us.es	Morillo-Huesca, Macarena/H-5144-2015; de la Cruz Muñoz-Centeno, Maria/F-7539-2016; Chavez, Sebastian S/F-7574-2011; Herreros, Fernando Gomez/F-2674-2016; Chávez, Sebastián/GXF-7069-2022; Rodríguez-Galán, Olga/K-5580-2015; IBIS, GENICA/O-1906-2015; DE LA CRUZ, JESUS/A-7309-2013	Morillo-Huesca, Macarena/0000-0002-2914-4871; Chavez, Sebastian S/0000-0002-8064-4839; Herreros, Fernando Gomez/0000-0002-5693-3489; Rodríguez-Galán, Olga/0000-0002-3137-8554; DE LA CRUZ, JESUS/0000-0001-5870-659X; Munoz Centeno, Maria de la Cruz/0000-0002-9973-8931; Maya Miles, Douglas/0000-0002-0669-6526; Arista-Romero, Maria/0000-0002-1992-070X	Spanish Ministry of Economy and Competitiveness; European Regional Development Fund (ERDF) Grants [BFU2007-67575-C03-02, BFU2010-21975-C03-03, BFU2010-15690]; Andalusian Government [P07-CVI-02623, P08-CVI-03508, BIO-271]; Andalusian Government; Formacion de Personal Investigador (FPI) fellowship	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Regional Development Fund (ERDF) Grants; Andalusian Government; Andalusian Government; Formacion de Personal Investigador (FPI) fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Spanish Ministry of Economy and Competitiveness and European Regional Development Fund (ERDF) Grants BFU2007-67575-C03-02 and BFU2010-21975-C03-03 (to S. C.) and BFU2010-15690 (to J. d. l. C.) and the Andalusian Government Grants P07-CVI-02623 and P08-CVI-03508, and BIO-271.; Recipient of a Formacion de Personal Investigador (FPI) fellowship. Present address: Centro Andaluz de Biolog a Molecular y Medicina Regenerativa, CABIMER, Avda. Americo Vespucio s/n, Parque Cientifico y Tecnologico Cartuja 41092 Sevilla, Spain.; Recipient of a fellowship from the Andalusian Government. Present address: Centre de Recherche en Cancerologie de Marseille (CRCM), INSERM UMR 1068, CNRS UMR 7258, Marseille, France.	Abulrob ANG, 2000, J DRUG TARGET, V8, P247, DOI 10.3109/10611860008997903; Akhtar N, 2011, EXPERT OPIN THER PAT, V21, P561, DOI 10.1517/13543776.2011.561784; Altan N, 1998, J EXP MED, V187, P1583, DOI 10.1084/jem.187.10.1583; ANTOINE JC, 1985, BIOL CELL, V55, P41, DOI 10.1111/j.1768-322X.1985.tb00408.x; BALDINI N, 1995, EUR J CELL BIOL, V68, P226; Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003; Barranco WT, 2006, BRIT J CANCER, V94, P884, DOI 10.1038/sj.bjc.6603009; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BRAUN M, 1989, EMBO J, V8, P3633, DOI 10.1002/j.1460-2075.1989.tb08537.x; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Fu D, 2004, INT J CANCER, V109, P174, DOI 10.1002/ijc.11659; Fu D, 2007, AM J PHYSIOL-CELL PH, V292, pC1543, DOI 10.1152/ajpcell.00068.2006; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Ivanova S, 2008, METHOD ENZYMOL, V442, P183, DOI 10.1016/S0076-6879(08)01409-2; JAFFREZOU JP, 1992, CANCER RES, V52, P6440; Kannan P, 2011, P NATL ACAD SCI USA, V108, P2593, DOI 10.1073/pnas.1014641108; Lavie Y, 1996, J BIOL CHEM, V271, P19530, DOI 10.1074/jbc.271.32.19530; Lovejoy DB, 2011, CANCER RES, V71, P5871, DOI 10.1158/0008-5472.CAN-11-1218; Mahoney BP, 2003, BIOCHEM PHARMACOL, V66, P1207, DOI 10.1016/S0006-2952(03)00467-2; Maraldi NM, 1999, BIOL CELL, V91, P17, DOI 10.1016/S0248-4900(99)80027-6; Molad Yair, 2002, Curr Rheumatol Rep, V4, P252, DOI 10.1007/s11926-002-0073-2; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Munteanu E, 2006, BIOCHEM PHARMACOL, V71, P1162, DOI 10.1016/j.bcp.2006.01.006; Paterson JK, 2007, EXP CELL RES, V313, P3100, DOI 10.1016/j.yexcr.2007.04.019; Pezzini F, 2011, BIOCHEM BIOPH RES CO, V416, P159, DOI 10.1016/j.bbrc.2011.11.016; Raghunand N, 2000, DRUG RESIST UPDATE, V3, P39, DOI 10.1054/drup.2000.0119; RICHARDSON DR, 1995, BLOOD, V86, P4295, DOI 10.1182/blood.V86.11.4295.bloodjournal86114295; Saparov SM, 2006, BIOPHYS J, V90, pL86, DOI 10.1529/biophysj.106.084343; SARKADI B, 1992, J BIOL CHEM, V267, P4854; Seelig A, 2007, J MOL NEUROSCI, V33, P32, DOI 10.1007/s12031-007-0055-y; SHAPIRO AB, 1994, J BIOL CHEM, V269, P3745; Shen F, 2008, J PHARMACOL EXP THER, V324, P95, DOI 10.1124/jpet.107.127704; SHIRAISHI N, 1986, CANCER LETT, V30, P251, DOI 10.1016/0304-3835(86)90049-2; Solazzo M, 2006, EXP CELL RES, V312, P4070, DOI 10.1016/j.yexcr.2006.09.005; Solazzo M, 2009, CANCER RES, V69, P7235, DOI 10.1158/0008-5472.CAN-08-4315; Stordal B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040717; Straubinger RM, 1995, TAXOL SCI APPL, P237; STYRT B, 1986, BLOOD, V67, P334; Taatjes DJ, 2001, CURR MED CHEM, V8, P15, DOI 10.2174/0929867013374029; VANROSMALEN A, 1995, NUCLEIC ACIDS RES, V23, P42, DOI 10.1093/nar/23.1.42; Wang YH, 2005, J CHEM INF MODEL, V45, P750, DOI 10.1021/ci050041k; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868	45	32	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31689	31771		10.1074/jbc.M113.500488	http://dx.doi.org/10.1074/jbc.M113.500488			89	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24043628	Green Published, hybrid			2022-12-25	WOS:000330596200027
J	Hall, BE; Wankhade, UD; Konkel, JE; Cherukuri, K; Nagineni, CN; Flanders, KC; Arany, PR; Chen, WJ; Rane, SG; Kulkarni, AB				Hall, Bradford E.; Wankhade, Umesh D.; Konkel, Joanne E.; Cherukuri, Karthik; Nagineni, Chandrasekharam N.; Flanders, Kathleen C.; Arany, Praveen R.; Chen, Wanjun; Rane, Sushil G.; Kulkarni, Ashok B.			Transforming Growth Factor-beta 3 (TGF-beta 3) Knock-in Ameliorates Inflammation Due to TGF-beta 1 Deficiency While Promoting Glucose Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BETA; TARGETED DISRUPTION; EXPRESSION PATTERNS; CRYSTAL-STRUCTURE; CLEFT-PALATE; MICE LACKING; GROWTH-FACTOR-BETA-1; ACTIVATION; CELLS; TRANSFORMING-GROWTH-FACTOR-BETA-3	Three homologues of TGF-beta exist in mammals as follows: TGF-beta 1, TGF-beta 2, and TGF-beta 3. All three proteins share high homology in their amino acid sequence, yet each TGF-beta isoform has unique heterologous motifs that are highly conserved during evolution. Although these TGF-beta proteins share similar properties in vitro, isoform-specific properties have been suggested through in vivo studies and by the unique phenotypes for each TGF-beta knock-out mouse. To test our hypothesis that each of these homologues has nonredundant functions, and to identify such isoform-specific roles, we genetically exchanged the coding sequence of the mature TGF-beta 1 ligand with a sequence from TGF-beta 3 using targeted recombination to create chimeric TGF-beta 1/3 knock-in mice (TGF-beta 1(L beta 3/L beta 3)). In the TGF-beta 1(L beta 3/L beta 3) mouse, localization and activation still occur through the TGF-beta 1 latent associated peptide, but cell signaling is triggered through the TGF-beta 3 ligand that binds to TGF-beta receptors. Unlike TGF-beta 1(-/-) mice, the TGF-beta 1(L beta 3/L beta 3) mice show neither embryonic lethality nor signs of multifocal inflammation, demonstrating that knock-in of the TGF-beta 3 ligand can prevent the vasculogenesis defects and autoimmunity associated with TGF-beta 1 deficiency. However, the TGF-beta 1(L beta 3/L beta 3) mice have a shortened life span and display tooth and bone defects, indicating that the TGF-beta homologues are not completely interchangeable. Remarkably, the TGF-beta 1(L beta 3/L beta 3) mice display an improved metabolic phenotype with reduced body weight gain and enhanced glucose tolerance by induction of beneficial changes to the white adipose tissue compartment. These findings reveal both redundant and unique nonoverlapping functional diversity in TGF-beta isoform signaling that has relevance to the design of therapeutics aimed at targeting the TGF-beta pathway in human disease.	[Hall, Bradford E.; Cherukuri, Karthik; Kulkarni, Ashok B.] NIDCR, Funct Genom Sect, Lab Cell & Dev Biol, NIH, Bethesda, MD 20892 USA; [Konkel, Joanne E.; Chen, Wanjun] NIDCR, Mucosal Immunol Sect, NIH, Bethesda, MD 20892 USA; [Arany, Praveen R.] NIDCR, Cell Regulat & Control Unit, NIH, Bethesda, MD 20892 USA; [Wankhade, Umesh D.; Rane, Sushil G.] NIDDK, Cell Growth & Metab Sect, NIH, Bethesda, MD 20892 USA; [Nagineni, Chandrasekharam N.] NEI, NIH, Bethesda, MD 20892 USA; [Flanders, Kathleen C.] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kulkarni, AB (corresponding author), NIDCR, Funct Genom Sect, Lab Cell & Dev Biol, NIH, 30 Convent Dr,Bldg 30,Rm 130, Bethesda, MD 20892 USA.	ak40m@nih.gov	Arany, Praveen/S-5329-2019; Wankhade, Umesh/J-8739-2015	Arany, Praveen/0000-0002-6116-2340; Wankhade, Umesh/0000-0003-4810-221X	National Institutes of Health [ZO1 DE000698-13]; Divisions of Intramural Research, NIDCR; Divisions of Intramural Research, NCI; Divisions of Intramural Research, NIDDK; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000741, ZIADE000101, ZIADE000664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK055106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Divisions of Intramural Research, NIDCR; Divisions of Intramural Research, NCI; Divisions of Intramural Research, NIDDK; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant ZO1 DE000698-13 and grants from Divisions of Intramural Research, NIDCR, NCI, and NIDDK.	Ask K, 2008, INT J BIOCHEM CELL B, V40, P484, DOI 10.1016/j.biocel.2007.08.016; Bandyopadhyay B, 2006, J CELL BIOL, V172, P1093, DOI 10.1083/jcb.200507111; Beffagna G, 2005, CARDIOVASC RES, V65, P366, DOI 10.1016/j.cardiores.2004.10.005; Bottinger EP, 1996, P NATL ACAD SCI USA, V93, P5877, DOI 10.1073/pnas.93.12.5877; BRUNET CL, 1995, INT J DEV BIOL, V39, P345; ChimalMonroy J, 1997, INT J DEV BIOL, V41, P91; D'Souza RN, 1998, EUR J ORAL SCI, V106, P185, DOI 10.1111/j.1600-0722.1998.tb02174.x; Datto MB, 1999, MOL CELL BIOL, V19, P2495; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; Doetschman T, 2012, GENESIS, V50, P59, DOI 10.1002/dvg.20789; Emanuelli M, 2008, GYNECOL OBSTET INVES, V65, P1, DOI 10.1159/000106497; Figueroa JD, 2010, BREAST CANCER RES TR, V121, P727, DOI 10.1007/s10549-009-0590-z; Geiser AG, 1998, BONE, V23, P87, DOI 10.1016/S8756-3282(98)00078-7; GEISER AG, 1991, MOL CELL BIOL, V11, P84, DOI 10.1128/MCB.11.1.84; GRAYCAR JL, 1989, MOL ENDOCRINOL, V3, P1977, DOI 10.1210/mend-3-12-1977; Hao JH, 2008, EXPERT OPIN BIOL TH, V8, P1485, DOI [10.1517/14712598.8.10.1485, 10.1517/14712598.8.10.1485 ]; Hart PJ, 2002, NAT STRUCT BIOL, V9, P203, DOI 10.1038/nsb766; Hu BC, 2010, CLIN CHIM ACTA, V411, P558, DOI 10.1016/j.cca.2010.01.014; Jakowlew SB, 1998, EXP LUNG RES, V24, P579, DOI 10.3109/01902149809087387; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; Kruit A, 2006, CHEST, V129, P1584, DOI 10.1378/chest.129.6.1584; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Laverty HG, 2009, CYTOKINE GROWTH F R, V20, P305, DOI 10.1016/j.cytogfr.2009.07.002; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; Li J, 1999, J BIOL CHEM, V274, P4213, DOI 10.1074/jbc.274.7.4213; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Lin HM, 2009, J BIOL CHEM, V284, P12246, DOI 10.1074/jbc.M805379200; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Lyon M, 1997, J BIOL CHEM, V272, P18000, DOI 10.1074/jbc.272.29.18000; LYONS RM, 1990, J CELL BIOL, V110, P1361, DOI 10.1083/jcb.110.4.1361; MASSAGUE J, 1987, CELL, V49, P437, DOI 10.1016/0092-8674(87)90443-0; MILLAN FA, 1991, DEVELOPMENT, V111, P131; MILLER DA, 1989, MOL ENDOCRINOL, V3, P1926, DOI 10.1210/mend-3-12-1926; Mittl PRE, 1996, PROTEIN SCI, V5, P1261, DOI 10.1002/pro.5560050705; Moioli EK, 2007, WOUND REPAIR REGEN, V15, P413, DOI 10.1111/j.1524-475X.2007.00244.x; Mu ZY, 2008, MECH DEVELOP, V125, P508, DOI 10.1016/j.mod.2008.01.003; Olsson N, 2000, J LEUKOCYTE BIOL, V67, P350, DOI 10.1002/jlb.67.3.350; Pellaud J, 1999, J BIOL CHEM, V274, P7699, DOI 10.1074/jbc.274.12.7699; PELTON RW, 1991, J CELL BIOL, V115, P1091, DOI 10.1083/jcb.115.4.1091; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; Roberts A. B., 1991, PEPTIDE GROWTH FACTO; ROBERTS AB, 1992, MOL REPROD DEV, V32, P91, DOI 10.1002/mrd.1080320203; Samad F, 1997, MOL MED, V3, P37, DOI 10.1007/BF03401666; SANDERSON N, 1995, P NATL ACAD SCI USA, V92, P2572, DOI 10.1073/pnas.92.7.2572; Sanford LP, 1997, DEVELOPMENT, V124, P2659; SCHULTZCHERRY S, 1993, J CELL BIOL, V122, P923, DOI 10.1083/jcb.122.4.923; SHAH M, 1995, J CELL SCI, V108, P985; Shah S, 2008, EUR J IMMUNOL, V38, P2488, DOI 10.1002/eji.200838201; Shaikh S, 2012, MED ORAL PATOL ORAL, V17, pE197, DOI 10.4317/medoral.17453; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; SPORN MB, 1987, J CELL BIOL, V105, P1039, DOI 10.1083/jcb.105.3.1039; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; TENDIJKE P, 1988, P NATL ACAD SCI USA, V85, P4715; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Vitsky A, 2009, AM J PATHOL, V174, P2137, DOI 10.2353/ajpath.2009.080723; WAKEFIELD LM, 1995, CLIN CANCER RES, V1, P129; Wolfraim LA, 2002, J IMMUNOL METHODS, V266, P7, DOI 10.1016/S0022-1759(02)00090-X; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Yang LT, 2007, DEV BIOL, V312, P384, DOI 10.1016/j.ydbio.2007.09.034; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044	66	25	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					32074	32092		10.1074/jbc.M113.480764	http://dx.doi.org/10.1074/jbc.M113.480764			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24056369	Green Published, hybrid			2022-12-25	WOS:000330596200058
J	Tanida, S; Akita, K; Ishida, A; Mori, Y; Toda, M; Inoue, M; Ohta, M; Yashiro, M; Sawada, T; Hirakawa, K; Nakada, H				Tanida, Shuhei; Akita, Kaoru; Ishida, Akiko; Mori, Yugo; Toda, Munetoyo; Inoue, Mizue; Ohta, Mariko; Yashiro, Masakazu; Sawada, Tetsuji; Hirakawa, Kosei; Nakada, Hiroshi			Binding of the Sialic Acid-binding Lectin, Siglec-9, to the Membrane Mucin, MUC1, Induces Recruitment of beta-Catenin and Subsequent Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOMA-ASSOCIATED ANTIGEN; INTERCELLULAR-ADHESION MOLECULE-1; TUMOR-PRODUCED MUCINS; BREAST-CARCINOMA; FACTOR RECEPTOR; C-SRC; TYROSINE KINASE; CANCER; LIGATION; PHOSPHORYLATION	Because MUC1 carries a variety of sialoglycans that are possibly recognized by the siglec family, we examined MUC1-binding siglecs and found that Siglec-9 prominently bound to MUC1. An immunochemical study showed that Siglec-9-positive immune cells were associated with MUC1-positive cells in human colon, pancreas, and breast tumor tissues. We investigated whether or not this interaction has any functional implications for MUC1-expressing cells. When mouse 3T3 fibroblast cells and a human colon cancer cell line, HCT116, stably transfected with MUC1cDNA were ligated with recombinant soluble Siglec-9, beta-catenin was recruited to the MUC1 C-terminal domain, which was enhanced on stimulation with soluble Siglec-9 in dose-and time-dependent manners. A co-culture model of MUC1-expressing cells and Siglec-9-expressing cells mimicking the interaction between MUC1-expressing malignant cells, and Siglec-9-expressing immune cells in a tumor microenvironment was designed. Brief co-incubation of Siglec-9-expressing HEK293 cells, but not mock HEK293 cells, with MUC1-expressing cells similarly enhanced the recruitment of beta-catenin to the MUC1 C-terminal domain. In addition, treatment of MUC1-expressing cells with neuraminidase almost completely abolished the effect of Siglec-9 on MUC1-mediated signaling. The recruited beta-catenin was thereafter transported to the nucleus, leading to cell growth. These findings suggest that Siglec-9 expressed on immune cells may play a role as a potential counterreceptor for MUC1 and that this signaling may be another MUC1-mediated pathway and function in parallel with a growth factor-dependent pathway.	[Tanida, Shuhei; Akita, Kaoru; Ishida, Akiko; Mori, Yugo; Toda, Munetoyo; Inoue, Mizue; Ohta, Mariko; Nakada, Hiroshi] Kyoto Sangyo Univ, Dept Mol Biosci, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan; [Yashiro, Masakazu; Sawada, Tetsuji; Hirakawa, Kosei] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 5458585, Japan; [Yashiro, Masakazu] Osaka City Univ, Grad Sch Med, Oncol Inst Geriatr & Med Sci, Osaka 5458585, Japan	Kyoto Sangyo University; Osaka Metropolitan University; Osaka Metropolitan University	Nakada, H (corresponding author), Kyoto Sangyo Univ, Dept Mol Biosci, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan.	hnakada@cc.kyoto-su.ac.jp						Al Masri A, 2005, ONCOGENE, V24, P5799, DOI 10.1038/sj.onc.1208738; Angata T, 2000, J BIOL CHEM, V275, P22127, DOI 10.1074/jbc.M002775200; BECKER JW, 1989, P NATL ACAD SCI USA, V86, P1088, DOI 10.1073/pnas.86.3.1088; Brabletz T, 2002, VIRCHOWS ARCH, V441, P1, DOI 10.1007/s00428-002-0642-9; Crocker PR, 2001, IMMUNOLOGY, V103, P137, DOI 10.1046/j.0019-2805.2001.01241.x; Gendler SJ, 2001, J MAMMARY GLAND BIOL, V6, P339, DOI 10.1023/A:1011379725811; Halwani R, 2004, J VIROL, V78, P7553, DOI 10.1128/JVI.78.14.7553-7564.2004; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; KLUG TL, 1988, CANCER RES, V48, P1505; LAN MS, 1990, J BIOL CHEM, V265, P15294; Li Y, 2003, CANCER BIOL THER, V2, P187, DOI 10.4161/cbt.2.2.282; Li YQ, 1998, MOL CELL BIOL, V18, P7216, DOI 10.1128/MCB.18.12.7216; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; Li YQ, 2001, J BIOL CHEM, V276, P6061, DOI 10.1074/jbc.C000754200; LIGTENBERG MJL, 1992, J BIOL CHEM, V267, P6171; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lock K, 2004, IMMUNOBIOLOGY, V209, P199, DOI 10.1016/j.imbio.2004.04.007; Mukherjee P, 2005, J LEUKOCYTE BIOL, V77, P90, DOI 10.1189/jlb.0604333; Nath D, 1999, IMMUNOLOGY, V98, P213; Ohta M, 2010, BIOCHEM BIOPH RES CO, V402, P663, DOI 10.1016/j.bbrc.2010.10.079; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; OSULLIVAN C, 1994, J PATHOL, V172, P229, DOI 10.1002/path.1711720302; Parry S, 2001, BIOCHEM BIOPH RES CO, V283, P715, DOI 10.1006/bbrc.2001.4775; Pochampalli MR, 2007, ONCOGENE, V26, P1693, DOI 10.1038/sj.onc.1209976; Rahn JJ, 2004, J BIOL CHEM, V279, P29386, DOI 10.1074/jbc.C400010200; Ren J, 2002, J BIOL CHEM, V277, P17616, DOI 10.1074/jbc.M200436200; Ren J, 2006, MOL CANCER RES, V4, P873, DOI 10.1158/1541-7786.MCR-06-0204; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Shen Q, 2008, MOL CANCER RES, V6, P555, DOI 10.1158/1541-7786.MCR-07-2033; SIDDIQUI J, 1988, P NATL ACAD SCI USA, V85, P2320, DOI 10.1073/pnas.85.7.2320; Toda M, 2009, BIOCHEM J, V417, P673, DOI 10.1042/BJ20081241; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; WESSELING J, 1995, J CELL BIOL, V129, P255, DOI 10.1083/jcb.129.1.255; Workman HC, 2009, CANCER RES, V69, P2845, DOI 10.1158/0008-5472.CAN-08-2089; Yamamoto M, 1997, J BIOL CHEM, V272, P12492, DOI 10.1074/jbc.272.19.12492; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200; Zhang JQ, 2000, J BIOL CHEM, V275, P22121, DOI 10.1074/jbc.M002788200; Zhao QC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-154	38	53	54	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31842	31852		10.1074/jbc.M113.471318	http://dx.doi.org/10.1074/jbc.M113.471318			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24045940	hybrid, Green Published			2022-12-25	WOS:000330596200034
J	McDowell, A; Nagy, I; Magyari, M; Barnard, E; Patrick, S				McDowell, Andrew; Nagy, Istvan; Magyari, Marta; Barnard, Emma; Patrick, Sheila			The Opportunistic Pathogen Propionibacterium acnes: Insights into Typing, Human Disease, Clonal Diversification and CAMP Factor Evolution	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; STAPHYLOCOCCUS-EPIDERMIDIS; COMPARATIVE GENOMICS; SEQUENCE; EXPRESSION; INFECTION; VIRULENCE; IDENTIFICATION; RECOMBINATION; DUPLICATION	We previously described a Multilocus Sequence Typing (MLST) scheme based on eight genes that facilitates population genetic and evolutionary analysis of P. acnes. While MLST is a portable method for unambiguous typing of bacteria, it is expensive and labour intensive. Against this background, we now describe a refined version of this scheme based on two housekeeping (aroE; guaA) and two putative virulence (tly; camp2) genes (MLST4) that correctly predicted the phylogroup (IA(1), IA(2), IB, IC, II, III), clonal complex (CC) and sequence type (ST) (novel or described) status for 91% isolates (n = 372) via cross-referencing of the four gene allelic profiles to the full eight gene versions available in the MLST database (http://pubmlst.org/pacnes/). Even in the small number of cases where specific STs were not completely resolved, the MLST4 method still correctly determined phylogroup and CC membership. Examination of nucleotide changes within all the MLST loci provides evidence that point mutations generate new alleles approximately 1.5 times as frequently as recombination; although the latter still plays an important role in the bacterium's evolution. The secreted/cell-associated 'virulence' factors tly and camp2 show no clear evidence of episodic or pervasive positive selection and have diversified at a rate similar to housekeeping loci. The co-evolution of these genes with the core genome might also indicate a role in commensal/normal existence constraining their diversity and preventing their loss from the P. acnes population. The possibility that members of the expanded CAMP factor protein family, including camp2, may have been lost from other propionibacteria, but not P. acnes, would further argue for a possible role in niche/host adaption leading to their retention within the genome. These evolutionary insights may prove important for discussions surrounding camp2 as an immunotherapy target for acne, and the effect such treatments may have on commensal lineages.	[McDowell, Andrew; Barnard, Emma; Patrick, Sheila] Queens Univ, Ctr Infect & Immun, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland; [Nagy, Istvan; Magyari, Marta] Hungarian Acad Sci, Biol Res Ctr, Inst Biochemy, H-6701 Szeged, Hungary	Queens University Belfast; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	McDowell, A (corresponding author), Queens Univ, Ctr Infect & Immun, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland.	a.mcdowell@qub.ac.uk		McDowell, Andrew/0000-0002-9649-0504; Magyari, Melinda/0000-0002-0972-5222	R & D Office of the Health and Personal Social Services Northern Ireland [HSCNI 9.41]; Prostate Cancer Charity, United Kingdom [110831]; IN: Hungarian National Office for Research and Technology Teller program [OMFB-00441/2007]; French-Hungarian Associated European Laboratory (LEA) SkinChroma [OMFB-00272/2009]; Public Health Agency [RRG/3241/05, SUS/4334/10] Funding Source: researchfish	R & D Office of the Health and Personal Social Services Northern Ireland; Prostate Cancer Charity, United Kingdom; IN: Hungarian National Office for Research and Technology Teller program; French-Hungarian Associated European Laboratory (LEA) SkinChroma; Public Health Agency	The work was supported by funding from the R & D Office of the Health and Personal Social Services Northern Ireland (grant number HSCNI 9.41; http://www.dhsspsni.gov.uk/ahp_research) and The Prostate Cancer Charity, United Kingdom (grant number 110831; http://www.prostate-cancer.org.uk/). IN: Hungarian National Office for Research and Technology Teller program OMFB-00441/2007, French-Hungarian Associated European Laboratory (LEA) SkinChroma OMFB-00272/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas NE, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-16; Ayer J, 2006, POSTGRAD MED J, V82, P500, DOI 10.1136/pgmj.2006.045377; Bruggemann H, 2004, SCIENCE, V305, P671, DOI 10.1126/science.1100330; Bruggemann Holger, 2012, Mob Genet Elements, V2, P145; Bruggemann H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034171; Cohan FM, 2006, PHILOS T R SOC B, V361, P1985, DOI 10.1098/rstb.2006.1918; Cohen RJ, 2005, J UROLOGY, V173, P1969, DOI 10.1097/01.ju.0000158161.15277.78; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dessinioti C, 2010, CLIN DERMATOL, V28, P2, DOI 10.1016/j.clindermatol.2009.03.012; Eisen JA, 1995, J MOL EVOL, V5, P163; Eishi Y, 2002, J CLIN MICROBIOL, V40, P198, DOI 10.1128/JCM.40.1.198-204.2002; Falentin H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011748; Fehri LF, 2011, INT J MED MICROBIOL, V301, P69, DOI 10.1016/j.ijmm.2010.08.014; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feil EJ, 2000, RES MICROBIOL, V151, P465, DOI 10.1016/S0923-2508(00)00168-6; Fitz-Gibbon S, 2013, J INVEST DERMATOL, V133, P2152, DOI 10.1038/jid.2013.21; Fitzpatrick DA, 2005, J MOL EVOL, V61, P90, DOI 10.1007/s00239-004-0290-6; Goodwin AC, 2008, MICROBIOL-SGM, V154, P2231, DOI 10.1099/mic.0.2007/016055-0; Hall V, 2006, PRINCIPLES PRACTICE, P575; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Hill C, 2012, J BACTERIOL, V194, P5725, DOI 10.1128/JB.00980-12; Ho-Huu J, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-195; Holland C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-230; Holmberg A, 2009, CLIN MICROBIOL INFEC, V15, P787, DOI 10.1111/j.1469-0691.2009.02747.x; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Hunyadkurti J, 2011, J BACTERIOL, V193, P4561, DOI 10.1128/JB.05372-11; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jahns AC, 2012, BRIT J DERMATOL, V167, P50, DOI 10.1111/j.1365-2133.2012.10897.x; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Leon-Kempis MD, 2006, MOL MICROBIOL, V60, P1262, DOI 10.1111/j.1365-2958.2006.05168.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu PF, 2011, VACCINE, V29, P3230, DOI 10.1016/j.vaccine.2011.02.036; Lodes MJ, 2006, MICROBIOL-SGM, V152, P3667, DOI 10.1099/mic.0.29219-0; Lomholt HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012277; Lynch VJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-2; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Mak Tim N, 2013, Prostate, V73, P770, DOI 10.1002/pros.22621; McDowell A, 2005, J CLIN MICROBIOL, V43, P326, DOI 10.1128/JCM.43.1.326-334.2005; McDowell A, 2008, J MED MICROBIOL, V57, P218, DOI 10.1099/jmm.0.47489-0; McDowell A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041480; McDowell A, 2012, J BACTERIOL, V194, P3260, DOI 10.1128/JB.00479-12; McDowell A, 2011, MICROBIOL-SGM, V157, P1990, DOI 10.1099/mic.0.049676-0; McGraw EA, 1999, MOL BIOL EVOL, V16, P12, DOI 10.1093/oxfordjournals.molbev.a026032; McLorinan GC, 2005, CLIN ORTHOP RELAT R, P67, DOI 10.1097/01.blo.0000175716.76247.81; Minegishi K, 2013, GENOME ANNOUNC, V1, P1; Miragaia M, 2007, J BACTERIOL, V189, P2540, DOI 10.1128/JB.01484-06; Motherway MO, 2011, P NATL ACAD SCI USA, V108, P11217, DOI 10.1073/pnas.1105380108; Nagy E, 2013, ANAEROBE, V20, P20, DOI 10.1016/j.anaerobe.2013.01.007; Nagy I, 2005, J INVEST DERMATOL, V124, P931, DOI 10.1111/j.0022-202X.2005.23705.x; Nagy I, 2006, MICROBES INFECT, V8, P2195, DOI 10.1016/j.micinf.2006.04.001; Nakatsuji T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014797; Niazi SA, 2010, J CLIN MICROBIOL, V48, P3859, DOI 10.1128/JCM.01326-10; O'Sullivan O, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-50; Olsson J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051434; Olsson J, 2012, APMIS, V120, P778, DOI 10.1111/j.1600-0463.2012.02905.x; Ordogh L, 2013, GENOME ANNOUNC, V1, DOI [10.1128/genomeA.00337-13., DOI 10.1128/GEN0MEA.00337-13]; Pancholi V, 2003, INT J MED MICROBIOL, V293, P391, DOI 10.1078/1438-4221-00283; Parizzi LP, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-562; Patrick S, 2011, BERGEYS MANUAL SYSTE, V5; Perry A, 2011, EXPERT REV ANTI-INFE, V9, P1149, DOI [10.1586/ERI.11.137, 10.1586/eri.11.137]; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Piper KE, 2009, J CLIN MICROBIOL, V47, P1878, DOI 10.1128/JCM.01686-08; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pushker R, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r27; Rahman A, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-35; Sampedro MF, 2009, DIAGN MICR INFEC DIS, V64, P138, DOI 10.1016/j.diagmicrobio.2009.01.024; Sanchez-Perez G, 2008, TRENDS GENET, V24, P154, DOI 10.1016/j.tig.2008.01.002; Shannon BA, 2006, BJU INT, V98, P388, DOI 10.1111/j.1464-410X.2006.06273.x; Shu MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055380; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Sleator RD, 2005, MOL MICROBIOL, V55, P1183, DOI 10.1111/j.1365-2958.2004.04454.x; Sorensen M, 2010, J MICROBIOL METH, V83, P211, DOI 10.1016/j.mimet.2010.09.008; Spratt BG, 1999, PHILOS T R SOC B, V354, P701, DOI 10.1098/rstb.1999.0423; Stirling A, 2001, LANCET, V357, P2024, DOI 10.1016/S0140-6736(00)05109-6; Tomida S, 2013, MBIO, V4, DOI 10.1128/mBio.00003-13; Torgerson DG, 2004, GENETICS, V168, P1421, DOI 10.1534/genetics.104.027631; Treangen TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001284; Tunney MM, 1999, J CLIN MICROBIOL, V37, P3281, DOI 10.1128/JCM.37.10.3281-3290.1999; Valanne S, 2005, MICROBIOL-SGM, V151, P1369, DOI 10.1099/mic.0.27788-0; Voros A, 2012, J BACTERIOL, V194, P1621, DOI 10.1128/JB.06758-11; Yasuhara T, 2005, ACTA OPHTHALMOL SCAN, V83, P364, DOI 10.1111/j.1600-0420.2005.00449.x; Zeller V, 2007, J INFECTION, V55, P119, DOI 10.1016/j.jinf.2007.02.006	84	90	99	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e70897	10.1371/journal.pone.0070897	http://dx.doi.org/10.1371/journal.pone.0070897			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058439	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000324408400001
J	Herrmann, M; Petit, C; Dawson, A; Biechele, J; Halfmann, A; von Muller, L; Graber, S; Wagenpfeil, S; Klein, R; Gartner, B				Herrmann, Mathias; Petit, Christine; Dawson, Alik; Biechele, Judith; Halfmann, Alexander; von Mueller, Lutz; Graeber, Stefan; Wagenpfeil, Stefan; Klein, Renate; Gaertner, Barbara			Methicillin-Resistant Staphylococcus aureus in Saarland, Germany: A Statewide Admission Prevalence Screening Study	PLOS ONE			English	Article							HOSPITAL ADMISSION; RISK-FACTORS; MRSA; COST; INFECTION; SURVEILLANCE; ACQUISITION; SYSTEM; COLONIZATION; REDUCTION	Background: The screening of hospital admission patients for methicillin resistant Staphylococcus aureus (MRSA) is of undisputed value in controlling and reducing the overall MRSA burden; yet, a concerted parallel universal screening intervention throughout all hospitals of an entire German Federal State has not yet been performed. Methodology/Principal Findings: During a four-week period, all 24 acute care hospitals of the State of Saarland participated in admission prevalence screening. Overall, 436/20,027 screened patients revealed MRSA carrier status (prevalence, 2.2/100 patients) with geriatrics and intensive care departments associated with highest prevalence (7.6/100 and 6.3/100, respectively). Risk factor analysis among 17,975 admission patients yielded MRSA history (OR, 4.3; CI95 2.7-6.8), a skin condition (OR, 3.2; CI95 2.1-5.0), and/or an indwelling catheter (OR, 2.2; CI95 1.4-3.5) among the leading risks. Hierarchical risk factor ascertainment of the six risk factors associated with highest odd's ratios would require 31% of patients to be laboratory screened to allow for detection of 67% of all MRSA positive admission patients in the State. Conclusions/Significance: State-wide admission prevalence screening in conjunction with risk factor ascertainment yields important information on the distribution of the MRSA burden for hospitals, and allows for data-based decisions on local or institutional MRSA screening policies considering risk factor prevalence and expected MRSA identification rates.	[Herrmann, Mathias; Petit, Christine; Dawson, Alik; Biechele, Judith; Halfmann, Alexander; von Mueller, Lutz; Gaertner, Barbara] Univ Saarland, Med Ctr, Inst & State Lab Med Microbiol & Hyg, Homburg, Germany; [Graeber, Stefan; Wagenpfeil, Stefan] Univ Saarland, Inst Med Biometry Epidemiol & Med Informat, Homburg, Germany; [Klein, Renate] Saarland Minist Social Affairs Hlth Women & Famil, Saarbrucken, Germany	Saarland University; Saarland University	Herrmann, M (corresponding author), Univ Saarland, Med Ctr, Inst & State Lab Med Microbiol & Hyg, Homburg, Germany.	mathias.herrmann@uks.eu	Herrmann, Mathias/B-6475-2013	Herrmann, Mathias/0000-0003-2638-2257; Herrmann, Mathias/0000-0003-3264-8672; von Muller, Lutz/0000-0001-9013-4245	German Ministry of Health; State of Saarland Government	German Ministry of Health; State of Saarland Government	The study has been funded by two funding bodies, the German Ministry of Health and the State of Saarland Government. Neither funding body had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The acknowledgment of one of the coauthors (R. K.) is solely for the purpose of declaring her employment by the State of Saarland Ministry of Social Affairs, Health, Women and Families (part of the State of Saarland Government); it does not impede above statement.	[Anonymous], 1999, BUNDESGESUNDHEITSBLA, V42, P958; [Anonymous], 2013, OECD 2012 HLTH GLANC, DOI DOI 10.1787/9789264183896-EN.ACCESSED; Ben-David D, 2009, INFECT CONT HOSP EP, V30, P453, DOI 10.1086/596731; Bjorholt I, 2004, EUR J CLIN MICROBIOL, V23, P688, DOI 10.1007/s10096-004-1198-1; Bocher S, 2010, J ANTIMICROB CHEMOTH, V65, P717, DOI 10.1093/jac/dkq001; Bourbeau PP, 2009, J CLIN MICROBIOL, V47, P1101, DOI 10.1128/JCM.01963-08; Davis KA, 2004, CLIN INFECT DIS, V39, P776, DOI 10.1086/422997; Diekema DJ, 2007, CLIN INFECT DIS, V44, P1101, DOI 10.1086/512820; Diller R, 2008, INT J HYG ENVIR HEAL, V211, P205, DOI 10.1016/j.ijheh.2007.06.001; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; Federal Ministry of Health, 2011, DART DTSCH ANT RES S; Gould IM, 2006, INT J ANTIMICROB AG, V28, P379, DOI 10.1016/j.ijantimicag.2006.09.001; Grabe C, 2012, EPIDEMIOLOGISCHES B, P163; Greub G, 2011, CLIN MICROBIOL INFEC, V17, P655, DOI 10.1111/j.1469-0691.2011.03513.x; Grundmann H, 2002, J INFECT DIS, V185, P481, DOI 10.1086/338568; Harbarth S, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.04.042; Harbarth S, 2000, CLIN INFECT DIS, V31, P1380, DOI 10.1086/317484; Harbarth S, 2008, JAMA-J AM MED ASSOC, V299, P1149, DOI 10.1001/jama.299.10.1149; Harbarth S, 2011, INT J ANTIMICROB AG, V37, P110, DOI 10.1016/j.ijantimicag.2010.10.022; Hardy K, 2010, CLIN MICROBIOL INFEC, V16, P333, DOI 10.1111/j.1469-0691.2009.02899.x; Herdman MT, 2009, J CLIN MICROBIOL, V47, P4102, DOI 10.1128/JCM.01332-09; Huang SS, 2003, CLIN INFECT DIS, V36, P281, DOI 10.1086/345955; Hubben G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014783; Jain R, 2011, NEW ENGL J MED, V364, P1419, DOI 10.1056/NEJMoa1007474; Jeyaratnam D, 2008, BMJ-BRIT MED J, V336, P927, DOI 10.1136/bmj.39525.579063.BE; Kock R, 2009, J HOSP INFECT, V71, P320, DOI 10.1016/j.jhin.2008.12.001; Kock R, 2011, DTSCH ARZTEBL INT, V108, P761, DOI 10.3238/arztebl.2011.0761; MacKenzie FM, 2007, CLIN MICROBIOL INFEC, V13, P269, DOI 10.1111/j.1469-0691.2006.01592.x; Mellmann A, 2006, PLOS MED, V3, P348, DOI 10.1371/journal.pmed.0030033; Meyer E, 2007, J HOSP INFECT, V65, P84, DOI 10.1016/j.jhin.2006.09.009; Murthy A, 2010, CLIN MICROBIOL INFEC, V16, P1747, DOI 10.1111/j.1469-0691.2010.03220.x; Peterson LR, 2010, J CLIN MICROBIOL, V48, P683, DOI 10.1128/JCM.02516-09; Pohle M, 2012, EPIDBULL, P63; Rao GG, 2007, J HOSP INFECT, V66, P15, DOI 10.1016/j.jhin.2007.01.013; Reilly JS, 2010, J HOSP INFECT, V74, P35, DOI 10.1016/j.jhin.2009.08.013; Rioux C, 2007, INFECT CONT HOSP EP, V28, P733, DOI 10.1086/516664; Robicsek A, 2008, ANN INTERN MED, V148, P409, DOI 10.7326/0003-4819-148-6-200803180-00003; Saegeman V, 2011, EUR J CLIN MICROBIOL, V30, P943, DOI 10.1007/s10096-011-1178-1; Salgado CD, 2006, INFECT CONT HOSP EP, V27, P116, DOI 10.1086/500624; Schulz M, 2009, EUR J CLIN MICROBIOL, V28, P1291, DOI 10.1007/s10096-009-0778-5; Smismans A, 2009, DIAGN MICR INFEC DIS, V65, P108, DOI 10.1016/j.diagmicrobio.2009.06.015; Struelens MJ, 2009, CLIN MICROBIOL INFEC, V15, P112, DOI 10.1111/j.1469-0691.2009.02698.x; van Rijen MML, 2009, EUR J CLIN MICROBIOL, V28, P1245, DOI 10.1007/s10096-009-0775-8; Wassenberg MWM, 2010, CLIN MICROBIOL INFEC, V16, P1754, DOI 10.1111/j.1469-0691.2010.03210.x; Wernitz MH, 2005, CLIN MICROBIOL INFEC, V11, P466, DOI 10.1111/j.1469-0691.2005.01153.x; Wertheim HFL, 2004, J HOSP INFECT, V56, P321, DOI 10.1016/j.jhin.2004.01.026; WESTH H, 1992, CLIN INFECT DIS, V14, P1186, DOI 10.1093/clinids/14.6.1186	47	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73876	10.1371/journal.pone.0073876	http://dx.doi.org/10.1371/journal.pone.0073876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040103	gold, Green Published, Green Submitted			2022-12-25	WOS:000326734500059
J	Cox, KH; So, NLT; Rissman, EF				Cox, Kimberly H.; So, Nina L. T.; Rissman, Emilie F.			Foster Dams Rear Fighters: Strain-Specific Effects of Mice Within-Strain Fostering on Aggressive Behavior in Male Mice	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; EARLY-LIFE STRESS; MATERNAL-BEHAVIOR; INTERMALE AGGRESSION; MUS-MUSCULUS; INBRED MICE; HYPOTHALAMIC VASOPRESSIN; SOCIAL EXPERIENCES; GENE-EXPRESSION; Y-CHROMOSOME	It is well known that genes and environment interact to produce behavioral phenotypes. One environmental factor with long-term effects on gene transcription and behavior is maternal care. A classic paradigm for examining maternal care and genetic interactions is to foster pups of one genetic strain to dams of a different strain ("between-strain fostering"). In addition, fostering to a dam of the same strain ("within-strain fostering") is used to reduce indirect effects, via behavioral changes in the dams, of gestation treatments on offspring. Using within-and between-strain fostering we examined the contributions of genetics/prenatal environment, maternal care, and the effects of fostering per se, on adult aggressive behavior in two inbred mouse strains, C57BL/6J (B6) and DBA/2J (DBA). We hypothesized that males reared by dams of the more aggressive DBA strain would attack intruders faster than those reared by B6 dams. Surprisingly, we found that both methods of fostering enhanced aggressive behavior, but only in B6 mice. Since all the B6 offspring are genetically identical, we asked if maternal behavior of B6 dams was affected by the relatedness of their pups. In fact, B6 dams caring for foster B6 pups displayed significantly reduced maternal behaviors. Finally, we measured vasopressin and corticotrophin releasing hormone mRNA in the amygdalae of adult B6 males reared by foster or biological dams. Both genes correlated with aggressive behavior in within-strain fostered B6 mice, but not in mice reared by their biological dams. In sum, we have demonstrated in inbred laboratory mice, that dams behave differently when rearing their own newborn pups versus pups from another dam of the same strain. These differences in maternal care affect aggression in the male offspring and transcription of Avp and Crh in the brain. It is likely that rearing by foster dams has additional effects and implications for other species.	[Cox, Kimberly H.] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Grad Program Neurosci, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Cox, KH (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	khcox@partners.org	Cox, Kimberly/P-1931-2016	Cox, Kimberly/0000-0002-7097-9563	National Institutes of Health [R01 MH057759];  [T32 HD007323]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by National Institutes of Health grant R01 MH057759. KHC was supported by T32 HD007323. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolomucci A, 2004, GENES BRAIN BEHAV, V3, P115, DOI 10.1111/j.1601-183X.2003.00059.x; Bester-Meredith JK, 2001, HORM BEHAV, V40, P51, DOI 10.1006/hbeh.2001.1666; Boccia ML, 2001, PSYCHONEUROENDOCRINO, V26, P657, DOI 10.1016/S0306-4530(01)00019-1; Bond TLY, 2002, PHYSIOL BEHAV, V75, P551, DOI 10.1016/S0031-9384(02)00659-5; Bonthuis PJ, 2012, HORM BEHAV, V61, P565, DOI 10.1016/j.yhbeh.2012.02.003; Brown RE, 1999, PHYSIOL BEHAV, V67, P599, DOI 10.1016/S0031-9384(99)00109-2; CARLIER M, 1982, BEHAV NEURAL BIOL, V35, P205, DOI 10.1016/S0163-1047(82)91213-4; CARLIER M, 1991, GENETICS, V129, P231; Case LK, 2010, CELL IMMUNOL, V260, P119, DOI 10.1016/j.cellimm.2009.10.002; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; Champagne FA, 2006, ENDOCRINOLOGY, V147, P2909, DOI 10.1210/en.2005-1119; Cox KH, 2010, HORM BEHAV, V58, P754, DOI 10.1016/j.yhbeh.2010.07.008; Curley JP, 2010, BEHAV GENET, V40, P220, DOI 10.1007/s10519-010-9334-4; Dureje L, 2011, AGGRESSIVE BEHAV, V37, P48, DOI 10.1002/ab.20371; Ebner K, 2002, EUR J NEUROSCI, V15, P384, DOI 10.1046/j.0953-816x.2001.01869.x; Francis DD, 2000, J NEUROENDOCRINOL, V12, P1145, DOI 10.1046/j.1365-2826.2000.00599.x; Francis DD, 2003, NAT NEUROSCI, V6, P445, DOI 10.1038/nn1038; Francis DD, 2002, J NEUROENDOCRINOL, V14, P349, DOI 10.1046/j.0007-1331.2002.00776.x; Francis DD, 1999, ANN NY ACAD SCI, V896, P66, DOI 10.1111/j.1749-6632.1999.tb08106.x; FRANKLIN BJK, 1997, MOUSE BRAIN STEREOTA; Gatewood JD, 2006, J NEUROSCI, V26, P2335, DOI 10.1523/JNEUROSCI.3743-05.2006; George ED, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-123; Gudsnuk KMA, 2011, CLIN PERINATOL, V38, P703, DOI 10.1016/j.clp.2011.08.005; GUILLOT PV, 1995, BEHAV GENET, V25, P357, DOI 10.1007/BF02197285; Hager R, 2003, NATURE, V421, P533, DOI 10.1038/nature01239; Hager R, 2009, P ROY SOC B-BIOL SCI, V276, P2949, DOI 10.1098/rspb.2009.0515; HENNESSY MB, 1980, DEV PSYCHOBIOL, V13, P573, DOI 10.1002/dev.420130603; HOFFMANN HJ, 1993, BEHAV GENET, V23, P391, DOI 10.1007/BF01067441; KALIN NH, 1994, BRAIN RES, V656, P182, DOI 10.1016/0006-8993(94)91382-X; KOOLHAAS JM, 1990, AGGRESSIVE BEHAV, V16, P223; LAVIOLA G, 1991, NEUROSCI BIOBEHAV R, V15, P501, DOI 10.1016/S0149-7634(05)80139-3; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Matsuyama S, 1997, BRAIN RES, V763, P127, DOI 10.1016/S0006-8993(97)00444-7; Matthews PA, 2011, J PHYSIOL-LONDON, V589, P3969, DOI 10.1113/jphysiol.2011.212324; MAXSON SC, 1981, BEHAV GENET, V11, P153, DOI 10.1007/BF01065626; MAXSON SC, 1979, BEHAV GENET, V9, P219, DOI 10.1007/BF01071302; Miczek KA, 2007, J NEUROSCI, V27, P11803, DOI 10.1523/JNEUROSCI.3500-07.2007; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Ogawa S, 1999, P NATL ACAD SCI USA, V96, P12887, DOI 10.1073/pnas.96.22.12887; OSTERMEYER MC, 1983, DEV PSYCHOBIOL, V16, P75, DOI 10.1002/dev.420160202; PLATT THK, 1989, BEHAV NEURAL BIOL, V52, P222, DOI 10.1016/S0163-1047(89)90341-5; Podhorna J, 2002, GENES BRAIN BEHAV, V1, P96, DOI 10.1034/j.1601-183X.2002.10205.x; Prakash P, 2006, BRAIN RES, V1111, P122, DOI 10.1016/j.brainres.2006.06.089; Priebe K, 2005, DEV PSYCHOBIOL, V47, P398, DOI 10.1002/dev.20098; Regev L, 2012, BIOL PSYCHIAT, V71, P317, DOI 10.1016/j.biopsych.2011.05.036; RESSLER RH, 1962, SCIENCE, V137, P129, DOI 10.1126/science.137.3524.129; ROUBERTOUX PL, 1994, GENETICS, V136, P225; Scordalakes EM, 2004, GENES BRAIN BEHAV, V3, P20, DOI 10.1111/j.1601-183X.2004.00036.x; Scordalakes EM, 2003, BEHAV NEUROSCI, V117, P38, DOI 10.1037/0735-7044.117.1.38; SELMANOFF MK, 1976, BEHAV GENET, V6, P53, DOI 10.1007/BF01065678; SELMANOFF MK, 1975, NATURE, V253, P529, DOI 10.1038/253529a0; SLUYTER F, 1995, BEHAV GENET, V25, P367, DOI 10.1007/BF02197287; SMOTHERMAN WP, 1974, BEHAV BIOL, V12, P55, DOI 10.1016/S0091-6773(74)91026-8; SPROTT R L, 1975, Experimental Aging Research, V1, P313, DOI 10.1080/03610737508257969; Sugawara A, 2012, PSYCHONEUROENDOCRINO, V37, P383, DOI 10.1016/j.psyneuen.2011.07.009; SVARE B, 1984, PHYSIOL BEHAV, V33, P137, DOI 10.1016/0031-9384(84)90024-6; van der Veen R, 2008, GENES BRAIN BEHAV, V7, P184, DOI 10.1111/j.1601-183X.2007.00337.x; Veenema AH, 2007, PSYCHONEUROENDOCRINO, V32, P437, DOI 10.1016/j.psyneuen.2007.02.008; Veenema AH, 2006, EUR J NEUROSCI, V24, P1711, DOI 10.1111/j.1460-9568.2006.05045.x; Veenema AH, 2012, HORM BEHAV, V61, P304, DOI 10.1016/j.yhbeh.2011.12.002; Weaver ICG, 2004, ANN NY ACAD SCI, V1024, P182, DOI 10.1196/annals.1321.099; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wolstenholme JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025448; Zohar I, 2011, J NEUROENDOCRINOL, V23, P320, DOI 10.1111/j.1365-2826.2011.02117.x	64	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e75037	10.1371/journal.pone.0075037	http://dx.doi.org/10.1371/journal.pone.0075037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040381	Green Published, gold, Green Submitted			2022-12-25	WOS:000327538600125
J	Ganesh, BP; Klopfleisch, R; Loh, G; Blaut, M				Ganesh, Bhanu Priya; Klopfleisch, Robert; Loh, Gunnar; Blaut, Michael			Commensal Akkermansia muciniphila Exacerbates Gut Inflammation in Salmonella Typhimurium-Infected Gnotobiotic Mice	PLOS ONE			English	Article							BOWEL-DISEASE; GASTROINTESTINAL-TRACT; VIRULENCE FACTORS; INTERFERON-GAMMA; MOUSE MODEL; M CELLS; MACROPHAGES; MICROBIOTA; MUCIN; MUCOSAL	Excessive mucin degradation by intestinal bacteria may contribute to inflammatory bowel diseases because access of luminal antigens to the intestinal immune system is facilitated. This study investigated how the presence of a mucin degrading commensal bacterium affects the severity of an intestinal Salmonella enterica Typhimurium-induced gut inflammation. Using a gnotobiotic C3H mouse model with a background microbiota of eight bacterial species (SIHUMI) the impact of the mucin-degrading commensal bacterium Akkermansia muciniphila (SIHUMI-A) on inflammatory and infectious symptoms caused by S. Typhimurium was investigated. Presence of A. muciniphila in S. Typhimurium-infected SIHUMI mice caused significantly increased histopathology scores and elevated mRNA levels of IFN-gamma, IP-10, TNF-alpha, IL-12, IL-17 and IL-6 in cecal and colonic tissue. The increase in pro-inflammatory cytokines was accompanied by 10-fold higher S. Typhimurium cell numbers in mesenteric lymph nodes of SIHUMI mice associated with A. muciniphila and S. Typhimurium (SIHUMI-AS) compared to SIHUMI mice with S. Typhimurium only (SIHUMI-S). The number of mucin filled goblet cells was 2- to 3- fold lower in cecal tissue of SIHUMI-AS mice compared to SIHUMI-S, SIHUMI-A or SIHUMI mice. Reduced goblet cell numbers significantly correlated with increased IFN-gamma mRNA levels (r(2) = -0.86, ***P<0.001) in all infected mice. In addition, loss of cecal mucin sulphation was observed in SIHUMI mice containing both A. muciniphila and S. Typhimurium compared to other mouse groups. Concomitant presence of A. muciniphila and S. Typhimurium resulted in a drastic change in microbiota composition of SIHUMI mice: the proportion of B. thetaiotaomicron in SIHUMI-AS mice was 0.02% of total bacteria compared to 78% - 88% in the other mouse groups and the proportion of S. Typhimurium was 94% in SIHUMI-AS mice but only 2.2% in the SIHUMI-S mice. These results indicate that A. muciniphila exacerbates S. Typhimurium-induced intestinal inflammation by its ability to disturb host mucus homeostasis.	[Ganesh, Bhanu Priya; Loh, Gunnar; Blaut, Michael] German Inst Human Nutr Potsdam Rehbrucke, Dept Gastrointestinal Microbiol, Nuthetal, Germany; [Klopfleisch, Robert] Free Univ Berlin, Inst Vet Pathol, Berlin, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Free University of Berlin	Loh, G (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Gastrointestinal Microbiol, Nuthetal, Germany.	loh@dife.de		Ganesh, Bhanu/0000-0003-1575-7914; Blaut, Michael/0000-0002-6628-2907; Klopfleisch, Robert/0000-0002-6308-0568	Deutsche Forschungsgemeinschaft Collaborative Research Center 852	Deutsche Forschungsgemeinschaft Collaborative Research Center 852(German Research Foundation (DFG))	This work has been funded by the Deutsche Forschungsgemeinschaft (wwww.dfg.de), Collaborative Research Center 852. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres JS, 2012, NAT MED, V18, P799, DOI 10.1038/nm.2729; Becker N, 2011, GUT MICROBES, V2, P25, DOI 10.4161/gmic.2.1.14651; Berclaz PY, 2002, BLOOD, V100, P4193, DOI 10.1182/blood-2002-04-1102; Bogaert S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025589; Bruno VM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000538; Campieri M, 2001, GUT, V48, P132, DOI 10.1136/gut.48.1.132; CAR BD, 1995, AM J PATHOL, V147, P1693; Chow J, 2010, CELL HOST MICROBE, V7, P265, DOI 10.1016/j.chom.2010.03.004; Clark MA, 1996, INFECT IMMUN, V64, P4363, DOI 10.1128/IAI.64.10.4363-4368.1996; Collado MC, 2007, APPL ENVIRON MICROB, V73, P7767, DOI 10.1128/AEM.01477-07; Corfield AP, 2000, GUT, V47, P589, DOI 10.1136/gut.47.4.589; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Derrien M, 2008, APPL ENVIRON MICROB, V74, P1646, DOI 10.1128/AEM.01226-07; Derrien M, 2010, GUT MICROBES, V1, P254, DOI 10.4161/gmic.1.4.12778; Duerkop BA, 2009, IMMUNITY, V31, P368, DOI 10.1016/j.immuni.2009.08.009; Endt K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001097; Falk PG, 1998, MICROBIOL MOL BIOL R, V62, P1157, DOI 10.1128/MMBR.62.4.1157-1170.1998; Foster N, 2010, J INFECT DIS, V202, P1916, DOI 10.1086/657415; Ganesh BP, 2012, BENEF MICROBES, V3, P43, DOI 10.3920/BM2011.0050; Gassler N, 2001, AM J PHYSIOL-GASTR L, V281, pG216, DOI 10.1152/ajpgi.2001.281.1.G216; Giannasca KT, 1996, INFECT IMMUN, V64, P135, DOI 10.1128/IAI.64.1.135-145.1996; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Johansson MEV, 2011, SCIENCE, V334, P182, DOI 10.1126/science.1213909; Kaiser P, 2012, IMMUNOL REV, V245, P56, DOI 10.1111/j.1600-065X.2011.01070.x; Kallis YN, 2011, GUT, V60, P525, DOI 10.1136/gut.2010.224436; Kaser A, 2010, MUCOSAL IMMUNOL, V3, P11, DOI 10.1038/mi.2009.122; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Kleessen B, 2002, SCAND J GASTROENTERO, V37, P1034, DOI 10.1080/003655202320378220; Lapaque N, 2009, J IMMUNOL, V182, P4339, DOI 10.4049/jimmunol.0803329; Linden SK, 2008, PLOS ONE, V3; Loetscher Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034812; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Malorny B, 2007, J VERBRAUCH LEBENSM, V2, P149, DOI 10.1007/s00003-007-0167-x; Mathur R, 2012, CELL, V151, P590, DOI 10.1016/j.cell.2012.08.042; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Moulin-Schouleur M, 2006, J CLIN MICROBIOL, V44, P3484, DOI 10.1128/JCM.00548-06; Munder M, 1998, J EXP MED, V187, P2103, DOI 10.1084/jem.187.12.2103; Nix RN, 2007, PLOS PATHOG, V3, P1982, DOI 10.1371/journal.ppat.0030193; RAOUF AH, 1992, CLIN SCI, V83, P623, DOI 10.1042/cs0830623; Sartor RB, 2009, NESTLE NUTR WORKS SE, V64, P121, DOI 10.1159/000235787; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Shkoda A, 2007, GASTROENTEROLOGY, V132, P190, DOI 10.1053/j.gastro.2006.10.030; Slezak K, 2013, BENEF MICROBES, V4, P253, DOI 10.3920/BM2012.0047; Smith WE, 2003, INFECT IMMUN, V71, P1497, DOI 10.1128/IAI.71.3.1497-1504.2003; Soderholm JD, 2001, AM J PHYSIOL-GASTR L, V280, pG7, DOI 10.1152/ajpgi.2001.280.1.G7; Songhet P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022459; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Swidsinski A, 2007, GUT, V56, P343, DOI 10.1136/gut.2006.098160; Thiennimitr P, 2012, CURR OPIN MICROBIOL, V15, P108, DOI 10.1016/j.mib.2011.10.002; van der Velden AWM, 2000, INFECT IMMUN, V68, P5702, DOI 10.1128/IAI.68.10.5702-5709.2000; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Wiggins R, 2001, SEX TRANSM INFECT, V77, P402, DOI 10.1136/sti.77.6.402; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Wohlgemuth S, 2009, ENVIRON MICROBIOL, V11, P1562, DOI 10.1111/j.1462-2920.2009.01883.x; Zirk NM, 1999, INFECT IMMUN, V67, P319, DOI 10.1128/IAI.67.1.319-326.1999	59	264	292	5	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74963	10.1371/journal.pone.0074963	http://dx.doi.org/10.1371/journal.pone.0074963			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040367	Green Published, gold, Green Submitted			2022-12-25	WOS:000327538600122
J	Jin, M; Jiang, YM; Sun, LL; Yin, JH; Fu, HH; Wu, GF; Gao, HC				Jin, Miao; Jiang, Yaoming; Sun, Linlin; Yin, Jianhua; Fu, Huihui; Wu, Genfu; Gao, Haichun			Unique Organizational and Functional Features of the Cytochrome c Maturation System in Shewanella oneidensis	PLOS ONE			English	Article							NITRITE REDUCTASE; DIMETHYL-SULFOXIDE; HEME-C; MR-1; IDENTIFICATION; RESPIRATION; BIOGENESIS; ATTACHMENT; EXPRESSION; ELEMENTS	Shewanella are renowned for their ability to respire on a wide range of electron acceptors, which has been partially accredited to the presence of a large number of the c-type cytochromes. In the model species S. oneidensis MR-1, at least 41 genes encode c-type cytochromes that are predicted to be intact, thereby likely functional. Previously, in-frame deletion mutants for 36 of these genes were obtained and characterized. In this study, first we completed the construction of an entire set of c-type cytochrome mutants utilizing a newly developed att-based mutagenesis approach, which is more effective and efficient than the approach used previously by circumventing the conventional cloning. Second, we investigated the cytochrome c maturation (Ccm) system in S. oneidensis. There are two loci predicted to encode components of the Ccm system, SO0259-SO0269 and SO0476-SO0478. The former is proven essential for cytochrome c maturation whereas the latter is dispensable. Unlike the single operon organization observed in other gamma-proteobacteria, genes at the SO0259-SO0269 locus are uniquely organized into four operons, ccmABCDE, scyA, SO0265, and ccmFGH-SO0269. Functional analysis revealed that the SO0265 gene rather than the scyA and SO0269 genes are relevant to cytochrome c maturation.	[Gao, Haichun] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; Zhejiang Univ, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Gao, HC (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	haichung@zju.edu.cn	Gao, Haichun/A-2160-2014; Gao, Haichun/AFU-4588-2022	Gao, Haichun/0000-0002-2647-6563; Gao, Haichun/0000-0002-2647-6563	Major State Basic Research Development Program (973 Program) [2010CB833803]; National Natural Science Foundation of China [31270097]; Natural Science Foundation of Zhejiang province [R3110096]	Major State Basic Research Development Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang province(Natural Science Foundation of Zhejiang Province)	This research was supported by Major State Basic Research Development Program (973 Program: 2010CB833803), National Natural Science Foundation of China (31270097), and Natural Science Foundation of Zhejiang province (R3110096) to HG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson SJ, 2007, FEBS LETT, V581, P3805, DOI 10.1016/j.febslet.2007.07.005; Beliaev AS, 2005, J BACTERIOL, V187, P7138, DOI 10.1128/JB.187.20.7138-7145.2005; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Bretschger O, 2007, APPL ENVIRON MICROB, V73, P7003, DOI 10.1128/AEM.01087-07; Cianciotto NP, 2005, MOL MICROBIOL, V56, P1408, DOI 10.1111/j.1365-2958.2005.04650.x; Eaves DJ, 1998, MOL MICROBIOL, V28, P205, DOI 10.1046/j.1365-2958.1998.00792.x; Einsle O, 2011, METHOD ENZYMOL, V496, P399, DOI 10.1016/B978-0-12-386489-5.00016-6; Fonseca BM, 2013, BIOCHEM J, V449, P101, DOI 10.1042/BJ20121467; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Fulop V, 2009, FEBS J, V276, P2822, DOI 10.1111/j.1742-4658.2009.07005.x; Gao HC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-42; Gao HC, 2010, MICROB BIOTECHNOL, V3, P455, DOI 10.1111/j.1751-7915.2010.00181.x; Gao HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015295; Gao HC, 2009, ISME J, V3, P966, DOI 10.1038/ismej.2009.40; Gao WM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-76; Gon S, 2002, J BACTERIOL, V184, P1262, DOI 10.1128/JB.184.5.1262-1269.2002; Gralnick JA, 2006, P NATL ACAD SCI USA, V103, P4669, DOI 10.1073/pnas.0505959103; Hartshorne RS, 2007, MOL MICROBIOL, V64, P1049, DOI 10.1111/j.1365-2958.2007.05712.x; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; House BL, 2004, APPL ENVIRON MICROB, V70, P2806, DOI 10.1128/AEM.70.5.2806-2815.2004; Kranz RG, 2009, MICROBIOL MOL BIOL R, V73, P510, DOI 10.1128/MMBR.00001-09; Lezhneva L, 2008, J BIOL CHEM, V283, P24608, DOI 10.1074/jbc.M803869200; Londer YY, 2008, PROTEIN EXPRES PURIF, V62, P128, DOI 10.1016/j.pep.2008.06.014; Lukat P, 2008, BIOCHEMISTRY-US, V47, P2080, DOI 10.1021/bi7021415; McMillan DGG, 2012, J BIOL CHEM, V287, P14215, DOI 10.1074/jbc.M112.348813; Meyer TE, 2004, OMICS, V8, P57, DOI 10.1089/153623104773547499; Mowat CG, 2004, NAT STRUCT MOL BIOL, V11, P1023, DOI 10.1038/nsmb827; MYERS CR, 1990, J BACTERIOL, V172, P6232, DOI 10.1128/jb.172.11.6232-6238.1990; Nissen S, 2012, BIOCHEM SOC T, V40, P1204, DOI 10.1042/BST20120182; Pisa R, 2002, MOL MICROBIOL, V43, P763, DOI 10.1046/j.1365-2958.2002.02784.x; Richter K, 2012, APPL ENVIRON MICROB, V78, P913, DOI 10.1128/AEM.06803-11; Romine MF, 2008, APPL ENVIRON MICROB, V74, P3257, DOI 10.1128/AEM.02720-07; Saltikov CW, 2003, P NATL ACAD SCI USA, V100, P10983, DOI 10.1073/pnas.1834303100; Sanders C, 2010, TRENDS MICROBIOL, V18, P266, DOI 10.1016/j.tim.2010.03.006; Schutz B, 2011, APPL ENVIRON MICROB, V77, P6172, DOI 10.1128/AEM.00606-11; Schwalb C, 2003, BIOCHEMISTRY-US, V42, P9491, DOI 10.1021/bi034456f; Shirodkar S, 2011, ENVIRON MICROBIOL, V13, P108, DOI 10.1111/j.1462-2920.2010.02313.x; Simon J, 2002, FEBS LETT, V522, P83, DOI 10.1016/S0014-5793(02)02885-5; Stevens JM, 2011, FEBS J, V278, P4170, DOI 10.1111/j.1742-4658.2011.08376.x; Thormann KM, 2005, J BACTERIOL, V187, P1014, DOI 10.1128/JB.187.3.1014-1021.2005; Wu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021479; Yuan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023701; Zhou GQ, 2013, ISME J, V7, P1752, DOI 10.1038/ismej.2013.62	43	86	87	6	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e75610	10.1371/journal.pone.0075610	http://dx.doi.org/10.1371/journal.pone.0075610			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040415	Green Submitted, Green Published, gold			2022-12-25	WOS:000327538600142
J	Farrand, L; Kim, JY; Im-Aram, A; Suh, JY; Lee, HJ; Tsang, BK				Farrand, Lee; Kim, Ji Young; Im-Aram, Akechai; Suh, Jeong-Yong; Lee, Hyong Joo; Tsang, Benjamin K.			An Improved Quantitative Approach for the Assessment of Mitochondrial Fragmentation in Chemoresistant Ovarian Cancer Cells	PLOS ONE			English	Article							FISSION; APOPTOSIS; DYNAMICS; PIPERLONGUMINE; MORPHOLOGY; CISPLATIN; DEPLETION; RECEPTOR; FUSION	Mitochondrial fission is a process that involves cleavage of mitochondria into smaller fragments and is regulated by the GTPase Dynamin-related protein 1 (Drp1). Higher levels of mitochondrial fission are associated with the induction of apoptosis in cancer cells. However, current methods to accurately quantify mitochondrial fission in order to compare therapeutics that target this process are often ambiguous or rely on subjective assessment. Mitochondria are also prone to aggregation, making accurate analysis difficult. Here we describe an improved approach for the quantification of mitochondrial fragmentation involving several differences from currently existing methods. Cells are first subjected to cytological centrifugation, which reduces cellular z-axis height and disperses individual mitochondria for easier observation. Three commercially available fluorescence analysis tools are then applied to disambiguate remaining mitochondrial clusters that require further inspection. Finally, cut-off scoring is applied, which can be tailored to individual cell type. The resultant approach allows for the efficient and objective assessment of mitochondrial fragmentation in response to treatment. We applied this technique to an experimental question involving chemosensitive and chemoresistant ovarian cancer (OVCA) cells. Cisplatin and the phytochemical piperlongumine were found to induce both mitochondrial fission and apoptosis in chemosensitive cells, while only piperlongumine was able to elicit these cellular responses in chemoresistant cells. Piperlongumine-induced apoptosis appeared to be mediated by Drp1-dependent mitochondrial fission since the apoptotic response was attenuated by the presence of the Drp1 inhibitor mDivi-1. Our study provides groundwork for a more objective approach to the quantification of mitochondrial fragmentation, and sheds further light on a potential mechanism of action for piperlongumine in the treatment of chemoresistant OVCA.	[Farrand, Lee; Kim, Ji Young; Im-Aram, Akechai; Suh, Jeong-Yong; Lee, Hyong Joo; Tsang, Benjamin K.] Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, Seoul 151, South Korea; [Kim, Ji Young; Tsang, Benjamin K.] Univ Ottawa, Dept Obstet & Gynaecol, Ottawa, ON, Canada; [Tsang, Benjamin K.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Kim, Ji Young; Tsang, Benjamin K.] Univ Ottawa, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada; [Tsang, Benjamin K.] Ottawa Hosp, Res Inst, Chron Dis Program, Ottawa, ON, Canada	Seoul National University (SNU); University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Tsang, BK (corresponding author), Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, Seoul 151, South Korea.	btsang@ohri.ca		Tsang, Benjamin K./0000-0003-1213-3946	World Class University (WCU) program through the National Research Foundation of Korea [R31-10056]; Ministry of Education, Science and Technology; Canadian Institutes of Health Research [MOP-119381]	World Class University (WCU) program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the World Class University (WCU) program (R31-10056) through the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology and the Canadian Institutes of Health Research (MOP-119381). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama S, 1999, ANTI-CANCER DRUG DES, V14, P143; ANDREWS PA, 1985, CANCER RES, V45, P6250; Asselin E, 2001, CANCER RES, V61, P1862; Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Delivani P, 2006, MOL CELL, V21, P761, DOI 10.1016/j.molcel.2006.01.034; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; DISAIA PJ, 1972, AM J OBSTET GYNECOL, V114, P979, DOI 10.1016/0002-9378(72)90109-3; Golovine KV, 2013, PROSTATE, V73, P23, DOI 10.1002/pros.22535; Iwashita M, 2007, EUR J PHARMACOL, V570, P38, DOI 10.1016/j.ejphar.2007.05.073; Kask P, 1999, P NATL ACAD SCI USA, V96, P13756, DOI 10.1073/pnas.96.24.13756; Koopman WJH, 2006, CYTOM PART A, V69A, P1, DOI 10.1002/cyto.a.20198; Kuznetsov AV, 2010, J CELL MOL MED, V14, P417, DOI 10.1111/j.1582-4934.2009.00750.x; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Peng JY, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002212; Pepperkok R, 2006, NAT REV MOL CELL BIO, V7, P690, DOI 10.1038/nrm1979; Perfettini JL, 2005, TRENDS CELL BIOL, V15, P179, DOI 10.1016/j.tcb.2005.02.005; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Sheridan C, 2008, MOL CELL, V31, P570, DOI 10.1016/j.molcel.2008.08.002; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Yu TZ, 2005, J CELL SCI, V118, P4141, DOI 10.1242/jcs.02537	25	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74008	10.1371/journal.pone.0074008	http://dx.doi.org/10.1371/journal.pone.0074008			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040144	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300149
J	Ugolotti, R; Mesejo, P; Zongaro, S; Bardoni, B; Berto, G; Bianchi, F; Molineris, I; Giacobini, M; Cagnoni, S; Di Cunto, F				Ugolotti, Roberto; Mesejo, Pablo; Zongaro, Samantha; Bardoni, Barbara; Berto, Gaia; Bianchi, Federico; Molineris, Ivan; Giacobini, Mario; Cagnoni, Stefano; Di Cunto, Ferdinando			Visual Search of Neuropil-Enriched RNAs from Brain In Situ Hybridization Data through the Image Analysis Pipeline Hippo-ATESC	PLOS ONE			English	Article							MESSENGER-RNA; DIFFERENTIAL EVOLUTION; LOCALIZATION; EXPRESSION; IDENTIFICATION; SPINOPHILIN; DYNAMICS; SPINES; REGION; SIGNAL	Motivation: RNA molecules specifically enriched in the neuropil of neuronal cells and in particular in dendritic spines are of great interest for neurobiology in virtue of their involvement in synaptic structure and plasticity. The systematic recognition of such molecules is therefore a very important task. High resolution images of RNA in situ hybridization experiments contained in the Allen Brain Atlas (ABA) represent a very rich resource to identify them and have been so far exploited for this task through human-expert analysis. However, software tools that may automatically address the same objective are not very well developed. Results: In this study we describe an automatic method for exploring in situ hybridization data and discover neuropil-enriched RNAs in the mouse hippocampus. We called it Hippo-ATESC (Automatic Texture Extraction from the Hippocampal region using Soft Computing). Bioinformatic validation showed that the Hippo-ATESC is very efficient in the recognition of RNAs which are manually identified by expert curators as neuropil-enriched on the same image series. Moreover, we show that our method can also highlight genes revealed by microdissection-based methods but missed by human visual inspection. We experimentally validated our approach by identifying a non-coding transcript enriched in mouse synaptosomes. The code is freely available on the web at http://ibislab.ce.unipr.it/software/hippo/.	[Ugolotti, Roberto; Mesejo, Pablo; Cagnoni, Stefano] Univ Parma, Dept Informat Engn, I-43100 Parma, Italy; [Zongaro, Samantha; Bardoni, Barbara] Univ Nice Sophia Antipolis, Inst Mol & Cellular Pharmacol, CNRS UMR 7275, Valbonne, France; [Berto, Gaia; Bianchi, Federico; Molineris, Ivan; Di Cunto, Ferdinando] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Ctr Mol Biotechnol, Turin, Italy; [Giacobini, Mario] Univ Turin, Dept Vet Sci, Turin, Italy; [Di Cunto, Ferdinando] Univ Turin, NIT, Turin, Italy	University of Parma; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; University of Turin; University of Turin; University of Turin	Cagnoni, S (corresponding author), Univ Parma, Dept Informat Engn, I-43100 Parma, Italy.	cagnoni@ce.unipr.it; ferdinando.dicunto@unito.it	cagnoni, stefano/E-7506-2010; Di Cunto, Ferdinando/K-5575-2016; Bardoni, Barbara/F-9918-2013; Mesejo, Pablo/K-4589-2014	cagnoni, stefano/0000-0003-4669-512X; Mesejo, Pablo/0000-0001-9955-2101; Molineris, Ivan/0000-0003-2102-0804; Bardoni, Barbara/0000-0001-6411-1517; di cunto, ferdinando/0000-0001-9367-6357; Bianchi, Federico Tommaso/0000-0002-8385-3310	Neuroscience Program of the "Compagnia di S.Paolo"; Telethon Foundation; Jerome Lejeune Foundation; European Commission [238819]; INSERM; CNRS; ANR [E-RARE 09]; Fondation pour la Recherche Medicale	Neuroscience Program of the "Compagnia di S.Paolo"; Telethon Foundation(Fondazione Telethon); Jerome Lejeune Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was funded by the Neuroscience Program of the "Compagnia di S.Paolo" to MG, SC and FDC. FDC is also funded by the Telethon Foundation and by the Jerome Lejeune Foundation. Roberto Ugolotti was funded through a fellowship from the same program. Pablo Mesejo was funded by the European Commission (MIBISOC Marie Curie Initial Training Network, FP7 PEOPLE-ITN-2008, GA n.238819). BB is supported by INSERM, CNRS, ANR (E-RARE 09), Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Banks A, 2007, NATURAL COMPUTING; Bockers TM, 2004, MOL CELL NEUROSCI, V26, P182, DOI 10.1016/j.mcn.2004.01.009; Bramham CR, 2008, CURR OPIN NEUROBIOL, V18, P524, DOI 10.1016/j.conb.2008.09.013; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BURGIN KE, 1990, J NEUROSCI, V10, P1788; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Das S, 2011, IEEE T EVOLUT COMPUT, V15, P4, DOI 10.1109/TEVC.2010.2059031; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; Gendreau M, 2010, HDB METAHEURISTICS; Goldberg D. E., 1989, GENETIC ALGORITHMS S, DOI DOI 10.1111/J.1365-2486.2009.02080.X; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hatada I, 2001, J BIOCHEM, V130, P187, DOI 10.1093/oxfordjournals.jbchem.a002971; Herb A, 1997, MOL CELL NEUROSCI, V8, P367, DOI 10.1006/mcne.1996.0594; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Holland J.H., 1992, ADAPTATION NATURAL A; Jain AK, 1998, SIGNAL PROCESS, V72; Kremerskothen J, 2006, J NEUROCHEM, V96, P1659, DOI 10.1111/j.1471-4159.2006.03679.x; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI [10.1090/qam/10666, DOI 10.1090/QAM/10666]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsumoto S, 2012, MITOCHONDRION, V12, P391, DOI 10.1016/j.mito.2012.02.004; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mesejo P, 2013, PATTERN RECOGN LETT, V34, P299, DOI 10.1016/j.patrec.2012.10.012; Mikl M, 2010, J COMP PHYSIOL A, V196, P321, DOI 10.1007/s00359-010-0520-x; Muslimov IA, 2006, J CELL BIOL, V175, P427, DOI 10.1083/jcb.200607008; Ng LL, 2012, INT REV NEUROBIOL, V104, P159, DOI 10.1016/B978-0-12-398323-7.00007-0; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Peyron F, 1997, J NEUROSCI RES, V50, P190; Poon MM, 2006, J NEUROSCI, V26, P13390, DOI 10.1523/JNEUROSCI.3432-06.2006; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Saneyoshi T, 2010, CURR OPIN NEUROBIOL, V20, P108, DOI 10.1016/j.conb.2009.09.013; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; Siegel G, 2011, CURR OPIN GENET DEV, V21, P491, DOI 10.1016/j.gde.2011.04.008; Sironi C, 2009, J CELL SCI, V122, P2108, DOI 10.1242/jcs.042325; Subramanian M, 2011, EMBO REP, V12, P697, DOI 10.1038/embor.2011.76; Swanger SA, 2011, CURR OPIN GENET DEV, V21, P414, DOI 10.1016/j.gde.2011.04.002; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Tiruchinapalli DM, 2003, J NEUROSCI, V23, P3251; Tolino M, 2012, EUR J NEUROSCI, V35, P1818, DOI 10.1111/j.1460-9568.2012.08160.x; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002; Zhong J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-17; Zhong J, 2009, J NEUROSCI, V29, P9977, DOI 10.1523/JNEUROSCI.3893-08.2009; Zongaro S, 2013, HUM MOL GEN IN PRESS	48	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74481	10.1371/journal.pone.0074481	http://dx.doi.org/10.1371/journal.pone.0074481			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040258	gold, Green Submitted, Green Published			2022-12-25	WOS:000326405300176
J	Kalezic, I; Steffens, H				Kalezic, Ivana; Steffens, Heinz			Changes in Tetrodotoxin-Resistant C-Fibre Activity during Fatiguing Isometric Contractions in the Rat	PLOS ONE			English	Article							IV MUSCLE AFFERENTS; GROUP-III; HINDLIMB MUSCLES; FOS EXPRESSION; REFLEX; STIMULATION; INHIBITION; POTENTIALS; RESPONSES; SKIN	It is by now well established that tetrodotoxin-resistant (TTX-R) afferent fibres from muscle in the rat exhibit a multisensitive profile, including nociception. TTX-R afferent fibres play an important role in motor control, via spinal and supraspinal loops, but their activation and function during muscle exercise and fatigue are still unknown. Therefore, the specific effect of isometric fatiguing muscle contraction on the responsiveness of TTX-R C-fibres has been investigated in this study. To quantify the TTX-R afferent input we recorded the cord dorsum potential (CDP), which is the result of the electrical fields set up within the spinal cord by the depolarisation of the interneurons located in the dorsal horn, activated by an incoming volley of TTX-R muscle afferents. The changes in TTX-R CDP size before, during and after fatiguing electrical stimulation of the gastrocnemius-soleus (GS) muscle have been taken as a measure of TTX-R C-unit activation. At the end of the fatiguing protocol, following an exponential drop in force, TTX-R CDP area decreased in the majority of trials (9/14) to 0.75 +/- 0.03% (mean +/- SEM) of the pre-fatigue value. Recovery to the control size of the TTX-R CDP was incomplete after 10 min. Furthermore, fatiguing trials could sensitise a fraction of the TTX-R C-fibres responding to muscle pinch. The results suggest a long-lasting activation of the TTX-R muscle afferents after fatiguing stimulation. The role of this behaviour in chronic muscle fatigue in connection with pain development is discussed. Accumulation of metabolites released into the interstitium during fatiguing stimulation might be one of the reasons underlying the C-fibres' long-lasting activation.	[Kalezic, Ivana] Umea Univ, Dept Surg & Perioperat Sci, Sport Med Unit, Umea, Sweden; [Kalezic, Ivana] Univ Gavle, Ctr Musculoskeletal Res, Umea, Sweden; [Steffens, Heinz] Univ Gottingen, Inst Physiol, D-37073 Gottingen, Germany	Umea University; University of Gavle; University of Gottingen	Kalezic, I (corresponding author), Umea Univ, Dept Surg & Perioperat Sci, Sport Med Unit, Umea, Sweden.	ilona@eunet.rs			Sport Medicine Unit, Umea University; STINT (The Swedish Foundation for International Cooperation in Research and Higher Education); Sport Medicine Unit, Umea University, Sweden	Sport Medicine Unit, Umea University; STINT (The Swedish Foundation for International Cooperation in Research and Higher Education); Sport Medicine Unit, Umea University, Sweden	IK was supported by Sport Medicine Unit, Umea University and by STINT (The Swedish Foundation for International Cooperation in Research and Higher Education). HS was supported by Sport Medicine Unit, Umea University, Sweden. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ANDERSSON O, 1981, ACTA PHYSIOL SCAND, V113, P89, DOI 10.1111/j.1748-1716.1981.tb06867.x; BIGLANDRITCHIE BR, 1986, J PHYSIOL-LONDON, V379, P451, DOI 10.1113/jphysiol.1986.sp016263; Darques JL, 1998, NEUROSCI LETT, V257, P109; Darques JL, 1997, BRAIN RES, V750, P147, DOI 10.1016/S0006-8993(96)01341-8; Decherchi P, 2003, CAN J NEUROL SCI, V30, P91, DOI 10.1017/S0317167100053348; Djouhri L, 2003, J PHYSIOL-LONDON, V550, P739, DOI 10.1113/jphysiol.2003.042127; Fang X, 2002, J NEUROSCI, V22, P7425; GARLAND SJ, 1988, J PHYSIOL-LONDON, V401, P547, DOI 10.1113/jphysiol.1988.sp017178; Gold MS, 1999, P NATL ACAD SCI USA, V96, P7645, DOI 10.1073/pnas.96.14.7645; Hill JM, 2000, BRAIN RES, V856, P240, DOI 10.1016/S0006-8993(99)02366-5; JOHANSSON H, 2003, CHRONIC WORK RELATED; Kalezic I, 2004, J PHYSIOL-LONDON, V556, P283, DOI 10.1113/jphysiol.2003.053249; KAUFMAN MP, 1987, CIRC RES, V61, P60; KAUFMAN MP, 1984, CARDIOVASC RES, V18, P663, DOI 10.1093/cvr/18.11.663; KAUFMAN MP, 1983, J APPL PHYSIOL, V55, P105, DOI 10.1152/jappl.1983.55.1.105; Lambertz D, 2008, EUR J PAIN, V12, P686, DOI 10.1016/j.ejpain.2007.10.015; Lambertz D, 2006, NEUROSCI LETT, V409, P14, DOI 10.1016/j.neulet.2006.09.016; Le Bars D, 2002, ANN FR ANESTH, V21, P315, DOI 10.1016/S0750-7658(02)00592-0; Maisky VA, 2002, AUTON NEUROSCI-BASIC, V101, P1, DOI 10.1016/S1566-0702(02)00146-7; Matthews EA, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-5; MCCLOSKE.DI, 1972, J PHYSIOL-LONDON, V224, P173, DOI 10.1113/jphysiol.1972.sp009887; MENSE S, 1983, J PHYSIOL-LONDON, V342, P383, DOI 10.1113/jphysiol.1983.sp014857; MENSE S, 1993, PAIN, V54, P241, DOI 10.1016/0304-3959(93)90027-M; MENSE S, 1986, NEUROSCI LETT, V66, P169, DOI 10.1016/0304-3940(86)90185-0; Noguchi E, 1999, J AUTONOM NERV SYST, V75, P78, DOI 10.1016/S0165-1838(98)00144-1; PAINTAL AS, 1960, J PHYSIOL-LONDON, V152, P250, DOI 10.1113/jphysiol.1960.sp006486; Pettorossi VE, 1999, J PHYSIOL-LONDON, V515, P599, DOI 10.1111/j.1469-7793.1999.599ac.x; Pilyavskii AI, 2001, BRAIN RES, V923, P91, DOI 10.1016/S0006-8993(01)03049-9; Rossi A, 1999, BRAIN RES, V815, P106, DOI 10.1016/S0006-8993(98)01111-1; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; Schomburg ED, 1999, NEUROSCI RES, V33, P195, DOI 10.1016/S0168-0102(99)00006-1; Schomburg ED, 2000, NEUROSCI RES, V37, P277, DOI 10.1016/S0168-0102(00)00129-2; Schomburg ED, 2011, NEUROSCI RES, V69, P241, DOI 10.1016/j.neures.2010.12.005; Steffens H, 2003, PFLUG ARCH EUR J PHY, V445, P607, DOI 10.1007/s00424-002-0970-2; Steffens H, 2001, NEUROSCI RES, V39, P413, DOI 10.1016/S0168-0102(01)00198-5; Williams CA, 2000, BRAIN RES, V852, P424, DOI 10.1016/S0006-8993(99)02217-9; Willis WD, 1999, EXP BRAIN RES, V124, P395, DOI 10.1007/s002210050637; Wilson LB, 1999, AM J PHYSIOL-REG I, V276, pR1639, DOI 10.1152/ajpregu.1999.276.6.R1639; Windhorst U, 1995, ADV EXP MED BIOL, V384, P241; Windhorst U, 1997, NEUROSCIENCE, V76, P915; Windhorst U, 1997, NEUROSCI RES, V27, P235, DOI 10.1016/S0168-0102(97)01157-7; WOODS JJ, 1987, J NEUROPHYSIOL, V58, P125, DOI 10.1152/jn.1987.58.1.125; Zimmermann K, 2007, NATURE, V447, P855, DOI 10.1038/nature05880	43	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73980	10.1371/journal.pone.0073980	http://dx.doi.org/10.1371/journal.pone.0073980			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040134	gold, Green Published, Green Submitted			2022-12-25	WOS:000324481600110
J	Luna, S; Cameron, DJ; Ethell, DW				Luna, Salvadore; Cameron, D. Joshua; Ethell, Douglas W.			Amyloid-beta and APP Deficiencies Cause Severe Cerebrovascular Defects: Important Work for an Old Villain	PLOS ONE			English	Article							GAMMA-SECRETASE INHIBITOR; ALZHEIMERS-DISEASE	Alzheimer's disease (AD) is marked by neuritic plaques that contain insoluble deposits of amyloid-beta (A beta), yet the physiological function of this peptide has remained unclear for more than two decades. Using genetics and pharmacology we have established that A beta plays an important role in regulating capillary bed density within the brain, a function that is distinct from other cleavage products of amyloid precursor protein (APP). APP-deficient zebrafish had fewer cerebrovascular branches and shorter vessels in the hindbrain than wild-type embryos; this phenotype was rescued by treatment with human A beta peptide, but not a smaller APP fragment called p3. Similar vascular defects were seen in zebrafish treated with a beta-secretase inhibitor (BSI) that blocked endogenous A beta production. BSI-induced vascular defects were also improved by treatment with human A beta, but not p3. Our results demonstrate a direct correlation between extracellular levels of A beta and cerebrovascular density in the developing hindbrain. These findings may be relevant to AD etiology where high levels of A beta in the brain parenchyma precede the development of neuritic plaques and dense aberrantly-branched blood vessel networks that appear between them. The ability of A beta to modify blood vessels may coordinate capillary density with local metabolic activity, which could explain the evolutionary conservation of this peptide from lobe-finned fish to man.	[Luna, Salvadore; Cameron, D. Joshua; Ethell, Douglas W.] Western Univ Hlth Sci, Pomona, CA USA; [Luna, Salvadore; Ethell, Douglas W.] Western Univ Hlth Sci, Grad Coll Biomed Sci, Pomona, CA USA; [Cameron, D. Joshua] Western Univ Hlth Sci, Coll Optometry, Pomona, CA USA; [Ethell, Douglas W.] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Pomona, CA USA	Western University of Health Sciences; Western University of Health Sciences; Western University of Health Sciences; Western University of Health Sciences	Ethell, DW (corresponding author), Western Univ Hlth Sci, Pomona, CA USA.	dougeth64@gmail.com		Cameron, Joshua/0000-0002-4821-2761; Ethell, Douglas/0000-0002-9237-0265	Molecular Neurobiology Laboratory; Western University of Health Sciences; California Institute for Regenerative Medicine [RN1-00538]	Molecular Neurobiology Laboratory; Western University of Health Sciences; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	Funding provided by the Molecular Neurobiology Laboratory and Western University of Health Sciences to DJC and DWE, and a grant from the California Institute for Regenerative Medicine to DWE (RN1-00538). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer A., 1907, ALLGEMEINE Z PSYCHIA, V64, P146, DOI DOI 10.1002/CA.980080612; Cameron DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039598; Carlson C, 2011, ALZHEIMERS DEMENT, V7, P396, DOI 10.1016/j.jalz.2011.05.2353; Coburn CA, 2004, J MED CHEM, V47, P6117, DOI 10.1021/jm049388p; Crump CJ, 2012, BIOCHEMISTRY-US, V51, P7209, DOI 10.1021/bi301137h; Cunvong K, 2013, INVEST OPHTH VIS SCI, V54, P1516, DOI 10.1167/iovs.12-10821; Ethell DW, 2010, NEUROSCIENTIST, V16, P614, DOI 10.1177/1073858410366162; Ethell DW, 2002, CURR BIOL, V12, P1595, DOI 10.1016/S0960-9822(02)01140-5; Extance A, 2010, NAT REV DRUG DISCOV, V9, P749, DOI 10.1038/nrd3288; Ghosh AK, 2007, J MED CHEM, V50, P2399, DOI 10.1021/jm061338s; Goate A, 2012, J NEUROCHEM, V120, P3, DOI 10.1111/j.1471-4159.2011.07575.x; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; Hopkins CR, 2011, ACS CHEM NEUROSCI, V2, P279, DOI 10.1021/cn2000469; Joshi P, 2009, DEV BIOL, V335, P1, DOI 10.1016/j.ydbio.2009.07.041; Meyer EP, 2008, P NATL ACAD SCI USA, V105, P3587, DOI 10.1073/pnas.0709788105; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schor NF, 2011, ANN NEUROL, V69, P237, DOI 10.1002/ana.22365; Siemers ER, 2006, NEUROLOGY, V66, P602, DOI 10.1212/01.WNL.0000198762.41312.E1; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Tong G, 2012, CLIN THER, V34, P654, DOI 10.1016/j.clinthera.2012.01.022; Westerfield M, 2007, ZEBRAFISH BOOK	22	36	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e75052	10.1371/journal.pone.0075052	http://dx.doi.org/10.1371/journal.pone.0075052			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040383	gold, Green Published, Green Submitted			2022-12-25	WOS:000324481600155
J	West, MB; Chen, YY; Wickham, S; Heroux, A; Cahill, K; Hanigan, MH; Mooers, BHM				West, Matthew B.; Chen, Yunyu; Wickham, Stephanie; Heroux, Ann; Cahill, Kyle; Hanigan, Marie H.; Mooers, Blaine H. M.			Novel Insights into Eukaryotic gamma-Glutamyltranspeptidase 1 from the Crystal Structure of the Glutamate-bound Human Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; CATALYTIC MECHANISM; ESCHERICHIA-COLI; PHASE-I; TRANSFERASE; GLYCOSYLATION; GLUTATHIONE; ACIVICIN; SEQUENCE; PROTEIN	The enzyme gamma-glutamyltranspeptidase 1 (GGT1) is a conserved member of the N-terminal nucleophile hydrolase family that cleaves the gamma-glutamyl bond of glutathione and other gamma-glutamyl compounds. In animals, GGT1 is expressed on the surface of the cell and has critical roles in maintaining cysteine levels in the body and regulating intracellular redox status. Expression of GGT1 has been implicated as a potentiator of asthma, cardiovascular disease, and cancer. The rational design of effective inhibitors of human GGT1(hGGT1) has been delayed by the lack of a reliable structural model. The available crystal structures of several bacterial GGTs have been of limited use due to differences in the catalytic behavior of bacterial and mammalian GGTs. We report the high resolution (1.67 angstrom) crystal structure of glutamate-bound hGGT1, the first of any eukaryotic GGT. Comparisons of the active site architecture of hGGT1 with those of its bacterial orthologs highlight key differences in the residues responsible for substrate binding, including a bimodal switch in the orientation of the catalytic nucleophile (Thr-381) that is unique to the human enzyme. Compared with several bacterial counterparts, the lid loop in the crystal structure of hGGT1 adopts an open conformation that allows greater access to the active site. The hGGT1 structure also revealed tightly bound chlorides near the catalytic residue that may contribute to catalytic activity. These are absent in the bacterial GGTs. These differences between bacterial and mammalian GGTs and the new structural data will accelerate the development of new therapies for GGT1-dependent diseases.	[West, Matthew B.; Wickham, Stephanie; Hanigan, Marie H.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Chen, Yunyu; Cahill, Kyle; Mooers, Blaine H. M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Hanigan, Marie H.; Mooers, Blaine H. M.] Univ Oklahoma, Hlth Sci Ctr, Stephenson Canc Ctr, Oklahoma City, OK 73104 USA; [Heroux, Ann] Brookhaven Natl Lab, Upton, NY 11973 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; United States Department of Energy (DOE); Brookhaven National Laboratory	Mooers, BHM (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, 975 NE 10th St,BRC 466, Oklahoma City, OK 73104 USA.	blaine-mooers@ouhsc.edu	Mooers, Blaine/S-4383-2017	Mooers, Blaine/0000-0001-8181-8987	United States Department of Energy Offices of Biological and Environmental Research; Basic Energy Sciences; National Institutes of Health [P41RR012408, P41GM103473]; NATIONAL CANCER INSTITUTE [R56CA057530, F32CA128338] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103473, P20GM103640] Funding Source: NIH RePORTER	United States Department of Energy Offices of Biological and Environmental Research(United States Department of Energy (DOE)); Basic Energy Sciences(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Donald Capra for a critical review of the manuscript. X-ray diffraction data were collected at the National Synchrotron Light Source, for which financial support comes principally from the United States Department of Energy Offices of Biological and Environmental Research and of Basic Energy Sciences and from National Institutes of Health Grants P41RR012408 and P41GM103473.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALLISON RD, 1985, METHOD ENZYMOL, V113, P419; Boanca G, 2007, J BIOL CHEM, V282, P534, DOI 10.1074/jbc.M607694200; Boanca G, 2006, J BIOL CHEM, V281, P19029, DOI 10.1074/jbc.M603381200; Castellano I, 2012, CELL MOL LIFE SCI, V69, P3381, DOI 10.1007/s00018-012-0988-3; Castonguay R, 2007, BIOCHEMISTRY-US, V46, P12253, DOI 10.1021/bi700956c; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cooper AJL, 2010, COMPREHENSIVE TOXICOLOGY, VOL 4: BIOTRANSFORMATION, 2ND EDITION, P323; CURTHOYS NP, 1979, ENZYME, V24, P383, DOI 10.1159/000458694; Diergaarde B, 2010, PANCREATOLOGY, V10, P194, DOI 10.1159/000236023; DUGGLEBY HJ, 1995, NATURE, V373, P264, DOI 10.1038/373264a0; EARHART RH, 1983, CANCER TREAT REP, V67, P683; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; ELCE JS, 1976, BIOCHEM J, V153, P223, DOI 10.1042/bj1530223; Emdin M, 2005, CIRCULATION, V112, P2078, DOI 10.1161/CIRCULATIONAHA.105.571919; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FLEISHMAN G, 1983, CANCER TREAT REP, V67, P843; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hanigan MH, 1999, CARCINOGENESIS, V20, P553, DOI 10.1093/carcin/20.4.553; HANIGAN MH, 1993, BIOCHEMISTRY-US, V32, P6302, DOI 10.1021/bi00075a026; Hidalgo M, 1998, CLIN CANCER RES, V4, P2763; Hu X, 2012, BIOCHEMISTRY-US, V51, P1199, DOI 10.1021/bi200987b; IKEDA Y, 1993, J BIOL CHEM, V268, P3980; IKEDA Y, 1995, J BIOL CHEM, V270, P22223, DOI 10.1074/jbc.270.38.22223; Ikeda Y, 1996, J BIOCHEM-TOKYO, V119, P1166; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; King JB, 2009, J BIOL CHEM, V284, P9059, DOI 10.1074/jbc.M809608200; Kinlough CL, 2005, METHOD ENZYMOL, V401, P426, DOI 10.1016/S0076-6879(05)01026-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lieberman MW, 1996, P NATL ACAD SCI USA, V93, P7923, DOI 10.1073/pnas.93.15.7923; Lodola A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032397; Lowry MH, 2008, AM J RESP CELL MOL, V38, P509, DOI 10.1165/rcmb.2007-0128OC; Minami H, 2003, ENZYME MICROB TECH, V32, P431, DOI 10.1016/S0141-0229(02)00314-9; Morrow AL, 2007, BIOCHEMISTRY-US, V46, P13407, DOI 10.1021/bi701599e; Oinonen C, 2000, PROTEIN SCI, V9, P2329, DOI 10.1110/ps.9.12.2329; Okada T, 2007, J BIOL CHEM, V282, P2433, DOI 10.1074/jbc.M607490200; RAJPERTDEMEYTS E, 1988, P NATL ACAD SCI USA, V85, P8840, DOI 10.1073/pnas.85.23.8840; Rojas E, 2000, MUTAT RES-FUND MOL M, V447, P305, DOI 10.1016/S0027-5107(99)00191-8; Shapovalov MV, 2011, STRUCTURE, V19, P844, DOI 10.1016/j.str.2011.03.019; SIAN J, 1994, ANN NEUROL, V36, P356, DOI 10.1002/ana.410360306; Suzuki H, 2002, J BIOL CHEM, V277, P43536, DOI 10.1074/jbc.M207680200; SUZUKI H, 1986, J BACTERIOL, V168, P1325, DOI 10.1128/jb.168.3.1325-1331.1986; Taniguchi N, 1998, ADV ENZYMOL RAMB, V72, P239; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorn A, 2011, J APPL CRYSTALLOGR, V44, P1285, DOI [10.1107/S00218898110417681285, 10.1107/S0021889811041768]; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wada K, 2010, FEBS J, V277, P1000, DOI 10.1111/j.1742-4658.2009.07543.x; West MB, 2013, ANTIOXID REDOX SIGN, V19, P1877, DOI 10.1089/ars.2012.4997; West MB, 2011, J BIOL CHEM, V286, P28876, DOI 10.1074/jbc.M111.248823; West MB, 2010, J BIOL CHEM, V285, P29511, DOI 10.1074/jbc.M110.145938; Wickham S, 2013, BIOCHEM J, V450, P547, DOI 10.1042/BJ20121435; Wickham S, 2012, J ENZYM INHIB MED CH, V27, P476, DOI 10.3109/14756366.2011.597748; Wickham S, 2011, ANAL BIOCHEM, V414, P208, DOI 10.1016/j.ab.2011.03.026	55	54	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31902	31913		10.1074/jbc.M113.498139	http://dx.doi.org/10.1074/jbc.M113.498139			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24047895	Green Published, hybrid			2022-12-25	WOS:000330596200039
J	Li, HL; Zuccolo, J; Kem, DC; Zillner, C; Lee, J; Smith, K; James, JA; Cunningham, MW; Yu, XC				Li, Hongliang; Zuccolo, Jonathan; Kem, David C.; Zillner, Caitlin; Lee, Jiyeon; Smith, Kenneth; James, Judith A.; Cunningham, Madeleine W.; Yu, Xichun			Implications of a Vasodilatory Human Monoclonal Autoantibody in Postural Hypotension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adrenergic Receptor; Autoimmunity; Cardiovascular Disease; Pathogenesis; Vascular; Human Monoclonal Autoantibody; Postural Hypotension; Vasodilatory	IDIOPATHIC DILATED CARDIOMYOPATHY; BETA-ADRENERGIC-RECEPTORS; MUSCARINIC RECEPTORS; ALPHA(1)-ADRENERGIC RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; ACTIVATING AUTOANTIBODIES; ORTHOSTATIC HYPOTENSION; ATRIAL-FIBRILLATION; EXTRACELLULAR LOOP; SEQUENCE-ANALYSIS	Functional autoantibodies to the autonomic receptors are increasingly recognized in the pathophysiology of cardiovascular diseases. To date, no human activating monoclonal autoantibodies to these receptors have been available. In this study, we describe for the first time a (2)-adrenergic receptor ((2)AR)-activating monoclonal autoantibody (C5F2) produced from the lymphocytes of a patient with idiopathic postural hypotension. C5F2, an IgG3 isotype, recognizes an epitope in the N terminus of the second extracellular loop (ECL2) of (2)AR. Surface plasmon resonance analysis revealed high binding affinity for the (2)AR ECL2 peptide. Immunoblotting and immunofluorescence demonstrated specific binding to (2)AR in H9c2 cardiomyocytes, CHO cells expressing human (2)AR, and rat aorta. C5F2 stimulated cyclic AMP production in (2)AR-transfected CHO cells and induced potent dilation of isolated rat cremaster arterioles, both of which were specifically blocked by the (2)AR-selective antagonist ICI-118551 and by the (2)AR ECL2 peptide. This monoclonal antibody demonstrated sufficient activity to produce postural hypotension in its host. Its availability provides a unique opportunity to identify previously unrecognized causes and new pharmacological management of postural hypotension and other cardiovascular diseases.	[Li, Hongliang; Kem, David C.; Zillner, Caitlin; Lee, Jiyeon; James, Judith A.; Yu, Xichun] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA; [Zuccolo, Jonathan; James, Judith A.; Cunningham, Madeleine W.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA; [Li, Hongliang; Kem, David C.; Zillner, Caitlin; Yu, Xichun] Oklahoma Med Res Fdn, Oklahoma City Vet Affairs Med Ctr, Oklahoma City, OK 73104 USA; [Smith, Kenneth; James, Judith A.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation	Yu, XC (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, TCH 6E103,1200 Everett Dr, Oklahoma City, OK 73104 USA.	xichun-yu@ouhsc.edu	Li, Hongliang/AAV-1697-2020		National Institutes of Health [R01 HL056267, P30 GM103510]; Veterans Affairs Merit Review grant; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL056267, R01HL056267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103510] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review grant(US Department of Veterans Affairs); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL056267 and P30 GM103510. This work was also supported by a Veterans Affairs Merit Review grant, an American Heart Association postdoctoral fellowship, and individual grant support from Will and Helen Webster.	Adderson EE, 1998, J IMMUNOL, V161, P2020; Baba A, 2004, EUR HEART J, V25, P1108, DOI 10.1016/j.ehj.2004.05.012; BENOVIC JL, 1984, BIOCHEMISTRY-US, V23, P4510, DOI 10.1021/bi00315a002; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Chiale PA, 2001, CIRCULATION, V103, P1765, DOI 10.1161/01.CIR.103.13.1765; Chiale PA, 2006, HEART RHYTHM, V3, P1182, DOI 10.1016/j.hrthm.2006.06.011; Dragun D, 2009, THROMB HAEMOSTASIS, V101, P643, DOI 10.1160/TH08-10-0710; FU MLX, 1994, LANCET, V344, P1660, DOI 10.1016/S0140-6736(94)90456-1; Fu MLX, 1996, CLIN IMMUNOL IMMUNOP, V78, P203, DOI 10.1006/clin.1996.0030; Giudicelli V, 2004, NUCLEIC ACIDS RES, V32, pW435, DOI 10.1093/nar/gkh412; Hill MA, 2000, AM J PHYSIOL-HEART C, V278, pH345, DOI 10.1152/ajpheart.2000.278.2.H345; Hoebeke J, 1996, INT J CARDIOL, V54, P103, DOI 10.1016/0167-5273(96)02586-7; Jahns R, 2004, J CLIN INVEST, V113, P1419, DOI 10.1172/JCI200420149; Jahns R, 1999, CIRCULATION, V99, P649, DOI 10.1161/01.CIR.99.5.649; Lebesgue D, 1998, EUR J PHARMACOL, V348, P123, DOI 10.1016/S0014-2999(98)00136-8; Li HL, 2013, HEART RHYTHM, V10, P436, DOI 10.1016/j.hrthm.2012.11.010; Li HL, 2012, HYPERTENSION, V59, P402, DOI 10.1161/HYPERTENSIONAHA.111.184937; Luther HP, 1997, HYPERTENSION, V29, P678, DOI 10.1161/01.HYP.29.2.678; MAGNUSSON Y, 1994, CIRCULATION, V89, P2760, DOI 10.1161/01.CIR.89.6.2760; Mascaro-Blanco A, 2008, AUTOIMMUNITY, V41, P442, DOI 10.1080/08916930802031579; Matsui S, 1997, J MOL CELL CARDIOL, V29, P641, DOI 10.1006/jmcc.1996.0307; McLachlan SM, 2004, CLIN ENDOCRINOL, V61, P10, DOI 10.1111/j.1365-2265.2004.02028.x; Mijares A, 2000, MOL PHARMACOL, V58, P373, DOI 10.1124/mol.58.2.373; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; MURRAY KJ, 1990, PHARMACOL THERAPEUT, V47, P329, DOI 10.1016/0163-7258(90)90060-F; NODA K, 1994, J BIOL CHEM, V269, P6743; Peter JC, 2003, J BIOL CHEM, V278, P36740, DOI 10.1074/jbc.M306877200; Queen LR, 2006, CELL MOL LIFE SCI, V63, P1070, DOI 10.1007/s00018-005-5451-2; Sanders J, 2003, LANCET, V362, P126, DOI 10.1016/S0140-6736(03)13866-4; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Stavrakis S, 2009, J AM COLL CARDIOL, V54, P1309, DOI 10.1016/j.jacc.2009.07.015; WALLUKAT G, 1991, EUR HEART J, V12, P178, DOI 10.1093/eurheartj/12.suppl_D.178; Wallukat G, 1999, LIFE SCI, V64, P465, DOI 10.1016/S0024-3205(98)00589-X; Wallukat G, 2000, HERZ, V25, P261, DOI 10.1007/s000590050017; Wenzel K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009409; Wenzel K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003742; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Yu XC, 2012, J AM SOC HYPERTENS, V6, P40, DOI 10.1016/j.jash.2011.10.003; Zhou ZH, 2005, CLIN IMMUNOL, V114, P164, DOI 10.1016/j.clim.2004.09.011	39	7	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30734	30741		10.1074/jbc.M113.477869	http://dx.doi.org/10.1074/jbc.M113.477869			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24043632	hybrid, Green Published			2022-12-25	WOS:000329868100073
J	Amaral, CRL; Brito, PM; Silva, DA; Carvalho, EF				Amaral, Cesar R. L.; Brito, Paulo M.; Silva, Dayse A.; Carvalho, Elizeu F.			A New Cryptic Species of South American Freshwater Pufferfish of the Genus Colomesus (Tetraodontidae), Based on Both Morphology and DNA Data	PLOS ONE			English	Article							TUNA SUSHI; IDENTIFICATION; BARCODES; FISHES; DIVERSIFICATION; BIOGEOGRAPHY; FAUNA	The Tetraodontidae are an Acantomorpha fish family with circumglobal distribution composed of 189 species grouped in 19 genera, occurring in seas, estuaries, and rivers between the tropical and temperate regions. Of these, the genus Colomesus is confined to South America, with what have been up to now considered only two species. C. asellus is spread over the entire Amazon, Tocantins-Araguaia drainages, and coastal environments from the Amazon mouth to Venezuela, and is the only freshwater puffers on that continent. C. psittacus is found in coastal marine and brackish water environments from Cuba to the northern coast of South America as far south as to Sergipe in Brazil. In the present contribution we used morphological data along with molecular systematics techniques to investigate the phylogeny and phylogeography of the freshwater pufferfishes of the genus Colomesus. The molecular part is based on a cytochrome C oxidase subunit I dataset constructed from both previously published and newly determined sequences, obtained from specimens collected from three distinct localities in South America. Our results from both molecular and morphological approaches enable us to identify and describe a new Colomesus species from the Tocantins River. We also discuss aspects of the historical biogeography and phylogeography of the South American freshwater pufferfishes, suggesting that it could be more recent than previously expected.	[Amaral, Cesar R. L.; Brito, Paulo M.] Univ Estado Rio de Janeiro, Dept Zool, BR-20550011 Rio De Janeiro, Brazil; [Amaral, Cesar R. L.; Silva, Dayse A.; Carvalho, Elizeu F.] Univ Estado Rio de Janeiro, Dept Ecol, BR-20550011 Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	Amaral, CRL (corresponding author), Univ Estado Rio de Janeiro, Dept Zool, BR-20550011 Rio De Janeiro, Brazil.	crlamaral@yahoo.com.br	DE CARVALHO, ELIZEU F/B-8525-2013; Silva, D A/I-2043-2012; Amaral, Cesar/AAS-6841-2021	DE CARVALHO, ELIZEU F/0000-0003-4620-7253; Silva, D A/0000-0003-3805-2837; Brito, Paulo/0000-0002-4853-8630	Brazilian National Counsel of Technological and Scientific Development; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro	Brazilian National Counsel of Technological and Scientific Development; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This study was supported by the Brazilian National Counsel of Technological and Scientific Development and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; Amaral AR, 2007, MAR FRESHWATER RES, V58, P505, DOI 10.1071/MF07050; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Blessing JJ, 2010, J FISH BIOL, V76, P2571, DOI 10.1111/j.1095-8649.2010.02633.x; Bloch ME, 1801, SYSTEMA ICHTHYOLOGIA; Bloom DD, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P137; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Cohen NJ, 2009, J FOOD PROTECT, V72, P810, DOI 10.4315/0362-028X-72.4.810; Collins RA, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028381, 10.1371/journal.pone.0030581]; Farias IP, 2008, MOL PHYLOGENET EVOL, V49, P32, DOI 10.1016/j.ympev.2008.05.033; Gill TN, 1885, P US NAT MUS, V7, P411; Golding GB, 2009, MOL ECOL RESOUR, V9, pIV, DOI 10.1111/j.1755-0998.2009.02654.x; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hogg ID, 2004, CAN J ZOOL, V82, P749, DOI [10.1139/z04-041, 10.1139/Z04-041]; Holmes BH, 2009, FISH RES, V95, P280, DOI 10.1016/j.fishres.2008.09.036; Hrbek T, 2007, MOL PHYLOGENET EVOL, V43, P986, DOI 10.1016/j.ympev.2006.06.009; Hubert N, 2007, MOL ECOL, V16, P2115, DOI 10.1111/j.1365-294X.2007.03267.x; Hubert N, 2006, J BIOGEOGR, V33, P1414, DOI 10.1111/j.1365-2699.2006.01518.x; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Jarnegren J, 2007, MAR BIOL, V152, P43, DOI 10.1007/s00227-007-0651-y; Jegu M, 1999, CR ACAD SCI III-VIE, V322, P1133, DOI 10.1016/S0764-4469(99)00113-4; Kerr KCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004379; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lima FCT, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P145; Lovejoy NR, 2006, J S AM EARTH SCI, V21, P5, DOI 10.1016/j.jsames.2005.07.009; Lovejoy NR, 1998, NATURE, V396, P421, DOI 10.1038/24757; Lovejoy NR, 1997, SYST BIOL, V46, P218, DOI 10.2307/2413647; Lowenstein JH, 2010, BIOL LETTERS, V6, P692, DOI 10.1098/rsbl.2010.0156; Lowenstein JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007866; Lukhtanov VA, 2009, MOL ECOL RESOUR, V9, P1302, DOI 10.1111/j.1755-0998.2009.02577.x; Mabragana E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028655; Muller J, 1849, REISEN BRIT GUIANA J; Nuttall C.P., 1990, Bulletin of the British Museum (Natural History) Geology, V45, P165; Padilla DK, 2004, FRONT ECOL ENVIRON, V2, P131, DOI 10.1890/1540-9295(2004)002[0131:BBWAAO]2.0.CO;2; Palumbi Stephen R., 1996, P205; Ploeg A, 2009, BIOSECURITY ORNAMENT; SAADI A, 1993, GEONOMOS, V1, P1, DOI DOI 10.18285/GEONOMOS.V1I1E2.233; Saadi A, 2005, QUATERNARIO BRASIL, P211; Santini F, 2003, ZOOL J LINN SOC-LOND, V139, P565, DOI 10.1111/j.1096-3642.2003.00088.x; Santini F, 2013, J EVOLUTION BIOL, P1; Saunders GW, 2005, PHILOS T R SOC B, V360, P1879, DOI 10.1098/rstb.2005.1719; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; SONG JK, 1995, COPEIA, P114; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1994, NUCLEIC ACIDS RES, V24, P4876, DOI DOI 10.1093/NAR/25.24.4876; TYLER JAMES C., 1964, PROC ACAD NATUR SCI PHILADELPHIA, V116, P119; Tyler JC, 1980, NOAA TECHNICAL REPOR, V434, P1, DOI DOI 10.5962/BHL.TITLE.63022; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; WEBB SD, 1995, SCIENCE, V269, P361, DOI 10.1126/science.269.5222.361; Yamanoue Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017410	59	25	26	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74397	10.1371/journal.pone.0074397	http://dx.doi.org/10.1371/journal.pone.0074397			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040239	Green Submitted, gold, Green Published			2022-12-25	WOS:000326734500090
J	Graham, JR; Chamberland, A; Lin, QC; Li, XJ; Dai, D; Zeng, WL; Ryan, MS; Rivera-Bermudez, MA; Flannery, CR; Yang, ZY				Graham, Julie R.; Chamberland, Angela; Lin, Qingcong; Li, X. Jian; Dai, David; Zeng, Weilan; Ryan, Mark S.; Rivera-Bermudez, Moises A.; Flannery, Carl R.; Yang, Zhiyong			Serine Protease HTRA1 Antagonizes Transforming Growth Factor-beta Signaling by Cleaving Its Receptors and Loss of HTRA1 In Vivo Enhances Bone Formation	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SMALL-VESSEL DISEASE; MACULAR DEGENERATION; CANCELLOUS BONE; III RECEPTOR; LONG BONES; EXPRESSION; GENE; CARTILAGE; PROTEINS	HTRA1 is a member of the High Temperature Requirement (HTRA1) family of serine proteases, which play a role in several biological and pathological processes. In part, HTRA1 regulation occurs by inhibiting the TGF-beta signaling pathway, however the mechanism of inhibition has not been fully defined. Previous studies have shown that HTRA1 is expressed in a variety of tissues, including sites of skeletal development. HTRA1 has also been implicated in the process of bone formation, although the precise manner of regulation is still unknown. This study investigated how HTRA1 regulates TGF-beta signaling and examined the in vivo effects of the loss of HTRA1. We demonstrated that recombinant HTRA1 was capable of cleaving both type II and type III TGF-beta receptors (T beta RII and T beta RIII) in vitro in a dose-dependent manner, but it did not affect the integrity of T beta RI or TGF-beta. Overexpression of HTRA1 led to decreased levels of both T beta RII and III on the cell surface but had no effect on T beta RI. Silencing HTRA1 expression significantly increased TGF-beta binding to the cell surface and TGF-beta responsiveness within the cell. To examine the role of HTRA1 in vivo, we generated mice with a targeted gene deletion of HTRA1. Embryonic fibroblasts isolated from these mice displayed an increase in TGF-beta-induced expression of several genes known to promote bone formation. Importantly, the loss of HTRA1 in the knockout mice resulted in a marked increase in trabecular bone mass. This study has identified a novel regulatory mechanism by which HTRA1 antagonizes TGF-beta signaling, and has shown that HTRA1 plays a key role in the regulation of bone formation.	[Graham, Julie R.; Chamberland, Angela; Li, X. Jian; Dai, David; Zeng, Weilan; Rivera-Bermudez, Moises A.; Flannery, Carl R.; Yang, Zhiyong] Pfizer BioTherapeut Res, Inflammat & Remodeling Res Unit, Cambridge, MA USA; [Lin, Qingcong] Pfizer BioTherapeut Res, Global BioTherapeut Technol, Cambridge, MA USA; [Ryan, Mark S.] Pfizer BioTherapeut Res, Immunosci Res Unit, Cambridge, MA USA	Pfizer; Pfizer; Pfizer	Yang, ZY (corresponding author), Pfizer BioTherapeut Res, Inflammat & Remodeling Res Unit, Cambridge, MA USA.	zhiyong.yang@pfizer.com			Pfizer Inc.	Pfizer Inc.(Pfizer)	The authors have the following interests: This study was funded by Pfizer Inc. All authors are either current or former Pfizer employees. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Baffi MO, 2004, DEV BIOL, V276, P124, DOI 10.1016/j.ydbio.2004.08.027; BONEWALD LF, 1990, CLIN ORTHOP RELAT R, P261; Canalis E, 2010, ENDOCRINOLOGY, V151, P3490, DOI 10.1210/en.2010-0145; Chamberland A, 2009, J BIOL CHEM, V284, P27352, DOI 10.1074/jbc.M109.037051; Chien J, 2009, MOL CELL BIOL, V29, P4177, DOI 10.1128/MCB.00035-09; Clawson GA, 2008, J CELL BIOCHEM, V105, P81, DOI 10.1002/jcb.21804; Daci E, 2003, J BONE MINER RES, V18, P1167, DOI 10.1359/jbmr.2003.18.7.1167; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; Hadfield KD, 2008, J BIOL CHEM, V283, P5928, DOI 10.1074/jbc.M709299200; Hara K, 2009, NEW ENGL J MED, V360, P1729, DOI 10.1056/NEJMoa0801560; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167; Hu SI, 1998, J BIOL CHEM, V273, P34406, DOI 10.1074/jbc.273.51.34406; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Kim YW, 2012, BIOCHEM J, V445, P403, DOI 10.1042/BJ20111923; Kirkbride KC, 2008, J BIOL CHEM, V283, P7628, DOI 10.1074/jbc.M704883200; Lengner CJ, 2004, J CELL PHYSIOL, V200, P327, DOI 10.1002/jcp.20118; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Murakami M, 2009, GENES CELLS, V14, P469, DOI 10.1111/j.1365-2443.2009.01283.x; Murwantoko, 2004, BIOCHEM J, V381, P895, DOI 10.1042/BJ20040435; Odgaard A, 1997, BONE, V20, P315, DOI 10.1016/S8756-3282(97)00007-0; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Ruegsegger P, 1996, CALCIFIED TISSUE INT, V58, P24, DOI 10.1007/s002239900006; SANKAR S, 1995, J BIOL CHEM, V270, P13567, DOI 10.1074/jbc.270.22.13567; Seo HS, 2007, DEV BIOL, V310, P304, DOI 10.1016/j.ydbio.2007.07.040; Seo HS, 2009, DEV BIOL, V334, P481, DOI 10.1016/j.ydbio.2009.08.015; Shiga A, 2011, HUM MOL GENET, V20, P1800, DOI 10.1093/hmg/ddr063; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Tiaden AN, 2012, STEM CELLS, V30, P2271, DOI 10.1002/stem.1190; Tocharus J, 2004, DEV GROWTH DIFFER, V46, P257; Tsuchiya A, 2005, BONE, V37, P323, DOI 10.1016/j.bone.2005.03.015; Van Themsche C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-216; Vierkotten S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022959; WESTERHAUSEN DR, 1991, J BIOL CHEM, V266, P1092; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Zumbrunn J, 1996, FEBS LETT, V398, P187, DOI 10.1016/S0014-5793(96)01229-X	39	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74094	10.1371/journal.pone.0074094	http://dx.doi.org/10.1371/journal.pone.0074094			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040176	Green Submitted, Green Published, gold			2022-12-25	WOS:000326734500071
J	Li, XH; Wang, JJ; Jia, ZQ; Cui, QH; Zhang, CG; Wang, WP; Chen, P; Ma, KT; Zhou, CY				Li, Xianhui; Wang, Jiaji; Jia, Zhuqing; Cui, Qinghua; Zhang, Chenguang; Wang, Weiping; Chen, Ping; Ma, Kangtao; Zhou, Chunyan			MiR-499 Regulates Cell Proliferation and Apoptosis during Late-Stage Cardiac Differentiation via Sox6 and Cyclin D1	PLOS ONE			English	Article							DOWN-REGULATION; EXPRESSION; HEART; GENE; REGENERATION; MICRORNA; DEATH	Background: MiR-499 is a cardiac-abundant miRNA. However, the biological functions of miR-499 in differentiated cardiomyocytes or in the cardiomyocyte differentiation process is not very clear. Sox6 is believed to be one of its targets, and is also believed to play a role in cardiac differentiation. Therefore, our aim was to investigate the association between Sox6 and miR-499 during cardiac differentiation. Methodology/Principal Findings: Using a well-established in vitro cardiomyocyte differentiation system, mouse P19CL6 cells, we found that miR-499 was highly expressed in the late stage of cardiac differentiation. In cells stably transfected with miR-499 (P-499 cells), it was found that miR-499 could promote the differentiation into cardiomyocytes at the early stage of cardiac differentiation. Notably, cell viability assay, EdU incorporation assay, and cell cycle profile analysis all showed that the P-499 cells displayed the distinctive feature of hyperplastic growth. Further investigation confirmed that miR-499 could promote neonatal rat cardiomyocyte proliferation. MiR-499 knockdown enhanced apoptosis in the late differentiation stage in P19CL6 cells, but overexpression of miR-499 resulted in a decrease in the apoptosis rate. Sox6 was identified as a direct target of miR-499 and its expression was detected from day 8 or day 10 of cardiac differentiation of P19CL6 cells. Sox6 played a role in cell viability, inhibited cell proliferation and promoted cell apoptosis in P19CL6 cells and cardiomyocytes. The overexpression of Sox6 could reverse the proliferation and anti-apoptosis effects of miR-499. It was also found that miR-499 might exert its function by regulating cyclin D1 via its influence on Sox6. Conclusions/Significance: miR-499 probably regulates the proliferation and apoptosis of P19CL6 cells in the late stage of cardiac differentiation via its effects on Sox6 and cyclin D1.	[Li, Xianhui; Wang, Jiaji; Jia, Zhuqing; Zhang, Chenguang; Wang, Weiping; Chen, Ping; Ma, Kangtao; Zhou, Chunyan] Peking Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Key Lab Mol Cardiovasc Sci,Minist Educ China, Beijing 100871, Peoples R China; [Cui, Qinghua] Peking Univ, Sch Basic Med Sci, Dept Biomed Informat, Beijing 100871, Peoples R China	Ministry of Education, China; Peking University; Peking University	Jia, ZQ (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Key Lab Mol Cardiovasc Sci,Minist Educ China, Beijing 100871, Peoples R China.	zhuqingjia@bjmu.edu.cn; chunyanzhou@bjmu.edu.cn			National Natural Science Foundation of China [81070112, 81071675, 81170713]; Specialized Research Fund for the Doctoral Program of Higher Education [20110001130001]; Natural Science Foundation of Beijing, China [5122021]; Leading Academic Discipline Project of Beijing Education Bureau; 111 Project of China [B07001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Beijing, China(Beijing Natural Science Foundation); Leading Academic Discipline Project of Beijing Education Bureau; 111 Project of China(Ministry of Education, China - 111 Project)	This work was supported by the National Natural Science Foundation of China (81070112, 81071675, 81170713), Specialized Research Fund for the Doctoral Program of Higher Education (20110001130001), the Natural Science Foundation of Beijing, China (5122021), Leading Academic Discipline Project of Beijing Education Bureau, and the 111 Project of China (B07001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Batista-Brito R, 2009, NEURON, V63, P466, DOI 10.1016/j.neuron.2009.08.005; Bell ML, 2010, MOL CELL BIOL, V30, P1937, DOI 10.1128/MCB.01370-09; Buja LM, 2008, CARDIOVASC PATHOL, V17, P349, DOI 10.1016/j.carpath.2008.02.004; Christoffels VM, 2000, DEV BIOL, V223, P266, DOI 10.1006/dbio.2000.9753; Cohen-Barak G, 2001, GENE, V265, P157, DOI 10.1016/S0378-1119(01)00346-8; Cohen-Barak O, 2003, NUCLEIC ACIDS RES, V31, P5941, DOI 10.1093/nar/gkg807; Dumitriu B, 2006, BLOOD, V108, P1198, DOI 10.1182/blood-2006-02-004184; EDWARDS MKS, 1983, MOL CELL BIOL, V3, P2280, DOI 10.1128/MCB.3.12.2280; Fu JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027417; HabaraOhkubo A, 1996, CELL STRUCT FUNCT, V21, P101, DOI 10.1247/csf.21.101; Hagiwara N, 2000, P NATL ACAD SCI USA, V97, P4180, DOI 10.1073/pnas.97.8.4180; Hosoda T, 2011, CIRCULATION, V123, P1287, DOI 10.1161/CIRCULATIONAHA.110.982918; Iguchi H, 2007, J BIOL CHEM, V282, P19052, DOI 10.1074/jbc.M700460200; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; McCarthy JJ, 2009, PHYSIOL GENOMICS, V39, P219, DOI 10.1152/physiolgenomics.00042.2009; Monzen K, 2002, BIOCHEM BIOPH RES CO, V298, P493, DOI 10.1016/S0006-291X(02)02497-X; Nishi K, 2009, J CELL BIOCHEM, V106, P63, DOI 10.1002/jcb.21978; Shieh JTC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019481; Sluijter JPG, 2010, ARTERIOSCL THROM VAS, V30, P859, DOI 10.1161/ATVBAHA.109.197434; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; van Amerongen MJ, 2008, J CELL MOL MED, V12, P2233, DOI 10.1111/j.1582-4934.2008.00439.x; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wilson KD, 2010, CIRC-CARDIOVASC GENE, V3, P426, DOI 10.1161/CIRCGENETICS.109.934281	26	60	70	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74504	10.1371/journal.pone.0074504	http://dx.doi.org/10.1371/journal.pone.0074504			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040263	Green Submitted, Green Published, gold			2022-12-25	WOS:000326734500098
J	Cunningham, SJ; Martin, RO; Hojem, CL; Hockey, PAR				Cunningham, Susan J.; Martin, Rowan O.; Hojem, Carryn L.; Hockey, Philip A. R.			Temperatures in Excess of Critical Thresholds Threaten Nestling Growth and Survival in a Rapidly-Warming Arid Savanna: A Study of Common Fiscals	PLOS ONE			English	Article							CLIMATE-CHANGE; AMBIENT-TEMPERATURE; PARENTAL EFFORT; HEAT WAVES; SMALL BIRD; BODY-SIZE; THERMOREGULATION; CONSEQUENCES; VARIABILITY; MORTALITY	Frequency, duration, and intensity of hot-weather events are all predicted to increase with climate warming. Despite this, mechanisms by which temperature increases affect individual fitness and drive population-level changes are poorly understood. We investigated the link between daily maximum air temperature (t(max)) and breeding success of Kalahari common fiscals (Lanius collaris) in terms of the daily effect on nestling body-mass gain, and the cumulative effect on size and age of fledglings. High t(max) reduced mass gain of younger, but not older nestlings and average nestling-period t(max) did not affect fledgling size. Instead, the frequency with which t(max) exceeded critical thresholds (t(crit)s) significantly reduced fledging body mass (t(crit)= 33 degrees C) and tarsus length (t(crit)= 37 degrees C), as well as delaying fledging (t(crit) = 35 degrees C). Nest failure risk was 4.2% per day therefore delays reduced fledging probability. Smaller size at fledging often correlates with reduced lifetime fitness and might also underlie documented adult body-size reductions in desert birds in relation to climate warming. Temperature thresholds above which organisms incur fitness costs are probably common, as physiological responses to temperature are non-linear. Understanding the shape of the relationship between temperature and fitness has implications for our ability to predict species' responses to climate change.	[Cunningham, Susan J.; Martin, Rowan O.; Hojem, Carryn L.; Hockey, Philip A. R.] Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst, ZA-7700 Rondebosch, South Africa	National Research Foundation - South Africa; University of Cape Town	Cunningham, SJ (corresponding author), Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst, ZA-7700 Rondebosch, South Africa.	susie.j.c@gmail.com	Cunningham, Susan/AAR-3915-2020	Cunningham, Susan/0000-0001-9934-2585; Martin, Rowan/0000-0002-0326-0161	Department of Science and Technology through the National Research Foundation of South Africa; Tswalu Foundation	Department of Science and Technology through the National Research Foundation of South Africa; Tswalu Foundation	This study was funded by a grant from the Department of Science and Technology (http://www.dst.gov.za/) through the National Research Foundation (http://www.nrf.ac.za/) of South Africa to the Centre of Excellence (CoE) in Birds as Keys to Biodiversity Conservation at the Percy FitzPatrick Institute of African Ornithology (http://www.fitzpatrick.uct.ac.za/docs/coe.html). Additional funding from the Tswalu Foundation (http://www.tswalu.com/blog/the-tswalufoundation/) covered accommodation costs at Tswalu Kalahari Reserve. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoon I., 2011, S AFRICAN RISK VULNE; Angilletta MJ, 2011, INTEGR COMP BIOL, V51, P653, DOI 10.1093/icb/icr091; Angilletta Michael J Jr, 2010, Front Biosci (Elite Ed), V2, P861; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; [Anonymous], PERTHNOW; AUSTIN GT, 1976, AUK, V93, P245; BAKKEN GS, 1985, AM ZOOL, V25, P933; Barton K., 2010, **DATA OBJECT**; Bates D., 2010, LME4 LINEAR MIXED EF; BOSQUE C, 1995, AM NAT, V145, P234, DOI 10.1086/285738; Buckley LB, 2010, ECOL LETT, V13, P1041, DOI 10.1111/j.1461-0248.2010.01479.x; Cahill AE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.1890; Calder W.A., 1974, AVIAN BIOL, V4, P259; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Dean WRJ, 2005, ROBERTS BIRDS SO AFR, P728; du Plessis KL, 2012, GLOBAL CHANGE BIOL, V18, P3063, DOI 10.1111/j.1365-2486.2012.02778.x; FINLAYSON H. H., 1932, SO AUSTRALIAN ORNITHOL, V11, P158; Fuchs J, 2011, J BIOGEOGR, V38, P2210, DOI 10.1111/j.1365-2699.2011.02545.x; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; Gardner JL, 2009, P ROY SOC B-BIOL SCI, V276, P3845, DOI 10.1098/rspb.2009.1011; Gebhardt-Henrich Sabine, 1998, Oxford Ornithology Series, V8, P324; Green DJ, 2001, J ANIM ECOL, V70, P505, DOI 10.1046/j.1365-2656.2001.00503.x; HAYWOOD S, 1992, P ROY SOC B-BIOL SCI, V249, P195, DOI 10.1098/rspb.1992.0103; Hoset KS, 2004, ARDEA, V92, P239; Immelmann K., 1973, P121; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Kilpatrick AM, 2002, CAN J ZOOL, V80, P145, DOI 10.1139/Z01-217; Kruger AC, 2013, INT J CLIMATOL, V33, P661, DOI 10.1002/joc.3455; Lenth R. V., 2013, LSMEANS LEAST SQUARE; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Low M, 2008, J ORNITHOL, V149, P515, DOI 10.1007/s10336-008-0300-3; Luck GW, 2001, EMU, V101, P221, DOI 10.1071/MU00028; MAGRATH RD, 1991, J ANIM ECOL, V60, P335, DOI 10.2307/5464; May JD, 2001, POULTRY SCI, V80, P581, DOI 10.1093/ps/80.5.581; MAYFIELD HF, 1975, WILSON BULL, V87, P456; McCarty JP, 1999, IBIS, V141, P286, DOI 10.1111/j.1474-919X.1999.tb07551.x; McKechnie AE, 2012, EMU, V112, pI, DOI 10.1071/MUv112n2_ED; McKechnie AE, 2010, BIOL LETTERS, V6, P253, DOI 10.1098/rsbl.2009.0702; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Moise AF, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009250; Moses MR, 2012, OECOLOGIA, V168, P257, DOI 10.1007/s00442-011-2073-2; MURPHY MT, 1985, ECOLOGY, V66, P162, DOI 10.2307/1941316; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Orians G.H., 1979, P155; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PORTER WP, 1969, ECOL MONOGR, V39, P227, DOI 10.2307/1948545; R Core Development Team, 2009, R LANG ENV STAT COMP; Rensel MA, 2011, HORM BEHAV, V59, P497, DOI 10.1016/j.yhbeh.2011.01.010; RICKLEFS RE, 1968, ECOLOGY, V49, P227, DOI 10.2307/1934451; SAETHER BE, 1993, BEHAV ECOL SOCIOBIOL, V33, P147, DOI 10.1007/BF00216594; SCHOLANDER PF, 1950, BIOL BULL, V99, P237, DOI 10.2307/1538741; SCHREIBER EA, 1994, COLON WATERBIRD, V17, P105, DOI 10.2307/1521289; Schwagmeyer PL, 2008, ANIM BEHAV, V75, P291, DOI 10.1016/j.anbehav.2007.05.023; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Soobramoney S, 2003, J THERM BIOL, V28, P581, DOI 10.1016/j.jtherbio.2003.08.004; Stienen EWM, 2002, IBIS, V144, P567, DOI 10.1046/j.1474-919X.2002.00086.x; THOMPSON CF, 1991, NEW ZEAL J ECOL, V15, P41; Tremblay I, 2005, IBIS, V147, P17, DOI 10.1111/j.1474-919x.2004.00312.x; WALSBERG GE, 1993, ORNIS SCAND, V24, P174, DOI 10.2307/3676733; Weimerskirch H, 2000, IBIS, V142, P103, DOI 10.1111/j.1474-919X.2000.tb07689.x; WEIMERSKIRCH H, 1995, BEHAV ECOL SOCIOBIOL, V36, P11; Welbergen JA, 2008, P ROY SOC B-BIOL SCI, V275, P419, DOI 10.1098/rspb.2007.1385; Wheelwright NT, 2003, ANIM BEHAV, V65, P435, DOI 10.1006/anbe.2003.2086; Wolf B, 2000, REV CHIL HIST NAT, V73, P395, DOI 10.4067/S0716-078X2000000300003; Wolf BO, 1996, J EXP BIOL, V199, P451; Yahav S, 2001, POULTRY SCI, V80, P1662, DOI 10.1093/ps/80.12.1662; Yom-Tov Y, 2001, P ROY SOC B-BIOL SCI, V268, P947, DOI 10.1098/rspb.2001.1592; Garamszegi LZ, 2009, BEHAV ECOL, V20, P1363, DOI 10.1093/beheco/arp137; [No title captured]	71	111	111	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74613	10.1371/journal.pone.0074613	http://dx.doi.org/10.1371/journal.pone.0074613			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040296	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300184
J	Guven, E; Duus, K; Laursen, I; Hojrup, P; Houen, G				Guven, Esin; Duus, Karen; Laursen, Inga; Hojrup, Peter; Houen, Gunnar			Aluminum Hydroxide Adjuvant Differentially Activates the Three Complement Pathways with Major Involvement of the Alternative Pathway	PLOS ONE			English	Article							ANTIGEN PRESENTATION; IMMUNE-RESPONSES	Al(OH)(3) is the most common adjuvant in human vaccines, but its mode of action remains poorly understood. Complement involvement in the adjuvant properties of Al(OH)(3) has been suggested in several reports together with a depot effect. It is here confirmed that Al(OH)(3) treatment of serum depletes complement components and activates the complement system. We show that complement activation by Al(OH)(3) involves the three major pathways by monitoring complement components in Al(OH)(3)-treated serum and in Al(OH)(3)-containing precipitates. Al(OH)(3) activation of complement results in deposition of C3 cleavage products and membrane attack complex (MAC) and in generation of the anaphylatoxins C3a and C5a. Complement activation was time dependent and inhibited by chelation with EDTA but not EGTA+Mg2+. We thus confirm that Al(OH)(3) activates the complement system and show that the alternative pathway is of major importance.	[Guven, Esin; Duus, Karen; Laursen, Inga; Houen, Gunnar] Statens Serum Inst, Dept Clin Biochem Immunol & Genet, DK-2300 Copenhagen, Denmark; [Hojrup, Peter] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark	Statens Serum Institut; University of Southern Denmark	Houen, G (corresponding author), Statens Serum Inst, Dept Clin Biochem Immunol & Genet, DK-2300 Copenhagen, Denmark.	gh@ssi.dk	Højrup, Peter/ABG-8477-2020	Houen, Gunnar/0000-0002-5948-4156; Hojrup, Peter/0000-0002-7838-6180	Statens Serum Institut	Statens Serum Institut	The work was financed by Statens Serum Institut. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar JC, 2007, VACCINE, V25, P3752, DOI 10.1016/j.vaccine.2007.01.111; Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Arvidsson S, 2007, BIOMATERIALS, V28, P1346, DOI 10.1016/j.biomaterials.2006.11.005; Chen ZB, 2000, J IMMUNOL, V164, P4522, DOI 10.4049/jimmunol.164.9.4522; Cox JC, 1997, VACCINE, V15, P248, DOI 10.1016/S0264-410X(96)00183-1; De Gregorio E, 2009, CURR OPIN IMMUNOL, V21, P339, DOI 10.1016/j.coi.2009.05.003; Degen Winfried G J, 2003, Expert Rev Vaccines, V2, P327, DOI 10.1586/14760584.2.2.327; Flach TL, 2011, NAT MED, V17, P479, DOI 10.1038/nm.2306; Ghimire TR, 2012, IMMUNOL LETT, V147, P55, DOI 10.1016/j.imlet.2012.06.002; Glenny A, 1926, J PATHOL BACTERIOL, V29, P38; Glenny AT, 1931, J PATHOL BACTERIOL, V34, P267, DOI 10.1002/path.1700340214; Gupta RK, 1998, ADV DRUG DELIVER REV, V32, P155, DOI 10.1016/S0169-409X(98)00008-8; HogenEsch H, 2002, VACCINE, V20, pS34, DOI 10.1016/S0264-410X(02)00169-X; Jin Bo-Ra, 2013, Immune Netw, V13, P10, DOI 10.4110/in.2013.13.1.10; Kolla RV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001044; Lindblad EB, 2004, IMMUNOL CELL BIOL, V82, P497, DOI 10.1111/j.0818-9641.2004.01286.x; Lindblad EB, 2004, VACCINE, V22, P3658, DOI 10.1016/j.vaccine.2004.03.032; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; Mckee AS, 2013, P NATL ACAD SCI USA, V110, pE1122, DOI 10.1073/pnas.1300392110; POLLEY MJ, 1975, J EXP MED, V141, P1261, DOI 10.1084/jem.141.6.1261; RAMANATHAN VD, 1979, IMMUNOLOGY, V37, P881; Roos A, 2003, MOL IMMUNOL, V39, P655, DOI 10.1016/S0161-5890(02)00254-7; Schijns VEJC, 2001, CRIT REV IMMUNOL, V21, P75; Seelen MA, 2005, J IMMUNOL METHODS, V296, P187, DOI 10.1016/j.jim.2004.11.016; Seya T, 2010, VACCINE, V28, P8041, DOI 10.1016/j.vaccine.2010.09.023; Tengvall P, 1998, BIOMATERIALS, V19, P935, DOI 10.1016/S0142-9612(98)00005-2; Tritto E, 2009, VACCINE, V27, P3331, DOI 10.1016/j.vaccine.2009.01.084; Vogel FR, 1998, DEV BIOL STAND, V92, P241; Yalcindag A, 2006, J ALLERGY CLIN IMMUN, V117, P1455, DOI 10.1016/j.jaci.2006.01.048	30	28	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74445	10.1371/journal.pone.0074445	http://dx.doi.org/10.1371/journal.pone.0074445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040248	Green Submitted, Green Published, gold			2022-12-25	WOS:000326405300171
J	Harada, K; Shiba, T; Doi, K; Morita, K; Kubo, T; Makihara, Y; Piattelli, A; Akagawa, Y				Harada, Kana; Shiba, Toshikazu; Doi, Kazuya; Morita, Koji; Kubo, Takayasu; Makihara, Yusuke; Piattelli, Adriano; Akagawa, Yasumasa			Inorganic Polyphosphate Suppresses Lipopolysaccharide-Induced Inducible Nitric Oxide Synthase (iNOS) Expression in Macrophages	PLOS ONE			English	Article							SIGNALING PATHWAY; ACTIVATION; CELLS; RECOGNITION; RECEPTORS; INDUCTION; GROWTH; FIBRIN	In response to infection, macrophages produce a series of inflammatory mediators, including nitric oxide (NO), to eliminate pathogens. The production of these molecules is tightly regulated via various mechanisms, as excessive responses are often detrimental to host tissues. Here, we report that inorganic polyphosphate [poly(P)], a linear polymer of orthophosphate ubiquitously found in mammalian cells, suppresses inducible nitric oxide synthase (iNOS) expression induced by lipopolysaccharide (LPS), a cell wall component of Gram-negative bacteria, in mouse peritoneal macrophages. Poly(P) with longer chains is more potent than those with shorter chains in suppressing LPS-induced iNOS expression. In addition, poly(P) decreased LPS-induced NO release. Moreover, poly(P) suppressed iNOS mRNA expression induced by LPS stimulation, thereby indicating that poly(P) reduces LPS-induced iNOS expression by down-regulation at the mRNA level. In contrast, poly(P) did not affect the LPS-induced release of TNF, another inflammatory mediator. Poly(P) may serve as a regulatory factor of innate immunity by modulating iNOS expression in macrophages.	[Harada, Kana; Doi, Kazuya; Morita, Koji; Kubo, Takayasu; Makihara, Yusuke; Akagawa, Yasumasa] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Adv Prosthodont, Hiroshima, Japan; [Shiba, Toshikazu] Regenetiss Inc, Koganei, Tokyo, Japan; [Shiba, Toshikazu] Kitasato Univ, Kitasato Inst Life Sci, Kitasato Inst, Lab Polyphosphate Res, Tokyo, Japan; [Piattelli, Adriano] Chieti Pescara Univ, Dept Med Oral & Biotechnol Sci, Chieti, Italy	Hiroshima University; Kitasato University; G d'Annunzio University of Chieti-Pescara	Harada, K (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Adv Prosthodont, Hiroshima, Japan.	haradak1289@hiroshima-u.ac.jp	Doi, Kazuya/J-6554-2016	Doi, Kazuya/0000-0001-9452-4750; Morita, Koji/0000-0002-5724-5573	Japan Society for the Promotion of Science [23890134]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid for Scientific Research (No. 23890134) from Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Docampo R, 2011, CELL CALCIUM, V50, P113, DOI 10.1016/j.ceca.2011.05.012; Hernandez-Ruiz L, 2006, HAEMATOLOGICA, V91, P1180; Holmstrom KM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2364; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawazoe Y, 2004, J DENT RES, V83, P613, DOI 10.1177/154405910408300806; Kawazoe Y, 2008, INT J BIOL SCI, V4, P37, DOI 10.7150/ijbs.4.37; Kim D, 2007, J NEUROSCI, V27, P6500, DOI 10.1523/JNEUROSCI.0623-07.2007; Kim Y, 2004, BIOCHEM BIOPH RES CO, V314, P695, DOI 10.1016/j.bbrc.2003.12.153; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; KUMBLE KD, 1995, J BIOL CHEM, V270, P5818, DOI 10.1074/jbc.270.11.5818; Leyhausen G, 1998, J BONE MINER RES, V13, P803, DOI 10.1359/jbmr.1998.13.5.803; Moreno-Sanchez D, 2012, J BIOL CHEM, V287, P28435, DOI 10.1074/jbc.M112.385823; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Mutch NJ, 2010, BLOOD, V115, P3980, DOI 10.1182/blood-2009-11-254029; Pautz A, 2010, NITRIC OXIDE-BIOL CH, V23, P75, DOI 10.1016/j.niox.2010.04.007; Pavlov E, 2010, J BIOL CHEM, V285, P9420, DOI 10.1074/jbc.M109.013011; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200; Segawa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023278; Shiba T, 2004, KEY ENG MATER, V254-2, P1119, DOI 10.4028/www.scientific.net/KEM.254-256.1119; Shiba T, 2003, J BIOL CHEM, V278, P26788, DOI 10.1074/jbc.M303468200; Shiba T, 2003, Japanese Patent Number, Patent No. 4698932; Smith SA, 2006, P NATL ACAD SCI USA, V103, P903, DOI 10.1073/pnas.0507195103; Smith SA, 2008, BLOOD, V112, P2810, DOI 10.1182/blood-2008-03-145755; Wang LH, 2003, P NATL ACAD SCI USA, V100, P11249, DOI 10.1073/pnas.1534805100; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550; Zakharian E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005404; Zhou XY, 2006, J BIOL CHEM, V281, P31337, DOI 10.1074/jbc.M602739200	30	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74650	10.1371/journal.pone.0074650	http://dx.doi.org/10.1371/journal.pone.0074650			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040305	Green Submitted, Green Published, gold			2022-12-25	WOS:000326405300186
J	Lyoo, IK; Yoon, S; Renshaw, PF; Hwang, J; Bae, S; Musen, G; Kim, JE; Bolo, N; Jeong, HS; Simonson, DC; Lee, SH; Weinger, K; Jung, JJ; Ryan, CM; Choi, Y; Jacobson, AM				Lyoo, In Kyoon; Yoon, Sujung; Renshaw, Perry F.; Hwang, Jaeuk; Bae, Sujin; Musen, Gail; Kim, Jieun E.; Bolo, Nicolas; Jeong, Hyeonseok S.; Simonson, Donald C.; Lee, Sun Hea; Weinger, Katie; Jung, Jiyoung J.; Ryan, Christopher M.; Choi, Yera; Jacobson, Alan M.			Network-Level Structural Abnormalities of Cerebral Cortex in Type 1 Diabetes Mellitus	PLOS ONE			English	Article							CORTICAL THICKNESS; BRAIN VOLUME; COGNITIVE PERFORMANCE; TOPOLOGICAL PATTERNS; PREFRONTAL CORTEX; YOUTH; HYPOGLYCEMIA; PLASTICITY; SYSTEM; MRI	Type 1 diabetes mellitus (T1DM) usually begins in childhood and adolescence and causes lifelong damage to several major organs including the brain. Despite increasing evidence of T1DM-induced structural deficits in cortical regions implicated in higher cognitive and emotional functions, little is known whether and how the structural connectivity between these regions is altered in the T1DM brain. Using inter-regional covariance of cortical thickness measurements from high-resolution T1-weighted magnetic resonance data, we examined the topological organizations of cortical structural networks in 81 T1DM patients and 38 healthy subjects. We found a relative absence of hierarchically high-level hubs in the prefrontal lobe of T1DM patients, which suggests ineffective top-down control of the prefrontal cortex in T1DM. Furthermore, inter-network connections between the strategic/executive control system and systems subserving other cortical functions including language and mnemonic/emotional processing were also less integrated in T1DM patients than in healthy individuals. The current results provide structural evidence for T1DM-related dysfunctional cortical organization, which specifically underlie the top-down cognitive control of language, memory, and emotion.	[Lyoo, In Kyoon; Lee, Sun Hea] Ewha W Univ, Ewha Brain Inst, Seoul, South Korea; [Lyoo, In Kyoon; Lee, Sun Hea] Ewha W Univ, Grad Sch Pharmaceut Sci, Coll Pharm, Seoul, South Korea; [Yoon, Sujung] Catholic Univ Korea, Coll Med, Dept Psychiat, Seoul, South Korea; [Renshaw, Perry F.; Bae, Sujin] Univ Utah, Inst Brain, Salt Lake City, UT USA; [Hwang, Jaeuk] Soonchunhyang Univ, Dept Psychiat, Coll Med, Seoul, South Korea; [Musen, Gail; Weinger, Katie; Jacobson, Alan M.] Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; [Musen, Gail; Bolo, Nicolas; Weinger, Katie] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Kim, Jieun E.] Ewha W Univ, Grad Sch, Dept Brain & Cognit Sci, Seoul, South Korea; [Jeong, Hyeonseok S.; Jung, Jiyoung J.; Choi, Yera] Seoul Natl Univ, Coll Nat Sci, Interdisciplinary Program Brain Sci, Seoul 151742, South Korea; [Simonson, Donald C.] Brigham & Womens Hosp, Dept Internal Med, Boston, MA 02115 USA; [Ryan, Christopher M.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Jacobson, Alan M.] Winthrop Univ Hosp, Dept Psychiat, Mineola, NY 11501 USA	Ewha Womans University; Ewha Womans University; Catholic University of Korea; Utah System of Higher Education; University of Utah; Soonchunhyang University; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Ewha Womans University; Seoul National University (SNU); Harvard University; Brigham & Women's Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Winthrop University Hospital	Lyoo, IK (corresponding author), Ewha W Univ, Ewha Brain Inst, Seoul, South Korea.	inkylyoo@ewha.ac.kr	Renshaw, Perry/O-1384-2018	Ryan, Christopher/0000-0003-4278-917X; Hwang, Jaeuk/0000-0003-0528-3305	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health [DK-060754, DK-084202]; Global Research Network Program, The Korea Research Foundation [KRF-2008-220-E00021]; National Research Foundation of Korea [2012R1A2A2A01010739]; Joslin Diabetes and Endocrinology Research Center [P30-DK-36836]; Joslin Diabetes Center Herbert Graetz Fund; Winthrop University Hospital Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060754, P30DK036836, R01DK084202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA031247] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Global Research Network Program, The Korea Research Foundation; National Research Foundation of Korea(National Research Foundation of Korea); Joslin Diabetes and Endocrinology Research Center; Joslin Diabetes Center Herbert Graetz Fund; Winthrop University Hospital Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (DK-060754 and DK-084202); a grant from the Global Research Network Program, The Korea Research Foundation (KRF-2008-220-E00021); a grant from the National Research Foundation of Korea (2012R1A2A2A01010739); a grant from Joslin Diabetes and Endocrinology Research Center (P30-DK-36836); a grant from the Joslin Diabetes Center Herbert Graetz Fund; and a grant from the Winthrop University Hospital Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Almeida S, 2008, MUSCLE NERVE, V37, P231, DOI 10.1002/mus.20919; Amiel SA, 1997, DIABETOLOGIA, V40, pS62, DOI 10.1007/s001250051404; Antenor-Dorsey JAV, 2013, DIABETES, V62, P581, DOI 10.2337/db12-0696; Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Biessels GJ, 2008, LANCET NEUROL, V7, P184, DOI 10.1016/S1474-4422(08)70021-8; Brands AMA, 2005, DIABETES CARE, V28, P726, DOI 10.2337/diacare.28.3.726; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Chen ZJ, 2011, NEUROIMAGE, V56, P235, DOI 10.1016/j.neuroimage.2011.01.010; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Del Arco A, 2009, J NEURAL TRANSM, V116, P941, DOI 10.1007/s00702-009-0243-8; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Ferguson SC, 2003, DIABETES, V52, P149, DOI 10.2337/diabetes.52.1.149; First M. D., 1996, USERS GUIDE STRUCTUR; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Franc DT, 2011, DIABETES, V60, P315, DOI 10.2337/db10-0598; Ghosh A, 2009, J NEUROSCI, V29, P12210, DOI 10.1523/JNEUROSCI.1828-09.2009; Giedd JN, 2010, NEURON, V67, P728, DOI 10.1016/j.neuron.2010.08.040; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2009, BRAIN, V132, P3366, DOI 10.1093/brain/awp089; Kamal A, 2000, DIABETOLOGIA, V43, P500, DOI 10.1007/s001250051335; Klein JP, 2003, LANCET NEUROL, V2, P548, DOI 10.1016/S1474-4422(03)00503-9; Kodl CT, 2008, DIABETES, V57, P3083, DOI 10.2337/db08-0724; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Lerch JP, 2006, NEUROIMAGE, V31, P993, DOI 10.1016/j.neuroimage.2006.01.042; Lobnig BM, 2006, DIABETIC MED, V23, P32, DOI 10.1111/j.1464-5491.2005.01716.x; Luna B, 2004, ANN NY ACAD SCI, V1021, P296, DOI 10.1196/annals.1308.035; Luna B, 2001, NEUROIMAGE, V13, P786, DOI 10.1006/nimg.2000.0743; Lyoo IK, 2006, BIPOLAR DISORD, V8, P65, DOI 10.1111/j.1399-5618.2006.00284.x; Lyoo IK, 2012, ARCH GEN PSYCHIAT, V69, P1267, DOI 10.1001/archgenpsychiatry.2012.543; Lyoo IK, 2011, ARCH GEN PSYCHIAT, V68, P701, DOI 10.1001/archgenpsychiatry.2011.70; Lyoo IK, 2009, ARCH GEN PSYCHIAT, V66, P878, DOI 10.1001/archgenpsychiatry.2009.86; McIntyre RS, 2010, ADV THER, V27, P63, DOI 10.1007/s12325-010-0011-z; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Miller BT, 2005, NEURON, V48, P535, DOI 10.1016/j.neuron.2005.11.002; Miyashita Y, 2004, SCIENCE, V306, P435, DOI 10.1126/science.1101864; Mollica RF, 2009, ARCH GEN PSYCHIAT, V66, P1221, DOI 10.1001/archgenpsychiatry.2009.127; Musen G, 2006, DIABETES, V55, P326, DOI 10.2337/diabetes.55.02.06.db05-0520; Musen G, 2008, CURR DIABETES REP, V8, P132, DOI 10.1007/s11892-008-0024-z; Narr KL, 2005, BIOL PSYCHIAT, V58, P32, DOI 10.1016/j.biopsych.2005.03.043; Northam EA, 2006, NAT CLIN PRACT NEURO, V2, P78, DOI 10.1038/ncpneuro0097; Northam EA, 2009, DIABETES CARE, V32, P445, DOI 10.2337/dc08-1657; Pell GS, 2012, DIABETES CARE, V35, P513, DOI 10.2337/dc11-1290; Perantie DC, 2007, DIABETES CARE, V30, P2331, DOI 10.2337/dc07-0351; Perantie DC, 2011, DIABETES, V60, P3006, DOI 10.2337/db11-0589; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Raj A, 2010, NEUROIMAGE, V52, P1302, DOI 10.1016/j.neuroimage.2010.05.045; Rapoport JL, 2008, NEUROPSYCHOPHARMACOL, V33, P181, DOI 10.1038/sj.npp.1301553; Rauch SL, 2004, BIOL PSYCHIAT, V55, P946, DOI 10.1016/j.biopsych.2003.12.022; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Reijmer YD, 2013, DIABETES, V62, P2112, DOI 10.2337/db12-1644; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Shaw P, 2006, ARCH GEN PSYCHIAT, V63, P540, DOI 10.1001/archpsyc.63.5.540; Shu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007228; SIESJO BK, 1988, DIABETES METAB REV, V4, P113, DOI 10.1002/dmr.5610040203; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Toga AW, 2006, TRENDS NEUROSCI, V29, P148, DOI 10.1016/j.tins.2006.01.007; van Dijk HW, 2010, INVEST OPHTH VIS SCI, V51, P3660, DOI 10.1167/iovs.09-5041; van Duinkerken E, 2012, DIABETES, V61, P1814, DOI 10.2337/db11-1358; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wessels AM, 2006, DIABETOLOGIA, V49, P2474, DOI 10.1007/s00125-006-0283-7; Yan C, 2011, CEREB CORTEX, V17, P92; Yogarajah M, 2010, BRAIN, V133, P2348, DOI 10.1093/brain/awq175; Zhu WL, 2012, NEUROBIOL AGING, V33, P899, DOI 10.1016/j.neurobiolaging.2010.06.022; Zielinski BA, 2010, P NATL ACAD SCI USA, V107, P18191, DOI 10.1073/pnas.1003109107	76	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e71304	10.1371/journal.pone.0071304	http://dx.doi.org/10.1371/journal.pone.0071304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24058401	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000324403200006
J	Fernandez, S; Genis, L; Torres-Aleman, I				Fernandez, S.; Genis, L.; Torres-Aleman, I.			A phosphatase-independent gain-of-function mutation in PTEN triggers aberrant cell growth in astrocytes through an autocrine IGF-1 loop	ONCOGENE			English	Article						glioma; PTEN; IGF-1; gain-of-function; PKA	FACTOR-KAPPA-B; CENTRAL-NERVOUS-SYSTEM; FACTOR-I RECEPTOR; SOMATIC MUTATIONS; RESPONSE ELEMENT; HUMAN GLIOMAS; PHOSPHORYLATION; CANCER; P53; EXPRESSION	Loss-of-function mutations in the phosphatase PTEN (phosphatase and tensin homolog deleted on chromosome10) contribute to aberrant cell growth in part through upregulation of the mitogenic IGF-1/PI3K/Akt pathway. In turn, this pathway exerts a homeostatic feedback over PTEN. Using mutagenesis analysis to explore a possible impact of this mutual control on astrocyte growth, we found that truncation of the C-terminal region of PTEN (Delta 51) associates with a marked increase in NF kappa B activity, a transcription factor overactivated in astrocyte tumors. Whereas mutations of PTEN are considered to lead to a loss-of-function, PTEN Delta 51, a truncation that comprises a region frequently mutated in human gliomas, displayed a neomorphic (gain-of-function) activity that was independent of its phosphatase activity. This gain-of-function of PTEN Delta 51 includes stimulation of IGF-1 synthesis through protein kinase A activation of the IGF-1 promoter. Increased IGF-1 originates an autocrine loop that activates Akt and NF kappa B. Constitutive activation of NF kappa B in PTEN Delta 51-expressing astrocytes leads to aberrant cell growth; astrocytes expressing this mutant PTEN generate colonies in vitro and tumors in vivo. Mutations converting a tumor suppressor such as PTEN into a tumor promoter through a gain-of-function involving IGF-1 production may further our understanding of the role played by this growth factor in glioma growth and help us define druggable targets for personalized therapy.	[Torres-Aleman, I.] Inst Cajal, CSIC, Dept Syst Neurosci, Madrid 28002, Spain; CIBERNED, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); CIBERNED	Torres-Aleman, I (corresponding author), Inst Cajal, Neuroendocrinol Lab, Madrid 28002, Spain.	torres@cajal.csic.es	Fernandez, Silvia/Z-4848-2019; Torres-Aleman, Ignacio/A-1613-2008	Torres-Aleman, Ignacio/0000-0001-8107-7947	Spanish Ministry of Science [SAF2007-60051, SAF2010-17036]; CIBERNED	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CIBERNED(Instituto de Salud Carlos III)	We are thankful to L. Guinea and M. Garcia for excellent technical support. This work was funded by Spanish Ministry of Science (SAF2007-60051 andSAF2010-17036) and by CIBERNED.	ANTONIADES HN, 1992, INT J CANCER, V50, P215, DOI 10.1002/ijc.2910500210; Bartkova J, 2010, ONCOGENE, V29, P5095, DOI 10.1038/onc.2010.249; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; BASERGA R, 1995, CANCER RES, V55, P249; Bredel M, 2011, NEW ENGL J MED, V364, P627, DOI 10.1056/NEJMoa1006312; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009; Chen TC, 1998, LAB INVEST, V78, P165; Duerr EM, 1998, ONCOGENE, V16, P2259, DOI 10.1038/sj.onc.1201756; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Feinman R, 1999, BLOOD, V93, P3044; Fernandez AM, 2007, J NEUROSCI, V27, P8745, DOI 10.1523/JNEUROSCI.1002-07.2007; Fernandez S, 2008, BBA-MOL CELL RES, V1783, P803, DOI 10.1016/j.bbamcr.2007.10.020; Forbes SA, 2008, CURR PROTOC HUM GENE, V39, pD945; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Franco C, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-51; Glick RP, 1997, J NEURO-ONCOL, V35, P315, DOI 10.1023/A:1005876819455; Green A, 2010, NEW ENGL J MED, V362, P369, DOI 10.1056/NEJMc0910063; Gustin JA, 2001, J BIOL CHEM, V276, P27740, DOI 10.1074/jbc.M102559200; Jacques TS, 2010, EMBO J, V29, P222, DOI 10.1038/emboj.2009.327; Jenkins LMM, 2012, CARCINOGENESIS, V33, P1441, DOI 10.1093/carcin/bgs145; Johnson RF, 2012, TRENDS BIOCHEM SCI, V37, P317, DOI 10.1016/j.tibs.2012.04.002; KACHRA Z, 1994, ENDOCRINOLOGY, V135, P1722, DOI 10.1210/en.135.5.1722; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Maier D, 1999, CANCER RES, V59, P5479; Maillet A, 2012, ANTIOXID REDOX SIGN, V16, P1285, DOI 10.1089/ars.2011.4434; MCCARTHY TL, 1995, ENDOCRINOLOGY, V136, P3901, DOI 10.1210/en.136.9.3901; Nowsheen S, 2009, MUTAT RES-GEN TOX EN, V674, P131, DOI 10.1016/j.mrgentox.2008.09.010; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pons S, 2000, J BIOL CHEM, V275, P38620, DOI 10.1074/jbc.M004531200; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Rasheed BKA, 1997, CANCER RES, V57, P4187; SANDBERG AC, 1988, NEUROSCI LETT, V93, P114, DOI 10.1016/0304-3940(88)90022-5; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Shono T, 2001, CANCER RES, V61, P4375; TAKAHASHI K, 1993, INT J CANCER, V55, P453, DOI 10.1002/ijc.2910550322; Tang YF, 2006, CANCER RES, V66, P736, DOI 10.1158/0008-5472.CAN-05-1557; Taniguchi CM, 2006, P NATL ACAD SCI USA, V103, P12093, DOI 10.1073/pnas.0604628103; Thomas MJ, 1996, J BIOL CHEM, V271, P21835, DOI 10.1074/jbc.271.36.21835; Vasudevan KM, 2004, MOL CELL BIOL, V24, P1007, DOI 10.1128/MCB.24.3.1007-1021.2004; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang Y, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-277; Werner Haim, 2009, Archives of Physiology and Biochemistry, V115, P58, DOI 10.1080/13813450902783106; Zumkeller W, 2001, J CLIN PATHOL-MOL PA, V54, P227, DOI 10.1136/mp.54.4.227	52	11	11	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 7	2014	33	32					4114	4122		10.1038/onc.2013.376	http://dx.doi.org/10.1038/onc.2013.376			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AN4YK	24056966				2022-12-25	WOS:000340595700002
J	Brickley, DR; Agyeman, AS; Kopp, RF; Hall, BA; Harbeck, MC; Belova, L; Volden, PA; Wu, W; Roe, MW; Conzen, SD				Brickley, Deanna R.; Agyeman, Abena S.; Kopp, Richard F.; Hall, Ben A.; Harbeck, Mark C.; Belova, Larissa; Volden, Paul A.; Wu, Wei; Roe, Michael W.; Conzen, Suzanne D.			Serum- and Glucocorticoid-induced Protein Kinase 1 (SGK1) Is Regulated by Store-operated Ca2+ Entry and Mediates Cytoprotection against Necrotic Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Calcium Signaling; Mitochondrial Apoptosis; Necrosis (Necrotic Death); Signal Transduction; SGK1; Cytoprotection; Mitochondrial Membrane Potential	EPITHELIAL SODIUM-CHANNEL; KAPPA-B KINASE; INTRACELLULAR CALCIUM; INDUCED GENE; ER STRESS; EXPRESSION; APOPTOSIS; SURVIVAL; ISCHEMIA; PHOSPHORYLATION	Background: Mechanisms underlying SGK1 activation are incompletely understood in epithelial cells. Results: Store-operated Ca2+ entry up-regulates SGK1, thereby modulating the lethal effects of Ca2+ overloading on mitochondrial membrane potential. Conclusion: Ca2+-induced SGK1 activates cytoprotective signaling and modifies mitochondrial function in epithelial cells. Significance: This work reveals a cytoprotective role for SGK1 in necrosis and has potential relevance for epithelial cell protection and cancer treatment. Serum and glucocorticoid-regulated kinase 1 (SGK1) encodes a phosphatidylinositol 3-kinase-dependent serine/threonine kinase that is rapidly induced in response to cellular stressors and is an important cell survival signal. Previous studies have suggested that an increase in cytoplasmic Ca2+ concentration ([Ca2+](c)) is required for increased SGK1 expression, but the subcellular source of Ca2+ regulating SGK1 transcription remains uncertain. Activation of endoplasmic reticulum stress (ERS) with thapsigargin (TG) increased SGK1 mRNA and protein expression in MDA-MB-231 cells. Intracellular Ca2+ imaging revealed that store-operated Ca2+ entry played a prominent role in SGK1 induction by TG. Neither ERS nor release of Ca2+ from the ER was sufficient to activate SGK1. Prolonged elevation of intracellular Ca2+ levels, however, triggered cell death with a much greater proportion of the cells undergoing necrosis rather than apoptosis. A relative increase in the percentage of cells undergoing necrosis was observed in cells expressing a short hairpin RNA targeted to the SGK1 gene. Necrotic cell death evoked by cytoplasmic Ca2+ overloading was associated with persistent hyperpolarization of the inner mitochondrial membrane and a modest increase in calpain activation, but did not involve detectable caspase 3 or caspase 7 activation. The effects of cytoplasmic Ca2+ overloading on mitochondrial membrane potential were significantly reduced in cells expressing SGK1 compared with SGK1-depleted cells. Our findings indicate that store-operated Ca2+ entry regulates SGK1 expression in epithelial cells and suggest that SGK1-dependent cytoprotective signaling involves effects on maintaining mitochondrial function.	[Brickley, Deanna R.; Agyeman, Abena S.; Hall, Ben A.; Belova, Larissa; Volden, Paul A.; Wu, Wei; Conzen, Suzanne D.] Univ Chicago, Dept Med, Sect Hematol Oncol, Chicago, IL 60637 USA; [Harbeck, Mark C.] Univ Chicago, Dept Med, Endocrinol Sect, Chicago, IL 60637 USA; [Conzen, Suzanne D.] Univ Chicago, Ben May Dept Canc Biol, Chicago, IL 60637 USA; [Kopp, Richard F.; Roe, Michael W.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA; [Roe, Michael W.] SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA	University of Chicago; University of Chicago; University of Chicago; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Roe, MW (corresponding author), SUNY Upstate Med Univ, Dept Med, 505 Irving Ave, Syracuse, NY 13210 USA.	roem@upstate.edu; sdconzen@uchicago.edu	wu, wei/J-2797-2019	wu, wei/0000-0002-6556-067X; Kopp, Richard/0000-0001-8190-1748	National Institutes of Health [R01 CA089208, R21 CA149472, R01 DK074966, R01 DK092616]; University of Chicago's Breast Cancer SPORE National Institutes of Health [P50 CA125183]; Comprehensive Cancer Center Support Grant for Core Facilities, National Institutes of Health [P30 CA014599]; NATIONAL CANCER INSTITUTE [P50CA125183, R01CA089208, P30CA014599, R21CA149472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092616, R01DK074966, T32DK087703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago's Breast Cancer SPORE National Institutes of Health; Comprehensive Cancer Center Support Grant for Core Facilities, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01 CA089208 and R21 CA149472 (to S. D. C.), R01 DK074966 and R01 DK092616 (to M. W. R.), as well as the University of Chicago's Breast Cancer SPORE National Institutes of Health Grant P50 CA125183 and Comprehensive Cancer Center Support Grant for Core Facilities, National Institutes of Health Grant P30 CA014599.	Aoyama T, 2005, CIRCULATION, V111, P1652, DOI 10.1161/01.CIR.0000160352.58142.06; Bell JR, 2011, CLIN EXP PHARMACOL P, V38, P717, DOI 10.1111/j.1440-1681.2011.05567.x; Belova L, 2008, J BIOL CHEM, V283, P18821, DOI 10.1074/jbc.M803289200; Belova L, 2006, BIOCHEM J, V400, P235, DOI 10.1042/BJ20060905; Bogusz AM, 2006, FEBS J, V273, P2913, DOI 10.1111/j.1742-4658.2006.05304.x; Boini KM, 2006, DIABETES, V55, P2059, DOI 10.2337/db05-1038; Brickley DR, 2002, J BIOL CHEM, V277, P43064, DOI 10.1074/jbc.M207604200; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Catela C, 2010, DEV DYNAM, V239, P2149, DOI 10.1002/dvdy.22345; Chang WJ, 2010, J INVEST SURG, V23, P228, DOI 10.3109/08941939.2010.496036; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Choi K, 2009, CURR NEUROVASC RES, V6, P213, DOI 10.2174/156720209789630375; Fagerli UM, 2011, ONCOGENE, V30, P3198, DOI 10.1038/onc.2011.79; Fejes-Toth G, 2007, ENDOCRINOLOGY, V148, P1502, DOI 10.1210/en.2006-1438; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Frosali S, 2009, BBA-MOL CELL RES, V1793, P572, DOI 10.1016/j.bbamcr.2008.11.018; George TC, 2004, CYTOM PART A, V59A, P237, DOI 10.1002/cyto.a.20048; Gouriou Y, 2011, BIOCHIMIE, V93, P2060, DOI 10.1016/j.biochi.2011.08.001; Harbeck M. C., 2006, SCI STKE, P6; Imai S, 2003, LIFE SCI, V72, P2199, DOI 10.1016/S0024-3205(03)00092-4; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Leong MLL, 2003, J BIOL CHEM, V278, P5871, DOI 10.1074/jbc.M211649200; Loffing J, 2006, ANNU REV PHYSIOL, V68, P461, DOI 10.1146/annurev.physiol.68.040104.131654; McCall K, 2010, CURR OPIN CELL BIOL, V22, P882, DOI 10.1016/j.ceb.2010.09.002; Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317; Mikosz CA, 2001, J BIOL CHEM, V276, P16649, DOI 10.1074/jbc.M010842200; Moran TJ, 2000, CANCER RES, V60, P867; Naray-Fejes-Toth A, 2000, J STEROID BIOCHEM, V75, P51, DOI 10.1016/S0960-0760(00)00136-9; Naray-Fejes-Toth A, 2000, KIDNEY INT, V57, P1290, DOI 10.1046/j.1523-1755.2000.00964.x; Nilius B, 2001, CELL CALCIUM, V29, P417, DOI 10.1054/ceca.2001.0201; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Orrenius S, 2011, TOXICOL SCI, V119, P3, DOI 10.1093/toxsci/kfq268; Pang D, 2006, CANCER BIOL THER, V5, P933, DOI 10.4161/cbt.5.8.2875; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Paschen W, 2004, J NEUROCHEM, V88, P983, DOI 10.1046/j.1471-4159.2003.02218.x; Perez-Pinzon MA, 2012, J CEREBR BLOOD F MET, V32, P1362, DOI 10.1038/jcbfm.2012.32; Perl A, 2009, CURR OPIN RHEUMATOL, V21, P454, DOI 10.1097/BOR.0b013e32832e977c; Pradelli LA, 2010, CELL MOL LIFE SCI, V67, P1589, DOI 10.1007/s00018-010-0285-y; Putney JW, 2007, J CELL SCI, V120, P1959, DOI 10.1242/jcs.03462; Richards JS, 2002, MOL ENDOCRINOL, V16, P580, DOI 10.1210/me.16.3.580; Rusai K, 2009, CELL PHYSIOL BIOCHEM, V24, P577, DOI 10.1159/000257527; Sahoo S, 2005, EUR J CANCER, V41, P2754, DOI 10.1016/j.ejca.2005.07.018; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Sheng H, 2008, AM J PHYSIOL-ENDOC M, V295, pE938, DOI 10.1152/ajpendo.90462.2008; Skulachev VP, 2006, APOPTOSIS, V11, P473, DOI 10.1007/s10495-006-5881-9; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Tai DJC, 2009, J BIOL CHEM, V284, P4073, DOI 10.1074/jbc.M805055200; Taruno A, 2008, AM J PHYSIOL-RENAL, V294, pF177, DOI 10.1152/ajprenal.00250.2007; THASTRUP O, 1989, AGENTS ACTIONS, V27, P17, DOI 10.1007/BF02222186; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Vanlangenakker N, 2008, CURR MOL MED, V8, P207, DOI 10.2174/156652408784221306; Verkhratsky A., 2007, V45, P465; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; WEBSTER MK, 1993, J BIOL CHEM, V268, P11482; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Yamashima T, 2012, J NEUROCHEM, V120, P477, DOI 10.1111/j.1471-4159.2011.07596.x; Yang YC, 2006, MOL CELL BIOL, V26, P8357, DOI 10.1128/MCB.01017-06; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Yun CC, 2002, J BIOL CHEM, V277, P7676, DOI 10.1074/jbc.M107768200; Zhang BH, 2001, J BIOL CHEM, V276, P31620, DOI 10.1074/jbc.M102808200; Zhang LP, 2005, CANCER RES, V65, P457; Zhou YP, 1998, J CLIN INVEST, V101, P1623, DOI 10.1172/JCI1245; Zhou YP, 2000, AM J PHYSIOL-ENDOC M, V278, pE340, DOI 10.1152/ajpendo.2000.278.2.E340	66	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32708	32719		10.1074/jbc.M113.507210	http://dx.doi.org/10.1074/jbc.M113.507210			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24043625	Green Published, hybrid			2022-12-25	WOS:000328681700055
J	Sirbu, BM; McDonald, WH; Dungrawala, H; Badu-Nkansah, A; Kavanaugh, GM; Chen, YY; Tabb, DL; Cortez, D				Sirbu, Bianca M.; McDonald, W. Hayes; Dungrawala, Huzefa; Badu-Nkansah, Akosua; Kavanaugh, Gina M.; Chen, Yaoyi; Tabb, David L.; Cortez, David			Identification of Proteins at Active, Stalled, and Collapsed Replication Forks Using Isolation of Proteins on Nascent DNA (iPOND) Coupled with Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOLOGOUS RECOMBINATION; PEPTIDE IDENTIFICATION; MMS22L-TONSL COMPLEX; GENE PRIORITIZATION; DAMAGE RESPONSE; MISMATCH REPAIR; ATR; PCNA; DYNAMICS; CHECKPOINT	Both DNA and chromatin need to be duplicated during each cell division cycle. Replication happens in the context of defects in the DNA template and other forms of replication stress that present challenges to both genetic and epigenetic inheritance. The replication machinery is highly regulated by replication stress responses to accomplish this goal. To identify important replication and stress response proteins, we combined isolation of proteins on nascent DNA (iPOND) with quantitative mass spectrometry. We identified 290 proteins enriched on newly replicated DNA at active, stalled, and collapsed replication forks. Approximately 16% of these proteins are known replication or DNA damage response proteins. Genetic analysis indicates that several of the newly identified proteins are needed to facilitate DNA replication, especially under stressed conditions. Our data provide a useful resource for investigators studying DNA replication and the replication stress response and validate the use of iPOND combined with mass spectrometry as a discovery tool.	[Sirbu, Bianca M.; McDonald, W. Hayes; Dungrawala, Huzefa; Badu-Nkansah, Akosua; Kavanaugh, Gina M.; Cortez, David] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Chen, Yaoyi; Tabb, David L.] Vanderbilt Univ, Dept Biomed Informat, Sch Med, Nashville, TN 37232 USA; [McDonald, W. Hayes] Vanderbilt Univ, Mass Spectrometry Res Ctr, Sch Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Cortez, D (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA.	david.cortez@vanderbilt.edu	Dungrawala, Huzefa/AAO-1931-2021; McDonald, W. Hayes/B-4109-2016	Dungrawala, Huzefa/0000-0003-1868-7923; McDonald, W. Hayes/0000-0002-3510-426X; Tabb, David/0000-0001-7223-578X	National Institutes of Health [R01 CA136933, R21 ES22319, P30 ES000267]; Department of Defense Breast Cancer Research Program Predoctoral Fellowship [W81XWH-10-1-0226]; Swim Across America; Center of Molecular Toxicology Grant for Vanderbilt Proteomics Core use; Vanderbilt-Ingram Cancer Center; NATIONAL CANCER INSTITUTE [T32CA009582, R01CA136933] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267, T32ES007028, R21ES022319] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program Predoctoral Fellowship(United States Department of Defense); Swim Across America; Center of Molecular Toxicology Grant for Vanderbilt Proteomics Core use; Vanderbilt-Ingram Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA136933 and R21 ES22319 (to D. C.) and P30 ES000267. This work was also supported by Department of Defense Breast Cancer Research Program Predoctoral Fellowship W81XWH-10-1-0226 (to B. M. S.), by a grant from Swim Across America (to B. M. S.), by a Center of Molecular Toxicology Grant for Vanderbilt Proteomics Core use, and by the Vanderbilt-Ingram Cancer Center.	Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Bansbach CE, 2009, GENE DEV, V23, P2405, DOI 10.1101/gad.1839909; Bensimon A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001034; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Chaudhury I, 2013, NUCLEIC ACIDS RES, V41, P6444, DOI 10.1093/nar/gkt348; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chen YY, 2012, ANAL BIOANAL CHEM, V404, P1115, DOI 10.1007/s00216-012-6011-x; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Couch FB, 2013, GENE DEV, V27, P1610, DOI 10.1101/gad.214080.113; Duro E, 2010, MOL CELL, V40, P632, DOI 10.1016/j.molcel.2010.10.023; Gilljam KM, 2009, J CELL BIOL, V186, P645, DOI 10.1083/jcb.200903138; Hombauer H, 2011, SCIENCE, V334, P1713, DOI 10.1126/science.1210770; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Joo W, 2011, SCIENCE, V333, P312, DOI 10.1126/science.1205805; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Landsverk HB, 2010, EMBO REP, V11, P868, DOI 10.1038/embor.2010.134; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Li M, 2010, J PROTEOME RES, V9, P4295, DOI 10.1021/pr100527g; Lopez-Contreras AJ, 2013, CELL REP, V3, P1105, DOI 10.1016/j.celrep.2013.03.009; Lovejoy CA, 2009, P NATL ACAD SCI USA, V106, P19304, DOI 10.1073/pnas.0909345106; Lujan SA, 2013, MOL CELL, V50, P437, DOI 10.1016/j.molcel.2013.03.017; Ma ZQ, 2009, J PROTEOME RES, V8, P3872, DOI 10.1021/pr900360j; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; O'Connell BC, 2010, MOL CELL, V40, P645, DOI 10.1016/j.molcel.2010.10.022; O'Donnell L, 2010, MOL CELL, V40, P619, DOI 10.1016/j.molcel.2010.10.024; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Poot RA, 2004, NAT CELL BIOL, V6, P1236, DOI 10.1038/ncb1196; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/NCHEMBIO.573, 10.1038/nchembio.573]; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sirbu BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012724; Sirbu BM, 2012, NAT PROTOC, V7, P594, DOI 10.1038/nprot.2012.010; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; Struhl K, 2013, NAT STRUCT MOL BIOL, V20, P267, DOI 10.1038/nsmb.2506; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; Toiber D, 2013, MOL CELL, V51, P454, DOI 10.1016/j.molcel.2013.06.018; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Yadon AN, 2011, CELL, V144, P454, DOI 10.1016/j.cell.2011.01.019; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Ye Y, 2009, MOL CANCER RES, V7, P1984, DOI 10.1158/1541-7786.MCR-09-0119; Yu DS, 2010, EMBO REP, V11, P876, DOI 10.1038/embor.2010.153; Yu YX, 2012, MOL CELL, V46, P7, DOI 10.1016/j.molcel.2012.01.019	47	134	134	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31458	31467		10.1074/jbc.M113.511337	http://dx.doi.org/10.1074/jbc.M113.511337			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24047897	Green Published, hybrid			2022-12-25	WOS:000330596200005
J	Stuparevic, I; Mosrin-Huaman, C; Hervouet-Coste, N; Remenaric, M; Rahmouni, AR				Stuparevic, Igor; Mosrin-Huaman, Christine; Hervouet-Coste, Nadege; Remenaric, Mateja; Rahmouni, A. Rachid			Cotranscriptional Recruitment of RNA Exosome Cofactors Rrp47p and Mpp6p and Two Distinct Trf-Air-Mtr4 Polyadenylation (TRAMP) Complexes Assists the Exonuclease Rrp6p in the Targeting and Degradation of an Aberrant Messenger Ribonucleoprotein Particle (mRNP) in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-QUALITY CONTROL; IN-VIVO; SUBUNIT; DOMAIN; EXPORT; CORE; SURVEILLANCE; BINDING; TRANSCRIPTS; EXPRESSION	The cotranscriptional mRNA processing and packaging reactions that lead to the formation of export-competent messenger ribonucleoprotein particles (mRNPs) are under the surveillance of quality control steps. Aberrant mRNPs resulting from faulty events are retained in the nucleus with ensuing elimination of their mRNA component. The molecular mechanisms by which the surveillance system recognizes defective mRNPs and stimulates their destruction by the RNA degradation machinery are still not completely elucidated. Using an experimental approach in which mRNP formation in yeast is disturbed by the action of the bacterial Rho helicase, we have shown previously that the targeting of Rho-induced aberrant mRNPs is mediated by Rrp6p, which is recruited cotranscriptionally in association with Nrd1p following Rho action. Here we investigated the specific involvement in this quality control process of different cofactors associated with the nuclear RNA degradation machinery. We show that, in addition to the main hydrolytic action of the exonuclease Rrp6p, the cofactors Rrp47p, Mpp6p as well as the Trf-Air-Mtr4 polyadenylation (TRAMP) components Trf4p, Trf5p, and Air2p contribute significantly by stimulating the degradation process upon their cotranscriptional recruitment. Trf4p and Trf5p are apparently recruited in two distinct TRAMP complexes that both contain Air2p as component. Surprisingly, Rrp47p appears to play an important role in mutual protein stabilization with Rrp6p, which highlights a close association between the two partners. Together, our results provide an integrated view of how different cofactors of the RNA degradation machinery cooperate to target and eliminate aberrant mRNPs.	[Stuparevic, Igor; Mosrin-Huaman, Christine; Hervouet-Coste, Nadege; Remenaric, Mateja; Rahmouni, A. Rachid] CNRS, UPR 4301, Ctr Biophys Mol, F-45071 Orleans, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)	Rahmouni, AR (corresponding author), CNRS, UPR 4301, Ctr Biophys Mol, Rue Charles Sadron, F-45071 Orleans, France.	rahmouni@cnrs-orleans.fr	Stuparevic, Igor/M-8771-2015	Stuparevic, Igor/0000-0002-9878-5007	la Ligue contre le Cancer Grand Ouest (Comite du Loiret); CNRS; Ecole Doctorale Sante, Sciences Biologiques et Chimie du Vivant of the University of Orleans	la Ligue contre le Cancer Grand Ouest (Comite du Loiret); CNRS(Centre National de la Recherche Scientifique (CNRS)); Ecole Doctorale Sante, Sciences Biologiques et Chimie du Vivant of the University of Orleans	This work was supported in part by la Ligue contre le Cancer Grand Ouest (Comite du Loiret) and by recurrent funding from the CNRS. This work was also supported by a postdoctoral fellowship from the CNRS (to I. S.) and by a doctoral fellowship from the Ecole Doctorale Sante, Sciences Biologiques et Chimie du Vivant of the University of Orleans (to M. R.).	Aguilera A, 2005, CURR OPIN CELL BIOL, V17, P242, DOI 10.1016/j.ceb.2005.03.001; Assenholt J, 2008, RNA, V14, P2305, DOI 10.1261/rna.1108008; BaudinBaillieu A, 1997, YEAST, V13, P353, DOI 10.1002/(SICI)1097-0061(19970330)13:4<353::AID-YEA86>3.0.CO;2-P; Callahan KP, 2010, J BIOL CHEM, V285, P3540, DOI 10.1074/jbc.M109.058396; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; Costello JL, 2011, J BIOL CHEM, V286, P4535, DOI 10.1074/jbc.M110.162826; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Fasken MB, 2005, NAT STRUCT MOL BIOL, V12, P482, DOI 10.1038/nsmb945; Feigenbutz M, 2013, J BIOL CHEM, V288, P15959, DOI 10.1074/jbc.M112.445759; Gudipati RK, 2012, MOL CELL, V48, P409, DOI 10.1016/j.molcel.2012.08.018; Holub P, 2012, NUCLEIC ACIDS RES, V40, P5679, DOI 10.1093/nar/gks223; Honorine R, 2011, NUCLEIC ACIDS RES, V39, P2809, DOI 10.1093/nar/gkq1192; Houseley J, 2006, EMBO REP, V7, P205, DOI 10.1038/sj.embor.7400612; Houseley J, 2008, BBA-GENE REGUL MECH, V1779, P239, DOI 10.1016/j.bbagrm.2007.12.008; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jensen TH, 2001, MOL CELL, V7, P887, DOI 10.1016/S1097-2765(01)00232-5; Johnson SA, 2009, MOL CELL, V33, P215, DOI 10.1016/j.molcel.2008.12.007; Kiss DL, 2011, RNA, V17, P1, DOI 10.1261/rna.2364811; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Libri D, 2002, MOL CELL BIOL, V22, P8254, DOI 10.1128/MCB.22.23.8254-8266.2002; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; Luna R, 2008, CHROMOSOMA, V117, P319, DOI 10.1007/s00412-008-0158-4; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Milligan L, 2008, MOL CELL BIOL, V28, P5446, DOI 10.1128/MCB.00463-08; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Mosrin-Huaman C, 2009, MOL CELL BIOL, V29, P4033, DOI 10.1128/MCB.00272-09; Paolo SS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000555; Phillips S, 2003, RNA, V9, P1098, DOI 10.1261/rna.5560903; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rougemaille M, 2008, CELL, V135, P308, DOI 10.1016/j.cell.2008.08.005; Rougemaille M, 2007, EMBO J, V26, P2317, DOI 10.1038/sj.emboj.7601669; Saguez C, 2005, CURR OPIN CELL BIOL, V17, P287, DOI 10.1016/j.ceb.2005.04.009; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Schmid M, 2008, CHROMOSOMA, V117, P419, DOI 10.1007/s00412-008-0166-4; Schmidt K, 2012, RNA, V18, P1934, DOI 10.1261/rna.033431.112; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Schneider C, 2012, MOL CELL, V48, P422, DOI 10.1016/j.molcel.2012.08.013; Schneider C, 2009, NUCLEIC ACIDS RES, V37, P1127, DOI 10.1093/nar/gkn1020; Stead JA, 2007, NUCLEIC ACIDS RES, V35, P5556, DOI 10.1093/nar/gkm614; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Villa T, 2008, BBA-GENE REGUL MECH, V1779, P524, DOI 10.1016/j.bbagrm.2008.06.009; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang XY, 2008, RNA, V14, P107, DOI 10.1261/rna.808608; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030	48	22	22	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31816	31829		10.1074/jbc.M113.491290	http://dx.doi.org/10.1074/jbc.M113.491290			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24047896	hybrid, Green Published			2022-12-25	WOS:000330596200032
J	Pandey, M; Srivastava, AK; D'Souza, SF; Penna, S				Pandey, Manish; Srivastava, Ashish Kumar; D'Souza, Stanislaus Francis; Penna, Suprasanna			Thiourea, a ROS Scavenger, Regulates Source-to-Sink Relationship to Enhance Crop Yield and Oil Content in Brassica juncea (L.)	PLOS ONE			English	Article							MEMBRANE-TRANSPORT; SUCROSE SYNTHESIS; PHOTOSYNTHESIS; TARGET; PLANTS; LEAF; IDENTIFICATION; ACCUMULATION; METABOLISM; COMPONENTS	In the present agricultural scenario, the major thrust is to increase crop productivity so as to ensure sustainability. In an earlier study, foliar application of thiourea (TU; a non physiological thiol based ROS scavenger) has been demonstrated to enhance the stress tolerance and yield of different crops under field condition. Towards this endeavor, present work deals with the effect of TU on photosynthetic efficiency and source-to-sink relationship of Indian mustard (Brassica juncea) for understanding its mode of action. The application of TU increased the efficiency of both PSI and PSII photosystems and vegetative growth of plant. The comparative analysis of sucrose to starch ratio and expression level of sugar transporters confirmed the higher source and sink strength in response to TU treatment. The biochemical evidence in support of this was derived from higher activities of sucrose phosphate synthase and fructose-1,6-bis-phosphatase at source; and sucrose synthase and different classes of invertases at both source and sink. This indicated an overall increase in photoassimilate level at sink. An additional contribution through pod photosynthesis was confirmed through the analysis of phosphoenol pyruvate carboxylase enzyme activity and level of organic acids. The increased photoassimilate level was also co-ordinated with acetyl coA carboxylase mediated oil biosynthesis. All these changes were ultimately reflected in the form of 10 and 20% increase in total yield and oil content, respectively under TU treatment as compared to control. Additionally, no change was observed in oil composition of seeds derived from TU treated plants. The study thus signifies the co-ordinated regulation of key steps of photosynthesis and source-to-sink relationship through the external application of TU resulting in increased crop yield and oil content.	[Pandey, Manish; Srivastava, Ashish Kumar; D'Souza, Stanislaus Francis; Penna, Suprasanna] Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Bombay 400085, Maharashtra, India	Bhabha Atomic Research Center (BARC)	Penna, S (corresponding author), Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Bombay 400085, Maharashtra, India.	prasanna@barc.gov.in	PENNA, Suprasanna/AAE-1208-2022	Srivastava, Ashish Kumar/0000-0001-9863-528X; Pandey, Manish/0000-0002-4101-6530	Department of Atomic Energy, India	Department of Atomic Energy, India(Department of Atomic Energy (DAE))	The Department of Atomic Energy, India supported the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2011, PLANT PHYSIOL, V155, P64, DOI 10.1104/pp.110.167684; Akbar E., 2009, EUR J SCI RES, V29, P396, DOI DOI 10.1016/j.optlaseng.2014.12.019; Amin AA, 2013, COMMUN SOIL SCI PLAN, V44, P1141, DOI 10.1080/00103624.2012.756006; Aranjuelo I, 2013, J EXP BOT, V64, P1879, DOI 10.1093/jxb/ert081; Ayre BG, 2011, MOL PLANT, V4, P377, DOI 10.1093/mp/ssr014; Bennett EJ, 2011, NEW PHYTOL, V190, P838, DOI 10.1111/j.1469-8137.2011.03714.x; Berjak P, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00177, 10.3389/fpls.2013.00478]; Cho MH, 2012, PHOTOSYNTH RES, V111, P261, DOI 10.1007/s11120-012-9720-2; Degenkolbe T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063637; Dietz KJ, 2011, PLANT PHYSIOL, V155, P1477, DOI 10.1104/pp.110.170043; Endler A, 2006, PLANT PHYSIOL, V141, P196, DOI 10.1104/pp.106.079533; Foulkes MJ, 2011, J EXP BOT, V62, P469, DOI 10.1093/jxb/erq300; Geigenberger P, 2011, PLANT PHYSIOL, V155, P1566, DOI 10.1104/pp.110.170399; Han SJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-179; Hua W, 2012, PLANT J, V69, P432, DOI 10.1111/j.1365-313X.2011.04802.x; KELNER MJ, 1990, J BIOL CHEM, V265, P1306; Keunen E, 2013, PLANT CELL ENVIRON, V36, P1242, DOI 10.1111/pce.12061; Kim YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044493; Li J, 2012, PLANT CELL PHYSIOL, V53, P433, DOI 10.1093/pcp/pcr193; Li ZM, 2012, J EXP BOT, V63, P1155, DOI 10.1093/jxb/err329; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mani F., 2012, Journal of Stress Physiology & Biochemistry, V8, P61; Maurino VG, 2013, J EXP BOT, V64, P743, DOI 10.1093/jxb/ers263; Mondal S, 2011, PLANT BREEDING, V130, P242, DOI 10.1111/j.1439-0523.2010.01787.x; Murata N, 2012, BBA-BIOENERGETICS, V1817, P1127, DOI 10.1016/j.bbabio.2012.02.020; Nagano T, 2012, J BIOL CHEM, V287, P28697, DOI 10.1074/jbc.M112.378067; Nishi Mathur, 2006, World Journal of Agricultural Sciences, V2, P185; O'Leary B, 2011, BIOCHEM J, V436, P15, DOI 10.1042/BJ20110078; Pandey M, 2012, J PLANT INTERACT, V7, P143, DOI 10.1080/17429145.2011.561934; Patrick JW, 2013, PLANT BIOTECHNOL J, V11, P142, DOI 10.1111/pbi.12002; Ruan YL, 2012, MOL PLANT, V5, P763, DOI 10.1093/mp/sss046; Sahu M.P., 2006, RES B RAU BARC, V1, P56; Schroeder JI, 2013, NATURE, V497, P60, DOI 10.1038/nature11909; Shahba MA, 2008, CROP SCI, V48, P756, DOI 10.2135/cropsci2007.07.0382; Shekhawat K, 2012, INT J AGRON, V2012, DOI 10.1155/2012/408284; Singh G, 2005, RES B RAU BARC, P1; Slewinski TL, 2012, J EXP BOT, V63, P4647, DOI 10.1093/jxb/ers124; Sonnewald U, 2013, PLANT BIOTECHNOL J, V11, P223, DOI 10.1111/pbi.12029; Srivastava AK, 2010, ANN BOT-LONDON, V106, P663, DOI 10.1093/aob/mcq163; Srivastava AK, 2009, ANN BOT-LONDON, V103, P403, DOI 10.1093/aob/mcn229; Srivastava AK, 2011, PLANT PHYSIOL BIOCH, V49, P676, DOI 10.1016/j.plaphy.2011.02.016; Srivastava AK, 2008, ENVIRON EXP BOT, V64, P250, DOI 10.1016/j.envexpbot.2008.03.002; Sun JD, 2011, PLANT CELL ENVIRON, V34, P592, DOI 10.1111/j.1365-3040.2010.02265.x; Tognetti JA, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23316; Weber APM, 2013, CURR OPIN BIOTECH, V24, P256, DOI 10.1016/j.copbio.2012.09.010; Xu SM, 2012, MOL PLANT, V5, P430, DOI 10.1093/mp/ssr090; Xue GP, 2013, PLANT MOL BIOL, V81, P71, DOI 10.1007/s11103-012-9983-1	47	35	38	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73921	10.1371/journal.pone.0073921	http://dx.doi.org/10.1371/journal.pone.0073921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058504	Green Published, Green Submitted, gold			2022-12-25	WOS:000324695900025
J	Meng, J; Xu, ZX; Guo, J; Yue, YX; Sun, X				Meng, Jing; Xu, Zixiang; Guo, Jing; Yue, Yunxia; Sun, Xiao			Analysis of Enhanced Current-Generating Mechanism of Geobacter sulfurreducens Strain via Model-Driven Metabolism Simulation	PLOS ONE			English	Article							MICROBIAL FUEL-CELLS; FLUX BALANCE ANALYSIS; C-TYPE CYTOCHROME; ELECTRON-TRANSFER; EVOLUTION	Microbial fuel cells (MFCs) are a class of ideal technologies that function via anaerobic respiration of electricigens, which bring current generation and environmental restoration together. An in-depth understanding of microbial metabolism is of great importance in engineering microbes to further improve their respiration. We employed flux balance analysis and selected Fe(iii) as a substitute for the electrode to simulate current-generating metabolism of Geobacter sulfurreducens PCA with a fixed acetate uptake rate. Simulation results indicated the fluxes of reactions directing acetate towards dissimilation to generate electrons increased under the suboptimal growth condition, resulting in an increase in the respiration rate and a decrease in the growth rate. The results revealed the competitive relationship between oxidative respiration and cell growth during the metabolism of microbe current generation. The results helped us quantitatively understand why microbes growing slowly have the potential to make good use of fuel in MFCs. At the same time, slow growth does not necessarily result in speedy respiration. Alternative respirations may exist under the same growth state due to redundant pathways in the metabolic network. The big difference between the maximum and minimum respiration mainly results from the total formate secretion. With iterative flux variability analysis, a relatively ideal model of variant of G. sulfurreducens PCA was reconstructed by deleting several enzymes in the wild model, which could reach simultaneous suboptimal growth and maximum respiration. Under this ideal condition, flux towards extracellular electron transfer rather than for biosynthesis is beneficial for the conversion of organic matter to electricity without large accumulations of biomass and electricigens may maximize utilization of limited fuel. Our simulations will provide an insight into the enhanced current-generating mechanism and identify theoretical range of respiration rates for guiding strain improvement in MFCs.	[Meng, Jing; Guo, Jing; Yue, Yunxia; Sun, Xiao] Southeast Univ, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China; [Xu, Zixiang] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Key Lab Syst Microbial Biotechnol, Tianjin, Peoples R China	Southeast University - China; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS	Sun, X (corresponding author), Southeast Univ, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China.	xsun@seu.edu.cn			Open Research Fund of State Key Laboratory of Bioelectronic, Southeast University; Metabolic network reconstruction of Shewanella loihica PV-4	Open Research Fund of State Key Laboratory of Bioelectronic, Southeast University; Metabolic network reconstruction of Shewanella loihica PV-4	This work was supported by the Open Research Fund of State Key Laboratory of Bioelectronic, Southeast University, Metabolic network reconstruction of Shewanella loihica PV-4 and its application in MFCs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler JE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-40; Franks AE, 2010, BIOFUELS-UK, V1, P589, DOI 10.4155/BFS.10.25; Franks AE, 2010, ENERGIES, V3, P899, DOI 10.3390/en3050899; Galushko AS, 2000, ARCH MICROBIOL, V174, P314, DOI 10.1007/s002030000208; Inoue K, 2010, APPL ENVIRON MICROB, V76, P3999, DOI 10.1128/AEM.00027-10; Izallalen M, 2008, METAB ENG, V10, P267, DOI 10.1016/j.ymben.2008.06.005; Leang C, 2013, ENERG ENVIRON SCI, V6, P1901, DOI 10.1039/c3ee40441b; Lee JM, 2006, BRIEF BIOINFORM, V7, P140, DOI 10.1093/bib/bbl007; Logan BE, 2009, NAT REV MICROBIOL, V7, P375, DOI 10.1038/nrmicro2113; Lovley D, 2006, SCIENTIST, V20, P46; Lovley DR, 2006, NAT REV MICROBIOL, V4, P497, DOI 10.1038/nrmicro1442; Mahadevan R, 2006, APPL ENVIRON MICROB, V72, P1558, DOI 10.1128/AEM.72.2.1558-1568.2006; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Mahadevan R, 2011, NAT REV MICROBIOL, V9, P39, DOI 10.1038/nrmicro2456; Malvankar NS, 2012, ENERG ENVIRON SCI, V5, P5790, DOI 10.1039/c2ee03388g; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Park JH, 2008, TRENDS BIOTECHNOL, V26, P404, DOI 10.1016/j.tibtech.2008.05.001; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Segura D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040036; Strycharz SM, 2011, ENERG ENVIRON SCI, V4, P896, DOI 10.1039/c0ee00260g; Sun J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-15; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Tremblay PL, 2011, ENVIRON MICROBIOL, V13, P13, DOI 10.1111/j.1462-2920.2010.02302.x; Yi HN, 2009, BIOSENS BIOELECTRON, V24, P3498, DOI 10.1016/j.bios.2009.05.004	25	11	11	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73907	10.1371/journal.pone.0073907	http://dx.doi.org/10.1371/journal.pone.0073907			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058500	Green Published, Green Submitted, gold			2022-12-25	WOS:000324408400040
J	Rodriguez-Pujadas, A; Sanjuan, A; Ventura-Campos, N; Roman, P; Martin, CD; Barcelo, F; Costa, A; Avila, C				Rodriguez-Pujadas, Aina; Sanjuan, Ana; Ventura-Campos, Noelia; Roman, Patricia; Martin, Clara D.; Barcelo, Francisco; Costa, Albert; Avila, Cesar			Bilinguals Use Language-Control Brain Areas More Than Monolinguals to Perform Non-Linguistic Switching Tasks	PLOS ONE			English	Article							COGNITIVE CONTROL; EXECUTIVE CONTROL; SIMON TASK; REPRESENTATION; 2ND-LANGUAGE; INFORMATION; ADVANTAGES; DISEASE	We tested the hypothesis that early bilinguals use language-control brain areas more than monolinguals when performing non-linguistic executive control tasks. We do so by exploring the brain activity of early bilinguals and monolinguals in a task-switching paradigm using an embedded critical trial design. Crucially, the task was designed such that the behavioural performance of the two groups was comparable, allowing then to have a safer comparison between the corresponding brain activity in the two groups. Despite the lack of behavioural differences between both groups, early bilinguals used language-control areas - such as left caudate, and left inferior and middle frontal gyri - more than monolinguals, when performing the switching task. Results offer direct support for the notion that, early bilingualism exerts an effect in the neural circuitry responsible for executive control. This effect partially involves the recruitment of brain areas involved in language control when performing domain-general executive control tasks, highlighting the cross-talk between these two domains.	[Rodriguez-Pujadas, Aina; Sanjuan, Ana; Ventura-Campos, Noelia; Roman, Patricia; Avila, Cesar] Univ Jaume 1, Dept Psychol, Castellon de La Plana, Spain; [Roman, Patricia] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Martin, Clara D.; Costa, Albert] Univ Pompeu Fabra, Dept Technol, Barcelona, Spain; [Martin, Clara D.] Basque Ctr Cognit Brain & Language, Donostia San Sebastian, Spain; [Martin, Clara D.] IKERBASQUE, Bilbao, Spain; [Barcelo, Francisco] Univ Balearic Isl, Dept Psychol, Palma De Mallorca, Balearic Island, Spain; [Costa, Albert] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Universitat Jaume I; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pompeu Fabra University; Universitat de les Illes Balears; ICREA	Rodriguez-Pujadas, A (corresponding author), Univ Jaume 1, Dept Psychol, Castellon de La Plana, Spain.	pujadas@psb.uji.es	2010, BRAINGLOT Consolider Ingenio/D-1235-2009; Avila, Cesar/B-4370-2011; Costa, Albert/D-2850-2009; Román, Patricia E./R-6981-2018; Barceló, Francisco/B-3629-2011; Martin, Clara/B-4563-2012; Campos, Noelia Ventura/L-4877-2014	Avila, Cesar/0000-0002-5840-605X; Costa, Albert/0000-0002-8477-5609; Román, Patricia E./0000-0001-9268-2560; Barceló, Francisco/0000-0001-6012-7116; Martin, Clara/0000-0003-2701-5045; Campos, Noelia Ventura/0000-0002-0443-8048; Basque Center on Cognition, Brain and Language, BCBL./0000-0002-8345-6892	Spanish Ministry of Science and Technology [CSD2007-00012]; Consolider-Ingenio programme;  [PSI2010-20168];  [PSI2008 -01191]; ICREA Funding Source: Custom	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consolider-Ingenio programme(Spanish Government); ; ; ICREA(ICREA)	This work was supported by two grants of the Spanish Ministry of Science and Technology given to CA (the BrainGlot Project, CSD2007-00012 (funded by the Consolider-Ingenio 2010 programme), and the grant PSI2010-20168) and a grant given to AC (PSI2008 -01191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abutalebi J, 2000, NEUROCASE, V6, P51, DOI 10.1080/13554790008402757; Abutalebi J, 2008, ACTA PSYCHOL, V128, P466, DOI 10.1016/j.actpsy.2008.03.014; Abutalebi J, 2008, CEREB CORTEX, V18, P1496, DOI 10.1093/cercor/bhm182; Abutalebi J, 2008, LANG COGNITIVE PROC, V23, P557, DOI 10.1080/01690960801920602; Abutalebi J, 2007, J NEUROSCI, V27, P13762, DOI 10.1523/JNEUROSCI.3294-07.2007; Abutalebi J, 2007, J NEUROLINGUIST, V20, P242, DOI 10.1016/j.jneuroling.2006.10.003; Abutalebi J, 2012, CEREB CORTEX, V22, P2076, DOI 10.1093/cercor/bhr287; Aron AR, 2003, J COGNITIVE NEUROSCI, V15, P629, DOI 10.1162/jocn.2003.15.5.629; Barac R, 2012, CHILD DEV, V83, P413, DOI 10.1111/j.1467-8624.2011.01707.x; Barcelo F, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.013.2007; Bialystok E, 2004, PSYCHOL AGING, V19, P290, DOI 10.1037/0882-7974.19.2.290; Bialystok E, 2005, NEUROIMAGE, V24, P40, DOI 10.1016/j.neuroimage.2004.09.044; Bialystok E., 2001, BILINGUALISM DEV LAN, DOI [10.1017/CBO9780511605963, DOI 10.1017/CBO9780511605963]; Bialystok E, 2009, COGNITION, V112, P494, DOI 10.1016/j.cognition.2009.06.014; Bialystok E, 2009, BILING-LANG COGN, V12, P3, DOI 10.1017/S1366728908003477; Chein JM, 2003, HDB NEUROPSYCHOLOGY, V9; Cools R, 2001, CEREB CORTEX, V11, P1136, DOI 10.1093/cercor/11.12.1136; Costa A, 2008, COGNITION, V106, P59, DOI 10.1016/j.cognition.2006.12.013; Costa A, 2009, COGNITION, V113, P135, DOI 10.1016/j.cognition.2009.08.001; Crinion J, 2006, SCIENCE, V312, P1537, DOI 10.1126/science.1127761; Frith CD, 1995, HUM BRAIN MAPP, V3, P153, DOI 10.1002/hbm.460030209; Garbin G, 2011, BRAIN LANG, V119, P129, DOI 10.1016/j.bandl.2011.03.011; Garbin G, 2010, NEUROIMAGE, V53, P1272, DOI 10.1016/j.neuroimage.2010.05.078; Green DW, 1998, BILING-LANG COGN, V2, P67; Hilchey MD, 2011, PSYCHON B REV, V18, P625, DOI 10.3758/s13423-011-0116-7; Luo L, 2010, COGNITION, V114, P29, DOI 10.1016/j.cognition.2009.08.014; Marian V, 2007, J CLIN EXP NEUROPSYC, V29, P247, DOI 10.1080/13803390600659376; Marien P, 2005, NEUROCASE, V11, P385, DOI 10.1080/13554790500212880; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Mishra RK, 2012, Q J EXP PSYCHOL, V65, P1502, DOI 10.1080/17470218.2012.657656; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Moritz-Gasser S, 2009, NEUROREPORT, V20, P1577, DOI 10.1097/WNR.0b013e328333907e; Price CJ, 1999, BRAIN, V122, P2221, DOI 10.1093/brain/122.12.2221; Robbins TW, 2007, PHILOS T R SOC B, V362, P917, DOI 10.1098/rstb.2007.2097; Robles SG, 2005, J NEUROL NEUROSUR PS, V76, P940, DOI 10.1136/jnnp.2004.045948; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695	36	42	42	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73028	10.1371/journal.pone.0073028	http://dx.doi.org/10.1371/journal.pone.0073028			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218BU	24058456	Green Published, gold, Green Submitted			2022-12-25	WOS:000324408400015
J	Zhang, YC; Liu, XD; McHale, C; Li, R; Zhang, LP; Wu, Y; Ye, X; Yang, X; Ding, SM				Zhang, Yuchao; Liu, Xudong; McHale, Cliona; Li, Rui; Zhang, Luoping; Wu, Yang; Ye, Xin; Yang, Xu; Ding, Shumao			Bone Marrow Injury Induced via Oxidative Stress in Mice by Inhalation Exposure to Formaldehyde	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; MYELODYSPLASTIC SYNDROMES; DNA-DAMAGE; LEUKEMIA; APOPTOSIS; PROLIFERATION; POLYMORPHISMS; ACTIVATION; EXPRESSION; MECHANISM	Objective: Formaldehyde, a ubiquitous environmental pollutant has been classified as a human leukemogen. However, toxicity of formaldehyde in bone marrow, the target site of leukemia induction, is still poorly understood. Methodology/Principal Findings: To investigate bone marrow toxicity (bone marrow pathology, hematotoxicity) and underlying mechanisms (oxidative stress, inflammation, apoptosis) in formaldehyde-exposed mice. Male Balb/c mice were exposed to formaldehyde (0, 0.5, and 3.0 mg/m(3)) by nose-only inhalation for 8 hours/day, over a two week period designed to simulate a factory work schedule, with an exposure-free "weekend'' on days 6 and 7, and were sacrificed on the morning of day 13. Counts of white blood cells, red blood cells and lymphocytes were significantly (p<0.05) decreased at 0.5 mg/m(3) (43%, 7%, and 39%, respectively) and 3.0 mg/m(3) (52%, 27%, and 43%, respectively) formaldehyde exposure, while platelet counts were significantly increased by 109% (0.5 mg/m(3)) and 67% (3.0 mg/m(3)). Biomarkers of oxidative stress (reactive oxygen species, glutathione depletion, cytochrome P450 1A1 and glutathione s-transferase theta 1 expression), inflammation (nuclear factor kappa-B, tomour necrosis factor alpha, interleukin-1 beta), and apoptosis (activity of cysteine-aspartic acid protease 3) in bone marrow tissues were induced at one or both formaldehyde doses mentioned above. Conclusions/Significance: Exposure of mice to formaldehyde by inhalation induced bone marrow toxicity, and that oxidative stress, inflammation and the consequential apoptosis jointly constitute potential mechanisms of such induced toxicity.	[Zhang, Yuchao; Liu, Xudong; Li, Rui; Wu, Yang; Ye, Xin; Yang, Xu; Ding, Shumao] Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Sect Environm Biomed, Wuhan, Peoples R China; [McHale, Cliona; Zhang, Luoping] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Genes & Environm Lab, Berkeley, CA 94720 USA	Central China Normal University; University of California System; University of California Berkeley	Ding, SM (corresponding author), Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Sect Environm Biomed, Wuhan, Peoples R China.	dingsm@mail.ccnu.edu.cn			China Key Technologies RD Program [2012BAJ02B03]; National Natural Science Foundation of China [21103059]	China Key Technologies RD Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by China Key Technologies R&D Program (2012BAJ02B03) and National Natural Science Foundation of China (21103059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apgar JM, 1998, J MICROSC-OXFORD, V191, P20; [ATSDR] Agent for Toxic Disease Substances Registry, 2010, TOX PROF FORM, P4; Battisti V, 2008, CLIN BIOCHEM, V41, P511, DOI 10.1016/j.clinbiochem.2008.01.027; Borset M, 1996, CYTOKINE, V8, P430, DOI 10.1006/cyto.1996.0059; Brown DM, 2004, AM J PHYSIOL-LUNG C, V286, pL344, DOI 10.1152/ajplung.00139.2003; Callera F, 1997, BRIT J HAEMATOL, V98, P18, DOI 10.1046/j.1365-2141.1997.1532971.x; Cha, 2007, J MICROBIOL BIOTECHN, V17, P1573; Cheng WW, 2011, INT J BIOCHEM CELL B, V43, P564, DOI 10.1016/j.biocel.2010.12.013; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Deutsch VR, 2006, BRIT J HAEMATOL, V134, P453, DOI 10.1111/j.1365-2141.2006.06215.x; Dostalek M, 2008, J BIOL CHEM, V283, P17147, DOI 10.1074/jbc.M802447200; Gao XZ, 1998, LEUKEMIA RES, V22, P429, DOI 10.1016/S0145-2126(98)00024-1; Hallek M, 1998, BLOOD, V91, P3, DOI 10.1182/blood.V91.1.3.3_3_21; HALLIWELL B, 1997, NUTR REV, V55, P44, DOI DOI 10.1111/J.1753-4887.1997.TB06100.X.PMID:9155225; Hsin YH, 2008, TOXICOL LETT, V179, P130, DOI 10.1016/j.toxlet.2008.04.015; IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2006, WHO INT AGENCY RES C, V88, P196; IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2012, WHO INT AGENCY RES F, V100F, P401; Jiang SF, 2010, MUTAT RES-GEN TOX EN, V695, P9, DOI 10.1016/j.mrgentox.2009.09.011; Jiang WW, 2011, BIOCHEM BIOPH RES CO, V407, P79, DOI 10.1016/j.bbrc.2011.02.113; Kadiiska MB, 2000, FREE RADICAL BIO MED, V28, P1106, DOI 10.1016/S0891-5849(00)00203-3; Klaunig JE, 2011, TOXICOL APPL PHARM, V254, P86, DOI 10.1016/j.taap.2009.11.028; Kryston TB, 2011, MUTAT RES-FUND MOL M, V711, P193, DOI 10.1016/j.mrfmmm.2010.12.016; KURZROCK R, 1993, EXP HEMATOL, V21, P80; Long MW, 1998, SEMIN HEMATOL, V35, P192; Lowery EW, 2013, CLIN J ONCOL NURS, V17, P312, DOI 10.1188/13.CJON.312-318; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu Z, 2008, INDOOR AIR, V18, P77, DOI 10.1111/j.1600-0668.2008.00524.x; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Matsuoka T, 2010, J TOXICOL SCI, V35, P721, DOI 10.2131/jts.35.721; Matsushita Hiromichi, 2011, Rinsho Byori, V59, P65; McHale CM, 2012, CARCINOGENESIS, V33, P240, DOI 10.1093/carcin/bgr297; Moeller BC, 2011, CHEM RES TOXICOL, V24, P162, DOI 10.1021/tx1004166; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; NTP (National Toxicology Program), 2011, REP CARC, P195; NTP (National Toxicology Program), 2010, REP CARCINOG BACKGR, pi; Oki Y, 2006, BLOOD, V107, P880, DOI 10.1182/blood-2005-06-2450; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Peleg S, 1997, J CLIN INVEST, V100, P1716, DOI 10.1172/JCI119696; Qujeq D, 2004, CLIN CHIM ACTA, V340, P79, DOI 10.1016/j.cccn.2003.09.023; RAZA A, 1995, BLOOD, V86, P268, DOI 10.1182/blood.V86.1.268.bloodjournal861268; Renstrom J, 2010, CHEM-BIOL INTERACT, V184, P7, DOI 10.1016/j.cbi.2009.11.012; Rhomberg LR, 2011, CRIT REV TOXICOL, V41, P555, DOI 10.3109/10408444.2011.560140; Rumchev KB, 2002, EUR RESPIR J, V20, P403, DOI 10.1183/09031936.02.00245002; Shetty V, 1996, LEUKEMIA RES, V20, P891, DOI 10.1016/S0145-2126(96)00008-2; Song K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048924; Stein SJ, 2013, BLOOD IN PRESS; Tang XJ, 2009, ENVIRON INT, V35, P1210, DOI 10.1016/j.envint.2009.06.002; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tong ZQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010234; Voulgarelis M, 2006, AM J HEMATOL, V81, P590, DOI 10.1002/ajh.20593; Wick Jeannette Y, 2013, Consult Pharm, V28, P16, DOI 10.4140/TCP.n.2013.16; Wlodarczyk M, 2012, MOL BIOL REP, V39, P5699, DOI 10.1007/s11033-011-1378-x; Wu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062827; Xavier JG, 2007, HISTOL HISTOPATHOL, V22, P651, DOI 10.14670/HH-22.651; Xiao GG, 2003, J BIOL CHEM, V278, P50781, DOI 10.1074/jbc.M306423200; Yahata T, 2011, BLOOD, V118, P2941, DOI 10.1182/blood-2011-01-330050; Zeller J, 2012, ARCH TOXICOL, V86, P1465, DOI 10.1007/s00204-012-0830-6; Zhang LP, 2010, CANCER EPIDEM BIOMAR, V19, P80, DOI 10.1158/1055-9965.EPI-09-0762; Zhang LP, 2009, MUTAT RES-REV MUTAT, V681, P150, DOI 10.1016/j.mrrev.2008.07.002; Zhou FL, 2010, J BIOL CHEM, V285, P15010, DOI 10.1074/jbc.M110.103713	60	54	54	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74974	10.1371/journal.pone.0074974	http://dx.doi.org/10.1371/journal.pone.0074974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040369	Green Submitted, Green Published, gold			2022-12-25	WOS:000326734500129
J	Miller, JH; Rajapakshe, KI; Infante, HL; Claycomb, JR				Miller, John H., Jr.; Rajapakshe, Kimal I.; Infante, Hans L.; Claycomb, James R.			Electric Field Driven Torque in ATP Synthase	PLOS ONE			English	Article							PROTON TRANSPORT; PATHOGENIC MECHANISM; AQUEOUS ACCESS; MUTATIONS; CANCER; SUBUNIT; VOLTAGE; T8993G; MOTOR; GENERATION	F-O-ATP synthase (F-O) is a rotary motor that converts potential energy from ions, usually protons, moving from high- to low-potential sides of a membrane into torque and rotary motion. Here we propose a mechanism whereby electric fields emanating from the proton entry and exit channels act on asymmetric charge distributions in the c-ring, due to protonated and deprotonated sites, and drive it to rotate. The model predicts a scaling between time-averaged torque and proton motive force, which can be hindered by mutations that adversely affect the channels. The torque created by the c-ring of F-O drives the gamma-subunit to rotate within the ATP-producing complex (F-1) overcoming, with the aid of thermal fluctuations, an opposing torque that rises and falls with angular position. Using the analogy with thermal Brownian motion of a particle in a tilted washboard potential, we compute ATP production rates vs. proton motive force. The latter shows a minimum, needed to drive ATP production, which scales inversely with the number of proton binding sites on the c-ring.	[Miller, John H., Jr.; Rajapakshe, Kimal I.; Infante, Hans L.; Claycomb, James R.] Univ Houston, Dept Phys, Houston, TX 77204 USA; [Miller, John H., Jr.; Rajapakshe, Kimal I.; Infante, Hans L.; Claycomb, James R.] Univ Houston, Texas Ctr Superconduct, Houston, TX USA; [Rajapakshe, Kimal I.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Claycomb, James R.] Houston Baptist Univ, Dept Math & Phys, Houston, TX USA	University of Houston System; University of Houston; University of Houston System; University of Houston; Baylor College of Medicine	Miller, JH (corresponding author), Univ Houston, Dept Phys, Houston, TX 77204 USA.	jhmiller@uh.edu	Rajapakshe, Kimal/P-1592-2015; Miller, John J/GZG-5663-2022		State of Texas, Texas Center for Superconductivity at the University of Houston; National Institutes of Health (NIH), NCI [R21CA133153]; NATIONAL CANCER INSTITUTE [R21CA133153] Funding Source: NIH RePORTER	State of Texas, Texas Center for Superconductivity at the University of Houston; National Institutes of Health (NIH), NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	State of Texas, Texas Center for Superconductivity at the University of Houston, http://www.tcsuh.com/. National Institutes of Health (NIH), NCI, R21CA133153, http://www.cancer.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksimentiev A, 2004, BIOPHYS J, V86, P1332, DOI 10.1016/S0006-3495(04)74205-8; AMBEGAOKAR V, 1969, PHYS REV LETT, V22, P1364, DOI 10.1103/PhysRevLett.22.1364; Angevine CM, 2003, J BIOL CHEM, V278, P6066, DOI 10.1074/jbc.M210199200; Arnold RS, 2009, PROSTATE, V69, P1, DOI 10.1002/pros.20854; Astumian RD, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.118102; BARDEEN J, 1982, PHYS REV LETT, V49, P493, DOI 10.1103/PhysRevLett.49.493; Bauer WR, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3026736; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Bustamante C, 2001, ACCOUNTS CHEM RES, V34, P412, DOI 10.1021/ar0001719; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Cortes-Hernandez P, 2007, J BIOL CHEM, V282, P1051, DOI 10.1074/jbc.M606828200; Dasgupta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006533; Dautant A, 2010, J BIOL CHEM, V285, P29502, DOI 10.1074/jbc.M110.124529; Elston T, 1998, NATURE, V391, P510, DOI 10.1038/35185; Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159; Feniouk BA, 2004, BIOPHYS J, V86, P4094, DOI 10.1529/biophysj.103.036962; Fillingame RH, 2000, NAT STRUCT BIOL, V7, P1002, DOI 10.1038/80902; Gitterman M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.011104; Gitterman M, 2002, PHYS REV E, V65; Gohlke H, 2012, J BIOL CHEM, V287, P36536, DOI 10.1074/jbc.M112.398396; GRUNER G, 1981, PHYS REV LETT, V46, P511, DOI 10.1103/PhysRevLett.46.511; Jackson J. D., 1999, CLASSICAL ELECTRODYN; Junge W, 2005, SCIENCE, V308, P642, DOI 10.1126/science.1112617; Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Kaim G, 1998, EMBO J, V17, P5887, DOI 10.1093/emboj/17.20.5887; Machura L, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031105; Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103; Motz C, 2004, J BIOL CHEM, V279, P49074, DOI 10.1074/jbc.M404543200; Nicholls D., 2002, BIOENERGETICS, V3; Nicholls DG, 2004, AGING CELL, V3, P35, DOI 10.1111/j.1474-9728.2003.00079.x; Oster G, 2000, PHILOS T ROY SOC B, V355, P523, DOI 10.1098/rstb.2000.0593; Palanisami A, 2010, NANO LETT, V10, P4146, DOI 10.1021/nl102414d; Panke O, 2001, BIOPHYS J, V81, P1220, DOI 10.1016/S0006-3495(01)75780-3; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Plak K, 2009, ONCOL REP, V21, P845, DOI 10.3892/or_00000293; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; Reimann P, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031104; Rosca MG, 2010, CARDIOVASC RES, V88, P40, DOI 10.1093/cvr/cvq240; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Schmitt UW, 1999, J CHEM PHYS, V111, P9361, DOI 10.1063/1.480032; Sgarbi G, 2006, BIOCHEM J, V395, P493, DOI 10.1042/BJ20051748; Shidara Y, 2005, CANCER RES, V65, P1655, DOI 10.1158/0008-5472.CAN-04-2012; Solaini G, 2008, BBA-BIOENERGETICS, V1777, P941, DOI 10.1016/j.bbabio.2008.04.034; Steed PR, 2008, J BIOL CHEM, V283, P12365, DOI 10.1074/jbc.M800901200; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; Stratonovich RL, 1965, RADIOTEKH ELEKTRON, V3, P497; Tan DJ, 2002, CANCER RES, V62, P972; Vazquez-Memije ME, 1998, J INHERIT METAB DIS, V21, P829, DOI 10.1023/A:1005418718299; VIK SB, 1994, J BIOL CHEM, V269, P30364; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16755; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; Xing JH, 2004, BIOPHYS J, V87, P2148, DOI 10.1529/biophysj.104.042093; Zhang D, 2003, BIOCHEMISTRY-US, V42, P331, DOI 10.1021/bi026649t	55	18	18	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74978	10.1371/journal.pone.0074978	http://dx.doi.org/10.1371/journal.pone.0074978			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040370	Green Submitted, gold, Green Published			2022-12-25	WOS:000327538600123
J	Chen, HY; Wang, Y; Zhang, JX; Ma, YX; Wang, CX; Zhou, Y; Gu, HC; Ying, WH				Chen, Heyu; Wang, Yao; Zhang, Jixi; Ma, Yingxin; Wang, Caixia; Zhou, Ying; Gu, Hongchen; Ying, Weihai			NAD(+)-Carrying Mesoporous Silica Nanoparticles Can Prevent Oxidative Stress-Induced Energy Failures of Both Rodent Astrocytes and PC12 Cells	PLOS ONE			English	Article							NAD(+) DEPLETION; NEURONAL DEATH; DRUG-DELIVERY; BRAIN-INJURY; SHELL; CORE	Aim: To test the hypothesis that NAD(+)-carrying mesoporous silica nanoparticles (M-MSNs@NAD(+)) can effectively deliver NAD(+) into cells to produce cytoprotective effects. Methods & Materials: NAD(+) was incorporated into M-MSNs. Primary rat astrocyte cultures and PC12 cells were treated with H2O2, followed by post-treatment with M-MSNs@NAD+. After various durations of the post-treatment, intracellular NAD(+) levels, intracellular ATP levels and lactate dehydrogenase (LDH) release were determined. Results & Discussion: M-MSNs can be effectively loaded with NAD(+). The M-MSNs@NAD+ can significantly attenuate H2O2-induced NAD(+) and ATP decreases in both astrocyte cultures and PC12 cells. M-MSNs@NAD+ can also partially prevent the H2O2-induced LDH release from both astrocyte cultures and PC12 cells. In contrast, the NAD(+) that is spontaneously released from the M-MSNs@NAD+ is insufficient to prevent the H2O2-induced damage. Conclusions: Our study has suggested the first approach that can effectively deliver NAD(+) into cells, which provides an important basis both for elucidating the roles of intracellular NAD(+) in biological functions and for therapeutic applications of NAD(+). Our study has also provided the first direct evidence demonstrating a key role of NAD(+) depletion in oxidative stress-induced ATP decreases.	[Ying, Weihai] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; Shanghai Jiao Tong Univ, Med Res Inst X, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Ying, WH (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China.	hongchen.gu@sjtu.edu.cn; weihaiy@sjtu.edu.cn	Zhang, Jixi/I-4980-2016; Zhang, Jixi/D-7124-2012; , WY/ABG-7072-2020	Zhang, Jixi/0000-0003-3460-0867; Wang, Yao/0000-0003-0470-9511	Key Shanghai Jiao Tong University; Shanghai Engineering Center Grant [11DZ2211000]; National Key Basic Research '973 Program' [2010CB834306]; Chinese National Science Foundation [81171098]	Key Shanghai Jiao Tong University; Shanghai Engineering Center Grant; National Key Basic Research '973 Program'(National Basic Research Program of China); Chinese National Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by a Key Shanghai Jiao Tong University Grant for Interdisciplinary Research on Engineering and Physical Sciences (to H. G. and W.Y.), Shanghai Engineering Center Grant #11DZ2211000 (to H.G. and W.Y.), a National Key Basic Research '973 Program' Grant #2010CB834306 (to W.Y.), and Chinese National Science Foundation Grant #81171098 (to W.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Cole KK, 2002, J NEUROCHEM, V82, P19, DOI 10.1046/j.1471-4159.2002.00935.x; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Furukawa A, 2007, CELL PHYSIOL BIOCHEM, V20, P45, DOI 10.1159/000104152; Haag F, 2007, PURINERG SIGNAL, V3, P71, DOI 10.1007/s11302-006-9038-7; Kim J, 2008, ANGEW CHEM INT EDIT, V47, P8438, DOI 10.1002/anie.200802469; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Li X, 2011, BIOMATERIALS, V32, P9546, DOI 10.1016/j.biomaterials.2011.08.068; Liong M, 2008, ACS NANO, V2, P889, DOI 10.1021/nn800072t; Liu Q, 2012, NANOSCALE, V4, P3415, DOI 10.1039/c2nr30352c; Lu J, 2007, NEW MATH NAT COMPUT, V3, P89, DOI 10.1142/S1793005707000641; Rosenholm JM, 2008, J CONTROL RELEASE, V128, P157, DOI 10.1016/j.jconrel.2008.02.013; Rosenholm JM, 2011, MICROPOR MESOPOR MAT, V145, P14, DOI 10.1016/j.micromeso.2011.04.022; Stohs S J, 1995, J Basic Clin Physiol Pharmacol, V6, P205; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Won SJ, 2012, J NEUROTRAUM, V29, P1401, DOI 10.1089/neu.2011.2228; Xu H, 2006, J AM CHEM SOC, V128, P15582, DOI 10.1021/ja066165a; Ying W, 2010, CURR MED CHEM, V17, P2152, DOI 10.2174/092986710791299911; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Ying WJ, 2007, FRONT BIOSCI-LANDMRK, V12, P2728, DOI 10.2741/2267; Ying WH, 2001, P NATL ACAD SCI USA, V98, P12227, DOI 10.1073/pnas.211202598; Ying WH, 2000, NEUROREPORT, V11, P1385, DOI 10.1097/00001756-200005150-00007; Ying WH, 1999, J NEUROCHEM, V73, P1549, DOI 10.1046/j.1471-4159.1999.0731549.x; Ying WH, 2003, BIOCHEM BIOPH RES CO, V308, P809, DOI 10.1016/S0006-291X(03)01483-9; Ying WH, 1997, GERONTOLOGY, V43, P242; Zhang JX, 2011, J COLLOID INTERF SCI, V361, P16, DOI 10.1016/j.jcis.2011.05.038; Zheng C, 2012, NEUROSCI LETT	28	12	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74100	10.1371/journal.pone.0074100	http://dx.doi.org/10.1371/journal.pone.0074100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040179	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300156
J	Fumel, B; Roy, S; Fouchecourt, S; Livera, G; Parent, AS; Casas, F; Guillou, F				Fumel, Betty; Roy, Stephanie; Fouchecourt, Sophie; Livera, Gabriel; Parent, Anne-Simone; Casas, Francois; Guillou, Florian			Depletion of the p43 Mitochondrial T3 Receptor Increases Sertoli Cell Proliferation in Mice	PLOS ONE			English	Article							REGULATES MYOBLAST DIFFERENTIATION; INCREASED ADULT TESTIS; SPERM PRODUCTION; OVEREXPRESSION; CDK4; EXPRESSION; SIZE; HYPOTHYROIDISM; JUND; MYC	Among T3 receptors, TR alpha 1 is ubiquitous and its deletion or a specific expression of a dominant-negative TR alpha 1 isoform in Sertoli cell leads to an increase in testis weight and sperm production. The identification of a 43-kDa truncated form of the nuclear receptor TR alpha 1 (p43) in the mitochondrial matrix led us to test the hypothesis that this mitochondrial transcription factor could regulate Sertoli cell proliferation. Here we report that p43 depletion in mice increases testis weight and sperm reserve. In addition, we found that p43 deletion increases Sertoli cell proliferation in postnatal testis at 3 days of development. Electron microscopy studies evidence an alteration of mitochondrial morphology observed specifically in Sertoli cells of p43-/- mice. Moreover, gene expression studies indicate that the lack of p43 in testis induced an alteration of the mitochondrial-nuclear cross-talk. In particular, the up-regulation of Cdk4 and c-myc pathway in p43-/- probably explain the extended proliferation recorded in Sertoli cells of these mice. Our finding suggests that T3 limits post-natal Sertoli cell proliferation mainly through its mitochondrial T3 receptor p43.	[Fumel, Betty; Roy, Stephanie; Fouchecourt, Sophie; Guillou, Florian] INRA, UMR85 Physiol Reprod & Comportements, F-37380 Nouzilly, France; [Fumel, Betty] CNRS, UMR7247 Physiol Reprod & Comportements, Nouzilly, France; [Fumel, Betty] Univ Tours, Tours, France; [Fumel, Betty] IFCE, Nouzilly, France; [Livera, Gabriel] Univ Paris Diderot, Sorbonne Paris Cite, CEA,DSV,iRCM,SCSR, INSERM U967,Lab Dve Gonades, Fontenay Aux Roses, France; [Parent, Anne-Simone] Univ Liege, CHU Sart Tilman, GIGA Neurosci, Dev Neuroendocrinol Unit, Liege, Belgium; [Casas, Francois] INRA, UMR Dynam Musculaire & Metab 866, F-34060 Montpellier, France; [Casas, Francois] Univ Montpellier I, Montpellier, France; [Casas, Francois] Univ Montpellier 2, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Tours; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; University of Liege; INRAE; Universite de Montpellier; Universite de Montpellier; Universite de Montpellier	Guillou, F (corresponding author), INRA, UMR85 Physiol Reprod & Comportements, F-37380 Nouzilly, France.	florian.guillou@tours.inra.fr	Parent, Anne-Simone/ABC-1458-2021; LIVERA, Gabriel/F-5740-2019	LIVERA, Gabriel/0000-0001-8436-4730; Fouchecourt, Sophie/0000-0001-6923-6220; Roy, Stephanie/0000-0002-5943-7106; Francois, Casas/0000-0002-5535-8195	Agence Nationale pour la Recherche; grant "Biodiversite, evolution des ecosystemes, ecosystemes productifs, agronomie"; Institut national de la recherche agronomique; fellowship Region Centre	Agence Nationale pour la Recherche(French National Research Agency (ANR)); grant "Biodiversite, evolution des ecosystemes, ecosystemes productifs, agronomie"; Institut national de la recherche agronomique; fellowship Region Centre(Region Centre-Val de Loire)	Funding was received from the Agence Nationale pour la Recherche; grant "Biodiversite, evolution des ecosystemes, ecosystemes productifs, agronomie" (SF, FG), Institut national de la recherche agronomique (FG, SF, FC) and a fellowship Region Centre (BF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchet E, 2011, FASEB J; Casas F, 1999, MOL CELL BIOL, V19, P7913; Casas F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005631; Casas F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002501; COOKE PS, 1991, ANN NY ACAD SCI, V637, P122, DOI 10.1111/j.1749-6632.1991.tb27305.x; COOKE PS, 1991, ENDOCRINOLOGY, V129, P237, DOI 10.1210/endo-129-1-237; COOKE PS, 1994, BIOL REPROD, V51, P1000, DOI 10.1095/biolreprod51.5.1000; Fumel B, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.098418; Grandemange S, 2005, CANCER RES, V65, P4282, DOI 10.1158/0008-5472.CAN-04-3652; Haas K, 1997, ONCOGENE, V15, P179, DOI 10.1038/sj.onc.1201171; Hadj-Sahraoui N, 2000, NEUROSCI LETT, V280, P79, DOI 10.1016/S0304-3940(00)00768-0; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; Hernandez JM, 2008, ONCOGENE, V27, P4757, DOI 10.1038/onc.2008.120; HOCHEREAUDEREVIERS MT, 1990, DOMEST ANIM ENDOCRIN, V7, P63, DOI 10.1016/0739-7240(90)90055-5; Holsberger DR, 2005, BIOL REPROD, V73, P396, DOI 10.1095/biolreprod.105.041426; JOYCE KL, 1993, J ANDROL, V14, P448; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Lecureuil C, 2007, MOL REPROD DEV, V74, P197, DOI 10.1002/mrd.20523; ORTH JM, 1988, ENDOCRINOLOGY, V122, P787, DOI 10.1210/endo-122-3-787; PALMERO S, 1995, J ENDOCRINOL, V145, P355, DOI 10.1677/joe.0.1450355; PALMERO S, 1994, EUR J ENDOCRINOL, V130, P308, DOI 10.1530/eje.0.1300308; Pessemesse L, 2012, FASEB J, V26, P748, DOI 10.1096/fj.11-195933; Pitetti JL, 2013, MOL ENDOCRINOL, V27, P814, DOI 10.1210/me.2012-1258; Rochard P, 2000, J BIOL CHEM, V275, P2733, DOI 10.1074/jbc.275.4.2733; Seyer P, 2006, J CELL PHYSIOL, V207, P75, DOI 10.1002/jcp.20539; Seyer P, 2011, EXP CELL RES, V317, P2059, DOI 10.1016/j.yexcr.2011.05.020; Tsutsui T, 1999, MOL CELL BIOL, V19, P7011; VANHAASTER LH, 1993, ENDOCRINOLOGY, V133, P755, DOI 10.1210/en.133.2.755; WRUTNIAK C, 1995, J BIOL CHEM, V270, P16347, DOI 10.1074/jbc.270.27.16347; Xiao L, 2007, BIOCHEM J, V403, P573, DOI 10.1042/BJ20061436; Zhang Q, 2011, EVID BASED COMPLEMEN, V2011	31	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74015	10.1371/journal.pone.0074015	http://dx.doi.org/10.1371/journal.pone.0074015			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040148	Green Published, gold			2022-12-25	WOS:000326405300150
J	Benito-Martin, A; Ucero, AC; Zubiri, I; Posada-Ayala, M; Fernandez-Fernandez, B; Cannata-Ortiz, P; Sanchez-Nino, MD; Ruiz-Ortega, M; Egido, J; Alvarez-Llamas, G; Ortiz, A				Benito-Martin, Alberto; Conrado Ucero, Alvaro; Zubiri, Irene; Posada-Ayala, Maria; Fernandez-Fernandez, Beatriz; Cannata-Ortiz, Pablo; Dolores Sanchez-Nino, Maria; Ruiz-Ortega, Marta; Egido, Jesus; Alvarez-Llamas, Gloria; Ortiz, Alberto			Osteoprotegerin in Exosome-Like Vesicles from Human Cultured Tubular Cells and Urine	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; DIABETIC-NEPHROPATHY; TRANSFERRIN RECEPTOR; MOLECULAR-BASIS; T-CELLS; APOPTOSIS; PROTEINS; MEMBRANE; MICROVESICLES; RELEASE	Urinary exosomes have been proposed as potential diagnostic tools. TNF superfamily cytokines and receptors may be present in exosomes and are expressed by proximal tubular cells. We have now studied the expression of selected TNF superfamily proteins in exosome-like vesicles from cultured human proximal tubular cells and human urine and have identified additional proteins in these vesicles by LC-MS/MS proteomics. Human proximal tubular cells constitutively released exosome-like vesicles that did not contain the TNF superfamily cytokines TRAIL or TWEAK. However, exosome-like vesicles contained osteoprotegerin (OPG), a TNF receptor superfamily protein, as assessed by Western blot, ELISA or selected reaction monitoring by nLC-(QQQ)MS/MS. Twenty-one additional proteins were identified in tubular cell exosome-like vesicles, including one (vitamin D binding protein) that had not been previously reported in exosome-like vesicles. Twelve were extracellular matrix proteins, including the basement membrane proteins type IV collagen, nidogen-1, agrin and fibulin-1. Urine from chronic kidney disease patients contained a higher amount of exosomal protein and exosomal OPG than urine from healthy volunteers. Specifically OPG was increased in autosomal dominant polycystic kidney disease urinary exosome-like vesicles and expressed by cystic epithelium in vivo. In conclusion, OPG is present in exosome-like vesicles secreted by proximal tubular epithelial cells and isolated from Chronic Kidney Disease urine.	[Benito-Martin, Alberto; Conrado Ucero, Alvaro; Fernandez-Fernandez, Beatriz; Ruiz-Ortega, Marta; Egido, Jesus; Ortiz, Alberto] Univ Autonoma Madrid, Dept Nephrol, Inst Invest Sanitarias Fdn Jimenez Diaz, Madrid, Spain; [Zubiri, Irene; Posada-Ayala, Maria; Alvarez-Llamas, Gloria] Univ Autonoma Madrid, Dept Immunol, Inst Invest Sanitarias Fdn Jimenez Diaz, Madrid, Spain; [Cannata-Ortiz, Pablo] Univ Autonoma Madrid, Dept Pathol, Inst Invest Sanitarias Fdn Jimenez Diaz, Madrid, Spain; [Dolores Sanchez-Nino, Maria] Hosp Univ La Paz, Inst Invest, Madrid, Spain; [Egido, Jesus; Ortiz, Alberto] Inst Reina Sofia Invest Nefrol, Madrid, Spain	Autonomous University of Madrid; Fundacion Jimenez Diaz; Autonomous University of Madrid; Fundacion Jimenez Diaz; Autonomous University of Madrid; Fundacion Jimenez Diaz; Hospital Universitario La Paz	Ortiz, A (corresponding author), Univ Autonoma Madrid, Dept Nephrol, Inst Invest Sanitarias Fdn Jimenez Diaz, Madrid, Spain.	aortiz@fjd.es	Ruiz-Ortega, Marta/D-3584-2012; Llamas, Gloria Alvarez/AAA-8090-2020; Posada-Ayala, María/F-6527-2016; Azcarate, Irene Zubiri/R-6699-2019; Sanchez-Niño, Maria Dolores/B-7350-2019; Ucero, Alvaro Conrado/AGQ-2114-2022; Alvarez-Llamas, Gloria/C-8938-2015; ortiz, alberto/Y-7582-2018; Ortega, Marta Ruiz/AAN-2136-2020; Ucero, Alvaro C/C-8437-2013; Benito-Martin, Alberto/GLU-6164-2022; ruiz-ortega, marta/D-3584-2012	Ruiz-Ortega, Marta/0000-0002-1495-6535; Llamas, Gloria Alvarez/0000-0002-3313-721X; Posada-Ayala, María/0000-0002-6941-5592; Sanchez-Niño, Maria Dolores/0000-0001-7110-6409; Ucero, Alvaro Conrado/0000-0002-5575-0808; Alvarez-Llamas, Gloria/0000-0002-3313-721X; ortiz, alberto/0000-0002-9805-9523; Ortega, Marta Ruiz/0000-0002-1495-6535; Ucero, Alvaro C/0000-0002-5575-0808; Benito-Martin, Alberto/0000-0002-0700-3891; ruiz-ortega, marta/0000-0002-1403-2690	Instituto de Salud Carlos III [ISCIIIRETIC REDINREN RD06/0016, RD12/0021, PI11/01854, PI10/00072 PI09/00641, PS09/00447, FIS PI11/01401, CP09/00229]; Comunidad de Madrid [Fibroteam S2010/BMD-2321, S2010/BMD-2378]; Sociedad Espanola de Nefrologia; European Network [HEALTH F2-2008-200647]; DIALOK European project [LSHB-CT-2007-036644]; Fundacion Lilly; IRSIN/FRIAT; Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM); Fundacion Conchita Rabago de Jimenez Diaz	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Comunidad de Madrid(Comunidad de Madrid); Sociedad Espanola de Nefrologia; European Network; DIALOK European project; Fundacion Lilly; IRSIN/FRIAT; Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM)(Instituto de Salud Carlos III); Fundacion Conchita Rabago de Jimenez Diaz	This work was supported by grants from the Instituto de Salud Carlos III (ISCIIIRETIC REDINREN RD06/0016, RD12/0021, PI11/01854, PI10/00072 PI09/00641 and PS09/00447); Comunidad de Madrid (Fibroteam S2010/BMD-2321, S2010/BMD-2378); Sociedad Espanola de Nefrologia; European Network (HEALTH F2-2008-200647); DIALOK European project LSHB-CT-2007-036644; Fundacion Lilly and IRSIN/FRIAT to JE; Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM) to AO; Instituto de Salud Carlos III (FIS PI11/01401, CP09/00229); and Fundacion Conchita Rabago de Jimenez Diaz to GAL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Blazquez-Medela AM, 2011, CURR MOL MED, V11, P401; Blazquez-Medela AM, 2012, EUR J CLIN INVEST, V42, P548, DOI 10.1111/j.1365-2362.2011.02619.x; de la Cuesta F, 2012, J PROTEOMICS, V75, P2960, DOI 10.1016/j.jprot.2011.12.005; Dear JW, 2012, PROTEOMICS; Sanchez-Nino MD, 2009, J AM SOC NEPHROL, V20, P353, DOI 10.1681/ASN.2008020194; Fernandez-Llama P, 2010, KIDNEY INT, V77, P736, DOI 10.1038/ki.2009.550; Groffen AJA, 1998, EUR J BIOCHEM, V254, P123, DOI 10.1046/j.1432-1327.1998.2540123.x; Hakulinen J, 2008, J CELL BIOCHEM, V105, P1211, DOI 10.1002/jcb.21923; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Hawari FI, 2004, P NATL ACAD SCI USA, V101, P1297, DOI 10.1073/pnas.0307981100; Hogan MC, 2009, J AM SOC NEPHROL, V20, P278, DOI 10.1681/ASN.2008060564; Idriss HT, 2000, MICROSC RES TECHNIQ, V50, P184, DOI 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H; Janowska-Wieczorek A, 2005, INT J CANCER, V113, P752, DOI 10.1002/ijc.20657; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Ji H, 2008, ELECTROPHORESIS, V29, P2660, DOI 10.1002/elps.200800015; Justo P, 2006, KIDNEY INT, V70, P1750, DOI 10.1038/sj.ki.5001866; KIRSCH T, 1994, J BIOL CHEM, V269, P11462; Kulkarni RN, 2012, BIOCHEM BIOPH RES CO, V420, P11, DOI 10.1016/j.bbrc.2012.02.099; Lanoix J, 1996, ONCOGENE, V13, P1153; LI T, 2012, STEM CELLS DEV; Lorz C, 2008, J AM SOC NEPHROL, V19, P904, DOI 10.1681/ASN.2007050581; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Martinez-Lorenzo MJ, 2007, CLIN IMMUNOL, V122, P28, DOI 10.1016/j.clim.2006.07.007; Martinez-Lorenzo MJ, 1999, J IMMUNOL, V163, P1274; Martinez-Lostao L, 2010, ARTHRITIS RHEUM-US, V62, P2272, DOI 10.1002/art.27501; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; Metcalf D, 2010, BIOCHEM SOC T, V38, P1469, DOI 10.1042/BST0381469; Miner JH, 2012, EXP CELL RES, V318, P973, DOI 10.1016/j.yexcr.2012.02.031; Miranda KC, 2010, KIDNEY INT, V78, P191, DOI 10.1038/ki.2010.106; Mitchell PJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-4; Nabhan JF, 2012, P NATL ACAD SCI USA, V109, P4146, DOI 10.1073/pnas.1200448109; Ortiz A, 1999, J NEPHROL, V12, P150; Ortiz A, 2009, CYTOKINE GROWTH F R, V20, P251, DOI 10.1016/j.cytogfr.2009.05.002; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; Park JE, 2010, MOL CELL PROTEOMICS, V9, P1085, DOI 10.1074/mcp.M900381-MCP200; Peng P, 2011, ONCOL REP, V25, P749, DOI 10.3892/or.2010.1119; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; Reich HN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013451; Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427; Sanchez-Nino MD, 2010, KIDNEY INT, V78, P737, DOI 10.1038/ki.2010.270; Sanchez-Nino MD, 2010, MEDIATORS INFLAMMATI; Sanz AB, 2008, J AM SOC NEPHROL, V19, P1634, DOI 10.1681/ASN.2007121336; Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shipman CM, 2003, CANCER RES, V63, P912; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Stinchcombe J, 2004, SCIENCE, V305, P55, DOI 10.1126/science.1095291; Takata K, 2008, HISTOCHEM CELL BIOL, V130, P197, DOI 10.1007/s00418-008-0457-0; Tao YX, 2005, KIDNEY INT, V67, P909, DOI 10.1111/j.1523-1755.2005.00155.x; Tat SK, 2006, BONE, V39, P706, DOI 10.1016/j.bone.2006.03.016; Mendoza EMT, 2008, BIOTECHNOL ANN REV, V14, P423, DOI 10.1016/S1387-2656(08)00019-7; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Toffoli B, 2011, ATHEROSCLEROSIS, V218, P61, DOI 10.1016/j.atherosclerosis.2011.05.019; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Van Campenhout A, 2009, ATHEROSCLEROSIS, V204, P321, DOI 10.1016/j.atherosclerosis.2008.09.033; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Watnick T, 1999, SEMIN NEPHROL, V19, P327; WOO D, 1995, NEW ENGL J MED, V333, P18, DOI 10.1056/NEJM199507063330104; Woroniecka KI, 2011, DIABETES, V60, P2354, DOI 10.2337/db10-1181; Zannettino ACW, 2005, J CELL PHYSIOL, V204, P714, DOI 10.1002/jcp.20354; Zauli G, 2006, CYTOKINE GROWTH F R, V17, P245, DOI 10.1016/j.cytogfr.2006.04.002; Zhang XA, 2012, CELL MOL LIFE SCI, V69, P2843, DOI 10.1007/s00018-012-0954-0; Zhou H, 2006, KIDNEY INT, V70, P1847, DOI 10.1038/sj.ki.5001874; Zhou XJ, 1998, DIAGN MOL PATHOL, V7, P65, DOI 10.1097/00019606-199804000-00001	69	39	42	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72387	10.1371/journal.pone.0072387	http://dx.doi.org/10.1371/journal.pone.0072387			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24058411	Green Published, gold, Green Submitted			2022-12-25	WOS:000324403200021
J	Cichon, MA; Szentpetery, Z; Caley, MP; Papadakis, ES; Mackenzie, IC; Brennan, CH; O'Toole, EA				Cichon, M. A.; Szentpetery, Z.; Caley, M. P.; Papadakis, E. S.; Mackenzie, I. C.; Brennan, C. H.; O'Toole, E. A.			The receptor tyrosine kinase Axl regulates cell-cell adhesion and stemness in cutaneous squamous cell carcinoma	ONCOGENE			English	Article						adhesion; Axl; cancer stem cell; chemotherapy resistance; epithelial-mesenchymal transition	EPITHELIAL-MESENCHYMAL TRANSITION; SIGNALING PATHWAY; GROWTH ARREST; UP-REGULATION; TUMOR-GROWTH; CANCER; CATENIN; RESISTANCE; IDENTIFICATION; INVOLVEMENT	Axl is a receptor tyrosine kinase (RTK) upregulated in various tumors including cutaneous squamous cell carcinoma (SCC). Axl expression correlates with poor prognosis and induction of epithelial-mesenchymal transition (EMT), hence we hypothesized that Axl is involved in the disruption of cell-cell adhesion to allow invasion and chemotherapy resistance of the cancer stem cell population. Cutaneous SCC cell lines with stable knockdown of Axl were generated using retroviral vectors. Axl depletion altered expression of intercellular junction molecules increasing cell-cell adhesion with downregulation of Wnt and TGF beta R signaling. Furthermore, Axl expression correlated with the expression of putative cancer stem cell markers, CD44 and ALDH1, increased resistance to chemotherapy drugs, enhanced sphere formation ability and expression of EMT features by cancer stem cells. Axl depletion resulted in loss of tumor formation in an in vivo zebrafish xenograft model. In conclusion, these data suggest that abrogation of Axl results in loss of cancer stem cell properties indicating a role for Axl as a therapeutic target in chemotherapy-resistant cancer.	[Cichon, M. A.; Szentpetery, Z.; Caley, M. P.; Mackenzie, I. C.; O'Toole, E. A.] Queen Mary Univ London, Barts & London SMD, Ctr Cutaneous Res, Blizard Inst, London E1 2AT, England; [Papadakis, E. S.] Univ Southampton, Canc Res UK Ctr, Canc Sci Div, Southampton, Hants, England; [Brennan, C. H.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	University of London; Queen Mary University London; Cancer Research UK; University of Southampton; University of London; Queen Mary University London	O'Toole, EA (corresponding author), Queen Mary Univ London, Barts & London SMD, Ctr Cutaneous Res, Blizard Inst, 4 Newark St, London E1 2AT, England.	e.a.otoole@qmul.ac.uk		O'Toole, Edel/0000-0002-4084-4836	DAT PhD studentship from the Medical Research Council; MRC Centenary award (MAC); DEBRA Ireland; British Skin Foundation; National Centre for the Replacement [G1000053/1, NC/L00061X/1] Funding Source: researchfish	DAT PhD studentship from the Medical Research Council; MRC Centenary award (MAC); DEBRA Ireland; British Skin Foundation; National Centre for the Replacement	We are grateful to Carolyn Byrne for the luciferase reporter plasmids, Irene Leigh and Charlotte Proby for the MET1 and SCC IC1 cell lines and Vera Martins-Cabecos for scientific advice. We would like to acknowledge Alan Storey who was integral to the initiation of this project. This work was supported by a DAT PhD studentship from the Medical Research Council, a MRC Centenary award (MAC) and project grants from DEBRA Ireland and the British Skin Foundation awarded to EAOT.	Asiedu MK, 2014, ONCOGENE, V33, P1316, DOI 10.1038/onc.2013.57; Bauer T, 2012, J EXP MED, V209, P2033, DOI 10.1084/jem.20120493; Biddle A, 2012, CANCER METAST REV, V31, P285, DOI 10.1007/s10555-012-9345-0; Biddle A, 2011, CANCER RES, V71, P5317, DOI 10.1158/0008-5472.CAN-11-1059; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Chen YC, 2009, BIOCHEM BIOPH RES CO, V385, P307, DOI 10.1016/j.bbrc.2009.05.048; Chidgey M, 2007, BRIT J CANCER, V96, P1783, DOI 10.1038/sj.bjc.6603808; Conacci-Sorrell M, 2002, J CLIN INVEST, V109, P987, DOI 10.1172/JCI200215429; de Oliveira SS, 2005, FEBS LETT, V579, P6179, DOI 10.1016/j.febslet.2005.09.091; del Valle-Perez B, 2011, J CELL SCI, V124, P2298, DOI 10.1242/jcs.082693; Dontu G, 2005, J MAMMARY GLAND BIOL, V10, P75, DOI 10.1007/s10911-005-2542-5; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Garcia-Gras E, 2006, J CLIN INVEST, V116, P2012, DOI 10.1172/JCI27751; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Green J, 2006, BRIT J CANCER, V94, P1446, DOI 10.1038/sj.bjc.6603135; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Harper LJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-166; Harris TJ, 2012, NAT REV MOL CELL BIO, V11, P502; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Honoki K, 2010, ONCOL REP, V24, P501, DOI 10.3892/or_00000885; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hutterer M, 2008, CLIN CANCER RES, V14, P130, DOI 10.1158/1078-0432.CCR-07-0862; Jacob ANK, 1999, CANCER DETECT PREV, V23, P325; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Lee CH, 2012, ANN SURG ONCOL, V19, pS500, DOI 10.1245/s10434-011-1985-8; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Li Y, 2009, ONCOGENE, V28, P3442, DOI 10.1038/onc.2009.212; Linger RM, 2010, EXPERT OPIN THER TAR, V14, P1073, DOI 10.1517/14728222.2010.515980; Liu L, 2009, CANCER RES, V69, P6871, DOI 10.1158/0008-5472.CAN-08-4490; Mahadevan D, 2007, ONCOGENE, V26, P3909, DOI 10.1038/sj.onc.1210173; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martins VL, 2009, J CELL SCI, V122, P1788, DOI 10.1242/jcs.042895; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Miwa N, 2001, ONCOL RES, V12, P469, DOI 10.3727/096504001108747477; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; Palka HL, 1997, J CELL SCI, V110, P2359; Papadakis ES, 2011, J INVEST DERMATOL, V131, P509, DOI 10.1038/jid.2010.326; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Polette M, 2005, CANCER RES, V65, P7691, DOI 10.1158/0008-5472.CAN-04-4230; Proby CM, 2000, EXP DERMATOL, V9, P104, DOI 10.1034/j.1600-0625.2000.009002104.x; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rochlitz C, 1999, LEUKEMIA, V13, P1352, DOI 10.1038/sj.leu.2401484; Song X, 2010, CANCER, V117, P734; Stemmler MP, 2008, MOL BIOSYST, V4, P835, DOI 10.1039/b719215k; Takahashi-Yanaga F, 2007, J PHARMACOL SCI, V104, P293, DOI 10.1254/jphs.CR0070024; Vajkoczy P, 2006, P NATL ACAD SCI USA, V103, P5799, DOI 10.1073/pnas.0510923103; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Wang JB, 2004, CURR OPIN GENET DEV, V14, P533, DOI 10.1016/j.gde.2004.07.013; Westerfield M, 2001, ZEBRAFISH BOOK GUIDE, P1; Ye X, 2010, ONCOGENE, V29, P5254, DOI 10.1038/onc.2010.268; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	53	46	47	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 7	2014	33	32					4185	4192		10.1038/onc.2013.388	http://dx.doi.org/10.1038/onc.2013.388			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AN4YK	24056961				2022-12-25	WOS:000340595700009
J	Hwang, JH; Jiang, T; Kulkarni, S; Faure, N; Schaffhausen, BS				Hwang, Justin H.; Jiang, Tao; Kulkarni, Shreya; Faure, Nathalie; Schaffhausen, Brian S.			Protein Phosphatase 2A Isoforms Utilizing A beta Scaffolds Regulate Differentiation through Control of Akt Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; TUMOR-SUPPRESSOR PP2A; PHOSPHATIDYLINOSITOL 3-KINASE; CELL-TRANSFORMATION; SUBUNIT INTERACTION; SIGNALING PATHWAY; T-ANTIGENS; KINASE; PHOSPHORYLATION; IDENTIFICATION	Protein phosphatase 2A (PP2A) regulates almost all cell signaling pathways. It consists of a scaffolding A subunit to which a catalytic C subunit and one of many regulatory B subunits bind. Of the more than 80 PP2A isoforms, 10% use A beta as a scaffold. This study demonstrates the isoform-specific function of the A scaffold subunits. Polyomaviruses have shown the importance of phosphotyrosine, PI3K, and p53 in transformation. Comparisons of polyoma and SV40 small T antigens implicate A beta in the control of differentiation. Knockdown of A beta enhanced differentiation. Akt signaling regulated differentiation; its activation or inhibition promoted or blocked it, respectively. A beta bound Akt. Enhancement of PP2A A beta/Akt interaction by polyoma small T antigen increased turnover of Akt Ser-473 phosphorylation. Conversely, knockdown of A beta promoted Akt activity and reduced turnover of phosphate at Ser-473 of Akt. These data provide new insight into the regulation of Akt, a protein of extreme importance in cancer. Furthermore, our results suggest that the role for A beta in differentiation and perhaps tumor suppression may lie partly in its ability to negatively regulate Akt.	[Hwang, Justin H.; Jiang, Tao; Faure, Nathalie; Schaffhausen, Brian S.] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; [Hwang, Justin H.; Kulkarni, Shreya; Schaffhausen, Brian S.] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Program Biochem, Boston, MA 02111 USA; [Kulkarni, Shreya] Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, Boston, MA 02111 USA	Tufts University; Tufts University; Tufts University	Schaffhausen, BS (corresponding author), Tufts Univ, Sch Med, Dept Biochem, 136 Harrison Ave, Boston, MA 02111 USA.	brian.schaffhausen@tufts.edu		Hwang, Justin/0000-0003-1686-7103	National Institutes of Health [R01 CA34722, P01 CA50661]; NATIONAL CANCER INSTITUTE [R01CA034722, P01CA050661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA34722 and P01 CA50661.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Andrabi S, 2007, P NATL ACAD SCI USA, V104, P19011, DOI 10.1073/pnas.0706696104; Andrabi S, 2011, J VIROL, V85, P10649, DOI 10.1128/JVI.05034-11; BRAUTIGAN DL, 1995, SEMIN CANCER BIOL, V6, P211, DOI 10.1006/scbi.1995.0028; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Cho US, 2007, PLOS BIOL, V5, P1810, DOI 10.1371/journal.pbio.0050202; Esplin ED, 2006, GENE CHROMOSOME CANC, V45, P182, DOI 10.1002/gcc.20284; Gherzi R, 2010, CELL DEATH DIFFER, V17, P975, DOI 10.1038/cdd.2009.194; Gonzalez I, 2004, MOL CELL BIOL, V24, P3607, DOI 10.1128/MCB.24.9.3607-3622.2004; Hao YS, 2008, MOL CELL BIOL, V28, P2851, DOI 10.1128/MCB.01917-07; HEMMINGS BA, 1990, BIOCHEMISTRY-US, V29, P3166, DOI 10.1021/bi00465a002; Heron-Milhavet L, 2008, J CELL PHYSIOL, V214, P158, DOI 10.1002/jcp.21177; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Janssens V, 2012, CURR MOL MED, V12, P268, DOI 10.2174/156652412799218930; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Kim SP, 2010, BIOCHEM BIOPH RES CO, V399, P55, DOI 10.1016/j.bbrc.2010.07.038; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Lechward K, 2001, ACTA BIOCHIM POL, V48, P921; Li XH, 2001, EMBO J, V20, P4122, DOI 10.1093/emboj/20.15.4122; Liu QS, 2011, J MED CHEM, V54, P1473, DOI 10.1021/jm101520v; McConnell JL, 2007, ONCOGENE, V26, P6021, DOI 10.1038/sj.onc.1210406; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Moreno CS, 2004, CANCER RES, V64, P6978, DOI 10.1158/0008-5472.CAN-04-1150; Naiki T, 2007, J BIOL CHEM, V282, P24075, DOI 10.1074/jbc.M701409200; Nazarewicz Rafal Robert, 2011, J Biol Chem, V286, P2886, DOI 10.1074/jbc.M110.141499; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; Rotwein P, 2009, J CELL PHYSIOL, V219, P503, DOI 10.1002/jcp.21692; Ruediger R, 2001, ONCOGENE, V20, P1892, DOI 10.1038/sj.onc.1204279; RUEDIGER R, 1992, MOL CELL BIOL, V12, P4872, DOI 10.1128/MCB.12.11.4872; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Tian Y, 2004, J VIROL, V78, P12657, DOI 10.1128/JVI.78.22.12657-12664.2004; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; WALTER G, 1990, P NATL ACAD SCI USA, V87, P2521, DOI 10.1073/pnas.87.7.2521; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001; Wilson EM, 2004, MOL BIOL CELL, V15, P497, DOI 10.1091/mbc.E03-05-0351; Xu Q, 2000, J BIOL CHEM, V275, P36750, DOI 10.1074/jbc.M005030200; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Yen A, 2001, J VIROL, V75, P5302, DOI 10.1128/JVI.75.11.5302-5314.2001; Yuan H, 2002, J VIROL, V76, P10685, DOI 10.1128/JVI.76.21.10685-10691.2002; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6; Zhou J, 2003, BIOCHEM J, V369, P387, DOI 10.1042/BJ20021244	48	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					32064	32073		10.1074/jbc.M113.497644	http://dx.doi.org/10.1074/jbc.M113.497644			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24052256	Green Published, hybrid			2022-12-25	WOS:000330596200057
J	Saburi, W; Kobayashi, M; Mori, H; Okuyama, M; Kimura, A				Saburi, Wataru; Kobayashi, Momoko; Mori, Haruhide; Okuyama, Masayuki; Kimura, Atsuo			Replacement of the Catalytic Nucleophile Aspartyl Residue of Dextran Glucosidase by Cysteine Sulfinate Enhances Transglycosylation Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; ALPHA-AMYLASE FAMILY; ENZYME INTERMEDIATE; CYCLODEXTRIN GLYCOSYLTRANSFERASE; STREPTOCOCCUS-MUTANS; CRYSTAL-STRUCTURE; SPECIFICITY; SUBSTRATE; CYSTEINESULFINATE; IDENTIFICATION	Dextran glucosidase from Streptococcus mutans (SmDG) catalyzes the hydrolysis of an alpha-1,6-glucosidic linkage at the non-reducing end of isomaltooligosaccharides and dextran. This enzyme has an Asp-194 catalytic nucleophile and two catalytically unrelated Cys residues, Cys-129 and Cys-532. Cys-free SmDG was constructed by replacement with Ser (C129S/C532S (2CS), the activity of which was the same as that of the wild type, SmDG). The nucleophile mutant of 2CS was generated by substitution of Asp-194 with Cys (D194C-2CS). The hydrolytic activity of D194C-2CS was 8.1 x 10(-4) % of 2CS. KI-associated oxidation of D194C-2CS increased the activity up to 0.27% of 2CS, which was 330 times higher than D194C-2CS. Peptide-mapping mass analysis of the oxidized D194C-2CS (Ox-D194C-2CS) revealed that Cys-194 was converted into cysteine sulfinate. Ox-D194C-2CS and 2CS shared the same properties (optimum pH, pI, and substrate specificity), whereas Ox-D194C-2CS had much higher transglucosylation activity than 2CS. This is the first study indicating that a more acidic nucleophile (-SOO-) enhances transglycosylation. The introduction of cysteine sulfinate as a catalytic nucleophile could be a novel approach to enhance transglycosylation.	[Saburi, Wataru; Kobayashi, Momoko; Mori, Haruhide; Okuyama, Masayuki; Kimura, Atsuo] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan	Hokkaido University	Kimura, A (corresponding author), Hokkaido Univ, Res Fac Agr, Kita Ku, Kita 9 Nishi 9, Sapporo, Hokkaido 0608589, Japan.	kimura@abs.agr.hokudai.ac.jp	Mori, Haruhide/AAV-6374-2021; Okuyama, Masayuki/D-8739-2012; Saburi, Wataru/A-4271-2012	Mori, Haruhide/0000-0001-7346-9131; Okuyama, Masayuki/0000-0001-7013-6032; Saburi, Wataru/0000-0002-2015-7086				Blanchard JE, 2001, CHEM BIOL, V8, P627, DOI 10.1016/S1074-5521(01)00038-2; Braun C, 1996, BIOCHEMISTRY-US, V35, P5458, DOI 10.1021/bi9526488; Brzozowski AM, 1997, BIOCHEMISTRY-US, V36, P10837, DOI 10.1021/bi970539i; Cockburn DW, 2010, BIOCHEMISTRY-US, V49, P2042, DOI 10.1021/bi1000596; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fierobe HP, 1998, BIOCHEMISTRY-US, V37, P3743, DOI 10.1021/bi972231x; GETHING MJH, 1972, EUR J BIOCHEM, V30, P352; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hondoh H, 2008, J MOL BIOL, V378, P913, DOI 10.1016/j.jmb.2008.03.016; Kobayashi M, 2011, BIOSCI BIOTECH BIOCH, V75, P1557, DOI 10.1271/bbb.110256; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Lawson SL, 1996, BIOCHEMISTRY-US, V35, P10110, DOI 10.1021/bi960586v; Lodge JA, 2003, J BIOL CHEM, V278, P19151, DOI 10.1074/jbc.M211626200; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6; McCarter JD, 1996, J BIOL CHEM, V271, P6889, DOI 10.1074/jbc.271.12.6889; MIWA I, 1972, CLIN CHIM ACTA, V37, P538, DOI 10.1016/0009-8981(72)90483-4; Moller MS, 2012, J BACTERIOL, V194, P4249, DOI 10.1128/JB.00622-12; MOORE S, 1948, J BIOL CHEM, V176, P367; Mosi R, 1997, BIOCHEMISTRY-US, V36, P9927, DOI 10.1021/bi970618u; PALMIERI F, 1979, BIOCHIM BIOPHYS ACTA, V555, P531, DOI 10.1016/0005-2736(79)90407-3; ROBERTSON JJ, 1957, J BACTERIOL, V73, P186, DOI 10.1128/JB.73.2.186-198.1957; Rydberg EH, 2002, BIOCHEMISTRY-US, V41, P4492, DOI 10.1021/bi011821z; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; Saburi W, 2006, BBA-PROTEINS PROTEOM, V1764, P688, DOI 10.1016/j.bbapap.2006.01.012; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; STREET IP, 1992, BIOCHEMISTRY-US, V31, P9970, DOI 10.1021/bi00156a016; TREVELYAN W. E., 1966, CARBOHYD RES, V2, P418, DOI 10.1016/S0008-6215(00)80337-7; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; VANSCHELTINGA ACT, 1995, BIOCHEMISTRY-US, V34, P15619, DOI 10.1021/bi00048a003; Watts AG, 2003, J AM CHEM SOC, V125, P7532, DOI 10.1021/ja0344967	33	10	10	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31670	31677		10.1074/jbc.M113.491449	http://dx.doi.org/10.1074/jbc.M113.491449			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24052257	Green Published, hybrid			2022-12-25	WOS:000330596200025
J	Xu, F; Silva, T; Joshi, M; Zahid, S; Nanda, V				Xu, Fei; Silva, Teresita; Joshi, Mihir; Zahid, Sohail; Nanda, Vikas			Circular Permutation Directs Orthogonal Assembly in Complex Collagen Peptide Mixtures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELIX; ELECTROSTATIC INTERACTIONS; COMPUTATIONAL DESIGN; FIBRILLAR COLLAGEN; BACTERIAL COLLAGEN; PROTEIN; EVOLUTION; STABILITY; SEQUENCE; TRIMERIZATION	Multiple types of natural collagens specifically assemble and co-exist in the extracellular matrix. Although noncollagenous trimerization domains facilitate the folding of triple-helical regions, it is intriguing to ask whether collagen sequences are also capable of controlling heterospecific association. In this study, we designed a model system mimicking simultaneous specific assembly of two collagen heterotrimers using a genetically inspired operation, circular permutation. Previously, surface charge-pair interactions were optimized on three collagen peptides to promote the formation of an abc-type heterotrimer. Circular permutation of these sequences retained networks of stabilizing interactions, preserving both triple-helical structure and heterospecificity of assembly. Combining original peptides A, B, and C and permuted peptides D, E, and F resulted primarily in formation of A: B: C and D: E: F, a heterospecificity of 2 of 56 possible stoichiometries. This degree of specificity in collagen molecular recognition is unprecedented in natural or synthetic collagens. Analysis of natural collagen sequences indicates low similarity between the neighboring exons. Combining the synthetic collagen model and bioinformatic analysis provides insight on how fibrillar collagens might have arisen from the duplication of smaller domains.	[Xu, Fei; Silva, Teresita; Joshi, Mihir; Zahid, Sohail; Nanda, Vikas] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Nanda, V (corresponding author), Rutgers State Univ UMDNJ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA.	nanda@cabm.rutgers.edu		Nanda, Vikas/0000-0003-2786-8347; Xu, Fei/0000-0003-1077-0431	National Institutes of Health New Innovator Award [DP2 OD006478-01]; National Science Foundation [DMR-0907273]; Direct For Mathematical & Physical Scien [0907273] Funding Source: National Science Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006478] Funding Source: NIH RePORTER	National Institutes of Health New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health New Innovator Award DP2 OD006478-01. This work was also supported by National Science Foundation Grant DMR-0907273.	BIRK DE, 1988, J CELL BIOL, V106, P999, DOI 10.1083/jcb.106.3.999; Birk DE, 2001, MICRON, V32, P223, DOI 10.1016/S0968-4328(00)00043-3; Bjorklund AK, 2006, PLOS COMPUT BIOL, V2, P959, DOI 10.1371/journal.pcbi.0020114; Boot-Handford RP, 2003, BIOESSAYS, V25, P142, DOI 10.1002/bies.10230; Boudko SP, 2012, INT J BIOCHEM CELL B, V44, P21, DOI 10.1016/j.biocel.2011.09.009; Bourhis JM, 2012, NAT STRUCT MOL BIOL, V19, P1031, DOI 10.1038/nsmb.2389; Bulaj G, 2004, PROTEIN SCI, V13, P1182, DOI 10.1110/ps.03563704; BUTTICE G, 1990, J MOL EVOL, V30, P479, DOI 10.1007/BF02101102; Chan VC, 1997, J BIOL CHEM, V272, P31441, DOI 10.1074/jbc.272.50.31441; Eisenbeis S, 2010, J PEPT SCI, V16, P538, DOI 10.1002/psc.1233; Fallas JA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2084; Gauba V, 2007, J AM CHEM SOC, V129, P2683, DOI 10.1021/ja0683640; Giddu S, 2013, PROTEINS, V81, P386, DOI 10.1002/prot.24194; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Haglund E, 2008, J BIOL CHEM, V283, P27904, DOI 10.1074/jbc.M801776200; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; Heino J, 2009, INT J BIOCHEM CELL B, V41, P341, DOI 10.1016/j.biocel.2008.08.021; HELLINGA HW, 1994, P NATL ACAD SCI USA, V91, P5803, DOI 10.1073/pnas.91.13.5803; Hennecke J, 1999, J MOL BIOL, V286, P1197, DOI 10.1006/jmbi.1998.2531; Iwakura M, 2000, NAT STRUCT BIOL, V7, P580, DOI 10.1038/76811; Kar K, 2006, J BIOL CHEM, V281, P33283, DOI 10.1074/jbc.M605747200; Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103; Krishna MMG, 2005, P NATL ACAD SCI USA, V102, P1053, DOI 10.1073/pnas.0409114102; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Lindberg M, 2002, NAT STRUCT BIOL, V9, P818, DOI 10.1038/nsb847; Lukatsky DB, 2007, J MOL BIOL, V365, P1596, DOI 10.1016/j.jmb.2006.11.020; McLaughlin SH, 1998, MATRIX BIOL, V16, P369, DOI 10.1016/S0945-053X(98)90010-5; Mechling DE, 2000, J BIOL CHEM, V275, P14532, DOI 10.1074/jbc.275.19.14532; Pandya MJ, 2000, BIOCHEMISTRY-US, V39, P8728, DOI 10.1021/bi000246g; Patthy L, 1999, GENE, V238, P103, DOI 10.1016/S0378-1119(99)00228-0; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Persikov AV, 2005, BIOCHEMISTRY-US, V44, P1414, DOI 10.1021/bi048216r; Reinke AW, 2010, J AM CHEM SOC, V132, P6025, DOI 10.1021/ja907617a; Sanders KE, 2002, BLOOD, V100, P299, DOI 10.1182/blood.V100.1.299; Summa CM, 2002, J MOL BIOL, V321, P923, DOI 10.1016/S0022-2836(02)00589-2; Thompson KE, 2012, ACS SYNTH BIOL, V1, P118, DOI 10.1021/sb200015u; Tonikian R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000218; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; VITELLAROZUCCARELLO L, 1992, CELL TISSUE RES, V268, P505, DOI 10.1007/BF00319157; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195; Wu JJ, 2009, J BIOL CHEM, V284, P5539, DOI 10.1074/jbc.M806369200; Xu CY, 2010, BIOMACROMOLECULES, V11, P348, DOI 10.1021/bm900894b; Xu F, 2011, J AM CHEM SOC, V133, P15260, DOI 10.1021/ja205597g; Yang W, 1997, J BIOL CHEM, V272, P28837, DOI 10.1074/jbc.272.46.28837; Yoshizumi A, 2011, J BIOL CHEM, V286, P17512, DOI 10.1074/jbc.M110.217364; Yu ZX, 2011, J BIOL CHEM, V286, P18960, DOI 10.1074/jbc.M110.217422	46	9	9	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31616	31623		10.1074/jbc.M113.501056	http://dx.doi.org/10.1074/jbc.M113.501056			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24043622	Green Published, hybrid			2022-12-25	WOS:000330596200020
J	DeLeon, S; Halitschke, R; Hames, RS; Kessler, A; DeVoogd, TJ; Dhondt, AA				DeLeon, Sara; Halitschke, Rayko; Hames, Ralph S.; Kessler, Andre; DeVoogd, Timothy J.; Dhondt, Andre A.			The Effect of Polychlorinated Biphenyls on the Song of Two Passerine Species	PLOS ONE			English	Article							BLACK-CAPPED CHICKADEES; REPERTOIRE SIZE; TREE SWALLOWS; REPRODUCTIVE SUCCESS; RELATIVE PITCH; ZEBRA FINCHES; HUDSON RIVER; MALE QUALITY; DAWN CHORUS; NEW-YORK	Polychlorinated biphenyls (PCBs) are synthetic chemical pollutants with demonstrated detrimental toxic and developmental effects on humans and wildlife. Laboratory studies suggest that PCBs influence behavior due to their effects on endocrine and neurological systems, yet little is known about the behavioral consequences of sublethal PCB exposure in the field. Additionally, specific PCB congener data (in contrast to total PCB load) is necessary to understand the possible effects of PCBs in living organisms since number and position of chlorine substitution in a PCB molecule dictates the toxicity and chemical fate of individual PCB congeners. We non-lethally investigated total PCB loads, congener specific PCB profiles, and songs of black-capped chickadees (Poecile atricapillus) and song sparrows (Melospiza melodia) along a historical PCB gradient at the Hudson River in New York State. Our results indicate that black-capped chickadees and song sparrows have higher total blood PCBs in regions with higher historic PCB contamination. The two bird species varied substantially in their congener-specific PCB profiles; within sites, song sparrows showed a significantly higher proportion of lower chlorinated PCBs, while black-capped chickadees had higher proportions of highly chlorinated PCBs. In areas of PCB pollution, the species-specific identity signal in black-capped chickadee song varied significantly, while variation in song sparrow trill performance was best predicted by the mono-ortho PCB load. Thus, PCBs may affect song production, an important component of communication in birds. In conclusion, we suggest that the ramifications of changes in song quality for bird populations may extend the toxic effects of environmental PCB pollution.	[DeLeon, Sara; Halitschke, Rayko; Kessler, Andre; Dhondt, Andre A.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [DeLeon, Sara] Drexel Univ, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA; [Hames, Ralph S.; Dhondt, Andre A.] Cornell Univ, Ornithol Lab, Ithaca, NY USA; [DeVoogd, Timothy J.] Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA	Cornell University; Drexel University; Cornell University; Cornell University	DeLeon, S (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.	sd823@drexel.edu	Hames, Ralph/AAI-8540-2020; Halitschke, Rayko/AAY-2365-2020; Dhondt, André/A-8292-2008	Halitschke, Rayko/0000-0002-1109-8782; Dhondt, Andre/0000-0002-4946-1401; Kessler, Andre/0000-0002-1797-7518	Cornell University Biogeochemistry and Environmental Biocomplexity Small Grant; Cornell Travel Grant; Mellon Grant; Kieckhefer-Adirondack Grants; State University of New York Fellowship; SLOAN Fellowship; Tibor T. Polgar Fellowship; National Sea Grant College Program of the U.S. Department of Commerce's National Oceanic and Atmospheric Administration [NA10OAR4170064]	Cornell University Biogeochemistry and Environmental Biocomplexity Small Grant; Cornell Travel Grant; Mellon Grant; Kieckhefer-Adirondack Grants; State University of New York Fellowship; SLOAN Fellowship(Alfred P. Sloan Foundation); Tibor T. Polgar Fellowship; National Sea Grant College Program of the U.S. Department of Commerce's National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	This work was supported in part by a Cornell University Biogeochemistry and Environmental Biocomplexity Small Grant; a Cornell Travel Grant; a Mellon Grant; and Kieckhefer-Adirondack Grants. S. DeLeon was supported by a State University of New York Fellowship; a SLOAN Fellowship; and a Tibor T. Polgar Fellowship. This publication is a resulting product from project R/CTP-43 funded under award NA10OAR4170064 from the National Sea Grant College Program of the U.S. Department of Commerce's National Oceanic and Atmospheric Administration, to the Research Foundation of State University of New York on behalf of New York Sea Grant. The statements, findings, conclusions, views, and recommendations are those of the authors and do not necessarily reflect the views of any of those organizations.	Arcese P, 2005, BIRDS N AM ONLINE; Ball GF, 2002, FRONT NEUROENDOCRIN, V23, P137, DOI 10.1006/frne.2002.0230; Bent AC, 1964, LIFE HIST N AM JAYS; BORROR DONALD J., 1965, WILSON BULL, V77, P5; Boyle Alfred W., 1992, Biodegradation, V3, P285, DOI 10.1007/BF00129089; Burns DA, 2013, BIOGEOCHEMISTRY, V113, P451, DOI 10.1007/s10533-012-9773-5; Catchpole Clive K, 2003, BIRD SONG BIOL THEME; Christie PJ, 2004, BEHAV ECOL SOCIOBIOL, V55, P341, DOI 10.1007/s00265-003-0711-3; Clotfelter ED, 2004, ANIM BEHAV, V68, P665, DOI 10.1016/j.anbehav.2004.05.004; Crisp TM, 1998, ENVIRON HEALTH PERSP, V106, P11, DOI 10.2307/3433911; Custer CM, 2010, ENVIRON TOXICOL CHEM, V29, P2286, DOI 10.1002/etc.276; DELLOMO G, 2002, ECOLOGICAL ENV TOXIC; Eng ML, 2012, TOXICOL SCI, V127, P269, DOI 10.1093/toxsci/kfs076; EPA USA, 1997, PHAS 2 REP FURTH S C; EPA USA, 1991, INT CHAR EV REP HUDS; Fang H, 2003, CHEM RES TOXICOL, V16, P1338, DOI 10.1021/tx030011g; Foote J. R., 2010, BIRDS N AM ONLINE; Gorissen L, 2005, OECOLOGIA, V145, P504, DOI 10.1007/s00442-005-0091-7; Hallinger KK, 2010, AUK, V127, P156, DOI 10.1525/auk.2009.09058; Harris Megan L., 2011, P477; HIEBERT SM, 1989, ANIM BEHAV, V37, P266, DOI 10.1016/0003-3472(89)90115-2; Hoogesteijn AL, 2008, ENVIRON TOXICOL CHEM, V27, P2071, DOI 10.1897/07-484.1; Hudson River Natural Resource Trustees, 2005, AN QUAL ASS PLAN HUD; Hughes M, 1998, BEHAV ECOL SOCIOBIOL, V42, P437, DOI 10.1007/s002650050458; Iwaniuk AN, 2006, BEHAV BRAIN RES, V173, P1, DOI 10.1016/j.bbr.2006.05.026; Judd SD, 1899, AM NAT, V33, P461; Lorey P, 1999, ENVIRON SCI TECHNOL, V33, P718, DOI 10.1021/es9800277; Lundqvist C, 2006, ACTA PAEDIATR, V95, P55, DOI 10.1080/08035320600886257; Markman S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001674; McCarty JP, 1999, ENVIRON TOXICOL CHEM, V18, P1433, DOI 10.1002/etc.5620180713; McCarty JP, 2000, AUK, V117, P987, DOI 10.1642/0004-8038(2000)117[0987:PEOPCO]2.0.CO;2; McCarty JP, 1999, AUK, V116, P55, DOI 10.2307/4089453; Mcintyre JW, 2010, BIRDS N AM ONLINE; McKay JL, 2012, ECOTOXICOLOGY, V21, P2391, DOI 10.1007/s10646-012-0994-0; Moore JM, 2011, P NATL ACAD SCI USA, V108, P16440, DOI 10.1073/pnas.1102077108; Neigh AM, 2006, ENVIRON TOXICOL CHEM, V25, P1503, DOI 10.1897/05-046R.1; Nice MM., 1937, STUDIES LIFE HIST SO; Otter K, 1997, BEHAV ECOL, V8, P167, DOI 10.1093/beheco/8.2.167; Park KJ, 2009, CHEMOSPHERE, V77, P1459, DOI 10.1016/j.chemosphere.2009.08.063; Pfaff JA, 2007, P ROY SOC B-BIOL SCI, V274, P2035, DOI 10.1098/rspb.2007.0170; Pliskova M, 2005, ENVIRON HEALTH PERSP, V113, P1277, DOI 10.1289/ehp.7745; Podos J, 1997, EVOLUTION, V51, P537, DOI 10.1111/j.1558-5646.1997.tb02441.x; Pyle P., 1987, IDENTIFICATION GUIDE; Rivera-Rodriguez LB, 2007, ENVIRON POLLUT, V148, P654, DOI 10.1016/j.envpol.2006.11.018; ROBBINS MB, 1986, AUK, V103, P655, DOI 10.1093/auk/103.4.655; SENTHILKUMAR K, 2002, ENVIRON SCI TECHNOL, V36, P2789; Smith S.M., 1991, BLACK CAPPED CHICKAD; Stauffer F., 1980, J WILDLIFE MANAGE, V44, DOI [10.2307/3808345, DOI 10.2307/3808345]; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; Van den Steen E, 2007, ENVIRON INT, V33, P257, DOI 10.1016/j.envint.2006.09.018; Waid John S., 1986, PCBS ENV; WEISMAN R, 1990, CONDOR, V92, P118, DOI 10.2307/1368390; Weisman R, 2004, AM SCI, V92, P532; Wolfe MF, 1998, ENVIRON TOXICOL CHEM, V17, P146, DOI [10.1897/1551-5028(1998)017&lt;0146:EOMOWA&gt;2.3.CO;2, 10.1002/etc.5620170203]; Yu X, 2011, ECOTOXICOLOGY, V20, P1543, DOI 10.1007/s10646-011-0717-y	55	20	21	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73471	10.1371/journal.pone.0073471	http://dx.doi.org/10.1371/journal.pone.0073471			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058475	Green Published, gold, Green Submitted			2022-12-25	WOS:000324695900014
J	Hu, ZH; Zhang, HY; Yuan, JW; Lu, MH; Chen, SP; Liu, HF				Hu, Zhenghui; Zhang, Heye; Yuan, Jinwei; Lu, Minhua; Chen, Siping; Liu, Huafeng			An H-infinity Strategy for Strain Estimation in Ultrasound Elastography Using Biomechanical Modeling Constraint	PLOS ONE			English	Article							ELASTICITY RECONSTRUCTION; MOTION ESTIMATION; CROSS-CORRELATION; TISSUE; DISPLACEMENT; BREAST; PERFORMANCE; SYSTEM; DIAGNOSIS; FRAMEWORK	The purpose of ultrasound elastography is to identify lesions by reconstructing the hardness characteristics of tissue reconstructed from ultrasound data. Conventional quasi-static ultrasound elastography is easily applied to obtain axial strain components along the compression direction, with the results inverted to represent the distribution of tissue hardness under the assumption of constant internal stresses. However, previous works of quasi-static ultrasound elastography have found it difficult to obtain the lateral and shear strain components, due to the poor lateral resolution of conventional ultrasound probes. The physical nature of the strain field is a continuous vector field, which should be fully described by the axial, lateral, and shear strain components, and the clinical value of lateral and shear strain components of deformed tissue is gradually being recognized by both engineers and clinicians. Therefore, a biomechanical-model-constrained filtering framework is proposed here for recovering a full displacement field at a high spatial resolution from the noisy ultrasound data. In our implementation, after the biomechanical model constraint is integrated into the state-space equation, both the axial and lateral displacement components can be recovered at a high spatial resolution from the noisy displacement measurements using a robust H-infinity filter, which only requires knowledge of the worst-case noise levels in the measurements. All of the strain components can then be calculated by applying a gradient operator to the recovered displacement field. Numerical experiments on synthetic data demonstrated the robustness and effectiveness of our approach, and experiments on phantom data and in-vivo clinical data also produced satisfying results.	[Hu, Zhenghui; Yuan, Jinwei; Liu, Huafeng] Zhejiang Univ, State Key Lab Modern Opt Instrumentat, Dept Opt Engn, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Heye] Chinese Acad Sci, Key Lab Hlth Informat, Shenzhen Adv Inst Technol, Shenzhen, Peoples R China; [Lu, Minhua; Chen, Siping] Shenzhen Univ, Natl Reg Key Technol Engn Lab Med Ultrasound, Guangdong Key Lab Biomed Measurements & Ultrasoun, Dept Biomed Engn,Sch Med, Shenzhen, Peoples R China	Zhejiang University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Shenzhen University	Lu, MH (corresponding author), Shenzhen Univ, Natl Reg Key Technol Engn Lab Med Ultrasound, Guangdong Key Lab Biomed Measurements & Ultrasoun, Dept Biomed Engn,Sch Med, Shenzhen, Peoples R China.	luminhua@szu.edu.cn	CHEN, SI/GZL-4800-2022; Hu, Zhenghui/F-1959-2015	Hu, Zhenghui/0000-0002-5775-0481	National Basic Research Program 973 [2010CB732504]; Guangdong Innovation Research Team Fund for Low-Cost Healthcare Technologies in China; External Cooperation Program of the Chinese Academy of Sciences [GJHZ1212]; Key Lab for Health Informatics of Chinese Academy of Sciences; Distinguished Youth Talents Fund of Shenzhen [JC201006020025A]; Natural Science Foundation of Zhejiang [R12F030004]; National Natural Science Foundation of China [81101120, 61271083, 61031003, 81271645]	National Basic Research Program 973(National Basic Research Program of China); Guangdong Innovation Research Team Fund for Low-Cost Healthcare Technologies in China; External Cooperation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Key Lab for Health Informatics of Chinese Academy of Sciences; Distinguished Youth Talents Fund of Shenzhen; Natural Science Foundation of Zhejiang(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the National Basic Research Program 973 (2010CB732504), the Guangdong Innovation Research Team Fund for Low-Cost Healthcare Technologies in China, the External Cooperation Program of the Chinese Academy of Sciences (GJHZ1212), the Key Lab for Health Informatics of Chinese Academy of Sciences, the Distinguished Youth Talents Fund of Shenzhen (JC201006020025A), the Natural Science Foundation of Zhejiang(R12F030004), and the National Natural Science Foundation of China (81101120, 61271083, 61031003, 81271645). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, FINITE ELEMENT PROCE; BOHS LN, 1995, ULTRASOUND MED BIOL, V21, P885, DOI 10.1016/0301-5629(95)00034-O; BOHS LN, 1991, IEEE T BIO-MED ENG, V38, P280, DOI 10.1109/10.133210; CESPEDES I, 1993, ULTRASONIC IMAGING, V15, P89, DOI 10.1006/uimg.1993.1008; Chen H, 2007, ULTRASOUND MED BIOL, V33, P48, DOI 10.1016/j.ultrasmedbio.2006.07.022; Chenevert TL, 1998, MAGNET RESON MED, V39, P482, DOI 10.1002/mrm.1910390319; Chung JH, 2008, BIOMECH MODEL MECHAN, V7, P43, DOI 10.1007/s10237-006-0074-6; de Korte CL, 2000, PHYS MED BIOL, V45, P1465, DOI 10.1088/0031-9155/45/6/305; deKorte CL, 1997, ULTRASOUND MED BIOL, V23, P735, DOI 10.1016/S0301-5629(97)00004-5; Doyley M., 2011, PHYS MED BIOL, V57, pR35; Doyley MM, 2005, ULTRASOUND MED BIOL, V31, P787, DOI 10.1016/j.ultrasmedbio.2005.02.005; Doyley MM, 2001, ULTRASOUND MED BIOL, V27, P1347, DOI 10.1016/S0301-5629(01)00429-X; Doyley MM, 2000, PHYS MED BIOL, V45, P1521, DOI 10.1088/0031-9155/45/6/309; FERTNER A, 1986, IEEE T ACOUST SPEECH, V34, P1329, DOI 10.1109/TASSP.1986.1164930; Fred A, 2004, INT C IEEE ENG MED B, P1; Friemel BH, 1995, ULTRASON, P1481, DOI 10.1109/ULTSYM.1995.495835; GABRIEL KJ, 1983, IEEE T ACOUST SPEECH, V31, P1023, DOI 10.1109/TASSP.1983.1164166; Garra BS, 1997, RADIOLOGY, V202, P79, DOI 10.1148/radiology.202.1.8988195; Hassibi B., 1999, INDEFINITE QUADRATIC; Hoyt K, 2006, ULTRASONICS, V44, P99, DOI 10.1016/j.ultras.2005.08.006; Ikeda N, 1996, ITOS STOCHASTIC CALC; Itoh A, 2006, RADIOLOGY, V239, P341, DOI 10.1148/radiol.2391041676; Kallel F, 1996, IEEE T MED IMAGING, V15, P299, DOI 10.1109/42.500139; Konofagou E, 1998, ULTRASOUND MED BIOL, V24, P1183, DOI 10.1016/S0301-5629(98)00109-4; Konofagou E, 2002, ULTRASOUND MED BIOL, V28; Konofagou EE, 2000, ULTRASONICS, V38, P400, DOI 10.1016/S0041-624X(99)00125-0; Krouskop TA, 1998, ULTRASONIC IMAGING, V20, P260, DOI 10.1177/016173469802000403; Li J, 2008, IEEE T ULTRASON FERR, V55, P319, DOI 10.1109/TUFFC.2008.651; Lorenz A, 1999, IEEE T ULTRASON FERR, V46, P1147, DOI 10.1109/58.796120; Lourens E, 2012, MECH SYST SIGNAL PR, V27, P446, DOI 10.1016/j.ymssp.2011.09.025; Lubinski MA, 1996, IEEE T ULTRASON FERR, V43, P247, DOI 10.1109/58.485950; Luo JW, 2009, ULTRASOUND MED BIOL, V35, P1352, DOI 10.1016/j.ultrasmedbio.2009.03.001; Mariani S, 2009, NONLINEAR DYNAM, V49, P131; Maurice RL, 2004, IEEE T MED IMAGING, V23, P164, DOI 10.1109/TMI.2003.823066; McGee KP, 2011, PHYS MED BIOL, V56, P4291, DOI 10.1088/0031-9155/56/14/006; MEUNIER J, 1995, IEEE T MED IMAGING, V14, P293, DOI 10.1109/42.387711; Miyanaga N, 2006, INT J UROL, V13, P1514, DOI 10.1111/j.1442-2042.2006.01612.x; Mueller S, 2010, HEPATIC MED-EVID RES, V2, P49; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; ODONNELL M, 1994, IEEE T ULTRASON FERR, V41, P314, DOI 10.1109/58.285465; Ophir J, 1999, P I MECH ENG H, V213, P203, DOI 10.1243/0954411991534933; OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W; Ophir J, 2011, CURR MED IMAGING, V7, P292, DOI 10.2174/157340511798038693; Parker KJ, 2011, PHYS MED BIOL, V56, pR1, DOI 10.1088/0031-9155/56/1/R01; Pesavento A, 1999, IEEE T ULTRASON FERR, V46, P1057, DOI 10.1109/58.796111; Rao M, 2007, ULTRASOUND MED BIOL, V33, P57, DOI 10.1016/j.ultrasmedbio.2006.07.027; Revell J, 2005, IEEE T MED IMAGING, V24, P755, DOI 10.1109/TMI.2005.848331; Rivaz H, 2011, IEEE T MED IMAGING, V30, P928, DOI 10.1109/TMI.2010.2091966; Rivaz H, 2008, LECT NOTES COMPUT SC, V5242, P458, DOI 10.1007/978-3-540-85990-1_55; Rogowska J, 2004, HEART, V90, P556, DOI 10.1136/hrt.2003.016956; Shen XM, 1999, IEEE T SPEECH AUDI P, V7, P391, DOI 10.1109/89.771261; Shi PC, 2003, MED IMAGE ANAL, V7, P445, DOI 10.1016/S1361-8415(03)00066-5; Shiina T, 1996, ULTRASON, P1331, DOI 10.1109/ULTSYM.1996.584292; Simon D, 2001, EMBED SYST PROGRAM, V14, P20; Simon D, 2006, IEEE T SIGNAL PROCES, V54, P405, DOI 10.1109/TSP.2005.861732; Simon D, 2006, OPTIMAL STATE ESTIMA, DOI DOI 10.1002/0470045345.CH11; SKOVORODA AR, 1995, IEEE T ULTRASON FERR, V42, P747, DOI 10.1109/58.393117; Viola F, 2003, IEEE T ULTRASON FERR, V50, P392, DOI 10.1109/TUFFC.2003.1197962; Wall ST, 2012, AM J PHYSIOL-HEART C, V302, pH206, DOI 10.1152/ajpheart.00272.2011; Yuan JW, 2011, I S BIOMED IMAGING, P532, DOI 10.1109/ISBI.2011.5872462; Zahiri-Azar R, 2006, IEEE T BIO-MED ENG, V53, P1990, DOI 10.1109/TBME.2006.881780; Zhou YJ, 2010, IEEE T ULTRASON FERR, V57, P1943, DOI 10.1109/TUFFC.2010.1642	62	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73093	10.1371/journal.pone.0073093	http://dx.doi.org/10.1371/journal.pone.0073093			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058460	gold, Green Submitted, Green Published			2022-12-25	WOS:000324408400018
J	Hori, YS; Kuno, A; Hosoda, R; Horio, Y				Hori, Yusuke S.; Kuno, Atsushi; Hosoda, Ryusuke; Horio, Yoshiyuki			Regulation of FOXOs and p53 by SIRT1 Modulators under Oxidative Stress	PLOS ONE			English	Article							PROMOTES CELL-SURVIVAL; TRANSCRIPTION FACTORS; RESVERATROL; HEART; DEACETYLASE; SIR2-ALPHA; ACTIVATION; EXPRESSION; LONGEVITY; SIRTUINS	Excessive reactive oxygen species (ROS) induce apoptosis and are associated with various diseases and with aging. SIRT1 (sirtuin-1), an NAD+-dependent protein deacetylase, decreases ROS levels and participates in cell survival under oxidative stress conditions. SIRT1 modulates the transcription factors p53, a tumor suppressor and inducer of apoptosis, and the forkhead O (FOXO) family, both of which play roles for cell survival and cell death. In this study, we aimed to know which is working greatly among p53 and FOXOs transcription factors in SIRT1's cell protective functions under oxidative stress conditions. The antimycin A-induced increase in ROS levels and apoptosis was enhanced by SIRT1 inhibitors nicotinamide and splitomicin, whereas it was suppressed by a SIRT1 activator, resveratrol, and a SIRT1 cofactor, NAD+. SIRT1-siRNA abolished the effects of splitomicin and resveratrol. p53-knockdown experiment in C2C12 cells and experiment using p53-deficient HCT116 cells showed that splitomicin and resveratrol modulated apoptosis by p53-dependent and p53-independent pathways. In p53-independent cell protective pathway, we found that FOXO1, FOXO3a, and FOXO4 were involved in SOD2's upregulation by resveratrol. The knockdown of these three FOXOs by siRNAs completely abolished the SOD2 induction, ROS reduction, and anti-apoptotic function of resveratrol. Our results indicate that FOXO1, FOXO3a and FOXO4, are indispensable for SIRT1-dependent cell survival against oxidative stress, although deacetylation of p53 has also some role for cell protective function of SIRT1.	[Hori, Yusuke S.; Kuno, Atsushi; Hosoda, Ryusuke; Horio, Yoshiyuki] Sapporo Med Univ, Sch Med, Dept Pharmacol, Sapporo, Hokkaido, Japan; [Kuno, Atsushi] Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University	Horio, Y (corresponding author), Sapporo Med Univ, Sch Med, Dept Pharmacol, Sapporo, Hokkaido, Japan.	horio@sapmed.ac.jp		Hori, Yusuke S./0000-0002-8195-8979; Horio, Yoshiyuki/0000-0002-5021-5929; Hori, Yusuke S./0000-0001-9921-6810; KUNO, ATSUSHI/0000-0001-6873-1297	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22590245]; Regional R&D Proposal-Based Program from the Northern Advancement Center for Science & Technology of Hokkaido, Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Regional R&D Proposal-Based Program from the Northern Advancement Center for Science & Technology of Hokkaido, Japan	This study was supported in part by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grant-in-Aid 22590245) and by the Regional R&D Proposal-Based Program from the Northern Advancement Center for Science & Technology of Hokkaido, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta G, 2004, CANCER RES, V64, P6233, DOI 10.1158/0008-5472.CAN-04-0494; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hori YS, 2011, J PHARMACOL EXP THER, V338, P784, DOI 10.1124/jpet.111.183210; Horio Y, 2011, CLIN SCI, V121, P191, DOI 10.1042/CS20100587; Hosoda R, 2013, J PHARMACOL EXP THER, V344, P124, DOI 10.1124/jpet.112.198937; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Khutornenko AA, 2010, P NATL ACAD SCI USA, V107, P12828, DOI 10.1073/pnas.0910885107; Konstantinidis K, 2012, ARTERIOSCL THROM VAS, V32, P1552, DOI 10.1161/ATVBAHA.111.224915; Kuno A, 2013, J BIOL CHEM, V288, P5963, DOI 10.1074/jbc.M112.392050; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Marinkovic D, 2007, J CLIN INVEST, V117, P2133, DOI 10.1172/JCI31807; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Sakamoto J, 2004, FEBS LETT, V556, P281, DOI 10.1016/S0014-5793(03)01444-3; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Shin SM, 2009, MOL PHARMACOL, V76, P884, DOI 10.1124/mol.109.058479; Tanno M, 2010, J BIOL CHEM, V285, P8375, DOI 10.1074/jbc.M109.090266; Tidball JG, 2007, J APPL PHYSIOL, V102, P1677, DOI 10.1152/japplphysiol.01145.2006; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9	28	238	259	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73875	10.1371/journal.pone.0073875	http://dx.doi.org/10.1371/journal.pone.0073875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040102	Green Published, gold, Green Submitted			2022-12-25	WOS:000326734500058
J	Jamme, F; Vindigni, JD; Mechin, V; Cherifi, T; Chardot, T; Froissard, M				Jamme, Frederic; Vindigni, Jean-David; Mechin, Valerie; Cherifi, Tamazight; Chardot, Thierry; Froissard, Marine			Single Cell Synchrotron FT-IR Microspectroscopy Reveals a Link between Neutral Lipid and Storage Carbohydrate Fluxes in S. cerevisiae	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; MULTIPLICATIVE SIGNAL CORRECTION; CENTRAL HYDROPHOBIC DOMAIN; OIL BODY PROTEIN; HETEROLOGOUS EXPRESSION; INFRARED-SPECTROSCOPY; ARABIDOPSIS-THALIANA; SECONDARY STRUCTURE; IN-VITRO; BODIES	In most organisms, storage lipids are packaged into specialized structures called lipid droplets. These contain a core of neutral lipids surrounded by a monolayer of phospholipids, and various proteins which vary depending on the species. Hydrophobic structural proteins stabilize the interface between the lipid core and aqueous cellular environment (perilipin family of proteins, apolipoproteins, oleosins). We developed a genetic approach using heterologous expression in Saccharomyces cerevisiae of the Arabidopsis thaliana lipid droplet oleosin and caleosin proteins AtOle1 and AtClo1. These transformed yeasts overaccumulate lipid droplets, leading to a specific increase in storage lipids. The phenotype of these cells was explored using synchrotron FT-IR microspectroscopy to investigate the dynamics of lipid storage and cellular carbon fluxes reflected as changes in spectral fingerprints. Multivariate statistical analysis of the data showed a clear effect on storage carbohydrates and more specifically, a decrease in glycogen in our modified strains. These observations were confirmed by biochemical quantification of the storage carbohydrates glycogen and trehalose. Our results demonstrate that neutral lipid and storage carbohydrate fluxes are tightly connected and co-regulated.	[Jamme, Frederic] INRA, UAR 1008, CEPIA, Nantes, France; [Jamme, Frederic] Synchrotron SOLEIL, Gif Sur Yvette, France; [Vindigni, Jean-David; Mechin, Valerie; Cherifi, Tamazight; Chardot, Thierry; Froissard, Marine] INRA, UMR1318, Inst Jean Pierre Bourgin, F-78026 Versailles, France; [Vindigni, Jean-David; Mechin, Valerie; Cherifi, Tamazight; Chardot, Thierry; Froissard, Marine] AgroParisTech, UMR1318, Inst Jean Pierre Bourgin, F-78026 Versailles, France	INRAE; SOLEIL Synchrotron; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Froissard, M (corresponding author), INRA, UMR1318, Inst Jean Pierre Bourgin, F-78026 Versailles, France.	marine.froissard@versailles.inra.fr	JAMME, Frederic/E-2170-2011	JAMME, Frederic/0000-0002-7398-7868; Chardot, Thierry/0000-0001-6689-6151	French national synchrotron facility SOLEIL (Gif-sur-Yvette, France) [20100195]; French grant CAER from the Direction Generale de l'Armement [DGA 2012/93 0805]	French national synchrotron facility SOLEIL (Gif-sur-Yvette, France); French grant CAER from the Direction Generale de l'Armement	This work was supported by a grant (proposal 20100195 on SMIS beamline) from the French national synchrotron facility SOLEIL (Gif-sur-Yvette, France) and by the French grant CAER from the Direction Generale de l'Armement (DGA 2012/93 0805). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell BM, 2004, PLANT J, V37, P461, DOI 10.1111/j.1365-313X.2003.01988.x; Adt I, 2006, ARCH MICROBIOL, V185, P277, DOI 10.1007/s00203-006-0094-8; Athenstaedt K, 2006, PROTEOMICS, V6, P1450, DOI 10.1002/pmic.200500339; Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; Azocar L, 2010, APPL MICROBIOL BIOT, V88, P621, DOI 10.1007/s00253-010-2804-z; Bassan P, 2010, J BIOPHOTONICS, V3, P609, DOI 10.1002/jbio.201000036; Bassan P, 2010, ANALYST, V135, P268, DOI 10.1039/b921056c; Bassan P, 2009, ANALYST, V134, P1586, DOI 10.1039/b904808a; Beaudoin F, 2000, PLANT J, V23, P159, DOI 10.1046/j.1365-313x.2000.00769.x; Beaudoin F, 2002, PLANTA, V215, P293, DOI 10.1007/s00425-002-0737-1; Beller M, 2010, FEBS LETT, V584, P2176, DOI 10.1016/j.febslet.2010.03.022; Beopoulos A, 2009, PROG LIPID RES, V48, P375, DOI 10.1016/j.plipres.2009.08.005; Binns D, 2006, J CELL BIOL, V173, P719, DOI 10.1083/jcb.200511125; Brasaemle DL, 2012, J BIOL CHEM, V287, P2273, DOI 10.1074/jbc.R111.309088; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Chapman KD, 2012, J LIPID RES, V53, P215, DOI 10.1194/jlr.R021436; Chen JCF, 1999, PLANT CELL PHYSIOL, V40, P1079, DOI 10.1093/oxfordjournals.pcp.a029490; Chen JCF, 2001, PLANT CELL PHYSIOL, V42, P1245, DOI 10.1093/pcp/pce160; Chen MCM, 2004, J AGR FOOD CHEM, V52, P3982, DOI 10.1021/jf035533g; Czabany T, 2007, BBA-MOL CELL BIOL L, V1771, P299, DOI 10.1016/j.bbalip.2006.07.001; Dean AP, 2010, BIORESOURCE TECHNOL, V101, P4499, DOI 10.1016/j.biortech.2010.01.065; Debelyy MO, 2011, EUKARYOT CELL, V10, P776, DOI 10.1128/EC.05040-11; Diem M, 2004, ANALYST, V129, P880, DOI 10.1039/b408952a; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Fei WH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002201; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frandsen GI, 2001, PHYSIOL PLANTARUM, V112, P301, DOI 10.1034/j.1399-3054.2001.1120301.x; Froissard Marine, 2006, Biotechnology Journal, V1, P308, DOI 10.1002/biot.200500034; Froissard M, 2009, FEMS YEAST RES, V9, P428, DOI 10.1111/j.1567-1364.2009.00483.x; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gohon Y, 2011, BBA-BIOMEMBRANES, V1808, P706, DOI 10.1016/j.bbamem.2010.12.002; Grillitsch K, 2011, BBA-MOL CELL BIOL L, V1811, P1165, DOI 10.1016/j.bbalip.2011.07.015; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Gupta A, 2012, J BIOSCI BIOENG, V114, P411, DOI 10.1016/j.jbiosc.2012.05.013; Hanano A, 2006, J BIOL CHEM, V281, P33140, DOI 10.1074/jbc.M605395200; Hodges BDM, 2010, J LIPID RES, V51, P262, DOI 10.1194/jlr.R003582; Huang AHC, 1996, PLANT PHYSIOL, V110, P1055, DOI 10.1104/pp.110.4.1055; Jamin N, 1998, P NATL ACAD SCI USA, V95, P4837, DOI 10.1073/pnas.95.9.4837; Jang YS, 2012, BIOTECHNOL ADV, V30, P989, DOI 10.1016/j.biotechadv.2011.08.015; Jiang PL, 2010, PLANT SIGNAL BEHAV, V5, P447, DOI 10.4161/psb.5.4.10874; Kohler A, 2008, APPL SPECTROSC, V62, P259, DOI 10.1366/000370208783759669; Lacey DJ, 1998, BIOCHEM J, V334, P469, DOI 10.1042/bj3340469; Li M, 2002, J BIOL CHEM, V277, P37888, DOI 10.1074/jbc.M202721200; MARTENS H, 1991, J PHARMACEUT BIOMED, V9, P625, DOI 10.1016/0731-7085(91)80188-F; Miglio R, 2013, J APPL PHYC IN PRESS; Miller LM, 2006, BBA-BIOMEMBRANES, V1758, P846, DOI 10.1016/j.bbamem.2006.04.010; Miller LM, 2010, CURR OPIN STRUC BIOL, V20, P649, DOI 10.1016/j.sbi.2010.07.007; Morin N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027966; Movasaghi Z, 2008, APPL SPECTROSC REV, V43, P134, DOI 10.1080/05704920701829043; Murphy DJ, 2012, PROTOPLASMA, V249, P541, DOI 10.1007/s00709-011-0329-7; Naested H, 2000, PLANT MOL BIOL, V44, P463, DOI 10.1023/A:1026564411918; Parrou JL, 1997, ANAL BIOCHEM, V248, P186, DOI 10.1006/abio.1997.2138; Parthibane V, 2012, J BIOL CHEM, V287, P1946, DOI 10.1074/jbc.M111.309955; Partridge M, 2009, PLANT PHYSIOL BIOCH, V47, P796, DOI 10.1016/j.plaphy.2009.04.005; Patil PD, 2011, BIORESOURCE TECHNOL, V102, P118, DOI 10.1016/j.biortech.2010.06.031; Poxleitner M, 2006, PLANT J, V47, P917, DOI 10.1111/j.1365-313X.2006.02845.x; Ratledge C, 2004, BIOCHIMIE, V86, P807, DOI 10.1016/j.biochi.2004.09.017; Roux E, 2004, J AGR FOOD CHEM, V52, P5245, DOI 10.1021/jf0355046; Saulou C, 2010, ANAL BIOANAL CHEM, V396, P1441, DOI 10.1007/s00216-009-3316-5; Schneiter Roger, 2006, Methods Mol Biol, V313, P75; Schneiter Roger, 2006, Methods Mol Biol, V313, P41; Shimada TL, 2008, PLANT J, V55, P798, DOI 10.1111/j.1365-313X.2008.03553.x; Siloto RMP, 2006, PLANT CELL, V18, P1961, DOI 10.1105/tpc.106.041269; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Ting JTL, 1997, J BIOL CHEM, V272, P3699, DOI 10.1074/jbc.272.6.3699; Usaite R, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.67; Vargo KB, 2012, P NATL ACAD SCI USA, V109, P11657, DOI [10.1073/pnas.1205426109, 10.1073/pnas.205426109]; Vindigni JD, 2013, BBA-BIOMEMBRANES, V1828, P1881, DOI 10.1016/j.bbamem.2013.04.009; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; Wang TD, 2007, P NATL ACAD SCI USA, V104, P15864, DOI 10.1073/pnas.0707567104; Wilson WA, 2010, FEMS MICROBIOL REV, V34, P952, DOI 10.1111/j.1574-6976.2010.00220.x; Yu WG, 2000, BLOOD, V95, P1078, DOI 10.1182/blood.V95.3.1078.003k16_1078_1085; Zhang J, 2010, CURR OPIN MICROBIOL, V13, P382, DOI 10.1016/j.mib.2010.04.004; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106	77	24	25	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74421	10.1371/journal.pone.0074421	http://dx.doi.org/10.1371/journal.pone.0074421			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040242	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500092
J	Jayashankar, V; Nguyen, MJ; Carr, BW; Zheng, DC; Rosales, JB; Rosales, JB; Weiser, DC				Jayashankar, Vaishali; Nguyen, Michael J.; Carr, Brandon W.; Zheng, Dale C.; Rosales, Joseph B.; Rosales, Joshua B.; Weiser, Douglas C.			Protein Phosphatase 1 beta Paralogs Encode the Zebrafish Myosin Phosphatase Catalytic Subunit	PLOS ONE			English	Article							PLANAR CELL POLARITY; SMOOTH-MUSCLE CONTRACTILITY; CONVERGENT EXTENSION; GASTRULATION MOVEMENTS; NONMUSCLE MYOSIN; VERTEBRATE GASTRULATION; XENOPUS GASTRULATION; TARGETING SUBUNIT-1; GENOME DUPLICATION; ACTS DOWNSTREAM	Background: The myosin phosphatase is a highly conserved regulator of actomyosin contractility. Zebrafish has emerged as an ideal model system to study the in vivo role of myosin phosphatase in controlling cell contractility, cell movement and epithelial biology. Most work in zebrafish has focused on the regulatory subunit of the myosin phosphatase called Mypt1. In this work, we examined the critical role of Protein Phosphatase 1, PP1, the catalytic subunit of the myosin phosphatase. Methodology/Principal Findings: We observed that in zebrafish two paralogous genes encoding PP1 beta, called ppp1cba and ppp1cbb, are both broadly expressed during early development. Furthermore, we found that both gene products interact with Mypt1 and assemble an active myosin phosphatase complex. In addition, expression of this complex results in dephosphorylation of the myosin regulatory light chain and large scale rearrangements of the actin cytoskeleton. Morpholino knock-down of ppp1cba and ppp1cbb results in severe defects in morphogenetic cell movements during gastrulation through loss of myosin phosphatase function. Conclusions/Significance: Our work demonstrates that zebrafish have two genes encoding PP1 beta, both of which can interact with Mypt1 and assemble an active myosin phosphatase. In addition, both genes are required for convergence and extension during gastrulation and correct dosage of the protein products is required.	[Jayashankar, Vaishali; Nguyen, Michael J.; Carr, Brandon W.; Zheng, Dale C.; Rosales, Joseph B.; Rosales, Joshua B.; Weiser, Douglas C.] Univ Pacific, Dept Biol Sci, Stockton, CA 95211 USA	University of the Pacific	Weiser, DC (corresponding author), Univ Pacific, Dept Biol Sci, Stockton, CA 95211 USA.	dweiser@pacific.edu			National Science Foundation grant [IOS-1121310]; Division Of Integrative Organismal Systems [1121310] Funding Source: National Science Foundation	National Science Foundation grant(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by an National Science Foundation grant (IOS-1121310) to DCW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020903; ATALIOTIS P, 1995, DEVELOPMENT, V121, P3099; BODKIN DK, 1985, J VIROL METHODS, V10, P45, DOI 10.1016/0166-0934(85)90087-4; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Butler T, 2013, AM J PHYSIOL-CELL PH, V304, pC485, DOI 10.1152/ajpcell.00161.2012; Carmody LC, 2008, FASEB J, V22, P1660, DOI 10.1096/fj.07-092841; Carreira-Barbosa F, 2003, DEVELOPMENT, V130, P4037, DOI 10.1242/dev.00567; Carreira-Barbosa F, 2009, DEVELOPMENT, V136, P383, DOI 10.1242/dev.026542; Ceulemans H, 2002, BIOESSAYS, V24, P371, DOI 10.1002/bies.10069; Chan J, 2001, DEV BIOL, V234, P470, DOI 10.1006/dbio.2001.0281; Cohen PTW, 2002, J CELL SCI, V115, P241; Coyle RC, 2008, EXP CELL RES, V314, P2150, DOI 10.1016/j.yexcr.2008.03.010; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Diz-Munoz A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000544; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Eto M, 2005, CELL MOTIL CYTOSKEL, V62, P100, DOI 10.1002/cm.20088; Eto M, 2009, J BIOL CHEM, V284, P35273, DOI 10.1074/jbc.R109.059972; Gibbons JA, 2007, J BIOL CHEM, V282, P21838, DOI 10.1074/jbc.M701272200; Goudevenou K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026548; Grassie ME, 2011, ARCH BIOCH BIOPHYS; Gutzman JH, 2010, DEVELOPMENT, V137, P795, DOI 10.1242/dev.042705; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Hagerty L, 2007, J BIOL CHEM, V282, P4884, DOI 10.1074/jbc.M609990200; Hammerschmidt M, 2008, DEVELOPMENT, V135, P3625, DOI 10.1242/dev.015701; Haystead TAJ, 2005, CELL SIGNAL, V17, P1313, DOI 10.1016/j.cellsig.2005.05.008; He WQ, 2013, GASTROENTEROLOGY, V144, P1456, DOI 10.1053/j.gastro.2013.02.045; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Heroes E, 2013, FEBS J, V280, P584, DOI 10.1111/j.1742-4658.2012.08547.x; Hirano K, 2003, MOL CELL BIOCHEM, V248, P105, DOI 10.1023/A:1024180101032; Huang H, 2008, DEVELOPMENT, V135, P3209, DOI 10.1242/dev.024406; Ihara E, 2007, CAN J PHYSIOL PHARM, V85, P79, DOI 10.1139/Y06-103; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Jopling C, 2005, EMBO REP, V6, P426, DOI 10.1038/sj.embor.7400386; Jopling C, 2007, PLOS GENET, V3, P2468, DOI 10.1371/journal.pgen.0030225; Jopling C, 2007, MECH DEVELOP, V124, P129, DOI 10.1016/j.mod.2006.10.003; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Kim SK, 2010, SCIENCE, V329, P1337, DOI 10.1126/science.1191184; Kirchner J, 2007, GENETICS, V176, P273, DOI 10.1534/genetics.106.069914; Kwan KM, 2005, DEVELOPMENT, V132, P4599, DOI 10.1242/dev.02041; Lai SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003439; Lai SL, 2005, MOL REPROD DEV, V71, P186, DOI 10.1002/mrd.20290; Landsverk ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010712; Landsverk ML, 2005, CELL MOL LIFE SCI, V62, P2270, DOI 10.1007/s00018-005-5176-2; Lesage B, 2004, J BIOL CHEM, V279, P55978, DOI 10.1074/jbc.M411911200; Lin F, 2005, J CELL BIOL, V169, P777, DOI 10.1083/jcb.200501104; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Miyagi C, 2004, J CELL BIOL, V166, P975, DOI 10.1083/jcb.200403110; Miyakoshi A, 2004, DIFFERENTIATION, V72, P48, DOI 10.1111/j.1432-0436.2004.07201004.x; Mizuno T, 2002, DEVELOPMENT, V129, P1215; Myers DC, 2002, DEV BIOL, V243, P81, DOI 10.1006/dbio.2001.0523; Okamoto R, 2005, TRANSGENIC RES, V14, P337, DOI 10.1007/s11248-005-3453-3; Piekny AJ, 2003, DEVELOPMENT, V130, P5695, DOI 10.1242/dev.00807; Pinheiro AS, 2011, J AM CHEM SOC, V133, P73, DOI 10.1021/ja107810r; Quick RE, 2012, GENE EXPR PATTERNS, V12, P254, DOI 10.1016/j.gep.2012.05.003; Roszko I, 2009, SEMIN CELL DEV BIOL, V20, P986, DOI 10.1016/j.semcdb.2009.09.004; Scotto-Lavino E, 2010, J BIOL CHEM, V285, P6419, DOI 10.1074/jbc.M109.074773; Sepich DS, 2011, DEVELOPMENT, V138, P543, DOI 10.1242/dev.053959; Shoval Y, 2007, PLOS GENET, V3, P1884, DOI 10.1371/journal.pgen.0030180; Solnica-Krezel L, 2012, ANNU REV CELL DEV BI, V28, P687, DOI 10.1146/annurev-cellbio-092910-154043; Solnica-Krezel L, 2006, CURR OPIN GENET DEV, V16, P433, DOI 10.1016/j.gde.2006.06.009; Symes K, 1996, P NATL ACAD SCI USA, V93, P9641, DOI 10.1073/pnas.93.18.9641; Tada M, 2012, CURR TOP DEV BIOL, V101, P77, DOI 10.1016/B978-0-12-394592-1.00004-1; Tada M, 2012, DEVELOPMENT, V139, P3897, DOI 10.1242/dev.073007; Tan CG, 2003, DEVELOPMENT, V130, P671, DOI 10.1242/dev.00298; Tanegashima K, 2008, EMBO J, V27, P606, DOI 10.1038/emboj.2008.9; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Taylor JS, 2001, PHILOS T R SOC B, V356, P1661, DOI 10.1098/rstb.2001.0975; Terry-Lorenzo RT, 2002, J BIOL CHEM, V277, P27716, DOI 10.1074/jbc.M203365200; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; van Eekelen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035913; van Eekelen M, 2010, DEV BIOL, V340, P626, DOI 10.1016/j.ydbio.2010.02.026; Varmuza S, 1999, DEV BIOL, V205, P98, DOI 10.1006/dbio.1998.9100; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Vereshchagina N, 2004, MOL BIOL CELL, V15, P4395, DOI 10.1091/mbc.E04-02-0139; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; von der Hardt S, 2007, CURR BIOL, V17, P475, DOI 10.1016/j.cub.2007.02.013; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Weiser DC, 2007, GENE DEV, V21, P1559, DOI 10.1101/gad.1535007; Weiser Douglas C, 2012, Methods Mol Biol, V839, P53, DOI 10.1007/978-1-61779-510-7_5; Weiser DC, 2009, DEVELOPMENT, V136, P2375, DOI 10.1242/dev.034892; Weiser DC, 2008, BIOCHEM BIOPH RES CO, V375, P512, DOI 10.1016/j.bbrc.2008.08.063; Xia DL, 2005, EXP CELL RES, V304, P506, DOI 10.1016/j.yexcr.2004.11.025; Yamashita S, 2002, DEV CELL, V2, P363, DOI 10.1016/S1534-5807(02)00126-0; Yin C, 2008, J CELL BIOL, V180, P221, DOI 10.1083/jcb.200704150; Yu JXA, 2011, DEV BIOL, V349, P225, DOI 10.1016/j.ydbio.2010.10.027; Zhu SZ, 2006, CELL SIGNAL, V18, P359, DOI 10.1016/j.cellsig.2005.05.019	89	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e75766	10.1371/journal.pone.0075766	http://dx.doi.org/10.1371/journal.pone.0075766			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040418	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500143
J	Li, HY; Li, B; Wei, YG; Yan, LN; Wen, TF; Xu, MQ; Wang, WT; Yang, JY				Li, HongYu; Li, Bo; Wei, YongGang; Yan, LvNan; Wen, TianFu; Xu, MingQing; Wang, WenTao; Yang, JiaYin			Outcome of Using Small-For-Size Grafts in Living Donor Liver Transplantation Recipients with High Model for End-Stage Liver Disease Scores: A Single Center Experience	PLOS ONE			English	Article							ADULT; LOBE; SURVIVAL	Aims: To evaluate the impact of small-for-size grafts (SFSG) in adult-to-adult living donor liver transplantation (AALDLT) on outcomes of recipients with different model for end-stage liver disease (MELD) score in a single liver transplant center. Materials and Methods: Clinical data of 118 patients underwent right-lobe AALDLT from January 2004 to December 2011 were retrospectively analyzed, Patients were divided into Group L (MELD score <= 25) and Group H (MELD score > 25) according to MELD score. The patients were further stratified into Group LS (MELD score <= 25, GBWR<0.8%), Group LN (MELD score <= 25, GBWR >= 0.8%), Group HS (MELD score > 25, GBWR<0.8%), and Group HN (MELD score > 25, GBWR >= 0.8%) to investigate the impact of graft size on recipients' complications and outcomes. Preoperative characteristics, post-operative complications graded by the Clavien score and patient survival were analyzed. Results: MELD scores between the two groups were significant different (12.4 +/- 4.9 vs 34.5 +/- 7.5, P=0.026). There was no significant difference in preoperative demographic data as well as postoperative liver function. Complication rate, length of ICU and hospital stay, graft loss, and mortality were similar in both groups. The 1- and 3-year survival were similar between group H and group L. When recipients were further stratified into group LS, LN, HS, and HN, no significant difference was found among groups in 1- and 3-year survival rate. In multivariate analysis, HCC was not a predictor for long term survival. Conclusion: Our single institution experience demonstrates that it is safe to use SFSGs in high pre-MELD score recipients with the improvement of intensive care and the selection of listing criteria.	[Li, HongYu; Li, Bo; Wei, YongGang; Yan, LvNan; Wen, TianFu; Xu, MingQing; Wang, WenTao; Yang, JiaYin] Sichuan Univ, Dept Liver & Vasc Surg, Ctr Liver Transplantat, West China Hosp, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University	Li, B (corresponding author), Sichuan Univ, Dept Liver & Vasc Surg, Ctr Liver Transplantat, West China Hosp, Chengdu 610064, Sichuan Provinc, Peoples R China.	doclibo@126.com	Li, Bo/AAA-8968-2020	Li, Bo/0000-0002-7294-6888	National Natural Science Foundation of China [81172372]; National Science and Technology Major Project of China [2008ZX10002-026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of China	This work was supported by grants from the National Natural Science Foundation of China (No. 81172372) and the National Science and Technology Major Project of China (2008ZX10002-026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asencio JM, 2013, MED HYPOTHESES, V80, P573, DOI 10.1016/j.mehy.2013.01.028; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; CLAVIEN PA, 1994, ANN SURG, V220, P109, DOI 10.1097/00000658-199408000-00002; Edwards E B, 2001, Clin Transpl, P19; Fan ST, 2003, ANN SURG, V238, P137, DOI 10.1097/01.sla.0000077921.38307.16; Freeman RB, 2002, LIVER TRANSPLANT, V8, P851, DOI 10.1053/jlts.2002.35927; Habib S, 2006, LIVER TRANSPLANT, V12, P440, DOI 10.1002/lt.20721; Hayashi PH, 2003, LIVER TRANSPLANT, V9, P737, DOI 10.1053/jlts.2003.50122; Ikegami T, 2013, J AM COLL SURGEONS, V216, P353, DOI 10.1016/j.jamcollsurg.2012.11.011; Li HY, 2012, HEPATO-GASTROENTEROL, V59, P2050, DOI 10.5754/hge12261; Lo CM, 2003, LIVER TRANSPLANT, V9, P626, DOI 10.1053/jlts.2003.50081; Poon KS, 2012, TRANSPL P, V44, P316, DOI 10.1016/j.transproceed.2012.02.006; Sugawara Y, 2003, TRANSPLANTATION, V75, pS20, DOI 10.1097/01.TP.0000046616.76542.DF; Terrault NA, 2007, LIVER TRANSPLANT, V13, P122, DOI 10.1002/lt.20995; Trotter JF, 2002, NEW ENGL J MED, V346, P1074, DOI 10.1056/NEJMra011629; Uchida Y, 2006, AM J TRANSPLANT, V6, P2443, DOI 10.1111/j.1600-6143.2006.01487.x; Yi NJ, 2009, LIVER TRANSPLANT, V15, P496, DOI 10.1002/lt.21606	17	9	10	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74081	10.1371/journal.pone.0074081	http://dx.doi.org/10.1371/journal.pone.0074081			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040171	gold, Green Submitted, Green Published			2022-12-25	WOS:000326734500070
J	Liu, FY; Li, RW; Safdar, J; Li, ZN; Guo, N; Xu, ZF; Ge, SF; Li, JL; Huang, SH; Tan, XX; Sun, CF				Liu, Fa-yu; Li, Rui-wu; Safdar, Jawad; Li, Zhen-ning; Guo, Nan; Xu, Zhong-fei; Ge, Shu-fen; Li, Jun-lin; Huang, Shao-hui; Tan, Xue-xin; Sun, Chang-fu			Modified Incision Design for Submental Flap: An Excellent Design Method for the Reconstruction of a Defect after Head and Neck Tumor Resection	PLOS ONE			English	Article								Background: The usage of submental flap is a good method for head and neck reconstruction, but it has some risk also, such as anatomical variations and surgical errors. In this article, we present a modified incision design for the submental flap. Methods: We designed a modified submental flap incision method based on the overlap of the incision outline of the submental flap, platysma myocutaneous flap and infrahyoid myocutaneous flap. If we found that the submental flap was unreliable during the neck dissection at the level III, II and Ib areas, the infrahyoid myocutaneous flap or platysma myocutaneous flap was used to replace it. Between 2004 and 2012, we performed 30 cases using this method. As control, 33 radial forearm free flaps were counted. Significant differences were evaluated using the chi(2) test and Mann-Whitney U. Survival and recurrence were analyzed using the Kaplan-Meier method. Results: Of the 30 patients, 27 finally received a submental flap, 1 patient received an infrahyoid myocutaneous flap, and 2 patients received a platysma myocutaneous flap. In patients who received the submental flap, the average operation time was 5.9 hours, 2.4 hours shorter than the radial forearm free flap group; the average age was 61.8, 6.1 years older than the radial forearm free flap group; the survival time and recurrence time did not significantly differ with those of the forearm free flap group; and the success rate was higher than traditional methods. Conclusions: The wider indications, less required time, the similar low risk of recurrence and death as radial forearm free flap, higher success rate than traditional submental flap harvest methods, and ability to safely harvest a submental flap make the modified incision design a reliable method.	[Liu, Fa-yu; Li, Rui-wu; Safdar, Jawad; Li, Zhen-ning; Xu, Zhong-fei; Ge, Shu-fen; Li, Jun-lin; Huang, Shao-hui; Tan, Xue-xin; Sun, Chang-fu] China Med Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, Dept Oromaxillofacial Head & Neck Surg, Shenyang, Heping District, Peoples R China; [Guo, Nan] Tumor Hosp Liaoning Prov, Dept Head & Neck Surg, Shenyang, Peoples R China	China Medical University	Sun, CF (corresponding author), China Med Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, Dept Oromaxillofacial Head & Neck Surg, 117 Nanjing Bei Jie, Shenyang, Heping District, Peoples R China.	cfsun@mail.cmu.edu.cn	SUN, CHANG/GXM-3680-2022		National Natural Science Foundation of China [30672331]; National Science Foundation for Young Scholars of China [81102058]; Foundation of Education Bureau of Liaoning Province, China [2009A755]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation for Young Scholars of China(National Natural Science Foundation of China (NSFC)); Foundation of Education Bureau of Liaoning Province, China	This study is supported by grants from the National Natural Science Foundation of China (No. 30672331), the National Science Foundation for Young Scholars of China (No. 81102058) and the Foundation of Education Bureau of Liaoning Province, China (No. 2009A755). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AA, 2011, HEAD NECK ONCOL, V3, DOI 10.1186/1758-3284-3-51; Faltaous AA, 1996, PLAST RECONSTR SURG, V97, P56, DOI 10.1097/00006534-199601000-00008; Gupta V, 2003, SURG RADIOL ANAT, V25, P36, DOI 10.1007/s00276-002-0080-z; HURWITZ DJ, 1983, PLAST RECONSTR SURG, V72, P302, DOI 10.1097/00006534-198309000-00005; Lee JC, 2013, EUR ARCH OTO-RHINO-L, V270, P319, DOI 10.1007/s00405-012-2033-4; Liu FY, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-135; MARTIN D, 1993, PLAST RECONSTR SURG, V92, P867, DOI 10.1097/00006534-199392050-00013; Moore BA, 2005, HEAD NECK-J SCI SPEC, V27, P1092, DOI 10.1002/hed.20252; Patel UA, 2007, LARYNGOSCOPE, V117, P186, DOI 10.1097/01.mlg.0000246519.77156.a4; Peng LW, 2005, INT J ORAL MAX SURG, V34, P507, DOI 10.1016/j.ijom.2004.10.022; Potter S, 2012, MICROSURG, V32, P502, DOI 10.1002/micr.21983; Tan ST, 2006, HEAD NECK-J SCI SPEC, V28, P46, DOI 10.1002/hed.20317; Varghese BT, 2011, J PLAST RECONSTR AES, V64, pE183, DOI 10.1016/j.bjps.2011.02.010; Windfuhr JP, 2006, EUR ARCH OTO-RHINO-L, V263, P1013, DOI 10.1007/s00405-006-0110-2	14	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74110	10.1371/journal.pone.0074110	http://dx.doi.org/10.1371/journal.pone.0074110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040181	Green Submitted, Green Published, gold			2022-12-25	WOS:000326734500072
J	Teichman, KJ; Cristescu, B; Nielsen, SE				Teichman, Kristine J.; Cristescu, Bogdan; Nielsen, Scott E.			Does Sex Matter? Temporal and Spatial Patterns of Cougar-Human Conflict in British Columbia	PLOS ONE			English	Article							BIALOWIEZA PRIMEVAL FOREST; HUMAN-CARNIVORE CONFLICT; HOME-RANGE; SOUTHERN CALIFORNIA; EURASIAN LYNX; CANIS-LUPUS; BLACK BEARS; MORTALITY; CONSERVATION; POPULATION	Wildlife-human conflicts occur wherever large carnivores overlap human inhabited areas. Conflict mitigation can be facilitated by understanding long-term dynamics and examining sex-structured conflict patterns. Predicting areas with high probability of conflict helps focus management strategies in order to proactively decrease carnivore mortality. We investigated the importance of cougar (Puma concolor) habitat, human landscape characteristics and the combination of habitat and human features on the temporal and spatial patterns of cougar-human conflicts in British Columbia. Conflicts (n = 1,727; 1978-2007) involved similar numbers of male and female cougars with conflict rate decreasing over the past decade. Conflicts were concentrated within the southern part of the province with the most conflicts per unit area occurring on Vancouver Island. For both sexes, the most supported spatial models for the most recent (1998-2007) conflicts contained both human and habitat variables. Conflicts were more likely to occur close to roads, at intermediate elevations and far from the northern edge of the cougar distribution range in British Columbia. Male cougar conflicts were more likely to occur in areas of intermediate human density. Unlike cougar conflicts in other regions, cattle density was not a significant predictor of conflict location. With human populations expanding, conflicts are expected to increase. Conservation tools, such as the maps predicting conflict hotspots from this study, can help focus management efforts to decrease carnivore-human conflict.	[Teichman, Kristine J.; Cristescu, Bogdan] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Nielsen, Scott E.] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada	University of Alberta; University of Alberta	Teichman, KJ (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	teichman@ualberta.ca	Nielsen, Scott/O-7482-2019; Nielsen, Scott/C-2842-2013; Moreira, Nei/AAK-1357-2020	Nielsen, Scott/0000-0002-9754-0630; Nielsen, Scott/0000-0002-9754-0630; Moreira, Nei/0000-0002-9236-667X; Cristescu, Bogdan/0000-0003-2964-5040				Ackerman B.B., 1986, P333; Alexander SM, 2006, J BIOGEOGR, V33, P2001, DOI 10.1111/j.1365-2699.2006.01564.x; Anderson AE, 1992, PUMA UNCOMPAHGRE PLA, V40, P1; B.C, 2003, WILDL HUM CONFL PREV; Bacon MM, 2011, WILDLIFE SOC B, V35, P409, DOI 10.1002/wsb.85; BEIER P, 1991, WILDLIFE SOC B, V19, P403; BELDEN RC, 1993, J WILDLIFE MANAGE, V57, P388, DOI 10.2307/3809438; Beyer H. L, 2007, HAWTHS ANAL TOOLS AR; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Brown JL, 2006, THERIOGENOLOGY, V66, P25, DOI 10.1016/j.theriogenology.2006.03.011; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Chatterjee S., 2006, REGRESSION ANAL EXAM, DOI DOI 10.1002/0470055464; Conde DA, 2010, BIOL CONSERV, V143, P1980, DOI 10.1016/j.biocon.2010.04.049; Cougar Management Guidelines Working Group, 2005, COUG MAN GUID; Crete M, 1999, ACTA VET HUNG, V47, P1, DOI 10.1556/AVet.47.1999.1.1; Cunningham SC, 1999, J RANGE MANAGE, V52, P202, DOI 10.2307/4003681; Czetwertynski SM, 2007, URSUS, V18, P1, DOI 10.2192/1537-6176(2007)18[1:EOHODP]2.0.CO;2; Dawe K, 2011, THESIS U ALBERTA EDM; Dickson BG, 2005, J WILDLIFE MANAGE, V69, P264, DOI 10.2193/0022-541X(2005)069&lt;0264:IOVTAR&gt;2.0.CO;2; Dickson BG, 2002, J WILDLIFE MANAGE, V66, P1235, DOI 10.2307/3802956; Fahrig L, 2009, ECOL SOC, V14; Falcucci A, 2009, J APPL ECOL, V46, P600, DOI 10.1111/j.1365-2664.2009.01634.x; Farrell MC, 2007, J WILDLIFE MANAGE, V71, P2727, DOI 10.2193/2006-085; Frair JL, 2008, J APPL ECOL, V45, P1504, DOI 10.1111/j.1365-2664.2008.01526.x; Fuller TK, 2001, CONSERV BIOL SER, V5, P163; Gill RB., 2009, COUGAR ECOLOGY CONSE, P5; Gunther KA, 1998, P INT C WILDL EC TRA, p395 ; HORSTMAN L P, 1982, Wildlife Society Bulletin, V10, P34; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; IRIARTE JA, 1991, REV CHIL HIST NAT, V64, P145; Jansen BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044625; Colino-Rabanal VJ, 2011, EUR J WILDLIFE RES, V57, P399, DOI 10.1007/s10344-010-0446-1; Jedrzejewski W, 2002, ANN ZOOL FENN, V39, P29; Karlsson J, 2010, J APPL ECOL, V47, P166, DOI 10.1111/j.1365-2664.2009.01747.x; Knopff KH, 2010, J WILDLIFE MANAGE, V74, P1435, DOI 10.2193/2009-314; Knopff KH, 2010, J WILDLIFE MANAGE, V74, P644, DOI 10.2193/2009-252; Laliberte AS, 2004, BIOSCIENCE, V54, P123, DOI 10.1641/0006-3568(2004)054[0123:RCONAC]2.0.CO;2; Lambert CMS, 2006, J WILDLIFE MANAGE, V70, P246, DOI 10.2193/0022-541X(2006)70[246:CPDAVI]2.0.CO;2; Lambert CS, 2003, THESIS WASHINGTON ST; Laundre JW, 2007, J MAMMAL, V88, P1300, DOI 10.1644/06-MAMM-A-296R.1; Lima SL, 1998, ADV STUD BEHAV, V27, P215; LINDSTEDT SL, 1986, ECOLOGY, V67, P413, DOI 10.2307/1938584; Linnell JDC, 1997, BIODIVERS CONSERV, V6, P1245, DOI 10.1023/B:BIOC.0000034011.05412.cd; Linnell JDC, 1999, WILDLIFE SOC B, V27, P698; Loe J, 2004, AMBIO, V33, P283, DOI 10.1639/0044-7447(2004)033[0283:LCAHSA]2.0.CO;2; Long RA, 2009, J WILDLIFE MANAGE, V73, P294, DOI 10.2193/2008-052; Lucherini M, 2009, J MAMMAL, V90, P1404, DOI 10.1644/09-MAMM-A-002R.1; Mattson David, 2011, Human-Wildlife Interactions, V5, P135; Mazzolli M, 2002, BIOL CONSERV, V105, P43, DOI 10.1016/S0006-3207(01)00178-1; McKinney T, 2010, COLORADO PLATEAU, P303; MCLELLAN BN, 1989, CAN J ZOOL, V67, P1861, DOI 10.1139/z89-265; Naves J, 2003, CONSERV BIOL, V17, P1276, DOI 10.1046/j.1523-1739.2003.02144.x; Nielsen SE, 2006, BIOL CONSERV, V130, P217, DOI 10.1016/j.biocon.2005.12.016; Nielsen SE, 2004, BIOL CONSERV, V120, P101, DOI 10.1016/j.biocon.2004.02.020; OKARMA H, 1995, ACTA THERIOL, V40, P197, DOI 10.4098/AT.arch.95-20; PAULEY GR, 1993, J WILDLIFE MANAGE, V57, P904, DOI 10.2307/3809096; Polisar J, 2003, BIOL CONSERV, V109, P297, DOI 10.1016/S0006-3207(02)00157-X; Quigley Howard, 2010, P59; Rea RV, 2003, WILDLIFE BIOL, V9, P81, DOI 10.2981/wlb.2003.030; Rodriguez A, 2004, BIOL CONSERV, V118, P151, DOI 10.1016/j.biocon.2003.07.018; ROSS PI, 1992, J WILDLIFE MANAGE, V56, P417, DOI 10.2307/3808853; Schmidt K, 1997, ACTA THERIOL, V42, P289, DOI 10.4098/AT.arch.97-30; SCHWARTZ CC, 1992, J WILDLIFE MANAGE, V56, P426, DOI 10.2307/3808854; Spreadbury BR, 1996, J WILDLIFE MANAGE, V60, P962, DOI 10.2307/3802398; SUKUMAR R, 1991, BIOL CONSERV, V55, P93, DOI 10.1016/0006-3207(91)90007-V; Sweanor LL, 2000, CONSERV BIOL, V14, P798, DOI 10.1046/j.1523-1739.2000.99079.x; Taylor SK, 2002, J WILDLIFE DIS, V38, P107, DOI 10.7589/0090-3558-38.1.107; Treves A, 2004, CONSERV BIOL, V18, P114, DOI 10.1111/j.1523-1739.2004.00189.x; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Treves Adrian, 2006, Human Dimensions of Wildlife, V11, P383, DOI 10.1080/10871200600984265; Treves A, 2011, BIOSCIENCE, V61, P451, DOI 10.1525/bio.2011.61.6.7; Treves A, 2009, J APPL ECOL, V46, P1350, DOI 10.1111/j.1365-2664.2009.01729.x; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Wainwright C. J., 2010, BRIT COLUMBIAS NEGLE; Wilson SM, 2006, BIOL CONSERV, V130, P47, DOI 10.1016/j.biocon.2005.12.001	75	21	21	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74663	10.1371/journal.pone.0074663	http://dx.doi.org/10.1371/journal.pone.0074663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040312	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500114
J	Wen, ST; Chen, W; Chen, HL; Lai, CW; Yen, CC; Lee, KH; Wu, SC; Chen, CM				Wen, Shih-Tao; Chen, Wei; Chen, Hsiao-Ling; Lai, Cheng-Wei; Yen, Chih-Ching; Lee, Kun-Hsiung; Wu, Shinn-Chih; Chen, Chuan-Mu			Amniotic Fluid Stem Cells from EGFP Transgenic Mice Attenuate Hyperoxia-Induced Acute Lung Injury	PLOS ONE			English	Article							EUROPEAN CONSENSUS CONFERENCE; CLINICAL-TRIAL COORDINATION; MESENCHYMAL STROMAL CELLS; BONE-MARROW; PROGENITOR CELLS; RELEVANT OUTCOMES; ARDS; MECHANISMS; THERAPY; REGENERATION	High concentrations of oxygen aggravate the severity of lung injury in patients requiring mechanical ventilation. Although mesenchymal stem cells have been shown to effectively attenuate various injured tissues, there is limited information regarding a role for amniotic fluid stem cells (AFSCs) in treating acute lung injury. We hypothesized that intravenous delivery of AFSCs would attenuate lung injury in an experimental model of hyperoxia-induced lung injury. AFSCs were isolated from EGFP transgenic mice. The in vitro differentiation, surface markers, and migration of the AFSCs were assessed by specific staining, flow cytometry, and a co-culture system, respectively. The in vivo therapeutic potential of AFSCs was evaluated in a model of acute hyperoxia-induced lung injury in mice. The administration of AFSCs significantly reduced the hyperoxia-induced pulmonary inflammation, as reflected by significant reductions in lung wet/dry ratio, neutrophil counts, and the level of apoptosis, as well as reducing the levels of inflammatory cytokine (IL-1 beta, IL-6, and TNF-alpha) and early-stage fibrosis in lung tissues. Moreover, EGFP-expressing AFSCs were detected and engrafted into a peripheral lung epithelial cell lineage by fluorescence microscopy and DAPI stain. Intravenous administration of AFSCs may offer a new therapeutic strategy for acute lung injury (ALI), for which efficient treatments are currently unavailable.	[Wen, Shih-Tao; Chen, Wei; Chen, Hsiao-Ling; Lai, Cheng-Wei; Yen, Chih-Ching; Chen, Chuan-Mu] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Dept Life Sci, Taichung 40227, Taiwan; [Chen, Wei] Chia Yi Christian Hosp, Div Pulm & Crit Care Med, Chiayi, Taiwan; [Chen, Hsiao-Ling] Da Yeh Univ, Dept Bioresources & Mol Biotechnol, Changhua, Taiwan; [Yen, Chih-Ching] China Med Univ Hosp, Div Pulm & Crit Care Med, Taichung, Taiwan; [Lee, Kun-Hsiung] Anim Technol Inst Taiwan, Div Biotechnol, Miaoli, Taiwan; [Wu, Shinn-Chih] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei 10764, Taiwan	National Chung Hsing University; Da Yeh University; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Taiwan University	Chen, CM (corresponding author), Natl Chung Hsing Univ, Agr Biotechnol Ctr, Dept Life Sci, Taichung 40227, Taiwan.	chchen1@dragon.nchu.edu.tw	Chen, Chuan-Mu/K-7049-2013	Chen, Chuan-Mu/0000-0003-2461-9150; Wu, Shinn-Chih/0000-0001-8881-1550	National Science Council [NSC-98-2313-B-005-012]; Ministry of Education, Taiwan, Republic of China, under the Aiming Top University plan [ATU-101-S0508]	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, Republic of China, under the Aiming Top University plan	This research was supported by grant NSC-98-2313-B-005-012 from the National Science Council and was partly supported by the Ministry of Education, Taiwan, Republic of China, under the Aiming Top University plan (ATU-101-S0508). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrazzak H, 2013, CURR STEM CELL RES T, V8, P117, DOI 10.2174/1574888X11308020002; Altemeier WA, 2007, CURR OPIN CRIT CARE, V13, P73, DOI 10.1097/MCC.0b013e32801162cb; Baksh D, 2003, EXP HEMATOL, V31, P723, DOI 10.1016/S0301-472X(03)00106-1; Barria E, 2004, STEM CELLS DEV, V13, P548, DOI 10.1089/scd.2004.13.548; BERNARD GR, 1994, INTENS CARE MED, V20, P225, DOI 10.1007/BF01704707; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bhandari V, 2008, FRONT BIOSCI-LANDMRK, V13, P6653, DOI 10.2741/3179; Brower RG, 2001, CHEST, V120, P1347, DOI 10.1378/chest.120.4.1347; Calfee CS, 2007, CHEST, V131, P913, DOI 10.1378/chest.06-1743; Carraro G, 2008, STEM CELLS, V26, P2902, DOI 10.1634/stemcells.2008-0090; Chen HL, 2008, VACCINE, V26, P891, DOI 10.1016/j.vaccine.2007.12.013; Chen JY, 2012, J ETHNOPHARMACOL, V142, P811, DOI 10.1016/j.jep.2012.06.005; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; Chun SY, 2012, J KOREAN MED SCI, V27, P1300, DOI 10.3346/jkms.2012.27.11.1300; CRAPO JD, 1986, ANNU REV PHYSIOL, V48, P721; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Fernandes RA, 2012, PLACENTA, V33, P640, DOI 10.1016/j.placenta.2012.03.009; Guidot DM, 2006, AM J PHYSIOL-LUNG C, V291, pL301, DOI 10.1152/ajplung.00153.2006; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Iyer SS, 2008, EXPERT OPIN BIOL TH, V8, P569, DOI 10.1517/14712598.8.5.569 ; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kahler CM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-50; Klemmt PAB, 2011, EXPERT OPIN BIOL TH, V11, P1297, DOI 10.1517/14712598.2011.587800; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Kumamoto M, 2009, EUR RESPIR J, V34, P740, DOI 10.1183/09031936.00128508; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Leblond AL, 2009, HUM GENE THER, V20, P1329, DOI 10.1089/hum.2009.035; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Mei SHJ, 2007, PLOS MED, V4, P1525, DOI 10.1371/journal.pmed.0040269; Minamino T, 2006, J CLIN INVEST, V116, P2316, DOI 10.1172/JCI29637; Moodley Y, 2009, AM J PATHOL, V175, P303, DOI 10.2353/ajpath.2009.080629; Nadri S, 2007, CYTOTHERAPY, V9, P729, DOI 10.1080/14653240701656061; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Orfanos SE, 2004, INTENS CARE MED, V30, P1702, DOI 10.1007/s00134-004-2370-x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rodrigues MT, 2012, BIOMATERIALS, V33, P6069, DOI 10.1016/j.biomaterials.2012.05.016; Roubelakis MG, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/107836; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Santana AC, 2012, TRANSPL P, V44, P2490, DOI 10.1016/j.transproceed.2012.07.022; Sessarego N, 2008, HAEMATOLOGICA, V93, P339, DOI 10.3324/haematol.11869; Shen CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032812; Skardal A, 2012, STEM CELL TRANSL MED, V1, P792, DOI 10.5966/sctm.2012-0088; SMITH LJ, 1985, J LAB CLIN MED, V106, P269; Tajiri N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043779; Tang PS, 2008, AM J PHYSIOL-LUNG C, V294, pL632, DOI 10.1152/ajplung.00262.2007; Tsai TC, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-88; Tung YT, 2011, MOL NUTR FOOD RES, V55, P1036, DOI 10.1002/mnfr.201000654; Turner CG, 2013, STEM CELLS DEV, V22, P548, DOI 10.1089/scd.2012.0215; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Yamada M, 2004, J IMMUNOL, V172, P1266, DOI 10.4049/jimmunol.172.2.1266; Yen CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026870; Yen CC, 2009, J INFECT DIS, V199, P590, DOI 10.1086/596212; Yoon BS, 2010, STEM CELLS DEV, V19, P887, DOI 10.1089/scd.2009.0138; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496	54	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e75383	10.1371/journal.pone.0075383	http://dx.doi.org/10.1371/journal.pone.0075383			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040409	Green Published, gold, Green Submitted			2022-12-25	WOS:000326734500139
J	Branca, RT; Zhang, L; Warren, WS; Auerbach, E; Khanna, A; Degan, S; Ugurbil, K; Maronpot, R				Branca, Rosa T.; Zhang, Le; Warren, Warren S.; Auerbach, Edward; Khanna, Arjun; Degan, Simone; Ugurbil, Kamil; Maronpot, Robert			In Vivo Noninvasive Detection of Brown Adipose Tissue through Intermolecular Zero-Quantum MRI	PLOS ONE			English	Article							COLD-EXPOSURE; FAT; MICE; IDENTIFICATION; THERMOGENESIS; PREVALENCE	The recent discovery of active Brown Adipose Tissue (BAT) in adult humans has opened new avenues for obesity research and treatment, as reduced BAT activity seem to be implicated in human energy imbalance, diabetes, and hypertension. However, clinical applications are currently limited by the lack of non-invasive tools for measuring mass and function of this tissue in humans. Here we present a new magnetic resonance imaging method based on the normally invisible intermolecular multiple-quantum coherence H-1 MR signal. This method, which doesn't require special hardware modifications, can be used to overcome partial volume effect, the major limitation of MR-based approaches that are currently being investigated for the detection of BAT in humans. With this method we can exploit the characteristic cellular structure of BAT to selectively image it, even when (as in humans) it is intimately mixed with other tissues. We demonstrate and validate this method in mice using PET scans and histology. We compare this methodology with conventional H-1 MR fat fraction methods. Finally, we investigate its feasibility for the detection of BAT in humans.	[Branca, Rosa T.] Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27515 USA; [Branca, Rosa T.; Zhang, Le] Univ N Carolina, Biomed Res Imaging Ctr, Chapel Hill, NC USA; [Zhang, Le] Univ N Carolina, Chapel Hill, NC USA; [Warren, Warren S.; Khanna, Arjun; Degan, Simone] Duke Univ, Dept Chem, Durham, NC 27706 USA; [Auerbach, Edward; Ugurbil, Kamil] Univ Minnesota, Ctr Magnet Resonance Res, Minneapolis, MN USA; [Maronpot, Robert] Expt Pathol Labs Inc, Res Triangle Pk, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; University of Minnesota System; University of Minnesota Twin Cities	Branca, RT (corresponding author), Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27515 USA.	rtbranca@unc.edu	Auerbach, Edward John/D-9980-2015; Zhang, Le/AAE-2142-2019; Ugurbil, Kamil/AAD-6058-2022	Auerbach, Edward John/0000-0003-4553-1545; Zhang, Le/0000-0003-1841-1986; Branca, Rosa Tamara/0000-0002-6871-1824; Degan, Simone/0000-0001-5417-1196	National Institutes of Health (NIH) [R21-DK090758, R01-EB002122, P41-RR008079]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK090758] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the following National Institutes of Health (NIH) grants: R21-DK090758, R01-EB002122 and P41-RR008079. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHERNE W, 1966, J PATHOL BACTERIOL, V91, P223, DOI 10.1002/path.1700910126; Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; Bouchard LS, 2002, MAGNET RESON MED, V48, P973, DOI 10.1002/mrm.10293; Branca RT, 2011, MAGN RESON MED, V65, P313, DOI 10.1002/mrm.22622; Brix G, 2005, J NUCL MED, V46, P608; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; CARNEHEIM C, 1984, AM J PHYSIOL, V246, pE327, DOI 10.1152/ajpendo.1984.246.4.E327; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004; Fueger BJ, 2006, J NUCL MED, V47, P999; Galiana G, 2008, SCIENCE, V322, P421, DOI 10.1126/science.1163242; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; HEATON JM, 1972, J ANAT, V112, P35; Hu HH, 2011, J MAGN RESON IMAGING, V35, P938; Hu HH, 2013, J MAGN RESO IN PRESS; Hu HH, 2013, AM J ROENTGENOL, V200, P177, DOI 10.2214/AJR.12.8996; Hu HH, 2010, J MAGN RESON IMAGING, V31, P1195, DOI 10.1002/jmri.22162; Huang BS, 2009, RADIOLOGY, V251, P166, DOI 10.1148/radiol.2511081300; Jokivarsi K, 2012, J NUCL MED, V53; Khanna A, 2012, MAGN RESON MED, V68, P1285, DOI 10.1002/mrm.24118; LEAN MEJ, 1989, P NUTR SOC, V48, P243, DOI 10.1079/PNS19890036; Lee P, 2011, J CLIN ENDOCR METAB, V96, P2450, DOI 10.1210/jc.2011-0487; Lee P, 2010, AM J PHYSIOL-ENDOC M, V299, pE601, DOI 10.1152/ajpendo.00298.2010; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Lunati E, 1999, J LIPID RES, V40, P1395; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Peng XG, 2013, AM J PHYSIOL-ENDOC M, V304, pE160, DOI 10.1152/ajpendo.00401.2012; PUCHALSKI W, 1987, J EXP ZOOL, V242, P263, DOI 10.1002/jez.1402420304; ROTHWELL NJ, 1983, CLIN SCI, V64, P19, DOI 10.1042/cs0640019; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Smith DL, 2013, J MAGN RESO IN PRESS; Tatsumi M, 2004, J NUCL MED, V45, P1189; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Warren WS, 1998, SCIENCE, V281, P247, DOI 10.1126/science.281.5374.247; Wijers SLJ, 2009, OBES REV, V10, P218, DOI 10.1111/j.1467-789X.2008.00538.x; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	40	37	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74206	10.1371/journal.pone.0074206	http://dx.doi.org/10.1371/journal.pone.0074206			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040203	Green Published, Green Submitted, gold			2022-12-25	WOS:000327538600075
J	Jorquera, PA; Choi, Y; Oakley, KE; Powell, TJ; Boyd, JG; Palath, N; Haynes, LM; Anderson, LJ; Tripp, RA				Jorquera, Patricia A.; Choi, Youngjoo; Oakley, Katie E.; Powell, Thomas J.; Boyd, James G.; Palath, Naveen; Haynes, Lia M.; Anderson, Larry J.; Tripp, Ralph A.			Nanoparticle Vaccines Encompassing the Respiratory Syncytial Virus (RSV) G Protein CX3C Chemokine Motif Induce Robust Immunity Protecting from Challenge and Disease	PLOS ONE			English	Article							ATTACHMENT G-GLYCOPROTEIN; T-CELL RESPONSES; G FUSION PROTEIN; BALB/C MICE; DENDRITIC CELLS; F-GLYCOPROTEIN; SEROPOSITIVE CHILDREN; ACID) NANOPARTICLES; ANTIBODY-RESPONSE; SUBUNIT VACCINE	Nanoparticle vaccines were produced using layer-by-layer fabrication and incorporating respiratory syncytial virus (RSV) G protein polypeptides comprising the CX3C chemokine motif. BALB/c mice immunized with G protein nanoparticle vaccines produced a neutralizing antibody response that inhibited RSV replication in the lungs following RSV challenge. ELISPOT analysis showed that G nanoparticle vaccinated mice had increased levels of RSV G protein-specific IL-4 and IFN-gamma secreting cells compared to controls following RSV challenge. Remarkably, RSV challenge of G protein nanoparticle vaccinated mice resulted in increased RSV M2-specific IL-4 and IFN-gamma secreting T cells, and increased M2-specific H-2Kd-tetramer positive CD8(+) T cells in the lungs compared to controls. Cell type analysis showed vaccination was not associated with increased pulmonary eosinophilia following RSV challenge. These results demonstrate that vaccination of mice with the RSV G protein nanoparticle vaccines induces a potent neutralizing antibody response, increased G protein-and M2- specific T cell responses, and a reduction in RSV disease pathogenesis.	[Jorquera, Patricia A.; Choi, Youngjoo; Oakley, Katie E.; Tripp, Ralph A.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA; [Powell, Thomas J.; Boyd, James G.; Palath, Naveen] Artificial Cell Technol, New Haven, CT USA; [Haynes, Lia M.] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA; [Anderson, Larry J.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA	University System of Georgia; University of Georgia; Centers for Disease Control & Prevention - USA; Emory University	Tripp, RA (corresponding author), Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.	ratripp@uga.edu		Tripp, Ralph/0000-0002-2924-9956	National Institutes of Health [5 R01 AI 99744-3]; Georgia Research Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported in part by the National Institutes of Health (5 R01 AI 99744-3) and through the Georgia Research Alliance to RT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audran R, 2003, VACCINE, V21, P1250, DOI 10.1016/S0264-410X(02)00521-2; BANGHAM CRM, 1985, J VIROL, V56, P55, DOI 10.1128/JVI.56.1.55-59.1985; Becker Y, 2006, VIRUS GENES, V33, P235, DOI 10.1007/s11262-006-0064-x; BELSHE RB, 1993, J INFECT DIS, V168, P1024, DOI 10.1093/infdis/168.4.1024; Brandt C, 1997, J INFECT DIS, V176, P884, DOI 10.1086/516503; Bueno SM, 2008, INT IMMUNOPHARMACOL, V8, P1320, DOI 10.1016/j.intimp.2008.03.012; Bueno SM, 2008, P NATL ACAD SCI USA, V105, P20822, DOI 10.1073/pnas.0806244105; Bukreyev A, 2006, J VIROL, V80, P5854, DOI 10.1128/JVI.02671-05; Cane PA, 2001, REV MED VIROL, V11, P103, DOI 10.1002/rmv.305; CANNON MJ, 1988, J EXP MED, V168, P1163, DOI 10.1084/jem.168.3.1163; Castilow EM, 2007, IMMUNOL RES, V39, P225, DOI 10.1007/s12026-007-0071-6; CHANOCK RM, 1961, JAMA-J AM MED ASSOC, V176, P647; Choi Y, 2012, VIRAL IMMUNOL, V25, P193, DOI 10.1089/vim.2011.0094; Corvaia N, 1997, J INFECT DIS, V176, P560, DOI 10.1086/514075; DENNY FW, 1979, REV INFECT DIS, V1, P1007; Dowell SF, 1996, J INFECT DIS, V174, P456, DOI 10.1093/infdis/174.3.456; Dudas RA, 1998, CLIN MICROBIOL REV, V11, P430, DOI 10.1128/CMR.11.3.430; Durbin JE, 2004, VIRAL IMMUNOL, V17, P370, DOI 10.1089/0882824041857120; ENGLUND JA, 1994, PEDIATR INFECT DIS J, V13, P449, DOI 10.1097/00006454-199405000-00037; Falsey AR, 2007, SEMIN RESP CRIT CARE, V28, P171, DOI 10.1055/s-2007-976489; Falsey AR, 1997, VACCINE, V15, P1130, DOI 10.1016/S0264-410X(97)00002-9; Fan CF, 2005, VACCINE, V23, P4453, DOI 10.1016/j.vaccine.2005.03.044; Gorman JJ, 1997, PROTEIN SCI, V6, P1308, DOI 10.1002/pro.5560060619; Groothuis JR, 1998, J INFECT DIS, V177, P467, DOI 10.1086/517377; Gudmundsson G, 1997, J CLIN INVEST, V99, P2386, DOI 10.1172/JCI119420; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; HALL CB, 1991, J INFECT DIS, V163, P693, DOI 10.1093/infdis/163.4.693; Hamdy S, 2007, J BIOMED MATER RES A, V81A, P652, DOI 10.1002/jbm.a.31019; Harcourt J, 2006, J IMMUNOL, V176, P1600, DOI 10.4049/jimmunol.176.3.1600; Haynes LM, 2009, J INFECT DIS, V200, P439, DOI 10.1086/600108; Hoebee B, 2003, J INFECT DIS, V187, P2, DOI 10.1086/345859; JOHNSON PR, 1987, J VIROL, V61, P3163, DOI 10.1128/JVI.61.10.3163-3166.1987; Johnson TR, 2008, J LEUKOCYTE BIOL, V84, P748, DOI 10.1189/jlb.0907621; Johnson TR, 1998, J VIROL, V72, P2871, DOI 10.1128/JVI.72.4.2871-2880.1998; Kamphuis T, 2013, INFLUENZA OTHER RESP; Kamphuis T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036812; KULKARNI AB, 1995, J VIROL, V69, P1261, DOI 10.1128/JVI.69.2.1261-1264.1995; Kwon YJ, 2005, J CONTROL RELEASE, V105, P199, DOI 10.1016/j.jconrel.2005.02.027; Makidon PE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002954; Martinez I, 1998, J GEN VIROL, V79, P2215, DOI 10.1099/0022-1317-79-9-2215; McGinnes LW, 2011, J VIROL, V85, P366, DOI 10.1128/JVI.01861-10; Melendi GA, 2011, VIRUS GENES, V42, P46, DOI 10.1007/s11262-010-0545-9; Miyairi I, 2008, CLIN MICROBIOL REV, V21, P686, DOI 10.1128/CMR.00017-08; Mottram PL, 2007, MOL PHARMACEUT, V4, P73, DOI 10.1021/mp060096p; Munoz FM, 2003, VACCINE, V21, P3465, DOI 10.1016/S0264-410X(03)00352-9; Murata Y, 2012, VACCINE, V30, P5382, DOI 10.1016/j.vaccine.2012.06.016; Murawski MR, 2010, J VIROL, V84, P1110, DOI 10.1128/JVI.01709-09; MURPHY BR, 1989, VACCINE, V7, P533, DOI 10.1016/0264-410X(89)90278-8; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nallet S, 2009, VACCINE, V27, P6415, DOI 10.1016/j.vaccine.2009.06.019; Nguyen TN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034331; Nokes JD, 2008, CURR OPIN INFECT DIS, V21, P639, DOI 10.1097/QCO.0b013e3283184245; OLMSTED RA, 1986, P NATL ACAD SCI USA, V83, P7462, DOI 10.1073/pnas.83.19.7462; Olson MR, 2008, EXPERT REV VACCINES, V7, P1239, DOI 10.1586/14760584.7.8.1239; Openshaw PJ, 1995, MOUSE MODELS AM J RE, V152, pS59, DOI [10.1164/ajrccm.152.1.7599863, DOI 10.1164/AJRCCM.152.1.7599863]; Oshansky CM, 2009, FUTURE MICROBIOL, V4, P279, DOI 10.2217/FMB.09.1; PARADISO PR, 1994, PEDIATR INFECT DIS J, V13, P792, DOI 10.1097/00006454-199409000-00008; Plotnicky-Gilquin H, 1999, VIROLOGY, V258, P128, DOI 10.1006/viro.1999.9702; Powell TJ, 2011, VACCINE, V29, P558, DOI 10.1016/j.vaccine.2010.10.001; Power UF, 2008, J CLIN VIROL, V41, P38, DOI 10.1016/j.jcv.2007.10.024; Puthothu B, 2006, DIS MARKERS, V22, P303, DOI 10.1155/2006/865890; Quan FS, 2011, J INFECT DIS, V204, P987, DOI 10.1093/infdis/jir474; Roux X, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001766; Siegrist CA, 1999, J INFECT DIS, V179, P1326, DOI 10.1086/314778; Solbrig CM, 2007, MOL PHARMACEUT, V4, P47, DOI 10.1021/mp060107e; Stegmann T, 2010, VACCINE, V28, P5543, DOI 10.1016/j.vaccine.2010.06.041; Stevens WW, 2007, J IMMUNOL METHODS, V327, P63, DOI 10.1016/j.jim.2007.07.011; TAYLOR G, 1985, J GEN VIROL, V66, P2533, DOI 10.1099/0022-1317-66-12-2533; Tripp RA, 2001, NAT IMMUNOL, V2, P732, DOI 10.1038/90675; Tripp RA, 2004, VIRAL IMMUNOL, V17, P165, DOI 10.1089/0882824041310513; Tripp RA, 2003, J VIROL, V77, P6580, DOI 10.1128/JVI.77.11.6580-6584.2003; Tripp RA, 1999, J VIROL, V73, P7099, DOI 10.1128/JVI.73.9.7099-7107.1999; Tripp Ralph A, 2005, Proc Am Thorac Soc, V2, P147, DOI 10.1513/pats.200502-014AW; TRISTRAM DA, 1993, J INFECT DIS, V167, P191, DOI 10.1093/infdis/167.1.191; Uto T, 2007, J IMMUNOL, V178, P2979, DOI 10.4049/jimmunol.178.5.2979; Varga SM, 2000, J IMMUNOL, V165, P6487, DOI 10.4049/jimmunol.165.11.6487; Varga SM, 2002, VIROLOGY, V295, P203, DOI 10.1006/viro.2002.1382; Varga SM, 2001, IMMUNITY, V15, P637, DOI 10.1016/S1074-7613(01)00209-6; WEIBEL RE, 1966, AM REV RESPIR DIS, V94, P362; Wright PF, 2000, J INFECT DIS, V182, P1331, DOI 10.1086/315859; Yang YW, 2008, BIOMATERIALS, V29, P2516, DOI 10.1016/j.biomaterials.2008.02.015; Zeng RH, 2006, VACCINE, V24, P941, DOI 10.1016/j.vaccine.2005.08.064; Zhang WL, 2010, J VIROL, V84, P1148, DOI 10.1128/JVI.01755-09; Zlateva KT, 2004, J VIROL, V78, P4675, DOI 10.1128/JVI.78.9.4675-4683.2004	84	38	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74905	10.1371/journal.pone.0074905	http://dx.doi.org/10.1371/journal.pone.0074905			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040360	Green Submitted, Green Published, gold			2022-12-25	WOS:000327538600120
J	Southcombe, JH; Ledee, N; d'Hauterive, SP; Turner, K; Child, T; Snider, JV; Redman, CWG; Sargent, IL; Granne, I				Southcombe, Jennifer H.; Ledee, Nathalie; d'Hauterive, Sophie Perrier; Turner, Karen; Child, Tim; Snider, James V.; Redman, Christopher W. G.; Sargent, Ian L.; Granne, Ingrid			Detection of Soluble ST2 in Human Follicular Fluid and Luteinized Granulosa Cells	PLOS ONE			English	Article							INTERLEUKIN-1 SYSTEM; G-CSF; EXPRESSION; RECEPTOR; CYTOKINES; MARKERS; PROTEIN; EMBRYO; GENES; IL-33	Follicular fluid (FF) contains various cytokines that are involved with folliculogenesis, some of which have been shown to be associated with oocyte quality and the implantation potential of a resulting embryo. Several IL-1 family members have previously been identified in FF. This study investigates a newly identified member of the family, IL-33, and its receptor ST2, comparing values to those of FF Granulocyte-Colony Stimulating Factor (G-CSF) - a known predictor of Assisted Reproductive Technology (ART) success. FF was collected from patients undergoing in vitro fertilisation/intra-cytoplasmic sperm injection (IVF/ICSI) at oocyte retrieval to analyse IL-33 and sST2 expression in human follicles. sST2, but not IL-33, is highly increased in the FF compared to plasma levels (up to 7.9-fold), with higher levels in larger follicles (p<0.05). Furthermore, we identify that human luteinised granulosa cells are one possible source of the FF sST2, as these cells express and secrete sST2 when cultured ex vivo. FF associated with oocytes which when fertilised develop into good quality embryos have higher sST2 levels than those which are graded average (p<0.01). These embryos were transferred to the patient and levels of FF sST2 compared between successful and unsuccessful ICSI cycles. However unlike G-CSF, sST2 levels cannot be used to predict cycle outcome.	[Southcombe, Jennifer H.; Turner, Karen; Child, Tim; Redman, Christopher W. G.; Sargent, Ian L.; Granne, Ingrid] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England; [Ledee, Nathalie] Univ Paris Diderot, Paris, France; [Ledee, Nathalie] INSERM, U976, Paris, France; [d'Hauterive, Sophie Perrier] Univ Liege, Liege, Belgium; [d'Hauterive, Sophie Perrier] Univ Liege, Ctr Procreat Medicalement Assistee, Liege, Belgium; [Turner, Karen; Child, Tim; Granne, Ingrid] Univ Oxford, Oxford Fertil Unit, Oxford, England; [Snider, James V.] Crit Diagnost, San Diego, CA USA	University of Oxford; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Liege; University of Liege; University of Oxford	Southcombe, JH (corresponding author), Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England.	jen.southcombe@obs-gyn.ox.ac.uk	LEDEE, nathalie/AAE-8303-2019	Southcombe, Jennifer/0000-0003-0699-650X; Granne, Ingrid/0000-0002-7056-5723; LEDEE, nathalie/0000-0002-3166-2643	Wellbeing of Women [RG1326]; Oxfordshire Health Services Research Committee (OSHRC) [1085, 8234]; Agence de la Biomedecine and Uteron SA; National Institute for Health Research [CL-2011-13-003] Funding Source: researchfish	Wellbeing of Women(Wellbeing of Women (WoW)); Oxfordshire Health Services Research Committee (OSHRC); Agence de la Biomedecine and Uteron SA; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the Wellbeing of Women (grant number RG1326), the Oxfordshire Health Services Research Committee (OSHRC 1085, charitable fund number 8234) and the Agence de la Biomedecine and Uteron SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; BRANNSTROM M, 1993, HUM REPROD, V8, P1762; de los Santos MJ, 1998, BIOL REPROD, V59, P1419; Gerard N, 2004, J ENDOCRINOL, V180, P203, DOI 10.1677/joe.0.1800203; GERY I, 1972, J EXP MED, V136, P143, DOI 10.1084/jem.136.1.143; Gillibert-Duplantier J, 2012, ONCOGENE, V31, P3516, DOI 10.1038/onc.2011.525; Granne I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024463; Gutman G, 2004, AM J REPROD IMMUNOL, V51, P381, DOI 10.1111/j.1600-0897.2004.00172.x; Haraldsen G, 2009, TRENDS IMMUNOL, V30, P227, DOI 10.1016/j.it.2009.03.003; HURWITZ A, 1992, J CLIN INVEST, V89, P1746, DOI 10.1172/JCI115777; KHAN SA, 1988, MOL CELL ENDOCRINOL, V58, P221, DOI 10.1016/0303-7207(88)90158-X; Ledee N, 2008, HUM REPROD, V23, P2001, DOI 10.1093/humrep/den192; Ledee N, 2013, HUM REPROD, V28, P406, DOI 10.1093/humrep/des354; Ledee N, 2011, FERTIL STERIL, V95, P94, DOI 10.1016/j.fertnstert.2010.03.010; Ledee N, 2010, J REPROD IMMUNOL, V86, P126, DOI 10.1016/j.jri.2010.05.003; MARCH CJ, 1985, NATURE, V315, P641, DOI 10.1038/315641a0; Mendoza C, 2002, HUM REPROD, V17, P1017, DOI 10.1093/humrep/17.4.1017; Revelli A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-40; Salker MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052252; Salmassi A, 2004, FERTIL STERIL, V81, P786, DOI 10.1016/j.fertnstert.2003.09.039; Sarapik A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/606459; Sattler S, 2013, ARCH IMMUNOL THER EX, V61, P107, DOI 10.1007/s00005-012-0208-8; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Takezako N, 2006, BIOCHEM BIOPH RES CO, V341, P425, DOI 10.1016/j.bbrc.2005.12.206; TOMINAGA S, 1989, FEBS LETT, V258, P301, DOI 10.1016/0014-5793(89)81679-5; Topping V, 2013, J MATERN-FETAL NEO M, V26, P327, DOI 10.3109/14767058.2012.735724; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787; Yoo SW, 2011, REPROD SCI, V18, P476, DOI 10.1177/1933719110388848	29	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74385	10.1371/journal.pone.0074385	http://dx.doi.org/10.1371/journal.pone.0074385			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040238	Green Submitted, Green Published, gold			2022-12-25	WOS:000327538600092
J	Zervou, MI; Myrthianou, E; Flouri, I; Plant, D; Chlouverakis, G; Castro-Giner, F; Rapsomaniki, P; Barton, A; Boumpas, DT; Sidiropoulos, P; Goulielmos, GN				Zervou, Maria I.; Myrthianou, Efsevia; Flouri, Irene; Plant, Darren; Chlouverakis, Gregory; Castro-Giner, Francesc; Rapsomaniki, Panayiota; Barton, Anne; Boumpas, Dimitrios T.; Sidiropoulos, Prodromos; Goulielmos, George N.			Lack of Association of Variants Previously Associated with Anti-TNF Medication Response in Rheumatoid Arthritis Patients: Results from a Homogeneous Greek Population	PLOS ONE			English	Article							STAT4 GENE POLYMORPHISM; SUSCEPTIBILITY GENES; RISK; METHOTREXATE; CRITERIA; THERAPY; DISEASE; FAMILY; LOCUS; CRETE	Treatment strategies blocking tumor necrosis factor (anti-TNF) have proven very successful in patients with rheumatoid arthritis (RA), showing beneficial effects in approximately 50-60% of the patients. However, a significant subset of patients does not respond to anti-TNF agents, for reasons that are still unknown. The aim of this study was to validate five single nucleotide polymorphisms (SNPs) of PTPRC, CD226, AFF3, MyD88 and CHUK gene loci that have previously been reported to predict anti-TNF outcome. In addition, two markers of RA susceptibility, namely TRAF1/C5 and STAT4 were assessed, in a cohort of anti-TNF-treated RA patients, from the homogeneous Greek island of Crete, Greece. The RA patient cohort consisted of 183 patients treated with either of 3 anti-TNF biologic agents (infliximab, adalimumab and etanercept) from the Clinic of Rheumatology of the University Hospital of Crete. The SNPs were genotyped by TaqMan assays or following the Restriction Fragments Length Polymorphisms (RFLPs) approach. Disease activity score in 28 joints (DAS28) at baseline and after 6 months were available for all patients and analysis of good versus poor response at 6 months was performed for each SNP. None of the 7 genetic markers correlated with treatment response. We conclude that the gene polymorphisms under investigation are not strongly predictive of anti-TNF response in RA patients from Greece.	[Zervou, Maria I.; Myrthianou, Efsevia; Goulielmos, George N.] Med Sch Crete, Lab Mol Med & Human Genet, Iraklion, Crete, Greece; [Flouri, Irene; Rapsomaniki, Panayiota; Sidiropoulos, Prodromos] Med Sch Crete, Dept Rheumatol Clin Immunol & Allergy, Iraklion, Greece; [Plant, Darren; Barton, Anne] Manchester Acad Hlth Sci, NIHR Manchester Musculoskeletal Biomed Res Unit, Manchester, Lancs, England; [Chlouverakis, Gregory] Univ Crete, Dept Social Med, Iraklion, Greece; [Castro-Giner, Francesc] Univ Oxford, Wellcome Trust Ctr Human Genet, Mol & Populat Genet Lab, Oxford, England; [Barton, Anne] Univ Manchester, Arthrit Res UK Epidemiol Unit, Manchester, Lancs, England; [Boumpas, Dimitrios T.] Univ Athens, Sch Med, Athens 11528, Greece; [Boumpas, Dimitrios T.] Acad Athens, Biomed Res Fdn, Athens, Greece; [Boumpas, Dimitrios T.] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Greece	University of Crete; University of Crete; University of Manchester; University of Crete; University of Oxford; Wellcome Centre for Human Genetics; University of Manchester; Athens Medical School; National & Kapodistrian University of Athens; Academy of Athens; Foundation for Research & Technology - Hellas (FORTH)	Goulielmos, GN (corresponding author), Med Sch Crete, Lab Mol Med & Human Genet, Iraklion, Crete, Greece.	goulielmos@med.uoc.gr	Castro-Giner, Francesc/D-7992-2014; Barton, Anne/N-2053-2014	Castro-Giner, Francesc/0000-0001-6111-0754; Barton, Anne/0000-0003-3316-2527	IMI [BeTheCure115142-2]; ROCHE; ELKE of the University of Crete [KA 3763]	IMI; ROCHE(Roche Holding); ELKE of the University of Crete	This study was supported in part by the IMI-funded project BeTheCure115142-2, an unrestricted grant from ROCHE and a short-term travelling grant from ELKE of the University of Crete (KA 3763). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolakis S, 2005, J CLIN VIROL, V34, P310, DOI 10.1016/j.jcv.2005.01.010; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barton A, 2009, HUM MOL GENET, V18, P2518, DOI 10.1093/hmg/ddp177; Bodin L, 2005, BLOOD, V106, P135, DOI 10.1182/blood-2005-01-0341; Canhao H, 2012, J TRANSL MED S3, V10, P31, DOI [10.1186/1479-5876-10-S2-A31, DOI 10.1186/1479-5876-10-S2-A31.PUBMED:22369209]; Criswell LA, 2004, ARTHRITIS RHEUM-US, V50, P2750, DOI 10.1002/art.20469; Cui J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003394; Cui J, 2010, ARTHRITIS RHEUM-US, V62, P1849, DOI 10.1002/art.27457; Feldmann M, 2004, BEST PRACT RES CL RH, V18, P59, DOI 10.1016/j.berh.2003.09.010; Hafler JP, 2009, GENES IMMUN, V10, P5, DOI 10.1038/gene.2008.82; Kurreeman FAS, 2007, PLOS MED, V4, P1515, DOI 10.1371/journal.pmed.0040278; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Mantaka A, 2012, HUM IMMUNOL, V73, P829, DOI 10.1016/j.humimm.2012.05.003; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; NICE, RHEUM ARTHR DRUGS TR; Patrinos GP, 1998, HUM GENET, V102, P629, DOI 10.1007/s004390050753; Plant D, 2012, ARTHRITIS RHEUM-US, V64, P665, DOI 10.1002/art.33381; Plant D, 2011, ARTHRITIS RHEUM-US, V63, P645, DOI 10.1002/art.30130; Plant D, 2010, ANN RHEUM DIS, V69, P1548, DOI 10.1136/ard.2009.121020; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Potter C, 2009, ANN RHEUM DIS, V68, P69, DOI 10.1136/ard.2007.084715; Prajapati R, 2011, PHARMACOGENOMICS, V12, P1571, DOI [10.2217/PGS.11.114, 10.2217/pgs.11.114]; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Spanaki C, 2004, NEUROLOGY, V62, P815, DOI 10.1212/01.WNL.0000113720.71387.88; Tan RJL, 2010, ANN RHEUM DIS, V69, P1029, DOI 10.1136/ard.2009.118406; Trusheim MR, 2011, NAT REV DRUG DISCOV, V10, P817, DOI 10.1038/nrd3557; Tsitsikov EN, 2001, IMMUNITY, V15, P647, DOI 10.1016/S1074-7613(01)00207-2; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Wajant H, 2001, CELL SIGNAL, V13, P389, DOI 10.1016/S0898-6568(01)00160-7; Zervou MI, 2008, HUM IMMUNOL, V69, P567, DOI 10.1016/j.humimm.2008.06.006; Zervou MI, 2009, HUM IMMUNOL, V70, P738, DOI 10.1016/j.humimm.2009.05.008	31	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74375	10.1371/journal.pone.0074375	http://dx.doi.org/10.1371/journal.pone.0074375			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040234	Green Published, Green Submitted, gold			2022-12-25	WOS:000327538600091
J	Asano, K; Yoshimura, S; Nakane, A				Asano, Krisana; Yoshimura, Sayuri; Nakane, Akio			Alteration of Intestinal Microbiota in Mice Orally Administered with Salmon Cartilage Proteoglycan, a Prophylactic Agent	PLOS ONE			English	Article							HUMAN GUT MICROBIOTA; SP-NOV.; GEN. NOV.; AUTOIMMUNE ENCEPHALOMYELITIS; CLOSTRIDIUM-HATHEWAYI; EMENDED DESCRIPTION; BACTERIUM; COLITIS; RESPONSES; MEMBER	Proteoglycan (PG) extracted from salmon nasal cartilage has potential to be a prophylactic agent. Daily oral administration of the PG attenuates systemic inflammatory response in the experimental mouse models. In this study, we applied the culture-independent approach to investigate an alteration of intestinal microbiota composition in PG-administered mice. The results indicated that the population level of bacilli increased in the small and large intestine upon PG administration. On the other hand, the population level of clostridia decreased in the large intestine. The proportion of bacteria that are able to ferment saccharides and produce short-chain fatty acids increased in the small intestine and decreased in the large intestine. Importantly, population level of probiotic lactobacilli and bacteria exhibiting the immunomodulatory effect increased in the PG-administered mice. In addition, several disease-associated bacteria decreased upon PG administration. These results provided an understanding of the specific role of PG involved in host immune modulation and supported our hypothesis that daily oral administration of PG improves the overall balance in composition of the intestinal microbial community.	[Asano, Krisana; Yoshimura, Sayuri; Nakane, Akio] Hirosaki Univ, Dept Microbiol & Immunol, Grad Sch Med, Hirosaki, Aomori, Japan	Hirosaki University	Nakane, A (corresponding author), Hirosaki Univ, Dept Microbiol & Immunol, Grad Sch Med, Hirosaki, Aomori, Japan.	a27k03n0@cc.hirosaki-u.ac.jp		, Akio/0000-0002-9583-8919	City Area Program for Promotion of Science and Technology in Regional Areas from Ministry of Education, Culture, Sports, Science and Technology [2010110001]	City Area Program for Promotion of Science and Technology in Regional Areas from Ministry of Education, Culture, Sports, Science and Technology	This study was supported by the City Area Program for Promotion of Science and Technology in Regional Areas from Ministry of Education, Culture, Sports, Science and Technology (Grant number 2010110001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; ASTHER M, 1984, BIOTECHNOL BIOENG, V26, P970, DOI 10.1002/bit.260260822; Atarashi K, 2011, CURR OPIN IMMUNOL, V23, P761, DOI 10.1016/j.coi.2011.11.002; Bandara M, 2010, IMMUNOL CELL BIOL, V88, P727, DOI 10.1038/icb.2010.26; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Berry D, 2013, BEST PRACT RES CL GA, V27, P47, DOI 10.1016/j.bpg.2013.03.005; Clavel T, 2010, INT J SYST EVOL MICR, V60, P1527, DOI 10.1099/ijs.0.015016-0; Danen EHJ, 2001, J CELL PHYSIOL, V189, P1, DOI 10.1002/jcp.1137; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]; Eeckhaut V, 2011, MICROB BIOTECHNOL, V4, P503, DOI 10.1111/j.1751-7915.2010.00244.x; Galvez J, 2005, MOL NUTR FOOD RES, V49, P601, DOI 10.1002/mnfr.200500013; Hardham JM, 2008, INT J SYST EVOL MICR, V58, P103, DOI 10.1099/ijs.0.63458-0; Hayashi H, 2002, MICROBIOL IMMUNOL, V46, P535, DOI 10.1111/j.1348-0421.2002.tb02731.x; Hufeldt MR, 2010, COMPARATIVE MED, V60, P336; Jena PK, 2013, MICROBIOL IMMUNOL, V57, P407, DOI 10.1111/1348-0421.12054; Karimi K, 2009, AM J RESP CRIT CARE, V179, P186, DOI 10.1164/rccm.200806-951OC; Kverka M, 2011, CLIN EXP IMMUNOL, V163, P250, DOI 10.1111/j.1365-2249.2010.04286.x; Lara-Villoslada F, 2006, EUR J NUTR, V45, P418, DOI 10.1007/s00394-006-0610-2; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Li F, 2009, J NUTR, V139, P1685, DOI 10.3945/jn.109.108191; Linscott AJ, 2005, ANAEROBE, V11, P97, DOI 10.1016/j.anaerobe.2004.10.002; Martinez I, 2013, ISME J, V7, P269, DOI 10.1038/ismej.2012.104; Maruo T, 2008, INT J SYST EVOL MICR, V58, P1221, DOI 10.1099/ijs.0.65404-0; Matthies C, 2000, INT J SYST EVOL MICR, V50, P1591, DOI 10.1099/00207713-50-4-1591; Mitsui T, 2010, BIOCHEM BIOPH RES CO, V402, P209, DOI 10.1016/j.bbrc.2010.09.123; Nagai F, 2009, INT J SYST EVOL MICR, V59, P1793, DOI 10.1099/ijs.0.002519-0; O'Hara AM, 2007, THESCIENTIFICWORLDJO, V7, P31, DOI 10.1100/tsw.2007.26; Pequegnat B, 2013, VACCINE, V31, P2787, DOI 10.1016/j.vaccine.2013.04.018; Pridmore RD, 2004, P NATL ACAD SCI USA, V101, P2512, DOI 10.1073/pnas.0307327101; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1111/j.1574-6968.2002.tb11467.x; ROGERS GM, 1991, INT J SYST BACTERIOL, V41, P140, DOI 10.1099/00207713-41-1-140; Sashinami H, 2006, BIOCHEM BIOPH RES CO, V351, P1005, DOI 10.1016/j.bbrc.2006.10.146; Sashinami H, 2012, LIFE SCI, V91, P1263, DOI 10.1016/j.lfs.2012.09.022; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; STEWART CS, 1990, FEMS MICROBIOL LETT, V72, P47, DOI 10.1016/0378-1097(90)90342-N; Szliszka E, 2011, ONCOL REP, V26, P533, DOI 10.3892/or.2011.1332; Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; WERNER H, 1975, ZBL BAKT-INT J MED M, V231, P133; WILKINS TD, 1974, INT J SYST BACTERIOL, V24, P408, DOI 10.1099/00207713-24-4-408; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Woo PCY, 2010, J CLIN MICROBIOL, V48, P319, DOI 10.1128/JCM.01459-09; Woo PCY, 2004, J CLIN MICROBIOL, V42, P5947, DOI 10.1128/JCM.42.12.5947-5949.2004; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Wurdemann D, 2009, INT J SYST EVOL MICR, V59, P1405, DOI 10.1099/ijs.0.005900-0; Ye JX, 2008, INFLAMM BOWEL DIS, V14, P1041, DOI 10.1002/ibd.20442	49	20	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e75008	10.1371/journal.pone.0075008	http://dx.doi.org/10.1371/journal.pone.0075008			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040376	gold, Green Published, Green Submitted			2022-12-25	WOS:000326405300196
J	Ferri, M; Del Monte, SR; Salerno, G; Bocchetti, T; Angeletti, S; Malisan, F; Cardelli, P; Ziparo, V; Torrisi, MR; Visco, V				Ferri, Mario; Del Monte, Simone Rossi; Salerno, Gerardo; Bocchetti, Tommaso; Angeletti, Stefano; Malisan, Florence; Cardelli, Patrizia; Ziparo, Vincenzo; Torrisi, Maria Rosaria; Visco, Vincenzo			Recovery of Immunological Homeostasis Positively Correlates Both with Early Stages of Right-Colorectal Cancer and Laparoscopic Surgery	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; SERUM INTERLEUKIN-6 LEVELS; OPEN RIGHT COLECTOMY; C-REACTIVE PROTEIN; COLON-CANCER; INFLAMMATORY RESPONSE; IMMUNE-RESPONSE; CLINICAL-TRIAL; RESECTION; SURVIVAL	Differences in postoperative outcome and recovery between patients subjected to laparoscopic-assisted versus open surgery for colorectal cancer (CRC) resection have been widely documented, though not specifically for right-sided tumors. We investigated the immunological responses to the different surgical approaches, by comparing postoperative data simultaneously obtained at systemic, local and cellular levels. A total of 25 right-sided CRC patients and controls were managed, assessing -in the immediate followup-the conventional perioperative parameters and a large panel of cytokines on plasma, peritoneal fluids and lipopolysaccharide (LPS)-stimulated peripheral blood mononuclear cells (PBMC) tissue cultures. A general better recovery for patients operated with laparoscopy compared to conventional procedure, as indicated by the analysis of typical pre- and post-surgical parameters, was observed. The synchronous evaluation of 12 cytokines showed that preoperative plasma levels of the proinflammatory cytokines IL-6, IL-8, IL-1 beta, TNF alpha were significantly lower in healthy donors versus CRC patients and that such differences progressively increase with tumor stage. After surgery, the IL-6 and IL-8 increases were significantly higher in open compared to laparoscopic approach only in CRC at early stages. The postsurgical whole panel of cytokine levels were significantly higher in peritoneal fluids compared to corresponding plasma, but with no significant differences depending on kind of surgery or stage of disease. Then we observed that, pre-compared to the corresponding post-surgery derived LPS-stimulated PBMC cultures, produced higher supernatant levels of the whole cytokine panel. In particular IL-6 in vitro production was significantly higher in PBMC derived from patients subjected to laparoscopic versus open intervention, but -again- only in CRC at early stages of disease. Our results thus show that laparoscopy compared to open right resection is associated with a shorter compromission of the immunological homeostasis, mainly in early stages of right-CRC patients.	[Ferri, Mario; Del Monte, Simone Rossi; Bocchetti, Tommaso; Angeletti, Stefano; Ziparo, Vincenzo] Univ Roma La Sapienza, Fac Med & Psychol, Surg & Med Dept Clin Sci Biomed Technol & Transla, I-00185 Rome, Italy; [Salerno, Gerardo; Cardelli, Patrizia; Torrisi, Maria Rosaria; Visco, Vincenzo] Univ Roma La Sapienza, Fac Med & Psychol, Dept Clin & Mol Med, Ist Pasteur,Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Ferri, Mario; Del Monte, Simone Rossi; Salerno, Gerardo; Bocchetti, Tommaso; Angeletti, Stefano; Cardelli, Patrizia; Ziparo, Vincenzo; Torrisi, Maria Rosaria; Visco, Vincenzo] St Andrea Hosp, Rome, Italy; [Malisan, Florence] Univ Roma Tor Vergata, Lab Immunol & Signal Transduct, Rome, Italy	Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; University of Rome Tor Vergata	Visco, V (corresponding author), Univ Roma La Sapienza, Fac Med & Psychol, Dept Clin & Mol Med, Ist Pasteur,Fdn Cenci Bolognetti, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	vincenzo.visco1@uniroma1.it		MALISAN, FLORENCE/0000-0002-0213-9407; Salerno, Gerardo/0000-0002-6597-1452	Associazione Italiana per la Ricerca sul Cancro, Italy [IG 10272]; Minstero dell'Instruzione, dell'Universita e della Ricerca	Associazione Italiana per la Ricerca sul Cancro, Italy(Fondazione AIRC per la ricerca sul cancro); Minstero dell'Instruzione, dell'Universita e della Ricerca	This work was partially supported by grants from the Minstero dell'Instruzione, dell'Universita e della Ricerca and from Associazione Italiana per la Ricerca sul Cancro (IG 10272), Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Belluco C, 2000, ANN SURG ONCOL, V7, P133, DOI 10.1007/s10434-000-0133-7; Bolla G, 2003, SURG ENDOSC, V17, P1247, DOI 10.1007/s00464-002-9135-9; Braga M, 2007, ANN SURG, V246, P1010, DOI 10.1097/SLA.0b013e31815c4065; Brozek W, 2005, EUR J CANCER, V41, P2347, DOI 10.1016/j.ejca.2005.07.014; Bunger S, 2011, J BIOMOL SCREEN, V16, P1018, DOI 10.1177/1087057111414894; Carter J J, 2001, Surg Oncol Clin N Am, V10, P655; Chen LM, 2011, ATL AMB PERVAS INTEL, V4, P1, DOI 10.1097/COC.0b013e3181fe41ed; Chung CC, 2007, ANN SURG, V246, P728, DOI 10.1097/SLA.0b013e318123fbdf; Chung YC, 2003, J SURG ONCOL, V83, P222, DOI 10.1002/jso.10269; Delgado S, 2001, DIS COLON RECTUM, V44, P638, DOI 10.1007/BF02234558; Dunker MS, 2003, DIS COLON RECTUM, V46, P1238, DOI 10.1007/s10350-004-6721-z; Evans C, 2009, AM J SURG, V197, P238, DOI 10.1016/j.amjsurg.2008.01.021; Flach R, 1999, CYTOKINE, V11, P173, DOI 10.1006/cyto.1998.0412; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Galizia G, 2002, CLIN IMMUNOL, V102, P169, DOI 10.1006/clim.2001.5163; Han SA, 2010, INT J COLORECTAL DIS, V25, P631, DOI 10.1007/s00384-010-0882-0; Hasegawa H, 2003, SURG ENDOSC, V17, P636, DOI 10.1007/s00464-002-8516-4; Hegarty N, 2008, CURR OPIN UROL, V18, P129, DOI 10.1097/MOU.0b013e3282f517fc; Heikkila K, 2007, CANCER EPIDEM BIOMAR, V16, P1155, DOI 10.1158/1055-9965.EPI-07-0093; Hemminki K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-688; Hildebrandt U, 2003, SURG ENDOSC, V17, P242, DOI 10.1007/s00464-001-9148-9; Jung IK, 2008, J SURG ONCOL, V98, P54, DOI 10.1002/jso.21075; Kaminska Janina, 2000, Pathology Oncology and Research, V6, P38; Klampfer L, 2011, CURR CANCER DRUG TAR, V11, P451, DOI 10.2174/156800911795538066; Knupfer H, 2010, INT J COLORECTAL DIS, V25, P135, DOI 10.1007/s00384-009-0818-8; Kuhry E, 2008, CANCER TREAT REV, V34, P498, DOI 10.1016/j.ctrv.2008.03.011; Lacy AM, 2002, LANCET, V359, P2224, DOI 10.1016/S0140-6736(02)09290-5; Lacy AM, 2008, ANN SURG, V248, P1, DOI 10.1097/SLA.0b013e31816a9d65; Lee SW, 2003, SURG ENDOSC, V17, P1996, DOI 10.1007/s00464-003-8154-5; Leung KL, 2003, SURG ENDOSC, V17, P1305, DOI 10.1007/s00464-002-9172-4; Liu CY, 2011, INT J COLORECTAL DIS, V26, P1375, DOI 10.1007/s00384-011-1281-x; Meguid RA, 2008, ANN SURG ONCOL, V15, P2388, DOI 10.1245/s10434-008-0015-y; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; Nelson H, 2004, NEW ENGL J MED, V350, P2050; Nikiteas NI, 2005, WORLD J GASTROENTERO, V11, P1639; Oppenheim J.J., 2001, CYTOKINE REFERENCE C; Ordemann J, 2001, SURG ENDOSC, V15, P600, DOI 10.1007/s004640090032; Pandolfi F, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/894704; Pascual M, 2011, BRIT J SURG, V98, P50, DOI 10.1002/bjs.7258; Sammour T, 2010, J SURG RES, V164, P28, DOI 10.1016/j.jss.2010.05.046; Schnuriger B, 2011, AM J SURG, V201, P111, DOI 10.1016/j.amjsurg.2010.02.008; Schwenk W, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003145.pub2; Seruga B, 2008, NAT REV CANCER, V8, P887, DOI 10.1038/nrc2507; Stage JG, 1997, BRIT J SURG, V84, P391, DOI 10.1046/j.1365-2168.1997.02516.x; Tanis E, 2012, INT J COLORECTAL DIS, V27, P797, DOI 10.1007/s00384-011-1404-4; Veenhof AA, 2010, COLORECTAL DIS; Wang Chia-Siu, 2009, Chang Gung Med J, V32, P471; Weiss JM, 2011, J CLIN ONCOL, V29, P4401, DOI 10.1200/JCO.2011.36.4414; Whelan RL, 2003, SURG ENDOSC, V17, P972, DOI 10.1007/s00464-001-8263-y; Wichmann MW, 2005, ARCH SURG-CHICAGO, V140, P692, DOI 10.1001/archsurg.140.7.692; Wu FPK, 2003, DIS COLON RECTUM, V46, P147, DOI 10.1007/s10350-004-6516-2	51	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74455	10.1371/journal.pone.0074455	http://dx.doi.org/10.1371/journal.pone.0074455			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040252	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300173
J	Gisser, JM; Cohen, AR; Yin, H; Gariepy, CE				Gisser, Jonathan M.; Cohen, Ariella R.; Yin, Han; Gariepy, Cheryl E.			A Novel Bidirectional Interaction between endothelin-3 and Retinoic Acid in Rat Enteric Nervous System Precursors	PLOS ONE			English	Article							CREST-DERIVED CELLS; IN-VITRO; HIRSCHSPRUNG-DISEASE; STEM-CELLS; MOUSE MODEL; B RECEPTOR; RESPONSE ELEMENT; TRANSCRIPTIONAL REGULATION; DIFFERENTIAL EXPRESSION; RET PROTOONCOGENE	Background: Signaling through the endothelin receptor B (EDNRB) is critical for the development of the enteric nervous system (ENS) and mutations in endothelin system genes cause Hirschsprung's aganglionosis in humans. Penetrance of the disease is modulated by other genetic factors. Mutations affecting retinoic acid (RA) signaling also produce aganglionosis in mice. Thus, we hypothesized that RA and endothelin signaling pathways may interact in controlling development of the ENS. Methods: Rat immunoselected ENS precursor cells were cultured with the EDNRB ligand endothelin-3, an EDNRB-selective antagonist (BQ-788), and/or RA for 3 or 14 days. mRNA levels of genes related to ENS development, RA- and EDNRB-signaling were measured at 3 days. Proliferating cells and cells expressing neuronal, glial, and myofibroblast markers were quantified. Results: Culture of isolated ENS precursors for 3 days with RA decreases expression of the endothelin-3 gene and that of its activation enzyme. These changes are associated with glial proliferation, a higher percentage of glia, and a lower percentage of neurons compared to cultures without RA. These changes are independent of EDNRB signaling. Conversely, EDNRB activation in these cultures decreases expression of RA receptors beta and gamma mRNA and affects the expression of the RA synthetic and degradative enzymes. These gene expression changes are associated with reduced glial proliferation and a lower percentage of glia in the culture. Over 14 days in the absence of EDNRB signaling, RA induces the formation of a heterocellular plexus replete with ganglia, glia and myofibroblasts. Conclusions: A complex endothelin-RA interaction exists that coordinately regulates the development of rat ENS precursors in vitro. These results suggest that environmental RA may modulate the expression of aganglionosis in individuals with endothelin mutations.	[Gisser, Jonathan M.; Cohen, Ariella R.; Gariepy, Cheryl E.] Nationwide Childrens Hosp, Res Inst, Ctr Mol & Human Genet, Columbus, OH USA; [Gisser, Jonathan M.; Gariepy, Cheryl E.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Yin, Han] Nationwide Childrens Hosp, Columbus, OH USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital	Gisser, JM (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Mol & Human Genet, Columbus, OH USA.	jonathan.gisser@nationwidechildrens.org	Gariepy, Cheryl/C-6141-2012; Gariepy, Cheryl/AAQ-3441-2021					Abu-Abed S, 2002, MECH DEVELOP, V110, P173, DOI 10.1016/S0925-4773(01)00572-X; Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Anderson RB, 2006, CELL TISSUE RES, V323, P11, DOI 10.1007/s00441-005-0047-6; Angrisano T, 2011, NUCLEIC ACIDS RES, V39, P1993, DOI 10.1093/nar/gkq864; Bachetti T, 2005, GENE EXPRESSION, V12, P137, DOI 10.3727/000000005783992106; Baldassarre G, 2000, CELL GROWTH DIFFER, V11, P517; Barlow A, 2003, NEURON, V40, P905, DOI 10.1016/S0896-6273(03)00730-X; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; Bixby S, 2002, NEURON, V35, P643, DOI 10.1016/S0896-6273(02)00825-5; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Bondurand N, 2006, DEVELOPMENT, V133, P2075, DOI 10.1242/dev.02375; Brennan A, 2000, DEV BIOL, V227, P545, DOI 10.1006/dbio.2000.9887; Cantrell VA, 2004, HUM MOL GENET, V13, P2289, DOI 10.1093/hmg/ddh243; Carrasquillo MM, 2002, NAT GENET, V32, P237, DOI 10.1038/ng998; Chalazonitis A, 1998, DEV BIOL, V204, P385, DOI 10.1006/dbio.1998.9090; Chalazonitis A, 2011, DEV BIOL, V350, P64, DOI 10.1016/j.ydbio.2010.11.017; Chi XD, 2003, BRIT J PHARMACOL, V139, P765, DOI 10.1038/sj.bjp.0705303; CHOMIENNE C, 1991, J CLIN INVEST, V88, P2150, DOI 10.1172/JCI115547; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; DETHE H, 1989, EMBO J, V8, P429, DOI 10.1002/j.1460-2075.1989.tb03394.x; Dobbs-McAuliffe B, 2004, MECH DEVELOP, V121, P339, DOI 10.1016/j.mod.2004.02.008; Druckenbrod NR, 2007, DEV DYNAM, V236, P84, DOI 10.1002/dvdy.20974; Elmi M, 2007, MOL CELL NEUROSCI, V36, P248, DOI 10.1016/j.mcn.2007.07.001; Faure C, 2007, DEV DYNAM, V236, P44, DOI 10.1002/dvdy.20943; Fu M, 2010, DEVELOPMENT, V137, P631, DOI 10.1242/dev.040550; Gariepy CE, 1996, P NATL ACAD SCI USA, V93, P867, DOI 10.1073/pnas.93.2.867; Gariepy CE, 1998, J CLIN INVEST, V102, P1092, DOI 10.1172/JCI3702; Gershon MD, 2011, J CLIN INVEST, V121, P3386, DOI 10.1172/JCI59573; Grummer MA, 2000, NEUROSCI LETT, V294, P73, DOI 10.1016/S0304-3940(00)01538-X; Hackett-Jones EJ, 2011, J THEOR BIOL, V287, P148, DOI 10.1016/j.jtbi.2011.07.013; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; Hearn CJ, 1998, DEV BIOL, V197, P93, DOI 10.1006/dbio.1998.8876; Heuckeroth RO, 1998, DEV BIOL, V200, P116, DOI 10.1006/dbio.1998.8955; Hotta R, 2013, J CLIN INVEST, V123, P1182, DOI 10.1172/JCI65963; Hsu JY, 1998, CANCER RES, V58, P4817; Hu P, 2008, DEV DYNAM, V237, P3798, DOI 10.1002/dvdy.21801; Idres N, 2005, BIOCHEM PHARMACOL, V69, P1595, DOI 10.1016/j.bcp.2005.02.024; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; Joseph NM, 2011, J CLIN INVEST, V121, P3398, DOI 10.1172/JCI58186; KAMEI Y, 1993, BIOCHEM J, V293, P807, DOI 10.1042/bj2930807; KAPUR RP, 1995, DEVELOPMENT, V121, P3787; Kawaguchi J, 2010, DEVELOPMENT, V137, P693, DOI 10.1242/dev.046896; Kenny SE, 2010, SEMIN PEDIATR SURG, V19, P194, DOI 10.1053/j.sempedsurg.2010.03.004; Kruger GM, 2003, NEURON, V40, P917, DOI 10.1016/S0896-6273(03)00727-X; Kumar M, 2007, STEM CELLS DEV, V16, P667, DOI 10.1089/scd.2006.0115; Lahav R, 1998, P NATL ACAD SCI USA, V95, P14214, DOI 10.1073/pnas.95.24.14214; Landman KA, 2011, J THEOR BIOL, V276, P250, DOI 10.1016/j.jtbi.2011.01.043; Lantieri F, 2006, ANN MED, V38, P11, DOI 10.1080/07853890500442758; Laranjeira C, 2011, J CLIN INVEST, V121, P3412, DOI 10.1172/JCI58200; Lee HO, 2003, DEV BIOL, V259, P162, DOI 10.1016/S0012-1606(03)00160-X; LEHMANN JM, 1992, MOL CELL BIOL, V12, P2976, DOI 10.1128/MCB.12.7.2976; Lehrke I, 2002, AM J PHYSIOL-RENAL, V282, pF741, DOI 10.1152/ajprenal.00026.2001; Leibl MA, 1999, GUT, V44, P246, DOI 10.1136/gut.44.2.246; Leon TYY, 2009, J PEDIATR SURG, V44, P1904, DOI 10.1016/j.jpedsurg.2008.11.055; LEROY P, 1991, EMBO J, V10, P59, DOI 10.1002/j.1460-2075.1991.tb07921.x; LEROY P, 1991, P NATL ACAD SCI USA, V88, P10138, DOI 10.1073/pnas.88.22.10138; Marill J, 2003, CURR DRUG METAB, V4, P1, DOI 10.2174/1389200033336900; McCallion AS, 2003, P NATL ACAD SCI USA, V100, P1826, DOI 10.1073/pnas.0337540100; Mollaaghababa R, 2003, ONCOGENE, V22, P3024, DOI 10.1038/sj.onc.1206442; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Nagy N, 2006, DEV BIOL, V293, P203, DOI 10.1016/j.ydbio.2006.01.032; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Nataf V, 1996, P NATL ACAD SCI USA, V93, P9645, DOI 10.1073/pnas.93.18.9645; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Niederreither K, 2003, DEVELOPMENT, V130, P2525, DOI 10.1242/dev.00463; Paratore C, 2002, HUM MOL GENET, V11, P3075, DOI 10.1093/hmg/11.24.3075; Paratore C, 2001, DEVELOPMENT, V128, P3949; Patrone G, 1997, FEBS LETT, V419, P76, DOI 10.1016/S0014-5793(97)01435-X; Pitera JE, 2001, AM J PATHOL, V159, P2321, DOI 10.1016/S0002-9440(10)63082-9; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; RIAZULHAQ, 1991, P NATL ACAD SCI USA, V88, P8272, DOI 10.1073/pnas.88.18.8272; Ross AC, 2001, CURR OPIN GASTROEN, V17, P184, DOI 10.1097/00001574-200103000-00015; Sasselli V, 2012, DEV BIOL, V366, P64, DOI 10.1016/j.ydbio.2012.01.012; Sato Y, 2008, DEV BIOL, V320, P185, DOI 10.1016/j.ydbio.2008.05.524; SCHEIBE RJ, 1991, J CELL BIOL, V113, P1173, DOI 10.1083/jcb.113.5.1173; Shoba T, 2002, NEUROSCI LETT, V318, P129, DOI 10.1016/S0304-3940(01)02491-0; Simpson MJ, 2007, DEV BIOL, V302, P553, DOI 10.1016/j.ydbio.2006.10.017; Simpson MJ, 2006, J THEOR BIOL, V243, P343, DOI 10.1016/j.jtbi.2006.06.021; Stanchina L, 2006, DEV BIOL, V295, P232, DOI 10.1016/j.ydbio.2006.03.031; SUCOV HM, 1990, P NATL ACAD SCI USA, V87, P5392, DOI 10.1073/pnas.87.14.5392; Thatcher JE, 2009, EXPERT OPIN DRUG MET, V5, P875, DOI 10.1517/17425250903032681; Villablanca EJ, 2011, GASTROENTEROLOGY, V141, P176, DOI 10.1053/j.gastro.2011.04.010; von Boyen GBT, 2010, MED SCI MONITOR, V16, pBR161; White JA, 1996, J BIOL CHEM, V271, P29922, DOI 10.1074/jbc.271.47.29922; White RJ, 2007, PLOS BIOL, V5, P2522, DOI 10.1371/journal.pbio.0050304; Wu JJ, 1999, DEVELOPMENT, V126, P1161; Yamada S, 2007, NEUROREPORT, V18, P359, DOI 10.1097/WNR.0b013e32801299b4; Yanagisawa H, 1998, DEVELOPMENT, V125, P825; Yokota J, 2001, ATHEROSCLEROSIS, V159, P491, DOI 10.1016/S0021-9150(01)00530-5; Young HM, 1999, DEV DYNAM, V216, P137, DOI 10.1002/(SICI)1097-0177(199910)216:2<137::AID-DVDY5>3.0.CO;2-6; Zhu L, 2004, NAT GENET, V36, P732, DOI 10.1038/ng1371	92	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74311	10.1371/journal.pone.0074311	http://dx.doi.org/10.1371/journal.pone.0074311			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040226	Green Submitted, gold, Green Published			2022-12-25	WOS:000326405300169
J	Guzman-Quevedo, O; Aragao, RD; Garcia, GP; Matos, RJB; Oliveira, ADB; de Castro, RM; Bolanos-Jimenez, F				Guzman-Quevedo, Omar; Aragao, Raquel Da Silva; Garcia, Georgina Perez; Matos, Rhowena J. B.; Braga Oliveira, Andre de Sa; de Castro, Raul Manhaes; Bolanos-Jimenez, Francisco			Impaired Hypothalamic mTOR Activation in the Adult Rat Offspring Born to Mothers Fed a Low-Protein Diet	PLOS ONE			English	Article							DEPENDENT DIABETES-MELLITUS; INDUCED OBESITY; METABOLIC SYNDROME; FOOD-INTAKE; INSULIN SENSITIVITY; PRENATAL INFLUENCES; GENE-EXPRESSION; BLOOD-PRESSURE; EARLY-LIFE; PREGNANCY	Several epidemiological and experimental studies have clearly established that maternal malnutrition induces a high risk of developing obesity and related metabolic diseases in the offspring. To determine if altered nutrient sensing might underlie this enhanced disease susceptibility, here we examined the effects of perinatal protein restriction on the activation of the nutrient sensor mTOR in response to acute variations in the nutritional status of the organism. Female Wistar rats were fed isocaloric diets containing either 17% protein (control) or 8% protein (PR) throughout pregnancy and lactation. At weaning offspring received standard chow and at 4 months of age the effects of fasting or fasting plus re-feeding on the phosphorylation levels of mTOR and its downstream target S6 ribosomal protein (rpS6) in the hypothalamus were assessed by immuno-fluorescence and western blot. Under ad libitum feeding conditions, PR rats exhibited decreased mTOR and rpS6 phosphorylation in the arcuate (ARC) and ventromedial (VMH) hypothalamic nuclei. Moreover, the phosphorylation of mTOR and rpS6 in these hypothalamic nuclei decreased with fasting in control but not in PR animals. Conversely, PR animals exhibited enhanced number of pmTOR imunostained cells in the paraventricular nucleus (PVN) and fasting decreased the activation of mTOR in the PVN of malnourished but not of control rats. These alterations occurred at a developmental stage at which perinatally-undernourished animals do not show yet obesity or glucose intolerance. Collectively, our observations suggest that altered hypothalamic nutrient sensing in response to an inadequate foetal and neonatal energetic environment is one of the basic mechanisms of the developmental programming of metabolic disorders and might play a causing role in the development of the metabolic syndrome induced by malnutrition during early life.	[Guzman-Quevedo, Omar; Aragao, Raquel Da Silva; Garcia, Georgina Perez; Braga Oliveira, Andre de Sa; Bolanos-Jimenez, Francisco] INRA, Unite Mixte Rech Physiol Adaptat Nutr 1280, Nantes, France; [Guzman-Quevedo, Omar; Aragao, Raquel Da Silva; Garcia, Georgina Perez; Braga Oliveira, Andre de Sa; Bolanos-Jimenez, Francisco] Nantes Atlantique Univ, Univ Nantes, Nantes, France; [Matos, Rhowena J. B.] Univ Fed Pernambuco, Nucleo Educ Fis & Ciencias Esporte, Vitoria De Santo Antao, PE, Brazil; [Aragao, Raquel Da Silva; Braga Oliveira, Andre de Sa; de Castro, Raul Manhaes] Univ Fed Pernambuco, Ctr Ciencias Saude, Dept Nutr, Recife, PE, Brazil	INRAE; Nantes Universite; Universidade Federal de Pernambuco; Universidade Federal de Pernambuco	Bolanos-Jimenez, F (corresponding author), INRA, Unite Mixte Rech Physiol Adaptat Nutr 1280, Nantes, France.	Francisco.Bolanos@univ-nantes.fr	da Silva Aragão, Raquel/AAE-4215-2019; Quevedo, omar Guzman/AAG-6327-2020; de Castro, Raul Manhaes/A-1635-2014; Guzman Quevedo, Omar/ABU-5276-2022	da Silva Aragão, Raquel/0000-0003-0630-7030; Quevedo, omar Guzman/0000-0003-1358-1783; Guzman Quevedo, Omar/0000-0003-1358-1783	Mexican Consejo Nacional de Ciencia y Tecnologia (CONACYT); Brazilian Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Comite Francais d'Evaluation de la Cooperation Universitaire et Scientifique avec le Bresil (COFECUB) [Me 657/09]	Mexican Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Brazilian Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Comite Francais d'Evaluation de la Cooperation Universitaire et Scientifique avec le Bresil (COFECUB)	O. Guzman-Quevedo and G. Perez Garcia were the recipients of, respectively, a doctoral and a post-doctoral fellowship from the Mexican Consejo Nacional de Ciencia y Tecnologia (CONACYT). R. Da Silva Aragao was the recipient of a doctoral fellowship from the Brazilian Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). This work was partially supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and the Comite Francais d'Evaluation de la Cooperation Universitaire et Scientifique avec le Bresil (COFECUB) (Action Number Me 657/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Bellinger L, 2005, CLIN SCI, V109, P413, DOI 10.1042/CS20050127; Bieswal F, 2006, OBESITY, V14, P1330, DOI 10.1038/oby.2006.151; Blouet C, 2008, CELL METAB, V8, P459, DOI 10.1016/j.cmet.2008.10.004; Chen JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004950; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Cota D, 2008, J NEUROSCI, V28, P7202, DOI 10.1523/JNEUROSCI.1389-08.2008; Cottrell EC, 2012, FASEB J, V26, P1866, DOI 10.1096/fj.12-203489; Coupe B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030616; Coupe B, 2010, ENDOCRINOLOGY, V151, P702, DOI 10.1210/en.2009-0893; Cripps RL, 2009, CLIN SCI, V117, P85, DOI 10.1042/CS20080393; de Souza SL, 2008, EUR J NEUROSCI, V27, P1400, DOI 10.1111/j.1460-9568.2008.06105.x; Desai M, 2007, AM J PHYSIOL-REG I, V293, pR2306, DOI 10.1152/ajpregu.00783.2006; Desai M, 2007, REPROD SCI, V14, P329, DOI 10.1177/1933719107303983; Erhuma A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1702, DOI 10.1152/ajpendo.00605.2006; Fowden AL, 2009, EXP PHYSIOL, V94, P607, DOI 10.1113/expphysiol.2008.046359; Gambling L, 2003, J PHYSIOL-LONDON, V552, P603, DOI 10.1113/jphysiol.2003.051383; Gluckman PD, 2004, TRENDS ENDOCRIN MET, V15, P183, DOI 10.1016/j.tem.2004.03.002; Gopalakrishnan GS, 2005, BRIT J NUTR, V94, P938, DOI 10.1079/BJN20051559; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Ikenasio-Thorpe BA, 2007, J ENDOCRINOL, V193, P31, DOI 10.1677/joe.1.07017; Krechowec SO, 2006, J ENDOCRINOL, V189, P355, DOI 10.1677/joe.1.06679; Leduc L, 2010, EUR J OBSTET GYN R B, V149, P127, DOI 10.1016/j.ejogrb.2009.12.005; Lillycrop KA, 2011, INT J OBESITY, V35, P72, DOI 10.1038/ijo.2010.122; Martin-Gronert MS, 2008, AM J PHYSIOL-REG I, V294, pR494, DOI 10.1152/ajpregu.00530.2007; McMullen S, 2005, AM J PHYSIOL-REG I, V288, pR85, DOI 10.1152/ajpregu.00435.2004; McMullen S, 2012, MED HYPOTHESES, V78, P88, DOI 10.1016/j.mehy.2011.09.047; Merezak S, 2004, DIABETOLOGIA, V47, P669, DOI 10.1007/s00125-004-1357-z; Mori H, 2009, CELL METAB, V9, P362, DOI 10.1016/j.cmet.2009.03.005; Orozco-Solis R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013537; Orozco-Solis R, 2009, PHYSIOL BEHAV, V96, P481, DOI 10.1016/j.physbeh.2008.11.016; Ozanne SE, 1996, AM J PHYSIOL-ENDOC M, V271, pE1128, DOI 10.1152/ajpendo.1996.271.6.E1128; Ozanne SE, 1997, AM J PHYSIOL-ENDOC M, V273, pE46, DOI 10.1152/ajpendo.1997.273.1.E46; Plagemann A, 2009, J PHYSIOL-LONDON, V587, P4963, DOI 10.1113/jphysiol.2009.176156; Reeves PG, 1997, J NUTR, V127, pS838; Reusens B, 2011, WORLD J DIABETES, V2, P149, DOI 10.4239/wjd.v2.i9.149; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sardinha FLC, 2006, NUTRITION, V22, P1152, DOI 10.1016/j.nut.2006.07.002; Toscano AE, 2008, NUTRITION, V24, P270, DOI 10.1016/j.nut.2007.12.004; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Vehaskari VM, 2001, KIDNEY INT, V59, P238, DOI 10.1046/j.1523-1755.2001.00484.x; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Villanueva EC, 2009, ENDOCRINOLOGY, V150, P4541, DOI 10.1210/en.2009-0642; Woods SC, 2008, ANNU REV NUTR, V28, P295, DOI 10.1146/annurev.nutr.28.061807.155505; Zambrano E, 2006, J PHYSIOL-LONDON, V571, P221, DOI 10.1113/jphysiol.2005.100313; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012	48	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74990	10.1371/journal.pone.0074990	http://dx.doi.org/10.1371/journal.pone.0074990			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040371	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300195
J	Malherbe, DC; Sanders, RW; van Gils, MJ; Park, B; Gomes, MM; Schuitemaker, H; Barnett, S; Haigwood, NL				Malherbe, Delphine C.; Sanders, Rogier W.; van Gils, Marit J.; Park, Byung; Gomes, Michelle M.; Schuitemaker, Hanneke; Barnett, Susan; Haigwood, Nancy L.			HIV-1 Envelope Glycoprotein Resistance to Monoclonal Antibody 2G12 Is Subject-Specific and Context-Dependent in Macaques and Humans	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NEUTRALIZING HUMORAL IMMUNITY; CD4 BINDING-SITE; SWISS-MODEL; LINKED GLYCOSYLATION; GP120; SENSITIVITY; EPITOPE; ESCAPE; GLYCAN	HIV-1 Envelope (Env) protein is the sole target of neutralizing antibodies (NAbs) that arise during infection to neutralize autologous variants. Under this immune pressure, HIV escape variants are continuously selected and over the course of infection Env becomes more neutralization resistant. Many common alterations are known to affect sensitivity to NAbs, including residues encoding potential N-linked glycosylation sites (PNGS). Knowledge of Env motifs associated with neutralization resistance is valuable for the design of an effective Env-based vaccine so we characterized Envs isolated longitudinally from a SHIVSF162P4 infected macaque for sensitivity to neutralizing monoclonal antibodies (MAbs) B12, 2G12, 4E10 and 2F5. The early Env, isolated from plasma at day 56 after infection, was the most sensitive and the late Env, from day 670, was the most resistant to MAbs. We identified four PNGS in these Envs that accumulated over time at positions 130, 139, 160 and 397. We determined that removal of these PNGS significantly increased neutralization sensitivity to 2G12, and conversely, we identified mutations by in silico analyses that contributed resistance to 2G12 neutralization. In order to expand our understanding of these PNGS, we analyzed Envs from clade B HIV-infected human subjects and identified additional glycan and amino acid changes that could affect neutralization by 2G12 in a context-dependent manner. Taken together, these in vitro and in silico analyses of clade B Envs revealed that 2G12 resistance is achieved by previously unrecognized PNGS substitutions in a context-dependent manner and by subject-specific pathways.	[Malherbe, Delphine C.; Gomes, Michelle M.; Haigwood, Nancy L.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Sanders, Rogier W.; van Gils, Marit J.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Virol,Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [Sanders, Rogier W.] Cornell Univ, Dept Microbiol & Immunol, Weill Med Coll, New York, NY 10021 USA; [Park, Byung] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA; [Schuitemaker, Hanneke] Univ Amsterdam, Acad Med Ctr, Lab Viral Immune Pathogenesis, Dept Expt Immunol,Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [Schuitemaker, Hanneke] Crucell, Leiden, Netherlands; [Barnett, Susan] Novartis Inst Biomed Res, Cambridge, MA USA	Oregon Health & Science University; Oregon National Primate Research Center; University of Amsterdam; Academic Medical Center Amsterdam; Cornell University; Oregon Health & Science University; University of Amsterdam; Academic Medical Center Amsterdam; Johnson & Johnson; Novartis	Haigwood, NL (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA.	haigwoon@ohsu.edu	van Gils, Marit J./H-4791-2019; Haigwood, Nancy Logan/AAV-7484-2020	van Gils, Marit J./0000-0003-3422-8161; Gomes, Michelle/0000-0003-4809-2664; Haigwood, Nancy/0000-0002-1477-9575	National Institutes of Health [P01 AI087064, P01 AI054564, P51 OD011092]; Bill and Melinda Gates Foundation; Netherlands Organization for Scientific Research (NWO) [917.11.314]; European Research Council [ERC-StG-2011-280829]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI054564] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants P01 AI087064 (NLH), P01 AI054564 (NLH) and P51 OD011092; and a Global Health Grand Challenges Explorations Grant from the Bill and Melinda Gates Foundation (NLH). RWS is a recipient of a Vidi grant from the Netherlands Organization for Scientific Research (NWO; #917.11.314) and a Starting Investigator Grant from the European Research Council (#ERC-StG-2011-280829). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Blay WM, 2007, J VIROL, V81, P13037, DOI 10.1128/JVI.01215-07; Blay WM, 2006, J VIROL, V80, P999, DOI 10.1128/JVI.80.2.999-1014.2006; Blish CA, 2008, PLOS MED, V5, P90, DOI 10.1371/journal.pmed.0050009; BROLIDEN PA, 1991, IMMUNOLOGY, V73, P371; Bunnik EM, 2009, VIROLOGY, V390, P348, DOI 10.1016/j.virol.2009.05.028; Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Chackerian B, 1997, J VIROL, V71, P7719, DOI 10.1128/JVI.71.10.7719-7727.1997; Chaillon A, 2011, J VIROL, V85, P3642, DOI 10.1128/JVI.02424-10; Chohan B, 2005, J VIROL, V79, P6528, DOI 10.1128/JVI.79.10.6528-6531.2005; CONLEY AJ, 1994, J VIROL, V68, P6994, DOI 10.1128/JVI.68.11.6994-7000.1994; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Duenas-Decamp MJ, 2010, J VIROL, V84, P9608, DOI 10.1128/JVI.00185-10; Duenas-Decamp MJ, 2008, J VIROL, V82, P5807, DOI 10.1128/JVI.02585-07; Euler Z, 2010, J INFECT DIS, V201, P1045, DOI 10.1086/651144; Gnanakaran S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000955; Gray ES, 2007, J VIROL, V81, P10769, DOI 10.1128/JVI.01106-07; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Koch M, 2003, VIROLOGY, V313, P387, DOI 10.1016/S0042-6822(03)00294-0; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Kraft Z, 2007, J VIROL, V81, P6402, DOI 10.1128/JVI.00424-07; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Lue J, 2002, J VIROL, V76, P10299, DOI 10.1128/JVI.76.20.10299-10306.2002; Mahalanabis M, 2009, J VIROL, V83, P662, DOI 10.1128/JVI.01328-08; Malherbe DC, 2011, J VIROL, V85, P5262, DOI 10.1128/JVI.02419-10; McCaffrey RA, 2004, J VIROL, V78, P3279, DOI 10.1128/JVI.78.7.3279-3295.2004; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Moore PL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000598; Nakowitsch S, 2005, AIDS, V19, P1957, DOI 10.1097/01.aids.0000189856.13817.76; O'Rourke SM, 2010, J VIROL, V84, P11200, DOI 10.1128/JVI.00790-10; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Pantophlet R, 2007, VIROLOGY, V364, P441, DOI 10.1016/j.virol.2007.03.007; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Quakkelaar ED, 2007, J VIROL, V81, P8533, DOI 10.1128/JVI.02816-06; Ringe R, 2012, VIROLOGY, V426, P34, DOI 10.1016/j.virol.2012.01.011; Rong R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000594; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Sanders RW, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-10; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scanlan CN, 2003, ADV EXP MED BIOL, V535, P205; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Trkola A, 2008, J VIROL, V82, P1591, DOI 10.1128/JVI.01792-07; Vaine M, 2009, BIODRUGS, V23, P137, DOI 10.2165/00063030-200923030-00001; van Gils MJ, 2010, J VIROL, V84, P3576, DOI 10.1128/JVI.02622-09; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; WATKINS BA, 1993, J VIROL, V67, P7493, DOI 10.1128/JVI.67.12.7493-7500.1993; Watkins BA, 1996, J VIROL, V70, P8431, DOI 10.1128/JVI.70.12.8431-8437.1996; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2003, J VIROL, V77, P5863, DOI 10.1128/JVI.77.10.5863-5876.2003	60	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e75277	10.1371/journal.pone.0075277	http://dx.doi.org/10.1371/journal.pone.0075277			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040404	Green Submitted, Green Published, gold			2022-12-25	WOS:000326405300202
J	Paez-Cortez, J; Krishnan, R; Arno, A; Aven, L; Ram-Mohan, S; Patel, KR; Lu, JN; King, OD; Ai, XB; Fine, A				Paez-Cortez, Jesus; Krishnan, Ramaswamy; Arno, Anneliese; Aven, Linh; Ram-Mohan, Sumati; Patel, Kruti R.; Lu, Jining; King, Oliver D.; Ai, Xingbin; Fine, Alan			A New Approach for the Study of Lung Smooth Muscle Phenotypes and Its Application in a Murine Model of Allergic Airway Inflammation	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MICROARRAY EXPERIMENTS; GENE-EXPRESSION; ASTHMA; INTERLEUKIN-13; CELLS	Phenotypes of lung smooth muscle cells in health and disease are poorly characterized. This is due, in part, to a lack of methodologies that allow for the independent and direct isolation of bronchial smooth muscle cells (BSMCs) and vascular smooth muscle cells (VSMCs) from the lung. In this paper, we describe the development of a bi-fluorescent mouse that permits purification of these two cell populations by cell sorting. By subjecting this mouse to an acute allergen based-model of airway inflammation that exhibits many features of asthma, we utilized this tool to characterize the phenotype of so-called asthmatic BSMCs. First, we examined the biophysical properties of single BSMCs from allergen sensitized mice and found increases in basal tone and cell size that were sustained ex vivo. We then generated for the first time, a comprehensive characterization of the global gene expression changes in BSMCs isolated from the bi-fluorescent mice with allergic airway inflammation. Using statistical methods and pathway analysis, we identified a number of differentially expressed mRNAs in BSMCs from allergen sensitized mice that code for key candidate proteins underlying changes in matrix formation, contractility, and immune responses. Ultimately, this tool will provide direction and guidance for the logical development of new markers and approaches for studying human lung smooth muscle.	[Paez-Cortez, Jesus; Arno, Anneliese; Aven, Linh; Patel, Kruti R.; Lu, Jining; Ai, Xingbin; Fine, Alan] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Krishnan, Ramaswamy; Ram-Mohan, Sumati] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA; [King, Oliver D.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA USA	Boston University; Harvard University; Beth Israel Deaconess Medical Center; University of Massachusetts System; University of Massachusetts Worcester	Fine, A (corresponding author), Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA.	afine@bu.edu		Patel, Kruti/0000-0002-4303-8717; Ai, Xingbin/0000-0002-2178-0080; Albert Goday Arno, Albert/0000-0001-7356-1595; Fine, Alan/0000-0001-9351-3048	National Institutes of Health (NIH) [R21HL112619, T32HL007035]; American Asthma Foundation [12-0086]; Parker Francis Foundation; CTSA [UL1-TR000157]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000157] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007035, R21HL112619] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; Parker Francis Foundation; CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by National Institutes of Health (NIH) grants R21HL112619 (to A. Fine and X. Ai) and T32HL007035 (to L. Aven), an American Asthma Foundation grant 12-0086 (to X. Ai), and The Parker Francis Foundation (to R. Krishnan). The authors also gratefully acknowledge CTSA grant UL1-TR000157. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SS, 2006, AM J RESP CELL MOL, V35, P55, DOI 10.1165/rcmb.2005-0453OC; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boxall C, 2006, EUR RESPIR J, V27, P208, DOI 10.1183/09031936.06.00130004; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Damera G, 2009, PULM PHARMACOL THER, V22, P353, DOI 10.1016/j.pupt.2008.12.006; Ghosh S, 2011, J BIOL CHEM, V286, P22678, DOI 10.1074/jbc.M111.241224; Gleason NR, 2009, J APPL PHYSIOL, V106, P1257, DOI 10.1152/japplphysiol.91314.2008; Hakonarson H, 1996, J CLIN INVEST, V97, P2593, DOI 10.1172/JCI118708; Jarai G, 2004, EUR J PHARMACOL, V497, P255, DOI 10.1016/j.ejphar.2004.06.055; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; Krishnan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005486; Lee JH, 2001, AM J RESP CELL MOL, V25, P474, DOI 10.1165/ajrcmb.25.4.4522; Morgan RK, 2007, J IMMUNOL, V178, P8081, DOI 10.4049/jimmunol.178.12.8081; Nials AT, 2008, DIS MODEL MECH, V1, P213, DOI 10.1242/dmm.000323; Ozier Annaig, 2011, J Allergy (Cairo), V2011, P742710, DOI 10.1155/2011/742710; Raja SG, 2011, THER ADV CHRONIC DIS, V2, P359, DOI 10.1177/2040622311420773; Siddiqui S, 2013, PULM PHARMACOL THER, V26, P132, DOI 10.1016/j.pupt.2012.08.008; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Woodruff Prescott G, 2008, Proc Am Thorac Soc, V5, P113, DOI 10.1513/pats.200705-059VS; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401; Yawn Barbara P, 2008, Prim Care Respir J, V17, P138, DOI 10.3132/pcrj.2008.00004; Yuyama N, 2002, CYTOKINE, V19, P287, DOI 10.1006/cyto.2002.1972; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895	25	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74469	10.1371/journal.pone.0074469	http://dx.doi.org/10.1371/journal.pone.0074469			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040256	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300175
J	Huang, W; Zhang, JF; Dorn, HC; Zhang, CM				Huang, Wei; Zhang, Jianfei; Dorn, Harry C.; Zhang, Chenming			Assembly of Bio-Nanoparticles for Double Controlled Drug Release	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; WALL CARBON NANOHORN; DELIVERY; CHEMOTHERAPY; DOXORUBICIN; MECHANISMS; PACLITAXEL; TOXICITY; TUMORS; HER-2	A critical limiting factor of chemotherapy is the unacceptably high toxicity. The use of nanoparticle based drug carriers has significantly reduced the side effects and facilitated the delivery of drugs. Source of the remaining side effect includes (1) the broad final in vivo distribution of the administrated nanoparticles, and (2) strong basal drug release from nanoparticles before they could reach the tumor. Despite the advances in pH-triggered release, undesirable basal drug release has been a constant challenge under in vivo conditions. In this study, functionalized single walled carbon nanohorn supported immunoliposomes were assembled for paclitaxel delivery. The immunoliposomes were formulated with polyethylene glycol, thermal stable and pH sensitive phospholipids. Each nanohorn was found to be encapsulated within one immunoliposome. Results showed a highly pH dependent release of paclitaxel in the presence of serum at body temperature with minimal basal release under physiological conditions. Upon acidification, paclitaxel was released at a steady rate over 30 days with a cumulative release of 90% of the loaded drug. The drug release results proved our hypothesized double controlled release mechanism from the nanoparticles. Other results showed the nanoparticles have doubled loading capacity compared to that of traditional liposomes and higher affinity to breast cancer cells overexpressing Her2 receptors. Internalized nanoparticles were found in lysosomes.	[Huang, Wei; Zhang, Chenming] Virginia Tech, Dept Biol Syst Engn, Blacksburg, VA 24061 USA; [Zhang, Jianfei; Dorn, Harry C.] Virginia Tech, Dept Chem, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Zhang, CM (corresponding author), Virginia Tech, Dept Biol Syst Engn, Blacksburg, VA 24061 USA.	Chzhang2@vt.edu	Zhang, Jianfei/D-7749-2012		Institute for Critical Technology and Applied Science (ICTAS) at Virginia Tech; Jeffress Memorial Trust [J-994]	Institute for Critical Technology and Applied Science (ICTAS) at Virginia Tech; Jeffress Memorial Trust	This work was supported primarily by the Institute for Critical Technology and Applied Science (ICTAS) at Virginia Tech, and partially funded by a grant from Jeffress Memorial Trust, Grant no. J-994. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreetta C, 2010, CRIT REV ONCOL HEMAT, V76, P99, DOI 10.1016/j.critrevonc.2010.01.007; Ashley CE, 2011, NAT MATER, V10, P389, DOI [10.1038/NMAT2992, 10.1038/nmat2992]; Baban DF, 1998, ADV DRUG DELIVER REV, V34, P109, DOI 10.1016/S0169-409X(98)00003-9; BRANNONPEPPAS L, 1995, INT J PHARMACEUT, V116, P1, DOI 10.1016/0378-5173(94)00324-X; Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Cho MJ, 2009, TOXICOL LETT, V189, P177, DOI 10.1016/j.toxlet.2009.04.017; Cirstoiu-Hapca A, 2010, J CONTROL RELEASE, V144, P324, DOI 10.1016/j.jconrel.2010.02.026; Dams ETM, 2000, J PHARMACOL EXP THER, V292, P1071; Dean-Colomb W, 2008, EUR J CANCER, V44, P2806, DOI 10.1016/j.ejca.2008.09.013; Dufort S, 2012, ADV DRUG DELIVER REV, V64, P179, DOI 10.1016/j.addr.2011.09.009; Ehrenberg MS, 2009, BIOMATERIALS, V30, P603, DOI 10.1016/j.biomaterials.2008.09.050; Extra JM, 2003, BREAST CANC RES T S1, V82, pA 217; Firme CP, 2010, NANOMED-NANOTECHNOL, V6, P245, DOI 10.1016/j.nano.2009.07.003; Fredenberg S, 2011, INT J PHARMACEUT, V415, P34, DOI 10.1016/j.ijpharm.2011.05.049; Gerweck LE, 1998, SEMIN RADIAT ONCOL, V8, P176, DOI 10.1016/S1053-4296(98)80043-X; Grobmyer SR, 2012, MATURITAS, V73, P19, DOI 10.1016/j.maturitas.2012.02.003; Guo W, 2005, ANAL BIOCHEM, V336, P213, DOI 10.1016/j.ab.2004.09.046; He CB, 2010, BIOMATERIALS, V31, P3657, DOI 10.1016/j.biomaterials.2010.01.065; Huang W, 2011, BIOCONJUGATE CHEM, V22, P1012, DOI 10.1021/bc200098k; Hughes GA, 2005, NANOMED-NANOTECHNOL, V1, P22, DOI 10.1016/j.nano.2004.11.009; HYNES NE, 1994, BBA-REV CANCER, V1198, P165, DOI 10.1016/0304-419X(94)90012-4; Jie P, 2005, J CONTROL RELEASE, V110, P20, DOI 10.1016/j.jconrel.2005.09.011; JONES MN, 1991, BIOCHIM BIOPHYS ACTA, V1065, P145, DOI 10.1016/0005-2736(91)90224-V; Kang SI, 2003, COLLOID SURFACE A, V231, P103, DOI 10.1016/j.colsurfa.2003.09.006; Kasuya D, 2002, J PHYS CHEM B, V106, P4947, DOI 10.1021/jp020387n; Kennel SJ, 2008, NUCL MED BIOL, V35, P501, DOI 10.1016/j.nucmedbio.2008.02.001; Lammers T, 2012, J CONTROL RELEASE, V161, P175, DOI 10.1016/j.jconrel.2011.09.063; Lasic DD, 1996, NATURE, V380, P561, DOI 10.1038/380561a0; Li SD, 2009, BBA-BIOMEMBRANES, V1788, P2259, DOI 10.1016/j.bbamem.2009.06.022; Liu JW, 2009, J AM CHEM SOC, V131, P1354, DOI 10.1021/ja808018y; Lynch RM, 2007, NANOTOXICOLOGY, V1, P157, DOI 10.1080/17435390701598496; Manjappa AS, 2011, J CONTROL RELEASE, V150, P2, DOI 10.1016/j.jconrel.2010.11.002; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; Miyawaki J, 2008, ACS NANO, V2, P213, DOI 10.1021/nn700185t; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Parveen S, 2012, NANOMED-NANOTECHNOL, V8, P147, DOI 10.1016/j.nano.2011.05.016; Patil Y, 2009, J CONTROL RELEASE, V136, P21, DOI 10.1016/j.jconrel.2009.01.021; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Puglisi F, 2006, AM J CANC, V5, P99; Reddy LH, 2005, J PHARM PHARMACOL, V57, P1231, DOI 10.1211/jpp.57.10.0001; Repnik U, 2012, BBA-PROTEINS PROTEOM, V1824, P22, DOI 10.1016/j.bbapap.2011.08.016; Sato KT, 2005, ACAD RADIOL, V12, P1342, DOI 10.1016/j.acra.2005.06.019; Shu CY, 2010, CHEM MATER, V22, P347, DOI 10.1021/cm902710n; Simoes S, 2001, BBA-BIOMEMBRANES, V1515, P23, DOI 10.1016/S0005-2736(01)00389-3; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Wilcken N, 2008, EUR J CANCER, V44, P2218, DOI 10.1016/j.ejca.2008.07.019; Xiao K, 2011, BIOMATERIALS, V32, P3435, DOI 10.1016/j.biomaterials.2011.01.021; Xu JX, 2008, CHEM PHYS LETT, V461, P189, DOI 10.1016/j.cplett.2008.06.077; Yang T, 2007, J CONTROL RELEASE, V120, P169, DOI 10.1016/j.jconrel.2007.05.011; Zhang JF, 2010, NANO LETT, V10, P2843, DOI 10.1021/nl1008635	53	17	19	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e74679	10.1371/journal.pone.0074679	http://dx.doi.org/10.1371/journal.pone.0074679			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040316	Green Published, gold, Green Submitted			2022-12-25	WOS:000324856500092
J	Kierdorf, H; Kierdorf, U; Frolich, K; Witzel, C				Kierdorf, Horst; Kierdorf, Uwe; Froelich, Kai; Witzel, Carsten			Lines of Evidence-Incremental Markings in Molar Enamel of Soay Sheep as Revealed by a Fluorochrome Labeling and Backscattered Electron Imaging Study	PLOS ONE			English	Article							DENTAL ENAMEL; TOOTH ENAMEL; LIFE-HISTORY; TEETH; PERIODICITY; MICROSTRUCTURE; CLOCK; DISTURBANCES; VARIABILITY; HYPOPLASIA	We studied the structural characteristics and periodicities of regular incremental markings in sheep enamel using fluorochrome injections for vital labeling of forming enamel and backscattered electron imaging in the scanning electron microscope. Microscopic analysis of mandibular first molars revealed the presence of incremental markings with a daily periodicity (laminations) that indicated successive positions of the forming front of interprismatic enamel. In addition to the laminations, incremental markings with a sub-daily periodicity were discernible both in interprismatic enamel and in enamel prisms. Five sub-daily increments were present between two consecutive laminations. Backscattered electron imaging revealed that each sub-daily growth increment consisted of a broader and more highly mineralized band and a narrower and less mineralized band (line). The sub-daily markings in the prisms of sheep enamel morphologically resembled the (daily) prisms cross striations seen in primate enamel. Incremental markings with a supra-daily periodicity were not observed in sheep enamel. Based on the periodicity of the incremental markings, maximum mean daily apposition rates of 17.0 mu m in buccal enamel and of 13.4 mu m in lingual enamel were recorded. Enamel extension rates were also high, with maximum means of 180 mu m/day and 217 mu m/day in upper crown areas of buccal and lingual enamel, respectively. Values in more cervical crown portions were markedly lower. Our results are in accordance with previous findings in other ungulate species. Using the incremental markings present in primate enamel as a reference could result in a misinterpretation of the incremental markings in ungulate enamel. Thus, the sub-daily growth increments in the prisms of ungulate enamel might be mistaken as prism cross striations with a daily periodicity, and the laminations misidentified as striae of Retzius with a supra-daily periodicity. This would lead to a considerable overestimation of crown formation times in ungulate teeth.	[Kierdorf, Horst; Kierdorf, Uwe; Froelich, Kai; Witzel, Carsten] Univ Hildesheim, Dept Biol, D-31141 Hildesheim, Germany; [Froelich, Kai] Tierpk Arche Warder eV, Warder, Germany	University of Hildesheim	Kierdorf, H (corresponding author), Univ Hildesheim, Dept Biol, D-31141 Hildesheim, Germany.	kierdorf@uni-hildesheim.de	Witzel, Carsten/AAD-9498-2022; Kierdorf, Uwe/F-2539-2012	Witzel, Carsten/0000-0002-1663-7618; Kierdorf, Uwe/0000-0003-0531-2460; Kierdorf, Horst/0000-0001-6411-9631				Antoine D, 2009, J ANAT, V214, P45, DOI 10.1111/j.1469-7580.2008.01010.x; Aoba T, 2002, CRIT REV ORAL BIOL M, V13, P155, DOI 10.1177/154411130201300206; Athanassiou-Papaefthymiou M, 2011, EUR J ORAL SCI, V119, P35, DOI 10.1111/j.1600-0722.2011.00918.x; Boyde A, 1997, CIBA F SYMP, V205, P18; Boyde A, 1971, Z ZELLFORSCH, V93, P583; Boyde A., 1989, HDB MICROSCOPIC ANAT, P309; BROMAGE TG, 1991, AM J PHYS ANTHROPOL, V86, P205, DOI 10.1002/ajpa.1330860209; Bromage TG, 2012, J THEOR BIOL, V305, P131, DOI 10.1016/j.jtbi.2012.04.007; Bromage TG, 2009, CALCIFIED TISSUE INT, V84, P388, DOI 10.1007/s00223-009-9221-2; Dean MC, 2006, P ROY SOC B-BIOL SCI, V273, P2799, DOI 10.1098/rspb.2006.3583; DEAN MC, 1991, AM J PHYS ANTHROPOL, V86, P215, DOI 10.1002/ajpa.1330860210; DEAN MC, 1987, J HUM EVOL, V16, P157, DOI 10.1016/0047-2484(87)90074-1; Dirks W, 2002, AM J PHYS ANTHROPOL, V118, P239, DOI 10.1002/ajpa.10089; GOODMAN AH, 1990, YEARB PHYS ANTHROPOL, V33, P59; GRINE FE, 1987, ACTA ODONTOL SCAND, V45, P1, DOI 10.3109/00016358709094349; Guatelli-Steinberg D, 2012, J HUM EVOL, V63, P475, DOI 10.1016/j.jhevol.2012.05.006; HALBERG F, 1973, International Journal of Chronobiology, V1, P31; HILLSON S, 1999, P 11 INT S DENT MORP, P102; Hillson S., 2005, TEETH; Hoppe KA, 2004, PALAEOGEOGR PALAEOCL, V206, P355, DOI 10.1016/j.palaeo.2004.01.012; Iinuma YM, 2004, J VET MED SCI, V66, P665, DOI 10.1292/jvms.66.665; Jordana X, 2011, PALAEOGEOGR PALAEOCL, V300, P59, DOI 10.1016/j.palaeo.2010.12.008; KIERDORF H, 1991, ANAT HISTOL EMBRYOL, V20, P237, DOI 10.1111/j.1439-0264.1991.tb00300.x; Kierdorf H, 2004, ANAT EMBRYOL, V207, P463, DOI 10.1007/s00429-003-0368-8; Kierdorf H, 2012, ANAT HISTOL EMBRYOL, V41, P419, DOI 10.1111/j.1439-0264.2012.01151.x; Kierdorf H, 2012, J ANAT, V220, P484, DOI 10.1111/j.1469-7580.2012.01482.x; Kierdorf H, 1997, CELL TISSUE RES, V289, P125, DOI 10.1007/s004410050858; Kierdorf U, 1996, J ANAT, V188, P183; KODAKA T, 1989, CARIES RES, V23, P290, DOI 10.1159/000261195; Kodaka Tetsuo, 1995, Bulletin of Tokyo Dental College, V36, P33; Kodaka Tetsuo, 1995, Acta Anatomica Nipponica, V70, P183; Kohn MJ, 1998, CHEM GEOL, V152, P97, DOI 10.1016/S0009-2541(98)00099-0; Lacruz RS, 2012, J BIOL RHYTHM, V27, P237, DOI 10.1177/0748730412442830; Li CF, 2004, ARCH ORAL BIOL, V49, P45, DOI 10.1016/S0003-9969(03)00195-X; Maas MC, 1999, EVOL ANTHROPOL, V8, P133; Macho GA, 2002, BIOL J LINN SOC, V75, P271, DOI 10.1111/j.1095-8312.2002.tb01427.x; MILHAUD G, 1991, RECL MED VET, V167, P121; Mimura T, 1939, J DENT RES, V13, P454; Nanci A., 2013, 10 CATES ORAL HISTOL, P122; NEWMAN HN, 1974, ARCH ORAL BIOL, V19, P1135, DOI 10.1016/0003-9969(74)90242-8; Ohtsuka-Isoya M, 2001, AM J PHYSIOL-REG I, V280, pR1364, DOI 10.1152/ajpregu.2001.280.5.R1364; Okada M., 1940, JAP J MED SCI PHARMA, V13, P92; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Reid DJ, 2006, J HUM EVOL, V50, P329, DOI 10.1016/j.jhevol.2005.09.003; Reid DJ, 2006, J HUM EVOL, V50, P195, DOI 10.1016/j.jhevol.2005.09.002; Risnes S, 1998, J HUM EVOL, V35, P331, DOI 10.1006/jhev.1998.0229; Risnes S., 1999, DENT MORPHOLOGY 1998, P312; ROSENBERG GD, 1980, CALCIFIED TISSUE INT, V32, P29, DOI 10.1007/BF02408519; Schour I, 1937, AM J DIS CHILD, V54, P757; Schwartz GT, 2006, INT J PRIMATOL, V27, P1201, DOI 10.1007/s10764-006-9051-2; Simmer JP, 2010, J DENT RES, V89, P1024, DOI 10.1177/0022034510375829; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Smith TM, 2008, J HUM EVOL, V54, P205, DOI 10.1016/j.jhevol.2007.09.020; Smith TM, 2006, J ANAT, V208, P99, DOI 10.1111/j.1469-7580.2006.00499.x; Tafforeau P, 2007, PALAEOGEOGR PALAEOCL, V246, P206, DOI 10.1016/j.palaeo.2006.10.001; Upex B, 2012, J ZOOL, V287, P259, DOI 10.1111/j.1469-7998.2012.00912.x; Warshawsky H., 1988, CELL TISSUE BIOL TXB, P595; WEINREB MM, 1964, AM J VET RES, V25, P891; Witzel C, 2008, AM J PHYS ANTHROPOL, V136, P400, DOI 10.1002/ajpa.20822; Witzel C, 2006, J ANAT, V209, P93, DOI 10.1111/j.1469-7580.2006.00581.x; Zheng L, 2013, BONE, V55, P158, DOI 10.1016/j.bone.2013.02.011; Zheng L, 2011, GENE EXPR PATTERNS, V11, P202, DOI 10.1016/j.gep.2010.12.002	62	36	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e74597	10.1371/journal.pone.0074597	http://dx.doi.org/10.1371/journal.pone.0074597			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040293	Green Published, gold, Green Submitted			2022-12-25	WOS:000324856500089
J	Marejkova, M; Blahova, K; Janda, J; Fruth, A; Petras, P				Marejkova, Monika; Blahova, Kveta; Janda, Jan; Fruth, Angelika; Petras, Petr			Enterohemorrhagic Escherichia coli as Causes of Hemolytic Uremic Syndrome in the Czech Republic	PLOS ONE			English	Article							CYTOLETHAL DISTENDING TOXIN; SPECTRUM-BETA-LACTAMASE; TANDEM-REPEAT ANALYSIS; TERM-FOLLOW-UP; GENE-CLUSTER; UNITED-STATES; TELLURITE RESISTANCE; MOLECULAR ANALYSIS; LARGE OUTBREAK; O157	Background: Enterohemorrhagic Escherichia coli (EHEC) cause diarrhea-associated hemolytic uremic syndrome (D+ HUS) worldwide, but no systematic study of EHEC as the causative agents of HUS was performed in the Czech Republic. We analyzed stools of all patients with D+ HUS in the Czech Republic between 1998 and 2012 for evidence of EHEC infection. We determined virulence profiles, phenotypes, antimicrobial susceptibilities and phylogeny of the EHEC isolates. Methodology/Principal Findings: Virulence loci were identified using PCR, phenotypes and antimicrobial susceptibilities were determined using standard procedures, and phylogeny was assessed using multilocus sequence typing. During the 15-year period, EHEC were isolated from stools of 39 (69.4%) of 56 patients. The strains belonged to serotypes [fliC types] O157:H7/NM[fliC(H7)] (50% of which were sorbitol-fermenting; SF), O26: H11/NM[fliC(H11)], O55:NM[fliC(H7)], O111:NM[fliC(H8)], O145:H28[fliC(H28)], O172: NM[fliC(H25)], and Orough: NM[fliC(H25)]. O26: H11/NM[fliC(H11)] was the most common serotype associated with HUS (41% isolates). Five stx genotypes were identified, the most frequent being stx(2a) (71.1% isolates). Most strains contained EHEC-hlyA encoding EHEC hemolysin, and a subset (all SF O157: NM and one O157: H7) harbored cdtV encoding cytolethal distending toxin. espP alpha encoding serine protease EspP alpha was found in EHEC O157: H7, O26: H11/NM, and O145: H28, whereas O172: NM and Orough: NM strains contained espP gamma. All isolates contained eae encoding adhesin intimin, which belonged to subtypes beta (O26), gamma (O55, O145, O157), gamma 2/0 (O111), and epsilon (O172, Orough). Loci encoding other adhesins (efa1, lpfA(O26), lpfA(O157OI-141), lpfA(O157OI-154), iha) were usually associated with particular serotypes. Phylogenetic analysis demonstrated nine sequence types (STs) which correlated with serotypes. Of these, two STs (ST660 and ST1595) were not found in HUS-associated EHEC before. Conclusions/Significance: EHEC strains, including O157: H7 and non-O157: H7, are frequent causes of D+ HUS in the Czech Republic. Identification of unusual EHEC serotypes/STs causing HUS calls for establishment of an European collection of HUS-associated EHEC, enabling to study properties and evolution of these important pathogens.	[Marejkova, Monika; Petras, Petr] Natl Inst Publ Hlth, Natl Reference Lab E Coli & Shigella, Prague, Czech Republic; [Marejkova, Monika] Charles Univ Prague, Fac Med 3, Prague, Czech Republic; [Blahova, Kveta; Janda, Jan] Charles Univ Prague, Fac Med 2, Dept Pediat, Prague, Czech Republic; [Blahova, Kveta; Janda, Jan] Univ Hosp Motol, Prague, Czech Republic; [Fruth, Angelika] Robert Koch Inst, Natl Reference Ctr Salmonella & Other Enter Patho, Wernigerode, Germany	National Institute of Public Health (SZU) - Czech Republic; Charles University Prague; Charles University Prague; Motol University Hospital; Robert Koch Institute	Marejkova, M (corresponding author), Natl Inst Publ Hlth, Natl Reference Lab E Coli & Shigella, Prague, Czech Republic.	monmarej@szu.cz						Aldick T, 2007, MICROBES INFECT, V9, P282, DOI 10.1016/j.micinf.2006.12.001; Alexa P, 2011, VET MED-CZECH, V56, P149, DOI 10.17221/3152-VETMED; Alpers K, 2009, EPIDEMIOL INFECT, V137, P389, DOI 10.1017/S0950268808001465; Ammon A, 1999, J INFECT DIS, V179, P1274, DOI 10.1086/314715; Banatvala N, 2001, J INFECT DIS, V183, P1063, DOI 10.1086/319269; Bauwens A, 2011, THROMB HAEMOSTASIS, V105, P515, DOI 10.1160/TH10-02-0140; Betz J, 2012, BIOL CHEM, V393, P133, DOI 10.1515/hsz-2011-0288; Betz J, 2011, J LIPID RES, V52, P618, DOI 10.1194/jlr.M010819; Bielaszewska M, 1997, EPIDEMIOL INFECT, V119, P299, DOI 10.1017/S0950268897008297; Bielaszewska M, 2005, J CLIN MICROBIOL, V43, P452, DOI 10.1128/JCM.43.1.452-454.2005; Bielaszewska M, 2000, J CLIN MICROBIOL, V38, P3470, DOI 10.1128/JCM.38.9.3470-3473.2000; Bielaszewska M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001024; Bielaszewska M, 2013, CLIN INFECT DIS, V56, P1373, DOI 10.1093/cid/cit055; Bielaszewska M, 2012, ANTIMICROB AGENTS CH, V56, P3277, DOI 10.1128/AAC.06315-11; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Bielaszewska M, 2011, MOL MICROBIOL, V79, P1024, DOI 10.1111/j.1365-2958.2010.07499.x; Blahova K, 2002, PEDIATR NEPHROL, V17, P400, DOI 10.1007/s00467-002-0836-z; Blanco A, 2004, J CLIN MICROBIOL, V42, P645, DOI 10.1128/JCM.42.2.645-651.2004; Bono JL, 2012, MOL BIOL EVOL, V29, P2047, DOI 10.1093/molbev/mss072; Brandal LT, 2012, J CLIN MICROBIOL, V50, P1825, DOI 10.1128/JCM.06435-11; Brockmeyer J, 2007, APPL ENVIRON MICROB, V73, P6351, DOI 10.1128/AEM.00920-07; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536; Buvens G, 2012, FOODBORNE PATHOG DIS, V9, P530, DOI 10.1089/fpd.2011.1073; Buvens G, 2012, J CLIN MICROBIOL, V50, P1336, DOI 10.1128/JCM.05317-11; Buvens G, 2010, ANTIMICROB AGENTS CH, V54, P4907, DOI 10.1128/AAC.00551-10; Chase-Topping ME, 2012, EMERG INFECT DIS, V18, P439, DOI 10.3201/eid1803.111236; Cizek A, 2008, J APPL MICROBIOL, V104, P852, DOI 10.1111/j.1365-2672.2007.03602.x; D'Souza JA, 2002, GENE, V297, P123, DOI 10.1016/S0378-1119(02)00876-4; Eklund M, 2001, J CLIN MICROBIOL, V39, P2829, DOI 10.1128/JCM.39.8.2829-2834.2001; Eklund M, 2006, CLIN MICROBIOL INFEC, V12, P634, DOI 10.1111/j.1469-0691.2006.01478.x; Elliott EJ, 2001, ARCH DIS CHILD, V85, P125, DOI 10.1136/adc.85.2.125; Espie E, 2008, PEDIATR INFECT DIS J, V27, P595, DOI 10.1097/INF.0b013e31816a062f; Ethelberg S, 2004, EMERG INFECT DIS, V10, P842, DOI 10.3201/eid1005.030576; EUCAST (the European Committee on Antimicrobial Susceptibility Testing), 2012, ANT SUSC TEST EUCAST; European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2012, EUCAST MIC ZON DIAM; Feng P, 1998, J INFECT DIS, V177, P1750, DOI 10.1086/517438; Folster JP, 2011, ANTIMICROB AGENTS CH, V55, P5955, DOI 10.1128/AAC.05545-11; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Friedrich AW, 2006, J CLIN MICROBIOL, V44, P1844, DOI 10.1128/JCM.44.5.1844-1846.2006; Friedrich AW, 2005, J CLIN MICROBIOL, V43, P546, DOI 10.1128/JCM.43.2.546-550.2005; Friedrich AW, 2002, J INFECT DIS, V185, P74, DOI 10.1086/338115; Guo H, 2004, J APPL MICROBIOL, V97, P181, DOI 10.1111/j.1365-2672.2004.02305.x; Haugum K, 2012, FEMS MICROBIOL LETT, V329, P102, DOI 10.1111/j.1574-6968.2012.02505.x; Hrabak J, 2009, J CLIN MICROBIOL, V47, P3353, DOI 10.1128/JCM.00901-09; Izumiya H, 2010, MICROBIOL IMMUNOL, V54, P569, DOI 10.1111/j.1348-0421.2010.00252.x; Janka A, 2003, INFECT IMMUN, V71, P3634, DOI 10.1128/IAI.71.6.3634-3638.2003; Janka A, 2002, INT J MED MICROBIOL, V292, P207, DOI 10.1078/1438-4221-00206; Jenke C, 2012, EMERG INFECT DIS, V18, P582, DOI 10.3201/eid1804.111414; Jenke C, 2011, J CLIN MICROBIOL, V49, P3644, DOI 10.1128/JCM.05035-11; Jenke C, 2010, EMERG INFECT DIS, V16, P610, DOI 10.3201/eid1604.091361; Kappeli U, 2011, EMERG INFECT DIS, V17, P180, DOI 10.3201/eid1702.100909; KARCH H, 1990, DEUT MED WOCHENSCHR, V115, P489, DOI 10.1055/s-2008-1065036; Karch H, 1999, INFECT IMMUN, V67, P5994, DOI 10.1128/IAI.67.11.5994-6001.1999; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; Leopold SR, 2009, P NATL ACAD SCI USA, V106, P8713, DOI 10.1073/pnas.0812949106; LOUISE CB, 1995, J INFECT DIS, V172, P1397, DOI 10.1093/infdis/172.5.1397; Lynn RM, 2005, EMERG INFECT DIS, V11, P590, DOI 10.3201/eid1104.040833; Marejkova M, 2012, FOLIA MICROBIOL, V57, P85, DOI 10.1007/s12223-011-0095-0; Mellmann A, 2008, EMERG INFECT DIS, V14, P1287, DOI 10.3201/eid1408.071082; Orth D, 2009, WIEN KLIN WOCHENSCHR, V121, P108, DOI 10.1007/s00508-008-1133-z; Paton AW, 1998, J CLIN MICROBIOL, V36, P598, DOI 10.1128/JCM.36.2.598-602.1998; Perelle S, 2004, MOL CELL PROBE, V18, P185, DOI 10.1016/j.mcp.2003.12.004; Pollock KGJ, 2010, EMERG INFECT DIS, V16, P881, DOI 10.3201/eid1605.091919; Prager R, 2011, INT J MED MICROBIOL, V301, P181, DOI 10.1016/j.ijmm.2010.06.003; Prager R, 2009, INT J MED MICROBIOL, V299, P343, DOI 10.1016/j.ijmm.2008.10.008; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Rivas M, 2006, FOODBORNE PATHOG DIS, V3, P88, DOI 10.1089/fpd.2006.3.88; Rosales A, 2012, CLIN INFECT DIS, V54, P1413, DOI 10.1093/cid/cis196; Rosser T, 2008, INFECT IMMUN, V76, P5598, DOI 10.1128/IAI.01180-08; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Schimmer B, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-41; Schmidt H, 1999, J INFECT DIS, V179, P115, DOI 10.1086/314537; SCHMIDT H, 1995, INFECT IMMUN, V63, P1055, DOI 10.1128/IAI.63.3.1055-1061.1995; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Toma C, 2004, J CLIN MICROBIOL, V42, P4937, DOI 10.1128/JCM.42.11.4937-4946.2004; Tozzi AE, 2003, EMERG INFECT DIS, V9, P106, DOI 10.3201/eid0901.020266; Tumbarello M, 2007, ANTIMICROB AGENTS CH, V51, P1987, DOI 10.1128/AAC.01509-06; van der Donk CFM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047707; Zhang WL, 2002, J CLIN MICROBIOL, V40, P4486, DOI 10.1128/JCM.40.12.4486-4492.2002; Zieg J, 2012, PEDIATR INT, V54, P166, DOI 10.1111/j.1442-200X.2011.03533.x; Zoja C, 2010, PEDIATR NEPHROL, V25, P2231, DOI 10.1007/s00467-010-1522-1	81	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73927	10.1371/journal.pone.0073927	http://dx.doi.org/10.1371/journal.pone.0073927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040117	Green Published, Green Submitted, gold			2022-12-25	WOS:000324856500066
J	Chen, LY; Tiu, CJ; Peng, SL; Siemann, E				Chen, Leiyi; Tiu, Candice J.; Peng, Shaolin; Siemann, Evan			Conspecific Plasticity and Invasion: Invasive Populations of Chinese Tallow (Triadica sebifera) Have Performance Advantage over Native Populations Only in Low Soil Salinity	PLOS ONE			English	Article							TREE SAPIUM-SEBIFERUM; PHENOTYPIC PLASTICITY; SEEDLING GROWTH; WATER RELATIONS; SIMULATED HERBIVORY; INTRODUCED RANGES; SAPLING GROWTH; SALT TOLERANCE; PLANT; RESPONSES	Global climate change may increase biological invasions in part because invasive species may have greater phenotypic plasticity than native species. This may be especially important for abiotic stresses such as salt inundation related to increased hurricane activity or sea level rise. If invasive species indeed have greater plasticity, this may reflect genetic differences between populations in the native and introduced ranges. Here, we examined plasticity of functional and fitness-related traits of Chinese tallow (Triadica sebifera) populations from the introduced and native ranges that were grown along a gradient of soil salinity (control: 0 ppt; Low: 5 ppt; Medium: 10 ppt; High: 15 ppt) in a greenhouse. We used both norm reaction and plasticity index (PIv) to estimate the conspecific phenotypic plasticity variation between invasive and native populations. Overall, invasive populations had higher phenotypic plasticity of height growth rate (HGR), aboveground biomass, stem biomass and specific leaf area (SLA). The plasticity Index (PIv) of height growth rate (HGR) and SLA each were higher for plants from invasive populations. Absolute performance was always comparable or greater for plants from invasive populations versus native populations with the greatest differences at low stress levels. Our results were consistent with the "Master-of-some" pattern for invasive plants in which the fitness of introduced populations was greater in more benign conditions. This suggests that the greater conspecific phenotypic plasticity of invasive populations compared to native populations may increase invasion success in benign conditions but would not provide a potential interspecific competitive advantage in higher salinity soils that may occur with global climate change in coastal areas.	[Chen, Leiyi; Peng, Shaolin] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Leiyi; Tiu, Candice J.; Siemann, Evan] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX USA; [Chen, Leiyi] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Tiu, Candice J.] Univ Tennessee, Dept Biol & Environm Sci, Chattanooga, TN USA	Sun Yat Sen University; Rice University; Chinese Academy of Sciences; Institute of Botany, CAS; University of Tennessee System; University of Tennessee at Chattanooga	Peng, SL (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	lsspsl@mail.sysu.edu.cn; siemann@rice.edu	Chen, Leiyi/U-8813-2018; Chen, Leiyi/AAK-4392-2020	Chen, Leiyi/0000-0002-3241-4676; Chen, Leiyi/0000-0002-3241-4676	U.S. National Science Foundation [DEB 0820560]; State Key Laboratory of Biocontrol [SKLBC12K09]	U.S. National Science Foundation(National Science Foundation (NSF)); State Key Laboratory of Biocontrol	This research was support by the U.S. National Science Foundation (DEB 0820560) and the Open Project of the State Key Laboratory of Biocontrol (SKLBC12K09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALARCON JJ, 1993, PHYSIOL PLANTARUM, V89, P441, DOI 10.1111/j.1399-3054.1993.tb05196.x; Baker H., 1986, ECOLOGY BIOL INVASIO, P44; Bayuelo-Jimenez JS, 2012, INT J AGRON, V2012, DOI 10.1155/2012/527673; Blair B, 2001, PLANT ECOL, V156, P199, DOI 10.1023/A:1012664431933; BLOOD ER, 1991, BIOTROPICA, V23, P348, DOI 10.2307/2388251; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Brock MT, 2005, AM J BOT, V92, P1311, DOI 10.3732/ajb.92.8.1311; Bruce KA, 1997, NAT AREA J, V17, P255; Burns JH, 2006, ECOL APPL, V16, P1367, DOI 10.1890/1051-0761(2006)016[1367:RAEATA]2.0.CO;2; Burns JH, 2004, DIVERS DISTRIB, V10, P387, DOI 10.1111/j.1366-9516.2004.00105.x; Bush JK, 1995, SOUTHWEST NAT, V40, P379; Cahill JF, 2000, OIKOS, V90, P311, DOI 10.1034/j.1600-0706.2000.900211.x; Cano L, 2008, J ECOL, V96, P468, DOI 10.1111/j.1365-2745.2008.01363.x; Chapman EL, 2008, FOREST ECOL MANAG, V256, P883, DOI 10.1016/j.foreco.2008.05.057; Chun YJ, 2007, ECOLOGY, V88, P1499, DOI 10.1890/06-0856; Conner WH, 2005, FOREST ECOL MANAG, V212, P127, DOI 10.1016/j.foreco.2005.03.008; CONNER WH, 1994, J COASTAL RES, V10, P1045; Conner William H., 1993, Castanea, V58, P214; da Silva EC, 2008, ENVIRON EXP BOT, V63, P147, DOI 10.1016/j.envexpbot.2007.11.010; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; DELAUNE RD, 1987, J COASTAL RES, V3, P535; Dewalt SJ, 2006, MOL ECOL NOTES, V6, P505, DOI 10.1111/j.1471-8286.2006.01296.x; DeWalt SJ, 2004, OECOLOGIA, V138, P521, DOI 10.1007/s00442-003-1462-6; Dodd GL, 1999, AM J BOT, V86, P1146, DOI 10.2307/2656978; Dorn LA, 2000, EVOLUTION, V54, P1982, DOI 10.1111/j.0014-3820.2000.tb01242.x; Funk JL, 2008, J ECOL, V96, P1162, DOI 10.1111/j.1365-2745.2008.01435.x; Gallagher RV, 2011, DIVERS DISTRIB, V17, P884, DOI 10.1111/j.1472-4642.2011.00805.x; Garcia-Serrano H, 2005, ECOSCIENCE, V12, P35, DOI 10.2980/i1195-6860-12-1-35.1; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Godoy O, 2011, FUNCT ECOL, V25, P1248, DOI 10.1111/j.1365-2435.2011.01886.x; Grotkopp E, 2002, AM NAT, V159, P396, DOI 10.1086/338995; Grotkopp E, 2007, AM J BOT, V94, P526, DOI 10.3732/ajb.94.4.526; Grotkopp E, 2010, J APPL ECOL, V47, P1320, DOI 10.1111/j.1365-2664.2010.01878.x; Hartley MK, 2007, AM MIDL NAT, V157, P92, DOI 10.1674/0003-0031(2007)157[92:ROPACT]2.0.CO;2; HilleRisLambers J, 2010, J ECOL, V98, P1147, DOI 10.1111/j.1365-2745.2010.01706.x; Hook D.D., 1991, J COASTAL RES, P291; Howard JJ, 2012, AM MIDL NAT, V168, P56, DOI 10.1674/0003-0031-168.1.56; Huang W, 2012, ECOLOGY, V93, P2343, DOI 10.1890/11-1964.1; IPCC, 2007, CONTRIBUTION WORKING; Kaufman SR, 2001, OECOLOGIA, V127, P487, DOI 10.1007/s004420000621; Koehler K, 2012, NEW PHYTOL, V193, P730, DOI 10.1111/j.1469-8137.2011.03992.x; Kolb A, 2003, BIOL INVASIONS, V5, P229, DOI 10.1023/A:1026185503777; Kuhn NL, 1997, ESTUARIES, V20, P391, DOI 10.2307/1352352; Lake JC, 2004, BIOL CONSERV, V117, P215, DOI 10.1016/S0006-3207(03)00294-5; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Lin J, 2004, OECOLOGIA, V139, P399, DOI 10.1007/s00442-004-1522-6; Lin J, 2002, OECOLOGIA, V132, P428, DOI 10.1007/s00442-002-0986-5; Liu G, 2012, PLOS ONE, V7; Maron JL, 2011, ECOL LETT, V14, P36, DOI 10.1111/j.1461-0248.2010.01547.x; McLeod KW, 1999, TREES-STRUCT FUNCT, V13, P178, DOI 10.1007/s004680050231; Molina-Montenegro MA, 2010, BIOL INVASIONS, V12, P2277, DOI 10.1007/s10530-009-9638-6; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Mozdzer TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042794; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Muth NZ, 2007, J ECOL, V95, P1001, DOI 10.1111/j.1365-2745.2007.01268.x; Nijjer S, 2008, APPL SOIL ECOL, V38, P1, DOI 10.1016/j.apsoil.2007.08.002; Pan XY, 2006, ACTA OECOL, V30, P333, DOI 10.1016/j.actao.2006.03.003; Park I, 2012, BIOL INVASIONS, V14, P2029, DOI 10.1007/s10530-012-0209-x; Parker IM, 2003, CONSERV BIOL, V17, P59, DOI 10.1046/j.1523-1739.2003.02019.x; Pigliucci M., 2001, SYN ECO EVO; Rajaniemi TK, 2002, J ECOL, V90, P316, DOI 10.1046/j.1365-2745.2001.00662.x; Richards CL, 2008, AM J BOT, V95, P931, DOI 10.3732/ajb.2007364; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Rodriguez P, 2005, ENVIRON EXP BOT, V53, P113, DOI 10.1016/j.envexpbot.2004.03.005; Rogers WE, 2005, PLANT ECOL, V181, P57, DOI 10.1007/s11258-005-3029-6; Rogers WE, 2003, AM J BOT, V90, P243, DOI 10.3732/ajb.90.2.243; Rogers WE, 2002, BASIC APPL ECOL, V3, P297, DOI 10.1078/1439-1791-00120; Ryser P, 2000, AM J BOT, V87, P402, DOI 10.2307/2656636; Saha S, 2011, CLIMATIC CHANGE, V107, P169, DOI 10.1007/s10584-011-0081-1; Schumacher E, 2008, BIOTROPICA, V40, P543, DOI 10.1111/j.1744-7429.2008.00407.x; Sexton JP, 2002, ECOL APPL, V12, P1652, DOI 10.1890/1051-0761(2002)012[1652:PAGDMA]2.0.CO;2; Shen XY, 2011, BIOL INVASIONS, V13, P869, DOI 10.1007/s10530-010-9875-8; Siemann E, 2003, J ECOL, V91, P923, DOI 10.1046/j.1365-2745.2003.00822.x; Siemann E, 2003, ECOLOGY, V84, P1489, DOI 10.1890/0012-9658(2003)084[1489:HDRLAS]2.0.CO;2; Siemann E, 2001, ECOL LETT, V4, P514, DOI 10.1046/j.1461-0248.2001.00274.x; Siemann E, 2007, GLOBAL CHANGE BIOL, V13, P2184, DOI 10.1111/j.1365-2486.2007.01425.x; Siemann E, 2007, J ECOL, V95, P689, DOI 10.1111/j.1365-2745.2007.01253.x; Stelzer CP, 2002, FUNCT ECOL, V16, P835, DOI 10.1046/j.1365-2435.2002.00693.x; Sugiyama S, 2010, NEW PHYTOL, V185, P747, DOI 10.1111/j.1469-8137.2009.03090.x; Sultan SE, 2002, AM NAT, V160, P271, DOI 10.1086/341015; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; Valladares F, 2006, J ECOL, V94, P1103, DOI 10.1111/j.1365-2745.2006.01176.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Wang HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029452, 10.1371/journal.pone.0041330, 10.1371/journal.pone.0038619]; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; WILLIAMS TM, 1993, USDA SO FOR, V93, P177; WILSON SD, 1995, ECOLOGY, V76, P1169, DOI 10.2307/1940924; Winn AA, 1999, J EVOLUTION BIOL, V12, P306; Yang Q, 2013, SOIL BIOL BIOCHEM, V65, P78, DOI 10.1016/j.soilbio.2013.05.004; Zou J, 2007, FUNCT ECOL, V21, P721, DOI 10.1111/j.1365-2435.2007.01298.x; Zou JW, 2008, ECOGRAPHY, V31, P663, DOI 10.1111/j.0906-7590.2008.05540.x; Zou JW, 2008, BIOL INVASIONS, V10, P291, DOI 10.1007/s10530-007-9130-0; Zou JW, 2006, OECOLOGIA, V150, P272, DOI 10.1007/s00442-006-0512-2; Zou JW, 2009, BASIC APPL ECOL, V10, P79, DOI 10.1016/j.baae.2007.11.010	94	16	16	1	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74961	10.1371/journal.pone.0074961	http://dx.doi.org/10.1371/journal.pone.0074961			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040366	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600153
J	Kaliukhovich, DAE; Vogels, R				Kaliukhovich, Dzmitry A. e; Vogels, Rufin			Decoding of Repeated Objects from Local Field Potentials in Macaque Inferior Temporal Cortex	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; INFEROTEMPORAL CORTEX; SPIKING ACTIVITY; FMRI-ADAPTATION; REPETITION SUPPRESSION; INDUCED DISSOCIATION; HEMODYNAMIC SIGNALS; RECOGNITION MEMORY; EVOKED-POTENTIALS; NEURONAL-ACTIVITY	Stimulus repetition produces a decrease of the response and affects neuronal synchronization of macaque inferior temporal (IT) neurons. Previously we showed that such stimulus-specific adaptation results in a decreased accuracy by which IT neurons encode repeated compared to non-repeated objects. Not only spiking activity, but also local field potentials (LFPs) are affected by repetition. Here we ask how the repetition-induced changes in IT LFPs affect object decoding accuracy. To answer this, we recorded local field potentials using a laminar microelectrode in macaque IT. We presented two familiar stimuli each for 500 ms successively with an inter-stimulus interval of 500 ms. Trials consisted either of a repetition of the same stimulus or of their alternation. Machine learning-based classifier was employed to decode stimulus identity from the LFP power in different frequency bands of each penetration. We found that the object classification accuracy depended strongly on spectral frequency, with frequencies below 30 Hz (alpha and beta) producing greater accuracies than gamma bands. However, the effect of repetition on classification accuracy was stronger at the gamma frequencies, showing a decrease in classification accuracy for repeated stimuli and a tendency for an improved object encoding when the stimulus was preceded by a different stimulus. The present results demonstrate that due to adapting input, stimulus encoding in IT (1) can be more accurate for stimuli that differ from recently preceding ones while being impaired for stimuli that are repeated, and (2) these effects are more pronounced at high spectral frequencies of the LFP.	[Kaliukhovich, Dzmitry A. e; Vogels, Rufin] KU Leuven Med Sch, Lab Neuro Psychofysiol, Louvain, Belgium	KU Leuven	Vogels, R (corresponding author), KU Leuven Med Sch, Lab Neuro Psychofysiol, Louvain, Belgium.	Rufin.Vogels@med.kuleuven.be		Kaliukhovich, Dzmitry/0000-0002-7476-5730	Fonds voor Wetenschappelijk Onderzoek Vlaanderen; Geconcerteerde Onderzoeksactie [GOA/10/019]; Interuniversitaire Attractiepool and Programma Financiering [PF 10/008]; Hercules Foundation; Flemish Government - department EWI	Fonds voor Wetenschappelijk Onderzoek Vlaanderen(FWO); Geconcerteerde Onderzoeksactie; Interuniversitaire Attractiepool and Programma Financiering; Hercules Foundation; Flemish Government - department EWI	This work was supported by Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Geconcerteerde Onderzoeksactie (GOA/10/019), Interuniversitaire Attractiepool and Programma Financiering (PF 10/008). For the computation of classifiers we used the infrastructure of the VSC - Flemish Supercomputer Center, funded by the Hercules Foundation and the Flemish Government - department EWI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson B, 2008, CEREB CORTEX, V18, P2540, DOI 10.1093/cercor/bhn015; Bartolo MJ, 2011, EUR J NEUROSCI, V34, P1857, DOI 10.1111/j.1460-9568.2011.07877.x; BAYLIS GC, 1987, EXP BRAIN RES, V65, P614; Belitski A, 2008, J NEUROSCI, V28, P5696, DOI 10.1523/JNEUROSCI.0009-08.2008; Belitski A, 2010, J COMPUT NEUROSCI, V29, P533, DOI 10.1007/s10827-010-0230-y; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Cardoso MMB, 2012, NAT NEUROSCI, V15, P1298, DOI 10.1038/nn.3170; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; De Baene W, 2010, CEREB CORTEX, V20, P2145, DOI 10.1093/cercor/bhp277; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Fang F, 2007, CEREB CORTEX, V17, P1402, DOI 10.1093/cercor/bhl053; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; GROSS CG, 1967, J NEUROPHYSIOL, V30, P833, DOI 10.1152/jn.1967.30.4.833; GROSS CG, 1969, SCIENCE, V166, P1303, DOI 10.1126/science.166.3910.1303; Gutnisky DA, 2008, NATURE, V452, P220, DOI 10.1038/nature06563; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Jia XX, 2013, NEURON, V77, P762, DOI 10.1016/j.neuron.2012.12.036; Jia XX, 2013, J NEUROSCI, V33, P17, DOI 10.1523/JNEUROSCI.1687-12.2013; Kaliukhovich DA, 2013, J COGNITIVE NEUROSCI, V25, P777, DOI 10.1162/jocn_a_00355; Kaliukhovich DA, 2012, J NEUROPHYSIOL, V107, P3509, DOI 10.1152/jn.00059.2012; Kaliukhovich DA, 2011, CEREB CORTEX, V21, P1547, DOI 10.1093/cercor/bhq207; Khawaja FA, 2009, J NEUROSCI, V29, P13702, DOI 10.1523/JNEUROSCI.2844-09.2009; Kreiman G, 2006, NEURON, V49, P433, DOI 10.1016/j.neuron.2005.12.019; Krekelberg B, 2006, TRENDS NEUROSCI, V29, P250, DOI 10.1016/j.tins.2006.02.008; Liu J, 2006, J NEUROSCI, V26, P7779, DOI 10.1523/JNEUROSCI.5052-05.2006; Liu Y, 2009, J NEUROPHYSIOL, V101, P418, DOI 10.1152/jn.90960.2008; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Magri C, 2012, J NEUROSCI, V32, P1395, DOI 10.1523/JNEUROSCI.3985-11.2012; Maier A, 2008, NAT NEUROSCI, V11, P1193, DOI 10.1038/nn.2173; McMahon DBT, 2007, J NEUROPHYSIOL, V97, P3532, DOI 10.1152/jn.01042.2006; MILLER EK, 1991, VISUAL NEUROSCI, V7, P357, DOI 10.1017/S0952523800004843; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; Misaki M, 2010, NEUROIMAGE, V53, P103, DOI 10.1016/j.neuroimage.2010.05.051; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; MITZDORF U, 1987, INT J NEUROSCI, V33, P33, DOI 10.3109/00207458708985928; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Patterson CA, 2013, J NEUROSCI, V33, P532, DOI 10.1523/JNEUROSCI.3345-12.2013; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Rauch A, 2008, P NATL ACAD SCI USA, V105, P6759, DOI 10.1073/pnas.0800312105; Ray S, 2008, J NEUROSCI, V28, P7334, DOI 10.1523/JNEUROSCI.1588-08.2008; Ray S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001477; Ray S, 2011, J NEUROSCI, V31, P12674, DOI 10.1523/JNEUROSCI.1856-11.2011; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; RICHES IP, 1991, J NEUROSCI, V11, P1763; Ringo JL, 1996, BEHAV BRAIN RES, V76, P191, DOI 10.1016/0166-4328(95)00197-2; Sawamura H, 2006, NEURON, V49, P307, DOI 10.1016/j.neuron.2005.11.028; Sirotin YB, 2009, NATURE, V457, P475, DOI 10.1038/nature07664; SOBOTKA S, 1993, EXP BRAIN RES, V96, P28, DOI 10.1007/BF00230436; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Verhoef BE, 2008, J NEUROSCI, V28, P10631, DOI 10.1523/JNEUROSCI.3333-08.2008; Viswanathan A, 2007, NAT NEUROSCI, V10, P1308, DOI 10.1038/nn1977; VOGELS R, 1995, VISUAL NEUROSCI, V12, P207, DOI 10.1017/S0952523800007884; Weiner KS, 2010, J NEUROPHYSIOL, V103, P3349, DOI 10.1152/jn.01108.2009; Zanos TP, 2011, J NEUROPHYSIOL, V105, P474, DOI 10.1152/jn.00642.2010	56	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74665	10.1371/journal.pone.0074665	http://dx.doi.org/10.1371/journal.pone.0074665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040313	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600141
J	Li, HH; Teo, YY; Tan, EK				Li, Huihua; Teo, Yik Ying; Tan, Eng King			Patterns of Linkage Disequilibrium of LRRK2 across Different Races: Implications for Genetic Association Studies	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT PARKINSONISM; DISEASE PATIENTS; MUTATIONS; VARIANTS; POPULATIONS; G2019S; LOCUS	Genome Wide Association Studies (GWASs) have identified trait-associated polymorphisms via a hypothesis-free approach. However, it is challenging when attempting to reproduce GWAS findings in different populations as it fundamentally relies on the similar patterns of linkage disequilibrium (LD) between the unknown causal variants and the genotyped single nucleotide polymorphisms (SNPs). To address this potential limitation, we examined the regional LD pattern of leucine-rich repeat kinase 2 (LRRK2) gene, which is responsible for both autosomal dominant and sporadic Parkinson's disease (PD), in Caucasians (CEU), Japanese (JPT) and Chinese (CHB) from HapMap and Chinese (CHS), Malays (MAS) and Indians (INS) from the Singapore Genome Variation Project (SGVP) utilizing the traditional heatmaps and targeted analysis of LRRK2 gene via Monte Carlo simulation through varLD scores of these ethnic groups. Both heatmaps and targeted analysis showed that LD pattern of JPT was different from that of INS (P=0.0001); while LD pattern of CEU was different from that in Asian except for INS (all P=0.0001). Our study suggests that there is a higher chance to detect associations between PD and those trait-associated SNPs of LRRK2 gene found in Caucasian studies in INS, while those found in Japanese studies are likely to be better replicated among CHB.	[Li, Huihua] Singapore Gen Hosp, Div Res, Hlth Serv Res & Biostat Unit, Singapore, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Tan, Eng King] Singapore Gen Hosp, Natl Inst Neurosci, Dept Clin Res, Singapore, Singapore; [Tan, Eng King] Singapore Gen Hosp, Natl Inst Neurosci, Dept Neurol, Singapore, Singapore; [Tan, Eng King] Duke NUS Grad Med Sch, Singapore, Singapore	Singapore General Hospital; National University of Singapore; National Neuroscience Institute (NNI); Singapore General Hospital; National Neuroscience Institute (NNI); Singapore General Hospital; National University of Singapore	Tan, EK (corresponding author), Singapore Gen Hosp, Natl Inst Neurosci, Dept Clin Res, Singapore, Singapore.	gnrtek@sgh.com.sg			National Medical Research Council	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by National Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Rijk MC, 2000, NEUROLOGY, V54, pS21; Di Fonzo A, 2006, EUR J HUM GENET, V14, P322, DOI 10.1038/sj.ejhg.5201539; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Funayama M, 2002, ANN NEUROL, V51, P296, DOI 10.1002/ana.10113; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Kachergus J, 2005, AM J HUM GENET, V76, P672, DOI 10.1086/429256; Lesage S, 2006, NEW ENGL J MED, V354, P422, DOI 10.1056/NEJMc055540; Nichols WC, 2005, LANCET, V365, P410, DOI 10.1016/S0140-6736(05)17828-3; Ozelius LJ, 2006, NEW ENGL J MED, V354, P424, DOI 10.1056/NEJMc055509; Paisan-Ruiz C, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.036889; Paisan-Ruiz C, 2009, HUM MUTAT, V30, P1153, DOI 10.1002/humu.21038; Punia S, 2006, NEUROSCI LETT, V409, P83, DOI 10.1016/j.neulet.2006.04.052; Ross OA, 2008, ANN NEUROL, V64, P88, DOI 10.1002/ana.21405; Sadhukhan T, 2012, DIS MARKERS, V32, P355, DOI [10.1155/2012/895065, 10.3233/DMA-2012-0898]; Sanyal J, 2010, GENET TEST MOL BIOMA, V14, P691, DOI 10.1089/gtmb.2010.0054; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Tan EK, 2007, HUM GENET, V120, P857, DOI 10.1007/s00439-006-0268-0; Tan EK, 2007, HUM MUTAT, V28, P641, DOI 10.1002/humu.20507; Tan EK, 2011, LANCET NEUROL, V10, P869, DOI 10.1016/S1474-4422(11)70185-5; Teo YY, 2009, GENOME RES, V19, P1849, DOI 10.1101/gr.092189.109; Teo YY, 2009, GENET EPIDEMIOL, V33, P128, DOI 10.1002/gepi.20366; Teo YY, 2010, GENET EPIDEMIOL, V34, P653, DOI 10.1002/gepi.20522; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005; Zimprich A, 2004, AM J HUM GENET, V74, P11, DOI 10.1086/380647	25	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e75041	10.1371/journal.pone.0075041	http://dx.doi.org/10.1371/journal.pone.0075041			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040382	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600154
J	Joo, R; Bertrand, S; Tam, J; Fablet, R				Joo, Rocio; Bertrand, Sophie; Tam, Jorge; Fablet, Ronan			Hidden Markov Models: The Best Models for Forager Movements?	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; SPATIAL-DISTRIBUTION; POSITIONAL ENTROPY; NEURAL NETWORKS; BEHAVIOR; SPACE; CLASSIFICATION; TELEMETRY; TRAJECTORIES; VALIDATION	One major challenge in the emerging field of movement ecology is the inference of behavioural modes from movement patterns. This has been mainly addressed through Hidden Markov models (HMMs). We propose here to evaluate two sets of alternative and state-of-the-art modelling approaches. First, we consider hidden semi-Markov models (HSMMs). They may better represent the behavioural dynamics of foragers since they explicitly model the duration of the behavioural modes. Second, we consider discriminative models which state the inference of behavioural modes as a classification issue, and may take better advantage of multivariate and non linear combinations of movement pattern descriptors. For this work, we use a dataset of >200 trips from human foragers, Peruvian fishermen targeting anchovy. Their movements were recorded through a Vessel Monitoring System (similar to 1 record per hour), while their behavioural modes (fishing, searching and cruising) were reported by on-board observers. We compare the efficiency of hidden Markov, hidden semi-Markov, and three discriminative models (random forests, artificial neural networks and support vector machines) for inferring the fishermen behavioural modes, using a cross-validation procedure. HSMMs show the highest accuracy (80%), significantly outperforming HMMs and discriminative models. Simulations show that data with higher temporal resolution, HSMMs reach nearly 100% of accuracy. Our results demonstrate to what extent the sequential nature of movement is critical for accurately inferring behavioural modes from a trajectory and we strongly recommend the use of HSMMs for such purpose. In addition, this work opens perspectives on the use of hybrid HSMM-discriminative models, where a discriminative setting for the observation process of HSMMs could greatly improve inference performance.	[Joo, Rocio; Bertrand, Sophie] IRD, UMR Exploited Marine Ecosyst 212, Sete, France; [Joo, Rocio; Tam, Jorge] Inst Mar Peru, Callao, Peru; [Fablet, Ronan] Inst TELECOM TELECOM Bretagne, UMR Informat & Commun Sci & Technol Lab LabSTIC 6, Brest, France	Institut de Recherche pour le Developpement (IRD); Instituto del Mar del Peru; IMT - Institut Mines-Telecom; IMT Atlantique	Joo, R (corresponding author), IRD, UMR Exploited Marine Ecosyst 212, Sete, France.	rocio.joo@ird.fr	fablet, ronan/L-5574-2019; Joo, Rocio/H-8238-2019; bertrand, sophie/F-4161-2012	fablet, ronan/0000-0002-6462-423X; bertrand, sophie/0000-0003-1976-3799; Tam, Jorge/0000-0001-8224-4313	ANR project TOPINEME (TOp Predators as INdicators of Exploited Marine Ecosystem dynamics); International Joint Laboratory DISCOH (DInamicas del Sistema de la COrriente de Humboldt); ARTS grant from IRD	ANR project TOPINEME (TOp Predators as INdicators of Exploited Marine Ecosystem dynamics)(French National Research Agency (ANR)); International Joint Laboratory DISCOH (DInamicas del Sistema de la COrriente de Humboldt); ARTS grant from IRD	This work was supported by and is a contribution to the ANR project TOPINEME (TOp Predators as INdicators of Exploited Marine Ecosystem dynamics) and the International Joint Laboratory DISCOH (DInamicas del Sistema de la COrriente de Humboldt). R. Joo was financially supported by an ARTS grant from IRD and managed by Campus France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1981, J ECONOMETRICS, V16, P3, DOI 10.1016/0304-4076(81)90071-3; Bengio Y., 1999, Neural Computing Surveys, V2; Bergman CM, 2000, OECOLOGIA, V123, P364, DOI 10.1007/s004420051023; Bertrand S, 2005, ICES J MAR SCI, V62, P477, DOI 10.1016/j.icesjms.2004.12.002; Bertrand S, 2012, J APPL ECOLOGY; Bertrand S, 2007, ECOL APPL, V17, P331, DOI 10.1890/06-0303; Bertrand S, 2008, PROG OCEANOGR, V79, P379, DOI 10.1016/j.pocean.2008.10.009; Bertrand S, 2008, PROG OCEANOGR, V79, P278, DOI 10.1016/j.pocean.2008.10.017; Bestley S, 2010, ECOLOGY, V91, P2373, DOI 10.1890/08-2019.1; Beyreuther M, 2011, NONLINEAR PROC GEOPH, V18, P81, DOI 10.5194/npg-18-81-2011; Bourlard H., 1994, CONNECTIONIST SPEECH; Bourlard H, 1998, LECT NOTES ARTIFICIA; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Byun H, 2002, LECT NOTES COMPUT SC, V2388, P213; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chapelle O., 2006, SEMISUPERVISED LEARN; Chavez FP, 2008, PROG OCEANOGR, V79, P95, DOI 10.1016/j.pocean.2008.10.012; Cook TR, 2012, MAR BIOL, V159, P373, DOI 10.1007/s00227-011-1815-3; Crisci C, 2012, ECOL MODEL, V240, P113, DOI 10.1016/j.ecolmodel.2012.03.001; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dean B, 2012, J ROYAL SOC INTERFAC, DOI DOI 10.1098/RSIF.2012.0570.; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dietterich T. G., 2002, Structural, Syntactic, and Statistical Pattern Recognition. Joint IAPR International Workshops SSPR 2002 and SPR 2002 (Lecture Notes in Computer Science Vol. 2396), P15; Dong M, 2007, MECH SYST SIGNAL PR, V21, P2248, DOI 10.1016/j.ymssp.2006.10.001; Dragon AC, 2012, MAR ECOL PROG SER, V452, P253, DOI 10.3354/meps09618; Franke A, 2004, ECOL MODEL, V173, P259, DOI 10.1016/j.ecolmodel.2003.06.004; Franke A, 2006, ECOL MODEL, V197, P237, DOI 10.1016/j.ecolmodel.2006.02.043; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI DOI 10.1007/978-0-387-84858-7; Ganapathiraju A., 2000, P INT C SPOK LANG PR, P504; Gimpel K, 2008, TECHNICAL REPORT; Guedon Y, 2003, J COMPUT GRAPH STAT, V12, P604, DOI 10.1198/1061860032030; Guedon Y, 2007, COMPUT STAT DATA AN, V51, P2379, DOI 10.1016/j.csda.2006.03.015; Guilford T, 2004, J THEOR BIOL, V227, P25, DOI 10.1016/j.jtbi.2003.07.003; Hart T, 2010, MAR BIOL, V157, P1543, DOI 10.1007/s00227-010-1428-2; He XD, 2008, IEEE SIGNAL PROC MAG, V25, P14, DOI 10.1109/MSP.2008.926652; Heaslip SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033259; Heskes T, 1996, IEEE T NEURAL NETWOR, V7, P919, DOI 10.1109/72.508935; Hijmans RJ, 2012, ECOLOGY, V93, P679, DOI 10.1890/11-0826.1; Jaiantilal A, 2009, CLASSIFICATION REGRE; JOHNSON AR, 1992, LANDSCAPE ECOL, V7, P63, DOI 10.1007/BF02573958; Jonsen ID, 2013, DEEP-SEA RES PT II, V88-89, P34, DOI 10.1016/j.dsr2.2012.07.008; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Joo R, 2011, ECOL MODEL, V222, P1048, DOI 10.1016/j.ecolmodel.2010.08.039; Kohavi R., 1998, MACH LEARN, V30-2, P271, DOI [DOI 10.1023/A:1017181826899, 10.1023/A:1017181826899]; Langrock R, 2012, ECOLOGY, V93, P2336, DOI 10.1890/11-2241.1; Lau KK, 2006, J THEOR BIOL, V239, P71, DOI 10.1016/j.jtbi.2005.07.013; Levinson S. E., 1986, Computer Speech and Language, V1, P29, DOI 10.1016/S0885-2308(86)80009-2; Mann RP, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002961; McSherry F, 2008, LECT NOTES COMPUT SC, V4956, P414; Meyer D, 2003, NEUROCOMPUTING, V55, P169, DOI 10.1016/S0925-2312(03)00431-4; Mjolsness E, 2001, SCIENCE, V293, P2051, DOI 10.1126/science.293.5537.2051; Morales JM, 2005, LANDSCAPE ECOL, V20, P301, DOI 10.1007/s10980-005-0061-9; Mountrakis G, 2011, ISPRS J PHOTOGRAMM, V66, P247, DOI 10.1016/j.isprsjprs.2010.11.001; Murphy, 1998, HIDDEN MARKOV MODEL; Nallapati R, 2004, P 27 ANN INT ACM SIG, P64, DOI [10.1145/1008992.1009006, DOI 10.1145/1008992.1009006.URL]; Nams VO, 1996, LANDSCAPE ECOL, V11, P289, DOI 10.1007/BF02059856; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Olden JD, 2008, Q REV BIOL, V83, P171, DOI 10.1086/587826; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Patterson TA, 2009, J ANIM ECOL, V78, P1113, DOI 10.1111/j.1365-2656.2009.01583.x; Pedersen MW, 2011, OIKOS, V120, P1281, DOI 10.1111/j.1600-0706.2011.19044.x; Peel D, 2011, CAN J FISH AQUAT SCI, V68, P1252, DOI 10.1139/F2011-055; Peraltilla S, IN SITU MEASUREMENTS; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Roberts S, 2004, J THEOR BIOL, V227, P39, DOI 10.1016/j.jtbi.2003.07.002; Sacks J, 2012, STAT SCI, V27, P308, DOI 10.1214/12-STS386; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SIEGEL S., 1956, NONPARAMETRIC STAT B; Stadermann J, 2004, ICSLP INTERSPEECH JE; Tan CO, 2006, ECOL INFORM, V1, P195, DOI 10.1016/j.ecoinf.2006.03.002; Thiebault A, SPLITTING A IN PRESS; Vermard Y, 2010, ECOL MODEL, V221, P1757, DOI 10.1016/j.ecolmodel.2010.04.005; Walker E, 2010, ECOL MODEL, V221, P2008, DOI 10.1016/j.ecolmodel.2010.05.007; Warner B, 1996, AM STAT, V50, P284, DOI 10.2307/2684922; Whitehead H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060901; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; WITH KA, 1994, LANDSCAPE ECOL, V9, P25, DOI 10.1007/BF00135076; Yu SZ, 2010, ARTIF INTELL, V174, P215, DOI 10.1016/j.artint.2009.11.011; Zhang GQP, 2000, IEEE T SYST MAN CY C, V30, P451, DOI 10.1109/5326.897072	80	51	51	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e71246	10.1371/journal.pone.0071246	http://dx.doi.org/10.1371/journal.pone.0071246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24058400	Green Published, gold, Green Submitted			2022-12-25	WOS:000324403200004
J	Kim, MY; Muto, J; Gallo, RL				Kim, Margaret Y.; Muto, Jun; Gallo, Richard L.			Hyaluronic Acid Oligosaccharides Suppress TLR3-Dependent Cytokine Expression in a TLR4-Dependent Manner	PLOS ONE			English	Article							NF-KAPPA-B; RHEUMATOID-ARTHRITIS; INCREASED MORTALITY; RECEPTOR; INFLAMMATION; INJURY; CD44; TRAF1; SKIN; MACROPHAGES	The release of endogenous molecules from the skin after injury has been proposed to influence inflammation. Recent studies have found that pro-inflammatory signals can be generated by damaged endogenous self-RNA, and this event is detected by TLR3. Conversely, release of endogenous fragments of hyaluronic acid (HA) after injury has been proposed to inhibit LPS induced inflammation driven by TLR4. In this study we investigated if HA oligomers could also influence inflammation mediated by TLR3. A tetramer form of HA (oligo-HA) was added to MH-S cells (mouse alveolar macrophage cell line) that were then activated by poly(I:C). ELISA analysis of culture supernatants showed that the presence of oligo-HA suppressed the poly(I:C) induced release of IL-6 and TNF alpha. IL-6 mRNA expression was also suppressed as measured by quantitative RT-PCR. To determine the mechanism of action for oligo-HA to inhibit poly(I:C), macrophages derived from wild-type (WT), Tlr2-/- or Tlr4-/- mice were treated with oligo-HA and poly(I:C). Similar to WT cells, Tlr2-/- macrophages were inhibited by oligo-HA and retained suppression of cytokine release. In contrast, Tlr4-/- macrophages lost the capacity to be suppressed by oligo-HA. An increase in Traf1 (TLR negative regulator) mRNA was observed after oligo-HA treatment of WT but not in Tlr4-/- macrophages, and oligo-HA did not suppress cytokine responsiveness in Traf1-/- macrophages. These results show that oligo-HA acts through TLR4 and TRAF1 to inhibit TLR3-dependent inflammation. This observation illustrates the complex immunomodulatory action of endogenous products released after injury.	[Gallo, Richard L.] Univ Calif San Diego, Div Dermatol, San Diego, CA 92103 USA; VA San Diego Hlth Care Syst, San Diego, CA USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Gallo, RL (corresponding author), Univ Calif San Diego, Div Dermatol, San Diego, CA 92103 USA.	rgallo@ucsd.edu	Gallo, Richard L/A-8931-2009	Gallo, Richard L/0000-0002-1401-7861	NIH [P01HL057345, P01HL107150]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107150, P01HL057345] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants P01HL057345 and P01HL107150. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2011, PHILOS T R SOC B, V366, P2748, DOI 10.1098/rstb.2011.0106; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Bernard J.J., 2012, NAT MED; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Goto M, 2001, CLIN EXP RHEUMATOL, V19, P377; HARDWICK C, 1992, J CELL BIOL, V117, P1343, DOI 10.1083/jcb.117.6.1343; Heldin P, 2008, CONNECT TISSUE RES, V49, P215, DOI 10.1080/03008200802143323; Henkler F, 2003, J BIOL CHEM, V278, P29216, DOI 10.1074/jbc.M211090200; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Lee SY, 2007, ADV EXP MED BIOL, V597, P25; Liang JR, 2007, J IMMUNOL, V178, P2469, DOI 10.4049/jimmunol.178.4.2469; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lin Q, 2012, J INVEST DERMATOL, V132, P2085, DOI 10.1038/jid.2012.120; Lin Q, 2011, J IMMUNOL, V186, P3710, DOI 10.4049/jimmunol.1003007; Muto J, 2009, MOL IMMUNOL, V47, P449, DOI 10.1016/j.molimm.2009.08.026; Panoulas VF, 2009, ARTHRITIS RHEUM-US, V60, P39, DOI 10.1002/art.24176; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Schwenzer R, 1999, J BIOL CHEM, V274, P19368, DOI 10.1074/jbc.274.27.19368; Su XQ, 2006, EUR J IMMUNOL, V36, P199, DOI 10.1002/eji.200535415; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; UNDERHILL CB, 1993, DEV BIOL, V155, P324, DOI 10.1006/dbio.1993.1032; van Nies JAB, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2947; Wen HT, 2010, J EXP MED, V207, P2943, DOI 10.1084/jem.20101138; Yamasaki K, 2009, J BIOL CHEM, V284, P12762, DOI 10.1074/jbc.M806084200	31	56	59	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72421	10.1371/journal.pone.0072421	http://dx.doi.org/10.1371/journal.pone.0072421			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24058413	Green Published, Green Submitted, gold			2022-12-25	WOS:000324403200024
J	Ozturk, O; Aksac, A; Elsheikh, A; Ozyer, T; Alhajj, R				Ozturk, Orkun; Aksac, Alper; Elsheikh, Abdallah; Ozyer, Tansel; Alhajj, Reda			A Consistency-Based Feature Selection Method Allied with Linear SVMs for HIV-1 Protease Cleavage Site Prediction	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; NEURAL-NETWORK; GENE SELECTION; PROTEINS	Background: Predicting type-1 Human Immunodeficiency Virus (HIV-1) protease cleavage site in protein molecules and determining its specificity is an important task which has attracted considerable attention in the research community. Achievements in this area are expected to result in effective drug design (especially for HIV-1 protease inhibitors) against this life-threatening virus. However, some drawbacks (like the shortage of the available training data and the high dimensionality of the feature space) turn this task into a difficult classification problem. Thus, various machine learning techniques, and specifically several classification methods have been proposed in order to increase the accuracy of the classification model. In addition, for several classification problems, which are characterized by having few samples and many features, selecting the most relevant features is a major factor for increasing classification accuracy. Results: We propose for HIV-1 data a consistency-based feature selection approach in conjunction with recursive feature elimination of support vector machines (SVMs). We used various classifiers for evaluating the results obtained from the feature selection process. We further demonstrated the effectiveness of our proposed method by comparing it with a state-of-the-art feature selection method applied on HIV-1 data, and we evaluated the reported results based on attributes which have been selected from different combinations. Conclusion: Applying feature selection on training data before realizing the classification task seems to be a reasonable data-mining process when working with types of data similar to HIV-1. On HIV-1 data, some feature selection or extraction operations in conjunction with different classifiers have been tested and noteworthy outcomes have been reported. These facts motivate for the work presented in this paper. Software availability: The software is available at http://ozyer.etu.edu.tr/c-fs-svm.rar. The software can be downloaded at esnag.etu.edu.tr/software/hiv_cleavage_site_prediction.rar; you will find a readme file which explains how to set the software in order to work.	[Ozturk, Orkun; Aksac, Alper; Ozyer, Tansel] TOBB Univ, eSNAg Res Grp, Dept Comp Engn, Ankara, Turkey; [Elsheikh, Abdallah; Alhajj, Reda] Univ Calgary, Dept Comp Sci, Calgary, AB T2N 1N4, Canada; [Alhajj, Reda] Global Univ, Dept Comp Sci, Beirut, Lebanon; [Ozturk, Orkun; Aksac, Alper; Ozyer, Tansel] Raccoon Software Comp R&D Ltd, Ankara, Turkey	TOBB Ekonomi ve Teknoloji University; University of Calgary	Alhajj, R (corresponding author), Univ Calgary, Dept Comp Sci, Calgary, AB T2N 1N4, Canada.	alhajj@ucalgary.ca			Natural Sciences and Engineering Research Council, Canada	Natural Sciences and Engineering Research Council, Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research is partially supported by a research discovery grant from the Natural Sciences and Engineering Research Council, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Cai YD, 1998, J PROTEIN CHEM, V17, P607, DOI 10.1007/BF02780962; Cai YD, 2002, J COMPUT CHEM, V23, P267, DOI 10.1002/jcc.10017; Calvo B, 2009, PATTERN RECOGN LETT, V30, P1027, DOI 10.1016/j.patrec.2009.04.015; Chou KC, 1996, PROTEINS, V24, P51, DOI 10.1002/(SICI)1097-0134(199601)24:1&lt;51::AID-PROT4&gt;3.0.CO;2-R; Chou KC, 1996, ANAL BIOCHEM, V233, P1, DOI 10.1006/abio.1996.0001; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dash M., 1997, Intelligent Data Analysis, V1; Dash M, 2003, ARTIF INTELL, V151, P155, DOI 10.1016/S0004-3702(03)00079-1; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Derrac J, 2011, SWARM EVOL COMPUT, V1, P3, DOI 10.1016/j.swevo.2011.02.002; Garcia S, 2010, INFORM SCIENCES, V180, P2044, DOI 10.1016/j.ins.2009.12.010; Glaab E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039932; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Guyon Isabelle, 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hall M., 2009, SIGKDD EXPLORATIONS, V11; Jaeger S, 2010, J DATA SCI, V8; Jayavardhana RGL, 2005, 2005 INTERNATIONAL CONFERENCE ON INTELLIGENT SENSING AND INFORMATION PROCESSING, PROCEEDINGS, P469, DOI 10.1109/ICISIP.2005.1529500; Kim G, 2008, P 2008 INT C BIOMEDI; Kim G, 2010, ARTIF INTELL MED, V48, P83, DOI 10.1016/j.artmed.2009.07.010; Kim H, 2008, COMPUT BIOL CHEM, V32, P72, DOI 10.1016/j.compbiolchem.2007.09.006; Liu H., 1996, ICML, V96, P319; Liu H, 2010, JMLR WORKSH CONF PRO, V10, P4; Loris N, 2006, PATTERN RECOGNITION, V39; Lumini A, 2006, PATTERN RECOGN LETT, V27, P1537, DOI 10.1016/j.patrec.2006.01.014; Machine SV, 2001, SEQUENTIAL MINIMAL O; Mitchell TM, 1997, ANN REV COMPUTER SCI, V4, P255; Nanni L, 2006, NEUROCOMPUTING, V69, P838, DOI 10.1016/j.neucom.2005.09.004; Nanni L, 2011, EXPERT SYST APPL, V38, P3185, DOI 10.1016/j.eswa.2010.09.005; Narayanan Ajit, 2002, Bioinformatics, V18 Suppl 1, pS5; Niu B, 2009, J COMPUT CHEM, V30, P33, DOI 10.1002/jcc.21024; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; Ogul H, 2009, BIOSYSTEMS, V96, P246, DOI 10.1016/j.biosystems.2009.03.001; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Rognvaldsson T, 2004, BIOINFORMATICS, V20, P1702, DOI 10.1093/bioinformatics/bth144; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Tan JY, 2009, LECT NOTES OPER RES, V11, P237; Thompson TB, 1995, J THEOR BIOL, V177, P369, DOI 10.1006/jtbi.1995.0254; Wood IA, 2007, BIOINFORMATICS, V23, P1363, DOI 10.1093/bioinformatics/btm117; Yang ZR, 2005, IEEE T NEURAL NETWOR, V16, P263, DOI 10.1109/TNN.2004.836196; Yang ZR, 2004, BIOINFORMATICS, V20, P735, DOI 10.1093/bioinformatics/btg477; You LW, 2005, J VIROL, V79, P12477, DOI 10.1128/JVI.79.19.12477-12486.2005; Yu  Y., 2008, COMPUTER ENG; Zhao YD, 2003, BIOINFORMATICS, V19, P1978, DOI 10.1093/bioinformatics/btg255	43	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e63145	10.1371/journal.pone.0063145	http://dx.doi.org/10.1371/journal.pone.0063145			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24058397	Green Submitted, Green Published, gold			2022-12-25	WOS:000324403200001
J	Wolfs, IMJ; Stoger, JL; Goossens, P; Pottgens, C; Gijbels, MJJ; Wijnands, E; van der Vorst, EPC; van Gorp, P; Beckers, L; Engel, D; Biessen, EAL; Kraal, G; van Die, I; Donners, MMPC; de Winther, MPJ				Wolfs, Ine M. J.; Stoger, J. Lauran; Goossens, Pieter; Pottgens, Chantal; Gijbels, Marion J. J.; Wijnands, Erwin; van der Vorst, Emiel P. C.; van Gorp, Patrick; Beckers, Linda; Engel, David; Biessen, Erik A. L.; Kraal, Georg; van Die, Irma; Donners, Marjo M. P. C.; de Winther, Menno P. J.			Reprogramming macrophages to an anti-inflammatory phenotype by helminth antigens reduces murine atherosclerosis	FASEB JOURNAL			English	Article						immune modulation; monocytes; inflammation; schistosome; mouse	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SCHISTOSOMA-MANSONI ANTIGENS; TRICHURIS-SUIS THERAPY; SOLUBLE EGG ANTIGEN; IMMUNE-RESPONSE; TH2 RESPONSES; IN-VIVO; MICE; ACTIVATION; DISEASE	Atherosclerosis is a lipid-driven inflammatory disease of the vessel wall, characterized by the chronic activation of macrophages. We investigated whether the helminth-derived antigens [soluble egg antigens (SEAs)] could modulate macrophage inflammatory responses and protect against atherosclerosis in mice. In bone marrow-derived macrophages, SEAs induce anti-inflammatory macrophages, typified by high levels of IL-10 and reduced secretion of proinflammatory mediators. In hyperlipidemic LDLR-/- mice, SEA treatment reduced plaque size by 44%, and plaques were less advanced compared with PBS-injected littermate controls. The atheroprotective effect of SEAs was found to be mainly independent of cholesterol lowering and T-lymphocyte responses but instead could be attributed to diminished myeloid cell activation. SEAs reduced circulating neutrophils and inflammatory Ly6C(high) monocytes, and macrophages showed high IL-10 production. In line with the observed systemic effects, atherosclerotic lesions of SEA-treated mice showed reduced intraplaque inflammation as inflammatory markers [TNF-, monocyte chemotactic protein 1 (MCP-1), intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and CD68], neutrophil content, and newly recruited macrophages were decreased. We show that SEA treatment protects against atherosclerosis development by dampening inflammatory responses. In the future, helminth-derived components may provide novel opportunities to treat chronic inflammatory diseases, as they diminish systemic inflammation and reduce the activation of immune cells.Wolfs, I. M. J., Stoger, J. L., Goossens, P., Pottgens, C., Gijbels, M. J. J., Wijnands, E., van der Vorst, E. P. C., van Gorp, P., Beckers, L., Engel, D., Biessen, E. A. L., Kraal, G., van Die, I., Donners, M. M. P. C., de Winther, M. P. J. Reprogramming macrophages to an anti-inflammatory phenotype by helminth antigens reduces murine atherosclerosis.	[Wolfs, Ine M. J.; Stoger, J. Lauran; Goossens, Pieter; Pottgens, Chantal; Gijbels, Marion J. J.; van der Vorst, Emiel P. C.; van Gorp, Patrick; Donners, Marjo M. P. C.; de Winther, Menno P. J.] Maastricht Univ, Cardiovasc Res Inst Maastricht CARIM, Dept Mol Genet, Maastricht, Netherlands; [Wolfs, Ine M. J.; Gijbels, Marion J. J.; Wijnands, Erwin; Beckers, Linda; Engel, David; Biessen, Erik A. L.; Donners, Marjo M. P. C.] Maastricht Univ, Cardiovasc Res Inst Maastricht CARIM, Dept Pathol, Maastricht, Netherlands; [Pottgens, Chantal] Maastricht Univ, Cardiovasc Res Inst Maastricht CARIM, Dept Physiol, Maastricht, Netherlands; [Stoger, J. Lauran; Gijbels, Marion J. J.; Beckers, Linda; de Winther, Menno P. J.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Goossens, Pieter] Aix Marseille Univ, Ctr Immunol Marseille Luminy, Marseille, France; [Kraal, Georg; van Die, Irma] Vrije Univ Amsterdam, Med Ctr Amsterdam, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands	Maastricht University; Maastricht University; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Vrije Universiteit Amsterdam	de Winther, MPJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Rm L01-146-2,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.dewinther@amc.uva.nl	van Gorp, Patrick/L-9580-2018; van Gorp, Patrick/S-3892-2019; Stöger, Lauran/AAE-9667-2021; Stoger, Lauran/AAX-5117-2021	van Gorp, Patrick/0000-0002-0355-5349; van Gorp, Patrick/0000-0002-0355-5349; Stöger, Lauran/0000-0002-4705-4837; Goossens, Pieter/0000-0002-7269-6372; Biessen, Erik/0000-0002-6454-8548; de Winther, Menno/0000-0002-4038-6636	Netherlands Heart Foundation [2007T034, 2012T079, 2007T067]; Nederlandse Organisatie voor Wetenschappelijk Onderz (NWO)-Vidi [917.066.329]	Netherlands Heart Foundation(Netherlands Heart Foundation); Nederlandse Organisatie voor Wetenschappelijk Onderz (NWO)-Vidi	M.M.P.C.D. and M.P.J.D.W. are supported by The Netherlands Heart Foundation (Dr. E. Dekker postdoctoral fellow grants 2007T034 and 2012T079 to M. M. P. C. D.; Dr. E. Dekker investigator grant 2007T067 to M.P.J.D.W.) and Nederlandse Organisatie voor Wetenschappelijk Onderz (NWO)-Vidi grant 917.066.329 (to M.P.J.D.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	ASSAADKHALIL SH, 1992, ANN BIOL CLIN-PARIS, V50, P697; Atochina O, 2006, EXP DERMATOL, V15, P461, DOI 10.1111/j.1600-0625.2006.00431.x; Atochina O, 2008, IMMUNOLOGY, V125, P111, DOI 10.1111/j.1365-2567.2008.02826.x; Bhargava P, 2012, NAT MED, V18, P1665, DOI 10.1038/nm.2962; BOROS DL, 1970, J EXP MED, V132, P488, DOI 10.1084/jem.132.3.488; Bouhlel MA, 2008, J INTERN MED, V263, P28, DOI 10.1111/j.1365-2796.2007.01892.x; Boyle J. J., 2005, Current Vascular Pharmacology, V3, P63, DOI 10.2174/1570161052773861; Burton OT, 2010, EUR J IMMUNOL, V40, P2221, DOI 10.1002/eji.200939998; Cooke A, 1999, PARASITE IMMUNOL, V21, P169, DOI 10.1046/j.1365-3024.1999.00213.x; Correale J, 2009, J IMMUNOL, V183, P5999, DOI 10.4049/jimmunol.0900897; Doenhoff MJ, 2002, PARASITOLOGY, V125, P415, DOI 10.1017/S0031182002002275; Dunne DW, 2005, NAT REV IMMUNOL, V5, P420, DOI 10.1038/nri1601; Eefting D, 2007, ATHEROSCLEROSIS, V193, P335, DOI 10.1016/j.atherosclerosis.2006.09.032; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; Feig JE, 2011, CIRCULATION, V123, P989, DOI 10.1161/CIRCULATIONAHA.110.984146; Fleming JO, 2011, MULT SCLER J, V17, P743, DOI 10.1177/1352458511398054; Fu GX, 2012, ENDOCRINE, V42, P676, DOI 10.1007/s12020-012-9675-2; Goh F, 2009, IMMUNOLOGY, V127, P326, DOI 10.1111/j.1365-2567.2008.02979.x; Goossens P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022327; Goossens P, 2010, CELL METAB, V12, P142, DOI 10.1016/j.cmet.2010.06.008; GRZYCH JM, 1991, J IMMUNOL, V146, P1322; Han XB, 2010, FASEB J, V24, P2869, DOI 10.1096/fj.09-148155; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Harnett W, 2010, NAT REV IMMUNOL, V10, P278, DOI 10.1038/nri2730; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Kreider T, 2007, CURR OPIN IMMUNOL, V19, P448, DOI 10.1016/j.coi.2007.07.002; Kuijk LM, 2010, IUBMB LIFE, V62, P303, DOI 10.1002/iub.304; La Flamme AC, 2007, PARASITE IMMUNOL, V29, P259, DOI 10.1111/j.1365-3024.2007.00942.x; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Nagayama Y, 2004, J IMMUNOL, V173, P2167, DOI 10.4049/jimmunol.173.3.2167; Okano M, 2001, J IMMUNOL, V167, P442, DOI 10.4049/jimmunol.167.1.442; Pancre V, 1999, IMMUNOLOGY, V98, P525, DOI 10.1046/j.1365-2567.1999.00887.x; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; PEARCE EJ, 1991, J EXP MED, V173, P159, DOI 10.1084/jem.173.1.159; Pearce EJ, 1996, INT IMMUNOL, V8, P435, DOI 10.1093/intimm/8.4.435; Potteaux S, 2011, J CLIN INVEST, V121, P2025, DOI 10.1172/JCI43802; Schramm G, 2010, MICROBES INFECT, V12, P881, DOI 10.1016/j.micinf.2010.06.001; Sewell D, 2003, INT IMMUNOL, V15, P59, DOI 10.1093/intimm/dxg012; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Smith P, 2007, J IMMUNOL, V178, P4557, DOI 10.4049/jimmunol.178.7.4557; Stoger JL, 2012, ATHEROSCLEROSIS, V225, P461, DOI 10.1016/j.atherosclerosis.2012.09.013; Summers RW, 2005, INFLAMM BOWEL DIS, V11, P783, DOI 10.1097/01.MIB.0000179316.50002.f3; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Summers RW, 2005, GUT, V54, P87, DOI 10.1136/gut.2004.041749; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Thomas PG, 2005, J IMMUNOL, V175, P2082, DOI 10.4049/jimmunol.175.4.2082; van der Valk FM, 2012, CURR OPIN LIPIDOL, V23, P532, DOI 10.1097/MOL.0b013e3283587543; van Die I, 2010, GLYCOBIOLOGY, V20, P2, DOI 10.1093/glycob/cwp140; Weinstock JV, 2012, NATURE, V491, P183, DOI 10.1038/491183a; Zaccone P, 2003, EUR J IMMUNOL, V33, P1439, DOI 10.1002/eji.200323910; Zaccone P, 2011, EUR J IMMUNOL, V41, P2709, DOI 10.1002/eji.201141429; Zaccone P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/795210; Zaccone P, 2009, EUR J IMMUNOL, V39, P1098, DOI 10.1002/eji.200838871; Zheng XP, 2008, J NEUROIMMUNOL, V194, P107, DOI 10.1016/j.jneuroim.2007.12.001	57	61	66	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					288	299		10.1096/fj.13-235911	http://dx.doi.org/10.1096/fj.13-235911			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24043262	Green Submitted			2022-12-25	WOS:000333526100028
J	Miura, A; Kambe, Y; Inoue, K; Tatsukawa, H; Kurihara, T; Griffin, M; Kojima, S; Miyata, A				Miura, Ayako; Kambe, Yuki; Inoue, Kazuhiko; Tatsukawa, Hideki; Kurihara, Takashi; Griffin, Martin; Kojima, Soichi; Miyata, Atsuro			Pituitary Adenylate Cyclase-activating Polypeptide Type 1 Receptor (PAC1) Gene Is Suppressed by Transglutaminase 2 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ER Stress; G Protein-coupled Receptors (GPCRs); Gene Expression; Ischemia; Neurons; Neuropeptide; Sp1; PAC1; Pituitary Adenylate Cyclase-activating Polypeptide; Transglutaminase 2	TRANSIENT FOCAL ISCHEMIA; NERVE GROWTH-FACTOR; ER-STRESS; TISSUE TRANSGLUTAMINASE; ENDOPLASMIC-RETICULUM; PC12 CELLS; EXPRESSION; SP1; INDUCTION; APOPTOSIS	Background: The expression of PAC1, a specific receptor for PACAP, is decreased in brain ischemia. Results:PAC1 expression was attenuated by inactivation of Sp1 through cross-linking by transglutaminase 2 (TG2) activated by ER stress. Conclusion: TG2 is involved in negative regulation of PAC1 gene expression. Significance: Suppression of PAC1 by TG2 might be involved in neuronal damage from brain ischemia. Pituitary adenylate cyclase-activating polypeptide (PACAP) functions as a neuroprotective factor through the PACAP type 1 receptor, PAC1. In a previous work, we demonstrated that nerve growth factor augmented PAC1 gene expression through the activation of Sp1 via the Ras/MAPK pathway. We also observed that PAC1 expression in Neuro2a cells was transiently suppressed during in vitro ischemic conditions, oxygen-glucose deprivation (OGD). Because endoplasmic reticulum (ER) stress is induced by ischemia, we attempted to clarify how ER stress affects the expression of PAC1. Tunicamycin, which induces ER stress, significantly suppressed PAC1 gene expression, and salubrinal, a selective inhibitor of the protein kinase RNA-like endoplasmic reticulum kinase signaling pathway of ER stress, blocked the suppression. In luciferase reporter assay, we found that two Sp1 sites were involved in suppression of PAC1 gene expression due to tunicamycin or OGD. Immunocytochemical staining demonstrated that OGD-induced transglutaminase 2 (TG2) expression was suppressed by salubrinal or cystamine, a TG activity inhibitor. Further, the OGD-induced accumulation of cross-linked Sp1 in nuclei was suppressed by cystamine or salubrinal. Together with cystamine, R283, TG2-specific inhibitor, and siRNA specific for TG2 also ameliorated OGD-induced attenuation of PAC1 gene expression. These results suggest that Sp1 cross-linking might be crucial in negative regulation of PAC1 gene expression due to TG2 in OGD-induced ER stress.	[Miura, Ayako; Kambe, Yuki; Inoue, Kazuhiko; Kurihara, Takashi; Miyata, Atsuro] Kagoshima Univ, Dept Pharmacol, Grad Sch Med & Dent Sci, Kagoshima 8908544, Japan; [Tatsukawa, Hideki; Kojima, Soichi] RIKEN, Mol Ligand Biol Res Team, Chem Genom Res Grp, Dept Biol Chem,Adv Sci Inst, Wako, Saitama 3510198, Japan; [Griffin, Martin] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	Kagoshima University; RIKEN; Aston University	Miyata, A (corresponding author), Kagoshima Univ, Dept Pharmacol, Grad Sch Med & Dent Sci, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	amiyata@m3.kufm.kagoshima-u.ac.jp	Tatsukawa, Hideki/AAE-8377-2020; Kojima, Soichi/N-7104-2015	Kojima, Soichi/0000-0002-5252-1612; Griffin, Martin/0000-0003-3824-306X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21591182]; Grants-in-Aid for Scientific Research [25462225] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research 21591182 (to A. M.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Caccamo D, 2004, AMINO ACIDS, V27, P373, DOI 10.1007/s00726-004-0117-1; Colak G, 2012, NEUROBIOL DIS, V45, P1042, DOI 10.1016/j.nbd.2011.12.023; Curro M, 2009, AMINO ACIDS, V36, P725, DOI 10.1007/s00726-008-0122-x; Griffin M, 2008, BIOORG MED CHEM LETT, V18, P5559, DOI 10.1016/j.bmcl.2008.09.006; Hayashi T, 2004, NEUROBIOL DIS, V15, P229, DOI 10.1016/j.nbd.2003.10.005; Hoffmann A, 1998, ANN NY ACAD SCI, V865, P49, DOI 10.1111/j.1749-6632.1998.tb11162.x; Ientile R, 2004, NEUROSCI LETT, V363, P173, DOI 10.1016/j.neulet.2004.04.003; Kambe Y, 2012, J MOL NEUROSCI, V48, P550, DOI 10.1007/s12031-012-9754-0; Kuo TF, 2012, J CELL PHYSIOL, V227, P1130, DOI 10.1002/jcp.22833; Lee J, 2006, FASEB J, V20, P2375, DOI 10.1096/fj.06-5957fje; Lee MH, 2004, PHARM RES-DORDR, V21, P736, DOI 10.1023/B:PHAM.0000026421.09367.b3; Lee TH, 1998, STROKE, V29, P1687, DOI 10.1161/01.STR.29.8.1687; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Miki N, 2004, J BIOL CHEM, V279, P15025, DOI 10.1074/jbc.M313186200; Miura A, 2012, FEBS LETT, V586, P1731, DOI 10.1016/j.febslet.2012.05.009; Nakka VP, 2010, NEUROTOX RES, V17, P189, DOI 10.1007/s12640-009-9110-5; Reglodi D, 2000, ANN NY ACAD SCI, V921, P119; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Riek-Burchardt M, 2010, NEUROPHARMACOLOGY, V58, P199, DOI 10.1016/j.neuropharm.2009.07.032; Ryu H, 2003, J NEUROSCI, V23, P3597; Shin DM, 2008, BIOCHEM BIOPH RES CO, V365, P509, DOI 10.1016/j.bbrc.2007.11.007; Skill NJ, 2004, J BIOL CHEM, V279, P47754, DOI 10.1074/jbc.M402698200; Szegezdi E, 2003, ANN NY ACAD SCI, V1010, P186, DOI 10.1196/annals.1299.032; Tatsukawa H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-4; Tatsukawa H, 2009, GASTROENTEROLOGY, V136, P1783, DOI 10.1053/j.gastro.2009.01.007; Tolentino PJ, 2004, J NEUROCHEM, V89, P1301, DOI 10.1111/j.1471-4159.2004.02436.x; Tominaga A, 2008, J MOL NEUROSCI, V36, P73, DOI 10.1007/s12031-008-9127-x; Uchida D, 1996, BRAIN RES, V736, P280, DOI 10.1016/0006-8993(96)00716-0; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Verhaar R, 2012, NEUROBIOL DIS, V45, P839, DOI 10.1016/j.nbd.2011.10.012; Woo SK, 2012, J CEREBR BLOOD F MET, V32, P525, DOI 10.1038/jcbfm.2011.159; Yeh SH, 2011, NUCLEIC ACIDS RES, V39, P5412, DOI 10.1093/nar/gkr161; Yoo JO, 2012, J BIOL CHEM, V287, P14377, DOI 10.1074/jbc.M111.326074	34	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32720	32730		10.1074/jbc.M113.452706	http://dx.doi.org/10.1074/jbc.M113.452706			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24045949	Green Published, hybrid			2022-12-25	WOS:000328681700056
J	Melo, Z; de los Heros, P; Cruz-Rangel, S; Vazquez, N; Bobadilla, NA; Pasantes-Morales, H; Alessi, DR; Mercado, A; Gamba, G				Melo, Zesergio; de los Heros, Paola; Cruz-Rangel, Silvia; Vazquez, Norma; Bobadilla, Norma A.; Pasantes-Morales, Herminia; Alessi, Dario R.; Mercado, Adriana; Gamba, Gerardo			N-terminal Serine Dephosphorylation Is Required for KCC3 Cotransporter Full Activation by Cell Swelling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-CL COTRANSPORTER; CORPUS-CALLOSUM; PROTEIN-KINASES; SPAK KINASES; PHOSPHORYLATION; WNK3; MECHANISM; NKCC2; OSR1; HYPERTENSION	The K+:Cl- cotransporter (KCC) activity is modulated by phosphorylation/dephosphorylation processes. In isotonic conditions, KCCs are inactive and phosphorylated, whereas hypotonicity promotes their dephosphorylation and activation. Two phosphorylation sites (Thr-991 and Thr-1048) in KCC3 have been found to be critical for its regulation. However, here we show that the double mutant KCC3-T991A/T1048A could be further activated by hypotonicity, suggesting that additional phosphorylation site(s) are involved. We observed that in vitro activated STE20/SPS1-related proline/alanine-rich kinase (SPAK) complexed to its regulatory MO25 subunit phosphorylated KCC3 at Ser-96 and that in Xenopus laevis oocytes Ser-96 of human KCC3 is phosphorylated in isotonic conditions and becomes dephosphorylated during incubation in hypotonicity, leading to a dramatic increase in KCC3 function. Additionally, WNK3, which inhibits the activity of KCC3, promoted phosphorylation of Ser-96 as well as Thr-991 and Thr-1048. These observations were corroborated in HEK293 cells stably transfected with WNK3. Mutation of Ser-96 alone (KCC3-S96A) had no effect on the activity of the cotransporter when compared with wild type KCC3. However, when compared with the double mutant KCC3-T991A/T1048A, the triple mutant KCC3-S96A/T991A/T1048A activity in isotonic conditions was significantly higher, and it was not further increased by hypotonicity or inhibited by WNK3. We conclude that serine residue 96 of human KCC3 is a third site that has to be dephosphorylated for full activation of the cotransporter during hypotonicity.	[Melo, Zesergio; Vazquez, Norma; Bobadilla, Norma A.; Gamba, Gerardo] Univ Nacl Autonoma Mexico, Mol Physiol Unit, Inst Invest Biomed, Mexico City 14000, DF, Mexico; [Melo, Zesergio; Vazquez, Norma; Bobadilla, Norma A.; Gamba, Gerardo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City 14000, DF, Mexico; [de los Heros, Paola; Alessi, Dario R.] Univ Dundee, Coll Life Sci, MRC, Prot Phosphorylat & Ubiquitylat Unit, Dundee DD1 5EH, Scotland; [Cruz-Rangel, Silvia; Pasantes-Morales, Herminia] Univ Nacl Autonoma Mexico, Div Neurociencias, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Mercado, Adriana] Inst Nacl Cardiol Ignacio Chavez, Dept Nefrol, Mexico City 14080, DF, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; University of Dundee; Universidad Nacional Autonoma de Mexico; National Institute of Cardiology - Mexico	Gamba, G (corresponding author), Mol Physiol Unit, Vasco Quiroga 15, Mexico City 14000, DF, Mexico.	gamba@biomedicas.unam.mx	Mercado, Adriana/AAR-6143-2021; Melo, Zesergio/AAB-7153-2022; Gamba, Gerardo/P-4873-2016	Mercado, Adriana/0000-0002-6881-0160; Alessi, Dario/0000-0002-2140-9185; Melo, Zesergio/0000-0002-6702-204X; Gamba, Gerardo/0000-0002-4378-9043	Mexican Council of Science and Technology (CONACYT) [132503, 165815]; Wellcome Trust [091415]; CONACYT-Mexico; Medical Research Council [MC_UU_12016/2, MC_U127070193] Funding Source: researchfish; MRC [MC_UU_12016/2, MC_U127070193] Funding Source: UKRI	Mexican Council of Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Wellcome Trust(Wellcome TrustEuropean Commission); CONACYT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Grants 132503 and 165815 from the Mexican Council of Science and Technology (CONACYT) (to A. M. and G. G., respectively), and by the Grant 091415 from the Wellcome Trust (to D. R. A. and G. G.).; Supported by a scholarship from CONACYT-Mexico.	Adragna NC, 2004, J MEMBRANE BIOL, V201, P109, DOI 10.1007/s00232-004-0695-6; BIANCHINI L, 1988, J EXP BIOL, V137, P303; Campbell David G, 2002, J Biomol Tech, V13, P119; Chen YF, 2010, AM J TRANSL RES, V2, P345; Cruz-Rangel S, 2012, PFLUG ARCH EUR J PHY, V464, P317, DOI 10.1007/s00424-012-1137-4; Cruz-Rangel S, 2011, AM J PHYSIOL-CELL PH, V301, pC601, DOI 10.1152/ajpcell.00070.2011; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; de los Heros P, 2006, P NATL ACAD SCI USA, V103, P1976, DOI 10.1073/pnas.0510947103; Filippi BM, 2011, EMBO J, V30, P1730, DOI 10.1038/emboj.2011.78; Flatman PW, 2002, BBA-BIOMEMBRANES, V1566, P140, DOI 10.1016/S0005-2736(02)00586-2; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gamba G, 2012, AM J PHYSIOL-RENAL, V303, pF1573, DOI 10.1152/ajprenal.00508.2012; Gimenez I, 2005, AM J PHYSIOL-RENAL, V289, pF1341, DOI 10.1152/ajprenal.00214.2005; Howard HC, 2002, NAT GENET, V32, P384, DOI 10.1038/ng1002; Khan MZH, 2012, BIOCHEM BIOPH RES CO, V425, P456, DOI 10.1016/j.bbrc.2012.07.124; LAUF PK, 1988, AM J PHYSIOL, V255, pC331, DOI 10.1152/ajpcell.1988.255.3.C331; Lauf PK, 2000, CELL PHYSIOL BIOCHEM, V10, P341, DOI 10.1159/000016357; Mercado A, 2005, AM J PHYSIOL-RENAL, V289, pF1246, DOI 10.1152/ajprenal.00464.2004; Mercado A, 2001, AM J PHYSIOL-CELL PH, V281, pC670, DOI 10.1152/ajpcell.2001.281.2.C670; Mercado A, 2000, J BIOL CHEM, V275, P30326, DOI 10.1074/jbc.M003112200; Pacheco-Alvarez D, 2006, J BIOL CHEM, V281, P28755, DOI 10.1074/jbc.M603773200; Pacheco-Alvarez D, 2012, CELL PHYSIOL BIOCHEM, V29, P291, DOI 10.1159/000337610; Pedersen NB, 2010, KIDNEY INT, V78, P160, DOI 10.1038/ki.2010.130; Ponce-Coria J, 2008, P NATL ACAD SCI USA, V105, P8458, DOI 10.1073/pnas.0802966105; Richardson C, 2008, J CELL SCI, V121, P3293, DOI 10.1242/jcs.029223; Richardson C, 2008, J CELL SCI, V121, P675, DOI 10.1242/jcs.025312; Richardson C, 2011, J CELL SCI, V124, P789, DOI 10.1242/jcs.077230; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Rust MB, 2006, CIRC RES, V98, P549, DOI 10.1161/01.RES.0000204449.83861.22; Salin-Cantegrel A, 2011, J BIOL CHEM, V286, P28456, DOI 10.1074/jbc.M111.226894; Uyanik G, 2006, NEUROLOGY, V66, P1044, DOI 10.1212/01.wnl.0000204181.31175.8b; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180	33	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31468	31476		10.1074/jbc.M113.475574	http://dx.doi.org/10.1074/jbc.M113.475574			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24043619	Green Published, hybrid			2022-12-25	WOS:000330596200006
J	Aritua, V; Achor, D; Gmitter, FG; Albrigo, G; Wang, N				Aritua, Valente; Achor, Diann; Gmitter, Frederick G.; Albrigo, Gene; Wang, Nian			Transcriptional and Microscopic Analyses of Citrus Stem and Root Responses to Candidatus Liberibacter asiaticus Infection	PLOS ONE			English	Article							ZINC-FINGER PROTEINS; GENE-EXPRESSION; HUANGLONGBING DISEASE; SWEET ORANGE; SALICYLIC-ACID; SINENSIS; FAMILY; RESISTANCE; FRUIT; RICE	Huanglongbing (HLB) is the most destructive disease that affects citrus worldwide. The disease has been associated with Candidatus Liberibacter. HLB diseased citrus plants develop a multitude of symptoms including zinc and copper deficiencies, blotchy mottle, corky veins, stunting, and twig dieback. Ca. L. asiaticus infection also seriously affects the roots. Previous study focused on gene expression of leaves and fruit to Ca. L. asiaticus infection. In this study, we compared the gene expression levels of stems and roots of healthy plants with those in Ca. L. asiaticus infected plants using microarrays. Affymetrix microarray analysis showed a total of 988 genes were significantly altered in expression, of which 885 were in the stems, and 111 in the roots. Of these, 551 and 56 were up-regulated, while 334 and 55 were down-regulated in the stem and root samples of HLB diseased trees compared to healthy plants, respectively. Dramatic differences in the transcriptional responses were observed between citrus stems and roots to Ca. L. asiaticus infection, with only 8 genes affected in both the roots and stems. The affected genes are involved in diverse cellular functions, including carbohydrate metabolism, cell wall biogenesis, biotic and abiotic stress responses, signaling and transcriptional factors, transportation, cell organization, protein modification and degradation, development, hormone signaling, metal handling, and redox. Microscopy analysis showed the depletion of starch in the roots of the infected plants but not in healthy plants. Collapse and thickening of cell walls were observed in HLB affected roots, but not as severe as in the stems. This study provides insight into the host response of the stems and roots to Ca. L. asiaticus infection.	[Aritua, Valente; Wang, Nian] Univ Florida, Dept Microbiol & Cell Sci, Citrus Res & Educ Ctr, Lake Alfred, FL USA; [Achor, Diann] Univ Florida, Citrus Res & Educ Ctr, Lake Alfred, FL USA; [Gmitter, Frederick G.; Albrigo, Gene] Univ Florida, Citrus Res & Educ Ctr, Dept Hort Sci, Lake Alfred, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Wang, N (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Citrus Res & Educ Ctr, Lake Alfred, FL USA.	nianwang@ufl.edu	Wang, Nian/HDM-2087-2022	Wang, Nian/0000-0001-7743-0728	Citrus Research and Development Foundation	Citrus Research and Development Foundation	This work was supported by the Citrus Research and Development Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achor D. S., 2010, Plant Pathology Journal (Faisalabad), V9, P56; Albrecht U, 2008, PLANT SCI, V175, P291, DOI 10.1016/j.plantsci.2008.05.001; Albrecht U, 2012, PLANT SCI, V185, P118, DOI 10.1016/j.plantsci.2011.09.008; Alleva K, 2012, FEBS LETT, V586, P2991, DOI 10.1016/j.febslet.2012.06.013; Baldwin E, 2010, J AGR FOOD CHEM, V58, P1247, DOI 10.1021/jf9031958; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bove JM, 2006, J PLANT PATHOL, V88, P7; Burkle L, 2003, PLANT J, V34, P13, DOI 10.1046/j.1365-313X.2003.01700.x; Campbell P, 1999, TRENDS PLANT SCI, V4, P361, DOI 10.1016/S1360-1385(99)01468-5; Dagulo L, 2010, J FOOD SCI, V75, pC199, DOI 10.1111/j.1750-3841.2009.01495.x; Darley CP, 2001, PLANT MOL BIOL, V47, P179, DOI 10.1023/A:1010687600670; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Etxeberria E, 2009, PHYSIOL MOL PLANT P, V74, P76, DOI 10.1016/j.pmpp.2009.09.004; Fan J, 2010, PLANT PATHOL, V59, P1037, DOI 10.1111/j.1365-3059.2010.02328.x; Fan J, 2012, MOL PLANT MICROBE IN, V25, P1396, DOI 10.1094/MPMI-06-12-0150-R; Fan J, 2011, PHYSIOL PLANTARUM, V143, P235, DOI 10.1111/j.1399-3054.2011.01502.x; Feng CP, 2004, PLANT SCI, V167, P1099, DOI 10.1016/j.plantsci.2004.06.014; Folimonova SY, 2010, PHYTOPATHOLOGY, V100, P949, DOI 10.1094/PHYTO-100-9-0949; Gao HY, 2005, MOL PLANT MICROBE IN, V18, P1035, DOI 10.1094/MPMI-18-1035; Gray-Mitsumune M, 2004, PLANT PHYSIOL, V135, P1552, DOI 10.1104/pp.104.039321; Gray-Mitsumunel M, 2004, PLANT BIOLOGY, V6, P47, DOI 10.1055/s-2003-44747; Husbands A, 2007, NUCLEIC ACIDS RES, V35, P6663, DOI 10.1093/nar/gkm775; Jang JY, 2012, PLANT SIGNAL BEHAV, V7, P1180, DOI 10.4161/psb.21178; Johnson E, 2012, PHYTOPATHOLOGY, V102, P59; Keegstra K, 2006, SCIENCE, V311, P1872, DOI 10.1126/science.1125938; Kim JS, 2009, PHYTOPATHOLOGY, V99, P50, DOI 10.1094/PHYTO-99-1-0050; Kogenaru S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-629; Kovi M, 2011, THEOR APPL GENET, V123, P705, DOI 10.1007/s00122-011-1620-x; Lai ZB, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-68; Lamport DTA, 2011, PLANT PHYSIOL, V156, P11, DOI 10.1104/pp.110.169011; Lawton K, 1995, MOL PLANT MICROBE IN, V8, P863, DOI 10.1094/MPMI-8-0863; Li M, 2009, PLANT J, V60, P1055, DOI 10.1111/j.1365-313X.2009.04022.x; Liao HL, 2012, J EXP BOT, V63, P3307, DOI 10.1093/jxb/ers070; Lijavetzky D, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-17; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mafra V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-247; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Martinelli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038039; Molina-Hidalgo FJ, 2013, J EXP BOT, V64, P1471, DOI 10.1093/jxb/ers386; Nomura K, 2005, CURR OPIN PLANT BIOL, V8, P361, DOI 10.1016/j.pbi.2005.05.005; Nwugo CC, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-59; Ogata T, 2008, P 1 INT RES C HUANGL, P184; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rosales R, 2011, J PLANT GROWTH REGUL, V30, P312, DOI 10.1007/s00344-011-9193-0; Rosti J, 2007, PLANT CELL, V19, P1565, DOI 10.1105/tpc.106.049619; Ryan CA, 2003, P NATL ACAD SCI USA, V100, P14577, DOI 10.1073/pnas.1934788100; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Scheidig A, 2002, PLANT J, V30, P581, DOI 10.1046/j.1365-313X.2002.01317.x; Schneider H., 1981, STAIN PROCED, V4th, P315; SCHUSTER B, 1995, P NATL ACAD SCI USA, V92, P8433, DOI 10.1073/pnas.92.18.8433; Seifert GJ, 2010, PLANT PHYSIOL, V153, P467, DOI 10.1104/pp.110.153940; Shuai B, 2002, PLANT PHYSIOL, V129, P747, DOI 10.1104/pp.010926; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Song HK, 1998, J MOL BIOL, V275, P347, DOI 10.1006/jmbi.1997.1469; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; STARK DM, 1992, SCIENCE, V258, P287, DOI 10.1126/science.258.5080.287; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; TAKATSUJI H, 1994, PLANT CELL, V6, P947, DOI 10.1105/tpc.6.7.947; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Tatineni S, 2008, PHYTOPATHOLOGY, V98, P592, DOI 10.1094/PHYTO-98-5-0592; Teakle GR, 2002, PLANT MOL BIOL, V50, P43, DOI 10.1023/A:1016062325584; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Verica JA, 2003, PLANT PHYSIOL, V133, P1732, DOI 10.1104/pp.103.028530; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; Wang N, 2013, PHYTOPATHOLOGY; Wang WH, 2012, NEW PHYTOL, V193, P432, DOI 10.1111/j.1469-8137.2011.03929.x; Whitham S, 1996, P NATL ACAD SCI USA, V93, P8776, DOI 10.1073/pnas.93.16.8776; Yanagisawa S, 1998, PLANT CELL, V10, P75, DOI 10.1105/tpc.10.1.75; Yool AJ, 2012, MOL ASPECTS MED, V33, P553, DOI 10.1016/j.mam.2012.02.001; Zheng ZL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-27; Zhou XG, 2010, PROTEIN CELL, V1, P520, DOI 10.1007/s13238-010-0065-3	75	100	104	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73742	10.1371/journal.pone.0073742	http://dx.doi.org/10.1371/journal.pone.0073742			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058486	gold, Green Submitted, Green Published			2022-12-25	WOS:000324408400033
J	Muturi, HT; Dreesen, JD; Nilewski, E; Jastrow, H; Giebel, B; Ergun, S; Singer, BB				Muturi, Harrison T.; Dreesen, Janine D.; Nilewski, Elena; Jastrow, Holger; Giebel, Bernd; Ergun, Suleyman; Singer, Bernhard B.			Tumor and Endothelial Cell-Derived Microvesicles Carry Distinct CEACAMs and Influence T-Cell Behavior	PLOS ONE			English	Article							CARCINOEMBRYONIC ANTIGEN FAMILY; BILIARY GLYCOPROTEIN CD66A; ADHESION MOLECULE-1; EPITHELIAL-CELLS; MEMBRANE-VESICLES; FACTOR-RECEPTOR; GROWTH-FACTOR; CANCER; EXPRESSION; PROLIFERATION	Normal and malignant cells release a variety of different vesicles into their extracellular environment. The most prominent vesicles are the microvesicles (MVs, 100-1 000 nm in diameter), which are shed of the plasma membrane, and the exosomes (70-120 nm in diameter), derivates of the endosomal system. MVs have been associated with intercellular communication processes and transport numerous proteins, lipids and RNAs. As essential component of immune-escape mechanisms tumor-derived MVs suppress immune responses. Additionally, tumor-derived MVs have been found to promote metastasis, tumor-stroma interactions and angiogenesis. Since members of the carcinoembryonic antigen related cell adhesion molecule (CEACAM)-family have been associated with similar processes, we studied the distribution and function of CEACAMs in MV fractions of different human epithelial tumor cells and of human and murine endothelial cells. Here we demonstrate that in association to their cell surface phenotype, MVs released from different human epithelial tumor cells contain CEACAM1, CEACAM5 and CEACAM6, while human and murine endothelial cells were positive for CEACAM1 only. Furthermore, MVs derived from CEACAM1 transfected CHO cells carried CEACAM1. In terms of their secretion kinetics, we show that MVs are permanently released in low doses, which are extensively increased upon cellular starvation stress. Although CEACAM1 did not transmit signals into MVs it served as ligand for CEACAM expressing cell types. We gained evidence that CEACAM1-positive MVs significantly increase the CD3 and CD3/CD28-induced T-cell proliferation. All together, our data demonstrate that MV-bound forms of CEACAMs play important roles in intercellular communication processes, which can modulate immune response, tumor progression, metastasis and angiogenesis.	[Muturi, Harrison T.; Dreesen, Janine D.; Nilewski, Elena; Jastrow, Holger; Ergun, Suleyman; Singer, Bernhard B.] Univ Hosp Essen, Inst Anat, Essen, Germany; [Giebel, Bernd] Univ Hosp Essen, Inst Transfus Med, Essen, Germany; [Ergun, Suleyman] Univ Wurzburg, Inst Anat & Cell Biol, D-97070 Wurzburg, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Wurzburg	Singer, BB (corresponding author), Univ Hosp Essen, Inst Anat, Essen, Germany.	BBSinger@gmx.de	Giebel, Bernd/AAH-1083-2021; Singer, Bernhard B./AAP-9999-2020	Giebel, Bernd/0000-0003-2446-948X; 	Deutsche Forschungsgesellschaft [ER276/9-1]	Deutsche Forschungsgesellschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgesellschaft to BBS and SE (ER276/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Rjaily GA, 2004, J CLIN INVEST, V114, P944, DOI 10.1172/JCI200421786; Beauchemin N, 1999, EXP CELL RES, V252, P243; Beauchemin N, 1997, ONCOGENE, V14, P783, DOI 10.1038/sj.onc.1200888; Beyer C, 2010, NAT REV RHEUMATOL, V6, P21, DOI 10.1038/nrrheum.2009.229; BRUMMER J, 1995, ONCOGENE, V11, P1649; Choice CV, 1998, J BIOL CHEM, V273, P22194, DOI 10.1074/jbc.273.35.22194; Clayton A, 2009, CURR ONCOL, V16, P187; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Ergun S, 2000, MOL CELL, V5, P311, DOI 10.1016/S1097-2765(00)80426-8; Ginestra A, 1999, ANTICANCER RES, V19, P3439; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Greicius G, 2003, J LEUKOCYTE BIOL, V74, P126, DOI 10.1189/jlb.1202594; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Holder BS, 2012, IMMUNOLOGY, V136, P184, DOI 10.1111/j.1365-2567.2012.03568.x; Horst AK, 2004, HANDB EXP PHARM, V165, P283, DOI 10.1007/978-3-540-68170-0_10; Hristov M, 2004, BLOOD, V104, P2761, DOI 10.1182/blood-2003-10-3614; Huber M, 1999, J BIOL CHEM, V274, P335, DOI 10.1074/jbc.274.1.335; Huber V, 2005, GASTROENTEROLOGY, V128, P1796, DOI 10.1053/j.gastro.2005.03.045; Kammerer R, 1998, EUR J IMMUNOL, V28, P3664, DOI 10.1002/(SICI)1521-4141(199811)28:11<3664::AID-IMMU3664>3.0.CO;2-D; KHAN WN, 1992, GENOMICS, V14, P384, DOI 10.1016/S0888-7543(05)80230-7; Kilic N, 2005, J BIOL CHEM, V280, P2361, DOI 10.1074/jbc.M409407200; Kilic N, 2007, BLOOD, V110, P4223, DOI 10.1182/blood-2007-06-097592; Kim HK, 2003, EUR J CANCER, V39, P184, DOI 10.1016/S0959-8049(02)00596-8; Krump-Konvalinkova V, 2003, ENDOTHELIUM-J ENDOTH, V10, P319, DOI 10.1080/714007546; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Ludwig AK, 2012, INT J BIOCHEM CELL B, V44, P11, DOI 10.1016/j.biocel.2011.10.005; Luo JS, 2000, TUMOR BIOL, V21, P11, DOI 10.1159/000030106; Muenzner P, 2001, J BIOL CHEM, V276, P24331, DOI 10.1074/jbc.M006883200; Muralidharan-Chari V, 2010, J CELL SCI, V123, P1603, DOI 10.1242/jcs.064386; Najjar SM, 2002, TRENDS ENDOCRIN MET, V13, P240, DOI 10.1016/S1043-2760(02)00608-2; Obrink B, 1997, CURR OPIN CELL BIOL, V9, P616, DOI 10.1016/S0955-0674(97)80114-7; Obrink B, 2008, LUNG CANCER, V60, P309, DOI 10.1016/j.lungcan.2008.03.020; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; Pan H, 2010, IMMUNITY, V33, P620, DOI 10.1016/j.immuni.2010.10.009; Pils S, 2008, INT J MED MICROBIOL, V298, P553, DOI 10.1016/j.ijmm.2008.04.005; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; REESJONES RW, 1985, J BIOL CHEM, V260, P4461; Sandvig K, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012914; SCHIRRMACHER V, 1986, BIOCHIM BIOPHYS ACTA, V860, P236, DOI 10.1016/0005-2736(86)90519-5; Singer BB, 2002, J IMMUNOL, V168, P5139, DOI 10.4049/jimmunol.168.10.5139; Singer BB, 2000, CANCER RES, V60, P1236; Slevogt H, 2008, NAT IMMUNOL, V9, P1270, DOI 10.1038/ni.1661; Sokolova V, 2011, COLLOID SURFACE B, V87, P146, DOI 10.1016/j.colsurfb.2011.05.013; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; THOMPSON J, 1988, TUMOR BIOL, V9, P63, DOI 10.1159/000217547; van Doormaal FF, 2009, NETH J MED, V67, P266; Wagener C, 2000, EXP CELL RES, V261, P19, DOI 10.1006/excr.2000.5038; Yuana Y, 2011, THROMB HAEMOSTASIS, V105, P396, DOI 10.1160/TH10-09-0595	48	44	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74654	10.1371/journal.pone.0074654	http://dx.doi.org/10.1371/journal.pone.0074654			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040308	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500111
J	Blakeway, D; Byers, M; Stoddart, J; Rossendell, J				Blakeway, David; Byers, Michael; Stoddart, James; Rossendell, Jason			Coral Colonisation of an Artificial Reef in a Turbid Nearshore Environment, Dampier Harbour, Western Australia	PLOS ONE			English	Article							EARLY POSTSETTLEMENT MORTALITY; SCLERACTINIAN CORAL; COMMUNITY STRUCTURE; RECRUITMENT; SURVIVAL; PATTERNS	A 0.6 hectare artificial reef of local rock and recycled concrete sleepers was constructed in December 2006 at Parker Point in the industrial port of Dampier, western Australia, with the aim of providing an environmental offset for a nearshore coral community lost to land reclamation. Corals successfully colonised the artificial reef, despite the relatively harsh environmental conditions at the site (annual water temperature range 18-32 degrees C, intermittent high turbidity, frequent cyclones, frequent nearby ship movements). Coral settlement to the artificial reef was examined by terracotta tile deployments, and later stages of coral community development were examined by in-situ visual surveys within fixed 25 x 25 cm quadrats on the rock and concrete substrates. Mean coral density on the tiles varied from 113 +/- 17 SE to 909 +/- 85 SE per m(2) over five deployments, whereas mean coral density in the quadrats was only 6.0 +/- 1.0 SE per m(2) at eight months post construction, increasing to 24.0 +/- 2.1 SE per m(2) at 62 months post construction. Coral taxa colonising the artificial reef were a subset of those on the surrounding natural reef, but occurred in different proportions-Pseudosiderastrea tayami, Mycedium elephantotus and Leptastrea purpurea being disproportionately abundant on the artificial reef. Coral cover increased rapidly in the later stages of the study, reaching 2.3 +/- 0.7 SE % at 62 months post construction. This study indicates that simple materials of opportunity can provide a suitable substrate for coral recruitment in Dampier Harbour, and that natural colonisation at the study site remains sufficient to initiate a coral community on artificial substrate despite ongoing natural and anthropogenic perturbations.	[Blakeway, David; Byers, Michael; Stoddart, James] MSci Pty Ltd, Marine Res, Nedlands, WA, Australia; [Rossendell, Jason] Rio Tinto Iron Ore, Coastal Operat, Dampier, WA, Australia	Rio Tinto	Blakeway, D (corresponding author), MSci Pty Ltd, Marine Res, Nedlands, WA, Australia.	Dave.Blakeway@mscience.net.au	Stoddart, James Fraser/H-1518-2011	Stoddart, James Fraser/0000-0003-3161-3697; Stoddart, James/0000-0002-4734-6565				Aerts LAM, 1997, MAR ECOL PROG SER, V148, P125, DOI 10.3354/meps148125; Babcock RC, 2003, ZOOL STUD, V42, P211; Baird AH, 2011, MAR BIOL, V158, P275, DOI 10.1007/s00227-010-1557-7; Blakeway D, 2005, CORALS DAMPIER HARBO, P1; Blakeway D, UNPUB; Blakeway DR, 2005, CORALS DAMPIER HARBO, P61; Browne NK, 2010, CORAL REEFS, V29, P683, DOI 10.1007/s00338-010-0640-3; Burt J, 2009, CORAL REEFS, V28, P663, DOI 10.1007/s00338-009-0500-1; Burt J, 2011, ECOL ENG, V37, P191, DOI 10.1016/j.ecoleng.2010.09.004; Cooper TF, 2008, MAR FRESHWATER RES, V59, P703, DOI 10.1071/MF08016; DPA, 2010, PORT DAMP DEV PLAN 2, P48; DPA, 2013, HIST DAMP PORT; Dunstan PK, 1998, CORAL REEFS, V17, P71, DOI 10.1007/s003380050098; EPA, 2007, PLUT LNG DEV BURR PE, V1259; Erftemeijer PLA, 2012, MAR POLLUT BULL, V64, P1737, DOI 10.1016/j.marpolbul.2012.05.008; Forde, 1985, TECHNICAL REPORT SUS, V215, P102; Fox HE, 2004, MAR ECOL PROG SER, V269, P131, DOI 10.3354/meps269131; Harriott V, 1997, CORAL RECRUITMENT TR, P1191; Hughes TP, 1999, NATURE, V397, P59, DOI 10.1038/16237; Hunt HL, 1997, MAR ECOL PROG SER, V155, P269, DOI 10.3354/meps155269; Jokiel PL, 2005, CORAL REEF RESTORATI, P19; Kilbane D, 2008, 11 INT COR REEF S FT; KINSMAN DJJ, 1964, NATURE, V202, P1280, DOI 10.1038/2021280a0; Kleczkowski M, 5 YEAR STUDY FISH SU; Kojis BL, 2001, B MAR SCI, V69, P967; Kuo KM, 2010, ZOOL STUD, V49, P724; Maekouchi N, 2008, 11 INT COR REEF S FT; Maina J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023064; MPRSWG, 1994, REP MAR RES SYST W A; Mundy CN, 2000, CORAL REEFS, V19, P124, DOI 10.1007/s003380000081; Pearce AF, 2003, P 12 INT MAR BIOL WO, V1, P13; Penin L, 2010, MAR ECOL PROG SER, V408, P55, DOI 10.3354/meps08554; Perkol-Finkel S, 2006, MAR ENVIRON RES, V61, P121, DOI 10.1016/j.marenvres.2005.08.001; Perkol-Finkel S, 2004, CORAL REEFS, V23, P195, DOI 10.1007/s00338-004-0384-z; PORTER JW, 1988, BIOL BULL, V175, P230, DOI 10.2307/1541563; Sammarco P.W., 1983, Coral Reefs, V1, P173, DOI 10.1007/BF00571194; SEMENIUK V, 1982, Journal of the Royal Society of Western Australia, V65, P97; Sheppard C, 2000, REEFS CORAL COMMUNIT, P257; Simpson CJ, 1988, ENV PROTECTION AUTHO, V23; Simpson CJ, 1985, ENV FACTORS AFFECTIN; SMITH SR, 1992, AM ZOOL, V32, P663; Stoddart C, 2012, CORAL REEFS, P1; Stoddart J.A., 2005, CORALS DAMPIER HARBO, P31; Stoddart JA, 2005, CORALS DAMPIER HARBO, P9; Thomas S, 2005, MAR POLLUT BULL, V51, P470, DOI 10.1016/j.marpolbul.2004.10.026; Vermeij MJA, 2009, OECOLOGIA, V159, P325, DOI 10.1007/s00442-008-1223-7; Webster NS, 2004, APPL ENVIRON MICROB, V70, P1213, DOI 10.1128/AEM.70.2.1213-1221.2004; Wilson J, 2005, CORAL REEFS, V24, P418, DOI 10.1007/s00338-005-0033-1	48	13	15	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e75281	10.1371/journal.pone.0075281	http://dx.doi.org/10.1371/journal.pone.0075281			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040405	Green Published, Green Submitted, gold			2022-12-25	WOS:000327538600133
J	Eichner, J; Kossler, N; Wrzodek, C; Kalkuhl, A; Toft, DB; Ostenfeldt, N; Richard, V; Zell, A				Eichner, Johannes; Kossler, Nadine; Wrzodek, Clemens; Kalkuhl, Arno; Toft, Dorthe Bach; Ostenfeldt, Nina; Richard, Virgile; Zell, Andreas			A Toxicogenomic Approach for the Prediction of Murine Hepatocarcinogenesis Using Ensemble Feature Selection	PLOS ONE			English	Article							NONGENOTOXIC HEPATOCARCINOGENICITY; INDUCTION; CANCER; IDENTIFICATION; RATS; CLASSIFICATION; MUTAGENICITY; CARCINOGENS; MECHANISMS; TOXICOLOGY	The current strategy for identifying the carcinogenicity of drugs involves the 2-year bioassay in male and female rats and mice. As this assay is cost-intensive and time-consuming there is a high interest in developing approaches for the screening and prioritization of drug candidates in preclinical safety evaluations. Predictive models based on toxicogenomics investigations after short-term exposure have shown their potential for assessing the carcinogenic risk. In this study, we investigated a novel method for the evaluation of toxicogenomics data based on ensemble feature selection in conjunction with bootstrapping for the purpose to derive reproducible and characteristic multi-gene signatures. This method was evaluated on a microarray dataset containing global gene expression data from liver samples of both male and female mice. The dataset was generated by the IMI MARCAR consortium and included gene expression profiles of genotoxic and nongenotoxic hepatocarcinogens obtained after treatment of CD-1 mice for 3 or 14 days. We developed predictive models based on gene expression data of both sexes and the models were employed for predicting the carcinogenic class of diverse compounds. Comparing the predictivity of our multi-gene signatures against signatures from literature, we demonstrated that by incorporating our gene sets as features slightly higher accuracy is on average achieved by a representative set of state-of-the art supervised learning methods. The constructed models were also used for the classification of Cyproterone acetate (CPA), Wy-14643 (WY) and Thioacetamid (TAA), whose primary mechanism of carcinogenicity is controversially discussed. Based on the extracted mouse liver gene expression patterns, CPA would be predicted as a nongenotoxic compound. In contrast, both WY and TAA would be classified as genotoxic mouse hepatocarcinogens.	[Eichner, Johannes; Wrzodek, Clemens; Zell, Andreas] Univ Tubingen, Ctr Bioinformat Tuebingen ZBIT, Tubingen, Germany; [Kossler, Nadine; Kalkuhl, Arno] Boehringer Ingelheim Pharma GmbH & Co KG, Nonclin Drug Safety, Biberach An Der Riss, Germany; [Toft, Dorthe Bach; Ostenfeldt, Nina] H Lundbeck & Co AS, Nonclin Drug Safety, Valby, Denmark; [Richard, Virgile] UCB Pharma SA, Nonclin Dev, Brussels, Belgium	Eberhard Karls University of Tubingen; Boehringer Ingelheim; Lundbeck Corporation; UCB Pharma SA	Eichner, J (corresponding author), Univ Tubingen, Ctr Bioinformat Tuebingen ZBIT, Tubingen, Germany.	johannes.eichner@uni-tuebingen.de		Wrzodek, Clemens/0000-0003-4995-780X	Innovative Medicine Initiative Joint Undertaking (IMI JU) [115001]; Deutsche Forschungsgemeinschaft; Tuebingen University	Innovative Medicine Initiative Joint Undertaking (IMI JU); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tuebingen University	The research leading to these results has received funding from the Innovative Medicine Initiative Joint Undertaking (IMI JU) under grant agreement nr. 115001 (MARCAR project). We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2010, BIOINFORMATICS, V26, P392, DOI 10.1093/bioinformatics/btp630; Afshari CA, 1999, CANCER RES, V59, P4759; Afshari CA, 2011, TOXICOL SCI, V120, pS225, DOI 10.1093/toxsci/kfq373; Auerbach SS, 2010, TOXICOL APPL PHARM, V243, P300, DOI 10.1016/j.taap.2009.11.021; Benigni R, 2013, CHEM REV, V113, P2940, DOI 10.1021/cr300206t; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; CATTLEY RC, 1989, CANCER RES, V49, P3246; CHIELI E, 1987, MUTAT RES, V192, P141, DOI 10.1016/0165-7992(87)90111-4; Deutsch WA, 2001, MUTAGENESIS, V16, P439, DOI 10.1093/mutage/16.5.439; Ellinger-Ziegelbauer H, 2008, MUTAT RES-FUND MOL M, V637, P23, DOI 10.1016/j.mrfmmm.2007.06.010; Fielden MR, 2007, TOXICOL SCI, V99, P90, DOI 10.1093/toxsci/kfm156; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GLAUERT HP, 1986, CANCER RES, V46, P4601; Gold LS, 2005, TOXICOL SCI, V85, P747, DOI 10.1093/toxsci/kfi161; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gonzalez FJ, 2008, TOXICOLOGY, V246, P2, DOI 10.1016/j.tox.2007.09.030; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; He ZY, 2010, COMPUT BIOL CHEM, V34, P215, DOI 10.1016/j.compbiolchem.2010.07.002; Hernandez LG, 2009, MUTAT RES-REV MUTAT, V682, P94, DOI 10.1016/j.mrrev.2009.07.002; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jonker MJ, 2009, CARCINOGENESIS, V30, P1805, DOI 10.1093/carcin/bgp190; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kirkland D, 2006, MUTAT RES-GEN TOX EN, V608, P29, DOI 10.1016/j.mrgentox.2006.04.017; Kuncheva LI, 2007, PROCEEDINGS OF THE IASTED INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND APPLICATIONS, P390; LANG R, 1979, MUTAT RES, V67, P361, DOI 10.1016/0165-1218(79)90033-8; Liu ZC, 2011, CHEM RES TOXICOL, V24, P1062, DOI 10.1021/tx2000637; Martelli A, 1996, CARCINOGENESIS, V17, P551, DOI 10.1093/carcin/17.3.551; MIRKOVA ET, 1994, MUTAT RES-GENET TOX, V322, P142, DOI 10.1016/0165-1218(94)90095-7; Morris SM, 2012, HEPATOLOGY, V55, P121, DOI 10.1002/hep.24653; Nie AY, 2006, MOL CARCINOGEN, V45, P914, DOI 10.1002/mc.20205; Park HJ, 2011, ARCH TOXICOL, V85, P1627, DOI 10.1007/s00204-011-0715-0; Sonnenburg S, 2010, J MACH LEARN RES, V11, P1799; Takasawa H, 2010, MUTAT RES-GEN TOX EN, V698, P24, DOI 10.1016/j.mrgentox.2010.02.010; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Uehara T, 2008, TOXICOLOGY, V250, P15, DOI 10.1016/j.tox.2008.05.013; Uehara T, 2011, TOXICOL APPL PHARM, V255, P297, DOI 10.1016/j.taap.2011.07.001; Uehara T, 2010, MOL NUTR FOOD RES, V54, P218, DOI 10.1002/mnfr.200900169; van Kreijl CF, 2001, TOXICOL PATHOL, V29, P117, DOI 10.1080/019262301301418928; Van Landeghem S, 2010, BIOINFORMATICS, V26, pi554, DOI 10.1093/bioinformatics/btq381; Waters MD, 2010, MUTAT RES-REV MUTAT, V705, P184, DOI 10.1016/j.mrrev.2010.04.005	40	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73938	10.1371/journal.pone.0073938	http://dx.doi.org/10.1371/journal.pone.0073938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040119	Green Published, Green Submitted, gold			2022-12-25	WOS:000327538600053
J	Martin-Lopez, E; Garcia-Marques, J; Nunez-Llaves, R; Lopez-Mascaraque, L				Martin-Lopez, Eduardo; Garcia-Marques, Jorge; Nunez-Llaves, Raul; Lopez-Mascaraque, Laura			Clonal Astrocytic Response to Cortical Injury	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; REACTIVE GLIOSIS; RAT-BRAIN; ASTROGLIOSIS; PROLIFERATION; HETEROGENEITY; REGENERATION; ORIGIN; TISSUE; SCAR	Astrocytes are a heterogeneous population of glial cells with multifaceted roles in the central nervous system. Recently, the new method for the clonal analysis Star Track evidenced the link between astrocyte heterogeneity and lineage. Here, we tested the morphological response to mechanical injury of clonally related astrocytes using the Star Track approach, which labels each cell lineage with a specific code of colors. Histological and immunohistochemical analyses at 7 days post injury revealed a variety of morphological changes that were different among distinct clones. In many cases, cells of the same clone responded equally to the injury, suggesting the dependence on their genetic codification (intrinsic response). However, in other cases cells of the same clone responded differently to the injury, indicating their response to extrinsic factors. Thus, whereas some clones exhibited a strong morphological alteration or a high proliferative response to the injury, other clones located at similar distances to the lesion were apparently unresponsive. Concurrence of different clonal responses to the injury reveals the importance of the development determining the astrocyte features in response to brain injuries. These features should be considered to develop therapies that affect glial function.	[Martin-Lopez, Eduardo; Garcia-Marques, Jorge; Nunez-Llaves, Raul; Lopez-Mascaraque, Laura] CSIC, Inst Cajal, E-28002 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Lopez-Mascaraque, L (corresponding author), CSIC, Inst Cajal, E-28002 Madrid, Spain.	mascaraque@cajal.csic.es	Garcia-Marques, Jorge/AAY-9349-2020; Lopez-Mascaraque, Laura/M-2448-2014; Martin-Lopez, Eduardo/K-8765-2019	Garcia-Marques, Jorge/0000-0001-5688-566X; Lopez-Mascaraque, Laura/0000-0002-7154-5687; Martin-Lopez, Eduardo/0000-0002-7654-638X; Nunez Llaves, Raul/0000-0002-6702-4774	Spanish Ministry of Economy and Competitiveness [BFU2010-15564]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by research grant BFU2010-15564 from the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderova M, 2004, GLIA, V48, P311, DOI 10.1002/glia.20076; Andriezen W L, 1893, Br Med J, V2, P227; Barreto GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027881; Benner EJ, 2013, NATURE, V497, P369, DOI 10.1038/nature12069; Bovolenta P, 1997, EUR J NEUROSCI, V9, P977, DOI 10.1111/j.1460-9568.1997.tb01448.x; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; CAVANAGH JB, 1970, J ANAT, V106, P471; ECLANCHER F, 1990, GLIA, V3, P502, DOI 10.1002/glia.440030609; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; FaberElman A, 1996, J CLIN INVEST, V97, P162, DOI 10.1172/JCI118385; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fernaud-Espinosa I, 1998, J NEUROBIOL, V36, P16, DOI 10.1002/(SICI)1097-4695(199807)36:1<16::AID-NEU2>3.0.CO;2-D; Freeman MR, 2010, SCIENCE, V330, P774, DOI 10.1126/science.1190928; Garcia DM, 2009, COMP BIOCHEM PHYS A, V152, P135, DOI 10.1016/j.cbpa.2008.09.026; Garcia-Marques J, 2012, CEREB CORTEX; Garcia-Marques J, 2010, GLIA, V58, P218, DOI 10.1002/glia.20918; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; HANSSON E, 1990, NEUROCHEM INT, V16, P237, DOI 10.1016/0197-0186(90)90097-D; Horii-Hayashi N, 2010, NEUROSCI LETT, V483, P67, DOI 10.1016/j.neulet.2010.07.064; Houades V, 2008, J NEUROSCI, V28, P5207, DOI 10.1523/JNEUROSCI.5100-07.2008; MATHEWSON AJ, 1985, BRAIN RES, V327, P61, DOI 10.1016/0006-8993(85)91499-4; Matyash V, 2010, BRAIN RES REV, V63, P2, DOI 10.1016/j.brainresrev.2009.12.001; Nieto-Sampedro M., 2004, BRAIN DAMAGE REPAIR, P323, DOI 10.1007/1-4020-2541-6_17; NORTON WT, 1992, NEUROCHEM RES, V17, P877, DOI 10.1007/BF00993263; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Pekny M, 2001, Prog Brain Res, V132, P23; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; WINDLE WF, 1952, J COMP NEUROL, V96, P359, DOI 10.1002/cne.900960207; Yeh TH, 2009, GLIA, V57, P1239, DOI 10.1002/glia.20845; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	37	51	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74039	10.1371/journal.pone.0074039	http://dx.doi.org/10.1371/journal.pone.0074039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040158	Green Published, gold, Green Submitted			2022-12-25	WOS:000327538600062
J	Morton, J; Karoonuthaisiri, N; Charlermroj, R; Stewart, LD; Elliott, CT; Grant, IR				Morton, Josephine; Karoonuthaisiri, Nitsara; Charlermroj, Ratthaphol; Stewart, Linda D.; Elliott, Christopher T.; Grant, Irene R.			Phage Display-Derived Binders Able to Distinguish Listeria monocytogenes from Other Listeria Species	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; SALMONELLA SPP.; RAPID DETECTION; TIME; IDENTIFICATION; FOOD; EXPRESSION; BIOSENSOR; ANTIGENS; ARRAY	The objective of this study was to produce phage display-derived binders with the ability to distinguish Listeria monocytogenes from other Listeria spp., which may have potential utility to enhance detection of Listeria monocytogenes. To obtain binders with the desired binding specificity a series of surface and solution phage-display biopannings were performed. Initially, three rounds of surface biopanning against gamma-irradiated L. monocytogenes serovar 4b cells were performed followed by an additional surface biopanning round against L. monocytogenes 4b which included prior subtraction biopanning against gamma-irradiated L. innocua cells. In an attempt to further enhance binder specificity for L. monocytogenes 4b two rounds of solution biopanning were performed, both rounds included initial subtraction solution biopanning against L. innocua. Subsequent evaluations were performed on the phage clones by phage binding ELISA. All phage clones tested from the second round of solution biopanning had higher specificity for L. monocytogenes 4b than for L. innocua and three other foodborne pathogens (Salmonella spp., Escherichia coli and Campylobacter jejuni). Further evaluation with five other Listeria spp. revealed that one phage clone in particular, expressing peptide GRIADLPPLKPN, was highly specific for L. monocytogenes with at least 43-fold more binding capability to L. monocytogenes 4b than to any other Listeria sp. This proof-of-principle study demonstrates how a combination of surface, solution and subtractive biopanning was used to maximise binder specificity. L. monocytogenes-specific binders were obtained which could have potential application in novel detection tests for L. monocytogenes, benefiting both the food and medical industries.	[Morton, Josephine; Karoonuthaisiri, Nitsara; Stewart, Linda D.; Elliott, Christopher T.; Grant, Irene R.] Queens Univ, Sch Biol Sci, Inst Global Food Secur, Belfast, Antrim, North Ireland; [Karoonuthaisiri, Nitsara; Charlermroj, Ratthaphol] Natl Ctr Genet Engn & Biotechnol, Microarray Lab, Khlong Laung, Pathum Thani, Thailand	Queens University Belfast; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Grant, IR (corresponding author), Queens Univ, Sch Biol Sci, Inst Global Food Secur, Belfast, Antrim, North Ireland.	i.grant@qub.ac.uk	Stewart, Linda/AFS-8631-2022	Stewart, Linda/0000-0002-2400-6162; McIvor, Mary Josephine/0000-0002-2451-9304; Grant, Irene/0000-0001-5860-3769	Department of Employment and Learning postgraduate studentship; safefood Listeria Network; European Union	Department of Employment and Learning postgraduate studentship; safefood Listeria Network; European Union(European Commission)	This research was supported by Department of Employment and Learning postgraduate studentship to JM, a safefood Listeria Network grant to IRG and JM, and an European Union FP7 Incoming Marie Curie Fellowship awarded to NK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, OFF J EUR UNION, VL 276, P33; ARUNASALAM G, 1989, J PHYTOPATHOL, V126, P160, DOI 10.1111/j.1439-0434.1989.tb01099.x; Bang J, 2013, INT J FOOD MICROBIOL, V161, P134, DOI 10.1016/j.ijfoodmicro.2012.11.023; Borucki MK, 2003, J CLIN MICROBIOL, V41, P5537, DOI 10.1128/JCM.41.12.5537-5540.2003; Carnazza S, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/39/395011; Charlermroj R, 2012, ANAL BIOCHEM, V421, P26, DOI 10.1016/j.ab.2011.10.005; Charlermroj R, 2011, ANAL LETT, V44, P1085, DOI 10.1080/00032719.2010.511736; Doumith M, 2004, J CLIN MICROBIOL, V42, P3819, DOI 10.1128/JCM.42.8.3819-3822.2004; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2597; Garrido A, 2013, FOOD CONTROL, V30, P76, DOI 10.1016/j.foodcont.2012.06.029; GOUIN E, 1994, INFECT IMMUN, V62, P3550, DOI 10.1128/IAI.62.8.3550-3553.1994; Huang J, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/101932; Iturria SJ, 2005, J BIOPHARM STAT, V15, P343, DOI 10.1081/BIP-200048798; Jacquet C, 2002, APPL ENVIRON MICROB, V68, P616, DOI 10.1128/AEM.68.2.616-622.2002; Karoonuthaisiri N, 2009, BIOSENS BIOELECTRON, V24, P1641, DOI 10.1016/j.bios.2008.08.026; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kim J, 2011, METHODS, V55, P303, DOI 10.1016/j.ymeth.2011.09.012; Lan Z, 2000, J BACTERIOL, V182, P6161, DOI 10.1128/JB.182.21.6161-6168.2000; Liu DY, 2006, J MED MICROBIOL, V55, P645, DOI 10.1099/jmm.0.46495-0; Low JC, 1997, VET J, V153, P9, DOI 10.1016/S1090-0233(97)80005-6; Morton J, 2013, J APPL MICROBIOL, V115, P271, DOI 10.1111/jam.12207; Nanduri V, 2007, BIOSENS BIOELECTRON, V23, P248, DOI 10.1016/j.bios.2007.04.007; Ohk SH, 2013, FOOD MICROBIOL, V33, P166, DOI 10.1016/j.fm.2012.09.013; Paoli GC, 2004, J IMMUNOL METHODS, V289, P147, DOI 10.1016/j.jim.2004.04.001; Paoli GC, 2007, J RAPID METH AUT MIC, V15, P77, DOI 10.1111/j.1745-4581.2007.00079.x; Paoli GC, 2007, FOODBORNE PATHOG DIS, V4, P74, DOI 10.1089/fpd.2006.65; Pochop J, 2012, J ENVIRON SCI HEAL B, V47, P212, DOI 10.1080/03601234.2012.634353; Portanti O, 2011, VET ITAL, V47, P281; ROCOURT J, 1992, INT J SYST BACTERIOL, V42, P171, DOI 10.1099/00207713-42-1-171; Shan XX, 2012, FOOD SCI BIOTECHNOL, V21, P101, DOI 10.1007/s10068-012-0012-6; Sim JH, 2012, SENSOR ACTUAT B-CHEM, V173, P752, DOI 10.1016/j.snb.2012.07.091; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Tamborrini M, 2010, CLIN VACCINE IMMUNOL, V17, P1446, DOI 10.1128/CVI.00205-10; Tang MJ, 2011, CURR MICROBIOL, V63, P511, DOI 10.1007/s00284-011-0013-3; Vodnik M, 2011, MOLECULES, V16, P790, DOI 10.3390/molecules16010790; Wiedmann M, 1997, INFECT IMMUN, V65, P2707, DOI 10.1128/IAI.65.7.2707-2716.1997; Ye KP, 2012, FOOD CONTROL, V25, P117, DOI 10.1016/j.foodcont.2011.10.025	37	9	10	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74312	10.1371/journal.pone.0074312	http://dx.doi.org/10.1371/journal.pone.0074312			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040227	gold, Green Published, Green Submitted			2022-12-25	WOS:000327538600087
J	Rapp, AM; Langohr, K; Mutschler, DE; Klingberg, S; Wild, B; Erb, M				Rapp, Alexander M.; Langohr, Karin; Mutschler, Dorothee E.; Klingberg, Stefan; Wild, Barbara; Erb, Michael			Isn't it ironic? Neural Correlates of Irony Comprehension in Schizophrenia	PLOS ONE			English	Article							SOCIAL COGNITION; SCHIZOTYPAL-PERSONALITY; NONLITERAL LANGUAGE; MIND; METAPHOR; BRAIN; COMMUNICATION; METAANALYSIS; DEFICITS; NETWORK	Ironic remarks are frequent in everyday language and represent an important form of social cognition. Increasing evidence indicates a deficit in comprehension in schizophrenia. Several models for defective comprehension have been proposed, including possible roles of the medial prefrontal lobe, default mode network, inferior frontal gyri, mirror neurons, right cerebral hemisphere and a possible mediating role of schizotypal personality traits. We investigated the neural correlates of irony comprehension in schizophrenia by using event-related functional magnetic resonance imaging (fMRI). In a prosody-free reading paradigm, 15 female patients with schizophrenia and 15 healthy female controls silently read ironic and literal text vignettes during fMRI. Each text vignette ended in either an ironic (n = 22) or literal (n = 22) statement. Ironic and literal text vignettes were matched for word frequency, length, grammatical complexity, and syntax. After fMRI, the subjects performed an off-line test to detect error rate. In this test, the subjects indicated by button press whether the target sentence has ironic, literal, or meaningless content. Schizotypal personality traits were assessed using the German version of the schizotypal personality questionnaire (SPQ). Patients with schizophrenia made significantly more errors than did the controls (correct answers, 85.3% vs. 96.3%) on a behavioural level. Patients showed attenuated blood oxygen level-dependent (BOLD) response during irony comprehension mainly in right hemisphere temporal regions (ironic. literal contrast) and in posterior medial prefrontal and left anterior insula regions (for ironic. visual baseline, but not for literal. visual baseline). In patients with schizophrenia, the parahippocampal gyrus showed increased activation. Across all subjects, BOLD response in the medial prefrontal area was negatively correlated with the SPQ score. These results highlight the role of the posterior medial prefrontal and right temporal regions in defective irony comprehension in schizophrenia and the mediating role of schizotypal personality traits.	[Rapp, Alexander M.; Langohr, Karin; Klingberg, Stefan; Wild, Barbara] Univ Tubingen, Dept Psychiat, Tubingen, Germany; [Mutschler, Dorothee E.] Marien Hosp, Dept Neurol, Stuttgart, Germany; [Erb, Michael] Univ Tubingen, Dept Radiol, Tubingen, Germany	Eberhard Karls University of Tubingen; St. Marien Hospital; Eberhard Karls University of Tubingen	Rapp, AM (corresponding author), Univ Tubingen, Dept Psychiat, Tubingen, Germany.	Alexander.Rapp@med.uni-tuebingen.de	Klingberg, Stefan/E-6676-2010	Klingberg, Stefan/0000-0001-8081-7181; Erb, Michael/0000-0002-9311-4693; Rapp, Alexander Michael/0000-0003-0086-6325				Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Andreasen N. C., 1984, SCALE ASSESSMENT POS; Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P789; [Anonymous], [No title captured]; Arcuri SM, 2012, SCHIZOPHR RES TREAT, V2012, DOI 10.1155/2012/176290; Arcuri SM, 2003, THESIS U LONDON LOND; Attardo S, 2003, HUMOR, V16, P243, DOI 10.1515/humr.2003.012; Behrendt RP, 2010, NEUROSCI BIOBEHAV R, V34, P1121, DOI 10.1016/j.neubiorev.2009.12.009; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Brent BK, 2014, SOC COGN AFFECT NEUR, V9, P273, DOI 10.1093/scan/nss129; Brunet-Gouet E, 2006, PSYCHIAT RES-NEUROIM, V148, P75, DOI 10.1016/j.pscychresns.2006.05.001; Bryant GA, 2005, LANG SPEECH, V48, P257, DOI 10.1177/00238309050480030101; Burgers C, 2012, J LANG SOC PSYCHOL, V31, P290, DOI 10.1177/0261927X12446596; Burgess C, 1996, METAPHOR SYMBOLIC AC, V11, P67, DOI [DOI 10.1207/S15327868MS1101_4, 10.1207/s15327868ms1101_4]; Cabanis M, 2013, COGN AFFECT BEHAV NE, V13, P330, DOI 10.3758/s13415-012-0143-5; Canli T, 2002, SCIENCE, V296, P2191, DOI 10.1126/science.1068749; Champagne-Lavau M, 2012, PSYCHIAT RES, V200, P184, DOI 10.1016/j.psychres.2012.06.011; Channon S, 2007, NEUROPSYCHOLOGIA, V45, P1725, DOI 10.1016/j.neuropsychologia.2006.12.021; Cochrane M, 2012, PSYCHIAT RES, V196, P230, DOI 10.1016/j.psychres.2012.02.010; Colich NL, 2012, METAPHOR SYMBOL, V27, P70, DOI 10.1080/10926488.2012.638856; Colston HL, 2004, METAPHOR SYMBOL, V19, P289, DOI 10.1207/s15327868ms1904_3; Colston HL, 2002, METAPHOR SYMBOL, V17, P57, DOI 10.1207/S15327868MS1701_5; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Crow TJ, 2010, J NEUROLINGUIST, V23, P1, DOI 10.1016/j.jneuroling.2009.08.005; DeLisi LE, 2001, SCHIZOPHRENIA BULL, V27, P481, DOI 10.1093/oxfordjournals.schbul.a006889; Denny BT, 2012, J COGNITIVE NEUROSCI, V24, P1742, DOI 10.1162/jocn_a_00233; Diana RA, 2007, TRENDS COGN SCI, V11, P379, DOI 10.1016/j.tics.2007.08.001; Diederen KMJ, 2010, AM J PSYCHIAT, V167, P427, DOI 10.1176/appi.ajp.2009.09040456; Dillmann J, 2003, THESIS U JEAN JENA; Dimaggio G, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00083; Drury VM, 1998, PSYCHOL MED, V28, P1101, DOI 10.1017/S0033291798006850; Ellison-Wright I, 2008, AM J PSYCHIAT, V165, P1015, DOI 10.1176/appi.ajp.2008.07101562; Gibbs R.W., 2012, INTERPRETING FIGURAT, DOI 10.1017/CBO9781139168779; Gibbs R.W., 2000, METAPHOR SYMBOL, V15, P5, DOI [DOI 10.1080/10926488.2000.9678862, 10.1207/S15327868MS1512_2, DOI 10.1207/S15327868MS1512_2]; Giora R., 2000, METAPHOR SYMBOL, V15, P63, DOI [10.1080/10926488.2000.9678865, DOI 10.1080/10926488.2000.9678865]; Giora R, 2001, PSYCHOL SOCIOLOGY LI; Grosselin A, 2010, ENCEPHALE, V36, P277, DOI 10.1016/j.encep.2009.12.011; HAPPE FGE, 1995, METAPHOR SYMB ACT, V10, P275, DOI 10.1207/s15327868ms1004_3; Harris M, 2003, DISCOURSE PROCESS, V36, P147, DOI 10.1207/S15326950DP3603_1; Hensler MM, 2009, THESIS U TUEBINGEN T; Herold R, 2002, PSYCHOL MED, V32, P1125, DOI 10.1017/S0033291702005433; Ivanko SL, 2004, J LANG SOC PSYCHOL, V23, P244, DOI 10.1177/0261927x04266809; Jardri R, 2011, AM J PSYCHIAT, V168, P73, DOI 10.1176/appi.ajp.2010.09101522; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keysers C, 2009, CURR OPIN NEUROBIOL, V19, P666, DOI 10.1016/j.conb.2009.10.006; Kircher TTJ, 2007, NEUROIMAGE, V34, P281, DOI 10.1016/j.neuroimage.2006.08.044; Kircher TTJ, 2002, PSYCHOL MED, V32, P439, DOI 10.1017/S0033291702005287; Kircher TTJ, 2001, SCHIZOPHR RES, V50, P27, DOI 10.1016/S0920-9964(00)00042-6; Klein C, 1997, DIAGNOSTICA, V43, P347; Klein C, 2001, SCHIZOTYPIE PSYCHOME, P349; Kosmidis MH, 2008, BEHAV NEUROL, V19, P65, DOI 10.1155/2008/157356; KREUZ RJ, 1991, METAPHOR SYMB ACT, V6, P149, DOI 10.1207/s15327868ms0603_1; Kumari V, 2004, J NEUROSCI, V24, P10636, DOI 10.1523/JNEUROSCI.3206-04.2004; Lagioia A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00035; Langdon R, 2004, PSYCHIAT RES, V125, P9, DOI 10.1016/j.psychres.2003.10.005; Langdon R, 2002, MIND LANG, V17, P68, DOI 10.1111/1468-0017.00189; Langdon R, 2002, PSYCHOL MED, V32, P1273, DOI 10.1017/S0033291702006396; LEHRL S, 1995, ACTA NEUROL SCAND, V91, P335, DOI 10.1111/j.1600-0404.1995.tb07018.x; Leitman DI, 2006, PSYCHOL MED, V36, P1075, DOI 10.1017/S0033291706007653; Leitman DI, 2011, BIOL PSYCHIAT, V70, P611, DOI 10.1016/j.biopsych.2011.05.032; Lenzenweger M.F., 2011, SCHIZOTYPY SCHIZOPHR; Leube D, 2012, NEUROPSYCHOBIOLOGY, V66, P24, DOI 10.1159/000337131; Mashal N, 2013, BRAIN LANG, V124, P66, DOI 10.1016/j.bandl.2012.11.012; Mehta UM, 2012, SCHIZOPHR RES, V141, P281, DOI 10.1016/j.schres.2012.07.005; Mitchell RLC, 2004, BRIT J PSYCHIAT, V184, P223, DOI 10.1192/bjp.184.3.223; Mitchell RLC, 2005, BRAIN, V128, P963, DOI 10.1093/brain/awh466; Mo SL, 2008, PSYCHIAT RES, V157, P21, DOI 10.1016/j.psychres.2006.04.002; Mutschler DE, 2010, THESIS U TUBINGEN TU; Nelson MT, 2013, NEUROSCI BIOBEHAV R, V37, P317, DOI 10.1016/j.neubiorev.2013.01.004; Papagno C, 2010, ITAL J LINGUIST, V22, P21; Pexman PM, 2008, CURR DIR PSYCHOL SCI, V17, P286, DOI 10.1111/j.1467-8721.2008.00591.x; RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555; Rankin KP, 2009, NEUROIMAGE, V47, P2005, DOI 10.1016/j.neuroimage.2009.05.077; Rapp AM, 2010, BRAIN LANG, V113, P1, DOI 10.1016/j.bandl.2009.11.007; Rapp A, 2009, LANGUAGE LATERALIZATION AND PSYCHOSIS, P147, DOI 10.1017/CBO9780511576744.011; Rapp AM, 2008, NEUROSCI LETT, V445, P242, DOI 10.1016/j.neulet.2008.09.017; Rapp AM, 2007, BRAIN LANG, V100, P142, DOI 10.1016/j.bandl.2006.04.004; Rapp AM, 2012, NEUROIMAGE, V63, P600, DOI 10.1016/j.neuroimage.2012.06.022; Rapp AM, 2011, J INT NEUROPSYCH SOC, V17, P207, DOI 10.1017/S1355617710001682; Rapp AM, 2013, SCHIZOPHR RES, DOI DOI 10.1016/J.SCHRES.2013.07.019.[; Reynolds CA, 2000, SCHIZOPHRENIA BULL, V26, P603, DOI 10.1093/oxfordjournals.schbul.a033481; Russell TA, 2000, AM J PSYCHIAT, V157, P2040, DOI 10.1176/appi.ajp.157.12.2040; Salvatore Giampaolo, 2007, Cogn Neuropsychiatry, V12, P144, DOI 10.1080/13546800600819921; Salvatore G, 2012, CLIN PSYCHOL PSYCHOT, V19, P247, DOI 10.1002/cpp.746; Schofield K, 2014, LATERALITY, V19, P178, DOI 10.1080/1357650X.2013.789883; Shamay SG, 2002, BRAIN COGNITION, V48, P558, DOI 10.1006/brcg.2001.1417; Shamay-Tsoory SG, 2006, SOC NEUROSCI-UK, V1, P149, DOI 10.1080/17470910600985589; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Shamay-Tsoory SG, 2007, SCHIZOPHR RES, V90, P274, DOI 10.1016/j.schres.2006.09.020; Shibata M, 2010, BRAIN RES, V1308, P114, DOI 10.1016/j.brainres.2009.10.030; Siever LJ, 2004, AM J PSYCHIAT, V161, P398, DOI 10.1176/appi.ajp.161.3.398; Sommer IEC, 2009, LANGUAGE LATERALIZATION AND PSYCHOSIS, P1, DOI 10.1017/CBO9780511576744; Sommer IEC, 2003, SCHIZOPHR RES, V60, P183, DOI 10.1016/S0920-9964(02)00300-6; Sommer IE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043516; Sparks A, 2010, SCHIZOPHR RES, V122, P172, DOI 10.1016/j.schres.2010.06.011; Spotorno N, 2012, NEUROIMAGE, V63, P25, DOI 10.1016/j.neuroimage.2012.06.046; Sterzer P, 2010, BRAIN STRUCT FUNCT, V214, P611, DOI 10.1007/s00429-010-0252-2; Sugranyes G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025322; Tewes U, 1994, HAWIE R HAMBURG WECH; Varga E, 2010, EUROPEAN PSYCHIAT, V25, P1572; Wang AT, 2006, SOC COGN AFFECT NEUR, V1, P107, DOI 10.1093/scan/nsl018; Wang AT, 2006, BRAIN, V129, P932, DOI 10.1093/brain/awl032; Wechsler S, 1981, WECHSLER ADULT INTEL; Whalen JM, 2012, BEHAV INF TECHNOL, P1; Whalen JM, 2009, J LANG SOC PSYCHOL, V28, P263, DOI 10.1177/0261927X09335253; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Winner E, 1998, BRAIN LANG, V62, P89, DOI 10.1006/brln.1997.1889; Zaidel E, 2002, BRAIN LANG, V80, P510, DOI 10.1006/brln.2001.2612; Ziv I, 2011, COGN NEUROPSYCHIATRY, V16, P71, DOI 10.1080/13546805.2010.492693	111	45	45	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74224	10.1371/journal.pone.0074224	http://dx.doi.org/10.1371/journal.pone.0074224			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259PK	24040207	Green Published, Green Submitted, gold			2022-12-25	WOS:000327538600078
J	Richard, EM; Thiyagarajan, T; Bunni, MA; Basher, F; Roddy, PO; Siskind, LJ; Nietert, PJ; Nowling, TK				Richard, Erin Morris; Thiyagarajan, Thirumagal; Bunni, Marlene A.; Basher, Fahmin; Roddy, Patrick O.; Siskind, Leah J.; Nietert, Paul J.; Nowling, Tamara K.			Reducing FLI1 Levels in the MRL/lpr Lupus Mouse Model Impacts T Cell Function by Modulating Glycosphingolipid Metabolism	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; CYTOKINE PRODUCTION; RENAL-DISEASE; ETS FAMILY; DECREASED EXPRESSION; ANTIGEN RECEPTOR; MURINE LUPUS; MICE; ERYTHEMATOSUS; LYMPHOCYTES	Systemic Lupus erythematosus (SLE) is an autoimmune disease caused, in part, by abnormalities in cells of the immune system including B and T cells. Genetically reducing globally the expression of the ETS transcription factor FLI1 by 50% in two lupus mouse models significantly improves disease measures and survival through an unknown mechanism. In this study we analyze the effects of reducing FLI1 in the MRL/lpr lupus prone model on T cell function. We demonstrate that adoptive transfer of MRL/lpr Fli1(+/+) or Fli1(+/-) T cells and B cells into Rag1-deficient mice results in significantly decreased serum immunoglobulin levels in animals receiving Fli1(+/-) lupus T cells compared to animals receiving Fli1(+/+) lupus T cells regardless of the genotype of co-transferred lupus B cells. Ex vivo analyses of MRL/lpr T cells demonstrated that Fli1(+/-) T cells produce significantly less IL-4 during early and late disease and exhibited significantly decreased TCR-specific activation during early disease compared to Fli1(+/+) T cells. Moreover, the Fli1(+/-) T cells expressed significantly less neuraminidase 1 (Neu1) message and decreased NEU activity during early disease and significantly decreased levels of glycosphingolipids during late disease compared to Fli1(+/+) T cells. FLI1 dose-dependently activated the Neu1 promoter in mouse and human T cell lines. Together, our results suggest reducing FLI1 in lupus decreases the pathogenicity of T cells by decreasing TCR-specific activation and IL-4 production in part through the modulation of glycosphingolipid metabolism. Reducing the expression of FLI1 or targeting the glycosphingolipid metabolic pathway in lupus may serve as a therapeutic approach to treating lupus.	[Richard, Erin Morris; Thiyagarajan, Thirumagal; Basher, Fahmin; Nowling, Tamara K.] Med Univ S Carolina, Dept Med, Div Rheumatol & Immunol, Charleston, SC 29425 USA; [Bunni, Marlene A.] Med Univ S Carolina, Dept Med, Div Nephrol, Charleston, SC 29425 USA; [Nietert, Paul J.] Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Roddy, Patrick O.; Siskind, Leah J.] Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA; [Siskind, Leah J.; Nowling, Tamara K.] Ralph H Johnson Vet Affairs Med Ctr, Res Serv, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Nowling, TK (corresponding author), Med Univ S Carolina, Dept Med, Div Rheumatol & Immunol, Charleston, SC 29425 USA.	nowling@musc.edu		Siskind, Leah/0000-0001-5026-5187; Nietert, Paul/0000-0002-3933-4986	Veteran's Administration [BX000115]; National Institutes of Health [NCRR P20 RR17677 COBRE, NIDDK R01 DK093462, NCRR UL1TR000062, NIAMS 1P60 AR062755-01]; Cancer Center Support Grant [P30 CA138313]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000062] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR062755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093462] Funding Source: NIH RePORTER	Veteran's Administration(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by funding from the Veteran's Administration (Merit Review Grant BX000115 to TKN) and in part by National Institutes of Health (NCRR P20 RR17677 COBRE in Lipidomics and Pathobiology pilot project and NIDDK R01 DK093462 to LJS) and Lipidomics Shared Resource of the Hollings Cancer Center at the Medical University of South Carolina supported by a Cancer Center Support Grant (P30 CA138313). Support for PJN was provided by the National Institutes of Health (NCRR UL1TR000062 and NIAMS 1P60 AR062755-01). The contents of this publication do not represent the views of the Department of Veterans Affairs or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MK, 1999, DEVELOPMENT, V126, P3131; Asano Y, 2010, AM J PATHOL, V176, P1983, DOI 10.2353/ajpath.2010.090593; BENDAVID Y, 1991, GENE DEV, V5, P908, DOI 10.1101/gad.5.6.908; BERNSTEIN KA, 1995, J IMMUNOL, V154, P2424; Bijl M, 2001, ANN RHEUM DIS, V60, P523, DOI 10.1136/ard.60.5.523; Blank N, 2005, BIOCHEM PHARMACOL, V71, P126, DOI 10.1016/j.bcp.2005.10.004; Chen XP, 1997, J IMMUNOL, V158, P3070; Chen XP, 2000, CYTOKINE, V12, P972, DOI 10.1006/cyto.1999.0596; Erb KJ, 1997, J EXP MED, V185, P329, DOI 10.1084/jem.185.2.329; GILKESON GS, 1989, J IMMUNOL, V142, P1482; Hoffman RW, 2004, CLIN IMMUNOL, V113, P4, DOI 10.1016/j.clim.2004.05.001; Hsu JC, 1999, MULTIPLE COMP THEORY, Vxiv, P274; JEVNIKAR AM, 1994, J EXP MED, V179, P1137, DOI 10.1084/jem.179.4.1137; Jury EC, 2004, J CLIN INVEST, V113, P1176, DOI 10.1172/JCI200420345; Kovacs B, 1996, CLIN IMMUNOL IMMUNOP, V81, P293, DOI 10.1006/clin.1996.0192; Krishnan S, 2004, J IMMUNOL, V172, P7821, DOI 10.4049/jimmunol.172.12.7821; Kyttaris VC, 2011, ARTHRITIS RHEUM-US, V63, P2058, DOI 10.1002/art.30353; Liang F, 2006, J BIOL CHEM, V281, P27526, DOI 10.1074/jbc.M605633200; Liossis SNC, 1996, J CLIN INVEST, V98, P2549, DOI 10.1172/JCI119073; MAO XH, 1994, J BIOL CHEM, V269, P18216; Mathenia J, 2010, CLIN EXP IMMUNOL; Melet F, 1996, MOL CELL BIOL, V16, P2708; Molano I, 2010, CLIN EXP IMMUNOL, V160, P275, DOI 10.1111/j.1365-2249.2009.04080.x; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Moulton VR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3251; Nagafuku M, 2012, P NATL ACAD SCI USA, V109, pE336, DOI 10.1073/pnas.1114965109; Nowling TK, 2008, MOL IMMUNOL, V45, P1, DOI 10.1016/j.molimm.2007.05.018; Odendahl M, 2000, J IMMUNOL, V165, P5970, DOI 10.4049/jimmunol.165.10.5970; Peng SL, 1996, J IMMUNOL, V157, P5689; Peng SL, 1997, J CLIN INVEST, V99, P1936, DOI 10.1172/JCI119361; Princen K, 2003, CYTOM PART A, V51A, P35, DOI 10.1002/cyto.a.10008; RAJAGOPALAN S, 1990, P NATL ACAD SCI USA, V87, P7020, DOI 10.1073/pnas.87.18.7020; SANTORO TJ, 1988, J EXP MED, V167, P1713, DOI 10.1084/jem.167.5.1713; SEAMAN WE, 1983, J IMMUNOL, V130, P1713; Sekine H, 2001, J IMMUNOL, V166, P6444, DOI 10.4049/jimmunol.166.10.6444; Suzuki E, 2012, CLIN IMMUNOL, V145, P201, DOI 10.1016/j.clim.2012.09.006; Svenson JL, 2010, GENES IMMUN, V11, P161, DOI 10.1038/gene.2009.73; TAIRA S, 1988, J IMMUNOL, V141, P440; Vratsanos GS, 2001, J EXP MED, V193, P329, DOI 10.1084/jem.193.3.329; WOFSY D, 1985, J IMMUNOL, V134, P852; ZHANG LQ, 1995, MOL CELL BIOL, V15, P6961; Zhang XK, 2008, J IMMUNOL, V181, P1644, DOI 10.4049/jimmunol.181.3.1644; Zhang XK, 2005, J BIOCHEM, V137, P297, DOI 10.1093/jb/mvi032; Zhang XK, 2004, J IMMUNOL, V173, P6481, DOI 10.4049/jimmunol.173.10.6481; Zhu YX, 2011, J BIOL CHEM, V286, P14787, DOI 10.1074/jbc.M111.218610; Zielinski CE, 2005, J IMMUNOL, V174, P5100, DOI 10.4049/jimmunol.174.8.5100	46	26	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e75175	10.1371/journal.pone.0075175	http://dx.doi.org/10.1371/journal.pone.0075175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040398	Green Published, Green Submitted, gold			2022-12-25	WOS:000327538600131
J	Rodriguez-Mari, A; Canestro, C; BreMiller, RA; Catchen, JM; Yan, YL; Postlethwait, JH				Rodriguez-Mari, Adriana; Canestro, Cristian; BreMiller, Ruth A.; Catchen, Julian M.; Yan, Yi-Lin; Postlethwait, John H.			Retinoic Acid Metabolic Genes, Meiosis, and Gonadal Sex Differentiation in Zebrafish	PLOS ONE			English	Article							GERM-CELL FATE; MEIOTIC INITIATION; STEM-CELLS; OOCYTE APOPTOSIS; ENTER MEIOSIS; MOUSE; EXPRESSION; FEMALE; CYP26B1; GENOME	To help understand the elusive mechanisms of zebrafish sex determination, we studied the genetic machinery regulating production and breakdown of retinoic acid (RA) during the onset of meiosis in gonadogenesis. Results uncovered unexpected mechanistic differences between zebrafish and mammals. Conserved synteny and expression analyses revealed that cyp26a1 in zebrafish and its paralog Cyp26b1 in tetrapods independently became the primary genes encoding enzymes available for gonadal RA-degradation, showing lineage-specific subfunctionalization of vertebrate genome duplication (VGD) paralogs. Experiments showed that zebrafish express aldh1a2, which encodes an RA-synthesizing enzyme, in the gonad rather than in the mesonephros as in mouse. Germ cells in bipotential gonads of all zebrafish analyzed were labeled by the early meiotic marker sycp3, suggesting that in zebrafish, the onset of meiosis is not sexually dimorphic as it is in mouse and is independent of Stra8, which is required in mouse but was lost in teleosts. Analysis of dead-end knockdown zebrafish depleted of germ cells revealed the germ cell-independent onset and maintenance of gonadal aldh1a2 and cyp26a1 expression. After meiosis initiated, somatic cell expression of cyp26a1 became sexually dimorphic: up-regulated in testes but not ovaries. Meiotic germ cells expressing the synaptonemal complex gene sycp3 occupied islands of somatic cells that lacked cyp26a1 expression, as predicted by the hypothesis that Cyp26a1 acts as a meiosis-inhibiting factor. Consistent with this hypothesis, females up-regulated cyp26a1 in oocytes that entered prophase-I meiotic arrest, and down-regulated cyp26a1 in oocytes resuming meiosis. Co-expression of cyp26a1 and the pluripotent germ cell stem cell marker pou5f1(oct4) in meiotically arrested oocytes was consistent with roles in mouse to promote germ cell survival and to prevent apoptosis, mechanisms that are central for tipping the sexual fate of gonads towards the female pathway in zebrafish.	[Rodriguez-Mari, Adriana; BreMiller, Ruth A.; Catchen, Julian M.; Yan, Yi-Lin; Postlethwait, John H.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; [Rodriguez-Mari, Adriana; Canestro, Cristian] Univ Barcelona, Dept Genet, Barcelona, Spain	University of Oregon; University of Barcelona	Canestro, C (corresponding author), Univ Barcelona, Dept Genet, Barcelona, Spain.	canestro@ub.edu; jpostle@uoneuro.uoregon.edu	Catchen, Julian/D-9795-2016; Yan, Yi/GSO-3046-2022; Cañestro, Cristian/L-9661-2014	Cañestro, Cristian/0000-0003-4623-8105	Generalitat de Catalunya [2009SGR336]; Ministerio de Economia y Competitividad (Spain) [BFU2010-14875]; National Institutes of Health [1R01GM085318, 2R01RR020833 (alias R01OD011116)];  [5P01HD022486]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR020833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085318] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011116] Funding Source: NIH RePORTER	Generalitat de Catalunya(Generalitat de Catalunya); Ministerio de Economia y Competitividad (Spain)(Spanish Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding support to the University of Oregon Zebrafish Facility came from grant 5P01HD022486, to CC came from grant 2009SGR336 from Generalitat de Catalunya and grant BFU2010-14875 from the Ministerio de Economia y Competitividad (Spain), and to JHP came from grants 1R01GM085318 and 2R01RR020833 (alias R01OD011116) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Abed SS, 1998, J BIOL CHEM, V273, P2409, DOI 10.1074/jbc.273.4.2409; Albalat R, 2009, CHEM-BIOL INTERACT, V178, P188, DOI 10.1016/j.cbi.2008.09.017; Alsop D, 2008, GEN COMP ENDOCR, V156, P51, DOI 10.1016/j.ygcen.2007.11.008; Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Anderson JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040701; Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Bassham S, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-35; Beer RL, 2013, DEV BIOL, V374, P308, DOI 10.1016/j.ydbio.2012.12.003; BOUILLET P, 1995, DEV BIOL, V170, P420, DOI 10.1006/dbio.1995.1226; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Bowles J, 2007, DEVELOPMENT, V134, P3401, DOI 10.1242/dev.001107; Bowles J, 2010, DEV CELL, V19, P440, DOI 10.1016/j.devcel.2010.08.010; Bowles J, 2009, DEV DYNAM, V238, P2073, DOI 10.1002/dvdy.22024; Bradley KM, 2011, G3-GENES GENOM GENET, V1, P3, DOI 10.1534/g3.111.000190; Brennan J, 2004, NAT REV GENET, V5, P509, DOI 10.1038/nrg1381; Bullejos M, 2004, MOL REPROD DEV, V68, P422, DOI 10.1002/mrd.20105; Canestro C, 2006, EVOL DEV, V8, P394, DOI 10.1111/j.1525-142X.2006.00113.x; Canestro C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000496; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chassot AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025641; Ciruna B, 2002, P NATL ACAD SCI USA, V99, P14919, DOI 10.1073/pnas.222459999; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Di Carlo A, 2000, INT J DEV BIOL, V44, P241; Dranow DB, 2013, DEV BIOL, V376, P43, DOI 10.1016/j.ydbio.2013.01.016; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Force A, 1999, GENETICS, V151, P1531; Graves JAM, 2013, DEV DYNAM, V242, P354, DOI 10.1002/dvdy.23887; Griswold MD, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096610; Gu XX, 2005, GENE EXPR PATTERNS, V5, P733, DOI 10.1016/j.modgep.2005.04.005; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Hernandez RE, 2007, DEVELOPMENT, V134, P177, DOI 10.1242/dev.02706; Herpin A, 2011, CURR BIOL, V21, pR656, DOI 10.1016/j.cub.2011.07.026; HILSCHER B, 1974, CELL TISSUE RES, V154, P443, DOI 10.1007/BF00219667; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Hunt PA, 2002, SCIENCE, V296, P2181, DOI 10.1126/science.1071907; Itoh N, 2007, BIOL PHARM BULL, V30, P1819, DOI 10.1248/bpb.30.1819; Jameson SA, 2012, DEV BIOL, V370, P24, DOI 10.1016/j.ydbio.2012.06.009; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kim Y, 2006, PLOS BIOL, V4, P1000, DOI 10.1371/journal.pbio.0040187; Koopman P, 2001, EXS, V91, P25; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Kumar S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1136; Le Bouffant R, 2010, HUM REPROD, V25, P2579, DOI 10.1093/humrep/deq195; Lesch BJ, 2012, NAT REV GENET, V13, P781, DOI 10.1038/nrg3294; Li H, 2011, BIOL REPROD, V84, P336, DOI 10.1095/biolreprod.110.086157; Li H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007501; Li H, 2009, BIOL REPROD, V81, P996, DOI 10.1095/biolreprod.109.078808; Liew WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034397; Lin YF, 2008, SCIENCE, V322, P1685, DOI 10.1126/science.1166340; LOVELLBADGE R, 1990, DEVELOPMENT, V109, P635; Maack G, 2003, J FISH BIOL, V62, P895, DOI 10.1046/j.1095-8649.2003.00074.x; MacLean G, 2001, MECH DEVELOP, V107, P195, DOI 10.1016/S0925-4773(01)00463-4; MacLean G, 2007, ENDOCRINOLOGY, V148, P4560, DOI 10.1210/en.2007-0492; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Mark M, 2008, J CELL SCI, V121, P3233, DOI 10.1242/jcs.035071; Marletaz F, 2006, INT J BIOL SCI, V2, P38; McLaren A, 1984, Symp Soc Exp Biol, V38, P7; Menke DB, 2003, DEV BIOL, V262, P303, DOI 10.1016/S0012-1606(03)00391-9; Morelli MA, 2005, REPRODUCTION, V130, P761, DOI 10.1530/rep.1.00865; Mu XY, 2013, J CELL PHYSIOL, V228, P627, DOI 10.1002/jcp.24172; Naillat F, 2010, HUM MOL GENET, V19, P1539, DOI 10.1093/hmg/ddq027; Nicol B, 2012, MOL REPROD DEV, V79, P51, DOI 10.1002/mrd.21404; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Novak I, 2006, STEM CELLS, V24, P1931, DOI 10.1634/stemcells.2005-0520; OuladAbdelghani M, 1996, J CELL BIOL, V135, P469, DOI 10.1083/jcb.135.2.469; Pittlik S, 2008, GENE EXPR PATTERNS, V8, P141, DOI 10.1016/j.gep.2007.11.003; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Postlethwait JH, 2007, J EXP ZOOL PART B, V308B, P563, DOI 10.1002/jez.b.21137; Ray WJ, 1997, J BIOL CHEM, V272, P18702, DOI 10.1074/jbc.272.30.18702; Reijntjes S, 2005, DEV BIOL, V285, P224, DOI 10.1016/j.ydbio.2005.06.019; Rodriguez-Mari A, 2005, GENE EXPR PATTERNS, V5, P655, DOI 10.1016/j.modgep.2005.02.008; Rodriguez-Mari A, 2011, METHOD CELL BIOL, V105, P461, DOI 10.1016/B978-0-12-381320-6.00020-5; Rodriguez-Mari A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001357; Rodriguez-Mari A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001034; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Sakai Y, 2004, DEV BIOL, V276, P143, DOI 10.1016/j.ydbio.2004.08.032; Siegfried KR, 2008, DEV BIOL, V324, P277, DOI 10.1016/j.ydbio.2008.09.025; Slanchev K, 2005, P NATL ACAD SCI USA, V102, P4074, DOI 10.1073/pnas.0407475102; Smith CA, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-85; Snyder EM, 2010, BIOL REPROD, V83, P783, DOI 10.1095/biolreprod.110.085811; Sun YL, 2012, FISH PHYSIOL BIOCHEM, V38, P1427, DOI 10.1007/s10695-012-9630-4; TAKAHASHI H, 1977, Bulletin of the Faculty of Fisheries Hokkaido University, V28, P57; Tedesco M, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106526; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trautmann E, 2008, CELL CYCLE, V7, P656, DOI 10.4161/cc.7.5.5482; Uchida D, 2004, COMP BIOCHEM PHYS A, V137, P11, DOI 10.1016/S1095-6433(03)00178-8; Uchida D, 2002, J EXP BIOL, V205, P711; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; Wallacides A, 2009, DEV DYNAM, V238, P1389, DOI 10.1002/dvdy.21948; Wang XG, 2007, J FISH BIOL, V70, P33, DOI 10.1111/j.1095-8649.2007.01363.x; Weidinger G, 2003, CURR BIOL, V13, P1429, DOI 10.1016/S0960-9822(03)00537-2; White JA, 1996, J BIOL CHEM, V271, P29922, DOI 10.1074/jbc.271.47.29922; Yamaguchi T, 2012, BIOCHEM BIOPH RES CO, V419, P287, DOI 10.1016/j.bbrc.2012.02.012; Yao HHC, 2003, DEVELOPMENT, V130, P5895, DOI 10.1242/dev.00836; Yoon C, 1997, DEVELOPMENT, V124, P3157; Yu ML, 2013, AMINO ACIDS, V44, P405, DOI 10.1007/s00726-012-1343-6; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zhao QS, 2005, GENE EXPR PATTERNS, V5, P363, DOI 10.1016/j.modgep.2004.09.011; Zhou Q, 2008, BIOL REPROD, V78, P537, DOI 10.1095/biolreprod.107.064337	104	61	61	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73951	10.1371/journal.pone.0073951	http://dx.doi.org/10.1371/journal.pone.0073951			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040125	Green Published, Green Submitted, gold			2022-12-25	WOS:000327538600054
J	Tu, T; Gao, Q; Luo, YT; Chen, JN; Lu, D; Feng, J; Yang, DL; Song, LN; Yan, XY				Tu, Tao; Gao, Qian; Luo, Yongting; Chen, Jianan; Lu, Di; Feng, Jing; Yang, Dongling; Song, Lina; Yan, Xiyun			CD146 Deletion in the Nervous System Impairs Appetite, Locomotor Activity and Spatial Learning in Mice	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; L1 KNOCKOUT MICE; IMMUNOGLOBULIN SUPERFAMILY; NEURITE OUTGROWTH; MONOCLONAL-ANTIBODY; EXPRESSION; GENE; EXTENSION; NEURONS; GICERIN	Cell adhesion molecules (CAMs) are crucial effectors for the development and maintenance of the nervous system. Mutations in human CAM genes are linked to brain disorders and psychological diseases, and CAM knockout mice always exhibit similar behavioral abnormalities. CD146 is a CAM of the immunoglobulin superfamily that interacts with Neurite Outgrowth Factor and involved in neurite extension in vitro. However, little is known about its in vivo function in the nervous system. In this study, we used a murine CD146 nervous system knockout (CD146(ns-ko)) model. We found that the brains of some CD146(ns-ko) mice were malformed with small olfactory bulbs. CD146(ns-ko) mice exhibited lower body weights and smaller food intake when compared with wild type littermates. Importantly, behavior tests revealed that CD146(ns-ko) mice exhibited significant decreased locomotor activity and impaired capacity for spatial learning and memory. Our results demonstrate that CD146 is important for mammalian nervous system development and proper behavior patterns.	[Tu, Tao; Gao, Qian; Luo, Yongting; Chen, Jianan; Lu, Di; Feng, Jing; Yang, Dongling; Song, Lina; Yan, Xiyun] Chinese Acad Sci, Inst Biophys, CAS Univ Tokyo Joint Lab Struct Virol & Immunol, Key Lab Prot & Peptide Pharmaceut, Beijing 100080, Peoples R China; [Tu, Tao; Gao, Qian; Chen, Jianan] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yan, XY (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Univ Tokyo Joint Lab Struct Virol & Immunol, Key Lab Prot & Peptide Pharmaceut, Beijing 100080, Peoples R China.	yanxy@ibp.ac.cn	Lu, Di/D-9836-2018	Lu, Di/0000-0002-4083-1656; Luo, Yongting/0000-0001-7834-8742	National Natural Science Foundation of China [91029732, 81272409]; National Basic Research Program of China (973 Program) [2009CB521704]; "Strategic Priority Research Program" of the Chinese Academy of Sciences, Stem Cell and Regenerative Medicine Research [XDA01040409]; National Important Science and Technology Specific Projects [2012ZX10002009-016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); "Strategic Priority Research Program" of the Chinese Academy of Sciences, Stem Cell and Regenerative Medicine Research; National Important Science and Technology Specific Projects	This work was supported by grants from the National Natural Science Foundation of China (Nos. 91029732 and 81272409), National Basic Research Program of China (973 Program; 2009CB521704), "Strategic Priority Research Program" of the Chinese Academy of Sciences, Stem Cell and Regenerative Medicine Research (XDA01040409), and the National Important Science and Technology Specific Projects (2012ZX10002009-016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Chazal G, 2000, J NEUROSCI, V20, P1446; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; Demyanenko GP, 1999, J NEUROSCI, V19, P4907; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; FRANSEN E, 1995, EUR J HUM GENET, V3, P273; Fransen E, 1998, HUM MOL GENET, V7, P999, DOI 10.1093/hmg/7.6.999; Garcia S, 2007, HUM PATHOL, V38, P830, DOI 10.1016/j.humpath.2006.11.015; Giger RJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001867; He XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046223; Hiroi S, 2005, INT J MOL MED, V16, P1009; Hiroi S, 2003, FEBS LETT, V554, P311, DOI 10.1016/S0014-5793(03)01176-1; Hulley P, 1998, J NEUROSCI RES, V53, P129, DOI 10.1002/(SICI)1097-4547(19980715)53:2<129::AID-JNR1>3.0.CO;2-9; Katidou Markella, 2008, Biotechnology Journal, V3, P1564, DOI 10.1002/biot.200800281; Kleene R, 2010, J NEUROSCI, V30, P10784, DOI 10.1523/JNEUROSCI.0297-10.2010; Kraev I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023433; Kristiansen G, 2003, ANAL CELL PATHOL, V25, P77, DOI 10.1155/2003/574829; LEHMANN JM, 1989, P NATL ACAD SCI USA, V86, P9891, DOI 10.1073/pnas.86.24.9891; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; MIRAGALL F, 1989, DEV BIOL, V135, P272, DOI 10.1016/0012-1606(89)90179-6; Myers MG, 2012, NATURE, V491, P357, DOI 10.1038/nature11705; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; Sakurai K, 2002, MOL PSYCHIATR, V7, P412, DOI 10.1038/sj.mp.4000973; Schrage A, 2008, HISTOCHEM CELL BIOL, V129, P441, DOI 10.1007/s00418-008-0379-x; Schwarz MJ, 1998, NEUROIMMUNOMODULAT, V5, P270, DOI 10.1159/000026347; Shi IM, 1999, J PATHOL, V189, P4, DOI 10.1002/(SICI)1096-9896(199909)189:1<4::AID-PATH332>3.0.CO;2-P; Silletti S, 2004, J BIOL CHEM, V279, P28880, DOI 10.1074/jbc.M404075200; Taira E, 2005, J CELL PHYSIOL, V204, P632, DOI 10.1002/jcp.20365; TAIRA E, 1994, NEURON, V12, P861, DOI 10.1016/0896-6273(94)90338-7; Taira E, 2004, J CELL PHYSIOL, V198, P377, DOI 10.1002/jcp.10413; Takei K, 1999, J NEUROSCI, V19, P9469; Todaro L, 2004, NEUROBIOL DIS, V15, P387, DOI 10.1016/j.nbd.2003.11.014; Vutskits L, 2001, EUR J NEUROSCI, V13, P1391, DOI 10.1046/j.0953-816x.2001.01516.x; Walsh FS, 1997, ANNU REV CELL DEV BI, V13, P425, DOI 10.1146/annurev.cellbio.13.1.425; Wolfgang MJ, 2006, ANNU REV NUTR, V26, P23, DOI 10.1146/annurev.nutr.25.050304.092532; Wu GJ, 2001, GENE, V279, P17, DOI 10.1016/S0378-1119(01)00736-3; Yan XY, 2003, BLOOD, V102, P184, DOI 10.1182/blood-2002-04-1004; Zhang Y, 2008, HYBRIDOMA, V27, P345, DOI 10.1089/hyb.2008.0034	39	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74124	10.1371/journal.pone.0074124	http://dx.doi.org/10.1371/journal.pone.0074124			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040184	Green Submitted, gold, Green Published			2022-12-25	WOS:000327538600070
J	Wielders, EAL; Houlleberghs, H; Isik, G; te Riele, H				Wielders, Eva A. L.; Houlleberghs, Hellen; Isik, Gozde; te Riele, Hein			Functional Analysis in Mouse Embryonic Stem Cells Reveals Wild-Type Activity for Three Msh6 Variants Found in Suspected Lynch Syndrome Patients	PLOS ONE			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; MISMATCH REPAIR DEFICIENCY; MICROSATELLITE INSTABILITY; METHYLATION TOLERANCE; GERMLINE MUTATIONS; MISSENSE VARIANTS; ES CELLS; GENES; HNPCC; PREDISPOSITION	Lynch syndrome confers an increased risk to various types of cancer, in particular early onset colorectal and endometrial cancer. Mutations in mismatch repair (MMR) genes underlie Lynch syndrome, with the majority of mutations found in MLH1 and MSH2. Mutations in MSH6 have also been found but these do not always cause a clear cancer predisposition phenotype and MSH6-defective tumors often do not show the standard characteristics of MMR deficiency, such as microsatellite instability. In particular, the consequences of MSH6 missense mutations are challenging to predict, which further complicates genetic counseling. We have previously developed a method for functional characterization of MSH2 missense mutations of unknown significance. This method is based on endogenous gene modification in mouse embryonic stem cells using oligonucleotide-directed gene targeting, followed by a series of functional assays addressing the MMR functions. Here we have adapted this method for the characterization of MSH6 missense mutations. We recreated three MSH6 variants found in suspected Lynch syndrome families, MSH6-P1087R, MSH6-R1095H and MSH6-L1354Q, and found all three to behave like wild type MSH6. Thus, despite suspicion for pathogenicity from clinical observations, our approach indicates these variants are not disease causing. This has important implications for counseling of mutation carriers.	[Wielders, Eva A. L.; Houlleberghs, Hellen; Isik, Gozde; te Riele, Hein] Netherlands Canc Inst, Div Biol Stress Response, Amsterdam, Netherlands	Netherlands Cancer Institute	te Riele, H (corresponding author), Netherlands Canc Inst, Div Biol Stress Response, Amsterdam, Netherlands.	h.t.riele@nki.nl		Isik, Gozde/0000-0002-1329-6782	Dutch Cancer Society grant [NKI 2004-3084]	Dutch Cancer Society grant(KWF Kankerbestrijding)	Dutch Cancer Society grant: NKI 2004-3084 (www.kwfkankerbestrijding.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl896; Bacher JW, 2005, MOL CARCINOGEN, V44, P285, DOI 10.1002/mc.20146; Baglietto L, 2010, JNCI-J NATL CANCER I, V102, P193, DOI 10.1093/jnci/djp473; Chao EC, 2008, HUM MUTAT, V29, P852, DOI 10.1002/humu.20735; Claij N, 2002, ONCOGENE, V21, P2873, DOI 10.1038/sj.onc.1205395; de Wind N, 1998, CANCER RES, V58, P248; de Wind N, 1999, NAT GENET, V23, P359, DOI 10.1038/15544; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; Giraldez MD, 2010, CLIN CANCER RES, V16, P5402, DOI 10.1158/1078-0432.CCR-10-1491; Domingo E, 2005, ONCOGENE, V24, P3995, DOI 10.1038/sj.onc.1208569; Doss CGP, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-42; Drost M, 2012, HUM MUTAT, V33, P488, DOI 10.1002/humu.22000; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Guerrette S, 1998, MOL CELL BIOL, V18, P6616, DOI 10.1128/MCB.18.11.6616; HEMMINKI A, 1994, NAT GENET, V8, P405, DOI 10.1038/ng1294-405; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kansikas M, 2011, HUM MUTAT, V32, P107, DOI 10.1002/humu.21409; Kantelinen J, 2010, BRIT J CANCER, V102, P1068, DOI 10.1038/sj.bjc.6605531; Kariola R, 2003, HUM GENET, V112, P105, DOI 10.1007/s00439-002-0866-4; Kariola R, 2002, HUM MOL GENET, V11, P1303, DOI 10.1093/hmg/11.11.1303; Kolodner RD, 1999, CANCER RES, V59, P5068; Ligtenberg MJL, 2009, NAT GENET, V41, P112, DOI 10.1038/ng.283; Lindor NM, 2006, JAMA-J AM MED ASSOC, V296, P1507, DOI 10.1001/jama.296.12.1507; Lynch HT, 1999, J MED GENET, V36, P801; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; Niessen RC, 2006, HUM GENET, V119, P206, DOI 10.1007/s00439-005-0118-5; Ou J, 2007, HUM MUTAT, V28, P1047, DOI 10.1002/humu.20580; Plaschke J, 2004, J CLIN ONCOL, V22, P4486, DOI 10.1200/JCO.2004.02.033; RIELE HT, 1990, NATURE, V348, P649, DOI 10.1038/348649a0; RIELE HT, 1992, P NATL ACAD SCI USA, V89, P5128, DOI 10.1073/pnas.89.11.5128; Tuupanen S, 2007, ONCOGENE, V26, P2513, DOI 10.1038/sj.onc.1210038; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Wielders EAL, 2011, HUM MUTAT, V32, P389, DOI 10.1002/humu.21448; Wijnen J, 1999, NAT GENET, V23, P142, DOI 10.1038/13773; Woods MO, 2005, CLIN CANCER RES, V11, P6853, DOI 10.1158/1078-0432.CCR-05-0726; You JF, 2010, BRIT J CANCER, V103, P1840, DOI 10.1038/sj.bjc.6605988; Yuen ST, 2002, ONCOGENE, V21, P7585, DOI 10.1038/sj.onc.1205968	38	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74766	10.1371/journal.pone.0074766	http://dx.doi.org/10.1371/journal.pone.0074766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040339	Green Submitted, Green Published, gold			2022-12-25	WOS:000327538600115
J	Zhang, XY; Xu, J; Wang, JJ; Gortner, L; Zhang, S; Wei, XJ; Song, J; Zhang, YP; Li, QP; Feng, ZC				Zhang, Xiaoying; Xu, Jing; Wang, Junjie; Gortner, Ludwig; Zhang, Sheng; Wei, Xiujuan; Song, Jie; Zhang, Yupei; Li, Qiuping; Feng, Zhichun			Reduction of MicroRNA-206 Contributes to the Development of Bronchopulmonary Dysplasia through Up-Regulation of Fibronectin 1	PLOS ONE			English	Article							LUNG INJURY; EXPRESSION; MIR-206; PROTEIN; DIFFERENTIATION; PROLIFERATION; INFLAMMATION; RECEPTOR; CELLS	Objective: To characterize microRNA-206 (miR-206) in the development of bronchopulmonary dysplasia (BPD). Design/Methods: We assessed the expression of miR-206 in BPD mouse lung tissues and blood samples of BPD patients by quantitative real-time PCR. Then, the role of miR-206 in regulating cell biology were examined by XTT assay, flow cytometry, transwell invasion assay, wound healing assay and adhesion assay in vitro. Furthermore, luciferase reporter assay, real-time PCR, western blot and Immunofluorescence staining were performed to figure out the target gene of miR-206. Results: A reduction in expression of miR-206 was observed in BPD mice compared with controls and in BPD patients compared with controls. miR-206 overexpression significantly induced cell apoptosis, reduced cell proliferation, migration and adhesion abilities, whereas the inhibition of miR-206 expression had the opposite effect. Fibronectin 1 (FN1) is a direct target of miR-206, and fn 1 can be transcriptionally and translationally regulated by miR-206. Down-regulation of miR-206 modulates biological functions of the cells, at least in part, by increasing the level of fn 1. Furthermore, fn 1 expression levels were increased in the BPD mice and BPD patients. Conclusions: The expression of miR-206 and its target gene, fn 1, may contribute to the progression of BPD.	[Zhang, Xiaoying; Xu, Jing; Zhang, Sheng; Wei, Xiujuan; Song, Jie; Zhang, Yupei; Li, Qiuping; Feng, Zhichun] Gen Mil Hosp Beijing PLA, BaYi Childrens Hosp, Dept Pediat, Beijing, Peoples R China; [Xu, Jing] Maternal & Child Hlth Hosp Guangxi Zhuang Autonom, Dept Pediat, Nanning, Peoples R China; [Wang, Junjie] Second Mil Med Univ, Changhai Hosp, Burn Ctr, Shanghai, Peoples R China; [Gortner, Ludwig] Univ Saarland, Pediat Univ Hosp, Homburg, Germany	Naval Medical University; Saarland University	Zhang, XY (corresponding author), Gen Mil Hosp Beijing PLA, BaYi Childrens Hosp, Dept Pediat, Beijing, Peoples R China.	xiaoyingzhang79@163.com; fengzhichun81@sina.com			National Natural Science Foundation of China [81170602, 81270059, 81000265]; Postdoctoral Science Foundation of China [2012T50889]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	This study was funded by the National Natural Science Foundation of China (81170602, 81270059, 81000265)https://isis.nsfc.gov.cn; Postdoctoral Science Foundation of China (2012T50889) http://210.79.234.200/V1/Manage/Login.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BD, 2009, ENDOCRINOLOGY, V150, P14, DOI 10.1210/en.2008-0984; Ali Z, 2013, ARCH GYNECOL OBSTET; Bach KP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047044; Boutet SC, 2012, CELL STEM CELL, V10, P327, DOI 10.1016/j.stem.2012.01.017; Durrmeyer X, 2012, J PEDIATR-US, V160, P578, DOI 10.1016/j.jpeds.2011.09.025; Fujiu K, 2011, J CLIN INVEST, V121, P3425, DOI 10.1172/JCI57582; Gagan J, 2012, J BIOL CHEM, V287, P40360, DOI 10.1074/jbc.M112.378414; Godoy-Guzman C, 2012, EUR J HISTOCHEM, V56, P179, DOI 10.4081/ejh.2012.e29; Kallopur SG, 2006, ARCH DIS CHILD-FETAL, V91, pF132, DOI 10.1136/adc.2004.068544; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kondo N, 2008, CANCER RES, V68, P5004, DOI 10.1158/0008-5472.CAN-08-0180; Kozakowska M, 2012, ANTIOXID REDOX SIGN, V16, P113, DOI 10.1089/ars.2011.3964; Kumarasamy A, 2009, AM J RESP CRIT CARE, V180, P1239, DOI 10.1164/rccm.200902-0215OC; Lewis A, 2012, THORAX, V67, P26, DOI 10.1136/thoraxjnl-2011-200309; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; McAdams RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046863; Radzikinas K, 2011, J NEUROSCI, V31, P15407, DOI 10.1523/JNEUROSCI.2745-11.2011; Sanders AJ, 2010, J ONCOL, V2010, DOI 10.1155/2010/817375; Soikkeli J, 2010, AM J PATHOL, V177, P387, DOI 10.2353/ajpath.2010.090748; Stahlhut C, 2012, DEVELOPMENT, V139, P4356, DOI 10.1242/dev.083774; Staunton David, 2009, V522, P73, DOI 10.1007/978-1-59745-413-1_5; Steffens S, 2012, ONCOL LETT, V3, P787, DOI 10.3892/ol.2012.566; Wagner TE, 2003, J HISTOCHEM CYTOCHEM, V51, P1307, DOI 10.1177/002215540305101008; Wijelath ES, 2004, J VASC SURG, V39, P655, DOI 10.1016/j.jvs.2003.10.042; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Wu JJ, 2013, TOXICOL APPL PHARM, V267, P238, DOI 10.1016/j.taap.2013.01.002; Zhang L, 2013, CANCER LETT, V332, P94, DOI 10.1016/j.canlet.2013.01.023; Zhang XY, 2012, CELL BIOL INT, V36, P589, DOI 10.1042/CBI20110447; Zhang XY, 2012, IN VITRO CELL DEV-AN, V48, P131, DOI 10.1007/s11626-012-9482-3; Zhang XY, 2011, RESP CARE, V56, P1009, DOI 10.4187/respcare.01032; Zhang XY, 2009, HEPATOLOGY, V50, P490, DOI 10.1002/hep.23008	31	7	7	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74750	10.1371/journal.pone.0074750	http://dx.doi.org/10.1371/journal.pone.0074750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040336	Green Published, gold, Green Submitted			2022-12-25	WOS:000327538600113
J	Ahn, JO; Lee, HW; Seo, KW; Kang, SK; Ra, JC; Youn, HY				Ahn, Jin Ok; Lee, Hee Woo; Seo, Kyoung Won; Kang, Sung Keun; Ra, Jeong Chan; Youn, Hwa Young			Anti-Tumor Effect of Adipose Tissue Derived-Mesenchymal Stem Cells Expressing Interferon-beta and Treatment with Cisplatin in a Xenograft Mouse Model for Canine Melanoma	PLOS ONE			English	Article							BREAST-CANCER CELLS; HUMAN BONE-MARROW; GENE-THERAPY; MALIGNANT-MELANOMA; STROMAL CELLS; IN-VITRO; GROWTH; IMMUNOTHERAPY; CARBOPLATIN; INHIBITION	Adipose tissue-derived mesenchymal stem cells (AT-MSCs) are attractive cell-therapy vehicles for the delivery of anti-tumor molecules into the tumor microenvironment. The innate tropism of AT-MSCs for tumors has important implications for effective cellular delivery of anti-tumor molecules, including cytokines, interferon, and pro-drugs. The present study was designed to determine the possibility that the combination of stem cell-based gene therapy with low-dose cisplatin would improve therapeutic efficacy against canine melanoma. The IFN-beta transduced canine AT-MSCs (cAT-MSC-IFN-beta) inhibited the growth of LMeC canine melanoma cells in direct and indirect in vitro co-culture systems. In animal experiments using BALB/c nude mouse xenografts, which developed by injecting LMeC cells, the combination treatment of cAT-MSC-IFN-beta and low-dose cisplatin significantly reduced tumor volume compared with the other treatment groups. Fluorescent microscopic analysis with a TUNEL (terminal deoxynucleotidyl transferase-mediated nick-end labeling) assay of tumor section provided evidence for homing of cAT-MSC-IFN-beta to the tumor site and revealed that the combination treatment of cAT-MSC-IFN-beta with low-dose cisplatin induced high levels of cell apoptosis. These findings may prove useful in further explorations of the application of these combined approaches to the treatment of malignant melanoma and other tumors.	[Ahn, Jin Ok; Lee, Hee Woo; Youn, Hwa Young] Seoul Natl Univ, Coll Vet Med, Dept Internal Med, Seoul, South Korea; [Seo, Kyoung Won] Chungnam Natl Univ, Coll Vet Med, Dept Internal Med, Taejon, South Korea; [Kang, Sung Keun; Ra, Jeong Chan] RNL Bio Co Ltd, Stem Cell Res Ctr, Seoul, South Korea	Seoul National University (SNU); Chungnam National University	Youn, HY (corresponding author), Seoul Natl Univ, Coll Vet Med, Dept Internal Med, Seoul, South Korea.	hyyoun@snu.ac.kr		Seo, Kyoung won/0000-0002-1561-3278	Korean Government through a National Research Foundation of Korea [2011-0000226]; Seoul National University Brain Fusion Program Research Grant	Korean Government through a National Research Foundation of Korea(National Research Foundation of Korea); Seoul National University Brain Fusion Program Research Grant	This research was supported by the Korean Government through a National Research Foundation of Korea Grant (number 2011-0000226) and the Seoul National University Brain Fusion Program Research Grant. The authors wish to thank the research Institute for Veterinary Science, Seoul National University, and BK21 Program for Veterinary Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong CA, 1996, CANCER RES, V56, P2191; Ayuzawa R, 2009, CANCER LETT, V280, P31, DOI 10.1016/j.canlet.2009.02.011; BALKWILL F, 1978, NATURE, V274, P798, DOI 10.1038/274798a0; Chawla-Sarkar M, 2001, CLIN CANCER RES, V7, P1821; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; Choi EA, 2004, CLIN CANCER RES, V10, P1535, DOI 10.1158/1078-0432.CCR-0040-03; Cousin B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006278; Damdinsuren B, 2003, ANN SURG ONCOL, V10, P1184, DOI 10.1245/ASO.2003.03.010; Einhorn S, 1996, J INTERF CYTOK RES, V16, P275, DOI 10.1089/jir.1996.16.275; Freeman KP, 2003, J VET INTERN MED, V17, P96, DOI 10.1892/0891-6640(2003)017<0096:TODWOM>2.3.CO;2; Fritz V, 2008, CURR STEM CELL RES T, V3, P32, DOI 10.2174/157488808783489462; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Horikoshi Takashi, 1995, Journal of Dermatology (Tokyo), V22, P631; HUBNER B, 1995, J CANCER RES CLIN, V121, P84, DOI 10.1007/BF01202218; Inoue K, 2004, J VET MED SCI, V66, P1437, DOI 10.1292/jvms.66.1437; Jonasch E, 2001, ONCOLOGIST, V6, P34, DOI 10.1634/theoncologist.6-1-34; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Kidd S, 2010, CYTOTHERAPY, V12, P615, DOI 10.3109/14653241003631815; Kim SK, 2006, CLIN CANCER RES, V12, P5550, DOI 10.1158/1078-0432.CCR-05-2508; KIRKWOOD JM, 1984, J CLIN ONCOL, V2, P336, DOI 10.1200/JCO.1984.2.4.336; KITCHELL BE, 1994, J AM VET MED ASSOC, V204, P229; Klopp AH, 2011, STEM CELLS, V29, P11, DOI 10.1002/stem.559; Komenaka I, 2004, CLIN DERMATOL, V22, P251, DOI 10.1016/j.clindermatol.2003.12.001; LOEHRER PJ, 1984, ANN INTERN MED, V100, P704, DOI 10.7326/0003-4819-100-5-704; Modiano JF, 1999, J VET INTERN MED, V13, P163, DOI 10.1892/0891-6640(1999)013&lt;0163:TMBOCM&gt;2.3.CO;2; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Nakaya K, 2001, AM J PHYSIOL-CELL PH, V281, pC1812, DOI 10.1152/ajpcell.2001.281.6.C1812; Neupane M, 2008, TISSUE ENG PT A, V14, P1007, DOI [10.1089/ten.tea.2007.0207, 10.1089/tea.2007.0207]; Ozawa K, 2008, J AUTOIMMUN, V30, P121, DOI 10.1016/j.jaut.2007.12.008; PARMIANI G, 1995, MELANOMA RES, V5, P295, DOI 10.1097/00008390-199510000-00001; Populo H, 2012, EXPERT OPIN THER TAR, V16, P689, DOI 10.1517/14728222.2012.691472; Qiao L, 2008, CANCER LETT, V269, P67, DOI 10.1016/j.canlet.2008.04.032; Rachakatla RS, 2007, CANCER GENE THER, V14, P828, DOI 10.1038/sj.cgt.7701077; Rassnick KM, 2001, J AM VET MED ASSOC, V218, P1444, DOI 10.2460/javma.2001.218.1444; Ren C, 2008, GENE THER, V15, P1446, DOI 10.1038/gt.2008.101; Rietschel P, 2006, HEMATOL ONCOL CLIN N, V20, P751, DOI 10.1016/j.hoc.2006.02.005; Rigel DS, 2000, CA-CANCER J CLIN, V50, P215, DOI 10.3322/canjclin.50.4.215; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Secchiero P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011140; Seo KW, 2011, CYTOTHERAPY, V13, P944, DOI 10.3109/14653249.2011.584864; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Studeny M, 2002, CANCER RES, V62, P3603; Thudi NK, 2011, PROSTATE, V71, P615, DOI 10.1002/pros.21277; Torsvik A, 2013, CANCER TREAT REV, V39, P180, DOI 10.1016/j.ctrv.2012.03.005; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; WHITLEY EM, 1995, ANTICANCER RES, V15, P923; Wingo PA, 1999, J NATL CANCER I, V91, P675, DOI 10.1093/jnci/91.8.675; Xu WT, 2009, CANCER LETT, V281, P32, DOI 10.1016/j.canlet.2009.02.022; Yan XL, 2012, BREAST CANCER RES TR, V132, P153, DOI 10.1007/s10549-011-1577-0	51	31	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74897	10.1371/journal.pone.0074897	http://dx.doi.org/10.1371/journal.pone.0074897			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040358	Green Submitted, Green Published, gold			2022-12-25	WOS:000326405300194
J	Kim, SH; Lee, Y; Lee, S; Mun, CW				Kim, Seong-Ho; Lee, Youngho; Lee, Sunggun; Mun, Chi-Woong			Evaluation of the Effectiveness of Pregabalin in Alleviating Pain Associated with Fibromyalgia: Using Functional Magnetic Resonance Imaging Study	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; PRESSURE-PAIN; STIMULATION; RESPONSES; INSULA; DOMAINS	Purpose: To assess the efficacy of pregabalin by showing differences in the neuronal activities of fibromyalgia (FM) patients before and after longitudinal treatment using functional magnetic resonance imaging (fMRI). Materials and Methods: In total, 21 female patients with FM and 11 age- and gender-matched healthy controls participated. FM patients underwent fMRI at baseline and following pharmacological therapy with pregabalin to diminish their pain. Pressure-pain stimuli were delivered on the subject's thumbnail bed during fMRI scans. Brain activation regions in fMRI were evaluated for longitudinal changes using a paired t-test. Changes in clinical features were also assessed with the Fibromyalgia Impact Questionnaire (FIQ), Brief Fatigue Inventory (BFI), Beck Depression Inventory (BDI), Widespread Pain Index (WPI), Symptom Severity Scale Score (SSS), and State-Trait Anxiety Inventory (STAI). Results: Clinical scores were reduced significantly following therapy with five of the six clinical tests (FIQ, BFI, BDI, WPI, SSS; p < 0.05). Brain activation post-treatment was significantly lower than that pre-treatment in 13 regions of the brain (p < 0.001). Conclusions: Our findings confirm that pregabalin influences aspects of the whole pain matrix, using fMRI, inducing longitudinal changes in neuronal activity during the pain state, and that it reduces pain and other core symptoms of FM. This method could be applied to other longitudinal clinical trials of pharmacological treatments for FM.	[Kim, Seong-Ho; Lee, Sunggun] Inje Univ, Coll Med, Haeundae Paik Hosp, Div Rheumatol,Dept Internal Med, Pusan, South Korea; [Lee, Youngho; Mun, Chi-Woong] Inje Univ, Dept Biomed Engn, UHRC, Gimhae, Gyeongnam, South Korea	Inje University; Inje University	Mun, CW (corresponding author), Inje Univ, Dept Biomed Engn, UHRC, Gimhae, Gyeongnam, South Korea.	mcw@inje.ac.kr		Lee, Sunggun/0000-0003-3640-9185	Inje University	Inje University	This work was supported by Grant from Inje University, 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Arnold LM, 2008, J PAIN, V9, P792, DOI 10.1016/j.jpain.2008.03.013; ARROYO JF, 1993, J RHEUMATOL, V20, P1925; Christopoulos GI, 2009, J NEUROSCI, V29, P12574, DOI 10.1523/JNEUROSCI.2614-09.2009; Cook DB, 2004, J RHEUMATOL, V31, P364; Crofford LJ, 2005, ARTHRITIS RHEUM-US, V52, P1264, DOI 10.1002/art.20983; Duncan GH, 1998, J NEUROPHYSIOL, V80, P3326, DOI 10.1152/jn.1998.80.6.3326; Gracely RH, 2004, BRAIN, V127, P835, DOI 10.1093/brain/awh098; Gracely RH, 2002, ARTHRITIS RHEUM-US, V46, P1333, DOI 10.1002/art.10225; GRACELY RH, 1988, PAIN, V35, P279, DOI 10.1016/0304-3959(88)90138-8; Gracely RH, 2011, BEST PRACT RES CL RH, V25, P271, DOI 10.1016/j.berh.2011.02.003; Hauser W, 2009, PAIN, V145, P69, DOI 10.1016/j.pain.2009.05.014; Harris RE, 2008, ARTHRITIS RHEUM, V58, P903, DOI 10.1002/art.23223; JADAD AR, 1992, LANCET, V339, P1367, DOI 10.1016/0140-6736(92)91194-D; Koeppe C, 2004, SCAND J RHEUMATOL, V33, P24, DOI 10.1080/03009740410006989; Kosek E, 1995, PAIN, V63, P335, DOI 10.1016/0304-3959(95)00061-5; LAUTENSCHLAGER J, 1988, Z RHEUMATOL, V47, P397; Matthews PM, 2004, J NEUROL NEUROSUR PS, V75, P6; McDermid AJ, 1996, PAIN, V66, P133, DOI 10.1016/0304-3959(96)03059-X; MCQUAY H, 1995, BRIT MED J, V311, P1047, DOI 10.1136/bmj.311.7012.1047; McQuay HJ, 1996, PAIN, V68, P217, DOI 10.1016/S0304-3959(96)03140-5; Mease PJ, 2008, J RHEUMATOL, V35, P502; Mease PJ, 2008, ARTHRIT RHEUM-ARTHR, V59, P952, DOI 10.1002/art.23826; MUFSON EJ, 1984, J COMP NEUROL, V227, P109, DOI 10.1002/cne.902270112; Ngian GS, 2011, INT J RHEUM DIS, V14, P6, DOI 10.1111/j.1756-185X.2010.01567.x; Petrovic P, 2000, PAIN, V85, P19, DOI 10.1016/S0304-3959(99)00232-8; Pujol J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005224; Rosenstock J, 2004, PAIN, V110, P628, DOI 10.1016/j.pain.2004.05.001; Sawamoto N, 2000, J NEUROSCI, V20, P7438; Spaeth M, 2008, NAT CLIN PRACT RHEUM, V4, P514, DOI 10.1038/ncprheum0906; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203	32	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e74099	10.1371/journal.pone.0074099	http://dx.doi.org/10.1371/journal.pone.0074099			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040178	Green Published, gold, Green Submitted			2022-12-25	WOS:000324856500076
J	Lien, TL; Ban, J; Tormen, M; Migliorini, E; Grenci, G; Pozzato, A; Torre, V				Thuy Linh Lien; Ban, Jelena; Tormen, Massimo; Migliorini, Elisa; Grenci, Gianluca; Pozzato, Alessandro; Torre, Vincent			Can Hippocampal Neurites and Growth Cones Climb over Obstacles?	PLOS ONE			English	Article							AXONAL OUTGROWTH; GUIDANCE; ADHESION; FILOPODIA; PROTEINS; PAXILLIN; NEURONS; DIFFERENTIATION; MECHANISMS; MOTILITY	Guidance molecules, such as Sema3A or Netrin-1, can induce growth cone (GC) repulsion or attraction in the presence of a flat surface, but very little is known of the action of guidance molecules in the presence of obstacles. Therefore we combined chemical and mechanical cues by applying a steady Netrin-1 stream to the GCs of dissociated hippocampal neurons plated on polydimethylsiloxane (PDMS) surfaces patterned with lines 2 mu m wide, with 4 mu m period and with a height varying from 100 to 600 nm. GC turning experiments performed 24 hours after plating showed that filopodia crawl over these lines within minutes. These filopodia do not show staining for the adhesion marker Paxillin. GCs and neurites crawl over lines 100 nm high, but less frequently and on a longer time scale over lines higher than 300 nm; neurites never crawl over lines 600 nm high. When neurons are grown for 3 days over patterned surfaces, also neurites can cross lines 300 nm and 600 nm high, grow parallel to and on top of these lines and express Paxillin. Axons - selectively stained with SMI 312 - do not differ from dendrites in their ability to cross these lines. Our results show that highly motile structures such as filopodia climb over high obstacle in response to chemical cues, but larger neuronal structures are less prompt and require hours or days to climb similar obstacles.	[Thuy Linh Lien; Ban, Jelena; Torre, Vincent] Int Sch Adv Studies SISSA, Neurobiol Sect, Trieste, Italy; [Tormen, Massimo; Migliorini, Elisa; Grenci, Gianluca; Pozzato, Alessandro] Ist Officina Mat IOM CNR, Trieste, Italy	International School for Advanced Studies (SISSA); Consiglio Nazionale delle Ricerche (CNR); Istituto Officina dei Materiali (IOM-CNR)	Torre, V (corresponding author), Int Sch Adv Studies SISSA, Neurobiol Sect, Trieste, Italy.	torre@sissa.it	Migliorini, Elisa/K-1304-2014; Grenci, Gianluca/L-4416-2019; Migliorini, Elisa/O-7065-2019; Ban, Jelena/R-3337-2018; Migliorini, Elisa/AFU-5371-2022	Migliorini, Elisa/0000-0003-3264-2027; Grenci, Gianluca/0000-0001-9313-6748; Migliorini, Elisa/0000-0003-3264-2027; Ban, Jelena/0000-0001-5792-3998; Migliorini, Elisa/0000-0003-3264-2027; Tormen, Massimo/0000-0001-7919-0692	European Union [214566, 270483]	European Union(European Commission)	This work was supported by the European Union's Seventh Framework Programme FP7 under Grant Agreement n. 214566 (NanoScale) and Grant Agreement n. 270483 (FOCUS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1; Bartoe JL, 2006, J NEUROSCI, V26, P3192, DOI 10.1523/JNEUROSCI.3469-05.2006; Bashaw GJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001941; BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.biophys.14.1.131; Cheng CM, 2011, J BIOMECH, V44, P856, DOI 10.1016/j.jbiomech.2010.12.006; Chilton JK, 2006, DEV BIOL, V292, P13, DOI 10.1016/j.ydbio.2005.12.048; Choi YJ, 2008, GENE DEV, V22, P2485, DOI 10.1101/gad.1685008; Cojoc D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001072; Cullen DK, 2007, ANN BIOMED ENG, V35, P835, DOI 10.1007/s10439-007-9292-z; Dehmelt L, 2005, GENOME BIOL, V6; Dent EW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001800; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Dowell-Mesfin NM, 2004, J NEURAL ENG, V1, P78, DOI 10.1088/1741-2560/1/2/003; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Fozdar DY, 2011, INT J NANOMED, V6, P45, DOI 10.2147/IJN.S12376; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114; Goldner JS, 2006, BIOMATERIALS, V27, P460, DOI 10.1016/j.biomaterials.2005.06.035; Gomez N, 2007, BIOMATERIALS, V28, P271, DOI 10.1016/j.biomaterials.2006.07.043; Gordon-Weeks PR, 2004, J NEUROBIOL, V58, P70, DOI 10.1002/neu.10266; Grunwald IC, 2002, CURR OPIN NEUROBIOL, V12, P250, DOI 10.1016/S0959-4388(02)00323-9; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Hoffman-Kim D, 2010, ANNU REV BIOMED ENG, V12, P203, DOI 10.1146/annurev-bioeng-070909-105351; Jalava NS, 2007, INT J DEV NEUROSCI, V25, P121, DOI 10.1016/j.ijdevneu.2006.12.001; Jimenez-Mateos EM, 2006, BIOCHEM J, V397, P53, DOI 10.1042/BJ20060205; Johansson F, 2006, BIOMATERIALS, V27, P1251, DOI 10.1016/j.biomaterials.2005.07.047; Kirfel G, 2003, CELL MOTIL CYTOSKEL, V55, P1, DOI 10.1002/cm.10106; Koch D, 2012, BIOPHYS J, V102, P452, DOI 10.1016/j.bpj.2011.12.025; Laishram J, 2009, DEV NEUROBIOL, V69, P731, DOI 10.1002/dneu.20733; Li NZ, 2005, EXP CELL RES, V311, P307, DOI 10.1016/j.yexcr.2005.10.007; Lin AC, 2007, EMBO J, V26, P3729, DOI 10.1038/sj.emboj.7601808; Mai J, 2009, J NEUROSCI, V29, P7450, DOI 10.1523/JNEUROSCI.1121-09.2009; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Migliorini E, 2013, BIOTECHNOL BIOENG, V110, P2301, DOI 10.1002/bit.24880; Migliorini E, 2011, BIOTECHNOL BIOENG, V108, P2736, DOI 10.1002/bit.23232; Miller C, 2002, TISSUE ENG, V8, P367, DOI 10.1089/107632702760184646; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Moore SW, 2007, ADV EXP MED BIOL, V621, P17, DOI 10.1007/978-0-387-76715-4_2; Moore SW, 2011, DEV NEUROBIOL, V71, P1090, DOI 10.1002/dneu.20947; Myers JP, 2011, DEV NEUROBIOL, V71, P901, DOI 10.1002/dneu.20931; Myers JP, 2011, J NEUROSCI, V31, P13585, DOI 10.1523/JNEUROSCI.2381-11.2011; Nakamoto T, 2004, CURR BIOL, V14, pR121, DOI 10.1016/j.cub.2004.01.020; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Pinato G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00675; Rajnicek AM, 1997, J CELL SCI, V110, P2905; Rosner H, 2007, BRAIN RES, V1176, P1, DOI 10.1016/j.brainres.2007.07.081; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Shekarabi M, 2005, J NEUROSCI, V25, P3132, DOI 10.1523/JNEUROSCI.1920-04.2005; Sia SK, 2003, ELECTROPHORESIS, V24, P3563, DOI 10.1002/elps.200305584; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; Suter DM, 2000, J NEUROBIOL, V44, P97, DOI 10.1002/1097-4695(200008)44:2<97::AID-NEU2>3.0.CO;2-U; Teixeira AI, 2009, BIOMATERIALS, V30, P4567, DOI 10.1016/j.biomaterials.2009.05.013; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Turner CE, 2000, J CELL SCI, V113, P4139; Tyler WJ, 2012, NAT REV NEUROSCI, V13, P867, DOI 10.1038/nrn3383; Wehrle-Haller B, 2002, TRENDS CELL BIOL, V12, P382, DOI 10.1016/S0962-8924(02)02321-8; Wen ZX, 2006, CURR OPIN NEUROBIOL, V16, P52, DOI 10.1016/j.conb.2005.12.005; Yao L, 2009, ACTA BIOMATER, V5, P580, DOI 10.1016/j.actbio.2008.09.002	61	4	4	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73966	10.1371/journal.pone.0073966	http://dx.doi.org/10.1371/journal.pone.0073966			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040128	Green Published, gold, Green Submitted			2022-12-25	WOS:000324856500068
J	He, L; Guo, L; Vathipadiekal, V; Sergent, PA; Growdon, WB; Engler, DA; Rueda, BR; Birrer, MJ; Orsulic, S; Mohapatra, G				He, L.; Guo, L.; Vathipadiekal, V.; Sergent, P. A.; Growdon, W. B.; Engler, D. A.; Rueda, B. R.; Birrer, M. J.; Orsulic, S.; Mohapatra, G.			Identification of LMX1B as a novel oncogene in human ovarian cancer	ONCOGENE			English	Article						ovarian cancer; aCGH; LMX1B; tumor progression; transcription factor	NAIL-PATELLA-SYNDROME; COMPARATIVE GENOMIC HYBRIDIZATION; MOUSE MODEL; MOLECULAR CHARACTERIZATION; HOMEODOMAIN PROTEINS; TRANSCRIPTION FACTOR; GENETIC CHANGES; BREAST CANCERS; KAPPA-B; INFLAMMATION	Ovarian cancers are thought to result from the accumulation of multiple genetic aberrations that transform ovarian and/or fallopian tube surface epithelial cells, allowing for their abnormal growth, proliferation and metastasis. In the report presented here, we carried out genome-wide copy-number analysis using comparative genomic hybridization on a panel of mouse ovarian cancer (OVCA) cell lines previously established in our laboratory. We identified a recurrent focal amplification on mouse chromosomal region 2qB, which contains the LIM-homeodomain-containing transcription factor 1B (Lmx1b) gene. LMX1B is not expressed in normal human ovary, but is expressed in many human OVCA cell lines and primary tumors. High expression of LMX1B correlates with poor outcome. To clarify the role of LMX1B in ovarian carcinogenesis, we transduced LMX1B into a panel of mouse and human OVCA cell lines and demonstrated that LMX1B strongly promotes migration of cancer cells in culture and promotes xenograft growth in nude mice. Conversely, knockdown of LMX1B in a human cell line with endogenous high expression of LMX1B inhibits cell migration in vitro and tumor growth in vivo. Microarray analysis of cells overexpressing LMX1B identified the nuclear factor (NF)-kappa B pathway as a potential mediator of tumor progression and subsequent treatment of NF kappa B inhibitor decreased the migratory capacity of these cells. Thus, our data demonstrate that LMX1B is a novel oncogene in OVCA pathogenesis.	[He, L.; Mohapatra, G.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [He, L.; Vathipadiekal, V.; Growdon, W. B.; Rueda, B. R.; Birrer, M. J.; Mohapatra, G.] Harvard Univ, Sch Med, Boston, MA USA; [Guo, L.; Sergent, P. A.; Growdon, W. B.; Rueda, B. R.] Massachusetts Gen Hosp, Dept Vincent Obstet & Gynecol, Vincent Ctr Reprod Biol, Boston, MA 02114 USA; [Vathipadiekal, V.; Birrer, M. J.] Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA; [Vathipadiekal, V.; Birrer, M. J.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Engler, D. A.] Brigham Young Univ, Dept Stat, Provo, UT 84602 USA; [Orsulic, S.] Cedars Sinai Med Ctr, Womens Canc Res Inst, Los Angeles, CA 90048 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Brigham Young University; Cedars Sinai Medical Center	Mohapatra, G (corresponding author), Massachusetts Gen Hosp, Dept Pathol, 70 Blossom St, Boston, MA 02114 USA.	gmohapatra@partners.org		Sergent, Petra/0000-0002-8244-8209; /0000-0002-8181-6890	American Cancer Society [118900-RSG-10-252-01-TBG]; Advanced Medical Research Foundation; Vincent Memorial Research Funds; Michael Wall Gynecologic Oncology Research Fund	American Cancer Society(American Cancer Society); Advanced Medical Research Foundation; Vincent Memorial Research Funds; Michael Wall Gynecologic Oncology Research Fund	We thank Jinsong Liu (MD Anderson Cancer Center) for the T29-immortalized human ovarian surface epithelial cell line. This work was supported by the American Cancer Society Grant 118900-RSG-10-252-01-TBG (SO), Advanced Medical Research Foundation (BRR) and Vincent Memorial Research Funds (BRR) and the Michael Wall Gynecologic Oncology Research Fund (GM).	Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bongers EMHF, 2002, PEDIATR NEPHROL, V17, P703, DOI 10.1007/s00467-002-0911-5; Burbach JPH, 2003, ANN NY ACAD SCI, V991, P61; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Dreyer SD, 1998, NAT GENET, V19, P47, DOI 10.1038/ng0598-47; Fishman A, 2005, INT J GYNECOL CANCER, V15, P261, DOI 10.1111/j.1525-1438.2005.15213.x; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gabeau-Lacet D, 2009, J NEUROPATH EXP NEUR, V68, P1155, DOI 10.1097/NEN.0b013e3181ba3952; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Guo C, 2007, DEVELOPMENT, V134, P317, DOI 10.1242/dev.02745; Hernandez L, 2010, CANCER RES, V70, P4005, DOI 10.1158/0008-5472.CAN-09-3912; Hunter C, 2005, MOL BIOL REP, V32, P67, DOI 10.1007/s11033-004-7657-z; Israeli O, 2004, CANCER GENET CYTOGEN, V154, P16, DOI 10.1016/j.cancergencyto.2004.02.006; Ivan C, 2013, GYNECOL ONCOL, V128, P506, DOI 10.1016/j.ygyno.2012.11.029; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Johnson JD, 1997, MOL CELL BIOL, V17, P3488, DOI 10.1128/MCB.17.7.3488; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Liu GZ, 2010, JNCI-J NATL CANCER I, V102, P812, DOI 10.1093/jnci/djq127; Liu JS, 2004, CANCER RES, V64, P1655, DOI 10.1158/0008-5472.CAN-03-3380; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Mantovani A, 2010, ANN MED, V42, P161, DOI 10.3109/07853890903405753; Mayr D, 2006, AM J CLIN PATHOL, V126, P101, DOI 10.1309/N6X5MB24BP42KP20; McCann CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028077; McIntosh I, 2005, ANN HUM GENET, V69, P349, DOI 10.1111/j.1529-8817.2005.00191.x; Miao J, 2007, P NATL ACAD SCI USA, V104, P17093, DOI 10.1073/pnas.0707938104; MOHAPATRA G, 1995, GENE CHROMOSOME CANC, V13, P86, DOI 10.1002/gcc.2870130203; Mok SC, 2009, CANCER CELL, V16, P521, DOI 10.1016/j.ccr.2009.10.018; Nanjundan M, 2007, CANCER RES, V67, P3074, DOI 10.1158/0008-5472.CAN-06-2366; Orsulic S, 2002, CANCER CELL, V1, P53, DOI 10.1016/S1535-6108(01)00002-2; Ozols RF, 2004, CANCER CELL, V5, P19, DOI 10.1016/S1535-6108(04)00002-9; Pinkel D, 2005, NAT GENET, V37, pS11, DOI 10.1038/ng1569; Pressman CL, 2000, GENESIS, V26, P15, DOI 10.1002/(SICI)1526-968X(200001)26:1<15::AID-GENE5>3.0.CO;2-V; Rascle A, 2009, EXP CELL RES, V315, P76, DOI 10.1016/j.yexcr.2008.10.012; Sato U, 2005, PEDIATR RES, V57, P783, DOI 10.1203/01.PDR.0000157674.63621.2C; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; White KL, 2011, CANCER CAUSE CONTROL, V22, P785, DOI 10.1007/s10552-011-9745-4; Xing DY, 2006, CANCER RES, V66, P8949, DOI 10.1158/0008-5472.CAN-06-1495; Xing DY, 2005, P NATL ACAD SCI USA, V102, P6936, DOI 10.1073/pnas.0502256102; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030	49	16	16	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 14	2014	33	33					4226	4235		10.1038/onc.2013.375	http://dx.doi.org/10.1038/onc.2013.375			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AO2MB	24056967				2022-12-25	WOS:000341155800004
J	Horimoto, S; Ninagawa, S; Okada, T; Koba, H; Sugimoto, T; Kamiya, Y; Kato, K; Takeda, S; Mori, K				Horimoto, Satoshi; Ninagawa, Satoshi; Okada, Tetsuya; Koba, Hibiki; Sugimoto, Takehiro; Kamiya, Yukiko; Kato, Koichi; Takeda, Shunichi; Mori, Kazutoshi			The Unfolded Protein Response Transducer ATF6 Represents a Novel Transmembrane-type Endoplasmic Reticulum-associated Degradation Substrate Requiring Both Mannose Trimming and SEL1L Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; TRANSCRIPTION FACTOR; STRESS; HOMOLOG	Proteins misfolded in the endoplasmic reticulum (ER) are cleared by the ubiquitin-dependent proteasome system in the cytosol, a series of events collectively termed ER-associated degradation (ERAD). It was previously shown that SEL1L, a partner protein of the E3 ubiquitin ligase HRD1, is required for degradation of misfolded luminal proteins (ERAD-Ls substrates) but not misfolded transmembrane proteins (ERAD-Lm substrates) in both mammalian and chicken DT40 cells. Here, we analyzed ATF6, a type II transmembrane glycoprotein that serves as a sensor/transducer of the unfolded protein response, as a potential ERAD-Lm substrate in DT40 cells. Unexpectedly, degradation of endogenous ATF6 and exogenously expressed chicken and human ATF6 by the proteasome required SEL1L. Deletion analysis revealed that the luminal region of ATF6 is a determinant for SEL1L-dependent degradation. Chimeric analysis showed that the luminal region of ATF6 confers SEL1L dependence on type I transmembrane protein as well. In contrast, degradation of other known type I ERAD-Lm substrates (BACE457, T-cell receptor-alpha, CD3-delta, and CD147) did not require SEL1L. Thus, ATF6 represents a novel type of ERAD-Lm substrate requiring SEL1L for degradation despite its transmembrane nature. In addition, endogenous ATF6 was markedly stabilized in wild-type cells treated with kifunensine, an inhibitor of alpha 1,2-mannosidase in the ER, indicating that degradation of ATF6 requires proper mannose trimming. Our further analyses revealed that the five ERAD-Lm substrates examined are classified into three subgroups based on their dependence on mannose trimming and SEL1L. Thus, ERAD-Lm substrates are degraded through much more diversified mechanisms in higher eukaryotes than previously thought.	[Horimoto, Satoshi; Ninagawa, Satoshi; Okada, Tetsuya; Koba, Hibiki; Sugimoto, Takehiro; Mori, Kazutoshi] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan; [Kamiya, Yukiko; Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448787, Japan; [Kamiya, Yukiko; Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi 4678603, Japan; [Takeda, Shunichi] Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Kyoto 6068501, Japan	Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Nagoya City University; Kyoto University	Mori, K (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.	mori@upr.biophys.kyoto-u.ac.jp	Mori, Kazutoshi/K-6106-2015; Mori, Kazutoshi/AAW-5449-2020	Kato, Koichi/0000-0001-7187-9612; Kamiya, Yukiko/0000-0001-7582-3886; Okada, Tetsuya/0000-0002-2513-1301; Takeda, Shunichi/0000-0002-7924-7991; Ninagawa, Satoshi/0000-0002-8005-4716	Ministry of Education, Culture, Sports, Science and Technology of Japan [19058009, 23221005, 22020039, 24249002]; Global Center of Excellence Program; Grants for Excellent Graduate Schools from the Ministry of Education, Culture, Sports and Technology of Japan; Grants-in-Aid for Scientific Research [25102008] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Center of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants for Excellent Graduate Schools from the Ministry of Education, Culture, Sports and Technology of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants 19058009 (to K. M.), 23221005 (to T. O.), 22020039 (to Y. K.), and 24249002 (to K. K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Global Center of Excellence Program "Formation of a Strategic Base for Biodiversity and Evolutionary Research: from Genome to Ecosystem"; and Grants for Excellent Graduate Schools from the Ministry of Education, Culture, Sports and Technology of Japan.	Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Chen X, 2011, J CELL BIOL, V192, P825, DOI 10.1083/jcb.201008090; Fonseca SG, 2010, J CLIN INVEST, V120, P744, DOI 10.1172/JCI39678; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hoseki J, 2010, J BIOCHEM, V147, P19, DOI 10.1093/jb/mvp194; Hosokawa N, 2010, GLYCOBIOLOGY, V20, P567, DOI 10.1093/glycob/cwq001; Ishikawa T, 2013, MOL BIOL CELL, V24, P1387, DOI 10.1091/mbc.E12-11-0830; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Ninagawa S, 2011, CELL STRUCT FUNCT, V36, P187, DOI 10.1247/csf.11018; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Sambrook J., 2002, MOL CLONING LAB MANU; Sato Y, 2011, CELL STRUCT FUNCT, V36, P35, DOI 10.1247/csf.10010; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; TOMIYA N, 1991, ANAL BIOCHEM, V193, P90, DOI 10.1016/0003-2697(91)90047-W; Tremblay LO, 1999, GLYCOBIOLOGY, V9, P1073, DOI 10.1093/glycob/9.10.1073; Tyler RE, 2012, MOL BIOL CELL, V23, P4668, DOI 10.1091/mbc.E12-06-0428; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Xie W, 2010, SEMIN CELL DEV BIOL, V21, P533, DOI 10.1016/j.semcdb.2010.02.007; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	26	53	53	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31517	31527		10.1074/jbc.M113.476010	http://dx.doi.org/10.1074/jbc.M113.476010			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24043630	Green Published, hybrid			2022-12-25	WOS:000330596200011
J	Kumari, R; Castillo, C; Francesconi, A				Kumari, Ranju; Castillo, Catherine; Francesconi, Anna			Agonist-dependent Signaling by Group I Metabotropic Glutamate Receptors Is Regulated by Association with Lipid Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM DEPRESSION; FRAGILE-X; TRANSMEMBRANE DOMAIN; MOUSE MODEL; PROTEIN; CHOLESTEROL; RAFTS; PALMITOYLATION; ACTIVATION; TRAFFICKING	Group I metabotropic glutamate receptors (mGluRs), mGluR1 and mGluR5, play critical functions in forms of activity-dependent synaptic plasticity and synapse remodeling in physiological and pathological states. Importantly, in animal models of fragile X syndrome, group I mGluR activity is abnormally enhanced, a dysfunction that may partly underlie cognitive deficits in the condition. Lipid rafts are cholesterol- and sphingolipid-enriched membrane domains that are thought to form transient signaling platforms for ligand-activated receptors. Many G protein-coupled receptors, including group I mGluRs, are present in lipid rafts, but the mechanisms underlying recruitment to these membrane domains remain incompletely understood. Here, we show that mGluR1 recruitment to lipid rafts is enhanced by agonist binding and is supported at least in part by an intact cholesterol recognition/interaction amino acid consensus (CRAC) motif in the receptor. Substitutions of critical residues in the motif reduce mGluR1 association with lipid rafts and agonist-induced, mGluR1-dependent activation of extracellular-signal-activated kinase1/2 MAP kinase (ERK-MAPK). We find that alteration of membrane cholesterol content or perturbation of lipid rafts regulates agonist-dependent activation of ERK-MAPK by group I mGluRs, suggesting a potential function for cholesterol as a positive allosteric modulator of receptor function(s). Together, these findings suggest that drugs that alter membrane cholesterol levels or directed to the receptor-cholesterol interface could be employed to modulate abnormal group I mGluR activity in neuropsychiatric conditions, including fragile X syndrome.	[Kumari, Ranju; Castillo, Catherine; Francesconi, Anna] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Francesconi, A (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	anna.francesconi@einstein.yu.edu			RFK-IDDRC Core services [NICHD P30 HD071593]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD071593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082870] Funding Source: NIH RePORTER	RFK-IDDRC Core services; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Drs. Anne Etgen and Diane Lebesgue (Albert Einstein College of Medicine) for reagents and assistance with binding assays. We acknowledge support by the RFK-IDDRC Core services (NICHD P30 HD071593).	ALALUF S, 1995, J NEUROCHEM, V64, P1548; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Allen JA, 2009, MOL PHARMACOL, V76, P1082, DOI 10.1124/mol.109.060160; Anwyl R, 2009, NEUROPHARMACOLOGY, V56, P735, DOI 10.1016/j.neuropharm.2009.01.002; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Bhatnagar A, 2004, J BIOL CHEM, V279, P34614, DOI 10.1074/jbc.M404673200; Bjork K, 2011, ANNU REV PHARMACOL, V51, P211, DOI 10.1146/annurev-pharmtox-010510-100520; Bruno A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042023; Burgueno J, 2003, J NEUROCHEM, V86, P785, DOI 10.1046/j.1471-4159.2003.01842.x; Carroll FY, 2001, MOL PHARMACOL, V59, P965, DOI 10.1124/mol.59.5.965; Catania MV, 2007, MOL NEUROBIOL, V35, P298, DOI 10.1007/s12035-007-0022-1; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Christian AE, 1997, J LIPID RES, V38, P2264; Dolen G, 2008, J PHYSIOL-LONDON, V586, P1503, DOI 10.1113/jphysiol.2008.150722; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; El Moustaine D, 2012, P NATL ACAD SCI USA, V109, P16342, DOI 10.1073/pnas.1205838109; Emery AC, 2012, MOL PHARMACOL, V82, P291, DOI 10.1124/mol.112.078444; Epand RM, 2008, BBA-BIOMEMBRANES, V1778, P1576, DOI 10.1016/j.bbamem.2008.03.016; Eroglu C, 2002, EMBO REP, V3, P491, DOI 10.1093/embo-reports/kvf088; Escriba PV, 2007, BBA-BIOMEMBRANES, V1768, P836, DOI 10.1016/j.bbamem.2006.09.001; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Francesconi A, 1998, J BIOL CHEM, V273, P5615, DOI 10.1074/jbc.273.10.5615; Francesconi A, 2009, J NEUROSCI, V29, P3590, DOI 10.1523/JNEUROSCI.5824-08.2009; Frisz JF, 2013, P NATL ACAD SCI USA, V110, pE613, DOI 10.1073/pnas.1216585110; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; Gao XX, 2011, P NATL ACAD SCI USA, V108, P14509, DOI 10.1073/pnas.1019386108; Gerber U, 2007, CURR OPIN PHARMACOL, V7, P56, DOI 10.1016/j.coph.2006.08.008; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hemstapat K, 2006, MOL PHARMACOL, V70, P616, DOI 10.1124/mol.105.021857; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Hong YH, 2009, J NEUROCHEM, V111, P61, DOI 10.1111/j.1471-4159.2009.06289.x; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Huang SL, 2011, P NATL ACAD SCI USA, V108, P15480, DOI 10.1073/pnas.1107775108; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; ITO I, 1992, NEUROREPORT, V3, P1013, DOI 10.1097/00001756-199211000-00017; Jafurulla M, 2011, BIOCHEM BIOPH RES CO, V404, P569, DOI 10.1016/j.bbrc.2010.12.031; Kaiser HJ, 2011, P NATL ACAD SCI USA, V108, P16628, DOI 10.1073/pnas.1103742108; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kirsch C, 2003, BIOCHEM PHARMACOL, V65, P843, DOI 10.1016/S0006-2952(02)01654-4; Kong MMC, 2007, MOL PHARMACOL, V72, P1157, DOI 10.1124/mol.107.034769; Kumari R, 2011, METHODS MOL BIOL, V746, P411, DOI 10.1007/978-1-61779-126-0_24; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; Lingwood D, 2011, NAT CHEM BIOL, V7, P260, DOI 10.1038/nchembio.551; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Litschig S, 1999, MOL PHARMACOL, V55, P453; Liu PS, 2002, J BIOL CHEM, V277, P41295, DOI 10.1074/jbc.R200020200; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Michalon A, 2012, NEURON, V74, P49, DOI 10.1016/j.neuron.2012.03.009; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Mutel V, 2000, J NEUROCHEM, V75, P2590, DOI 10.1046/j.1471-4159.2000.0752590.x; Nicodemo AA, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-4; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Oates J, 2011, CURR OPIN STRUC BIOL, V21, P802, DOI 10.1016/j.sbi.2011.09.007; Oddi S, 2011, J NEUROCHEM, V116, P858, DOI 10.1111/j.1471-4159.2010.07041.x; Osterweil EK, 2013, NEURON, V77, P243, DOI 10.1016/j.neuron.2012.01.034; Parmentier ML, 1996, J NEUROSCI, V16, P6687; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Patel H. H., 2008, V186, P167, DOI 10.1007/978-3-540-72843-6_7; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Ponce J, 2008, STROKE, V39, P1269, DOI 10.1161/STROKEAHA.107.498923; Pontier SM, 2008, J BIOL CHEM, V283, P24659, DOI 10.1074/jbc.M800778200; Prezeau L, 1996, MOL PHARMACOL, V49, P422; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Silvius JR, 2005, BBA-MOL CELL RES, V1746, P193, DOI 10.1016/j.bbamcr.2005.09.003; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Takayasu Y, 2010, P NATL ACAD SCI USA, V107, P21778, DOI 10.1073/pnas.1015553107; Wang JQ, 2007, J NEUROCHEM, V100, P1, DOI 10.1111/j.1471-4159.2006.04208.x; Waung MW, 2009, CURR OPIN NEUROBIOL, V19, P319, DOI 10.1016/j.conb.2009.03.011; WEDEGAERTNER PB, 1993, J BIOL CHEM, V268, P25001; Xiang Y, 2002, J BIOL CHEM, V277, P34280, DOI 10.1074/jbc.M201644200; Yanagawa M, 2009, MOL PHARMACOL, V76, P201, DOI 10.1124/mol.109.056549; Zheng H, 2008, P NATL ACAD SCI USA, V105, P9421, DOI 10.1073/pnas.0802253105; Zheng H, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-6	81	27	27	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					32004	32019		10.1074/jbc.M113.475863	http://dx.doi.org/10.1074/jbc.M113.475863			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24045944	Green Published, hybrid			2022-12-25	WOS:000330596200053
J	Lemke, S; Muller, C; Lipke, E; Uhl, G; Hildebrandt, JP				Lemke, Sarah; Mueller, Christian; Lipke, Elisabeth; Uhl, Gabriele; Hildebrandt, Jan-Peter			May Salivary Gland Secretory Proteins from Hematophagous Leeches (Hirudo verbana) Reach Pharmacologically Relevant Concentrations in the Vertebrate Host?	PLOS ONE			English	Article							MEDICINAL LEECH; INHIBITORS; THROMBIN; BINDING	Saliva of hematophagous leeches (Hirudo sp.) contains bioactive proteins which allow the leech proper feeding and storage of ingested blood, but may also exert effects in the host. Leech therapy is used to treat many different ailments in humans, although only a small fraction of salivary proteins are characterized yet. Moreover, we do not know whether complete transfer of salivary proteins stored in the unicellular salivary glands in a leech to the host during feeding may generate concentrations that are sufficiently high to affect physiological processes in the host. Our 3D reconstruction of a portion of internal leech tissue from histological sections revealed that one leech contains approx. 37,000 salivary gland cells. Using tissue slices from pig liver and mouse skeletal muscle for reference, we obtained data for protein densities in leech salivary gland cells. As individual salivary cells are voluminous (67,000 mu m(3)) and the stored proteins are densely packed (approx. 500 mg/mu m(3)), we extrapolated that a single leech may contain up to 1.2 mg of salivary proteins. Analyzing protein extracts of unfed or fed leeches by 2D electrophoresis, we calculated the relative molar amounts of individual salivary proteins in the mass range of 17-60 kDa which may be released from a single leech during feeding. Distribution of these salivary proteins in the host (assumed plasma volume of 5 l) may result in concentrations of individual compounds between 3 and 236 pmol/l. Such concentrations seem sufficiently high to exert biochemical interactions with target molecules in the host.	[Lemke, Sarah; Mueller, Christian; Lipke, Elisabeth; Uhl, Gabriele; Hildebrandt, Jan-Peter] Ernst Moritz Arndt Univ Greifswald, Museum & Inst Zool, Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald	Hildebrandt, JP (corresponding author), Ernst Moritz Arndt Univ Greifswald, Museum & Inst Zool, Greifswald, Germany.	jph@uni-greifswald.de	Müller, Christian/AAE-3806-2021	Uhl, Gabriele/0000-0001-8758-7913; Hildebrandt, Jan-Peter/0000-0001-7827-8481				ASCENZI P, 1992, J MOL BIOL, V225, P177, DOI 10.1016/0022-2836(92)91034-M; ASCENZI P, 1995, MOL ASPECTS MED, V16, P215, DOI 10.1016/0098-2997(95)00002-X; Baskova IP, 2007, BIOCHEMISTRY-MOSCOW+, V72, P219, DOI 10.1134/S0006297907020137; Baskova IP, 2004, BIOCHEMISTRY-MOSCOW+, V69, P770, DOI 10.1023/B:BIRY.0000040202.21965.2a; Baskova IP, 2001, BIOCHEMISTRY-MOSCOW+, V66, P703, DOI 10.1023/A:1010223325313; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DAMAS D, 1974, Archives de Zoologie Experimentale et Generale, V115, P279; DAMAS D, 1972, Archives de Zoologie Experimentale et Generale, V113, P401; Gabe M., 1968, TECHNIQUES HISTOLOGI; Greinacher A, 2008, THROMB HAEMOSTASIS, V99, P819, DOI 10.1160/TH07-11-0693; Hach W, 2005, GEFASSCHIRURGIE, V10, P195, DOI 10.1007/s00772-005-0396-1; Haycraft J. B., 1884, P ROY SOC LOND B BIO, V36, P478, DOI [10.1098/rspl.1883.0135, DOI 10.1098/RSPL.1883.0135]; Hildebrandt JP, 2011, NATURWISSENSCHAFTEN, V98, P995, DOI 10.1007/s00114-011-0859-z; LENT CM, 1988, J EXP BIOL, V137, P513; MANN KH, 1962, LEECHES HIRUDINEA; MARSHALL CG, 1988, J EXP BIOL, V137, P89; Min GS, 2010, J PARASITOL, V96, P1211, DOI 10.1645/GE-2496.1; Nowak G, 2007, THROMB HAEMOSTASIS, V98, P116, DOI 10.1160/Th07-05-0364; OPPLER P, 1904, THESIS U BERN; Pilcher H, 2004, NATURE, V432, P10, DOI 10.1038/432010a; Riede F, 2010, J DTSCH DERMATOL GES, V8, P881, DOI 10.1111/j.1610-0387.2010.07473.x; Rigbi M, 1996, SEMIN THROMB HEMOST, V22, P273, DOI 10.1055/s-2007-999019; Sawyer RT, 1986, LEECH BIOL BEHAV 2 F; STONE SR, 1991, BIOCHEMISTRY-US, V30, P3950, DOI 10.1021/bi00230a021; Whitaker IS, 2004, BRIT J PLAST SURG, V57, P348, DOI 10.1016/j.bjps.2003.12.016; Yanes O, 2005, MOL CELL PROTEOMICS, V4, P1602, DOI 10.1074/mcp.M500145-MCP200; Zaidi SMA, 2011, ALTERN MED REV, V16, P59	28	9	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73809	10.1371/journal.pone.0073809	http://dx.doi.org/10.1371/journal.pone.0073809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058492	Green Published, gold, Green Submitted			2022-12-25	WOS:000324695900022
J	Rath, SL; Senapati, S				Rath, Soumya Lipsa; Senapati, Sanjib			Molecular Basis of Differential Selectivity of Cyclobutyl-Substituted Imidazole Inhibitors against CDKs: Insights for Rational Drug Design	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASES; ACTIVATION; MECHANISM; ROSCOVITINE; DYNAMICS; BINDING; SIMULATIONS; SPECIFICITY; FAMILY; POTENT	Cyclin-dependent kinases (CDKs) belong to the CMGC subfamily of protein kinases and play crucial roles in eukaryotic cell division cycle. At least seven different CDKs have been reported to be implicated in the cell cycle regulation in vertebrates. These CDKs are highly homologous and contain a conserved catalytic core. This makes the design of inhibitors specific for a particular CDK difficult. There is, however, growing need for CDK5 specific inhibitors to treat various neurodegenerative diseases. Recently, cis-substituted cyclobutyl-4-aminoimidazole inhibitors have been identified as potent CDK5 inhibitors that gave up to 30-fold selectivity over CDK2. Available IC50 values also indicate a higher potency of this class of inhibitors over commercially available drugs, such as roscovitine. To understand the molecular basis of higher potency and selectivity of these inhibitors, here, we present molecular dynamics simulation results of CDK5/p25 and CDK2/CyclinE complexed with a series of cyclobutyl-substituted imidazole inhibitors and roscovitine. The atomic details of the stereospecificity and selectivity of these inhibitors are obtained from energetics and binding characteristics to the CDK binding pocket. The study not only complements the experimental findings, but also provides a wealth of detailed information that could help the structure-based drug designing processes.	[Rath, Soumya Lipsa; Senapati, Sanjib] Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Senapati, S (corresponding author), Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	sanjibs@iitm.ac.in	Rath, Soumya Lipsa/AGD-5056-2022	Rath, Soumya Lipsa/0000-0003-0767-3016	Department of Biotechnology (DBT), Government of India [BT/01/COE/07/04]	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	The authors acknowledge Department of Biotechnology (DBT), Government of India for financial support (grant number BT/01/COE/07/04). The computer resources of Computer Centre, IIT Madras are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JS, 2005, CHEM BIOL, V12, P811, DOI 10.1016/j.chembiol.2005.05.011; Bartova I, 2005, PROTEIN SCI, V14, P445, DOI 10.1110/ps.04959705; Bettayeb K, 2008, ONCOGENE, V27, P5797, DOI 10.1038/onc.2008.191; Beuming T, 2009, PROTEIN SCI, V18, P1609, DOI 10.1002/pro.177; Brandl M, 2001, J MOL BIOL, V307, P357, DOI 10.1006/jmbi.2000.4473; Case D.A., 2022, AMBER 2020; Cicenas J, 2011, J CANCER RES CLIN, V137, P1409, DOI 10.1007/s00432-011-1039-4; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Dhariwala FA, 2008, CELL MOL NEUROBIOL, V28, P351, DOI 10.1007/s10571-007-9242-1; Diaz-Padilla I, 2009, INVEST NEW DRUG, V27, P586, DOI 10.1007/s10637-009-9236-6; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Frisch M., 2016, GAUSSIAN 16 REVISION; Hao GF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010742; Helal CJ, 2009, BIOORG MED CHEM LETT, V19, P5703, DOI 10.1016/j.bmcl.2009.08.019; Honda R, 2005, EMBO J, V24, P452, DOI 10.1038/sj.emboj.7600554; Hornak V, 2006, J AM CHEM SOC, V128, P2812, DOI 10.1021/ja058211x; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hubbard SJ, 1993, NACCESS COMPUTER PRO; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kannan N, 2004, PROTEIN SCI, V13, P2059, DOI 10.1110/ps.04637904; Lau LF, 2002, J MOL NEUROSCI, V19, P267, DOI 10.1385/JMN:19:3:267; Li L, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-9; Malumbres M, 2011, PHYSIOL REV, V91, P973, DOI 10.1152/physrev.00025.2010; Mapelli M, 2005, J MED CHEM, V48, P671, DOI 10.1021/jm049323m; Mapelli M, 2003, NEUROSIGNALS, V12, P164, DOI 10.1159/000074617; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Morris MC, 2002, J BIOL CHEM, V277, P23847, DOI 10.1074/jbc.M107890200; Nakamura S, 1997, ACTA NEUROPATHOL, V94, P153, DOI 10.1007/s004010050687; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; RADZIOANDZELM E, 1995, STRUCTURE, V3, P1135; Russo AA, 1993, NATURE, V3, P696; Singh G, 2008, BIOCHEMISTRY-US, V47, P10657, DOI 10.1021/bi8006725; Tarricone C, 2001, MOL CELL, V8, P657, DOI 10.1016/S1097-2765(01)00343-4; Toth G, 2006, BIOCHEMISTRY-US, V45, P6606, DOI 10.1021/bi060188k; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Zhang B, 2007, BIOCHEMISTRY-US, V46, P10841, DOI 10.1021/bi700890t; Zhang B, 2007, J MOL MODEL, V13, P79, DOI 10.1007/s00894-006-0127-x	42	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73836	10.1371/journal.pone.0073836	http://dx.doi.org/10.1371/journal.pone.0073836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058495	gold, Green Published, Green Submitted			2022-12-25	WOS:000324408400036
J	Kuznetsov, E; Kucerova, H; Vachova, L; Palkova, Z				Kuznetsov, Evgeny; Kucerova, Helena; Vachova, Libuse; Palkova, Zdena			SUN Family Proteins Sun4p, Uth1p and Sim1p Are Secreted from Saccharomyces cerevisiae and Produced Dependently on Oxygen Level	PLOS ONE			English	Article							YEAST COLONY DEVELOPMENT; CELL-WALL BIOGENESIS; CANDIDA-ALBICANS; BIOFILM FORMATION; CONGO RED; GENE; DEATH; MORPHOGENESIS; EXPRESSION; OSCILLATIONS	The SUN family is comprised of proteins that are conserved among various yeasts and fungi, but that are absent in mammals and plants. Although the function(s) of these proteins are mostly unknown, they have been linked to various, often unrelated cellular processes such as those connected to mitochondrial and cell wall functions. Here we show that three of the four Saccharomyces cerevisiae SUN family proteins, Uth1p, Sim1p and Sun4p, are efficiently secreted out of the cells in different growth phases and their production is affected by the level of oxygen. The Uth1p, Sim1p, Sun4p and Nca3p are mostly synthesized during the growth phase of both yeast liquid cultures and colonies. Culture transition to slow-growing or stationary phases is linked with a decreased cellular concentration of Sim1p and Sun4p and with their efficient release from the cells. In contrast, Uth1p is released mainly from growing cells. The synthesis of Uth1p and Sim1p, but not of Sun4p, is repressed by anoxia. All four proteins confer cell sensitivity to zymolyase. In addition, Uth1p affects cell sensitivity to compounds influencing cell wall composition and integrity (such as Calcofluor white and Congo red) differently when growing on fermentative versus respiratory carbon sources. In contrast, Uth1p is essential for cell resistance to boric acids irrespective of carbon source. In summary, our novel findings support the hypothesis that SUN family proteins are involved in the remodeling of the yeast cell wall during the various phases of yeast culture development and under various environmental conditions. The finding that Uth1p is involved in cell sensitivity to boric acid, i.e. to a compound that is commonly used as an important antifungal in mycoses, opens up new possibilities of investigating the mechanisms of boric acid's action.	[Kuznetsov, Evgeny; Kucerova, Helena; Vachova, Libuse; Palkova, Zdena] Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Prague, Czech Republic; [Kucerova, Helena; Vachova, Libuse] Acad Sci Czech Republic, Inst Microbiol, Vvi, Prague, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Palkova, Z (corresponding author), Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Prague, Czech Republic.	zdenap@natur.cuni.cz	Vachova, Libuse/H-7620-2014; Palkova, Zdena/M-8692-2014	Vachova, Libuse/0000-0002-8143-6054; Palkova, Zdena/0000-0002-0864-8042	Grant Agency of the Czech Republic [13-08605S]; Ministry of Education [MSM0021620858]; Charles University in Prague [UNCE 204013, GAUK 903313]; RVO [61388971]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education; Charles University in Prague; RVO	This study was supported by the Grant Agency of the Czech Republic 13-08605S, the Ministry of Education MSM0021620858, Charles University in Prague (UNCE 204013 and GAUK 903313) and RVO 61388971. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Uscanga B, 2003, LETT APPL MICROBIOL, V37, P268, DOI 10.1046/j.1472-765X.2003.01394.x; Austriaco NR, 1996, YEAST, V12, P623, DOI 10.1002/(SICI)1097-0061(19960615)12:7<623::AID-YEA968>3.0.CO;2-G; Bandara PDS, 1998, CURR GENET, V34, P259, DOI 10.1007/s002940050395; Camougrand N, 2004, FEMS YEAST RES, V5, P133, DOI 10.1016/j.femsyr.2004.05.001; Camougrand N, 2003, MOL MICROBIOL, V47, P495, DOI 10.1046/j.1365-2958.2003.03311.x; Camougrand NM, 2000, ARCH BIOCHEM BIOPHYS, V375, P154, DOI 10.1006/abbi.1999.1655; Cappellaro C, 1998, J BACTERIOL, V180, P5030, DOI 10.1128/JB.180.19.5030-5037.1998; Cohen BD, 2001, NUCLEIC ACIDS RES, V29, P799, DOI 10.1093/nar/29.3.799; DAHMANN C, 1995, CURR BIOL, V5, P1257, DOI 10.1016/S0960-9822(95)00252-1; Deffieu M, 2009, J BIOL CHEM, V284, P14828, DOI 10.1074/jbc.M109.005181; Du LL, 2002, MOL BIOL CELL, V13, P503, DOI 10.1091/mbc.01-07-0365; Firon A, 2007, MOL MICROBIOL, V66, P1256, DOI 10.1111/j.1365-2958.2007.06011.x; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Hiller E, 2007, EUKARYOT CELL, V6, P2056, DOI 10.1128/EC.00285-07; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Karunanithi S, 2010, CURR BIOL, V20, P1389, DOI 10.1016/j.cub.2010.06.033; KENNEDY BK, 1995, CELL, V80, P485, DOI 10.1016/0092-8674(95)90499-9; Kissova I, 2007, AUTOPHAGY, V3, P329, DOI 10.4161/auto.4034; Kissova I, 2006, J BIOL CHEM, V281, P36187, DOI 10.1074/jbc.M607444200; Mouassite M, 2000, YEAST, V16, P905, DOI 10.1002/1097-0061(200007)16:10<905::AID-YEA584>3.0.CO;2-1; Norice CT, 2007, EUKARYOT CELL, V6, P2046, DOI 10.1128/EC.00314-07; Palkova Z, 2002, MOL BIOL CELL, V13, P3901, DOI 10.1091/mbc.E01-12-0149; Palkova Z, 2009, MOL MEMBR BIOL, V26, P228, DOI 10.1080/09687680902893130; PELISSIER P, 1995, CURR GENET, V27, P409, DOI 10.1007/BF00311209; Posch A., 2008, METHOD MOL BIOL, V425, P217; Ritch JJ, 2010, FEMS YEAST RES, V10, P168, DOI 10.1111/j.1567-1364.2009.00601.x; RONCERO C, 1985, J BACTERIOL, V163, P1180, DOI 10.1128/JB.163.3.1180-1185.1985; Santos B, 2000, MOL BIOL CELL, V11, P435, DOI 10.1091/mbc.11.2.435; Schmidt M., 2010, INT J MICROBIOL, P930465, DOI 10.1155/2010/930465; Setiadi ER, 2006, J MOL BIOL, V361, P399, DOI 10.1016/j.jmb.2006.06.040; SKORY CD, 1995, APPL ENVIRON MICROB, V61, P518, DOI 10.1128/AEM.61.2.518-525.1995; Snoek ISI, 2007, YEAST, V24, P1, DOI 10.1002/yea.1430; Sosinska GJ, 2008, MICROBIOL-SGM, V154, P510, DOI 10.1099/mic.0.2007/012617-0; Vachova L, 2005, J CELL BIOL, V169, P711, DOI 10.1083/jcb.200410064; Vachova L, 2009, ENVIRON MICROBIOL, V11, P494, DOI 10.1111/j.1462-2920.2008.01789.x; VANNINI GL, 1987, CYTOBIOS, V49, P89; Velours G, 2002, FEMS MICROBIOL LETT, V207, P165, DOI 10.1111/j.1574-6968.2002.tb11046.x; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C	39	12	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73882	10.1371/journal.pone.0073882	http://dx.doi.org/10.1371/journal.pone.0073882			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040106	Green Submitted, gold, Green Published			2022-12-25	WOS:000326734500060
J	Pacheco, A; Azevedo, F; Rego, A; Santos, J; Chaves, SR; Corte-Real, M; Sousa, MJ				Pacheco, Andreia; Azevedo, Flavio; Rego, Antonio; Santos, Julia; Chaves, Susana R.; Corte-Real, Manuela; Sousa, Maria Joao			C2-Phytoceramide Perturbs Lipid Rafts and Cell Integrity in Saccharomyces cerevisiae in a Sterol-Dependent Manner	PLOS ONE			English	Article							ACTIVATED PROTEIN PHOSPHATASE; CHRONOLOGICAL LIFE-SPAN; SIGNAL-TRANSDUCTION; HYPEROSMOTIC STRESS; CERAMIDE; APOPTOSIS; YEAST; DEATH; SPHINGOLIPIDS; AUTOPHAGY	Specific ceramides are key regulators of cell fate, and extensive studies aimed to develop therapies based on ceramide-induced cell death. However, the mechanisms regulating ceramide cytotoxicity are not yet fully elucidated. Since ceramides also regulate growth and stress responses in yeast, we studied how different exogenous ceramides affect yeast cells. C2-phytoceramide, a soluble form of phytoceramides, the yeast counterparts of mammalian ceramides, greatly reduced clonogenic survival, particularly in the G2/M phase, but did not induce autophagy nor increase apoptotic markers. Rather, the loss of clonogenic survival was associated with PI positive staining, disorganization of lipid rafts and cell wall weakening. Sensitivity to C2-phytoceramide was exacerbated in mutants lacking Hog1p, the MAP kinase homolog of human p38 kinase. Decreasing sterol membrane content reduced sensitivity to C2-phytoceramide, suggesting sterols are the targets of this compound. This study identified a new function of C2-phytoceramide through disorganization of lipid rafts and induction of a necrotic cell death under hypo-osmotic conditions. Since lipid rafts are important in mammalian cell signaling and adhesion, our findings further support pursuing the exploitation of yeast to understand the basis of synthetic ceramides' cytotoxicity to provide novel strategies for therapeutic intervention in cancer and other diseases.	[Pacheco, Andreia; Azevedo, Flavio; Rego, Antonio; Chaves, Susana R.; Corte-Real, Manuela; Sousa, Maria Joao] Univ Minho, Dept Biol, CBMA Ctr Mol & Environm Biol, Braga, Portugal; [Santos, Julia] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Braga, Portugal; [Santos, Julia] ICVS Bs PT Govt Associate Lab, Braga, Portugal	Universidade do Minho; Universidade do Minho	Sousa, MJ (corresponding author), Univ Minho, Dept Biol, CBMA Ctr Mol & Environm Biol, Braga, Portugal.	mjsousa@bio.uminho.pt	Corte-Real, Manuela/B-6328-2013; Sousa, Maria/HCI-9642-2022; Sousa, Maria João/H-8775-2013; Chaves, Susana R/H-8786-2013; Rego, António/AAD-5742-2020; Santos, Júlia M/D-4894-2013	Corte-Real, Manuela/0000-0002-1423-1331; Sousa, Maria João/0000-0001-9424-4150; Chaves, Susana R/0000-0002-6004-9872; Rego, António/0000-0003-2849-4017; Santos, Júlia M/0000-0002-4035-0692; Pacheco, Andreia/0000-0002-3196-8642	Fundacao para a Ciencia e Tecnologia [PTDC/BIA-BCM/69448/2006, PEst-C/BIA/UI4050/2011, SFRH/BPD/65003, SFRH/BD/80934/2011]; FEDER through POFC - COMPETE; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BCM/69448/2006, PD/BD/135249/2017] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER through POFC - COMPETE; Fundação para a Ciência e a Tecnologia	This work was supported by Fundacao para a Ciencia e Tecnologia through projects PTDC/BIA-BCM/69448/2006 and PEst-C/BIA/UI4050/2011, and fellowships to A. P. (SFRH/BPD/65003) and F. A. (SFRH/BD/80934/2011), as well as by FEDER through POFC - COMPETE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida T, 2008, MOL BIOL CELL, V19, P865, DOI 10.1091/mbc.E07-06-0604; Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; Balguerie A, 2002, EUKARYOT CELL, V1, P1021, DOI 10.1128/EC.1.6.1021-1031.2002; Barbosa AD, 2011, MOL MICROBIOL, V81, P515, DOI 10.1111/j.1365-2958.2011.07714.x; BIELAWSKA A, 1992, FEBS LETT, V307, P211, DOI 10.1016/0014-5793(92)80769-D; Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P763, DOI 10.1038/cdd.2009.219; Carmona-Gutierrez D, 2011, CELL CYCLE, V10, P3973, DOI 10.4161/cc.10.22.18212; Chapman JV, 2010, BIOCHEM PHARMACOL, V80, P308, DOI 10.1016/j.bcp.2010.04.001; Dickson RC, 1998, ANNU REV BIOCHEM, V67, P27, DOI 10.1146/annurev.biochem.67.1.27; Ferreira C, 2008, BBA-BIOMEMBRANES, V1778, P2648, DOI 10.1016/j.bbamem.2008.08.011; Fortuna M., 2001, CURR PROTOC CYTOM; Galgoczy DJ, 2004, P NATL ACAD SCI USA, V101, P18069, DOI 10.1073/pnas.0407611102; Guenther GG, 2008, P NATL ACAD SCI USA, V105, P17402, DOI 10.1073/pnas.0802781105; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hickman MJ, 2011, GENETICS, V188, P325, DOI 10.1534/genetics.111.128322; Hwang O, 2001, MOL PHARMACOL, V59, P1249, DOI 10.1124/mol.59.5.1249; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; London M, 2004, J BIOL CHEM, V279, P9997, DOI 10.1074/jbc.M309992200; Ludovico P, 2001, MICROBIOL-SGM, V147, P3335, DOI 10.1099/00221287-147-12-3335; Lussier M, 1997, GENETICS, V147, P435; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; Mencarelli C, 2013, CELL MOL LIFE SCI, V70, P181, DOI 10.1007/s00018-012-1038-x; Mullen TD, 2012, ANTI-CANCER AGENT ME, V12, P340, DOI 10.2174/187152012800228661; Nickels JT, 1996, GENE DEV, V10, P382, DOI 10.1101/gad.10.4.382; Pereira C, 2007, MOL MICROBIOL, V66, P571, DOI 10.1111/j.1365-2958.2007.05926.x; Rego A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048571; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Ruvolo PP, 2003, PHARMACOL RES, V47, P383, DOI 10.1016/S1043-6618(03)00050-1; Saito H, 2012, GENETICS, V192, P289, DOI 10.1534/genetics.112.140863; Silva RD, 2005, MOL MICROBIOL, V58, P824, DOI 10.1111/j.1365-2958.2005.04868.x; Tanigawa M, 2012, MOL CELL BIOL, V32, P2861, DOI 10.1128/MCB.06111-11; Thevissen K, 2010, FEMS MICROBIOL LETT, V303, P163, DOI 10.1111/j.1574-6968.2009.01869.x; Todde V, 2009, BBA-MOL BASIS DIS, V1792, P3, DOI 10.1016/j.bbadis.2008.10.016; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Widau RC, 2010, J BIOL CHEM, V285, P13827, DOI 10.1074/jbc.M109.085076; WOLFF RA, 1994, J BIOL CHEM, V269, P19605; Yang Z, 2006, FEMS YEAST RES, V6, P751, DOI 10.1111/j.1567-1364.2006.00052.x; Young MM, 2013, J LIPID RES, V54, P5, DOI 10.1194/jlr.R031278; Zhang NN, 2006, MOL BIOL CELL, V17, P3409, DOI 10.1091/mbc.E06-03-0177	41	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74240	10.1371/journal.pone.0074240	http://dx.doi.org/10.1371/journal.pone.0074240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040213	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500080
J	Link, H; Piepenburg, D; Archambault, P				Link, Heike; Piepenburg, Dieter; Archambault, Philippe			Are Hotspots Always Hotspots? The Relationship between Diversity, Resource and Ecosystem Functions in the Arctic	PLOS ONE			English	Article							MACOMA-BALTHICA COMMUNITY; CANADIAN BEAUFORT SHELF; DEEP-SEA MEIOFAUNA; BENTHIC COMMUNITY; ORGANIC-MATTER; BIOGEOCHEMICAL FLUXES; TEMPORAL VARIABILITY; SPECIES-DIVERSITY; CONTINENTAL-SHELF; BIODIVERSITY LOSS	The diversity-ecosystem function relationship is an important topic in ecology but has not received much attention in Arctic environments, and has rarely been tested for its stability in time. We studied the temporal variability of benthic ecosystem functioning at hotspots (sites with high benthic boundary fluxes) and coldspots (sites with lower fluxes) across two years in the Canadian Arctic. Benthic remineralisation function was measured as fluxes of oxygen, silicic acid, phosphate, nitrate and nitrite at the sediment-water interface. In addition we determined sediment pigment concentration and taxonomic and functional macrobenthic diversity. To separate temporal from spatial variability, we sampled the same nine sites from the Mackenzie Shelf to Baffin Bay during the same season (summer or fall) in 2008 and 2009. We observed that temporal variability of benthic remineralisation function at hotspots is higher than at coldspots and that taxonomic and functional macrobenthic diversity did not change significantly between years. Temporal variability of food availability (i.e., sediment surface pigment concentration) seemed higher at coldspot than at hotspot areas. Sediment chlorophyll a (Chl a) concentration, taxonomic richness, total abundance, water depth and abundance of the largest gallery-burrowing polychaete Lumbrineris tetraura together explained 42% of the total variation in fluxes. Food supply proxies (i.e., sediment Chl a and depth) split hot-from coldspot stations and explained variation on the axis of temporal variability, and macrofaunal community parameters explained variation mostly along the axis separating eastern from western sites with hot-or coldspot regimes. We conclude that variability in benthic remineralisation function, food supply and diversity will react to climate change on different time scales, and that their interactive effects may hide the detection of progressive change, particularly at hotspots. Time-series of benthic functions and its related parameters should be conducted at both hot-and coldspots to produce reliable predictive models.	[Link, Heike; Archambault, Philippe] Univ Quebec, Inst Sci Mer Rimouski, Rimouski, PQ G5L 3A1, Canada; [Piepenburg, Dieter] Univ Kiel, Inst Polar Ecol, Mainz Acad Sci Humanities & Literature, Kiel, Germany	University of Quebec; University of Kiel	Link, H (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	link.heike@gmail.com	Piepenburg, Dieter/H-3251-2019; Piepenburg, Dieter/GQP-9916-2022	Piepenburg, Dieter/0000-0003-3977-2860; Archambault, Philippe/0000-0001-5986-6149; Link, Heike/0000-0002-8484-845X	Natural Sciences and Engineering Research Council of Canada (NSERC) through the Canadian Healthy Oceans Network [NETGP-340843-06]; Network of Centres of Excellence of Canada ArcticNet; Fonds quebecois de la recherche sur la nature et les technologies; Quebec-Ocean; Agence nationale de la recherche; Institut national des sciences de l'univers - Centre national de la recherche scientifique; Centre national d'etudes spatiales; European Space Agency; IPY; NSERC	Natural Sciences and Engineering Research Council of Canada (NSERC) through the Canadian Healthy Oceans Network(Natural Sciences and Engineering Research Council of Canada (NSERC)); Network of Centres of Excellence of Canada ArcticNet; Fonds quebecois de la recherche sur la nature et les technologies(FQRNT); Quebec-Ocean; Agence nationale de la recherche(French National Research Agency (ANR)); Institut national des sciences de l'univers - Centre national de la recherche scientifique(Centre National de la Recherche Scientifique (CNRS)); Centre national d'etudes spatiales(Centre National D'etudes Spatiales); European Space Agency(European Space AgencyEuropean Commission); IPY; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Financial support was received by the Natural Sciences and Engineering Research Council of Canada (NSERC) through the Canadian Healthy Oceans Network (http://www.chone.ca; NETGP-340843-06) and the Network of Centres of Excellence of Canada ArcticNet (http://www.arcticnet.ulaval.ca). Partial funding was provided by the Fonds quebecois de la recherche sur la nature et les technologies and Quebec-Ocean to HL. Part of this study was conducted in the frame of the Malina Scientific Program (http://malina.obs-vlfr.fr) funded by Agence nationale de la recherche, Institut national des sciences de l'univers - Centre national de la recherche scientifique, Centre national d'etudes spatiales and European Space Agency and in the frame of the IPY project Circumpolar Flaw Lead System Study financed by IPY and NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Appeltans W, 2012, WORLD REGISTER MARIN; Archambault P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012182; Ardyna M, 2011, MAR ECOL PROG SER, V442, P37, DOI 10.3354/meps09378; Arrigo KR, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018978; Baldwin RJ, 1998, DEEP-SEA RES PT II, V45, P643, DOI 10.1016/S0967-0645(97)00097-0; Boetius A, 1998, DEEP-SEA RES PT I, V45, P239, DOI 10.1016/S0967-0637(97)00052-6; Braeckman U, 2010, MAR ECOL PROG SER, V399, P173, DOI 10.3354/meps08336; Bremner J, 2003, MAR ECOL PROG SER, V254, P11, DOI 10.3354/meps254011; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Clarke K.R, 2006, PRIMER V6 USER MANUA; Clough LM, 2005, CAN J FISH AQUAT SCI, V62, P1756, DOI 10.1139/F05-102; Cochrane SKJ, 2012, J MARINE SYST, V94, P204, DOI 10.1016/j.jmarsys.2011.12.001; Conlan K, 2008, J MARINE SYST, V74, P864, DOI 10.1016/j.jmarsys.2007.10.002; Cumming GS, 2009, PHILOS T R SOC B, V364, P1683, DOI 10.1098/rstb.2008.0317; Cusson M, 2007, MAR ECOL PROG SER, V331, P291, DOI 10.3354/meps331291; Danovaro R, 2012, MARINE BIODIVERSITY AND ECOSYSTEM FUNCTIONING: FRAMEWORKS, METHODOLOGIES, AND INTEGRATION, P115; Darnis G, 2012, CLIMATIC CHANGE, V115, P179, DOI 10.1007/s10584-012-0483-8; Davenport ES, 2012, DEEP-SEA RES PT II, V65-70, P163, DOI 10.1016/j.dsr2.2012.02.004; Deming JW, 2011, POLAR BIOL, V34, P1797, DOI 10.1007/s00300-011-1125-8; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Dumont D, 2009, J PHYS OCEANOGR, V39, P1448, DOI 10.1175/2008JPO3965.1; Emmerson MC, 2001, NATURE, V411, P73, DOI 10.1038/35075055; Farias L, 2004, DEEP-SEA RES PT II, V51, P2491, DOI 10.1016/j.dsr2.2004.07.029; Fauchald K., 1979, Oceanography and Marine Biology an Annual Review, V17, P193; Forest A, 2013, BIOGEOSCIENCES, V10, P2833, DOI 10.5194/bg-10-2833-2013; Forest A, 2007, J MARINE SYST, V68, P39, DOI 10.1016/j.jmarsys.2006.10.008; Forest A, 2011, PROG OCEANOGR, V91, P410, DOI 10.1016/j.pocean.2011.05.002; Forest A, 2010, DEEP-SEA RES PT I, V57, P125, DOI 10.1016/j.dsr.2009.10.002; Fortier M, 2002, MAR ECOL PROG SER, V225, P1, DOI 10.3354/meps225001; Fridley JD, 2002, OECOLOGIA, V132, P271, DOI 10.1007/s00442-002-0965-x; Gamfeldt L, 2008, ECOLOGY, V89, P1223, DOI 10.1890/06-2091.1; Glover AG, 2010, ADV MAR BIOL, V58, P1, DOI [10.1016/B978-0-12-381015-1.00001-0, 10.1016/S0065-2881(10)58001-5]; Glud RN, 2000, MAR ECOL PROG SER, V206, P59, DOI 10.3354/meps206059; Godbold JA, 2009, MAR ECOL PROG SER, V396, P273, DOI 10.3354/meps08401; Godbold JA, 2012, MARINE BIODIVERSITY AND ECOSYSTEM FUNCTIONING: FRAMEWORKS, METHODOLOGIES, AND INTEGRATION, P101; GRAF G, 1992, OCEANOGR MAR BIOL, V30, P149; Grant J, 2002, DEEP-SEA RES PT II, V49, P5259, DOI 10.1016/S0967-0645(02)00189-3; Grebmeier JM, 2006, PROG OCEANOGR, V71, P331, DOI 10.1016/j.pocean.2006.10.001; Grebmeier JM, 2012, ANNU REV MAR SCI, V4, P63, DOI 10.1146/annurev-marine-120710-100926; Hargrave BT, 2002, DEEP-SEA RES PT II, V49, P5227, DOI 10.1016/S0967-0645(02)00187-X; Harvey E, 2013, ECOLOGY, V94, P169, DOI 10.1890/12-0414.1; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hoste E, 2007, DEEP-SEA RES PT I, V54, P109, DOI 10.1016/j.dsr.2006.09.007; Hunter WR, 2012, ISME J, V6, P2140, DOI 10.1038/ismej.2012.44; Ieno EN, 2006, MAR ECOL PROG SER, V311, P263, DOI 10.3354/meps311263; Ingram RG, 2002, DEEP-SEA RES PT II, V49, P4893, DOI 10.1016/S0967-0645(02)00169-8; Jorgensen BB, 2005, MAR ECOL PROG SER, V292, P85, DOI 10.3354/meps292085; Jorgensen BB., 2006, MARINE GEOCHEMISTRY, P169, DOI DOI 10.1007/3-540-32144-6_5; Juul-Pedersen T, 2010, MAR ECOL PROG SER, V410, P55, DOI 10.3354/meps08608; Kedra M, 2010, POLAR BIOL, V33, P1, DOI 10.1007/s00300-009-0679-1; KENCHINGTON E, 2011, 2011071 DEP FISH OC, V4; Klein B, 2002, DEEP-SEA RES PT II, V49, P4983, DOI 10.1016/S0967-0645(02)00174-1; LALANDE C, 2003, COMPOSITION STRUCTUR, P59; Lalande C, 2009, CONT SHELF RES, V29, P2157, DOI 10.1016/j.csr.2009.08.009; Lepore K, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003555; LINK H, 2012, BIOGEOSCIENCES DISCU, V9, P16933, DOI DOI 10.5194/BGD-9-16933-2012; Link H, 2011, POLAR BIOL, V34, P2025, DOI 10.1007/s00300-011-1046-6; MacDonald IR, 2010, DEEP-SEA RES PT II, V57, P136, DOI 10.1016/j.dsr2.2009.08.012; *MARLIN, 2006, PLYMOUTH MARINE BIOL; *MARLIN, 2009, AR LIF INF NETW; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; MCLAUGHLIN FA, 2006, GLOBAL COASTAL OCEAN, P163; Michaud E, 2006, J EXP MAR BIOL ECOL, V337, P178, DOI 10.1016/j.jembe.2006.06.025; Michaud E, 2009, J MAR RES, V67, P43, DOI 10.1357/002224009788597926; Michel C, 2006, PROG OCEANOGR, V71, P379, DOI 10.1016/j.pocean.2006.09.006; Morata N, 2008, DEEP-SEA RES PT II, V55, P2381, DOI 10.1016/j.dsr2.2008.05.004; Mundy CJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038837; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Na T, 2008, J MAR RES, V66, P691, DOI 10.1357/002224008787536826; Naeem S, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P3; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; Nascimento FJA, 2012, LIMNOL OCEANOGR, V57, P338, DOI 10.4319/lo.2012.57.1.0338; O'Brien MC, 2006, CONT SHELF RES, V26, P41, DOI 10.1016/j.csr.2005.09.007; Pearson TH, 2001, OCEANOGR MAR BIOL, V39, P233; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Piepenburg Dieter, 2011, Marine Biodiversity, V41, P51, DOI 10.1007/s12526-010-0059-7; PIOT A, 2012, IMPACTS CHANGEMENTS; Renaud PE, 2007, J EXP MAR BIOL ECOL, V349, P248, DOI 10.1016/j.jembe.2007.05.021; Renaud PE, 2007, J MARINE SYST, V67, P1, DOI 10.1016/j.jmarsys.2006.07.006; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Riaux-Gobin C, 1993, HDB METHODS AQUATIC, P369, DOI DOI 10.1201/9780203752746-43; Robert P, 2013, MAR POLLUT BULL, V66, P92, DOI 10.1016/j.marpolbul.2012.11.003; Rysgaard S, 2004, LIMNOL OCEANOGR, V49, P1493, DOI 10.4319/lo.2004.49.5.1493; Sakshaug E, 2004, ORGANIC CARBON CYCLE IN THE ARCTIC OCEAN, P57; Sallon A, 2011, POLAR BIOL, V34, P1989, DOI 10.1007/s00300-011-1055-5; Schmid Bernhard, 2009, P14; Smith CR, 2008, TRENDS ECOL EVOL, V23, P518, DOI 10.1016/j.tree.2008.05.002; Smith KL, 2001, LIMNOL OCEANOGR, V46, P543, DOI 10.4319/lo.2001.46.3.0543; Snelgrove PVR, 2012, FISHERIES, V37, P296, DOI 10.1080/03632415.2012.696002; Soltwedel T., 2005, OCEANOGRAPHY, V18, P46, DOI [10.5670/oceanog.2005.24, DOI 10.5670/0CEAN0G.2005.24]; Sun MY, 2007, J MAR RES, V65, P561, DOI 10.1357/002224007782689094; THOMSON DH, 1982, ARCTIC, V35, P61; Thouzeau G, 2007, ESTUAR COAST SHELF S, V72, P432, DOI 10.1016/j.ecss.2006.11.028; Todd J.A., 2001, NEOGENE MARINE BIOTA; Tremblay JE, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048825; Veit-Kohler G, 2011, DEEP-SEA RES PT II, V58, P1983, DOI 10.1016/j.dsr2.2011.05.008; Villeger S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040679; Wahl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019514; Wassmann P, 2011, GLOBAL CHANGE BIOL, V17, P1235, DOI 10.1111/j.1365-2486.2010.02311.x; Welch HE, 1997, CAN J FISH AQUAT SCI, V54, P999, DOI 10.1139/f97-006; Witman JD, 2008, ECOLOGY, V89, pS66, DOI 10.1890/07-1201.1; Witte U, 2003, MAR ECOL PROG SER, V251, P27, DOI 10.3354/meps251027	104	38	40	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74077	10.1371/journal.pone.0074077	http://dx.doi.org/10.1371/journal.pone.0074077			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040169	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000327538600067
J	McGovern, AP; de Lusignan, S; van Vlymen, J; Liyanage, H; Tomson, CR; Gallagher, H; Rafiq, M; Jones, S				McGovern, Andrew Peter; de Lusignan, Simon; van Vlymen, Jeremy; Liyanage, Harshana; Tomson, Charles Richard; Gallagher, Hugh; Rafiq, Meena; Jones, Simon			Serum Phosphate as a Risk Factor for Cardiovascular Events in People with and without Chronic Kidney Disease: A Large Community Based Cohort Study	PLOS ONE			English	Article							VASCULAR CALCIFICATION; SECONDARY HYPERPARATHYROIDISM; HEMODIALYSIS-PATIENTS; MINERAL METABOLISM; MORTALITY RISK; PHOSPHORUS; CALCIUM; ATHEROSCLEROSIS; ASSOCIATION; MISCLASSIFICATION	Background: Serum phosphate is a known risk factor for cardiovascular events and mortality in people with chronic kidney disease (CKD), however data on the association of these outcomes with serum phosphate in the general population are scarce. We investigate this relationship in people with and without CKD in a large community-based population. Methods: Three groups from an adult cohort of the Quality Improvement in Chronic Kidney Disease (QICKD) cluster randomised trial (ISRCTN56023731) were followed over a period of 2.5 years: people with normal renal function (N = 24,184), people with CKD stages 1-2 (N = 20,356), and people with CKD stages 3-5 (N = 13,292). We used a multilevel logistic regression model to determine the association between serum phosphate, in these groups, and a composite outcome of all-cause mortality, cardiovascular events, and advanced coronary artery disease. We adjusted for known cardiovascular risk factors. Findings: Higher phosphate levels were found to correlate with increased cardiovascular risk. In people with normal renal function and CKD stages 1-2, Phosphate levels between 1.25 and 1.50 mmol/l were associated with increased cardiovascular events; odds ratio (OR) 1.36 (95% CI 1.06-1.74; p = 0.016) in people with normal renal function and OR 1.40 (95% CI 1.09-1.81; p = 0.010) in people with CKD stages 1-2. Hypophosphatemia (<0.75 mmol/l) was associated with fewer cardiovascular events in people with normal renal function; OR 0.59 (95% CI 0.36-0.97; p = 0.049). In people with CKD stages 3-5, hyperphosphatemia (>1.50 mmol/l) was associated with increased cardiovascular risk; OR 2.34 (95% CI 1.64-3.32; p<0.001). Other phosphate ranges were not found to have a significant impact on cardiovascular events in people with CKD stages 3-5. Conclusions: Serum phosphate is associated with cardiovascular events in people with and without CKD. Further research is required to determine the mechanisms underlying these associations.	[McGovern, Andrew Peter; de Lusignan, Simon; van Vlymen, Jeremy; Liyanage, Harshana; Rafiq, Meena; Jones, Simon] Univ Surrey, Dept Hlth Care Management & Policy, Guildford GU2 5XH, Surrey, England; [de Lusignan, Simon; Gallagher, Hugh] St Georges Univ London, Div Populat Hlth Sci & Educ, London, England; [Tomson, Charles Richard] Southmead Hosp North Bristol NHS Trust, Dept Renal Med, Bristol, Avon, England; [Gallagher, Hugh] St Helier Hosp, South West Thames Renal & Transplantat Unit, Carshalton SM5 1AA, Surrey, England	University of Surrey; St Georges University London; North Bristol NHS Trust; St Helier Hospital	McGovern, AP (corresponding author), Univ Surrey, Dept Hlth Care Management & Policy, Guildford GU2 5XH, Surrey, England.	andy@mcgov.co.uk	Liyanage, Harshana/Q-6605-2019; Liyanage, Harshana/AAN-5206-2021; de Lusignan, Smion/S-7838-2019; McGovern, Andrew/N-4179-2015	Liyanage, Harshana/0000-0001-9738-6349; de Lusignan, Smion/0000-0002-8553-2641; McGovern, Andrew/0000-0002-6833-9399; Jones, Simon/0000-0002-8267-5647; Tomson, Charles/0000-0002-0224-8726	National Institute for Health Research [ACF-2013-18-501] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Abramowitz M, 2010, CLIN J AM SOC NEPHRO, V5, P1064, DOI 10.2215/CJN.08621209; Abutaleb N, 2007, NEPHROL DIAL TRANSPL, V22, P2728, DOI 10.1093/ndt/gfm349; Amann K, 2003, KIDNEY INT, V63, P1296, DOI 10.1046/j.1523-1755.2003.00864.x; Bates D, 2012, LME4 LINEAR MIXED EF; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; Chue CD, 2010, HEART, V96, P817, DOI 10.1136/hrt.2009.184879; Cunningham J, 2011, CLIN J AM SOC NEPHRO, V6, P913, DOI 10.2215/CJN.06040710; de Lusignan S, 2012, DIABETIC MED, V29, P181, DOI 10.1111/j.1464-5491.2011.03419.x; de Lusignan S, 2010, DIABETIC MED, V27, P203, DOI 10.1111/j.1464-5491.2009.02917.x; de Lusignan S, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-39; Dhingra R, 2007, ARCH INTERN MED, V167, P879, DOI 10.1001/archinte.167.9.879; Di Iorio B, 2012, CLIN J AM SOC NEPHRO, V7, P487, DOI 10.2215/CJN.03820411; Felsenfeld AJ, 2012, AM J KIDNEY DIS, V60, P655, DOI 10.1053/j.ajkd.2012.03.024; Foley RN, 2008, AM HEART J, V156, P556, DOI 10.1016/j.ahj.2008.05.016; Foley RN, 2009, J AM SOC NEPHROL, V20, P397, DOI 10.1681/ASN.2008020141; Gonzalez-Parra E, 2012, CARDIOVASC PATHOL, V21, P372, DOI 10.1016/j.carpath.2012.02.008; Guida B, 2011, NUTR METAB CARDIOVAS, V21, P879, DOI 10.1016/j.numecd.2010.02.021; Gutierrez OM, 2011, J RENAL NUTR, V21, P140, DOI 10.1053/j.jrn.2010.03.001; Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10; Jung HH, 2006, NEPHROL DIAL TRANSPL, V21, P1915, DOI 10.1093/ndt/gfl118; KEMP GJ, 1992, CLIN CHEM, V38, P400; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Lamb EJ, 2009, ANN CLIN BIOCHEM, V46, P205, DOI 10.1258/acb.2009.009007; Lau WL, 2011, ADV CHRONIC KIDNEY D, V18, P105, DOI 10.1053/j.ackd.2010.12.002; Linefsky JP, 2011, J AM COLL CARDIOL, V58, P291, DOI 10.1016/j.jacc.2010.11.073; Lusignan de S, 2013, KIDNEY INT; Lynch KE, 2011, CLIN J AM SOC NEPHRO, V6, P620, DOI 10.2215/CJN.04620510; Maindonald J. H., 2010, CAMBRIDGE SERIES STA; Mathew S, 2008, J AM SOC NEPHROL, V19, P1092, DOI 10.1681/ASN.2007070760; National Institute for Health and Clinical Excellence, 2008, CHRON KIDN DIS EARL; Navaneethan SD, 2009, AM J KIDNEY DIS, V54, P619, DOI 10.1053/j.ajkd.2009.06.004; O'Seaghdha CM, 2011, NEPHROL DIAL TRANSPL, V26, P2885, DOI 10.1093/ndt/gfq808; Palmer SC, 2011, JAMA-J AM MED ASSOC, V305, P1119, DOI 10.1001/jama.2011.308; Pencina MJ, 2009, CIRCULATION, V119, P3078, DOI 10.1161/CIRCULATIONAHA.108.816694; POCOCK SJ, 1989, J CLIN PATHOL, V42, P172, DOI 10.1136/jcp.42.2.172; Raggi P, 2002, J AM COLL CARDIOL, V39, P695, DOI 10.1016/S0735-1097(01)01781-8; Ritz E, 2012, DTSCH ARZTEBL INT, V109, P49, DOI 10.3238/arztebl.2012.0049; Roderick P, 2011, J EPIDEMIOLOGY COMMU, V65; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Van TV, 2012, J CLIN BIOCHEM NUTR, V51, P27, DOI 10.3164/jcbn.11-96; Terai K, 2009, BRIT J PHARMACOL, V156, P1267, DOI 10.1111/j.1476-5381.2008.00108.x; Tonelli M, 2005, CIRCULATION, V112, P2627, DOI 10.1161/CIRCULATIONAHA.105.553198; Toussain ND, 2008, NEPHROL DIAL TRANSPL, V23, P586, DOI 10.1093/ndt/gfm660; Yildiz A, 2005, NEPHROL DIAL TRANSPL, V20, P760, DOI 10.1093/ndt/gfh611	45	87	95	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74996	10.1371/journal.pone.0074996	http://dx.doi.org/10.1371/journal.pone.0074996			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040373	Green Published, gold, Green Submitted			2022-12-25	WOS:000327538600124
J	Simone, LC; Caplan, S; Naslavsky, N				Simone, Laura C.; Caplan, Steve; Naslavsky, Naava			Role of Phosphatidylinositol 4,5-Bisphosphate in Regulating EHD2 Plasma Membrane Localization	PLOS ONE			English	Article							EARLY ENDOSOMAL TRANSPORT; MAMMALIAN-CELLS; IN-VIVO; CAVEOLAE; PROTEIN; DOMAIN; SYNAPTOJANIN; ENDOCYTOSIS; OLIGOMERIZATION; ASSOCIATION	The four mammalian C-terminal Eps15 homology domain-containing proteins (EHD1-EHD4) play pivotal roles in endocytic membrane trafficking. While EHD1, EHD3 and EHD4 associate with intracellular tubular/vesicular membranes, EHD2 localizes to the inner leaflet of the plasma membrane. Currently, little is known about the regulation of EHD2. Thus, we sought to define the factors responsible for EHD2's association with the plasma membrane. The subcellular localization of endogenous EHD2 was examined in HeLa cells using confocal microscopy. Although EHD partner proteins typically mediate EHD membrane recruitment, EHD2 was targeted to the plasma membrane independent of two well-characterized binding proteins, syndapin2 and EHBP1. Additionally, the EH domain of EHD2, which facilitates canonical EHD protein interactions, was not required to direct overexpressed EHD2 to the cell surface. On the other hand, several lines of evidence indicate that the plasma membrane phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2) plays a crucial role in regulating EHD2 subcellular localization. Pharmacologic perturbation of PIP2 metabolism altered PIP2 plasma membrane distribution (as assessed by confocal microscopy), and caused EHD2 to redistribute away from the plasma membrane. Furthermore, overexpressed EHD2 localized to PIP2-enriched vacuoles generated by active Arf6. Finally, we show that although cytochalasin D caused actin microfilaments to collapse, EHD2 was nevertheless maintained at the plasma membrane. Intriguingly, cytochalasin D induced relocalization of both PIP2 and EHD2 to actin aggregates, supporting a role of PIP2 in controlling EHD2 subcellular localization. Altogether, these studies emphasize the significance of membrane lipid composition for EHD2 subcellular distribution and offer new insights into the regulation of this important endocytic protein.	[Caplan, Steve] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; Univ Nebraska Med Ctr, Eppley Canc Ctr, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Caplan, S (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	scaplan@unmc.edu; nnaslavsky@unmc.edu			National Institutes of Health (NIH) [RO1GM074876]; Nebraska Center for Cell Signaling Grant from the National Institute of General Medical Sciences [5P20GM103489-10]; NIH/National Cancer Institute (NCI) [5T32 CA009476-23]; NATIONAL CANCER INSTITUTE [T32CA009476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074876, P20GM103489] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Center for Cell Signaling Grant from the National Institute of General Medical Sciences; NIH/National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) Grant RO1GM074876 (SC), the Nebraska Center for Cell Signaling Grant 5P20GM103489-10 from the National Institute of General Medical Sciences (SC and NN), and by an NIH/National Cancer Institute (NCI) Training Grant 5T32 CA009476-23 (LCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aboulaich N, 2004, BIOCHEM J, V383, P237, DOI 10.1042/BJ20040647; Bastiani M, 2010, J CELL SCI, V123, P3831, DOI 10.1242/jcs.070102; Blume JJ, 2007, EXP CELL RES, V313, P219, DOI 10.1016/j.yexcr.2006.10.006; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Caplan S, 2001, J CELL BIOL, V154, P109, DOI 10.1083/jcb.200102142; Chang-Ileto B, 2011, DEV CELL, V20, P206, DOI 10.1016/j.devcel.2010.12.008; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Cockcroft S, 2009, BBA-MOL CELL BIOL L, V1791, P905, DOI 10.1016/j.bbalip.2009.03.007; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Fujimoto T, 1997, J HISTOCHEM CYTOCHEM, V45, P1197, DOI 10.1177/002215549704500903; Fujita A, 2009, P NATL ACAD SCI USA, V106, P9256, DOI 10.1073/pnas.0900216106; Galperin E, 2002, TRAFFIC, V3, P575, DOI 10.1034/j.1600-0854.2002.30807.x; George M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-3; Giridharan SS, 2013, MOL BIOL CELL; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Guilherme A, 2004, J BIOL CHEM, V279, P10593, DOI 10.1074/jbc.M307702200; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887; Hansen CG, 2011, J CELL SCI, V124, P2777, DOI 10.1242/jcs.084319; Henry GD, 2010, BIOCHEMISTRY-US, V49, P3381, DOI 10.1021/bi100065r; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Khvotchev M, 1998, J BIOL CHEM, V273, P2306, DOI 10.1074/jbc.273.4.2306; Kieken F, 2010, J BIOL CHEM, V285, P8687, DOI 10.1074/jbc.M109.045666; Koch D, 2012, HISTOCHEM CELL BIOL, V138, P215, DOI 10.1007/s00418-012-0945-0; Lee DW, 2005, J BIOL CHEM, V280, P17213, DOI 10.1074/jbc.M412751200; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; McMahon KA, 2009, EMBO J, V28, P1001, DOI 10.1038/emboj.2009.46; Modregger J, 2000, J CELL SCI, V113, P4511; Moren B, 2012, MOL BIOL CELL, V23, P1316, DOI 10.1091/mbc.E11-09-0787; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2007, J BIOL CHEM, V282, P16612, DOI 10.1074/jbc.M609493200; Naslavsky N, 2009, J CELL SCI, V122, P389, DOI 10.1242/jcs.037051; Nemoto Y, 1997, J BIOL CHEM, V272, P30817, DOI 10.1074/jbc.272.49.30817; Ortegren U, 2004, EUR J BIOCHEM, V271, P2028, DOI 10.1111/j.1432-1033.2004.04117.x; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pitto M, 2000, GLYCOCONJUGATE J, V17, P215, DOI 10.1023/A:1026593307882; Powner DJ, 2005, J CELL SCI, V118, P2975, DOI 10.1242/jcs.02432; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Sandvig K, 2011, CURR OPIN CELL BIOL, V23, P413, DOI 10.1016/j.ceb.2011.03.007; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Senju Y, 2011, J CELL SCI, V124, P2032, DOI 10.1242/jcs.086264; Sharma M, 2008, TRAFFIC, V9, P995, DOI 10.1111/j.1600-0854.2008.00732.x; Sharma M, 2009, MOL BIOL CELL, V20, P5181, DOI 10.1091/mbc.E09-06-0535; Stoeber M, 2012, EMBO J, V31, P2350, DOI 10.1038/emboj.2012.98; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; Zhang Li, 2012, Subcell Biochem, V59, P177, DOI 10.1007/978-94-007-3015-1_6	49	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74519	10.1371/journal.pone.0074519	http://dx.doi.org/10.1371/journal.pone.0074519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040268	gold, Green Published, Green Submitted			2022-12-25	WOS:000327538600098
J	Bradaric, MJ; Penumatsa, K; Barua, A; Edassery, SL; Yu, Y; Abramowicz, JS; Bahr, JM; Luborsky, JL				Bradaric, Michael J.; Penumatsa, Krishna; Barua, Animesh; Edassery, Seby L.; Yu, Yi; Abramowicz, Jacques S.; Bahr, Janice M.; Luborsky, Judith L.			Immune Cells in the Normal Ovary and Spontaneous Ovarian Tumors in the Laying Hen (Gallus domesticus) Model of Human Ovarian Cancer	PLOS ONE			English	Article							REGULATORY T-CELLS; INFILTRATING LYMPHOCYTES; POSTOVULATORY REGRESSION; PRECLINICAL-MODEL; FOLLICULAR-GROWTH; SEX STEROIDS; AVIAN MODEL; CHICKEN; EXPRESSION; LOCALIZATION	Background: Spontaneous ovarian cancer in chickens resembles human tumors both histologically and biochemically. The goal was to determine if there are differences in lymphocyte content between normal ovaries and ovarian tumors in chickens as a basis for further studies to understand the role of immunity in human ovarian cancer progression. Methods: Hens were selected using grey scale and color Doppler ultrasound to determine if they had normal or tumor morphology. Cells were isolated from ovaries (n = 6 hens) and lymphocyte numbers were determined by flow cytometry using antibodies to avian CD4 and CD8 T and B (Bu1a) cells. Ovarian sections from another set of hens (n = 26) were assessed to verify tumor type and stage and to count CD4, CD8 and Bu1a immunostained cells by morphometric analysis. Results: T and B cells were more numerous in ovarian tumors than in normal ovaries by flow cytometry and immunohistochemistry. There were less CD4+ cells than CD8+ and Bu1a+ cells in normal ovaries or ovarian tumors. CD8+ cells were the dominant T cell sub-type in both ovarian stroma and in ovarian follicles compared to CD4+ cells. Bu1a+ cells were consistently found in the stroma of normal ovaries and ovarian tumors but were not associated with follicles. The number of immune cells was highest in late stage serous tumors compared to endometrioid and mucinous tumors. Conclusions: The results suggest that similar to human ovarian cancer there are comparatively more immune cells in chicken ovarian tumors than in normal ovaries, and the highest immune cell content occurs in serous tumors. Thus, this study establishes a foundation for further study of tumor immune responses in a spontaneous model of ovarian cancer which will facilitate studies of the role of immunity in early ovarian cancer progression and use of the hen in pre-clinical vaccine trials.	[Bradaric, Michael J.; Penumatsa, Krishna; Barua, Animesh; Edassery, Seby L.; Yu, Yi; Luborsky, Judith L.] Rush Univ, Dept Pharmacol, Med Ctr, Chicago, IL 60612 USA; [Barua, Animesh] Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA; [Barua, Animesh; Abramowicz, Jacques S.; Luborsky, Judith L.] Rush Univ, Med Ctr, Dept Obstet & Gynecol, Chicago, IL 60612 USA; [Bahr, Janice M.] Univ Illinois, Dept Anim Sci, Champaign, IL USA	Rush University; Rush University; Rush University; University of Illinois System; University of Illinois Urbana-Champaign	Luborsky, JL (corresponding author), Rush Univ, Dept Pharmacol, Med Ctr, Chicago, IL 60612 USA.	Judith_Luborsky@rush.edu	Abramowicz, Jacques/ABH-2444-2020	Bradaric, Michael/0000-0003-4804-8911; Abramowicz, Jacques/0000-0003-4695-5972	NIH [R01AI055060]; DOD [OC073325]; Segal Foundation; Prevent Cancer Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055060] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); Segal Foundation; Prevent Cancer Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by NIH R01AI055060 (JL), DOD OC073325 (JL), the Segal Foundation (JL) and the Prevent Cancer Foundation (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansenberger K, 2009, GYNECOL ONCOL, V113, P362, DOI 10.1016/j.ygyno.2009.02.011; BAHR JM, 1984, J EXP ZOOL, V232, P495, DOI 10.1002/jez.1402320316; Barnes MN, 2002, GYNECOL ONCOL, V87, P57, DOI 10.1006/gyno.2002.6806; Barua A, 1998, POULTRY SCI, V77, P1417, DOI 10.1093/ps/77.9.1417; Barua A, 1998, J REPROD FERTIL, V114, P253, DOI 10.1530/jrf.0.1140253; Barua A, 1998, J REPROD FERTIL, V114, P11, DOI 10.1530/jrf.0.1140011; Barua A, 1999, GEN COMP ENDOCR, V114, P28, DOI 10.1006/gcen.1998.7232; Barua A, 2001, REPRODUCTION, V121, P953, DOI 10.1530/reprod/121.6.953; Barua A, 2007, J ULTRAS MED, V26, P909, DOI 10.7863/jum.2007.26.7.909; Barua A, 2007, AM J REPROD IMMUNOL, V57, P243, DOI 10.1111/j.1600-0897.2007.00470.x; Barua A, 2011, J ULTRAS MED, V30, P333, DOI 10.7863/jum.2011.30.3.333; Barua A, 2010, J ULTRAS MED, V29, P173, DOI 10.7863/jum.2010.29.2.173; Barua A, 2009, INT J GYNECOL CANCER, V19, P500, DOI 10.1111/IGC.0b013e3181a39db1; Barua A, 2009, INT J GYNECOL CANCER, V19, P531, DOI 10.1111/IGC.0b013e3181a41613; Bosquet JG, 2011, GYNECOL ONCOL, V120, P256, DOI 10.1016/j.ygyno.2010.10.030; Bukulmez O, 2000, HUM REPROD UPDATE, V6, P1, DOI 10.1093/humupd/6.1.1; Cheeseman JH, 2004, POULTRY SCI, V83, P911, DOI 10.1093/ps/83.6.911; Clarke B, 2009, MODERN PATHOL, V22, P393, DOI 10.1038/modpathol.2008.191; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Connolly DC, 2009, CANCER TREAT RES, V149, P353, DOI 10.1007/978-0-387-98094-2_17; COOPER MD, 1965, NATURE, V205, P143, DOI 10.1038/205143a0; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Davison TF, 2003, BRIT POULTRY SCI, V44, P6, DOI 10.1080/0007166031000085364; de Visser KE, 2008, CANCER IMMUNOL IMMUN, V57, P1531, DOI 10.1007/s00262-008-0501-x; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; Dong HP, 2006, AM J CLIN PATHOL, V125, P451, DOI 10.1309/15B66DQMFYYM78CJ; Erf GF, 2004, POULTRY SCI, V83, P580, DOI 10.1093/ps/83.4.580; Fisher DT, 2006, IMMUNOL INVEST, V35, P251, DOI 10.1080/08820130600745430; FREDRICKSON TN, 1987, ENVIRON HEALTH PERSP, V73, P35, DOI 10.2307/3430596; Gajewski TF, 2006, IMMUNOL REV, V213, P131, DOI 10.1111/j.1600-065X.2006.00442.x; Giles JR, 2006, EXP BIOL MED, V231, P1718, DOI 10.1177/153537020623101108; Giles JR, 2010, INT J GYNECOL CANCER, V20, P738, DOI 10.1111/IGC.0b013e3181da2c49; Gnjatic S, 2010, P NATL ACAD SCI USA, V107, P5088, DOI 10.1073/pnas.0914213107; GUPTA SK, 1988, J REPROD FERTIL, V82, P219, DOI 10.1530/jrf.0.0820219; Hakim AA, 2009, CANCER PREV RES, V2, P114, DOI 10.1158/1940-6207.CAPR-08-0065; Hales DB, 2008, ENDOCRINE, V33, P235, DOI 10.1007/s12020-008-9080-z; Jackson E, 2007, GYNECOL ONCOL, V104, P192, DOI 10.1016/j.ygyno.2006.07.024; Johnson PA, 2006, POULTRY SCI, V85, P246, DOI 10.1093/ps/85.2.246; Kaufman J, 1999, NATURE, V401, P923, DOI 10.1038/44856; Kaufman J, 1999, IMMUNOL REV, V167, P101, DOI 10.1111/j.1600-065X.1999.tb01385.x; Leffers N, 2009, CANCER IMMUNOL IMMUN, V58, P449, DOI 10.1007/s00262-008-0583-5; Liu JS, 2004, CANCER RES, V64, P1655, DOI 10.1158/0008-5472.CAN-03-3380; Lowe KA, 2008, CANCER EPIDEM BIOMAR, V17, P2480, DOI 10.1158/1055-9965.EPI-08-0150; MCCORMACK WT, 1991, ANNU REV IMMUNOL, V9, P219; McKenna ES, 2009, CELL CYCLE, V8, P23, DOI 10.4161/cc.8.1.7290; Milne K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006412; Negus RPM, 1997, AM J PATHOL, V150, P1723; Oakley OR, 2010, ENDOCRINOLOGY, V151, P4551, DOI 10.1210/en.2009-1444; Papadopoulos N, 2002, EUR J GYNAECOL ONCOL, V23, P533; Quinn BA, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-24; Ratcliffe MJH, 2006, DEV COMP IMMUNOL, V30, P101, DOI 10.1016/j.dci.2005.06.018; REYNAUD CA, 1989, CELL, V59, P171, DOI 10.1016/0092-8674(89)90879-9; Rodriguez-Burford C, 2001, GYNECOL ONCOL, V81, P373, DOI 10.1006/gyno.2001.6191; Seo HW, 2011, ONCOL REP, V25, P49, DOI 10.3892/or_00001040; Shah CA, 2008, GYNECOL ONCOL, V109, P215, DOI 10.1016/j.ygyno.2008.01.010; Stakleff KDS, 2003, INT J GYNECOL CANCER, V13, P405, DOI 10.1046/j.1525-1438.2003.13317.x; Stammer K, 2008, GYNECOL ONCOL, V109, P115, DOI 10.1016/j.ygyno.2007.12.030; Suzuki T, 1998, HUM REPROD, V13, P2186, DOI 10.1093/humrep/13.8.2186; Taylor DD, 2009, GYNECOL ONCOL, V115, P112, DOI 10.1016/j.ygyno.2009.06.031; Tomsova M, 2008, GYNECOL ONCOL, V108, P415, DOI 10.1016/j.ygyno.2007.10.016; Torres MP, 2009, MINERVA MED, V100, P385; Tregaskes CA, 1996, IMMUNOGENETICS, V44, P212, DOI 10.1007/BF02602587; Urick ME, 2008, GYNECOL ONCOL, V110, P418, DOI 10.1016/j.ygyno.2008.05.018; Urick ME, 2006, GYNECOL ONCOL, V103, P673, DOI 10.1016/j.ygyno.2006.05.012; Urick ME, 2009, GYNECOL ONCOL, V112, P166, DOI 10.1016/j.ygyno.2008.09.032; Vanderhyden Barbara C, 2003, Reprod Biol Endocrinol, V1, P67, DOI 10.1186/1477-7827-1-67; Wilke CM, 2011, INT REV IMMUNOL, V30, P120, DOI 10.3109/08830185.2011.567362; Yu Y, 2011, J OVARIAN RES, V4, DOI 10.1186/1757-2215-4-12	68	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74147	10.1371/journal.pone.0074147	http://dx.doi.org/10.1371/journal.pone.0074147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040191	Green Submitted, Green Published, gold			2022-12-25	WOS:000326405300161
J	Lai, HL; Wang, QT				Lai, Hsiao-Lei; Wang, Q. Tian			Additional Sex Combs-Like 2 Is Required for Polycomb Repressive Complex 2 Binding at Select Targets	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; PHD FINGER; LYSINE-27 METHYLATION; MURINE HOMOLOG; GROUP PROTEINS; GENE; DROSOPHILA; DNA; H3; TRITHORAX	Polycomb Group (PcG) proteins are epigenetic repressors of gene expression. The Drosophila Additional sex combs (Asx) gene and its mammalian homologs exhibit PcG function in genetic assays; however, the mechanism by which Asx family proteins mediate gene repression is not well understood. ASXL2, one of three mammalian homologs for Asx, is highly expressed in the mammalian heart and is required for the maintenance of cardiac function. We have previously shown that Asxl2 deficiency results in a reduction in the bulk level of histone H3 lysine 27 trimethylation (H3K27me3), a repressive mark generated by the Polycomb Repressive Complex 2 (PRC2). Here we identify several ASXL2 target genes in the heart and investigate the mechanism by which ASXL2 facilitates their repression. We show that the Asxl2-deficient heart is defective in converting H3K27me2 to H3K27me3 and in removing ubiquitin from mono-ubiquitinated histone H2A. ASXL2 and PRC2 interact in the adult heart and co-localize to target promoters. ASXL2 is required for the binding of PRC2 and for the enrichment of H3K27me3 at target promoters. These results add a new perspective to our understanding of the mechanisms that regulate PcG activity and gene repression.	[Lai, Hsiao-Lei; Wang, Q. Tian] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Wang, QT (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	qtwang@uic.edu			National Institutes of Health [R21HL097113]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL097113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant R21HL097113 to QTW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab O, 2012, CANCER CELL, V22, P180, DOI 10.1016/j.ccr.2012.06.032; Aravind L, 2012, CELL CYCLE, V11, P119, DOI 10.4161/cc.11.1.18475; Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; Baskind HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004750; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Bischoff K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008106; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brown JL, 2003, DEVELOPMENT, V130, P285, DOI 10.1242/dev.00204; Brown JL, 1998, MOL CELL, V1, P1057, DOI 10.1016/S1097-2765(00)80106-9; CAMPBELL RB, 1995, MOL GEN GENET, V246, P291, DOI 10.1007/BF00288601; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2008, MOL CELL BIOL, V28, P1862, DOI 10.1128/MCB.01589-07; Chen EP, 2001, ANN THORAC SURG, V71, P1320, DOI 10.1016/S0003-4975(00)01754-9; Cho YS, 2006, J BIOL CHEM, V281, P17588, DOI 10.1074/jbc.M512616200; Delgado-Olguin P, 2012, NAT GENET, V44, P343, DOI 10.1038/ng.1068; Feng JJ, 2009, NEUROMUSCULAR DISORD, V19, P6, DOI 10.1016/j.nmd.2008.09.005; Fisher CL, 2010, DEV BIOL, V337, P9, DOI 10.1016/j.ydbio.2009.10.004; Fisher CL, 2006, GENE, V369, P109, DOI 10.1016/j.gene.2005.10.033; Fisher CL, 2003, GENE, V306, P115, DOI 10.1016/S0378-1119(03)00430-X; Gould A, 1997, CURR OPIN GENET DEV, V7, P488, DOI 10.1016/S0959-437X(97)80075-5; Huang ZM, 2011, FRONT BIOSCI-LANDMRK, V16, P3047, DOI 10.2741/3898; JURGENS G, 1985, NATURE, V316, P153, DOI 10.1038/316153a0; Katoh M, 2004, INT J ONCOL, V24, P1617; Katoh M, 2003, INT J ONCOL, V23, P845; Kennison JA, 1995, ANNU REV GENET, V29, P289, DOI 10.1146/annurev.ge.29.120195.001445; Kim SY, 2006, DEVELOPMENT, V133, P4957, DOI 10.1242/dev.02677; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lai HL, 2012, J MOL CELL CARDIOL, V53, P734, DOI 10.1016/j.yjmcc.2012.08.014; Lee SW, 2010, J BIOL CHEM, V285, P18, DOI 10.1074/jbc.M109.065862; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Milne TA, 1999, MOL GEN GENET, V261, P753, DOI 10.1007/s004380050018; Mohd-Sarip A, 2002, MOL CELL BIOL, V22, P7473, DOI 10.1128/MCB.22.21.7473-7483.2002; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Nekrasov M, 2007, EMBO J, V26, P4078, DOI 10.1038/sj.emboj.7601837; Ng RK, 2008, CELL CYCLE, V7, P1173, DOI 10.4161/cc.7.9.5791; O'Connell S, 2001, J BIOL CHEM, V276, P43065, DOI 10.1074/jbc.M104294200; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Petruk S, 2008, DEVELOPMENT, V135, P2383, DOI 10.1242/dev.023275; Sarma K, 2008, MOL CELL BIOL, V28, P2718, DOI 10.1128/MCB.02017-07; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Sinclair DAR, 1998, DEVELOPMENT, V125, P1207; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yu H, 2010, MOL CELL BIOL, V30, P5071, DOI 10.1128/MCB.00396-10; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	57	19	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73983	10.1371/journal.pone.0073983	http://dx.doi.org/10.1371/journal.pone.0073983			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040135	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300146
J	Mihalik, KB; Feigelstock, DA				Mihalik, Kathleen B.; Feigelstock, Dino A.			Sensitivity of a Ribavirin Resistant Mutant of Hepatitis C Virus to Other Antiviral Drugs	PLOS ONE			English	Article							DEPENDENT RNA-POLYMERASE; ERROR-PRONE REPLICATION; MOUTH-DISEASE VIRUS; IN-VITRO; PROTEASE INHIBITOR; EFFICIENT PRODRUG; PLUS RIBAVIRIN; HUH-7 CELLS; INTERFERON; NS5A	Background: While ribavirin mono-therapy regimens have minimal effect on patients with chronic hepatitis C virus (HCV) infections, they can be efficacious when combined with interferon. Clinical studies show that interferon-free combination therapies containing ribavirin are also efficacious, suggesting that an interferon-free therapy could be adopted in the near future. However, generation of drug resistant mutants and cross resistance to other drugs could impair the efficacy of the treatment. Therefore, understanding the mechanism of HCV resistance to ribavirin and cross resistance to other antiviral drugs could be of major importance. Methods: We tested the ability of a J6/JFH1 derived HCV ribavirin resistant mutant to grow in tissue cultured Huh7D cells in the presence of the mutagen 5-Fluorouracil and the nucleoside analog 2'-C-Methylcytidine. Virus replication was assessed by detecting HCV antigens by immunofluorescence and by titrating virus present in the supernatants. Recovered viruses were amplified by RT-PCR and sequenced. Results: The sensitivity of HCV-RR relative to parental J6/JFH1 to the tested drugs varied. HCV-RR was more resistant than J6/JFH1 to 5-Fluorouracil but was not more resistant than J6/JFH1 to 2'-C-Methylcytidine. Growth of HCV-RR in 5-Fluorouracil allowed the selection of an HCV-RR derived mutant resistant to 5-Fluorouracil (HCV-5FU). HCV-5FU grows to moderate levels in the presence of high concentrations of 5-Fluorouracil and to parental levels in the absence of the drug. Sequence of its genome shows that HCV-5FU accumulated multiple synonymous and non-synonymous mutations. Conclusions: These results indicate that determinants of resistance to ribavirin could also confer resistance to other anti-HCV drugs, shedding light toward understanding the mechanism of action of ribavirin and highlighting the importance of combination drug selection for HCV treatment. The results also show that it is possible to select a 5-Fluorouracil HCV resistant mutant that replicates to levels similar to parental virus when grown in the absence of 5-Fluorouracil.	[Mihalik, Kathleen B.; Feigelstock, Dino A.] US FDA, Ctr Biol Evaluat & Res, Div Viral Prod, Bethesda, MD USA	US Food & Drug Administration (FDA)	Feigelstock, DA (corresponding author), US FDA, Ctr Biol Evaluat & Res, Div Viral Prod, Bethesda, MD USA.	dino.feigelstock@fda.hhs.gov			Food and Drug Administration	Food and Drug Administration(United States Department of Health & Human Services)	This work was supported by internal funding from the Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFDAHL N, 2004, 55 ANN M AM ASS STUD, pA726; Airaksinen A, 2003, VIROLOGY, V311, P339, DOI 10.1016/S0042-6822(03)00144-2; Alter H, 1997, VIRAL HEPATITIS, P467; Biswal BK, 2005, J BIOL CHEM, V280, P18202, DOI 10.1074/jbc.M413410200; Brochot E, 2007, ANTIVIR THER, V12, P805; Carroll SS, 2011, ANTIMICROB AGENTS CH, V55, P3854, DOI 10.1128/AAC.01152-10; Chung Raymond T, 2008, Hepatology, V47, P306, DOI 10.1002/hep.22070; Coelmont L, 2006, ANTIMICROB AGENTS CH, V50, P3444, DOI 10.1128/AAC.00372-06; Contreras AM, 2002, J VIROL, V76, P8505, DOI 10.1128/JVI.76.17.8505-8517.2002; Crotty S, 2000, NAT MED, V6, P1375, DOI 10.1038/82191; Day CW, 2005, ANTIVIR RES, V67, P38, DOI 10.1016/j.antiviral.2005.04.002; Dietz J, 2013, J VIROL, V87, P6172, DOI 10.1128/JVI.02778-12; ENOMOTO N, 1995, J CLIN INVEST, V96, P224, DOI 10.1172/JCI118025; Feigelstock DA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-402; Feigelstock DA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-44; Feld JJ, 2010, GASTROENTEROLOGY, V139, P154, DOI 10.1053/j.gastro.2010.03.037; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Godofsky E, 2004, GASTROENTEROLOGY; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Graci JD, 2012, J VIROL, V86, P2869, DOI 10.1128/JVI.05712-11; Hofmann WP, 2007, GASTROENTEROLOGY, V132, P921, DOI 10.1053/j.gastro.2006.12.005; HSU HH, 1993, HEPATOLOGY, V17, P763, DOI 10.1016/0270-9139(93)90149-H; Kanda T, 2004, J VIRAL HEPATITIS, V11, P479, DOI 10.1111/j.1365-2893.2004.00531.x; Kwong AD, 2008, CURR OPIN PHARMACOL, V8, P522, DOI 10.1016/j.coph.2008.09.007; Lanford RE, 2001, J VIROL, V75, P8074, DOI 10.1128/JVI.75.17.8074-8081.2001; Le Pogam S, 2006, VIROLOGY, V351, P349, DOI 10.1016/j.virol.2006.03.045; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Limaye AR, 2011, NEW ENGL J MED, V365, P176, DOI 10.1056/NEJMc1105515; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Lutchman G, 2007, GASTROENTEROLOGY, V132, P1757, DOI 10.1053/j.gastro.2007.03.035; Maag D, 2001, J BIOL CHEM, V276, P46094, DOI 10.1074/jbc.C100349200; Macdonald A, 2004, J GEN VIROL, V85, P2485, DOI 10.1099/vir.0.80204-0; Malet-Martino M, 2002, ONCOLOGIST, V7, P288, DOI 10.1634/theoncologist.7-4-288; Moradpour D, 2004, J VIROL, V78, P7400, DOI 10.1128/JVI.78.14.7400-7409.2004; Moreno H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032550; Perales C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005554; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; Pierra C, 2005, NUCLEOS NUCLEOT NUCL, V24, P767, DOI 10.1081/NCN-200060112; Pierra C, 2006, J MED CHEM, V49, P6614, DOI 10.1021/jm0603623; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Severson WE, 2003, J VIROL, V77, P481, DOI 10.1128/JVI.77.1.481-488.2003; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Sierra M, 2007, J VIROL, V81, P2012, DOI 10.1128/JVI.01606-06; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; Uka K, 2007, J GASTROENTEROL, V42, P845, DOI 10.1007/s00535-007-2099-8; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Vo NV, 2003, BIOCHEMISTRY-US, V42, P10462, DOI 10.1021/bi0344681; Zeuzem S, 2012, HEPATOLOGY, V55, P749, DOI 10.1002/hep.24744; Zeuzem S, 2011, GASTROENTEROLOGY, V141, P2047, DOI 10.1053/j.gastro.2011.08.051; [No title captured]	51	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74027	10.1371/journal.pone.0074027	http://dx.doi.org/10.1371/journal.pone.0074027			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040153	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600113
J	Pakrashi, S; Dalai, S; Humayun, A; Chakravarty, S; Chandrasekaran, N; Mukherjee, A				Pakrashi, Sunandan; Dalai, Swayamprava; Humayun, Ahmed; Chakravarty, Sujay; Chandrasekaran, Natarajan; Mukherjee, Amitava			Ceriodaphnia dubia as a Potential Bio-Indicator for Assessing Acute Aluminum Oxide Nanoparticle Toxicity in Fresh Water Environment	PLOS ONE			English	Article							DAPHNIA-MAGNA; TITANIUM-DIOXIDE; CYTOTOXICITY; TIO2; RESPONSES; NANOMATERIALS; NANOSYSTEMS; SUSPENSIONS; BACTERIA; DELIVERY	Growing nanomaterials based consumer applications have raised concerns about their potential release into the aquatic ecosystems and the consequent toxicological impacts. So environmental monitoring of the nanomaterials in aqueous systems becomes imperative. The current study reveals the potential of Ceriodaphnia dubia (C. dubia) as a bio-indicator for aluminum oxide nanoparticles in a fresh water aquatic ecosystem where it occupies an important ecological niche as a primary consumer. This study aims to investigate the aluminium oxide nanoparticle induced acute toxicity on Ceriodaphnia dubia in a freshwater system. The bioavailability of the aluminum oxide nanoparticles has been studied with respect to their aggregation behavior in the system and correlated with the toxicity endpoints. The oxidative stress generated by the particles contributed greatly toward their toxicity. The crucial role of leached aluminium ion mediated toxicity in the later phases (48 h and 72 h) in conjunction with the effects from the nano-sized particles in the initial phases (24 h) puts forth the dynamics of nanotoxicity in the test system. The internalization of nanoparticles (both gross and systemic uptake) as substantiated through the transmission electron microscopy (TEM) and inductively coupled plasma optical emission spectral (ICP-OES) analysis was another major contributor toward acute toxicity. Concluding the present study, Ceriodaphnia dubia can be a promising candidate for bio-monitoring the aluminium oxide nanoparticles in a fresh water system.	[Pakrashi, Sunandan; Dalai, Swayamprava; Humayun, Ahmed; Chandrasekaran, Natarajan; Mukherjee, Amitava] VIT Univ, Ctr Nanobiotechnol, Vellore, Tamil Nadu, India; [Chakravarty, Sujay] UGC DAE CSR, Kokilamedu, India	Vellore Institute of Technology; UGC DAE Consortium for Scientific Research	Mukherjee, A (corresponding author), VIT Univ, Ctr Nanobiotechnol, Vellore, Tamil Nadu, India.	amitav@vit.ac.in	Mukherjee, Amitava/H-5560-2011; Chakravarty, Sujay/AFV-0884-2022; Chandrasekaran, Natarajan/F-2312-2018; Dalai, Swayamprava/AAD-8677-2021	Mukherjee, Amitava/0000-0001-8682-4278; Chakravarty, Sujay/0000-0003-2509-4464; Chandrasekaran, Natarajan/0000-0002-0586-134X; Dalai, Swayamprava/0000-0001-5311-4763	Life Science Research Board-Defence Research and Development Organization (LSRB-DRDO); Council of Scientific & Industrial Research (CSIR), India	Life Science Research Board-Defence Research and Development Organization (LSRB-DRDO); Council of Scientific & Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	The research work was funded by Life Science Research Board-Defence Research and Development Organization (LSRB-DRDO). SP and SD received fellowship from Council of Scientific & Industrial Research (CSIR), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASS DA, 1983, J IMMUNOL, V130, P1910; Blaise C, 2005, SMALL SCALE FRESHWAT, V1; Blaylock RL, 2013, CHEMTRAILS NANOALUMI; Brayner R, 2006, NANO LETT, V6, P866, DOI 10.1021/nl052326h; Connon R, 2008, ENVIRON SCI TECHNOL, V42, P2181, DOI 10.1021/es702469b; COUVREUR P, 1993, ADV DRUG DELIVER REV, V10, P141, DOI 10.1016/0169-409X(93)90046-7; Dalai S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062970; Dalai S, 2012, TOXICOL RES-UK, V1, P116, DOI 10.1039/c2tx00012a; De Luca LT, 2005, COMBUST EXPLO SHOCK+, V41, P680, DOI 10.1007/s10573-005-0080-5; DeFriend KA, 2003, J MEMBRANE SCI, V224, P11, DOI 10.1016/S0376-7388(03)00344-2; Dimkpa CO, 2011, ENVIRON POLLUT, V159, P1749, DOI 10.1016/j.envpol.2011.04.020; Frey A, 1997, BIOCONJUGATE CHEM, V8, P424, DOI 10.1021/bc970036p; Future Markets Inc, 2013, GLOB MARK MET OX NAN; Gaiser BK, 2011, J ENVIRON MONITOR, V13, P1227, DOI 10.1039/c1em10060b; Ganesh S, 2013, BIOMATERIALS, V34, P3489, DOI 10.1016/j.biomaterials.2013.01.077; Ghosh S, 2008, LANGMUIR, V24, P12385, DOI 10.1021/la802015f; Heckmann LH, 2011, ECOTOXICOLOGY, V20, P226, DOI 10.1007/s10646-010-0574-0; Heinlaan M, 2008, CHEMOSPHERE, V71, P1308, DOI 10.1016/j.chemosphere.2007.11.047; Hou WC, 2013, ENVIRON SCI-PROC IMP, V15, P103, DOI 10.1039/c2em30686g; Khanna AS., 2008, ASIAN J EXP SCI, V21, P25; Landry V, 2008, PROG ORG COAT, V61, P76, DOI 10.1016/j.porgcoat.2007.09.013; Lewis WK, 2011, J PHYS CHEM C, V115, P70, DOI 10.1021/jp107264h; Li YX, 2012, J HAZARD MATER, V219, P221, DOI 10.1016/j.jhazmat.2012.03.083; Lin Weisheng, 2008, Toxicological and Environmental Chemistry, V90, P983, DOI 10.1080/02772240701802559; Lovern SB, 2007, ENVIRON SCI TECHNOL, V41, P4465, DOI 10.1021/es062146p; Lushchak V. I., 2006, Ukrainskii Biokhimicheskii Zhurnal, V78, P113; Lushchak VI, 2011, AQUAT TOXICOL, V101, P13, DOI 10.1016/j.aquatox.2010.10.006; Maynard AD, 2006, NATURE, V444, P267, DOI 10.1038/444267a; McTeer J., 2013, NANOTOXICOLOGY, P1; NAPPER DH, 1983, POLYM STABILIZATION; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; OECD, 2004, TEST 202 DAPHN SP AC, DOI [10.1787/9789264069947-en, DOI 10.1787/9789264069947-EN]; Pakrashi S, 2013, AQUAT TOXICOL, V132, P34, DOI 10.1016/j.aquatox.2013.01.018; Pakrashi S, 2011, CHEM RES TOXICOL, V24, P1899, DOI 10.1021/tx200244g; Parent L, 1996, ENVIRON SCI TECHNOL, V30, P1713, DOI 10.1021/es950718s; Rittner MN, 1998, JOM-J MIN MET MAT S, V50, P36, DOI 10.1007/s11837-998-0065-4; Robel I, 2006, J AM CHEM SOC, V128, P2385, DOI 10.1021/ja056494n; Roco MC, 2005, J NANOPART RES, V7, P1, DOI 10.1007/s11051-004-2336-5; Sadiq IM, 2011, J NANOPART RES, V13, P3287, DOI 10.1007/s11051-011-0243-0; Sadrieh N, 2010, TOXICOL SCI, V115, P156, DOI 10.1093/toxsci/kfq041; Sawyer WG, 2003, WEAR, V254, P573, DOI 10.1016/S0043-1648(03)00252-7; Sayes CM, 2009, WIRES NANOMED NANOBI, V1, P660, DOI 10.1002/wnan.58; Stille JK, 1963, INTRO POLYM CHEM; STUMM W, 1990, REV GEOPHYS, V28, P53, DOI 10.1029/RG028i001p00053; U.S. Environmental Protection Agency, 2013, 600486032 US EPA; Vasir JK, 2005, CURR NANOSCI, V1, P47, DOI 10.2174/1573413052953110; Versteeg DJ, 1997, CHEMOSPHERE, V34, P869, DOI 10.1016/S0045-6535(97)00014-3; Win KY, 2005, BIOMATERIALS, V26, P2713, DOI 10.1016/j.biomaterials.2004.07.050; WINNER RW, 1988, ENVIRON TOXICOL CHEM, V7, P153, DOI [10.1897/1552-8618(1988)7[153:EOTRSO]2.0.CO;2, 10.1002/etc.5620070209]; Wong KFV, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/34/345702; Zauner W, 2001, J CONTROL RELEASE, V71, P39, DOI 10.1016/S0168-3659(00)00358-8; Zeng Y, 2012, PROCEDIA ENVIRON SCI, V13, P71, DOI 10.1016/j.proenv.2012.01.006; Zhu XS, 2008, J ENVIRON SCI HEAL A, V43, P278, DOI 10.1080/10934520701792779; Zhu XS, 2010, CHEMOSPHERE, V78, P209, DOI 10.1016/j.chemosphere.2009.11.013; Zhu XS, 2009, J NANOPART RES, V11, P67, DOI 10.1007/s11051-008-9426-8	55	50	53	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74003	10.1371/journal.pone.0074003	http://dx.doi.org/10.1371/journal.pone.0074003			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040143	Green Submitted, gold, Green Published			2022-12-25	WOS:000324481600112
J	Li, ZM; Peng, H; Qin, L; Qi, J; Zuo, XB; Liu, JY; Zhang, JT				Li, Zhaomin; Peng, Hui; Qin, Li; Qi, Jing; Zuo, Xiaobing; Liu, Jing-Yuan; Zhang, Jian-Ting			Determinants of 14-3-3 sigma Protein Dimerization and Function in Drug and Radiation Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; BREAST-CANCER CELLS; X-RAY-SCATTERING; PROTEOMIC ANALYSIS; MITOTIC CATASTROPHE; PHOSPHORYLATION; OLIGOMERIZATION; APOPTOSIS; SURVIVAL; ABCG2	Many proteins exist and function as homodimers. Understanding the detailed mechanism driving the homodimerization is important and will impact future studies targeting the "undruggable" oncogenic protein dimers. In this study, we used 14-3-3 sigma as a model homodimeric protein and performed a systematic investigation of the potential roles of amino acid residues in the interface for homodimerization. Unlike other members of the conserved 14-3-3 protein family, 14-3-3 sigma prefers to form a homodimer with two subareas in the dimeric interface that has 180 degrees symmetry. We found that both subareas of the dimeric interface are required to maintain full dimerization activity. Although the interfacial hydrophobic core residues Leu(12) and Tyr(84) play important roles in 14-3-3 sigma dimerization, the non-core residue Phe(25) appears to be more important in controlling 14-3-3 sigma dimerization activity. Interestingly, a similar non-core residue (Val(81)) is less important than Phe(25) in contributing to 14-3-3 sigma dimerization. Furthermore, dissociating dimeric 14-3-3 sigma into monomers by mutating the Leu(12), Phe(25), or Tyr(84) dimerization residue individually diminished the function of 14-3-3 sigma in resisting drug-induced apoptosis and in arresting cells at G(2)/M phase in response to DNA-damaging treatment. Thus, dimerization appears to be required for the function of 14-3-3 sigma.	[Li, Zhaomin; Peng, Hui; Qin, Li; Qi, Jing; Liu, Jing-Yuan; Zhang, Jian-Ting] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Zhang, Jian-Ting] Indiana Univ Sch Med, IU Simon Canc Ctr, Indianapolis, IN 46202 USA; [Zuo, Xiaobing] Argonne Natl Lab, Xray Sci Div, Argonne, IL 60439 USA; [Liu, Jing-Yuan] Indiana Univ Purdue Univ, Dept Comp & Informat Sci, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; United States Department of Energy (DOE); Argonne National Laboratory; Indiana University System; Indiana University-Purdue University Indianapolis	Liu, JY (corresponding author), IUPUI, 723 W Michigan St,SL280C, Indianapolis, IN 46202 USA.	jliu2@iupui.edu; jianzhan@iupui.edu	Zhang, Jian-Ting/L-8334-2015	Zhang, Jian-Ting/0000-0002-2803-9914	United States Department of Energy [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [R01CA140582] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge the use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, which is supported by the United States Department of Energy under Contract DE-AC02-06CH11357.	Benzinger A, 2005, MOL CELL PROTEOMICS, V4, P785, DOI 10.1074/mcp.M500021-MCP200; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Chu K, 2004, RADIAT RES, V162, P270, DOI 10.1667/RR3221; Dong ZZ, 2009, EXP CELL RES, V315, P1889, DOI 10.1016/j.yexcr.2009.03.009; Dong ZZ, 2005, NUCLEIC ACIDS RES, V33, P2715, DOI 10.1093/nar/gki569; Ferguson AT, 2000, P NATL ACAD SCI USA, V97, P6049, DOI 10.1073/pnas.100566997; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Glatter O., 1982, SMALL ANGLE X RAY SC; Han BG, 2006, MOL CANCER THER, V5, P903, DOI 10.1158/1535-7163.MCT-05-0393; Hermeking H, 2006, SEMIN CANCER BIOL, V16, P183, DOI 10.1016/j.semcancer.2006.03.002; Hirai M, 2004, BIOCHEMISTRY-US, V43, P9036, DOI 10.1021/bi0499664; Laronga C, 2000, J BIOL CHEM, V275, P23106, DOI 10.1074/jbc.M905616199; Li Zhaomin, 2010, BMC Cancer, V10, P598, DOI 10.1186/1471-2407-10-598; Li ZM, 2009, AM J TRANSL RES, V1, P326; Liu JY, 2011, J CHEM INF MODEL, V51, P2612, DOI 10.1021/ci200212y; Liu Y, 2006, CANCER RES, V66, P3248, DOI 10.1158/0008-5472.CAN-05-3801; Mo W, 2012, BIOCHEMISTRY-US, V51, P3634, DOI 10.1021/bi300301a; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; Neupane D, 2008, CLIN CANCER RES, V14, P7614, DOI 10.1158/1078-0432.CCR-08-1366; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; Samuel T, 2001, J BIOL CHEM, V276, P45201, DOI 10.1074/jbc.M106427200; Shen YH, 2003, MOL BIOL CELL, V14, P4721, DOI 10.1091/mbc.E02-12-0821; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Vercoutter-Edouart AS, 2001, CANCER RES, V61, P76; Verdoodt B, 2006, CELL CYCLE, V5, P2920, DOI 10.4161/cc.5.24.3571; Wilker EW, 2007, NATURE, V446, P329, DOI 10.1038/nature05584; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Woodcock JM, 2003, J BIOL CHEM, V278, P36323, DOI 10.1074/jbc.M304689200; Xu JK, 2007, CANCER RES, V67, P4373, DOI 10.1158/0008-5472.CAN-06-3169; Yang YY, 2010, BIOCHEMISTRY-US, V49, P10854, DOI 10.1021/bi101350x; Yang YY, 2002, J BIOL CHEM, V277, P44268, DOI 10.1074/jbc.M207003200; Zhang JT, 2007, CANCER TREAT REV, V33, P741, DOI 10.1016/j.ctrv.2007.07.018; Zhang JT, 2000, J CELL SCI, V113, P2545; Zhou Y, 2003, J BIOL CHEM, V278, P10073, DOI 10.1074/jbc.M211907200	35	12	12	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31447	31457		10.1074/jbc.M113.467753	http://dx.doi.org/10.1074/jbc.M113.467753			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24043626	Green Published, hybrid			2022-12-25	WOS:000330596200004
J	Pietras, Z; Hardwick, SW; Swiezewski, S; Luisi, BF				Pietras, Zbigniew; Hardwick, Steven W.; Swiezewski, Szymon; Luisi, Ben F.			Potential Regulatory Interactions of Escherichia coli RraA Protein with DEAD-box Helicases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA HELICASE; CRYSTAL-STRUCTURE; NUCLEOPORIN NUP214; DEGRADOSOME; RECOGNITION; INHIBITOR; MUTATION; REVEALS; BINDING; ATPASE	Members of the DEAD-box family of RNA helicases contribute to virtually every aspect of RNA metabolism, in organisms from all domains of life. Many of these helicases are constituents of multicomponent assemblies, and their interactions with partner proteins within the complexes underpin their activities and biological function. In Escherichia coli the DEAD-box helicase RhlB is a component of the multienzyme RNA degradosome assembly, and its interaction with the core ribonuclease RNase E boosts the ATP-dependent activity of the helicase. Earlier studies have identified the regulator of ribonuclease activity A (RraA) as a potential interaction partner of both RNase E and RhlB. We present structural and biochemical evidence showing how RraA can bind to, and modulate the activity of RhlB and another E. coli DEAD-box enzyme, SrmB. Crystallographic structures are presented of RraA in complex with a portion of the natively unstructured C-terminal tail of RhlB at 2.8-angstrom resolution, and in complex with the C-terminal RecA-like domain of SrmB at 2.9 angstrom. The models suggest two distinct mechanisms by which RraA might modulate the activity of these and potentially other helicases.	[Pietras, Zbigniew; Hardwick, Steven W.; Luisi, Ben F.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Pietras, Zbigniew; Swiezewski, Szymon] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland	University of Cambridge; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Luisi, BF (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1GA, England.	bfl20@cam.ac.uk		Pietras, Zbigniew/0000-0002-0365-7257; Swiezewski, Szymon/0000-0002-2007-2779; Hardwick, Steven/0000-0001-9246-1864	Wellcome Trust; Biotechnology and Biological Sciences Research Council; Peterhouse studentships	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Peterhouse studentships	This work was supported in part by the Wellcome Trust.; Supported by Biotechnology and Biological Sciences Research Council and Peterhouse studentships.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bizebard T, 2004, BIOCHEMISTRY-US, V43, P7857, DOI 10.1021/bi049852s; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; Callaghan AJ, 2004, J MOL BIOL, V340, P965, DOI 10.1016/j.jmb.2004.05.046; Calleja M., 2004, P 2004 UK E SCI ALL; Carabetta VJ, 2010, J BACTERIOL, V192, P3713, DOI 10.1128/JB.00300-10; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; Cartier G, 2010, BIOCHEMISTRY-US, V49, P2636, DOI 10.1021/bi902082d; Chandran V, 2006, J MOL BIOL, V358, P8, DOI 10.1016/j.jmb.2006.02.012; Chandran V, 2007, J MOL BIOL, V367, P113, DOI 10.1016/j.jmb.2006.12.014; Chang JH, 2009, P NATL ACAD SCI USA, V106, P3148, DOI 10.1073/pnas.0808275106; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Elles LM, 2008, NUCLEIC ACIDS RES, V36, P41, DOI 10.1093/nar/gkm926; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gorna MW, 2010, RNA, V16, P553, DOI 10.1261/rna.1858010; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Iost I, 2013, BBA-GENE REGUL MECH, V1829, P866, DOI 10.1016/j.bbagrm.2013.01.012; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee KS, 2003, CELL, V114, P623, DOI 10.1016/j.cell.2003.08.003; Mallam AL, 2011, P NATL ACAD SCI USA, V108, P12254, DOI 10.1073/pnas.1109566108; Manasherob R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038426; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOLIN S, 1977, J BACTERIOL, V131, P7, DOI 10.1128/JB.131.1.7-17.1977; Monzingo AF, 2003, J MOL BIOL, V332, P1015, DOI 10.1016/S0022-2836(03)00970-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Napetschnig J, 2009, P NATL ACAD SCI USA, V106, P3089, DOI 10.1073/pnas.0813267106; NICOL SM, 1995, P NATL ACAD SCI USA, V92, P11681, DOI 10.1073/pnas.92.25.11681; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Proux F, 2011, MOL MICROBIOL, V82, P300, DOI 10.1111/j.1365-2958.2011.07779.x; Prud'homme-Genereux A, 2004, MOL MICROBIOL, V54, P1409, DOI 10.1111/j.1365-2958.2004.04360.x; Pulk A, 2010, MOL MICROBIOL, V75, P801, DOI 10.1111/j.1365-2958.2009.07002.x; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Taghbalout A, 2010, J BACTERIOL, V192, P3222, DOI 10.1128/JB.00105-10; Tamura M, 2012, J BACTERIOL, V194, P1919, DOI 10.1128/JB.06652-11; Tang JA, 2010, PROTEIN J, V29, P583, DOI 10.1007/s10930-010-9293-x; Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105; Trubetskoy D, 2009, NUCLEIC ACIDS RES, V37, P6540, DOI 10.1093/nar/gkp685; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; von Moeller H, 2009, NAT STRUCT MOL BIOL, V16, P247, DOI 10.1038/nsmb.1561; Worrall JAR, 2008, J BIOL CHEM, V283, P5567, DOI 10.1074/jbc.M708620200	51	9	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31919	31929		10.1074/jbc.M113.502146	http://dx.doi.org/10.1074/jbc.M113.502146			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24045937	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000330596200044
J	Shen, YZ; Wang, ZY; Lu, HZ; Wang, JR; Chen, J; Liu, L; Zhang, RF; Zheng, YF				Shen, Yinzhong; Wang, Zhenyan; Lu, Hongzhou; Wang, Jiangrong; Chen, Jun; Liu, Li; Zhang, Renfang; Zheng, Yufang			Prevalence of Anemia among Adults with Newly Diagnosed HIV/AIDS in China	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTED PATIENTS; AIDS; INDIVIDUALS; COHORT; WOMEN	Background: The prevalence of anemia among antiretroviral-naive HIV-infected patients in China has not been well characterized. We conducted a cross-sectional study to estimate the prevalence of anemia among Chinese adults with newly diagnosed HIV/AIDS. Methods: One thousand nine hundred and forty-eight newly diagnosed HIV-infected patients in China were selected during 2009 and 2010. Serum samples obtained from each individual were collected to measure hemoglobin levels. Demographics and medical histories were recorded. Factors associated with the presence of anemia were analysed by logistic regression. Results: Among the 1948 patients, 75.8% were male. Median age was 40 years (range: 18-80 years). The overall prevalence of anemia among HIV-infected patients was 51.9% (51.5% among men, 53.2% among women). The prevalences of mild anemia, of moderate anemia, of severe anemia were 32.4%, 17.0%, and 2.5%, respectively. The prevalence of anemia was higher among ethnic minority patients than among the Han patients (70.9% versus 45.9%). The prevalence of anemia increased with increasing age (49.6%, 53.5% and 60.1% among patients who were 18-39, 40-59, and >= 60 years of age respectively) and with decreasing CD4 count (14.0%, 22.4%, 50.7%, and 74.6% among patients with CD4 count of >= 350, 200-349, 50-199, and <50 cells/mm(3) respectively). The logistic regression analysis showed that older age, lower CD4 count and minority ethnicity were significantly associated with an increased risk of anemia. Conclusions: Anemia is highly prevalent among Chinese adults with newly diagnosed HIV/AIDS, but severe anemia is less prevalent in this population. Older age, lower CD4 count and minority ethnicity are associated with an increased risk of anemia.	[Shen, Yinzhong; Wang, Zhenyan; Lu, Hongzhou; Wang, Jiangrong; Chen, Jun; Liu, Li; Zhang, Renfang; Zheng, Yufang] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Infect Dis, Shanghai 200433, Peoples R China	Fudan University	Lu, HZ (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Infect Dis, Shanghai 200433, Peoples R China.	luhongzhou@fudan.edu.cn	Chen, Jun/K-2085-2012	Chen, Jun/0000-0002-3850-4875	Ministry of Science and Technolgy, the People's Republic of China [2012ZX10001-003, 2011ZX09302-016]	Ministry of Science and Technolgy, the People's Republic of China	This work was supported by Key Research grants from the Ministry of Science and Technolgy, the People's Republic of China (NO: 2012ZX10001-003, 2011ZX09302-016). Website: http://www.most.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastos K, 2004, JAIDS-J ACQ IMM DEF, V35, P383, DOI 10.1097/00126334-200404010-00008; BELLO JL, 1990, AM J HEMATOL, V33, P230, DOI 10.1002/ajh.2830330403; Belperio PS, 2004, AM J MED, V116, P27, DOI 10.1016/j.amjmed.2003.12.010; Berhane K, 2004, JAIDS-J ACQ IMM DEF, V37, P1245, DOI 10.1097/01.qai.0000134759.01684.27; Cleveland RP, 1996, BLOOD, V87, P2275, DOI 10.1182/blood.V87.6.2275.bloodjournal8762275; Erhabor O, 2005, Niger J Med, V14, P33; Gonzalez Lucia, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P485, DOI 10.1016/S2221-1691(12)60081-1; Mata-Marin Jose A, 2010, BMC Res Notes, V3, P230, DOI 10.1186/1756-0500-3-230; Meidani M, 2012, J RES MED SCI, V17, P138; Mildvan D, 2007, CURR MED RES OPIN, V23, P343, DOI 10.1185/030079906X162683; Moore RD, 2002, J ACQ IMMUN DEF SYND, V29, P54, DOI 10.1097/00042560-200201010-00007; Mugisha JO, 2008, TROP MED INT HEALTH, V13, P788, DOI 10.1111/j.1365-3156.2008.02069.x; Munyazesa E, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001600; Omoregie R, 2009, Tanzan J Health Res, V11, P1; Parinitha SS, 2012, AUSTRALAS MED J, V5, P157, DOI [10.4066/AMJ.20121008, 10.4066/AMJ.2012.100]; RICHMAN DD, 1987, NEW ENGL J MED, V317, P192, DOI 10.1056/NEJM198707233170402; Semba RD, 2001, J ACQ IMMUN DEF SYND, V26, P315, DOI 10.1097/00126334-200104010-00003; SPIVAK JL, 1989, JAMA-J AM MED ASSOC, V261, P3104, DOI 10.1001/jama.261.21.3104; Subbaraman R, 2009, INT J STD AIDS, V20, P489, DOI 10.1258/ijsa.2008.008370; Sullivan PS, 1998, BLOOD, V91, P301, DOI 10.1182/blood.V91.1.301.301_301_308; Wills Todd S, 2004, AIDS Read, V14, P305; ZON LI, 1987, BRIT J HAEMATOL, V66, P251, DOI 10.1111/j.1365-2141.1987.tb01307.x	22	23	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73807	10.1371/journal.pone.0073807	http://dx.doi.org/10.1371/journal.pone.0073807			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058490	gold, Green Published, Green Submitted			2022-12-25	WOS:000324695900020
J	Das Roy, P; Sengupta, D; Dasgupta, AK; Kundu, S; Chaudhuri, U; Thakur, I; Guha, P; Majumder, M; Roy, R; Roy, B				Das Roy, Puspita; Sengupta, Dhriti; Dasgupta, Anjan Kr; Kundu, Sudip; Chaudhuri, Utpal; Thakur, Indranil; Guha, Pradipta; Majumder, Mousumi; Roy, Roshni; Roy, Bidyut			Single Nucleotide Polymorphism Network: A Combinatorial Paradigm for Risk Prediction	PLOS ONE			English	Article							INDUCED PLATELET-AGGREGATION; CORONARY-ARTERY-DISEASE; ORAL LEUKOPLAKIA; P2Y(12) RECEPTOR; CANCER; ADP; ACTIVATION; REPAIR; GENE; ASSOCIATION	Risk prediction for a particular disease in a population through SNP genotyping exploits tests whose primary goal is to rank the SNPs on the basis of their disease association. This manuscript reveals a different approach of predicting the risk through network representation by using combined genotypic data (instead of a single allele/haplotype). The aim of this study is to classify diseased group and prediction of disease risk by identifying the responsible genotype. Genotypic combination is chosen from five independent loci present on platelet receptor genes P2RY1 and P2RY12. Genotype-sets constructed from combinations of genotypes served as a network input, the network architecture constituting super-nodes (e. g., case and control) and nodes representing individuals, each individual is described by a set of genotypes containing M markers (M = number of SNP). The analysis becomes further enriched when we consider a set of networks derived from the parent network. By maintaining the super-nodes identical, each network is carrying an independent combination of M-1 markers taken from M markers. For each of the network, the ratio of case specific and control specific connections vary and the ratio of super-node specific connection shows variability. This method of network has also been applied in another case-control study which includes oral cancer, precancer and control individuals to check whether it improves presentation and interpretation of data. The analyses reveal a perfect segregation between super-nodes, only a fraction of mixed state being connected to both the super-nodes (i.e. common genotype set). This kind of approach is favorable for a population to classify whether an individual with a particular genotypic combination can be in a risk group to develop disease. In addition with that we can identify the most important polymorphism whose presence or absence in a population can make a large difference in the number of case and control individuals.	[Das Roy, Puspita; Dasgupta, Anjan Kr] Univ Calcutta, Dept Biochem, Kolkata, W Bengal, India; [Sengupta, Dhriti; Kundu, Sudip] Univ Calcutta, Dept Biophys, Kolkata, W Bengal, India; [Chaudhuri, Utpal] Calcutta Med Coll, Inst Haematol & Transfus Med, Kolkata, W Bengal, India; [Thakur, Indranil; Guha, Pradipta] Calcutta Med Coll, Dept Internal Med, Kolkata, W Bengal, India; [Majumder, Mousumi; Roy, Roshni; Roy, Bidyut] Indian Stat Inst, Human Genet Unit, Kolkata, W Bengal, India	University of Calcutta; University of Calcutta; Indian Statistical Institute; Indian Statistical Institute Kolkata	Dasgupta, AK (corresponding author), Univ Calcutta, Dept Biochem, Kolkata, W Bengal, India.	adgcal@gmail.com	Dasgupta, Anjan/T-5634-2019	Thakur, Indranil/0000-0003-4163-0167; Sengupta, Dhriti/0000-0001-6315-7804	University Grants Commission	University Grants Commission(University Grants Commission, India)	There are no current external funding sources for this study, and the study was conducted entirely by the internal support provided by the University, which in turn is funded by University Grants Commission. The first author also receives a fellowship from the same grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad T, 2011, NAT REV CARDIOL, V8, P560, DOI 10.1038/nrcardio.2011.111; Araujo FD, 2002, ONCOGENE, V21, P4176, DOI 10.1038/sj.onc.1205539; Batagelj V, 2002, P INT S GRAPH DRAW, P8; Cattaneo M, 2003, P NATL ACAD SCI USA, V100, P1978, DOI 10.1073/pnas.0437879100; Elahi A, 2002, CARCINOGENESIS, V23, P1229, DOI 10.1093/carcin/23.7.1229; Fontana P, 2003, CIRCULATION, V108, P989, DOI 10.1161/01.CIR.0000085073.69189.88; FUSTER V, 1992, NEW ENGL J MED, V326, P242, DOI 10.1056/NEJM199201233260406; Gregg D, 2003, CIRCULATION, V108, pE88, DOI 10.1161/01.CIR.0000086897.15588.4B; HEPTINSTALL S, 1977, BRIT J HAEMATOL, V36, P565, DOI 10.1111/j.1365-2141.1977.tb00997.x; Hetherington SL, 2005, ARTERIOSCL THROM VAS, V25, P252, DOI 10.1161/01.ATV.0000148708.44691.27; HJEMDAHL P, 1994, ARTERIOSCLER THROMB, V14, P77, DOI 10.1161/01.ATV.14.1.77; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Jacobson KA, 2011, PURINERG SIGNAL, V7, P305, DOI 10.1007/s11302-011-9216-0; Jin JG, 2002, BLOOD, V99, P193, DOI 10.1182/blood.V99.1.193; Jin JG, 1998, J BIOL CHEM, V273, P2030, DOI 10.1074/jbc.273.4.2030; Kottke-Marchant Kandice, 2009, Cleve Clin J Med, V76 Suppl 1, pS2, DOI 10.3949/ccjm.76.s1.01; Leon C, 1996, GENE, V171, P295, DOI 10.1016/0378-1119(96)00027-3; Majumder M, 2005, CANCER EPIDEM BIOMAR, V14, P2106, DOI 10.1158/1055-9965.EPI-05-0108; Majumder M, 2007, INT J CANCER, V120, P2148, DOI 10.1002/ijc.22547; Moshfegh K, 1999, LANCET, V353, P351, DOI 10.1016/S0140-6736(98)06448-4; Murata M, 1997, CIRCULATION, V96, P3281; O'Donnell CJ, 2001, CIRCULATION, V103, P3051, DOI 10.1161/01.CIR.103.25.3051; Perry Tjorvi E, 2008, Anesthesiol Clin, V26, P399, DOI 10.1016/j.anclin.2008.04.002; Sak SC, 2005, BRIT J CANCER, V92, P2262, DOI 10.1038/sj.bjc.6602616; Storey RF, 2001, PLATELETS, V12, P443, DOI 10.1080/09537100120085450; von Beckerath N, 2005, BLOOD COAGUL FIBRIN, V16, P199, DOI 10.1097/01.mbc.0000164429.21040.0a; Weiss EJ, 1996, NEW ENGL J MED, V334, P1090, DOI 10.1056/NEJM199604253341703	27	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74067	10.1371/journal.pone.0074067	http://dx.doi.org/10.1371/journal.pone.0074067			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040168	Green Submitted, gold, Green Published			2022-12-25	WOS:000326734500069
J	Kumakura, Y; Gjedde, A; Caprioli, D; Kienast, T; Beck, A; Plotkin, M; Schlagenhauf, F; Vernaleken, I; Grunder, G; Bartenstein, P; Heinz, A; Cumming, P				Kumakura, Yoshitaka; Gjedde, Albert; Caprioli, Daniele; Kienast, Thorsten; Beck, Anne; Plotkin, Michail; Schlagenhauf, Florian; Vernaleken, Ingo; Gruender, Gerhard; Bartenstein, Peter; Heinz, Andreas; Cumming, Paul			Increased Turnover of Dopamine in Caudate Nucleus of Detoxified Alcoholic Patients	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; EARLY PARKINSONS-DISEASE; DECARBOXYLASE ACTIVITY; VENTRAL STRIATUM; RECEPTOR AVAILABILITY; HUMAN BRAIN; COGNITIVE PERFORMANCE; SYNTHESIS CAPACITY; STORAGE CAPACITY; HEALTHY-SUBJECTS	A previous study of the DOPA decarboxylase substrate 6-[F-18] fluoro-L-DOPA (FDOPA) with positron emission tomography (PET) detected no difference of the net blood-brain transfer rate (K-in(app)) between detoxified alcoholic patients and healthy controls. Instead, the study revealed an inverse correlation between K-in(app) in left ventral striatum and alcohol craving scores. To resolve the influx and efflux phases of radiolabeled molecules, we independently estimated the unidirectional blood-brain FDOPA clearance rate (K) and the washout rate of [F-18] fluorodopamine and its deaminated metabolites (k(loss)), and we also calculated the total distribution volume of decarboxylated metabolites and unmetabolized FDOPA as a steady-state index of the dopamine storage capacity (V-d) in brain. The craving scores in the 12 alcoholics correlated positively with the rate of loss (k(loss)) in the left ventral striatum. We conclude that craving is most pronounced in the individuals with relatively rapid dopamine turnover in the left ventral striatum. The blood-brain clearance rate (K), corrected for subsequent loss of radiolabeled molecules from brain, was completely normal throughout the brain of the alcoholics, in whom the volume of distribution (V-d) was found to be significantly lower in the left caudate nucleus. The magnitude of V-d in the left caudate head was reduced by 43% relative to the 16 controls, consistent with a 58% increase of k(loss). We interpret the findings as indicating that a trait for rapid dopamine turnover in the ventral striatum subserves craving and reward-dependence, leading to an acquired state of increased dopamine turnover in the dorsal striatum of detoxified alcoholic patients.	[Kumakura, Yoshitaka; Gjedde, Albert] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Kumakura, Yoshitaka; Gjedde, Albert] Aarhus Univ, Ctr Functionally Integrat Neurosci, Aarhus C, Denmark; [Kumakura, Yoshitaka] Univ Tokyo, Dept Nucl Med, Tokyo, Japan; [Caprioli, Daniele] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; [Kienast, Thorsten; Beck, Anne; Schlagenhauf, Florian; Heinz, Andreas] Charite, Dept Psychiat, D-13353 Berlin, Germany; [Plotkin, Michail] Charite, Dept Nucl Med, D-13353 Berlin, Germany; [Vernaleken, Ingo; Gruender, Gerhard] Univ Aachen, Dept Psychiat, Aachen, Germany; [Bartenstein, Peter; Cumming, Paul] Univ Munich, Dept Nucl Med, Munich, Germany	University of Copenhagen; Aarhus University; University of Tokyo; University of Cambridge; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; RWTH Aachen University; University of Munich	Kumakura, Y (corresponding author), Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark.	yoshi.kumakura@gmail.com	Heinz, Andreas/ABB-7736-2020; Gjedde, Albert/U-3751-2019; Caprioli, Daniele/AAA-7536-2019; Gjedde, Albert/I-2452-2019; Schlagenhauf, Florian/AFV-1764-2022	Heinz, Andreas/0000-0001-5405-9065; Gjedde, Albert/0000-0002-3756-7401; Caprioli, Daniele/0000-0001-6198-0776; Cumming, Paul/0000-0002-0257-9621; Schlagenhauf, Florian/0000-0001-8340-5027	University of Mainz; State Rheinland-Pfalz; Denmark's National Science Foundation; Medical Research Council; Strategic International Cooperative Program, Japan Science and Technology Agency (JST)	University of Mainz; State Rheinland-Pfalz; Denmark's National Science Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Strategic International Cooperative Program, Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This research was supported by grants from the University of Mainz and the State Rheinland-Pfalz, and by Denmark's National Science Foundation and Medical Research Council. This research was also supported in part by Strategic International Cooperative Program, Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Boileau I, 2003, SYNAPSE, V49, P226, DOI 10.1002/syn.10226; Braskie MN, 2008, J NEUROSCI, V28, P14320, DOI 10.1523/JNEUROSCI.3729-08.2008; Bruck A, 2005, NEUROBIOL AGING, V26, P891, DOI 10.1016/j.neurobiolaging.2004.07.014; Carbon M, 2004, NEUROIMAGE, V21, P1497, DOI 10.1016/j.neuroimage.2003.12.014; CUMMING P, 1995, J NEUROCHEM, V65, P1381; Cumming P, 2003, NEUROIMAGE, V19, P1127, DOI 10.1016/S1053-8119(03)00079-X; CUMMING P, 1993, J CEREBR BLOOD F MET, V13, P668, DOI 10.1038/jcbfm.1993.85; Cumming P, 2001, SYNAPSE, V41, P212, DOI 10.1002/syn.1077; Cumming P, 2011, BRIT J PHARMACOL, V163, P1586, DOI 10.1111/j.1476-5381.2010.01036.x; Diana M, 2003, ALCOHOL CLIN EXP RES, V27, P354, DOI 10.1097/01.ALC.0000057121.36127.19; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; First M. B., 1997, STRUCTURED CLIN INTE; First MB, 2002, STRUCTURED CLIN INTE; Gillings NM, 2001, NUCL MED BIOL, V28, P97, DOI 10.1016/S0969-8051(00)00187-6; Gilman S, 1998, ANN NEUROL, V44, P326, DOI 10.1002/ana.410440307; GJEDDE A, 1993, J NEUROCHEM, V61, P1538, DOI 10.1111/j.1471-4159.1993.tb13651.x; GJEDDE A, 1991, P NATL ACAD SCI USA, V88, P2721, DOI 10.1073/pnas.88.7.2721; Gjedde A, 2010, P NATL ACAD SCI USA, V107, P3870, DOI 10.1073/pnas.0912319107; Grace AA, 2000, ADDICTION, V95, pS119; Grahn JA, 2009, BEHAV BRAIN RES, V199, P53, DOI 10.1016/j.bbr.2008.11.020; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; Guardia J, 2000, AM J PSYCHIAT, V157, P127, DOI 10.1176/ajp.157.1.127; Haber SN, 2000, J NEUROSCI, V20, P2369; Heinz A, 2005, AM J PSYCHIAT, V162, P1515, DOI 10.1176/appi.ajp.162.8.1515; Heinz A, 2004, AM J PSYCHIAT, V161, P1783, DOI 10.1176/appi.ajp.161.10.1783; HIETALA J, 1994, PSYCHOPHARMACOLOGY, V116, P285, DOI 10.1007/BF02245330; Holden JE, 1997, J NUCL MED, V38, P1568; HolthoffDetto VA, 1997, ARCH NEUROL-CHICAGO, V54, P145, DOI 10.1001/archneur.1997.00550140025008; Howes OD, 2012, ARCH GEN PSYCHIAT, V69, P776, DOI 10.1001/archgenpsychiatry.2012.169; HUANG SC, 1991, J CEREBR BLOOD F MET, V11, P898, DOI 10.1038/jcbfm.1991.155; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Kamarajan C, 2010, J PSYCHIATR RES, V44, P576, DOI 10.1016/j.jpsychires.2009.11.019; Kumakura Y, 2006, J CEREBR BLOOD F MET, V26, P358, DOI 10.1038/sj.jcbfm.9600202; Kumakura Y, 2005, J CEREBR BLOOD F MET, V25, P807, DOI 10.1038/sj.jcbfm.9600079; Kumakura Y, 2004, ACTA NEUROL SCAND, V110, P188, DOI 10.1111/j.1600-0404.2004.00299.x; Kumakura Y, 2007, J NEUROSCI, V27, P8080, DOI 10.1523/JNEUROSCI.0805-07.2007; Kumakura Y, 2010, NEUROIMAGE, V49, P2933, DOI 10.1016/j.neuroimage.2009.11.035; Kumakura Y, 2009, NEUROSCIENTIST, V15, P635, DOI 10.1177/1073858409338217; Kumakura Y, 2010, NEUROBIOL AGING, V31, P447, DOI 10.1016/j.neurobiolaging.2008.05.005; KUWABARA H, 1993, J CEREBR BLOOD F MET, V13, P43, DOI 10.1038/jcbfm.1993.7; Laine TPJ, 1999, MOL PSYCHIATR, V4, P189, DOI 10.1038/sj.mp.4000514; Landau SM, 2009, CEREB CORTEX, V19, P445, DOI 10.1093/cercor/bhn095; Lind NM, 2005, BEHAV BRAIN RES, V164, P172, DOI 10.1016/j.bbr.2005.06.008; Martin-Soelch C, 2011, EUR J NEUROSCI, V33, P1706, DOI 10.1111/j.1460-9568.2011.07642.x; Martinez D, 2005, BIOL PSYCHIAT, V58, P779, DOI 10.1016/j.biopsych.2005.04.044; Mash DC, 1996, NEUROREPORT, V7, P457, DOI 10.1097/00001756-199601310-00020; Nagano-Saito A, 2004, NEUROIMAGE, V22, P553, DOI 10.1016/j.neuroimage.2004.01.030; Oswald LM, 2005, NEUROPSYCHOPHARMACOL, V30, P821, DOI 10.1038/sj.npp.1300667; Repo E, 1999, PSYCHOPHARMACOLOGY, V147, P314, DOI 10.1007/s002130051173; Rominger A, 2011, ADDICTION BIOL; Salokangas RKR, 2000, AM J PSYCHIAT, V157, P632, DOI 10.1176/appi.ajp.157.4.632; See RE, 2007, PSYCHOPHARMACOLOGY, V194, P321, DOI 10.1007/s00213-007-0850-8; Siessmeier T, 2006, EUR J NEUROSCI, V24, P305, DOI 10.1111/j.1460-9568.2006.04903.x; Singleton E, 1994, ALCOHOL CRAVING QUES; SKINNER HA, 1982, J STUD ALCOHOL, V43, P1157, DOI 10.15288/jsa.1982.43.1157; Sossi V, 2001, J CEREBR BLOOD F MET, V21, P469, DOI 10.1097/00004647-200104000-00015; Tiihonen J, 1998, MOL PSYCHIATR, V3, P156, DOI 10.1038/sj.mp.4000365; TIIHONEN J, 1995, NAT MED, V1, P654, DOI 10.1038/nm0795-654; Tupala E, 2003, HUM BRAIN MAPP, V20, P91, DOI 10.1002/hbm.10129; van Beilen M, 2008, PARKINSONISM RELAT D, V14, P224, DOI 10.1016/j.parkreldis.2007.08.011; Vernaleken I, 2006, NEUROIMAGE, V30, P1332, DOI 10.1016/j.neuroimage.2005.11.014; Vernaleken I, 2008, NEUROIMAGE, V40, P1222, DOI 10.1016/j.neuroimage.2007.12.045; Vernaleken I, 2007, HUM BRAIN MAPP, V28, P931, DOI 10.1002/hbm.20325; Volkow ND, 2002, PSYCHIAT RES-NEUROIM, V116, P163, DOI 10.1016/S0925-4927(02)00087-2; Volkow ND, 1996, ALCOHOL CLIN EXP RES, V20, P1594, DOI 10.1111/j.1530-0277.1996.tb05936.x; Volkow ND, 2007, J NEUROSCI, V27, P12700, DOI 10.1523/JNEUROSCI.3371-07.2007; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Weder BJ, 1999, HUM BRAIN MAPP, V8, P1; Weiss F, 2002, J NEUROSCI, V22, P3332	72	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73903	10.1371/journal.pone.0073903	http://dx.doi.org/10.1371/journal.pone.0073903			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040111	Green Published, gold			2022-12-25	WOS:000326734500062
J	Moller, W; Schuschnig, U; Celik, G; Munzing, W; Bartenstein, P; Haussinger, K; Kreyling, WG; Knoch, M; Canis, M; Becker, S				Moeller, Winfried; Schuschnig, Uwe; Celik, Guelnaz; Muenzing, Wolfgang; Bartenstein, Peter; Haeussinger, Karl; Kreyling, Wolfgang G.; Knoch, Martin; Canis, Martin; Becker, Sven			Topical Drug Delivery in Chronic Rhinosinusitis Patients before and after Sinus Surgery Using Pulsating Aerosols	PLOS ONE			English	Article							PARANASAL SINUSES; AIR-FLOW; NASAL POLYPOSIS; INHALATION; MANAGEMENT; DEPOSITION; THERAPY; VENTILATION; CLEARANCE; DEVICES	Objectives: Chronic rhinosinusitis (CRS) is a common chronic disease of the upper airways and has considerable impact on quality of life. Topical delivery of drugs to the paranasal sinuses is challenging, therefore the rate of surgery is high. This study investigates the delivery efficiency of a pulsating aerosol in comparison to a nasal pump spray to the sinuses and the nose in healthy volunteers and in CRS patients before and after sinus surgery. Methods: Tc-99m-DTPA pulsating aerosols were applied in eleven CRSsNP patients without nasal polyps before and after sinus surgery. In addition, pulsating aerosols were studied in comparison to nasal pump sprays in eleven healthy volunteers. Total nasal and frontal, maxillary and sphenoidal sinus aerosol deposition and lung penetration were assessed by anterior and lateral planar gamma camera imaging. Results: In healthy volunteers nasal pump sprays resulted in 100% nasal, non-significant sinus and lung deposition, while pulsating aerosols resulted 61.3+/-8.6% nasal deposition and 38.7% exit the other nostril. 9.7+/-2.0 % of the nasal dose penetrated into maxillary and sphenoidal sinuses. In CRS patients, total nasal deposition was 56.7+/-13.3% and 46.7+/-12.7% before and after sinus surgery, respectively (p<0.01). Accordingly, maxillary and sphenoidal sinus deposition was 4.8+/-2.2% and 8.2+/-3.8% of the nasal dose (p<0.01). Neither in healthy volunteers nor in CRS patients there was significant dose in the frontal sinuses. Conclusion: In contrast to nasal pump sprays, pulsating aerosols can deliver significant doses into posterior nasal spaces and paranasal sinuses, providing alternative therapy options before and after sinus surgery. Patients with chronic lung diseases based on clearance dysfunction may also benefit from pulsating aerosols, since these diseases also manifest in the upper airways.	[Moeller, Winfried; Celik, Guelnaz; Kreyling, Wolfgang G.] Helmholtz Zentrum Munchen, Inst Lung Biol & Dis, Neuherberg, Germany; [Schuschnig, Uwe; Knoch, Martin] PARI Pharma GmbH, BU Pharma, Grafelfing, Germany; [Muenzing, Wolfgang; Bartenstein, Peter] LMU Med Ctr Grosshadern, Dept Nucl Med, Munich, Germany; [Haeussinger, Karl] Asklepios Hosp, Dept Pulm Med, Gauting, Germany; [Canis, Martin] Univ Gottingen, Med Ctr, Dept Otolaryngol, D-37073 Gottingen, Germany; [Becker, Sven] LMU Med Ctr Grosshadern, Dept Otolaryngol Head & Neck Surg, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Gottingen; University of Munich	Moller, W (corresponding author), Helmholtz Zentrum Munchen, Inst Lung Biol & Dis, Neuherberg, Germany.	moeller@helmholtz-muenchen.de	Strebhardt, Klaus/E-8765-2011; Kreyling, rer. nat. Wolfgang G./P-6515-2018; Becker, Sven/AEN-1860-2022; Becker, Sven/AAV-5316-2021	Kreyling, rer. nat. Wolfgang G./0000-0002-0702-6567; Schuschnig, Uwe/0000-0002-7142-3575	Pari GmbH, Starnberg, Germany; Bavarian Research foundation [AZ-914-10]	Pari GmbH, Starnberg, Germany; Bavarian Research foundation	The study was supported by research grants from Pari GmbH, Starnberg, Germany and from the Bavarian Research foundation (AZ-914-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilles N, 2013, CURR ALLERGY ASTHM R, V13, P229, DOI 10.1007/s11882-013-0339-y; [Anonymous], 1994, Ann ICRP, V24, P1; Bachert C, 2003, ALLERGY, V58, P176, DOI 10.1034/j.1398-9995.2003.02172.x; Cochrane MG, 2000, CHEST, V117, P542, DOI 10.1378/chest.117.2.542; Dolovich MB, 2011, LANCET, V377, P1032, DOI 10.1016/S0140-6736(10)60926-9; Eccles R, 2010, CURR MED RES OPIN, V26, P889, DOI 10.1185/03007991003648015; Fasano MB, 2010, CURR OPIN OTOLARYNGO, V18, P15, DOI 10.1097/MOO.0b013e328334aa0e; FOKKENS W, 2007, RHINOL S, V20, P1; FOKKENS WJ, 2012, RHINOLOGY, V50, P1, DOI DOI 10.4193/RHINO12.000; GUILLERM R, 1959, PRESSE MED, V67, P1097; Hamilos DL, 2011, J ALLERGY CLIN IMMUN, V128, P693, DOI 10.1016/j.jaci.2011.08.004; Huang A, 2013, CURR OPIN OTOLARYNGO, V21, P31, DOI 10.1097/MOO.0b013e32835bc4ab; HYO N, 1989, Rhinology (Utrecht), V27, P17; KALENDER WA, 1985, J COMPUT ASSIST TOMO, V9, P524, DOI 10.1097/00004728-198505000-00022; Kauf H., 1968, ARCH KLIN EXPT OHREN, V190, P95; Lai L, 2006, J ASTHMA, V43, P719, DOI 10.1080/02770900600620269; Laube BL, 2011, EUR RESPIR J, V37, P1308, DOI 10.1183/09031936.00166410; Laube BL, 2007, J AEROSOL MED, V20, pS5, DOI 10.1089/jam.2007.0569; Lund Valerie J., 1993, Rhinology (Utrecht), V31, P183; Mainz JG, 2012, CURR ALLERGY ASTHM R, V12, P163, DOI 10.1007/s11882-012-0250-y; Mainz JG, 2011, AURIS NASUS LARYNX, V38, P220, DOI 10.1016/j.anl.2010.09.001; Maniscalco M, 2006, EUR J CLIN INVEST, V36, P509, DOI 10.1111/j.1365-2362.2006.01654.x; Moller W, 2011, RHINOLOGY, V49, P286, DOI 10.4193/Rhino10.268; Moller W, 2011, CURR OPIN OTOLARYNGO, V19, P48, DOI 10.1097/MOO.0b013e3283420f39; Moller W, 2010, OTOLARYNG HEAD NECK, V142, P382, DOI 10.1016/j.otohns.2009.12.028; Moller W, 2009, RHINOLOGY, V47, P405, DOI 10.4193/Rhin08.180; Molimard M, 2005, CURR MED RES OPIN, V21, pS33, DOI 10.1185/030079905X61776; Pleis John R, 2009, Vital Health Stat 10, P1; Sahin-Yilmaz Asli, 2011, Proc Am Thorac Soc, V8, P31, DOI 10.1513/pats.201007-050RN; SCHAPPERT SM, 2008, NATL HLTH STAT REPOR, V8, P1; Shields RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055339; Skretting A, 2009, NUCL MED COMMUN, V30, P629, DOI 10.1097/MNM.0b013e32832c32b3; Suh JD, 2010, CURR OPIN OTOLARYNGO, V18, P27, DOI 10.1097/MOO.0b013e328334f670; Suman JD, 1999, PHARMACEUT RES, V16, P1648, DOI 10.1023/A:1011933410898; Zinreich SJ, 2004, ANN OTO RHINOL LARYN, V113, P19, DOI 10.1177/00034894041130S506	35	39	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74991	10.1371/journal.pone.0074991	http://dx.doi.org/10.1371/journal.pone.0074991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040372	Green Published, gold, Green Submitted			2022-12-25	WOS:000326734500130
J	Fisher, ML; Allen, R; Luo, YQ; Curtiss, R				Fisher, Michael L.; Allen, Rebecca; Luo, Yingqin; Curtiss, Roy, III			Export of Extracellular Polysaccharides Modulates Adherence of the Cyanobacterium Synechocystis	PLOS ONE			English	Article							ESCHERICHIA-COLI; MONOMER COMPOSITION; EPS PRODUCTION; GENE-CLUSTER; FATTY-ACIDS; O-ANTIGENS; LIPOPOLYSACCHARIDE; EXOPOLYSACCHARIDES; PCC-6803; CELL	The field of cyanobacterial biofuel production is advancing rapidly, yet we know little of the basic biology of these organisms outside of their photosynthetic pathways. We aimed to gain a greater understanding of how the cyanobacterium Synechocystis PCC 6803 (Synechocystis, hereafter) modulates its cell surface. Such understanding will allow for the creation of mutants that autoflocculate in a regulated way, thus avoiding energy intensive centrifugation in the creation of biofuels. We constructed mutant strains lacking genes predicted to function in carbohydrate transport or synthesis. Strains with gene deletions of slr0977 (predicted to encode a permease component of an ABC transporter), slr0982 (predicted to encode an ATP binding component of an ABC transporter) and slr1610 (predicted to encode a methyltransferase) demonstrated flocculent phenotypes and increased adherence to glass. Upon bioinformatic inspection, the gene products of slr0977, slr0982, and slr1610 appear to function in O-antigen (OAg) transport and synthesis. However, the analysis provided here demonstrated no differences between OAg purified from wild-type and mutants. However, exopolysaccharides (EPS) purified from mutants were altered in composition when compared to wild-type. Our data suggest that there are multiple means to modulate the cell surface of Synechocystis by disrupting different combinations of ABC transporters and/or glycosyl transferases. Further understanding of these mechanisms may allow for the development of industrially and ecologically useful strains of cyanobacteria. Additionally, these data imply that many cyanobacterial gene products may possess as-yet undiscovered functions, and are meritorious of further study.	[Fisher, Michael L.; Allen, Rebecca; Luo, Yingqin; Curtiss, Roy, III] Arizona State Univ, Ctr Infect Dis & Vaccinol, Biodesign Inst, Tempe, AZ 85287 USA; [Luo, Yingqin] Yeshiva Univ, Albert Einstein Coll Med, Harold & Muriel Block Inst Clin & Translat Res Ei, Res Informat Core, Bronx, NY USA	Arizona State University; Arizona State University-Tempe; Yeshiva University; Albert Einstein College of Medicine	Curtiss, R (corresponding author), Arizona State Univ, Ctr Infect Dis & Vaccinol, Biodesign Inst, Tempe, AZ 85287 USA.	rcurtiss@asu.edu			US Department of Energy Advanced Research Projects Agency-Energy Grant [DE-AR00000011]; ASU Lightworks; Department of Energy [DE-FG02-93ER-20097]	US Department of Energy Advanced Research Projects Agency-Energy Grant; ASU Lightworks; Department of Energy(United States Department of Energy (DOE))	MLF, RA, and YL were supported by US Department of Energy Advanced Research Projects Agency-Energy Grant (DE-AR00000011). MLF and RA recieved additional funding from ASU Lightworks, (http://asulightworks.com/). Carbohydrate analysis was funded in part by the Department of Energy grant number DE-FG02-93ER-20097. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN MM, 1968, J GEN MICROBIOL, V51, P203, DOI 10.1099/00221287-51-2-203; BLOMFIELD IC, 1991, MOL MICROBIOL, V5, P1447, DOI 10.1111/j.1365-2958.1991.tb00791.x; CARLONE GM, 1986, J CLIN MICROBIOL, V24, P330, DOI 10.1128/JCM.24.3.330-332.1986; Chen LZ, 2009, J INTEGR PLANT BIOL, V51, P194, DOI 10.1111/j.1744-7909.2008.00784.x; Cuthbertson L, 2005, J BIOL CHEM, V280, P30310, DOI 10.1074/jbc.M504371200; Cuthbertson L, 2010, MICROBIOL MOL BIOL R, V74, P341, DOI 10.1128/MMBR.00009-10; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07; Hausman BS, 1998, BIOCHEM BIOPH RES CO, V245, P572, DOI 10.1006/bbrc.1998.8423; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; IKEUCHI M, 1991, J BIOL CHEM, V266, P11111; Jittawuttipoka T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055564; Kaneko T, 1997, PLANT CELL PHYSIOL, V38, P1171, DOI 10.1093/oxfordjournals.pcp.a029103; KIDO N, 1995, J BACTERIOL, V177, P2178, DOI 10.1128/jb.177.8.2178-2187.1995; Lan SB, 2010, EUR J SOIL BIOL, V46, P381, DOI 10.1016/j.ejsobi.2010.08.002; Liu XY, 2012, J BIOTECHNOL, V161, P445, DOI 10.1016/j.jbiotec.2012.08.013; Liu XY, 2011, P NATL ACAD SCI USA, V108, P6899, DOI 10.1073/pnas.1103014108; Liu XY, 2011, P NATL ACAD SCI USA, V108, P6905, DOI 10.1073/pnas.1103016108; Liu XY, 2009, P NATL ACAD SCI USA, V106, P21550, DOI 10.1073/pnas.0911953106; Merkle Roberta K., 1994, V230, P1; Micheletti E, 2008, APPL ENVIRON MICROB, V74, P2797, DOI 10.1128/AEM.02212-07; Mohamed HE, 2005, J BACTERIOL, V187, P6883, DOI 10.1128/JB.187.20.6883-6892.2005; Nakao M, 2010, NUCLEIC ACIDS RES, V38, pD379, DOI 10.1093/nar/gkp915; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Ozturk S, 2010, BIORESOURCE TECHNOL, V101, P9742, DOI 10.1016/j.biortech.2010.07.105; Ozturk S, 2010, ENVIRON SCI POLLUT R, V17, P595, DOI 10.1007/s11356-009-0233-2; Ozturk S, 2009, BIORESOURCE TECHNOL, V100, P5588, DOI 10.1016/j.biortech.2009.06.001; PANOFF JM, 1988, ARCH MICROBIOL, V150, P558, DOI 10.1007/BF00408249; Pereira S, 2011, MICROBIOL-SGM, V157, P451, DOI 10.1099/mic.0.041038-0; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; Sambrook J., 2002, MOL CLONING LAB MANU; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; Santander J, 2007, ELECT J BIOTECHN, V10; SCHMIDT W, 1980, ARCH MICROBIOL, V127, P217, DOI 10.1007/BF00427196; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Uduman N, 2010, J RENEW SUSTAIN ENER, V2, DOI 10.1063/1.3294480; Xu XD, 1997, J BACTERIOL, V179, P2884, DOI 10.1128/jb.179.9.2884-2891.1997; Yi EC, 2000, ANALYST, V125, P651, DOI 10.1039/b000368i; York WS, 1985, METHOD ENZYMOL, P3, DOI DOI 10.1016/0076-6879(86)18062-1	42	49	51	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74514	10.1371/journal.pone.0074514	http://dx.doi.org/10.1371/journal.pone.0074514			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040267	gold, Green Published, Green Submitted			2022-12-25	WOS:000327538600097
J	Nachev, V; Stich, KP; Winter, Y				Nachev, Vladislav; Stich, Kai Petra; Winter, York			Weber's Law, the Magnitude Effect and Discrimination of Sugar Concentrations in Nectar-Feeding Animals	PLOS ONE			English	Article							NEAR-MISS; PSYCHOMETRIC FUNCTION; FOOD SELECTION; HUMMINGBIRD; VOLUME; BEE; PSYCHOPHYSICS; POLLINATION; CHOICE; MEMORY	Weber's law quantifies the perception of difference between stimuli. For instance, it can explain why we are less likely to detect the removal of three nuts from a bowl if the bowl is full than if it is nearly empty. This is an example of the magnitude effect - the phenomenon that the subjective perception of a linear difference between a pair of stimuli progressively diminishes when the average magnitude of the stimuli increases. Although discrimination performances of both human and animal subjects in various sensory modalities exhibit the magnitude effect, results sometimes systematically deviate from the quantitative predictions based on Weber's law. An attempt to reformulate the law to better fit data from acoustic discrimination tasks has been dubbed the "near-miss to Weber's law". Here, we tested the gustatory discrimination performance of nectar-feeding bats (Glossophaga soricina), in order to investigate whether the original version of Weber's law accurately predicts choice behavior in a two-alternative forced choice task. As expected, bats either preferred the sweeter of the two options or showed no preference. In 4 out of 6 bats the near-miss to Weber's law provided a better fit and Weber's law underestimated the magnitude effect. In order to test the generality of this observation in nectar-feeders, we reviewed previously published data on bats, hummingbirds, honeybees, and bumblebees. In all groups of animals the near-miss to Weber's law provided better fits than Weber's law. Furthermore, whereas the magnitude effect was stronger than predicted by Weber's law in vertebrates, it was weaker than predicted in insects. Thus nectar-feeding vertebrates and insects seem to differ in how their choice behavior changes as sugar concentration is increased. We discuss the ecological and evolutionary implications of the observed patterns of sugar concentration discrimination.	[Nachev, Vladislav; Winter, York] Humboldt Univ, D-10099 Berlin, Germany; [Stich, Kai Petra] Univ Bielefeld, D-33615 Bielefeld, Germany	Humboldt University of Berlin; University of Bielefeld	Nachev, V (corresponding author), Humboldt Univ, D-10099 Berlin, Germany.	vladislav.nachev@charite.de		Nachev, Vladislav/0000-0003-0521-6153; Winter, York/0000-0002-7828-1872	Volkswagen Foundation	Volkswagen Foundation(Volkswagen)	The research was supported by a grant from the Volkswagen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustin T, 2008, J MATH PSYCHOL, V52, P37, DOI 10.1016/j.jmp.2007.11.001; Augustin T, 2009, MATH SOC SCI, V57, P117, DOI 10.1016/j.mathsocsci.2008.08.003; Baker HG, 1998, BIOTROPICA, V30, P559, DOI 10.1111/j.1744-7429.1998.tb00097.x; BOLTEN AB, 1979, OECOLOGIA, V41, P301, DOI 10.1007/BF00377434; Cnaani J, 2006, ETHOLOGY, V112, P278, DOI 10.1111/j.1439-0310.2006.01174.x; Doble CW, 2003, PSYCHOL REV, V110, P365, DOI 10.1037/0033-295X.110.2.365; Fechner G. T., 1860, ELEMENTE PSYCHOPHYSI; Fleming TH, 2009, ANN BOT-LONDON, V104, P1017, DOI 10.1093/aob/mcp197; Fruend I, 2011, J VISION, V11, DOI 10.1167/11.6.16; HAINSWORTH FR, 1972, COMP BIOCHEM PHYSIOL, V42, P359, DOI 10.1016/0300-9629(72)90117-X; HAINSWORTH FR, 1976, OECOLOGIA, V25, P101, DOI 10.1007/BF00368847; HARDER LD, 1986, OECOLOGIA, V69, P309, DOI 10.1007/BF00377639; HARDER LD, 1987, ECOLOGY, V68, P1104, DOI 10.2307/1938384; Iverson GJ, 2006, J MATH PSYCHOL, V50, P271, DOI 10.1016/j.jmp.2005.11.007; Kacelnik A, 1998, J THEOR BIOL, V194, P289, DOI 10.1006/jtbi.1998.0763; Kim W, 2011, P NATL ACAD SCI USA, V108, P16618, DOI 10.1073/pnas.1108642108; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Kuss M, 2005, J VISION, V5, P478, DOI 10.1167/5.5.8; Livnat A, 2008, J THEOR BIOL, V250, P410, DOI 10.1016/j.jtbi.2007.09.044; MCGILL WJ, 1968, PERCEPT PSYCHOPHYS, V4, P105, DOI 10.3758/BF03209518; Nachev V, 2013, DRYAD DIGITAL REPOSI, DOI DOI 10.5061/DRYAD.0838C; Nachev V, 2013, ANIM COGN, V16, P417, DOI 10.1007/s10071-012-0582-y; Nachev V, 2012, ANIM COGN, V15, P393, DOI 10.1007/s10071-011-0465-7; Nicolson SW, 2003, PLANT SYST EVOL, V238, P139, DOI 10.1007/s00606-003-0276-7; NORWICH KH, 1984, PERCEPT PSYCHOPHYS, V35, P269, DOI 10.3758/BF03205941; Papini MR, 2006, LEARN MOTIV, V37, P357, DOI 10.1016/j.lmot.2006.01.001; Perez SM, 1996, AM ZOOL, V36, P435; Poinar GO, 2006, SCIENCE, V314, P614, DOI 10.1126/science.1134103; PYKE GH, 1981, BIOTROPICA, V13, P260, DOI 10.2307/2387804; R Development Core Team, 2012, R LANG ENV STAT COMP; R Development Core Team, 2009, R FDN STAT COMP; Roberts WM, 1996, ANIM BEHAV, V52, P361; Roces F., 1993, ANIMAL PLANT INTERAC, P159; Rodriguez-Pena N, 2007, J MAMMAL, V88, P1466, DOI 10.1644/06-MAMM-A-353R1.1; Roscher T., 2008, PSYCHOL SCI Q, V50, P469; Sanderson C, 2006, THESIS U TULSA TULSA; Shafir S, 2005, ANIM BEHAV, V69, P859, DOI 10.1016/j.anbehav.2004.07.011; Shafir S, 2008, NATURE, V453, P917, DOI 10.1038/nature06841; Smith SD, 2010, NEW PHYTOL, V188, P354, DOI 10.1111/j.1469-8137.2010.03292.x; STEVENS SS, 1961, SCIENCE, V133, P80, DOI 10.1126/science.133.3446.80; Strasburger H, 2001, PERCEPT PSYCHOPHYS, V63, P1348, DOI 10.3758/BF03194547; Thomson JD, 2008, INT J PLANT SCI, V169, P23, DOI 10.1086/523361; Thurstone LL, 1927, PSYCHOL REV, V34, P273, DOI 10.1037/h0070288; Toelch U, 2007, J COMP PHYSIOL A, V193, P265, DOI 10.1007/s00359-006-0189-3; Treutwein B, 1999, PERCEPT PSYCHOPHYS, V61, P87, DOI 10.3758/BF03211951; Uwer P, 2007, ARXIV07102896; VANHELVERSEN O, 1984, OECOLOGIA, V63, P178, DOI 10.1007/BF00379875; von Frisch K, 1927, NATURWISSENSCHAFTEN, V15, P321; Waldron F.A., 2005, INT J COMP PSYCHOL, V18, P358; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Winter Y, 2005, J EXP BIOL, V208, P539, DOI 10.1242/jeb.01416	51	16	16	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74144	10.1371/journal.pone.0074144	http://dx.doi.org/10.1371/journal.pone.0074144			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040189	gold, Green Published, Green Submitted			2022-12-25	WOS:000327538600071
J	Bjorkenstam, C; Moller, J; Ringback, G; Salmi, P; Hallqvist, J; Ljung, R				Bjorkenstam, Charlotte; Moller, Jette; Ringback, Gunilla; Salmi, Peter; Hallqvist, Johan; Ljung, Rickard			An Association between Initiation of Selective Serotonin Reuptake Inhibitors and Suicide - A Nationwide Register-Based Case-Crossover Study	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; ANTIDEPRESSANT TREATMENT; SUBTHRESHOLD BIPOLARITY; RISK; BEHAVIOR; AGGRESSION; EVENTS; ADULTS	Background: Treatment with selective serotonin reuptake inhibitors (SSRI) is one of the most common treatments for depression. It is however not clear whether or not there is an increased short-term suicide risk during initiation with SSRI. Methods: A register-based nationwide case-crossover study including 5,866 suicides, 1,698 women and 4,168 men, from the Death Register 2007-2010 in Sweden. SSRI initiation was defined as a dispensed prescription of SSRI within 28 days prior to the date of suicide with no previous dispensed prescription of SSRI within 4 months prior that prescription. The control period took place one year earlier. Odds ratio (OR) was estimated using conditional logistic regression. Result: During the 28 day period prior to suicide 48 women and 138 men were exposed to SSRI initiation (while not being exposed in the control period) and 22 women and 43 men were exposed in the control period (while not being exposed in the case period). The OR for suicide after initiation with SSRI was 2.7 (95% CI: 1.6-44) for women, and 4.3 (95% CI: 3.0-6.1) for men. The highest OR was found 8-11 days after initiation with SSRI 9.7 (95% CI: 3.0-31.7) for women and men combined. Conclusion: The main limitation in this study is confounding by indication, but the descriptive question is however not confounded by indication. Together with plausible biological mechanisms and previous clinical and epidemiological observations our findings, linking initiation of SSRI to increased short-term suicide risk, deserve further attention specifically in the clinical setting.	[Bjorkenstam, Charlotte; Moller, Jette] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Bjorkenstam, Charlotte; Ringback, Gunilla; Salmi, Peter] Natl Board Hlth & Welf, Dept Stat Monitoring & Evaluat, Stockholm, Sweden; [Hallqvist, Johan] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Ljung, Rickard] Dept Mol Med & Surg, Stockholm, Sweden	Karolinska Institutet; National Board of Health & Welfare; Uppsala University	Bjorkenstam, C (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.	charlotte.bjorkenstam@ki.se	Ljung, Rickard/E-6752-2011	Moller, Jette/0000-0001-9513-5896; Ljung, Rickard/0000-0002-0654-4530				Angst J, 2010, AM J PSYCHIAT, V167, P1194, DOI 10.1176/appi.ajp.2010.09071011; Bridge JA, 2005, ANN MED, V37, P404, DOI 10.1080/07853890500284937; Courtet P, 2010, NEUROPSYCH DIS TREAT, V6, P3, DOI 10.2147/NDT.S11774; Frankle WG, 2005, AM J PSYCHIAT, V162, P915, DOI 10.1176/appi.ajp.162.5.915; Friedman RA, 2007, NEW ENGL J MED, V356, P2343, DOI 10.1056/NEJMp078015; Geddes JR, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3066; Gibbons RD, 2007, AM J PSYCHIAT, V164, P1044, DOI 10.1176/appi.ajp.164.7.1044; Gibbons RD, 2012, ARCH GEN PSYCHIAT, V69, P580, DOI 10.1001/archgenpsychiatry.2011.2048; Gvion Y, 2011, ARCH SUICIDE RES, V15, P93, DOI 10.1080/13811118.2011.565265; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Harada T, 2008, DEPRESS ANXIETY, V25, P1014, DOI 10.1002/da.20438; Jick H, 2004, JAMA-J AM MED ASSOC, V292, P338, DOI 10.1001/jama.292.3.338; Kato M, 2010, MOL PSYCHIATR, V15, P473, DOI 10.1038/mp.2008.116; Leon AC, 2011, J CLIN PSYCHIAT, V72, P580, DOI 10.4088/JCP.10m06552; Linsley KR, 2001, BRIT J PSYCHIAT, V178, P465, DOI 10.1192/bjp.178.5.465; Ludwig J, 2009, J HEALTH ECON, V28, P659, DOI 10.1016/j.jhealeco.2009.02.002; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Malkesman O, 2009, TRENDS PHARMACOL SCI, V30, P165, DOI 10.1016/j.tips.2009.01.004; MITTLEMAN MA, 1995, AM J EPIDEMIOL, V142, P91, DOI 10.1093/oxfordjournals.aje.a117550; Moller HJ, 2006, EUR ARCH PSY CLIN N, V256, P476, DOI 10.1007/s00406-006-0689-8; Nomura M, 2006, ANN NY ACAD SCI, V1086, P134, DOI 10.1196/annals.1377.004; Olfson M, 2006, ARCH GEN PSYCHIAT, V63, P865, DOI 10.1001/archpsyc.63.8.865; Reutfors J, 2009, J AFFECT DISORDERS, V119, P59, DOI 10.1016/j.jad.2009.02.020; Stone M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2880; the National Board of Health and Welfare, 2011, CAUS DEATHS 2010; TOLLEFSON GD, 1994, J CLIN PSYCHOPHARM, V14, P163; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Witte AV, 2009, HUM BRAIN MAPP, V30, P2558, DOI 10.1002/hbm.20687; Zimmermann P, 2009, ARCH GEN PSYCHIAT, V66, P1341, DOI 10.1001/archgenpsychiatry.2009.158	29	22	22	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73973	10.1371/journal.pone.0073973	http://dx.doi.org/10.1371/journal.pone.0073973			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	244QV	24040131	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300145
J	James, G; Foster, SR; Key, B; Beverdam, A				James, Gregory; Foster, Simon R.; Key, Brian; Beverdam, Annemiek			The Expression Pattern of EVA1C, a Novel Slit Receptor, Is Consistent with an Axon Guidance Role in the Mouse Nervous System	PLOS ONE			English	Article							CINGULATE PIONEERING AXONS; SENSORY NEURON AXONS; GANGLION-CELL AXONS; SPINAL-CORD; ROBO-SLIT; OPTIC CHIASM; MIDLINE; PROTEINS; TRACTS; GROWTH	The Slit/Robo axon guidance families play a vital role in the formation of neural circuitry within select regions of the developing mouse nervous system. Typically Slits signal through the Robo receptors, however they also have Robo-independent functions. The novel Slit receptor Eva-1, recently discovered in C. elegans, and the human orthologue of which is located in the Down syndrome critical region on chromosome 21, could account for some of these Robo independent functions as well as provide selectivity to Robo-mediated axon responses to Slit. Here we investigate the expression of the mammalian orthologue EVA1C in regions of the developing mouse nervous system which have been shown to exhibit Robo-dependent and -independent responses to Slit. We report that EVA1C is expressed by axons contributing to commissures, tracts and nerve pathways of the developing spinal cord and forebrain. Furthermore it is expressed by axons that display both Robo-dependent and -independent functions of Slit, supporting a role for EVA1C in Slit/Robo mediated neural circuit formation in the developing nervous system.	[James, Gregory; Foster, Simon R.; Key, Brian; Beverdam, Annemiek] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia	University of Queensland	Key, B (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.	brian.key@uq.edu.au; A.Beverdam@unsw.edu.au	Foster, Simon R./I-1552-2014; Beverdam, Annemiek/A-2010-2010	Foster, Simon R./0000-0003-3034-1351; Beverdam, Annemiek/0000-0003-4893-0162; Key, Brian/0000-0002-1150-3848; James, Gregory/0000-0001-7569-2513	NHMRC [631598]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by an NHMRC grant, #631598 (http://www.nhmrc.gov.au) to BK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews W, 2006, DEVELOPMENT, V133, P2243, DOI 10.1242/dev.02379; Andrews WD, 2007, J ANAT, V211, P188, DOI 10.1111/j.1469-7580.2007.00750.x; Anitha A, 2008, AM J MED GENET B, V147B, P1019, DOI 10.1002/ajmg.b.30697; Bacon C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019887; Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; Bai G, 2011, CELL, V144, P106, DOI 10.1016/j.cell.2010.11.053; BIFFO S, 1990, EUR J NEUROSCI, V2, P487, DOI 10.1111/j.1460-9568.1990.tb00440.x; Bravo-Ambrosio A, 2012, DEVELOPMENT, V139, P1435, DOI 10.1242/dev.072256; Bulow HE, 2008, CURR BIOL, V18, P1978, DOI 10.1016/j.cub.2008.11.023; Chen Z, 2008, NEURON, V58, P325, DOI 10.1016/j.neuron.2008.02.016; Cheng AW, 2004, DEV NEUROSCI-BASEL, V26, P255, DOI 10.1159/000082142; Cho JH, 2012, DEV BIOL, V371, P269, DOI 10.1016/j.ydbio.2012.08.028; Cho JH, 2007, J NEUROSCI, V27, P9094, DOI 10.1523/JNEUROSCI.2217-07.2007; Conway CD, 2011, J NEUROSCI, V31, P1955, DOI 10.1523/JNEUROSCI.2579-10.2011; Deck M, 2013, NEURON, V77, P472, DOI 10.1016/j.neuron.2012.11.031; Engle EC, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001784; Erskine L, 2000, J NEUROSCI, V20, P4975; Farmer WT, 2008, DEVELOPMENT, V135, P3643, DOI 10.1242/dev.023325; Fisher D, 2011, J NEUROSCI, V31, P14051, DOI 10.1523/JNEUROSCI.1737-11.2011; Fujisawa K, 2007, SCIENCE, V317, P1934, DOI 10.1126/science.1144874; HOLLEY JA, 1982, J COMP NEUROL, V207, P333, DOI 10.1002/cne.902070405; Hussain SA, 2006, J BIOL CHEM, V281, P39693, DOI 10.1074/jbc.M609384200; James G, 2014, BRAIN STRUCT FUNCT, V219, P861, DOI 10.1007/s00429-013-0540-8; Jaworski A, 2010, J NEUROSCI, V30, P9445, DOI 10.1523/JNEUROSCI.6290-09.2010; Jen JC, 2004, SCIENCE, V304, P1509, DOI 10.1126/science.1096437; Kastenhuber E, 2009, J NEUROSCI, V29, P8914, DOI 10.1523/JNEUROSCI.0568-09.2009; KEY B, 1991, NEURON, V6, P381, DOI 10.1016/0896-6273(91)90247-W; KOESTER SE, 1994, J NEUROSCI, V14, P6608; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Lopez-Bendito G, 2007, J NEUROSCI, V27, P3395, DOI 10.1523/JNEUROSCI.4605-06.2007; Ma L, 2007, J NEUROSCI, V27, P6843, DOI 10.1523/JNEUROSCI.1479-07.2007; Mambetisaeva ET, 2005, DEV DYNAM, V233, P41, DOI 10.1002/dvdy.20324; Mitsunaga K, 2009, J BIOCHEM, V146, P369, DOI 10.1093/jb/mvp079; Nguyen-Ba-Charvet KT, 2008, J NEUROSCI, V28, P4244, DOI 10.1523/JNEUROSCI.5671-07.2008; Niclou SP, 2000, J NEUROSCI, V20, P4962; Olson LE, 2007, HUM MOL GENET, V16, P774, DOI 10.1093/hmg/ddm022; Patel K, 2001, DEVELOPMENT, V128, P5031; Petros TJ, 2008, ANNU REV NEUROSCI, V31, P295, DOI 10.1146/annurev.neuro.31.060407.125609; Piper M, 2009, CEREB CORTEX, V19, pI11, DOI 10.1093/cercor/bhp027; Plachez C, 2008, MOL CELL NEUROSCI, V37, P719, DOI 10.1016/j.mcn.2007.12.017; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Pratt T, 2006, J NEUROSCI, V26, P6911, DOI 10.1523/JNEUROSCI.0505-06.2006; Rash BG, 2001, J COMP NEUROL, V434, P147, DOI 10.1002/cne.1170; Saitsu H, 2012, AM J MED GENET A, V158A, P199, DOI 10.1002/ajmg.a.34363; Sakai N, 2012, J NEUROSCI, V32, P15377, DOI 10.1523/JNEUROSCI.2225-12.2012; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Seron-Ferre Maria, 2007, Birth Defects Research, V81, P204, DOI 10.1002/bdrc.20101; SILVER J, 1982, J COMP NEUROL, V210, P10, DOI 10.1002/cne.902100103; St John JA, 2013, NEUROSCI LETT, V545, P11, DOI 10.1016/j.neulet.2013.04.009; Sundaresan V, 2004, J COMP NEUROL, V468, P467, DOI 10.1002/cne.10984; Takahashi H, 2012, NAT NEUROSCI, V15, P389, DOI 10.1038/nn.3040; Thompson H, 2006, DEV BIOL, V296, P476, DOI 10.1016/j.ydbio.2006.06.017; Treloar HB, 1999, J COMP NEUROL, V413, P289; Unni DK, 2012, DEV BIOL, V365, P36, DOI 10.1016/j.ydbio.2012.02.004; WOLFER DP, 1994, J COMP NEUROL, V345, P1, DOI 10.1002/cne.903450102; Yamagishi S, 2011, EMBO J, V30, P2920, DOI 10.1038/emboj.2011.189; Ypsilanti AR, 2010, DEVELOPMENT, V137, P1939, DOI 10.1242/dev.044511; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371	58	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74115	10.1371/journal.pone.0074115	http://dx.doi.org/10.1371/journal.pone.0074115			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040182	Green Submitted, Green Published, gold			2022-12-25	WOS:000326405300157
J	Lamarque, LJ; Porte, AJ; Eymeric, C; Lasnier, JB; Lortie, CJ; Delzon, S				Lamarque, Laurent J.; Porte, Annabel J.; Eymeric, Camille; Lasnier, Jean-Baptiste; Lortie, Christopher J.; Delzon, Sylvain			A Test for Pre-Adapted Phenotypic Plasticity in the Invasive Tree Acer negundo L	PLOS ONE			English	Article							SEEDLING GROWTH; INTRODUCED POPULATIONS; TARAXACUM-OFFICINALE; PLANT INVASIVENESS; PURPLE LOOSESTRIFE; BIOMASS ALLOCATION; GENETIC-VARIATION; LIGHT; TRAITS; PHOTOSYNTHESIS	Phenotypic plasticity is a key mechanism associated with the spread of exotic plants and previous studies have found that invasive species are generally more plastic than co-occurring species. Comparatively, the evolution of phenotypic plasticity in plant invasion has received less attention, and in particular, the genetic basis of plasticity is largely unexamined. Native from North America, Acer negundo L. is aggressively impacting the riparian forests of southern and eastern Europe thanks to higher plasticity relative to co-occurring native species. We therefore tested here whether invasive populations have evolved increased plasticity since introduction. The performance of 1152 seedlings from 8 native and 8 invasive populations was compared in response to nutrient availability. Irrespective of nutrients, invasive populations had higher growth and greater allocation to above-ground biomass relative to their native conspecifics. More importantly, invasive genotypes did not show increased plasticity in any of the 20 traits examined. This result suggests that the high magnitude of plasticity to nutrient variation of invasive seedlings might be pre-adapted in the native range. Invasiveness of A. negundo could be explained by higher mean values of traits due to genetic differentiation rather than by evolution of increased plasticity.	[Lamarque, Laurent J.; Lortie, Christopher J.] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Lamarque, Laurent J.; Porte, Annabel J.; Eymeric, Camille; Lasnier, Jean-Baptiste; Delzon, Sylvain] Univ Bordeaux, UMR BIOGECO 1202, Talence, France; [Lamarque, Laurent J.; Porte, Annabel J.; Eymeric, Camille; Lasnier, Jean-Baptiste; Delzon, Sylvain] INRA, UMR BIOGECO 1202, Cestas, France	York University - Canada; UDICE-French Research Universities; Universite de Bordeaux; INRAE	Lamarque, LJ (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada.	llamarqueab@gmail.com	lortie, christopher j/F-6241-2014; Delzon, Sylvain/R-9538-2018	lortie, christopher j/0000-0002-4291-7023; Delzon, Sylvain/0000-0003-3442-1711	NSERC DG; Canada Foundation for Innovation	NSERC DG(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This research was supported by NSERC DG and Canada Foundation for Innovation grant to CJL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SAS MIXED MODELS; BAKER H. G., 1965, The genetics of colonizing species: Proc. 1st Internat, Union biol Sci., Asilomar, California., P147; Bastlova D, 2002, FLORA, V197, P332, DOI 10.1078/0367-2530-00049; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Bossdorf O, 2008, DIVERS DISTRIB, V14, P676, DOI 10.1111/j.1472-4642.2008.00471.x; Burns JH, 2006, BIOL INVASIONS, V8, P797, DOI 10.1007/s10530-005-3838-5; Castro-Diez P, 2009, BIOL INVASIONS, V11, P1973, DOI 10.1007/s10530-008-9374-3; Chun YJ, 2007, ECOLOGY, V88, P1499, DOI 10.1890/06-0856; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Dawson W, 2012, NEW PHYTOL, V194, P859, DOI 10.1111/j.1469-8137.2012.04104.x; Delmas CEL, 2011, COMMUNITY ECOL, V12, P171, DOI 10.1556/ComEc.12.2011.2.4; DeWalt SJ, 2004, OECOLOGIA, V138, P521, DOI 10.1007/s00442-003-1462-6; Dewine JM, 2008, J APPL ECOL, V45, P505, DOI 10.1111/j.1365-2664.2007.01440.x; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Droste T, 2010, PLANT ECOL, V207, P297, DOI 10.1007/s11258-009-9673-5; Erfmeier A, 2011, BIOL INVASIONS, V13, P1599, DOI 10.1007/s10530-010-9917-2; Feng YL, 2011, J ECOL, V99, P1116, DOI 10.1111/j.1365-2745.2011.01843.x; Feng YL, 2009, P NATL ACAD SCI USA, V106, P1853, DOI 10.1073/pnas.0808434106; Flory SL, 2011, ECOLOGY, V92, P2248, DOI 10.1890/11-0363.1; Franks SJ, 2008, AM NAT, V171, P678, DOI 10.1086/587078; Funk JL, 2008, J ECOL, V96, P1162, DOI 10.1111/j.1365-2745.2008.01435.x; Funk JL, 2010, BIOL INVASIONS, V12, P1685, DOI 10.1007/s10530-009-9581-6; Godoy O, 2012, NEW PHYTOL, V195, P912, DOI 10.1111/j.1469-8137.2012.04205.x; Godoy O, 2011, FUNCT ECOL, V25, P1248, DOI 10.1111/j.1365-2435.2011.01886.x; Gonzalez AV, 2004, ACTA OECOL, V26, P185, DOI 10.1016/j.actao.2004.05.001; Grotkopp E, 2002, AM NAT, V159, P396, DOI 10.1086/338995; Grotkopp E, 2007, AM J BOT, V94, P526, DOI 10.3732/ajb.94.4.526; Guesewell S, 2006, FUNCT ECOL, V20, P575, DOI 10.1111/j.1365-2435.2006.01141.x; He WM, 2010, BIOL INVASIONS, V12, P3591, DOI 10.1007/s10530-010-9753-4; Hillstrom C, 2011, INT J PLANT SCI, V172, P763, DOI 10.1086/660103; Huang W, 2010, J ECOL, V98, P1157, DOI 10.1111/j.1365-2745.2010.01704.x; Kaufman SR, 2001, OECOLOGIA, V127, P487, DOI 10.1007/s004420000621; Kowarik I., 2003, BIOL INVASIONEN NEOP; Lamarque LJ, 2012, ECOGRAPHY, V35, P803, DOI 10.1111/j.1600-0587.2011.07300.x; Lamarque LJ, 2011, BIOL INVASIONS, V13, P1969, DOI 10.1007/s10530-011-0015-x; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Leger EA, 2003, ECOL LETT, V6, P257, DOI 10.1046/j.1461-0248.2003.00423.x; Lei YB, 2011, BIOL INVASIONS, V13, P2703, DOI 10.1007/s10530-011-9940-y; Little E., 1971, CONIFERS IMPORTANT H, V1; Little EL, 1979, CHECKLIST US TREES N; Lorenzo P, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2009082; MAEGLIN RR, 1973, B TORREY BOT CLUB, V100, P357, DOI 10.2307/2484104; Maestre FT, 2007, PLANT SOIL, V296, P53, DOI 10.1007/s11104-007-9289-2; Matesanz S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044955; Medrzycki P, 2007, NOBANIS INVASIVE ALI; Molina-Montenegro MA, 2011, PLANT ECOL DIVERS, V4, P37, DOI 10.1080/17550874.2011.577459; Molina-Montenegro MA, 2010, BIOL INVASIONS, V12, P2277, DOI 10.1007/s10530-009-9638-6; Mozdzer TJ, 2010, J ECOL, V98, P451, DOI 10.1111/j.1365-2745.2009.01625.x; Niinemets U, 2003, PLANT CELL ENVIRON, V26, P941, DOI 10.1046/j.1365-3040.2003.01027.x; Pan XY, 2006, ACTA OECOL, V30, P333, DOI 10.1016/j.actao.2006.03.003; Paquette A, 2012, TREE PHYSIOL, V32, P1339, DOI 10.1093/treephys/tps092; Pattison RR, 1998, OECOLOGIA, V117, P449, DOI 10.1007/s004420050680; Peperkorn R, 2005, FUNCT PLANT BIOL, V32, P933, DOI 10.1071/FP04197; Pigliucci M., 2001, SYN ECO EVO; PINAY G, 1993, J APPL ECOL, V30, P581, DOI 10.2307/2404238; Pinay G, 2000, BIOGEOCHEMISTRY, V50, P163, DOI 10.1023/A:1006317004639; Pintado A, 1997, ANN BOT-LONDON, V80, P345, DOI 10.1006/anbo.1997.0453; PlantyTabacchi AM, 1996, CONSERV BIOL, V10, P598, DOI 10.1046/j.1523-1739.1996.10020598.x; Porte Annabel J., 2011, BMC Ecology, V11, P28, DOI 10.1186/1472-6785-11-28; Portsmuth A, 2007, FUNCT ECOL, V21, P61, DOI 10.1111/j.1365-2435.2006.01208.x; Pysek Petr, 2007, V193, P97; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Rothmaler W, 1984, EXKURSIONSFLORA GEBI; Salazar A, 2012, J ECOL, V100, P1411, DOI 10.1111/j.1365-2745.2012.02028.x; Sanchez-Gomez D, 2006, TREE PHYSIOL, V26, P1425, DOI 10.1093/treephys/26.11.1425; Sayer EJ, 2006, BIOL REV, V81, P1, DOI 10.1017/S1464793105006846; Schlaepfer DR, 2010, NEW PHYTOL, V185, P1087, DOI 10.1111/j.1469-8137.2009.03114.x; SCHLICHTING CD, 1986, ANNU REV ECOL SYST, V17, P667, DOI 10.1146/annurev.es.17.110186.003315; Schumacher E, 2009, BIOL INVASIONS, V11, P1941, DOI 10.1007/s10530-008-9371-6; Sexton JP, 2002, ECOL APPL, V12, P1652, DOI 10.1890/1051-0761(2002)012[1652:PAGDMA]2.0.CO;2; Shustack DP, 2009, BIOL INVASIONS, V11, P1357, DOI 10.1007/s10530-008-9343-x; Siemann E, 2001, ECOL LETT, V4, P514, DOI 10.1046/j.1461-0248.2001.00274.x; Skalova H, 2012, ANN BOT-LONDON, V110, P1429, DOI 10.1093/aob/mcr316; Sultan SE, 2001, ECOLOGY, V82, P328, DOI 10.1890/0012-9658(2001)082[0328:PPFFCI]2.0.CO;2; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Tabacchi E, 2003, RIVER RES APPL, V19, P251, DOI 10.1002/rra.755; Valladares F, 2000, ECOLOGY, V81, P1925, DOI 10.1890/0012-9658(2000)081[1925:PPRTLO]2.0.CO;2; Valladares F, 2006, J ECOL, V94, P1103, DOI 10.1111/j.1365-2745.2006.01176.x; van Kleunen M, 2011, J BIOGEOGR, V38, P1294, DOI 10.1111/j.1365-2699.2011.02495.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; van Wilgen NJ, 2011, DIVERS DISTRIB, V17, P172, DOI 10.1111/j.1472-4642.2010.00717.x; Ward JK, 2002, TREE PHYSIOL, V22, P339, DOI 10.1093/treephys/22.5.339; Werner C, 2010, PLANT ECOL, V206, P83, DOI 10.1007/s11258-009-9625-0; Williams JL, 2008, OECOLOGIA, V157, P239, DOI 10.1007/s00442-008-1075-1; Wolkovich EM, 2011, FRONT ECOL ENVIRON, V9, P287, DOI 10.1890/100033; Xu CY, 2007, OECOLOGIA, V154, P11, DOI 10.1007/s00442-007-0807-y; Yamashita N, 2002, PLANT CELL ENVIRON, V25, P1341, DOI 10.1046/j.1365-3040.2002.00907.x; Zhao YJ, 2010, HYDROBIOLOGIA, V637, P143, DOI 10.1007/s10750-009-9992-5; Zou J, 2007, FUNCT ECOL, V21, P721, DOI 10.1111/j.1365-2435.2007.01298.x; Zou JW, 2009, BASIC APPL ECOL, V10, P79, DOI 10.1016/j.baae.2007.11.010	90	25	26	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74239	10.1371/journal.pone.0074239	http://dx.doi.org/10.1371/journal.pone.0074239			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040212	gold, Green Published			2022-12-25	WOS:000326405300167
J	Martinez, G; Perez, DS; Soraci, AL; Tapia, MO				Martinez, Guadalupe; Perez, Denisa S.; Soraci, Alejandro L.; Tapia, Maria O.			Penetration of Fosfomycin into IPEC-J2 Cells in the Presence or Absence of Deoxynivalenol	PLOS ONE			English	Article							FUSARIUM-TOXIN DEOXYNIVALENOL; INTESTINAL EPITHELIAL-CELLS; BACTERICIDAL ACTIVITY; DISODIUM-FOSFOMYCIN; CONTAMINATED WHEAT; LINES IPEC-1; IN-VITRO; MYCOTOXINS; PHARMACOKINETICS; DON	Fosfomycin (FOS) is an antibiotic used in pig farms for treatment and prevention of infections caused by resistant bacteria during the post-weaning period. Antibiotics and non-toxic concentrations of mycotoxins, such as deoxynivalenol (DON) are frequently found in the diet of animals. These compounds can establish interactions in the intestinal tract, which could affect and/or modify the penetration of FOS to enterocytes. The aim of this study was to determine the penetration of FOS into IPECJ-2 cells, a cell line derived from the small intestine of piglets, in the presence and absence of DON. The results from this study showed that there was statistically significant difference in the intracellular concentration of FOS between cells incubated with 580 mu g/ml FOS and cells incubated with 580 mu g/ml FOS and 1 mg/ml DON. The C-max of the intracellular antibiotic in the culture plates incubated with FOS in absence of DON was 45.81 mu g/ml with a t(max) of 4 h. When IPEC-2 cells were incubated with FOS and DON the C-max was 20.06 mu g/ml and the t(max) was 30 min. It is concluded that the non-toxic concentration of DON on IPEC-J2 cells after short-term exposure, interferes with the pharmacokinetics of the antibiotic.	[Martinez, Guadalupe; Perez, Denisa S.; Soraci, Alejandro L.; Tapia, Maria O.] Ctr Invest Vet Tandil CIVETAN CONICET FCV, Tandil, Buenos Aires, Argentina; [Martinez, Guadalupe; Perez, Denisa S.; Soraci, Alejandro L.; Tapia, Maria O.] Univ Nacl Ctr Prov Buenos Aires, Lab Toxicol, Fac Ciencias Vet, Tandil, Buenos Aires, Argentina	Comision Nacional de Energia Atomica (CNEA)	Martinez, G (corresponding author), Ctr Invest Vet Tandil CIVETAN CONICET FCV, Tandil, Buenos Aires, Argentina.	guadam@vet.unicen.edu.ar						Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; Awad WA, 2007, POULTRY SCI, V86, P15, DOI 10.1093/ps/86.1.15; Roige MB, 2009, REV IBEROAM MICOL, V26, P233, DOI 10.1016/j.riam.2009.03.003; BERGSJO B, 1992, J VET MED A, V39, P752, DOI 10.1111/j.1439-0442.1992.tb00240.x; BORSA F, 1988, ANTIMICROB AGENTS CH, V32, P938, DOI 10.1128/AAC.32.6.938; Bouhet S, 2005, VET IMMUNOL IMMUNOP, V108, P199, DOI 10.1016/j.vetimm.2005.08.010; Bouhet S, 2006, FOOD CHEM TOXICOL, V44, P1768, DOI 10.1016/j.fct.2006.05.018; Brosnahan AJ, 2012, VET MICROBIOL, V156, P229, DOI 10.1016/j.vetmic.2011.10.017; Danicke S, 2010, FOOD CHEM TOXICOL, V48, P2154, DOI 10.1016/j.fct.2010.05.022; Danicke S, 2012, FOOD CHEM TOXICOL, V50, P979, DOI 10.1016/j.fct.2011.12.024; Danicke S, 2006, TOXICOL LETT, V165, P297, DOI 10.1016/j.toxlet.2006.05.006; Davis SS, 2001, J PHARM PHARMACOL, V53, P33, DOI 10.1211/0022357011775163; Diesing AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034136; Diesing AK, 2011, TOXICOL LETT, V200, P8, DOI 10.1016/j.toxlet.2010.10.006; Eriksen GS, 2004, ANIM FEED SCI TECH, V114, P205, DOI 10.1016/j.anifeedsci.2003.08.008; Falagas ME, 2008, CLIN INFECT DIS, V46, P1069, DOI 10.1086/527442; FAO/WHO Expert Committee on Food Additives, 2001, WHO TECHN REP SER, V906, P35; Gattringer R, 2006, J ANTIMICROB CHEMOTH, V58, P367, DOI 10.1093/jac/dkl251; Geens MM, 2011, CYTOTECHNOLOGY, V63, P415, DOI 10.1007/s10616-011-9362-9; Gobernado M, 2003, Rev Esp Quimioter, V16, P15; Goyarts T, 2006, TOXICOL LETT, V163, P171, DOI 10.1016/j.toxlet.2005.10.007; Gupta RC, 2012, VET TOXICOL, P1254; Gutierrez OL, 2008, RES VET SCI, V85, P156, DOI 10.1016/j.rvsc.2007.08.011; HOGER PH, 1985, PEDIATR RES, V19, P38; ISHIZAWA T, 1990, J PHARMACOBIO-DYNAM, V13, P292, DOI 10.1248/bpb1978.13.292; ISHIZAWA T, 1991, J PHARMACOBIO-DYNAM, V14, P583, DOI 10.1248/bpb1978.14.583; ISHIZAWA T, 1991, J PHARMACOBIO-DYNAM, V14, P82, DOI 10.1248/bpb1978.14.82; ISHIZAWA T, 1992, J PHARMACOBIO-DYNAM, V15, P481, DOI 10.1248/bpb1978.15.481; KAHAN FM, 1974, ANN NY ACAD SCI, V235, P364, DOI 10.1111/j.1749-6632.1974.tb43277.x; Kiem S, 2008, ANTIMICROB AGENTS CH, V52, P24, DOI 10.1128/AAC.00133-06; Kim JC, 2012, ANIM FEED SCI TECH, V173, P3, DOI 10.1016/j.anifeedsci.2011.12.022; Lawlor PG, 2001, IRISH VET J, V54, P172; Maresca M, 2002, J NUTR, V132, P2723, DOI 10.1093/jn/132.9.2723; Mariani V, 2009, VET IMMUNOL IMMUNOP, V131, P278, DOI 10.1016/j.vetimm.2009.04.006; Martinez G, 2011, ANALEC VET, V31, P23; MATA JM, 1977, CHEMOTHERAPY, V23, P23, DOI 10.1159/000222022; Monbaliu S, 2010, J AGR FOOD CHEM, V58, P66, DOI 10.1021/jf903859z; Oswald IP, 2006, VET RES, V37, P359, DOI 10.1051/vetres:2006006; Oswald IP, 2005, FOOD ADDIT CONTAM A, V22, P354, DOI 10.1080/02652030500058320; Perez DS, 2013, IJAVMS IN PRESS; Pestka JJ, 2008, TOXICOL SCI, V104, P4, DOI 10.1093/toxsci/kfm284; Pestka JJ, 2007, ANIM FEED SCI TECH, V137, P283, DOI 10.1016/j.anifeedsci.2007.06.006; Pinton P, 2009, TOXICOL APPL PHARM, V237, P41, DOI 10.1016/j.taap.2009.03.003; POLLMANN DS, 1985, J ANIM SCI, V60, P239, DOI 10.2527/jas1985.601239x; Popovic M, 2010, EUR J CLIN MICROBIOL, V29, P127, DOI 10.1007/s10096-009-0833-2; ROTTER BA, 1994, FUND APPL TOXICOL, V23, P117, DOI 10.1006/faat.1994.1087; Ruckebusch Y, 1981, PHYSL PHARM THERAPEU; Sauermann R, 2005, ANTIMICROB AGENTS CH, V49, P4448, DOI 10.1128/AAC.49.11.4448-4454.2005; Schierack P, 2006, HISTOCHEM CELL BIOL, V125, P293, DOI 10.1007/s00418-005-0067-z; Soraci AL, 2011, RES VET SCI, V90, P498, DOI 10.1016/j.rvsc.2010.07.011; Steffansen B, 2004, EUR J PHARM SCI, V21, P3, DOI 10.1016/j.ejps.2003.10.010; Tamai I, 1996, ADV DRUG DELIVER REV, V20, P5, DOI 10.1016/0169-409X(95)00128-T; TRAUB WH, 1983, CHEMOTHERAPY, V29, P48, DOI 10.1159/000238173; TRAUTMANN M, 1992, INFECTION, V20, P350, DOI 10.1007/BF01710683; Vandenbroucke V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023871	56	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e75068	10.1371/journal.pone.0075068	http://dx.doi.org/10.1371/journal.pone.0075068			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040387	Green Published, Green Submitted, gold			2022-12-25	WOS:000324856500103
J	Di Bartolo, BA; Cartland, SP; Harith, HH; Bobryshev, YV; Schoppet, M; Kavurma, MM				Di Bartolo, Belinda A.; Cartland, Sian P.; Harith, Hanis H.; Bobryshev, Yuri V.; Schoppet, Michael; Kavurma, Mary M.			TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKL	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; KAPPA-B LIGAND; APOPTOSIS-INDUCING LIGAND; CORONARY-ARTERY-DISEASE; SERUM OSTEOPROTEGERIN LEVELS; CHONDROCYTE-LIKE CELLS; MATRIX GLA PROTEIN; RECEPTOR ACTIVATOR; OSTEOCLASTIC DIFFERENTIATION; OSTEOBLAST DIFFERENTIATION	The osteoprotegerin (OPG) and receptor activator of nuclear factor-kappa B ligand (RANKL) cytokine system, not only controls bone homeostasis, but has been implicated in regulating vascular calcification. TNF-related apoptosis-inducing ligand (TRAIL) is a second ligand for OPG, and although its effect in vascular calcification in vitro is controversial, its role in vivo is not yet established. This study aimed to investigate the role of TRAIL in vascular calcification in vitro using vascular smooth muscle cells (VSMCs) isolated from TRAIL(-/-) and wild-type mice, as well as in vivo, in advanced atherosclerotic lesions of TRAIL(-/-) ApoE(-/-) mice. The involvement of OPG and RANKL in this process was also examined. TRAIL dose-dependently inhibited calcium-induced calcification of human VSMCs, while TRAIL(-/-) VSMCs demonstrated accelerated calcification induced by multiple concentrations of calcium compared to wild-type cells. Consistent with this, RANKL mRNA was significantly elevated with 24 h calcium treatment, while OPG and TRAIL expression in human VSMCs was inhibited. Brachiocephalic arteries from TRAIL(-/-) ApoE(-/-) and ApoE(-/-) mice fed a high fat diet for 12 w demonstrated increased chondrocyte-like cells in atherosclerotic plaque, as well as increased aortic collagen II mRNA expression in TRAIL(-/-) ApoE(-/-) mice, with significant increases in calcification observed at 20 w. TRAIL(-/-) ApoE(-/-) aortas also had significantly elevated RANKL, BMP-2, IL-1 beta, and PPAR-gamma expression at 12 w. Our data provides the first evidence that TRAIL deficiency results in accelerated cartilaginous metaplasia and calcification in atherosclerosis, and that TRAIL plays an important role in the regulation of RANKL and inflammatory markers mediating bone turn over in the vasculature.	[Di Bartolo, Belinda A.; Cartland, Sian P.; Harith, Hanis H.; Kavurma, Mary M.] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia; [Harith, Hanis H.; Bobryshev, Yuri V.; Kavurma, Mary M.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Harith, Hanis H.] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Biomed Sci, Serdang 43400, Malaysia; [Schoppet, Michael] Univ Marburg, Dept Internal Med & Cardiol, Marburg, Germany	University of New South Wales Sydney; University of New South Wales Sydney; Universiti Putra Malaysia; Philipps University Marburg	Kavurma, MM (corresponding author), Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia.	m.kavurma@unsw.edu.au	Di Bartolo, Belinda/AAF-5153-2021	Cartland, Sian/0000-0003-1723-2679; Kavurma, Mary/0000-0001-7353-0932; Harith, Hanis/0000-0001-7066-8119; Di Bartolo, Belinda/0000-0001-8420-0461	NHMRC [568627]; Heart Foundation of Australia	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Heart Foundation of Australia(National Heart Foundation of Australia)	This project was supported by NHMRC Project Grant 568627. MMK is supported by a Heart Foundation of Australia Career Development Fellowship. BAD is supported by an NHMRC Early Career Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Fakhri N, 2005, THROMB HAEMOSTASIS, V94, P1335, DOI 10.1160/TH05-06-1335; Allison MA, 2004, ARTERIOSCL THROM VAS, V24, P331, DOI 10.1161/01.ATV.0000110786.02097.0c; Azahri NSM, 2013, CELL MOL LIFE SCI, V70, P3617, DOI 10.1007/s00018-013-1264-x; Azahri NSM, 2012, J CELL BIOCHEM, V113, P2597, DOI 10.1002/jcb.24135; Azijli K, 2013, CELL DEATH DIFFER, V20, P858, DOI 10.1038/cdd.2013.28; Bobryshev YV, 2005, J PATHOL, V205, P641, DOI 10.1002/path.1743; Braam LAJLM, 2000, ARTERIOSCL THROM VAS, V20, P1257, DOI 10.1161/01.ATV.20.5.1257; Breuil V, 2003, FASEB J, V17, P1751, DOI 10.1096/fj.02-1188fje; Browner WS, 2001, J CLIN ENDOCR METAB, V86, P631, DOI 10.1210/jc.86.2.631; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Byon CH, 2011, ARTERIOSCL THROM VAS, V31, P1387, DOI 10.1161/ATVBAHA.110.222547; Chan J, 2010, CIRC RES, V106, P1061, DOI 10.1161/CIRCRESAHA.109.206029; Chasseraud M, 2011, THER APHER DIAL, V15, P140, DOI 10.1111/j.1744-9987.2010.00886.x; Collin-Osdoby P, 2004, CIRC RES, V95, P1046, DOI 10.1161/01.RES.0000149165.99974.12; Collin-Osdoby P, 2001, J BIOL CHEM, V276, P20659, DOI 10.1074/jbc.M010153200; DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306; Di Bartolo BA, 2011, DIABETOLOGIA, V54, P3157, DOI 10.1007/s00125-011-2308-0; Di Bartolo BA, 2011, CARDIOVASC RES, V91, P537, DOI 10.1093/cvr/cvr084; Doehring LC, 2010, AM J PATHOL, V177, P473, DOI 10.2353/ajpath.2010.090758; Doherty TM, 2003, P NATL ACAD SCI USA, V100, P11201, DOI 10.1073/pnas.1932554100; Duer MJ, 2008, ARTERIOSCL THROM VAS, V28, P2030, DOI 10.1161/ATVBAHA.108.172387; Fu MG, 2002, BIOCHEM BIOPH RES CO, V294, P597, DOI 10.1016/S0006-291X(02)00533-8; Goldring SR, 2004, CLIN ORTHOP RELAT R, pS27, DOI 10.1097/01.blo.0000144854.66565.8f; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Hameed AG, 2012, J EXP MED, V209, P1919, DOI 10.1084/jem.20112716; Helas S, 2009, AM J PATHOL, V175, P473, DOI 10.2353/ajpath.2009.080957; Hofbauer LC, 2004, JAMA-J AM MED ASSOC, V292, P490, DOI 10.1001/jama.292.4.490; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Jono S, 2002, CIRCULATION, V106, P1192, DOI 10.1161/01.CIR.0000031524.49139.29; Kaden JJ, 2004, J MOL CELL CARDIOL, V36, P57, DOI 10.1016/j.yjmcc.2003.09.015; Kavurma MM, 2008, ARTERIOSCL THROM VAS, V28, P1694, DOI 10.1161/ATVBAHA.107.155143; Kavurma MM, 2008, BIOCHEM PHARMACOL, V75, P1441, DOI 10.1016/j.bcp.2007.10.020; Kavurma MM, 2008, J BIOL CHEM, V283, P7754, DOI 10.1074/jbc.M706927200; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Lee SW, 2004, ARTHRITIS RHEUM-US, V50, P534, DOI 10.1002/art.20052; LeGeros R Z, 2001, Z Kardiol, V90 Suppl 3, P116; Lencel P, 2011, LAB INVEST, V91, P1434, DOI 10.1038/labinvest.2011.83; Liu X, 2007, BIOCHEM BIOPH RES CO, V358, P18, DOI 10.1016/j.bbrc.2007.03.209; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Mody N, 2003, J NUCL CARDIOL, V10, P177, DOI 10.1067/mnc.2003.0012; Morony S, 2012, CALCIFIED TISSUE INT, V91, P379, DOI 10.1007/s00223-012-9655-9; Morony S, 2008, CIRCULATION, V117, P411, DOI 10.1161/CIRCULATIONAHA.107.707380; Olesen M, 2012, MOL CELL ENDOCRINOL, V362, P149, DOI 10.1016/j.mce.2012.06.004; Osako MK, 2010, CIRC RES, V107, P466, DOI 10.1161/CIRCRESAHA.110.216846; Panizo S, 2009, CIRC RES, V104, P1041, DOI 10.1161/CIRCRESAHA.108.189001; Price PA, 2001, ARTERIOSCL THROM VAS, V21, P1610, DOI 10.1161/hq1001.097102; Rattazzi M, 2005, ARTERIOSCL THROM VAS, V25, P1420, DOI 10.1161/01.ATV.0000166600.58468.1b; Sato K, 2006, J EXP MED, V203, P239, DOI 10.1084/jem.20051062; Sattler AM, 2004, CALCIFIED TISSUE INT, V74, P103, DOI 10.1007/s00223-003-0011-y; Schoppet M, 2004, J CLIN ENDOCR METAB, V89, P4104, DOI 10.1210/jc.2003-031432; Schoppet M, 2003, CIRCULATION, V107, pE76, DOI 10.1161/01.CIR.0000060815.25798.02; Schoppet M, 2003, J CLIN ENDOCR METAB, V88, P1024, DOI 10.1210/jc.2002-020775; Schoppet M, 2002, ARTERIOSCL THROM VAS, V22, P549, DOI 10.1161/01.ATV.0000012303.37971.DA; Secchiero P, 2006, CIRCULATION, V114, P1522, DOI 10.1161/CIRCULATIONAHA.106.643841; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Susperregui ARG, 2008, J CELL PHYSIOL, V216, P144, DOI 10.1002/jcp.21389; Tseng W, 2010, J BIOL CHEM, V285, P29925, DOI 10.1074/jbc.M110.117366; Volpato S, 2011, ATHEROSCLEROSIS, V215, P452, DOI 10.1016/j.atherosclerosis.2010.11.004; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wittrant Y, 2006, INT J ONCOL, V28, P261; Yuan LQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029037; Zauli G, 2004, BLOOD, V104, P2044, DOI 10.1182/blood-2004-03-1196	65	47	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74211	10.1371/journal.pone.0074211	http://dx.doi.org/10.1371/journal.pone.0074211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040204	Green Published, gold			2022-12-25	WOS:000324481600121
J	Mishra, J; Verma, RK; Alpini, G; Meng, FY; Kumar, N				Mishra, Jayshree; Verma, Raj K.; Alpini, Gianfranco; Meng, Fanyin; Kumar, Narendra			Role of Janus Kinase 3 in Mucosal Differentiation and Predisposition to Colitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DSS-INDUCED COLITIS; TYROSINE PHOSPHORYLATION; CELL-DIFFERENTIATION; JAK3; ACTIVATION; EXPRESSION; JUNCTIONS; DISEASE; FAMILY; MICE	Janus kinase 3 (Jak3) is a nonreceptor tyrosine kinase expressed in both hematopoietic and nonhematopoietic cells. Previously, we characterized the functions of Jak3 in cytoskeletal remodeling, epithelial wound healing, and mucosal homeostasis. However, the role of Jak3 in mucosal differentiation and inflammatory bowel disease was not known. In this report, we characterize the role of Jak3 in mucosal differentiation, basal colonic inflammation, and predisposition toward colitis. Using the Jak3 knock-out (KO) mouse model, we show that Jak3 is expressed in colonic mucosa of mice, and the loss of mucosal expression of Jak3 resulted in reduced expression of differentiation markers for the cells of both enterocytic and secretory lineages. Jak3 KO mice showed reduced expression of colonic villin, carbonic anhydrase, secretory mucin muc2, and increased basal colonic inflammation reflected by increased levels of pro-inflammatory cytokines IL-6 and IL-17A in colon along with increased colonic myeloperoxidase activity. The inflammations in KO mice were associated with shortening of colon length, reduced cecum length, decreased crypt heights, and increased severity toward dextran sulfate sodium-induced colitis. In differentiated human colonic epithelial cells, Jak3 redistributed to basolateral surfaces and interacted with adherens junction (AJ) protein beta-catenin. Jak3 expression in these cells was essential for AJ localization of beta-catenin and maintenance of epithelial barrier functions. Collectively, these results demonstrate the essential role of Jak3 in the colon where it facilitated mucosal differentiation by promoting the expression of differentiation markers and enhanced colonic barrier functions through AJ localization of beta-catenin.	[Mishra, Jayshree; Verma, Raj K.; Kumar, Narendra] Texas A&M Univ Syst Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, Kingsville, TX 78363 USA; [Alpini, Gianfranco; Meng, Fanyin] Cent Texas Vet Hlth Care Syst, Scott & White Digest Dis Res Ctr, Temple, TX 76504 USA; [Alpini, Gianfranco; Meng, Fanyin] Texas A&M Hlth Sci Ctr Coll Med, Temple, TX 76504 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Kumar, N (corresponding author), Texas A&M Univ HSC, Coll Pharm, 1010 West Ave,B MSC 131, Kingsville, TX 78363 USA.	nkumar@tamhsc.edu	MISHRA, JAYSHREE/O-3468-2018	MISHRA, JAYSHREE/0000-0003-0619-0629; Kumar, Narendra/0000-0002-1193-0954	National Institutes of Health [DK081661]; Crohn's and Colitis Foundation of America [CCFA 2188]; Dr. Nicholas C. Hightower Centennial Chair of Gastroenterology Endowment from the Scott and White Hospital; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK081661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Dr. Nicholas C. Hightower Centennial Chair of Gastroenterology Endowment from the Scott and White Hospital; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK081661 (to N. K.). This work was also supported by Crohn's and Colitis Foundation of America Grant CCFA 2188 and the Dr. Nicholas C. Hightower Centennial Chair of Gastroenterology Endowment from the Scott and White Hospital (to G. A.).	Ahmed M, 2010, CYTOKINE GROWTH F R, V21, P449, DOI 10.1016/j.cytogfr.2010.10.005; Assi K, 2008, GUT, V57, P931, DOI 10.1136/gut.2007.142778; Banner KH, 2004, BRIT J PHARMACOL, V143, P590, DOI 10.1038/sj.bjp.0705982; Beck PL, 2010, AM J PHYSIOL-GASTR L, V299, pG43, DOI 10.1152/ajpgi.00228.2009; Bekku S, 1998, RES EXP MED, V198, P175, DOI 10.1007/s004330050101; Brimnes J, 2000, CLIN IMMUNOL, V96, P222, DOI 10.1006/clim.2000.4891; CHANTRET I, 1988, CANCER RES, V48, P1936; Christodoulou K, 2013, GUT, V62, P977, DOI 10.1136/gutjnl-2011-301833; COOPER HS, 1993, LAB INVEST, V69, P238; Cormet-Boyaka E, 2002, P NATL ACAD SCI USA, V99, P12477, DOI 10.1073/pnas.192203899; Cornejo MG, 2009, INT J BIOCHEM CELL B, V41, P2376, DOI 10.1016/j.biocel.2009.09.004; Dai SX, 2013, DIGEST DIS SCI, V58, P88, DOI 10.1007/s10620-012-2327-9; Dignass AU, 2001, INFLAMM BOWEL DIS, V7, P68, DOI 10.1097/00054725-200102000-00014; Dorofeyev AE, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/431231; Elrod JW, 2005, INFLAMM BOWEL DIS, V11, P883, DOI 10.1097/01.MIB.0000182871.76434.57; Ganta VC, 2010, INFLAMM BOWEL DIS, V16, P1029, DOI 10.1002/ibd.21150; Gersemann M, 2009, DIFFERENTIATION, V77, P84, DOI 10.1016/j.diff.2008.09.008; Hass DJ, 2006, CLIN GASTROENTEROL H, V4, P482, DOI 10.1016/j.cgh.2005.12.015; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Jang YN, 2012, CELL SIGNAL, V24, P742, DOI 10.1016/j.cellsig.2011.11.009; Johansson MEV, 2014, GUT, V63, P281, DOI 10.1136/gutjnl-2012-303207; Joo M, 2009, HUM PATHOL, V40, P872, DOI 10.1016/j.humpath.2008.12.003; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kosa P, 2012, ONCOGENE, V31, P3679, DOI 10.1038/onc.2011.545; Kumar N, 2007, J BIOL CHEM, V282, P30341, DOI 10.1074/jbc.C600319200; Lin Q, 2005, AM J PATHOL, V167, P969, DOI 10.1016/S0002-9440(10)61187-X; Lo SF, 2013, ARCH PATHOL LAB MED, V137, P912, DOI 10.5858/arpa.2012-0152-CP; Mackay F, 1998, GASTROENTEROLOGY, V115, P1464, DOI 10.1016/S0016-5085(98)70025-3; Mariadason JM, 2001, CANCER RES, V61, P3465; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; Mishra J, 2013, CRIT REV ONCOL HEMAT, V86, P232, DOI 10.1016/j.critrevonc.2012.09.014; Mishra J, 2012, J BIOL CHEM, V287, P41386, DOI 10.1074/jbc.C112.363507; Mishra J, 2012, AM J PHYSIOL-CELL PH, V302, pC735, DOI 10.1152/ajpcell.00316.2011; Murata Y, 2002, INT IMMUNOL, V14, P627, DOI 10.1093/intimm/dxf031; Murphy KM, 2008, IMMUNITY, V28, P725, DOI 10.1016/j.immuni.2008.05.004; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Papageorgiou AC, 2004, TRENDS PHARMACOL SCI, V25, P558, DOI 10.1016/j.tips.2004.09.008; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Piedra J, 2001, J BIOL CHEM, V276, P20436, DOI 10.1074/jbc.M100194200; PULLAN RD, 1994, GUT, V35, P353, DOI 10.1136/gut.35.3.353; Safford MG, 1997, EXP HEMATOL, V25, P374; Sancho E, 2003, CURR OPIN CELL BIOL, V15, P763, DOI 10.1016/j.ceb.2003.10.012; Sann H, 2013, LIFE SCI, V92, P708, DOI 10.1016/j.lfs.2013.01.028; Sheth P, 2007, AM J PHYSIOL-GASTR L, V293, pG308, DOI 10.1152/ajpgi.00582.2006; Shi M, 2008, IMMUNITY, V28, P763, DOI 10.1016/j.immuni.2008.04.016; Shin JK, 2013, MOD RHEUMATOL, V23, P406, DOI 10.1007/s10165-012-0675-0; TAKAHASHI T, 1994, FEBS LETT, V342, P124, DOI 10.1016/0014-5793(94)80485-0; Tominaga J, 2008, GENES CELLS, V13, P67, DOI 10.1111/j.1365-2443.2007.01149.x; Vuitton L., 2013, CURR DRUG T IN PRESS; Xu YH, 2008, CELL RES, V18, P1220, DOI 10.1038/cr.2008.310; You H, 2013, J CELL SCI, V126, P2718, DOI 10.1242/jcs.122903; Zhang HJ, 2012, J GASTROEN HEPATOL, V27, P603, DOI 10.1111/j.1440-1746.2011.06879.x; Zuniga LA, 2010, J IMMUNOL, V185, P6947, DOI 10.4049/jimmunol.1001269	53	26	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31795	31806		10.1074/jbc.M113.504126	http://dx.doi.org/10.1074/jbc.M113.504126			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24045942	hybrid, Green Published			2022-12-25	WOS:000330596200030
J	Zhou, XM; Sebastian, TT; Graham, TR				Zhou, Xiaoming; Sebastian, Tessy T.; Graham, Todd R.			Auto-inhibition of Drs2p, a Yeast Phospholipid Flippase, by Its Carboxyl-terminal Tail	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE H+-ATPASE; P-TYPE ATPASE; AMINOPHOSPHOLIPID TRANSLOCASE; GOLGI; IDENTIFICATION; TRANSPORT; PHOSPHORYLATION; ACTIVATION; BINDING; MECHANISM	Drs2p, a yeast type IV P-type ATPase (P4-ATPase), or flippase, couples ATP hydrolysis to phosphatidylserine translocation and the establishment of membrane asymmetry. A previous study has shown that affinity-purified Drs2p, possessing an N-terminal tandem affinity purification tag (TAPN-Drs2), retains ATPase and translocase activity, but Drs2p purified using a C-terminal tag (Drs2-TAPC) was inactive. In this study, we show that the ATPase activity of N-terminally purified Drs2p associates primarily with a proteolyzed form of Drs2p lacking the C-terminal cytosolic tail. Truncation of most of the Drs2p C-terminal tail sequence activates its ATPase activity by similar to 4-fold. These observations are consistent with the hypothesis that the C-terminal tail of Drs2p is auto-inhibitory to Drs2p activity. Phosphatidylinositol 4-phosphate (PI(4)P) has been shown to positively regulate Drs2p activity in isolated Golgi membranes through interaction with the C-terminal tail. In proteoliposomes reconstituted with purified, N-terminally TAP-tagged Drs2p, both ATPase and flippase activity were significantly higher in the presence of PI(4) P. In contrast, PI(4) P had no significant effect on the activity of a truncated form of Drs2p, which lacked the C-terminal tail. This work provides the first direct evidence, in a purified system, that a phospholipid flippase is subject to auto-inhibition by its C-terminal tail, which can be relieved by a phosphoinositide to stimulate flippase activity.	[Zhou, Xiaoming; Sebastian, Tessy T.; Graham, Todd R.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Graham, TR (corresponding author), Vanderbilt Univ, Dept Biol Sci, VU Stn B, Box 35-1634, Nashville, TN 37235 USA.	tr.graham@vanderbilt.edu		Zhou, Xiaoming/0000-0001-8866-7245	National Institutes of Health [R01GM062367]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107978, R01GM062367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM062367 (to T. R. G.).	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; AU KS, 1987, BIOCHIM BIOPHYS ACTA, V905, P273, DOI 10.1016/0005-2736(87)90455-X; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Baldridge RD, 2013, J BIOL CHEM, V288, P19516, DOI 10.1074/jbc.M113.476911; Baldridge RD, 2013, P NATL ACAD SCI USA, V110, pE358, DOI 10.1073/pnas.1216948110; Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; CALDOGNO FR, 1993, PLANT PHYSIOL, V103, P385; CARAFOLI E, 1994, FASEB J, V8, P993, DOI 10.1096/fasebj.8.13.7926378; CARONI P, 1981, J BIOL CHEM, V256, P9371; CARTER SG, 1982, J BIOCHEM BIOPH METH, V7, P7, DOI 10.1016/0165-022X(82)90031-8; Chantalat S, 2004, J CELL SCI, V117, P711, DOI 10.1242/jcs.00896; Chen CY, 1999, J CELL BIOL, V147, P1223, DOI 10.1083/jcb.147.6.1223; Chen S, 2006, TRAFFIC, V7, P1503, DOI 10.1111/j.1600-0854.2006.00485.x; Coleman JA, 2012, P NATL ACAD SCI USA, V109, P1449, DOI 10.1073/pnas.1108862109; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; Cornelius F, 2005, BIOCHEMISTRY-US, V44, P13051, DOI 10.1021/bi0504456; Ding JT, 2000, J BIOL CHEM, V275, P23378, DOI 10.1074/jbc.M910319199; Ekberg K, 2010, J BIOL CHEM, V285, P7344, DOI 10.1074/jbc.M109.096123; Fuglsang AT, 1999, J BIOL CHEM, V274, P36774, DOI 10.1074/jbc.274.51.36774; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; Hwang I, 2000, PLANT PHYSIOL, V122, P157, DOI 10.1104/pp.122.1.157; Jacquot A, 2012, J BIOL CHEM, V287, P13249, DOI 10.1074/jbc.M111.313916; JAMES P, 1988, J BIOL CHEM, V263, P2905; JAMES PH, 1989, BIOCHEMISTRY-US, V28, P4253, DOI 10.1021/bi00436a020; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Maudoux O, 2000, J BIOL CHEM, V275, P17762, DOI 10.1074/jbc.M909690199; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Natarajan P, 2009, NAT CELL BIOL, V11, P1421, DOI 10.1038/ncb1989; Olsson A, 1998, PLANT PHYSIOL, V118, P551, DOI 10.1104/pp.118.2.551; PALMGREN MG, 1991, J BIOL CHEM, V266, P20470; PALMGREN MG, 1990, J BIOL CHEM, V265, P13423; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; Paterson JK, 2006, BIOCHEMISTRY-US, V45, P5367, DOI 10.1021/bi052359b; Peyroche A, 1996, NATURE, V384, P479, DOI 10.1038/384479a0; Peyroche A, 2001, J CELL SCI, V114, P2241; Piotrowski M, 1998, J BIOL CHEM, V273, P30018, DOI 10.1074/jbc.273.45.30018; Portillo F, 2000, BBA-REV BIOMEMBRANES, V1469, P31, DOI 10.1016/S0304-4157(99)00011-8; PORTILLO F, 1989, FEBS LETT, V247, P381, DOI 10.1016/0014-5793(89)81375-4; RASICALDOGNO F, 1995, PLANT PHYSIOL, V108, P105, DOI 10.1104/pp.108.1.105; RASICALDOGNO F, 1992, PLANT PHYSIOL, V98, P1202, DOI 10.1104/pp.98.3.1202; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sze H, 2000, ANNU REV PLANT PHYS, V51, P433, DOI 10.1146/annurev.arplant.51.1.433; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Tsai PC, 2013, P NATL ACAD SCI USA, V110, pE668, DOI 10.1073/pnas.1221484110; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106; ZIMMERMAN ML, 1993, BIOCHEMISTRY-US, V32, P12257, DOI 10.1021/bi00096a040	52	36	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31807	31815		10.1074/jbc.M113.481986	http://dx.doi.org/10.1074/jbc.M113.481986			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24045945	hybrid, Green Published			2022-12-25	WOS:000330596200031
J	Chang, T; Alexopoulos, H; Pettingill, P; McMenamin, M; Deacon, R; Erdelyi, F; Szabo, G; Buckley, CJ; Vincent, A				Chang, Thashi; Alexopoulos, Harry; Pettingill, Philippa; McMenamin, Mary; Deacon, Robert; Erdelyi, Ferenc; Szabo, Gabor; Buckley, Camilla J.; Vincent, Angela			Immunization against GAD Induces Antibody Binding to GAD-Independent Antigens and Brainstem GABAergic Neuronal Loss	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; STIFF-PERSON SYNDROME; AUTOIMMUNE-RESPONSE; AUTOANTIBODIES; DISEASES; RECEPTOR; DYSFUNCTION; PROJECTION; CELLS; RATS	Stiff person syndrome (SPS) is a highly-disabling neurological disorder of the CNS characterized by progressive muscular rigidity and spasms. In approximately 60-80% of patients there are autoantibodies to glutamic acid decarboxylase (GAD), the enzyme that synthesizes gamma-amino butyric acid (GABA), the predominant inhibitory neurotransmitter of the CNS. Although GAD is intracellular, it is thought that autoimmunity to GAD65 may play a role in the development of SPS. To test this hypothesis, we immunized mice, that expressed enhanced green fluorescent protein (EGFP) under the GAD65 promoter, with either GAD65 (n = 13) or phosphate buffered saline (PBS) (n = 13). Immunization with GAD65 resulted in autoantibodies that immunoprecipitated GAD, bound to CNS tissue in a highly characteristic pattern, and surprisingly bound not only to GAD intracellularly but also to the surface of cerebellar neurons in culture. Moreover, immunization resulted in immunoglobulin diffusion into the brainstem, and a partial loss of GAD-EGFP expressing cells in the brainstem. Although immunization with GAD65 did not produce any behavioral abnormality in the mice, the induction of neuronal-surface antibodies and the trend towards loss of GABAergic neurons in the brainstem, supports a role for humoral autoimmunity in the pathogenesis of SPS and suggests that the mechanisms may involve spread to antigens expressed on the surface of these neurons.	[Chang, Thashi; Alexopoulos, Harry; Pettingill, Philippa; Buckley, Camilla J.; Vincent, Angela] Univ Oxford, John Radcliffe Hosp, Neuroimmunol Grp, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Chang, Thashi; Alexopoulos, Harry; Pettingill, Philippa; Buckley, Camilla J.; Vincent, Angela] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [McMenamin, Mary] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Deacon, Robert] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Erdelyi, Ferenc; Szabo, Gabor] Hungarian Acad Sci, Inst Expt Med, Dept Gene Technol & Dev Neurobiol, Budapest, Hungary; [Chang, Thashi] Univ Colombo, Dept Clin Med, Colombo, Sri Lanka	University of Oxford; University of Oxford; University of Oxford; University of Oxford; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; University of Colombo	Vincent, A (corresponding author), Univ Oxford, John Radcliffe Hosp, Neuroimmunol Grp, Weatherall Inst Mol Med, Oxford OX3 9DU, England.	angela.vincent@ndcn.ox.ac.uk	Vincent, Angela/AAE-7310-2019; Szabo, Gabor/A-5087-2008	Szabo, Gabor/0000-0001-5438-5151; Alexopoulos, Harry/0000-0002-8672-7619; Chang, Thashi/0000-0002-6027-7883	Commonwealth Scholarship Commission; DANA Foundation; Medical Research Council of Great Britain; Wellcome Trust Oxion Ion Channel initiative; Medical Research Council [G0401222, G0501898] Funding Source: researchfish; MRC [G0401222, G0501898] Funding Source: UKRI	Commonwealth Scholarship Commission; DANA Foundation; Medical Research Council of Great Britain(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Oxion Ion Channel initiative; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Commonwealth Scholarship Commission (TC), the DANA Foundation (MM, AV), the Medical Research Council of Great Britain (HA, PP, CJB) and the Wellcome Trust Oxion Ion Channel initiative (RD, AV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baekkeskov S, 2000, J AUTOIMMUN, V15, P279, DOI 10.1006/jaut.2000.0443; Bien CG, 2012, BRAIN, V135, P1622, DOI 10.1093/brain/aws082; Bilimoria PM, 2008, CSH PROTOC, V2008; Bischof F, 2004, J IMMUNOL, V173, P600, DOI 10.4049/jimmunol.173.1.600; Brager DH, 2003, J NEUROSCI, V23, P10475; Burton AR, 2010, J IMMUNOL, V184, P4863, DOI 10.4049/jimmunol.0903728; Chang T, 2013, JAMA NEUROLOGY, DOI [10.1001/jamaneurol.2013.3499, DOI 10.1001/JAMANEUR0L.2013.3499]; Dalakas MC, 2000, NEUROLOGY, V55, P1531, DOI 10.1212/WNL.55.10.1531; Deacon RMJ, 2006, PHYSIOL BEHAV, V87, P723, DOI 10.1016/j.physbeh.2006.01.013; Deacon RMJ, 2006, NAT PROTOC, V1, P118, DOI 10.1038/nprot.2006.19; Duddy ME, 2009, FRONT NEUROL NEUROSC, V26, P147, DOI 10.1159/000212375; Geis C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016775; Geis C, 2010, BRAIN, V133, P3166, DOI 10.1093/brain/awq253; Gilbert SL, 2006, NAT GENET, V38, P245, DOI 10.1038/ng1715; Hansen N, 2013, EXP NEUROL, V239, P202, DOI 10.1016/j.expneurol.2012.10.013; HOLSTEGE JC, 1991, BRAIN RES, V566, P308, DOI 10.1016/0006-8993(91)91715-D; Honnorat J, 2001, ARCH NEUROL-CHICAGO, V58, P225, DOI 10.1001/archneur.58.2.225; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; Kowal C, 2004, IMMUNITY, V21, P179, DOI 10.1016/j.immuni.2004.07.011; Levy Lucien M., 1999, Annals of Internal Medicine, V131, P522; LUDDENS H, 1990, NATURE, V346, P648, DOI 10.1038/346648a0; Malter MP, 2010, ANN NEUROL, V67, P470, DOI 10.1002/ana.21917; Meinck HM, 2002, MOVEMENT DISORD, V17, P853, DOI 10.1002/mds.10279; Meinck HM, 2001, J NEUROL NEUROSUR PS, V71, P100, DOI 10.1136/jnnp.71.1.100; MOERSCH FP, 1956, P STAFF M MAYO CLIN, V31, P421; PATRICK J, 1973, SCIENCE, V180, P871, DOI 10.1126/science.180.4088.871; REICHLING DB, 1990, J COMP NEUROL, V302, P370, DOI 10.1002/cne.903020213; ROSE NR, 1993, IMMUNOL TODAY, V14, P426, DOI 10.1016/0167-5699(93)90244-F; SchwartzGiblin S, 1996, BRAIN RES, V710, P178, DOI 10.1016/0006-8993(95)01304-0; SOLIMENA M, 1991, TRENDS NEUROSCI, V14, P452, DOI 10.1016/0166-2236(91)90044-U; SOLIMENA M, 1990, NEW ENGL J MED, V322, P1555, DOI 10.1056/NEJM199005313222202; Vincent A, 2011, LANCET NEUROL, V10, P759, DOI 10.1016/S1474-4422(11)70096-5	32	29	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e72921	10.1371/journal.pone.0072921	http://dx.doi.org/10.1371/journal.pone.0072921			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058450	Green Published, gold, Green Submitted			2022-12-25	WOS:000324695900005
J	Allegretti, YL; Bondar, C; Guzman, L; Rua, EC; Chopita, N; Fuertes, M; Zwirner, NW; Chirdo, FG				Allegretti, Yessica L.; Bondar, Constanza; Guzman, Luciana; Cueto Rua, Eduardo; Chopita, Nestor; Fuertes, Mercedes; Zwirner, Norberto W.; Chirdo, Fernando G.			Broad MICA/B Expression in the Small Bowel Mucosa: A Link between Cellular Stress and Celiac Disease	PLOS ONE			English	Article							MHC-CLASS-I; ACTIVATED T-LYMPHOCYTES; SMALL-INTESTINAL MUCOSA; OXIDATIVE STRESS; EPITHELIAL-CELLS; IMMUNE-RESPONSE; CHAIN-A; NKG2D; GLIADIN; LIGANDS	The MICA/B genes (MHC class I chain related genes A and B) encode for non conventional class I HLA molecules which have no role in antigen presentation. MICA/B are up-regulated by different stress conditions such as heat-shock, oxidative stress, neoplasic transformation and viral infection. Particularly, MICA/B are expressed in enterocytes where they can mediate enterocyte apoptosis when recognised by the activating NKG2D receptor present on intraepithelial lymphocytes. This mechanism was suggested to play a major pathogenic role in active celiac disease (CD). Due to the importance of MICA/B in CD pathogenesis we studied their expression in duodenal tissue from CD patients. By immunofluorescence confocal microscopy and flow cytometry we established that MICA/B was mainly intracellularly located in enterocytes. In addition, we identified MICA/B+ T cells in both the intraepithelial and lamina propria compartments. We also found MICA/B+ B cells, plasma cells and some macrophages in the lamina propria. The pattern of MICA/B staining in mucosal tissue in severe enteropathy was similar to that found in in vitro models of cellular stress. In such models, MICA/B were located in stress granules that are associated to the oxidative and ER stress response observed in active CD enteropathy. Our results suggest that expression of MICA/B in the intestinal	[Allegretti, Yessica L.; Bondar, Constanza; Chirdo, Fernando G.] Univ Nacl La Plata, Fac Ciencias Exactas, Dept Ciencias Biol, Lab Invest Sistema Inmune LISIN, La Plata, Buenos Aires, Argentina; [Guzman, Luciana; Cueto Rua, Eduardo] Hosp Ninos Sor Maria Ludovica, Serv Gastroenterol, La Plata, Buenos Aires, Argentina; [Chopita, Nestor] Hosp San Martin La Plata, Serv Gastroenterol, La Plata, Buenos Aires, Argentina; [Fuertes, Mercedes; Zwirner, Norberto W.] Consejo Nacl Invest Cient & Tecn CONICET, Lab Fisiopatol Inmunidad Innata, IBYME, Buenos Aires, DF, Argentina; [Fuertes, Mercedes] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Zwirner, Norberto W.] Univ Buenos Aires, Fac Med, Dept Microbiol Parasitol & Inmunol, Buenos Aires, DF, Argentina	National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires; University of Buenos Aires	Chirdo, FG (corresponding author), Univ Nacl La Plata, Fac Ciencias Exactas, Dept Ciencias Biol, Lab Invest Sistema Inmune LISIN, La Plata, Buenos Aires, Argentina.	fchirdo@biol.unlp.edu.ar	Chirdo, Fernando/AAL-7928-2020; Zwirner, Norberto/AAI-8961-2020	Fuertes, Mercedes Beatriz/0000-0002-2734-1468; Chirdo, Fernando/0000-0002-7099-9142; Zwirner, Norberto/0000-0001-7098-359X	Fundacion Ciencias Exactas; Facultad de Ciencias Exactas; Universidad Nacional de La Plata	Fundacion Ciencias Exactas; Facultad de Ciencias Exactas; Universidad Nacional de La Plata(National University of La Plata)	The funders, Fundacion Ciencias Exactas, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2011, ANNU REV IMMUNOL, V29, P493, DOI 10.1146/annurev-immunol-040210-092915; Adolph TE, 2012, DIGEST DIS, V30, P341, DOI 10.1159/000338121; Barone MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017039; Bernardo D, 2008, CLIN EXP IMMUNOL, V154, P64, DOI 10.1111/j.1365-2249.2008.03743.x; Caputo I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045209; Cerboni C, 2007, BLOOD, V110, P606, DOI 10.1182/blood-2006-10-052720; Circu ML, 2012, SEMIN CELL DEV BIOL, V23, P729, DOI 10.1016/j.semcdb.2012.03.014; Daniels I, 2005, CLIN CHIM ACTA, V356, P134, DOI 10.1016/j.cccn.2005.01.029; Eagle RA, 2007, NAT REV IMMUNOL, V7, P737, DOI 10.1038/nri2144; Ebert EC, 2005, IMMUNOLOGY, V115, P118, DOI 10.1111/j.1365-2567.2005.02132.x; Ferretti G, 2012, NUTRIENTS, V4, P243, DOI 10.3390/nu4040243; Thomas MG, 2009, J CELL SCI, V122, P563, DOI 10.1242/jcs.038208; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Gleimer M, 2003, IMMUNITY, V19, P469, DOI 10.1016/S1074-7613(03)00272-3; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Gulow K, 2002, J CELL SCI, V115, P2443; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Iltanen S, 1999, AUTOIMMUNITY, V31, P125, DOI 10.3109/08916939908994056; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Maiuri L, 2000, GASTROENTEROLOGY, V119, P996, DOI 10.1053/gast.2000.18149; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; Maiuri L, 2010, GUT, V59, P311, DOI 10.1136/gut.2009.183608; Martin-Pagola A, 2004, IMMUNOGENETICS, V56, P549, DOI 10.1007/s00251-004-0724-8; Martin-Pagola A, 2003, J CLIN IMMUNOL, V23, P498, DOI 10.1023/B:JOCI.0000010426.16956.cc; Matusali G, 2013, FASEB J, V27, P2440, DOI 10.1096/fj.12-223057; Mention JJ, 2003, GASTROENTEROLOGY, V125, P730, DOI 10.1016/S0016-5085(03)01047-3; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Meresse B, 2012, IMMUNITY, V36, P907, DOI 10.1016/j.immuni.2012.06.006; Molinero LL, 2004, J IMMUNOL, V173, P5583, DOI 10.4049/jimmunol.173.9.5583; Molinero LL, 2003, J LEUKOCYTE BIOL, V73, P815, DOI 10.1189/jlb.0602329; Molinero LL, 2002, J LEUKOCYTE BIOL, V71, P791; Moss SF, 1996, GUT, V39, P811, DOI 10.1136/gut.39.6.811; Nielsen N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031959; Ostberg JR, 2002, INT J HYPERTHER, V18, P552, DOI 10.1080/02656730210166168; Rivabene R, 1999, BBA-MOL BASIS DIS, V1453, P152, DOI 10.1016/S0925-4439(98)00095-7; Roberts AI, 2001, J IMMUNOL, V167, P5527, DOI 10.4049/jimmunol.167.10.5527; Stastny P, 2006, HUM IMMUNOL, V67, P141, DOI 10.1016/j.humimm.2006.02.019; Stojiljkovic V, 2009, CLIN BIOCHEM, V42, P1431, DOI 10.1016/j.clinbiochem.2009.06.009; Thomas KE, 2006, J IMMUNOL, V176, P2512, DOI 10.4049/jimmunol.176.4.2512; Venkataraman GM, 2007, J IMMUNOL, V178, P961, DOI 10.4049/jimmunol.178.2.961; Yang PC, 2007, J GASTROEN HEPATOL, V22, P1823, DOI 10.1111/j.1440-1746.2006.04710.x	43	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73658	10.1371/journal.pone.0073658	http://dx.doi.org/10.1371/journal.pone.0073658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058482	Green Published, Green Submitted, gold			2022-12-25	WOS:000324408400031
J	Huo, YL; Luo, T; Guccione, JM; Teague, SD; Tan, WC; Navia, JA; Kassab, GS				Huo, Yunlong; Luo, Tong; Guccione, Julius M.; Teague, Shawn D.; Tan, Wenchang; Navia, Jose A.; Kassab, Ghassan S.			Mild Anastomotic Stenosis in Patient-Specific CABG Model May Enhance Graft Patency: A New Hypothesis	PLOS ONE			English	Article							CORONARY ARTERIAL TREE; LONG-TERM PATENCY; BYPASS GRAFT; INTIMAL HYPERPLASIA; NEOINTIMAL HYPERPLASIA; VEIN GRAFTS; BLOOD-FLOW; DISTAL ANASTOMOSES; SAPHENOUS-VEIN; WALL SHEAR	It is well known that flow patterns at the anastomosis of coronary artery bypass graft (CABG) are complex and may affect the long-term patency. Various attempts at optimal designs of anastomosis have not improved long-term patency. Here, we hypothesize that mild anastomotic stenosis (area stenosis of about 40-60%) may be adaptive to enhance the hemodynamic conditions, which may contribute to slower progression of atherosclerosis. We further hypothesize that proximal/distal sites to the stenosis have converse changes that may be a risk factor for the diffuse expansion of atherosclerosis from the site of stenosis. Twelve (12) patient-specific models with various stenotic degrees were extracted from computed tomography images using a validated segmentation software package. A 3-D finite element model was used to compute flow patterns including wall shear stress (WSS) and its spatial and temporal gradients (WSS gradient, WSSG, and oscillatory shear index, OSI). The flow simulations showed that mild anastomotic stenosis significantly increased WSS (> 15 dynes.cm(-2)) and decreased OSI (< 0.02) to result in a more uniform distribution of hemodynamic parameters inside anastomosis albeit proximal/distal sites to the stenosis have a decrease of WSS (< 4 dynes.cm(-2)). These findings have significant implications for graft adaptation and long-term patency.	[Huo, Yunlong; Tan, Wenchang] Peking Univ, Coll Engn, Beijing, Peoples R China; [Huo, Yunlong; Tan, Wenchang] Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Beijing, Peoples R China; [Luo, Tong; Kassab, Ghassan S.] Indiana Univ Purdue Univ Indianapolis, Indianapolis, IN USA; [Teague, Shawn D.; Kassab, Ghassan S.] Indiana Univ Purdue Univ, Indianapolis, IN 46202 USA; [Guccione, Julius M.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Navia, Jose A.] Austral Univ, Buenos Aires, DF, Argentina	Peking University; Peking University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of California System; University of California San Francisco; Austral University	Kassab, GS (corresponding author), Indiana Univ Purdue Univ Indianapolis, Indianapolis, IN USA.	gkassab@iupui.edu	Tan, Wenchang/I-9949-2014; Huo, Yunlong/N-8155-2013	Huo, Yunlong/0000-0003-4121-3224	National Institute of Health-National Heart, Lung, and Blood Institute [HL092048, HL086400, HL077921]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077921, R01HL086400, R01HL092048] Funding Source: NIH RePORTER	National Institute of Health-National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research is supported by the National Institute of Health-National Heart, Lung, and Blood Institute Grants HL092048 (to GSK), HL086400, HL077921 (to JMG). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheung SCP, 2010, AUSTRALAS PHYS ENG S, V33, P319, DOI 10.1007/s13246-010-0050-4; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; DILLEY RJ, 1988, ARCH SURG-CHICAGO, V123, P691; FEI DY, 1994, J BIOMECH ENG-T ASME, V116, P331, DOI 10.1115/1.2895739; FITZGIBBON GM, 1991, J AM COLL CARDIOL, V17, P1075, DOI 10.1016/0735-1097(91)90834-V; FitzGibbon GM, 1996, J AM COLL CARDIOL, V28, P616, DOI 10.1016/0735-1097(96)00206-9; FUJIWARA T, 1988, CIRCULATION, V78, P1210, DOI 10.1161/01.CIR.78.5.1210; Giordana S, 2005, J BIOMECH ENG-T ASME, V127, P1087, DOI 10.1115/1.2073507; Goldman S, 2004, J AM COLL CARDIOL, V44, P2149, DOI 10.1016/j.jacc.2004.08.064; Haruguchi Hiroaki, 2003, J Artif Organs, V6, P227, DOI 10.1007/s10047-003-0232-x; Hillis LD, 2012, J THORAC CARDIOV SUR, V143, P4, DOI 10.1016/j.jtcvs.2011.10.015; Huo Y, 2004, INT J HEAT MASS TRAN, V47, P3533, DOI 10.1016/j.ijheatmasstransfer.2004.01.021; Huo Y, 2013, RADIOLOGY, DOI [10.1148/radiol.13122181, DOI 10.1148/RADI0L.13122181]; Huo Y, 2005, FINITE ELEMENT MODEL; Huo Y, 2007, AM J PHYSIOL-HEART C, V293, pH2959, DOI 10.1152/ajpheart.00586.2007; Huo YL, 2012, J R SOC INTERFACE, V9, P1325, DOI 10.1098/rsif.2011.0605; Huo Y, 2012, J BIOMECH, V45, P1273, DOI 10.1016/j.jbiomech.2012.01.033; Huo YL, 2009, J BIOMECH, V42, P594, DOI 10.1016/j.jbiomech.2008.12.011; Jiang ZH, 2007, AM J PHYSIOL-HEART C, V293, pH482, DOI 10.1152/ajpheart.01372.2006; Jiang ZH, 2009, AM J PHYSIOL-HEART C, V297, pH1200, DOI 10.1152/ajpheart.00268.2009; KALAN JM, 1990, AM HEART J, V119, P1164, DOI 10.1016/S0002-8703(05)80249-2; Kassab GS, 2006, ANNU REV BIOMED ENG, V8, P499, DOI 10.1146/annurev.bioeng.8.010506.105023; Kent KC, 2004, ANN VASC SURG, V18, P135, DOI 10.1007/s10016-004-0019-4; KEYNTON RS, 1991, J BIOMECH ENG-T ASME, V113, P458, DOI 10.1115/1.2895427; Keynton RS, 2001, J BIOMECH ENG-T ASME, V123, P464, DOI 10.1115/1.1389461; Kleinstreuer C, 2001, CRIT REV BIOMED ENG, V29, P1, DOI 10.1615/CritRevBiomedEng.v29.i1.10; Lei M, 1997, J VASC SURG, V25, P637, DOI 10.1016/S0741-5214(97)70289-1; Lemson MS, 2000, EUR J VASC ENDOVASC, V19, P336, DOI 10.1053/ejvs.1999.1040; Li W, 2002, J HYDRAULIC ENG, V10, P7; Loth F, 2008, ANNU REV FLUID MECH, V40, P367, DOI 10.1146/annurev.fluid.40.111406.102119; MADRAS PN, 1981, SURGERY, V90, P922; Nichols W., 2005, MCDONALDS BLOOD FLOW, V5th; Parang P, 2009, CAN J CARDIOL, V25, pE57, DOI 10.1016/S0828-282X(09)70486-6; Qi Y, 2005, CHINA WATER RESOURCE, V11, P29; RITTGERS SE, 1978, CIRC RES, V42, P792, DOI 10.1161/01.RES.42.6.792; Spray T L, 1977, Cardiovasc Clin, V8, P11; STARY HC, 1994, CIRCULATION, V89, P2462, DOI 10.1161/01.CIR.89.5.2462; Tu JY, 2011, J MED IMAG HEALTH IN, V1, P116, DOI 10.1166/jmihi.2011.1018; UREN NG, 1994, NEW ENGL J MED, V330, P1782, DOI 10.1056/NEJM199406233302503; Weman SM, 1999, INT J LEGAL MED, V112, P107, DOI 10.1007/s004140050211; Wischgoll T, 2008, ANN BIOMED ENG, V36, P356, DOI 10.1007/s10439-008-9443-x; Wischgoll T, 2009, AM J PHYSIOL-HEART C, V297, pH1949, DOI 10.1152/ajpheart.00093.2009; Wong K, 2006, MED BIOL ENG COMPUT, V44, P971, DOI 10.1007/s11517-006-0113-6; Wong KKL, 2013, J MECH MED BIOL, V13, DOI 10.1142/S0219519413500012; Wong KKL, 2013, METHODS IN RESEARCH AND DEVELOPMENT OF BIOMEDICAL DEVICES, P1, DOI 10.1142/8621; Wu JX, 2009, AM J PHYSIOL-HEART C, V297, pH1194, DOI 10.1152/ajpheart.00703.2009; Zhang LS, 2002, J VASC SURG, V36, P824, DOI 10.1067/mva.2002.126308	47	18	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73769	10.1371/journal.pone.0073769	http://dx.doi.org/10.1371/journal.pone.0073769			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058488	gold, Green Published			2022-12-25	WOS:000324408400034
J	Carson, BP; Del Bas, JM; Moreno-Navarrete, JM; Fernandez-Real, JM; Mora, S				Carson, Brian P.; Del Bas, Josep Maria; Moreno-Navarrete, Jose Maria; Fernandez-Real, Jose Manuel; Mora, Silvia			The Rab11 Effector Protein FIP1 Regulates Adiponectin Trafficking and Secretion	PLOS ONE			English	Article							COMPLEMENT-RELATED PROTEIN; INDUCED INSULIN-RESISTANCE; ACTIVATED RECEPTOR-GAMMA; PANCREATIC BETA-CELLS; 3T3-L1 ADIPOCYTES; ADIPOSE-TISSUE; PPAR-GAMMA; MYOSIN VB; EXPRESSION; PATHWAY	Adiponectin is an adipokine secreted by white adipocytes involved in regulating insulin sensitivity in peripheral tissues. Secretion of adiponectin in adipocytes relies on the endosomal system, however, the intracellular machinery involved in mediating adiponectin release is unknown. We have previously reported that intracellular adiponectin partially compartmentalizes with rab 5 and rab11, markers for the early/sorting and recycling compartments respectively. Here we have examined the role of several rab11 downstream effector proteins (rab11 FIPs) in regulating adiponectin trafficking and secretion. Overexpression of wild type rab11 FIP1, FIP3 and FIP5 decreased the amount of secreted adiponectin expressed in HEK293 cells, whereas overexpression of rab11 FIP2 or FIP4 had no effect. Furthermore shRNA-mediated depletion of FIP1 enhanced adiponectin release whereas knock down of FIP5 decreased adiponectin secretion. Knock down of FIP3 had no effect. In 3T3L1 adipocytes, endogenous FIP1 co-distributed intracellularly with endogenous adiponectin and FIP1 depletion enhanced adiponectin release without altering insulin-mediated trafficking of the glucose transporter Glut4. While adiponectin receptors internalized with transferrin receptors, there were no differences in transferrin receptor recycling between wild type and FIP1 depleted adipocytes. Consistent with its inhibitory role, FIP1 expression was decreased during adipocyte differentiation, by treatment with thiazolidinediones, and with increased BMI in humans. In contrast, FIP1 expression increased upon exposure of adipocytes to TNF alpha. In all, our findings identify FIP1 as a novel protein involved in the regulation of adiponectin trafficking and release.	[Carson, Brian P.; Del Bas, Josep Maria; Mora, Silvia] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England; [Moreno-Navarrete, Jose Maria; Fernandez-Real, Jose Manuel] Hosp Dr Josep Trueta, Sect Diabet Endocrinol & Nutr, Girona, Spain; [Carson, Brian P.] Univ Limerick, Dept Phys Educ & Sport Sci, Limerick, Ireland	University of Liverpool; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; University of Limerick	Mora, S (corresponding author), Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England.	mora@liverpool.ac.uk	Fernández-Real, Jose Manuel/AGH-3599-2022; Moreno-Navarrete, José María/ABG-5548-2021; del Bas, Josep M/K-2327-2014; Carson, Brian P/D-3438-2012; Moreno-Navarrete, José María/H-9772-2015; Mora, Silvia/Y-3131-2019; del Bas, Josep Maria/K-9310-2019	Fernández-Real, Jose Manuel/0000-0002-7442-9323; Moreno-Navarrete, José María/0000-0002-2883-511X; del Bas, Josep M/0000-0002-0700-2004; Carson, Brian P/0000-0001-8350-1481; Moreno-Navarrete, José María/0000-0002-2883-511X; del Bas, Josep Maria/0000-0002-0700-2004; Mora, Silvia/0000-0002-8473-1497	Diabetes UK	Diabetes UK(Diabetes UK)	This work was funded by a research grant from Diabetes UK (www.diabetes.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Bauche IB, 2006, BIOCHEM BIOPH RES CO, V345, P1414, DOI 10.1016/j.bbrc.2006.05.033; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Bruun JM, 2003, AM J PHYSIOL-ENDOC M, V285, pE527, DOI 10.1152/ajpendo.00110.2003; Clarke M, 2006, BIOCHEM BIOPH RES CO, V342, P1361, DOI 10.1016/j.bbrc.2006.02.102; Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120; Combs TP, 2002, ENDOCRINOLOGY, V143, P998, DOI 10.1210/endo.143.3.8662; Damiani MT, 2004, TRAFFIC, V5, P785, DOI 10.1111/j.1600-0854.2004.00220.x; Famulla S, 2012, INT J OBESITY, V36, P986, DOI 10.1038/ijo.2011.200; Fan GH, 2004, MOL BIOL CELL, V15, P2456, DOI 10.1091/mbc.E03-09-0706; Feng LJ, 2003, J BIOL CHEM, V278, P31486, DOI 10.1074/jbc.M305690200; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Ge Q, 2011, AM J PHYSIOL-ENDOC M, V301, pE326, DOI 10.1152/ajpendo.00153.2011; Hales CM, 2001, J BIOL CHEM, V276, P39067, DOI 10.1074/jbc.M104831200; Horgan CP, 2010, BIOCHEM BIOPH RES CO, V394, P387, DOI 10.1016/j.bbrc.2010.03.028; Horgan CP, 2010, J CELL SCI, V123, P181, DOI 10.1242/jcs.052670; Horgan CP, 2009, BIOCHEM SOC T, V37, P1032, DOI 10.1042/BST0371032; Horgan CP, 2004, BIOCHEM BIOPH RES CO, V319, P83, DOI 10.1016/j.bbrc.2004.04.157; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Hug C, 2002, BIOTECHNIQUES, V33, P654, DOI 10.2144/02333dd01_11829a; Jing JA, 2010, MOL BIOL CELL, V21, P3041, DOI 10.1091/mbc.E10-04-0313; Jing J, 2009, HISTOL HISTOPATHOL, V24, P1171, DOI 10.14670/HH-24.1171; Kelly EE, 2010, BIOL CELL, V102, P51, DOI 10.1042/BC20090068; Lagathu C, 2003, BIOCHEM BIOPH RES CO, V311, P372, DOI 10.1016/j.bbrc.2003.10.013; Lara-Lemus R, 2006, J CELL SCI, V119, P1833, DOI 10.1242/jcs.02905; Lindsay AJ, 2004, J CELL SCI, V117, P4365, DOI 10.1242/jcs.01280; Lindsay AJ, 2002, J BIOL CHEM, V277, P27193, DOI 10.1074/jbc.M200757200; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Moreno-Navarrete JM, 2011, J CLIN ENDOCR METAB, V96, pE1816, DOI 10.1210/jc.2011-0310; Martinez L, 2010, BIOCHEM PHARMACOL, V79, P1300, DOI 10.1016/j.bcp.2009.12.013; Millar CA, 2000, TRAFFIC, V1, P141, DOI 10.1034/j.1600-0854.2000.010206.x; Motley AM, 2006, MOL BIOL CELL, V17, P5298, DOI 10.1091/mbc.E06-05-0452; Nedvetsky PI, 2007, TRAFFIC, V8, P110, DOI 10.1111/j.1600-0854.2006.00508.x; O'Rourke RW, 2011, DIABETOLOGIA, V54, P1480, DOI 10.1007/s00125-011-2103-y; Peden AA, 2004, MOL BIOL CELL, V15, P3530, DOI 10.1091/mbc.E03-12-0918; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; Trujillo ME, 2005, J INTERN MED, V257, P167, DOI 10.1111/j.1365-2796.2004.01426.x; Turner MD, 2000, J BIOL CHEM, V275, P14025, DOI 10.1074/jbc.275.19.14025; Welsh GI, 2007, J CELL SCI, V120, P4197, DOI 10.1242/jcs.007310; Xie LL, 2008, BBA-MOL BASIS DIS, V1782, P99, DOI 10.1016/j.bbadis.2007.12.003; Xie LL, 2006, J BIOL CHEM, V281, P7253, DOI 10.1074/jbc.M511313200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yang WS, 2002, DIABETES CARE, V25, P376, DOI 10.2337/diacare.25.2.376; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Yu JG, 2002, DIABETES, V51, P2968, DOI 10.2337/diabetes.51.10.2968	48	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74687	10.1371/journal.pone.0074687	http://dx.doi.org/10.1371/journal.pone.0074687			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040321	gold, Green Published, Green Submitted			2022-12-25	WOS:000326734500115
J	Huang, W; Li, GR; Qiu, JM; Gonzalez, P; Challa, P				Huang, Wei; Li, Guorong; Qiu, Jianming; Gonzalez, Pedro; Challa, Pratap			Protective Effects of Resveratrol in Experimental Retinal Detachment	PLOS ONE			English	Article							FOXO TRANSCRIPTION FACTORS; OXIDATIVE STRESS; PHOTORECEPTOR APOPTOSIS; NEURONAL APOPTOSIS; CELL-DEATH; CALPAIN; ACTIVATION; POLYPHENOL; SIRT1; MODEL	Background: Oxidative stress is one of the major factors that trigger photoreceptor apoptosis. To investigate whether resveratrol, a potent antioxidant and small molecule activator of the FoxO pathway, would be neuroprotective against photoreceptor cell death in a rodent model of retinal detachment. Methods: Retinal detachment was created in adult Brown Norway rats by subretinal injection of sodium hyaluronate. The animals were treated daily with vehicle or resveratrol (20mg/kg) intraperitoneal injection. Photoreceptor death was assessed by counting the number of apoptotic cells with TdT-dUTP terminal nick-end labeling (TUNEL) and measurement of the outer nuclear layer (ONL) thickness 3 days after RD. Changes in expression of FoxO1a, FoxO3a, and FoxO4 were analyzed by western blot. The activity of caspase 3, caspase 8, caspase 9, spectrin and their cleavage forms were studied. Results: Three days after retinal detachment, caspase 3, caspase 8 and caspase 9 were significantly activated in the detached retina. Spectrin cleavage products at 120 and 145 kDa were also detected. Both caspase and calpain activation are involved in apoptotic photoreceptor cell death in detached retinas. Treatment with resveratrol increases FoxO1a, FoxO3a, and FoxO4 protein expression in detached retinas only. Resveratrol treatment decreases activation of intrinsic and extrinsic caspase apoptotic pathways triggered by RD. The number of TUNEL-positive cells decreases from 1301 +/- 51 cells/mm(2) in control groups to 430 +/- 35 cells/mm(2) in treatment groups (p<0.05). Resveratrol treatment also demonstrates 59% less ONL thickness loss compared to controls. Conclusions: Resveratrol treatment up-regulates the FoxO family and blocks Caspase3, 8, and 9 activation. Resveratrol has the potential to be used as a novel therapeutic agent for preventing vision loss in diseases characterized by photoreceptor detachment.	[Huang, Wei; Li, Guorong; Qiu, Jianming; Gonzalez, Pedro; Challa, Pratap] Duke Univ, Duke Eye Ctr, Durham, NC 27710 USA	Duke University	Challa, P (corresponding author), Duke Univ, Duke Eye Ctr, Durham, NC 27710 USA.	pratap.challa@dm.duke.edu			NIH [K23 EY014019]; Duke Eye Center Core grant [EY01894, EY016228, EY05722]; Research to Prevent Blindness (RPB); NATIONAL EYE INSTITUTE [P30EY005722, R01EY016228, R01EY001894, K23EY014019] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke Eye Center Core grant; Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	NIH K23 EY014019, Duke Eye Center Core grant EY01894, EY016228, EY05722 (http://www.nei.nih.gov/funding/). Research to Prevent Blindness (RPB)(http://www.rpbusa.org/rpb/grants/grants/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JG, 2005, AM J OPHTHALMOL, V139, P605, DOI 10.1016/j.ajo.2004.11.046; Baarine M, 2011, GENES NUTR, V6, P161, DOI 10.1007/s12263-011-0232-z; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen F, 2013, CNS NEUROSCI THER, V19, P675, DOI 10.1111/cns.12131; Doonan F, 2012, EXP CELL RES, V318, P1278, DOI 10.1016/j.yexcr.2012.02.003; Furukawa-Hibi Y, 2005, ANTIOXID REDOX SIGN, V7, P752, DOI 10.1089/ars.2005.7.752; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; Hamlaoui S, 2012, J PHYSIOL PHARMACOL, V63, P293; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Huang W, 2010, INVEST OPHTH VIS SCI, V51, P3049, DOI 10.1167/iovs.09-4364; Kim YH, 2010, DIABETES, V59, P1825, DOI 10.2337/db09-1431; Kurus M, 2009, INHAL TOXICOL, V21, P979, DOI 10.1080/08958370802666380; Li GR, 2011, INVEST OPHTH VIS SCI, V52, P4395, DOI 10.1167/iovs.10-6652; Lin TK, 2012, APOPTOSIS, V17, P871, DOI 10.1007/s10495-012-0732-3; Lin Y, 2013, J MOL NEUROSCI, V50, P504, DOI 10.1007/s12031-013-9977-8; Lopez-Miranda V, 2012, REV NEUROLOGIA, V54, P349, DOI 10.33588/rn.5406.2011611; Mantopoulos D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024245; Nakajima E, 2006, INVEST OPHTH VIS SCI, V47, P5469, DOI 10.1167/iovs.06-0567; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; Nguyen ATH, 2012, ADV EXP MED BIOL, V723, P547, DOI 10.1007/978-1-4614-0631-0_69; Pallas M, 2009, CURR NEUROVASC RES, V6, P70, DOI 10.2174/156720209787466019; Roh MI, 2011, INVEST OPHTH VIS SCI, V52, P3825, DOI 10.1167/iovs.10-6797; Sengupta A, 2011, J BIOL CHEM, V286, P7468, DOI 10.1074/jbc.M110.179242; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; YOSHIMURA N, 1984, BIOCHEM J, V223, P47, DOI 10.1042/bj2230047; Zacks DN, 2003, INVEST OPHTH VIS SCI, V44, P1262, DOI 10.1167/iovs.02-0492	27	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e75735	10.1371/journal.pone.0075735	http://dx.doi.org/10.1371/journal.pone.0075735			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040416	Green Published, gold, Green Submitted			2022-12-25	WOS:000326734500141
J	Peulen, O; Gonzalez, A; Peixoto, P; Turtoi, A; Mottet, D; Delvenne, P; Castronovo, V				Peulen, Olivier; Gonzalez, Arnaud; Peixoto, Paul; Turtoi, Andrei; Mottet, Denis; Delvenne, Philippe; Castronovo, Vincent			The Anti-Tumor Effect of HDAC Inhibition in a Human Pancreas Cancer Model Is Significantly Improved by the Simultaneous Inhibition of Cyclooxygenase 2	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; GENE-EXPRESSION; TRICHOSTATIN-A; PHASE-I; CELL-LINES; GROWTH; ADENOCARCINOMA; CARCINOMA; COMBINATION; COX-2	Pancreatic ductal adenocarcinoma is the fourth leading cause of cancer death worldwide, with no satisfactory treatment to date. In this study, we tested whether the combined inhibition of cyclooxygenase-2 (COX-2) and class I histone deacetylase (HDAC) may results in a better control of pancreatic ductal adenocarcinoma. The impact of the concomitant HDAC and COX-2 inhibition on cell growth, apoptosis and cell cycle was assessed first in vitro on human pancreas BxPC-3, PANC-1 or CFPAC-1 cells treated with chemical inhibitors (SAHA, MS-275 and celecoxib) or HDAC1/2/3/7 siRNA. To test the potential antitumoral activity of this combination in vivo, we have developed and characterized, a refined chick chorioallantoic membrane tumor model that histologically and proteomically mimics human pancreatic ductal adenocarcinoma. The combination of HDAC1/3 and COX-2 inhibition significantly impaired proliferation of BxPC-3 cells in vitro and stalled entirely the BxPC-3 cells tumor growth onto the chorioallantoic membrane in vivo. The combination was more effective than either drug used alone. Consistently, we showed that both HDAC1 and HDAC3 inhibition induced the expression of COX-2 via the NF-kB pathway. Our data demonstrate, for the first time in a Pancreatic Ductal Adenocarcinoma (PDAC) model, a significant action of HDAC and COX-2 inhibitors on cancer cell growth, which sets the basis for the development of potentially effective new combinatory therapies for pancreatic ductal adenocarcinoma patients.	[Peulen, Olivier; Gonzalez, Arnaud; Peixoto, Paul; Turtoi, Andrei; Mottet, Denis; Castronovo, Vincent] Univ Liege, Metastasis Res Lab, GIGA Canc, Liege, Belgium; [Delvenne, Philippe] Univ Liege, Lab Expt Pathol, GIGA Canc, Liege, Belgium	University of Liege; University of Liege	Castronovo, V (corresponding author), Univ Liege, Metastasis Res Lab, GIGA Canc, Liege, Belgium.	vcastronovo@ulg.ac.be	Turtoi, Andrei/ABD-1271-2021; Peulen, Olivier/C-1250-2018	Turtoi, Andrei/0000-0003-3813-6635; Peulen, Olivier/0000-0002-6933-0134; Peixoto, Paul/0000-0001-6302-7823	Belgium National Fund for Scientific Research; Televie; Centre Anti-Cancereux pres de l'Universite de Liege	Belgium National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Televie; Centre Anti-Cancereux pres de l'Universite de Liege	This work was supported by the Belgium National Fund for Scientific Research (http://www.frs-fnrs.be) and Televie; the Centre Anti-Cancereux pres de l'Universite de Liege (http://www.cac.ulg.ac.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A. Gonzalez is a Televie fellow. A. Turtoi and D. Mottet are respectively Postdoctoral Researcher and Research Associate at the Belgium National Fund for Scientific Research.	ALLUM WH, 1986, J CLIN PATHOL, V39, P610, DOI 10.1136/jcp.39.6.610; [Anonymous], 2011, LANCET, V378, P1050, DOI 10.1016/S0140-6736(11)61465-7; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Bai JR, 2006, BIOCHEM BIOPH RES CO, V348, P1245, DOI 10.1016/j.bbrc.2006.07.185; Bots M, 2009, CLIN CANCER RES, V15, P3970, DOI 10.1158/1078-0432.CCR-08-2786; Broude EV, 2007, ONCOGENE, V26, P6954, DOI 10.1038/sj.onc.1210516; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chun SG, 2009, CANCER BIOL THER, V8, P19; Colby JK, 2008, NEOPLASIA, V10, P782, DOI 10.1593/neo.08330; Daniluk J, 2012, J CLIN INVEST, V122, P1519, DOI 10.1172/JCI59743; de Bono JS, 2008, CLIN CANCER RES, V14, P6663, DOI 10.1158/1078-0432.CCR-08-0376; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Deroanne CF, 2002, ONCOGENE, V21, P427, DOI 10.1038/sj.onc.1205108; Deryugina EI, 2008, HISTOCHEM CELL BIOL, V130, P1119, DOI 10.1007/s00418-008-0536-2; Detry C, 2008, BONE, V42, P422, DOI 10.1016/j.bone.2007.10.016; Donadelli M, 2007, BBA-MOL CELL RES, V1773, P1095, DOI 10.1016/j.bbamcr.2007.05.002; Dumartin L, 2010, GASTROENTEROLOGY, V138, P1595, DOI 10.1053/j.gastro.2009.12.061; Ellis L, 2010, PHARMACEUTICALS, V3, P2441, DOI 10.3390/ph3082441; Fritsche P, 2009, GUT, V58, P1399, DOI 10.1136/gut.2009.180711; Glaser KB, 2003, MOL CANCER THER, V2, P151; Gore L, 2008, CLIN CANCER RES, V14, P4517, DOI 10.1158/1078-0432.CCR-07-1461; Hill R, 2012, MOL CANCER THER, V11, P2127, DOI 10.1158/1535-7163.MCT-12-0342; Ijichi H, 2011, WORLD J CLIN ONCOL, V2, P195, DOI 10.5306/wjco.v2.i5.195; Iwahashi S, 2011, INT J CLIN ONCOL, V16, P671, DOI 10.1007/s10147-011-0246-y; Iwahashi S, 2011, J MED INVESTIG, V58, P106, DOI 10.2152/jmi.58.106; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jeong S, 2005, WORLD J GASTROENTERO, V11, P6765, DOI 10.3748/wjg.v11.i43.6765; Jones J, 2008, INT J MOL MED, V22, P293, DOI 10.3892/ijmm_00000022; Khan O, 2012, IMMUNOL CELL BIOL, V90, P85, DOI 10.1038/icb.2011.100; Kim HJ, 2011, AM J TRANSL RES, V3, P166; Kumagai T, 2007, INT J CANCER, V121, P656, DOI 10.1002/ijc.22558; Lamour V, 2010, INT J CANCER, V126, P1797, DOI 10.1002/ijc.24751; Lee MJ, 2003, MODERN PATHOL, V16, P403, DOI 10.1097/01.MP.0000067683.84284.66; Lehmann A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-395; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; Mehdi O, 2012, PANCREATOLOGY, V12, P466, DOI 10.1016/j.pan.2012.10.001; Miyake K, 2008, PANCREAS, V36, pE1, DOI 10.1097/MPA.0b013e31815f2c2a; Molina MA, 1999, CANCER RES, V59, P4356; Mottet D, 2009, ONCOGENE, V28, P243, DOI 10.1038/onc.2008.371; Mottet D, 2007, CIRC RES, V101, P1237, DOI 10.1161/CIRCRESAHA.107.149377; Mukherjee P, 2009, J IMMUNOL, V182, P216, DOI 10.4049/jimmunol.182.1.216; Naito Yoshiki, 2006, Kurume Medical Journal, V53, P59, DOI 10.2739/kurumemedj.53.59; Ouaissi M, 2008, CANCER BIOL THER, V7, P523, DOI 10.4161/cbt.7.4.5480; Ouaissi M, 2008, ANN SURG ONCOL, V15, P2318, DOI 10.1245/s10434-008-9940-z; Padillo FJ, 2010, J PINEAL RES, V49, P264, DOI 10.1111/j.1600-079X.2010.00791.x; Peixoto P, 2012, CELL DEATH DIFFER, V19, P1239, DOI 10.1038/cdd.2012.3; Penning TD, 1997, J MED CHEM, V40, P1347, DOI 10.1021/jm960803q; Piacentini P, 2006, VIRCHOWS ARCH, V448, P797, DOI 10.1007/s00428-006-0173-x; Pili R, 2012, BRIT J CANCER, V106, P77, DOI 10.1038/bjc.2011.527; Reid MD, 2013, J SURG ONCOL, V107, P67, DOI 10.1002/jso.23194; Richards DA, 2006, ANN ONCOL, V17, P1096, DOI 10.1093/annonc/mdl081; Rosendahl AH, 2012, PANCREATOLOGY, V12, P219, DOI 10.1016/j.pan.2012.04.005; SCHOUMACHER RA, 1990, P NATL ACAD SCI USA, V87, P4012, DOI 10.1073/pnas.87.10.4012; Sun WH, 2009, CANCER LETT, V275, P247, DOI 10.1016/j.canlet.2008.10.023; Takahashi H, 2011, PANCREAS, V40, P453, DOI 10.1097/MPA.0b013e31820b9733; TAN MH, 1986, CANCER INVEST, V4, P15, DOI 10.3109/07357908609039823; Tinari N, 2012, CURR CANCER DRUG TAR, V12, P439, DOI 10.2174/156800912800190884; Turtoi A, 2011, J PROTEOME RES, V10, P4302, DOI 10.1021/pr200527z; Wang XQ, 2013, MOL CARCINOGEN, V52, P218, DOI 10.1002/mc.21846; Wu ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036940; Zafar SF, 2012, EXPERT OPIN THER TAR, V16, P707, DOI 10.1517/14728222.2012.691473; Zhang HY, 2007, DRUG DEVELOP RES, V68, P61, DOI 10.1002/ddr.20167; Zhou WQ, 2011, CANCER BIOL THER, V11, P659, DOI 10.4161/cbt.11.7.14720	63	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e75102	10.1371/journal.pone.0075102	http://dx.doi.org/10.1371/journal.pone.0075102			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040391	Green Published, gold, Green Submitted			2022-12-25	WOS:000326734500134
J	Sakurai, T; Mochida, K; Yoshida, T; Akiyama, K; Ishitani, M; Seki, M; Shinozaki, K				Sakurai, Tetsuya; Mochida, Keiichi; Yoshida, Takuhiro; Akiyama, Kenji; Ishitani, Manabu; Seki, Motoaki; Shinozaki, Kazuo			Genome-Wide Discovery and Information Resource Development of DNA Polymorphisms in Cassava	PLOS ONE			English	Article							NB-ARC DOMAIN; FOX HUNTING SYSTEM; FULL-LENGTH CDNA; FUNCTIONAL ANNOTATION; PLANT; DATABASE; CLONES; ROOT; PREVALENCE; COLLECTION	Cassava (Manihot esculenta Crantz) is an important crop that provides food security and income generation in many tropical countries, and is known for its adaptability to various environmental conditions. Its draft genome sequence and many expressed sequence tags are now publicly available, allowing the development of cassava polymorphism information. Here, we describe the genome-wide discovery of cassava DNA polymorphisms. Using the alignment of predicted transcribed sequences from the cassava draft genome sequence and ESTs from GenBank, we discovered 10,546 single-nucleotide polymorphisms and 647 insertions and deletions. To facilitate molecular marker development for cassava, we designed 9,316 PCR primer pairs to amplify the genomic region around each DNA polymorphism. Of the discovered SNPs, 62.7% occurred in protein-coding regions. Disease-resistance genes were found to have a significantly higher ratio of nonsynonymous-to-synonymous substitutions. We identified 24 read-through (changes of a stop codon to a coding codon) and 38 premature stop (changes of a coding codon to a stop codon) single-nucleotide polymorphisms, and found that the 5 gene ontology terms in biological process were significantly different in genes with read-through single-nucleotide polymorphisms compared with all cassava genes. All data on the discovered DNA polymorphisms were organized into the Cassava Online Archive database, which is available at http://cassava.psc.riken.	[Sakurai, Tetsuya; Mochida, Keiichi; Yoshida, Takuhiro; Akiyama, Kenji; Seki, Motoaki; Shinozaki, Kazuo] RIKEN Ctr Sustainable Resource Sci, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Mochida, Keiichi; Shinozaki, Kazuo] RIKEN Biomass Engn Program, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Mochida, Keiichi; Seki, Motoaki] Yokohama City Univ, Kihara Inst Biol Res, Totsuka Ku, Yokohama, Kanagawa 232, Japan; [Ishitani, Manabu] Int Ctr Trop Agr CIAT, Agrobiodivers Res Area, Cali, Colombia	RIKEN; RIKEN; Yokohama City University; Alliance; International Center for Tropical Agriculture - CIAT	Sakurai, T (corresponding author), RIKEN Ctr Sustainable Resource Sci, Tsurumi Ku, Yokohama, Kanagawa, Japan.	tetsuya.sakurai@riken.jp	Mochida, Keiichi/N-9052-2014; Shinozaki, Kazuo/G-4202-2013; Sakurai, Tetsuya/B-2690-2010; Shinozaki, Kazuo/AAB-4945-2019; Seki, Motoaki/I-2854-2012; Mochida, Keiichi/T-2866-2019	Mochida, Keiichi/0000-0003-1299-0024; Shinozaki, Kazuo/0000-0002-6317-9867; Sakurai, Tetsuya/0000-0003-2046-8973; Shinozaki, Kazuo/0000-0002-6317-9867; Seki, Motoaki/0000-0001-8288-0467; Mochida, Keiichi/0000-0003-1299-0024	Strategic Funds for the Promotion of Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Japan Society for the Promotion of Science [21710205, 23119524]	Strategic Funds for the Promotion of Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Strategic Funds for the Promotion of Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and the Grant-in-Aid for Scientific Research for Young Scientists (B) (21710205) to T. S. from the Japan Society for the Promotion of Science. This work was also partially supported by the Grant-in-Aid for Scientific Research for Scientific Research on Innovative Areas (23119524) to K. M. from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akano AO, 2002, THEOR APPL GENET, V105, P521, DOI 10.1007/s00122-002-0891-7; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amutha R, 2001, J BIOSCI BIOENG, V92, P560, DOI 10.1016/S1389-1723(01)80316-9; An D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-64; Anderson JV, 2004, PLANT MOL BIOL, V56, P527, DOI 10.1007/s11103-004-5046-6; [Anonymous], 2009, BMC PLANT BIOL, DOI DOI 10.1186/1471-2229-9-118; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bewick V, 2004, CRIT CARE, V8, P46, DOI 10.1186/cc2428; Bewick V, 2003, CRIT CARE, V7, P451, DOI 10.1186/cc2401; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Childs KL, 2007, NUCLEIC ACIDS RES, V35, pD846, DOI 10.1093/nar/gkl785; Cho RJ, 1999, NAT GENET, V23, P203, DOI 10.1038/13833; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Close Timothy J., 2007, V406, P161; COCK JH, 1982, SCIENCE, V218, P755, DOI 10.1126/science.7134971; Donlin Maureen J, 2009, Curr Protoc Bioinformatics, VChapter 9, DOI 10.1002/0471250953.bi0909s28; Duvick J, 2008, NUCLEIC ACIDS RES, V36, pD959, DOI 10.1093/nar/gkm1041; El-Sharkawy MA, 2004, PLANT MOL BIOL, V56, P481, DOI 10.1007/s11103-005-2270-7; El-Sharkawy MA, 2002, EXP AGR, V38, P333, DOI 10.1017/S001447970200306X; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ferguson ME, 2012, THEOR APPL GENET, V124, P685, DOI 10.1007/s00122-011-1739-9; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Hillocks R., 2002, CASSAVA BIOL PRODUCT, DOI DOI 10.1079/9780851995243.0000; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Ichikawa T, 2006, PLANT J, V48, P974, DOI 10.1111/j.1365-313X.2006.02924.x; Jimenez-Gomez JM, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-85; Kalyna M, 2012, NUCLEIC ACIDS RES, V40, P2454, DOI 10.1093/nar/gkr932; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; Kondou Y, 2009, PLANT J, V57, P883, DOI 10.1111/j.1365-313X.2008.03733.x; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Lokko Y, 2007, PLANT CELL REP, V26, P1605, DOI 10.1007/s00299-007-0378-8; Lopez C, 2004, PLANT MOL BIOL, V56, P541, DOI 10.1007/s11103-004-0123-4; Lopez C, 2005, THEOR APPL GENET, V110, P425, DOI 10.1007/s00122-004-1833-3; Mochida K, 2011, PLANT CELL PHYSIOL, V52, P2017, DOI 10.1093/pcp/pcr153; Nanjo T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-448; Okogbenin E, 2002, THEOR APPL GENET, V106, P58, DOI 10.1007/s00122-002-1068-0; Prochnik S, 2012, TROP PLANT BIOL, V5, P88, DOI 10.1007/s12042-011-9088-z; Rabbi I, 2012, THEOR APPL GENET, V125, P329, DOI 10.1007/s00122-012-1836-4; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Raheem D., 2001, Agriculture and Human Values, V18, P383, DOI 10.1023/A:1015233606665; Rozen S, 2000, Methods Mol Biol, V132, P365; Sakurai T, 2011, PLANT CELL PHYSIOL, V52, P265, DOI 10.1093/pcp/pcq190; Sakurai T, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-66; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Soderlund C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000740; Sojikul P, 2010, PHYSIOL PLANTARUM, V140, P189, DOI 10.1111/j.1399-3054.2010.01389.x; Sraphet S, 2011, THEOR APPL GENET, V122, P1161, DOI 10.1007/s00122-010-1520-5; Syvanen AC, 2001, NAT REV GENET, V2, P930, DOI 10.1038/35103535; Taji T, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-115; Tameling WIL, 2006, PLANT PHYSIOL, V140, P1233, DOI 10.1104/pp.105.073510; Tonukari NJ, 2004, ELECTRON J BIOTECHN, V7, P5, DOI 10.2225/vol7-issue1-fulltext-i02; Umezawa T, 2008, DNA RES, V15, P333, DOI 10.1093/dnares/dsn024; Utsumi Y, 2012, DNA RES, V19, P335, DOI 10.1093/dnares/dss016; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; Van Ooijen G, 2008, J EXP BOT, V59, P1383, DOI 10.1093/jxb/ern045; Whankaew S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-266; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Yamaguchi-Kabata Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003393; Yngvadottir B, 2009, AM J HUM GENET, V84, P224, DOI 10.1016/j.ajhg.2009.01.008; Youens-Clark K, 2011, NUCLEIC ACIDS RES, V39, pD1085, DOI 10.1093/nar/gkq1148	66	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74056	10.1371/journal.pone.0074056	http://dx.doi.org/10.1371/journal.pone.0074056			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040164	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500068
J	Vanhems, P; Barrat, A; Cattuto, C; Pinton, JF; Khanafer, N; Regis, C; Kim, BA; Comte, B; Voirin, N				Vanhems, Philippe; Barrat, Alain; Cattuto, Ciro; Pinton, Jean-Francois; Khanafer, Nagham; Regis, Corinne; Kim, Byeul-a; Comte, Brigitte; Voirin, Nicolas			Estimating Potential Infection Transmission Routes in Hospital Wards Using Wearable Proximity Sensors	PLOS ONE			English	Article							HEALTH-CARE WORKERS; NOSOCOMIAL TRANSMISSION; DISEASE TRANSMISSION; SOCIAL CONTACTS; MIXING PATTERNS; SPREAD; TUBERCULOSIS; INFLUENZA; NETWORK; MODELS	Background: Contacts between patients, patients and health care workers (HCWs) and among HCWs represent one of the important routes of transmission of hospital-acquired infections (HAI). A detailed description and quantification of contacts in hospitals provides key information for HAIs epidemiology and for the design and validation of control measures. Methods and Findings: We used wearable sensors to detect close-range interactions ("contacts") between individuals in the geriatric unit of a university hospital. Contact events were measured with a spatial resolution of about 1.5 meters and a temporal resolution of 20 seconds. The study included 46 HCWs and 29 patients and lasted for 4 days and 4 nights. 14,037 contacts were recorded overall, 94.1% of which during daytime. The number and duration of contacts varied between mornings, afternoons and nights, and contact matrices describing the mixing patterns between HCW and patients were built for each time period. Contact patterns were qualitatively similar from one day to the next. 38% of the contacts occurred between pairs of HCWs and 6 HCWs accounted for 42% of all the contacts including at least one patient, suggesting a population of individuals who could potentially act as super-spreaders. Conclusions: Wearable sensors represent a novel tool for the measurement of contact patterns in hospitals. The collected data can provide information on important aspects that impact the spreading patterns of infectious diseases, such as the strong heterogeneity of contact numbers and durations across individuals, the variability in the number of contacts during a day, and the fraction of repeated contacts across days. This variability is however associated with a marked statistical stability of contact and mixing patterns across days. Our results highlight the need for such measurement efforts in order to correctly inform mathematical models of HAIs and use them to inform the design and evaluation of prevention strategies.	[Vanhems, Philippe; Khanafer, Nagham; Voirin, Nicolas] Hop Edouard Herriot, Hosp Civils Lyon, Serv Hyg Epidemiol & Prevent, Lyon, France; [Vanhems, Philippe; Khanafer, Nagham; Regis, Corinne; Voirin, Nicolas] Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, Equipe Epidemiol & Sante Publ,UMR 5558, F-69365 Lyon, France; [Barrat, Alain] Aix Marseille Univ, CNRS, CPT, UMR 7332, Marseille, France; [Barrat, Alain] Univ Toulon & Var, CNRS, CPT, UMR 7332, La Garde, France; [Barrat, Alain; Cattuto, Ciro] ISI Fdn, Data Sci Lab, Turin, Italy; [Pinton, Jean-Francois] Ecole Normale Super Lyon, CNRS, Lab Phys, UMR 5672, F-69364 Lyon, France; [Kim, Byeul-a; Comte, Brigitte] Hop Edouard Herriot, Hosp Civils Lyon, Serv Geriatrie, Lyon, France	CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Toulon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Ecole Normale Superieure de Lyon (ENS de LYON); CHU Lyon	Voirin, N (corresponding author), Hop Edouard Herriot, Hosp Civils Lyon, Serv Hyg Epidemiol & Prevent, Lyon, France.	nicolas.voirin@chu-lyon.fr	Khanafer, Nagham/AAQ-7114-2020	Khanafer, Nagham/0000-0001-6455-238X; Voirin, Nicolas/0000-0003-3317-056X	Board of Directors of the Leiden University Medical Center (LUMC).; Netherlands Heart Foundation [2009T038, 2007T067]; Netherlands CardioVascular Research Initiative [CVON2011-19]	Board of Directors of the Leiden University Medical Center (LUMC).; Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands CardioVascular Research Initiative	MR Boon is supported by the Board of Directors of the Leiden University Medical Center (LUMC). PCN Rensen and MPJ de Winther are Established Investigators of the Netherlands Heart Foundation (2009T038 and 2007T067). The authors thank the support from the Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation, Dutch Federation of University Medical Centres, the Netherlands Organisation for Health Research and Development and the Royal Netherlands Academy of Sciences for the GENIUS project "Generating the best evidence-based pharmaceutical targets for atherosclerosis" (CVON2011-19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar I, 2012, LANCET INFECT DIS, V12, P66, DOI 10.1016/S1473-3099(11)70246-8; Albrich WC, 2008, LANCET INFECT DIS, V8, P289, DOI 10.1016/S1473-3099(08)70097-5; Baker MG, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2424; Bernard H, 2009, EMERG INFECT DIS, V15, P1438, DOI 10.3201/eid1509.081475; Beutels P, 2006, EPIDEMIOL INFECT, V134, P1158, DOI 10.1017/S0950268806006418; Botelho-Nevers E, 2012, VACCINE, V30, P3996, DOI 10.1016/j.vaccine.2012.04.023; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Chamchod F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029757; Curtis DE, 2010, P 1 ACM INT HLTH INF, P287; Eames KTD, 2008, THEOR POPUL BIOL, V73, P104, DOI 10.1016/j.tpb.2007.09.007; Fennelly KP, 2004, AM J RESP CRIT CARE, V169, P604, DOI 10.1164/rccm.200308-1101OC; Fries J, 2012, INFECT CONT HOSP EP, V33, P689, DOI 10.1086/666346; Halloran ME, 2006, AM J EPIDEMIOL, V164, P945, DOI 10.1093/aje/kwj318; Hornbeck Thomas, 2012, J INFECT DIS; Isella L, 2010, J THEOR BIOL; Isella L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017144; Linquist JA, 2002, AM J INFECT CONTROL, V30, P307, DOI 10.1067/mic.2002.123394; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Mccaw JM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-166; Mikolajczyk RT, 2008, EPIDEMIOL INFECT, V136, P813, DOI 10.1017/S0950268807009181; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Orendi JM, 2010, J HOSP INFECT, V75, P258, DOI 10.1016/j.jhin.2010.03.023; Polgreen PM, 2010, INFECT CONT HOSP EP, V31, P893, DOI 10.1086/655466; Read JM, 2012, EPIDEMIOL INFECT, V140, P2117, DOI 10.1017/S0950268812000842; Richards C, 2004, INFECT CONT HOSP EP, V25, P221, DOI 10.1086/502382; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Shenoi SV, 2010, CLIN INFECT DIS, V50, pS231, DOI 10.1086/651496; Smieszek T, 2012, EPIDEMIOL INFECT, V140, P744, DOI 10.1017/S0950268811001130; Smieszek T, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-35; Smieszek T, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-11; Stehle J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023176; Stehle J, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-87; Temime L, 2009, P NATL ACAD SCI USA, V106, P18420, DOI 10.1073/pnas.0900974106; Trop Skaza A, 2011, EURO SURVEILL; Vanhems P, 2011, ARCH INTERN MED, V171, P151, DOI 10.1001/archinternmed.2010.500; Voirin N, 2009, J HOSP INFECT, V71, P1, DOI 10.1016/j.jhin.2008.08.013; Zagheni E, 2008, AM J EPIDEMIOL, V168, P1082, DOI 10.1093/aje/kwn220; 2003, MMWR MORB MORTAL WKL, V52, P405	38	213	217	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73970	10.1371/journal.pone.0073970	http://dx.doi.org/10.1371/journal.pone.0073970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040129	Green Published, gold, Green Submitted			2022-12-25	WOS:000326734500064
J	Antognelli, C; Mezzasoma, L; Mearini, E; Talesa, VN				Antognelli, Cinzia; Mezzasoma, Letizia; Mearini, Ettore; Talesa, Vincenzo Nicola			Glyoxalase 1-419C > A Variant Is Associated with Oxidative Stress: Implications in Prostate Cancer Progression	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; GENOME-WIDE ASSOCIATION; I GENE; METHYLGLYOXAL; POLYMORPHISMS; RISK; ARGPYRIMIDINE; APOPTOSIS; RAGE; HEAT-SHOCK-PROTEIN-27	Glyoxalase 1 is a scavenging enzyme of potent precursors in reactive oxygen species formation and is involved in the occurrence and progression of human malignancies. Glyoxalase I A111E polymorphism has been suggested to influence its enzymatic activity. The present study was aimed at investigating the association of this polymorphism with oxidative stress and its implications in prostate cancer progression or survival. The polymorphism was genotyped in human differently aggressive and invasive prostate cancer cell lines, in 571 prostate cancer or 588 benign prostatic hyperplasia patients, and 580 healthy subjects by Polymerase Chain Reaction/Restriction Fragment Length Polymorphism. Glyoxalase 1 activity, the pro-oxidant Glyoxalase 1-related Argpyrimidine and oxidative stress biomarkers were evaluated by biochemical analyses. Glyoxalase 1 polymorphism was associated with an increase in Glyoxalase 1-related pro-oxidant Argpyrimidine and oxidative stress levels and cancer progression. The mutant A allele conferred a modest risk of prostate cancer, a marked risk of prostate cancer progression and a lower survival time, compared to the wild C allele. The results of our exploratory study point out a significant role for Glyoxalase 1 in prostate cancer progression, providing an additional candidate for risk assessment in prostate cancer patients and an independent prognostic factor for survival. Finally, we provided evidence of the biological plausibility of Glyoxalase 1 polymorphism, either alone or in combination with other ones, all related to oxidative stress control that represents a key event in PCa development and progression.	[Antognelli, Cinzia; Mezzasoma, Letizia; Talesa, Vincenzo Nicola] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy; [Mearini, Ettore] Univ Perugia, Dept Med Surg Specialties & Publ Hlth, I-06100 Perugia, Italy	University of Perugia; University of Perugia	Talesa, VN (corresponding author), Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy.	talesa@unipg.it	Mearini, Ettore/AAB-9418-2022	ANTOGNELLI, Cinzia/0000-0002-8259-680X; Mezzasoma, Letizia/0000-0002-6159-0927				Acharya A, 2010, OXID MED CELL LONGEV, V3, P23, DOI 10.4161/oxim.3.1.10095; Allmen EU, 2008, PROSTATE, V68, P748, DOI 10.1002/pros.20736; Antognelli C, 2005, PROSTATE, V63, P240, DOI 10.1002/pros.20184; Antognelli C, 2013, PROSTATE, V73, P121, DOI 10.1002/pros.22547; Antognelli C, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-115; Barua M, 2011, AUTISM RES, V4, P262, DOI 10.1002/aur.197; Basu A, 2011, PROSTATE, V71, P755, DOI 10.1002/pros.21292; Chavan Sushant V, 2011, Indian J Med Res, V134, P458; Chen YC, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-41; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Desai KM, 2010, CAN J PHYSIOL PHARM, V88, P273, DOI 10.1139/Y10-001; Ferro E, 2012, FREE RADICAL BIO MED, V53, P1829, DOI 10.1016/j.freeradbiomed.2012.08.592; Fettucciari K, 2006, J IMMUNOL, V176, P7542, DOI 10.4049/jimmunol.176.12.7542; Gebhardt C, 2008, J EXP MED, V205, P275, DOI 10.1084/jem.20070679; Gupta-Elera G, 2012, EUR J CANCER PREV, V21, P155, DOI 10.1097/CEJ.0b013e32834a8002; Guzel S, 2012, BIOL TRACE ELEM RES, V145, P23, DOI 10.1007/s12011-011-9162-2; Hermani A, 2005, EXP CELL RES, V312, P184, DOI 10.1016/j.yexcr.2005.10.013; Ishak MB, 2011, CANCER EPIDEM BIOMAR, V20, P1599, DOI 10.1158/1055-9965.EPI-11-0312; Ishiguro H, 2005, PROSTATE, V64, P92, DOI 10.1002/pros.20219; Jansson KF, 2012, EUR UROL, V62, P656, DOI 10.1016/j.eururo.2012.02.032; Junaid MA, 2004, AM J MED GENET A, V131A, P11, DOI 10.1002/ajmg.a.30349; Kalousova M, 2008, ANN NY ACAD SCI, V1126, P268, DOI 10.1196/annals.1433.012; Kalousova M, 2010, KIDNEY BLOOD PRESS R, V33, P30, DOI 10.1159/000285845; Khandrika L, 2009, CANCER LETT, V282, P125, DOI 10.1016/j.canlet.2008.12.011; Kim J, 2012, EXP MOL MED, V44, P167, DOI 10.3858/emm.2012.44.2.012; Kim KM, 2012, EXP CELL RES, V318, P152, DOI 10.1016/j.yexcr.2011.10.013; Kim ST, 2010, PROSTATE, V70, P1729, DOI 10.1002/pros.21208; Krechler T, 2010, CLIN BIOCHEM, V43, P882, DOI 10.1016/j.clinbiochem.2010.04.004; Larsen MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066262; Mannervik B, 1981, Methods Enzymol, V77, P297; Meagher EA, 2000, FREE RADICAL BIO MED, V28, P1745, DOI 10.1016/S0891-5849(00)00232-X; Mearini E, 2009, BIOMARKERS, V14, P235, DOI 10.1080/13547500902807306; Nakadate Y, 2009, BIOCHEM BIOPH RES CO, V378, P209, DOI 10.1016/j.bbrc.2008.11.028; Nie J, 2012, CHINESE MED J-PEKING, V125, P2598, DOI 10.3760/cma.j.issn.0366-6999.2012.14.035; Peculis R, 2013, GENE, V515, P140, DOI 10.1016/j.gene.2012.11.009; Politi P, 2006, NEUROSCI LETT, V396, P163, DOI 10.1016/j.neulet.2005.11.028; Rabbani N, 2012, AMINO ACIDS, V42, P1133, DOI 10.1007/s00726-010-0783-0; Raj DSC, 2004, AM J KIDNEY DIS, V43, P154, DOI 10.1053/j.ajkd.2003.09.021; Sakamoto H, 2002, J BIOL CHEM, V277, P45770, DOI 10.1074/jbc.M207485200; Sena CM, 2012, PHARMACOL RES, V65, P497, DOI 10.1016/j.phrs.2012.03.004; Shiota M, 2011, FREE RADICAL BIO MED, V51, P1320, DOI 10.1016/j.freeradbiomed.2011.07.011; Sidoti A, 2007, MULT SCLER J, V13, P446, DOI 10.1177/13524585070130040201; Stark JR, 2009, J CLIN ONCOL, V27, P3459, DOI 10.1200/JCO.2008.20.4669; Szabados E, 1999, FREE RADICAL BIO MED, V27, P1103, DOI 10.1016/S0891-5849(99)00151-3; Talesa VN, 2009, CANCER BIOMARK, V5, P241, DOI 10.3233/CBM-2009-0109; Thornalley PJ, 2011, SEMIN CELL DEV BIOL, V22, P318, DOI 10.1016/j.semcdb.2011.02.006; Van der Velden WJFM, 2011, BONE MARROW TRANSPL, V46, P906, DOI 10.1038/bmt.2010.211; van Heijst JWJ, 2006, CANCER LETT, V241, P309, DOI 10.1016/j.canlet.2005.10.042; Varghese JS, 2010, CURR OPIN GENET DEV, V20, P201, DOI 10.1016/j.gde.2010.03.012; Williams RP, 2009, IBM J RES DEV, V53, P1, DOI 10.1147/JRD.2009.5429026; Wu JC, 2011, GENET TEST MOL BIOMA, V15, P273, DOI 10.1089/gtmb.2010.0075	51	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74014	10.1371/journal.pone.0074014	http://dx.doi.org/10.1371/journal.pone.0074014			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040147	Green Published, gold, Green Submitted			2022-12-25	WOS:000327538600059
J	Chen, HY; Ma, XM; Ye, M; Hou, YL; Xie, HY; Bai, YR				Chen, Hai-yan; Ma, Xiu-mei; Ye, Ming; Hou, Yan-li; Xie, Hua-Ying; Bai, Yong-rui			Effectiveness and Toxicities of Intensity-Modulated Radiotherapy for Patients with Locally Recurrent Nasopharyngeal Carcinoma	PLOS ONE			English	Article							RETROSPECTIVE ANALYSIS; RADIATION-THERAPY; REIRRADIATION; SURVIVAL; PATTERNS; SALVAGE	Purpose: To analyze the effectiveness and toxicities in the re-irradiation of locally recurrent nasopharyngeal carcinoma (NPC) using intensity-modulated radiotherapy (IMRT). Methods: This is a retrospective analysis of 54 NPC patients with local recurrence re-irradiated with IMRT. The re-staging for rT1, rT2, rT3, rT4 were 3 (5.6%), 8 (14.8%), 9 (16.7%), 34 (63%) respectively. The average dose to GTV was 69.95 Gy (49.8-76.58 Gy), the average BED3Gy was 116.8 Gy (83.5-127.9 Gy). V-95 was 96%, and D-95 was 65.75Gy. 33.3% of them received concurrent chemoradiotherapy. Results: Median overall survival (OS) was 21 months (1-93 mon). The 1-, 2-year local progression free survival (LPFS) rate was 84.5%, 64% and OS rate was 71.7%, 44.3%. Severe late adverse events (SLAE) occurred in 48.1% of patients, including 31.5% with ulcer or necrosis of the nasopharyngeal mucosa, 20.4% with difficulty in feeding, 18.5% with temporal lobe necrosis, 11.1% with massive hemorrhage. 15.4% died of local regional progression, 5.8% died of distant metastasis, 25% died of SLAE, 9.6% died of both local regional progression and SLAE that could not be differentiated, 5.8% died of other medical complications. Concurrent chemoradiotherapy was the independent negative prognostic factors for LPFS; PTV>100 ml was a predictive factor of poor OS; patients with invasion of post-styloid space were at higher risk of SLAE. Conclusions: The present study demonstrated that IMRT with 70Gy was efficient for local tumor control. However, we observed a high frequency of serious late complications. More optimized combination treatment and patient selection are required to achieve excellent local control without significant late morbidities in locally recurrent NPC.	[Chen, Hai-yan; Ma, Xiu-mei; Ye, Ming; Hou, Yan-li; Xie, Hua-Ying; Bai, Yong-rui] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Radiat Oncol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Bai, YR (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Radiat Oncol, Shanghai 200030, Peoples R China.	baiyongrui@renji.com	Chen, Haiyan/HGB-6216-2022					Chang JTC, 2000, RADIOTHER ONCOL, V54, P135, DOI 10.1016/S0167-8140(99)00177-2; Chua DTT, 2005, RADIOTHER ONCOL, V77, P290, DOI 10.1016/j.radonc.2005.10.010; Corry J, 2006, INT J RADIAT ONCOL, V64, P63, DOI 10.1016/j.ijrobp.2005.06.041; Han F, 2012, CLIN ONCOL-UK, V24, P569, DOI 10.1016/j.clon.2011.11.010; Hua YJ, 2009, HEAD NECK-J SCI SPEC, V31, P807, DOI 10.1002/hed.21036; Jurado JA, 2008, CATHETER CARDIO INTE, V72, P563, DOI 10.1002/ccd.21681; Koutcher L, 2010, INT J RADIAT ONCOL, V76, P130, DOI 10.1016/j.ijrobp.2009.01.055; LEE AWM, 1993, INT J RADIAT ONCOL, V26, P773, DOI 10.1016/0360-3016(93)90491-D; LEE AWM, 1992, INT J RADIAT ONCOL, V23, P261, DOI 10.1016/0360-3016(92)90740-9; Leung TW, 2000, INT J RADIAT ONCOL, V48, P1331, DOI 10.1016/S0360-3016(00)00776-8; Lu TX, 2004, INT J RADIAT ONCOL, V58, P682, DOI 10.1016/S0360-3016(03)01508-6; MARX RE, 1983, J ORAL MAXIL SURG, V41, P283, DOI 10.1016/0278-2391(83)90294-X; Ozyigit G, 2011, INT J RADIAT ONCOL, V81, pE263, DOI 10.1016/j.ijrobp.2011.02.054; Qiu SF, 2012, INT J RADIAT ONCOL, V83, P676, DOI 10.1016/j.ijrobp.2011.07.006; Suarez C, 2010, EUR ARCH OTO-RHINO-L, V267, P1811, DOI 10.1007/s00405-010-1385-x; WANG CC, 1987, INT J RADIAT ONCOL, V13, P953, DOI 10.1016/0360-3016(87)90030-7; Wee J, 2005, J CLIN ONCOL, V23, P6730, DOI 10.1200/JCO.2005.16.790; Wu Jun-xin, 2012, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V47, P185	18	39	45	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73918	10.1371/journal.pone.0073918	http://dx.doi.org/10.1371/journal.pone.0073918			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040115	Green Published, gold, Green Submitted			2022-12-25	WOS:000327538600052
J	Maldonado, AY; Burz, DS; Reverdatto, S; Shekhtman, A				Maldonado, Andres Y.; Burz, David S.; Reverdatto, Sergey; Shekhtman, Alexander			Fate of Pup inside the Mycobacterium Proteasome Studied by in-Cell NMR	PLOS ONE			English	Article							UBIQUITIN-LIKE PROTEIN; INTRINSICALLY DISORDERED PROTEIN; ATPASE MPA; STINT-NMR; TUBERCULOSIS; SPECTROSCOPY; PATHWAY; PUPYLATION; MECHANISMS; TETRAMER	The Mycobacterium tuberculosis proteasome is required for maximum virulence and to resist killing by the host immune system. The prokaryotic ubiquitin-like protein, Pup-GGE, targets proteins for proteasome-mediated degradation. We demonstrate that Pup-GGQ, a precursor of Pup-GGE, is not a substrate for proteasomal degradation. Using STINT-NMR, an in-cell NMR technique, we studied the interactions between Pup-GGQ, mycobacterial proteasomal ATPase, Mpa, and Mtb proteasome core particle (CP) inside a living cell at amino acid residue resolution. We showed that under in-cell conditions, in the absence of the proteasome CP, Pup-GGQ interacts with Mpa only weakly, primarily through its C-terminal region. When Mpa and non-stoichiometric amounts of proteasome CP are present, both the N-terminal and C-terminal regions of Pup-GGQ bind strongly to Mpa. This suggests a mechanism by which transient binding of Mpa to the proteasome CP controls the fate of Pup.	[Maldonado, Andres Y.; Burz, David S.; Reverdatto, Sergey; Shekhtman, Alexander] SUNY Albany, Dept Chem, Albany, NY 12222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany	Shekhtman, A (corresponding author), SUNY Albany, Dept Chem, Albany, NY 12222 USA.	ashekhtman@albany.edu		Shekhtman, Alexander/0000-0003-2649-2675	NIH [R01GM085006]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085006] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by NIH grant (www.nih.gov), R01GM085006 to A.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Burns KE, 2010, MOL CELL, V39, P821, DOI 10.1016/j.molcel.2010.07.019; Burns KE, 2010, J BACTERIOL, V192, P2933, DOI 10.1128/JB.01639-09; Burns KE, 2009, J BIOL CHEM, V284, P3069, DOI 10.1074/jbc.M808032200; Burz DS, 2006, NAT PROTOC, V1, P146, DOI 10.1038/nprot.2006.23; Burz DS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002571; BURZ DS, 1994, BIOCHEMISTRY-US, V33, P8399, DOI 10.1021/bi00194a003; Burz DS, 2006, NAT METHODS, V3, P91, DOI 10.1038/NMETH851; Cerda-Maira FA, 2011, EMBO REP, V12, P863, DOI 10.1038/embor.2011.109; Cerda-Maira FA, 2010, MOL MICROBIOL, V77, P1123, DOI 10.1111/j.1365-2958.2010.07276.x; Chen X, 2009, J MOL BIOL, V392, P208, DOI 10.1016/j.jmb.2009.07.018; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Creighton T.E., 1992, PROTEINS STRUCTURES; Darwin KH, 2005, MOL MICROBIOL, V55, P561, DOI 10.1111/j.1365-2958.2004.04403.x; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; Delley CL, 2012, J BIOL CHEM, V287, P7907, DOI 10.1074/jbc.M111.331124; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Goodsell D. S., 2009, MACHINERY LIFE; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hu GQ, 2006, MOL MICROBIOL, V59, P1417, DOI 10.1111/j.1365-2958.2005.05036.x; Imkamp F, 2010, EMBO REP, V11, P791, DOI 10.1038/embor.2010.119; Imkamp F, 2010, MOL MICROBIOL, V75, P744, DOI 10.1111/j.1365-2958.2009.07013.x; Li CG, 2008, J AM CHEM SOC, V130, P6310, DOI 10.1021/ja801020z; Li DY, 2010, EMBO J, V29, P2037, DOI 10.1038/emboj.2010.95; Liao SH, 2009, BIOCHEM J, V422, P207, DOI 10.1042/BJ20090738; Lin G, 2006, MOL MICROBIOL, V59, P1405, DOI 10.1111/j.1365-2958.2005.05035.x; Maldonado AY, 2011, PROG NUCL MAG RES SP, V59, P197, DOI 10.1016/j.pnmrs.2010.11.002; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Serber Z, 2001, BIOCHEMISTRY-US, V40, P14317, DOI 10.1021/bi011751w; Striebel F, 2010, EMBO J, V29, P1262, DOI 10.1038/emboj.2010.23; Striebel F, 2009, NAT STRUCT MOL BIOL, V16, P647, DOI 10.1038/nsmb.1597; Sutter M, 2010, J AM CHEM SOC, V132, P5610, DOI 10.1021/ja910546x; Sutter M, 2009, FEBS LETT, V583, P3151, DOI 10.1016/j.febslet.2009.09.020; Tomko RJ, 2011, CELL BIOCHEM BIOPHYS, V60, P13, DOI 10.1007/s12013-011-9178-4; Wang T, 2010, NAT STRUCT MOL BIOL, V17, P1352, DOI 10.1038/nsmb.1918; Wang T, 2009, STRUCTURE, V17, P1377, DOI 10.1016/j.str.2009.08.010; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Zimhony O, 2004, J BACTERIOL, V186, P4051, DOI 10.1128/JB.186.13.4051-4055.2004	43	27	27	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74576	10.1371/journal.pone.0074576	http://dx.doi.org/10.1371/journal.pone.0074576			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040288	Green Submitted, gold, Green Published			2022-12-25	WOS:000327538600099
J	Greer, C; Lee, M; Westerhof, M; Milholland, B; Spokony, R; Vijg, J; Secombe, J				Greer, Christina; Lee, Moonsook; Westerhof, Maaike; Milholland, Brandon; Spokony, Rebecca; Vijg, Jan; Secombe, Julie			Myc-Dependent Genome Instability and Lifespan in Drosophila	PLOS ONE			English	Article							C-MYC; DNA-DAMAGE; GROWTH; REARRANGEMENTS; MAINTENANCE; SENESCENCE; INITIATION; STABILITY; MECHANISM; INSULIN	The Myc family of transcription factors are key regulators of cell growth and proliferation that are dysregulated in a large number of human cancers. When overexpressed, Myc family proteins also cause genomic instability, a hallmark of both transformed and aging cells. Using an in vivo lacZ mutation reporter, we show that overexpression of Myc in Drosophila increases the frequency of large genome rearrangements associated with erroneous repair of DNA double-strand breaks (DSBs). In addition, we find that overexpression of Myc shortens adult lifespan and, conversely, that Myc haploinsufficiency reduces mutation load and extends lifespan. Our data provide the first evidence that Myc may act as a pro-aging factor, possibly through its ability to greatly increase genome instability.	[Greer, Christina; Lee, Moonsook; Westerhof, Maaike; Milholland, Brandon; Vijg, Jan; Secombe, Julie] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Spokony, Rebecca] Univ Chicago, Dept Human Genet, Knapp Ctr Biomed Discovery, Chicago, IL 60637 USA	Yeshiva University; Albert Einstein College of Medicine; University of Chicago	Secombe, J (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA.	julie.secombe@einstein.yu.edu	Spokony, Rebecca/AAD-3014-2020	Greer, Christina/0000-0001-6863-5975	Einstein Shock Center Pilot grant [AG038072];  [AG17242]; NATIONAL INSTITUTE ON AGING [P01AG017242, P30AG038072] Funding Source: NIH RePORTER	Einstein Shock Center Pilot grant; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by AG17242 to J.V. and a Einstein Shock Center Pilot grant to J.S. (AG038072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; de la Cova C, 2006, SEMIN CANCER BIOL, V16, P303, DOI 10.1016/j.semcancer.2006.07.010; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Garcia Ana Maria, 2007, Methods Mol Biol, V371, P267; Garcia AM, 2007, NAT METHODS, V4, P401, DOI 10.1038/NMETH1027; Garcia AM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r121; Garcia AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000950; GARDNER L, 2002, ENCY CANC; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Ilic N, 2011, P NATL ACAD SCI USA, V108, pE699, DOI 10.1073/pnas.1108237108; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Jungreis I, 2011, GENOME RES, V21, P2096, DOI 10.1101/gr.119974.110; Knoch J, 2012, EUR J DERMATOL, V22, P443, DOI 10.1684/ejd.2012.1654; Kuschak TI, 1999, GENE, V238, P351, DOI 10.1016/S0378-1119(99)00341-8; Li WG, 2012, GERONTOLOGY, V58, P129, DOI 10.1159/000334368; Li ZZ, 2012, NEOPLASIA, V14, P1190, DOI 10.1593/neo.121258; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Luoto KR, 2010, CANCER RES, V70, P8748, DOI 10.1158/0008-5472.CAN-10-0944; Mai Sabine, 1999, Neoplasia (New York), V1, P241, DOI 10.1038/sj.neo.7900030; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Muellner MK, 2011, NAT CHEM BIOL, V7, P787, DOI 10.1038/nchembio.695; Mushinski JF, 1999, CURR TOP MICROBIOL, V246, P183; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Orian A, 2005, COLD SH Q B, V70, P299, DOI 10.1101/sqb.2005.70.019; Parisi F, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-65; Pierce SB, 2004, DEVELOPMENT, V131, P2317, DOI 10.1242/dev.01108; Prober DA, 2002, GENE DEV, V16, P2286, DOI 10.1101/gad.991102; Prober DA, 2001, CURR OPIN GENET DEV, V11, P19, DOI 10.1016/S0959-437X(00)00151-9; Prochownik EV, 2007, CELL CYCLE, V6, P1024, DOI 10.4161/cc.6.9.4161; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ray S, 2006, CANCER RES, V66, P6598, DOI 10.1158/0008-5472.CAN-05-3115; Rockwood LD, 2002, ONCOGENE, V21, P7235, DOI 10.1038/sj.onc.1205697; Secombe J, 2007, CELL CYCLE, V6, P1324, DOI 10.4161/cc.6.11.4269; Shen J, 2009, AGING-US, V1, P191, DOI 10.18632/aging.100018; Taylor C, 1997, CURR TOP MICROBIOL, V224, P201; Taylor C, 1998, CANCER DETECT PREV, V22, P350, DOI 10.1046/j.1525-1500.1998.CDOA36.x; Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/NMETH.1331, 10.1038/nmeth.1331]; Vijg J, 2005, ANNU REV MED, V56, P193, DOI 10.1146/annurev.med.56.082103.104617; Vijg J, 2002, MECH AGEING DEV, V123, P907, DOI 10.1016/S0047-6374(02)00028-3; Vijg J., 2007, AGING GENOME; Vijg J, 2013, ANNU REV PHYSIOL, V75, P645, DOI 10.1146/annurev-physiol-030212-183715; Wolfer A, 2010, CELL CYCLE, V9, P3639, DOI 10.4161/cc.9.18.13220; Wolfer A, 2010, P NATL ACAD SCI USA, V107, P3698, DOI 10.1073/pnas.0914203107	55	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e74641	10.1371/journal.pone.0074641	http://dx.doi.org/10.1371/journal.pone.0074641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040302	Green Published, gold			2022-12-25	WOS:000324856500090
J	Uberto, R; Moomaw, EW				Uberto, Richard; Moomaw, Ellen W.			Protein Similarity Networks Reveal Relationships among Sequence, Structure, and Function within the Cupin Superfamily	PLOS ONE			English	Article							SEED STORAGE PROTEINS; PRELIMINARY-X-RAY; CRYSTAL-STRUCTURE; BACILLUS-SUBTILIS; QUERCETIN 2,3-DIOXYGENASE; ACIREDUCTONE DIOXYGENASE; OXALATE DECARBOXYLASE; DIVERGENT EVOLUTION; MICROBIAL RELATIVES; ANGSTROM RESOLUTION	The cupin superfamily is extremely diverse and includes catalytically inactive seed storage proteins, sugar-binding metal-independent epimerases, and metal-dependent enzymes possessing dioxygenase, decarboxylase, and other activities. Although numerous proteins of this superfamily have been structurally characterized, the functions of many of them have not been experimentally determined. We report the first use of protein similarity networks (PSNs) to visualize trends of sequence and structure in order to make functional inferences in this remarkably diverse superfamily. PSNs provide a way to visualize relatedness of structure and sequence among a given set of proteins. Structure- and sequence-based clustering of cupin members reflects functional clustering. Networks based only on cupin domains and networks based on the whole proteins provide complementary information. Domain-clustering supports phylogenetic conclusions that the N- and C-terminal domains of bicupin proteins evolved independently. Interestingly, although many functionally similar enzymatic cupin members bind the same active site metal ion, the structure and sequence clustering does not correlate with the identity of the bound metal. It is anticipated that the application of PSNs to this superfamily will inform experimental work and influence the functional annotation of databases.	[Uberto, Richard; Moomaw, Ellen W.] Kennesaw State Univ, Dept Chem & Biochem, Kennesaw, GA 30144 USA	University System of Georgia; Kennesaw State University	Moomaw, EW (corresponding author), Kennesaw State Univ, Dept Chem & Biochem, Kennesaw, GA 30144 USA.	emoomaw@kennesaw.edu		Moomaw, Ellen/0000-0002-2341-1676	National Science Foundation [MCB-1041912]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (MCB-1041912) to EWM (http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2001, J MOL BIOL, V305, P291, DOI 10.1006/jmbi.2000.4310; Adams M, 2005, J BIOL CHEM, V280, P28675, DOI 10.1074/jbc.M501034200; Agarwal G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005736; Allewell NM, 2012, J BIOL CHEM, V287, P1, DOI 10.1074/jbc.R111.307322; Anand R, 2002, BIOCHEMISTRY-US, V41, P7659, DOI 10.1021/bi0200965; Anantharaman V, 2003, CURR OPIN CHEM BIOL, V7, P12, DOI 10.1016/S1367-5931(02)00018-2; Anantharaman V, 2001, J MOL BIOL, V307, P1271, DOI 10.1006/jmbi.2001.4508; Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039; Atkinson HJ, 2009, TRENDS PARASITOL, V25, P573, DOI 10.1016/j.pt.2009.09.006; Atkinson HJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000541; Atkinson HJ, 2009, BIOCHEMISTRY-US, V48, P11108, DOI 10.1021/bi901180v; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; Barber AE, 2012, BIOINFORMATICS, V28, P2845, DOI 10.1093/bioinformatics/bts532; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bitto E, 2005, ACTA CRYSTALLOGR F, V61, P469, DOI 10.1107/S1744309105011565; Blaby-Haas CE, 2012, BBA-MOL CELL RES, V1823, P1531, DOI 10.1016/j.bbamcr.2012.04.010; Bowater L, 2004, FEBS LETT, V557, P45, DOI 10.1016/S0014-5793(03)01439-X; Brown SD, 2012, J BIOL CHEM, V287, P35, DOI 10.1074/jbc.R111.283408; Chang YY, 2011, BIOCHEM J, V433, P295, DOI 10.1042/BJ20101418; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Christendat D, 2000, J BIOL CHEM, V275, P24608, DOI 10.1074/jbc.C000238200; Chruszcz M, 2011, J BIOL CHEM, V286, P39318, DOI 10.1074/jbc.M111.270132; Cleasby A, 1996, NAT STRUCT BIOL, V3, P470, DOI 10.1038/nsb0596-470; Clissold PM, 2001, TRENDS BIOCHEM SCI, V26, P7, DOI 10.1016/S0968-0004(00)01700-X; Colabroy KL, 2005, BIOCHEMISTRY-US, V44, P7623, DOI 10.1021/bi0473455; Dai Y, 1999, J BIOL CHEM, V274, P1193, DOI 10.1074/jbc.274.3.1193; Dai Y, 2001, BIOCHEMISTRY-US, V40, P6379, DOI 10.1021/bi010110y; Davis ML, 2007, J BIOL CHEM, V282, P19227, DOI 10.1074/jbc.M702529200; Dilovic I, 2009, BIOPOLYMERS, V91, P1189, DOI 10.1002/bip.21167; Dong C, 2007, J MOL BIOL, V365, P146, DOI 10.1016/j.jmb.2006.09.063; Dong CJ, 2003, STRUCTURE, V11, P715, DOI 10.1016/S0969-2126(03)00098-4; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Dunwell JM, 2000, MICROBIOL MOL BIOL R, V64, P153, DOI 10.1128/MMBR.64.1.153-179.2000; Dunwell JM, 1998, BIOTECHNOL GENET ENG, V15, P1; Dunwell JM, 1998, J MOL EVOL, V46, P147, DOI 10.1007/PL00006289; Fusetti F, 2002, STRUCTURE, V10, P259, DOI 10.1016/S0969-2126(02)00704-9; Galperin MY, 2012, J BIOL CHEM, V287, P21, DOI 10.1074/jbc.R111.241976; Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209; Gerlt JA, 2012, J BIOL CHEM, V287, P29, DOI 10.1074/jbc.R111.240945; Giraud MF, 2000, NAT STRUCT BIOL, V7, P398; Glasner ME, 2006, CURR OPIN CHEM BIOL, V10, P492, DOI 10.1016/j.cbpa.2006.08.012; Gopal B, 2005, BIOCHEMISTRY-US, V44, P193, DOI 10.1021/bi0484421; Hicks MA, 2011, PROTEINS, V79, P3082, DOI 10.1002/prot.23135; Hong X, 2010, P NATL ACAD SCI USA, V107, P14568, DOI 10.1073/pnas.1008832107; Horton JR, 2011, J MOL BIOL, V406, P1, DOI 10.1016/j.jmb.2010.12.013; IRVING H, 1953, J CHEM SOC, P3192, DOI 10.1039/jr9530003192; Iyer LM, 2010, NUCLEIC ACIDS RES, V38, P5261, DOI 10.1093/nar/gkq265; Jakimowicz P, 2006, PROTEINS, V63, P261, DOI 10.1002/prot.20818; Jakimowicz P, 2003, ACTA CRYSTALLOGR D, V59, P1507, DOI 10.1107/S0907444903012848; Just VJ, 2004, J BIOL CHEM, V279, P19867, DOI 10.1074/jbc.M313820200; Kantardjieff KA, 2004, ACTA CRYSTALLOGR D, V60, P895, DOI 10.1107/S0907444904005323; Kato M, 2011, NUCLEIC ACIDS RES, V39, P1576, DOI 10.1093/nar/gkq919; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; LAWRENCE MC, 1994, J MOL BIOL, V238, P748, DOI 10.1006/jmbi.1994.1333; Levin EJ, 2007, STRUCTURE, V15, P1040, DOI 10.1016/j.str.2007.06.019; Lo Conte L, 2002, NUCLEIC ACIDS RES, V30, P264; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Maruyama N, 2003, BBA-PROTEINS PROTEOM, V1648, P99, DOI 10.1016/S1570-9639(03)00113-4; McCoy JG, 2006, P NATL ACAD SCI USA, V103, P3084, DOI 10.1073/pnas.0509262103; Merkel AB, 2002, ACTA CRYSTALLOGR D, V58, P1226, DOI 10.1107/S0907444902007382; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Noma A, 2010, J BIOL CHEM, V285, P34503, DOI 10.1074/jbc.M110.156398; O'Brien JR, 2003, BIOCHEMISTRY-US, V42, P5547, DOI 10.1021/bi0341096; Opaleye O, 2006, J BIOL CHEM, V281, P6428, DOI 10.1074/jbc.M510256200; Pieper Ursula, 2009, Journal of Structural and Functional Genomics, V10, P107, DOI 10.1007/s10969-008-9056-5; Pochapsky TC, 2006, J BIOMOL NMR, V34, P117, DOI 10.1007/s10858-005-5735-8; Pochapsky TC, 2002, NAT STRUCT BIOL, V9, P966, DOI 10.1038/nsb863; Rajavel M, 2009, J BIOL CHEM, V284, P31882, DOI 10.1074/jbc.M109.014522; Sagurthi SR, 2009, ACTA CRYSTALLOGR D, V65, P724, DOI 10.1107/S0907444909013328; Schaab MR, 2006, BIOCHEMISTRY-US, V45, P1009, DOI 10.1021/bi051571c; Sengoku T, 2011, GENE DEV, V25, P2266, DOI 10.1101/gad.172296.111; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; STIRK HJ, 1992, FEBS LETT, V308, P1, DOI 10.1016/0014-5793(92)81036-L; Tandang-Silvas MRG, 2010, BBA-PROTEINS PROTEOM, V1804, P1432, DOI 10.1016/j.bbapap.2010.02.016; Tanner A, 2001, J BIOL CHEM, V276, P43627, DOI 10.1074/jbc.M107202200; Teplyakov A, 2005, J BACTERIOL, V187, P5520, DOI 10.1128/JB.187.16.5520-5527.2005; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Upadhyay AK, 2012, J MOL BIOL, V416, P319, DOI 10.1016/j.jmb.2011.12.036; Woo EJ, 2000, ACTA CRYSTALLOGR D, V56, P1476, DOI 10.1107/S0907444900010714; Woo EJ, 2000, NAT STRUCT BIOL, V7, P1036; Xu QP, 2006, PROTEINS, V64, P808, DOI 10.1002/prot.20947; Yang M, 2011, FEBS J, V278, P1086, DOI 10.1111/j.1742-4658.2011.08022.x; Yang Y, 2010, CELL RES, V20, P886, DOI 10.1038/cr.2010.86; Ye S, 2007, J BIOL CHEM, V282, P3391, DOI 10.1074/jbc.M609337200; Yu L, 2010, CELL RES, V20, P166, DOI 10.1038/cr.2010.8; Zhang Y, 2005, BIOCHEMISTRY-US, V44, P7632, DOI 10.1021/bi047353l; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	91	43	43	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e74477	10.1371/journal.pone.0074477	http://dx.doi.org/10.1371/journal.pone.0074477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040257	gold, Green Published, Green Submitted			2022-12-25	WOS:000324856500083
J	Machuca, MA; Sosa, LM; Gonzalez, CI				Alejandra Machuca, Mayra; Miguel Sosa, Luis; Isabel Gonzalez, Clara			Molecular Typing and Virulence Characteristic of Methicillin-Resistant Staphylococcus Aureus Isolates from Pediatric Patients in Bucaramanga, Colombia	PLOS ONE			English	Article							VALENTINE LEUCOCIDIN GENES; TOXIN GENES; PROTEIN-A; RAPID IDENTIFICATION; PCR STRATEGY; COMMUNITY; INFECTIONS; STRAINS; CLONE; MEC	Background: Staphylococcus aureus is among the most common global nosocomial pathogens. The emergence and spread of methicillin-resistant Staphylococcus aureus (MRSA) is a public health problem worldwide that causes nosocomial and community infections. The goals of this study were to establish the clonal complexes (CC) of the isolates of MRSA obtained from pediatric patients in a university hospital in Colombia and to investigate its molecular characteristics based on the virulence genes and the genes of staphylococcal toxins and adhesins. Methods: A total of 53 MRSA isolates from pediatric patients with local or systemic infections were collected. The MRSA isolates were typed based on the SCCmec, MLST, spa and agr genes. The molecular characterization included the detection of Panton-Valentine Leukocidin, superantigenic and exfoliative toxins, and adhesin genes. The correlation between the molecular types identified and the profile of virulence factors was determined for all isolates. Results: Four CC were identified, including CC8, CC5, CC80 and CC78. The ST8-MRSA-IVc-agrI was the predominant clone among the isolates, followed by the ST5-MRSA-I-agrII and ST5-MRSA-IVc-agrII clones. Twelve spa types were identified, of which t10796 and t10799 were new repeat sequences. The isolates were carriers of toxin genes, and hlg (100%), sek (92%) and pvl (88%) were the most frequent. Ten toxin gene profiles were observed, and the most frequent were seq-sek-hlg (22.6%), sek-hlg (22.6%), seb-seq-sek-hlg (18.9%) and seb-sek-hlg (15.1%). The adhesion genes were present in most of the MRSA isolates, including the following: clf-A (89%), clf-B (87%), fnb-A (83%) and ica (83%). The majority of the strains carried SCCmec-IVc and were identified as causing nosocomial infection. No significant association between a molecular type and the virulence factors was found. Conclusion: Four major MRSA clone complexes were identified among the isolates. ST8-MRSA-IVc-agrI pvl+ (USA300-LV) was the most frequent, confirming the presence of community-associated MRSA in Colombian hospitals.	[Alejandra Machuca, Mayra; Isabel Gonzalez, Clara] Univ Ind Santander, Fac Salud, GIEM, Bucaramanga, Colombia; [Miguel Sosa, Luis] Univ Ind Santander, Fac Salud, Hosp Univ Santander, Dept Pediat,Grp PAIDOS, Bucaramanga, Colombia	Universidad Industrial de Santander; Universidad Industrial de Santander	Gonzalez, CI (corresponding author), Univ Ind Santander, Fac Salud, GIEM, Bucaramanga, Colombia.	cig@uis.edu.co		Gonzalez, Clara Isabel/0000-0002-0278-1512	Departamento Administrativo de Ciencia, Tecnologia e Innovacion - COLCIENCIAS [1102-408-20559]	Departamento Administrativo de Ciencia, Tecnologia e Innovacion - COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This research was supported by the Departamento Administrativo de Ciencia, Tecnologia e Innovacion - COLCIENCIAS, Project: 1102-408-20559. The funding sources had no role in the study design, data collection and analysis; the decision to publish; or preparation of the manuscript.	Abdel-Haq N, 2009, EUR J CLIN MICROBIOL, V28, P547, DOI 10.1007/s10096-008-0658-4; Alvarez CA, 2010, AM J INFECT CONTROL, V38, P315, DOI 10.1016/j.ajic.2009.05.013; [Anonymous], 2009, PERFORMANCE STANDARD, V19; Arias CA, 2008, NEW ENGL J MED, V359, P2177, DOI 10.1056/NEJMc0804021; Arvidson S, 2001, INT J MED MICROBIOL, V291, P159, DOI 10.1078/1438-4221-00112; Becker AP, 2011, EPIDEMIOL INFECT, P1; Becker K, 2003, J CLIN MICROBIOL, V41, P1434, DOI 10.1128/JCM.41.4.1434-1439.2003; Chongtrakool P, 2006, ANTIMICROB AGENTS CH, V50, P1001, DOI 10.1128/AAC.50.3.1001-1012.2006; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Cruz C, 2005, INT J ANTIMICROB AG, V26, P457, DOI 10.1016/j.ijantimicag.2005.08.013; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Deresinski S, 2005, CLIN INFECT DIS, V40, P562, DOI 10.1086/427701; Deurenberg RH, 2008, INFECT GENET EVOL, V8, P747, DOI 10.1016/j.meegid.2008.07.007; Dohin B, 2007, PEDIATR INFECT DIS J, V26, P1042, DOI 10.1097/INF.0b013e318133a85e; Dufour P, 2002, CLIN INFECT DIS, V35, P819, DOI 10.1086/342576; Elasri MO, 2002, BONE, V30, P275, DOI 10.1016/S8756-3282(01)00632-9; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Frenay HME, 1996, EUR J CLIN MICROBIOL, V15, P60, DOI 10.1007/BF01586186; Gardella N., 2005, Rev. argent. microbiol., V37, P156; Gilot P, 2002, J CLIN MICROBIOL, V40, P4060, DOI 10.1128/JCM.40.11.4060-4067.2002; Gomes AR, 2001, MICROB DRUG RESIST, V7, P23, DOI 10.1089/107662901750152729; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Ho CM, 2010, EUR J CLIN MICROBIOL, V29, P383, DOI 10.1007/s10096-009-0868-4; Holmes A, 2005, J CLIN MICROBIOL, V43, P2384, DOI 10.1128/JCM.43.5.2384-2390.2005; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Jeric PE, 2006, MEDICINA-BUENOS AIRE, V66, P36; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Larkin EA, 2009, CURR MED CHEM, V16, P4003, DOI 10.2174/092986709789352321; Leon E., 1996, COLOMB MEDICA, V27, P69; Lim KT, 2012, TROP BIOMED, V29, P212; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lo WT, 2010, BRIT J DERMATOL, V162, P1110, DOI 10.1111/j.1365-2133.2010.09679.x; LONDOÑO JUAN F, 2006, Infect., V10, P160; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Lu PL, 2008, NEPHROL DIAL TRANSPL, V23, P1659, DOI 10.1093/ndt/gfm806; Marimon JM, 2012, J INFECTION, V64, P47, DOI 10.1016/j.jinf.2011.10.010; Mayor L, 2007, J CLIN MICROBIOL, V45, P2298, DOI 10.1128/JCM.00040-07; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; MOREILLON P, 1995, INFECT IMMUN, V63, P4738, DOI 10.1128/IAI.63.12.4738-4743.1995; Jimenez JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038576; Jimenez JN, 2011, MEM I OSWALDO CRUZ, V106, P980, DOI 10.1590/S0074-02762011000800013; Nimmo GR, 2012, CLIN MICROBIOL INFEC, V18, P725, DOI 10.1111/j.1469-0691.2012.03822.x; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Palmqvist N, 2002, MICROB PATHOGENESIS, V33, P239, DOI 10.1006/mpat.2002.0533; Peacock SJ, 2002, INFECT IMMUN, V70, P4987, DOI 10.1128/IAI.70.9.4987-4996.2002; Perez D, 2003, UNIVERSITAS MED, V44; Rodriguez-Noriega E, 2010, INT J INFECT DIS, V14, pE560, DOI 10.1016/j.ijid.2009.08.018; Sakoulas G, 2002, ANTIMICROB AGENTS CH, V46, P1492, DOI 10.1128/AAC.46.5.1492-1502.2002; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Shopsin B, 2003, J CLIN MICROBIOL, V41, P456, DOI 10.1128/JCM.41.1.456-459.2003; Sola C, 2006, J CLIN MICROBIOL, V44, P192, DOI 10.1128/JCM.44.1.192-200.2006; Sola C, 2002, J CLIN MICROBIOL, V40, P1427, DOI 10.1128/JCM.40.4.1427-1435.2002; Sola C, 2008, J CLIN MICROBIOL, V46, P1826, DOI 10.1128/JCM.01949-07; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; Tokajian ST, 2010, EPIDEMIOL INFECT, V138, P707, DOI 10.1017/S0950268810000440; Tristan A, 2007, J HOSP INFECT, V65, P105, DOI 10.1016/S0195-6701(07)60025-5; van Trijp MJCA, 2010, DIAGN MICR INFEC DIS, V66, P222, DOI 10.1016/j.diagmicrobio.2009.08.021; Wang JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009489; Wang WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030394; Wu DJ, 2010, DIAGN MICR INFEC DIS, V67, P1, DOI 10.1016/j.diagmicrobio.2009.12.006	62	38	40	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e73434	10.1371/journal.pone.0073434	http://dx.doi.org/10.1371/journal.pone.0073434			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24058415	Green Published, Green Submitted, gold			2022-12-25	WOS:000324403200050
J	Spratt, DE; Mercier, P; Shaw, GS				Spratt, Donald E.; Mercier, Pascal; Shaw, Gary S.			Structure of the HHARI Catalytic Domain Shows Glimpses of a HECT E3 Ligase	PLOS ONE			English	Article							UBIQUITIN-CONJUGATING ENZYME; SIDE-CHAIN RESONANCES; RING DOMAIN; BACKBONE AMIDE; HUMAN HOMOLOG; XPLOR-NIH; PARKIN; PROTEINS; INSIGHTS; REVEALS	The ubiquitin-signaling pathway utilizes E1 activating, E2 conjugating, and E3 ligase enzymes to sequentially transfer the small modifier protein ubiquitin to a substrate protein. During the last step of this cascade different types of E3 ligases either act as scaffolds to recruit an E2 enzyme and substrate (RING), or form an ubiquitin-thioester intermediate prior to transferring ubiquitin to a substrate (HECT). The RING-inBetweenRING-RING (RBR) proteins constitute a unique group of E3 ubiquitin ligases that includes the Human Homologue of Drosophila Ariadne (HHARI). These E3 ligases are proposed to use a hybrid RING/HECT mechanism whereby the enzyme uses facets of both the RING and HECT enzymes to transfer ubiquitin to a substrate. We now present the solution structure of the HHARI RING2 domain, the key portion of this E3 ligase required for the RING/HECT hybrid mechanism. The structure shows the domain possesses two Zn2+-binding sites and a single exposed cysteine used for ubiquitin catalysis. A structural comparison of the RING2 domain with the HECT E3 ligase NEDD4 reveals a near mirror image of the cysteine and histidine residues in the catalytic site. Further, a tandem pair of aromatic residues exists near the C-terminus of the HHARI RING2 domain that is conserved in other RBR E3 ligases. One of these aromatic residues is remotely located from the catalytic site that is reminiscent of the location found in HECT E3 enzymes where it is used for ubiquitin catalysis. These observations provide an initial structural rationale for the RING/HECT hybrid mechanism for ubiquitination used by the RBR E3 ligases.	[Spratt, Donald E.; Mercier, Pascal; Shaw, Gary S.] Univ Western Ontario, Dept Biochem, Schulich Sch Med & Dent, London, ON, Canada	Western University (University of Western Ontario)	Shaw, GS (corresponding author), Univ Western Ontario, Dept Biochem, Schulich Sch Med & Dent, London, ON, Canada.	gshaw1@uwo.ca	Shaw, Gary S./C-7656-2009	Shaw, Gary S./0000-0002-4685-9625; Spratt, Donald/0000-0002-0699-155X	Canadian Institutes of Health Research [MOP-14606]; Canada Research Chairs Program; Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research (MOP-14606), the Canada Research Chairs Program (GSS) and a fellowship (DES) from the Canadian Institutes of Health Research (DES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera M, 2000, GENETICS, V155, P1231; Ardley HC, 2001, J BIOL CHEM, V276, P19640, DOI 10.1074/jbc.M011028200; Baryshnikova OK, 2008, J BIOMOL NMR, V41, P5, DOI 10.1007/s10858-008-9234-6; Beasley SA, 2007, P NATL ACAD SCI USA, V104, P3095, DOI 10.1073/pnas.0610548104; Budhidarmo R, 2012, TRENDS BIOCHEM SCI, V37, P58, DOI 10.1016/j.tibs.2011.11.001; Capili AD, 2004, J MOL BIOL, V340, P1117, DOI 10.1016/j.jmb.2004.05.035; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Duda DM, 2013, STRUCTURE, V21, P1030, DOI 10.1016/j.str.2013.04.019; Elmehdawi F, 2013, EXP CELL RES, V319, P161, DOI 10.1016/j.yexcr.2012.10.002; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; JOHN BK, 1993, J MAGN RESON SER A, V101, P113, DOI 10.1006/jmra.1993.1019; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; Kee Y, 2007, BIOCHEM BIOPH RES CO, V354, P329, DOI 10.1016/j.bbrc.2007.01.025; Kornhaber GJ, 2006, J BIOMOL NMR, V34, P259, DOI 10.1007/s10858-006-0027-5; KRIZEK BA, 1993, INORG CHEM, V32, P937, DOI 10.1021/ic00058a030; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LaVoie MJ, 2007, J NEUROCHEM, V103, P2354, DOI 10.1111/j.1471-4159.2007.04911.x; Lucas JI, 2006, J MOL BIOL, V357, P9, DOI 10.1016/j.jmb.2005.12.068; Marin I, 2004, PHYSIOL GENOMICS, V17, P253, DOI 10.1152/physiolgenomics.00226.2003; Martinez-Noel G, 1999, FEBS LETT, V454, P257, DOI 10.1016/S0014-5793(99)00823-6; Maspero E, 2013, NAT STRUCT MOL BIOL, V20, P696, DOI 10.1038/nsmb.2566; Moynihan TP, 1999, J BIOL CHEM, V274, P30963, DOI 10.1074/jbc.274.43.30963; Okui M, 2005, EXP CELL RES, V309, P220, DOI 10.1016/j.yexcr.2005.05.018; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; Salvat C, 2004, J BIOL CHEM, V279, P18935, DOI 10.1074/jbc.M312201200; Schlehe JS, 2008, J BIOL CHEM, V283, P13771, DOI 10.1074/jbc.M707494200; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Smit JJ, 2012, EMBO J, V31, P3833, DOI 10.1038/emboj.2012.217; Spratt DE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2983; Stieglitz B, 2012, EMBO REP, V13, P840, DOI 10.1038/embor.2012.105; Sudmeier JL, 2003, J AM CHEM SOC, V125, P8430, DOI 10.1021/ja034072c; Tan NGS, 2003, FEBS LETT, V554, P501, DOI 10.1016/S0014-5793(03)01235-3; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777	44	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e74047	10.1371/journal.pone.0074047	http://dx.doi.org/10.1371/journal.pone.0074047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	24058416	Green Published, gold			2022-12-25	WOS:000323378000122
J	Fitzgerald, JC; Ugun-Klusek, A; Allen, G; De Girolamo, LA; Hargreaves, I; Ufer, C; Abramov, AY; Billett, EE				Fitzgerald, Julia C.; Ugun-Klusek, Aslihan; Allen, George; De Girolamo, Luigi A.; Hargreaves, Iain; Ufer, Christoph; Abramov, Andrey Y.; Billett, E. Ellen			Monoamine oxidase-A knockdown in human neuroblastoma cells reveals protection against mitochondrial toxins	FASEB JOURNAL			English	Article						reactive oxygen species; neurodegeneration; electron transport chain; Parkinson's disease	MAO-B ELEVATION; COMPLEX-I; SUPEROXIDE-PRODUCTION; PARKINSONS-DISEASE; OXIDATIVE STRESS; SITES; PATHOGENESIS; LOCALIZATION; INHIBITION; EXPRESSION	The study examined how the mitochondrial enzyme monoamine oxidase-A (MAO-A), which produces hydrogen peroxide as a catalytic by-product, influences death and survival mechanisms. Targeted microRNA (miRNA) was used to stably knock down MAO-A mRNA, protein, and catalytic activity by 60-70% in SH-SY5Y human neuroblastoma cells. The effects of MAO-A knockdown (KD) on ATP, oxidative stress, electron transport chain, and survival following exposure to mitochondrial toxins were assessed. In control cells, complex I inhibition resulted in caspase-mediated cell death linked with ROS production and reduced ATP, followed by up-regulation of MAO-A mRNA, protein, and enzyme activity levels. Inhibition of complex III and IV resulted in a similar increase in MAO-A expression, while up-regulation of MAO-A was lower following complex II inhibition. MAO-A KD decreased basal reactive oxygen species levels by 50% and increased levels of ATP and reduced glutathione and Bcl-2. MAO-A KD specifically increased the activity of complex I but had no effect on complex II-IV activities. Furthermore, MAO-A KD protected against inhibitors of complex I, III, and IV. In summary, endogenous MAO-A levels influence mitochondrial function, notably complex I activity, and MAO-A may be a target for protection against neurodegenerative conditions that involve oxidative stress and mitochondrial dysfunction as underlying pathogenic factors.Fitzgerald, J. C., Ugun-Klusek, A., Allen, G., De Girolamo, L. A., Hargreaves, I., Ufer, C., Abramov, A. Y., Billett, E. E. Monoamine oxidase-A knockdown in human neuroblastoma cells reveals protection against mitochondrial toxins.	[Fitzgerald, Julia C.; Ugun-Klusek, Aslihan; De Girolamo, Luigi A.; Ufer, Christoph; Billett, E. Ellen] Nottingham Trent Univ, Sch Sci & Technol, Nottingham NG11 8NS, England; [Fitzgerald, Julia C.] Hertie Inst Clin Brain Res, Funct Neurogen Lab, Tubingen, Germany; [Allen, George; Abramov, Andrey Y.] UCL, Inst Neurol, Dept Mol Neurosci, London, England; [Hargreaves, Iain] Natl Hosp Neurol & Neurosurg, Neurometab Unit, London WC1N 3BG, England; [Ufer, Christoph] Charite, Inst Biochem, D-13353 Berlin, Germany	Nottingham Trent University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Billett, EE (corresponding author), Nottingham Trent Univ, Sch Sci & Technol, Nottingham NG11 8NS, England.	ellen.billett@ntu.ac.uk	Hargreaves, Iain/AAJ-6757-2020; Abramov, Andrey Y/H-9053-2012; Abramov, Andrey/AAC-6712-2019	Abramov, Andrey Y/0000-0002-7646-7235; Abramov, Andrey/0000-0002-7646-7235; Ugun Klusek, Aslihan/0000-0002-0199-0275; Billett, Ellen/0000-0001-8245-6519	Nottingham Trent University; British Council; Deutscher Akademischer Austauschdienst (DAAD)	Nottingham Trent University; British Council(The British Council in India); Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	The authors thank Hartmut Kuhn and Dr. Pavlos Chaitidis (Institute of Biochemistry, University Medicine Berlin-Charite, Berlin, Germany). Funding for this study was provided by Nottingham Trent University, British Council, and Deutscher Akademischer Austauschdienst (DAAD).	Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; BACH AWJ, 1988, P NATL ACAD SCI USA, V85, P4934, DOI 10.1073/pnas.85.13.4934; Bongioanni P, 1996, NEURODEGENERATION, V5, P351, DOI 10.1006/neur.1996.0047; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Burte F, 2011, J PROTEOME RES, V10, P1974, DOI 10.1021/pr101211k; CADENAS E, 2000, FREE RADIC BIOL MED, V29, P220; Caneda-Ferron B, 2008, J NEUROCHEM, V105, P225, DOI 10.1111/j.1471-4159.2007.05130.x; Cao X, 2009, J NEUROCHEM, V111, P101, DOI 10.1111/j.1471-4159.2009.06300.x; CHURCH RJ, 1994, P R MICROSC SOC, V29, P243; Cohen G, 1997, P NATL ACAD SCI USA, V94, P4890, DOI 10.1073/pnas.94.10.4890; Danielczyk M. L., 1998, ACTA PSYCHIAT SCAND, V78, P730; Davey GP, 1998, J BIOL CHEM, V273, P12753, DOI 10.1074/jbc.273.21.12753; Day BJ, 1997, ARCH BIOCHEM BIOPHYS, V347, P256, DOI 10.1006/abbi.1997.0341; De Zutter GS, 2001, P NATL ACAD SCI USA, V98, P6168, DOI 10.1073/pnas.111027698; Edmondson D. E., 2013, CURR PHARM DES; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fitzgerald JC, 2008, FEBS J, V275, P5758, DOI 10.1111/j.1742-4658.2008.06708.x; Fitzgerald JC, 2007, J NEUROCHEM, V103, P2189, DOI 10.1111/j.1471-4159.2007.04921.x; FOWLER CJ, 1980, J NEURAL TRANSM, V49, P1, DOI 10.1007/BF01249185; Gandhi S, 2005, HUM MOL GENET, V14, P2749, DOI 10.1093/hmg/ddi308; Gerlach M., 1993, MONOAMINE OXIDASE, P147; Gu M, 1998, J NEUROL SCI, V158, P24, DOI 10.1016/S0022-510X(98)00095-1; Hajieva P, 2009, J NEUROCHEM, V110, P118, DOI 10.1111/j.1471-4159.2009.06114.x; Hargreaves IP, 2007, MITOCHONDRION, V7, P284, DOI 10.1016/j.mito.2007.02.001; Hauptmann N, 1996, ARCH BIOCHEM BIOPHYS, V335, P295, DOI 10.1006/abbi.1996.0510; Heo JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032629; Hu LF, 2009, MOL PHARMACOL, V75, P27, DOI 10.1124/mol.108.047985; Jiang HB, 2006, J BIOL CHEM, V281, P8591, DOI 10.1074/jbc.M510926200; JIN YZ, 1990, BIOCHEM BIOPH RES CO, V172, P1338, DOI 10.1016/0006-291X(90)91596-K; JOHNSTON JP, 1968, BIOCHEM PHARMACOL, V17, P1285, DOI 10.1016/0006-2952(68)90066-X; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; Kumar MJ, 2003, J BIOL CHEM, V278, P46432, DOI 10.1074/jbc.M306378200; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Lotharius J, 2000, J BIOL CHEM, V275, P38581, DOI 10.1074/jbc.M005385200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mallajosyula JK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001616; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Musatov A, 2012, FREE RADICAL RES, V46, P1313, DOI 10.3109/10715762.2012.717273; Naoi M, 2009, J NEURAL TRANSM, V116, P1371, DOI 10.1007/s00702-009-0309-7; Ou XM, 2006, P NATL ACAD SCI USA, V103, P10923, DOI 10.1073/pnas.0601515103; Perfeito R, 2012, FREE RADICAL BIO MED, V53, P1791, DOI 10.1016/j.freeradbiomed.2012.08.569; Quinlan CL, 2012, FREE RADICAL BIO MED, V53, P1807, DOI 10.1016/j.freeradbiomed.2012.08.015; RIEDERER P, 1989, J NEUROCHEM, V52, P515, DOI 10.1111/j.1471-4159.1989.tb09150.x; Rodriguez MJ, 2000, J HISTOCHEM CYTOCHEM, V48, P147, DOI 10.1177/002215540004800115; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Schapira AHV, 2009, NEUROLOGY, V72, pS44, DOI 10.1212/WNL.0b013e3181990438; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; Siddiqui A, 2012, FREE RADICAL RES, V46, P1011, DOI 10.3109/10715762.2012.662277; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Tang B, 2012, MOL MED REP, V5, P1271, DOI 10.3892/mmr.2012.806; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Wang J, 2011, BIOCHEMISTRY-US, V50, P2499, DOI 10.1021/bi101722b; Wei Z, 2012, J NEURAL TRANSM, V119, P1285, DOI 10.1007/s00702-012-0779-x; Westlund K., 1994, MONOAMINE OXIDASE IN, P1; WESTLUND KN, 1988, NEUROSCIENCE, V25, P439, DOI 10.1016/0306-4522(88)90250-3; Zhou G, 2001, J NEUROL NEUROSUR PS, V70, P229, DOI 10.1136/jnnp.70.2.229; ZHUANG ZP, 1992, J BIOL CHEM, V267, P591	60	27	27	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					218	229		10.1096/fj.13-235481	http://dx.doi.org/10.1096/fj.13-235481			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24051032				2022-12-25	WOS:000333526100022
J	Kishimoto, K; Nishizuka, M; Katoh, D; Kato, A; Osada, S; Imagawa, M				Kishimoto, Keishi; Nishizuka, Makoto; Katoh, Daiki; Kato, Ayumi; Osada, Shigehiro; Imagawa, Masayoshi			FAD104, a Regulatory Factor of Adipogenesis, Acts as a Novel Regulator of Calvarial Bone Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOCYTE DIFFERENTIATION; OSTEOBLAST DIFFERENTIATION; EARLY-STAGE; POSITIVE REGULATOR; 3T3-L1 CELLS; GENE FAD104; CRANIOSYNOSTOSIS; IDENTIFICATION; PHOSPHATASES; MECHANISMS	Osteogenesis is a complex process that is orchestrated by several growth factors, extracellular cues, signaling molecules, and transcriptional factors. Understanding the mechanisms of bone formation is pivotal for clarifying the pathogenesis of bone diseases. Previously, we reported that fad104 (factor for adipocyte differentiation 104), a novel positive regulator of adipocyte differentiation, negatively regulated the differentiation of mouse embryonic fibroblasts into osteocytes. However, the physiological role of fad104 in bone formation has not been elucidated. Here, we clarified the role of fad104 in bone formation in vivo and in vitro. fad104 disruption caused craniosynostosis-like premature ossification of the calvarial bone. Furthermore, analyses using primary calvarial cells revealed that fad104 negatively regulated differentiation and BMP/Smad signaling pathway. FAD104 interacted with Smad1/5/8. The N-terminal region of FAD104, which contains a proline-rich motif, was capable of binding to Smad1/5/8. We demonstrated that down-regulation of Smad1/5/8 phosphorylation by FAD104 is dependent on the N-terminal region of FAD104 and that fad104 functions as a novel negative regulator of BMP/Smad signaling and is required for proper development for calvarial bone. These findings will aid a comprehensive description of the mechanism that controls normal and premature calvarial ossification.	[Kishimoto, Keishi; Nishizuka, Makoto; Katoh, Daiki; Kato, Ayumi; Osada, Shigehiro; Imagawa, Masayoshi] Nagoya City Univ, Dept Mol Biol, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan	Nagoya City University	Imagawa, M (corresponding author), Nagoya City Univ, Dept Mol Biol, Grad Sch Pharmaceut Sci, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	imagawa@phar.nagoya-cu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Society for the Promotion of Science (JSPS); Mitsui Sumitomo Insurance Welfare Foundation; Nakatomi Foundation	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mitsui Sumitomo Insurance Welfare Foundation(Mitsui Sumitomo Insurance Welfare Foundation); Nakatomi Foundation	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, the Japan Society for the Promotion of Science (JSPS), JSPS Research Fellow, the Mitsui Sumitomo Insurance Welfare Foundation, and the Nakatomi Foundation.	Bruce DL, 2012, FEBS LETT, V586, P1897, DOI 10.1016/j.febslet.2012.02.001; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Canalis E, 2009, J CELL BIOCHEM, V108, P769, DOI 10.1002/jcb.22322; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Chen HB, 2006, GENE DEV, V20, P648, DOI 10.1101/gad.1384706; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; Hishida T, 2008, FEBS J, V275, P5576, DOI 10.1111/j.1742-4658.2008.06682.x; Huang W, 2007, FRONT BIOSCI-LANDMRK, V12, P3068, DOI 10.2741/2296; Imagawa M, 1999, BIOCHEM BIOPH RES CO, V254, P299, DOI 10.1006/bbrc.1998.9937; Kanamoto T, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-70; Karsenty G, 2003, NATURE, V423, P316, DOI 10.1038/nature01654; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kishimoto K, 2011, EXP CELL RES, V317, P2110, DOI 10.1016/j.yexcr.2011.06.003; Kishimoto K, 2010, BIOCHEM BIOPH RES CO, V397, P187, DOI 10.1016/j.bbrc.2010.05.077; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Marie PJ, 2002, HISTOL HISTOPATHOL, V17, P877, DOI 10.14670/HH-17.877; Maxson Robert, 2008, V12, P197, DOI 10.1159/000115042; Mei W, 2005, BIOCHEM BIOPH RES CO, V328, P651, DOI 10.1016/j.bbrc.2004.11.067; MUSACCHIO A, 1992, FEBS LETT, V307, P55, DOI 10.1016/0014-5793(92)80901-R; Nishizuka M, 2002, BIOCHEM J, V361, P629, DOI 10.1042/0264-6021:3610629; Nishizuka M, 2009, EXP CELL RES, V315, P809, DOI 10.1016/j.yexcr.2008.12.013; Obholz KL, 2006, DEV BIOL, V298, P498, DOI 10.1016/j.ydbio.2006.06.054; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Passos-Bueno Maria Rita, 2008, V12, P107, DOI 10.1159/000115035; Rice DPC, 2003, EUR J ORTHODONT, V25, P139, DOI 10.1093/ejo/25.2.139; Suenaga M, 2013, CYTOKINE, V64, P138, DOI 10.1016/j.cyto.2013.07.011; Tagariello A, 2006, J MED GENET, V43, P534, DOI 10.1136/jmg.2005.037820; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tominaga K, 2004, J CELL SCI, V117, P6217, DOI 10.1242/jcs.01546; Tominaga K, 2004, FEBS LETT, V577, P49, DOI 10.1016/j.febslet.2004.09.062; Tominaga K, 2004, J BIOL CHEM, V279, P34840, DOI 10.1074/jbc.M312927200	32	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31772	31783		10.1074/jbc.M113.452961	http://dx.doi.org/10.1074/jbc.M113.452961			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24052261	Green Published, hybrid			2022-12-25	WOS:000330596200028
J	Die, JV; Rowland, LJ				Die, Jose V.; Rowland, Lisa J.			Superior Cross-Species Reference Genes: A Blueberry Case Study	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; RT-PCR; EXPRESSION ANALYSIS; RELATIVE QUANTIFICATION; SYSTEMATIC VALIDATION; SEED-GERMINATION; NORMALIZATION; TRANSCRIPTOME; FRUIT; IDENTIFICATION	The advent of affordable Next Generation Sequencing technologies has had major impact on studies of many crop species, where access to genomic technologies and genome-scale data sets has been extremely limited until now. The recent development of genomic resources in blueberry will enable the application of high throughput gene expression approaches that should relatively quickly increase our understanding of blueberry physiology. These studies, however, require a highly accurate and robust workflow and make necessary the identification of reference genes with high expression stability for correct target gene normalization. To create a set of superior reference genes for blueberry expression analyses, we mined a publicly available transcriptome data set from blueberry for orthologs to a set of Arabidopsis genes that showed the most stable expression in a developmental series. In total, the expression stability of 13 putative reference genes was evaluated by qPCR and a set of new references with high stability values across a developmental series in fruits and floral buds of blueberry were identified. We also demonstrated the need to use at least two, preferably three, reference genes to avoid inconsistencies in results, even when superior reference genes are used. The new references identified here provide a valuable resource for accurate normalization of gene expression in Vaccinium spp. and may be useful for other members of the Ericaceae family as well.	[Die, Jose V.; Rowland, Lisa J.] ARS, USDA, Beltsville, MD USA	United States Department of Agriculture (USDA)	Rowland, LJ (corresponding author), ARS, USDA, Beltsville, MD USA.	Jeannine.Rowland@ars.usda.gov	Die, Jose V./H-3381-2019	Die, Jose V./0000-0002-7506-8590				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chao WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042839; Cook DR, 2010, CURR OPIN PLANT BIOL, V13, P115, DOI 10.1016/j.pbi.2010.03.003; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; Dekkers BJW, 2012, PLANT CELL PHYSIOL, V53, P28, DOI 10.1093/pcp/pcr113; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Die JV, 2013, MOL BREEDING, V32, P493, DOI 10.1007/s11032-013-9893-1; Die JV, 2012, J EXP BOT, V63, P6069, DOI 10.1093/jxb/ers276; Die JV, 2011, ANAL BIOCHEM, V419, P336, DOI 10.1016/j.ab.2011.08.012; Fu JX, 2013, MOL BREEDING, V31, P205, DOI 10.1007/s11032-012-9784-x; Gibbs PJ, 2003, TRANSPL IMMUNOL, V12, P89, DOI 10.1016/S0966-3274(03)00010-8; Graeber K, 2011, PLANT CELL, V23, P2045, DOI 10.1105/tpc.111.084103; Graeber K, 2010, PLANT MOL BIOL, V73, P67, DOI 10.1007/s11103-009-9583-x; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Gutierrez L, 2008, PLANT CELL, V20, P1734, DOI 10.1105/tpc.108.059774; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Huggett J, 2011, ACCREDIT QUAL ASSUR, V16, P399, DOI 10.1007/s00769-011-0769-y; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Li XY, 2012, GENE, V511, P54, DOI 10.1016/j.gene.2012.09.021; Linkies A, 2010, J EXP BOT, V61, P491, DOI 10.1093/jxb/erp318; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin C, 2008, PLANT CELL, V20, P1727, DOI 10.1105/tpc.108.200780; Meyer E, 2012, PLANT J, V70, P879, DOI 10.1111/j.1365-313X.2012.04938.x; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Regier N, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-57; Rowland L.J., 2011, GENETICS GENOMICS BR, P1; Rowland LJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-46; Santiago-Domenech N, 2008, J EXP BOT, V59, P2769, DOI 10.1093/jxb/ern142; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; USDA-NASS, 2013, NONC FRUITS NUTS 201; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Vashisth T, 2011, PLANT CELL REP, V30, P2167, DOI 10.1007/s00299-011-1121-z; Zifkin M, 2012, PLANT PHYSIOL, V158, P200, DOI 10.1104/pp.111.180950; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	50	34	37	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73354	10.1371/journal.pone.0073354	http://dx.doi.org/10.1371/journal.pone.0073354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058469	Green Published, Green Submitted, gold			2022-12-25	WOS:000324695900011
J	Li, HX; Xiao, Y; Cao, LL; Yan, X; Li, C; Shi, HY; Wang, JW; Ye, YH				Li, Hong-Xia; Xiao, Yu; Cao, Ling-Ling; Yan, Xu; Li, Cong; Shi, Hai-Yan; Wang, Jian-Wen; Ye, Yong-Hao			Cerebroside C Increases Tolerance to Chilling Injury and Alters Lipid Composition in Wheat Roots	PLOS ONE			English	Article							PHOSPHOLIPASE-D; PLANT-GROWTH; LIPOXYGENASE ACTIVITY; OXIDATIVE STRESS; XANTHINE-OXIDASE; ABIOTIC STRESS; FATTY-ACID; MEMBRANE; TEMPERATURE; INVOLVEMENT	Chilling tolerance was increased in seed germination and root growth of wheat seedlings grown in media containing 20 mu g/mL cerebroside C (CC), isolated from the endophytic Phyllosticta sp. TG78. Seeds treated with 20 mu g/mL CC at 4 degrees C expressed the higher germination rate (77.78%), potential (23.46%), index (3.44) and the shorter germination time (6.19 d); root growth was also significantly improved by 13.76% in length, 13.44% in fresh weight and 6.88% in dry mass compared to controls. During the cultivation process at 4 degrees C for three days and the followed 24 h at 25 degrees C, lipid peroxidation, expressed by malondialdehyde (MDA) content and relative membrane permeability (RMP) was significantly reduced in CC-treated roots; activities of lipoxygenase (LOX), phospholipid C (PLC) and phospholipid D (PLD) were inhibited by 13.62-62.26%, 13.54-63.93% and 13.90-61.17%, respectively; unsaturation degree of fatty acids was enhanced through detecting the contents of CC-induced linoleic acid, linolenic acid, palmitic acid and stearic acid using GC-MS; capacities of superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-Px) were individually increased by 7.69-46.06%, 3.37-37.96%, and 27.00-178.07%. These results suggest that increased chilling tolerance may be due, in part, to the reduction of lipid peroxidation and alternation of lipid composition of roots in the presence of CC.	[Li, Hong-Xia; Xiao, Yu; Cao, Ling-Ling; Yan, Xu; Li, Cong; Shi, Hai-Yan; Ye, Yong-Hao] Nanjing Agr Univ, Coll Plant Protect, Jiangsu Key Lab Pesticide Sci, Nanjing, Jiangsu, Peoples R China; [Li, Hong-Xia; Xiao, Yu; Cao, Ling-Ling; Yan, Xu; Li, Cong; Shi, Hai-Yan; Ye, Yong-Hao] Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China; [Wang, Jian-Wen] Soochow Univ, Coll Pharmaceut Sci, Suzhou, Peoples R China; [Li, Hong-Xia] Jilin Univ, Sch Pharm, Changchun 130023, Peoples R China	Nanjing Agricultural University; Soochow University - China; Jilin University	Ye, YH (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Jiangsu Key Lab Pesticide Sci, Nanjing, Jiangsu, Peoples R China.	jwwang@suda.edu.cn; yeyh@njau.edu.cn	Wang, Jian Wen/B-3254-2009; Yan, Xu/H-9140-2015; Wang, Jian Wen/AAE-4412-2020; Ye, Yonghao/M-1830-2017	Wang, Jian Wen/0000-0002-3095-7394; Wang, Jian Wen/0000-0002-3095-7394; 	National Basic Research Program of China [2010CB126100]; National Natural Science Foundation of China [30901854, 81273487]; Fundamental Research Funds for the Central Universities [KYZ201107]; Special Fund for Agro-scientific Research in the Public Interest [201303023]; Open Research Fund Program of Jiangsu Key Laboratory of Pesticide Science [NYXKT201202]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Special Fund for Agro-scientific Research in the Public Interest; Open Research Fund Program of Jiangsu Key Laboratory of Pesticide Science	This work was co-supported by National Basic Research Program of China (2010CB126100), National Natural Science Foundation of China (30901854, 81273487), Fundamental Research Funds for the Central Universities (KYZ201107), Special Fund for Agro-scientific Research in the Public Interest (201303023) and Open Research Fund Program of Jiangsu Key Laboratory of Pesticide Science (NYXKT201202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MB, 2005, PLANT PHYSIOL BIOCH, V43, P213, DOI 10.1016/j.plaphy.2005.01.007; Antonacci S, 2011, POSTHARVEST BIOL TEC, V59, P43, DOI 10.1016/j.postharvbio.2010.07.007; Bacon C. W., 1996, P155; Baque MA, 2010, PLANT CELL REP, V29, P685, DOI 10.1007/s00299-010-0854-4; BEEORTZAHAR T, 1995, FEBS LETT, V366, P151, DOI 10.1016/0014-5793(95)00521-A; Boonsiri K, 2007, POSTHARVEST BIOL TEC, V45, P358, DOI 10.1016/j.postharvbio.2007.03.014; Candan AP, 2008, POSTHARVEST BIOL TEC, V47, P107, DOI 10.1016/j.postharvbio.2007.06.009; Chen CJ, 2007, PEST MANAG SCI, V63, P1201, DOI 10.1002/ps.1449; CRIQUI MC, 1992, PLANT MOL BIOL, V18, P623, DOI 10.1007/BF00040684; Cortes-Sanchez AD, 2013, MICROBIOL RES, V168, P22, DOI 10.1016/j.micres.2012.07.002; Debbab A, 2011, FUNGAL DIVERS, V49, P1, DOI 10.1007/s13225-011-0114-0; Faeth SH, 2002, OIKOS, V98, P25, DOI 10.1034/j.1600-0706.2002.980103.x; Ferrareze JP, 2013, POSTHARVEST BIOL TEC, V77, P11, DOI 10.1016/j.postharvbio.2012.11.003; FOYER CH, 1994, PHYSIOL PLANTARUM, V92, P696, DOI 10.1111/j.1399-3054.1994.tb03042.x; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; GUPTA MN, 1980, LIPIDS, V15, P594, DOI 10.1007/BF02534185; Hassan A, 2010, J NUTR, V140, P1714, DOI 10.3945/jn.109.119768; Herbette S, 2005, BBA-GEN SUBJECTS, V1724, P108, DOI 10.1016/j.bbagen.2005.04.018; Ishii T, 2006, J NAT PROD, V69, P1080, DOI 10.1021/np050530e; Khan AL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-3; Kim SI, 2011, EUPHYTICA, V178, P437, DOI 10.1007/s10681-010-0343-4; Lin KH, 2006, PLANT GROWTH REGUL, V49, P249, DOI 10.1007/s10725-006-9135-1; Liu XL, 2007, FOOD CHEM, V105, P548, DOI 10.1016/j.foodchem.2007.04.008; MACCARRONE M, 1994, BBA-BIOMEMBRANES, V1190, P164, DOI 10.1016/0005-2736(94)90046-9; Maggio B, 2004, CURR OPIN COLLOID IN, V8, P448, DOI 10.1016/j.cocis.2004.01.004; Mao LC, 2007, PLANT SCI, V172, P400, DOI 10.1016/j.plantsci.2006.10.002; Mao LC, 2007, POSTHARVEST BIOL TEC, V44, P42, DOI 10.1016/j.postharvbio.2006.11.009; Margesin R, 2007, NATURWISSENSCHAFTEN, V94, P77, DOI 10.1007/s00114-006-0162-6; MEERA MS, 1994, PHYTOPATHOLOGY, V84, P1399, DOI 10.1094/Phyto-84-1399; Nishida I, 1996, ANNU REV PLANT PHYS, V47, P541, DOI 10.1146/annurev.arplant.47.1.541; PARKIN KL, 1989, PLANT PHYSIOL, V90, P1049, DOI 10.1104/pp.90.3.1049; Pinhero RG, 1998, PLANT PHYSIOL BIOCH, V36, P213, DOI 10.1016/S0981-9428(97)86878-7; Powell N, 2012, FUNCT PLANT BIOL, V39, P539, DOI 10.1071/FP12078; Redman RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014823; Rui HJ, 2010, J SCI FOOD AGR, V90, P1557, DOI 10.1002/jsfa.3993; Shu RG, 2004, LIPIDS, V39, P667, DOI 10.1007/s11745-004-1280-9; Song YC, 2004, FEMS MICROBIOL LETT, V241, P67, DOI 10.1016/j.femsle.2004.10.005; Tan RX, 2003, NAT PROD REP, V20, P509, DOI 10.1039/b307243f; Tanji M., 2004, J OLEO SCI, V53, P127; Uemura M, 2006, PHYSIOL PLANTARUM, V126, P81, DOI 10.1111/j.1399-3054.2005.00594.x; Umemura K, 2000, PLANT CELL PHYSIOL, V41, P676, DOI 10.1093/pcp/41.6.676; Upchurch RG, 2008, BIOTECHNOL LETT, V30, P967, DOI 10.1007/s10529-008-9639-z; Wan SB, 2009, PLANT PHYSIOL BIOCH, V47, P504, DOI 10.1016/j.plaphy.2008.12.010; Wang JW, 2007, APPL MICROBIOL BIOT, V75, P1183, DOI 10.1007/s00253-007-0927-7; Wang JW, 2009, APPL MICROBIOL BIOT, V85, P285, DOI 10.1007/s00253-009-2090-9; [王建成 Wang Jiancheng], 2004, [种子, Seed], V23, P6; Wikee S, 2011, FUNGAL DIVERS, V51, P43, DOI 10.1007/s13225-011-0146-5; Wongsheree T, 2009, POSTHARVEST BIOL TEC, V51, P91, DOI 10.1016/j.postharvbio.2008.05.015; Wu GL, 2011, PLANT ECOL EVOL, V144, P275, DOI 10.5091/plecevo.2011.459; Xia XJ, 2009, PLANT PHYSIOL, V150, P801, DOI 10.1104/pp.109.138230; Yang GP, 1996, AUST J PLANT PHYSIOL, V23, P437, DOI 10.1071/PP9960437	51	80	85	5	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73380	10.1371/journal.pone.0073380	http://dx.doi.org/10.1371/journal.pone.0073380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058471	gold, Green Published, Green Submitted			2022-12-25	WOS:000324408400023
J	Pinto, PR; McIntyre, T; Ferrero, R; Almeida, A; Araujo-Soares, V				Pinto, Patricia R.; McIntyre, Teresa; Ferrero, Ramon; Almeida, Armando; Araujo-Soares, Vera			Risk Factors for Moderate and Severe Persistent Pain in Patients Undergoing Total Knee and Hip Arthroplasty: A Prospective Predictive Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; COMMON-SENSE MODEL; POSTSURGICAL PAIN; ILLNESS PERCEPTIONS; POSTOPERATIVE PAIN; UNITED-STATES; PRIMARY-CARE; REPLACEMENT; SURGERY; OSTEOARTHRITIS	Persistent post-surgical pain (PPSP) is a major clinical problem with significant individual, social and health care costs. The aim of this study was to examine the joint role of demographic, clinical and psychological risk factors in the development of moderate and severe PPSP after Total Knee and Hip Arthroplasty (TKA and THA, respectively). This was a prospective study wherein a consecutive sample of 92 patients were assessed 24 hours before (T1), 48 hours after (T2) and 4-6 months (T3) after surgery. Hierarchical logistic regression analyses were performed to identify predictors of moderate and severe levels of PPSP. Four to six months after TKA and THA, 54 patients (58.7%) reported none or mild pain (Numerical Rating Scale: NRS <= 3), whereas 38 (41.3%) reported moderate to severe pain (NRS > 3). In the final multivariate hierarchical logistic regression analyses, illness representations concerning the condition leading to surgery (osteoarthritis), such as a chronic timeline perception of the disease, emerged as a significant predictor of PPSP. Additionally, post-surgical anxiety also showed a predictive role in the development of PPSP. Pre-surgical pain was the most significant clinical predictive factor and, as expected, undergoing TKA was associated with greater odds of PPSP development than THA. The findings on PPSP predictors after major joint arthroplasties can guide clinical practice in terms of considering cognitive and emotional factors, together with clinical factors, in planning acute pain management before and after surgery.	[Pinto, Patricia R.; Almeida, Armando] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Pinto, Patricia R.; Almeida, Armando] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Pinto, Patricia R.; Araujo-Soares, Vera] Newcastle Univ, Hlth Psychol Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [McIntyre, Teresa] Univ Houston, TIMES, Houston, TX USA; [McIntyre, Teresa] Univ Houston, Dept Psychol, Houston, TX USA; [Ferrero, Ramon] Alto Ave Hosp Ctr, Orthoped Unit, Guimaraes, Portugal; [Araujo-Soares, Vera] Newcastle Univ, Fac Med Sci, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Universidade do Minho; Newcastle University - UK; University of Houston System; University of Houston; University of Houston System; University of Houston; Newcastle University - UK	Araujo-Soares, V (corresponding author), Newcastle Univ, Hlth Psychol Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	vera.araujo-soares@ncl.ac.uk	Araujo-Soares, Vera/ABF-8144-2021; Pinto, Patrícia J R/AAA-6721-2020; Almeida, Armando/H-5122-2011; Araujo-Soares, Vera/F-1806-2015	Araujo-Soares, Vera/0000-0003-4044-2527; Pinto, Patrícia J R/0000-0003-3428-5801; Almeida, Armando/0000-0002-6233-4693; Araujo-Soares, Vera/0000-0003-4044-2527; McIntyre, Teresa/0000-0002-0746-0830	Portuguese Foundation of Science and Technology [SFRH/BD/36368/2007]; COMPETE; FEDER;  [PTDC/SAU-NEU/108557/2008]; Fundação para a Ciência e a Tecnologia [PTDC/SAU-NEU/108557/2008] Funding Source: FCT	Portuguese Foundation of Science and Technology(Portuguese Foundation for Science and Technology); COMPETE; FEDER(European Commission); ; Fundação para a Ciência e a Tecnologia	This work was supported by a Project grant (PTDC/SAU-NEU/108557/2008) and by a PhD grant (SFRH/BD/36368/2007) from the Portuguese Foundation of Science and Technology, COMPETE and FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmeier CJM, 2001, OSTEOARTHR CARTILAGE, V9, P137, DOI 10.1053/joca.2000.0369; Beswick AD, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000435; Bisgaard T, 2005, SCAND J GASTROENTERO, V40, P1358, DOI 10.1080/00365520510023675; Bodian CA, 2001, ANESTHESIOLOGY, V95, P1356, DOI 10.1097/00000542-200112000-00013; Botha-Scheepers S, 2008, OSTEOARTHR CARTILAGE, V14, P1104; Brander VA, 2003, CLIN ORTHOP RELAT R, P27, DOI 10.1097/01.blo.0000092983.12414.e9; Brander V, 2007, CLIN ORTHOP RELAT R, P21, DOI 10.1097/BLO.0b013e318126c032; Brandsborg B, 2007, ANESTHESIOLOGY, V106, P1003, DOI 10.1097/01.anes.0000265161.39932.e8; Bruehl S, 2004, PAIN: PSYCHOLOGICAL PERSPECTIVES, P245; Buvanendran A, 2010, ANESTH ANALG, V110, P199, DOI 10.1213/ANE.0b013e3181c4273a; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Dihle A, 2006, CLIN J PAIN, V22, P617, DOI 10.1097/01.ajp.0000210905.57546.c1; Dolin SJ, 2002, BRIT J ANAESTH, V89, P409, DOI 10.1093/bja/aef207; Ebrahimpour PB, 2011, J ARTHROPLASTY, V26, P133, DOI 10.1016/j.arth.2011.04.011; Eisenach JC, 2008, PAIN, V140, P87, DOI 10.1016/j.pain.2008.07.011; Faller H, 2003, GEN HOSP PSYCHIAT, V25, P372, DOI 10.1016/S0163-8343(03)00062-8; Fitz Gerald JD, 2004, ARTHRIT RHEUM-ARTHR, V51, P100, DOI 10.1002/art.20090; Forsythe ME, 2008, PAIN RES MANAG, V13, P335, DOI 10.1155/2008/730951; Foster NE, 2008, PAIN, V136, P177, DOI 10.1016/j.pain.2007.12.007; Frostholm L, 2007, J PSYCHOSOM RES, V62, P129, DOI 10.1016/j.jpsychores.2006.09.003; Gerbershagen HJ, 2009, EUR J PAIN, V13, P1054, DOI 10.1016/j.ejpain.2008.11.020; Gerbershagen HJ, 2009, EUR J PAIN, V13, P853, DOI 10.1016/j.ejpain.2008.10.001; Goncalves L, 2008, EXP NEUROL, V213, P48, DOI 10.1016/j.expneurol.2008.04.043; GRAVER V, 1995, J PSYCHOSOM RES, V39, P465, DOI 10.1016/0022-3999(94)00148-X; Groarke AM, 2005, PSYCHOL HEALTH, V20, P597, DOI 10.1080/14768320500094177; Hagger MS, 2003, PSYCHOL HEALTH, V18, P141, DOI 10.1080/088704403100081321; Hamel MB, 2008, ARCH INTERN MED, V168, P1430, DOI 10.1001/archinte.168.13.1430; Hanley MA, 2007, J PAIN, V8, P102, DOI 10.1016/j.jpain.2006.06.004; Hartrick Craig T, 2003, Pain Pract, V3, P310; Haythornthwaite JA, 1998, J UROLOGY, V160, P1761, DOI 10.1016/S0022-5347(01)62400-5; Hermele Sandy, 2007, Psychol Health Med, V12, P580, DOI 10.1080/13548500601162705; Hudak PL, 2002, MED DECIS MAKING, V22, P272, DOI 10.1177/02789X02022003009; Johnston Marie, 1993, Annals of Behavioral Medicine, V15, P245; Jones CA, 2000, J RHEUMATOL, V27, P1745; Jones CA, 2003, PHYS THER, V83, P696, DOI 10.1093/ptj/83.8.696; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Kehlet H, 2010, ANESTHESIOLOGY, V112, P514, DOI 10.1097/ALN.0b013e3181cf423d; Kosek E, 2000, EUR J PAIN, V4, P229, DOI 10.1053/eujp.2000.0175; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Learmonth ID, 2007, LANCET, V370, P1508, DOI 10.1016/S0140-6736(07)60457-7; Leventhal H., 1984, HDB PSYCHOL HLTH, V4, P219; Leventhal H, 1991, MENTAL REPRESENTATIO, P247, DOI DOI 10.1007/978-1-4613-9074-9_11; Leventhal H., 1997, PERCEPTIONS HLTH ILL, V2, P19; Lingard EA, 2004, J BONE JOINT SURG AM, V86A, P2179, DOI 10.2106/00004623-200410000-00008; Linsell L, 2006, J PUBLIC HEALTH-UK, V28, P267, DOI 10.1093/pubmed/fdl020; Llewellyn CD, 2007, J PSYCHOSOM RES, V63, P17, DOI 10.1016/j.jpsychores.2007.01.013; Losina E, 2009, ARCH INTERN MED, V169, P1113, DOI 10.1001/archinternmed.2009.136; Lundblad H, 2008, J BONE JOINT SURG BR, V90B, P166, DOI 10.1302/0301-620X.90B2.19640; Macrae WA, 2008, BRIT J ANAESTH, V101, P77, DOI 10.1093/bja/aen099; McCarthy SC, 2003, PSYCHOL HEALTH, V18, P109, DOI 10.1080/0887044031000080674; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Moss-Morris R, 2007, CLIN J PAIN, V23, P558, DOI 10.1097/AJP.0b013e318093fcab; Neugebauer V, 2009, BRAIN RES REV, V60, P226, DOI 10.1016/j.brainresrev.2008.12.014; Nikolajsen L, 2006, ACTA ANAESTH SCAND, V50, P495, DOI 10.1111/j.1399-6576.2006.00976.x; Nikolajsen L, 2001, BRIT J ANAESTH, V87, P107, DOI 10.1093/bja/87.1.107; Nilsdotter AK, 2003, ANN RHEUM DIS, V62, P923, DOI 10.1136/ard.62.10.923; Nilsdotter AK, 2001, ANN RHEUM DIS, V60, P228, DOI 10.1136/ard.60.3.228; ODRISCOLL SL, 1974, BMJ-BRIT MED J, V3, P714, DOI 10.1136/bmj.3.5933.714; Orbell S, 1998, SOC SCI MED, V47, P93, DOI 10.1016/S0277-9536(97)10132-0; Perkins F, 2003, TECH REG ANESTH PAIN, V7, P122; Peters ML, 2007, ANN SURG, V245, P487, DOI 10.1097/01.sla.0000245495.79781.65; Petrie KJ, 2006, CLIN MED, V6, P536, DOI 10.7861/clinmedicine.6-6-536; Petrie KJ, 1996, BRIT MED J, V312, P1191; Pinto PR, 2013, J PAIN, V14, P502, DOI 10.1016/j.jpain.2012.12.020; Pinto PR, 2012, J PAIN, V13, P1045, DOI 10.1016/j.jpain.2012.07.014; Pinto-Ribeiro F, 2008, BRAIN RES, V1197, P63, DOI 10.1016/j.brainres.2007.12.038; Poleshuck EL, 2006, J PAIN, V7, P626, DOI 10.1016/j.jpain.2006.02.007; Puolakka PAE, 2010, EUR J ANAESTH, V27, P455, DOI 10.1097/EJA.0b013e328335b31c; Riley JL, 1997, CLIN J PAIN, V13, P156, DOI 10.1097/00002508-199706000-00010; Rolfson O, 2009, J BONE JOINT SURG BR, V91B, P157, DOI 10.1302/0301-620X.91B2.20765; Rozema H, 2009, PSYCHO-ONCOLOGY, V18, P849, DOI 10.1002/pon.1488; Salmon P, 2001, ARCH PHYS MED REHAB, V82, P360, DOI 10.1053/apmr.2001.21522; Schaible HG, 2006, ANN NY ACAD SCI, V966, P343; Scharloo M, 2005, HEAD NECK-J SCI SPEC, V27, P857, DOI 10.1002/hed.20251; Singh JA, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-90; Sjoling M, 2003, PATIENT EDUC COUNS, V51, P169, DOI 10.1016/S0738-3991(02)00191-X; Sniehotta FF, 2010, PSYCHOL HEALTH, V25, P839, DOI 10.1080/08870440902915915; Stoddard JA, 2005, J CLIN PSYCHOL MED S, V12, P99, DOI 10.1007/s10880-005-3269-6; Sullivan M, 2011, PAIN, V152, P2287, DOI 10.1016/j.pain.2011.06.014; Vaughan R, 2003, BRIT J HEALTH PSYCH, V8, P287, DOI 10.1348/135910703322370860; Vissers MM, 2012, SEMIN ARTHRITIS RHEU, V41, P576, DOI 10.1016/j.semarthrit.2011.07.003; Vuorenmaa M, 2008, J REHABIL MED, V40, P570, DOI 10.2340/16501977-0213; WATSONJONES R, 1956, J BONE JOINT SURG BR, V38, P353, DOI 10.1302/0301-620X.38B1.353; Wylde V, 2007, KNEE, V14, P417, DOI 10.1016/j.knee.2007.06.001; Wylde V, 2011, PAIN, V152, P566, DOI 10.1016/j.pain.2010.11.023; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	90	76	78	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73917	10.1371/journal.pone.0073917	http://dx.doi.org/10.1371/journal.pone.0073917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058502	Green Published, Green Submitted, gold			2022-12-25	WOS:000324408400042
J	von Schonfels, W; von Kampen, O; Patsenker, E; Stickel, F; Schniewind, B; Hinz, S; Ahrens, M; Balschun, K; Egberts, JH; Richter, K; Landrock, A; Sipos, B; Will, O; Huebbe, P; Schreiber, S; Nothnagel, M; Rocken, C; Rimbach, G; Becker, T; Hampe, J; Schafmayer, C				von Schoenfels, Witigo; von Kampen, Oliver; Patsenker, Eleonora; Stickel, Felix; Schniewind, Bodo; Hinz, Sebastian; Ahrens, Markus; Balschun, Katharina; Egberts, Jan-Hendrik; Richter, Klaus; Landrock, Andreas; Sipos, Bence; Will, Olga; Huebbe, Patrizia; Schreiber, Stefan; Nothnagel, Michael; Roecken, Christoph; Rimbach, Gerald; Becker, Thomas; Hampe, Jochen; Schafmayer, Clemens			Metabolic Signature of Electrosurgical Liver Dissection	PLOS ONE			English	Article							LIPID-PEROXIDATION; OXIDATION; ACID; PRODUCTS; PROFILES; HEPATECTOMY; RESECTION	Background and Aims: High frequency electrosurgery has a key role in the broadening application of liver surgery. Its molecular signature, i.e. the metabolites evolving from electrocauterization which may inhibit hepatic wound healing, have not been systematically studied. Methods: Human liver samples were thus obtained during surgery before and after electrosurgical dissection and subjected to a two-stage metabolomic screening experiment (discovery sample: N = 18, replication sample: N = 20) using gas chromatography/mass spectrometry. Results: In a set of 208 chemically defined metabolites, electrosurgical dissection lead to a distinct metabolic signature resulting in a separation in the first two dimensions of a principal components analysis. Six metabolites including glycolic acid, azelaic acid, 2-n-pentylfuran, dihydroactinidiolide, 2-butenal and n-pentanal were consistently increased after electrosurgery meeting the discovery (p<2.0x10(-4)) and the replication thresholds (p<3.5x10(-3)). Azelaic acid, a lipid peroxidation product from the fragmentation of abundant sn-2 linoleoyl residues, was most abundant and increased 8.1-fold after electrosurgical liver dissection (p(replication) = 1.6x10(-4)). The corresponding phospholipid hexadecyl azelaoyl glycerophosphocholine inhibited wound healing and tissue remodelling in scratch-and proliferation assays of hepatic stellate cells and cholangiocytes, and caused apoptosis dose-dependently in vitro, which may explain in part the tissue damage due to electrosurgery. Conclusion: Hepatic electrosurgery generates a metabolic signature with characteristic lipid peroxidation products. Among these, azelaic acid shows a dose-dependent toxicity in liver cells and inhibits wound healing. These observations potentially pave the way for pharmacological intervention prior liver surgery to modify the metabolic response and prevent postoperative complications.	[von Schoenfels, Witigo; Schniewind, Bodo; Hinz, Sebastian; Ahrens, Markus; Egberts, Jan-Hendrik; Becker, Thomas; Schafmayer, Clemens] Univ Hosp Schleswig Holstein, Dept Gen & Thorac Surg, Kiel, Germany; [von Kampen, Oliver; Schreiber, Stefan; Hampe, Jochen] Univ Hosp Schleswig Holstein, Dept Internal Med 1, Kiel, Germany; [Patsenker, Eleonora; Stickel, Felix] Univ Bern, Inst Clin Pharmacol & Visceral Res, Bern, Switzerland; [Balschun, Katharina; Roecken, Christoph] Univ Hosp Schleswig Holstein, Inst Pathol, Kiel, Germany; [Richter, Klaus; Landrock, Andreas] GWT TUD, Dresden, Germany; [Sipos, Bence] Univ Tubingen Hosp, Inst Pathol, Tubingen, Germany; [Will, Olga] Univ Kiel, Mol Imaging North Competence Ctr, Kiel, Germany; [Huebbe, Patrizia; Rimbach, Gerald] Univ Kiel, Inst Human Nutr & Food Sci, Kiel, Germany; [Nothnagel, Michael] Univ Hosp Schleswig Holstein, Inst Med Stat & Informat, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Bern; University of Kiel; Schleswig Holstein University Hospital; Technische Universitat Dresden; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Kiel; University of Kiel; University of Kiel; Schleswig Holstein University Hospital	Schafmayer, C (corresponding author), Univ Hosp Schleswig Holstein, Dept Gen & Thorac Surg, Kiel, Germany.	Clemens.Schafmayer@uk-sh.de	Röcken, Christoph/A-9239-2010; Egberts, Jan-Hendrik/E-3211-2015; Hampe, Jochen/A-2555-2010	Röcken, Christoph/0000-0002-6989-8002; Rimbach, Gerald/0000-0001-7888-4684; Nothnagel, Michael/0000-0001-8305-7114; Hampe, Jochen/0000-0002-2421-6127	German Ministry of Education and Research (BMBF) through the Virtual Liver Project; Medical Faculty of the University of Kiel	German Ministry of Education and Research (BMBF) through the Virtual Liver Project(Federal Ministry of Education & Research (BMBF)); Medical Faculty of the University of Kiel	This study was supported by the German Ministry of Education and Research (BMBF) through the Virtual Liver Project and through institutional funds from the Medical Faculty of the University of Kiel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 2011, J AGR FOOD CHEM, V59, P11058, DOI 10.1021/jf202448v; BUTTE W, 1983, J CHROMATOGR, V261, P142, DOI 10.1016/S0021-9673(01)87931-0; Chen R, 2007, J BIOL CHEM, V282, P24842, DOI 10.1074/jbc.M702865200; Chen R, 2009, J BIOL CHEM, V284, P26297, DOI 10.1074/jbc.M109.018978; Dickey LA, 2002, N AM J AQUACULT, V64, P158, DOI 10.1577/1548-8454(2002)064&lt;0158:COADTM&gt;2.0.CO;2; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; FRANKEL EN, 1984, PROG LIPID RES, V23, P197, DOI 10.1016/0163-7827(84)90011-0; Gilgenkrantz H, 2011, CLIN RES HEPATOL GAS, V35, P623, DOI 10.1016/j.clinre.2011.04.002; Glover J L, 1978, Curr Probl Surg, V15, P1, DOI 10.1016/S0011-3840(78)80017-3; Jamagin WR, 2002, ANN SURG, V236, P397, DOI 10.1097/01.SLA.0000029003.66466.B3; Jia CK, 2011, EXPERT REV GASTROENT, V5, P105, DOI [10.1586/egh.10.87, 10.1586/EGH.10.87]; Jochheim-Richter A, 2006, DIFFERENTIATION, V74, P167, DOI 10.1111/j.1432-0436.2006.00066.x; Keen W W, 1899, Ann Surg, V30, P267, DOI 10.1097/00000658-189907000-00023; Koch M, 2011, SURGERY, V149, P680, DOI 10.1016/j.surg.2010.12.002; LANDROCK A, 1995, FRESEN J ANAL CHEM, V351, P536, DOI 10.1007/BF00322729; Landrock A, 2011, METHOD SYSTEM INTERN; Lee SJ, 2010, J FOOD SCI, V75, pC147, DOI 10.1111/j.1750-3841.2009.01461.x; Maksimovic V, 2006, CARBOHYD RES, V341, P2360, DOI 10.1016/j.carres.2006.06.023; Mallia S, 2009, J AGR FOOD CHEM, V57, P7464, DOI 10.1021/jf9002158; MARKELOV M, 1993, ANAL CHIM ACTA, V276, P235, DOI 10.1016/0003-2670(93)80390-7; Meier S, 2006, J CHROMATOGR A, V1104, P291, DOI 10.1016/j.chroma.2005.11.045; Mullin EJ, 2005, AM J SURG, V190, P87, DOI 10.1016/j.amjsurg.2005.01.043; Packer L, 2001, J NUTR, V131, p369S, DOI 10.1093/jn/131.2.369S; Poon RT, 2004, ANN SURG, V240, P698, DOI 10.1097/01.sla.0000141195.66155.0c; Rahbari NN, 2011, HPB, V13, P528, DOI 10.1111/j.1477-2574.2011.00319.x; Sommerburg O, 2003, FREE RADICAL BIO MED, V35, P1480, DOI 10.1016/j.freeradbiomed.2003.08.020; Spiteller P, 2001, BBA-MOL CELL BIOL L, V1531, P188, DOI 10.1016/S1388-1981(01)00100-7; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; STANGELO AJ, 1980, LIPIDS, V15, P45, DOI 10.1007/BF02534117; Sugden KD, 1997, CHEM RES TOXICOL, V10, P1397, DOI 10.1021/tx970135r; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; TAPPEL AL, 1960, NATURE, V185, P35, DOI 10.1038/185035a0; Tinker MB, 1935, ANN SURG, V102, P728, DOI 10.1097/00000658-193510000-00020; Tokumura A, 1996, LIPIDS, V31, P1251, DOI 10.1007/BF02587909; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307	35	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e72022	10.1371/journal.pone.0072022	http://dx.doi.org/10.1371/journal.pone.0072022			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058442	Green Published, Green Submitted, gold			2022-12-25	WOS:000324408400004
J	Bissonnette, S; Vaillancourt, M; Hebert, SS; Drolet, G; Samadi, P				Bissonnette, Stephanie; Vaillancourt, Mylene; Hebert, Sebastien S.; Drolet, Guy; Samadi, Pershia			Striatal Pre-Enkephalin Overexpression Improves Huntington's Disease Symptoms in the R6/2 Mouse Model of Huntington's Disease	PLOS ONE			English	Article							DELTA-OPIOID RECEPTORS; PREPROENKEPHALIN MESSENGER-RNA; DEEP BRAIN-STIMULATION; IN-SITU HYBRIDIZATION; RAT-BRAIN; PROJECTION NEURONS; GLOBUS-PALLIDUS; TRANSGENIC MICE; PARKINSONS-DISEASE; DIFFERENTIAL LOSS	The reduction of pre-enkephalin (pENK) mRNA expression might be an early sign of striatal neuronal dysfunction in Huntington's disease (HD), due to mutated huntingtin protein. Indeed, striatopallidal (pENK-containing) neurodegeneration occurs at earlier stage of the disease, compare to the loss of striatonigral neurons. However, no data are available about the functional role of striatal pENK in HD. According to the neuroprotective properties of opioids that have been recognized recently, the objective of this study was to investigate whether striatal overexpression of pENK at early stage of HD can improve motor dysfunction, and/or reduce striatal neuronal loss in the R6/2 transgenic mouse model of HD. To achieve this goal recombinant adeno-associated-virus (rAAV2)-containing green fluorescence protein (GFP)-pENK was injected bilaterally in the striatum of R6/2 mice at 5 weeks old to overexpress opioid peptide pENK. Striatal injection of rAAV2-GFP was used as a control. Different behavioral tests were carried out before and/or after striatal injections of rAAV2. The animals were euthanized at 10 weeks old. Our results demonstrate that striatal overexpression of pENK had beneficial effects on behavioral symptoms of HD in R6/2 by: delaying the onset of decline in muscular force; reduction of clasping; improvement of fast motor activity, short-term memory and recognition; as well as normalization of anxiety-like behavior. The improvement of behavioral dysfunction in R6/2 mice having received rAAV2-GFP-pENK associated with upregulation of striatal pENK mRNA; the increased level of enkephalin peptide in the striatum, globus pallidus and substantia nigra; as well as the slight increase in the number of striatal neurons compared with other groups of R6/2. Accordingly, we suggest that at early stage of HD upregulation of striatal enkephalin might play a key role at attenuating illness symptoms.	[Bissonnette, Stephanie; Vaillancourt, Mylene; Hebert, Sebastien S.; Drolet, Guy; Samadi, Pershia] CHUL, CHU Quebec, Ctr Rech, Quebec City, PQ, Canada; [Hebert, Sebastien S.; Drolet, Guy; Samadi, Pershia] Univ Laval, Dept Psychiat & Neurosci, Quebec City, PQ, Canada	Laval University; Laval University	Samadi, P (corresponding author), CHUL, CHU Quebec, Ctr Rech, Quebec City, PQ, Canada.	Pershia.samadi@fmed.ulaval.ca	Hébert, Sébastien S./Q-2729-2017		CHUQ; faculty of medicine at Laval University	CHUQ; faculty of medicine at Laval University	This work was supported by start-up grant from CHUQ, and faculty of medicine at Laval University to PS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUKHALIL B, 1984, BRAIN RES, V323, P21, DOI 10.1016/0006-8993(84)90261-0; ALBIN RL, 1991, ANN NEUROL, V30, P542, DOI 10.1002/ana.410300406; Andre VM, 2010, CNS NEUROSCI THER, V16, P163, DOI 10.1111/j.1755-5949.2010.00134.x; Ariano MA, 2002, J NEUROSCI RES, V68, P716, DOI 10.1002/jnr.10272; Ayalon L, 2004, EXP NEUROL, V186, P46, DOI 10.1016/S0014-4886(03)00312-1; Bailoo JD, 2010, J NEUROSCI METH, V188, P45, DOI 10.1016/j.jneumeth.2010.01.035; Barry U, 2005, CURR PHARM DESIGN, V11, P1343, DOI 10.2174/1381612053507459; Baydyuk M, 2011, P NATL ACAD SCI USA, V108, P1669, DOI 10.1073/pnas.1004744108; Beal MF, 2004, NAT REV NEUROSCI, V5, P373, DOI 10.1038/nrn1386; Beaudry G, 2000, J NEUROCHEM, V75, P1694, DOI 10.1046/j.1471-4159.2000.0751694.x; Bezard E, 2003, TRENDS NEUROSCI, V26, P215, DOI 10.1016/S0166-2236(03)00038-9; Bezard E, 2001, NEUROBIOL DIS, V8, P343, DOI 10.1006/nbdi.2000.0375; Bodnar RJ, 2009, PEPTIDES, V30, P2432, DOI 10.1016/j.peptides.2009.09.027; Borlongan CV, 2000, NEUROREPORT, V11, P923, DOI 10.1097/00001756-200004070-00005; Borlongan CV, 2001, CELL TRANSPLANT, V10, P53; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Cepeda C, 2007, PROG NEUROBIOL, V81, P253, DOI 10.1016/j.pneurobio.2006.11.001; Chan CS, 2009, TRENDS NEUROSCI, V32, P249, DOI 10.1016/j.tins.2009.01.006; Crook ZR, 2011, NEURON, V69, P423, DOI 10.1016/j.neuron.2010.12.035; Dai Y, 2009, J NEUROSCI, V29, P11550, DOI 10.1523/JNEUROSCI.3307-09.2009; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; DELFS JM, 1994, J COMP NEUROL, V345, P46, DOI 10.1002/cne.903450104; Deng YP, 2004, J CHEM NEUROANAT, V27, P143, DOI 10.1016/j.jchemneu.2004.02.005; Drouin-Ouellet J, 2012, BRAIN BEHAV IMMUN, V26, P880, DOI 10.1016/j.bbi.2012.02.007; File SE, 1998, BRAIN RES, V805, P234, DOI 10.1016/S0006-8993(98)00736-7; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Fusco FR, 1999, J NEUROSCI, V19, P1189; Fusco FR, 2003, NEUROSCI LETT, V339, P53, DOI 10.1016/S0304-3940(02)01474-X; Giralt A, 2011, HUM MOL GENET, V20, P4232, DOI 10.1093/hmg/ddr351; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; JIANG ZG, 1992, J NEUROSCI, V12, P356; Johnson SM, 2010, ANN NY ACAD SCI, V1198, P260, DOI 10.1111/j.1749-6632.2010.05434.x; Lei WL, 2004, J NEUROSCI, V24, P8289, DOI 10.1523/JNEUROSCI.1990-04.2004; Lemiere J, 2004, J NEUROL, V251, P935, DOI 10.1007/s00415-004-0461-9; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; Ma MC, 2005, J BIOL CHEM, V280, P16208, DOI 10.1074/jbc.M408055200; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mathis C, 2011, GENES BRAIN BEHAV, V10, P299, DOI 10.1111/j.1601-183X.2010.00666.x; Menalled L, 2000, EXP NEUROL, V162, P328, DOI 10.1006/exnr.1999.7327; Miller BR, 2008, NEUROSCIENCE, V153, P329, DOI 10.1016/j.neuroscience.2008.02.004; Milnerwood AJ, 2007, J PHYSIOL-LONDON, V585, P817, DOI 10.1113/jphysiol.2007.142448; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Nambu A, 1997, J COMP NEUROL, V377, P85; Ogura M, 2000, J NEUROPHYSIOL, V83, P3366, DOI 10.1152/jn.2000.83.6.3366; Parent A, 2000, TRENDS NEUROSCI, V23, pS20, DOI 10.1016/S1471-1931(00)00022-7; Peckys D, 1999, NEUROSCIENCE, V88, P1093, DOI 10.1016/S0306-4522(98)00251-6; Polakiewicz RD, 1998, J BIOL CHEM, V273, P23534, DOI 10.1074/jbc.273.36.23534; Poulin JF, 2013, EUR J NEUROSCI, V37, P1357, DOI 10.1111/ejn.12134; Qin LY, 2005, ANN NY ACAD SCI, V1053, P107, DOI 10.1196/annals.1344.009; REINER A, 1988, P NATL ACAD SCI USA, V85, P5733, DOI 10.1073/pnas.85.15.5733; Reiner A, 2004, EXP NEUROL, V186, P1, DOI 10.1016/j.expneurol.2003.11.002; Rigamonti D, 2007, J BIOL CHEM, V282, P24554, DOI 10.1074/jbc.M609885200; ROSS CA, 1995, NEURON, V15, P493, DOI 10.1016/0896-6273(95)90138-8; Sadikot AF, 1997, J COMP NEUROL, V389, P193; Samadi P, 2005, NEUROPHARMACOLOGY, V49, P165, DOI 10.1016/j.neuropharm.2005.02.009; Samadi P, 2013, GENES BRAIN BEHAV, V12, P108, DOI 10.1111/j.1601-183X.2012.00858.x; Samadi P, 2006, TRENDS PHARMACOL SCI, V27, P512, DOI 10.1016/j.tips.2006.08.002; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schiefer J, 2002, MOVEMENT DISORD, V17, P748, DOI 10.1002/mds.10229; Schlefer J, 2004, BRAIN RES, V1019, P246, DOI 10.1016/j.brainres.2004.06.005; Stack EC, 2005, J COMP NEUROL, V490, P354, DOI 10.1002/cne.20680; Stack EC, 2007, J NEUROSCI, V27, P12908, DOI 10.1523/JNEUROSCI.4318-07.2007; Su DS, 2007, NEUROSCI LETT, V423, P113, DOI 10.1016/j.neulet.2007.06.044; Sun Z, 2002, NEUROBIOL DIS, V11, P369, DOI 10.1006/nbdi.2002.0554; Tan SKH, 2010, NEUROSURGERY, V67, P1073, DOI 10.1227/NEU.0b013e3181ee3580; Temel Y, 2006, NEUROSCI LETT, V406, P138, DOI 10.1016/j.neulet.2006.07.036; Tokuno H, 2002, NEUROSCI LETT, V332, P5, DOI 10.1016/S0304-3940(02)00837-6; Torres-Peraza JF, 2008, NEUROBIOL DIS, V29, P409, DOI 10.1016/j.nbd.2007.10.003; Van Raamsdonk JM, 2005, J NEUROSCI, V25, P4169, DOI 10.1523/JNEUROSCI.0590-05.2005; Vlamings R, 2012, NEUROBIOL DIS, V48, P488, DOI 10.1016/j.nbd.2012.07.006; Waldhoer M, 2004, ANNU REV BIOCHEM, V73, P953, DOI 10.1146/annurev.biochem.73.011303.073940; Wang H, 2001, J NEUROSCI, V21, P3242, DOI 10.1523/JNEUROSCI.21-09-03242.2001; Wang SY, 2011, EUR J PHARMACOL, V658, P140, DOI 10.1016/j.ejphar.2011.02.006; Weeks RA, 1997, J CEREBR BLOOD F MET, V17, P943, DOI 10.1097/00004647-199709000-00003; Wei CJ, 2011, LEARN MEMORY, V18, P459, DOI 10.1101/lm.2136011; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; Yang YL, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-55; Yin HH, 2004, LEARN MEMORY, V11, P459, DOI 10.1101/lm.81004; YOSHIKAWA K, 1984, J BIOL CHEM, V259, P4301; Zhai WG, 2005, CELL, V123, P1241, DOI 10.1016/j.cell.2005.10.030; Zhu M, 2009, BRAIN RES, V1252, P183, DOI 10.1016/j.brainres.2008.11.030; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	83	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e75099	10.1371/journal.pone.0075099	http://dx.doi.org/10.1371/journal.pone.0075099			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040390	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500133
J	Schoneberg, J; Noe, F				Schoeneberg, Johannes; Noe, Frank			ReaDDy - A Software for Particle-Based Reaction-Diffusion Dynamics in Crowded Cellular Environments	PLOS ONE			English	Article							BROWNIAN DYNAMICS; SECRETORY GRANULES; MOLECULAR-DYNAMICS; SIMULATIONS; RHODOPSIN; MEMBRANE; ALGORITHMS; MICROSCOPY; BIOLOGY; SPACE	We introduce the software package ReaDDy for simulation of detailed spatiotemporal mechanisms of dynamical processes in the cell, based on reaction-diffusion dynamics with particle resolution. In contrast to other particle-based reaction kinetics programs, ReaDDy supports particle interaction potentials. This permits effects such as space exclusion, molecular crowding and aggregation to be modeled. The biomolecules simulated can be represented as a sphere, or as a more complex geometry such as a domain structure or polymer chain. ReaDDy bridges the gap between small-scale but highly detailed molecular dynamics or Brownian dynamics simulations and large-scale but little-detailed reaction kinetics simulations. ReaDDy has a modular design that enables the exchange of the computing core by efficient platform-specific implementations or dynamical models that are different from Brownian dynamics.	[Schoeneberg, Johannes; Noe, Frank] Free Univ Berlin, Dept Math, Berlin, Germany	Free University of Berlin	Noe, F (corresponding author), Free Univ Berlin, Dept Math, Berlin, Germany.	frank.noe@fu-berlin.de	Noe, Frank/Y-2766-2019	Schoneberg, Johannes/0000-0001-7083-1828	Deutsche Forschungsgemeinschaft [SFB 740, SFB 958]; ERC	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission)	This work was supported by Deutsche Forschungsgemeinschaft through SFB 740 (http://www.dfg.de/foerderung/programme/listen/projektdetails/index.jsp?id = 25065445); Deutsche Forschungsgemeinschaft through SFB 958 (http://www.dfg.de/foerderung/programme/listen/projektdetails/index.jsp?id = 184695641); and ERC starting grant "pcCell". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ander M., 2004, Systems Biology, V1, P129, DOI 10.1049/sb:20045017; Anderson JA, 2008, J COMPUT PHYS, V227, P5342, DOI 10.1016/j.jcp.2008.01.047; Ando T, 2010, P NATL ACAD SCI USA, V107, P18457, DOI 10.1073/pnas.1011354107; Andrews S, 2010, PLOS COMPUTATIONAL B; Arjunan Satya Nanda Vel, 2010, Syst Synth Biol, V4, P35, DOI 10.1007/s11693-009-9047-2; Atkins P., 2009, PHYS CHEM; Banks DS, 2005, BIOPHYS J, V89, P12; Bar-On D, 2012, J BIOL CHEM, V287, P27158, DOI 10.1074/jbc.M112.353250; Barg S, 2010, P NATL ACAD SCI USA, V107, P20804, DOI 10.1073/pnas.1014823107; Bell RJ, 1968, NATURE, P1; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Boon J.-P., 1980, MOL HYDRODYNAMICS; Boulianne L, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-66; Bowers K.J., 2006, P 2006 ACM IEEE C SU, DOI [10.1109/SC.2006.54, DOI 10.1109/SC.2006.54]; Bull JM, 2001, BENCHMARKING JAVA C, P97; Burns M.E., 2004, VISUAL NEUROSCIENCES, P215; Buzhynskyy N, 2011, J MOL RECOGNIT, V24, P483, DOI 10.1002/jmr.1086; Cangiano L, 2013, FEBS LETT, V587, P1, DOI 10.1016/j.febslet.2012.11.015; Casanova H, 2004, INT J HIGH PERFORM C, V18, P3, DOI 10.1177/1094342004041290; Casanova H, 2001, INT J HIGH PERFORM C, V15, P243, DOI 10.1177/109434200101500304; Dauty E, 2004, J MOL RECOGNIT, V17, P441, DOI 10.1002/jmr.709; Dell'Orco D, 2011, BIOCH J; Dell'Orco D, 2008, J PHYS CHEM B, V112, P4419, DOI 10.1021/jp709963f; Dematte L, 2012, IEEE ACM T COMPUT BI, V9, P655, DOI 10.1109/TCBB.2011.106; Dlugosz M, 2011, J COMPUT CHEM, V32, P2734, DOI 10.1002/jcc.21847; Dlugosz M, 2011, BMC BIOPHYS, V4, DOI 10.1186/2046-1682-4-3; Dushek O, 2011, BIOPHYS J, V100, P1189, DOI 10.1016/j.bpj.2011.01.060; Eastman P, 2010, COMPUTING SCI ENG; Eastman P, 2012, J CHEM THEORY COMPUT; Elcock AH, 2002, BIOPHYS J, V82, P2326, DOI 10.1016/S0006-3495(02)75578-1; Ellis RJ, 2001, TRENDS BIOCH, V26; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; Erban R, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046001; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Galli Thierry, 2004, Sci STKE, V2004, pre19, DOI 10.1126/stke.2642004re19; Geyer T, 2011, BMC BIOPHYS, V4, DOI 10.1186/2046-1682-4-7; Goodsell D. S., 2009, MACHINERY LIFE; Goodsell DS, 2007, PLOS BIOL, V5, P2759, DOI 10.1371/journal.pbio.0050308; Goodsell DS, 2005, STRUCTURE, V13, P347, DOI 10.1016/j.str.2005.01.012; Govardovskii VI, 2009, MOL VIS, V15, P1717; Hattne J, 2005, BIOINFORMATICS, V21, P2923, DOI 10.1093/bioinformatics/bti431; Haucke V, 2011, NAT REV NEUROSCI, V12, P127, DOI 10.1038/nrn2948; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Holcombe MM, 2011, INTEGRATIVE BIOL, V4, P53; Huber GA, 2010, COMPUT PHYS COMMUN, V181, P1896, DOI 10.1016/j.cpc.2010.07.022; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kerr RA, 2008, SIAM J SCI COMPUT, V30, P3126, DOI 10.1137/070692017; Klann M, 2012, INT J MOL SCI, V13, P7798, DOI 10.3390/ijms13067798; Klann MT, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-71; Knowles MK, 2010, P NATL ACAD SCI USA, V107, P20810, DOI 10.1073/pnas.1014840107; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Lee PH, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4757265; MADURA JD, 1995, COMPUT PHYS COMMUN, V91, P57, DOI 10.1016/0010-4655(95)00043-F; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; Mereghetti P, 2011, BMC BIOPHYS, V4, DOI 10.1186/2046-1682-4-9; Minton AP, 2006, J CELL SCI; Minton AP, 2001, J BIOL CHEM; MORI H, 1965, PROG THEOR PHYS, V33, P423, DOI 10.1143/PTP.33.423; Periole X, 2012, J AM CHEM SOC, V134, P10959, DOI 10.1021/ja303286e; Phillips CL, 2011, J COMPUT PHYS, V230, P7191, DOI 10.1016/j.jcp.2011.05.021; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Phillips R., 2009, PHYS BIOL CELL; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Plimpton S, 2003, CHEMCELL PARTICLE BA, P1; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; Rahman A, 1971, J CHEM PHYS, V55, P3336, DOI 10.1063/1.1676585; Ridgway D, 2008, BIOPHYS J, V94, P3748, DOI 10.1529/biophysj.107.116053; Ridgway D, 2006, CURR OPIN BIOTECH, V17, P493, DOI 10.1016/j.copbio.2006.08.004; Roberts E, 2009, P 2009 IEEE INT S PA, P1; Roberts E, 2013, J COMPUT CHEM, V34, P245, DOI 10.1002/jcc.23130; Roberts E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002010; Rodriguez JV, 2006, BIOINFORMATICS, V22, P1895, DOI 10.1093/bioinformatics/btl271; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sanford C, 2006, BIOINFORMATICS, V22, P2918, DOI 10.1093/bioinformatics/btl497; Shafi A, 2009, CONCURR COMP-PRACT E, V21, P1882, DOI 10.1002/cpe.1416; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Slepchenko BM, 2003, TRENDS CELL BIOL, V13, P570, DOI 10.1016/j.tcb.2003.09.002; Smoluchowski M., 1917, Z PHYS CHEM, V92, P129, DOI [10.1515/zpch-1918-9209, DOI 10.1515/ZPCH-1918-9209]; SZABO A, 1989, J PHYS CHEM-US, V93, P6929, DOI 10.1021/j100356a011; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Todorov IT, 2006, J MAT CHEM; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; van Zon JS, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2137716; VanKampen, 1992, STOCHASTIC PROCESSES; Verkman AS, 2002, TRENDS BIOCHEM SCI, V27, P27, DOI 10.1016/S0968-0004(01)02003-5; Wade RC, 2011, BMC BIOPHYSICS, V4; Yachie-Kinoshita A, 2010, J BIOMED BIOTECHNOL, V2010, P642420; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331; Zwanzig R., 1973, J STAT PHYS, V9, P215, DOI DOI 10.1007/BF01008729	95	90	90	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74261	10.1371/journal.pone.0074261	http://dx.doi.org/10.1371/journal.pone.0074261			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040218	Green Submitted, Green Published, gold			2022-12-25	WOS:000326734500081
J	van der Velden, YU; Wang, LQ; Cano, LQ; Haramis, APG				van der Velden, Yme U.; Wang, Liqin; Cano, Laia Querol; Haramis, Anna-Pavlina G.			The Polycomb Group Protein Ring1b/Rnf2 Is Specifically Required for Craniofacial Development	PLOS ONE			English	Article							ZEBRAFISH NEURAL CREST; CELL FATE; OSTEOBLAST DIFFERENTIATION; BRANCHIAL ARCH; BONE-FORMATION; HEAD SKELETON; HISTONE H2A; GENE; EXPRESSION; MECHANISMS	Polycomb group (PcG) genes are chromatin modifiers that mediate epigenetic silencing of target genes. PcG-mediated epigenetic silencing is implicated in embryonic development, stem cell plasticity, cell fate maintenance, cellular differentiation and cancer. However, analysis of the roles of PcG proteins in maintaining differentiation programs during vertebrate embryogenesis has been hampered due to the early embryonic lethality of several PcG knock-outs in the mouse. Here, we show that zebrafish Ring1b/Rnf2, the single E3 ubiquitin ligase in the Polycomb Repressive Complex 1, critically regulates the developmental program of craniofacial cell lineages. Zebrafish ring1b mutants display a severe craniofacial phenotype, which includes an almost complete absence of all cranial cartilage, bone and musculature. We show that Cranial Neural Crest (CNC)-derived cartilage precursors migrate correctly into the pharyngeal arches, but fail to differentiate into chondrocytes. This phenotype is specific for cartilage precursors, since other neural crest-derived cell lineages, including glia, neurons and chromatophores, are formed normally in ring1b mutants. Our results therefore reveal a critical and specific role for Ring1b in promoting the differentiation of cranial neural crest cells into chondrocytes. The molecular mechanisms underlying the pathogenesis of craniofacial abnormalities, which are among the most common genetic birth defects in humans, remain poorly understood. The zebrafish ring1b mutant provides a molecular model for investigating these mechanisms and may lead to the discovery of new treatments or preventions of craniofacial abnormalities.	[van der Velden, Yme U.; Wang, Liqin; Haramis, Anna-Pavlina G.] Netherlands Canc Inst, Dept Mol Genet, Amsterdam, Netherlands; [van der Velden, Yme U.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Wang, Liqin] Netherlands Canc Inst, Dept Mol Carcinogenesis, Amsterdam, Netherlands; [Cano, Laia Querol; Haramis, Anna-Pavlina G.] Leiden Univ, Inst Biol, Leiden, Netherlands	Netherlands Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Cancer Institute; Leiden University; Leiden University - Excl LUMC	Haramis, APG (corresponding author), Netherlands Canc Inst, Dept Mol Genet, Amsterdam, Netherlands.	a.haramis@biology.leidenuniv.nl	Cano, Laia Querol/AAC-2738-2021		Netherlands Organization for Scientific Research [(NWO-ZonMW)-Vidi 91756322]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	The work was funded in part by the Netherlands Organization for Scientific Research [(NWO-ZonMW)-Vidi 91756322] to A.-P. G.H. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Andermann P, 2002, DEV BIOL, V251, P45, DOI 10.1006/dbio.2002.0820; Angelo S, 2000, MECH DEVELOP, V95, P231, DOI 10.1016/S0925-4773(00)00334-8; BADER D, 1982, J CELL BIOL, V95, P763, DOI 10.1083/jcb.95.3.763; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Curran K, 2010, DEV BIOL, V344, P107, DOI 10.1016/j.ydbio.2010.04.023; Curran K, 2009, DEV BIOL, V332, P408, DOI 10.1016/j.ydbio.2009.06.010; David NB, 2002, DEVELOPMENT, V129, P4457; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dutton KA, 2001, DEVELOPMENT, V128, P4113; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Flores MV, 2006, DEV DYNAM, V235, P3166, DOI 10.1002/dvdy.20957; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; Herzog W, 2004, DEVELOPMENT, V131, P3681, DOI 10.1242/dev.01235; Hogan BM, 2004, DEV BIOL, V276, P508, DOI 10.1016/j.ydbio.2004.09.018; Hong SK, 2005, P NATL ACAD SCI USA, V102, P18473, DOI 10.1073/pnas.0509457102; Kelsh RN, 1996, DEVELOPMENT, V123, P369; Kelsh RN, 2000, MECH DEVELOP, V93, P161, DOI 10.1016/S0925-4773(00)00250-1; Knight RD, 2006, ADV EXP MED BIOL, V589, P120; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; LaBonne C, 1999, ANNU REV CELL DEV BI, V15, P81, DOI 10.1146/annurev.cellbio.15.1.81; Le Guyader S, 2002, PIGM CELL RES, V15, P27; Li FF, 2011, J BONE MINER RES, V26, P2899, DOI 10.1002/jbmr.504; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; Nissen RM, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-28; Odenthal J, 1996, DEVELOPMENT, V123, P391; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; RAIBLE DW, 1994, DEVELOPMENT, V120, P495; Rau MJ, 2006, DEV BIOL, V296, P83, DOI 10.1016/j.ydbio.2006.04.437; Schilling TF, 1996, DEVELOPMENT, V123, P329; Schilling TF, 1997, DEVELOPMENT, V124, P2945; SCHILLING TF, 1994, DEVELOPMENT, V120, P483; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; van der Velden YU, DEVELOPMENT, V139, P2210; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wada N, 2005, DEVELOPMENT, V132, P3977, DOI 10.1242/dev.01943; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; YAN YL, 1995, DEV DYNAM, V203, P363, DOI 10.1002/aja.1002030308; Yan YL, 2005, DEVELOPMENT, V132, P1069, DOI 10.1242/dev.01674; Yan YL, 2002, DEVELOPMENT, V129, P5065	45	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73997	10.1371/journal.pone.0073997	http://dx.doi.org/10.1371/journal.pone.0073997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040141	Green Published, gold, Green Submitted			2022-12-25	WOS:000326734500067
J	Dhar, I; Dhar, A; Wu, LY; Desai, KM				Dhar, Indu; Dhar, Arti; Wu, Lingyun; Desai, Kaushik M.			Increased Methylglyoxal Formation with Upregulation of Renin Angiotensin System in Fructose Fed Sprague Dawley Rats	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; OXIDATIVE STRESS; METABOLIC SYNDROME; DIABETIC COMPLICATIONS; INSULIN-RESISTANCE; HYPERTENSION DEVELOPMENT; CARDIOVASCULAR-DISEASE; MOLECULAR-MECHANISM; ALDOSTERONE SYSTEM; URIC-ACID	The current epidemic of obesity and type 2 diabetes is attributed to a high carbohydrate diet, containing mainly high fructose corn syrup and sucrose. More than two thirds of diabetic patients have hypertension. Methylglyoxal is a highly reactive dicarbonyl generated during glucose and fructose metabolism, and a major precursor of advanced glycation end products (AGEs). Plasma methylglyoxal levels are increased in hypertensive rats and diabetic patients. Our aim was to examine the levels of methylglyoxal, mediators of the renin angiotensin system and blood pressure in male Sprague-Dawley rats treated with a high fructose diet (60% of total calories) for 4 months. The thoracic aorta and kidney were used for molecular studies, along with cultured vascular smooth muscle cells (VSMCs). HPLC, Western blotting and Q-PCR were used to measure methylglyoxal and reduced glutathione (GSH), proteins and mRNA, respectively. Fructose treated rats developed a significant increase in blood pressure. Methylglyoxal level and protein and mRNA for angiotensin II, AT(1) receptor, adrenergic alpha(1D) receptor and renin were significantly increased, whereas GSH levels were decreased, in the aorta and/or kidney of fructose fed rats. The protein expression of the receptor for AGEs (RAGE) and NF-kappa B were also significantly increased in the aorta of fructose fed rats. MG treated VSMCs showed increased protein for angiotensin II, AT(1) receptor, and alpha(1D) receptor. The effects of methylglyoxal were attenuated by metformin, a methylglyoxal scavenger and AGEs inhibitor. In conclusion, we report a strong association between elevated levels of methylglyoxal, RAGE, NF-kappa B, mediators of the renin angiotensin system and blood pressure in high fructose diet fed rats.	[Dhar, Indu; Dhar, Arti; Desai, Kaushik M.] Univ Saskatchewan, Coll Med, Dept Pharmacol, Saskatoon, SK S7N 0W0, Canada; [Wu, Lingyun] Lakehead Univ, Dept Hlth Sci, Thunder Bay, ON P7B 5E1, Canada; [Wu, Lingyun] Thunder Bay Reg Res Inst, Thunder Bay, ON, Canada	University of Saskatchewan; Lakehead University; Northern Ontario School of Medicine	Wu, LY (corresponding author), Lakehead Univ, Dept Hlth Sci, Thunder Bay, ON P7B 5E1, Canada.	lwu@lakeheadu.ca; k.desai@usask.ca		Desai, Kaushik/0000-0001-9355-4528	Heart and Stroke Foundation of Saskatchewan [G-10-DE-4379]; Saskatchewan Health Research Foundation	Heart and Stroke Foundation of Saskatchewan; Saskatchewan Health Research Foundation	This work was supported by a grant-in-aid from the Heart and Stroke Foundation of Saskatchewan (G-10-DE-4379) to KD and LW, and by a New Investigator grant from the Saskatchewan Health Research Foundation to KD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beisswenger PJ, 1999, DIABETES, V48, P198, DOI 10.2337/diabetes.48.1.198; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Ceriello A, 2004, ARTERIOSCL THROM VAS, V24, P816, DOI 10.1161/01.ATV.0000122852.22604.78; Ceriello A, 2008, DIABETES CARE, V31, pS181, DOI 10.2337/dc08-s245; Cowley AW, 1996, JAMA-J AM MED ASSOC, V275, P1581, DOI 10.1001/jama.275.20.1581; Desai Kaushik, 2007, Recent Pat Cardiovasc Drug Discov, V2, P89; Desai KM, 2006, EUR J PHARMACOL, V546, P120, DOI 10.1016/j.ejphar.2006.06.072; Desai Kaushik M., 2008, Drug Metabolism and Drug Interactions, V23, P151; Dhar A, 2008, METABOLISM, V57, P1211, DOI 10.1016/j.metabol.2008.04.014; Dhar A, 2011, DIABETES, V60, P899, DOI 10.2337/db10-0627; Dhar A, 2009, J CHROMATOGR B, V877, P1093, DOI 10.1016/j.jchromb.2009.02.055; Fyhrquist F, 2008, J INTERN MED, V264, P224, DOI 10.1111/j.1365-2796.2008.01981.x; Government of Saskatchewan Health website, 2000, DIAB 2000; HALL JE, 1990, HYPERTENSION, V15, P547, DOI 10.1161/01.HYP.15.6.547; Harman D, 1998, J Int Fed Clin Chem, V10, P24; Hitomi H, 2007, CURR OPIN CARDIOL, V22, P311, DOI 10.1097/HCO.0b013e3281532b53; HWANG IS, 1987, HYPERTENSION, V10, P512, DOI 10.1161/01.HYP.10.5.512; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; Johnson RJ, 2009, ENDOCR REV, V30, P96, DOI 10.1210/er.2008-0033; KAUFMAN LN, 1991, AM J PHYSIOL, V260, pE95, DOI 10.1152/ajpendo.1991.260.1.E95; Le MT, 2012, METABOLISM, V61, P641, DOI 10.1016/j.metabol.2011.09.013; Madero M, 2011, CURR HYPERTENS REP, V13, P29, DOI 10.1007/s11906-010-0163-x; Manrique C, 2009, MED CLIN N AM, V93, P569, DOI 10.1016/j.mcna.2009.02.014; MCLELLAN AC, 1994, CLIN SCI, V87, P21, DOI 10.1042/cs0870021; Michelotti GA, 2000, PHARMACOL THERAPEUT, V88, P281, DOI 10.1016/S0163-7258(00)00092-9; Perez-Pozo SE, 2010, INT J OBESITY, V34, P454, DOI 10.1038/ijo.2009.259; Ramasamy R, 2011, ANN NY ACAD SCI, V1243, P88, DOI 10.1111/j.1749-6632.2011.06320.x; Rena G, 2013, DIABETOLOGIA, V56, P1898, DOI 10.1007/s00125-013-2991-0; Ruggiero-Lopez D, 1999, BIOCHEM PHARMACOL, V58, P1765, DOI 10.1016/S0006-2952(99)00263-4; Sanchez-Lozada LG, 2007, AM J PHYSIOL-RENAL, V292, pF423, DOI 10.1152/ajprenal.00124.2006; Selvaraju V, 2012, TOXICOL MECH METHOD, V22, P330, DOI 10.3109/15376516.2012.666648; Stanhope KL, 2012, ANNU REV MED, V63, P329, DOI 10.1146/annurev-med-042010-113026; Vander Jagt DL, 2003, CHEM-BIOL INTERACT, V143, P341, DOI 10.1016/S0009-2797(02)00212-0; Wang H, 2007, CLIN BIOCHEM, V40, P1232, DOI 10.1016/j.clinbiochem.2007.07.016; Wang XX, 2008, J HYPERTENS, V26, P765, DOI 10.1097/HJH.0b013e3282f4a13c; Wang XX, 2007, AM J HYPERTENS, V20, P629, DOI 10.1016/j.amjhyper.2006.12.003; Wang XX, 2005, J HYPERTENS, V23, P1565, DOI 10.1097/01.hjh.0000173778.85233.1b; Wendt Thoralf, 2002, Curr Atheroscler Rep, V4, P228, DOI 10.1007/s11883-002-0024-4; Wu LY, 2002, HYPERTENSION, V39, P809, DOI 10.1161/hy0302.105207; Zaman MA, 2002, NAT REV DRUG DISCOV, V1, P621, DOI 10.1038/nrd873	40	37	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74212	10.1371/journal.pone.0074212	http://dx.doi.org/10.1371/journal.pone.0074212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040205	Green Submitted, Green Published, gold			2022-12-25	WOS:000327538600076
J	Liu, B; Ma, Y; Yi, J; Xu, ZW; Zhang, YS; Zhang, CM; Zhuang, R; Yu, HT; Wang, JP; Yang, AG; Zhang, Y; Jin, BQ				Liu, Bei; Ma, Ying; Yi, Jing; Xu, Zhuwei; Zhang, Yu Si; Zhang, Chunmei; Zhuang, Ran; Yu, Haitao; Wang, Jiuping; Yang, Angang; Zhang, Yun; Jin, Boquan			Elevated Plasma Soluble Sema4D/CD100 Levels Are Associated with Disease Severity in Patients of Hemorrhagic Fever with Renal Syndrome	PLOS ONE			English	Article							IV SEMAPHORIN CD100; LYMPHOCYTE SEMAPHORIN; T-LYMPHOCYTES; BIOLOGICAL-ACTIVITY; CELL ACTIVATION; IMMUNE-SYSTEM; B-CELL; ANGIOGENESIS; SURFACE; RECRUITMENT	Background: Hantaan virus (HTNV) could cause a severe lethal hemorrhagic fever with renal syndrome (HFRS) in humans. Despite a limited understanding of the pathogenesis of HFRS, the importance of host-related immune responses in the pathogenesis of HFRS has been widely recognized. CD100/Sema4D has been demonstrated to play an important role in physiological and pathological immune responses, but the functional role of CD100 in infectious diseases has only been inadequately reported. The aim of this study was to investigate the pathological significance of CD100 in patients after HTNV infection. Methodology/Principal Findings: Blood samples were collected from 99 hospitalized patients in Tangdu Hospital and 27 health controls. The level of soluble CD100 (sCD100) in plasma were quantified by ELISA and the relationship between sCD100 and the disease course or severity were analyzed. The expressions of membrane CD100 on various subpopulations of peripheral blood mononuclear cell (PBMC) were analyzed by flow cytometry. The results showed that sCD100 level in acute phase of HFRS was significantly higher in patients than that in healthy controls (P<0.0001) and the sCD100 level declined in convalescent phase. Multivariate model analysis showed that platelet count, white blood cell count, serum creatinine level and blood urea nitrogen level were associated with sCD100 levels and contributed independently to the elevated sCD100 levels. The expression of membrane CD100 on PBMCs decreased in the acute phase of HFRS patients compared with that of the normal controls and recovered in the convalescent phase. Conclusions: We reported the elevated level of plasma sCD100 in HFRS patients and the elevated level might be a result from the shedding of membrane CD100 on PBMC. The elevated level of sCD100 was associated with disease severity, suggesting that sCD100 might be a cause or a consequence of progression of HFRS. The underlying mechanisms should be explored further.	[Liu, Bei; Ma, Ying; Xu, Zhuwei; Zhang, Yu Si; Zhang, Chunmei; Zhuang, Ran; Yang, Angang; Zhang, Yun; Jin, Boquan] Fourth Mil Med Univ, Dept Immunol, Xian 710032, Peoples R China; [Yi, Jing] Fourth Mil Med Univ, Xijing Hosp, Dept Blood Transfus, Xian 710032, Peoples R China; [Yu, Haitao; Wang, Jiuping] Fourth Mil Med Univ, Tangdu Hosp, Dept Infect Dis, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Zhang, Y (corresponding author), Fourth Mil Med Univ, Dept Immunol, Xian 710032, Peoples R China.	immuzy@fmmu.edu.cn; immu_jin@fmmu.edu.cn	Zhuang, Ran/I-7336-2019	Zhuang, Ran/0000-0002-3614-0422	National Natural Science Foundation of China [30930087]; National Basic Research Program of China [2012CB518905]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by The National Natural Science Foundation of China (No. 30930087) and the National Basic Research Program of China (No. 2012CB518905). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Basile JR, 2007, J BIOL CHEM, V282, P6899, DOI 10.1074/jbc.M609570200; Basile JR, 2004, CANCER RES, V64, P5212, DOI 10.1158/0008-5472.CAN-04-0126; Besliu A, 2011, AUTOIMMUNITY, V44, P427, DOI 10.3109/08916934.2010.541171; Binmadi NO, 2011, ANGIOGENESIS, V14, P309, DOI 10.1007/s10456-011-9214-4; BOUGERET C, 1992, J IMMUNOL, V148, P318; Conrotto P, 2005, BLOOD, V105, P4321, DOI 10.1182/blood-2004-07-2885; Delaire S, 2001, J IMMUNOL, V166, P4348, DOI 10.4049/jimmunol.166.7.4348; Elhabazi A, 2001, J IMMUNOL, V166, P4341, DOI 10.4049/jimmunol.166.7.4341; Eriksson EM, 2012, BLOOD, V119, P745, DOI 10.1182/blood-2010-12-324848; Giraudon P, 2004, J IMMUNOL, V172, P1246, DOI 10.4049/jimmunol.172.2.1246; Hayasaka D, 2007, VIRUS RES, V123, P120, DOI 10.1016/j.virusres.2006.08.006; Herold C, 1996, J IMMUNOL, V157, P5262; Ishida I, 2003, INT IMMUNOL, V15, P1027, DOI 10.1093/intimm/dxg098; JOKINEN EJ, 1978, CLIN NEPHROL, V9, P1; Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09; Khaiboullina SF, 2005, CURR MOL MED, V5, P773, DOI 10.2174/156652405774962317; Kumanogoh A, 2002, J IMMUNOL, V169, P1175, DOI 10.4049/jimmunol.169.3.1175; Kumanogoh A, 2000, IMMUNITY, V13, P621, DOI 10.1016/S1074-7613(00)00062-5; Li M, 2006, J IMMUNOL, V177, P3406, DOI 10.4049/jimmunol.177.5.3406; Li M, 2009, IMMUNOLOGY, V128, P114, DOI 10.1111/j.1365-2567.2009.03098.x; Ma Ying, 2012, Clin Dev Immunol, V2012, P812386, DOI 10.1155/2012/812386; Mackow ER, 2009, THROMB HAEMOSTASIS, V102, P1030, DOI 10.1160/TH09-09-0640; Muranyi W, 2005, J AM SOC NEPHROL, V16, P3669, DOI 10.1681/ASN.2005050561; PENTTINEN K, 1981, J INFECT DIS, V143, P15, DOI 10.1093/infdis/143.1.15; Shi W, 2000, IMMUNITY, V13, P633, DOI 10.1016/S1074-7613(00)00063-7; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Wang XS, 2001, BLOOD, V97, P3498, DOI 10.1182/blood.V97.11.3498; Watanabe C, 2001, J IMMUNOL, V167, P4321, DOI 10.4049/jimmunol.167.8.4321; Xu Xiao-guang, 2003, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V19, P80; Yi J, 2013, J INFECT DIS, V207, P1457, DOI 10.1093/infdis/jis475; Zhou H, 2012, ANGIOGENESIS, V15, P391, DOI 10.1007/s10456-012-9268-y	31	19	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73958	10.1371/journal.pone.0073958	http://dx.doi.org/10.1371/journal.pone.0073958			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040126	Green Published, Green Submitted, gold			2022-12-25	WOS:000327538600055
J	Tian, YH; Xie, Q; Tian, YM; Liu, Y; Huang, ZP; Fan, CD; Hou, B; Sun, D; Yao, KT; Chen, TF				Tian, Yunhong; Xie, Qiang; Tian, Yunming; Liu, Ying; Huang, Zuoping; Fan, Cundong; Hou, Bing; Sun, Dan; Yao, Kaitai; Chen, Tianfeng			Radioactive I-125 Seed Inhibits the Cell Growth, Migration, and Invasion of Nasopharyngeal Carcinoma by Triggering DNA Damage and Inactivating VEGF-A/ERK Signaling	PLOS ONE			English	Article							SALVAGE THERAPY; PERMANENT IMPLANTATION; CANCER-CELLS; IN-VITRO; IRRADIATION; ACTIVATION; RADIOTHERAPY; SURVIVAL; PROTEIN; TUMORS	Although radiotherapy technology has progressed rapidly in the past decade, the inefficiency of radiation and cancer cell resistance mean that the 5-year survival rate of patients with nasopharyngeal carcinoma (NPC) is low. Radioactive I-125 seed implantation has received increasing attention as a clinical treatment for cancers. Vascular endothelial growth factor-A (VEGF-A) is one of the most important members of the VEGF family and plays an important role in cell migration through the extracellular-signal-regulated kinase (ERK) pathway. Here we show that radioactive I-125 seeds more effectively inhibit NPC cell growth through DNA damage and subsequent induction of apoptosis, compared with X-ray irradiation. Moreover, cell migration was effectively inhibited by I-125 seed irradiation through VEGF-A/ERK inactivation. VEGF-A pretreatment significantly blocked I-125 seed irradiation-induced inhibition of cell migration by recovering the levels of phosphorylated ERK (p-ERK) protein. Interestingly, in vivo study results confirmed that I-125 seed irradiation was more effective in inhibiting tumor growth than X-ray irradiation. Taken together, these results suggest that radioactive I-125 seeds exert novel anticancer activity by triggering DNA damage and inactivating VEGF-A/ERK signaling. Our finding provides evidence for the efficacy of I-125 seeds for treating NPC patients, especially those with local recurrence.	[Tian, Yunhong; Yao, Kaitai] Southern Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China; [Tian, Yunhong; Xie, Qiang; Liu, Ying; Huang, Zuoping; Hou, Bing; Sun, Dan] Armed Police Hosp Guangdong Prov, Dept Oncol, Guangzhou, Guangdong, Peoples R China; [Xie, Qiang] Jinan Univ, Coll Med, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Tian, Yunming] State Key Lab Oncol Southern China, Guangzhou, Guangdong, Peoples R China; [Tian, Yunming] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China; [Fan, Cundong; Chen, Tianfeng] Jinan Univ, Dept Chem, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Jinan University; State Key Lab Oncology South China; Sun Yat Sen University; Jinan University	Yao, KT (corresponding author), Southern Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China.	yao.kaitai@yahoo.cn; tchentf@jnu.edu.cn	Fan, Cundong/HGU-6774-2022; Fan, Cundong/ABG-5600-2021; Chen, Tianfeng/AAG-6123-2019	Fan, Cundong/0000-0003-4485-1344; 	National Natural Science Foundation of China-Guangdong Joint Fund [u0732006]; National Science and Technology support program; Natural Science Foundation of China; Program for New Century Excellent Talents in University	National Natural Science Foundation of China-Guangdong Joint Fund; National Science and Technology support program; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This study was supported by the National Natural Science Foundation of China-Guangdong Joint Fund (u0732006), National Science and Technology support program, Natural Science Foundation of China and Program for New Century Excellent Talents in University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bucher N, 2008, BRIT J CANCER, V98, P523, DOI 10.1038/sj.bjc.6604208; Chen TF, 2009, BIOMED PHARMACOTHER, V63, P105, DOI 10.1016/j.biopha.2008.03.009; Cheng CM, 2009, J BIOL CHEM, V284, P8786, DOI 10.1074/jbc.M806144200; Coatmeur O, 2004, RADIOTHER ONCOL, V70, P177, DOI 10.1016/j.radonc.2004.01.016; Deckbar D, 2011, CRIT REV BIOCHEM MOL, V46, P271, DOI 10.3109/10409238.2011.575764; Du J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025213, 10.1371/journal.pone.0026204]; Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677; Feng J, 2012, CELL SIGNAL, V24, P1116, DOI 10.1016/j.cellsig.2012.01.013; Gupta VK, 2002, CANCER J, V8, P47, DOI 10.1097/00130404-200201000-00009; Hua YJ, 2012, EUR J CANCER, V48, P3422, DOI 10.1016/j.ejca.2012.06.016; Jiang YL, 2010, CANCER BIOL THER, V9, P959, DOI 10.4161/cbt.9.12.11700; Kil WJ, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-25; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; Lee AWM, 2012, RADIOTHER ONCOL, V104, P272, DOI 10.1016/j.radonc.2012.08.001; Li YH, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-1; Liang YL, 2009, WORLD J SURG, V33, P661, DOI 10.1007/s00268-008-9840-1; Liao AY, 2010, INTEGR CANCER THER, V9, P59, DOI 10.1177/1534735409357758; Liu C, 2011, INT J BIOL SCI, V7, P168, DOI 10.7150/ijbs.7.168; Meng N, 2012, CANCER INVEST, V30, P236, DOI 10.3109/07357907.2012.654869; Mitchell CR, 2002, RADIAT RES, V158, P311, DOI 10.1667/0033-7587(2002)158[0311:EOETLD]2.0.CO;2; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Ogata T, 2005, CANCER RES, V65, P113; Pan J, 2012, HEAD NECK-J SCI SPEC, V35, P1238, DOI [10.1002/hed.23116, DOI 10.1002/HED.23116.PUBMED:22972415.PUBMED:22972415]; Sassoli C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037512; Shi DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043898; SPRUCK CH, 1992, CANCER RES, V52, P4787; Suarez C, 2010, EUR ARCH OTO-RHINO-L, V267, P1811, DOI 10.1007/s00405-010-1385-x; Timoshenko AV, 2007, BRIT J CANCER, V97, P1090, DOI 10.1038/sj.bjc.6603993; Uchida F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056381; Wang F, 2011, J BIOL CHEM, V286, P9097, DOI 10.1074/jbc.M110.165605; Wang J, 2009, POWDER DIFFR, V24, P24, DOI 10.1154/1.3079687; Wang JJ, 2009, INT J COLORECTAL DIS, V24, P391, DOI 10.1007/s00384-008-0628-4; Wild-Bode C, 2001, CANCER RES, V61, P2744; Wu CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057036; Wu Y, 2006, INT J CANCER, V119, P1519, DOI 10.1002/ijc.21865; Yan Y, 2010, ONCOGENE, V29, P4317, DOI 10.1038/onc.2010.187; Ye JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042890; Zhuang HQ, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-12	38	25	26	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74038	10.1371/journal.pone.0074038	http://dx.doi.org/10.1371/journal.pone.0074038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040157	Green Submitted, gold, Green Published			2022-12-25	WOS:000327538600061
J	Zhao, XQ; Nie, XL; Xiao, XG				Zhao, Xiao-Qiang; Nie, Xuan-Li; Xiao, Xing-Guo			Over-Expression of a Tobacco Nitrate Reductase Gene in Wheat (Triticum aestivum L.) Increases Seed Protein Content and Weight without Augmenting Nitrogen Supplying	PLOS ONE			English	Article							NICOTIANA-PLUMBAGINIFOLIA; USE EFFICIENCY; TRANSFORMATION; PLANTS; ASSIMILATION; DEPOSITION; METABOLISM; ACTIVATION; CHALLENGES; PHYSIOLOGY	Heavy nitrogen (N) application to gain higher yield of wheat (Triticum aestivum L.) resulted in increased production cost and environment pollution. How to diminish the N supply without losing yield and/or quality remains a challenge. To meet the challenge, we integrated and expressed a tobacco nitrate reductase gene (NR) in transgenic wheat. The 35S-NR gene was transferred into two winter cultivars, "Nongda146" and "Jimai6358", by Agrobacterium-mediation. Over-expression of the transgene remarkably enhanced T-1 foliar NR activity and significantly augmented T-2 seed protein content and 1000-grain weight in 63.8% and 68.1% of T-1 offspring (total 67 individuals analyzed), respectively. Our results suggest that constitutive expression of foreign nitrate reductase gene(s) in wheat might improve nitrogen use efficiency and thus make it possible to increase seed protein content and weight without augmenting N supplying.	[Zhao, Xiao-Qiang; Nie, Xuan-Li; Xiao, Xing-Guo] China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China	China Agricultural University	Xiao, XG (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China.	xiaoxg@cau.edu.cn			Ministry of Agriculture of China [2008ZX08002-001-07, 2011ZX08002-001-07]	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	This work was supported by grants for XGX from Transgenic Plant R&D Key Program, the Ministry of Agriculture of China (Grant Nos. 2008ZX08002-001-07 and 2011ZX08002-001-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2008, ENVIRON POLLUT, V154, P462, DOI 10.1016/j.envpol.2007.10.007; Banziger M., 1997, Crop Science, V37, P1103, DOI 10.2135/cropsci1997.0011183X003700040013x; Barro F, 1998, THEOR APPL GENET, V97, P684, DOI 10.1007/s001220050944; BLACKWOOD GC, 1979, NEW PHYTOL, V82, P417, DOI 10.1111/j.1469-8137.1979.tb02668.x; Camargo JA, 2006, ENVIRON INT, V32, P831, DOI 10.1016/j.envint.2006.05.002; Campbell WH, 2001, CELL MOL LIFE SCI, V58, P194, DOI 10.1007/PL00000847; CATALDO DA, 1975, COMMUN SOIL SCI PLAN, V6, P71, DOI 10.1080/00103627509366547; Cheng M, 1997, PLANT PHYSIOL, V115, P971, DOI 10.1104/pp.115.3.971; CULLIMORE JV, 1992, CAN J MICROBIOL, V38, P461, DOI 10.1139/m92-077; Curtis IS, 1999, PLANT CELL REP, V18, P889, DOI 10.1007/s002990050680; de Borne FD, 1993, THESIS; Djennane S, 2004, PLANTA, V219, P884, DOI 10.1007/s00425-004-1287-5; Djennane S, 2002, TRANSGENIC RES, V11, P175, DOI 10.1023/A:1015299711171; Djennane S, 2002, J EXP BOT, V53, P1037, DOI 10.1093/jexbot/53.371.1037; Dorlhac de Borne F, 1994, ANN TABAC, V26, P19; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Dubois V, 2005, J EXP BOT, V56, P2379, DOI 10.1093/jxb/eri230; FerrarioMery S, 1997, PLANTA, V202, P510, DOI 10.1007/s004250050156; FOYER CH, 1994, PLANT PHYSIOL, V104, P171, DOI 10.1104/pp.104.1.171; Freschi L, 2009, PHYSIOL PLANTARUM, V137, P201, DOI 10.1111/j.1399-3054.2009.01283.x; Garnica M, 2010, J SCI FOOD AGR, V90, P357, DOI 10.1002/jsfa.3811; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Harwood WA, 2012, J EXP BOT, V63, P1791, DOI 10.1093/jxb/err380; Harwood Wendy A., 2009, V478, P137, DOI 10.1007/978-1-59745-379-0_9; HERNANDEZ HH, 1974, CEREAL CHEM, V51, P330; HOFF T, 1994, PLANT CELL ENVIRON, V17, P489, DOI 10.1111/j.1365-3040.1994.tb00145.x; Hu C. X., 1992, J HUAZHONG AGR U, V11, P239; JENNER CF, 1991, AUST J PLANT PHYSIOL, V18, P211, DOI 10.1071/PP9910211; Kashkush K, 2002, GENETICS, V160, P1651; LAWLOR DW, 1987, J EXP BOT, V38, P378, DOI 10.1093/jxb/38.3.378; Li Y., 1999, THESIS; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Nejidat A, 1997, PLANT SCI, V130, P41, DOI 10.1016/S0168-9452(97)00203-3; Nikolic M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-66; Rosales EP, 2011, PLANT PHYSIOL BIOCH, V49, P124, DOI 10.1016/j.plaphy.2010.10.009; Pathak RR, 2008, CURR SCI INDIA, V94, P1394; Peoples M. B., 1995, Nitrogen fertilization in the environment., P565; Presterl T, 2003, CROP SCI, V43, P1259, DOI 10.2135/cropsci2003.1259; QUILLERE I, 1994, J EXP BOT, V45, P1205, DOI 10.1093/jxb/45.9.1205; Raun WR, 1999, AGRON J, V91, P357, DOI 10.2134/agronj1999.00021962009100030001x; [任鹏 REN Peng], 2007, [麦类作物学报, Journal of Triticeae Crops], V27, P438; Santosh Kumari, 2011, Journal of Agricultural Science (Toronto), V3, P170; Stitt M, 2002, J EXP BOT, V53, P959, DOI 10.1093/jexbot/53.370.959; Sun FF, 2008, SCI HORTIC-AMSTERDAM, V119, P1, DOI 10.1016/j.scienta.2008.06.030; SUN X, 2004, THESIS; UGALDE TD, 1990, AUST J PLANT PHYSIOL, V17, P395, DOI 10.1071/PP9900395; VINCENTZ M, 1991, EMBO J, V10, P1027, DOI 10.1002/j.1460-2075.1991.tb08041.x; Vouillot MO, 1996, EUR J AGRON, V5, P227, DOI 10.1016/S1161-0301(96)02026-6; WALSH DE, 1976, CEREAL CHEM, V53, P469; Wang F, 2003, THESIS; Wang PC, 2011, PLANT SIGNAL BEHAV, V6, P889, DOI 10.4161/psb.6.6.15308; Wang Yong-Qin, 2002, Yi Chuan Xue Bao, V29, P260; Wang Z.Y., 2005, THESIS; [奚亚军 Xi Yajun], 2002, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V11, P17; Xia LQ, 2012, J EXP BOT, V63, P1785, DOI 10.1093/jxb/err342; Zhang YM, 2006, J HEBEI AGR SCI, V10, P1; Zhang YP, 2009, ANHUI NONGYE KEXUE, V37, P14597; Zhu ZL, 2002, NUTR CYCL AGROECOSYS, V63, P117, DOI 10.1023/A:1021107026067	58	19	22	5	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74678	10.1371/journal.pone.0074678	http://dx.doi.org/10.1371/journal.pone.0074678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040315	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300188
J	Takeda, M; Kusumi, J; Mizoiri, S; Aibara, M; Mzighani, SI; Sato, T; Terai, Y; Okada, N; Tachida, H				Takeda, Miyuki; Kusumi, Junko; Mizoiri, Shinji; Aibara, Mitsuto; Mzighani, Semvua Isa; Sato, Tetsu; Terai, Yohey; Okada, Norihiro; Tachida, Hidenori			Genetic Structure of Pelagic and Littoral Cichlid Fishes from Lake Victoria	PLOS ONE			English	Article							POPULATION-STRUCTURE; PLEISTOCENE DESICCATION; ADAPTIVE RADIATION; EAST-AFRICA; SPECIATION; FLOW; MITOCHONDRIAL; ORIGIN; POLYMORPHISMS; EVOLUTION	The approximately 700 species of cichlids found in Lake Victoria in East Africa are thought to have evolved over a short period of time, and they represent one of the largest known examples of adaptive radiation. To understand the processes that are driving this spectacular radiation, we must determine the present genetic structure of these species and elucidate how this structure relates to the ecological conditions that caused their adaptation. We analyzed the genetic structure of two pelagic and seven littoral species sampled from the southeast area of Lake Victoria using sequences from the mtDNA control region and 12 microsatellite loci as markers. Using a Bayesian model-based clustering method to analyze the microsatellite data, we separated these nine species into four groups: one group composed of pelagic species and another three groups composed mainly of rocky-shore species. Furthermore, we found significant levels of genetic variation between species within each group at both marker loci using analysis of molecular variance (AMOVA), although the nine species often shared mtDNA haplotypes. We also found significant levels of genetic variation between populations within species. These results suggest that initial groupings, some of which appear to have been related to habitat differences, as well as divergence between species within groups took place among the cichlid species of Lake Victoria.	[Takeda, Miyuki; Kusumi, Junko; Tachida, Hidenori] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan; [Mizoiri, Shinji; Aibara, Mitsuto; Mzighani, Semvua Isa; Sato, Tetsu; Terai, Yohey; Okada, Norihiro] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan; [Mzighani, Semvua Isa] Tanzania Fisheries Res Inst TAFIRI, Mwanza, Tanzania; [Okada, Norihiro] Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan	Kyushu University; Tokyo Institute of Technology; National Cheng Kung University	Okada, N (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan.	nokada@bio.titech.ac.jp; htachida@kyudai.jp	Kusumi, Junko/AFT-6398-2022	Kusumi, Junko/0000-0002-1693-7071; Sato, Tetsu/0000-0002-4482-8841	Ministry of Education, Culture, Sports, Science and Technology of Japan;  [16057201]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was partially supported by a Grant-in-Aid for Scientific Research on Priority Areas No. 16057201 to HT and grants by the Ministry of Education, Culture, Sports, Science and Technology of Japan to NO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAREL CDN, 1977, NETH J ZOOL, V27, P333; Bezault E, 2011, EVOLUTION, V65, P3381, DOI 10.1111/j.1558-5646.2011.01417.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Danley PD, 2001, MOL ECOL, V10, P1075, DOI 10.1046/j.1365-294X.2001.01283.x; Elmer KR, 2009, P NATL ACAD SCI USA, V106, P13404, DOI 10.1073/pnas.0902299106; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Fay JC, 1999, MOL BIOL EVOL, V16, P1003, DOI 10.1093/oxfordjournals.molbev.a026175; Genner MJ, 2007, MOL BIOL EVOL, V24, P1269, DOI 10.1093/molbev/msm050; GREENWOOD P. H., 1957, BULL BRIT MUS [NAT HIST] ZOOL, V5, P76; Greenwood P. H., 1974, B BRIT MUSEUM LOND S, V6, P1; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Hudson RR, 2000, GENETICS, V155, P2011; HUDSON RR, 1992, GENETICS, V132, P583; Johnson TC, 1996, SCIENCE, V273, P1091, DOI 10.1126/science.273.5278.1091; Keller I, 2013, MOL ECOL, V22, P2848, DOI 10.1111/mec.12083; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Konijnendijk N, 2011, INT J EVOL BIOL; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maeda K, 2008, MOL ECOL RESOUR, V8, P428, DOI 10.1111/j.1471-8286.2007.01981.x; Maeda K, 2009, GENE, V441, P67, DOI 10.1016/j.gene.2008.11.008; Magalhaes IS, 2012, EVOL ECOL RES, V14, P381; Magalhaes IS, 2010, MOL ECOL, V19, P3285, DOI 10.1111/j.1365-294X.2010.04751.x; MANTEL N, 1967, CANCER RES, V27, P209; Mzighani SI, 2010, GENE, V450, P39, DOI 10.1016/j.gene.2009.10.002; Nagl S, 1998, P NATL ACAD SCI USA, V95, P14238, DOI 10.1073/pnas.95.24.14238; Nagl S, 2000, P ROY SOC B-BIOL SCI, V267, P1049, DOI 10.1098/rspb.2000.1109; Nei M., 1987, MOL EVOLUTIONARY GEN; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pereyra R, 2004, MOL ECOL, V13, P2691, DOI 10.1111/j.1365-294X.2004.02224.x; PFEFFER G., 1896, DTSCH OST AFRIKA, V3, pI; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 1996, SE AL SEQUENCE ALIGN; Rousset F, 1997, GENETICS, V145, P1219; Samonte IE, 2007, MOL BIOL EVOL, V24, P2069, DOI 10.1093/molbev/msm138; Schneider S, 1999, GENETICS, V152, P1079; Seegers Lothar, 2008, Zoosystematics and Evolution, V84, P149, DOI 10.1002/zoos.200800003; Seehausen O, 2003, P ROY SOC B-BIOL SCI, V270, P129, DOI 10.1098/rspb.2002.2153; Seehausen O., 1996, LAKE VICTORIA ROCK C; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Seehausen O, 2006, P ROY SOC B-BIOL SCI, V273, P1987, DOI 10.1098/rspb.2006.3539; Seehausen Ole, 1998, Ichthyological Exploration of Freshwaters, V9, P129; Shaw PW, 2000, P ROY SOC B-BIOL SCI, V267, P2273, DOI 10.1098/rspb.2000.1279; SLATKIN M, 1995, GENETICS, V139, P457; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Terai Y, 2006, PLOS BIOL, V4, P2244, DOI 10.1371/journal.pbio.0040433; Turner GF, 2001, MOL ECOL, V10, P793, DOI 10.1046/j.1365-294x.2001.01200.x; Verheyen E, 2003, SCIENCE, V300, P325, DOI 10.1126/science.1080699; Wagner CE, 2013, MOL ECOL, V22, P787, DOI 10.1111/mec.12023; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9	54	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e74088	10.1371/journal.pone.0074088	http://dx.doi.org/10.1371/journal.pone.0074088			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040175	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000324856500074
J	Wu, DG; Gu, J; Zhang, MQ				Wu, Dingming; Gu, Jin; Zhang, Michael Q.			FastDMA: An Infinium HumanMethylation450 Beadchip Analyzer	PLOS ONE			English	Article							DNA-METHYLATION; HIGH-THROUGHPUT; BREAST-CANCER; GENOME; GENES; NORMALIZATION; PROBES	DNA methylation is vital for many essential biological processes and human diseases. Illumina Infinium HumanMethylation450 Beadchip is a recently developed platform studying genome-wide DNA methylation state on more than 480,000 CpG sites and a few CHG sites with high data quality. To analyze the data of this promising platform, we developed FastDMA which can be used to identify significantly differentially methylated probes. Besides single probe analysis, FastDMA can also do region-based analysis for identifying the differentially methylated region (DMRs). A uniformed statistical model, analysis of covariance (ANCOVA), is used to achieve all the analyses in FastDMA. We apply FastDMA on three large-scale DNA methylation datasets from The Cancer Genome Atlas (TCGA) and find many differentially methylated genomic sites in different types of cancer. On the testing datasets, FastDMA shows much higher computational efficiency than current tools. FastDMA can benefit the data analyses of large-scale DNA methylation studies with an integrative pipeline and a high computational efficiency. The software is freely available via http://bioinfo.au.tsinghua.edu.cn/software/fastdma/.	[Wu, Dingming; Gu, Jin; Zhang, Michael Q.] Tsinghua Univ, Dept Automat, TNLIST, Ctr Synthet & Syst Biol,Bioinformat Div, Beijing, Peoples R China; [Zhang, Michael Q.] Univ Texas Dallas, Ctr Syst Biol, Dept Mol & Cell Biol, Dallas, TX 75230 USA	Tsinghua University; University of Texas System; University of Texas Dallas	Gu, J (corresponding author), Tsinghua Univ, Dept Automat, TNLIST, Ctr Synthet & Syst Biol,Bioinformat Div, Beijing, Peoples R China.	jgu@tsinghua.edu.cn; michael.zhang@utdallas.edu			National Basic Research Program of China [2012CB316503]; National Natural Science Foundation of China [91019016, 31061160497, 61005040]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by National Basic Research Program of China 2012CB316503 and National Natural Science Foundation of China Nos. 91019016, 31061160497 and 61005040. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI 10.2217/EPI.09.14; Blair JD, 2012, AM J HUM GENET, V91, P760, DOI 10.1016/j.ajhg.2012.05.028; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Dedeurwaerder S, 2011, EPIGENOMICS-UK, V3, P771, DOI [10.2217/EPI.11.105, 10.2217/epi.11.105]; Easwaran HP, 2010, CANCER RES, V70, P8015, DOI 10.1158/0008-5472.CAN-10-0765; Fackler MJ, 2011, CANCER RES, V71, P6195, DOI 10.1158/0008-5472.CAN-11-1630; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Jaffe AE, 2012, INT J EPIDEMIOL, V41, P200, DOI 10.1093/ije/dyr238; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Serre D, 2010, NUCLEIC ACIDS RES, V38, P391, DOI 10.1093/nar/gkp992; Shearstone JR, 2011, SCIENCE, V334, P799, DOI 10.1126/science.1207306; Shen J, 2012, EPIGENETICS, V8; Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259; Wang D, 2012, BIOINFORMATICS, V28, P729, DOI 10.1093/bioinformatics/bts013; Zhuang J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002517	22	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74275	10.1371/journal.pone.0074275	http://dx.doi.org/10.1371/journal.pone.0074275			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040221	gold, Green Published, Green Submitted			2022-12-25	WOS:000324481600124
J	Liu, T; O'Rourke, B				Liu, Ting; O'Rourke, Brian			Regulation of the Na+/Ca2+ Exchanger by Pyridine Nucleotide Redox Potential in Ventricular Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGER; CARDIAC SARCOLEMMAL VESICLES; INDUCED HEART-FAILURE; NA+-CA2+ EXCHANGER; ISCHEMIA/REPERFUSION INJURY; DEPENDENT REGULATION; SELECTIVE INHIBITOR; RAT-HEART; CELLS; EXPRESSION	The cardiac Na+/Ca2+ exchanger (NCX) is the major Ca2+ efflux pathway on the sarcolemma, counterbalancing Ca2+ influx via L-type Ca2+ current during excitation-contraction coupling. Altered NCX activity modulates the sarcoplastic reticulum Ca2+ load and can contribute to abnormal Ca2+ handling and arrhythmias. NADH/NAD(+) is the main redox couple controlling mitochondrial energy production, glycolysis, and other redox reactions. Here, we tested whether cytosolic NADH/NAD(+) redox potential regulates NCX activity in adult cardiomyocytes. NCX current (I-NCX), measured with whole cell patch clamp, was inhibited in response to cytosolic NADH loaded directly via pipette or increased by extracellular lactate perfusion, whereas an increase of mitochondrial NADH had no effect. Reactive oxygen species (ROS) accumulation was enhanced by increasing cytosolic NADH, and NADH-induced I-NCX inhibition was abolished by the H2O2 scavenger catalase. NADH-induced ROS accumulation was independent of mitochondrial respiration (rotenone-insensitive) but was inhibited by the flavoenzyme blocker diphenylene iodonium. NADPH oxidase was ruled out as the effector because I-NCX was insensitive to cytosolic NADPH, and NADH-induced ROS and I-NCX inhibition were not abrogated by the specific NADPH oxidase inhibitor gp91ds-tat. This study reveals a novel mechanism of NCX regulation by cytosolic NADH/NAD(+) redox potential through a ROS-generating NADH-driven flavoprotein oxidase. The mechanism is likely to play a key role in Ca2+ homeostasis and the response to alterations in the cytosolic pyridine nucleotide redox state during ischemia-reperfusion or other cardiovascular diseases.	[Liu, Ting; O'Rourke, Brian] Johns Hopkins Univ, Dept Med, Div Cardiol, Baltimore, MD 21205 USA	Johns Hopkins University	O'Rourke, B (corresponding author), Johns Hopkins Univ, Dept Med, Div Cardiol, 720 Rutland Ave,1060 Ross Bldg, Baltimore, MD 21205 USA.	bor@jhmi.edu		O'Rourke, Brian/0000-0002-5548-4853; Liu, Ting/0000-0002-8304-5751	NHLBI National Institutes of Health [R01HL105216, R01HL101235]; Leducq Foundation Transatlantic Networks of Excellence Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105216, R01HL101235] Funding Source: NIH RePORTER	NHLBI National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Leducq Foundation Transatlantic Networks of Excellence Program(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI National Institutes of Health Grants R01HL105216 and R01HL101235 (to B. O.). This work was also supported by the Leducq Foundation Transatlantic Networks of Excellence Program.	Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Boyman L, 2011, J BIOL CHEM, V286, P28811, DOI 10.1074/jbc.M110.214106; BULLIARD C, 1990, J BIOENERG BIOMEMBR, V22, P645, DOI 10.1007/BF00809069; COLLINS A, 1992, J PHYSIOL-LONDON, V454, P27, DOI 10.1113/jphysiol.1992.sp019253; CONDRESCU M, 1995, J BIOL CHEM, V270, P9137, DOI 10.1074/jbc.270.16.9137; Crawford SO, 2010, INT J EPIDEMIOL, V39, P1647, DOI 10.1093/ije/dyq126; DIXON IMC, 1990, MOL CELL BIOCHEM, V99, P125; Feng NC, 2006, J CARDIOVASC PHARM, V47, P263, DOI 10.1097/01.fjc.0000202561.69291.ac; Flesch M, 1996, CIRCULATION, V94, P992, DOI 10.1161/01.CIR.94.5.992; Forner F, 2006, MOL CELL PROTEOMICS, V5, P608, DOI 10.1074/mcp.M500298-MCP200; Hagihara H, 2005, AM J PHYSIOL-HEART C, V288, pH1699, DOI 10.1152/ajpheart.01033.2004; HAWORTH RA, 1987, CIRC RES, V60, P586, DOI 10.1161/01.RES.60.4.586; HAWORTH RA, 1992, CIRC RES, V71, P210, DOI 10.1161/01.RES.71.1.210; Hobai IA, 2000, CIRC RES, V87, P690, DOI 10.1161/01.RES.87.8.690; Hobai IA, 2004, CIRC RES, V95, P292, DOI 10.1161/01.RES.0000136817.28691.2d; Huschenbett J, 1998, BBA-BIOMEMBRANES, V1374, P34, DOI 10.1016/S0005-2736(98)00121-7; Imahashi K, 2005, CIRC RES, V97, P916, DOI 10.1161/01.RES.0000187456.06162.cb; Iwamoto T, 1996, J BIOL CHEM, V271, P13609, DOI 10.1074/jbc.271.23.13609; Liu M, 2010, CIRC RES, V107, P967, DOI 10.1161/CIRCRESAHA.110.220673; Liu M, 2009, CIRC RES, V105, P737, DOI 10.1161/CIRCRESAHA.109.197277; LOVEJOY J, 1992, METABOLISM, V41, P22, DOI 10.1016/0026-0495(92)90185-D; Maack C, 2005, CIRC RES, V96, P91, DOI 10.1161/01.RES.0000151334.48676.68; Maddaford TG, 2010, AM J PHYSIOL-HEART C, V298, pH360, DOI 10.1152/ajpheart.00932.2009; Missan S, 2004, BRIT J PHARMACOL, V143, P943, DOI 10.1038/sj.bjp.0706011; MohazzabH KM, 1997, CIRCULATION, V96, P614; Nicoll DA, 1999, J BIOL CHEM, V274, P910, DOI 10.1074/jbc.274.2.910; O'Rourke B, 1999, CIRC RES, V84, P562, DOI 10.1161/01.RES.84.5.562; Ohtsuka M, 2004, BIOCHEM BIOPH RES CO, V314, P849, DOI 10.1016/j.bbrc.2003.12.165; OROURKE B, 1994, SCIENCE, V265, P962, DOI 10.1126/science.8052856; PHILIPSON KD, 1982, CIRC RES, V50, P287, DOI 10.1161/01.RES.50.2.287; Piacentino V, 2002, ANN NY ACAD SCI, V976, P476; Pogwizd SM, 1999, CIRC RES, V85, P1009; REEVES JP, 1986, J BIOL CHEM, V261, P4948; Riedel MJ, 2006, EMBO J, V25, P4605, DOI 10.1038/sj.emboj.7601321; Santacruz-Toloza L, 2000, J BIOL CHEM, V275, P182, DOI 10.1074/jbc.275.1.182; SCHOLZ TD, 1995, PEDIATR RES, V38, P221, DOI 10.1203/00006450-199508000-00015; Schulze DH, 2003, J BIOL CHEM, V278, P28849, DOI 10.1074/jbc.M300754200; Shigekawa M, 2001, CIRC RES, V88, P864, DOI 10.1161/hh0901.090298; Sipido KR, 2002, CARDIOVASC RES, V53, P782, DOI 10.1016/S0008-6363(01)00470-9; Takahashi K, 2003, EUR J PHARMACOL, V458, P155, DOI 10.1016/S0014-2999(02)02732-2; Takimoto E, 2002, FASEB J, V16, DOI 10.1096/fj.01-0735com; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; Vernon C, 2010, CRIT CARE CLIN, V26, P255, DOI 10.1016/j.ccc.2009.12.007; Wagner S, 2013, ANTIOXID REDOX SIGN, V18, P1063, DOI 10.1089/ars.2012.4818; Yang YC, 2013, ADV EXP MED BIOL, V961, P163, DOI 10.1007/978-1-4614-4756-6_14; Zhang QH, 2002, SCIENCE, V295, P1895; Zima AV, 2006, CARDIOVASC RES, V71, P310, DOI 10.1016/j.cardiores.2006.02.019; Zima AV, 2004, J PHYSIOL-LONDON, V555, P727, DOI 10.1113/jphysiol.2003.055848	50	23	27	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31984	31992		10.1074/jbc.M113.496588	http://dx.doi.org/10.1074/jbc.M113.496588			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24045952	Green Published, hybrid			2022-12-25	WOS:000330596200051
J	Castro, JB; Ramanathan, A; Chennubhotla, CS				Castro, Jason B.; Ramanathan, Arvind; Chennubhotla, Chakra S.			Categorical Dimensions of Human Odor Descriptor Space Revealed by Non-Negative Matrix Factorization	PLOS ONE			English	Article							OLFACTORY PERCEPTION; NEURAL ACTIVITY; IDENTIFICATION; DISCOVERY; CODE	In contrast to most other sensory modalities, the basic perceptual dimensions of olfaction remain unclear. Here, we use non-negative matrix factorization (NMF) - a dimensionality reduction technique - to uncover structure in a panel of odor profiles, with each odor defined as a point in multi-dimensional descriptor space. The properties of NMF are favorable for the analysis of such lexical and perceptual data, and lead to a high-dimensional account of odor space. We further provide evidence that odor dimensions apply categorically. That is, odor space is not occupied homogenously, but rather in a discrete and intrinsically clustered manner. We discuss the potential implications of these results for the neural coding of odors, as well as for developing classifiers on larger datasets that may be useful for predicting perceptual qualities from chemical structures.	[Castro, Jason B.] Bates Coll, Dept Psychol, Lewiston, ME 04240 USA; [Castro, Jason B.] Bates Coll, Program Neurosci, Lewiston, ME 04240 USA; [Ramanathan, Arvind] Oak Ridge Natl Lab, Computat Data Analyt Grp, Computat Sci & Engn Div, Oak Ridge, TN USA; [Chennubhotla, Chakra S.] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Castro, JB (corresponding author), Bates Coll, Dept Psychol, Lewiston, ME 04240 USA.	jcastro@bates.edu; chakracs@pitt.edu			NIH [GM086238]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086238] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	CSC was partially supported by NIH GM086238. No additional external funding was received for this study. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	AMOORE JE, 1974, ANN NY ACAD SCI, V237, P137, DOI 10.1111/j.1749-6632.1974.tb49850.x; AMOORE JE, 1967, NATURE, V214, P1095, DOI 10.1038/2141095a0; Arzi A, 2011, TRENDS COGN SCI, V15, P537, DOI 10.1016/j.tics.2011.09.007; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Berry MW, 2007, COMPUT STAT DATA AN, V52, P155, DOI 10.1016/j.csda.2006.11.006; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; DRAVNIEKS A, 1982, SCIENCE, V218, P799, DOI 10.1126/science.7134974; Dravnieks A, 1985, ASTM DATA SERIES; Gottfried JA, 2009, CURR OPIN NEUROBIOL, V19, P422, DOI 10.1016/j.conb.2009.07.012; Haddad R, 2010, J NEUROSCI, V30, P9017, DOI 10.1523/JNEUROSCI.0398-10.2010; Henning, 1916, DER GERUCH; Hinton GE., 2002, NIPS, V15, P833; Khan AG, 2008, NEURON, V57, P571, DOI 10.1016/j.neuron.2008.01.008; Khan RM, 2007, J NEUROSCI, V27, P10015, DOI 10.1523/JNEUROSCI.1158-07.2007; Kim PM, 2003, GENOME RES, V13, P1706, DOI 10.1101/gr.903503; Koulakov AA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00065; Laing D.G., 1991, HUMAN SENSE SMELL; Lapid H, 2011, NAT NEUROSCI, V14, P1455, DOI 10.1038/nn.2926; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; LENNIE P, 1988, CRIT REV NEUROBIOL, V3, P333; Lotto RB, 2002, TRENDS NEUROSCI, V25, P84, DOI 10.1016/S0166-2236(02)02059-3; Mamlouk AM, 2003, NEUROCOMPUTING, V52-4, P591, DOI 10.1016/S0925-2312(02)00805-6; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Niessing J, 2010, NATURE, V465, P47, DOI 10.1038/nature08961; PAATERO P, 1994, ENVIRONMETRICS, V5, P111, DOI 10.1002/env.3170050203; Paatero P, 1997, CHEMOMETR INTELL LAB, V37, P23, DOI 10.1016/S0169-7439(96)00044-5; SCHIFFMAN SS, 1974, ANN NY ACAD SCI, V237, P164, DOI 10.1111/j.1749-6632.1974.tb49852.x; SCHIFFMAN SS, 1974, SCIENCE, V185, P112, DOI 10.1126/science.185.4146.112; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wise PM, 2000, CHEM SENSES, V25, P429, DOI 10.1093/chemse/25.4.429; Xu W, 2003, P 26 ANN INT ACM SIG, P267, DOI [10.1145/860435.860485, DOI 10.1145/860435.860485]; Zarzo M, 2006, CHEM SENSES, V31, P713, DOI 10.1093/chemse/bjl013; Zarzo M, 2009, ATTEN PERCEPT PSYCHO, V71, P225, DOI 10.3758/APP.71.2.225	34	73	78	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73289	10.1371/journal.pone.0073289	http://dx.doi.org/10.1371/journal.pone.0073289			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058466	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000324695900010
J	Kessler, J; Myers, JE; Nucifora, KA; Mensah, N; Kowalski, A; Sweeney, M; Toohey, C; Khademi, A; Shepard, C; Cutler, B; Braithwaite, RS				Kessler, Jason; Myers, Julie E.; Nucifora, Kimberly A.; Mensah, Nana; Kowalski, Alexis; Sweeney, Monica; Toohey, Christopher; Khademi, Amin; Shepard, Colin; Cutler, Blayne; Braithwaite, R. Scott			Averting HIV Infections in New York City: A Modeling Approach Estimating the Future Impact of Additional Behavioral and Biomedical HIV Prevention Strategies	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; COST-EFFECTIVENESS; CASE-MANAGEMENT; UNITED-STATES; DRUG-USERS; VIRAL LOAD; RISK; TRANSMISSION; MEN; INTERVENTION	Background: New York City (NYC) remains an epicenter of the HIV epidemic in the United States. Given the variety of evidence-based HIV prevention strategies available and the significant resources required to implement each of them, comparative studies are needed to identify how to maximize the number of HIV cases prevented most economically. Methods: A new model of HIV disease transmission was developed integrating information from a previously validated micro-simulation HIV disease progression model. Specification and parameterization of the model and its inputs, including the intervention portfolio, intervention effects and costs were conducted through a collaborative process between the academic modeling team and the NYC Department of Health and Mental Hygiene. The model projects the impact of different prevention strategies, or portfolios of prevention strategies, on the HIV epidemic in NYC. Results: Ten unique interventions were able to provide a prevention benefit at an annual program cost of less than $360,000, the threshold for consideration as a cost-saving intervention (because of offsets by future HIV treatment costs averted). An optimized portfolio of these specific interventions could result in up to a 34% reduction in new HIV infections over the next 20 years. The cost-per-infection averted of the portfolio was estimated to be $106,378; the total cost was in excess of $2 billion (over the 20 year period, or approximately $100 million per year, on average). The cost-savings of prevented infections was estimated at more than $5 billion (or approximately $250 million per year, on average). Conclusions: Optimal implementation of a portfolio of evidence-based interventions can have a substantial, favorable impact on the ongoing HIV epidemic in NYC and provide future cost-saving despite significant initial costs.	[Kessler, Jason; Nucifora, Kimberly A.; Kowalski, Alexis; Toohey, Christopher; Braithwaite, R. Scott] NYU, Sch Med, Div Comparat Effectiveness & Decis Sci, Dept Populat Hlth, New York, NY 10003 USA; [Myers, Julie E.; Mensah, Nana; Sweeney, Monica; Shepard, Colin; Cutler, Blayne] New York City Dept Hlth & Mental Hyg, Bur HIV AIDS Prevent & Control, New York, NY USA; [Myers, Julie E.] Columbia Univ, Div Infect Dis, Med Ctr, New York, NY USA; [Khademi, Amin] Univ Pittsburgh, Dept Ind Engn, Pittsburgh, PA USA	New York University; New York City Department of Health & Mental Hygiene; Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kessler, J (corresponding author), NYU, Sch Med, Div Comparat Effectiveness & Decis Sci, Dept Populat Hlth, New York, NY 10003 USA.	Jason.Kessler@nyumc.org		Braithwaite, Ronald Scott/0000-0001-7067-3655	Department of Health and Mental Hygiene, Bureau of HIV/AIDS Prevention and Control	Department of Health and Mental Hygiene, Bureau of HIV/AIDS Prevention and Control	The study was funded through a sub-contract with the Department of Health and Mental Hygiene, Bureau of HIV/AIDS Prevention and Control (http://www.nyc.gov/html/doh/html/ah/ah.shtml). Other than the named authors, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimora AA, 2007, AM J PUBLIC HEALTH, V97, P2230, DOI 10.2105/AJPH.2006.099069; Anaya HD, 2008, J GEN INTERN MED, V23, P800, DOI 10.1007/s11606-008-0617-x; [Anonymous], 2012, GUIDELINES USE ANTIR; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Auvert B, 2004, JAIDS-J ACQ IMM DEF, V36, P613, DOI 10.1097/00126334-200405010-00010; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Barash EA, 2010, AIDS PATIENT CARE ST, V24, P689, DOI 10.1089/apc.2010.0173; BENEDETTI J, 1994, ANN INTERN MED, V121, P847, DOI 10.7326/0003-4819-121-11-199412010-00004; Bertholet N, 2005, ARCH INTERN MED, V165, P986, DOI 10.1001/archinte.165.9.986; Blower Sally, 2003, Current Drug Targets - Infectious Disorders, V3, P345, DOI 10.2174/1568005033480999; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Brady JE, 2008, J URBAN HEALTH, V85, P323, DOI 10.1007/s11524-007-9248-5; Braithwaite RS, 2007, ANN INTERN MED, V146, P133, DOI 10.7326/0003-4819-146-2-200701160-00008; Braithwaite RS, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-38; Braithwaite RS, 2005, AM J MED, V118, P890, DOI 10.1016/j.amjmed.2004.12.034; Buchacz K, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/869841; Calderon Y, 2011, PEDIATRICS, V127, P911, DOI 10.1542/peds.2010-1443; Charania MR, 2011, AIDS BEHAV, V15, P1283, DOI 10.1007/s10461-010-9812-y; Cohen DA, 2004, JAIDS-J ACQ IMM DEF, V37, P1404, DOI 10.1097/01.qai.0000123271.76723.96; El-Sadr WM, 2010, JAIDS-J ACQ IMM DEF, V55, pS63, DOI 10.1097/QAI.0b013e3181fbbc7e; Gardner LI, 2005, AIDS, V19, P423, DOI 10.1097/01.aids.0000161772.51900.eb; Gold MR, 2006, COST EFFECTIVENESS H; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Hart JE, 2010, JAIDS-J ACQ IMM DEF, V54, P167, DOI 10.1097/QAI.0b013e3181d9a330; Hogben M, 2007, AM J PREV MED, V33, pS89, DOI 10.1016/j.amepre.2007.04.015; Jin FY, 2010, AIDS, V24, P907, DOI 10.1097/QAD.0b013e3283372d90; Kurth Ann E, 2011, Curr HIV/AIDS Rep, V8, P62, DOI 10.1007/s11904-010-0063-3; Lasry A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037545; Lasry A, 2011, HEALTH CARE MANAG SC, V14, P115, DOI 10.1007/s10729-010-9147-2; Latkin CA, 2003, HEALTH PSYCHOL, V22, P332, DOI 10.1037/0278-6133.22.4.332; Long EF, 2010, ANN INTERN MED, V153, P778, DOI 10.7326/0003-4819-153-12-201012210-00004; MARCUS R, 1993, AM J MED, V94, P363, DOI 10.1016/0002-9343(93)90146-G; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; Mermin J, 2011, C RETR OPP INF CROI; Mosher WD, 2005, ADV DATA, V362; Mullins TLK, 2010, ARCH PEDIAT ADOL MED, V164, P870, DOI 10.1001/archpediatrics.2010.161; New York City Department of Health and Mental Hygiene, 2009, COMM HLTH SURV; New York City Department of Health and Mental Hygiene, 2009, NEW YORK CIT HIV AID; New York City Department of Health and Mental Hygiene, 2009, HIV RISK PREV NEW YO; New York City Department of Health and Mental Hygiene, 2009, HIV EP FIELD SERV PR; New York City Department of Mental Health and Hygiene, 2009, VIT STAT; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Rhodes SD, 2011, HEALTH EDUC BEHAV, V38, P311, DOI 10.1177/1090198110379572; Robles RR, 2004, J SUBST ABUSE TREAT, V27, P145, DOI 10.1016/j.jsat.2004.06.004; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Simoni JM, 2006, JAIDS-J ACQ IMM DEF, V43, pS23, DOI 10.1097/01.qai.0000248342.05438.52; TOKARS JI, 1993, ANN INTERN MED, V118, P913, DOI 10.7326/0003-4819-118-12-199306150-00001; Vissers DC, 2011, EPIDEMIOL INFECT, P1; Walensky RP, 2010, CLIN INFECT DIS, V51, P392, DOI 10.1086/655130; Wilton L, 2009, AIDS BEHAV, V13, P532, DOI 10.1007/s10461-009-9529-y; Wunsch-Hitzig R, 2003, PREVALENCE COST ESTI; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	53	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73269	10.1371/journal.pone.0073269	http://dx.doi.org/10.1371/journal.pone.0073269			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218BU	24058465	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000324408400020
J	Agostini, F; Dotti, CG; Perez-Canamas, A; Ledesma, MD; Benetti, F; Legname, G				Agostini, Federica; Dotti, Carlos G.; Perez-Canamas, Azucena; Ledesma, Maria Dolores; Benetti, Federico; Legname, Giuseppe			Prion Protein Accumulation in Lipid Rafts of Mouse Aging Brain	PLOS ONE			English	Article							ACID SPHINGOMYELINASE; CHOLESTEROL; NEURONS; EXPRESSION; MICE; CONTRIBUTES; DEPLETION; SURFACE	The cellular form of the prion protein (PrPC) is a normal constituent of neuronal cell membranes. The protein misfolding causes rare neurodegenerative disorders known as transmissible spongiform encephalopathies or prion diseases. These maladies can be sporadic, genetic or infectious. Sporadic prion diseases are the most common form mainly affecting aging people. In this work, we investigate the biochemical environment in which sporadic prion diseases may develop, focusing our attention on the cell membrane of neurons in the aging brain. It is well established that with aging the ratio between the most abundant lipid components of rafts undergoes a major change: while cholesterol decreases, sphingomyelin content rises. Our results indicate that the aging process modifies the compartmentalization of PrPC. In old mice, this change favors PrPC accumulation in detergent-resistant membranes, particularly in hippocampi. To confirm the relationship between lipid content changes and PrPC translocation into detergent-resistant membranes (DRMs), we looked at PrPC compartmentalization in hippocampi from acid sphingomyelinase (ASM) knockout (KO) mice and synaptosomes enriched in sphingomyelin. In the presence of high sphingomyelin content, we observed a significant increase of PrPC in DRMS. This process is not due to higher levels of total protein and it could, in turn, favor the onset of sporadic prion diseases during aging as it increases the PrP intermolecular contacts into lipid rafts. We observed that lowering sphingomyelin in scrapie-infected cells by using fumonisin B1 led to a 50% decrease in protease-resistant PrP formation. This may suggest an involvement of PrP lipid environment in prion formation and consequently it may play a role in the onset or development of sporadic forms of prion diseases.	[Agostini, Federica; Benetti, Federico; Legname, Giuseppe] SISSA, Dept Neurosci, Lab Prion Biol, Trieste, Italy; [Dotti, Carlos G.] KU VIB, Ctr Biol Dis, Dept Mol & Dev Genet, Louvain, Belgium; [Agostini, Federica; Dotti, Carlos G.] KU, Dept Human Genet, Louvain, Belgium; [Legname, Giuseppe] Italian Inst Technol, Trieste, Italy; [Legname, Giuseppe] Sincrotrone Trieste SCpA, ELETTRA Lab, Trieste, Italy; [Perez-Canamas, Azucena; Ledesma, Maria Dolores] Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain	International School for Advanced Studies (SISSA); Flanders Institute for Biotechnology (VIB); KU Leuven; Istituto Italiano di Tecnologia - IIT; Elettra Sincrotrone Trieste; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Legname, G (corresponding author), SISSA, Dept Neurosci, Lab Prion Biol, Trieste, Italy.	legname@sissa.it	Dotti, Carlos G/I-5533-2015; Perez-Canamas, Azucena/AAW-7254-2021; Ledesma, Maria Dolores/I-5619-2015; Legname, Giuseppe/C-1723-2012	Dotti, Carlos G/0000-0003-4052-1719; Perez-Canamas, Azucena/0000-0003-3635-6298; Ledesma, Maria Dolores/0000-0002-5679-6891; Legname, Giuseppe/0000-0003-0716-4393; Benetti, Federico/0000-0001-6491-4715	European Community [222887]; CGD laboratory in Leuven	European Community(European Commission); CGD laboratory in Leuven	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 222887 - the PRIORITY project. FA received a travelling fellowship from the Journal of Cell Science to start a collaboration with CGD laboratory in Leuven, where part of the experiments presented in this paper was performed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Bate C, 2011, J BIOL CHEM, V286, P8752, DOI 10.1074/jbc.M110.186833; Bate C, 2010, J BIOL CHEM, V285, P22017, DOI 10.1074/jbc.M110.108548; Benvegnu S, 2010, J COMP NEUROL, V518, P1879, DOI 10.1002/cne.22357; Brown K, 2010, J GERIATR PSYCH NEUR, V23, P277, DOI 10.1177/0891988710383576; Brugger B, 2004, J BIOL CHEM, V279, P7530, DOI 10.1074/jbc.M310207200; Budka H, 2003, BRIT MED BULL, V66, P121, DOI 10.1093/bmb/66.1.121; Colling SB, 1997, BRAIN RES, V755, P28, DOI 10.1016/S0006-8993(97)00087-5; Criado JR, 2005, NEUROBIOL DIS, V19, P255, DOI 10.1016/j.nbd.2005.01.001; Ford MJ, 2002, NEUROSCIENCE, V111, P533, DOI 10.1016/S0306-4522(01)00603-0; Galvan C, 2008, MOL BIOL CELL, V19, P509, DOI 10.1091/mbc.E07-05-0439; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Leclerc E, 2003, J MOL BIOL, V326, P475, DOI 10.1016/S0022-2836(02)01365-7; Legname G., 2012, NONFIBRILLAR AMYLOID, P289; Loberto N, 2005, J NEUROCHEM, V95, P771, DOI 10.1111/j.1471-4159.2005.03397.x; MANSON J, 1992, DEVELOPMENT, V115, P117; Marijanovic Z, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000426; Martin M, 2010, BBA-MOL CELL BIOL L, V1801, P934, DOI 10.1016/j.bbalip.2010.03.011; Martin MG, 2008, MOL BIOL CELL, V19, P2101, DOI 10.1091/mbc.E07-09-0897; Martin MG, 2011, NEUROBIOL AGING, V32, P933, DOI 10.1016/j.neurobiolaging.2009.04.022; MeivarLevy I, 1997, J BIOL CHEM, V272, P1558, DOI 10.1074/jbc.272.3.1558; NAGY A, 1984, J NEUROCHEM, V43, P1114, DOI 10.1111/j.1471-4159.1984.tb12851.x; Naslavsky N, 1999, J BIOL CHEM, V274, P20763, DOI 10.1074/jbc.274.30.20763; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; NOVAK M, 1991, P NATL ACAD SCI USA, V88, P5837, DOI 10.1073/pnas.88.13.5837; Ohno-Iwashita Y, 2010, GERIATR GERONTOL INT, V10, pS41, DOI 10.1111/j.1447-0594.2010.00600.x; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Piccinini M, 2010, MOL NEUROBIOL, V41, P314, DOI 10.1007/s12035-009-8096-6; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 1998, BRAIN PATHOL, V8, P499; Rushworth JV, 2013, J BIOL CHEM, V288, P8935, DOI 10.1074/jbc.M112.400358; Sales N, 2002, EUR J NEUROSCI, V15, P1163, DOI 10.1046/j.1460-9568.2002.01953.x; Schatzl HM, 1997, J VIROL, V71, P8821; Schuchman EH, 2010, FEBS LETT, V584, P1895, DOI 10.1016/j.febslet.2009.11.083; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Soderoa AO, 2011, NEUROBIOL AGING, V32, P1043, DOI 10.1016/j.neurobiolaging.2010.06.001; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; SVENNERHOLM L, 1994, J NEUROCHEM, V63, P1802; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Trovo L, 2013, NAT NEUROSCI, V16, P449, DOI 10.1038/nn.3342; Trovo L, 2011, J CELL SCI, V124, P1308, DOI 10.1242/jcs.078766; Vilette D, 2008, VET RES, V39, DOI 10.1051/vetres:2007049; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Whitehouse IJ, 2010, J ALZHEIMERS DIS, V22, P1023, DOI 10.3233/JAD-2010-101071; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998	48	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74244	10.1371/journal.pone.0074244	http://dx.doi.org/10.1371/journal.pone.0074244			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040215	gold, Green Published, Green Submitted			2022-12-25	WOS:000327538600080
J	Ganash, M; Phung, D; Sedelnikova, SE; Lindback, T; Granum, PE; Artymiuk, PJ				Ganash, Magdah; Phung, Danh; Sedelnikova, Svetlana E.; Lindback, Toril; Granum, Per Einar; Artymiuk, Peter J.			Structure of the NheA Component of the Nhe Toxin from Bacillus cereus: Implications for Function	PLOS ONE			English	Article							RAY CRYSTAL-STRUCTURE; PORE-FORMING PROTEIN; ESCHERICHIA-COLI; OUTER-MEMBRANE; HEMOLYSIN-BL; ENTEROTOXIN; CLYA; CYTOTOXIN; STRAINS; BINDING	The structure of NheA, a component of the Bacillus cereus Nhe tripartite toxin, has been solved at 2.05 A resolution using selenomethionine multiple-wavelength anomalous dispersion (MAD). The structure shows it to have a fold that is similar to the Bacillus cereus Hbl-B and E. coli ClyA toxins, and it is therefore a member of the ClyA superfamily of alpha-helical pore forming toxins (alpha-PFTs), although its head domain is significantly enlarged compared with those of ClyA or Hbl-B. The hydrophobic beta-hairpin structure that is a characteristic of these toxins is replaced by an amphipathic beta-hairpin connected to the main structure via a beta-latch that is reminiscent of a similar structure in the beta-PFT Staphylococcus aureus a-hemolysin. Taken together these results suggest that, although it is a member of an archetypal alpha-PFT family of toxins, NheA may be capable of forming a beta rather than an alpha pore.	[Ganash, Magdah; Phung, Danh; Sedelnikova, Svetlana E.; Artymiuk, Peter J.] Univ Sheffield, Krebs Inst, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Phung, Danh; Lindback, Toril; Granum, Per Einar] Norwegian Sch Vet Sci, Dept Food Safety & Infect Biol, Oslo, Norway	University of Sheffield; Norwegian University of Life Sciences	Granum, PE (corresponding author), Norwegian Sch Vet Sci, Dept Food Safety & Infect Biol, Oslo, Norway.	pereinar.granum@nvh.no; p.artymiuk@sheffield.ac.uk	Lindbäck, Toril/AAZ-9278-2020; Ganash, Magdah/AAY-6666-2020	Ganash, Magdah/0000-0003-3709-0487; Lindback, Toril/0000-0002-5245-1087	King Abdulaziz University in Saudi Arabia; Norwegian School of Veterinary Science, Oslo; Federation of European Microbiological Societies Research Fellowship; BBSRC [BB/D524975/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D524975/1] Funding Source: researchfish	King Abdulaziz University in Saudi Arabia; Norwegian School of Veterinary Science, Oslo; Federation of European Microbiological Societies Research Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	MG was supported by King Abdulaziz University in Saudi Arabia. DP was supported by the Norwegian School of Veterinary Science, Oslo. DP would like to thank a Federation of European Microbiological Societies Research Fellowship grant for support. The authors thank Diamond Light Source for access to beamline I03 and I02 (BAG number MX1218) that contributed to the results presented here. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; BEECHER DJ, 1990, INFECT IMMUN, V58, P2220, DOI 10.1128/IAI.58.7.2220-2227.1990; BEECHER DJ, 1991, INFECT IMMUN, V59, P1778, DOI 10.1128/IAI.59.5.1778-1784.1991; Buchanan SK, 1999, BIOCHEM SOC T, V27, P903, DOI 10.1042/bst0270903; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Phung D, 2012, ACTA CRYSTALLOGR F, V68, P1073, DOI 10.1107/S1744309112030813; Phung D, 2012, FEMS MICROBIOL LETT, V330, P98, DOI 10.1111/j.1574-6968.2012.02538.x; Didier A, 2012, INFECT IMMUN, V80, P832, DOI 10.1128/IAI.05681-11; Eifler N, 2006, EMBO J, V25, P2652, DOI 10.1038/sj.emboj.7601130; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fagerlund A, 2008, MICROBIOL-SGM, V154, P693, DOI 10.1099/mic.0.2007/014134-0; Fagerlund A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-43; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Granum PE, 1999, FEMS MICROBIOL LETT, V177, P225, DOI 10.1111/j.1574-6968.1999.tb13736.x; Hardy SP, 2001, FEMS MICROBIOL LETT, V197, P47, DOI 10.1111/j.1574-6968.2001.tb10581.x; Haug TM, 2010, J MEMBRANE BIOL, V237, P1, DOI 10.1007/s00232-010-9298-6; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lai XH, 2000, INFECT IMMUN, V68, P4363, DOI 10.1128/IAI.68.7.4363-4367.2000; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Lindback T, 2004, MICROBIOL-SGM, V150, P3959, DOI 10.1099/mic.0.27359-0; Lindback T, 2010, INFECT IMMUN, V78, P3813, DOI 10.1128/IAI.00247-10; Ludwig A, 1995, MOL GEN GENET, V249, P474, DOI 10.1007/BF00290573; Ludwig A, 1999, MOL MICROBIOL, V31, P557, DOI 10.1046/j.1365-2958.1999.01196.x; Lund T, 2000, MOL MICROBIOL, V38, P254, DOI 10.1046/j.1365-2958.2000.02147.x; Lund T, 1997, MICROBIOL-UK, V143, P3329, DOI 10.1099/00221287-143-10-3329; Lund T, 1996, FEMS MICROBIOL LETT, V141, P151, DOI 10.1016/0378-1097(96)00208-X; Madegowda M, 2008, PROTEINS, V71, P534, DOI 10.1002/prot.21888; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Moravek M, 2006, FEMS MICROBIOL LETT, V257, P293, DOI 10.1111/j.1574-6968.2006.00185.x; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olson R, 1999, NAT STRUCT BIOL, V6, P134; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; SLAVIK J, 1982, BIOCHIM BIOPHYS ACTA, V694, P1, DOI 10.1016/0304-4157(82)90012-0; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Wallace AJ, 2000, CELL, V100, P265, DOI 10.1016/S0092-8674(00)81564-0; Wimley WC, 2003, CURR OPIN STRUC BIOL, V13, P404, DOI 10.1016/S0959-440X(03)00099-X; Wimley WC, 2002, PROTEIN SCI, V11, P301, DOI 10.1110/ps.29402	44	47	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74748	10.1371/journal.pone.0074748	http://dx.doi.org/10.1371/journal.pone.0074748			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040335	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000327538600112
J	Hurst, ZM; McCleery, RA; Collier, BA; Fletcher, RJ; Silvy, NJ; Taylor, PJ; Monadjem, A				Hurst, Zachary M.; McCleery, Robert A.; Collier, Bret A.; Fletcher, Robert J., Jr.; Silvy, Nova J.; Taylor, Peter J.; Monadjem, Ara			Dynamic Edge Effects in Small Mammal Communities across a Conservation-Agricultural Interface in Swaziland	PLOS ONE			English	Article							SPECIES RICHNESS; CLIMATE-CHANGE; HABITAT; BIODIVERSITY; LANDSCAPE; DIVERSITY; INTENSIFICATION; FRAGMENTATION; GRASSLAND; ABUNDANCE	Across the planet, high-intensity farming has transformed native vegetation into monocultures, decreasing biodiversity on a landscape scale. Yet landscape-scale changes to biodiversity and community structure often emerge from processes operating at local scales. One common process that can explain changes in biodiversity and community structure is the creation of abrupt habitat edges, which, in turn, generate edge effects. Such effects, while incredibly common, can be highly variable across space and time; however, we currently lack a general analytical framework that can adequately capture such spatio-temporal variability. We extend previous approaches for estimating edge effects to a non-linear mixed modeling framework that captures such spatio-temporal heterogeneity and apply it to understand how agricultural land-uses alter wildlife communities. We trapped small mammals along a conservation-agriculture land-use interface extending 375 m into sugarcane plantations and conservation land-uses at three sites during dry and wet seasons in Swaziland, Africa. Sugarcane plantations had significant reductions in species richness and heterogeneity, and showed an increase in community similarity, suggesting a more homogenized small mammal community. Furthermore, our modeling framework identified strong variation in edge effects on communities across sites and seasons. Using small mammals as an indicator, intensive agricultural practices appear to create high-density communities of generalist species while isolating interior species in less than 225 m. These results illustrate how agricultural land-use can reduce diversity across the landscape and that effects can be masked or magnified, depending on local conditions. Taken together, our results emphasize the need to create or retain natural habitat features in agricultural mosaics.	[Hurst, Zachary M.; Silvy, Nova J.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [McCleery, Robert A.; Fletcher, Robert J., Jr.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32610 USA; [Collier, Bret A.] Texas A&M Univ, Inst Renewable Nat Resources, College Stn, TX USA; [Taylor, Peter J.] Univ Venda, Dept Ecol & Resource Management, Thohoyandou, Limpopo, South Africa; [Monadjem, Ara] Univ Swaziland, Dept Biol Sci, All Out Africa Res Unit, Kwaluseni, Manzini, Eswatini; [Monadjem, Ara] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, Gauteng, South Africa	Texas A&M University System; Texas A&M University College Station; State University System of Florida; University of Florida; Texas A&M University System; Texas A&M University College Station; University of Venda; University of Pretoria	McCleery, RA (corresponding author), Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32610 USA.	ramccleery@ufl.edu	Taylor, Peter/E-8655-2011; Taylor, Peter John/N-3172-2019; Monadjem, Ara/K-7279-2014	Taylor, Peter/0000-0001-9048-7366; Monadjem, Ara/0000-0003-1906-4023; McCleery, Robert/0000-0001-7018-005X; Fletcher, Robert/0000-0003-1717-5707	Texas A&M Agrilife Research; Institute of Renewable Natural Resources; Texas AgriLife Research at Texas AM University	Texas A&M Agrilife Research; Institute of Renewable Natural Resources; Texas AgriLife Research at Texas AM University	Funding for the project was provided by Texas A&M Agrilife Research. B. A. Collier's work was supported by the Institute of Renewable Natural Resources and Texas AgriLife Research at Texas A&M University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Angelstam P, 1992, ECOLOGICAL PRINCIPLE, P436; ATKESON TD, 1979, AM MIDL NAT, V101, P385, DOI 10.2307/2424604; Avenant NL, 2007, INTEGR ZOOL, V2, P212, DOI 10.1111/j.1749-4877.2007.00064.x; Balata D, 2007, ECOLOGY, V88, P2455, DOI 10.1890/07-0053.1; Begon M, 2009, ECOLOGY; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Bolger DT, 2000, ECOL APPL, V10, P1230, DOI 10.1890/1051-0761(2000)010[1230:AIUHFI]2.0.CO;2; Bothma JP., 2010, GAME RANCH MANAGEMEN; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Caro TM, 2001, BIOL CONSERV, V98, P251, DOI 10.1016/S0006-3207(00)00105-1; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clough Y, 2005, J BIOGEOGR, V32, P2007, DOI 10.1111/j.1365-2699.2005.01367.x; Dauber J, 2004, BIODIVERS CONSERV, V13, P901, DOI 10.1023/B:BIOC.0000014460.65462.2b; Donald PF, 2004, CONSERV BIOL, V18, P17, DOI 10.1111/j.1523-1739.2004.01803.x; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Ewers RM, 2006, J APPL ECOL, V43, P527, DOI 10.1111/j.1365-2664.2006.01151.x; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Flaspohler DJ, 2001, ECOL APPL, V11, P32, DOI 10.1890/1051-0761(2001)011[0032:SSEEON]2.0.CO;2; Fletcher RJ, 2005, J ANIM ECOL, V74, P342, DOI 10.1111/j.1365-2656.2005.00930.x; Gannon W, 2009, J MAMMAL, V88, P809; Gardner TA, 2007, CONSERV BIOL, V21, P1516, DOI 10.1111/j.1523-1739.2007.00794.x; HACKEL JD, 1993, HUM ECOL, V21, P295, DOI 10.1007/BF00891541; HESKE EJ, 1995, J MAMMAL, V76, P562, DOI 10.2307/1382364; Hoffman A, 2005, BELG J ZOOL, V13, P591; Hulley R, 2007, SUGAR ASS ANN REPORT; Jones C, 1996, CAPTURING MAMMALS ME; Jones Clyde, 1996, P115; Keesing F, 2000, BIOSCIENCE, V50, P205, DOI 10.1641/0006-3568(2000)050[0205:CCATEO]2.3.CO;2; Krebs C. J., 1999, ECOLOGICAL METHODOLO; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Kunz Thomas H., 1996, P279; Lacher TEJ, 1999, BIODIVERSITY AGROECO, P147; Lankford BA, 2007, RISE LARGE SCALE FOR; LAURANCE WF, 1991, BIOL CONSERV, V55, P77, DOI 10.1016/0006-3207(91)90006-U; Laurance WF, 2000, TRENDS ECOL EVOL, V15, P134, DOI 10.1016/S0169-5347(00)01838-3; Laurance WF, 2008, BIOL CONSERV, V141, P1731, DOI 10.1016/j.biocon.2008.05.011; Lindenmayer D, 2008, ECOL LETT, V11, P78, DOI 10.1111/j.1461-0248.2007.01114.x; Manson RH, 2001, ECOLOGY, V82, P3320, DOI 10.2307/2680155; MATLACK GR, 1993, BIOL CONSERV, V66, P185, DOI 10.1016/0006-3207(93)90004-K; Matondo JI, 2005, PHYS CHEM EARTH, V30, P943, DOI 10.1016/j.pce.2005.08.041; Matondo JI, 2004, PHYS CHEM EARTH, V29, P1181, DOI 10.1016/j.pce.2004.09.033; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; McCune B, 2002, ANAL ECOLOGICAL COMM; Monadjem A, 2005, BIODIVERS CONSERV, V14, P2079, DOI 10.1007/s10531-004-4358-9; Monadjem A, 2003, AFR ZOOL, V38, P127; Monadjem A, 1998, S AFR J WILDL RES, V28, P1; Monadjem A, 2011, WILDLIFE RES, V38, P603, DOI 10.1071/WR10130; Mucina L., 2006, VEGETATION S AFRICA; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Osbourne JD, 2005, WILDLIFE SOC B, V33, P814, DOI 10.2193/0091-7648(2005)33[814:EOHOSD]2.0.CO;2; Pearson DE, 2003, WILDLIFE SOC B, V31, P454; Prevedello JA, 2010, BIODIVERS CONSERV, V19, P1205, DOI 10.1007/s10531-009-9750-z; Puettker Thomas, 2008, BMC Ecology, V8, P9, DOI 10.1186/1472-6785-8-9; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; RAMANKUTTY N, 2008, GLOBAL BIOGEOCHEM CY, V0022; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Ries L, 2010, OIKOS, V119, P1636, DOI 10.1111/j.1600-0706.2010.18414.x; RISSER PG, 1995, BIOSCIENCE, V45, P318, DOI 10.2307/1312492; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Sirami C, 2012, DIVERS DISTRIB, V18, P390, DOI 10.1111/j.1472-4642.2011.00810.x; SKINNER JD, 2005, MAMMALS SO AFRICAN S; Slade NA, 2000, J MAMMAL, V81, P1035, DOI 10.1644/1545-1542(2000)081<1035:AETOUC>2.0.CO;2; Stevens SM, 1998, BIOL CONSERV, V85, P1, DOI 10.1016/S0006-3207(98)00003-2; Tembo M, 2011, COMP SUGARCANE PRODU; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Williams B.K., 2002, ANAL MANAGEMENT ANIM; Wretenberg J, 2006, J APPL ECOL, V43, P1110, DOI 10.1111/j.1365-2664.2006.01216.x; Yaap B., 2010, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V5, P1, DOI 10.1079/PAVSNNR20105019; YAHNER RH, 1988, CONSERV BIOL, V2, P333, DOI 10.1111/j.1523-1739.1988.tb00197.x; Yarnell RW, 2007, OECOLOGIA, V154, P387, DOI 10.1007/s00442-007-0841-9	71	32	34	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74520	10.1371/journal.pone.0074520	http://dx.doi.org/10.1371/journal.pone.0074520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040269	Green Published, gold			2022-12-25	WOS:000326405300178
J	Sureban, SM; May, R; Qu, DF; Weygant, N; Chandrakesan, P; Ali, N; Lightfoot, SA; Pantazis, P; Rao, CV; Postier, RG; Houchen, CW				Sureban, Sripathi M.; May, Randal; Qu, Dongfeng; Weygant, Nathaniel; Chandrakesan, Parthasarathy; Ali, Naushad; Lightfoot, Stan A.; Pantazis, Panayotis; Rao, Chinthalapally V.; Postier, Russell G.; Houchen, Courtney W.			DCLK1 Regulates Pluripotency and Angiogenic Factors via microRNA-Dependent Mechanisms in Pancreatic Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; REPROGRAMMING FACTOR LIN28; STEM-CELLS; TUMOR-GROWTH; DOWN-REGULATION; FEEDBACK LOOP; EGF RECEPTOR; EXPRESSION; INHIBITION; LET-7	Stem cell pluripotency, angiogenesis and epithelial-mesenchymal transition (EMT) have been shown to be significantly upregulated in pancreatic ductal adenocarcinoma (PDAC) and many other aggressive cancers. The dysregulation of these processes is believed to play key roles in tumor initiation, progression, and metastasis, and is contributory to PDAC being the fourth leading cause of cancer-related deaths in the US. The tumor suppressor miRNA miR-145 downregulates critical pluripotency factors and oncogenes and results in repressed metastatic potential in PDAC. Additionally, the miR-200 family regulates several angiogenic factors which have been linked to metastasis in many solid tumors. We have previously demonstrated that downregulation of DCLK1 can upregulate critical miRNAs in both in vitro and in vivo cancer models and results in downregulation of c-MYC, KRAS, NOTCH1 and EMT-related transcription factors. A recent report has also shown that Dclk1 can distinguish between normal and tumor stem cells in Apc(min/+) mice and that ablation of Dclk1(+) cells resulted in regression of intestinal polyps without affecting homeostasis. Here we demonstrate that the knockdown of DCLK1 using poly(lactide-co-glycolide)-encapsulated-DCLK1-siRNA results in AsPC1 tumor growth arrest. Examination of xenograft tumors revealed, (a) increased miR-145 which results in decreased pluripotency maintenance factors OCT4, SOX2, NANOG, KLF4 as well as KRAS and RREB1; (b) increased let-7a which results in decreased pluripotency factor LIN28B; and (c) increased miR-200 which results in decreased VEGFR1, VEGFR2 and EMT-related transcription factors ZEB1, ZEB2, SNAIL and SLUG. Specificity of DCLK1 post-transcriptional regulation of the downstream targets of miR-145, miR-200 and let-7a was accomplished utilizing a luciferase-based reporter assay. We conclude that DCLK1 plays a significant master regulatory role in pancreatic tumorigenesis through the regulation of multiple tumor suppressor miRNAs and their downstream pro-tumorigenic pathways. This novel concept of targeting DCLK1 alone has several advantages over targeting single pathway or miRNA-based therapies for PDAC.	[Sureban, Sripathi M.; May, Randal; Qu, Dongfeng; Weygant, Nathaniel; Chandrakesan, Parthasarathy; Ali, Naushad; Rao, Chinthalapally V.; Houchen, Courtney W.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73190 USA; [Lightfoot, Stan A.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Postier, Russell G.] Univ Oklahoma, Hlth Sci Ctr, Dept Surg, Oklahoma City, OK USA; [Sureban, Sripathi M.; May, Randal; Qu, Dongfeng; Lightfoot, Stan A.; Houchen, Courtney W.] Dept Vet Affairs Med Ctr, Oklahoma City, OK USA; [Sureban, Sripathi M.; Ali, Naushad; Rao, Chinthalapally V.; Houchen, Courtney W.] Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK USA; [Pantazis, Panayotis] COARE Biotechnol Inc, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Houchen, CW (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73190 USA.	courtney-houchen@ouhsc.edu	Sureban, Sripathi/Q-8232-2019; Chandrakesan, Parthasarathy/AAB-9136-2020	Weygant, Nathaniel/0000-0001-7861-6532; Ali, Naushad/0000-0002-0058-7396; Sureban, Sripathi/0000-0001-5476-9593; Chandrakesan, Parthasarathy/0000-0002-7587-9553	National Institutes of Health and National Cancer Institute [CA-137482]; Oklahoma Center for the Advancement of Science and Technology; Oklahoma Center for Adult Stem Cell Research; NATIONAL CANCER INSTITUTE [R21CA137482] Funding Source: NIH RePORTER	National Institutes of Health and National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Oklahoma Center for the Advancement of Science and Technology; Oklahoma Center for Adult Stem Cell Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health and National Cancer Institute grants: CA-137482 (CWH); Oklahoma Center for the Advancement of Science and Technology, and Oklahoma Center for Adult Stem Cell Research (CWH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2007, CANCER SCI, V98, P1914, DOI 10.1111/j.1349-7006.2007.00618.x; Ali N, 2011, J VIROL, V85, P12292, DOI 10.1128/JVI.05920-11; Bao B, 2011, CANCER LETT, V307, P26, DOI 10.1016/j.canlet.2011.03.012; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bhattacharya R, 2005, FASEB J, V19, P1692, DOI 10.1096/fj.05-3889fje; Bjerknes M, 2012, DEV BIOL, V362, P194, DOI 10.1016/j.ydbio.2011.12.009; Brabletz S, 2011, EMBO J, V30, P770, DOI 10.1038/emboj.2010.349; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Cao YH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.259re1; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Cho WCS, 2011, RNA BIOL, V8, P125, DOI 10.4161/rna.8.1.14259; Choi YC, 2011, MOL CELLS, V32, P77, DOI 10.1007/s10059-011-1042-2; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; De Fougerolles AR, 2008, HUM GENE THER, V19, P125, DOI 10.1089/hum.2008.928; Diehn M, 2006, J NATL CANCER I, V98, P1755, DOI 10.1093/jnci/djj505; Gerbe F, 2011, J CELL BIOL, V192, P767, DOI 10.1083/jcb.201010127; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hoshida T, 2002, PANCREAS, V25, P111, DOI 10.1097/00006676-200208000-00001; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jimeno A, 2009, MOL CANCER THER, V8, P310, DOI 10.1158/1535-7163.MCT-08-0924; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kent OA, 2010, GENE DEV, V24, P2754, DOI 10.1101/gad.1950610; Korc M, 2003, Mol Cancer, V2, P8, DOI 10.1186/1476-4598-2-8; Lee YJ, 2010, CANCER RES, V70, P8357, DOI 10.1158/0008-5472.CAN-10-1138; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mondalek Fadee G., 2010, Journal of Nanobiotechnology, V8, P17, DOI 10.1186/1477-3155-8-17; Nakanishi Y, 2013, NAT GENET, V45, P98, DOI 10.1038/ng.2481; Navas C, 2012, CANCER CELL, V22, P318, DOI 10.1016/j.ccr.2012.08.001; Ogawa T, 2002, CANCER GENE THER, V9, P633, DOI 10.1038/sj.cgt.7700478; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peng XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020341; Perera RM, 2012, CANCER CELL, V22, P281, DOI 10.1016/j.ccr.2012.08.019; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534; Pramanik D, 2011, MOL CANCER THER, V10, P1470, DOI 10.1158/1535-7163.MCT-11-0152; Prasad NB, 2005, CANCER RES, V65, P1619, DOI 10.1158/0008-5472.CAN-04-1413; Roybal JD, 2011, MOL CANCER RES, V9, P25, DOI 10.1158/1541-7786.MCR-10-0497; Shankar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016530; Solorzano CC, 2001, CANCER BIOTHER RADIO, V16, P359, DOI 10.1089/108497801753354267; Sureban SM, 2012, PANCREATIC DISORDERS, V02; Sureban SM, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-40; Sureban SM, 2011, CANCER RES, V71, P2328, DOI 10.1158/0008-5472.CAN-10-2738; Sureban SM, 2009, GASTROENTEROLOGY, V137, P649, DOI 10.1053/j.gastro.2009.05.004; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Turley EA, 2008, NAT CLIN PRACT ONCOL, V5, P280, DOI 10.1038/ncponc1089; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wei DY, 2010, GASTROENTEROLOGY, V139, P2135, DOI 10.1053/j.gastro.2010.08.022; Wen J, 2010, PANCREAS, V39, P622, DOI 10.1097/MPA.0b013e3181c75f5e; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang XJ, 2010, CANCER RES, V70, P9463, DOI 10.1158/0008-5472.CAN-10-2388; Yao J, 2011, P NATL ACAD SCI USA, V108, P11590, DOI 10.1073/pnas.1109029108; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zhong XM, 2010, J BIOL CHEM, V285, P41961, DOI 10.1074/jbc.M110.169607; Zhu HY, 2011, MOL CANCER RES, V9, P960, DOI 10.1158/1541-7786.MCR-10-0531	60	108	110	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73940	10.1371/journal.pone.0073940	http://dx.doi.org/10.1371/journal.pone.0073940			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040120	Green Submitted, Green Published, gold			2022-12-25	WOS:000326405300142
J	Han, H; Yang, XJ; Pandiyan, K; Liang, GN				Han, Han; Yang, Xiaojing; Pandiyan, Kurinji; Liang, Gangning			Synergistic Re-Activation of Epigenetically Silenced Genes by Combinatorial Inhibition of DNMTs and LSD1 in Cancer Cells	PLOS ONE			English	Article							LYSINE DEMETHYLASE LSD1; DNA METHYLATION; HUMAN GENOME; HISTONE; DIFFERENTIATION; TRANSCRIPTION; COMPLEX; ACETYLATION; CHROMATIN; LEUKEMIA	Epigenetic gene silencing, mediated by aberrant promoter DNA hypermethylation and repressive histone modifications, is a hallmark of cancer. Although heritable, the dynamic nature and potential reversibility through pharmacological interventions make such aberrations attractive targets. Since cancers contain multiple epigenetic abnormalities, combining therapies that target different defects could potentially enhance their individual efficacies. 5-Aza-2'-deoxycytidine (5-Aza-CdR), FDA-approved drug for the treatment of myelodysplastic syndrome, can inhibit DNA methyltransferases (DNMTs) upon incorporation into the DNA of dividing cells, resulting in global demethylation. More recently, the first histone demethylase, lysine specific demethylase 1 (LSD1), which demethylates both histone and non-histone substrates, has become a new target for epigenetic therapy. Using, clorgyline, an LSD1 inhibitor (LSD1i) to treat cancer cell lines, we show that clorgyline employs two mechanisms of action depending on the cell type: it can either induce global DNA demethylation or inhibit LSD1-driven H3K4me2 and H3K4me1 demethylation to establish an active chromatin configuration. We also investigate the therapeutic efficacy of combining 5-Aza-CdR with clorgyline and determine that this combinatorial treatment has synergistic effects on reactivating aberrantly silenced genes by enriching H3K4me2 and H3K4me1. Many of the reactivated genes are categorized as cancer testis antigens or belong to the interferon-signaling pathway, suggesting potential implications for immunotherapy. Together, our results demonstrate that combinatorial treatment consisting of a DNMT inhibitor (DNMTi) and an LSD1i have enhanced therapeutic values and could improve the efficacy of epigenetic therapy.	[Han, Han] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA USA; [Han, Han; Yang, Xiaojing; Pandiyan, Kurinji; Liang, Gangning] Univ So Calif, Keck Sch Med, Dept Urol, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Han, Han; Yang, Xiaojing; Pandiyan, Kurinji; Liang, Gangning] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Pandiyan, Kurinji] Johns Hopkins Sch Med, Program Human Genet, Baltimore, MD USA	University of Southern California; University of Southern California; University of Southern California; Johns Hopkins University; Johns Hopkins Medicine	Liang, GN (corresponding author), Univ So Calif, Keck Sch Med, Dept Urol, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA.	gliang@usc.edu		Liang, Gangning/0000-0001-8664-922X	National Institutes of Health (NIH) [RO1CA124518, CA138794]; Stand Up to Cancer [2000901485]; NATIONAL CANCER INSTITUTE [R01CA124518, R01CA138794] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stand Up to Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health (NIH) [RO1CA124518 and CA138794] to GL. XY and KP are supported generously by the Stand Up to Cancer [2000901485]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers SN, 2010, FUTURE ONCOL, V6, P717, DOI [10.2217/fon.10.36, 10.2217/FON.10.36]; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bender CM, 1999, MOL CELL BIOL, V19, P6690; Bennani-Baiti IM, 2012, HUM PATHOL, V43, P1300, DOI 10.1016/j.humpath.2011.10.010; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Boumber Y, 2011, ONCOLOGY-NY, V25, P220; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Egger G, 2006, P NATL ACAD SCI USA, V103, P14080, DOI 10.1073/pnas.0604602103; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Hayami S, 2011, INT J CANCER, V128, P574, DOI 10.1002/ijc.25349; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; Hervas-Stubbs S, 2011, CLIN CANCER RES, V17, P2619, DOI 10.1158/1078-0432.CCR-10-1114; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang Y, 2009, CLIN CANCER RES, V15, P7217, DOI 10.1158/1078-0432.CCR-09-1293; Jones PA, 2002, ONCOGENE, V21, P5358, DOI 10.1038/sj.onc.1205597; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Karpf AR, 2006, EPIGENETICS-US, V1, P116, DOI 10.4161/epi.1.3.2988; Kauffman EC, 2011, MOL CARCINOGEN, V50, P931, DOI 10.1002/mc.20758; Kelly TK, 2010, NAT BIOTECHNOL, V28, P1069, DOI 10.1038/nbt.1678; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kubicek S, 2004, CELL, V119, P903, DOI 10.1016/j.cell.2004.12.006; Liang G, 2002, CANCER RES, V62, P961; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Lokken AA, 2012, CANCER CELL, V21, P451, DOI 10.1016/j.ccr.2012.03.027; McDonald OG, 2011, NAT STRUCT MOL BIOL, V18, P867, DOI 10.1038/nsmb.2084; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Nicholson TB, 2009, EPIGENETICS-US, V4, P129, DOI 10.4161/epi.4.3.8443; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Okada H, 2011, J CLIN ONCOL, V29, P330, DOI 10.1200/JCO.2010.30.7744; Quintas-Cardama A, 2011, LEUKEMIA, V25, P226, DOI 10.1038/leu.2010.276; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Schildhaus HU, 2011, HUM PATHOL, V42, P1667, DOI 10.1016/j.humpath.2010.12.025; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Yang XJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002604; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zhao HJ, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-55; Zhu QS, 2012, AMINO ACIDS, V42, P887, DOI 10.1007/s00726-011-1004-1	46	30	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e75136	10.1371/journal.pone.0075136	http://dx.doi.org/10.1371/journal.pone.0075136			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040395	gold, Green Published, Green Submitted			2022-12-25	WOS:000324856500105
J	Bhalla, D; Chea, K; Hun, C; Chan, V; Huc, P; Chan, S; Sebbag, R; Gerard, D; Dumas, M; Oum, S; Druet-Cabanac, M; Preux, PM				Bhalla, Devender; Chea, Kimly; Hun, Chamroeun; Chan, Vichea; Huc, Pierre; Chan, Samleng; Sebbag, Robert; Gerard, Daniel; Dumas, Michel; Oum, Sophal; Druet-Cabanac, Michel; Preux, Pierre-Marie			Epilepsy in Cambodia-Treatment Aspects and Policy Implications: A Population-Based Representative Survey	PLOS ONE			English	Article							SUICIDAL EXPRESSIONS; ANTIEPILEPTIC DRUGS; YOUNG-PEOPLE; COMMUNITY; PROGRAM; HEALTH	Introduction: We tested two treatment strategies to determine: treatment (a) prognosis (seizure frequency, mortality, suicide, and complications), (b) safety and adherence of treatment, (c) self-reported satisfaction with treatment and self-reported productivity, and policy aspects (a) number of required tablets for universal treatment (NRT), (b) cost of management, (c) manpower-gap and requirements for scaling-up of epilepsy care. Methods: We performed a random-cluster survey (N = 16510) and identified 96 cases (>= 1 year of age) in 24 villages. They were screened by using a validated instrument and diagnosed by the neurologists. International guidelines were used for defining and classifying epilepsy. All were given phenobarbital or valproate (cost-free) in two manners patient's door-steps (March 2009-March 2010, primary-treatment-period, PTP) and treatment through health-centers (March 2010-June 2011, treatment-continuation-period, TCP). The emphasis was to start on a minimum dosage and regime, without any polytherapy, according to the age of the recipients. No titration was done. Seizure-frequency was monthly and self-reported. Results: The number of seizures reduced from 12.6 (pre-treatment) to 1.2 (end of PTP), following which there was an increase to 3.4 (end of TCP). Between start of PTP and end of TCP,>60.0% became and remained seizure-free. During TCP, similar to 26.0% went to health centers to collect their treatment. Complications reduced from 12.5% to 4.2% between start and end of PTP and increased to 17.2% between start and end of TCP. Adverse events reduced from 46.8% to 16.6% between start and end of PTP. Nearly 33 million phenobarbital 100 mg tablets are needed in Cambodia. Conclusions: Epilepsy responded sufficiently well to the conventional treatment, even when taken at a minimal dosage and a simple daily regimen, without any polytherapy. This is yet another confirmation that it is possible to substantially reduce direct burden of epilepsy through means that are currently available to us.	[Bhalla, Devender; Dumas, Michel; Druet-Cabanac, Michel; Preux, Pierre-Marie] INSERM, UMR 1094, Limoges, France; [Bhalla, Devender; Huc, Pierre; Dumas, Michel; Druet-Cabanac, Michel; Preux, Pierre-Marie] Univ Limoges, Sch Med, CNRS, Inst Neuroepidemiol & Trop Neurol,FR GEIST 3503, Limoges, France; [Bhalla, Devender; Druet-Cabanac, Michel; Preux, Pierre-Marie] Ctr Hosp Univ Limoges, Limoges, France; [Chea, Kimly; Hun, Chamroeun; Chan, Samleng; Oum, Sophal] Univ Hlth Sci, Phnom Penh, Cambodia; [Bhalla, Devender; Hun, Chamroeun; Chan, Vichea; Chan, Samleng] Cambodian Soc Neurol, Phnom Penh, Cambodia; [Hun, Chamroeun; Chan, Vichea; Chan, Samleng] Calmette Hosp, Dept Neurol, Phnom Penh, Cambodia; [Sebbag, Robert; Gerard, Daniel] Dept Access Med, Gentilly, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Franche-Comte; Universite de Limoges; CHU Limoges	Preux, PM (corresponding author), INSERM, UMR 1094, Limoges, France.	preux@unilim.fr	Preux, Pierre-Marie/N-3538-2019; PREUX, Pierre-Marie/B-8393-2014	Preux, Pierre-Marie/0000-0002-2171-2977; PREUX, Pierre-Marie/0000-0002-2171-2977; Druet-Cabanac, Michel/0000-0001-5711-3346	Department of Access to Medicines, Sanofi	Department of Access to Medicines, Sanofi	The project was financially supported by the Department of Access to Medicines, Sanofi (www.sanofi.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, EPILEPSIA, V34, P592; Augustine A, 2011, REV HLTH LEADERSHIP; Baker GA, 1997, EPILEPSIA, V38, P353, DOI 10.1111/j.1528-1157.1997.tb01128.x; BANCAUD J, 1981, EPILEPSIA, V22, P489, DOI 10.1111/j.1528-1157.1981.tb06159.x; Bhalla D, 2013, NEUROEPIDEMIOLOGY, V40, P260, DOI 10.1159/000345118; Bhalla D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046296; Bhargava A, 2010, MODELING EFFECTS PHY; Bleck Thomas P, 2007, ACP J Club, V147, P74; Boekaerts M, 1999, DISABIL REHABIL, V21, P311; Buck D, 1997, SEIZURE, V6, P87, DOI 10.1016/S1059-1311(97)80060-X; CDHS, 2005, CAMB DEM HLTH SURV; CDHS, 2005, CAMB DEM HLTH SURV P; COCKERELL OC, 1994, LANCET, V344, P918, DOI 10.1016/S0140-6736(94)92270-5; Dayrit Manuel M, 2011, Rev Peru Med Exp Salud Publica, V28, P327; FEKSI AT, 1991, LANCET, V337, P406, DOI 10.1016/0140-6736(91)91176-U; FEKSI AT, 1991, EPILEPSY RES, V8, P252, DOI 10.1016/0920-1211(91)90072-N; Gopinath M, 2011, EPILEPSY BEHAV, V20, P44, DOI 10.1016/j.yebeh.2010.10.013; Henderson LN, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-18; Jegannathan B, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-47; LIVANAINEN M, 1990, ACTA NEUROL SCAND, V82, P121; Lu B, 2012, EPILEPSIA, V53, pe25, DOI 10.1111/j.1528-1167.2011.03331.x; Mac TL, 2007, LANCET NEUROL, V6, P533, DOI 10.1016/S1474-4422(07)70127-8; Mani KS, 2001, LANCET, V357, P1316, DOI 10.1016/S0140-6736(00)04516-5; Mbuba CK, 2008, EPILEPSIA, V49, P1491, DOI 10.1111/j.1528-1167.2008.01693.x; Medina CO, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-28; Munson JF., 2010, MED REC, V77, P58; Nguyen AT, 2009, EPILEPSIA, V50, P2320, DOI 10.1111/j.1528-1167.2009.02298.x; Nimaga K, 2002, B WORLD HEALTH ORGAN, V80, P532; NIRD, 2010, DEV IND CIRDAP SAARC, P1; Olesen JB, 2010, PHARMACOEPIDEM DR S, V19, P518, DOI 10.1002/pds.1932; PAHO, 2011, STRAT PLAN ACT EP, P1; Perucca E, 2005, ACTA NEUROL SCAND, V112, P30, DOI 10.1111/j.1600-0404.2005.00506.x; Preux PM, 2011, EPILEPSIA, V52, P1382, DOI 10.1111/j.1528-1167.2011.03102.x; Preux PM, 2005, LANCET NEUROL, V4, P21, DOI 10.1016/S1474-4422(04)00963-9; Ratsepp M, 2000, SEIZURE-EUR J EPILEP, V9, P394, DOI 10.1053/seiz.2000.0439; RYAN CA, 1993, CAN MED ASSOC J, V148, P781; Sander JW, 2004, EPILEPSIA, V45, P28, DOI 10.1111/j.0013-9580.2004.455005.x; Satishchandra P, 2001, EPILEPSY OUT SHADOWS; Sharon T, 2011, SOCIAL PSYCHOL ISSUE; STATA, 2012, STATA DAT AN STAT SO; Stevens DL, 1997, J NEUROL NEUROSUR PS, V63, pS67, DOI 10.1136/jnnp.63.2008.67S; Tran DS, 2008, EPILEPSIA, V49, P539, DOI 10.1111/j.1528-1167.2007.01529_3.x; Uy Sophoat, 2007, Nagoya J Med Sci, V69, P71; WATTS AE, 1989, BRIT MED J, V298, P805, DOI 10.1136/bmj.298.6676.805; WHO, 2001, EP WHO S E AS REG BR; Wiebe S, 1999, CAN J NEUROL SCI, V26, P263, DOI 10.1017/S0317167100000354; World Health Organization, 2004, GLOB CAMP EP OUT SHA	47	12	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74817	10.1371/journal.pone.0074817	http://dx.doi.org/10.1371/journal.pone.0074817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040345	gold, Green Published, Green Submitted			2022-12-25	WOS:000324481600148
J	Montufar-Chaveznava, R; Trejo-Munoz, L; Hernandez-Campos, O; Navarrete, E; Caldelas, I				Montufar-Chaveznava, Rodrigo; Trejo-Munoz, Lucero; Hernandez-Campos, Oscar; Navarrete, Erika; Caldelas, Ivette			Maternal Olfactory Cues Synchronize the Circadian System of Artificially Raised Newborn Rabbits	PLOS ONE			English	Article							CLOCK GENE-EXPRESSION; MAMMARY PHEROMONE; BODY-TEMPERATURE; SUPRACHIASMATIC NUCLEUS; LOCOMOTOR-ACTIVITY; DAILY RHYTHMS; BULBECTOMY; ODOR; BULB; RESPONSES	In European newborn rabbits, once-daily nursing acts as a strong non-photic entraining cue for the pre-visual circadian system. Nevertheless, there is a lack of information regarding which of the non-photic cues are capable of modulating pup circadian system. In this study, for the first time, we determined that the mammary pheromone 2-methylbut-2-enal (2MB2) presented in the maternal milk acts as a non-photic entraining cue. We evaluated the effect of once-daily exposure to maternal olfactory cues on the temporal pattern of core body temperature, gross locomotor activity and metabolic variables (liver weight, serum glucose, triacylglycerides, free fatty acids, cholecystokinin and cholesterol levels) in newborn rabbits. Rabbit pups were separated from their mothers from postnatal day 1 (P1) to P8 and were randomly assigned to one of the following conditions: nursed by a lactating doe (NAT); exposed to a 3-min pulse of maternal milk (M-Milk), mammary pheromone (2MB2), or water (H2O). To eliminate maternal stimulation, the pups of the last three groups were artificially fed once every 24-h. On P8, the rabbits were sacrificed at different times of the day. In temperature and activity, the NAT, M-Milk and 2MB2 groups exhibited clear diurnal rhythmicity with a conspicuous anticipatory rise hours prior to nursing. In contrast, the H2O group exhibited atypical rhythmicity in both parameters, lacking the anticipatory component. At the metabolic level, all of the groups exhibited a diurnal pattern with similar phases in liver weight and metabolites examined. The results obtained in this study suggest that during pre-visual stages of development, the circadian system of newborn rabbits is sensitive to the maternal olfactory cues contained in milk, indicating that these cues function as non-photic entraining signals mainly for the central oscillators regulating the expression of temperature and behavior, whereas in metabolic diurnal rhythmicity, these cues lack an effect, indicating that peripheral oscillators respond to milk administration.	[Trejo-Munoz, Lucero; Hernandez-Campos, Oscar; Navarrete, Erika; Caldelas, Ivette] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Celular & Fisiol, Distrito Federal, Mexico; [Montufar-Chaveznava, Rodrigo] Asociac Mexicana Innovac Tecnolo Educ AC, AMITE, Distrito Federal, Mexico	Universidad Nacional Autonoma de Mexico	Caldelas, I (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Celular & Fisiol, Distrito Federal, Mexico.	caldelas@biomedicas.unam.mx			Consejo Nacional para la Ciencia y la Tecnologia, Mexico [131314]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico [IN208513-3]	Consejo Nacional para la Ciencia y la Tecnologia, Mexico; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico)	This work was supported by a research grant from the Consejo Nacional para la Ciencia y la Tecnologia, Mexico (#131314) and Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico (IN208513-3). PAPIIT http://dgapa.unam.mx/html/papiit/papit.html CONACyT http://www.conacyt.gob.mx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham U, 2013, J BIOL RHYTHM, V28, P26, DOI 10.1177/0748730412469353; Alberts J. R., 1976, MAMMALIAN OLFACTION, P67; Alberts JR, 2007, DEV PSYCHOBIOL, V49, P22, DOI 10.1002/dev.20190; Amir S, 1999, NEUROSCIENCE, V92, P1165, DOI 10.1016/S0306-4522(99)00222-5; Caldelas I, 2007, NEUROSCIENCE, V144, P395, DOI 10.1016/j.neuroscience.2006.09.020; Caldelas I, 2005, BIOL RHYTHM RES, V36, P23, DOI 10.1080/09291010400028500; Caldellas I, 2009, DEV NEUROBIOL, V69, P47, DOI 10.1002/dneu.20687; Charra R, 2012, BEHAV BRAIN RES, V226, P179, DOI 10.1016/j.bbr.2011.09.008; Coureaud G, 2004, CHEM SENSES, V29, P341, DOI 10.1093/chemse/bjh037; Coureaud G, 2001, ANIM BEHAV, V61, P153, DOI 10.1006/anbe.2000.1563; Coureaud G, 2008, CHEMOECOLOGY, V18, P53, DOI 10.1007/s00049-007-0392-x; Coureaud G, 2006, CHEMOECOLOGY, V16, P169, DOI 10.1007/s00049-006-0345-9; Coureaud G, 2010, J COMP PHYSIOL A, V196, P779, DOI 10.1007/s00359-010-0548-y; Coureaud G, 2008, PHYSIOL BEHAV, V95, P194, DOI 10.1016/j.physbeh.2008.05.018; Deutsch J. A., 1957, British Journal of Animal Behaviour, V5, P53, DOI 10.1016/S0950-5601(57)80026-4; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Doucet S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007579; Escobar C, 2000, J COMP PHYSIOL A, V186, P33, DOI 10.1007/s003590050004; Escobar C, 2011, PHYSIOL BEHAV, V104, P555, DOI 10.1016/j.physbeh.2011.05.001; FLUXMAN S, 1993, CHRONOBIOL INT, V10, P159, DOI 10.3109/07420529309073884; Gilbert C, 2007, AM J PHYSIOL-REG I, V293, pR867, DOI 10.1152/ajpregu.00081.2007; Granados-Fuentes D, 2004, EUR J NEUROSCI, V19, P898, DOI 10.1111/j.0953-816X.2004.03117.x; Granados-Fuentes D, 2004, J NEUROSCI, V24, P615, DOI 10.1523/JNEUROSCI.4002-03.2004; Granados-Fuentes D, 2006, J NEUROSCI, V26, P12219, DOI 10.1523/JNEUROSCI.3445-06.2006; Granados-Fuentes D, 2011, J BIOL RHYTHM, V26, P552, DOI 10.1177/0748730411420247; HUDSON R, 1983, BEHAVIOUR, V85, P260, DOI 10.1163/156853983X00255; HUDSON R, 1982, BEHAVIOUR, V79, P255, DOI 10.1163/156853982X00292; HUDSON R, 1985, DEV PSYCHOBIOL, V18, P575, DOI 10.1002/dev.420180612; HUDSON R, 1986, PHYSIOL BEHAV, V37, P123, DOI 10.1016/0031-9384(86)90394-X; Jechura TJ, 2006, AM J PHYSIOL-REG I, V291, pR1808, DOI 10.1152/ajpregu.00005.2006; Jilge B, 2000, J BIOL RHYTHM, V15, P329, DOI 10.1177/074873000129001431; JILGE B, 1993, J BIOL RHYTHM, V8, P247, DOI 10.1177/074873049300800307; Jilge B, 2001, LAB ANIM-UK, V35, P364, DOI 10.1258/0023677011911831; Logan DW, 2012, CURR BIOL, V22, P1998, DOI 10.1016/j.cub.2012.08.041; Marcilhac A, 1997, ARCH PHYSIOL BIOCHEM, V105, P552, DOI 10.1076/apab.105.6.552.3273; Mistlberger RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031772; Mistlberger RE, 2009, EUR J NEUROSCI, V30, P1718, DOI 10.1111/j.1460-9568.2009.06965.x; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Montufar-Chaveznava R, 2012, NEUROSCIENCE, V207, P198, DOI 10.1016/j.neuroscience.2012.01.025; Morgado E, 2011, EUR J NEUROSCI, V34, P1807, DOI 10.1111/j.1460-9568.2011.07898.x; NUESSLEINHILDESHEIM B, 1995, J COMP PHYSIOL B, V165, P13, DOI 10.1007/BF00264681; Perret M, 2003, J BIOL RHYTHM, V18, P392, DOI 10.1177/0748730403254248; PIEPER DR, 1991, AM J PHYSIOL, V261, pR973, DOI 10.1152/ajpregu.1991.261.4.R973; Pittendrigh C, 1981, HDB BEHAVIORAL NEURO, V4, P57; Pongracz P, 1999, DEV PSYCHOBIOL, V35, P241, DOI 10.1002/(SICI)1098-2302(199911)35:3&lt;241::AID-DEV8&gt;3.0.CO;2-R; POSSIDENTE B, 1990, BRAIN RES, V513, P325, DOI 10.1016/0006-8993(90)90475-Q; Reppert S, 1989, RES PRENATAL MED, VIX, P25; ROSENBLATT JS, 1983, DEV PSYCHOBIOL, V16, P347, DOI 10.1002/dev.420160502; Rovirosa MJ, 2005, DEV BRAIN RES, V158, P92, DOI 10.1016/j.devbrainres.2005.06.007; Saucier D, 2005, CHEM SENSES, V30, pA180, DOI [10.1093/chemse/bjh173, DOI 10.1093/CHEMSE/BJH173]; Schaal B, 2003, NATURE, V424, P68, DOI 10.1038/nature01739; Schley P, 1980, MUTTERLOSE AUFZUCHT; SINGH PJ, 1976, PHYSIOL BEHAV, V17, P373, DOI 10.1016/0031-9384(76)90094-9; Tanida M, 2005, BRAIN RES, V1058, P44, DOI 10.1016/j.brainres.2005.07.048; Tanida M, 2008, NEUROSCI LETT, V439, P192, DOI 10.1016/j.neulet.2008.05.021; TEICHER MH, 1976, SCIENCE, V193, P422, DOI 10.1126/science.935878; Tosini G, 2007, FASEB J, V21, P3866, DOI 10.1096/fj.07-8371com; Trejo-Munoz L, 2012, PHYSIOL BEHAV, V106, P587, DOI 10.1016/j.physbeh.2012.04.005; ZARROW MX, 1965, SCIENCE, V150, P1835, DOI 10.1126/science.150.3705.1835; Zhao H, 2005, NEUROSCIENCE, V132, P519, DOI 10.1016/j.neuroscience.2005.01.012	60	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74048	10.1371/journal.pone.0074048	http://dx.doi.org/10.1371/journal.pone.0074048			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040161	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600115
J	Yu, YM; Schurpf, T; Springer, TA				Yu, Yamei; Schuerpf, Thomas; Springer, Timothy A.			How Natalizumab Binds and Antagonizes alpha(4) Integrins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adhesion; Cell Surface; Crystal Structure; Immunology; Integrins; Structure	CELL-ADHESION MOLECULE-1; AMINO-ACID-RESIDUES; LIGAND-BINDING; COST-EFFECTIVENESS; CRYSTAL-STRUCTURE; AFFINITY; VCAM-1; ANTIBODIES; RECEPTOR; SITES	Natalizumab antibody to (4)-integrins is used in therapy of multiple sclerosis and Crohn's disease. A crystal structure of the Fab bound to an (4) integrin -propeller and thigh domain fragment shows that natalizumab recognizes human-mouse differences on the circumference of the -propeller domain. The epitope is adjacent to but outside of a ligand-binding groove formed at the interface with the -subunit I domain and shows no difference in structure when bound to Fab. Competition between Fab and the ligand vascular cell adhesion molecule (VCAM) for binding to cell surface (41) shows noncompetitive antagonism. In agreement, VCAM docking models suggest that binding of domain 1 of VCAM to (4)-integrins is unimpeded by the Fab, and that bound Fab requires a change in orientation between domains 1 and 2 of VCAM for binding to (41). Mapping of species-specific differences onto (41) and (47) shows that their ligand-binding sites are highly conserved. Skewing away from these conserved regions of the epitopes recognized by current therapeutic function-blocking antibodies has resulted in previously unanticipated mechanisms of action.	[Springer, Timothy A.] Harvard Univ, Sch Med, Childrens Hosp Boston, Program Cellular & Mol Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Springer, TA (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Program Cellular & Mol Med, Boston, MA 02115 USA.	timothy.springer@childrens.harvard.edu	Schürpf, Thomas/E-7380-2012	Schurpf, Thomas/0000-0003-3023-1136	National Institutes of Health [HL-103526]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health inhibitors than was originally envisioned. Grant HL-103526.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bakhshai Justin, 2010, J Med Econ, V13, P63, DOI 10.3111/13696990903543424; Bauer M, 2009, P NATL ACAD SCI USA, V106, P1920, DOI 10.1073/pnas.0808909106; Chen X, 2010, P NATL ACAD SCI USA, V107, P14727, DOI 10.1073/pnas.1008663107; Chigaev A, 2003, J BIOL CHEM, V278, P38174, DOI 10.1074/jbc.M210472200; CHIU HH, 1995, J IMMUNOL, V155, P5257; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; CHULUYAN HE, 1995, J IMMUNOL, V155, P3135; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DAVIS LS, 1990, J IMMUNOL, V145, P785; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; IRIE A, 1995, EMBO J, V14, P5550, DOI 10.1002/j.1460-2075.1995.tb00242.x; JONES EY, 1995, NATURE, V373, P539, DOI 10.1038/373539a0; KABSCH W, 2001, CRYSTALLOGRAPHY BIOL, P730; KAMATA T, 1995, BIOCHEM J, V305, P945, DOI 10.1042/bj3050945; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; KENT SJ, 1995, J NEUROIMMUNOL, V58, P1, DOI 10.1016/0165-5728(94)00165-K; LAZARENO S, 1993, BRIT J PHARMACOL, V109, P1110, DOI 10.1111/j.1476-5381.1993.tb13737.x; Leger Olivier J. P., 1997, Human Antibodies, V8, P3; Li S, 2009, P NATL ACAD SCI USA, V106, P4349, DOI 10.1073/pnas.0810844106; Luo BH, 2004, J BIOL CHEM, V279, P27466, DOI 10.1074/jbc.M404354200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mi LZ, 2008, BIOCHEMISTRY-US, V47, P10314, DOI 10.1021/bi801006s; MURZIN AG, 1992, PROTEINS, V14, P191, DOI 10.1002/prot.340140206; Nagae M, 2012, J CELL BIOL, V197, P131, DOI 10.1083/jcb.201111077; Newham P, 1998, J IMMUNOL, V160, P4508; Newham P, 1997, J BIOL CHEM, V272, P19429, DOI 10.1074/jbc.272.31.19429; O'Day Ken, 2011, J Med Econ, V14, P617, DOI 10.3111/13696998.2011.602444; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pei JM, 2001, BIOINFORMATICS, V17, P700, DOI 10.1093/bioinformatics/17.8.700; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; PULIDO R, 1991, J BIOL CHEM, V266, P10241; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; SCHIFFER SG, 1995, J BIOL CHEM, V270, P14270, DOI 10.1074/jbc.270.24.14270; Schurpf T, 2011, EMBO J, V30, P4712, DOI 10.1038/emboj.2011.333; Shapiro RI, 2011, J PHARMACEUT BIOMED, V55, P168, DOI 10.1016/j.jpba.2011.01.006; Sidhu SS, 2012, FEBS LETT, V586, P2778, DOI 10.1016/j.febslet.2012.05.044; Soler D, 2009, J PHARMACOL EXP THER, V330, P864, DOI 10.1124/jpet.109.153973; Springer TA, 2000, CELL, V102, P275, DOI 10.1016/S0092-8674(00)00033-7; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Springer TA, 1997, P NATL ACAD SCI USA, V94, P65, DOI 10.1073/pnas.94.1.65; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; Targan SR, 2007, GASTROENTEROLOGY, V132, P1672, DOI 10.1053/j.gastro.2007.03.024; Thomas Saskia, 2012, Inflammopharmacology, V20, P1, DOI 10.1007/s10787-011-0104-6; von Andrian UH, 2003, NEW ENGL J MED, V348, P68, DOI 10.1056/NEJMe020157; VONDERHEIDE RH, 1994, J CELL BIOL, V125, P215, DOI 10.1083/jcb.125.1.215; VONDERHEIDE RH, 1992, J EXP MED, V175, P1433, DOI 10.1084/jem.175.6.1433; Wang JH, 1996, ACTA CRYSTALLOGR D, V52, P369, DOI 10.1107/S0907444995012352; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Yu YM, 2012, J CELL BIOL, V196, P131, DOI 10.1083/jcb.201110023	51	49	51	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32314	32325		10.1074/jbc.M113.501668	http://dx.doi.org/10.1074/jbc.M113.501668			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24047894	Green Published, hybrid			2022-12-25	WOS:000328681700018
J	Henderson, DM; Manca, M; Haley, NJ; Denkers, ND; Nalls, AV; Mathiason, CK; Caughey, B; Hoover, EA				Henderson, Davin M.; Manca, Matteo; Haley, Nicholas J.; Denkers, Nathaniel D.; Nalls, Amy V.; Mathiason, Candace K.; Caughey, Byron; Hoover, Edward A.			Rapid Antemortem Detection of CWD Prions in Deer Saliva	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; QUAKING-INDUCED CONVERSION; INFECTIOUS PRIONS; SPONGIFORM ENCEPHALOPATHY; CEREBROSPINAL-FLUID; MULE DEER; TRANSGENIC MICE; PROTEIN; TRANSMISSION; SHEEP	Chronic wasting disease (CWD) is an efficiently transmitted prion disease of cervids, now identified in 22 United States, 2 Canadian provinces and Korea. One hallmark of CWD is the shedding of infectious prions in saliva, as demonstrated by bioassay in deer. It is also clear that the concentration of prions in saliva, blood, urine and feces is much lower than in the nervous system or lymphoid tissues. Rapid in vitro detection of CWD (and other) prions in body fluids and excreta has been problematic due to the sensitivity limits of direct assays (western blotting, ELISA) and the presence of inhibitors in these complex biological materials that hamper detection. Here we use real-time quaking induced conversion (RT-QuIC) to demonstrate CWD prions in both diluted and prion-enriched saliva samples from asymptomatic and symptomatic white-tailed deer. CWD prions were detected in 14 of 24 (58.3%) diluted saliva samples from CWD-exposed white-tailed deer, including 9 of 14 asymptomatic animals (64.2%). In addition, a phosphotungstic acid enrichment enhanced the RT-QuIC assay sensitivity, enabling detection in 19 of 24 (79.1%) of the above saliva samples. Bioassay in Tg[CerPrP] mice confirmed the presence of infectious prions in 2 of 2 RT-QuIC-positive saliva samples so examined. The modified RT-QuIC analysis described represents a non-invasive, rapid ante-mortem detection of prions in complex biologic fluids, excreta, or environmental samples as well as a tool for exploring prion trafficking, peripheralization, and dissemination.	[Henderson, Davin M.; Haley, Nicholas J.; Denkers, Nathaniel D.; Nalls, Amy V.; Mathiason, Candace K.; Hoover, Edward A.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Manca, Matteo; Caughey, Byron] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, Hamilton, MT USA; [Manca, Matteo] Univ Cagliari, Dept Biomed Sci, Monserrato, Italy	Colorado State University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Cagliari	Hoover, EA (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Edward.Hoover@colostate.edu	Mathiason, Candace K/E-7843-2017; Mathiason, Candace/H-9769-2017	Mathiason, Candace K/0000-0002-5920-4556; Mathiason, Candace/0000-0002-5920-4556	NIH NINDS [R01 NS-061902]; Morris Animal Foundation [D12ZO-045]; NIAID; Sardinia Regional Government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061902] Funding Source: NIH RePORTER	NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Morris Animal Foundation; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Sardinia Regional Government(Regione Sardegna); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NIH NINDS grant R01 NS-061902 and by grant D12ZO-045 from the Morris Animal Foundation. This work was also supported in part by the Intramural Research Program of the NIAID. We gratefully acknowledge the Sardinia Regional Government for the financial support of Matteo Manca through his Ph.D. scholarship (P.O.R. Sardegna F.S.E. Operational Programme of the Autonomous Region of Sardinia, European Social Fund 2007-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi R, 2011, PRION, V5, P150, DOI 10.4161/pri.5.3.16893; Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; Bamborough P, 1996, COLD SPRING HARB SYM, V61, P495; BENDHEIM PE, 1992, NEUROLOGY, V42, P149, DOI 10.1212/WNL.42.1.149; Browning SR, 2004, J VIROL, V78, P13345, DOI 10.1128/JVI.78.23.13345-13350.2004; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Colby DW, 2007, P NATL ACAD SCI USA, V104, P20914, DOI 10.1073/pnas.0710152105; Colby DW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000736; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; D'Castro L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015679; Gabizon R, 1996, NAT MED, V2, P59, DOI 10.1038/nm0196-59; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; Gough KC, 2012, J VIROL, V86, P566, DOI 10.1128/JVI.05579-11; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Heisey DM, 2010, J VIROL, V84, P210, DOI 10.1128/JVI.00560-09; Helmerhorst EJ, 2010, J PROTEOME RES, V9, P5413, DOI 10.1021/pr100653r; Kurt TD, 2011, J VIROL, V85, P8528, DOI 10.1128/JVI.00809-11; LIAO YCJ, 1986, SCIENCE, V233, P364, DOI 10.1126/science.3014653; Maddison BC, 2010, J INFECT DIS, V201, P1672, DOI 10.1086/652457; Marsh RF, 2005, J VIROL, V79, P13794, DOI 10.1128/JVI.79.21.13794-13796.2005; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Mathiason CK, 2013, J VIROL, V87, P1947, DOI 10.1128/JVI.02592-12; Mathiason CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005916; McGuire LI, 2012, ANN NEUROL, V72, P278, DOI 10.1002/ana.23589; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Okada H, 2012, EMERG INFECT DIS, V18, P2091, DOI [10.3201/eid1812.120528, 10.3201/1812.120528]; Orru CD, 2012, J CLIN MICROBIOL, V50, P1464, DOI 10.1128/JCM.06099-11; Orru CD, 2011, MBIO, V2, DOI 10.1128/mBio.00078-11; Pastrana MA, 2006, BIOCHEMISTRY-US, V45, P15710, DOI 10.1021/bi0615442; Peden AH, 2012, J GEN VIROL, V93, P438, DOI 10.1099/vir.0.033365-0; Perrott MR, 2012, J GEN VIROL, V93, P212, DOI 10.1099/vir.0.035006-0; PRUSINER SB, 1984, CELL, V38, P127, DOI 10.1016/0092-8674(84)90533-6; Raymond GJ, 2007, J VIROL, V81, P4305, DOI 10.1128/JVI.02474-06; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Sigurdson CJ, 2008, J COMP PATHOL, V138, P189, DOI 10.1016/j.jcpa.2008.01.004; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Siqueira WL, 2008, J DENT RES, V87, P445, DOI 10.1177/154405910808700508; Spraker TR, 1997, J WILDLIFE DIS, V33, P1, DOI 10.7589/0090-3558-33.1.1; Sun XL, 2009, FASEB J, V23, P2691, DOI 10.1096/fj.09-131045; Tamguney G, 2012, PRION, V6, P52, DOI 10.4161/pri.6.1.16984; Tamguney G, 2009, NATURE, V461, P529, DOI 10.1038/nature08289; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Thackray AM, 2007, BIOCHEM J, V401, P475, DOI 10.1042/BJ20061264; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; WILLIAMS ES, 1982, J WILDLIFE DIS, V18, P465, DOI 10.7589/0090-3558-18.4.465; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89	51	77	78	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74377	10.1371/journal.pone.0074377	http://dx.doi.org/10.1371/journal.pone.0074377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040235	Green Submitted, gold, Green Published			2022-12-25	WOS:000326734500087
J	Li, JJ; Zhao, SY; Zhou, X; Zhang, T; Zhao, L; Miao, P; Song, SL; Sun, XG; Liu, JJ; Zhao, XP; Huang, G				Li, Jiajin; Zhao, Shiyan; Zhou, Xiang; Zhang, Teng; Zhao, Li; Miao, Ping; Song, Shaoli; Sun, Xiaoguang; Liu, Jianjun; Zhao, Xiaoping; Huang, Gang			Inhibition of Lipolysis by Mercaptoacetate and Etomoxir Specifically Sensitize Drug-Resistant Lung Adenocarcinoma Cell to Paclitaxel	PLOS ONE			English	Article							FATTY-ACID OXIDATION; ENERGY-METABOLISM; CANCER METABOLISM; BREAST-CANCER; GLUCOSE; 2-MERCAPTOACETATE; DEHYDROGENASE; INVITRO; GROWTH	Chemoresistance is a major cause of treatment failure in patients with lung cancer. Although the extensive efforts have been made in overcoming chemoresistance, the underlying mechanisms are still elusive. Cancer cells reprogram cellular metabolism to satisfy the demands of malignant phenotype. To reveal roles of cancer metabolism in regulating chemoresistance, we profiled the metabolic characteristics in paclitaxel-resistant lung cancer cells by flux assay. Glucose and oleate metabolism were significantly different between resistant and non-resistant cells. In addition, targeting metabolism as a strategy to overcome drug resistance was investigated using specific metabolic inhibitors. Inhibition of glycolysis and oxidative phosphorylation by 2-deoxyglucose and malonate, respectively, potentiated the effects of paclitaxel on nonresistant lung adenocarcinoma cells but not paclitaxel-resistant cells. By contrast, inhibition of lipolysis by mercaptoacetate or etomoxir synergistically inhibited drug-resistant lung adenocarcinoma cell proliferation. We conclude that lipolysis inhibition potentially be a therapeutic strategy to overcome drug resistance in lung cancer.	[Li, Jiajin; Zhao, Shiyan; Zhou, Xiang; Zhang, Teng; Zhao, Li; Miao, Ping; Song, Shaoli; Sun, Xiaoguang; Liu, Jianjun; Zhao, Xiaoping; Huang, Gang] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Nucl Med, Shanghai 200030, Peoples R China; [Zhou, Xiang; Zhang, Teng; Miao, Ping; Huang, Gang] Shanghai Jiao Tong Univ, Inst Hlth Sci, Sch Med, Shanghai 200030, Peoples R China; [Zhou, Xiang; Zhang, Teng; Miao, Ping; Huang, Gang] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Huang, G (corresponding author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Nucl Med, Shanghai 200030, Peoples R China.	huang2802@163.com	song, sl/GRS-1884-2022	Li, Jiajin/0000-0003-1300-6025	"973" Project [2012CB932604]; New Drug Discovery Project [2012ZX09506-001-005]; Shanghai Leading Academic Discipline Project [S30203]; National Natural Science Foundation of China [81071180, 81001008]; Shanghai Pujiang Program [13PJ1406000]; Science and Technology Commission of Shanghai Municipality [134119a5600]	"973" Project(National Basic Research Program of China); New Drug Discovery Project; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	The study was supported by research grants from "973" Project (No.2012CB932604), New Drug Discovery Project (No.2012ZX09506-001-005), Shanghai Leading Academic Discipline Project (No.S30203), National Natural Science Foundation of China (No. 81071180 & 81001008), Shanghai Pujiang Program (No.13PJ1406000) and Science and Technology Commission of Shanghai Municipality (No.134119a5600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUCHE F, 1982, BIOCHEM J, V206, P53, DOI 10.1042/bj2060053; BAUCHE F, 1983, BIOCHEM J, V215, P457, DOI 10.1042/bj2150457; Boisvert FM, 2010, MOL CELL PROTEOMICS, V9, P457, DOI 10.1074/mcp.M900429-MCP200; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; El Mjiyad N, 2011, ONCOGENE, V30, P253, DOI 10.1038/onc.2010.466; Funakoshi T, 2011, TOXICOL IN VITRO, V25, P1581, DOI 10.1016/j.tiv.2011.05.028; Giovannetti E, 2012, PHARMACOGENOMICS, V13, P1073, DOI [10.2217/PGS.12.91, 10.2217/pgs.12.91]; Gottschling S, 2012, CANCER GENOM PROTEOM, V9, P275; Hadzic T, 2010, FREE RADICAL BIO MED, V48, P1024, DOI 10.1016/j.freeradbiomed.2010.01.018; Harper ME, 2002, FASEB J, V16, P1550, DOI 10.1096/fj.02-0541com; Hernlund E, 2008, INT J CANCER, V123, P476, DOI 10.1002/ijc.23525; KANE MT, 1977, J REPROD FERTIL, V49, P261, DOI 10.1530/jrf.0.0490261; Lonning PE, 2013, ONCOGENE, V32, P5315, DOI 10.1038/onc.2013.48; Tirado-Velez JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046484; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; Michelsen U, 2009, METHOD ENZYMOL, V463, P305, DOI 10.1016/S0076-6879(09)63019-6; Nakano A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027222; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Rosenberg N, 2007, CYTOTECHNOLOGY, V54, P1, DOI 10.1007/s10616-007-9066-3; Samudio I, 2010, J CLIN INVEST, V120, P142, DOI 10.1172/JCI38942; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Shen YC, 2013, BRIT J CANCER, V108, P72, DOI 10.1038/bjc.2012.559; Sun QL, 2011, J CANCER RES CLIN, V137, P521, DOI 10.1007/s00432-010-0913-9; Tang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063965; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Vincourt V, 2011, CELL BIOL TOXICOL, V27, P363, DOI 10.1007/s10565-011-9193-7; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Zahreddine H, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00028; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211; Zhao XP, 2012, J CLIN INVEST, V122, P2417, DOI 10.1172/JCI61462; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60; Zhao YH, 2011, CANCER RES, V71, P4585, DOI 10.1158/0008-5472.CAN-11-0127	32	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74623	10.1371/journal.pone.0074623	http://dx.doi.org/10.1371/journal.pone.0074623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040298	Green Published, gold, Green Submitted			2022-12-25	WOS:000326734500107
J	Plack, CJ; Oxenham, AJ; Kreft, HA; Carlyon, RP				Plack, Christopher J.; Oxenham, Andrew J.; Kreft, Heather A.; Carlyon, Robert P.			Central Auditory Masking by an Illusory Tone	PLOS ONE			English	Article							BRAIN-STEM IMPLANT; NARROW-BAND NOISE; BINAURAL INTERACTION; HUGGINS PITCH; NONSIMULTANEOUS MASKING; LEVEL DIFFERENCES; TIME-COURSE; NERVE DATA; SOUNDS; DISCRIMINATION	Many natural sounds fluctuate over time. The detectability of sounds in a sequence can be reduced by prior stimulation in a process known as forward masking. Forward masking is thought to reflect neural adaptation or neural persistence in the auditory nervous system, but it has been unclear where in the auditory pathway this processing occurs. To address this issue, the present study used a "Huggins pitch" stimulus, the perceptual effects of which depend on central auditory processing. Huggins pitch is an illusory tonal sensation produced when the same noise is presented to the two ears except for a narrow frequency band that is different (decorrelated) between the ears. The pitch sensation depends on the combination of the inputs to the two ears, a process that first occurs at the level of the superior olivary complex in the brainstem. Here it is shown that a Huggins pitch stimulus produces more forward masking in the frequency region of the decorrelation than a noise stimulus identical to the Huggins-pitch stimulus except with perfect correlation between the ears. This stimulus has a peripheral neural representation that is identical to that of the Huggins-pitch stimulus. The results show that processing in, or central to, the superior olivary complex can contribute to forward masking in human listeners.	[Plack, Christopher J.] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [Oxenham, Andrew J.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Oxenham, Andrew J.; Kreft, Heather A.] Univ Minnesota, Dept Otolaryngol, Minneapolis, MN USA; [Carlyon, Robert P.] MRC, Cognit & Brain Sci Unit, Cambridge, England	University of Manchester; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Plack, CJ (corresponding author), Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England.	chris.plack@manchester.ac.uk	Plack, Christopher/P-4209-2017	Plack, Christopher/0000-0002-2987-5332; Carlyon, Robert/0000-0002-6166-501X; Oxenham, Andrew/0000-0002-9365-1157	National Institute on Deafness and Other Communication Disorders [R01 DC005216]; Medical Research Council (UK) [G0900591]; MRC [G0900591, MC_U105559842] Funding Source: UKRI; Medical Research Council [MC_U105559842, G0900591] Funding Source: researchfish; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005216] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The research was funded by the National Institute on Deafness and Other Communication Disorders (www.nidcd.nih.gov), grant number R01 DC005216, and by the Medical Research Council (UK), grant number G0900591. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Pinto A, 2010, JARO-J ASSOC RES OTO, V11, P477, DOI 10.1007/s10162-010-0215-6; Backus BC, 2006, J ACOUST SOC AM, V119, P2889, DOI 10.1121/1.2169918; Bleeck S, 2006, HEARING RES, V212, P176, DOI 10.1016/j.heares.2005.12.005; Buss E, 2011, J ACOUST SOC AM, V129, P907, DOI 10.1121/1.3514528; CARLYON RP, 1988, HEARING RES, V32, P65, DOI 10.1016/0378-5955(88)90147-5; Carlyon RP, 2004, TRENDS COGN SCI, V8, P465, DOI 10.1016/j.tics.2004.08.008; Chait M, 2006, CEREB CORTEX, V16, P835, DOI 10.1093/cercor/bhj027; COLBURN HS, 1973, J ACOUST SOC AM, V54, P1458, DOI 10.1121/1.1914445; COLBURN HS, 1977, J ACOUST SOC AM, V61, P525, DOI 10.1121/1.381294; Cooper NP, 2006, J PHYSIOL-LONDON, V576, P49, DOI 10.1113/jphysiol.2006.114991; CRAMER EM, 1958, J ACOUST SOC AM, V30, P413, DOI 10.1121/1.1909628; Culling JF, 1998, J ACOUST SOC AM, V103, P3509, DOI 10.1121/1.423059; DUIFHUIS H, 1973, J ACOUST SOC AM, V54, P1471, DOI 10.1121/1.1914446; DURLACH NI, 1962, J ACOUST SOC AM, V34, P1096, DOI 10.1121/1.1918251; DURLACH NI, 1960, J ACOUST SOC AM, V32, P1075, DOI 10.1121/1.1908315; ELLIOTT LL, 1962, J ACOUST SOC AM, V34, P1116, DOI 10.1121/1.1918254; Gockel HE, 2011, JARO-J ASSOC RES OTO, V12, P253, DOI 10.1007/s10162-010-0250-3; Hall DA, 2009, CEREB CORTEX, V19, P576, DOI 10.1093/cercor/bhn108; HANNA TE, 1982, J ACOUST SOC AM, V72, P1171, DOI 10.1121/1.388317; Hertrich I, 2005, NEUROREPORT, V16, P193, DOI 10.1097/00001756-200502080-00026; HIRSH IJ, 1948, J ACOUST SOC AM, V20, P536, DOI 10.1121/1.1906407; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Lim HH, 2008, NEUROSCIENCE, V154, P370, DOI 10.1016/j.neuroscience.2008.02.041; Lorenzi C, 2006, P NATL ACAD SCI USA, V103, P18866, DOI 10.1073/pnas.0607364103; MILLER GA, 1950, J ACOUST SOC AM, V22, P167, DOI 10.1121/1.1906584; NEFF DL, 1986, J ACOUST SOC AM, V79, P1519, DOI 10.1121/1.393678; Nelson PC, 2009, J NEUROSCI, V29, P2553, DOI 10.1523/JNEUROSCI.5359-08.2009; Otto SR, 2002, J NEUROSURG, V96, P1063, DOI 10.3171/jns.2002.96.6.1063; Oxenham AJ, 2001, J ACOUST SOC AM, V109, P732, DOI 10.1121/1.1336501; Plack CJ, 2006, J NEUROSCI, V26, P8767, DOI 10.1523/JNEUROSCI.1134-06.2006; Plack CJ, 2011, J ACOUST SOC AM, V129, P1, DOI 10.1121/1.3518745; Puschmann S, 2010, NEUROIMAGE, V49, P1641, DOI 10.1016/j.neuroimage.2009.09.045; RELKIN EM, 1988, J ACOUST SOC AM, V84, P584, DOI 10.1121/1.396836; SHAILER MJ, 1987, J ACOUST SOC AM, V81, P1110, DOI 10.1121/1.394631; SMALL AM, 1972, J ACOUST SOC AM, V51, P1365, DOI 10.1121/1.1912984; YAMA MF, 1992, J ACOUST SOC AM, V91, P327, DOI 10.1121/1.402775; Yin TCT, 2010, REESAR PALMER, P271; YOST WA, 1977, J ACOUST SOC AM, V61, P1376, DOI 10.1121/1.381406; Zheng JF, 2011, BIOPHYS J, V100, P1627, DOI 10.1016/j.bpj.2011.02.025	40	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e75822	10.1371/journal.pone.0075822	http://dx.doi.org/10.1371/journal.pone.0075822			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040419	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000326734500144
J	Tamura, T; Arai, S; Nagaya, H; Mizuguchi, J; Wada, I				Tamura, Taku; Arai, Seisuke; Nagaya, Hisao; Mizuguchi, Jun; Wada, Ikuo			Stepwise Assembly of Fibrinogen Is Assisted by the Endoplasmic Reticulum Lectin-Chaperone System in HepG2 Cells	PLOS ONE			English	Article							MOLECULAR CHAPERONES; SECRETORY PATHWAY; ENVELOPE GLYCOPROTEINS; DISULFIDE BONDS; CALNEXIN; CALRETICULIN; ERP57; CHAINS; ASSOCIATION; BIOSYNTHESIS	The endoplasmic reticulum (ER) plays essential roles in protein folding and assembly of secretory proteins. ER-resident molecular chaperones and related enzymes assist in protein maturation by co-operated interactions and modifications. However, the folding/assembly of multimeric proteins is not well understood. Here, we show that the maturation of fibrinogen, a hexameric secretory protein (two trimers from alpha, beta and c subunits), occurs in a stepwise manner. The alpha gamma complex, a precursor for the trimer, is retained in the ER by lectin-like chaperones, and the beta subunit is incorporated into the alpha gamma complex immediately after translation. ERp57, a protein disulfide isomerase homologue, is involved in the hexamer formation from two trimers. Our results indicate that the fibrinogen hexamer is formed sequentially, rather than simultaneously, using kinetic pause by lectin chaperones. This study provides a novel insight into the assembly of most abundant multi-subunit secretory proteins.	[Tamura, Taku; Arai, Seisuke; Nagaya, Hisao; Wada, Ikuo] Fukushima Med Univ, Inst Biomed Sci, Dept Cell Sci, Fukushima, Japan; [Tamura, Taku; Nagaya, Hisao; Wada, Ikuo] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol, Tokyo, Japan; [Mizuguchi, Jun] Chemoserotherapeut Res Inst Kaketsuken, Kumamoto, Japan	Fukushima Medical University; Japan Science & Technology Agency (JST)	Tamura, T (corresponding author), Akita Univ, Fac Engn & Resource, Dept Life Sci, Akita 010, Japan.	taku@gipc.akita-u.ac.jp		Wada, Ikuo/0000-0001-5668-6994; Tamura, Taku/0000-0001-6074-9273	Japan Society for the Promotion of Science [14380295]; Core Research for Evolutional Science and Technology (CREST); Japan Science and Technology Agency; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [25840066] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was in part supported by grant-in-aid (14380295) from the Japan Society for the Promotion of Science to IW, Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency to TT, HN and IW, and The Uehara Memorial Foundation to TT. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2000, P NATL ACAD SCI USA, V97, P7290, DOI 10.1073/pnas.140210297; Bass J, 1998, J CELL BIOL, V141, P637, DOI 10.1083/jcb.141.3.637; Braakman I, 2000, TRAFFIC, V1, P533, DOI 10.1034/j.1600-0854.2000.010702.x; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Chakravarthi S, 2004, J BIOL CHEM, V279, P39872, DOI 10.1074/jbc.M406912200; Chapman DC, 2010, SEMIN CELL DEV BIOL, V21, P512, DOI 10.1016/j.semcdb.2009.12.013; Christis C, 2008, FEBS J, V275, P4700, DOI 10.1111/j.1742-4658.2008.06590.x; Doolittle RF, 1998, CURR OPIN STRUC BIOL, V8, P792, DOI 10.1016/S0959-440X(98)80100-0; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Eriksson KK, 2004, J BIOL CHEM, V279, P44600, DOI 10.1074/jbc.M407972200; Freedman RB, 2002, EMBO REP, V3, P136, DOI 10.1093/embo-reports/kvf035; HARTWIG R, 1991, J BIOL CHEM, V266, P6578; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; HUANG SM, 1993, J BIOL CHEM, V268, P8919; Huang SM, 1996, J BIOL CHEM, V271, P27942, DOI 10.1074/jbc.271.44.27942; Kamada A, 2004, J BIOL CHEM, V279, P21533, DOI 10.1074/jbc.M401403200; Kang SJ, 2002, J BIOL CHEM, V277, P44838, DOI 10.1074/jbc.M207831200; Kulp MS, 2006, J BIOL CHEM, V281, P876, DOI 10.1074/jbc.M511764200; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Moore P, 2010, MOL BIOL CELL, V21, P1305, DOI 10.1091/mbc.E09-09-0826; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Oliver JD, 1999, MOL BIOL CELL, V10, P2573, DOI 10.1091/mbc.10.8.2573; Paulsson K, 2003, BBA-MOL CELL RES, V1641, P1, DOI 10.1016/S0167-4889(03)00048-X; Redman CM, 2001, ANN NY ACAD SCI, V936, P480; ROY S, 1992, J BIOL CHEM, V267, P23151; Roy S, 1996, J BIOL CHEM, V271, P24544, DOI 10.1074/jbc.271.40.24544; Schrag JD, 2003, TRENDS BIOCHEM SCI, V28, P49, DOI 10.1016/S0968-0004(02)00004-X; SOUSA M, 1995, EMBO J, V14, P4196, DOI 10.1002/j.1460-2075.1995.tb00093.x; Tamura T, 2002, FEBS LETT, V513, P153, DOI 10.1016/S0014-5793(02)02229-9; Tomita Y, 1999, J BIOCHEM-TOKYO, V126, P1090, DOI 10.1093/oxfordjournals.jbchem.a022554; Trombetta ES, 2003, GLYCOBIOLOGY, V13, p77R, DOI [10.1093/glycob/cwg075., DOI 10.1093/GLYC0B/CWG075]; Van der Wal FJ, 1998, EUR J BIOCHEM, V256, P51, DOI 10.1046/j.1432-1327.1998.2560051.x; Wada I, 1997, EMBO J, V16, P5420, DOI 10.1093/emboj/16.17.5420; Wanamaker CP, 2003, ANN NY ACAD SCI, V998, P66, DOI 10.1196/annals.1254.009; YU S, 1984, J BIOL CHEM, V259, P574; YU S, 1983, J BIOL CHEM, V258, P3407; Zapun A, 1998, J BIOL CHEM, V273, P6009, DOI 10.1074/jbc.273.11.6009; ZHANG JZ, 1994, J BIOL CHEM, V269, P652; Zhang Y, 2009, J BIOL CHEM, V284, P10160, DOI 10.1074/jbc.M808356200	39	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74580	10.1371/journal.pone.0074580	http://dx.doi.org/10.1371/journal.pone.0074580			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040290	Green Published, gold, Green Submitted			2022-12-25	WOS:000327538600101
J	Balakrishnan, M; Yant, SR; Tsai, L; O'Sullivan, C; Bam, RA; Tsai, A; Niedziela-Majka, A; Stray, KM; Sakowicz, R; Cihlar, T				Balakrishnan, Mini; Yant, Stephen R.; Luong Tsai; O'Sullivan, Christopher; Bam, Rujuta A.; Tsai, Angela; Niedziela-Majka, Anita; Stray, Kirsten M.; Sakowicz, Roman; Cihlar, Tomas			Non-Catalytic Site HIV-1 Integrase Inhibitors Disrupt Core Maturation and Induce a Reverse Transcription Block in Target Cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SMALL-MOLECULE INHIBITORS; TYPE-1 INTEGRASE; BINDING-SITE; COFACTOR LEDGF/P75; VIRAL REPLICATION; IN-VIVO; PROTEIN; DOMAIN; IDENTIFICATION	HIV-1 integrase (IN) is the target for two classes of antiretrovirals: i) the integrase strand-transfer inhibitors (INSTIs) and ii) the non-catalytic site integrase inhibitors (NCINIs). NCINIs bind at the IN dimer interface and are thought to interfere primarily with viral DNA (vDNA) integration in the target cell by blocking IN-vDNA assembly as well as the IN-LEDGF/p75 interaction. Herein we show that treatment of virus-producing cells, but not of mature virions or target cells, drives NCINI antiviral potency. NCINIs target an essential late-stage event in HIV replication that is insensitive to LEDGF levels in the producer cells. Virus particles produced in the presence of NCINIs displayed normal Gag-Pol processing and endogenous reverse transcriptase activity, but were defective at initiating vDNA synthesis following entry into the target cell. NCINI-resistant virus carrying a T174I mutation in the IN dimer interface was less sensitive to the compound-induced late-stage effects, including the reverse transcription block. Wild-type, but not T174I virus, produced in the presence of NCINIs exhibited striking defects in core morphology and an increased level of IN oligomers that was not observed upon treatment of mature cell-free particles. Collectively, these results reveal that NCINIs act through a novel mechanism that is unrelated to the previously observed inhibition of IN activity or IN-LEDGF interaction, and instead involves the disruption of an IN function during HIV-1 core maturation and assembly.	[Balakrishnan, Mini; Yant, Stephen R.; Luong Tsai; O'Sullivan, Christopher; Bam, Rujuta A.; Tsai, Angela; Niedziela-Majka, Anita; Stray, Kirsten M.; Sakowicz, Roman; Cihlar, Tomas] Gilead Sci Inc, Foster City, CA 94404 USA	Gilead Sciences	Balakrishnan, M (corresponding author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.	mini.balakrishnan@gilead.com		Yant, Stephen R,/0000-0002-4444-7483	Gilead Sciences Inc.	Gilead Sciences Inc.(Gilead Sciences)	All authors of this manuscript are current employees of Gilead Sciences Inc. They are receiving regular compensation according to the company employment policies. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aiken Christopher, 2009, V485, P41, DOI 10.1007/978-1-59745-170-3_4; Al-Mawsawi LQ, 2007, TRENDS PHARMACOL SCI, V28, P526, DOI 10.1016/j.tips.2007.09.005; Al-Mawsawi LQ, 2006, P NATL ACAD SCI USA, V103, P10080, DOI 10.1073/pnas.0511254103; Briones MS, 2010, J VIROL, V84, P5181, DOI 10.1128/JVI.02382-09; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Challita-Eid PM, 1998, AIDS RES HUM RETROV, V14, P1617, DOI 10.1089/aid.1998.14.1617; Chamoun AM, 2012, ANTIMICROB AGENTS CH, V56, P672, DOI 10.1128/AAC.05722-11; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Christ F, 2012, ANTIMICROB AGENTS CH, V56, P4365, DOI 10.1128/AAC.00717-12; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Cooper DA, 2008, NEW ENGL J MED, V359, P355, DOI 10.1056/NEJMoa0708978; De Luca L, 2009, CHEMMEDCHEM, V4, P1311, DOI 10.1002/cmdc.200900070; De Rijck J, 2006, J VIROL, V80, P11498, DOI 10.1128/JVI.00801-06; Delelis O, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-114; Du L, 2008, ACTA PHARMACOL SIN, V29, P1261, DOI 10.1111/j.1745-7254.2008.00863.x; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; ENGELMAN A, 1995, J VIROL, V69, P2729, DOI 10.1128/JVI.69.5.2729-2736.1995; Engelman A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000046; Feng L, 2013, J BIOL CHEM, V288, P15813, DOI 10.1074/jbc.M112.443390; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Hehl EA, 2004, J VIROL, V78, P5056, DOI 10.1128/JVI.78.10.5056-5067.2004; Hu GP, 2012, J MED CHEM, V55, P10108, DOI 10.1021/jm301226a; Hung M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058035; Jones GS, 2009, ANTIMICROB AGENTS CH, V53, P1194, DOI 10.1128/AAC.00984-08; Jurado KA, 2013, P NATL ACAD SCI USA, V110, P8690, DOI 10.1073/pnas.1300703110; Kessl JJ, 2012, J BIOL CHEM, V287, P16801, DOI 10.1074/jbc.M112.354373; Kessl JJ, 2009, MOL PHARMACOL, V76, P824, DOI 10.1124/mol.109.058883; Kobayashi M, 2011, ANTIMICROB AGENTS CH, V55, P813, DOI 10.1128/AAC.01209-10; Linde ME, 2013, J PROTEOME RES, V12, P2045, DOI 10.1021/pr300918r; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Llano M, 2006, J MOL BIOL, V360, P760, DOI 10.1016/j.jmb.2006.04.073; Lu R, 2005, J VIROL, V79, P10356, DOI 10.1128/JVI.79.16.10356-10368.2005; Marozsan AJ, 2004, J VIROL, V78, P11130, DOI 10.1128/JVI.78.20.11130-11141.2004; Marshall HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001340; Min S, 2010, ANTIMICROB AGENTS CH, V54, P254, DOI 10.1128/AAC.00842-09; Molteni V, 2001, ACTA CRYSTALLOGR D, V57, P536, DOI 10.1107/S0907444901001652; Poeschla EM, 2008, CELL MOL LIFE SCI, V65, P1403, DOI 10.1007/s00018-008-7540-5; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; Quan YD, 1998, J MOL BIOL, V277, P237, DOI 10.1006/jmbi.1997.1592; Santos S, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-65; Schrijvers R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002558; Shimura Kazuya, 2009, Antiviral Chemistry & Chemotherapy, V20, P79, DOI 10.3851/IMP1397; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Steigbigel RT, 2008, NEW ENGL J MED, V359, P339, DOI 10.1056/NEJMoa0708975; Tsantrizos Y., 2009, Patent No. [WO2009/062285A1, 2009062285]; Tsantrizos Y. S., 2009, WO Patent, Patent No. [2009062289A1, 2009062289, WO 2,009,062,289 (A1)]; Tsantrizos YS, 2007, International patent, Patent No. [WO 2007/131350 A1, 2007131350, WO2007/131350A1, 2007131350 2007131350]; Tsiang M, 2012, J BIOL CHEM, V287, P21189, DOI 10.1074/jbc.M112.347534; Turlure F, 2006, NUCLEIC ACIDS RES, V34, P1653, DOI 10.1093/nar/gkl052; Vandekerckhove L, 2006, J VIROL, V80, P1886, DOI 10.1128/JVI.80.4.1886-1896.2006; YEE JK, 1994, METHOD CELL BIOL, V43, P99; Zhu K, 2004, J VIROL, V78, P5045, DOI 10.1128/JVI.78.10.5045-5055.2004; Zolopa AR, 2010, J INFECT DIS, V201, P814, DOI 10.1086/650698	55	99	105	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74163	10.1371/journal.pone.0074163	http://dx.doi.org/10.1371/journal.pone.0074163			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040198	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300163
J	Costa, P; Scales, TME; Ivaska, J; Parsons, M				Costa, Patricia; Scales, Tim M. E.; Ivaska, Johanna; Parsons, Maddy			Integrin-Specific Control of Focal Adhesion Kinase and RhoA Regulates Membrane Protrusion and Invasion	PLOS ONE			English	Article							GENE-EXPRESSION; CARCINOMA-CELLS; BREAST; BETA-1-INTEGRIN; METASTASIS; INHIBITION; MIGRATION; DYNAMICS; PROMOTES; FAK	Cell invasion through extracellular matrix (ECM) is a hallmark of the metastatic cascade. Cancer cells require adhesion to surrounding tissues for efficient migration to occur, which is mediated through the integrin family of receptors. Alterations in expression levels of beta 1 and beta 3 integrins have previously been reported in a number of human cancers. However, whether there are specific roles for these ubiquitous receptors in mediating cell invasion remains unclear. Here we demonstrate that loss of beta 1 but not beta 3 integrins leads to increased spread cell area and focal adhesion number in cells on 2D immobilized fibronectin. Increased adhesion numbers in beta 1 knockdown cells correlated with decreased cell migration on 2D surfaces. Conversely, cells depleted of beta 1 integrins showed increased migration speed on 3D cell-derived matrix as well as in 3D organotypic cultures and inverted invasion assays. This increased invasive potential was also seen in cells lacking beta 3 integrin but only in 3D cultures containing fibroblasts. Mechanistically, in situ analysis using FRET biosensors revealed that enhanced invasion in cells lacking beta 1 integrins was directly coupled with reduced activation of focal adhesion kinase (FAK) and the small GTPase RhoA resulting in formation of enhanced dynamic protrusions and increased invasion. These reductions in FAK-RhoA signal activationwere not detected in beta 3 knockdown cells under the same conditions. This data demonstrates a specific role for beta 1 integrins in the modulation of a FAK-RhoA-actomyosin signaling axis to regulate cell invasion through complex ECM environments.	[Costa, Patricia; Scales, Tim M. E.; Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London, England; [Ivaska, Johanna] VTT Tech Res Ctr Finland, Turku, Finland; [Ivaska, Johanna] Univ Turku, Ctr Biotechnol, Turku, Finland	University of London; King's College London; VTT Technical Research Center Finland; University of Turku	Parsons, M (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, London, England.	maddy.parsons@kcl.ac.uk	Parsons, Maddy/B-2203-2013	Parsons, Maddy/0000-0002-2021-8379; Ivaska, Johanna/0000-0002-6295-6556	Royal Society; Fundacao para a Ciencia e a Tecnologia (FCT); Cancer Research UK [A9503]	Royal Society(Royal Society of London); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Cancer Research UK(Cancer Research UK)	The authors would like to thank Nymeth Ali, Sabari Vallath and John Marshall for help with organotypic cultures and the Royal Society, Fundacao para a Ciencia e a Tecnologia (FCT) and Cancer Research UK (#A9503) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Baldassarre M, 2003, MOL BIOL CELL, V14, P1074, DOI 10.1091/mbc.E02-05-0308; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bradley WD, 2006, MOL BIOL CELL, V17, P4827, DOI 10.1091/mbc.E06-02-0132; Brakebusch C, 1999, ONCOGENE, V18, P3852, DOI 10.1038/sj.onc.1202770; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Calderwood DA, 2004, J BIOL CHEM, V279, P28889, DOI 10.1074/jbc.M402161200; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Caswell PT, 2008, J CELL BIOL, V183, P143, DOI 10.1083/jcb.200804140; Chan KT, 2009, J CELL BIOL, V185, P357, DOI 10.1083/jcb.200809110; Danen EHJ, 2005, J CELL BIOL, V169, P515, DOI 10.1083/jcb.200412081; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hodivala-Dilke KM, 1998, J CELL BIOL, V142, P1357, DOI 10.1083/jcb.142.5.1357; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kappert K, 2009, INT J BIOCHEM CELL B, V41, P1511, DOI 10.1016/j.biocel.2009.01.004; King SJ, 2011, EMBO J, V30, P1705, DOI 10.1038/emboj.2011.82; Koskinen K, 2004, BLOOD, V103, P3388, DOI 10.1182/blood-2003-09-3275; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lichtner RB, 1998, EXP CELL RES, V240, P368, DOI 10.1006/excr.1998.4012; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Matthews HK, 2008, DEVELOPMENT, V135, P1771, DOI 10.1242/dev.017350; Morozevich G, 2009, CELL CYCLE, V8, P2219, DOI 10.4161/cc.8.14.8980; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Nystrom ML, 2005, J PATHOL, V205, P468, DOI 10.1002/path.1716; Papusheva E, 2009, J CELL SCI, V122, P656, DOI 10.1242/jcs.028738; Parsons M, 2008, J CELL SCI, V121, P265, DOI 10.1242/jcs.018440; Ramsay AG, 2007, CANCER RES, V67, P5275, DOI 10.1158/0008-5472.CAN-07-0318; Rathinam R, 2010, CANCER METAST REV, V29, P223, DOI 10.1007/s10555-010-9211-x; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Sakai K, 2011, STRUCT CONCRETE, V12, P3; Sameni M, 2008, MOL IMAGING, V7, P199, DOI 10.2310/7290.2008.00019; Sarmiento C, 2008, J CELL BIOL, V180, P1245, DOI 10.1083/jcb.200708123; Scales TM, 2012, ONCOGENE; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Starnes TW, 2011, METHODS MOL BIOL, V769, P111, DOI 10.1007/978-1-61779-207-6_9; Stokes JB, 2011, MOL CANCER THER, V10, P2135, DOI 10.1158/1535-7163.MCT-11-0261; Takino T, 2007, CANCER RES, V67, P11621, DOI 10.1158/0008-5472.CAN-07-5251; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; Wolf K, 2009, CLIN EXP METASTAS, V26, P289, DOI 10.1007/s10585-008-9190-2; Worth DC, 2010, J CELL BIOL, V189, P369, DOI 10.1083/jcb.200912014; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Yu HG, 2011, CANCER RES, V71, P360, DOI 10.1158/0008-5472.CAN-10-2894; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183; Zhai JB, 2003, J BIOL CHEM, V278, P24865, DOI 10.1074/jbc.M302381200; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	53	35	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74659	10.1371/journal.pone.0074659	http://dx.doi.org/10.1371/journal.pone.0074659			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040310	gold, Green Submitted, Green Published			2022-12-25	WOS:000326405300187
J	Song, Y; Zhao, XP; Song, K; Shang, ZJ				Song, Yong; Zhao, Xiao-Ping; Song, Kai; Shang, Zheng-Jun			Ephrin-A1 Is Up-Regulated by Hypoxia in Cancer Cells and Promotes Angiogenesis of HUVECs through a Coordinated Cross-Talk with eNOS	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ENDOTHELIAL GROWTH-FACTOR; TUMOR ANGIOGENESIS; EPHA2 RECEPTOR; IN-VIVO; ACTIVATION; EXPRESSION; PROGRESSION; VEGF; PHOSPHORYLATION	Hypoxia, ephrin-A1 and endothelial nitric oxide synthase (eNOS) have been proved to play critical roles in tumor angiogenesis. However, how ephrin-A1 is regulated by hypoxia and whether ephrin-A1 cooperates with eNOS in modulation of angiogenesis remain to be addressed in details. Here we demonstrated that both ephrin-A1 in squamous cell carcinoma cells (SCC-9) and especially soluble ephrin-A1 in the supernatants were up-regulated under hypoxic condition. An increased nitric oxide (NO) production in human umbilical vein endothelial cells (HUVECs) was observed in ephrin-A1-induced angiogenesis which was reversed after co-culture with eNOS specific inhibitor, N-nitro-L-arginine methyl ester hydrochloride (L-NAME). Western blot analysis confirmed that both phosphorylation of Akt(Ser473) and eNOS(Ser1177) were up-regulated in ephrin-A1-stimulated HUVECs, with the total eNOS expression unchanged. The specific inhibitor of phosphatidylinositol 3-kinase (PI3K), LY294002, significantly down-regulated ephrin-A1-induced expression of phosphorylated Akt(Ser473) as well as phosphorylation of eNOS(Ser1177). These results revealed a possible novel mechanism whereby ephrin-A1 is regulated in tumor microenvironment and promotes angiogenesis through a coordinated cross-talk with PI3K/Akt-dependent eNOS activation which may relate to normal vascular development and tumor neovascularization.	[Song, Yong; Zhao, Xiao-Ping; Song, Kai; Shang, Zheng-Jun] Wuhan Univ, Minist Educ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430072, Peoples R China; [Song, Yong; Zhao, Xiao-Ping; Song, Kai; Shang, Zheng-Jun] Wuhan Univ, Minist Educ, Key Lab Oral Biomed, Wuhan 430072, Peoples R China; [Shang, Zheng-Jun] Wuhan Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial Head & Neck Oncol, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Shang, ZJ (corresponding author), Wuhan Univ, Minist Educ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430072, Peoples R China.	shangzhengjun@hotmail.com			National Natural Science Foundation of China [81172570, 30872893]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81172570 and No. 30872893). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker T, 2003, CELL TISSUE RES, V314, P145, DOI 10.1007/s00441-003-0763-8; Beauchamp A, 2012, MOL CELL BIOL, V32, P3253, DOI 10.1128/MCB.06791-11; Beauchamp Debinski W, 2011, SEMINARS CELL DEV BI, V23, P109; Brantley DM, 2002, ONCOGENE, V21, P7011, DOI 10.1038/sj.onc.1205679; Brantley-Sieders DM, 2006, CANCER RES, V66, P10315, DOI 10.1158/0008-5472.CAN-06-1560; Brantley-Sieders DM, 2004, J CELL SCI, V117, P2037, DOI 10.1242/jcs.01061; Cale JM, 2006, BIOCHEM J, V398, P279, DOI 10.1042/BJ20060371; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen G, 2013, CARDIOVASC RES, V98, P437, DOI 10.1093/cvr/cvt035; Cheng N, 2002, CYTOKINE GROWTH F R, V13, P75, DOI 10.1016/S1359-6101(01)00031-4; Cheng N, 2001, J BIOL CHEM, V276, P13771, DOI 10.1074/jbc.M009147200; Cui XD, 2010, INT J CANCER, V126, P940, DOI 10.1002/ijc.24798; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Gallo O, 1998, J NATL CANCER I, V90, P587, DOI 10.1093/jnci/90.8.587; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Izumi Y, 2002, NATURE, V416, P279, DOI 10.1038/416279b; Le QT, 2007, INT J RADIAT ONCOL, V69, P167, DOI 10.1016/j.ijrobp.2007.01.071; Liu W, 2000, APOPTOSIS, V5, P323, DOI 10.1023/A:1009679307513; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; Namkoong S, 2009, CELL SIGNAL, V21, P906, DOI 10.1016/j.cellsig.2009.01.038; Ongusaha PP, 2004, CANCER RES, V64, P5283, DOI 10.1158/0008-5472.CAN-04-0925; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Pratt RL, 2002, ONCOGENE, V21, P7690, DOI 10.1038/sj.onc.1205758; Saharinen P, 2011, TRENDS MOL MED, V17, P347, DOI 10.1016/j.molmed.2011.01.015; Saik JE, 2011, BIOMACROMOLECULES, V12, P2715, DOI 10.1021/bm200492h; Sbaa E, 2005, TRENDS CARDIOVAS MED, V15, P157, DOI 10.1016/j.tcm.2005.05.006; Sessa WC, 2004, J CELL SCI, V117, P2427, DOI 10.1242/jcs.01165; Shao Z, 2008, ORAL ONCOL, V44, P1110, DOI 10.1016/j.oraloncology.2008.01.018; Shi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040365; Uemura M, 2010, CLIN CANCER RES, V16, P4636, DOI 10.1158/1078-0432.CCR-10-0407; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Vihanto MM, 2005, FASEB J, V19, P1689, DOI 10.1096/fj.04-3647fje; Wykosky J, 2005, MOL CANCER RES, V3, P541, DOI 10.1158/1541-7786.MCR-05-0056; Wykosky J, 2008, ONCOGENE, V27, P7260, DOI 10.1038/onc.2008.328; Yamashita T, 2008, J BIOL CHEM, V283, P18926, DOI 10.1074/jbc.M709133200; Zhuang GL, 2007, J BIOL CHEM, V282, P2683, DOI 10.1074/jbc.M608509200	41	19	21	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74464	10.1371/journal.pone.0074464	http://dx.doi.org/10.1371/journal.pone.0074464			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040255	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300174
J	Degletagne, C; Roussel, D; Rouanet, JL; Baudimont, F; Moureaux, EM; Harvey, S; Duchamp, C; Le Maho, Y; Raccurt, M				Degletagne, Cyril; Roussel, Damien; Rouanet, Jean Louis; Baudimont, Fanny; Moureaux, Elodie-Marie; Harvey, Steve; Duchamp, Claude; Le Maho, Yvon; Raccurt, Mireille			Growth Prior to Thermogenesis for a Quick Fledging of Adelie Penguin Chicks (Pygoscelis adeliae)	PLOS ONE			English	Article							AVIAN UNCOUPLING PROTEIN; SKELETAL-MUSCLE; MESSENGER-RNA; TRANSCRIPTIONAL COACTIVATOR; PROTON CONDUCTANCE; SHOREBIRD CHICKS; SATELLITE CELLS; UP-REGULATION; SLOW-TWITCH; FACTOR-I	The evolutionary trade-off between tissue growth and mature function restricts the post natal development of polar birds. The present study uses an original integrative approach as it includes gene expression, plus biochemical and physiological analysis to investigate how Adelie penguin chicks achieve a rapid growth despite the energetic constraints linked to the cold and the very short breeding season in Antarctica. In pectoralis muscle, the main thermogenic tissue in birds, our data show that the transition from ectothermy to endothermy on Day 15 post-hatching is associated with substantial and coordinated changes in the transcription of key genes. While the early activation of genes controlling cell growth and differentiation (avGHR, avIGF-1R, T3R beta) is rapidly down-regulated after hatching, the global increase in the relative expression of genes involved in thermoregulation (avUCP, avANT, avLPL) and transcriptional regulation (avPGC1 alpha, avT3R beta) underlie the muscular acquisition of oxidative metabolism. Adelie chicks only become real endotherms at 15 days of age with the development of an oxidative muscle phenotype and the ability to shiver efficiently. The persistent muscular expression of IGF-1 throughout growth probably acts as a local mediator to adjust muscle size and its oxidative capacity to anticipate the new physiological demands of future Dives in cold water. The up-regulation of T3R beta mRNA levels suggests that circulating T3 may play an important role in the late maturation of skeletal muscle by reinforcing, at least in part, the paracrine action of IGF-1. From day 30, the metabolic shift from mixed substrate to lipid metabolism, with the markedly increased mRNA levels of muscle avLPL, avANT and avUCP, suggests the late development of a fatty acid-enhanced muscle non-shivering thermogenesis mechanism. This molecular control is the key to this finely-tuned strategy by which the Adelie penguin chick successfully heads for the sea on schedule.	[Degletagne, Cyril; Roussel, Damien; Rouanet, Jean Louis; Baudimont, Fanny; Moureaux, Elodie-Marie; Duchamp, Claude; Raccurt, Mireille] Univ Lyon 1, Lab Ecol Hydrosyst Nat & Anthropises, UMR5023, F-69622 Villeurbanne, France; [Harvey, Steve] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Le Maho, Yvon] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Alberta; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Raccurt, M (corresponding author), Univ Lyon 1, Lab Ecol Hydrosyst Nat & Anthropises, UMR5023, F-69622 Villeurbanne, France.	mireille.raccurt@univ-lyon1.fr		Roussel, Damien/0000-0002-8865-5428	french polar Institute; french Ministere de l'Enseignement Superieur et de la Recherche	french polar Institute; french Ministere de l'Enseignement Superieur et de la Recherche	This work was financially supported by the french polar Institute. C. Degletagne was a receipt of a fellowship from the french Ministere de l'Enseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRE H, 1985, AM J PHYSIOL, V249, pR533, DOI 10.1152/ajpregu.1985.249.5.R533; Bezaire V, 2007, FASEB J, V21, P312, DOI 10.1096/fj.06-6966rev; BUCHER TL, 1990, RESP PHYSIOL, V82, P369, DOI 10.1016/0034-5687(90)90106-9; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; Collin A, 2005, DOMEST ANIM ENDOCRIN, V29, P78, DOI 10.1016/j.domaniend.2005.02.007; Collin A, 2003, AM J PHYSIOL-ENDOC M, V284, pE771, DOI 10.1152/ajpendo.00478.2002; Collin A, 2003, GEN COMP ENDOCR, V130, P70, DOI 10.1016/S0016-6480(02)00571-3; DECUYPERE E, 1987, REPROD NUTR DEV, V27, P555, DOI 10.1051/rnd:19870414; Dietz MW, 1997, PHYSIOL ZOOL, V70, P502, DOI 10.1086/515859; DUCHAMP C, 1991, AM J PHYSIOL, V261, pR1438, DOI 10.1152/ajpregu.1991.261.6.R1438; Duchamp C, 2002, COMP BIOCHEM PHYS A, V131, P765, DOI 10.1016/S1095-6433(02)00014-4; Duclos M J, 2005, J Physiol Pharmacol, V56 Suppl 3, P25; DUCLOS MJ, 1991, J ENDOCRINOL, V128, P35, DOI 10.1677/joe.0.1280035; Guernec A, 2003, GROWTH HORM IGF RES, V13, P8, DOI 10.1016/S1096-6374(02)00136-3; Halevy O, 1996, GEN COMP ENDOCR, V101, P43, DOI 10.1006/gcen.1996.0006; HILL RW, 1982, PHYSIOL ZOOL, V55, P250, DOI 10.1086/physzool.55.3.30157889; Hirabayashi M, 2005, ENDOCRINOLOGY, V146, P399, DOI 10.1210/en.2004-0723; Hull KL, 1998, J ENDOCRINOL, V156, P323, DOI 10.1677/joe.0.1560323; King J. R., 1961, BIOL COMP PHYSL BIRD, P215, DOI 10.1016/B978-1-4832-3143-3.50014-9.; Krijgsveld KL, 2001, PHYSIOL BIOCHEM ZOOL, V74, P250, DOI 10.1086/319655; Kuhn ER, 2002, COMP BIOCHEM PHYS B, V132, P299, DOI 10.1016/S1096-4959(02)00037-4; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Mao JNC, 1998, J ENDOCRINOL, V156, P67, DOI 10.1677/joe.0.1560067; Marsh RL, 1982, AM J PHYSIOL-REG I, V242, P563; Olson JM, 2001, J COMP PHYSIOL B, V171, P527; Price ER, 2011, J EXP BIOL, V214, P2823, DOI 10.1242/jeb.057620; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Raccurt M, 2008, AM J PHYSIOL-REG I, V295, pR1671, DOI 10.1152/ajpregu.90371.2008; Rey Benjamin, 2010, BMC Physiology, V10, P5, DOI 10.1186/1472-6793-10-5; Ricklefs R.E., 1983, P1; RICKLEFS RE, 1985, AUK, V102, P369, DOI 10.2307/4086781; RICKLEFS RE, 1994, EVOLUTION, V48, P1080, DOI 10.1111/j.1558-5646.1994.tb05295.x; RICKLEFS RE, 1979, BIOL REV, V54, P269, DOI 10.1111/j.1469-185X.1979.tb01013.x; RICKLEFS RE, 1973, IBIS, V115, P177, DOI 10.1111/j.1474-919X.1973.tb02636.x; Ricklefs Robert E., 1998, Oxford Ornithology Series, V8, P266; Roussel D, 2000, FEBS LETT, V477, P141, DOI 10.1016/S0014-5793(00)01790-7; SCANES CG, 1981, LIFE SCI, V28, P2895, DOI 10.1016/0024-3205(81)90264-2; Scanes CG, 2009, GEN COMP ENDOCR, V163, P24, DOI 10.1016/j.ygcen.2009.04.013; Schekkerman H, 2003, OECOLOGIA, V134, P332, DOI 10.1007/s00442-002-1124-0; SCHOLANDER PF, 1950, BIOL BULL, V99, P237, DOI 10.2307/1538741; SUN SS, 1992, COMP BIOCHEM PHYS A, V102, P235, DOI 10.1016/0300-9629(92)90127-C; SUZUKI A, 1985, J MORPHOL, V185, P145, DOI 10.1002/jmor.1051850202; Talbot DA, 2004, J PHYSIOL-LONDON, V558, P123, DOI 10.1113/jphysiol.2004.063768; Talbot DA, 2003, BIOCHEM BIOPH RES CO, V312, P983, DOI 10.1016/j.bbrc.2003.11.022; Teulier L, 2010, J EXP BIOL, V213, P2476, DOI 10.1242/jeb.043489; Toyomizu M, 2002, FEBS LETT, V529, P313, DOI 10.1016/S0014-5793(02)03395-1; Ueda M, 2005, FEBS LETT, V579, P11, DOI 10.1016/j.febslet.2004.11.039; VasilatosYounken R, 1997, GEN COMP ENDOCR, V105, P31, DOI 10.1006/gcen.1996.6795; VOLKMAN NJ, 1980, J ZOOL, V191, P521; Weber JM, 2009, J EXP BIOL, V212, P593, DOI 10.1242/jeb.015024; Williams JB, 2007, PHYSIOL BIOCHEM ZOOL, V80, P500, DOI 10.1086/520126	51	13	13	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e74154	10.1371/journal.pone.0074154	http://dx.doi.org/10.1371/journal.pone.0074154			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040194	gold, Green Published, Green Submitted			2022-12-25	WOS:000324856500078
J	Gober, V; Hohl, A; Gahl, B; Dick, F; Eigenmann, V; Carrel, TP; Tevaearai, HT				Goeber, Volkhard; Hohl, Andreas; Gahl, Brigitta; Dick, Florian; Eigenmann, Verena; Carrel, Thierry P.; Tevaearai, Hendrik T.			Early Troponin T and Prediction of Potentially Correctable In-Hospital Complications after Coronary Artery Bypass Grafting Surgery	PLOS ONE			English	Article							CREATINE-KINASE-MB; MYOCARDIAL-INFARCTION; CARDIAC-SURGERY; PROGNOSTIC VALUE; EARLY-DIAGNOSIS; MORTALITY; DYSFUNCTION; INOTROPE; TERM	Background: Peak levels of troponin T (TnT) reliably predict morbidity and mortality after cardiac surgery. However, the therapeutic window to manage CABG-related in-hospital complications may close before the peak is reached. We investigated whether early TnT levels correlate as well with complications after coronary artery bypass grafting (CABG) surgery. Methods: A 12 month consecutive series of patients undergoing elective isolated CABG procedures (mini-extracorporeal circuit, Cardioplegic arrest) was analyzed. Logistic regression modeling was used to investigate whether TnT levels 6 to 8 hours after surgery were independently associated with in-hospital complications (either postoperative myocardial infarction, stroke, new-onset renal insufficiency, intensive care unit (ICU) readmission, prolonged ICU stay (> 48 hours), prolonged need for vasopressors (> 24 hours), resuscitation or death). Results: A total of 290 patients, including 36 patients with complications, was analyzed. Early TnT levels (odds ratio (OR): 6.8, 95% confidence interval (CI): 2.2-21.4, P=.001), logistic EuroSCORE (OR: 1.2, 95% CI: 1.0-1.3, P=.007) and the need for vasopressors during the first 6 postoperative hours (OR: 2.7, 95% CI: 1.0-7.1, P=.05) were independently associated with the risk of complications. With consideration of vasopressor use during the first 6 postoperative hours, the sum of specificity (0.958) and sensitivity (0.417) of TnT for subsequent complications was highest at a TnT cut-off value of 0.8 ng/mL. Conclusion: Early TnT levels may be useful to guide ICU management of CABG patients. They predict clinically relevant complications within a potential therapeutic window, particularly in patients requiring vasopressors during the first postoperative hours, although with only moderate sensitivity.	[Dick, Florian] Univ Hosp Bern, Dept Cardiovasc Surg, Inselspital, CH-3010 Bern, Switzerland; Univ Bern, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern	Dick, F (corresponding author), Univ Hosp Bern, Dept Cardiovasc Surg, Inselspital, CH-3010 Bern, Switzerland.	florian.dick@insel.ch	Carrel, Thierry/AAI-5910-2021	Dick, Florian/0000-0003-1561-2619				Aarones M, 2011, AM HEART J, V161, P1031, DOI 10.1016/j.ahj.2010.09.021; Buse GAL, 2010, EUR J CARDIO-THORAC, V37, P399, DOI 10.1016/j.ejcts.2009.05.054; Carrier M, 2000, ANN THORAC SURG, V69, P435, DOI 10.1016/S0003-4975(99)01294-1; Fransen EJ, 2002, CHEST, V122, P1316, DOI 10.1378/chest.122.4.1316; Immer FF, 2007, ANN THORAC SURG, V84, P1515, DOI 10.1016/j.athoracsur.2007.05.069; Kathiresan S, 2004, AM J CARDIOL, V94, P879, DOI 10.1016/j.amjcard.2004.06.022; Keller T, 2009, NEW ENGL J MED, V361, P868, DOI 10.1056/NEJMoa0903515; Lehrke S, 2004, CLIN CHEM, V50, P1560, DOI 10.1373/clinchem.2004.031468; Majak P, 2012, SCAND CARDIOVASC J, V46, P99, DOI 10.3109/14017431.2011.649489; Mohammed AA, 2009, CIRCULATION, V120, P843, DOI 10.1161/CIRCULATIONAHA.108.837278; Muehlschlegel JD, 2010, ANESTH ANALG, V111, P1101, DOI 10.1213/ANE.0b013e3181dd9516; Nesher N, 2008, ANN THORAC SURG, V85, P1348, DOI 10.1016/j.athoracsur.2007.12.077; Ong ATL, 2006, AM HEART J, V151, P1194, DOI 10.1016/j.ahj.2005.07.017; Peivandi AA, 2004, HERZ, V29, P658, DOI 10.1007/s00059-004-2543-y; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Shahin J, 2011, CRIT CARE, V15, DOI 10.1186/cc10302; Soraas CL, 2012, AM HEART J, V164, P779, DOI 10.1016/j.ahj.2012.05.027; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Vikenes K, 2010, AM J CARDIOL, V106, P780, DOI 10.1016/j.amjcard.2010.04.038; White HD, 2011, J AM COLL CARDIOL, V57, P2406, DOI 10.1016/j.jacc.2011.01.029; Williams JB, 2011, J CARDIAC SURG, V26, P572, DOI 10.1111/j.1540-8191.2011.01301.x	21	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e74241	10.1371/journal.pone.0074241	http://dx.doi.org/10.1371/journal.pone.0074241			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040214	Green Submitted, Green Published, gold			2022-12-25	WOS:000324856500080
J	Wang, HB; Jiang, YC; Shi, D; Quilliam, LA; Chrzanowska-Wodnicka, M; Wittchen, ES; Li, DY; Hartnett, ME				Wang, Haibo; Jiang, Yanchao; Shi, Dallas; Quilliam, Lawrence A.; Chrzanowska-Wodnicka, Magdalena; Wittchen, Erika S.; Li, Dean Y.; Hartnett, M. Elizabeth			Activation of Rap1 inhibits NADPH oxidase-dependent ROS generation in retinal pigment epithelium and reduces choroidal neovascularization	FASEB JOURNAL			English	Article						barrier integrity; GTPase-activating proteins; p22phox; p47phox; NOX4	ENDOTHELIAL-CELL TRANSMIGRATION; MACULAR DEGENERATION; JUNCTIONAL INTEGRITY; PROTEIN; RPE; PHOSPHORYLATION; PATHOGENESIS; ASSOCIATION; VARIANT; BINDING	Activation of Rap1 GTPase can improve the integrity of the barrier of the retina pigment epithelium (RPE) and reduce choroidal neovascularization (CNV). Inhibition of NADPH oxidase activation also reduces CNV. We hypothesize that Rap1 inhibits NADPH oxidase-generated ROS and thereby reduces CNV formation. Using a murine model of laser-induced CNV, we determined that reduced Rap1 activity in RPE/choroid occurred with CNV formation and that activation of Rap1 by 2-O-Me-cAMP (8CPT)-reduced laser-induced CNV via inhibiting NADPH oxidase-generated ROS. In RPE, inhibition of Rap1 by Rap1 GTPase-activating protein (Rap1GAP) increased ROS generation, whereas activation of Rap1 by 8CPT reduced ROS by interfering with the assembly of NADPH oxidase membrane subunit p22phox with NOX4 or cytoplasmic subunit p47phox. Activation of NADPH oxidase with Rap1GAP reduced RPE barrier integrity via cadherin phosphorylation and facilitated choroidal EC migration across the RPE monolayer. Rap1GAP-induced ROS generation was inhibited by active Rap1a, but not Rap1b, and activation of Rap1a by 8CPT in Rap1b(-/-) mice reduced laser-induced CNV, in correlation with decreased ROS generation in RPE/choroid. These findings provide evidence that active Rap1 reduces CNV by interfering with the assembly of NADPH oxidase subunits and increasing the integrity of the RPE barrier.Wang, H., Jiang, Y., Shi, D., Quilliam, L. A., Chrzanowska-Wodnicka, M., Wittchen, E. S., Li, D. Y., Hartnett, M. E. Activation of Rap1 inhibits NADPH oxidase-dependent ROS generation in retinal pigment epithelium and reduces choroidal neovascularization.	[Wang, Haibo; Jiang, Yanchao; Hartnett, M. Elizabeth] Univ Utah, John A Moran Eye Ctr, Salt Lake City, UT 84132 USA; [Shi, Dallas; Li, Dean Y.] Univ Utah, Dept Cell & Dev Biol, Salt Lake City, UT 84132 USA; [Quilliam, Lawrence A.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Chrzanowska-Wodnicka, Magdalena] Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI USA; [Wittchen, Erika S.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Indiana University System; Indiana University Bloomington; Versiti Blood Center of Wisconsin; University of North Carolina; University of North Carolina Chapel Hill	Hartnett, ME (corresponding author), Univ Utah, John A Moran Eye Ctr, 65 N Mario Capecchi Dr, Salt Lake City, UT 84132 USA.	me.hartnett@hsc.utah.edu	Quilliam, Lawrence/B-6447-2015; Quilliam, Lawrence/Q-4987-2019	Chrzanowska, Magdalena/0000-0003-4182-2126	U.S. National Institutes of Health (NIH)/National Eye Institute [R01 R01-EY015130, R01-EY017011]; NIH [R01HL111582]; American Heart Association [10SDG3430042]; NATIONAL EYE INSTITUTE [R01EY015130, P30EY014800, R01EY017011] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111582] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by U.S. National Institutes of Health (NIH)/National Eye Institute grants R01 R01-EY015130 and R01-EY017011 (M. E. H.), NIH grant R01HL111582 (M.C.-W.), and American Heart Association grant 10SDG3430042 (E.S.W.).	Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Bailey TA, 2004, INVEST OPHTH VIS SCI, V45, P675, DOI 10.1167/iovs.03-0351; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bhutto IA, 2006, EXP EYE RES, V82, P99, DOI 10.1016/j.exer.2005.05.007; Bird AC, 2010, J CLIN INVEST, V120, P3033, DOI 10.1172/JCI42437; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; BOKOCH GM, 1991, SCIENCE, V254, P1794, DOI 10.1126/science.1763330; Bressler NM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1621; Campbell M, 2013, ADV EXP MED BIOL, V763, P70; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Chrzanowska-Wodnicka M, 2013, EXP CELL RES, V319, P2350, DOI 10.1016/j.yexcr.2013.07.022; Clark SJ, 2006, J BIOL CHEM, V281, P24713, DOI 10.1074/jbc.M605083200; Costa RA, 2006, INVEST OPHTH VIS SCI, V47, P4569, DOI 10.1167/iovs.06-0433; Despriet DDG, 2006, JAMA-J AM MED ASSOC, V296, P301, DOI 10.1001/jama.296.3.301; Dunaief JL, 2006, INVEST OPHTH VIS SCI, V47, P4660, DOI 10.1167/iovs.06-0568; Gehrs KM, 2006, ANN MED, V38, P450, DOI 10.1080/07853890600946724; Kalayoglu MV, 2005, GRAEF ARCH CLIN EXP, V243, P1080, DOI 10.1007/s00417-005-1169-y; Katsube T, 2007, BBA-MOL CELL RES, V1773, P794, DOI 10.1016/j.bbamcr.2007.03.002; Kim JH, 2012, INT J BIOCHEM CELL B, V44, P808, DOI 10.1016/j.biocel.2012.02.005; King A, 2004, PHOTOCHEM PHOTOBIOL, V79, P470, DOI 10.1562/LE-03-17.1; Klenotic PA, 2004, J BIOL CHEM, V279, P30469, DOI 10.1074/jbc.M403026200; Li QH, 2008, MOL THER, V16, P1688, DOI 10.1038/mt.2008.164; Li Y, 2007, J IMMUNOL, V179, P8322, DOI 10.4049/jimmunol.179.12.8322; Liu JJ, 2011, MOL BIOL CELL, V22, P2509, DOI 10.1091/mbc.E11-02-0157; MALY FE, 1994, J BIOL CHEM, V269, P18743; McLeod DS, 2002, INVEST OPHTH VIS SCI, V43, P1986; Mettu PS, 2012, MOL ASPECTS MED, V33, P376, DOI 10.1016/j.mam.2012.04.006; Monaghan-Benson E, 2010, AM J PATHOL, V177, P2091, DOI 10.2353/ajpath.2010.090878; Noda K, 2010, MOL BIOL CELL, V21, P584, DOI 10.1091/mbc.E09-07-0580; Peng SM, 2011, INVEST OPHTH VIS SCI, V52, P1392, DOI 10.1167/iovs.10-5984; Peterson LJ, 2007, EXP EYE RES, V84, P737, DOI 10.1016/j.exer.2006.12.012; Petronio MS, 2013, MOLECULES, V18, P2821, DOI 10.3390/molecules18032821; QUINN MT, 1989, NATURE, V342, P198, DOI 10.1038/342198a0; QUINN MT, 1995, METHOD ENZYMOL, V255, P476; Rizzolo LJ, 2011, PROG RETIN EYE RES, V30, P296, DOI 10.1016/j.preteyeres.2011.06.002; Sallee JL, 2006, J BIOL CHEM, V281, P16189, DOI 10.1074/jbc.R600003200; Santulli RJ, 2008, J PHARMACOL EXP THER, V324, P894, DOI 10.1124/jpet.107.131656; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P774, DOI 10.1001/archopht.123.6.774; Seddon JM, 2007, JAMA-J AM MED ASSOC, V297, P1793, DOI 10.1001/jama.297.16.1793; Seddon JM, 2006, HUM HERED, V61, P157, DOI 10.1159/000094141; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; Thurman JM, 2009, J BIOL CHEM, V284, P16939, DOI 10.1074/jbc.M808166200; van Buul JD, 2005, J BIOL CHEM, V280, P21129, DOI 10.1074/jbc.M500898200; Vikstrom E, 2009, EXP CELL RES, V315, P313, DOI 10.1016/j.yexcr.2008.10.044; Wang H, 2011, EYE BRAIN, V3, P19, DOI 10.2147/EB.S24951; Wang H, 2011, INVEST OPHTH VIS SCI, V52, P570, DOI 10.1167/iovs.10-5595; Wilkinson-Berka JL, 2013, CLIN SCI, V124, P597, DOI 10.1042/CS20120212; Wittchen E. S., 2013, PLOS ONE IN PRESS; Wittchen Erika S, 2011, Small GTPases, V2, P65; Wittchen ES, 2011, INVEST OPHTH VIS SCI, V52, P7455, DOI 10.1167/iovs.11-7295; Wittchen ES, 2005, J BIOL CHEM, V280, P11675, DOI 10.1074/jbc.M412595200; Xu HZ, 2011, INVEST OPHTH VIS SCI, V52, P2160, DOI 10.1167/iovs.10-6518; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103	55	20	22	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					265	274		10.1096/fj.13-240028	http://dx.doi.org/10.1096/fj.13-240028			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24043260	Green Published			2022-12-25	WOS:000333526100026
J	Maddur, AA; Swanson, R; Izaguirre, G; Gettins, PGW; Olson, ST				Maddur, Ashoka A.; Swanson, Richard; Izaguirre, Gonzalo; Gettins, Peter G. W.; Olson, Steven T.			Kinetic Intermediates en Route to the Final Serpin-Protease Complex STUDIES OF COMPLEXES OF alpha(1)-PROTEASE INHIBITOR WITH TRYPSIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; PROTEINASE COMPLEX; CONFORMATIONAL-CHANGE; MICHAELIS COMPLEX; COVALENT COMPLEX; MECHANISM; PITTSBURGH; ANTITHROMBIN; DEFORMATION; DISTORTION	Serpin protein protease inhibitors inactivate their target proteases through a unique mechanism in which a major serpin conformational change, resulting in a 70-angstrom translocation of the protease from its initial reactive center loop docking site to the opposite pole of the serpin, kinetically traps the acyl-intermediate complex. Although the initial Michaelis and final trapped acyl-intermediate complexes have been well characterized structurally, the intermediate stages involved in this remarkable transformation are not well understood. To better characterize such intermediate steps, weundertook rapid kinetic studies of the FRET and fluorescence perturbation changes of site-specific fluorophore-labeled derivatives of the serpin, alpha(1)-protease inhibitor (alpha 1PI), which report the serpin and protease conformational changes involved in transforming the Michaelis complex to the trapped acyl-intermediate complex in reactions with trypsin. Two kinetically resolvable conformational changes were observed in the reactions, ascribable to (i) serpin reactive center loop insertion into sheet A with full protease translocation but incomplete protease distortion followed by, (ii) full conformational distortion and movement of the protease and coupled serpin conformational changes involving the F helix-sheet A interface. Kinetic studies of calcium effects on the labeled alpha 1PI-trypsin reactions demonstrated both inactive and low activity states of the distorted protease in the final complex that were distinct from the intermediate distorted state. These studies provide new insights into the nature of the serpin and protease conformational changes involved in trapping the acyl-intermediate complex in serpin-protease reactions and support a previously proposed role for helix F in the trapping mechanism.	Univ Illinois, Ctr Mol Biol Oral Dis, Chicago, IL 60612 USA; Univ Illinois, Dept Periodont, Chicago, IL 60612 USA; [Gettins, Peter G. W.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Olson, ST (corresponding author), 801 South Paulina St,MC 860, Chicago, IL 60612 USA.	stolson@uic.edu			National Institutes of Health [R01 HL-78827, R37 HL39888]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL039888, R01HL078827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL-78827 and R37 HL39888 (to S. T. O.).	Calugaru SV, 2001, J BIOL CHEM, V276, P32446, DOI 10.1074/jbc.M104731200; Dementiev A, 2003, J BIOL CHEM, V278, P37881, DOI 10.1074/jbc.M305195200; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; Futamura A, 1998, BIOCHEMISTRY-US, V37, P13110, DOI 10.1021/bi981234m; Gettins PGW, 2002, FEBS LETT, V523, P2, DOI 10.1016/S0014-5793(02)02924-1; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gooptu B, 2000, P NATL ACAD SCI USA, V97, P67, DOI 10.1073/pnas.97.1.67; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Izaguirre G, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702462200; Izaguirre G, 2009, J BIOL CHEM, V284, P1550, DOI 10.1074/jbc.M807340200; LINDAHL P, 1991, BIOCHEM J, V276, P387, DOI 10.1042/bj2760387; OLSON ST, 1995, J BIOL CHEM, V270, P30007; Olson ST, 2001, BIOCHEMISTRY-US, V40, P11742, DOI 10.1021/bi0107290; Olson ST, 2011, PROG MOL BIOL TRANSL, V99, P185, DOI 10.1016/S1877-1173(11)99005-X; PANNELL R, 1974, BIOCHEMISTRY-US, V13, P5439, DOI 10.1021/bi00723a031; Perron MJ, 2003, J BIOL CHEM, V278, P48197, DOI 10.1074/jbc.M306184200; Peterson FC, 2000, BIOCHEMISTRY-US, V39, P11884, DOI 10.1021/bi001152+; Peterson FC, 2001, BIOCHEMISTRY-US, V40, P6284, DOI 10.1021/bi010100x; Silverman GA, 2010, J BIOL CHEM, V285, P24299, DOI 10.1074/jbc.R110.112771; Stratikos E, 1997, P NATL ACAD SCI USA, V94, P453, DOI 10.1073/pnas.94.2.453; Stratikos E, 1998, J BIOL CHEM, V273, P15582, DOI 10.1074/jbc.273.25.15582; Stratikos E, 1999, P NATL ACAD SCI USA, V96, P4808, DOI 10.1073/pnas.96.9.4808; Swanson R, 2007, J BIOL CHEM, V282, P2305, DOI 10.1074/jbc.M609546200; Tew DJ, 2001, FEBS LETT, V494, P30, DOI 10.1016/S0014-5793(01)02305-5; Ye S, 2001, NAT STRUCT BIOL, V8, P979, DOI 10.1038/nsb1101-979	25	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					32020	32035		10.1074/jbc.M113.510990	http://dx.doi.org/10.1074/jbc.M113.510990			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24047901	Green Published, hybrid			2022-12-25	WOS:000330596200054
J	Zheng, YH; Yang, WW; Aldape, K; He, J; Lu, ZM				Zheng, Yanhua; Yang, Weiwei; Aldape, Kenneth; He, Jie; Lu, Zhimin			Epidermal Growth Factor (EGF)-enhanced Vascular Cell Adhesion Molecule-1 (VCAM-1) Expression Promotes Macrophage and Glioblastoma Cell Interaction and Tumor Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SMOOTH-MUSCLE-CELLS; ENDOTHELIAL-CELLS; MAMMARY-TUMORS; BREAST-CANCER; ANTICANCER THERAPIES; PTP-PEST; PROGRESSION; METASTASIS; MIGRATION	Activated EGF receptor (EGFR) signaling plays an instrumental role in glioblastoma (GBM) progression. However, how EGFR activation regulates the tumor microenvironment to promote GBM cell invasion remains to be clarified. Here, we demonstrate that the levels of EGFR activation in tumor cells correlated with the levels of macrophage infiltration in human GBM specimens. This was supported by our observation that EGFR activation enhanced the interaction between macrophages and GBM cells. In addition, EGF treatment induced up-regulation of vascular cell adhesion molecule-1 (VCAM-1) expression in a PKC epsilon- and NF-kappa B-dependent manner. Depletion of VCAM-1 interrupted the binding of macrophages to GBM cells and inhibited EGF-induced and macrophage-promoted GBM cell invasion. These results demonstrate an instrumental role for EGF-induced up-regulation of VCAM-1 expression in EGFR activation-promoted macrophage-tumor cell interaction and tumor cell invasion and indicate that VCAM-1 is a potential molecular target for improving cancer therapy.	[Zheng, Yanhua; Yang, Weiwei; Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA; [Zheng, Yanhua; Yang, Weiwei; Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Aldape, Kenneth] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [He, Jie] Chinese Acad Med Sci, Peking Union Med Coll, Canc Inst & Hosp, Lab Thorac Surg, Beijing 100730, Peoples R China; [Lu, Zhimin] Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; University of Texas System; University of Texas Health Science Center Houston	Lu, ZM (corresponding author), Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA.	zhiminlu@mdanderson.org	yang, zheng/HGC-7753-2022		National Institutes of Health from NCI [2R01CA109035, 1R0CA169603]; MD Anderson Cancer Center Support Grant [CA016672]; Cancer Prevention and Research Institute of Texas Research [RP110252, RP130389]; American Cancer Society Research Scholar Grant [RSG-09-277-01-CSM]; James S. McDonnell Foundation 21st Century Science Initiative in Brain Cancer Research Award [220020318]; Sister Institution Network Fund grants from the MDAnderson Cancer Center; Cancer Institute and Hospital of Chinese Academy of Medical Sciences; NATIONAL CANCER INSTITUTE [R01CA109035, P30CA016672, R01CA169603] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MD Anderson Cancer Center Support Grant; Cancer Prevention and Research Institute of Texas Research; American Cancer Society Research Scholar Grant(American Cancer Society); James S. McDonnell Foundation 21st Century Science Initiative in Brain Cancer Research Award; Sister Institution Network Fund grants from the MDAnderson Cancer Center; Cancer Institute and Hospital of Chinese Academy of Medical Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants 2R01CA109035 and 1R0CA169603 (to Z. L.) from NCI. This work was also supported by MD Anderson Cancer Center Support Grant CA016672, Cancer Prevention and Research Institute of Texas Research Grants RP110252 and RP130389 (to Z. L.), American Cancer Society Research Scholar Grant RSG-09-277-01-CSM (to Z. L.), James S. McDonnell Foundation 21st Century Science Initiative in Brain Cancer Research Award 220020318 (to Z. L.), and Sister Institution Network Fund grants from the MDAnderson Cancer Center (to Z. L.) and the Cancer Institute and Hospital of Chinese Academy of Medical Sciences (to J. H.).	Andjelkovic AV, 1998, BRAIN RES, V814, P13, DOI 10.1016/S0006-8993(98)00830-0; Ayuso-Sacido A, 2010, J NEURO-ONCOL, V97, P323, DOI 10.1007/s11060-009-0035-x; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Chen Q, 2012, CLIN CANCER RES, V18, P5520, DOI 10.1158/1078-0432.CCR-11-2904; Chen Q, 2011, CANCER CELL, V20, P538, DOI 10.1016/j.ccr.2011.08.025; Clarke J, 2010, ARCH NEUROL-CHICAGO, V67, P279, DOI 10.1001/archneurol.2010.5; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Cook-Mills JM, 2002, MOL IMMUNOL, V39, P499, DOI 10.1016/S0161-5890(02)00206-7; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; Green CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006713; Heidemann J, 2006, INT J ONCOL, V28, P77; Heimberger AB, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-38; Huang PH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.287re6; IADEMARCO MF, 1992, J BIOL CHEM, V267, P16323; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Kim JY, 2012, VASC PHARMACOL, V56, P131, DOI 10.1016/j.vph.2011.11.007; Komohara Y, 2011, CANCER SCI, V102, P1424, DOI 10.1111/j.1349-7006.2011.01945.x; Larysz D, 2011, FOLIA NEUROPATHOL, V49, P28; Lewis C, 2005, AM J PATHOL, V167, P627, DOI 10.1016/S0002-9440(10)62038-X; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; LIBERMANN TA, 1984, CANCER RES, V44, P753; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lu X, 2011, CANCER CELL, V20, P701, DOI 10.1016/j.ccr.2011.11.002; Maenpaa A, 1997, ACTA NEUROPATHOL, V94, P216, DOI 10.1007/s004010050696; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Qin ZY, 2012, ATHEROSCLEROSIS, V221, P2, DOI 10.1016/j.atherosclerosis.2011.09.003; Ruco LP, 1996, J PATHOL, V179, P266; SCHLEGEL J, 1994, INT J CANCER, V56, P72; Shin J, 2006, CELL PHYSIOL BIOCHEM, V17, P211, DOI 10.1159/000094126; Sun DI, 2008, INT IMMUNOPHARMACOL, V8, P1272, DOI 10.1016/j.intimp.2008.05.006; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Yang CR, 2005, J IMMUNOL, V174, P1647, DOI 10.4049/jimmunol.174.3.1647; Yang WW, 2012, MOL CELL, V48, P771, DOI 10.1016/j.molcel.2012.09.028; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Zerfaoui M, 2008, CELL SIGNAL, V20, P186, DOI 10.1016/j.cellsig.2007.10.007; Zheng YH, 2011, MOL CELL BIOL, V31, P4258, DOI 10.1128/MCB.05547-11; Zheng YH, 2009, MOL CELL, V35, P11, DOI 10.1016/j.molcel.2009.06.013; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032; Zhu YA, 2002, NAT REV CANCER, V2, P616, DOI 10.1038/nrc866	45	41	46	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31488	31495		10.1074/jbc.M113.499020	http://dx.doi.org/10.1074/jbc.M113.499020			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24045955	Green Published, hybrid			2022-12-25	WOS:000330596200008
J	Tadesse, S				Tadesse, Sebsibe			Validating the InterVA Model to Estimate the Burden of Mortality from Verbal Autopsy Data: A Population-Based Cross-Sectional Study	PLOS ONE			English	Article							DATA-DERIVED ALGORITHMS; ASSIGNING CAUSES; ADULT DEATHS; PERFORMANCE; VALIDITY; MISCLASSIFICATION; ASSIGNMENT	Background: In countries with incomplete or no vital registration systems, verbal autopsy data are often reviewed by physicians in order to assign the probable cause of death. But in addition to being time and energy consuming, the method is liable to produce inconsistent results. The aim of this study is to validate the InterVA model for estimating the burden of mortality from verbal autopsy data by using physician review as a reference standard. Methods and Findings: A population-based cross-sectional study was conducted from March to April, 2012. All adults aged >= 14 years and died between 01 January, 2010 and 15 February, 2012 were included in the study. The verbal autopsy interviews were reviewed by the InterVA model and physicians to estimate cause-specific mortality fractions. Cohen's kappa statistic, sensitivity, specificity, positive predictive value, and negative predictive value were applied to compare the agreement between the InterVA model and the physician review. A total of 408 adult deaths were studied. There was a general similarity and just slight differences between the InterVA model and the physicians in assigning cause-specific mortality. Both approaches showed an overall agreement in 298 (73%) cases [kappa = 0.49, 95% CI: 0.37-0.60]. The observed sensitivities and specificities across causes of death categories varied from 13.3% to 81.9% and 77.7% to 99.5%, respectively. Conclusions: In understanding the burden of disease and setting health intervention priorities in areas that lack reliable vital registration systems, an accurate analysis of verbal autopsies is essential. Therefore, users should be aware of the suboptimal performance of the InterVA model. Similar validation studies need to be undertaken considering the limitation of the physician review as gold standard since physicians may misinterpret some of the verbal autopsy data and finally reach a wrong conclusion of the cause of death.	Univ Gondar, Inst Publ Hlth, Gondar, Ethiopia	University of Gondar	Tadesse, S (corresponding author), Univ Gondar, Inst Publ Hlth, Gondar, Ethiopia.	sbsbtadesse90@gmail.com	Tadesse, Sebsibe/AGG-7272-2022	Tadesse, Sebsibe/0000-0002-9153-5400	University of Gondar	University of Gondar	Financial support was obtained from the University of Gondar. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikins AD, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-5; Anker M, 1997, INT J EPIDEMIOL, V26, P1090, DOI 10.1093/ije/26.5.1090; Bauni E, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-49; Boulle A, 2001, INT J EPIDEMIOL, V30, P515, DOI 10.1093/ije/30.3.515; Byass P, 2006, SCAND J PUBLIC HEALT, V34, P26, DOI 10.1080/14034940510032202; Byass P, 2003, SCAND J PUBLIC HEALT, V31, P32, DOI 10.1080/14034950310015086; Byass P, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19281; Byass P, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-46; Byass P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000325; Byass P, 2007, PLOS MED, V4, P1715, DOI 10.1371/journal.pmed.0040333; Central Statistical Authority, 2007, POP HOUS CENS ETH RE; Chandrahoman D, 2001, THESIS LONDON SCH HY; Chandramohan D, 2001, INT J EPIDEMIOL, V30, P509, DOI 10.1093/ije/30.3.509; Chandramohan D, 1998, TROP MED INT HEALTH, V3, P436, DOI 10.1046/j.1365-3156.1998.00255.x; Coldham C, 2000, TROP MED INT HEALTH, V5, P134, DOI 10.1046/j.1365-3156.2000.00505.x; Fantahun M, 2006, B WORLD HEALTH ORGAN, V84, P204, DOI 10.2471/BLT.05.028712; Flaxman AD, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-29; Fottrell E, 2009, GLOB HLTH ACTION, V2, P10; Fottrell Edward, 2007, Popul Health Metr, V5, P1, DOI 10.1186/1478-7954-5-1; Fottrell E, 2010, EPIDEMIOL REV, V32, P38, DOI 10.1093/epirev/mxq003; Freeman JV, 2005, PAEDIATR PERINAT EP, V19, P323, DOI 10.1111/j.1365-3016.2005.00652.x; Herbst AJ, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-47; James SL, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-31; Kahn K, 2000, TROP MED INT HEALTH, V5, P824, DOI 10.1046/j.1365-3156.2000.00638.x; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Keshinro B, 2006, TROP DOCT, V36, P68, DOI 10.1258/004947506776593396; Khademi H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011183; Kumar R, 2006, Indian J Public Health, V50, P90; Kyobutungi Catherine, 2008, Popul Health Metr, V6, P1, DOI 10.1186/1478-7954-6-1; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lozano R, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-50; Lozano R, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-32; Marsh DR, 2003, PAEDIATR PERINAT EP, V17, P132, DOI 10.1046/j.1365-3016.2003.00475.x; Misganaw A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-130; Murray CJL, 2007, PLOS MED, V4, P1739, DOI 10.1371/journal.pmed.0040327; Murray CJL, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-30; Murray CJL, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-28; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Myers J., 2008, INT ENCY PUBLIC HLTH, P421; Oti SO, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-21; Polprasert W, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-13; Quigley MA, 1999, INT J EPIDEMIOL, V28, P1081, DOI 10.1093/ije/28.6.1081; Quigley MA, 2000, TROP MED INT HEALTH, V5, P33, DOI 10.1046/j.1365-3156.2000.00517.x; Reeves BC, 1997, INT J EPIDEMIOL, V26, P1080, DOI 10.1093/ije/26.5.1080; Ronsmans C, 1998, INT J EPIDEMIOL, V27, P660, DOI 10.1093/ije/27.4.660; Setel PW, 2007, LANCET, V370, P1569, DOI 10.1016/S0140-6736(07)61307-5; Setel PW, 2006, TROP MED INT HEALTH, V11, P681, DOI 10.1111/j.1365-3156.2006.01603.x; Soleman N, 2006, B WORLD HEALTH ORGAN, V84, P239, DOI 10.2471/BLT.05.027003; Tadesse S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1039; TODD JE, 1994, ANN TROP PAEDIATR, V14, P31, DOI 10.1080/02724936.1994.11747689; van Eijk AM, 2008, TROP MED INT HEALTH, V13, P1314, DOI 10.1111/j.1365-3156.2008.02136.x; Vergnano S, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-48; World Health Organization, 2004, NUMB REV MAT DEATHS; Yang GH, 2006, INT J EPIDEMIOL, V35, P741, DOI 10.1093/ije/dyi181	55	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73463	10.1371/journal.pone.0073463	http://dx.doi.org/10.1371/journal.pone.0073463			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058474	Green Submitted, gold, Green Published			2022-12-25	WOS:000324408400025
J	Hudjashov, G; Villems, R; Kivisild, T				Hudjashov, Georgi; Villems, Richard; Kivisild, Toomas			Global Patterns of Diversity and Selection in Human Tyrosinase Gene	PLOS ONE			English	Article							RECENT POSITIVE SELECTION; WHOLE-GENOME ASSOCIATION; SKIN COLOR VARIATION; HUMAN PIGMENTATION; HAPLOTYPE RECONSTRUCTION; STATISTICAL-METHOD; NATURAL-SELECTION; EVOLUTION; POLYMORPHISM; SEQUENCE	Global variation in skin pigmentation is one of the most striking examples of environmental adaptation in humans. More than two hundred loci have been identified as candidate genes in model organisms and a few tens of these have been found to be significantly associated with human skin pigmentation in genome-wide association studies. However, the evolutionary history of different pigmentation genes is rather complex: some loci have been subjected to strong positive selection, while others evolved under the relaxation of functional constraints in low UV environment. Here we report the results of a global study of the human tyrosinase gene, which is one of the key enzymes in melanin production, to assess the role of its variation in the evolution of skin pigmentation differences among human populations. We observe a higher rate of non-synonymous polymorphisms in the European sample consistent with the relaxation of selective constraints. A similar pattern was previously observed in the MC1R gene and concurs with UV radiation-driven model of skin color evolution by which mutations leading to lower melanin levels and decreased photoprotection are subject to purifying selection at low latitudes while being tolerated or even favored at higher latitudes because they facilitate UV-dependent vitamin D production. Our coalescent date estimates suggest that the non-synonymous variants, which are frequent in Europe and North Africa, are recent and have emerged after the separation of East and West Eurasian populations.	[Hudjashov, Georgi; Villems, Richard; Kivisild, Toomas] Estonian Bioctr, Evolutionary Biol Grp, Tartu, Estonia; [Hudjashov, Georgi; Villems, Richard; Kivisild, Toomas] Univ Tartu, Dept Evolutionary Biol, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Villems, Richard] Estonian Acad Sci, EE-200103 Tallinn, Estonia; [Kivisild, Toomas] Univ Cambridge, Div Biol Anthropol, Cambridge, England	Estonian Biocentre; University of Tartu; Estonian Academy of Sciences; University of Cambridge	Hudjashov, G (corresponding author), Estonian Bioctr, Evolutionary Biol Grp, Tartu, Estonia.	hudja@ebc.ee	Kivisild, Toomas/P-5889-2017; Hudjashov, Georgi/H-1254-2015	Kivisild, Toomas/0000-0002-6297-7808; Hudjashov, Georgi/0000-0002-7536-9086	Tartu University [PBGMR06901]; ERC [FP7 - 261213]; European Commission [ECOGENE 205419]	Tartu University; ERC(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	This research was supported by Tartu University grant (PBGMR06901) to T. K.; ERC Starting Investigator grant (FP7 - 261213) to T. K.; and European Commission grant (ECOGENE 205419) to G. H. and R. V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Alonso S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-74; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anno S, 2010, EXPERT REV MOL DIAGN, V10, P987, DOI 10.1586/ERM.10.90; Aoki K, 2002, ANN HUM BIOL, V29, P589, DOI 10.1080/0301446021000019144; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Behar DM, 2010, NATURE, V466, P238, DOI 10.1038/nature09103; Beleza S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003372; Beleza S, 2013, MOL BIOL EVOL, V30, P24, DOI 10.1093/molbev/mss207; Blum MGB, 2011, MOL BIOL EVOL, V28, P889, DOI 10.1093/molbev/msq265; BRANDA RF, 1978, SCIENCE, V201, P625, DOI 10.1126/science.675247; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Candille SI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048294; Cann HM, 2002, SCIENCE, V296, P261; Chaki M, 2011, J INVEST DERMATOL, V131, P260, DOI 10.1038/jid.2010.274; Chaubey G, 2011, MOL BIOL EVOL, V28, P1013, DOI 10.1093/molbev/msq288; Chen FC, 2001, J HERED, V92, P481, DOI 10.1093/jhered/92.6.481; Core R Team, 2013, R LANG ENV STAT COMP; de Gruijter Johanna Maria, 2011, Investig Genet, V2, P24, DOI 10.1186/2041-2223-2-24; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Edwards M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000867; Elias PM, 2010, AM J HUM BIOL, V22, P526, DOI 10.1002/ajhb.21043; Ellis N, 2002, GENOME RES, V12, P339; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Ferrer-Admetlla A, 2009, MOL BIOL EVOL, V26, P1993, DOI 10.1093/molbev/msp108; Foster CB, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-56; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garrigan D, 2006, NAT REV GENET, V7, P669, DOI 10.1038/nrg1941; Grossman SR, 2013, CELL, V152, P703, DOI 10.1016/j.cell.2013.01.035; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Henn BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002397; Hudjashov G, 2007, P NATL ACAD SCI USA, V104, P8726, DOI 10.1073/pnas.0702928104; Ibarrola-Villava M, 2012, EUR J CANCER, V48, P2183, DOI 10.1016/j.ejca.2012.03.006; Izagirre N, 2006, MOL BIOL EVOL, V23, P1697, DOI 10.1093/molbev/msl030; Jablonski NG, 2004, ANNU REV ANTHROPOL, V33, P585, DOI 10.1146/annurev.anthro.33.070203.143955; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; Kayser M, 2010, CURR BIOL, V20, pR194, DOI 10.1016/j.cub.2009.12.004; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kenny EE, 2012, SCIENCE, V336, P554, DOI 10.1126/science.1217849; KUTZBACH JE, 1988, SCIENCE, V241, P1043, DOI 10.1126/science.241.4869.1043; Lalueza-Fox C, 2007, SCIENCE, V318, P1453, DOI 10.1126/science.1147417; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; LANGERGRABER KE, 2012, P NATL ACAD SCI USA, P91323; Lao O, 2007, ANN HUM GENET, V71, P354, DOI 10.1111/j.1469-1809.2006.00341.x; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOOMIS WF, 1967, SCIENCE, V157, P501, DOI 10.1126/science.157.3788.501; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Lyngso RB, 2005, LECT NOTES COMPUT SC, V3692, P239; McEvoy B, 2006, HUM MOL GENET, V15, pR176, DOI 10.1093/hmg/ddl217; McEvoy BP, 2010, AM J HUM GENET, V87, P297, DOI 10.1016/j.ajhg.2010.07.008; Metspalu M, 2011, AM J HUM GENET, V89, P731, DOI 10.1016/j.ajhg.2011.11.010; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Miller CT, 2007, CELL, V131, P1179, DOI 10.1016/j.cell.2007.10.055; MONTOLIU L, 2012, COLOR GENES; Murisier F, 2006, HISTOL HISTOPATHOL, V21, P567, DOI 10.14670/HH-21.567; Myles S, 2007, HUM GENET, V120, P613, DOI 10.1007/s00439-006-0256-4; Nan HM, 2009, INT J CANCER, V125, P909, DOI 10.1002/ijc.24327; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; *NIEHS, 2013, SNPS NIEHS ENV GEN P; Nielsen R, 2001, HEREDITY, V86, P641, DOI 10.1046/j.1365-2540.2001.00895.x; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Parra EJ, 2007, YEARB PHYS ANTHROPOL, V50, P85, DOI 10.1002/ajpa.20727; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rambaut A, 2007, TRACER V 1 5; Rana BK, 1999, GENETICS, V151, P1547; Ray K, 2007, PROG RETIN EYE RES, V26, P323, DOI 10.1016/j.preteyeres.2007.01.001; Regales L, 2003, PIGM CELL RES, V16, P685, DOI 10.1046/j.1600-0749.2003.00100.x; Relethford JH, 2002, AM J PHYS ANTHROPOL, V118, P393, DOI 10.1002/ajpa.10079; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Savage SA, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-31; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; SIMONSEN KL, 1995, GENETICS, V141, P413; Soejima M, 2006, MOL BIOL EVOL, V23, P179, DOI 10.1093/molbev/msj018; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stokowski RP, 2007, AM J HUM GENET, V81, P1119, DOI 10.1086/522235; Sturm RA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-248; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; TAJIMA F, 1989, GENETICS, V123, P585; TRIPATHI RK, 1992, J BIOL CHEM, V267, P23707; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Wooding S, 2004, AM J HUM GENET, V74, P637, DOI 10.1086/383092; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7	100	13	13	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74307	10.1371/journal.pone.0074307	http://dx.doi.org/10.1371/journal.pone.0074307			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040225	Green Published, gold, Green Submitted			2022-12-25	WOS:000326734500082
J	Wang, XY; Liu, QT; Hou, BX; Zhang, W; Yan, M; Jia, HM; Li, HJ; Yan, D; Zheng, FM; Ding, W; Yi, C; Wang, H				Wang, Xiyan; Liu, Quentin; Hou, Benxin; Zhang, Wei; Yan, Min; Jia, Huimin; Li, Haijun; Yan, Dong; Zheng, Feimeng; Ding, Wei; Yi, Chao; Wang, Hai			Concomitant Targeting of Multiple Key Transcription Factors Effectively Disrupts Cancer Stem Cells Enriched in Side Population of Human Pancreatic Cancer Cells	PLOS ONE			English	Article							DECOY OLIGODEOXYNUCLEOTIDES; EXPRESSION; ADENOCARCINOMA; RESISTANCE; NANOG; IDENTIFICATION; OCTAMER; OCT4; SOX2	Background: A major challenge in the treatment of pancreatic ductal adenocarcinoma is the failure of chemotherapy, which is likely due to the presence of the cancer stem cells (CSCs). Objective: To identify side population (SP) cells and characterize s-like properties in human pancreatic cancer cell lines (h-PCCLs) and to exploit the efficacy of concomitant targeting of multiple key transcription factors governing the stemness of pancreatic CSCs in suppressing CSC-like phenotypes. Methods: Flow cytometry and Hoechst 33342 DNA-binding dye efflux assay were used to sort SP and non-SP (NSP) cells from three h-PCCLs: PANC-1, SW1990, and BxPc-3. The self-renewal ability, invasiveness, migration and drug resistance of SP cells were evaluated. Expression of CSC marker genes was analyzed. Tumorigenicity was assessed using a xenograft model in nude mice. Effects of a complex decoy oligonucleotide (cdODN-SCO) designed to simultaneously targeting Sox2, Oct4 and c-Myc were assessed. Results: CSCs were enriched in the side proportion (SP) cells contained in the h-PCCLs and they possessed aggressive growth, invasion, migration and drug-resistance properties, compared with NSP cells. SP cells overexpressed stem cell markers CD133 and ALDH1, pluripotency maintaining factors Nanog, Sox2 and Oct4, oncogenic transcription factor c-Myc, signaling molecule Notch1, and drug resistant gene ABCG2. Moreover, SP cells consistently demonstrated significantly greater tumorigenicity than NSP cells in xenograft model of nude mice. CdODN-SOC efficiently suppressed all CSC properties and phenotypes, and minimized the tumorigenic capability of the SP cells and the resistance to chemotherapy. By comparison, the negative control failed to do so. Conclusion: The findings indicate that targeting the key genes conferring the stemness of CSCs can efficiently eliminate CSC-like phenotypes, and thus may be considered a new approach for cancer therapy. Specifically, the present study establishes the combination of Sox2/Oct4/c-Myc targeting as a potential anti-pancreatic cancer agent worthy of further studies in preclinical settings.	[Wang, Xiyan; Hou, Benxin; Jia, Huimin; Li, Haijun; Yan, Dong; Ding, Wei; Yi, Chao; Wang, Hai] Xinjiang Med Univ, Canc Affiliated Hosp, Dept Hepatobiliary Surg, Urumqi, Peoples R China; [Liu, Quentin; Zhang, Wei; Yan, Min; Zheng, Feimeng] Sun Yat Sen Univ, State Key Lab Oncol South China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	Xinjiang Medical University; State Key Lab Oncology South China; Sun Yat Sen University	Wang, XY (corresponding author), Xinjiang Med Univ, Canc Affiliated Hosp, Dept Hepatobiliary Surg, Urumqi, Peoples R China.	wangxysci@163.com; liuq9_sysu@126.com		Zheng, Feimeng/0000-0001-8793-6677				Balic A, 2012, EXP CELL RES, V318, P691, DOI 10.1016/j.yexcr.2011.11.007; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; Douville J, 2009, STEM CELLS DEV, V18, P17, DOI 10.1089/scd.2008.0055; Gao HH, 2006, MOL PHARMACOL, V70, P1621, DOI 10.1124/mol.106.024273; Garber K, 2007, J NATL CANCER I, V99, P1284, DOI 10.1093/jnci/djm148; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Goodell Margaret A, 2005, Methods Mol Biol, V290, P343; Haimeur A, 2004, CURR DRUG METAB, V5, P21, DOI 10.2174/1389200043489199; Hidalgo M, 2012, CLIN CANCER RES, V18, P4249, DOI 10.1158/1078-0432.CCR-12-1327; Huang DZ, 2009, STEM CELLS DEV, V18, P465, DOI 10.1089/scd.2008.0033; Ikegame A, 2012, LEUKEMIA, V26, P2124, DOI 10.1038/leu.2012.78; Konig J, 2005, INT J CANCER, V115, P359, DOI 10.1002/ijc.20831; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Li CW, 2009, METHODS MOL BIOL, V568, P161, DOI 10.1007/978-1-59745-280-9_10; Liang DM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-201; Lowe AW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000323; Mann MJ, 2000, J CLIN INVEST, V106, P1071, DOI 10.1172/JCI11459; Marquardt JU, 2011, HEPATOLOGY, V54, P1031, DOI 10.1002/hep.24454; Mimeault M, 2010, CANCER LETT, V295, P69, DOI 10.1016/j.canlet.2010.02.015; Morishita R, 2001, ANN NY ACAD SCI, V947, P294; Nishii T, 2009, CANCER SCI, V100, P1397, DOI 10.1111/j.1349-7006.2009.01211.x; Picanco-Castro V, 2012, CELL REPROGRAM, V14, P187, DOI 10.1089/cell.2011.0094; Rasheed ZA, 2012, J GASTROEN HEPATOL, V27, P15, DOI 10.1111/j.1440-1746.2011.07015.x; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; ROTH M, 2005, PHARMACOLOGYONLINE, V1, P45; Sergeant G, 2009, NAT REV CLIN ONCOL, V6, P580, DOI 10.1038/nrclinonc.2009.127; Shankar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016530; Simeone DM, 2008, CLIN CANCER RES, V14, P5646, DOI 10.1158/1078-0432.CCR-08-0584; Singh S, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-73; Van den Broeck A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-354; Vizio B, 2012, ONCOL REP, V27, P69, DOI 10.3892/or.2011.1461; Wang XQ, 2010, HEPATOLOGY, V52, P528, DOI 10.1002/hep.23692; Wang YH, 2009, NEOPLASMA, V56, P371, DOI 10.4149/neo_2009_05_371; Xiang R, 2011, BRIT J CANCER, V104, P1410, DOI 10.1038/bjc.2011.94; Yao J, 2010, ONCOL REP, V23, P1375, DOI 10.3892/or_00000774; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; ZHANG J, 2012, ONCOGENE, DOI DOI 10.1038/0NC.2012.461.PUBMED:23085761; Zhang SN, 2010, TUMORI J, V96, P985, DOI 10.1177/548.6520	40	23	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73942	10.1371/journal.pone.0073942	http://dx.doi.org/10.1371/journal.pone.0073942			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040121	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500063
J	Miyamoto, I; Ishikawa, A; Morimoto, Y; Takahashi, T				Miyamoto, Ikuya; Ishikawa, Ayataka; Morimoto, Yasuhiro; Takahashi, Tetsu			Potential Risk of Asymptomatic Osteomyelitis around Mandibular Third Molar Tooth for Aged People: A Computed Tomography and Histopathologic Study	PLOS ONE			English	Article							CORTICAL BONE; TITANIUM IMPLANTS; GAP-JUNCTIONS; DENSITY; QUALITY; ACCUMULATION; MICROCRACKS; SURGERY	The purpose of this study was to explore the relationship between bone mineral density and histopathological features of mandibular alveolar bone evaluated quantitatively by Hounsfield units [HU] and by histopathology in human subjects. Fifty-six mandibular molars were extracted in 50 patients. Computed tomography was obtained preoperatively, and a cortical bone biopsy was obtained on the extracted sites for histopathological evaluation. The mean cortical and cancellous bone radiodensity was 1846 +/- 118 HU and 926 +/- 436 HU, respectively. There was no correlation between age and cortical bone HU (r=20.004, P=0.976); however, the correlation between age and cancellous bone HU was significant (r=0.574, P<0.0000). Significant differences in the cancellous bone between young (0-30 years), middle (31-60 years) and old patient groups (61<years) were evident (P<0.05), whereas the cortical bone presented no significant differences. The histopathological evaluation showed that the young patient group had relatively few osteomyelitis, whereas the old patient group showed 100% focal sclerotic osteomyelitis regardless of the fact that the patients had no clinical symptoms. The mean osteocyte number/unit bone area was 170.7 +/- 82.2. Negative correlation between age and osteocyte number was significant (r=20.51, P<0.0001). Mean lacunae numbers/unit cortical bone area were 413.1 +/- 130 with non-significant negative correlation (r=20.257, P=0.056). The mean empty lacunae numbers/cortical bone were 242.5 +/- 145, with no correlation (r=0.081, P=0.559). The young patients had high osteocyte number, whereas the old patients showed reduction of the osteocytes in the cortical bone (P<0.05). Bone quality might correlate better to viable cell numbers, which influenced the osseous healing. It is suggested that the outermost layer of cortical bone may have lost its cellular activities over the years due to chronic infection, which may have provoked sclerotic changes in the cancellous bone around tooth.	[Miyamoto, Ikuya] Kyushu Dent Univ, Div Oral Med, Fukuoka, Japan; [Ishikawa, Ayataka] Saitama Canc Ctr, Dept Pathol, Saitama, Japan; [Morimoto, Yasuhiro] Kyushu Dent Univ, Div Oral & Maxillofacial Radiol, Fukuoka, Japan; [Takahashi, Tetsu] Tohoku Univ, Grad Sch Dent, Dept Oral Med & Surg, Div Oral & Maxillofacial Surg, Sendai, Miyagi 980, Japan	Kyushu Dental University; Kyushu Dental University; Tohoku University	Miyamoto, I (corresponding author), Kyushu Dent Univ, Div Oral Med, Fukuoka, Japan.	r08miyamoto@fa.kyu-dent.ac.jp	Ishikawa, Akimasa/G-6916-2012					Akadiri OA, 2009, J ORAL MAXIL SURG, V67, P771, DOI 10.1016/j.joms.2008.08.010; ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776; Albrektsson T, 2002, AGING OSTEOPOROSIS D, P15; [Anonymous], 2001, JAMA-J AM MED ASSOC, V285, P785, DOI [DOI 10.1001/JAMA.285.6.785, 10.1001/jama.285.6.785]; ASA Physical Status Classification System, 2009, ASA PHYS STAT CLASS; Baltensperger MM, 2010, OSTEOMYELITIS JAWS, P5; Bartold PM, 2011, CLIN ORAL IMPLAN RES, V22, P613, DOI 10.1111/j.1600-0501.2010.02024.x; BOYDE A, 1990, ANAT EMBRYOL, V181, P235; BOYDE A, 1986, SCAN ELECTRON MICROS, V1986, P1537; Currey J., 2002, BONES STRUCTURE MECH, P54; Donahue HJ, 2000, BONE, V26, P417, DOI 10.1016/S8756-3282(00)00245-3; DOTY SB, 1981, CALCIFIED TISSUE INT, V33, P509, DOI 10.1007/BF02409482; FRIBERG B, 1995, CLIN ORAL IMPLAN RES, V6, P213, DOI 10.1034/j.1600-0501.1995.060403.x; FROST HM, 1960, J BONE JOINT SURG AM, V42, P144, DOI 10.2106/00004623-196042010-00012; Grynpas MD, 2002, AGING, OSTEOPOROSIS, AND DENTAL IMPLANTS, P25; Kassolis JD, 2010, BONE, V47, P127, DOI 10.1016/j.bone.2010.04.588; Krakowiak PA, 2011, ORAL MAXIL SURG CLIN, V23, P401, DOI 10.1016/j.coms.2011.04.005; Lekholm U, 1987, TISSUE INTEGRATED PR, P199; Lettry S, 2003, BONE, V32, P35, DOI 10.1016/S8756-3282(02)00921-3; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Miyamoto I, 2005, BONE, V37, P776, DOI 10.1016/j.bone.2005.06.019; Mullender MG, 2005, CALCIFIED TISSUE INT, V77, P291, DOI 10.1007/s00223-005-0043-6; Najafi AR, 2007, J BIOMECH, V40, P2788, DOI 10.1016/j.jbiomech.2007.01.017; Noble BS, 2008, ARCH BIOCHEM BIOPHYS, V473, P106, DOI 10.1016/j.abb.2008.04.009; O'Brien FJ, 2003, J BIOMECH, V36, P973, DOI 10.1016/S0021-9290(03)00066-6; Peterson L.J., 2003, CONT ORAL MAXILLOFAC, P184; Qiu SJ, 2005, BONE, V37, P10, DOI 10.1016/j.bone.2005.01.023; Queral-Godoy E, 2005, ORAL SURG ORAL MED O, V99, P259, DOI 10.1016/j.tripleo.2004.06.001; Quirynen M, 2003, CLIN ORAL IMPLAN RES, V14, P280, DOI 10.1034/j.1600-0501.2003.140305.x; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; SENNERBY L, 1988, ACTA ODONTOL SCAND, V46, P135, DOI 10.3109/00016358809004759; Shahlaie M, 2003, INT J ORAL MAX IMPL, V18, P224; Shapurian T, 2006, INT J ORAL MAX IMPL, V21, P290; Valmaseda-Castellon E, 2001, ORAL SURG ORAL MED O, V92, P377, DOI 10.1067/moe.2001.118284; Vashishth D, 2004, J BIOMECH, V37, P943, DOI 10.1016/j.jbiomech.2003.11.003; Vashishth D, 2000, BONE, V26, P375, DOI 10.1016/S8756-3282(00)00236-2; Watzek G, 2002, AGING, OSTEOPOROSIS, AND DENTAL IMPLANTS, P67	37	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73897	10.1371/journal.pone.0073897	http://dx.doi.org/10.1371/journal.pone.0073897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040109	gold, Green Published, Green Submitted			2022-12-25	WOS:000327538600050
J	Song, CY; Simpson, AJR; Harte, CA; Pearce, MT; Sandler, MB				Song, Chunyang; Simpson, Andrew J. R.; Harte, Christopher A.; Pearce, Marcus T.; Sandler, Mark B.			Syncopation and the Score	PLOS ONE			English	Article							TEMPO; PERCEPTION; RHYTHM	The score is a symbolic encoding that describes a piece of music, written according to the conventions of music theory, which must be rendered as sound (e.g., by a performer) before it may be perceived as music by the listener. In this paper we provide a step towards unifying music theory with music perception in terms of the relationship between notated rhythm (i.e., the score) and perceived syncopation. In our experiments we evaluated this relationship by manipulating the score, rendering it as sound and eliciting subjective judgments of syncopation. We used a metronome to provide explicit cues to the prevailing rhythmic structure (as defined in the time signature). Three-bar scores with time signatures of 4/4 and 6/8 were constructed using repeated one-bar rhythm-patterns, with each pattern built from basic half-bar rhythm-components. Our manipulations gave rise to various rhythmic structures, including polyrhythms and rhythms with missing strong- and/or down-beats. Listeners (N = 10) were asked to rate the degree of syncopation they perceived in response to a rendering of each score. We observed higher degrees of syncopation in time signatures of 6/8, for polyrhythms, and for rhythms featuring a missing down-beat. We also found that the location of a rhythm-component within the bar has a significant effect on perceived syncopation. Our findings provide new insight into models of syncopation and point the way towards areas in which the models may be improved.	[Song, Chunyang; Simpson, Andrew J. R.; Harte, Christopher A.; Pearce, Marcus T.; Sandler, Mark B.] Queen Mary Univ London, Ctr Digital Mus, London, England	University of London; Queen Mary University London	Song, CY (corresponding author), Queen Mary Univ London, Ctr Digital Mus, London, England.	csong@eecs.qmul.ac.uk		Sandler, Mark/0000-0002-5691-8107	EPSRC DTA	EPSRC DTA(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The first and second authors were supported by an EPSRC DTA (www.epsrc.ac.uk) studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arom S., 1991, AFRICAN POLYPHONY PO; Bergeson TR, 2006, MUSIC PERCEPT, V23, P345, DOI 10.1525/mp.2006.23.4.345; Clarke EF, 1999, PSYCHOL MUSIC, P437; DRAKE C, 1993, PERCEPT PSYCHOPHYS, V53, P25, DOI 10.3758/BF03211712; Drake C, 1997, POLISH Q DEV PSYCHOL, V3, P43; DUKE RA, 1988, J RES MUSIC EDUC, V36, P108, DOI 10.2307/3345244; Fitch WT, 2007, MUSIC PERCEPT, V25, P43, DOI 10.1525/mp.2007.25.1.43; Gmez Francisco, 2007, P INT COMP MUS C COP; Gomez F., 2005, P BRIDGES MATH CONN, P73; HANDEL S, 1993, PERCEPT PSYCHOPHYS, V54, P370, DOI 10.3758/BF03205273; HANDEL S, 1981, PERCEPT PSYCHOPHYS, V30, P1, DOI 10.3758/BF03206130; HANDEL S, 1983, PERCEPT PSYCHOPHYS, V34, P103, DOI 10.3758/BF03211335; Hannon EE, 2004, J EXP PSYCHOL HUMAN, V30, P956, DOI 10.1037/0096-1523.30.5.956; Huron D.B., 2006, SWEET ANTICIPATION M; Kamenetsky S.B., 1997, PSYCHOL MUSIC, V25, P149, DOI 10.1177/ 0305735697252005.; Keith Michael., 1991, POLYCHORDS POLYA ADV; Kennedy Michael, 1994, OXFORD DICT MUSIC; LEBLANC A, 1981, J RES MUSIC EDUC, V29, P143, DOI 10.2307/3345023; Lerdahl F., 1983, GENERATIVE THEORY TO; London J., 2004, HEARING TIME; LONGUETHIGGINS HC, 1984, MUSIC PERCEPT, V1, P424; PALMER C, 1990, J EXP PSYCHOL HUMAN, V16, P728, DOI 10.1037/0096-1523.16.4.728; Poulton E.C., 1989, BIAS QUANTIFYING JUD; POVEL DJ, 1985, MUSIC PERCEPT, V2, P411; PRESSING J., 1997, P 4 C AUSTRALASIAN C; RANDEL D. M., 1986, HARVARD DICT MUSIC, V4th; Repp BH, 2002, MUSIC PERCEPT, V19, P565, DOI 10.1525/mp.2002.19.4.565; Shmulevich I, 2000, J NEW MUSIC RES, V29, P61, DOI 10.1076/0929-8215(200003)29:01;1-P;FT061; Sioros G., 2011, P 12 INT SOC MUS INF, P381; SMITH KC, 1989, J EXP PSYCHOL HUMAN, V15, P457, DOI 10.1037/0096-1523.15.3.457; SMITH L. M., 2006, P INT COMP MUS C, P688; Snyder J, 2001, MUSIC PERCEPT, V18, P455, DOI 10.1525/mp.2001.18.4.455; Stevens SS, 1975, PSYCHOPHYSICS INTRO; Thul E., 2008, P 9 INT C MUS INF RE, P663; Toiviainen P, 2003, MUSIC PERCEPT, V21, P43, DOI 10.1525/mp.2003.21.1.43; Toussaint G., 2002, P BRIDGES MATH CONN, P157; Toussaint GT, 2004, AM MATH SOC PHOEN JA, p[25, 248]; Trainor LJ, 2007, EMPIR MUSICOL REV, V2, P17, DOI 10.18061/1811/24480	38	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74692	10.1371/journal.pone.0074692	http://dx.doi.org/10.1371/journal.pone.0074692			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040323	gold, Green Published, Green Submitted			2022-12-25	WOS:000327538600108
J	Laudani, L; Vannozzi, G; Sawacha, Z; della Croce, U; Cereatti, A; Macaluso, A				Laudani, Luca; Vannozzi, Giuseppe; Sawacha, Zimi; della Croce, Ugo; Cereatti, Andrea; Macaluso, Andrea			Association between Physical Activity Levels and Physiological Factors Underlying Mobility in Young, Middle-Aged and Older Individuals Living in a City District	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MUSCLE STRENGTH; ACTIVITY QUESTIONNAIRE; ANAEROBIC THRESHOLD; POWER OUTPUT; WOMEN; FITNESS; ADULTS; ACCELEROMETRY; DETERMINANTS	Maintaining adequate levels of physical activity is known to preserve health status and functional independence as individuals grow older. However, the relationship between determinants of physical activity (volume and intensity) and physiological factors underlying mobility (cardio-respiratory fitness, neuromuscular function and functional abilities) is still unclear. The aim of this study was to investigate the association between objectively quantified physical activity and a spectrum of physiological factors underlying mobility in young, middle-aged and older individuals living in a city district. Experiments were carried out on 24 young (28 +/- 2 years), 24 middle-aged (48 +/- 2 years) and 24 older (70 +/- 3 years) gender-matched volunteers. Physical activity was monitored by a wearable activity monitor to quantify volume and intensity of overall physical activity and selected habitual activities over 24 hours. Ventilatory threshold was assessed during an incremental cycling test. Torque, muscle fiber conduction velocity and agonist-antagonist coactivation were measured during maximal voluntary contraction of knee extensors and flexors. Ground reaction forces were measured during sit-to-stand and counter-movement jump. K-means cluster analysis was used to classify the participants' physical activity levels based on parameters of volume and intensity. Two clusters of physical activity volume (i.e., high and low volume) and three clusters of physical activity intensity (i.e. high, medium and low intensity) were identified in all participants. Cardiorespiratory fitness was associated with volume of overall physical activity as well as lying, sitting, standing, walking and stair climbing. On the other hand, neuromuscular function and functional abilities showed a significant association with intensity of overall physical activity as well as postural transition, walking and stair climbing. As a practical application, the relative role played by volume and intensity of overall physical activity and selected habitual activities should be taken into account in the design of preventative training interventions to preserve mobility as individuals grow older.	[Laudani, Luca; Vannozzi, Giuseppe; Macaluso, Andrea] Univ Rome Foro Italico, Dept Human Movement Social & Hlth Sci, Rome, Italy; [Sawacha, Zimi] Univ Padua, Dept Informat Engn, Padua, Italy; [della Croce, Ugo; Cereatti, Andrea] Univ Sassari, Informat Engn Unit, Dept POLCOMING, I-07100 Sassari, Italy	Foro Italico University of Rome; University of Padua; University of Sassari	Macaluso, A (corresponding author), Univ Rome Foro Italico, Dept Human Movement Social & Hlth Sci, Rome, Italy.	andrea.macaluso@uniroma4.it	Della Croce, Ugo/V-9092-2017; Macaluso, Andrea/K-1101-2014; sawacha, zimi/AAC-2185-2022; Vannozzi, Giuseppe/G-9897-2013	Macaluso, Andrea/0000-0001-9029-6156; sawacha, zimi/0000-0002-2624-5415; Vannozzi, Giuseppe/0000-0002-2359-6076; Della Croce, Ugo/0000-0001-5151-7403; LAUDANI, LUCA/0000-0003-2638-3639	Italian Ministry of Education, University and Research (PRIN) [2007FW2XLW_002]	Italian Ministry of Education, University and Research (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	The study was financially supported by the Italian Ministry of Education, University and Research (PRIN project, code 2007FW2XLW_002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Bento T, 2012, REV SAUDE PUBL, V46, P561, DOI 10.1590/S0034-89102012005000022; BERLIN JA, 1990, AM J EPIDEMIOL, V132, P612, DOI 10.1093/oxfordjournals.aje.a115704; Copeland JL, 2009, J AGING PHYS ACTIV, V17, P17, DOI 10.1123/japa.17.1.17; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; DAVIES CTM, 1968, NATURE, V217, P770, DOI 10.1038/217770a0; DAVIS JA, 1985, MED SCI SPORT EXER, V17, P6; Davis MG, 2007, EUR J APPL PHYSIOL, V100, P581, DOI 10.1007/s00421-006-0320-8; De Vito G, 1998, EUR J APPL PHYSIOL O, V78, P59, DOI 10.1007/s004210050387; De Vito G, 1994, PHYS ACTIVITY AGIN 1, VIII; DiPietro L, 2001, J GERONTOL A-BIOL, V56, P13, DOI 10.1093/gerona/56.suppl_2.13; Duffy CR, 2012, J SPORT SCI, V30, P1311, DOI 10.1080/02640414.2012.710752; Ferrari AU, 2003, J APPL PHYSIOL, V95, P2591, DOI 10.1152/japplphysiol.00601.2003; FLEG JL, 1988, J APPL PHYSIOL, V65, P1147, DOI 10.1152/jappl.1988.65.3.1147; Fogelholm M, 2006, MED SCI SPORT EXER, V38, P753, DOI 10.1249/01.mss.0000194075.16960.20; Forte R, 2008, J SPORT SCI, V26, P1431, DOI 10.1080/02640410802208994; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; GREIG CA, 1994, AGE AGEING, V23, P185, DOI 10.1093/ageing/23.3.185; LACROIX AZ, 1993, AM J EPIDEMIOL, V137, P858, DOI 10.1093/oxfordjournals.aje.a116747; Macaluso A, 2004, EUR J APPL PHYSIOL, V91, P450, DOI 10.1007/s00421-003-0991-3; Macaluso A, 2002, MUSCLE NERVE, V25, P858, DOI 10.1002/mus.10113; Macaluso A, 2003, J APPL PHYSIOL, V95, P2544, DOI 10.1152/japplphysiol.00416.2003; Macaluso A, 2003, EUR J APPL PHYSIOL, V90, P458, DOI 10.1007/s00421-003-0866-7; Merletti R, 2002, MUSCLE NERVE, V25, P65, DOI 10.1002/mus.10014; Morie M, 2010, J AM GERIATR SOC, V58, P1727, DOI 10.1111/j.1532-5415.2010.03012.x; Nokes N, 2009, J SPORT MED PHYS FIT, V49, P136; Nusselder WJ, 2008, J EPIDEMIOL COMMUN H, V62, P823, DOI 10.1136/jech.2007.067165; Oja P, 2001, MED SCI SPORT EXER, V33, pS428, DOI 10.1097/00005768-200106001-00011; POWELL KE, 1987, ANNU REV PUBL HEALTH, V8, P253, DOI 10.1146/annurev.publhealth.8.1.253; Puthoff Michael L, 2008, J Geriatr Phys Ther, V31, P24; Rainoldi A, 2001, J ELECTROMYOGR KINES, V11, P425, DOI 10.1016/S1050-6411(01)00022-0; Sawacha Zimi, 2010, J Diabetes Sci Technol, V4, P1127; Sjostrom M, 2006, J PUBLIC HEALTH-HEID, V14, P291, DOI 10.1007/s10389-006-0031-y; Thomas EE, 2007, J APPL PHYSIOL, V103, P1598, DOI 10.1152/japplphysiol.00399.2007; Trost SG, 2000, MED SCI SPORT EXER, V32, P426, DOI 10.1097/00005768-200002000-00025; Vannozzi G, 2007, COMPUT METH PROG BIO, V88, P85, DOI 10.1016/j.cmpb.2007.07.007; Vannozzi Giuseppe, 2004, J Neuroeng Rehabil, V1, P7, DOI 10.1186/1743-0003-1-7; Wasserman K, 1999, PRINCIPLES EXERCISE; Westerterp KR, 2001, J GERONTOL A-BIOL, V56, P7, DOI 10.1093/gerona/56.suppl_2.7; World Health Organization, 2009, GLOB HLTH RISKS MORT; Zhang K, 2003, OBES RES, V11, P33, DOI 10.1038/oby.2003.7	41	29	29	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e74227	10.1371/journal.pone.0074227	http://dx.doi.org/10.1371/journal.pone.0074227			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	224BO	24040209	Green Published, gold, Green Submitted			2022-12-25	WOS:000324856500079
J	Moulle, VS; Le Foll, C; Philippe, E; Kassis, N; Rouch, C; Marsollier, N; Bui, LC; Guissard, C; Dairou, J; Lorsignol, A; Penicaud, L; Levin, BE; Cruciani-Guglielmacci, C; Magnan, C				Moulle, Valentine S.; Le Foll, Christelle; Philippe, Erwann; Kassis, Nadim; Rouch, Claude; Marsollier, Nicolas; Bui, Linh-Chi; Guissard, Christophe; Dairou, Julien; Lorsignol, Anne; Penicaud, Luc; Levin, Barry E.; Cruciani-Guglielmacci, Celine; Magnan, Christophe			Fatty Acid Transporter CD36 Mediates Hypothalamic Effect of Fatty Acids on Food Intake in Rats	PLOS ONE			English	Article							LIPOPROTEIN-LIPASE; OLEIC-ACID; NEURONS; BRAIN; ACTIVATION; MECHANISMS; OXIDATION; INFUSION; KINASE	Variations in plasma fatty acid (FA) concentrations are detected by FA sensing neurons in specific brain areas such as the hypothalamus. These neurons play a physiological role in the control of food intake and the regulation of hepatic glucose production. Le Foll et al. previously showed in vitro that at least 50% of the FA sensing in ventromedial hypothalamic (VMH) neurons is attributable to the interaction of long chain FA with FA translocase/CD36 (CD36). The present work assessed whether in vivo effects of hypothalamic FA sensing might be partly mediated by CD36 or intracellular events such as acylCoA synthesis or beta-oxidation. To that end, a catheter was implanted in the carotid artery toward the brain in male Wistar rats. After 1 wk recovery, animals were food-deprived for 5 h, then 10 min infusions of triglyceride emulsion, Intralipid +/- heparin (IL, ILH, respectively) or saline/heparin (S-H) were carried out and food intake was assessed over the next 5 h. Experimental groups included: 1) Rats previously injected in ventromedian nucleus (VMN) with shRNA against CD36 or scrambled RNA; 2) Etomoxir (CPT1 inhibitor) or saline co-infused with ILH/SH; and 3) Triacsin C (acylCoA synthase inhibitor) or saline co-infused with ILH/S-H. ILH significantly lowered food intake during refeeding compared to S-H (p < 0.001). Five hours after refeeding, etomoxir did not affect this inhibitory effect of ILH on food intake while VMN CD36 depletion totally prevented it. Triacsin C also prevented ILH effects on food intake. In conclusion, the effect of FA to inhibit food intake is dependent on VMN CD36 and acylCoA synthesis but does not required FA oxidation.	[Moulle, Valentine S.; Philippe, Erwann; Kassis, Nadim; Rouch, Claude; Marsollier, Nicolas; Bui, Linh-Chi; Dairou, Julien; Cruciani-Guglielmacci, Celine; Magnan, Christophe] Univ Paris Diderot, CNRS, Unit Funct & Adapt Biol, EAC 4413, Paris, France; [Le Foll, Christelle; Levin, Barry E.] NJ Med Sch, Dept Neurol & Neurosci, Newark, NJ USA; [Guissard, Christophe; Lorsignol, Anne] Univ Toulouse 3, CNRS EFS INSERM U1031, STROMA Lab IFR150, UMR 5273, F-31062 Toulouse, France; [Penicaud, Luc] Univ Bourgogne, CNRS, Ctr Sci Gout & Alimentat, INRA 1324,UMR 6265, Dijon, France; [Levin, Barry E.] VA Med Ctr, Neurol Serv, E Orange, NJ USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Rutgers State University New Brunswick; Rutgers State University Medical Center; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Magnan, C (corresponding author), Univ Paris Diderot, CNRS, Unit Funct & Adapt Biol, EAC 4413, Paris, France.	christophe.magnan@univ-paris-diderot.fr	Le Foll, Christelle/N-4847-2019; moullé, valentine/AAZ-9333-2020; Le Foll, Christelle/S-1126-2018; magnan, christophe/AAJ-7622-2021	Le Foll, Christelle/0000-0002-6677-5488; Le Foll, Christelle/0000-0002-6677-5488; magnan, christophe/0000-0002-7044-2571; GUISSARD, CHRISTOPHE/0000-0003-0777-7683; Cruciani-Guglielmacci, Celine/0000-0002-2562-5360; LORSIGNOL, Anne/0000-0001-7662-1872	French National Agency for Research [ANR-05-PNRA-0004, ANR 11 BSV1 021 01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053181] Funding Source: NIH RePORTER	French National Agency for Research(French National Research Agency (ANR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was granted by both ANR-05-PNRA-0004 and ANR 11 BSV1 021 01 (funding from French National Agency for Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benani A, 2007, DIABETES, V56, P152, DOI 10.2337/db06-0440; Blazquez C, 1999, J NEUROCHEM, V73, P1674, DOI 10.1046/j.1471-4159.1999.731674.x; Blouet C, 2010, BEHAV BRAIN RES, V209, P1, DOI 10.1016/j.bbr.2009.12.024; Cowley MA, 2003, EUR J PHARMACOL, V480, P3, DOI 10.1016/j.ejphar.2003.08.087; Cruciani-Guglielmacci C, 2004, DIABETOLOGIA, V47, P2032, DOI 10.1007/s00125-004-1569-2; EDMOND J, 1992, CAN J PHYSIOL PHARM, V70, pS118, DOI 10.1139/y92-253; El-Yassimi A, 2008, J BIOL CHEM, V283, P12949, DOI 10.1074/jbc.M707478200; Gentile CL, 2010, MOL CELL BIOCHEM, V344, P99, DOI 10.1007/s11010-010-0533-3; Gilbert M, 2003, DIABETES, V52, P277, DOI 10.2337/diabetes.52.2.277; Gribble FM, 1998, J BIOL CHEM, V273, P26383, DOI 10.1074/jbc.273.41.26383; Hoeks J, 2010, DIABETES, V59, P2117, DOI 10.2337/db10-0519; Kahler A, 1999, NUTRITION, V15, P819, DOI 10.1016/S0899-9007(99)00212-9; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; Le Foll C, 2009, AM J PHYSIOL-REG I, V297, pR655, DOI 10.1152/ajpregu.00223.2009; Levin BE, 2011, ENDOCRINOLOGY, V152, P2552, DOI 10.1210/en.2011-0194; Luquet Serge, 2009, Front Biosci (Schol Ed), V1, P448; Lutz TA, 1997, AM J PHYSIOL-REG I, V273, pR442, DOI 10.1152/ajpregu.1997.273.1.R442; Marsollier N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006649; Martin C, 2011, PHYSIOL BEHAV, V105, P36, DOI 10.1016/j.physbeh.2011.02.029; Migrenne S, 2011, DIABETES METAB, V37, P83, DOI 10.1016/j.diabet.2010.11.001; Migrenne S, 2006, DIABETES, V55, pS139, DOI 10.2337/db06-S017; Moulle VSF, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00385; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; OOMURA Y, 1975, PHYSIOL BEHAV, V14, P483, DOI 10.1016/0031-9384(75)90015-3; Ooyama K, 2009, J NUTR SCI VITAMINOL, V55, P423, DOI 10.3177/jnsv.55.423; Paulino G, 2008, PHYSIOL BEHAV, V93, P930, DOI 10.1016/j.physbeh.2007.12.015; Penicaud L, 2006, CURR OPIN CLIN NUTR, V9, P458, DOI 10.1097/01.mco.0000232908.84483.e0; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; RITTER S, 1990, AM J PHYSIOL, V258, pR1395, DOI 10.1152/ajpregu.1990.258.6.R1395; Robertson MD, 2006, PHYSIOL BEHAV, V89, P4, DOI 10.1016/j.physbeh.2006.01.030; Ruge T, 2009, J CLIN ENDOCR METAB, V94, P1781, DOI 10.1210/jc.2008-2090; Sanchez-Lasheras C, 2010, FRONT NEUROENDOCRIN, V31, P4, DOI 10.1016/j.yfrne.2009.08.002; SCHARRER E, 1986, AM J PHYSIOL, V250, P1003, DOI 10.1152/ajpregu.1986.250.6.R1003; Wang H, 2012, ANNU REV NUTR, V32, P147, DOI 10.1146/annurev-nutr-071811-150703; Wang H, 2011, CELL METAB, V13, P105, DOI 10.1016/j.cmet.2010.12.006; Wang R, 2006, J NEUROPHYSIOL, V95, P1491, DOI 10.1152/jn.00697.2005; Watson C, 2006, RAT BRAIN STEREOTAXI; WHAYNE TF, 1970, CIRC RES, V26, P545, DOI 10.1161/01.RES.26.5.545; Yue JTY, 2012, CELL METAB, V15, P646, DOI 10.1016/j.cmet.2012.01.013	41	24	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e74021	10.1371/journal.pone.0074021	http://dx.doi.org/10.1371/journal.pone.0074021			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040150	Green Published, gold, Green Submitted			2022-12-25	WOS:000324856500071
J	Schurr, TG; Dulik, MC; Cafaro, TA; Suarez, MF; Urrets-Zavalia, JA; Serra, HM				Schurr, Theodore G.; Dulik, Matthew C.; Cafaro, Thamara A.; Suarez, Maria F.; Urrets-Zavalia, Julio A.; Serra, Horacio M.			Genetic Background and Climatic Droplet Keratopathy Incidence in a Mapuche Population from Argentina	PLOS ONE			English	Article							HEREDITARY OPTIC NEUROPATHY; NATIVE-AMERICAN; MTDNA; POLYMORPHISMS; DEGENERATION; HAPLOTYPE; MUTATION; ESKIMOS; HISTORY; ORIGIN	Purpose: To determine whether the incidence of and susceptibility to climatic droplet keratopathy (CDK), an acquired, often bilateral degenerative corneal disease, is influenced by the genetic background of the individuals who exhibit the disorder. Methods: To determine whether the disease expression was influenced by the genetic ancestry of CDK cases in native Mapuche of the northwest area of Patagonia in Argentina, we examined mitochondrial DNA and Y-chromosome variation in 53 unrelated individuals. Twenty-nine of them were part of the CDK (patient) population, while 24 were part of the control group. The analysis revealed the maternal and paternal lineages that were present in the two study groups. Results: This analysis demonstrated that nearly all persons had a Native American mtDNA background, whereas 50% of the CDK group and 37% of the control group had Native American paternal ancestry, respectively. There was no significant difference in the frequencies of mtDNA haplogroups between the CDK patient and control groups. Although the Y-chromosome data revealed differences in specific haplogroup frequencies between these two groups, there was no statistically significant relationship between individual paternal genetic backgrounds and the incidence or stage of disease. Conclusions: These results indicate a lack of correlation between genetic ancestry as represented by haploid genetic systems and the incidence of CDK in Mapuche populations. In addition, the mtDNA appears to play less of a role in CDK expression than for other complex diseases linked to bioenergetic processes. However, further analysis of the mtDNA genome sequence and other genes involved in corneal function may reveal the more precise role that mitochondria play in the expression of CDK.	[Schurr, Theodore G.; Dulik, Matthew C.] Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA; [Cafaro, Thamara A.; Suarez, Maria F.; Serra, Horacio M.] Natl Univ Cordoba, Fac Chem, CIBIC Ctr Invest Bioquim Clin & Inmunol, Cordoba, Argentina; [Urrets-Zavalia, Julio A.] Catholic Univ Cordoba, Dept Ophthalmol, Cordoba, Argentina	University of Pennsylvania; National University of Cordoba; Catholic University of Cordoba	Serra, HM (corresponding author), Natl Univ Cordoba, Fac Chem, CIBIC Ctr Invest Bioquim Clin & Inmunol, Cordoba, Argentina.	hserra@fcq.unc.edu.ar		SERRA, HORACIO/0000-0003-4979-8642; Suarez, Maria Fernanda/0000-0002-5519-9286	CONICET, (HS, Argentina) [PIP 112-200801-01455]; NICHD (TGS, USA) [2-R24-HD-044964-06]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD044964] Funding Source: NIH RePORTER	CONICET, (HS, Argentina); NICHD (TGS, USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	CONICET PIP 112-200801-01455 (HS, Argentina, www.conicet.gov.ar), NICHD 2-R24-HD-044964-06 (TGS, USA, www.nichd.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON J, 1976, BRIT J OPHTHALMOL, V60, P256, DOI 10.1136/bjo.60.4.256; Atilano SR, 2005, INVEST OPHTH VIS SCI, V46, P1256, DOI 10.1167/iovs.04-1395; Bolnick DA, 2006, MOL BIOL EVOL, V23, P2161, DOI 10.1093/molbev/msl088; Boonstra F, 2002, Ophthalmic Genet, V23, P247, DOI 10.1076/opge.23.4.247.13882; Bortolini MC, 2003, AM J HUM GENET, V73, P524, DOI 10.1086/377588; Brown MD, 2002, HUM GENET, V110, P130, DOI 10.1007/s00439-001-0660-8; Cabana GS, 2006, AM J PHYS ANTHROPOL, V131, P108, DOI 10.1002/ajpa.20410; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; Colyer MH, 2007, BRIT J OPHTHALMOL, V91, P696, DOI 10.1136/bjo.2006.101055; Cristina Kenney M, 2003, Cont Lens Anterior Eye, V26, P139; D'Aurelio M, 2010, HUM MOL GENET, V19, P374, DOI 10.1093/hmg/ddp503; Demarchi DA, 2001, AM J PHYS ANTHROPOL, V115, P199, DOI 10.1002/ajpa.1074; Duhaiman AS, 1997, SAUDI B OPHTHALMOL, V3, P147; Estey T, 2007, EXP EYE RES, V84, P3, DOI 10.1016/j.exer.2006.04.010; FORSIUS H, 1972, ACTA OPHTHALMOL, V50, P532; FORSIUS H, 1973, CAN J OPHTHALMOL, V8, P280; FORSIUS H, 1970, ARCTIC ANTHROPOL, V7, P9; FREEDMAN A, 1973, ARCH OPHTHALMOL-CHIC, V89, P193, DOI 10.1001/archopht.1973.01000040195006; Gaieski JB, 2011, AM J PHYS ANTHROPOL, V146, P392, DOI 10.1002/ajpa.21588; GARNER A, 1973, ARCH OPHTHALMOL-CHIC, V89, P198, DOI 10.1001/archopht.1973.01000040200007; Gokcumen O, 2008, AM J PHYS ANTHROPOL, V136, P278, DOI 10.1002/ajpa.20802; GRAY RH, 1992, SURV OPHTHALMOL, V36, P241, DOI 10.1016/0039-6257(92)90093-9; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; JOHNSON GJ, 1978, BRIT J OPHTHALMOL, V62, P53, DOI 10.1136/bjo.62.1.53; Kaji Y, 2007, BRIT J OPHTHALMOL, V91, P85, DOI 10.1136/bjo.2006.099812; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Lamminen T, 1997, EUR J HUM GENET, V5, P271, DOI 10.1159/000484777; Lee HF, 2006, PEDIATR NEUROL, V34, P464, DOI 10.1016/j.pediatrneurol.2005.12.002; Lell JT, 1997, HUM GENET, V100, P536, DOI 10.1007/s004390050548; Lell JT, 2002, AM J HUM GENET, V70, P192, DOI 10.1086/338457; Menegay M, 2008, INVEST OPHTH VIS SCI, V49, P2829, DOI 10.1167/iovs.07-1438; MERRIWETHER DA, 1995, AM J PHYS ANTHROPOL, V98, P411, DOI 10.1002/ajpa.1330980404; Moraga ML, 2000, AM J PHYS ANTHROPOL, V113, P19, DOI 10.1002/1096-8644(200009)113:1<19::AID-AJPA3>3.0.CO;2-X; Nickerson ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010760; ORMEROD LD, 1994, OPHTHALMOLOGY, V101, P448; RESNIKOFF S, 1988, J FR OPHTALMOL, V11, P733; RESNIKOFF S, 1991, BRIT J OPHTHALMOL, V75, P734, DOI 10.1136/bjo.75.12.734; RODGER FC, 1973, BRIT J OPHTHALMOL, V57, P657, DOI 10.1136/bjo.57.9.657; RODGER FC, 1974, ACTA OPHTHALMOL, V52, P777; Rubinstein S, 2008, HUM BIOL, V80, P203, DOI 10.3378/1534-6617-80.3.203; Schurr TG, 1999, AM J PHYS ANTHROPOL, V108, P1, DOI 10.1002/(SICI)1096-8644(199901)108:1<1::AID-AJPA1>3.0.CO;2-1; Schurr TG, 2012, AM J PHYS ANTHROPOL, V148, P422, DOI 10.1002/ajpa.22068; Seielstad M, 2003, AM J HUM GENET, V73, P700, DOI 10.1086/377589; SINGH D, 1978, T OPHTHAL SOC UK, V98, P10; Sridhar MS, 2000, CORNEA, V19, P455, DOI 10.1097/00003226-200007000-00009; Sudoyo H, 2002, J HUM GENET, V47, P594, DOI 10.1007/s100380200091; TABBARA KF, 1986, INT OPHTHALMOL CLIN, V26, P63, DOI 10.1097/00004397-198602640-00006; Torroni A, 1996, GENETICS, V144, P1835; Torroni A, 1997, AM J HUM GENET, V60, P1107; TORRONI A, 1994, AM J HUM GENET, V55, P760; TORRONI A, 1993, AM J HUM GENET, V53, P563; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Urrets-Zavalia JA, 2006, AM J OPHTHALMOL, V141, P744, DOI 10.1016/j.ajo.2005.10.044; Urrets-Zavalia JA, 2007, CORNEA, V26, P800, DOI 10.1097/ICO.0b013e31806bef31; Yen MY, 2002, JPN J OPHTHALMOL, V46, P45, DOI 10.1016/S0021-5155(01)00460-9; Zhadanov SI, 2010, AM J PHYS ANTHROPOL, V142, P579, DOI 10.1002/ajpa.21281; Zhadanov SI, 2006, J HUM GENET, V51, P161, DOI 10.1007/s10038-005-0340-y; Zhou L, 2009, J PROTEOME RES, V8, P1992, DOI 10.1021/pr800962q	62	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74593	10.1371/journal.pone.0074593	http://dx.doi.org/10.1371/journal.pone.0074593			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040292	gold, Green Published, Green Submitted			2022-12-25	WOS:000324481600137
J	Mihara, K; Ramachandran, R; Renaux, B; Saifeddine, M; Hollenberg, MD				Mihara, Koichiro; Ramachandran, Rithwik; Renaux, Bernard; Saifeddine, Mahmoud; Hollenberg, Morley D.			Neutrophil Elastase and Proteinase-3 Trigger G Protein-biased Signaling through Proteinase-activated Receptor-1 (PAR1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Signaling; Endothelial Cell; G Protein-coupled Receptors (GPCR); Intracellular Trafficking; MAP Kinases (MAPKs); Neutrophil; Thrombin; Biased Signaling; Proteinase-activated Receptor	BREAST-CANCER CELLS; THROMBIN-RECEPTOR; MOLECULAR-CLONING; ENDOTHELIAL-CELLS; FUNCTIONAL SELECTIVITY; TETHERED-LIGAND; C RECEPTOR; EXPRESSION; INFLAMMATION; PLATELET	Background: Proteinase-activated receptor-1 (PAR1) is a proteolytically activated G protein-coupled receptor. Neutrophil-derived enzymes might regulate PAR1 signaling. Results: Neutrophil elastase and proteinase-3 cleave and activate PAR1 signaling that is distinct from thrombin-triggered responses. Neutrophil elastase and proteinase-3 signaling through PAR1 modulates endothelial cell signaling. Conclusion: Neutrophil enzymes are G(i)-biased agonists for PAR1. Significance: Biased PAR1-activating compounds may prove of value as therapeutic agents to treat cardiovascular and inflammatory diseases. Neutrophil proteinases released at sites of inflammation can affect tissue function by either activating or disarming signal transduction mediated by proteinase-activated receptors (PARs). Because PAR1 is expressed at sites where abundant neutrophil infiltration occurs, we hypothesized that neutrophil-derived enzymes might also regulate PAR1 signaling. We report here that both neutrophil elastase and proteinase-3 cleave the human PAR1 N terminus at sites distinct from the thrombin cleavage site. This cleavage results in a disarming of thrombin-activated calcium signaling through PAR1. However, the distinct non-canonical tethered ligands unmasked by neutrophil elastase and proteinase-3, as well as synthetic peptides with sequences derived from these novel exposed tethered ligands, selectively stimulated PAR1-mediated mitogen-activated protein kinase activation. This signaling was blocked by pertussis toxin, implicating a G(i)-triggered signal pathway. We conclude that neutrophil proteinases trigger biased PAR1 signaling and we describe a novel set of tethered ligands that are distinct from the classical tethered ligand revealed by thrombin. We further demonstrate the function of this biased signaling in regulating endothelial cell barrier integrity.	[Mihara, Koichiro; Ramachandran, Rithwik; Renaux, Bernard; Saifeddine, Mahmoud; Hollenberg, Morley D.] Univ Calgary, Inflammat Res Network, Snyder Inst Chron Dis, Calgary, AB T2N 4N1, Canada; [Mihara, Koichiro; Ramachandran, Rithwik; Renaux, Bernard; Saifeddine, Mahmoud; Hollenberg, Morley D.] Univ Calgary, Dept Physiol & Pharmacol, Fac Med, Calgary, AB T2N 4N1, Canada; [Hollenberg, Morley D.] Univ Calgary, Dept Med, Fac Med, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary; University of Calgary	Mihara, K (corresponding author), Univ Calgary, Inflammat Res Network, Snyder Inst Chron Dis, Calgary, AB T2N 4N1, Canada.	mihara@ucalgary.ca; rramacha@ucalgary.ca	Hollenberg, Morley/AFV-6966-2022; Ramachandran, Rithwik/N-7815-2015	Ramachandran, Rithwik/0000-0001-9557-9905	Canadian Foundation Innovation; Alberta Science and Research Authority	Canadian Foundation Innovation(Canada Foundation for Innovation); Alberta Science and Research Authority	The microscopy work was supported by the Snyder Institute Live Cell Imaging Facility funded by an equipment and infrastructure grant from the Canadian Foundation Innovation and the Alberta Science and Research Authority.	Adams MN, 2011, PHARMACOL THERAPEUT, V130, P248, DOI 10.1016/j.pharmthera.2011.01.003; Al-Ani B, 2002, J PHARMACOL EXP THER, V302, P1046, DOI 10.1124/jpet.302.3.1046; Andrade-Gordon P, 1999, P NATL ACAD SCI USA, V96, P12257, DOI 10.1073/pnas.96.22.12257; Ayoub MA, 2010, FASEB J, V24, P3522, DOI 10.1096/fj.10-154997; Bae JS, 2008, J THROMB HAEMOST, V6, P954, DOI 10.1111/j.1538-7836.2008.02924.x; Bae JS, 2007, BLOOD, V110, P3909, DOI 10.1182/blood-2007-06-096651; Blackburn JS, 2009, ONCOGENE, V28, P4237, DOI 10.1038/onc.2009.272; Blackburn JS, 2008, AM J PATHOL, V173, P1736, DOI 10.2353/ajpath.2008.080512; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Burgun C, 2000, FEBS LETT, V484, P189, DOI 10.1016/S0014-5793(00)02153-0; Chackalamannil S, 2005, J MED CHEM, V48, P5884, DOI 10.1021/jm0502236; Chackalamannil S, 2008, J MED CHEM, V51, P3061, DOI 10.1021/jm800180e; Jaffre F, 2012, CIRCULATION, V125, P2993, DOI 10.1161/CIRCULATIONAHA.111.066787; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kenakin T, 2013, BRIT J PHARMACOL, V168, P554, DOI 10.1111/j.1476-5381.2012.02223.x; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Knecht W, 2007, J BIOL CHEM, V282, P26089, DOI 10.1074/jbc.M703840200; LEROYVIARD K, 1989, EXP CELL RES, V181, P1, DOI 10.1016/0014-4827(89)90177-8; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; McLaughlin JN, 2005, J BIOL CHEM, V280, P25048, DOI 10.1074/jbc.M414090200; MOLINO M, 1995, J BIOL CHEM, V270, P11168, DOI 10.1074/jbc.270.19.11168; Mosnier LO, 2012, BLOOD, V120, P5237, DOI 10.1182/blood-2012-08-452169; NYSTEDT S, 1995, J BIOL CHEM, V270, P5950, DOI 10.1074/jbc.270.11.5950; NYSTEDT S, 1995, EUR J BIOCHEM, V232, P84, DOI 10.1111/j.1432-1033.1995.tb20784.x; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Ramachandran R, 2008, BRIT J PHARMACOL, V153, pS263, DOI 10.1038/sj.bjp.0707507; Ramachandran R, 2012, NAT REV DRUG DISCOV, V11, P69, DOI 10.1038/nrd3615; Ramachandran R, 2011, J BIOL CHEM, V286, P24638, DOI 10.1074/jbc.M110.201988; Ramachandran R, 2009, MOL PHARMACOL, V76, P791, DOI 10.1124/mol.109.055509; RASMUSSEN UB, 1991, FEBS LETT, V288, P123, DOI 10.1016/0014-5793(91)81017-3; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Russo A, 2009, P NATL ACAD SCI USA, V106, P6393, DOI 10.1073/pnas.0810687106; Schuepbach RA, 2012, J THROMB HAEMOST, V10, P1675, DOI 10.1111/j.1538-7836.2012.04825.x; Schuepbach RA, 2008, BLOOD, V111, P2667, DOI 10.1182/blood-2007-09-113076; Schuepbach RA, 2009, THROMB HAEMOSTASIS, V101, P724, DOI 10.1160/TH08-10-0632; Soh UJK, 2011, P NATL ACAD SCI USA, V108, pE1372, DOI 10.1073/pnas.1112482108; Tressel SL, 2011, EMBO MOL MED, V3, P370, DOI 10.1002/emmm.201100145; Trivedi V, 2009, CELL, V137, P332, DOI 10.1016/j.cell.2009.02.018; Verrall S, 1997, J BIOL CHEM, V272, P6898, DOI 10.1074/jbc.272.11.6898; Villegas-Mendez A, 2007, J THROMB HAEMOST, V5, P980, DOI 10.1111/j.1538-7836.2007.02480.x; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; Yang E, 2009, CANCER RES, V69, P6223, DOI 10.1158/0008-5472.CAN-09-0187; Zania P, 2009, J PHARMACOL EXP THER, V328, P378, DOI 10.1124/jpet.108.145664	49	82	84	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32979	32990		10.1074/jbc.M113.483123	http://dx.doi.org/10.1074/jbc.M113.483123			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24052258	Green Published, hybrid			2022-12-25	WOS:000328841700015
J	Migliore, J; Baumel, A; Juin, M; Fady, B; Roig, A; Duong, N; Medail, F				Migliore, Jeremy; Baumel, Alex; Juin, Marianick; Fady, Bruno; Roig, Anne; Nathalie Duong; Medail, Frederic			Surviving in Mountain Climate Refugia: New Insights from the Genetic Diversity and Structure of the Relict Shrub Myrtus nivellei (Myrtaceae) in the Sahara Desert	PLOS ONE			English	Article							EUROPAEA SUBSP-LAPERRINEI; MULTILOCUS GENOTYPE DATA; CLONAL GROWTH; PERSISTENCE; INFERENCE; OLEACEAE; PLANTS; TREE; L.; DIVERSIFICATION	The identification of past glacial refugia has become a key topic for conservation under environmental change, since they contribute importantly to shaping current patterns of biodiversity. However, little attention has been paid so far to interglacial refugia despite their key role for the survival of relict species currently occurring in climate refugia. Here, we focus on the genetic consequences of range contraction on the relict populations of the evergreen shrub Myrtus nivellei, endemic in the Saharan mountains since at least the end of the last Green Sahara period, around 5.5 ka B.P. Multilocus genotypes (nuclear microsatellites and AFLP) were obtained from 215 individuals collected from 23 wadis (temporary rivers) in the three main mountain ranges in southern Algeria (the Hoggar, Tassili n'Ajjer and Tassili n'Immidir ranges). Identical genotypes were found in several plants growing far apart within the same wadis, a pattern taken as evidence of clonality. Multivariate analyses and Bayesian clustering revealed that genetic diversity was mainly structured among the mountain ranges, while low isolation by distance was observed within each mountain range. The range contraction induced by the last episode of aridification has likely increased the genetic isolation of the populations of M. nivellei, without greatly affecting the genetic diversity of the species as a whole. The pattern of genetic diversity observed here suggests that high connectivity may have prevailed during humid periods, which is consistent with recent paleoenvironmental reconstructions.	[Migliore, Jeremy; Baumel, Alex; Juin, Marianick; Nathalie Duong; Medail, Frederic] Aix Marseille Univ, Avignon Univ, UMR CNRS IRD 7263 237, Inst Mediterraneen Biodivers & Ecol Marine & Cont, Aix En Provence, France; [Fady, Bruno; Roig, Anne] Ecol Forets Mediterraneennes URFM, INRA, UR 629, Avignon, France	Avignon Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); INRAE	Migliore, J (corresponding author), Aix Marseille Univ, Avignon Univ, UMR CNRS IRD 7263 237, Inst Mediterraneen Biodivers & Ecol Marine & Cont, Campus Aix Technopole Environnement Arbois Medite, Aix En Provence, France.	jeremy.migliore@imbe.fr	Baumel, Alex/AAD-4699-2021	Migliore, Jeremy/0000-0002-7534-9667	Provence-Alpes-Cote d'Azur Region; Conservatoire Botanique National de Corse (Office de l'Environnement de la Corse); Conservatoire Botanique National Mediterraneen de Porquerolles	Provence-Alpes-Cote d'Azur Region(Region Provence-Alpes-Cote d'Azur); Conservatoire Botanique National de Corse (Office de l'Environnement de la Corse)(Region Corse); Conservatoire Botanique National Mediterraneen de Porquerolles	This study was supported by the Provence-Alpes-Cote d'Azur Region, the Conservatoire Botanique National de Corse (Office de l'Environnement de la Corse) and the Conservatoire Botanique National Mediterraneen de Porquerolles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoun F, 2002, CR BIOL, V325, P617, DOI 10.1016/S1631-0691(02)01433-6; Albaladejo RG, 2009, PLANT BIOLOGY, V11, P442, DOI 10.1111/j.1438-8677.2008.00121.x; Albaladejo RG, 2010, AM J BOT, V97, pE23, DOI 10.3732/ajb.1000060; Anthelme F, 2008, J ARID ENVIRON, V72, P2232, DOI 10.1016/j.jaridenv.2008.07.003; Anthelme F, 2008, PLANT ECOL, V198, P73, DOI 10.1007/s11258-007-9386-6; Aparicio A, 2012, DIVERS DISTRIB, V18, P226, DOI 10.1111/j.1472-4642.2011.00823.x; Arenas M, 2012, MOL BIOL EVOL, V29, P207, DOI 10.1093/molbev/msr187; Ashcroft MB, 2010, J BIOGEOGR, V37, P1407, DOI 10.1111/j.1365-2699.2010.02300.x; Baali-Cherif D, 2005, ANN BOT-LONDON, V96, P823, DOI 10.1093/aob/mci232; Bakker EG, 2001, PLANT BIOLOGY, V3, P616, DOI 10.1055/s-2001-19365; Battandier J.B., 1911, B SOC BOT FR, V58, P669, DOI [10.1080/00378941.1911.10832371, DOI 10.1080/00378941.1911.10832371]; Bennett KD, 2008, QUATERNARY SCI REV, V27, P2449, DOI 10.1016/j.quascirev.2008.08.019; Besnard G, 2007, HEREDITY, V99, P649, DOI 10.1038/sj.hdy.6801051; Besnard G, 2012, ACTA BOT GALLICA, V159, P319, DOI 10.1080/12538078.2012.724281; Biebach H, 2000, IBIS, V142, P623, DOI 10.1111/j.1474-919X.2000.tb04462.x; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Brito JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014734; Brochet AL, 2009, ECOGRAPHY, V32, P919, DOI 10.1111/j.1600-0587.2009.05757.x; Crawford R.M.M., 2008, ECOLOGICAL LIMITS CL; Danin A, 1999, BOT REV, V65, P93, DOI 10.1007/BF02857625; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; Douady CJ, 2003, P NATL ACAD SCI USA, V100, P8325, DOI 10.1073/pnas.0832467100; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Drake NA, 2008, PALAEOGEOGR PALAEOCL, V263, P131, DOI 10.1016/j.palaeo.2008.02.005; Dubief J, 1959, MEMOIRE I RECHERCHES; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Garcia D, 2003, J VEG SCI, V14, P921, DOI 10.1111/j.1654-1103.2003.tb02227.x; Genner MJ, 2010, J FISH BIOL, V76, P435, DOI 10.1111/j.1095-8649.2009.02549.x; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Govaerts R., 2008, WORLD CHECKLIST MYRT; Habel JC, 2010, RELICT SPECIES: PHYLOGEOGRAPHY AND CONSERVATION BIOLOGY, P1, DOI 10.1007/978-3-540-92160-8; Hampe A, 2013, NEW PHYTOL, V197, P16, DOI 10.1111/nph.12059; Hampe A, 2011, ANNU REV ECOL EVOL S, V42, P313, DOI 10.1146/annurev-ecolsys-102710-145015; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Honnay O, 2005, OIKOS, V108, P427, DOI 10.1111/j.0030-1299.2005.13569.x; Jombart T., 2010, BMC GENET, V11, P1, DOI [10.1186/1471-2156-11-94, DOI 10.1186/1471-2156-11-94]; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Kropelin S, 2008, SCIENCE, V320, P765, DOI 10.1126/science.1154913; Kropf M, 2003, MOL ECOL, V12, P931, DOI 10.1046/j.1365-294X.2003.01781.x; Kropf M, 2012, J BIOGEOGR, V39, P799, DOI 10.1111/j.1365-2699.2011.02668.x; Leredde C, 1957, TRAVAUX I RECHERCHES, VII; Lezine AM, 2008, POLLEN OUTIL ETUDE E; Maley J, 1981, TRAVAUX DOCUMENTS OR, V129; Maley J, 2011, PALAEOECO A, V30, P227; May MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008346; Medail F, 2009, J BIOGEOGR, V36, P1333, DOI 10.1111/j.1365-2699.2008.02051.x; Migliore J, 2012, J BIOGEOGR, V39, P942, DOI 10.1111/j.1365-2699.2011.02646.x; Moreau R. E., 1961, Ibis, V103a, P373, DOI 10.1111/j.1474-919X.1961.tb02454.x; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Feliner GN, 2011, TAXON, V60, P365, DOI 10.1002/tax.602007; Osborne AH, 2008, P NATL ACAD SCI USA, V105, P16444, DOI 10.1073/pnas.0804472105; PARKS JC, 1993, AM J BOT, V80, P537, DOI 10.2307/2445369; Patiny S, 2007, INSECT SYST EVOL, V38, P19, DOI 10.1163/187631207788784012; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pepper M, 2011, MOL PHYLOGENET EVOL, V61, P750, DOI 10.1016/j.ympev.2011.08.009; Petit-Maire N., 1991, PALEOENVIRONNEMENTS; Pichot C, 2001, NATURE, V412, P39, DOI 10.1038/35083687; Pritchard JK, 2000, GENETICS, V155, P945; QUEZEL P, 1978, ANN MO BOT GARD, V65, P479, DOI 10.2307/2398860; Quezel P, 1997, REV ECOLOGY DESERT C, P159; Quezel P, 1958, MISSION BOT TIBESTI, P4; Quezel P., 1965, VEGETATION SAHARA TC; Quezel P., 1960, LIBYCA, V6/7, P211; Quezel P, 1954, I RECHERCHES SAHARIE, V2; Rognon P., 1980, PALAEOECOL AFR, V27, P45; Rossetto M, 2005, J ECOL, V93, P906, DOI 10.1111/j.1365-2745.2005.01046.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Salewski V, 2010, J ORNITHOL, V151, P371, DOI 10.1007/s10336-009-0464-5; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Swezey CS, 2009, J AFR EARTH SCI, V53, P89, DOI 10.1016/j.jafrearsci.2008.08.001; Trape S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004400; Vonlanthen B, 2010, AM J BOT, V97, P234, DOI 10.3732/ajb.0800329; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Watrin J, 2009, CR GEOSCI, V341, P656, DOI 10.1016/j.crte.2009.06.007; Weiss S, 2007, PHYLOGEOGRAPHY SO EU; Wesche K, 2011, FLORA, V206, P91, DOI 10.1016/j.flora.2010.01.012; WICKENS G E, 1976, Kew Bulletin, V31, P105, DOI 10.2307/4108999; Wilson JS, 2012, DIVERS DISTRIB, V18, P1139, DOI 10.1111/j.1472-4642.2012.00902.x; Wright S, 1943, GENETICS, V28, P114	87	31	32	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73795	10.1371/journal.pone.0073795	http://dx.doi.org/10.1371/journal.pone.0073795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058489	Green Published, Green Submitted, gold			2022-12-25	WOS:000324695900019
J	Obata, K; Kojima, T; Masaki, T; Okabayashi, T; Yokota, S; Hirakawa, S; Nomura, K; Takasawa, A; Murata, M; Tanaka, S; Fuchimoto, J; Fujii, N; Tsutsumi, H; Himi, T; Sawada, N				Obata, Kazufumi; Kojima, Takashi; Masaki, Tomoyuki; Okabayashi, Tamaki; Yokota, Shinichi; Hirakawa, Satoshi; Nomura, Kazuaki; Takasawa, Akira; Murata, Masaki; Tanaka, Satoshi; Fuchimoto, Jun; Fujii, Nobuhiro; Tsutsumi, Hiroyuki; Himi, Tetsuo; Sawada, Norimasa			Curcumin Prevents Replication of Respiratory Syncytial Virus and the Epithelial Responses to It in Human Nasal Epithelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; TIGHT JUNCTIONS; VIRAL REPLICATION; CYCLOOXYGENASE 2; M2-1 PROTEIN; IN-VITRO; ACTIVATION; EXPRESSION; INHIBITOR; INDUCTION	The human nasal epithelium is the first line of defense during respiratory virus infection. Respiratory syncytial virus (RSV) is the major cause of bronchitis, asthma and severe lower respiratory tract disease in infants and young children. We previously reported in human nasal epithelial cells (HNECs), the replication and budding of RSV and the epithelial responses, including release of proinflammatory cytokines and enhancement of the tight junctions, are in part regulated via an NF-kappa B pathway. In this study, we investigated the effects of the NF-kappa B in HNECs infected with RSV. Curcumin prevented the replication and budding of RSV and the epithelial responses to it without cytotoxicity. Furthermore, the upregulation of the epithelial barrier function caused by infection with RSV was enhanced by curcumin. Curcumin also has wide pharmacokinetic effects as an inhibitor of NF-kappa B, eIF-2 alpha dephosphorylation, proteasome and COX2. RSV-infected HNECs were treated with the eIF-2 alpha dephosphorylation blocker salubrinal and the proteasome inhibitor MG132, and inhibitors of COX1 and COX2. Treatment with salubrinal, MG132 and COX2 inhibitor, like curcumin, prevented the replication of RSV and the epithelial responses, and treatment with salubrinal and MG132 enhanced the upregulation of tight junction molecules induced by infection with RSV. These results suggest that curcumin can prevent the replication of RSV and the epithelial responses to it without cytotoxicity and may act as therapy for severe lower respiratory tract disease in infants and young children caused by RSV infection.	[Obata, Kazufumi; Masaki, Tomoyuki; Nomura, Kazuaki; Himi, Tetsuo] Sapporo Med Univ, Sch Med, Dept Otolaryngol, Sapporo, Hokkaido, Japan; [Obata, Kazufumi; Kojima, Takashi; Nomura, Kazuaki; Takasawa, Akira; Murata, Masaki; Tanaka, Satoshi; Fuchimoto, Jun; Sawada, Norimasa] Sapporo Med Univ, Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan; [Kojima, Takashi] Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Cell Sci, Sapporo, Hokkaido, Japan; [Okabayashi, Tamaki] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 565, Japan; [Yokota, Shinichi; Fujii, Nobuhiro] Sapporo Med Univ, Sch Med, Dept Microbiol, Sapporo, Hokkaido, Japan; [Hirakawa, Satoshi; Tsutsumi, Hiroyuki] Sapporo Med Univ, Sch Med, Dept Pediat, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Osaka University; Sapporo Medical University; Sapporo Medical University	Kojima, T (corresponding author), Sapporo Med Univ, Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan.	ktakashi@sapmed.ac.jp	Yokota, Shin-ichi/K-8139-2019	Yokota, Shin-ichi/0000-0002-0831-3429	Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare of Japan; Japan Science and Technology Agency; Program for developing the supporting system for upgrading education and research; Grants-in-Aid for Scientific Research [24659750] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Program for developing the supporting system for upgrading education and research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology and Ministry of Health, Labor, and Welfare of Japan, the Japan Science and Technology Agency and the Program for developing the supporting system for upgrading education and research.	Al-Sadi RM, 2007, J IMMUNOL, V178, P4641, DOI 10.4049/jimmunol.178.7.4641; Bitko V, 1997, VIROLOGY, V232, P369, DOI 10.1006/viro.1997.8582; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chen LX, 2010, MOL BIOL REP, V37, P3105, DOI 10.1007/s11033-009-9888-5; Choudhary S, 2005, J VIROL, V79, P8948, DOI 10.1128/JVI.79.14.8948-8959.2005; COLLINS PL, 1991, J GEN VIROL, V72, P3095, DOI 10.1099/0022-1317-72-12-3095; Dikshit P, 2006, BIOCHEM BIOPH RES CO, V342, P1323, DOI 10.1016/j.bbrc.2006.02.104; Groskreutz DJ, 2010, J BIOL CHEM, V285, P24023, DOI 10.1074/jbc.M109.077321; Groskreutz DJ, 2006, J IMMUNOL, V176, P1733, DOI 10.4049/jimmunol.176.3.1733; Guttman JA, 2009, BBA-BIOMEMBRANES, V1788, P832, DOI 10.1016/j.bbamem.2008.10.028; Hansdottir S, 2010, J IMMUNOL, V184, P965, DOI 10.4049/jimmunol.0902840; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; Koizumi JI, 2008, MOL PHARMACOL, V74, P432, DOI 10.1124/mol.107.043711; Kurose M, 2007, CELL TISSUE RES, V330, P63, DOI 10.1007/s00441-007-0453-z; LEVINE S, 1987, J GEN VIROL, V68, P2521, DOI 10.1099/0022-1317-68-9-2521; Lindcluist ME, 2011, VIROLOGY, V413, P103, DOI 10.1016/j.virol.2011.02.009; Liu TS, 2005, VIROLOGY, V343, P12, DOI 10.1016/j.virol.2005.08.012; Lupfer C, 2010, VIRUS RES, V149, P36, DOI 10.1016/j.virusres.2009.12.010; Masaki T, 2011, MOL BIOL CELL, V22, P2144, DOI 10.1091/mbc.E10-11-0875; Milacic V, 2008, CANCER RES, V68, P7283, DOI 10.1158/0008-5472.CAN-07-6246; Okabayashi T, 2011, VIRUS RES, V160, P360, DOI 10.1016/j.virusres.2011.07.011; Plummer SM, 1999, ONCOGENE, V18, P6013, DOI 10.1038/sj.onc.1202980; Radi ZA, 2010, VIRAL IMMUNOL, V23, P43, DOI 10.1089/vim.2009.0042; Rafiee P, 2009, AM J PHYSIOL-GASTR L, V296, pG388, DOI 10.1152/ajpgi.90428.2008; Reimers K, 2005, VIROLOGY, V331, P260, DOI 10.1016/j.virol.2004.10.031; Richardson JY, 2005, J IMMUNOL, V174, P4356, DOI 10.4049/jimmunol.174.7.4356; Sawada Norimasa, 2003, Medical Electron Microscopy, V36, P147, DOI 10.1007/s00795-003-0219-y; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; SCHNEEBERGER EE, 1992, AM J PHYSIOL, V262, pL647, DOI 10.1152/ajplung.1992.262.6.L647; SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995; Sutherland KA, 2001, VIROLOGY, V288, P295, DOI 10.1006/viro.2001.1105; Taylor GM, 2011, BLOOD, V118, P5528, DOI 10.1182/blood-2011-04-347112; Tayyari F, 2011, NAT MED, V17, P1132, DOI 10.1038/nm.2444; Thomas LH, 1998, J IMMUNOL, V161, P1007; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Wang N, 2012, DIGEST DIS SCI, V57, P1792, DOI 10.1007/s10620-012-2094-7; Wilken R, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-12; Wong TS, 2010, ANTICANCER RES, V30, P2851; Yoboua F, 2010, J VIROL, V84, P7267, DOI 10.1128/JVI.00142-10; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356	42	42	45	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e70225	10.1371/journal.pone.0070225	http://dx.doi.org/10.1371/journal.pone.0070225			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058438	Green Published, gold, Green Submitted			2022-12-25	WOS:000324695900002
J	Goodman, KR; O'Grady, P				Goodman, Kari Roesch; O'Grady, Patrick			Molecular Phylogeny and Biogeography of the Hawaiian Craneflies Dicranomyia (Diptera: Limoniidae)	PLOS ONE			English	Article							EVOLUTION; DROSOPHILA; RADIATION; INFERENCE; ORIGIN; AGES; FLY	The Hawaiian Diptera offer an opportunity to compare patterns of diversification across large and small endemic radiations with varying species richness and levels of single island endemism. The craneflies (Limoniidae: Dicranomyia) represent a small radiation of 13 described species that have diversified within the Hawaiian Islands. We used Bayesian and maximum likelihood approaches to generate a molecular phylogeny of the Hawaiian Dicranomyia using a combination of nuclear and mitochondrial loci, estimated divergence times and reconstructed ancestral ranges. Divergence time estimation and ancestral range reconstruction suggest that the colonization that led to most of the diversity within the craneflies arrived prior to the formation of Kauai and demonstrates that the two major clades within that radiation contrast sharply in their patterns of diversification.	[Goodman, Kari Roesch; O'Grady, Patrick] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Goodman, Kari Roesch] Bernice P Bishop Museum, Honolulu, HI USA	University of California System; University of California Berkeley	Goodman, KR (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	krgoodman@berkeley.edu	O'Grady, Patrick/J-3421-2019	O'Grady, Patrick/0000-0002-6075-8951	NSF DEB award [0842348]	NSF DEB award	This work was funded by an NSF DEB award 0842348 to PMO (http://www.nsf.gov/div/index.jsp?div = DEB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C. P., 1914, Annals of the Entomological Society of America, V7; Alexander C. P., 1947, Occasional Papers of the Bishop Museum Honolulu, V18, P337; Alexander C. P., 1921, Bulletin of the Brooklyn Entomological Society, V16, P9; Alexander CP, 1935, BP BISHOP MUSEUM B, V142, P123; Alexander CP, 1932, OCCASIONAL PAPERS BP, V9, P1; Alexander CP, 1920, CORNELL U AGR EXPT S, V38, P693; Alexander CP, 1933, BP BISHOP MUSEUM B, V113, P53; Baldwin BG, 2006, ANN MO BOT GARD, V93, P64, DOI 10.3417/0026-6493(2006)93[64:CPAPOE]2.0.CO;2; Bennett GM, 2012, MOL PHYLOGENET EVOL, V65, P705, DOI 10.1016/j.ympev.2012.07.024; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Brown J. M., 2006, INSTRUMENTA BIODIVER, V7, P1; Brunetti E, 1912, FAUNA BRIT INDIA INC, V1, P1, DOI DOI 10.5962/BHL.TITLE.19492; Byers G.W., 1982, Memoirs of the Entomological Society of Washington, P37; BYERS GW, 1985, INT J ENTOMOL, V27, P239; BYERS GW, 1994, P ENTOMOL SOC WASH, V96, P496; Carlquist S, 1965, ISLAND LIFE; CARR G D, 1985, Allertonia, V4, P1; Carson Hampton L., 1995, P14; CARSON HL, 1976, ANNU REV ECOL SYST, V7, P311, DOI 10.1146/annurev.es.07.110176.001523; Clague DA, 1987, VOLCANISM HAWAII, V1350, P5; Clague David A., 1996, P35; Coyne JA, 2004, SPECIATION, V37; Ribeiro GC, 2008, INVERTEBR SYST, V22, P627, DOI 10.1071/IS08017; Douglas Pratt H., 2005, HAWAIIAN HONEYCREEPE; Drummond AJ, 2007, ROUGH GUIDE BEAST 1; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duncan RA, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000704; EDWARDS F. W., 1927, ANN & MAG NAT HIST, V20, P236; EDWARDS F. W., 1928, P23; Eldredge LG, 2003, BISHOP MUSEUM OCCASI, V75; EVENHUIS NL, 2004, CATALOGUE FOSSIL FLI; Evenhuis NL, 2009, DIPTERA DIVERSITY ST, P459; Evenhuis NL, 2013, COMMUNICATION; Fleischer RC, 1998, MOL ECOL, V7, P533, DOI 10.1046/j.1365-294x.1998.00364.x; Funk VA, 1995, BIOGEOGRAPHIC PATTER; Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875; Goodman KR, 2012, EVOLUTION, V66, P2798, DOI 10.1111/j.1558-5646.2012.01643.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hardy D.E., 1960, INSECTS HAWAII, V10, P1; Heads M, 2005, CLADISTICS, V21, P62, DOI 10.1111/j.1096-0031.2005.00052.x; Ho SYW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001615; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Juvik J. O., 1998, ATLAS HAWAII, P103; KAMBYSELLIS MP, 1995, CURR BIOL, V5, P1129, DOI 10.1016/S0960-9822(95)00229-6; Kaneshiro Kenneth Y., 1997, Pacific Science, V51, P450; Krzeminski Wieslaw, 2001, Polskie Pismo Entomologiczne, V70, P333; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lerner HRL, 2011, CURR BIOL, V21, P1838, DOI 10.1016/j.cub.2011.09.039; Liebherr JK, 2000, HAWAIIAN CARABIDAE 1; MADDISON WP, 2000, MACCLADE VERSION 4; Magnacca KN, 2006, CLADISTICS, V22, P393, DOI 10.1111/j.1096-0031.2006.00119.x; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; MOORE JG, 1992, GEOL SOC AM BULL, V104, P1471, DOI 10.1130/0016-7606(1992)104<1471:VGAEOT>2.3.CO;2; Moulton JK, 2004, MOL PHYLOGENET EVOL, V31, P363, DOI 10.1016/S1055-7903(03)00284-7; NISHIDA G. M., 2002, HAWAIIAN TERRESTRIAL; Nitta JH, 2008, MOL PHYLOGENET EVOL, V46, P1182, DOI 10.1016/j.ympev.2007.12.021; O'Grady PM, 2012, RAPIDLY EVOLVING GENES AND GENETIC SYSTEMS, P176; O'Grady PM, 2011, MOL PHYLOGENET EVOL, V58, P244, DOI 10.1016/j.ympev.2010.11.022; OGrady PM, 2009, ENCY ISLANDS, P232; Oosterbroek P., 2011, CATALOGUE CRANEFLIES; Ort BS, 2012, PLOS ONE, DOI [10.1371/journal.pone.0040550, DOI 10.1371/J0URNAL.P0NE.0040550]; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Price Jonathan Paul, 2004, Pacific Science, V58, P27, DOI 10.1353/psc.2004.0008; PRITCHARD G, 1983, ANNU REV ENTOMOL, V28, P1, DOI 10.1146/annurev.en.28.010183.000245; Quek SP, 2004, EVOLUTION, V58, P554, DOI 10.1111/j.0014-3820.2004.tb01678.x; R Core Team, 2012, R LANG ENV STAT COMP; Rambaut A, 2012, TRAC V1 7 2 OBT WORK; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Roderick GK, 1998, MOL ECOL, V7, P519, DOI 10.1046/j.1365-294x.1998.00309.x; Rubinoff D, 2010, P NATL ACAD SCI USA, V107, P5903, DOI 10.1073/pnas.0912501107; Sharp WD, 2006, SCIENCE, V313, P1281, DOI 10.1126/science.1128489; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swezey OH, 1915, P HAWAIIAN ENTOMOLOG, V3, P87; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Wagner WL, 1995, HAWAIIAN BIOGEOGRAPH; Williams F. X., 1943, Proceedings of the Hawaiian Entomological Society, V11, P313; WILSON JT, 1963, CAN J PHYS, V41, P863, DOI 10.1139/p63-094	78	8	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73019	10.1371/journal.pone.0073019	http://dx.doi.org/10.1371/journal.pone.0073019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058455	Green Published, Green Submitted, gold			2022-12-25	WOS:000324408400014
J	Fiz-Palacios, O; Romeralo, M; Ahmadzadeh, A; Weststrand, S; Ahlberg, PE; Baldauf, S				Fiz-Palacios, Omar; Romeralo, Maria; Ahmadzadeh, Afsaneh; Weststrand, Stina; Ahlberg, Per Erik; Baldauf, Sandra			Did Terrestrial Diversification of Amoebas (Amoebozoa) Occur in Synchrony with Land Plants?	PLOS ONE			English	Article							VASE-SHAPED MICROFOSSILS; DIVERGENCE TIMES; CHUAR GROUP; PHYLOGENY; CLASSIFICATION; EVOLUTION; ORIGIN; CALIBRATION; DIVERSITY; TAXONOMY	Evolution of lineage diversification through time is an active area of research where much progress has been made in the last decade. Contrary to the situation in animals and plants little is known about how diversification rates have evolved in most major groups of protist. This is mainly due to uncertainty about phylogenetic relationships, scarcity of the protist fossil record and the unknown diversity within these lineages. We have analyzed the evolutionary history of the supergroup Amoebozoa over the last 1000 million years using molecular dating and species number estimates. After an origin in the marine environment we have dated the colonization of terrestrial habitats by three distinct lineages of Amoebozoa: Dictyostelia, Myxogastria and Arcellinida. The common ancestor of the two sister taxa, Dictyostelia and Myxogastria, appears to have existed before the colonization of land by plants. In contrast Arcellinida seems to have diversify in synchrony with land plant radiation, and more specifically with that of mosses. Detection of acceleration of diversification rates in Myxogastria and Arcellinida points to a co-evolution within the terrestrial habitats, where land plants and the amoebozoans may have interacted during the evolution of these new ecosystems.	[Fiz-Palacios, Omar; Romeralo, Maria; Ahmadzadeh, Afsaneh; Weststrand, Stina; Baldauf, Sandra] Evolutionary Biol Ctr, Systemat Biol Program, Dept Organismal Biol, Uppsala, Sweden; [Ahlberg, Per Erik] Evolutionary Biol Ctr, Evolut & Dev Program, Dept Organismal Biol, Uppsala, Sweden		Fiz-Palacios, O (corresponding author), Evolutionary Biol Ctr, Systemat Biol Program, Dept Organismal Biol, Norbyvagen 18 D, Uppsala, Sweden.	fizpal@gmail.com		Baldauf, Sandra/0000-0003-4485-6671; Ahlberg, Per/0000-0001-9054-2900	Marie Curie Intra European Fellowship [PIEF-GA-2009-236501]; Swedish Research Council [2007-8731]	Marie Curie Intra European Fellowship(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission)	MR was supported by a Marie Curie Intra European Fellowship (PIEF-GA-2009-236501). This work was supported by a Swedish Research Council Linne grant (2007-8731) to SLB and PAE, with a personal sub-grant awarded to OFP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Berney C, 2006, P ROY SOC B-BIOL SCI, V273, P1867, DOI 10.1098/rspb.2006.3537; Bhattacharya D, 2010, TIMETREE LIFE, P116; BONFIELD JK, 1995, NUCLEIC ACIDS RES, V23, P1406, DOI 10.1093/nar/23.8.1406; Caron DA, 2012, ANNU REV MAR SCI, V4, P467, DOI 10.1146/annurev-marine-120709-142802; Cavalier-Smith T, 2009, J EUKARYOT MICROBIOL, V56, P26, DOI 10.1111/j.1550-7408.2008.00373.x; Clarke JT, 2011, NEW PHYTOL, V192, P266, DOI 10.1111/j.1469-8137.2011.03794.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EDWARDS D, 1980, NATURE, V287, P41, DOI 10.1038/287041a0; Fiz-Palacios O, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-341; Glime JM, 2012, BRYOPHYTE ECOLOGY, V2, P47; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1, DOI 10.1016/B978-0-444-59425-9.00001-9; GRAY J, 1993, PALAEOGEOGR PALAEOCL, V104, P153, DOI 10.1016/0031-0182(93)90127-5; Groussin M, 2011, MOL PHYLOGENET EVOL, V61, P157, DOI 10.1016/j.ympev.2011.06.008; Hackett Jeremiah D., 2007, P109; Heidel AJ, 2011, GENOME RES, V21, P1882, DOI 10.1101/gr.121137.111; Knoll AH, 2006, PHILOS T R SOC B, V361, P1023, DOI 10.1098/rstb.2006.1843; Lahr DJG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022780; Lara E, 2011, PROTIST, V162, P14, DOI 10.1016/j.protis.2010.05.003; Li CW, 1998, SCIENCE, V279, P879, DOI 10.1126/science.279.5352.879; Magallon S, 2009, TIMETREE LIFE, P133; Miller CN, 1999, BOT REV, V65, P239, DOI 10.1007/BF02857631; Minge MA, 2009, P ROY SOC B-BIOL SCI, V276, P597, DOI 10.1098/rspb.2008.1358; Near TJ, 2005, AM NAT, V165, P137, DOI 10.1086/427734; Nikolaev SI, 2006, INT J SYST EVOL MICR, V56, P1449, DOI 10.1099/ijs.0.63763-0; Parfrey LW, 2011, P NATL ACAD SCI USA, V108, P13624, DOI 10.1073/pnas.1110633108; Pawlowski J, 2009, J EUKARYOT MICROBIOL, V56, P16, DOI 10.1111/j.1550-7408.2008.00379.x; Porter SM, 2000, PALEOBIOLOGY, V26, P360, DOI 10.1666/0094-8373(2000)026<0360:TAITNE>2.0.CO;2; Porter SM, 2003, J PALEONTOL, V77, P409, DOI 10.1666/0022-3360(2003)077<0409:VMFTNC>2.0.CO;2; Raper K. B., 1984, DICTYOSTELIDS; Retallack G.J., 2008, SOILS INTRO PALEOPED; Romeralo M, 2007, EUKARYOT CELL, V6, P110, DOI 10.1128/EC.00233-06; Romeralo M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-84; Rubinstein CV, 2010, NEW PHYTOL, V188, P365, DOI 10.1111/j.1469-8137.2010.03433.x; Sanderson MJ, 2003, AM J BOT, V90, P954, DOI 10.3732/ajb.90.6.954; Sauquet H, 2012, SYST BIOL, V61, P289, DOI 10.1093/sysbio/syr116; Schenk JJ, 2010, SYST BOT, V35, P578, DOI 10.1600/036364410792495809; Schmidt AR, 2006, NATURE, V444, P835, DOI 10.1038/444835a; Schnitter Maria, 2012, SYLLABUS PLANZENFA 1, P46; Schroter D, 2003, OIKOS, V102, P294, DOI 10.1034/j.1600-0579.2003.12064.x; Shadwick LL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006754; Signor P.W., 1992, Topics in Geobiology, V10, P3; Smirnov A, 2005, PROTIST, V156, P129, DOI 10.1016/j.protis.2005.06.002; Smirnov AV, 2007, PROTIST, V158, P295, DOI 10.1016/j.protis.2007.04.004; Smirnov AV, 2011, PROTIST, V162, P545, DOI 10.1016/j.protis.2011.04.004; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steemans P, 2009, SCIENCE, V324, P353, DOI 10.1126/science.1169659; STEPHENSON S.L., 1994, MYXOMYCETES HDB SLIM; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Taylor TN, 1999, NATURE, V399, P648, DOI 10.1038/21349; Taylor TN, 2009, PALEOBOTANY: THE BIOLOGY AND EVOLUTION OF FOSSIL PLANTS, 2ND EDITION, P1; Tekle YI, 2008, MOL PHYLOGENET EVOL, V47, P339, DOI 10.1016/j.ympev.2007.11.015; Wheat CW, 2013, SYST BIOL, V62, P93, DOI 10.1093/sysbio/sys074; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075	59	23	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74374	10.1371/journal.pone.0074374	http://dx.doi.org/10.1371/journal.pone.0074374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040233	Green Published, gold, Green Submitted			2022-12-25	WOS:000326734500086
J	Gao, YJ; Katz, DF				Gao, Yajing; Katz, David F.			Multicompartmental Pharmacokinetic Model of Tenofovir Delivery by a Vaginal Gel	PLOS ONE			English	Article							HIV-NEGATIVE WOMEN; DISOPROXIL FUMARATE; GENITAL-TRACT; MICROBICIDE; PREMENOPAUSAL; METABOLISM; PREVENTION; SAFETY; LAYER; PMPA	Background: Trials of a vaginal Tenofovir gel for pre-exposure prophylaxis (PrEP) for HIV have given conflicting results. Knowledge of concentrations of Tenofovir and its active form Tenofovir diphosphate, at putative sites of anti-HIV functioning, is central to understanding trial outcomes and design of products and dosage regimens. Topical Tenofovir delivery to the vaginal environment is complex, multivariate and non-linear; determinants relate to drug, vehicle, dosage regimen, and environment. Experimental PK methods cannot yield mechanistic understanding of this process, and have uncontrolled variability in drug sampling. Mechanistic modeling of the process could help delineate its determinants, and be a tool in design and interpretation of products and trials. Methods and Findings: We created a four-compartment mass transport model for Tenofovir delivery by a gel: gel, epithelium, stroma, blood. Transport was diffusion-driven in vaginal compartments; blood concentration was time-varying but homogeneous. Parameters for the model derived from in vitro and in vivo PK data, to which model predictions gave good agreement. Steep concentration gradients occurred in stroma <= 8 hours after gel release. Increasing epithelial thickness delayed initial TFV delivery to stroma and its decline: t(max) increased but AUC at 24 hours was not significantly altered. At 24 and 48 hours, stromal concentrations were 6.3% and 0.2% of C-max. Concentrations in simulated biopsies overestimated stromal concentrations, as much as similar to 5X, depending upon time of sampling, biopsy thickness and epithelial thickness. Conclusions: There was reasonably good agreement of model predictions with clinical PK data. Conversion of TFV to TFV-DP was not included, but PK data suggest a linear relationship between them. Thus contrasts predicted by this model can inform design of gels and dosage regimens in clinical trials, and interpretation of PK data. This mass transport based approach can be extended to TFV conversion to TFV-DP, and to other drugs and dosage forms.	[Gao, Yajing; Katz, David F.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Katz, David F.] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Durham, NC 27706 USA	Duke University; Duke University	Gao, YJ (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	yajing.gao@duke.edu			National Institutes of Health [RO1 HD072702]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072702] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Support for this project was provided by National Institutes of Health (www.nih.gov) Grant RO1 HD072702. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; Ballard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037410; Balzarini J, 2007, LANCET, V369, P787, DOI 10.1016/S0140-6736(07)60202-5; Barditch-Crovo P, 2001, ANTIMICROB AGENTS CH, V45, P2733, DOI 10.1128/AAC.45.10.2733-2739.2001; Barnhart KT, 2006, HUM REPROD, V21, P1618, DOI 10.1093/humrep/del022; Briz V, 2006, J ANTIMICROB CHEMOTH, V57, P619, DOI 10.1093/jac/dkl027; Chandrasekhar S, 1943, REV MOD PHYS, V15, P0001, DOI 10.1103/RevModPhys.15.1; Clark GD M. R., 2012, PRECLINICAL PHARMACO; Clark MR, 2012, AIDS RES HUM RETROV, V28, P1458, DOI [10.1089/aid.2011.0328, 10.1089/AID.2011.0328]; Dezzutti CS, 2012, J ANTIMICROB CHEMOTH, V67, P2139, DOI 10.1093/jac/dks173; Dumond JB, 2012, CLIN PHARMACOKINET, V51, P809, DOI 10.1007/s40262-012-0012-y; Fernandez-Romero JA, 2007, SEX TRANSM DIS, V34, P9, DOI 10.1097/01.olq.0000223287.46097.4b; Geonnotti AR, 2008, BIOMACROMOLECULES, V9, P748, DOI 10.1021/bm701018w; Geonnotti AR, 2006, BIOPHYS J, V91, P2121, DOI 10.1529/biophysj.106.086322; Geonnotti AR, 2010, J PHARM SCI-US, V99, P3514, DOI 10.1002/jps.22120; Hendrix CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055013; Hendrix CW, 2009, ANNU REV PHARMACOL, V49, P349, DOI 10.1146/annurev.pharmtox.48.113006.094906; Hendrix CW, 2008, MTN 001 PHASE 2 ADHE; Hladik Florian, 2009, Curr HIV/AIDS Rep, V6, P20, DOI 10.1007/s11904-009-0004-1; Howett MK, 2005, CURR PHARM DESIGN, V11, P3731, DOI 10.2174/138161205774580633; Jeanne Marrazzo GR, 2013, C RETR OPP INF ATL G; Justin-Temu M, 2004, J WOMENS HEALTH, V13, P834, DOI 10.1089/jwh.2004.13.834; Katz DF, 2011, DRUG DELIV TRANSL RE, V1, P256, DOI 10.1007/s13346-011-0029-z; Kearney BP, 2004, CLIN PHARMACOKINET, V43, P595, DOI 10.2165/00003088-200443090-00003; Lai BE, 2010, MICR 2010 M PITTSB P; Mahalingam A, 2011, ANTIMICROB AGENTS CH, V55, P1650, DOI 10.1128/AAC.01368-10; Masters WH., 1966, HUMAN SEXUAL RESPONS; MATLAB, 2019, MATLAB VERS 9 10 0 1; Nel A, 2009, JAIDS-J ACQ IMM DEF, V51, P416, DOI 10.1097/QAI.0b013e3181acb536; Nel AM, 2010, AIDS RES HUM RETROV, V26, P1181, DOI 10.1089/aid.2009.0227; Network MT, 2011, MTN STATEMENT DECISI; Nuttall J, 2012, ANTIMICROB AGENTS CH, V56, P103, DOI 10.1128/AAC.00597-11; Owen DH, 1999, CONTRACEPTION, V59, P91, DOI 10.1016/S0010-7824(99)00010-4; Patton DL, 2000, AM J OBSTET GYNECOL, V183, P967, DOI 10.1067/mob.2000.108857; Pendergrass PB, 2003, GYNECOL OBSTET INVES, V55, P110, DOI 10.1159/000070184; Robbins BL, 1998, ANTIMICROB AGENTS CH, V42, P612, DOI 10.1128/AAC.42.3.612; Rohan LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009310; Schwartz JL, 2011, PLOS ONE, V6; SEMMELINK HJF, 1990, CYTOMETRY, V11, P700, DOI 10.1002/cyto.990110607; Shaw JP, 1997, PHARMACEUT RES, V14, P1824, DOI 10.1023/A:1012108719462; Stone A, 2002, NAT REV DRUG DISCOV, V1, P977, DOI 10.1038/nrd959; Tasoglu S, 2011, PHYS FLUIDS, V23; Tasoglu S, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4793598; Tasoglu S, 2012, J NON-NEWTON FLUID, V187, P36, DOI 10.1016/j.jnnfm.2012.08.008; Truskey G. A., 2004, TRANSPORT PHENOMENA; Vermund SH, 2011, SCIENCE, V331, P284, DOI 10.1126/science.331.6015.284-a; Vourvahis M, 2008, JAIDS-J ACQ IMM DEF, V47, P329, DOI 10.1097/QAI.0b013e3181632cc3	47	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74404	10.1371/journal.pone.0074404	http://dx.doi.org/10.1371/journal.pone.0074404			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040241	gold, Green Published, Green Submitted			2022-12-25	WOS:000326734500091
J	Koohestani, F; Braundmeier, AG; Mahdian, A; Seo, J; Bi, JJ; Nowak, RA				Koohestani, Faezeh; Braundmeier, Andrea G.; Mahdian, Arash; Seo, Jane; Bi, JiaJia; Nowak, Romana A.			Extracellular Matrix Collagen Alters Cell Proliferation and Cell Cycle Progression of Human Uterine Leiomyoma Smooth Muscle Cells	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; ACTIVATED PROTEIN-KINASE; FOCAL ADHESION; GENE-EXPRESSION; FACTOR RECEPTOR; PC12 CELLS; SIGNALING PATHWAYS; MAP KINASE; IN-VITRO; INTEGRIN	Uterine leiomyomas (ULs) are benign tumors occurring in the majority of reproductive aged women. Despite the high prevalence of these tumors, little is known about their etiology. A hallmark of ULs is the excessive deposition of extracellular matrix (ECM), primarily collagens. Collagens are known to modulate cell behavior and function singularly or through interactions with integrins and growth factor-mediated mitogenic pathways. To better understand the pathogenesis of ULs and the role of ECM collagens in their growth, we investigated the interaction of leiomyoma smooth muscle cells (LSMCs) with two different forms of collagen, non-polymerized collagen (monomeric) and polymerized collagen (fibrillar), in the absence or presence of platelet-derived growth factor (PDGF), an abundant growth factor in ULs. Primary cultures of human LSMCS from symptomatic patients were grown on these two different collagen matrices and their morphology, cytoskeletal organization, cellular proliferation, and signaling pathways were evaluated. Our results showed that LSMCs had distinct morphologies on the different collagen matrices and their basal as well as PDGF-stimulated proliferation varied on these matrices. These differences in proliferation were accompanied by changes in cell cycle progression and p21, an inhibitory cell cycle protein. In addition we found alterations in the phosphorylation of focal adhesion kinase, cytoskeletal reorganization, and activation of the mitogen activated protein kinase (MAPK) signaling pathway. In conclusion, our results demonstrate a direct effect of ECM on the proliferation of LSMCs through interplay between the collagen matrix and the PDGF-stimulated MAPK pathway. In addition, these findings will pave the way for identifying novel therapeutic approaches for ULs that target ECM proteins and their signaling pathways in ULs.	[Koohestani, Faezeh; Braundmeier, Andrea G.; Seo, Jane; Bi, JiaJia; Nowak, Romana A.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Mahdian, Arash] Wolfram Res, Champaign, IL USA	University of Illinois System; University of Illinois Urbana-Champaign	Nowak, RA (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.	ranowak@illinois.edu	Braundmeier-Fleming, Andrea/AAQ-4014-2020	Braundmeier-Fleming, Andrea/0000-0001-7136-9567	National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD057877] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded by the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreadi C, 2012, BIOCHEM SOC T, V40, P67, DOI 10.1042/BST20110621; Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Bhadriraju K, 2009, BIOMATERIALS, V30, P6687, DOI 10.1016/j.biomaterials.2009.08.036; Bowden W, 2009, MOL HUM REPROD, V15, P563, DOI 10.1093/molehr/gap050; Catherino WH, 2004, GENE CHROMOSOME CANC, V40, P204, DOI 10.1002/gcc.20035; Caunt CJ, 2008, J BIOL CHEM, V283, P6241, DOI 10.1074/jbc.M706624200; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Coleman ML, 2003, EMBO J, V22, P2036, DOI 10.1093/emboj/cdg189; Cretel E, 2008, CELL MOL BIOENG, V1, P5, DOI 10.1007/s12195-008-0009-7; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; DeMali KA, 1999, J BIOL CHEM, V274, P19551, DOI 10.1074/jbc.274.28.19551; DIKIC I, 1994, CURR BIOL, V4, P702, DOI 10.1016/S0960-9822(00)00155-X; Dimitrova IK, 2009, FERTIL STERIL, V91, P2650, DOI 10.1016/j.fertnstert.2008.03.071; Elliott JT, 2003, LANGMUIR, V19, P1506, DOI 10.1021/la026216r; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Fassett J, 2006, MOL BIOL CELL, V17, P345, DOI 10.1091/mbc.E05-09-0871; Gao XH, 2012, AM J PHYSIOL-ENDOC M, V303, pE1025, DOI 10.1152/ajpendo.00107.2012; Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; Grinnell F, 2000, TRENDS CELL BIOL, V10, P362, DOI 10.1016/S0962-8924(00)01802-X; Henriet P, 2000, P NATL ACAD SCI USA, V97, P10026, DOI 10.1073/pnas.170290997; Herz DB, 2003, J UROLOGY, V170, P2072, DOI 10.1097/01.ju.0000091810.33953.13; Hintze V, 2012, J TISSUE ENG REGEN M, V4, P226; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; Hollenbeck ST, 2004, BIOCHEM BIOPH RES CO, V325, P328, DOI 10.1016/j.bbrc.2004.10.031; Hong SK, 2009, J BIOL CHEM, V284, P33006, DOI 10.1074/jbc.M109.012591; Hou GP, 2012, CARDIOVASC PATHOL, V21, P214, DOI 10.1016/j.carpath.2011.07.006; Houston KD, 2001, TOXICOL PATHOL, V29, P100, DOI 10.1080/019262301301418900; Hwu YM, 2008, FERTIL STERIL, V89, P468, DOI 10.1016/j.fertnstert.2007.02.031; Ichii T, 2001, CIRC RES, V88, P460, DOI 10.1161/01.RES.88.5.460; Isoda M, 2009, MOL BIOL CELL, V20, P2186, DOI 10.1091/mbc.E09-01-0008; Iwahashi M, 2011, FERTIL STERIL, V95, P2137, DOI 10.1016/j.fertnstert.2010.12.028; Karra L, 2010, FERTIL STERIL, V93, P2646, DOI 10.1016/j.fertnstert.2009.03.100; KAWAGUCHI K, 1989, AM J OBSTET GYNECOL, V160, P637, DOI 10.1016/S0002-9378(89)80046-8; Klein EA, 2009, CURR BIOL, V19, P1511, DOI 10.1016/j.cub.2009.07.069; Kojima N, 1998, HISTOCHEM CELL BIOL, V110, P121, DOI 10.1007/s004180050273; Koyama H, 1996, CELL, V87, P1069, DOI 10.1016/S0092-8674(00)81801-2; Kuzuya M, 1999, EXP CELL RES, V248, P498, DOI 10.1006/excr.1999.4422; Kwon SH, 2008, REPROD SCI, V15, P400, DOI 10.1177/1933719107314063; Le Beyec J, 2007, EXP CELL RES, V313, P3066, DOI 10.1016/j.yexcr.2007.04.022; Leppert PC, 2004, FERTIL STERIL, V82, P1182, DOI 10.1016/j.fertnstert.2004.04.030; Leppert PC, 2006, AM J OBSTET GYNECOL, V195, P415, DOI 10.1016/j.ajog.2005.12.059; Liang ML, 2006, CANCER BIOL THER, V5, P28, DOI 10.4161/cbt.5.1.2234; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lu KK, 2011, CARDIOVASC PATHOL, V20, P71, DOI 10.1016/j.carpath.2009.12.006; Mahabeleshwar GH, 2007, CIRC RES, V101, P570, DOI 10.1161/CIRCRESAHA.107.155655; Malik M, 2012, FERTIL STERIL, V97, P1287, DOI 10.1016/j.fertnstert.2012.02.037; Malik M, 2010, SEMIN REPROD MED, V28, P168, DOI 10.1055/s-0030-1251475; McDaniel DP, 2007, BIOPHYS J, V92, P1759, DOI 10.1529/biophysj.106.089003; Mesquita FS, 2010, BIOL REPROD, V82, P341, DOI 10.1095/biolreprod.108.075887; Mettouchi A, 2001, MOL CELL, V8, P115, DOI 10.1016/S1097-2765(01)00285-4; Mierke CT, 2010, J BIOL CHEM, V285, P13121, DOI 10.1074/jbc.M109.087171; NAKAGAWA S, 1989, EXP CELL RES, V182, P572, DOI 10.1016/0014-4827(89)90260-7; NGUYEN TT, 1993, J BIOL CHEM, V268, P9803; Norian JM, 2012, MATRIX BIOL, V31, P57, DOI 10.1016/j.matbio.2011.09.001; Palmer SS, 1998, J SOC GYNECOL INVEST, V5, P203, DOI 10.1016/S1071-5576(98)00009-4; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pickering JG, 2001, CIRC RES, V88, P458, DOI 10.1161/01.RES.88.5.458; PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349, DOI 10.1091/mbc.6.10.1349; Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299; Provenzano PP, 2011, J CELL SCI, V124, P1195, DOI 10.1242/jcs.067009; Raines EW, 2000, ANN NY ACAD SCI, V902, P39; Raines EW, 2000, INT J EXP PATHOL, V81, P173, DOI 10.1046/j.1365-2613.2000.00155.x; Rescan C, 2001, MOL BIOL CELL, V12, P725, DOI 10.1091/mbc.12.3.725; Rogers R, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.11.057; Ross RS, 2004, CARDIOVASC RES, V63, P381, DOI 10.1016/j.cardiores.2004.04.027; Sato K, 2003, CELL STRUCT FUNCT, V28, P229, DOI 10.1247/csf.28.229; Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600; Schrader J, 2011, HEPATOLOGY, V53, P1192, DOI 10.1002/hep.24108; Schuliga M, 2010, AM J PHYSIOL-LUNG C, V298, pL584, DOI 10.1152/ajplung.00312.2009; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; Soung YH, 2010, BMB REP, V43, P311, DOI 10.5483/BMBRep.2010.43.5.311; STEWART EA, 1994, J CLIN ENDOCR METAB, V79, P900, DOI 10.1210/jc.79.3.900; Stewart EA, 2001, LANCET, V357, P293, DOI 10.1016/S0140-6736(00)03622-9; Tee SY, 2011, BIOPHYS J, V100, pL25, DOI 10.1016/j.bpj.2010.12.3744; Torii S, 2006, CANCER SCI, V97, P697, DOI 10.1111/j.1349-7006.2006.00244.x; Tsai KS, 2010, J BIOMED MATER RES A, V94A, P673, DOI 10.1002/jbm.a.32693; Tsibris JCM, 2002, FERTIL STERIL, V78, P114, DOI 10.1016/S0015-0282(02)03191-6; Wall SJ, 2005, J BIOL CHEM, V280, P40187, DOI 10.1074/jbc.M508226200; Wall SJ, 2007, J BIOL CHEM, V282, P24471, DOI 10.1074/jbc.M702697200; Wolanska M, 1998, MOL CELL BIOCHEM, V189, P145, DOI 10.1023/A:1006914301565; Wolanska M, 2004, GYNECOL OBSTET INVES, V58, P14, DOI 10.1159/000077177; Woodard AS, 1998, J CELL SCI, V111, P469; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; WREN FE, 1986, J CELL PHYSIOL, V127, P297, DOI 10.1002/jcp.1041270217; Yamada KM, 2002, NAT CELL BIOL, V4, pE75, DOI 10.1038/ncb0402-e75; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044; Yeh YT, 2012, BIOMATERIALS, V33, P6728, DOI 10.1016/j.biomaterials.2012.06.030; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Zhao J, 2001, MOL BIOL CELL, V12, P4066, DOI 10.1091/mbc.12.12.4066	94	58	59	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e75844	10.1371/journal.pone.0075844	http://dx.doi.org/10.1371/journal.pone.0075844			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040420	gold, Green Submitted, Green Published			2022-12-25	WOS:000326734500145
J	Li, C; Fan, JC; Song, XC; Zhang, B; Chen, Y; Li, CH; Mi, K; Ma, HF; Song, YF; Tao, XF; Li, GJ				Li, Chao; Fan, Jinchuan; Song, Xicheng; Zhang, Bing; Chen, Yu; Li, Chunhua; Mi, Kun; Ma, Hong; Song, Yufeng; Tao, Xiaofeng; Li, Guojun			Expression of Angiopoietin-2 and Vascular Endothelial Growth Factor Receptor-3 Correlates with Lymphangiogenesis and Angiogenesis and Affects Survival of Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							LYMPHATIC VESSELS; TUMOR-METASTASIS; DENSITY; D2-40	Background: Both Ang-2 and VEGFR-3 are major regulators of angiogenesis and lymphangiogenesis, respectively, and thus may affect prognosis of OSCC. We sought to determine the associations between Ang-2 and VEGFR-3 expression and survival of OSCC. Methods: Ang-2 and VEGFR-3 expression was determined immunohistochemically in tumor tissues from 112 patients with OSCC; OSCC-adjacent noncancerous oral tissue from 85 OSCC patients; and normal oral mucosa from 37 cancer-free individuals. A log-rank test and Cox proportional hazard models were used to compare survival among different groups with expression of Ang-2 and VEGFR-3. Results: Ang-2 and VEGFR-3 expression was upregulated in OSCC compared to nontumor tissue (all P<0.05). High Ang-2 expression positively correlated with microvessel density (MVD) (P<0.01), and high VEGFR-3 expression positively correlated with lymph node metastasis (P<0.01) and lymphatic vessel density (LVD) (P<0.01). The patients with high expression of Ang-2 alone or in combination with VEGFR-3 had a significantly worse survival than in patients with low expression of Ang-2 or any other co-expression status (all P<0.05), respectively. Furthermore, multivariable analysis showed that patients with high expression of Ang-2 alone or in combination with VEGFR-3 had a significantly increased risk of death compared with those with low expression of Ang-2 or any other co-expression status (HR, 2.7, 95% CI, 1.1-6.2 and 5.0, 1.3-15.4, respectively). Conclusions: These results suggest that increased expression in tumors of Ang-2 may individually, or in combination with VEGFR-3, predict poor prognosis of OSCC.	[Li, Chao; Fan, Jinchuan; Zhang, Bing; Li, Chunhua; Mi, Kun] Sichuan Canc Hosp, Dept Head & Neck Surg, Chengdu, Peoples R China; [Li, Chao; Chen, Yu] Sichuan Univ, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China; [Song, Xicheng] Qingdao Univ, Yuhuangding Hosp, Dept Otorhinolaryngol Head & Neck Surg, Yantai, Peoples R China; [Ma, Hong; Song, Yufeng] Guiyang Med Coll, Affiliated Hosp, Dept Oral & Maxillary Surg, Guiyang, Peoples R China; [Tao, Xiaofeng] Shanghai Jiao Tong Univ, Sch Med, Dept Radiol, Shanghai Peoples Hosp 9, Shanghai 200030, Peoples R China; [Li, Guojun] UT MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX USA	Sichuan University; Qingdao University; Guizhou Medical University; Shanghai Jiao Tong University; University of Texas System; UTMD Anderson Cancer Center	Tao, XF (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Radiol, Shanghai Peoples Hosp 9, Shanghai 200030, Peoples R China.	cjr.taoxiaofeng.@vip.163.com; gli@mdanderson.org			Sichuan Provincial Bureau of Health [080390, 100572]; Sichuan Provincial Science and Technology Department [2009JY0093, 11ZC0323]	Sichuan Provincial Bureau of Health; Sichuan Provincial Science and Technology Department	The work was supported by grants from the Sichuan Provincial Bureau of Health, No. 080390 and No. 100572; Sichuan Provincial Science and Technology Department, No. 2009JY0093 and No. 11ZC0323. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Botting SK, 2010, TRANSL ONCOL, V3, P170, DOI 10.1593/tlo.09292; BRYNE M, 1992, J PATHOL, V166, P375, DOI 10.1002/path.1711660409; Dumoff KL, 2005, MODERN PATHOL, V18, P97, DOI 10.1038/modpathol.3800269; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Fogt F, 2004, ONCOL REP, V11, P47; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; He YL, 2005, CANCER RES, V65, P4739, DOI 10.1158/0008-5472.CAN-04-4576; Holopainen T, 2012, J NATL CANCER I, V104, P461, DOI 10.1093/jnci/djs009; Li C, 2005, CHIN GERM J CLIN ONC, V4, P232; Makinen T, 2001, NAT MED, V7, P199, DOI 10.1038/84651; Massano J, 2006, ORAL SURG ORAL MED O, V102, P67, DOI 10.1016/j.tripleo.2005.07.038; Nisato RE, 2003, THROMB HAEMOSTASIS, V90, P591, DOI 10.1160/TH03-04-0206; Ochiumi T, 2004, INT J ONCOL, V24, P539; Saharinen P, 2004, TRENDS IMMUNOL, V25, P387, DOI 10.1016/j.it.2004.05.003; Urabe A, 2004, HISTOPATHOLOGY, V4, P493; Urabe A, 2006, BRIT J CANCER, V95, P1611; WEIDNER N, 1995, BREAST CANCER RES TR, V36, P169, DOI 10.1007/BF00666038; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yashiro M, 2009, BRIT J CANCER, V101, P1100, DOI 10.1038/sj.bjc.6605296	20	15	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e75388	10.1371/journal.pone.0075388	http://dx.doi.org/10.1371/journal.pone.0075388			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040410	gold, Green Published, Green Submitted			2022-12-25	WOS:000326734500140
J	Holliday, MW; Cox, SB; Kang, MH; Maurer, BJ				Holliday, Michael W., Jr.; Cox, Stephen B.; Kang, Min H.; Maurer, Barry J.			C22:0-and C24:0-dihydroceramides Confer Mixed Cytotoxicity in T-Cell Acute Lymphoblastic Leukemia Cell Lines	PLOS ONE			English	Article							MAMMALIAN CERAMIDE SYNTHASES; DIHYDROCERAMIDE DESATURASE; N-(4-HYDROXYPHENYL)RETINAMIDE-INDUCED APOPTOSIS; CANCER-CELLS; METABOLISM; SPHINGOLIPIDS; FENRETINIDE; SPHINGOSINE; C2-CERAMIDE; INVOLVEMENT	We previously reported that fenretinide (4-HPR) was cytotoxic to acute lymphoblastic leukemia (ALL) cell lines in vitro in association with increased levels of de novo synthesized dihydroceramides, the immediate precursors of ceramides. However, the cytotoxic potentials of native dihydroceramides have not been defined. Therefore, we determined the cytotoxic effects of increasing dihydroceramide levels via de novo synthesis in T-cell ALL cell lines and whether such cytotoxicity was dependent on an absolute increase in total dihydroceramide mass versus an increase of certain specific dihydroceramides. A novel method employing supplementation of individual fatty acids, sphinganine, and the dihydroceramide desaturase-1 (DES) inhibitor, GT-11, was used to increase de novo dihydroceramide synthesis and absolute levels of specific dihydroceramides and ceramides. Sphingolipidomic analyses of four T-cell ALL cell lines revealed strong positive correlations between cytotoxicity and levels of C22:0-dihydroceramide (rho = 0.74-0.81, P <= 0.04) and C24:0-dihydroceramide (rho = 0.84-0.90, P <= 0.004), but not between total or other individual dihydroceramides, ceramides, or sphingoid bases or phosphorylated derivatives. Selective increase of C22:0- and C24:0-dihydroceramide increased level and flux of autophagy marker, LC3B-II, and increased DNA fragmentation (TUNEL assay) in the absence of an increase of reactive oxygen species; pan-caspase inhibition blocked DNA fragmentation but not cell death. C22:0-fatty acid supplemented to 4-HPR treated cells further increased C22:0-dihydroceramide levels (P <= 0.001) and cytotoxicity (P <= 0.001). These data demonstrate that increases of specific dihydroceramides are cytotoxic to T-cell ALL cells by a caspase-independent, mixed cell death mechanism associated with increased autophagy and suggest that dihydroceramides may contribute to 4-HPR-induced cytotoxicity. The targeted increase of specific acyl chain dihydroceramides may constitute a novel anticancer approach.	[Holliday, Michael W., Jr.; Kang, Min H.; Maurer, Barry J.] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Ctr Canc, Lubbock, TX 79430 USA; [Cox, Stephen B.] Res & Testing Lab, Lubbock, TX USA; [Kang, Min H.; Maurer, Barry J.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA; [Kang, Min H.] Texas Tech Univ, Hlth Sci Ctr, Dept Pediat, Lubbock, TX 79430 USA; [Maurer, Barry J.] Texas Tech Univ, Hlth Sci Ctr, Dept Med, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Maurer, BJ (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Sch Med, Ctr Canc, Lubbock, TX 79430 USA.	barry.maurer@ttuhsc.edu		Kang, Min H/0000-0003-3603-7035; Holliday, Michael/0000-0001-6951-2424	National Cancer Institute [R01 CA100895]; Tyler's Team Leukemia Fund; NATIONAL CANCER INSTITUTE [R01CA100895] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Tyler's Team Leukemia Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the National Cancer Institute (Grant # R01 CA100895, cancer.gov) and the Tyler's Team Leukemia Fund (teamtylerfoundation.com) to BJM. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn EH, 2002, EXP BIOL MED, V227, P345, DOI 10.1177/153537020222700507; Apraiz A, 2012, BIOCHEM CELL BIOL, V90, P209, DOI [10.1139/O2012-001, 10.1139/o2012-001]; BIELAWSKA A, 1993, J BIOL CHEM, V268, P26226; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; DELIA D, 1993, CANCER RES, V53, P6036; Delia D, 1997, CARCINOGENESIS, V18, P943, DOI 10.1093/carcin/18.5.943; Devlin CM, 2011, J BIOL CHEM, V286, P38069, DOI 10.1074/jbc.M111.297994; Fabrias G, 2012, PROG LIPID RES, V51, P82, DOI 10.1016/j.plipres.2011.12.002; Faderl S, 2003, LEUKEMIA RES, V27, P259, DOI 10.1016/S0145-2126(02)00162-5; Frgala T, 2007, MOL CANCER THER, V6, P886, DOI 10.1158/1535-7163.MCT-04-0331; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Ghafourifar P, 1999, J BIOL CHEM, V274, P6080, DOI 10.1074/jbc.274.10.6080; Hail N, 2000, CANCER EPIDEM BIOMAR, V9, P1293; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Jiang Q, 2012, INT J CANCER, V130, P685, DOI 10.1002/ijc.26054; Kang MH, 2008, JNCI-J NATL CANCER I, V100, P580, DOI 10.1093/jnci/djn076; Kong G, 2008, LEUKEMIA, V22, P1258, DOI 10.1038/sj.leu.2405023; Kraveka JM, 2007, J BIOL CHEM, V282, P16718, DOI 10.1074/jbc.M700647200; Kummar S, 2011, ANTICANCER RES, V31, P961; Lahiri S, 2007, FEBS LETT, V581, P5289, DOI 10.1016/j.febslet.2007.10.018; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao ZH, 2010, J BIOL CHEM, V285, P29078, DOI 10.1074/jbc.M110.105296; Maurer BJ, 2007, CLIN CANCER RES, V13, P3079, DOI 10.1158/1078-0432.CCR-06-1889; Maurer BJ, 2000, JNCI-J NATL CANCER I, V92, P1897, DOI 10.1093/jnci/92.23.1897; Maurer BJ, 1999, JNCI-J NATL CANCER I, V91, P1138, DOI 10.1093/jnci/91.13.1138; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; O'Donnell PH, 2002, LEUKEMIA, V16, P902, DOI 10.1038/sj.leu.2402485; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Oridate N, 1997, J NATL CANCER I, V89, P1191, DOI 10.1093/jnci/89.16.1191; Rahmaniyan M, 2011, J BIOL CHEM, V286, P24754, DOI 10.1074/jbc.M111.250779; Reynolds CP, 2004, CANCER LETT, V206, P169, DOI 10.1016/j.canlet.2003.08.034; Sandhoff R, 2010, FEBS LETT, V584, P1907, DOI 10.1016/j.febslet.2009.12.032; Schulz A, 2006, J BIOL CHEM, V281, P2784, DOI 10.1074/jbc.M509483200; Separovic D, 2009, BRIT J CANCER, V100, P626, DOI 10.1038/sj.bjc.6604896; Shikata K, 2003, BIOORGAN MED CHEM, V11, P2723, DOI 10.1016/S0968-0896(03)00228-1; Signorelli P, 2009, CANCER LETT, V282, P238, DOI 10.1016/j.canlet.2009.03.020; SINGH I, 1983, J LIPID RES, V24, P662; Sugiki H, 2000, BRIT J DERMATOL, V143, P1154, DOI 10.1046/j.1365-2133.2000.03882.x; Sun SY, 1999, CANCER RES, V59, P2493; Triola G, 2003, J ORG CHEM, V68, P9924, DOI 10.1021/jo030141u; VANVELDHOVEN PP, 1988, BIOCHIM BIOPHYS ACTA, V959, P185, DOI 10.1016/0005-2760(88)90030-6; Wang H, 2008, MOL CANCER THER, V7, P2967, DOI 10.1158/1535-7163.MCT-08-0549; Wang HT, 2001, CANCER RES, V61, P5102; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	47	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74768	10.1371/journal.pone.0074768	http://dx.doi.org/10.1371/journal.pone.0074768			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040340	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300192
J	Bahar, MH; Hegedus, D; Soroka, J; Coutu, C; Bekkaoui, D; Dosdall, L				Bahar, Md Habibullah; Hegedus, Dwayne; Soroka, Juliana; Coutu, Cathy; Bekkaoui, Diana; Dosdall, Lloyd			Survival and Hsp70 Gene Expression in Plutella xylostella and Its Larval Parasitoid Diadegma insulare Varied between Slowly Ramping and Abrupt Extreme Temperature Regimes	PLOS ONE			English	Article							THERMAL LIMITS DEPEND; HEAT-SHOCK; DIAMONDBACK MOTH; STRESS; EVOLUTIONARY; LEPIDOPTERA; VARIABILITY; ADAPTATION; PLASTICITY; DROSOPHILA	Background: In nature, insects have evolved behavioural and physiological adaptations to cope with short term exposure to extreme temperatures. Extreme heat events may increase as a result of climate change; this in turn will affect insect population dynamics. We examined the effect of abrupt and ecologically relevant gradual exposure to high temperatures on the survival and hsp70 gene expression in diamondback moth (DBM) adults and the parasitoid Diadegma insulare, as well as in parasitized and non-parasitized DBM larvae. Principal Findings: Tolerance to high temperatures in DBM adults was higher than in D. insulare adults. There was no difference in the survival of DBM adults between abrupt and ramped increases from 25 to 38 degrees C; however, at 40 degrees C survival was higher when the temperature increased gradually. In contrast, more D. insulare adults survived when the temperature was ramped rather than shifted abruptly to both 38 and 40 degrees C. There was no heat stress effect of up to 40 degrees C on the survival of either parasitized or non-parasitized DBM larvae. In adults of both species, more hsp70 expression was observed when temperatures increased abruptly to 38 degrees C compared to ramping. In contrast, at 40 degrees C significantly more expression was found in insects exposed to the ramping rather than the abrupt regime. Hsp70 expression level was in agreement with adult survival data and appears to be a good indicator of stress levels. In parasitized and non-parasitized larvae, hsp70 expression was significantly higher after abrupt shifts compared to ramping at both temperatures. Conclusions/Significance: Hsp70 gene expression was responsive to extreme temperatures in both DBM and D. insulare, which may underlie the ability of these insects to survive in extreme temperatures. Survival and hsp70 expression upon abrupt changes are distinctly different from those after ramping indicating that experimental protocol must be considered before extrapolating laboratory results to natural field situations.	[Bahar, Md Habibullah; Hegedus, Dwayne; Soroka, Juliana; Coutu, Cathy; Bekkaoui, Diana] Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada; [Dosdall, Lloyd] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada	Agriculture & Agri Food Canada; University of Alberta	Bahar, MH (corresponding author), Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada.	MD.Bahar@AGR.GC.CA			Canola/Flax Canadian Agri-Science Cluster Project [04772]; Agriculture Agri-Food Canada Canadian Crop Genomics Initiative	Canola/Flax Canadian Agri-Science Cluster Project; Agriculture Agri-Food Canada Canadian Crop Genomics Initiative	Financial support was provided by Canola/Flax Canadian Agri-Science Cluster Project No. 04772 and Agriculture Agri-Food Canada Canadian Crop Genomics Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew NR, 2013, PEERJ, V1, DOI 10.7717/peerj.11; Angilletta MJ, 2002, J THERM BIOL, V27, P199, DOI 10.1016/S0306-4565(01)00084-5; Bahar MH, 2012, ENVIRON ENTOMOL, V41, P1653, DOI 10.1603/EN12156; Bahrndorff S, 2009, FUNCT ECOL, V23, P340, DOI 10.1111/j.1365-2435.2008.01503.x; Arias MB, 2011, J THERM BIOL, V36, P355, DOI 10.1016/j.jtherbio.2011.06.011; Bosch R, 1982, INTRO BIOL CONTROL, P117; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; Chown SL, 2009, FUNCT ECOL, V23, P133, DOI 10.1111/j.1365-2435.2008.01481.x; Dosdall L. M., 2011, PRAIRIE SOILS CROPS, V4, P66; Environment Canada, 2012, CAN CLIM NORM 1971 2; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Furlong MJ, 2013, ANNU REV ENTOMOL, V58, P517, DOI 10.1146/annurev-ento-120811-153605; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Institute SAS Inc, 2011, BAS SAS 9 3 PROC GUI; Karl I, 2012, PHYSIOL ENTOMOL, V37, P103, DOI 10.1111/j.1365-3032.2011.00814.x; Kiang JG, 1998, PHARMACOL THERAPEUT, V80, P183, DOI 10.1016/S0163-7258(98)00028-X; Lyons CL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-226; Mahroof R, 2005, COMP BIOCHEM PHYS A, V141, P247, DOI 10.1016/j.cbpb.2005.05.044; McMillan DM, 2005, FUNCT ECOL, V19, P844, DOI 10.1111/j.1365-2435.2005.01031.x; Messenger P.S., 1971, BIOL CONTROL, P68, DOI DOI 10.1007/978-1-4615-6528-4_3; Mitchell KA, 2010, FUNCT ECOL, V24, P694, DOI 10.1111/j.1365-2435.2009.01666.x; Overgaard J, 2008, CRYOBIOLOGY, V56, P159, DOI 10.1016/j.cryobiol.2008.01.001; Overgaard J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032758; R Core Team, 2021, R LANG ENV STAT COMP; Sarfraz M, 2005, BIOCONTROL SCI TECHN, V15, P763, DOI 10.1080/09583150500136956; Scriber JM, 2011, INSECT SCI, V18, P435, DOI 10.1111/j.1744-7917.2011.01432.x; Sinclair BJ, 2001, OIKOS, V93, P286, DOI 10.1034/j.1600-0706.2001.930211.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sonoda S, 2008, APPL ENTOMOL ZOOL, V43, P241, DOI 10.1303/aez.2008.241; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Terblanche JS, 2007, P ROY SOC B-BIOL SCI, V274, P2935, DOI 10.1098/rspb.2007.0985; Terblanche JS, 2011, J EXP BIOL, V214, P3713, DOI 10.1242/jeb.061283; Terblanche JS, 2010, ENTOMOL EXP APPL, V137, P304, DOI 10.1111/j.1570-7458.2010.01067.x; Waagner D, 2010, COMP BIOCHEM PHYS A, V157, P177, DOI 10.1016/j.cbpa.2010.06.171; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Xu PJ, 2010, MOL BIOL REP, V37, P2265, DOI 10.1007/s11033-009-9715-z	37	23	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73901	10.1371/journal.pone.0073901	http://dx.doi.org/10.1371/journal.pone.0073901			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040110	Green Published, Green Submitted, gold			2022-12-25	WOS:000324856500065
J	Komaki-Yasuda, K; Okuwaki, M; Nagata, K; Kawazu, S; Kano, S				Komaki-Yasuda, Kanako; Okuwaki, Mitsuru; Nagata, Kyosuke; Kawazu, Shin-ichiro; Kano, Shigeyuki			Identification of a Novel and Unique Transcription Factor in the Intraerythrocytic Stage of Plasmodium falciparum	PLOS ONE			English	Article							MALARIA PARASITES; DNA-BINDING; COMPARATIVE GENOMICS; GENE-EXPRESSION; CHROMATIN; PROTEINS; PEROXIREDOXINS; DISCOVERY	The mechanisms of stage-specific gene regulation in the malaria parasite Plasmodium falciparum are largely unclear, with only a small number of specific regulatory transcription factors (AP2 family) having been identified. In particular, the transcription factors that function in the intraerythrocytic stage remain to be elucidated. Previously, as a model case for stage-specific transcription in the P. falciparum intraerythrocytic stage, we analyzed the transcriptional regulation of pf1-cys-prx, a trophozoite/schizont-specific gene, and suggested that some nuclear factors bind specifically to the cis-element of pf1-cys-prx and enhance transcription. In the present study, we purified nuclear factors from parasite nuclear extract by 5 steps of chromatography, and identified a factor termed PREBP. PREBP is not included in the AP2 family, and is a novel protein with four K-homology (KH) domains. The KH domain is known to be found in RNA-binding or single-stranded DNA-binding proteins. PREBP is well conserved in Plasmodium species and partially conserved in phylum Apicomplexa. To evaluate the effects of PREBP overexpression, we used a transient overexpression and luciferase assay combined approach. Overexpression of PREBP markedly enhanced luciferase expression under the control of the pf1-cys-prx cis-element. These results provide the first evidence of a novel transcription factor that activates the gene expression in the malaria parasite intraerythrocytic stage. These findings enhance our understanding of the evolution of specific transcription machinery in Plasmodium and other eukaryotes.	[Komaki-Yasuda, Kanako; Kano, Shigeyuki] Natl Ctr Global Hlth & Med, Res Inst, Shinjuku Ku, Tokyo, Japan; [Okuwaki, Mitsuru; Nagata, Kyosuke] Univ Tsukuba, Grad Sch Comprehens Human Sci, Ibaraki, Japan; [Okuwaki, Mitsuru; Nagata, Kyosuke] Univ Tsukuba, Inst Basic Med Sci, Ibaraki, Japan; [Kawazu, Shin-ichiro] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 080, Japan	National Center for Global Health & Medicine - Japan; University of Tsukuba; University of Tsukuba; Obihiro University of Agriculture & Veterinary Medicine	Komaki-Yasuda, K (corresponding author), Natl Ctr Global Hlth & Med, Res Inst, Shinjuku Ku, Tokyo, Japan.	komaki@ri.ncgm.go.jp	Okuwaki, Mitsuru/R-3038-2019	Okuwaki, Mitsuru/0000-0003-2118-442X	Japan Science and Technology Agency; JSPS KAKENHI [20790328, 22790400, 24590515]; Grants-in-Aid for Scientific Research [21113005] Funding Source: KAKEN	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant for Precursory Research for Embryonic Science and Technology from the Japan Science and Technology Agency (www.jst.go.jp/kisoken/presto/; to SIK) and JSPS KAKENHI (www.jsps.go.jp/j-grantsinaid/; Grant Numbers 20790328, 22790400, and 24590515 to KKY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Braddock DT, 2002, NATURE, V415, P1051, DOI 10.1038/4151051a; Chowdhury I, 2009, FREE RADICAL BIO MED, V46, P146, DOI 10.1016/j.freeradbiomed.2008.09.027; Coulson RMR, 2004, GENOME RES, V14, P1548, DOI 10.1101/gr.2218604; Coulson RMR, 2003, NUCLEIC ACIDS RES, V31, P653, DOI 10.1093/nar/gkg156; Crabb BS, 1997, MOL BIOCHEM PARASIT, V90, P131, DOI 10.1016/S0166-6851(97)00143-6; Cui L, 2007, EUKARYOT CELL, V6, P1219, DOI 10.1128/EC.00062-07; De Silva EK, 2008, P NATL ACAD SCI USA, V105, P8393, DOI 10.1073/pnas.0801993105; Duffy MF, 2012, CELL MICROBIOL, V14, P819, DOI 10.1111/j.1462-5822.2012.01777.x; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; EPPING RJ, 1988, MOL BIOCHEM PARASIT, V28, P1, DOI 10.1016/0166-6851(88)90173-9; Fan Q, 2004, EUKARYOT CELL, V3, P264, DOI 10.1128/EC.3.2.264-276.2004; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Furey TS, 2012, NAT REV GENET, V13, P840, DOI 10.1038/nrg3306; Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P638, DOI 10.1093/nar/29.3.638; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; Hasenkamp S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-210; Iwanaga S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047557; Iyer LM, 2008, INT J PARASITOL, V38, P1, DOI 10.1016/j.ijpara.2007.07.018; Kawazu S, 2001, MOL BIOCHEM PARASIT, V116, P73, DOI 10.1016/S0166-6851(01)00308-5; Kawazu S, 2000, MOL BIOCHEM PARASIT, V109, P165, DOI 10.1016/S0166-6851(00)00243-7; Kawazu SI, 2008, PARASITOL INT, V57, P1, DOI 10.1016/j.parint.2007.08.001; Kimura R, 2013, PARASITOL INT, V62, P137, DOI 10.1016/j.parint.2012.11.005; Komaki-Yasuda K, 2008, MOL BIOCHEM PARASIT, V162, P40, DOI 10.1016/j.molbiopara.2008.07.002; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Richards JS, 2009, IMMUNOL CELL BIOL, V87, P377, DOI 10.1038/icb.2009.27; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Voss TS, 2003, MOL MICROBIOL, V48, P1593, DOI 10.1046/j.1365-2958.2003.03528.x; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Yano K, 2005, PARASITOL INT, V54, P35, DOI 10.1016/j.parint.2004.08.005; Yuda M, 2010, MOL MICROBIOL, V75, P854, DOI 10.1111/j.1365-2958.2009.07005.x; Yuda M, 2009, MOL MICROBIOL, V71, P1402, DOI 10.1111/j.1365-2958.2009.06609.x	40	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74701	10.1371/journal.pone.0074701	http://dx.doi.org/10.1371/journal.pone.0074701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040327	gold, Green Submitted, Green Published			2022-12-25	WOS:000324481600145
J	Morohaku, K; Phuong, NS; Selvaraj, V				Morohaku, Kanako; Phuong, Newton S.; Selvaraj, Vimal			Developmental Expression of Translocator Protein/Peripheral Benzodiazepine Receptor in Reproductive Tissues	PLOS ONE			English	Article							ACUTE REGULATORY PROTEIN; SIDE-CHAIN CLEAVAGE; OVARIAN SURFACE EPITHELIUM; DIAZEPAM-BINDING INHIBITOR; LEYDIG TUMOR-CELLS; CHOLESTEROL TRANSPORT; LUTEINIZING-HORMONE; STEROIDOGENIC ENZYMES; TARGETED DISRUPTION; GRANULOSA-CELLS	Translocator protein (TSPO) present in the outer mitochondrial membrane has been suggested to be critical for cholesterol import, a rate-limiting step for steroid hormone biosynthesis. Despite the importance of steroidogenesis in regulating reproductive functions, the developmental profile of TSPO expression in the gonads and accessory sex organs has not been completely characterized. As a first step towards understanding the function of TSPO, we studied its expression in male and female murine reproductive organs. We examined testes and ovaries at embryonic days 14.5 and 18.5, and postnatal days 0, 7, 14, 21 and 56 of development. In the adult testis, TSPO was expressed in both Leydig cells and Sertoli cells. In the developing testes TSPO expression was seen in immature Sertoli cells, fetal Leydig cells and gonocytes. In the ovary, TSPO was expressed in the ovarian surface epithelium, interstitial cells granulosa cells and luteal cells. Corpora lutea of ovaries from pregnant mice showed strong expression of TSPO. In the developing ovary, TSPO expression was seen in the squamous pregranulosa cells associated with germ line cysts, together with progressively increasing expression in interstitial cells and the ovarian surface epithelium. In adult mice, the epithelia of other reproductive tissues like the epididymis, prostate, seminal vesicle, oviduct and uterus also showed distinct patterns of TSPO expression. In summary, TSPO expression in both male and female reproductive tissues was not only restricted to steroidogenic cells. Expression in Sertoli cells, ovarian surface epithelium, efferent ductal epithelium, prostatic epithelium, seminal vesiclular epithelium, uterine epithelium and oviductal epithelium suggest either previously unknown sites for de novo steroidogenesis or functions for TSPO distinct from its well-studied role in steroid hormone production.	[Morohaku, Kanako; Phuong, Newton S.; Selvaraj, Vimal] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA	Cornell University	Selvaraj, V (corresponding author), Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA.	vs88@cornell.edu	Selvaraj, Vimal/AAC-2853-2022					ADAMS CS, 1989, HISTOCHEMISTRY, V91, P495, DOI 10.1007/BF00492522; AMANN RP, 1987, J ANDROL, V8, P238; AMSTERDAM A, 1991, ENDOCRINOLOGY, V129, P503, DOI 10.1210/endo-129-1-503; ANHOLT RRH, 1986, J BIOL CHEM, V261, P576; ANTKIEWICZMICHALUK L, 1988, J BIOL CHEM, V263, P17317; ASCOLI M, 1981, ENDOCRINOLOGY, V108, P88, DOI 10.1210/endo-108-1-88; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; BASS JJ, 1973, J ENDOCRINOL, V56, P321, DOI 10.1677/joe.0.0560321; Batarseh A, 2008, BIOCHEMISTRY-US, V47, P12886, DOI 10.1021/bi8012643; BLACK SM, 1994, P NATL ACAD SCI USA, V91, P7247, DOI 10.1073/pnas.91.15.7247; BRAESTRUP C, 1977, NATURE, V269, P702, DOI 10.1038/269702a0; BRAESTRUP C, 1977, P NATL ACAD SCI USA, V74, P3805, DOI 10.1073/pnas.74.9.3805; Breton S, 1996, NAT MED, V2, P470, DOI 10.1038/nm0496-470; CANTOR EH, 1984, P NATL ACAD SCI-BIOL, V81, P1549, DOI 10.1073/pnas.81.5.1549; Carmel I, 1999, BIOCHEM PHARMACOL, V58, P273, DOI 10.1016/S0006-2952(99)00093-3; Caron KM, 1997, P NATL ACAD SCI USA, V94, P11540, DOI 10.1073/pnas.94.21.11540; CLARK BJ, 1994, J BIOL CHEM, V269, P28314; Das A, 2009, P NATL ACAD SCI USA, V106, P12542, DOI 10.1073/pnas.0901647106; DESOUZA EB, 1985, ENDOCRINOLOGY, V116, P567, DOI 10.1210/endo-116-2-567; Dorrington J H, 1979, Recent Prog Horm Res, V35, P301; DORRINGTON JH, 1978, INT J ANDROL, P53, DOI 10.1111/j.1365-2605.1978.tb00006.x; DRUGAN RC, 1986, PHARMACOL BIOCHEM BE, V24, P1673, DOI 10.1016/0091-3057(86)90504-6; Encinas G, 2012, CELLS TISSUES ORGANS, V195, P443, DOI 10.1159/000329245; ERICKSON GF, 1985, ENDOCR REV, V6, P371, DOI 10.1210/edrv-6-3-371; Everett H, 2002, J EXP MED, V196, P1127, DOI 10.1084/jem.20011247; Fan J, 2012, CURR MOL MED, V12, P369; Fan JJ, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097535; Ford SL, 1999, MOL CELL ENDOCRINOL, V157, P87, DOI 10.1016/S0303-7207(99)00155-0; FORTUNE JE, 1977, ENDOCRINOLOGY, V100, P1341, DOI 10.1210/endo-100-5-1341; FORTUNE JE, 1978, ENDOCRINOLOGY, V102, P227, DOI 10.1210/endo-102-1-227; Gavish M, 1999, PHARMACOL REV, V51, P629; Giatzakis C, 2004, ENDOCRINOLOGY, V145, P1113, DOI 10.1210/en.2003-1330; Giatzakis C, 2007, BIOCHEMISTRY-US, V46, P4763, DOI 10.1021/bi062208o; GRECO TL, 1994, ENDOCRINOLOGY, V135, P262, DOI 10.1210/en.135.1.262; Gregory CW, 1998, BIOL REPROD, V58, P470, DOI 10.1095/biolreprod58.2.470; Harvey WR, 1997, J EXP BIOL, V200, P203; Hauet T, 2005, MOL ENDOCRINOL, V19, P540, DOI 10.1210/me.2004-0307; Hauet T, 2002, ENDOCR RES, V28, P395, DOI 10.1081/ERC-120016814; HIRSCH JD, 1989, MOL PHARMACOL, V35, P157; HOYER PB, 1986, BIOL REPROD, V34, P905, DOI 10.1095/biolreprod34.5.905; Hu J, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-47; HUHTANIEMI I, 1992, P SOC EXP BIOL MED, V201, P125, DOI 10.3181/00379727-201-43493; IKEDA Y, 1994, MOL ENDOCRINOL, V8, P654, DOI 10.1210/me.8.5.654; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Kelly-Hershkovitz E, 1998, J BIOL CHEM, V273, P5478, DOI 10.1074/jbc.273.10.5478; LENFANT M, 1986, INT J IMMUNOPHARMACO, V8, P825, DOI 10.1016/0192-0561(86)90021-4; Li H, 2001, P NATL ACAD SCI USA, V98, P1267, DOI 10.1073/pnas.031461598; LIN D, 1995, SCIENCE, V267, P1828, DOI 10.1126/science.7892608; Liu J, 2006, J BIOL CHEM, V281, P38879, DOI 10.1074/jbc.M608820200; Maaser K, 2001, BRIT J CANCER, V85, P1771, DOI 10.1054/bjoc.2001.2181; Manku G, 2012, CURR MOL MED, V12, P467; Manna PR, 2009, MOL HUM REPROD, V15, P321, DOI 10.1093/molehr/gap025; MARANGOS PJ, 1982, MOL PHARMACOL, V22, P26; MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170; MCNATTY KP, 1979, J CLIN ENDOCR METAB, V49, P687, DOI 10.1210/jcem-49-5-687; MERCER KA, 1992, J RECEPTOR RES, V12, P413, DOI 10.3109/10799899209074804; Mesenholler M, 2000, EUR J PHARMACOL, V406, P171, DOI 10.1016/S0014-2999(00)00646-4; Midzak A, 2011, MOL CELL ENDOCRINOL, V336, P70, DOI 10.1016/j.mce.2010.12.007; Miller WL, 2007, MOL CELL ENDOCRINOL, V265, P46, DOI 10.1016/j.mce.2006.12.002; Murail S, 2008, BBA-BIOMEMBRANES, V1778, P1375, DOI 10.1016/j.bbamem.2008.03.012; Murdoch WJ, 2002, REPRODUCTION, V123, P743, DOI 10.1530/rep.0.1230743; Neess D, 2011, J BIOL CHEM, V286, P3460, DOI 10.1074/jbc.M110.161109; NOVAS ML, 1987, EUR J PHARMACOL, V135, P243, DOI 10.1016/0014-2999(87)90619-4; Ostuni MA, 2004, AM J PHYSIOL-GASTR L, V286, pG1069, DOI 10.1152/ajpgi.00290.2003; Papadopoulos V, 1997, J BIOL CHEM, V272, P32129, DOI 10.1074/jbc.272.51.32129; PAPADOPOULOS V, 1990, J BIOL CHEM, V265, P3772; Papadopoulos V, 2004, ENDOCR RES, V30, P677, DOI 10.1081/ERC-200043971; PAPADOPOULOS V, 1991, ENDOCRINOLOGY, V129, P1481, DOI 10.1210/endo-129-3-1481; Papadopoulos V, 1997, STEROIDS, V62, P21, DOI 10.1016/S0039-128X(96)00154-7; PAYNE AH, 1995, BIOL REPROD, V52, P217, DOI 10.1095/biolreprod52.2.217; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Pollack SE, 1997, J CLIN ENDOCR METAB, V82, P4243, DOI 10.1210/jc.82.12.4243; PYTHON CP, 1993, ENDOCRINOLOGY, V132, P1489, DOI 10.1210/en.132.4.1489; Rampon C, 2009, FASEB J, V23, P4181, DOI 10.1096/fj.09-129262; RAO IM, 1991, ANAT REC, V229, P177, DOI 10.1002/ar.1092290204; RITTA MN, 1989, NEUROENDOCRINOLOGY, V49, P262, DOI 10.1159/000125126; Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; Shum WWC, 2009, J EXP BIOL, V212, P1753, DOI 10.1242/jeb.027284; SPRENGEL R, 1989, J BIOL CHEM, V264, P20415; STAROSTARUBINSTEIN S, 1987, P NATL ACAD SCI USA, V84, P891, DOI 10.1073/pnas.84.3.891; Stocco DM, 1996, ENDOCR REV, V17, P221, DOI 10.1210/er.17.3.221; TAKETANI S, 1995, J BIOCHEM-TOKYO, V117, P875, DOI 10.1093/oxfordjournals.jbchem.a124790; TAO YX, 1995, MOL CELL ENDOCRINOL, V111, pR9, DOI 10.1016/0303-7207(95)03564-N; Tao YX, 1998, J ANDROL, V19, P343; Thompson WE, 1999, J HISTOCHEM CYTOCHEM, V47, P769, DOI 10.1177/002215549904700606; TORANZO D, 1994, ANAT EMBRYOL, V190, P383; Turner TT, 2011, J ANDROL, V32, P705, DOI 10.2164/jandrol.111.013003; VANDERVU.GJ, 1973, BIOCHIM BIOPHYS ACTA, V297, P179, DOI 10.1016/0304-4165(73)90062-7; Veenman L, 2008, J BIOENERG BIOMEMBR, V40, P199, DOI 10.1007/s10863-008-9142-1; Veenman L, 2007, CURR PHARM DESIGN, V13, P2385; WANG JKT, 1984, P NATL ACAD SCI-BIOL, V81, P753, DOI 10.1073/pnas.81.3.753; Yeliseev AA, 1997, P NATL ACAD SCI USA, V94, P5101, DOI 10.1073/pnas.94.10.5101	92	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74509	10.1371/journal.pone.0074509	http://dx.doi.org/10.1371/journal.pone.0074509			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040265	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600133
J	Schunn, AM; Conraths, FJ; Staubach, C; Frohlich, A; Forbes, A; Schnieder, T; Strube, C				Schunn, Anne-Marie; Conraths, Franz J.; Staubach, Christoph; Froehlich, Andreas; Forbes, Andrew; Schnieder, Thomas; Strube, Christina			Lungworm Infections in German Dairy Cattle Herds - Seroprevalence and GIS-Supported Risk Factor Analysis	PLOS ONE			English	Article							DICTYOCAULUS-VIVIPARUS INFECTIONS; SPATIAL-DISTRIBUTION; ELISA; MILK; COWS; ANTIBODIES; ENGLAND	In November 2008, a total of 19,910 bulk tank milk (BTM) samples were obtained from dairy farms from all over Germany, corresponding to about 20% of all German dairy herds, and analysed for antibodies against the bovine lungworm Dictyocaulus viviparus by use of the recombinant MSP-ELISA. A total number of 3,397 (17.1%; n = 19,910) BTM samples tested seropositive. The prevalences in individual German federal states varied between 0.0% and 31.2% positive herds. A geospatial map was drawn to show the distribution of seropositive and seronegative herds per postal code area. ELISA results were further analysed for associations with land-use and climate data. Bivariate statistical analysis was used to identify potential spatial risk factors for dictyocaulosis. Statistically significant positive associations were found between lungworm seropositive herds and the proportion of water bodies and grassed area per postal code area. Variables that showed a statistically significant association with a positive BTM test were included in a logistic regression model, which was further refined by controlled stepwise selection of variables. The low Pseudo R-2 values (0.08 for the full model and 0.06 for the final model) and further evaluation of the model by ROC analysis indicate that additional, unrecorded factors (e.g. management factors) or random effects may substantially contribute to lungworm infections in dairy cows. Veterinarians should include lungworms in the differential diagnosis of respiratory disease in dairy cattle, particularly those at pasture. Monitoring of herds through BTM screening for antibodies can help farmers and veterinarians plan and implement appropriate control measures.	[Schunn, Anne-Marie; Schnieder, Thomas; Strube, Christina] Univ Vet Med Hannover, Inst Parasitol, Hannover, Germany; [Conraths, Franz J.; Staubach, Christoph; Froehlich, Andreas] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Epidemiol, Wusterhausen, Germany; [Forbes, Andrew] Merial, Lyon, France	University of Veterinary Medicine Hannover, Foundation; Friedrich Loeffler Institute; Merial SASU	Strube, C (corresponding author), Univ Vet Med Hannover, Inst Parasitol, Hannover, Germany.	christina.strube@tiho-hannover.de	Forbes, Andrew/AAI-8687-2020	Conraths, Franz/0000-0002-7400-9409; Forbes, Andrew/0000-0003-4269-914X; Strube, Christina/0000-0002-9093-1006	Merial	Merial	The presented study has been partially supported financially by Merial. The company had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bennema S, 2009, VET PARASITOL, V165, P51, DOI 10.1016/j.vetpar.2009.07.006; Bennema SC, 2011, INT J PARASITOL, V41, P225, DOI 10.1016/j.ijpara.2010.09.003; BOON JH, 1984, VET QUART, V6, P13, DOI 10.1080/01652176.1984.9693900; Cornelissen JBWJ, 1997, VET PARASITOL, V70, P153, DOI 10.1016/S0304-4017(96)01141-7; Eerola U, 2010, ACTA VET SCAND S1, pS28; EU (European Union), 2011, DIR GEN AGR RUR DEV; EYSKER M, 1994, VET PARASITOL, V53, P263, DOI 10.1016/0304-4017(94)90189-9; Federal Statistical Office of Germany (Destatis), 2011, FED STAT OFF GERM DE, V3; Fiedor C, 2009, VET PARASITOL, V166, P255, DOI 10.1016/j.vetpar.2009.09.002; Hoglund J, 2004, VET PARASITOL, V125, P343, DOI 10.1016/j.vetpar.2004.07.018; Hoglund J, 2010, VET PARASITOL, V171, P293, DOI 10.1016/j.vetpar.2010.04.002; Holzhauer M, 2011, VET REC, V169, P494, DOI 10.1136/vr.d4736; Jimenez AE, 2007, VET PARASITOL, V148, P262, DOI 10.1016/j.vetpar.2007.06.015; Klewer AM, 2012, PREV VET MED, V103, P243, DOI 10.1016/j.prevetmed.2011.08.008; Kuerpick B, 2013, PARASITOLOGY, V140, P1051, DOI 10.1017/S0031182013000395; Matthews J, 2008, LIVESTOCK, V13, P1; McCann CM, 2010, VET REC, V166, P612, DOI 10.1136/vr.b4836; McCann CM, 2010, INT J PARASITOL, V40, P1021, DOI 10.1016/j.ijpara.2010.02.009; McKeand JB, 2000, PARASITOLOGY, V120, pS17, DOI 10.1017/S0031182099005727; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Ploeger HW, 2012, VET PARASITOL, V185, P335, DOI 10.1016/j.vetpar.2011.10.026; Ploeger HW, 2012, VET PARASITOL, V184, P168, DOI 10.1016/j.vetpar.2011.08.032; Ploeger HW, 2002, TRENDS PARASITOL, V18, P329, DOI 10.1016/S1471-4922(02)02317-6; SCHNIEDER T, 1993, VET REC, V132, P167, DOI 10.1136/vr.132.7.167; SCHNIEDER T, 1993, VET PARASITOL, V47, P289, DOI 10.1016/0304-4017(93)90030-Q; Schunn AM, 2012, VET PARASITOL, V189, P291, DOI 10.1016/j.vetpar.2012.04.012; SOLIMAN KN, 1953, J COMP PATHOL THERAP, V63, P75, DOI 10.1016/S0368-1742(53)80009-3; von Holtum C, 2008, VET PARASITOL, V151, P218, DOI 10.1016/j.vetpar.2007.11.006; Wapenaar W, 2007, JAVMA-J AM VET MED A, V231, P1715, DOI 10.2460/javma.231.11.1715; Woolley H., 1997, Cattle Practice, V5, P315	30	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74429	10.1371/journal.pone.0074429	http://dx.doi.org/10.1371/journal.pone.0074429			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040243	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600127
J	Richter, K; Kiefer, KP; Grzesik, BA; Clauss, WG; Fronius, M				Richter, Katrin; Kiefer, Kevin P.; Grzesik, Benno A.; Clauss, Wolfgang G.; Fronius, Martin			Hydrostatic pressure activates ATP-sensitive K channels in lung epithelium by ATP release through pannexin and connexin hemichannels	FASEB JOURNAL			English	Article						mechanotransduction; Ussing chamber; stretch; transepithelial ion transport; Xenopus laevis	SULFONYLUREA RECEPTOR; SIGNAL-TRANSDUCTION; MECHANICAL FORCES; POTASSIUM CHANNEL; SODIUM-CHANNELS; ION-TRANSPORT; AIRWAY; STRESS; PATHWAYS; PROTEIN	Lungs of air-breathing vertebrates are constantly exposed to mechanical forces and therefore are suitable for investigation of mechanotransduction processes in nonexcitable cells and tissues. Freshly dissected Xenopus laevis lungs were used for transepithelial short-circuit current (I-SC) recordings and were exposed to increased hydrostatic pressure (HP; 5 cm fluid column, modified Ussing chamber). I-SC values obtained under HP (I-5cm) were normalized to values before HP (I-0cm) application (I-5cm/I-0cm). Under control conditions, HP decreased I-SC (I-5cm/I-0cm=0.84; n=68; P<0.0001). This effect was reversible and repeatable 30 times. Preincubation with ATP-sensitive K+ channel (K-ATP) inhibitors (HMR1098 and glibenclamide) prevented the decrease in I-SC (I-5cm/I-0cm: HMR1098=1.19, P<0.0001; glibenclamide=1.11, P<0.0001). Similar effects were observed with hemichannel inhibitors (I-5cm/I-0cm: meclofenamic acid=1.09, P<0.0001; probenecid=1.0, P<0.0001). The HP effect was accompanied by release of ATP (P<0.05), determined by luciferin-luciferase luminescence in perfusion solution from the luminal side of an Ussing chamber. ATP release was abrogated by both meclofenamic acid and probenecid. RT-PCR experiments revealed the expression of pannexin and connexin hemichannels and K-ATP subunit transcripts in X. laevis lung. These data show an activation of K-ATP in pulmonary epithelial cells in response to HP that is induced by ATP release through mechanosensitive pannexin and connexin hemichannels. These findings represent a novel mechanism of mechanotransduction in nonexcitable cells.Richter, K., Kiefer, K. P., Grzesik, B. A., Clauss, W. G., Fronius, M. Hydrostatic pressure activates ATP-sensitive K+ channels in lung epithelium by ATP release through pannexin and connexin hemichannels.	[Richter, Katrin; Kiefer, Kevin P.; Clauss, Wolfgang G.; Fronius, Martin] Univ Giessen, Inst Anim Physiol, D-35392 Giessen, Germany; [Grzesik, Benno A.] Univ Giessen, Dept Internal Med, D-35392 Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen	Fronius, M (corresponding author), Univ Giessen, Inst Anim Physiol, Heinrich Buff Ring 26, D-35392 Giessen, Germany.	martin.fronius@bio.uni-giessen.de	Fronius, Martin/K-4118-2013	Richter, Katrin/0000-0002-2450-1083				Althaus M, 2007, FASEB J, V21, P2389, DOI 10.1096/fj.06-7694com; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Bardou O, 2009, AM J PHYSIOL-LUNG C, V296, pL145, DOI 10.1152/ajplung.90525.2008; Barth K, 2009, FEBS J, V276, P341, DOI 10.1111/j.1742-4658.2008.06795.x; Bell PD, 2003, P NATL ACAD SCI USA, V100, P4322, DOI 10.1073/pnas.0736323100; Bogdan R, 2008, PFLUG ARCH EUR J PHY, V456, P1109, DOI 10.1007/s00424-008-0486-5; Burke MA, 2008, CIRC RES, V102, P164, DOI 10.1161/CIRCRESAHA.107.165324; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Burnstock G, 2012, PHARMACOL REV, V64, P834, DOI 10.1124/pr.111.005389; Button B, 2007, J PHYSIOL-LONDON, V580, P577, DOI 10.1113/jphysiol.2006.126086; Cavanaugh KJ, 2001, AM J RESP CELL MOL, V25, P584, DOI 10.1165/ajrcmb.25.5.4486; Chatterjee S, 2006, MICROCIRCULATION, V13, P633, DOI 10.1080/10739680600930255; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; D'hondt C, 2011, CELL SIGNAL, V23, P305, DOI 10.1016/j.cellsig.2010.07.018; de Boer TP, 2005, DIFFERENTIATION, V73, P330, DOI 10.1111/j.1432-0436.2005.00026.x; Dobbs LG, 2001, COMP BIOCHEM PHYS A, V129, P261, DOI 10.1016/S1095-6433(01)00322-1; Eckle T, 2013, FASEB J, V27, P3078, DOI 10.1096/fj.13-228551; Edwards YS, 2001, COMP BIOCHEM PHYS A, V129, P245, DOI 10.1016/S1095-6433(01)00321-X; FISCHER H, 1989, AM J PHYSIOL, V256, pC764, DOI 10.1152/ajpcell.1989.256.4.C764; Fitz J Gregory, 2007, Trans Am Clin Climatol Assoc, V118, P199; Fox JEM, 2002, BRIT J PHARMACOL, V135, P480, DOI 10.1038/sj.bjp.0704455; Fredberg JJ, 2006, ANNU REV PHYSIOL, V68, P507, DOI 10.1146/annurev.physiol.68.072304.114110; Fronius M, 2004, RESP PHYSIOL NEUROBI, V139, P133, DOI 10.1016/j.resp.2003.09.007; Fronius M., 2012, LUNG DIS SELECTED ST, P561; Fronius M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00146; Gogelein H, 2001, N-S ARCH PHARMACOL, V364, P33, DOI 10.1007/s002100000391; Gogelein H, 1998, J PHARMACOL EXP THER, V286, P1453; Gout Taras, 2012, Ann Thorac Med, V7, P115, DOI 10.4103/1817-1737.98842; Gribble FM, 1998, DIABETES, V47, P1412, DOI 10.2337/diabetes.47.9.1412; Guyot A, 2002, J PHYSIOL-LONDON, V545, P199, DOI 10.1113/jphysiol.2002.030148; Hanner F, 2012, AM J PHYSIOL-RENAL, V303, pF1454, DOI 10.1152/ajprenal.00206.2011; Hollenhorst MI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/174306; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; Kessler S, 2011, PFLUG ARCH EUR J PHY, V462, P419, DOI 10.1007/s00424-011-0980-z; Khakh BS, 2009, SCI AM, V301, P84, DOI 10.1038/scientificamerican1209-84; KIM KJ, 1990, RESP PHYSIOL, V81, P29, DOI 10.1016/0034-5687(90)90067-9; Knight MM, 2009, J ANAT, V214, P275, DOI 10.1111/j.1469-7580.2008.01021.x; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; KREBS HA, 1975, J EXP ZOOL, V194, P221, DOI 10.1002/jez.1401940115; Leroy C, 2004, AM J PHYSIOL-LUNG C, V286, pL1027, DOI 10.1152/ajplung.00249.2003; Li A, 2010, AM J PHYSIOL-CELL PH, V299, pC1308, DOI 10.1152/ajpcell.00333.2010; Liu MY, 2000, J APPL PHYSIOL, V89, P2078, DOI 10.1152/jappl.2000.89.5.2078; Liu MY, 1999, AM J PHYSIOL-LUNG C, V277, pL667, DOI 10.1152/ajplung.1999.277.4.L667; Luckprom P, 2011, J PERIODONTAL RES, V46, P607, DOI 10.1111/j.1600-0765.2011.01379.x; Maina JN, 2000, ANAT REC, V261, P25; Maina JN, 2005, PHYSIOL REV, V85, P811, DOI 10.1152/physrev.00022.2004; MEBAN C, 1973, J ANAT, V114, P235; Mironov SL, 2000, BRAIN RES, V853, P60, DOI 10.1016/S0006-8993(99)02234-9; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Okada SF, 2006, J BIOL CHEM, V281, P22992, DOI 10.1074/jbc.M603019200; Okada SF, 2013, AM J RESP CELL MOL, V49, P814, DOI 10.1165/rcmb.2012-0493OC; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Power JHT, 1999, J EXP BIOL, V202, P2543; Prat AG, 1996, AM J PHYSIOL-CELL PH, V270, pC538, DOI 10.1152/ajpcell.1996.270.2.C538; Proks P, 2009, PROG BIOPHYS MOL BIO, V99, P7, DOI 10.1016/j.pbiomolbio.2008.10.002; Ramsingh R., 2011, AM J PHYSIOL-LUNG C, V4, P587; Ransford GA, 2009, AM J RESP CELL MOL, V41, P525, DOI 10.1165/rcmb.2008-0367OC; Reigada D, 2005, AM J PHYSIOL-CELL PH, V288, pC132, DOI 10.1152/ajpcell.00201.2004; Rooney SA, 2001, COMP BIOCHEM PHYS A, V129, P233, DOI 10.1016/S1095-6433(01)00320-8; Sakuma T, 1998, PHARMACOL TOXICOL, V83, P16, DOI 10.1111/j.1600-0773.1998.tb01436.x; Sesma JI, 2013, AM J PHYSIOL-CELL PH, V304, pC976, DOI 10.1152/ajpcell.00371.2012; Shestopalov VI, 2008, CELL MOL LIFE SCI, V65, P376, DOI 10.1007/s00018-007-7200-1; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Sridharan M, 2010, AM J PHYSIOL-HEART C, V299, pH1146, DOI 10.1152/ajpheart.00301.2010; Taylor AL, 1998, AM J PHYSIOL-CELL PH, V275, pC1391, DOI 10.1152/ajpcell.1998.275.5.C1391; VANWAGONER DR, 1993, CIRC RES, V72, P973, DOI 10.1161/01.RES.72.5.973; Wang J, 1997, PHARM RES-DORDR, V14, P1524, DOI 10.1023/A:1012113931332; Waza AA, 2012, EXP CELL RES, V318, P2559, DOI 10.1016/j.yexcr.2012.08.004; Wheeler A, 2008, MOL PHARMACOL, V74, P1333, DOI 10.1124/mol.108.048355; Wirtz HR, 2000, RESP PHYSIOL, V119, P1, DOI 10.1016/S0034-5687(99)00092-4; Zhang HX, 2011, J MOL CELL CARDIOL, V50, P552, DOI 10.1016/j.yjmcc.2010.12.011	72	18	20	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					45	55		10.1096/fj.13-229252	http://dx.doi.org/10.1096/fj.13-229252			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24048216				2022-12-25	WOS:000333526100007
J	Gilliland, CT; Salanga, CL; Kawamura, T; Trejo, J; Handel, TM				Gilliland, C. Taylor; Salanga, Catherina L.; Kawamura, Tetsuya; Trejo, JoAnn; Handel, Tracy M.			The Chemokine Receptor CCR1 Is Constitutively Active, Which Leads to G Protein-independent, beta-Arrestin-mediated Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arrestin; Bioluminescence Resonance Energy Transfer (BRET); Cell Migration; Chemokines; G Protein-coupled Receptors (GPCR); CCR1; Constitutive Activity; Internalization	COUPLED RECEPTORS; DEPENDENT INTERNALIZATION; CONFORMATIONAL-CHANGES; ADENYLYL-CYCLASE; POINT MUTATION; ACTIVATION; AGONIST; ANTAGONIST; CXCR4; PHOSPHORYLATION	Activation of G protein-coupled receptors by their associated ligands has been extensively studied, and increasing structural information about the molecular mechanisms underlying ligand-dependent receptor activation is beginning to emerge with the recent expansion in GPCR crystal structures. However, some GPCRs are also able to adopt active conformations in the absence of agonist binding that result in the initiation of signal transduction and receptor down-modulation. In this report, we show that the CC-type chemokine receptor 1 (CCR1) exhibits significant constitutive activity leading to a variety of cellular responses. CCR1 expression is sufficient to induce inhibition of cAMP formation, increased F-actin content, and basal migration of human and murine leukocytes. The constitutive activity leads to basal phosphorylation of the receptor, recruitment of beta-arrestin-2, and subsequent receptor internalization. CCR1 concurrently engages G alpha(i) and beta-arrestin-2 in a multiprotein complex, which may be accommodated by homo-oligomerization or receptor clustering. The data suggest the presence of two functional states for CCR1; whereas receptor coupled to G alpha(i) functions as a canonical GPCR, albeit with high constitutive activity, the CCR1.beta-arrestin-2 complex is required for G protein-independent constitutive receptor internalization. The pertussis toxin-insensitive uptake of chemokine by the receptor suggests that the CCR1.beta-arrestin-2 complex may be related to a potential scavenging function of the receptor, which may be important for maintenance of chemokine gradients and receptor responsiveness in complex fields of chemokines during inflammation.	[Gilliland, C. Taylor; Salanga, Catherina L.; Kawamura, Tetsuya; Handel, Tracy M.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Trejo, JoAnn] Univ Calif San Diego, Dept Pharmacol, Sch Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Handel, TM (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr,MC0684, La Jolla, CA 92093 USA.	thandel@ucsd.edu		TREJO, JOANN/0000-0003-4405-6228	National Institutes of Health [U01 GM094612, R01 GM081763, R01 GM090689]; University of California, San Diego; NIGMS, National Institutes of Health [T32 GM007752]; NIGMS, National Institutes of Health, MARC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081763, R01GM090689, T32GM007752, U01GM094612] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Diego(University of California System); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS, National Institutes of Health, MARC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants U01 GM094612 and R01 GM081763 (to T. M. H.) and R01 GM090689 (to J. T.).; Supported in part by the University of California, San Diego, Graduate Training Program in Cellular and Molecular Pharmacology through an institutional training grant from NIGMS, National Institutes of Health, Grant T32 GM007752.; Supported by an NIGMS, National Institutes of Health, MARC Predoctoral F31 fellowship.	Allen SJ, 2011, CYTOKINE, V55, P168, DOI 10.1016/j.cyto.2011.05.002; Allen SJ, 2009, PROTEIN EXPRES PURIF, V66, P73, DOI 10.1016/j.pep.2009.03.001; Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; Arai H, 1997, P NATL ACAD SCI USA, V94, P14495, DOI 10.1073/pnas.94.26.14495; Arias DA, 2003, J BIOL CHEM, V278, P36513, DOI 10.1074/jbc.M303739200; Bacart Johan, 2008, Biotechnol J, V3, P311, DOI 10.1002/biot.200700222; Barak LS, 2001, P NATL ACAD SCI USA, V98, P93, DOI 10.1073/pnas.011303698; Benned-Jensen T, 2010, BRIT J PHARMACOL, V159, P1092, DOI 10.1111/j.1476-5381.2009.00633.x; Benned-Jensen T, 2008, MOL PHARMACOL, V74, P1008, DOI 10.1124/mol.108.049676; Bennett LD, 2011, IMMUNOLOGY, V134, P246, DOI 10.1111/j.1365-2567.2011.03485.x; Borroni EM, 2013, METHOD ENZYMOL, V521, P151, DOI 10.1016/B978-0-12-391862-8.00008-9; Borroni EM, 2013, SCI SIGNAL, V6, pS1; Bouschet T, 2007, J CELL SCI, V120, P2489, DOI 10.1242/jcs.03469; Burger M, 1999, J IMMUNOL, V163, P2017; Cancellieri C, 2013, MOL IMMUNOL, V55, P87, DOI 10.1016/j.molimm.2012.08.003; Cardona AE, 2008, BLOOD, V112, P256, DOI 10.1182/blood-2007-10-118497; Chou CC, 2002, BRIT J PHARMACOL, V137, P663, DOI 10.1038/sj.bjp.0704907; COSTA T, 1989, P NATL ACAD SCI USA, V86, P7321, DOI 10.1073/pnas.86.19.7321; Damian M, 2012, J BIOL CHEM, V287, P3630, DOI 10.1074/jbc.M111.288324; de Ligt RAF, 2000, BRIT J PHARMACOL, V130, P1, DOI 10.1038/sj.bjp.0703311; DECAILLOT FM, 2011, J BIOL CHEM; El Far O, 2002, BIOCHEM J, V365, P329, DOI 10.1042/BJ20020481; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Flower DR, 1999, BBA-REV BIOMEMBRANES, V1422, P207, DOI 10.1016/S0304-4157(99)00006-4; Franci C, 1996, J IMMUNOL, V157, P5606; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Gao JL, 1997, J EXP MED, V185, P1959, DOI 10.1084/jem.185.11.1959; Gao W, 2000, J CLIN INVEST, V105, P35, DOI 10.1172/JCI8126; Gladue RP, 2010, CURR TOP MED CHEM, V10, P1268; Godessart N, 2001, CURR OPIN IMMUNOL, V13, P670, DOI 10.1016/S0952-7915(01)00277-1; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Hall DA, 1999, BRIT J PHARMACOL, V126, P810, DOI 10.1038/sj.bjp.0702329; Halls ML, 2012, BRIT J PHARMACOL, V165, P1644, DOI 10.1111/j.1476-5381.2011.01470.x; Halls ML, 2010, EMBO J, V29, P2772, DOI 10.1038/emboj.2010.168; Hamdan FF, 2007, J BIOL CHEM, V282, P29089, DOI 10.1074/jbc.M700577200; Hamdan Fadi F, 2006, Curr Protoc Neurosci, VChapter 5, DOI 10.1002/0471142301.ns0523s34; Horuk R, 2005, MINI-REV MED CHEM, V5, P791, DOI 10.2174/1389557054867057; Horuk R, 2001, IMMUNOL LETT, V76, P193, DOI 10.1016/S0165-2478(01)00172-9; Horuk R, 2001, J BIOL CHEM, V276, P4199, DOI 10.1074/jbc.M007457200; Hoshino A, 2010, J BIOL CHEM, V285, P28826, DOI 10.1074/jbc.M109.099424; Hvas J, 1997, SCAND J IMMUNOL, V46, P195, DOI 10.1046/j.1365-3083.1997.d01-100.x; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Jensen PC, 2007, MOL PHARMACOL, V72, P327, DOI 10.1124/mol.106.035543; KARPUS WJ, 1995, J IMMUNOL, V155, P5003; Kenakin T, 2005, TRENDS PHARMACOL SCI, V26, P603, DOI 10.1016/j.tips.2005.10.007; Kim IS, 2004, BIOCHEM PHARMACOL, V68, P611, DOI 10.1016/j.bcp.2004.03.041; Kleemann P, 2008, N-S ARCH PHARMACOL, V378, P261, DOI 10.1007/s00210-008-0313-8; Kocan M, 2009, MOL ENDOCRINOL, V23, P559, DOI 10.1210/me.2008-0321; Lagane B, 2005, MOL PHARMACOL, V67, P1966, DOI 10.1124/mol.104.009779; Lebre MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021772; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Loetscher P, 2002, ARTHRITIS RES, V4, P233, DOI 10.1186/ar412; Luker KE, 2010, ONCOGENE, V29, P4599, DOI 10.1038/onc.2010.212; Munoz LM, 2012, IMMUNOL LETT, V145, P23, DOI 10.1016/j.imlet.2012.04.012; Miller AL, 2006, J IMMUNOL, V176, P2562, DOI 10.4049/jimmunol.176.4.2562; Miller WE, 2003, J BIOL CHEM, V278, P21663, DOI 10.1074/jbc.M303219200; Min L, 2000, MOL ENDOCRINOL, V14, P1797, DOI 10.1210/me.14.11.1797; Ninichuk V, 2005, AM J NEPHROL, V25, P365, DOI 10.1159/000087185; Olbrich H, 1999, J LEUKOCYTE BIOL, V65, P281, DOI 10.1002/jlb.65.3.281; Parnot C, 2002, TRENDS ENDOCRIN MET, V13, P336, DOI 10.1016/S1043-2760(02)00628-8; PEI G, 1994, P NATL ACAD SCI USA, V91, P2699, DOI 10.1073/pnas.91.7.2699; PERALTA EG, 1988, NATURE, V334, P434, DOI 10.1038/334434a0; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Proudfoot A E, 2001, Curr Protoc Pharmacol, VChapter 12, DOI 10.1002/0471141755.ph1204s14; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rodriguez-Frade JM, 1999, P NATL ACAD SCI USA, V96, P3628, DOI 10.1073/pnas.96.7.3628; Rodriguez-Sosa M, 2003, IMMUNOL CELL BIOL, V81, P114, DOI 10.1046/j.0818-9641.2002.01132.x; Rondou P, 2010, CELL SIGNAL, V22, P900, DOI 10.1016/j.cellsig.2010.01.014; Schall TJ, 2011, NAT REV IMMUNOL, V11, P355, DOI 10.1038/nri2972; Schneider EH, 2009, BIOCHEMISTRY-US, V48, P1424, DOI 10.1021/bi802050d; Scholten DJ, 2012, BRIT J PHARMACOL, V165, P1617, DOI 10.1111/j.1476-5381.2011.01551.x; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Slack RJ, 2012, BRIT J PHARMACOL, V166, P1774, DOI 10.1111/j.1476-5381.2012.01901.x; Spooren A, 2010, CELL SIGNAL, V22, P600, DOI 10.1016/j.cellsig.2009.11.013; Springael JY, 2007, CELL SIGNAL, V19, P1446, DOI 10.1016/j.cellsig.2007.01.022; Srinivasan S, 2004, J CLIN INVEST, V114, P1158, DOI 10.1172/JCI200421927; Stephens B, 2013, PROG MOL BIOL TRANSL, V115, P375, DOI 10.1016/B978-0-12-394587-7.00009-9; SterneMarr R, 1995, VITAM HORM, V51, P193, DOI 10.1016/S0083-6729(08)61039-0; Tao YX, 2008, PHARMACOL THERAPEUT, V120, P129, DOI 10.1016/j.pharmthera.2008.07.005; Tenenbaum J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008383; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Tsou CL, 1998, J EXP MED, V188, P603, DOI 10.1084/jem.188.3.603; Vergunst CE, 2009, ARTHRITIS RHEUM-US, V60, P3572, DOI 10.1002/art.24978; Vielhauer V, 2004, KIDNEY INT, V66, P2264, DOI 10.1111/j.1523-1755.2004.66038.x; Vishnivetskiy SA, 2011, J BIOL CHEM, V286, P24288, DOI 10.1074/jbc.M110.213835; Volpe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037208; Wan YT, 2002, EUR J PHARMACOL, V456, P1, DOI 10.1016/S0014-2999(02)02621-3; Wells TNC, 2006, TRENDS PHARMACOL SCI, V27, P41, DOI 10.1016/j.tips.2005.11.001; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200	95	50	50	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32194	32210		10.1074/jbc.M113.503797	http://dx.doi.org/10.1074/jbc.M113.503797			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24056371	Green Published, hybrid			2022-12-25	WOS:000328681700009
J	Hess, V; Schuchmann, K; Muller, V				Hess, Verena; Schuchmann, Kai; Mueller, Volker			The Ferredoxin: NAD(+) Oxidoreductase (Rnf) from the Acetogen Acetobacterium woodii Requires Na+ and Is Reversibly Coupled to the Membrane Potential	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP SYNTHASE; TRANSLOCATING ATPASE; SODIUM-IONS; IDENTIFICATION; METHYLTRANSFERASE; DECARBOXYLASE; DEHYDROGENASE; PURIFICATION; F1F0-ATPASE; COMPLEX	The anaerobic acetogenic bacterium Acetobacterium woodii has a novel Na+-translocating electron transport chain that couples electron transfer from reduced ferredoxin to NAD(+) with the generation of a primary electrochemical Na+ potential across its cytoplasmic membrane. In previous assays in which Ti3+ was used to reduce ferredoxin, Na+ transport was observed, but not a Na+ dependence of the electron transfer reaction. Here, we describe a new biological reduction system for ferredoxin in which ferredoxin is reduced with CO, catalyzed by the purified acetyl-CoA synthase/CO dehydrogenase from A. woodii. Using CO-reduced ferredoxin, NAD(+) reduction was highly specific and strictly dependent on ferredoxin and occurred at a rate of 50 milliunits/mg of protein. Most important, this assay revealed for the first time a strict Na+ dependence of this electron transfer reaction. The K-m was 0.2 mM. Na+ could be partly substituted by Li+. Na+ dependence was observed at neutral and acidic pH values, indicating the exclusive use of Na+ as a coupling ion. Electron transport from reduced ferredoxin to NAD(+) was coupled to electrogenic Na+ transport, indicating the generation of Delta(mu) over tilde (Na+). Vice versa, endergonic ferredoxin reduction with NADH as reductant was possible, but only in the presence of Delta(mu) over tilde (Na+), and was accompanied by Na+ efflux out of the vesicles. This is consistent with the hypothesis that Rnf also catalyzes ferredoxin reduction at the expense of an electrochemical Na+ gradient. The physiological significance of this finding is discussed.	[Hess, Verena; Schuchmann, Kai; Mueller, Volker] Goethe Univ Frankfurt, Dept Mol Microbiol & Bioenerget, Inst Mol Biosci, D-60438 Frankfurt, Germany	Goethe University Frankfurt	Muller, V (corresponding author), Goethe Univ Frankfurt, Dept Mol Microbiol & Bioenerget, Inst Mol Biosci, Max von Laue Str 9, D-60438 Frankfurt, Germany.	vmueller@bio.uni-frankfurt.de	Mueller, Volker/ABE-4305-2021	Mueller, Volker/0000-0001-7955-5508	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft.	BECHER B, 1992, J BACTERIOL, V174, P7656, DOI 10.1128/JB.174.23.7656-7660.1992; Biegel E, 2011, CELL MOL LIFE SCI, V68, P613, DOI 10.1007/s00018-010-0555-8; Biegel E, 2010, P NATL ACAD SCI USA, V107, P18138, DOI 10.1073/pnas.1010318107; Biegel E, 2009, ENVIRON MICROBIOL, V11, P1438, DOI 10.1111/j.1462-2920.2009.01871.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUCKEL W, 1982, FEBS LETT, V148, P35, DOI 10.1016/0014-5793(82)81237-4; Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002; DIMROTH P, 1982, EUR J BIOCHEM, V121, P443, DOI 10.1111/j.1432-1033.1982.tb05807.x; Fritz M, 2007, FEBS J, V274, P3421, DOI 10.1111/j.1742-4658.2007.05874.x; GARTNER P, 1994, EUR J BIOCHEM, V226, P465, DOI 10.1111/j.1432-1033.1994.tb20071.x; HEISE R, 1989, J BACTERIOL, V171, P5473, DOI 10.1128/jb.171.10.5473-5478.1989; HEISE R, 1992, EUR J BIOCHEM, V206, P553, DOI 10.1111/j.1432-1033.1992.tb16959.x; IMAE Y, 1989, J BIOENERG BIOMEMBR, V21, P705, DOI 10.1007/BF00762688; Imkamp F, 2007, J BACTERIOL, V189, P8145, DOI 10.1128/JB.01017-07; Jayamani E., 2008, THESIS PHILIPPS U MA; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAUBINGER W, 1988, BIOCHEMISTRY-US, V27, P7531, DOI 10.1021/bi00419a053; Muller V, 1995, ARCH MICROBIOL, V164, P363, DOI 10.1007/s002030050276; Muller V, 2003, APPL ENVIRON MICROB, V69, P6345, DOI 10.1128/AEM.69.11.6345-6353.2003; Muller V, 2001, BBA-BIOENERGETICS, V1505, P108, DOI 10.1016/S0005-2728(00)00281-4; Pisa KY, 2007, FEBS J, V274, P3928, DOI 10.1111/j.1742-4658.2007.05925.x; Poehlein A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033439; RAGSDALE SW, 1983, J BACTERIOL, V155, P1224, DOI 10.1128/JB.155.3.1224-1237.1983; REIDLINGER J, 1994, EUR J BIOCHEM, V223, P275, DOI 10.1111/j.1432-1033.1994.tb18992.x; Schlegel K, 2012, P NATL ACAD SCI USA, V109, P947, DOI 10.1073/pnas.1115796109; SCHMEHL M, 1993, MOL GEN GENET, V241, P602, DOI 10.1007/BF00279903; Schmidt S, 2009, BBA-BIOENERGETICS, V1787, P691, DOI 10.1016/j.bbabio.2008.12.015; SCHONHEIT P, 1978, FEBS LETT, V89, P219, DOI 10.1016/0014-5793(78)80221-X; Schuchmann K, 2012, J BIOL CHEM, V287, P31165, DOI 10.1074/jbc.M112.395038; TAKASE K, 1994, J BIOL CHEM, V269, P11037; Terahara N, 2008, P NATL ACAD SCI USA, V105, P14359, DOI 10.1073/pnas.0802106105; Wittig I, 2007, ELECTROPHORESIS, V28, P3811, DOI 10.1002/elps.200700367; ZEHNDER AJB, 1976, SCIENCE, V194, P1165, DOI 10.1126/science.793008	33	104	110	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31496	31502		10.1074/jbc.M113.510255	http://dx.doi.org/10.1074/jbc.M113.510255			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24045950	Green Published, hybrid			2022-12-25	WOS:000330596200009
J	Feldman, JL; Baeza, J; Denu, JM				Feldman, Jessica L.; Baeza, Josue; Denu, John M.			Activation of the Protein Deacetylase SIRT6 by Long-chain Fatty Acids and Widespread Deacylation by Mammalian Sirtuins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; METABOLISM; ACYLATION; GLUCOSE; ASSAYS	Mammalian sirtuins (SIRT1 through SIRT7) are members of a highly conserved family of NAD(+)-dependent protein deacetylases that function in metabolism, genome maintenance, and stress responses. Emerging evidence suggests that some sirtuins display substrate specificity toward other acyl groups attached to the lysine epsilon-amine. SIRT6 was recently reported to preferentially hydrolyze long-chain fatty acyl groups over acetyl groups. Here we investigated the catalytic ability of all sirtuins to hydrolyze 13 different acyl groups from histone H3 peptides, ranging in carbon length, saturation, and chemical diversity. We find that long-chain deacylation is a general feature of mammalian sirtuins, that SIRT1 and SIRT2 act as efficient decrotonylases, and that SIRT1, SIRT2, SIRT3, and SIRT4 can remove lipoic acid. These results provide new insight into sirtuin function and a means for cellular removal of an expanding list of endogenous lysine modifications. Given that SIRT6 is a poor deacetylase in vitro, but binds and prefers to hydrolyze long-chain acylated peptides, we hypothesize that binding of certain free fatty acids (FFAs) could stimulate deacetylation activity. Indeed, we demonstrate that several biologically relevant FFAs (including myristic, oleic, and linoleic acids) at physiological concentrations induce up to a 35-fold increase in catalytic efficiency of SIRT6 but not SIRT1. The activation mechanism is consistent with fatty acid inducing a conformation that binds acetylated H3 with greater affinity. Binding of long-chain FFA and myristoylated H3 peptide is mutually exclusive. We discuss the implications of discovering endogenous, small-molecule activators of SIRT6.	[Feldman, Jessica L.; Baeza, Josue; Denu, John M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53715 USA; [Feldman, Jessica L.; Baeza, Josue; Denu, John M.] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53715 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Denu, JM (corresponding author), Univ Wisconsin, 330 N Orchard St,WID 2178, Madison, WI 53715 USA.	jmdenu@wisc.edu		Baeza, Josue/0000-0003-4960-3905	National Institutes of Health [GM065386]; American Heart Association [11PRE7300059]; National Science Foundation [1256259]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065386, T32GM007215, R37GM059785] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM065386 (to J.M.D.), a predoctoral fellowship (to J.L.F.) from the American Heart Association (11PRE7300059) and a predoctoral fellowship (to J.B.) from the National Science Foundation (1256259).	Adkins Y, 2010, J NUTR BIOCHEM, V21, P781, DOI 10.1016/j.jnutbio.2009.12.004; Berndsen CE, 2005, METHODS, V36, P321, DOI 10.1016/j.ymeth.2005.03.002; Borra MT, 2004, METHOD ENZYMOL, V376, P171; Calder PC, 2010, NUTRIENTS, V2, P355, DOI 10.3390/nu2030355; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Feldman JL, 2012, J BIOL CHEM, V287, P42419, DOI 10.1074/jbc.R112.378877; de Albuquerque CFG, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/601032; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; JUMP DB, 1994, J LIPID RES, V35, P1076; Jump DB, 2002, CURR OPIN LIPIDOL, V13, P155, DOI 10.1097/00041433-200204000-00007; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Lin HN, 2012, ACS CHEM BIOL, V7, P947, DOI 10.1021/cb3001793; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Nakagawa T, 2011, J CELL SCI, V124, P833, DOI 10.1242/jcs.081067; NORTHROP DB, 1983, ANAL BIOCHEM, V132, P457, DOI 10.1016/0003-2697(83)90034-9; Pan PW, 2011, J BIOL CHEM, V286, P14575, DOI 10.1074/jbc.M111.218990; Preyat N, 2013, J LEUKOCYTE BIOL, V93, P669, DOI 10.1189/jlb.1112557; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Spalding MD, 2010, MICROBIOL MOL BIOL R, V74, P200, DOI 10.1128/MMBR.00008-10; STEVENSON FT, 1992, J EXP MED, V176, P1053, DOI 10.1084/jem.176.4.1053; Sundaresan NR, 2012, NAT MED, V18, P1643, DOI 10.1038/nm.2961; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Tholstrup T, 2001, AM J CLIN NUTR, V73, P198; Xu JH, 2006, J BIOL CHEM, V281, P18351, DOI 10.1074/jbc.M601277200; Yang B, 2009, CELL CYCLE, V8, P2662, DOI 10.4161/cc.8.16.9329; Yuan C, 2009, J BIOL CHEM, V284, P10046, DOI 10.1074/jbc.M808634200; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041; Zhu AY, 2012, ACS CHEM BIOL, V7, P155, DOI 10.1021/cb200230x	36	432	438	5	64	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31350	31356		10.1074/jbc.C113.511261	http://dx.doi.org/10.1074/jbc.C113.511261			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24052263	Green Published, hybrid			2022-12-25	WOS:000330778900051
J	Yan, F; Liu, LP; Dempsey, PJ; Tsai, YH; Raines, EW; Wilson, CL; Cao, HL; Cao, Z; Liu, LS; Polk, DB				Yan, Fang; Liu, Liping; Dempsey, Peter J.; Tsai, Yu-Hwai; Raines, Elaine W.; Wilson, Carole L.; Cao, Hailong; Cao, Zheng; Liu, LinShu; Polk, D. Brent			A Lactobacillus rhamnosus GG-derived Soluble Protein, p40, Stimulates Ligand Release from Intestinal Epithelial Cells to Transactivate Epidermal Growth Factor Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Epidermal Growth Factor (EGF); Intestinal Epithelium; Probiotics; Tight Junctions	ALPHA-CONVERTING-ENZYME; EGF RECEPTOR; COLONIC-MUCOSA; POTENTIAL ROLE; DRUG-DELIVERY; MICE; INFLAMMATION; ACTIVATION; PROBIOTICS; COLITIS	p40, a Lactobacillus rhamnosus GG (LGG)-derived soluble protein, ameliorates intestinal injury and colitis, reduces apoptosis, and preserves barrier function by transactivation of the EGF receptor (EGFR) in intestinal epithelial cells. The aim of this study is to determine the mechanisms by which p40 transactivates the EGFR in intestinal epithelial cells. Here we show that p40-conditioned medium activates EGFR in young adult mouse colon epithelial cells and human colonic epithelial cell line, T84 cells. p40 up-regulates a disintegrin and metalloproteinase domain-containing protein 17 (ADAM17) catalytic activity, and broad spectrum metalloproteinase inhibitors block EGFR transactivation by p40 in these two cell lines. In ADAM17-deficient mouse colonic epithelial (ADAM17(-/-) MCE) cells, p40 transactivation of EGFR is blocked, but can be rescued by re-expression with WT ADAM17. Furthermore, p40 stimulates release of heparin binding (HB)-EGF, but not transforming growth factor (TGF) or amphiregulin, in young adult mouse colon cells and ADAM17(-/-) MCE cells overexpressing WT ADAM17. Knockdown of HB-EGF expression by siRNA suppresses p40 effects on transactivating EGFR and Akt, preventing apoptosis, and preserving tight junction function. The effects of p40 on HB-EGF release and ADAM17 activation in vivo are examined after administration of p40-containing pectin/zein hydrogel beads to mice. p40 stimulates ADAM17 activity and EGFR activation in colonic epithelial cells and increases HB-EGF levels in blood from WT mice, but not from mice with intestinal epithelial cell-specific ADAM17 deletion. Thus, these data define a mechanism of a probiotic-derived soluble protein in modulating intestinal epithelial cell homeostasis through ADAM17-mediated HB-EGF release, leading to transactivation of EGFR.	[Yan, Fang; Liu, Liping; Cao, Hailong] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Cao, Zheng] Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37232 USA; [Dempsey, Peter J.; Tsai, Yu-Hwai] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Dempsey, Peter J.; Tsai, Yu-Hwai] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Raines, Elaine W.; Wilson, Carole L.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Cao, Hailong] Tianjin Med Univ, Gen Hosp, Dept Gastroenterol, Tianjin 300052, Peoples R China; [Liu, LinShu] ARS, Eastern Reg Res Ctr, USDA, Wyndmoor, PA 19038 USA; [Polk, D. Brent] Univ So Calif, Dept Pediat, Los Angeles, CA 90089 USA; [Polk, D. Brent] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; [Polk, D. Brent] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90089 USA	Vanderbilt University; Vanderbilt University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle; Tianjin Medical University; United States Department of Agriculture (USDA); University of Southern California; University of Southern California; Children's Hospital Los Angeles	Polk, DB (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Div Gastroenterol Hepatol & Nutr, 2215 Garland Ave,MRB 4,Rm 1035, Nashville, TN 37232 USA.	fang.yan@vanderbilt.edu	liu, li/HGC-0900-2022	Liu, LinShu/0000-0003-3962-290X	National Institutes of Health [R01DK081134, R01DK93697, R01HL067267, P01HL018645, R01DK56008, R01DK54993, R01DK066176, P30DK058404]; Tianjin Research Program of Application Foundation and Advanced Technology for Young Scientists of China [13JCQNJC10600]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018645, R01HL067267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056008, R01DK093697, R01DK066176, R01DK081134, R01DK054993, P30DK058404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tianjin Research Program of Application Foundation and Advanced Technology for Young Scientists of China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK081134 (to F. Y.), R01DK93697 (to P. J. D), R01HL067267 and P01HL018645 (to E W. R.), and R01DK56008, R01DK54993, and R01DK066176 (to D. B. P.). This work was also supported by Tianjin Research Program of Application Foundation and Advanced Technology for Young Scientists of China Grant 13JCQNJC10600 (to H. C.) and core services performed through Vanderbilt University Medical Center Digestive Disease Research Center supported by National Institutes of Health Grant P30DK058404.	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Arribas J, 2003, CURR TOP DEV BIOL, V54, P125, DOI 10.1016/S0070-2153(03)54007-8; Bauerl C, 2010, J MOL MICROB BIOTECH, V19, P231, DOI 10.1159/000322233; Basu S, 2009, J CLIN GASTROENTEROL, V43, P208, DOI 10.1097/MCG.0b013e31815a5780; Besselink MGH, 2008, LANCET, V371, P651, DOI 10.1016/S0140-6736(08)60207-X; Blaydon DC, 2011, NEW ENGL J MED, V365, P1502, DOI 10.1056/NEJMoa1100721; Blobel CR, 2009, EXP CELL RES, V315, P671, DOI 10.1016/j.yexcr.2008.10.011; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Brandl K, 2010, P NATL ACAD SCI USA, V107, P19967, DOI 10.1073/pnas.1014669107; Brynskov J, 2002, GUT, V51, P37, DOI 10.1136/gut.51.1.37; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Claes IJJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031588; Colon AL, 2001, CYTOKINE, V16, P220, DOI 10.1006/cyto.2001.0969; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Dise RS, 2008, AM J PHYSIOL-GASTR L, V294, pG276, DOI 10.1152/ajpgi.00340.2007; Doron S, 2005, GASTROENTEROL CLIN N, V34, P483, DOI 10.1016/j.gtc.2005.05.011; Dube PE, 2012, J CLIN INVEST, V122, P2780, DOI 10.1172/JCI62888; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Elson CO, 2012, GUT MICROBES, V3, P332, DOI [10.4161/gmic.20228, 10.1038/s41577-019-0268-7]; FAN SJ, 1994, CANCER RES, V54, P5824; Garton KJ, 2003, J BIOL CHEM, V278, P37459, DOI 10.1074/jbc.M305877200; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gorbach SL, 1996, NUTR TODAY, V31, P25, DOI DOI 10.1097/00017285-199611001-00002; Land MH, 2005, PEDIATRICS, V115, P178, DOI 10.1542/peds.2004-2137; Liu LS, 2006, DRUG DELIV, V13, P417, DOI 10.1080/10717540500394935; Liu LS, 2003, BIOMATERIALS, V24, P3333, DOI 10.1016/S0142-9612(03)00213-8; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Ohtsu H, 2006, AM J PHYSIOL-CELL PH, V291, pC1, DOI 10.1152/ajpcell.00620.2005; Regulski K., 2012, PLOS ONE, V7; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Seth A, 2008, AM J PHYSIOL-GASTR L, V294, pG1060, DOI 10.1152/ajpgi.00202.2007; Sinha A, 2003, NEW ENGL J MED, V349, P350, DOI 10.1056/NEJMoa013136; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Szajewska H, 2011, ALIMENT PHARM THER, V34, P1079, DOI 10.1111/j.1365-2036.2011.04837.x; Vahabnezhad E, 2013, J CLIN GASTROENTEROL, V47, P437, DOI 10.1097/MCG.0b013e318279abf0; Vanderpool C, 2008, INFLAMM BOWEL DIS, V14, P1585, DOI 10.1002/ibd.20525; Whitehead RH, 1999, GASTROENTEROLOGY, V117, P858, DOI 10.1016/S0016-5085(99)70344-6; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Wilson CL, 2013, MECH DEVELOP, V130, P272, DOI 10.1016/j.mod.2013.01.001; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; Yamaoka T, 2008, P NATL ACAD SCI USA, V105, P11772, DOI 10.1073/pnas.0801463105; Yan F, 2002, J BIOL CHEM, V277, P50959, DOI 10.1074/jbc.M207050200; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Yan F, 2011, CURR OPIN GASTROEN, V27, P496, DOI 10.1097/MOG.0b013e32834baa4d; Yan F, 2011, J CLIN INVEST, V121, P2242, DOI 10.1172/JCI44031; Yan F, 2010, CURR OPIN GASTROEN, V26, P95, DOI 10.1097/MOG.0b013e328335239a; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zocco MA, 2006, ALIMENT PHARM THER, V23, P1567, DOI 10.1111/j.1365-2036.2006.02927.x	49	91	94	6	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30742	30751		10.1074/jbc.M113.492397	http://dx.doi.org/10.1074/jbc.M113.492397			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24043629	Green Published, hybrid			2022-12-25	WOS:000329868100074
J	Warzybok, A; Migocka, M				Warzybok, Anna; Migocka, Magdalena			Reliable Reference Genes for Normalization of Gene Expression in Cucumber Grown under Different Nitrogen Nutrition	PLOS ONE			English	Article							TIME RT-PCR; ENDOGENOUS CONTROL GENES; HOUSEKEEPING GENES; TRANSCRIPTOME ANALYSIS; INTERNAL CONTROL; REAL; SELECTION; VALIDATION; IDENTIFICATION; NITRATE	In plants, nitrogen is the most important nutritional factor limiting the yield of cultivated crops. Since nitrogen is essential for synthesis of nucleotides, amino acids and proteins, studies on gene expression in plants cultivated under different nitrogen availability require particularly careful selection of suitable reference genes which are not affected by nitrogen limitation. Therefore, the objective of this study was to select the most reliable reference genes for qPCR analysis of target cucumber genes under varying nitrogen source and availability. Among twelve candidate cucumber genes used in this study, five are highly homologous to the commonly used internal controls, whereas seven novel candidates were previously identified through the query of the cucumber genome. The expression of putative reference genes and the target CsNRT1.1 gene was analyzed in roots, stems and leaves of cucumbers grown under nitrogen deprivation, varying nitrate availability or different sources of nitrogen (glutamate, glutamine or NH3). The stability of candidate genes expression significantly varied depending on the tissue type and nitrogen supply. However, in most of the outputs genes encoding CACS, TIP41, F-box protein and EF alpha proved to be the most suitable for normalization of CsNRT1.1 expression. In addition, our results suggest the inclusion of 3 or 4 references to obtain highly reliable results of target genes expression in all cucumber organs under nitrogen-related stress.	[Warzybok, Anna; Migocka, Magdalena] Univ Wroclaw, Inst Expt Biol, Dept Plant Mol Physiol, PL-50138 Wroclaw, Poland	University of Wroclaw	Warzybok, A (corresponding author), Univ Wroclaw, Inst Expt Biol, Dept Plant Mol Physiol, PL-50138 Wroclaw, Poland.	anka.warzybok@biol.uni.wroc.pl			Polish National Science Centre [N N303 818740]; European Social Fund of European Union	Polish National Science Centre; European Social Fund of European Union	The research was mainly supported by the Polish National Science Centre (grant no. N N303 818740). AW was financially supported by the fellowship for young PhD researchers granted by European Social Fund of European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn CS, 2011, PLANT CELL, V23, P185, DOI 10.1105/tpc.110.074005; Alberts B, 2002, MOL BIOL CELL; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Boava Leonardo P, 2010, BMC Res Notes, V3, P43, DOI 10.1186/1756-0500-3-43; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carvalho K, 2010, ANAL BIOCHEM, V402, P197, DOI 10.1016/j.ab.2010.03.038; Catalan V, 2007, HORM METAB RES, V39, P495, DOI 10.1055/s-2007-982502; Craig KL, 1999, PROG BIOPHYS MOL BIO, V72, P299, DOI 10.1016/S0079-6107(99)00010-3; Crawford NM, 1998, TRENDS PLANT SCI, V3, P389, DOI 10.1016/S1360-1385(98)01311-9; Cruz F, 2009, MOL BREEDING, V23, P607, DOI 10.1007/s11032-009-9259-x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; DeLong A, 2006, CURR OPIN PLANT BIOL, V9, P470, DOI 10.1016/j.pbi.2006.07.015; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; EPSTEIN E, 1972, P412; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Faccioli P, 2007, PLANT MOL BIOL, V63, P679, DOI 10.1007/s11103-006-9116-9; Forde BG, 1999, ADV BOT RES, V30, P1; Galloway JN, 2002, AMBIO, V31, P64, DOI 10.1639/0044-7447(2002)031[0064:RNATWY]2.0.CO;2; Garg R, 2010, BIOCHEM BIOPH RES CO, V396, P283, DOI 10.1016/j.bbrc.2010.04.079; Gu YR, 2011, J ANIM BREED GENET, V128, P319, DOI 10.1111/j.1439-0388.2011.00920.x; Hochstrasser M, 1996, CELL, V84, P813, DOI 10.1016/S0092-8674(00)81058-2; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Li QF, 2010, PLANT MOL BIOL REP, V28, P49, DOI 10.1007/s11105-009-0124-1; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Liu Q, 2009, J EXP BOT, V60, P801, DOI 10.1093/jxb/ern329; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Maathuis Frans J M, 2009, Curr Opin Plant Biol, V12, P250, DOI 10.1016/j.pbi.2009.04.003; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Marschner H., 1995, MINERAL NUTR HIGHER, Vsecond, DOI DOI 10.1016/B978-0-12-473542-2.X5000-7; Matta BP, 2011, DEV GENES EVOL, V221, P49, DOI 10.1007/s00427-011-0356-6; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Mehta R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-39; Migocka M, 2013, PLANT SOIL, V364, P245, DOI 10.1007/s11104-012-1345-x; Migocka M, 2011, MOL BREEDING, V28, P343, DOI 10.1007/s11032-010-9487-0; Morgante Carolina V, 2011, BMC Res Notes, V4, P339, DOI 10.1186/1756-0500-4-339; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Podevin N, 2012, MOL BREEDING, V30, P1237, DOI 10.1007/s11032-012-9711-1; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Silveira ED, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-84; Tea M, 2013, MOL VIS, V19, P501; Tenea Gabriela N, 2011, BMC Res Notes, V4, P373, DOI 10.1186/1756-0500-4-373; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Uddin Muhammad Jasim, 2011, BMC Res Notes, V4, P441, DOI 10.1186/1756-0500-4-441; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; Woycicki R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022728	61	49	51	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e72887	10.1371/journal.pone.0072887	http://dx.doi.org/10.1371/journal.pone.0072887			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058446	Green Published, gold, Green Submitted			2022-12-25	WOS:000324408400007
J	Eriksen, II; Melberg, HO; Bringedal, B				Eriksen, Ida Iren; Melberg, Hans Olav; Bringedal, Berit			Norwegian Physicians' Knowledge of the Prices of Pharmaceuticals: A Survey	PLOS ONE			English	Article							GENERAL-PRACTITIONERS; COST CONSCIOUSNESS; ATTITUDES; PATIENT; AWARENESS	The objectives of this study are to measure physicians' knowledge of the prices of pharmaceuticals, and investigate whether there are differences in knowledge of prices between groups of physicians. This article reports on a survey study of physicians' knowledge of the prices of pharmaceuticals conducted on a representative sample of Norwegian physicians in the autumn of 2010. The importance of physicians' knowledge of costs derives from their influence on total spending and allocation of limited health-care resources. Physicians are important drivers in the effort to contain costs in health care, but only if they have the knowledge needed to choose the most cost-effective treatment options. A survey was sent to 1 543 Norwegian physicians, asking them for price estimates and their opinions on the importance of considering the cost of treatment to society as a decision factor when treating their patients. This article deals with a subsection in which the physicians were asked to estimate the price of five pharmaceuticals: simvastatin, alendronate (Fosamax), infliximab (Remicade), natalizumab (Tysabri) and escitalopram (Cipralex). The response rate was 65%. For all the five pharmaceuticals, more than 50% and as many as 83% gave responses that differed more than 50% from the actual drug price. The price of more expensive pharmaceuticals was underestimated, while the opposite was the case for less expensive medicines. The data show that physicians in general have poor knowledge of the prices of the pharmaceuticals they offer their patients. However, the physicians who frequently deal with a drug have better knowledge of its price than those who do not handle a medication as often. The data also suggest that those physicians who agree that cost of care to society is an important decision factor have better knowledge of drug prices.	[Eriksen, Ida Iren; Melberg, Hans Olav] Univ Oslo, Dept Hlth Management & Hlth Econ, Oslo, Norway; [Bringedal, Berit] Inst Studies Med Profess, LEFO, Oslo, Norway	University of Oslo	Eriksen, II (corresponding author), Univ Oslo, Dept Hlth Management & Hlth Econ, Oslo, Norway.	i.i.eriksen@gmail.com		Melberg, Hans Olav/0000-0002-2349-5902	Accenture; Research Council of Norway, through The Industrial Ph.D. scheme	Accenture; Research Council of Norway, through The Industrial Ph.D. scheme(Research Council of Norway)	Ida Iren Eriksen's work is funded by Accenture and The Research Council of Norway, through The Industrial Ph.D. scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan GM, 2008, INT J TECHNOL ASSESS, V24, P158, DOI 10.1017/S0266462308080227; Allan GM, 2007, PLOS MED, V4, P1486, DOI 10.1371/journal.pmed.0040283; Allan GM, 2004, CAN FAM PHYSICIAN, V50, P263; Andersson K, 2006, SCAND J PUBLIC HEALT, V34, P654, DOI 10.1080/14034940600551111; ARNESEN T, 1995, J MED ETHICS, V21, P158, DOI 10.1136/jme.21.3.158; Conti G, 1998, INTENS CARE MED, V24, P1194, DOI 10.1007/s001340050744; DENIG P, 1993, J INTERN MED, V234, P155, DOI 10.1111/j.1365-2796.1993.tb00725.x; Ernst ME, 2000, ARCH FAM MED, V9, P1002, DOI 10.1001/archfami.9.10.1002; Feldman LS, 2013, JAMA INTERN MED, V173, P903, DOI 10.1001/jamainternmed.2013.232; FOWKES FGR, 1985, MED EDUC, V19, P113, DOI 10.1111/j.1365-2923.1985.tb01150.x; Ginsburg ME, 2000, WESTERN J MED, V173, P390, DOI 10.1136/ewjm.173.6.390; Godager G, 2012, J HEALTH ECON, V31, P296, DOI 10.1016/j.jhealeco.2011.11.003; HOFFMAN J, 1995, J PAIN SYMPTOM MANAG, V10, P432, DOI 10.1016/0885-3924(95)00018-T; Kann IC, 2010, J HEALTH ECON, V29, P751, DOI 10.1016/j.jhealeco.2010.07.004; Korn LM, 2003, J GEN INTERN MED, V18, P31, DOI 10.1046/j.1525-1497.2003.20115.x; Magnezi R, 2010, BR J HLTH CARE MANAG, V16, P62; Melberg Hans Olav, 2010, Tidsskr Nor Laegeforen, V130, P598, DOI 10.4045/tidsskr.08.0071; Norway Central, 2009, PHARM TRUST LEG INNK; Norwegian Medicines Agency, 2011, PHIS PHARM PROF NORW; Phelps CE., 2000, HDB HLTH EC, V1; Reichert S, 2000, ARCH INTERN MED, V160, P2799, DOI 10.1001/archinte.160.18.2799; RYAN M, 1990, BRIT MED J, V300, P1316, DOI 10.1136/bmj.300.6735.1316; RYAN M, 1992, BRIT J GEN PRACT, V42, P6; Sakshaug S, 2006, EVALUERING NYTT REFU; Schlunzen L, 1999, ACTA ANAESTH SCAND, V43, P202, DOI 10.1034/j.1399-6576.1999.430214.x; Snyder L, 2012, ANN INTERN MED, V156, DOI 10.7326/0003-4819-156-1-201201031-00001; Tek Sehgal Raj, 2011, J Grad Med Educ, V3, P182, DOI 10.4300/JGME-D-10-00186.1; the Norwegian Medical Association, 2011, REF PAN OUR MOST IMP; Weinstein MC, 2001, J MED ETHICS, V27, P268, DOI 10.1136/jme.27.4.268; Wilf-Miron R, 2008, INT J TECHNOL ASSESS, V24, P45, DOI 10.1017/S0266462307080063	30	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e75218	10.1371/journal.pone.0075218	http://dx.doi.org/10.1371/journal.pone.0075218			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	248VW	24040402	Green Submitted, Green Published, gold			2022-12-25	WOS:000326734500137
J	Kawata, K; Tsuda, M; Yang, GX; Zhang, WC; Tanaka, H; Tsuneyama, K; Leung, P; He, XS; Knechtle, S; Ansari, AA; Coppel, RL; Gershwin, ME				Kawata, Kazuhito; Tsuda, Masanobu; Yang, Guo-Xiang; Zhang, Weici; Tanaka, Hajime; Tsuneyama, Koichi; Leung, Patrick; He, Xiao-Song; Knechtle, Stuart; Ansari, Aftab A.; Coppel, Ross L.; Gershwin, M. Eric			Identification of Potential Cytokine Pathways for Therapeutic Intervention in Murine Primary Biliary Cirrhosis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; T-CELL; TH17 CELLS; II MICE; C57BL/6 MICE; MOUSE MODEL; IL-23; IL-12; INFLAMMATION; INDUCTION	Primary biliary cirrhosis (PBC) is considered a model autoimmune disease, with the most highly directed and specific autoantibody in both murine and human autoimmunity, the anti-mitochondrial autoantibody (AMA). However, therapeutic advances in this disease have lagged behind. Herein we have taken advantage of our unique model of murine PBC in which mice immunized with 2-octynoic acid coupled to BSA (2OA-BSA), a compound identified by quantitative structure activity relationships (QSAR) of human AMA binding, develop an intense inflammatory cholangitis with striking similarities to humans with PBC. In particular, we have constructed several unique gene-deleted mice, including mice deleted of IL-12p40, IL-12p35, IFN-gamma, IL-23p19, IL-17A, IL-17F and IL-22, immunized these animals with 2OA-BSA and followed the natural history of immunopathology to identify key pathways that might provide clues for successful therapy. Our data indicate that whereas both IL-12/Th1 and IL-23/Th17 are involved in cholangitis, it is the IL-12/Th1 signaling pathway that elicits pathology. In fact, deletion of IFN-gamma prevents disease and suppresses autoantibodies. Importantly, deletion of the Th17 cytokines IL-17A and IL-22, but not IL-17F, reduces biliary damage; IL-17A-knockout mice have reduced levels of antimitochondrial antibody. We further demonstrate that the production of IFN-gamma is significantly decreased in the liver of IL-23p19(-/-), IL-17A(-/-) and IL-22(-/-) mice compared with controls. However, the ability of T cells to produce IFN-gamma was not affected in Th17 cytokine-deficient mice. Our data indicate that a deficient Th17 pathway suppresses the accumulation of IFN-gamma producing cells in liver during the early phase of cholangitis. In conclusion, whereas IFN-gamma has a pivotal role in the early events involved in the pathogenesis of autoimmune cholangitis induced by 2OA-BSA, the IL-23/Th17 pathway potentiates the effects of IL-12/IFN-gamma-mediated immunopathology.	[Kawata, Kazuhito; Tsuda, Masanobu; Yang, Guo-Xiang; Zhang, Weici; Tanaka, Hajime; Tsuneyama, Koichi; Leung, Patrick; He, Xiao-Song; Gershwin, M. Eric] Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA; [Kawata, Kazuhito] Hamamatsu Univ Sch Med, Dept Internal Med, Hepatol Div, Shizuoka, Japan; [Tsuda, Masanobu] Kansai Med Univ, Dept Emergency & Crit Care Med, Osaka, Japan; [Tsuneyama, Koichi] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Diagnost Pathol, Toyama 930, Japan; [Knechtle, Stuart] Emory Clin & Hosp, Emory Transplant Ctr, Dept Surg, Atlanta, GA USA; [Ansari, Aftab A.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Coppel, Ross L.] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia	University of California System; University of California Davis; Hamamatsu University School of Medicine; Kansai Medical University; University of Toyama; Emory University; Emory University; Monash University	Yang, GX (corresponding author), Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA.	gxyang@ucdavis.edu; megershwin@ucdavis.edu	Coppel, Ross L/A-6626-2008	Coppel, Ross L/0000-0002-4476-9124; Knechtle, Stuart/0000-0002-1625-385X; Tsuneyama, Koichi/0000-0002-0670-9868	National Institutes of Health [DK067003]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067003] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by funds from National Institutes of Health grant DK067003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini YM, 2011, CLIN EXP IMMUNOL, V166, P110, DOI 10.1111/j.1365-2249.2011.04453.x; Ando Y, 2012, HEPATOLOGY, V56, P1418, DOI 10.1002/hep.25803; Becher B, 2002, J CLIN INVEST, V110, P493, DOI 10.1172/JCI200215751; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Chen DY, 2012, LUPUS, V21, P1385, DOI 10.1177/0961203312457718; Chen Y, 2006, J CLIN INVEST, V116, P1317, DOI 10.1172/JCI25308; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dardalhon V, 2008, J AUTOIMMUN, V31, P252, DOI 10.1016/j.jaut.2008.04.017; Dhirapong A, 2013, HEPATOLOGY, V57, P708, DOI 10.1002/hep.26067; Dhirapong A, 2011, HEPATOLOGY, V53, P527, DOI 10.1002/hep.24044; Ferber IA, 1996, J IMMUNOL, V156, P5; Geboes L, 2009, ARTHRITIS RHEUM-US, V60, P390, DOI 10.1002/art.24220; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Gran B, 2002, J IMMUNOL, V169, P7104, DOI 10.4049/jimmunol.169.12.7104; Harada K, 2009, CLIN EXP IMMUNOL, V157, P261, DOI 10.1111/j.1365-2249.2009.03947.x; Harada K, 1997, HEPATOLOGY, V25, P791, DOI 10.1002/hep.510250402; Haylock-Jacobs S, 2011, J AUTOIMMUN, V36, P278, DOI 10.1016/j.jaut.2011.02.006; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Lan RYZ, 2009, J AUTOIMMUN, V32, P43, DOI 10.1016/j.jaut.2008.11.001; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee S, 2004, AIDS, V18, P1337, DOI 10.1097/00002030-200406180-00014; Li L, 2010, J CLIN INVEST, V120, P331, DOI 10.1172/JCI38702; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Moritoki Y, 2009, GASTROENTEROLOGY, V136, P1037, DOI 10.1053/j.gastro.2008.11.035; Oertelt S, 2006, J IMMUNOL, V177, P1655, DOI 10.4049/jimmunol.177.3.1655; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Rong G, 2009, CLIN EXP IMMUNOL, V156, P217, DOI 10.1111/j.1365-2249.2009.03898.x; Shindo M, 1996, CLIN EXP IMMUNOL, V105, P254, DOI 10.1046/j.1365-2249.1996.d01-759.x; Singh N, 2012, J AUTOIMMUN, V39, P229, DOI 10.1016/j.jaut.2012.05.019; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JCI33194, 10.1172/JC133194]; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Tsuda M, 2013, HEPATOLOGY, V57, P806, DOI 10.1002/hep.25829; van Wanrooij RLJ, 2012, J AUTOIMMUN, V39, P359, DOI 10.1016/j.jaut.2012.06.002; Wakabayashi K, 2008, HEPATOLOGY, V48, P531, DOI 10.1002/hep.22390; Willenborg DO, 1996, J IMMUNOL, V157, P3223; Wozniak TM, 2006, INFECT IMMUN, V74, P557, DOI 10.1128/IAI.74.1.557-565.2006; Yoshida K, 2009, HEPATOLOGY, V50, P1494, DOI 10.1002/hep.23132; Zhang J, 2012, J AUTOIMMUN, V38, P20, DOI 10.1016/j.jaut.2011.11.017	40	45	47	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74225	10.1371/journal.pone.0074225	http://dx.doi.org/10.1371/journal.pone.0074225			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040208	Green Published, gold, Green Submitted			2022-12-25	WOS:000327538600079
J	Kumar, N; Shariq, M; Kumari, R; Tyagi, RK; Mukhopadhyay, G				Kumar, Navin; Shariq, Mohd; Kumari, Rajesh; Tyagi, Rakesh K.; Mukhopadhyay, Gauranga			Cag Type IV Secretion System: CagI Independent Bacterial Surface Localization of CagA	PLOS ONE			English	Article							HELICOBACTER-PYLORI CAGA; PROTEIN-INTERACTION MAP; PATHOGENICITY ISLAND; TRANSLOCATION; IDENTIFICATION; SUBASSEMBLIES; ARCHITECTURE; STRATEGIES; INDUCTION; EVOLUTION	Helicobacter pylori Cag type IV secretion system (Cag-T4SS) is a multi-component transporter of oncoprotein CagA across the bacterial membranes into the host epithelial cells. To understand the role of unique Cag-T4SS component CagI in CagA translocation, we have characterized it by biochemical and microscopic approaches. We observed that CagI is a predominantly membrane attached periplasmic protein partially exposed to the bacterial surface especially on the pili. The association of the protein with membrane appeared to be loose as it could be easily recovered in soluble fraction. We documented that the stability of the protein is dependent on several key components of the secretion system and it has multiple interacting partners including a non-cag-PAI protein HP1489. Translocation of CagA across the bacterial membranes to cell surface is CagI-independent process. The observations made herein are expected to assist in providing an insight into the substrate translocation by the Cag-T4SS system and Helicobacter pylori pathogenesis.	[Kumar, Navin; Shariq, Mohd; Kumari, Rajesh; Tyagi, Rakesh K.; Mukhopadhyay, Gauranga] Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Kumar, N (corresponding author), Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India.	navinkumar_20@yahoo.co.in; garunga@hotmail.com	Shariq, Mohd/AAF-4328-2020	Shariq, Mohd/0000-0002-4438-8612	Council of Scientific and Industrial Research (CSIR), India [37(1266)06/EMR-II]	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	The research work presented in this paper was financially supported by a research grant to GM from Council of Scientific and Industrial Research (CSIR), India [Grant no. 37(1266)06/EMR-II]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J, 2010, P NATL ACAD SCI USA, V107, P3758, DOI 10.1073/pnas.0914940107; Akopyants NS, 1998, MOL MICROBIOL, V28, P37, DOI 10.1046/j.1365-2958.1998.00770.x; Amieva MR, 2008, GASTROENTEROLOGY, V134, P306, DOI 10.1053/j.gastro.2007.11.009; Andrzejewska J, 2006, J BACTERIOL, V188, P5865, DOI 10.1128/JB.00060-06; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Cameron TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042219; Cendron L, 2011, FEBS J, V278, P1223, DOI 10.1111/j.1742-4658.2011.08038.x; Cendron L, 2009, J MOL BIOL, V386, P204, DOI 10.1016/j.jmb.2008.12.018; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; DOIG P, 1994, INFECT IMMUN, V62, P4526, DOI 10.1128/IAI.62.10.4526-4533.1994; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; Fischer W, 2010, NUCLEIC ACIDS RES, V38, P6089, DOI 10.1093/nar/gkq378; Ge ZM, 2001, INFECT IMMUN, V69, P3502, DOI 10.1128/IAI.69.5.3502-3506.2001; HAAS R, 1993, MOL MICROBIOL, V8, P753, DOI 10.1111/j.1365-2958.1993.tb01618.x; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Jimenez-Soto LF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000684; Jurik A, 2010, INFECT IMMUN, V78, P5244, DOI 10.1128/IAI.00796-10; Pham KT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035341; Krall L, 2002, P NATL ACAD SCI USA, V99, P11405, DOI 10.1073/pnas.172390699; Kutter S, 2008, J BACTERIOL, V190, P2161, DOI 10.1128/JB.01341-07; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Lawley TD, 2003, FEMS MICROBIOL LETT, V224, P1, DOI 10.1016/S0378-1097(03)00430-0; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Ogura K, 2000, J EXP MED, V192, P1601, DOI 10.1084/jem.192.11.1601; Painbeni E, 1997, P NATL ACAD SCI USA, V94, P6712, DOI 10.1073/pnas.94.13.6712; Parsonnet J, 1997, GUT, V40, P297, DOI 10.1136/gut.40.3.297; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Pinto-Santini DM, 2009, J BACTERIOL, V191, P7343, DOI 10.1128/JB.00946-09; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Rohde M, 2003, MOL MICROBIOL, V49, P219, DOI 10.1046/j.1365-2958.2003.03549.x; Sabarth N, 2002, J BIOL CHEM, V277, P27896, DOI 10.1074/jbc.M204473200; Shaffer CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002237; Sivanesan D, 2011, J BACTERIOL, V193, P2097, DOI 10.1128/JB.00907-10; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tanaka J, 2003, CELL MICROBIOL, V5, P395, DOI 10.1046/j.1462-5822.2003.00286.x; Tegtmeyer N, 2011, FEBS J, V278, P1190, DOI 10.1111/j.1742-4658.2011.08035.x; Terradot L, 2004, MOL CELL PROTEOMICS, V3, P809, DOI 10.1074/mcp.M400048-MCP200; Terradot L, 2011, FEBS J, V278, P1213, DOI 10.1111/j.1742-4658.2011.08037.x; Tolia NH, 2006, NAT METHODS, V3, P55, DOI 10.1038/nmeth0106-55; van Amsterdam K, 2005, ANTIMICROB AGENTS CH, V49, P1477, DOI 10.1128/AAC.49.4.1477-1482.2005; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Wang H, 2012, CURR MICROBIOL, V64, P191, DOI 10.1007/s00284-011-0043-x	43	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74620	10.1371/journal.pone.0074620	http://dx.doi.org/10.1371/journal.pone.0074620			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040297	Green Submitted, Green Published, gold			2022-12-25	WOS:000327538600102
J	Rausch, S; Held, J; Fischer, A; Heimesaat, MM; Kuhl, AA; Bereswill, S; Hartmann, S				Rausch, Sebastian; Held, Josephin; Fischer, Andre; Heimesaat, Markus M.; Kuehl, Anja A.; Bereswill, Stefan; Hartmann, Susanne			Small Intestinal Nematode Infection of Mice Is Associated with Increased Enterobacterial Loads alongside the Intestinal Tract	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; REGULATORY T-CELLS; HELIGMOSOMOIDES-POLYGYRUS; GUT MICROBIOTA; INDUCED COLITIS; MUCOSAL FLORA; UP-REGULATION; IMMUNOPATHOLOGY; INFLAMMATION; PROMOTES	Parasitic nematodes are potent modulators of immune reactivity in mice and men. Intestinal nematodes live in close contact with commensal gut bacteria, provoke biased Th2 immune responses upon infection, and subsequently lead to changes in gut physiology. We hypothesized that murine nematode infection is associated with distinct changes of the intestinal bacterial microbiota composition. We here studied intestinal inflammatory and immune responses in mice following infection with the hookworm Heligmosomoides polygyrus bakeri and applied cultural and molecular techniques to quantitatively assess intestinal microbiota changes in the ileum, cecum and colon. At day 14 post nematode infection, mice harbored significantly higher numbers of gamma-Proteobacteria/Enterobacteriaceae and members of the Bacteroides/Prevotella group in their cecum as compared to uninfected controls. Abundance of Gram-positive species such as Lactobacilli, Clostridia as well as the total bacterial load was not affected by worm infection. The altered microbiota composition was independent of the IL-4/-13 - STAT6 signaling axis, as infected IL-4R alpha(-/-) mice showed a similar increase in enterobacterial loads. In conclusion, infection with an enteric nematode is accompanied by distinct intestinal microbiota changes towards higher abundance of gram-negative commensal species at the small intestinal site of infection (and inflammation), but also in the parasite-free large intestinal tract. Further studies should unravel the impact of nematode-induced microbiota changes in inflammatory bowel disease to allow for a better understanding of how theses parasites interfere with intestinal inflammation and bacterial communities in men.	[Rausch, Sebastian; Hartmann, Susanne] Free Univ Berlin, Dept Vet Med, Inst Immunol, Berlin, Germany; [Held, Josephin] Charite, Dept Neuropathol, D-13353 Berlin, Germany; [Fischer, Andre; Heimesaat, Markus M.; Bereswill, Stefan] Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany; [Kuehl, Anja A.] Charite, Res Ctr ImmunoSci RCIS, Dept Internal Med Rheumatol & Clin Immunol, D-13353 Berlin, Germany	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rausch, S (corresponding author), Free Univ Berlin, Dept Vet Med, Inst Immunol, Berlin, Germany.	sebastian.rausch@fu-berlin.de	Hartmann, Susanne/M-9154-2016	Heimesaat, Markus/0000-0001-6399-651X; Hartmann, Susanne/0000-0001-6846-0650; Kuhl, Anja/0000-0003-2293-5387	Deutsche Forschungsgemeinschaft [SFB 852, SFB 650, SFB 633]; American Broad Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); American Broad Foundation	This work was supported by grants of the collaborative research centers SFB 852 (to SH), SFB 650 (to SH), SFB 633 (to SB, AF and MMH) and the Heisenberg-Program (to SH) from the Deutsche Forschungsgemeinschaft and by the American Broad Foundation (to SH). The funders had no role in study design, datacollection and analysis, decision to publish, or preparation of the manuscript.	Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; Bereswill S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020953; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Broadhurst MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003000; Chen CC, 2005, INFECT IMMUN, V73, P5468, DOI 10.1128/IAI.73.9.5468-5481.2005; D'Elia R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-492; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Elliott DE, 2004, EUR J IMMUNOL, V34, P2690, DOI 10.1002/eji.200324833; Erridge C, 2010, PLOS ONE, V5, P2; Finney CAM, 2007, EUR J IMMUNOL, V37, P1874, DOI 10.1002/eji.200636751; Fox JG, 2000, NAT MED, V6, P536, DOI 10.1038/75015; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Heilig HGHJ, 2002, APPL ENVIRON MICROB, V68, P114, DOI 10.1128/AEM.68.1.114-123.2002; Heimesaat MM, 2007, GUT, V56, P941, DOI 10.1136/gut.2006.104497; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Heimesaat MM, 2010, GUT, V59, P1079, DOI 10.1136/gut.2009.197434; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Iimura M, 2005, J IMMUNOL, V174, P4901, DOI 10.4049/jimmunol.174.8.4901; Ince MN, 2006, J IMMUNOL, V176, P726, DOI 10.4049/jimmunol.176.2.726; Kelly D, 2005, TRENDS IMMUNOL, V26, P326, DOI 10.1016/j.it.2005.04.008; Kruidenier L, 2003, J PATHOL, V201, P28, DOI 10.1002/path.1409; Kuhbacher T, 2006, GUT, V55, P833, DOI 10.1136/gut.2005.078303; Lee DH, 1996, APPL ENVIRON MICROB, V62, P3112, DOI 10.1128/AEM.62.9.3112-3120.1996; Lee IA, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-7; Li RW, 2012, INFECT IMMUN, V80, P2150, DOI 10.1128/IAI.00141-12; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Magalhaes JG, 2007, SEMIN IMMUNOL, V19, P106, DOI 10.1016/j.smim.2006.12.006; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Metwali A, 2006, AM J PHYSIOL-GASTR L, V291, pG253, DOI 10.1152/ajpgi.00409.2005; MONROY FG, 1992, PARASITOL TODAY, V8, P49, DOI 10.1016/0169-4758(92)90084-F; Ouellette AJ, 2011, CELL MOL LIFE SCI, V68, P2215, DOI 10.1007/s00018-011-0714-6; Rausch S, 2010, EUR J IMMUNOL, V40, P2804, DOI 10.1002/eji.201040306; Rausch S, 2009, EUR J IMMUNOL, V39, P3066, DOI 10.1002/eji.200939644; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Setiawan T, 2007, INFECT IMMUN, V75, P4655, DOI 10.1128/IAI.00358-07; Shea-Donohue T, 2001, J IMMUNOL, V167, P2234, DOI 10.4049/jimmunol.167.4.2234; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Steenwinckel V, 2009, J IMMUNOL, V182, P4737, DOI 10.4049/jimmunol.0801941; Su CW, 2011, INFECT IMMUN, V79, P2285, DOI 10.1128/IAI.01123-10; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Sun LL, 2011, CURR OPIN GASTROEN, V27, P321, DOI 10.1097/MOG.0b013e32834661b4; Sundaram U, 1999, AM J PHYSIOL-GASTR L, V276, pG211, DOI 10.1152/ajpgi.1999.276.1.G211; Sutton TL, 2008, INFECT IMMUN, V76, P4772, DOI 10.1128/IAI.00744-07; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Van Dyke MI, 2002, APPL ENVIRON MICROB, V68, P2049, DOI 10.1128/AEM.68.4.2049-2053.2002; Walk ST, 2010, INFLAMM BOWEL DIS, V16, P1841, DOI 10.1002/ibd.21299; Walter J, 2001, APPL ENVIRON MICROB, V67, P2578, DOI 10.1128/AEM.67.6.2578-2585.2001; Weinstock JV, 2009, INFLAMM BOWEL DIS, V15, P128, DOI 10.1002/ibd.20633; Whelan RAK, 2012, PROTOPLASMA, V249, P871, DOI 10.1007/s00709-011-0342-x; Wise MG, 2007, J APPL MICROBIOL, V102, P1138, DOI 10.1111/j.1365-2672.2006.03153.x; Wohlgemuth S, 2009, ENVIRON MICROBIOL, V11, P1562, DOI 10.1111/j.1462-2920.2009.01883.x; Wu ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035470; Zhao AP, 2003, J IMMUNOL, V171, P948, DOI 10.4049/jimmunol.171.2.948	59	107	108	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74026	10.1371/journal.pone.0074026	http://dx.doi.org/10.1371/journal.pone.0074026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040152	gold, Green Submitted, Green Published			2022-12-25	WOS:000327538600060
J	Sugisaki, K; Seki, N; Tanabe, N; Saito, R; Sasaki, A; Sasaki, S; Suzuki, H				Sugisaki, Koshu; Seki, Nao; Tanabe, Naohito; Saito, Reiko; Sasaki, Asami; Sasaki, Satoshi; Suzuki, Hiroshi			Effective School Actions for Mitigating Seasonal Influenza Outbreaks in Niigata, Japan	PLOS ONE			English	Article							VACCINATING SCHOOLCHILDREN; CLOSURE; INTERVENTIONS; TRANSMISSION; ABSENTEEISM; CHILDREN; HEALTH; IMPACT	Background: Japan has implemented various school actions during seasonal influenza outbreaks since the 1950's under the School Health Law. However, the effective duration, extent, and timing of closures remain unresolved. Materials and Methods: We conducted a retrospective study on the relationship between elementary class closures and influenza outbreak control during four consecutive influenza seasons from the 2004-2005 to 2007-2008 school years in Joetsu, Niigata, Japan. Among a total of 1,061 classes of 72 schools, 624 cases of influenza outbreaks were documented among 61 schools. Results: Class closures were carried out in a total of 62 cases in response to influenza outbreak, which was defined as a student absentee rate of greater than 10% due to influenza or influenza-like illness. Of these cases, two-day class closures were conducted the day after reaching a 10% student absentee rate in 28 cases and other types of closures were initiated in 34 cases. A markedly higher number of outbreak cases ended within one week for two-day class closures compared to the other types of closures (82.1% vs. 20.6%, respectively). The significant association between two-day class closures and interruption of an outbreak within one week was confirmed using a multivariable model adjusted for the season, grade, day of the week of an outbreak start, and absentee rate on the day of an outbreak start (OR, 3.18; 95% CI, 1.12-9.07; p = 0.030). Conclusions: Our results suggest that a two-day class closure carried out the day after reaching a 10% absentee rate is an effective approach for mitigating influenza outbreaks in elementary schools.	[Sugisaki, Koshu] Niigata Univ Hlth & Welf, Dept Hlth & Sports, Niigata, Japan; [Seki, Nao] Niigata Univ, Fac Med, Sch Hlth Sci, Niigata, Japan; [Tanabe, Naohito; Sasaki, Asami] Univ Niigata Prefecture, Fac Human Life Studies, Dept Hlth & Nutr, Niigata, Japan; [Saito, Reiko] Niigata Univ, Grad Sch Med & Dent Sci, Div Int Hlth, Niigata, Japan; [Sasaki, Satoshi] Soka Univ, Sch Excellence Educ Dev, Hachioji, Tokyo, Japan; [Suzuki, Hiroshi] Niigata Seiryo Univ, Dept Nursing, Niigata, Japan	Niigata University; Niigata University; University Niigata Prefecture; Niigata University; Soka University	Sugisaki, K (corresponding author), Niigata Univ Hlth & Welf, Dept Hlth & Sports, Niigata, Japan.	sugisaki@nuhw.ac.jp		Sugisaki, Koshu/0000-0003-4327-9462				Bell D, 2006, EMERG INFECT DIS, V12, P88; Carcione D, 2010, EMERG INFECT DIS, V16, P1388, DOI 10.3201/eid1609.100076; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; Cowling BJ, 2008, EMERG INFECT DIS, V14, P1660, DOI 10.3201/eid1410.080646; Fukimi H, 1963, HIST ASIAN PANDEMIC, P276; Gift TL, 2010, EMERG INFECT DIS, V16, P1315, DOI 10.3201/eid1608.091827; Glezen WP, 2008, NEW ENGL J MED, V359, P2579, DOI 10.1056/NEJMcp0807498; Haber MJ, 2007, EMERG INFECT DIS, V13, P581, DOI 10.3201/eid1304.060828; Halloran ME, 2006, SCIENCE, V311, P615, DOI 10.1126/science.1122143; Heymann A, 2004, PEDIATR INFECT DIS J, V23, P675, DOI 10.1097/01.inf.0000128778.54105.06; House T, 2009, PLOS CURR, V1, DOI DOI 10.1371/CURRENTS.RRN1119; Jarquin VG, 2011, EMERG INFECT DIS, V17, P751, DOI [10.3201/eid1704.100906, 10.3201/eid1706.100906]; Johnson AJ, 2008, EMERG INFECT DIS, V14, P1024, DOI 10.3201/eid1407.080096; Kawaguchi R, 2009, EMERG INFECT DIS, V15, P1685, DOI 10.3201/eid1510.091029; Kawai S, 2011, CLIN INFECT DIS, V53, P130, DOI 10.1093/cid/cir336; Koonin LM, 2009, EMERG INFECT DIS, V15, P137, DOI 10.3201/eid1501.081289; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; Mikolajczyk RT, 2008, EPIDEMIOL INFECT, V136, P813, DOI 10.1017/S0950268807009181; Neuzil KM, 2002, ARCH PEDIAT ADOL MED, V156, P986, DOI 10.1001/archpedi.156.10.986; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Rodriguez CV, 2009, EPIDEMIOLOGY, V20, P787, DOI 10.1097/EDE.0b013e3181b5f3ec; Sasaki A, 2009, EMERG INFECT DIS, V15, P1841, DOI 10.3201/eid1511.090798; Sugisaki K, 2010, NIIGATA MED J, V124, P437; Sugisaki K, 2008, J JPN PEDIAT SOC, V112, P696; Sypsa V, 2009, EUROSURVEILLANCE, V14; Timperio C. G., 2009, Morbidity and Mortality Weekly Report, V58, P1405; Vynnycky E, 2008, EPIDEMIOL INFECT, V136, P166, DOI 10.1017/S0950268807008369; WHO, 2009, MEAS SCH SETT	29	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74716	10.1371/journal.pone.0074716	http://dx.doi.org/10.1371/journal.pone.0074716			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040329	gold, Green Published, Green Submitted			2022-12-25	WOS:000327538600109
J	Cuff, J; Salari, K; Clarke, N; Esheba, GE; Forster, AD; Huang, S; West, RB; Higgins, JP; Longacre, TA; Pollack, JR				Cuff, Justin; Salari, Keyan; Clarke, Nicole; Esheba, Ghada E.; Forster, Andrew D.; Huang, Stephanie; West, Robert B.; Higgins, John P.; Longacre, Teri A.; Pollack, Jonathan R.			Integrative Bioinformatics Links HNF1B with Clear Cell Carcinoma and Tumor-Associated Thrombosis	PLOS ONE			English	Article							HEPATOCYTE NUCLEAR FACTOR-1-BETA; PROSTATE-CANCER RISK; VENOUS THROMBOSIS; PROTHROMBIN GENE; POOR-PROGNOSIS; OVARIAN-CANCER; EXPRESSION; SURVIVAL; MUTATIONS; ENDOMETRIOSIS	Clear cell carcinoma (CCC) is a histologically distinct carcinoma subtype that arises in several organ systems and is marked by cytoplasmic clearing, attributed to abundant intracellular glycogen. Previously, transcription factor hepatocyte nuclear factor 1-beta (HNF1B) was identified as a biomarker of ovarian CCC. Here, we set out to explore more broadly the relation between HNF1B and carcinomas with clear cell histology. HNF1B expression, evaluated by immunohistochemistry, was significantly associated with clear cell histology across diverse gynecologic and renal carcinomas (P<0.001), as was hypomethylation of the HNF1B promoter (P<0.001). From microarray analysis, an empirically-derived HNF1B signature was significantly enriched for computationally-predicted targets (with HNF1 binding sites) (P<0.03), as well as genes associated with glycogen metabolism, including glucose-6-phophatase, and strikingly the blood clotting cascade, including fibrinogen, prothrombin and factor XIII. Enrichment of the clotting cascade was also evident in microarray data from ovarian CCC versus other histotypes (P<0.01), and HNF1B-associated prothrombin expression was verified by immunohistochemistry (P = 0.015). Finally, among gynecologic carcinomas with cytoplasmic clearing, HNF1B immunostaining was linked to a 3.0-fold increased risk of clinically-significant venous thrombosis (P = 0.043), and with a 2.3-fold increased risk (P = 0.011) in a combined gynecologic and renal carcinoma cohort. Our results define HNF1B as a broad marker of clear cell phenotype, and support a mechanistic link to glycogen accumulation and thrombosis, possibly reflecting (for gynecologic CCC) derivation from secretory endometrium. Our findings also implicate a novel mechanism of tumor-associated thrombosis (a major cause of cancer mortality), based on the direct production of clotting factors by cancer cells.	[Cuff, Justin; Salari, Keyan; Clarke, Nicole; Esheba, Ghada E.; Forster, Andrew D.; Huang, Stephanie; West, Robert B.; Higgins, John P.; Longacre, Teri A.; Pollack, Jonathan R.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Salari, Keyan] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Esheba, Ghada E.] Tanta Univ, Fac Med, Dept Pathol, Tanta, Egypt	Stanford University; Stanford University; Egyptian Knowledge Bank (EKB); Tanta University	Pollack, JR (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.	pollack1@stanford.edu	Esheba, Ghada/B-6009-2019	Esheba, Ghada/0000-0003-1779-3927; West, Robert/0000-0002-8330-8283	Stanford University Department of Pathology; NATIONAL CANCER INSTITUTE [P30CA124435] Funding Source: NIH RePORTER	Stanford University Department of Pathology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported with funds from the Stanford University Department of Pathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson FA, 2003, CIRCULATION, V107, pI9, DOI 10.1161/01.CIR.0000078469.07362.E6; Behbakht K, 1998, GYNECOL ONCOL, V70, P255, DOI 10.1006/gyno.1998.5071; Bellanne-Chantelot C, 2004, ANN INTERN MED, V140, P510, DOI 10.7326/0003-4819-140-7-200404060-00009; CEREGHINI S, 1992, DEVELOPMENT, V116, P783; Chew HK, 2006, ARCH INTERN MED, V166, P458; Chou JY, 2008, HUM MUTAT, V29, P921, DOI 10.1002/humu.20772; Cillo C, 1999, EXP CELL RES, V248, P1, DOI 10.1006/excr.1999.4451; Coffinier C, 1999, MECH DEVELOP, V89, P211, DOI 10.1016/S0925-4773(99)00221-X; Dahlback B, 2000, LANCET, V355, P1627, DOI 10.1016/S0140-6736(00)02225-X; DONATI MB, 1995, THROMB HAEMOSTASIS, V74, P278; Edghill EL, 2006, J MED GENET, V43, P84, DOI 10.1136/jmg.2005.032854; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fazleabas AT, 2004, PLACENTA, V25, pS26, DOI 10.1016/j.placenta.2004.01.014; Fowler DJ, 2000, HUM REPROD UPDATE, V6, P495, DOI 10.1093/humupd/6.5.495; Gale AJ, 2001, ACTA HAEMATOL-BASEL, V106, P25, DOI 10.1159/000046586; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Goff BA, 1996, GYNECOL ONCOL, V60, P412, DOI 10.1006/gyno.1996.0065; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Haumaitre C, 2005, P NATL ACAD SCI USA, V102, P1490, DOI 10.1073/pnas.0405776102; Haumaitre C, 2006, HUM MOL GENET, V15, P2363, DOI 10.1093/hmg/ddl161; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; JENISON EL, 1989, GYNECOL ONCOL, V32, P65, DOI 10.1016/0090-8258(89)90852-4; Jiang XX, 1998, CANCER RES, V58, P1707; Kamphuisen PW, 1999, THROMB HAEMOSTASIS, V81, P680, DOI 10.1055/s-0037-1614553; Kato N, 2006, MODERN PATHOL, V19, P83, DOI 10.1038/modpathol.3800492; Kato N, 2008, VIRCHOWS ARCH, V452, P175, DOI 10.1007/s00428-007-0543-z; Khorana AA, 2007, CANCER-AM CANCER SOC, V110, P2339, DOI 10.1002/cncr.23062; Kobel M, 2009, AM J SURG PATHOL, V33, P14, DOI 10.1097/PAS.0b013e3181788546; KOSTER T, 1994, THROMB HAEMOSTASIS, V71, P719; Kwei KA, 2008, ONCOGENE, V27, P3635, DOI 10.1038/sj.onc.1211012; Lee AYY, 2010, HEMATOL-AM SOC HEMAT, P144, DOI 10.1182/asheducation-2010.1.144; Levine M, 1997, HAEMOSTASIS, V27, P38; Levitan N, 1999, MEDICINE, V78, P285, DOI 10.1097/00005792-199909000-00001; Lockwood CJ, 2006, CLIN OBSTET GYNECOL, V49, P836, DOI 10.1097/01.grf.0000211952.82206.16; Lowe Henry J, 2009, AMIA Annu Symp Proc, V2009, P391; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; MILWIDSKY A, 1980, J CLIN ENDOCR METAB, V51, P765, DOI 10.1210/jcem-51-4-765; NORRIS HJ, 1971, CANCER-AM CANCER SOC, V28, P1074, DOI 10.1002/1097-0142(1971)28:4<1074::AID-CNCR2820280434>3.0.CO;2-K; Pectasides D, 2006, ONCOLOGIST, V11, P1089, DOI 10.1634/theoncologist.11-10-1089; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Prandoni P, 2005, LANCET ONCOL, V6, P401, DOI 10.1016/S1470-2045(05)70207-2; Rebouissou S, 2005, HUM MOL GENET, V14, P603, DOI 10.1093/hmg/ddi057; Recio F, 1996, CANCER, V78, P2157, DOI 10.1002/(SICI)1097-0142(19961115)78:10<2157::AID-CNCR17>3.0.CO;2-Y; Reitsma PH, 2012, ARTERIOSCL THROM VAS, V32, P563, DOI 10.1161/ATVBAHA.111.242818; Schwartz DR, 2002, CANCER RES, V62, P4722; Senkel S, 2005, BBA-GENE STRUCT EXPR, V1731, P179, DOI 10.1016/j.bbaexp.2005.10.003; Sorensen HT, 1998, NEW ENGL J MED, V338, P1169, DOI 10.1056/NEJM199804233381701; Stany MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021121; Stenberg LM, 2001, BIOCHEM BIOPH RES CO, V280, P1036, DOI 10.1006/bbrc.2000.4145; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suehiro Y, 2000, ONCOLOGY-BASEL, V59, P50, DOI 10.1159/000012137; Sun J, 2008, NAT GENET, V40, P1153, DOI 10.1038/ng.214; Terasawa K, 2006, BRIT J CANCER, V94, P914, DOI 10.1038/sj.bjc.6602984; TRONCHE F, 1992, BIOESSAYS, V14, P579, DOI 10.1002/bies.950140902; Tsimafeyeu IV, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-30; Tsuchiya A, 2003, AM J PATHOL, V163, P2503, DOI 10.1016/S0002-9440(10)63605-X; Varki A, 2007, BLOOD, V110, P1723, DOI 10.1182/blood-2006-10-053736; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Yamamoto S, 2007, HUM PATHOL, V38, P1074, DOI 10.1016/j.humpath.2006.12.018	61	35	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74562	10.1371/journal.pone.0074562	http://dx.doi.org/10.1371/journal.pone.0074562			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040285	gold, Green Published, Green Submitted			2022-12-25	WOS:000326405300182
J	Lee, JY; Choi, DC; Oh, TH; Yune, TY				Lee, Jee Y.; Choi, Doo C.; Oh, Tae H.; Yune, Tae Y.			Analgesic Effect of Acupuncture Is Mediated via Inhibition of JNK Activation in Astrocytes after Spinal Cord Injury	PLOS ONE			English	Article							TERMINAL KINASE JNK; PERIPHERAL-NERVE INJURY; PRIMARY SENSORY NEURONS; NEUROPATHIC PAIN; PROTEIN-KINASE; MICROGLIAL ACTIVATION; MECHANICAL ALLODYNIA; SIGNAL-TRANSDUCTION; CCL20 PRODUCTION; UP-REGULATION	Acupuncture (AP) has been used worldwide to relieve pain. However, the mechanism of action of AP is poorly understood. Here, we found that AP relieved neuropathic pain (NP) by inhibiting Jun-N-terminal kinase (JNK) activation in astrocytes after spinal cord injury (SCI). After contusion injury which induces the below-level (L4-L5) NP, Shuigou (GV26) and Yanglingquan (GB34) acupoints were applied. At 31 d after injury, both mechanical allodynia and thermal hyperalgesia were significantly alleviated by AP applied at GV26 and GB34. Immunocytochemistry revealed that JNK activation was mainly observed in astrocytes after injury. AP inhibited JNK activation in astrocytes at L4-L5 level of spinal cord. The level of p-c-Jun known, a downstream molecule of JNK, was also decreased by AP. In addition, SCI-induced GFAP expression, a marker for astrocytes, was decreased by AP as compared to control groups. Especially, the number of hypertrophic, activated astrocytes in laminae I-II of dorsal horn at L4-5 was markedly decreased by AP treatment when compared with vehicle and simulated AP-treated groups. When animals treated with SP600125, a specific JNK inhibitor, after SCI, both mechanical allodynia and thermal hyperalgesia were significantly attenuated by the inhibitor, suggesting that JNK activation is likely involved in SCI-induced NP. Also, the expression of chemokines which is known to be mediated through JNK pathway was significantly decreased by AP and SP600125 treatment. Therefore, our results indicate that analgesic effect of AP is mediated in part by inhibiting JNK activation in astrocytes after SCI.	[Lee, Jee Y.; Choi, Doo C.; Oh, Tae H.; Yune, Tae Y.] Kyung Hee Univ, Age Related & Brain Dis Res Ctr, Seoul, South Korea; [Lee, Jee Y.; Yune, Tae Y.] Kyung Hee Univ, Neurodegenerat Control Res Ctr, Seoul, South Korea; [Yune, Tae Y.] Kyung Hee Univ, Dept Biochem & Mol Biol, Sch Med, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University	Yune, TY (corresponding author), Kyung Hee Univ, Age Related & Brain Dis Res Ctr, Seoul, South Korea.	tyune@khu.ac.kr			National Research Foundation of Korea; Ministry of Science, ICT & Future Planning [2010-0019349, 2008-0061888]; Korea Health technology Research & Development Project, Ministry of Health & Welfare, Republic of Korea [A101198]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); Korea Health technology Research & Development Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning [No. 2010-0019349 (Pioneer Research Center Program), No. 2008-0061888 (SRC)] and a grant of the Korea Health technology Research & Development Project, Ministry of Health & Welfare, Republic of Korea (A101198). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini E, 2005, J NEUROPATH EXP NEUR, V64, P706, DOI 10.1097/01.jnen.0000173893.01929.fc; Baron R, 2006, NAT CLIN PRACT NEURO, V2, P95, DOI 10.1038/ncpneuro0113; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beric A, 1997, PAIN, V72, P295, DOI 10.1097/00006396-199709000-00001; Bernateck M, 2008, FORSCH KOMPLEMENTMED, V15, P187, DOI 10.1159/000141929; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Cherkin DC, 2009, ARCH INTERN MED, V169, P858, DOI 10.1001/archinternmed.2009.65; Choi DC, 2012, EXP NEUROL, V236, P268, DOI 10.1016/j.expneurol.2012.05.014; Choi DC, 2010, NEUROBIOL DIS, V39, P272, DOI 10.1016/j.nbd.2010.04.003; Christensen MD, 1997, J NEUROTRAUM, V14, P517, DOI 10.1089/neu.1997.14.517; Coyle DE, 1998, GLIA, V23, P75; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Gao YJ, 2010, PHARMACOL THERAPEUT, V126, P56, DOI 10.1016/j.pharmthera.2010.01.002; Gao YJ, 2009, J NEUROSCI, V29, P4096, DOI 10.1523/JNEUROSCI.3623-08.2009; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Gwak YS, 2009, NEUROSCIENCE, V161, P895, DOI 10.1016/j.neuroscience.2009.03.055; Hains BC, 2006, J NEUROSCI, V26, P4308, DOI 10.1523/JNEUROSCI.0003-06.2006; Hains BC, 2001, J NEUROTRAUM, V18, P409, DOI 10.1089/089771501750170994; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hopton A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056806; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Ji RR, 2001, NEUROBIOL DIS, V8, P1, DOI 10.1006/nbdi.2000.0360; JI RR, 2004, SCI STKE, V252, P54629; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; Jin SX, 2003, J NEUROSCI, V23, P4017; Kanda N, 2009, EUR J IMMUNOL, V39, P996, DOI 10.1002/eji.200838852; Kang JM, 2007, BRAIN RES, V1131, P211, DOI 10.1016/j.brainres.2006.10.089; Katsura H, 2008, GLIA, V56, P723, DOI 10.1002/glia.20648; Lau WK, 2008, NEUROSCIENCE, V155, P463, DOI 10.1016/j.neuroscience.2008.06.016; Ledeboer A, 2005, PAIN, V115, P71, DOI 10.1016/j.pain.2005.02.009; Lee HL, 2004, NEUROREPORT, V15, P2807; Lee JY, 2012, ENDOCRINOLOGY, V153, P3815, DOI 10.1210/en.2012-1068; Li M, 2011, J CLIN ENDOCR METAB, V96, P2502, DOI 10.1210/jc.2011-0055; Li QM, 2007, J NEUROSCI, V27, P8395, DOI 10.1523/JNEUROSCI.2478-07.2007; Liu J, 2007, NEUROSCI LETT, V412, P268, DOI 10.1016/j.neulet.2006.11.022; Ma WY, 2002, PAIN, V99, P175, DOI 10.1016/S0304-3959(02)00097-0; Mei XP, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-6; MESTRE C, 1994, J PHARMACOL TOX MET, V32, P197, DOI 10.1016/1056-8719(94)90087-6; Migita K, 2009, RHEUMATOLOGY, V48, P741, DOI 10.1093/rheumatology/kep089; Milligan ED, 2003, J NEUROSCI, V23, P1026; Moalem G, 2006, BRAIN RES REV, V51, P240, DOI 10.1016/j.brainresrev.2005.11.004; Norrbrink C, 2011, ACUPUNCT MED, V29, P108, DOI 10.1136/aim.2010.003269; Obata K, 2004, J NEUROSCI, V24, P10211, DOI 10.1523/JNEUROSCI.3388-04.2004; Ohtori S, 2004, SPINE, V29, P1082, DOI 10.1097/00007632-200405150-00006; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Repici M, 2012, NEUROBIOL DIS, V46, P710, DOI 10.1016/j.nbd.2012.03.014; Siddall PJ, 1997, SPINAL CORD, V35, P69, DOI 10.1038/sj.sc.3100365; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Yeh ML, 2010, ALTERN THER HEALTH M, V16, P10; Yin CS, 2008, RES VET SCI, V84, P159, DOI 10.1016/j.rvsc.2007.04.004; Yoshimura K, 2011, NEUROSCI RES, V71, P266, DOI 10.1016/j.neures.2011.07.1830; Yune TY, 2007, J NEUROSCI, V27, P7751, DOI 10.1523/JNEUROSCI.1661-07.2007; Zhang H, 2007, J NEUROSCI, V27, P12067, DOI 10.1523/JNEUROSCI.0496-07.2007; Zhao P, 2007, J NEUROSCI, V27, P2357, DOI 10.1523/JNEUROSCI.0138-07.2007; Zhou Z, 2008, GENE THER, V15, P183, DOI 10.1038/sj.gt.3303054; Zhuang ZY, 2006, J NEUROSCI, V26, P3551, DOI 10.1523/JNEUROSCI.5290-05.2006	57	31	43	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73948	10.1371/journal.pone.0073948	http://dx.doi.org/10.1371/journal.pone.0073948			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040124	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300144
J	Daino, K; Imaoka, T; Morioka, T; Tani, S; Iizuka, D; Nishimura, M; Shimada, Y				Daino, Kazuhiro; Imaoka, Tatsuhiko; Morioka, Takamitsu; Tani, Shusuke; Iizuka, Daisuke; Nishimura, Mayumi; Shimada, Yoshiya			Loss of the BRCA1-Interacting Helicase BRIP1 Results in Abnormal Mammary Acinar Morphogenesis	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID RECEPTORS; BREAST-CANCER; EPITHELIAL-CELLS; DNA-REPAIR; GENE-EXPRESSION; DAMAGE RESPONSE; FAMILY-HISTORY; OVARIAN-CANCER; BRCA1; MUTATIONS	BRIP1 is a DNA helicase that directly interacts with the C-terminal BRCT repeat of the breast cancer susceptibility protein BRCA1 and plays an important role in BRCA1-dependent DNA repair and DNA damage-induced checkpoint control. Recent studies implicate BRIP1 as a moderate/low-penetrance breast cancer susceptibility gene. However, the phenotypic effects of BRIP1 dysfunction and its role in breast cancer tumorigenesis remain unclear. To explore the function of BRIP1 in acinar morphogenesis of mammary epithelial cells, we generated BRIP1-knockdown MCF-10A cells by short hairpin RNA (shRNA)-mediated RNA interference and examined its effect in a three-dimensional culture model. Genome-wide gene expression profiling by microarray and quantitative RT-PCR were performed to identify alterations in gene expression in BRIP1-knockdown cells compared with control cells. The microarray data were further investigated using the pathway analysis and Gene Set Enrichment Analysis (GSEA) for pathway identification. BRIP1 knockdown in non-malignant MCF-10A mammary epithelial cells by RNA interference induced neoplastic-like changes such as abnormal cell adhesion, increased cell proliferation, large and irregular-shaped acini, invasive growth, and defective lumen formation. Differentially expressed genes, including MCAM, COL8A1, WIPF1, RICH2, PCSK5, GAS1, SATB1, and ELF3, in BRIP1-knockdown cells compared with control cells were categorized into several functional groups, such as cell adhesion, polarity, growth, signal transduction, and developmental process. Signaling-pathway analyses showed dysregulation of multiple cellular signaling pathways, involving LPA receptor, Myc, Wnt, PI3K, PTEN as well as DNA damage response, in BRIP1-knockdown cells. Loss of BRIP1 thus disrupts normal mammary morphogenesis and causes neoplastic-like changes, possibly via dysregulating multiple cellular signaling pathways functioning in the normal development of mammary glands.	[Daino, Kazuhiro; Imaoka, Tatsuhiko; Morioka, Takamitsu; Tani, Shusuke; Iizuka, Daisuke; Nishimura, Mayumi; Shimada, Yoshiya] Natl Inst Radiol Sci, Radiobiol Childrens Hlth Program, Res Ctr Radiat Protect, Chiba 260, Japan; [Daino, Kazuhiro; Imaoka, Tatsuhiko; Morioka, Takamitsu; Nishimura, Mayumi; Shimada, Yoshiya] Natl Inst Radiol Sci, Radiat Effect Accumulat & Prevent Project, Fukushima Project Headquarters, Chiba 260, Japan; [Iizuka, Daisuke] Hiroshima Univ, Dept Expt Oncol, Div Genome Biol, Res Inst Radiat Biol & Med, Hiroshima, Japan	National Institutes for Quantum Science & Technology; National Institutes for Quantum Science & Technology; Hiroshima University	Daino, K (corresponding author), Natl Inst Radiol Sci, Radiobiol Childrens Hlth Program, Res Ctr Radiat Protect, Chiba 260, Japan.	k_daino@nirs.go.jp; y_shimad@nirs.go.jp	Imaoka, Tatsuhiko/E-5134-2012	Imaoka, Tatsuhiko/0000-0003-1507-585X; IIZUKA, Daisuke/0000-0003-3990-4800	Japan Society for the Promotion of Science [23710075]; Grants-in-Aid for Scientific Research [23710071] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	A part of this study was financially supported by a Grant-in-Aid for Young Scientists (B) (#23710075) from the Japan Society for the Promotion of Science. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Boras-Granic Kata, 2008, Organogenesis, V4, P116; Byrnes GB, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2099; Callahan R, 1998, BIOCHEM SOC SYMP, P211; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Cantor SB, 2011, FUTURE ONCOL, V7, P253, DOI [10.2217/fon.10.191, 10.2217/FON.10.191]; Cechowska-Pasko M, 2006, INT J EXP PATHOL, V87, P289, DOI 10.1111/j.1365-2613.2006.00486.x; Chang CH, 1997, ONCOGENE, V14, P1617, DOI 10.1038/sj.onc.1200978; Chen YH, 2008, EXPERT REV ANTICANC, V8, P1689, DOI 10.1586/14737140.8.10.1689; Contos JJA, 2000, MOL PHARMACOL, V58, P1188, DOI 10.1124/mol.58.6.1188; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; De Nicolo A, 2008, CLIN CANCER RES, V14, P4672, DOI 10.1158/1078-0432.CCR-08-0087; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Deng CX, 2003, HUM MOL GENET, V12, pR113, DOI 10.1093/hmg/ddg082; Easton D F, 1999, Breast Cancer Res, V1, P14, DOI 10.1186/bcr6; Fournier MV, 2009, CANCER RES, V69, P4545, DOI 10.1158/0008-5472.CAN-08-1694; Furuta S, 2005, P NATL ACAD SCI USA, V102, P9176, DOI 10.1073/pnas.0503793102; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Heng S, 2011, ENDOCRINOLOGY, V152, P5041, DOI 10.1210/en.2011-1273; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Ishida Y, 2010, CARCINOGENESIS, V31, P1694, DOI 10.1093/carcin/bgq145; Kitayama J, 2004, BREAST CANCER RES, V6, pR640, DOI 10.1186/bcr935; Kurisu S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-226; Liu H, 2004, J CELL BIOL, V164, P603, DOI 10.1083/jcb.200306090; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Neve R, 1998, FASEB J, V12, P1541, DOI 10.1096/fasebj.12.14.1541; Ordinario E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051786; Patani N, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-18; Peng M, 2006, ONCOGENE, V25, P2245, DOI 10.1038/sj.onc.1209257; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; Phelan CM, 1998, CANCER RES, V58, P1004; Phillips ER, 2007, ONCOGENE, V26, P7799, DOI 10.1038/sj.onc.1210877; Ponder BAJ, 2005, COLD SH Q B, V70, P35, DOI 10.1101/sqb.2005.70.029; Rollason R, 2009, J CELL BIOL, V184, P721, DOI 10.1083/jcb.200804154; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Schubert EK, 1997, AM J HUM GENET, V60, P1031; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Serova OM, 1997, AM J HUM GENET, V60, P486; Shih LM, 1997, AM J PATHOL, V151, P745; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szabo CI, 1997, AM J HUM GENET, V60, P1013; Tu ZG, 2011, DEV CELL, V21, P1077, DOI 10.1016/j.devcel.2011.10.010; Xu Jinhua, 2010, Genes Cancer, V1, P629, DOI 10.1177/1947601910378691; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753	51	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e74013	10.1371/journal.pone.0074013	http://dx.doi.org/10.1371/journal.pone.0074013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040146	gold, Green Published, Green Submitted			2022-12-25	WOS:000324856500070
J	Lasker, HR				Lasker, Howard R.			Recruitment and Resilience of a Harvested Caribbean Octocoral	PLOS ONE			English	Article							ADULT DISTRIBUTION; POPULATION-DYNAMICS; LARVAL DISPERSAL; RED CORAL; GROWTH; REEF; CONNECTIVITY; DEMOGRAPHICS; PATTERNS; RECOVERY	Disturbance events are an important component of the ecology of coral reefs and increasingly frequent disturbances coupled with a lack of population resilience may contribute to changes in the structure of coral reef communities. The harvest of the Caribbean octocoral Antillogorgia elisabethae provides an opportunity to explore the relationship between adult abundance and recruitment and the manner in which recruitment contributes to the resilience of local populations. Recruitment of A. elisabethae was monitored in 20, 1-m(2) quadrats at 8 sites along the southern edge of the Little Bahama Bank from 2004 through 2007. A. elisabethae has been harvested in The Bahamas for over fifteen years and all of the sites had been harvested three times, including a harvest during the course of the study. Abundances of adult colonies at those sites as well as a location that had not been harvested were also determined. Recruitment was highly variable, differing between sites, transects within sites, and, depending on the site, between years. Recruitment was best correlated with adult abundance averaged across the surrounding site. Regression analyses suggest abundance on smaller scales had only small effects on recruitment. The effects of the harvesting were site specific ranging from a 38 to 67% reduction in the density of mature colonies. The sites with the most abundant A. elisabethae continued to have the highest abundances after harvesting and there was no significant difference in recruitment before and after harvesting. Population size-structure at 6 of 8 sites that have been harvested multiple times exhibited an overall depletion in small colonies suggesting long term suppression of recruitment and declining populations. Severe depression of adult abundances coupled with local recruitment can create a negative feedback and lead to the decline of local populations. Populations that are dependent on self-recruitment are not resilient to large disturbance events.	[Lasker, Howard R.] SUNY Buffalo, Dept Geol, Buffalo, NY 14260 USA; [Lasker, Howard R.] SUNY Buffalo, Grad Program Evolut Ecol & Behav, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Lasker, HR (corresponding author), SUNY Buffalo, Dept Geol, Buffalo, NY 14260 USA.	hlasker@buffalo.edu		Lasker, Howard/0000-0002-5280-0742	US National Science Foundation [0327129, 0825625]	US National Science Foundation(National Science Foundation (NSF))	Funding provided by the US National Science Foundation (http://www.nsf.gov/) Grants 0327129 and 0825625. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1961, SHALLOW WATER OCTOCO; Arnold SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028681; Arnold SN, 2010, MAR ECOL PROG SER, V414, P91, DOI 10.3354/meps08724; Ayre DJ, 2000, EVOLUTION, V54, P1590; BALL MM, 1967, J GEOL, V75, P583, DOI 10.1086/627283; Beiring EA, 2000, MAR ECOL PROG SER, V196, P169, DOI 10.3354/meps196169; BIRKELAND C, 1974, PROSTAGLANDINS PLEXA, P115; Botsford LW, 2009, CORAL REEFS, V28, P327, DOI 10.1007/s00338-009-0466-z; Bramanti L, 2007, HYDROBIOLOGIA, V580, P219, DOI 10.1007/s10750-006-0452-1; BYTHELL JC, 1993, J EXP MAR BIOL ECOL, V172, P171, DOI 10.1016/0022-0981(93)90096-7; Castanaro J, 2003, INVERTEBR BIOL, V122, P299; Costantini F, 2007, MAR ECOL PROG SER, V340, P109, DOI 10.3354/meps340109; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Cupido R, 2008, AQUAT CONSERV, V18, P984, DOI 10.1002/aqc.904; Cupido R, 2012, MAR ECOL PROG SER, V469, P25, DOI 10.3354/meps09976; Edmunds PJ, 2007, ECOL MONOGR, V77, P3, DOI 10.1890/05-1081; Edmunds PJ, 2010, MAR ECOL PROG SER, V418, P87, DOI 10.3354/meps08823; Edmunds PJ, 2001, P NATL ACAD SCI USA, V98, P5067, DOI 10.1073/pnas.071524598; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Glynn PW, 1965, CARIBB J SCI, V4, P335; Goffredo S, 2008, CORAL REEFS, V27, P751, DOI 10.1007/s00338-008-0391-6; Goffredo S, 2006, J EXP MAR BIOL ECOL, V336, P221, DOI 10.1016/j.jembe.2006.05.012; GOTELLI NJ, 1991, ECOLOGY, V72, P457, DOI 10.2307/2937187; GOTELLI NJ, 1988, ECOLOGY, V69, P157, DOI 10.2307/1943170; Grigg Richard W., 2001, Pacific Science, V55, P291, DOI 10.1353/psc.2001.0022; GRIGG RW, 1988, MAR ECOL PROG SER, V45, P121, DOI 10.3354/meps045121; Gutierrez-Rodrigueza C, 2004, INVERTEBR BIOL, V123, P54; Harii S, 2003, CORAL REEFS, V22, P188, DOI 10.1007/s00338-003-0302-9; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; Jamison JL, 2008, LIMNOL OCEANOGR, V53, P1963, DOI 10.4319/lo.2008.53.5.1963; KINZIE RA, 1973, B MAR SCI, V23, P93; Lasker HR, 2003, BIOL BULL-US, V205, P319, DOI 10.2307/1543295; LASKER HR, 1983, MAR ECOL PROG SER, V13, P21, DOI 10.3354/meps013021; LASKER HR, 1990, ECOLOGY, V71, P1578, DOI 10.2307/1938293; Ledoux JB, 2010, MOL ECOL, V19, P4204, DOI 10.1111/j.1365-294X.2010.04814.x; Linares C, 2005, MAR ECOL PROG SER, V305, P127, DOI 10.3354/meps305127; Linares C, 2007, ECOLOGY, V88, P918, DOI 10.1890/05-1931; Linares C, 2012, MAR ECOL PROG SER, V452, P81, DOI 10.3354/meps09586; Linares C, 2010, MAR ECOL PROG SER, V402, P59, DOI 10.3354/meps08437; McMurray SE, 2010, ECOLOGY, V91, P560, DOI 10.1890/08-2060.1; Page CA, 2012, J EXP MAR BIOL ECOL, V434, P47, DOI 10.1016/j.jembe.2012.07.022; Roff G, 2012, TRENDS ECOL EVOL, V27, P404, DOI 10.1016/j.tree.2012.04.007; Ruzicka R, 2010, CREMP 2009 FINAL REP; Sanchez Juan A., 1998, Caribbean Journal of Science, V34, P250; STODDART D. R., 1963, ATOLL RES BULL, V95, P1; Stoddart DR, 1974, POSTHURRICANE CHANGE; Vermeij MJA, 2005, MAR ECOL PROG SER, V295, P123, DOI 10.3354/meps295123; WARNER RR, 1985, AM NAT, V125, P769, DOI 10.1086/284379; Williams DE, 2008, CORAL REEFS, V27, P697, DOI 10.1007/s00338-008-0386-3; Williams GC, 2012, ZOOTAXA, P39; WOODLEY JD, 1981, SCIENCE, V214, P749, DOI 10.1126/science.214.4522.749	53	16	16	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e74587	10.1371/journal.pone.0074587	http://dx.doi.org/10.1371/journal.pone.0074587			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040291	Green Submitted, Green Published, gold			2022-12-25	WOS:000324856500088
J	Sen, I; Veprintsev, D; Akhmanova, A; Steinmetz, MO				Sen, Indrani; Veprintsev, Dmitry; Akhmanova, Anna; Steinmetz, Michel O.			End Binding Proteins Are Obligatory Dimers	PLOS ONE			English	Article							MICROTUBULE; TRACKING; INSIGHTS; TIPS	End binding (EB) proteins are responsible for the recruitment of an array of microtubule plus-end tracking proteins (+TIPs) to growing microtubules ends. EBs encompass an N-terminal calponin homology domain that confers microtubule tip tracking activity to the protein. The C-terminal domain of EBs contains a coiled coil that mediates the parallel dimerization of EB monomers. This part of the protein is also responsible for partner binding. While dimerization is not essential for microtubule tip tracking by EBs it is a prerequisite for +TIP partner binding. The concentration of EBs in cells has been estimated to be in the range of hundreds of nanomoles. In contrast, in in vitro single molecule experiments EB concentrations of subnanomoles are employed. From a mechanistic point of view it is important to assess the oligomerization state of EBs at physiologically and experimentally relevant protein concentrations, in particular if the goal of a study is to model the behavior of EB-dependent dynamic +TIP networks. Here we have determined the stability of the EB1 and EB3 dimers using multi-angle light scattering and fluorescence analytical ultracentrifugation. We show that these EBs form stable dimers and do not dissociate even at very low nanomolar concentrations. The dimers remained stable at both room temperature as well as at the physiologically relevant temperature of 37 degrees C. Together, our results reveal that EBs are obligatory dimers, a conclusion that has implications for the mechanistic understanding of these key proteins involved in the orchestration of dynamic protein networks at growing microtubule ends.	[Sen, Indrani; Veprintsev, Dmitry; Steinmetz, Michel O.] Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland; [Akhmanova, Anna] Univ Utrecht, Fac Sci, Utrecht, Netherlands	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Utrecht University	Steinmetz, MO (corresponding author), Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland.	michel.steinmetz@psi.ch	Veprintsev, Dmitry B/H-2228-2012; Steinmetz, Michel O/AAA-3349-2022	Veprintsev, Dmitry B/0000-0002-3583-5409; Steinmetz, Michel O/0000-0001-6157-3687	Swiss National Science Foundation [31003A_122545, 310030B_138659]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grant 31003A_122545 and 310030B_138659 from the Swiss National Science Foundation (to MOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Buey RM, 2011, MOL BIOL CELL, V22, P2912, DOI 10.1091/mbc.E11-01-0017; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; De Groot CO, 2010, J BIOL CHEM, V285, P5802, DOI 10.1074/jbc.M109.068130; Galjart N, 2010, CURR BIOL, V20, pR528, DOI 10.1016/j.cub.2010.05.022; Gouveia SM, 2010, CURR BIOL, V20, P1717, DOI 10.1016/j.cub.2010.08.020; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; Honnappa S, 2006, MOL CELL, V23, P663, DOI 10.1016/j.molcel.2006.07.013; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Kumar P, 2012, TRENDS CELL BIOL, V22, P418, DOI 10.1016/j.tcb.2012.05.005; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Slep KC, 2010, CURR OPIN CELL BIOL, V22, P88, DOI 10.1016/j.ceb.2009.10.009; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	19	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e74448	10.1371/journal.pone.0074448	http://dx.doi.org/10.1371/journal.pone.0074448			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040250	Green Submitted, Green Published, gold			2022-12-25	WOS:000324856500082
J	Campello, L; Esteve-Rudd, J; Bru-Martinez, R; Herrero, MT; Fernandez-Villalba, E; Cuenca, N; Martin-Nieto, J				Campello, Laura; Esteve-Rudd, Julian; Bru-Martinez, Roque; Trinidad Herrero, Maria; Fernandez-Villalba, Emiliano; Cuenca, Nicolas; Martin-Nieto, Jose			Alterations in Energy Metabolism, Neuroprotection and Visual Signal Transduction in the Retina of Parkinsonian, MPTP-Treated Monkeys	PLOS ONE			English	Article							NEURON-SPECIFIC ENOLASE; NITRIC-OXIDE SYNTHASE; ENDOPLASMIC-RETICULUM STRESS; GRP78 PROTECTS NEURONS; INDUCED ANIMAL-MODELS; APOPTOTIC CELL-DEATH; PROTEOMIC ANALYSIS; MITOCHONDRIAL DYSFUNCTION; ALZHEIMERS-DISEASE; POLYACRYLAMIDE GELS	Parkinson disease is mainly characterized by the degeneration of dopaminergic neurons in the central nervous system, including the retina. Different interrelated molecular mechanisms underlying Parkinson disease-associated neuronal death have been put forward in the brain, including oxidative stress and mitochondrial dysfunction. Systemic injection of the proneurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to monkeys elicits the appearance of a parkinsonian syndrome, including morphological and functional impairments in the retina. However, the intracellular events leading to derangement of dopaminergic and other retinal neurons in MPTP-treated animal models have not been so far investigated. Here we have used a comparative proteomics approach to identify proteins differentially expressed in the retina of MPTP-treated monkeys. Proteins were solubilized from the neural retinas of control and MPTP-treated animals, labelled separately with two different cyanine fluorophores and run pairwise on 2D DIGE gels. Out of >700 protein spots resolved and quantified, 36 were found to exhibit statistically significant differences in their expression levels, of at least +/- 1.4-fold, in the parkinsonian monkey retina compared with controls. Most of these spots were excised from preparative 2D gels, trypsinized and subjected to MALDI-TOF MS and LC-MS/MS analyses. Data obtained were used for protein sequence database interrogation, and 15 different proteins were successfully identified, of which 13 were underexpressed and 2 overexpressed. These proteins were involved in key cellular functional pathways such as glycolysis and mitochondrial electron transport, neuronal protection against stress and survival, and phototransduction processes. These functional categories underscore that alterations in energy metabolism, neuroprotective mechanisms and signal transduction are involved in MPTP-induced neuronal degeneration in the retina, in similarity to mechanisms thought to underlie neuronal death in the Parkinson's diseased brain and neurodegenerative diseases of the retina proper.	[Campello, Laura; Esteve-Rudd, Julian; Cuenca, Nicolas; Martin-Nieto, Jose] Univ Alicante, Fac Ciencias, Dept Fisiol Genet & Microbiol, E-03080 Alicante, Spain; [Bru-Martinez, Roque; Martin-Nieto, Jose] Univ Alicante, Fac Ciencias, Dept Agroquim & Bioquim, E-03080 Alicante, Spain; [Bru-Martinez, Roque; Cuenca, Nicolas] Univ Alicante, Inst Multidisciplinar Estudio Medio Ramon Margale, E-03080 Alicante, Spain; [Trinidad Herrero, Maria] Univ Jaume 1, Fac Ciencias Salud, Dept Med, Unidad Neurociencia Clin & Expt NiCE,Ctr Invest B, Castellon de La Plana, Spain; [Trinidad Herrero, Maria; Fernandez-Villalba, Emiliano] Univ Murcia, Fac Med, NiCE CIBERNED, Dept Anat Humana & Psicobiol, Murcia, Spain	Universitat d'Alacant; Universitat d'Alacant; Universitat d'Alacant; Universitat Jaume I; CIBERNED; University of Murcia	Martin-Nieto, J (corresponding author), Univ Alicante, Fac Ciencias, Dept Fisiol Genet & Microbiol, E-03080 Alicante, Spain.	jmnieto@ua.es	Villalba, Emiliano Fernández/AAP-1187-2021; Bru-Martinez, Roque/L-5713-2014; MARTÍN-NIETO, JOSÉ/R-5428-2018; Cuenca, Nicolas/I-2007-2015	Bru-Martinez, Roque/0000-0003-3465-3766; MARTÍN-NIETO, JOSÉ/0000-0002-7815-6887; Cuenca, Nicolas/0000-0002-6767-5710; HERRERO, MARIA TRINIDAD/0000-0003-4953-1446; Campello, Laura/0000-0002-0869-1315	Instituto de Salud Carlos III [ISCIII; PI09/1623]; Fundacion Seneca [FS/15329/PI/10, ISCIII (PI10/02827)]; Centro de Investigacion Biomidica en Red sobre Enfermedades Neurodegenerativas (CIBERNED); MINECO [BFU2012-36845]; ISCIII [RETICS RD07/0062/0012, RD12/0034/0010]; Universidad de Alicante	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Seneca(Fundacion Seneca); Centro de Investigacion Biomidica en Red sobre Enfermedades Neurodegenerativas (CIBERNED); MINECO(Spanish Government); ISCIII(Instituto de Salud Carlos III); Universidad de Alicante	This research was supported by grants from the Instituto de Salud Carlos III (ISCIII; PI09/1623) to JM-N, from Fundacion Seneca (FS/15329/PI/10), ISCIII (PI10/02827) and Centro de Investigacion Biomidica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) to MTH, and from MINECO (BFU2012-36845) and ISCIII (RETICS RD07/0062/0012 and RD12/0034/0010) to NC. JE-R and LC were recipients of predoctoral contracts from the Universidad de Alicante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam CR, 2013, J NEURO-OPHTHALMOL, V33, P137, DOI 10.1097/WNO.0b013e31828c4e1a; Agou F, 1999, J BIOL CHEM, V274, P19630, DOI 10.1074/jbc.274.28.19630; Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; AMES A, 1992, J NEUROSCI, V12, P4234; Andrade J, 2004, BIOCHEM J, V384, P327, DOI 10.1042/BJ20040622; Archibald NK, 2009, BRAIN, V132, P1128, DOI 10.1093/brain/awp068; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atamna H, 2007, MITOCHONDRION, V7, P297, DOI 10.1016/j.mito.2007.06.001; Barcia C, 2003, NEUROENDOCRINOLOGY, V78, P118, DOI 10.1159/000071967; Basso M, 2004, PROTEOMICS, V4, P3943, DOI 10.1002/pmic.200400848; Bernstein SL, 2000, INVEST OPHTH VIS SCI, V41, P2857; Blanchard-Fillion B, 2001, J BIOL CHEM, V276, P46017, DOI 10.1074/jbc.M105564200; Bodis-Wollner I, 2013, BEHAV NEUROSCI, V127, P139, DOI 10.1037/a0031225; Bodis-Wollner I, 2009, J NEURAL TRANSM, V116, P1493, DOI 10.1007/s00702-009-0292-z; Buchman VL, 1998, NAT NEUROSCI, V1, P101, DOI 10.1038/349; Campello L, 2013, MOL NEUROBIOL, V47, P790, DOI 10.1007/s12035-012-8391-5; Castegna A, 2003, J NEUROCHEM, V85, P1394, DOI 10.1046/j.1471-4159.2003.01786.x; Castegna A, 2002, J NEUROCHEM, V82, P1524, DOI 10.1046/j.1471-4159.2002.01103.x; Celsi F, 2009, BBA-BIOENERGETICS, V1787, P335, DOI 10.1016/j.bbabio.2009.02.021; Cheon MS, 2001, J NEURAL TRANSM-SUPP, P281; Chin MH, 2008, J PROTEOME RES, V7, P666, DOI 10.1021/pr070546l; Chiquet C, 2002, NEUROSCIENCE, V115, P1323, DOI 10.1016/S0306-4522(02)00327-5; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Clark J, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/659694; Cuello F, 2003, J BIOL CHEM, V278, P7220, DOI 10.1074/jbc.M210304200; Cuenca N, 2005, J COMP NEUROL, V493, P261, DOI 10.1002/cne.20761; Curbo S, 2006, GENOMICS, V87, P410, DOI 10.1016/j.ygeno.2005.09.017; Dancik V, 1999, J COMPUT BIOL, V6, P327, DOI 10.1089/106652799318300; Danielson SR, 2008, FREE RADICAL BIO MED, V44, P1787, DOI 10.1016/j.freeradbiomed.2008.03.005; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; De Iuliis A, 2005, CLIN CHIM ACTA, V357, P202, DOI 10.1016/j.cccn.2005.03.028; Dean DO, 1999, INVEST OPHTH VIS SCI, V40, P2952; Esteve-Rudd J, 2011, NEUROBIOL DIS, V44, P102, DOI 10.1016/j.nbd.2011.06.009; Esteve-Rudd J, 2010, BRAIN RES, V1352, P70, DOI 10.1016/j.brainres.2010.07.019; Ethen CM, 2006, INVEST OPHTH VIS SCI, V47, P2280, DOI 10.1167/iovs.05-1395; Evans P, 2008, BIOCHEM J, V409, P691, DOI 10.1042/BJ20070993; Ferrer I, 2007, NEUROSCI LETT, V415, P205, DOI 10.1016/j.neulet.2007.01.026; Fort PE, 2011, EXP EYE RES, V92, P98, DOI 10.1016/j.exer.2010.11.008; Fort PE, 2009, MOL CELL PROTEOMICS, V8, P767, DOI 10.1074/mcp.M800326-MCP200; Fox DA, 1999, ANN NY ACAD SCI, V893, P282, DOI 10.1111/j.1749-6632.1999.tb07837.x; FUCHS S, 1995, NAT GENET, V10, P360, DOI 10.1038/ng0795-360; GERMAN DC, 1992, ANN NY ACAD SCI, V648, P42, DOI 10.1111/j.1749-6632.1992.tb24523.x; GHILARDI MF, 1988, LIFE SCI, V43, P255; GHILARDI MF, 1989, ANN NEUROL, V25, P357, DOI 10.1002/ana.410250407; GHILARDI MF, 1988, BRAIN, V111, P131, DOI 10.1093/brain/111.1.131; Goldenberg-Cohen N, 2012, APOPTOSIS, V17, P278, DOI 10.1007/s10495-011-0678-x; Greene JG, 2010, NEUROBIOL DIS, V38, P476, DOI 10.1016/j.nbd.2010.03.014; Hajee ME, 2009, ARCH OPHTHALMOL-CHIC, V127, P737, DOI 10.1001/archophthalmol.2009.106; Hantraye P, 1996, NAT MED, V2, P1017, DOI 10.1038/nm0996-1017; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; HARGRAVE PA, 1992, FASEB J, V6, P2323, DOI 10.1096/fasebj.6.6.1544542; HATTORI T, 1995, NEUROSCI RES, V21, P191, DOI 10.1016/0168-0102(94)00849-B; HATTORI T, 1994, BIOCHEM BIOPH RES CO, V202, P25, DOI 10.1006/bbrc.1994.1888; Hauck SM, 2005, PROTEOMICS, V5, P3623, DOI 10.1002/pmic.200401223; Herrero Maria Trinidad, 2011, Neurologist, V17, pS54, DOI 10.1097/NRL.0b013e31823968fc; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; HEUKESHOVEN J, 1985, ELECTROPHORESIS, V6, P103, DOI 10.1002/elps.1150060302; Imbert C, 2000, J NEUROSCI METH, V96, P71, DOI 10.1016/S0165-0270(99)00184-3; Inokuchi Y, 2009, INVEST OPHTH VIS SCI, V50, P334, DOI 10.1167/iovs.08-2123; Jin JH, 2005, MOL BRAIN RES, V134, P119, DOI 10.1016/j.molbrainres.2004.10.003; Johnsson P, 2000, ANN THORAC SURG, V69, P750, DOI 10.1016/S0003-4975(99)01393-4; Jones Stephen E., 2000, Molecular Cell Biology Research Communications, V4, P20, DOI 10.1006/mcbr.2000.0250; Kapphahn RJ, 2006, EXP EYE RES, V83, P165, DOI 10.1016/j.exer.2005.11.017; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; KELLER A, 1994, J NEUROSCI RES, V38, P493, DOI 10.1002/jnr.490380503; Kim JM, 2006, DNA RES, V13, P275, DOI 10.1093/dnares/dsl016; Kim SH, 2000, CELL MOL LIFE SCI, V57, P1810, DOI 10.1007/PL00000661; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klinker JF, 1999, EUR J BIOCHEM, V261, P72, DOI 10.1046/j.1432-1327.1999.00209.x; KOLAKOWSKI LF, 1988, NUCLEIC ACIDS RES, V16, P10441, DOI 10.1093/nar/16.22.10441; Lansbury PT, 2002, CURR OPIN GENET DEV, V12, P299, DOI 10.1016/S0959-437X(02)00302-7; Li JM, 2009, FEBS LETT, V583, P1521, DOI 10.1016/j.febslet.2009.04.007; Liberatore GT, 1999, NAT MED, V5, P1403; Licker V, 2009, J PROTEOMICS, V73, P10, DOI 10.1016/j.jprot.2009.07.007; Liedtke T, 2007, MOL CELL PROTEOMICS, V6, P895, DOI 10.1074/mcp.M600245-MCP200; Liedtke W, 2002, AM J PATHOL, V160, P469, DOI 10.1016/S0002-9440(10)64866-3; Liu SQ, 2007, WORLD J GASTROENTERO, V13, P2118, DOI 10.3748/wjg.v13.i14.2118; Lotharius J, 2002, HUM MOL GENET, V11, P2395, DOI 10.1093/hmg/11.20.2395; Lutz W, 2003, BIOCHEM BIOPH RES CO, V303, P1186, DOI 10.1016/S0006-291X(03)00499-6; Martinez-Navarrete GC, 2007, MOL VIS, V13, P949; Mori N, 2002, J NEUROSCI RES, V70, P264, DOI 10.1002/jnr.10353; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Ninkina N, 2009, HUM MOL GENET, V18, P1779, DOI 10.1093/hmg/ddp090; Nookala S, 2010, INVEST OPHTH VIS SCI, V51, P2736, DOI 10.1167/iovs.09-4286; Nordgaard CL, 2006, INVEST OPHTH VIS SCI, V47, P815, DOI 10.1167/iovs.05-0976; Nordgaard CL, 2008, INVEST OPHTH VIS SCI, V49, P2848, DOI 10.1167/iovs.07-1352; Nowacka Barbara, 2010, Klin Oczna, V112, P247; Organisciak D, 2006, PHOTOCHEM PHOTOBIOL, V82, P1088, DOI 10.1562/2005-06-30-RA-599; Orlov NY, 1996, FEBS LETT, V389, P186, DOI 10.1016/0014-5793(96)00575-3; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Periquet M, 2005, J NEUROCHEM, V95, P1259, DOI 10.1111/j.1471-4159.2005.03442.x; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rasband W.S., 2006, IMAGEJ; Ridge KD, 2003, TRENDS BIOCHEM SCI, V28, P479, DOI 10.1016/S0968-0004(03)00172-5; Saraswathy S, 2009, INVEST OPHTH VIS SCI, V50, P5559, DOI 10.1167/iovs.08-2842; Schapira AHV, 1998, BBA-BIOENERGETICS, V1364, P261, DOI 10.1016/S0005-2728(98)00032-2; Schober A, 2004, CELL TISSUE RES, V318, P215, DOI 10.1007/s00441-004-0938-y; SCHULZ JB, 1995, J NEUROCHEM, V64, P936, DOI 10.1046/j.1471-4159.1995.64020936.x; Selles-Marchart S, 2008, J PROTEOME RES, V7, P4095, DOI 10.1021/pr700687c; Smith WC, 2011, INVEST OPHTH VIS SCI, V52, P1832, DOI 10.1167/iovs.10-5724; Spund B, 2013, J NEURAL TRANSM, V120, P745, DOI 10.1007/s00702-012-0909-5; Strey CW, 2004, AM J PATHOL, V165, P1701, DOI 10.1016/S0002-9440(10)63426-8; Surguchev A, 2010, BRAIN RES BULL, V81, P12, DOI 10.1016/j.brainresbull.2009.09.015; Surgucheva I, 2005, CELL MOL NEUROBIOL, V25, P1051, DOI 10.1007/s10571-005-8474-1; Surguchov A, 2001, CELL MOTIL CYTOSKEL, V49, P218, DOI 10.1002/cm.1035; Terzioglu M, 2008, FEBS J, V275, P1384, DOI 10.1111/j.1742-4658.2008.06302.x; Tezel G, 2005, INVEST OPHTH VIS SCI, V46, P3177, DOI 10.1167/iovs.05-0208; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Tran CTL, 2003, ATHEROSCLEROSIS SUPP, V4, P33, DOI 10.1016/S1567-5688(03)00032-1; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Uversky VN, 2004, CELL TISSUE RES, V318, P225, DOI 10.1007/s00441-004-0937-z; VanGuilder HD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016271; Vorum H, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-5; Wang YD, 2007, CURR EYE RES, V32, P891, DOI 10.1080/02713680701593702; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6; Xi JH, 2003, MOL VIS, V9, P410; Yang S, 2008, NEUROSCIENCE, V154, P1107, DOI 10.1016/j.neuroscience.2008.04.012; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101; Yoo BC, 2001, BIOCHEM BIOPH RES CO, V280, P249, DOI 10.1006/bbrc.2000.4109; Yu Q, 2001, MOL VIS, V7, P48; Yu ZF, 1999, EXP NEUROL, V155, P302, DOI 10.1006/exnr.1998.7002	124	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74439	10.1371/journal.pone.0074439	http://dx.doi.org/10.1371/journal.pone.0074439			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040246	gold, Green Submitted, Green Published			2022-12-25	WOS:000324481600129
J	Hagedorn, TJ; Dufour, AB; Riskowski, JL; Hillstrom, HJ; Menz, HB; Casey, VA; Hannan, MT				Hagedorn, Thomas J.; Dufour, Alyssa B.; Riskowski, Jody L.; Hillstrom, Howard J.; Menz, Hylton B.; Casey, Virginia A.; Hannan, Marian T.			Foot Disorders, Foot Posture, and Foot Function: The Framingham Foot Study	PLOS ONE			English	Article							RISK-FACTORS; PLANTAR FORCES; HALLUX-VALGUS; OLDER-PEOPLE; PAIN; PRESSURES; WALKING; PLANUS	Introduction: Foot disorders are common among older adults and may lead to outcomes such as falls and functional limitation. However, the associations of foot posture and foot function to specific foot disorders at the population level remain poorly understood. The purpose of this study was to assess the relation between specific foot disorders, foot posture, and foot function. Methods: Participants were from the population-based Framingham Foot Study. Quintiles of the modified arch index and center of pressure excursion index from plantar pressure scans were used to create foot posture and function subgroups. Adjusted odds ratios of having each specific disorder were calculated for foot posture and function subgroups relative to a referent 3 quintiles. Results: Pes planus foot posture was associated with increased odds of hammer toes and overlapping toes. Cavus foot posture was not associated with the foot disorders evaluated. Odds of having hallux valgus and overlapping toes were significantly increased in those with pronated foot function, while odds of hallux valgus and hallux rigidus were significantly decreased in those with supinated function. Conclusions: Foot posture and foot function were associated with the presence of specific foot disorders.	[Hagedorn, Thomas J.; Dufour, Alyssa B.; Riskowski, Jody L.; Casey, Virginia A.; Hannan, Marian T.] Hebrew SeniorLife, Inst Aging Res, Boston, MA USA; [Dufour, Alyssa B.; Hannan, Marian T.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Riskowski, Jody L.] Glasgow Caledonian Univ, Inst Appl Hlth Res, Glasgow G4 0BA, Lanark, Scotland; [Hillstrom, Howard J.] Hosp Special Surg, Mot Anal Lab, New York, NY 10021 USA; [Menz, Hylton B.] La Trobe Univ, Fac Hlth Sci, Lower Extrem & Gait Studies Program, Bundoora, Vic, Australia	Harvard University; Hebrew SeniorLife; Harvard University; Harvard Medical School; Glasgow Caledonian University; La Trobe University	Hannan, MT (corresponding author), Hebrew SeniorLife, Inst Aging Res, Boston, MA USA.	Hannan@hsl.harvard.edu	Menz, Hylton B/B-4508-2013	Menz, Hylton B/0000-0002-2045-3846; Dufour, Alyssa/0000-0001-8061-9599; Hannan, Marian/0000-0002-9586-6928	National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR047853]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047853] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding provided by National Institute of Arthritis and Musculoskeletal and Skin Diseases R01 AR047853 (http://www.niams.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajis Adam, 2005, J Foot Ankle Surg, V44, P236, DOI 10.1053/j.jfas.2005.02.005; Badlissi F, 2005, J AM GERIATR SOC, V53, P1029, DOI 10.1111/j.1532-5415.2005.53315.x; BINGOLD AC, 1950, J BONE JOINT SURG BR, V32, P214, DOI 10.1302/0301-620X.32B2.214; Bryant A., 1999, FOOT, V9, P115, DOI DOI 10.1054/F00T.1999.0538; Buchbinder R, 2004, NEW ENGL J MED, V350, P2159, DOI 10.1056/NEJMcp032745; CHU WC, 1995, IEEE T BIO-MED ENG, V42, P1088, DOI 10.1109/10.469375; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Deschamps K, 2010, GAIT POSTURE, V32, P102, DOI 10.1016/j.gaitpost.2010.03.017; Dufour AB, 2009, ARTHRIT CARE RES, V61, P1352, DOI 10.1002/art.24733; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Golightly YM, 2012, ARTHRIT CARE RES, V64, P1756, DOI 10.1002/acr.21752; Golightly YM, 2011, ARTHRIT CARE RES, V63, P654, DOI 10.1002/acr.20432; Hillstrom HJ, 2013, GAIT POSTURE, V37, P445, DOI 10.1016/j.gaitpost.2012.09.007; Irving DB, 2006, J SCI MED SPORT, V9, P11, DOI 10.1016/j.jsams.2006.02.004; Kaufman KR, 1999, AM J SPORT MED, V27, P585, DOI 10.1177/03635465990270050701; Kernozek TW, 2003, J AM PODIAT MED ASSN, V93, P97, DOI 10.7547/87507315-93-2-97; KILMARTIN TE, 1992, FOOT ANKLE, V13, P53, DOI 10.1177/107110079201300201; MANN RA, 1981, CLIN ORTHOP RELAT R, P31; MCCLUSKEY WP, 1989, CLIN ORTHOP RELAT R, P27; McPoil TG, 1999, J AM PODIAT MED ASSN, V89, P495, DOI 10.7547/87507315-89-10-495; Menz HB, 2008, FOOT PROBLEINS OLDER; Menz HB, 2006, GAIT POSTURE, V24, P229, DOI 10.1016/j.gaitpost.2005.09.002; Menz HB, 2006, J GERONTOL A-BIOL, V61, P866, DOI 10.1093/gerona/61.8.866; Mickle KJ, 2009, CLIN BIOMECH, V24, P787, DOI 10.1016/j.clinbiomech.2009.08.011; Murphy DF, 2003, BRIT J SPORT MED, V37, P13, DOI 10.1136/bjsm.37.1.13; Nix SE, 2012, OSTEOARTHR CARTILAGE, V20, P1059, DOI 10.1016/j.joca.2012.06.007; Ribeiro AP, 2011, CLINICS, V66, P1027, DOI 10.1590/S1807-59322011000600018; Richard B, 1998, COMMON FOOT PROBLEMS, VHanley & Belfus, Inc.; Riddle D, 2003, J BONE JOINT SURG AM, V85A, P872, DOI 10.2106/00004623-200305000-00015; ROOT ML, 1977, NORMAL ABNORMAL FUNC; Scott G, 2007, GAIT POSTURE, V26, P68, DOI 10.1016/j.gaitpost.2006.07.009; Shiang TY, 1998, IEEE ENG MED BIOL, V17, P62; Shibuya N, 2010, J FOOT ANKLE SURG, V49, P363, DOI 10.1053/j.jfas.2010.04.001; SHINE IB, 1965, BRIT MED J, V1, P1648; Song JS, 1996, J AM PODIAT MED ASSN, V86, P16, DOI 10.7547/87507315-86-1-16; Wu K K, 1996, J Foot Ankle Surg, V35, P112; Zammit GV, 2008, J ORTHOP RES, V26, P1665, DOI 10.1002/jor.20700; Zammit GV, 2010, J FOOT ANKLE RES, V3, DOI 10.1186/1757-1146-3-11; Zammit GV, 2009, J ORTHOP SPORT PHYS, V39, P733, DOI 10.2519/jospt.2009.3003	39	61	61	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74364	10.1371/journal.pone.0074364	http://dx.doi.org/10.1371/journal.pone.0074364			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040231	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600126
J	Heslot, N; Rutkoski, J; Poland, J; Jannink, JL; Sorrells, ME				Heslot, Nicolas; Rutkoski, Jessica; Poland, Jesse; Jannink, Jean-Luc; Sorrells, Mark E.			Impact of Marker Ascertainment Bias on Genomic Selection Accuracy and Estimates of Genetic Diversity	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; ARRAYS TECHNOLOGY DART; QUANTITATIVE TRAITS; PREDICTION; INFORMATION; PACKAGE	Genome-wide molecular markers are often being used to evaluate genetic diversity in germplasm collections and for making genomic selections in breeding programs. To accurately predict phenotypes and assay genetic diversity, molecular markers should assay a representative sample of the polymorphisms in the population under study. Ascertainment bias arises when marker data is not obtained from a random sample of the polymorphisms in the population of interest. Genotyping-by-sequencing (GBS) is rapidly emerging as a low-cost genotyping platform, even for the large, complex, and polyploid wheat (Triticum aestivum L.) genome. With GBS, marker discovery and genotyping occur simultaneously, resulting in minimal ascertainment bias. The previous platform of choice for whole-genome genotyping in many species such as wheat was DArT (Diversity Array Technology) and has formed the basis of most of our knowledge about cereals genetic diversity. This study compared GBS and DArT marker platforms for measuring genetic diversity and genomic selection (GS) accuracy in elite U.S. soft winter wheat. From a set of 365 breeding lines, 38,412 single nucleotide polymorphism GBS markers were discovered and genotyped. The GBS SNPs gave a higher GS accuracy than 1,544 DArT markers on the same lines, despite 43.9% missing data. Using a bootstrap approach, we observed significantly more clustering of markers and ascertainment bias with DArT relative to GBS. The minor allele frequency distribution of GBS markers had a deficit of rare variants compared to DArT markers. Despite the ascertainment bias of the DArT markers, GS accuracy for three traits out of four was not significantly different when an equal number of markers were used for each platform. This suggests that the gain in accuracy observed using GBS compared to DArT markers was mainly due to a large increase in the number of markers available for the analysis.	[Heslot, Nicolas; Rutkoski, Jessica; Jannink, Jean-Luc; Sorrells, Mark E.] Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY 14853 USA; [Jannink, Jean-Luc] Cornell Univ, USDA ARS, RW Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA; [Poland, Jesse] Kansas State Univ, USDA ARS, Hard Winter Wheat Genet Res Unit, Ctr Grain & Anim Hlth Res,Northern Plains Area, Manhattan, KS 66506 USA; [Heslot, Nicolas] Limagrain Europe, Chappes, France	Cornell University; Cornell University; United States Department of Agriculture (USDA); Kansas State University; United States Department of Agriculture (USDA)	Sorrells, ME (corresponding author), Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY 14853 USA.	mes12@cornell.edu	Rutkoski, Jessica/Y-9255-2019	Rutkoski, Jessica/0000-0001-8435-4049; Poland, Jesse/0000-0002-7856-1399; Jannink, Jean-Luc/0000-0003-4849-628X	Bill and Melinda Gates Foundation; USDA-NIFA-AFRI [2011-68002-30029]; Hatch project [149-449]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); USDA-NIFA-AFRI(United States Department of Agriculture (USDA)); Hatch project(United States Department of Agriculture (USDA))	This research was supported in part by the Bill and Melinda Gates Foundation (Durable Rust Resistance in Wheat), USDA-NIFA-AFRI grant award number 2011-68002-30029 and by Hatch project 149-449. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Albrechtsen A, 2010, MOL BIOL EVOL, V27, P2534, DOI 10.1093/molbev/msq148; ANDERSON JA, 1993, CROP SCI, V33, P453, DOI 10.2135/cropsci1993.0011183X003300030008x; Asoro FG, 2011, PLANT GENOME-US, V4, P132, DOI 10.3835/plantgenome2011.02.0007; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; FEDERER W. T., 1956, Hawaiian Planters' Record, V55, P191; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Frascaroli E, 2013, THEOR APPL GENET, V126, P133, DOI 10.1007/s00122-012-1968-6; Gilmour A. R., 1997, Journal of Agricultural, Biological, and Environmental Statistics, V2, P269, DOI 10.2307/1400446; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Hamblin MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001367; Heffner EL, 2011, PLANT GENOME-US, V4, P65, DOI [10.3835/plantgenome2010.12.0029, 10.3835/plantgenome.2010.12.0029]; Heffner EL, 2010, CROP SCI, V50, P1681, DOI 10.2135/cropsci2009.11.0662; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lorenz AJ, 2011, ADV AGRON, V110, P77, DOI 10.1016/B978-0-12-385531-2.00002-5; Ly D, 2013, CROP SCI, V53, P1312, DOI 10.2135/cropsci2012.11.0653; Malosetti M, 2008, EUPHYTICA, V161, P241, DOI 10.1007/s10681-007-9594-0; Meuwissen THE, 2001, GENETICS, V157, P1819; Mohring J, 2009, CROP SCI, V49, P1977, DOI 10.2135/cropsci2009.02.0083; Moragues M, 2010, THEOR APPL GENET, V120, P1525, DOI 10.1007/s00122-010-1273-1; Munkvold JD, 2009, THEOR APPL GENET, V119, P1223, DOI 10.1007/s00122-009-1123-1; Nielsen R, 2003, THEOR POPUL BIOL, V63, P245, DOI 10.1016/S0040-5809(03)00005-4; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; R Core Team, 2021, R LANG ENV STAT COMP; Rutkoski JE, 2013, G3-GENES GENOM GENET, V3, P427, DOI 10.1534/g3.112.005363; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101	34	102	104	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74612	10.1371/journal.pone.0074612	http://dx.doi.org/10.1371/journal.pone.0074612			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040295	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600138
J	Kim, M; Song, LK; Moon, J; Sun, ZYJ; Bershteyn, A; Hanson, M; Cain, D; Goka, S; Kelsoe, G; Wagner, G; Irvine, D; Reinherz, EL				Kim, Mikyung; Song, Likai; Moon, James; Sun, Zhen-Yu J.; Bershteyn, Anna; Hanson, Melissa; Cain, Derek; Goka, Selasie; Kelsoe, Garnett; Wagner, Gerhard; Irvine, Darrell; Reinherz, Ellis L.			Immunogenicity of Membrane-bound HIV-1 gp41 Membrane-proximal External Region (MPER) Segments Is Dominated by Residue Accessibility and Modulated by Stereochemistry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL RESPONSES; IMMUNE-RESPONSE; NEUTRALIZING ANTIBODIES; PEPTIDE EPITOPE; VIRUS; PROTEIN; AFFINITY; ANTIGEN; MATURATION; BROAD	Structural characterization of epitope-paratope pairs has contributed to the understanding of antigenicity. By contrast, few structural studies relate to immunogenicity, the process of antigen-induced immune responses in vivo. Using a lipid-arrayed membrane-proximal external region (MPER) of HIV-1 glycoprotein 41 as a model antigen, we investigated the influence of physicochemical properties on immunogenicity in relation to structural modifications of MPER/liposome vaccines. Anchoring the MPER to the membrane via an alkyl tail or transmembrane domain retained the MPER on liposomes in vivo, while preserving MPER secondary structure. However, structural modifications that affected MPER membrane orientation and antigenic residue accessibility strongly impacted induced antibody responses. The solvent-exposed MPER tryptophan residue (Trp-680) was immunodominant, focusing immune responses, despite sequence variability elsewhere. Nonetheless, immunogenicity could be readily manipulated using site-directed mutagenesis or structural constraints to modulate amino acid surface display. These studies provide fundamental insights for immunogen design aimed at targeting B cell antibody responses.	[Kim, Mikyung; Goka, Selasie; Reinherz, Ellis L.] Dana Farber Canc Inst, Immunobiol Lab, Boston, MA 02115 USA; [Kim, Mikyung; Goka, Selasie; Reinherz, Ellis L.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Kim, Mikyung] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Song, Likai] Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Moon, James; Bershteyn, Anna; Hanson, Melissa; Irvine, Darrell] MIT, Dept Mat Sci & Engn & Biol Engn, Cambridge, MA 02139 USA; [Sun, Zhen-Yu J.; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Cain, Derek; Kelsoe, Garnett] Duke Univ, Dept Immunol, Sch Med, Durham, NC 27710 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; State University System of Florida; Florida State University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Duke University	Kim, M (corresponding author), Dana Farber Canc Inst, Immunobiol Lab, Boston, MA 02115 USA.	mikyung_kim@dfci.harvard.edu; ellis_reinherz@dfci.harvard.edu	Moon, James/AAA-9905-2020; Moon, James J/ABE-4429-2021	Moon, James/0000-0001-8071-1491; Moon, James J/0000-0003-2238-2372; Hanson, Melissa/0000-0003-3270-8460	National Institutes of Health [AI 84785, AI 91693, AI 81579]; NIAID [HHSN272201000053C]; Bill and Melinda Gates Foundation; National High Magnetic Field Laboratory User Collaboration Grants Program [5080]; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084785, R01AI081579, U19AI091693] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National High Magnetic Field Laboratory User Collaboration Grants Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI 84785 (to E. L. R. and G. W.), AI 91693 (to E. L. R., G. W., G. H. K., and D. I.), AI 81579 and HHSN272201000053C from NIAID and a Collaboration for AIDS Vaccine Discovery grant from the Bill and Melinda Gates Foundation (to E. L. R., G. W. and D. I.) and a Global Health grant from the Bill and Melinda Gates Foundation (to G. H. K.).; Supported by National High Magnetic Field Laboratory User Collaboration Grants Program Grant 5080.	Azoitei ML, 2011, SCIENCE, V334, P373, DOI 10.1126/science.1209368; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Bershteyn A, 2008, SOFT MATTER, V4, P1787, DOI 10.1039/b804933e; BERZOFSKY JA, 1985, SCIENCE, V229, P932, DOI 10.1126/science.2410982; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Chies MD, 2001, IMMUNOLOGY, V103, P172, DOI 10.1046/j.1365-2567.2001.01242.x; CHUA MM, 1987, J IMMUNOL, V138, P1281; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; CLARKE SH, 1990, J IMMUNOL, V144, P2795; Dal Porto JM, 1998, J IMMUNOL, V161, P5373; Dennison SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027824; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; FOOTE J, 1991, NATURE, V352, P530, DOI 10.1038/352530a0; GEYSEN HM, 1987, SCIENCE, V235, P1184, DOI 10.1126/science.3823878; GRASMASSE HS, 1986, MOL IMMUNOL, V23, P1391, DOI 10.1016/0161-5890(86)90025-8; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Guenaga J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016074; HARAN G, 1993, BIOCHIM BIOPHYS ACTA, V1151, P201, DOI 10.1016/0005-2736(93)90105-9; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Jackson RM, 1999, PROTEIN SCI, V8, P603; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Kim M, 2011, NAT STRUCT MOL BIOL, V18, P1235, DOI 10.1038/nsmb.2154; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; KOCKS C, 1988, P NATL ACAD SCI USA, V85, P8206, DOI 10.1073/pnas.85.21.8206; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Lazarski CA, 2005, IMMUNITY, V23, P29, DOI 10.1016/j.immuni.2005.05.009; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; McLellan JS, 2011, J MOL BIOL, V409, P853, DOI 10.1016/j.jmb.2011.04.044; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; Nakra P, 2000, J IMMUNOL, V164, P5615, DOI 10.4049/jimmunol.164.11.5615; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Parren PWHI, 1997, NAT MED, V3, P366, DOI 10.1038/nm0497-366d; Rubinstein ND, 2008, MOL IMMUNOL, V45, P3477, DOI 10.1016/j.molimm.2007.10.016; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; Song LK, 2009, P NATL ACAD SCI USA, V106, P9057, DOI 10.1073/pnas.0901474106; Stanfield RL, 2011, J MOL BIOL, V414, P460, DOI 10.1016/j.jmb.2011.10.014; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; TAINER JA, 1984, NATURE, V312, P127, DOI 10.1038/312127a0; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; TORCHILIN VP, 1994, BBA-BIOMEMBRANES, V1195, P11, DOI 10.1016/0005-2736(94)90003-5; Vijayakrishnan L, 1997, J IMMUNOL, V159, P1809; Watson DS, 2009, VACCINE, V27, P4672, DOI 10.1016/j.vaccine.2009.05.059; WESTHOF E, 1984, NATURE, V311, P123, DOI 10.1038/311123a0; Yang G, 2013, J EXP MED, V210, P241, DOI 10.1084/jem.20121977; Yu XC, 2008, J IMMUNOL METHODS, V336, P142, DOI 10.1016/j.jim.2008.04.008; Zlatkovic J, 2011, J VIROL, V85, P1994, DOI 10.1128/JVI.01886-10	55	35	38	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31888	31901		10.1074/jbc.M113.494609	http://dx.doi.org/10.1074/jbc.M113.494609			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24047898	hybrid, Green Published			2022-12-25	WOS:000330596200038
J	Kuebler, M; Yom-Tov, E; Pelleg, D; Puhl, RM; Muennig, P				Kuebler, Meghan; Yom-Tov, Elad; Pelleg, Dan; Puhl, Rebecca M.; Muennig, Peter			When Overweight Is the Normal Weight: An Examination of Obesity Using a Social Media Internet Database	PLOS ONE			English	Article							BODY-MASS INDEX; SELF-REPORTED HEIGHT; UNITED-STATES; METABOLICALLY HEALTHY; STIGMA; PREVALENCE; CHILDREN; STRESS; DISCRIMINATION; MISPERCEPTION	Using a large social media database, Yahoo Answers, we explored postings to an online forum in which posters asked whether their height and weight qualify themselves as "skinny,'' "thin,'' "fat,'' or "obese'' over time and across forum topics. We used these data to better understand whether a higher-than-average body mass index (BMI) in one's county might, in some ways, be protective for one's mental and physical health. For instance, we explored whether higher proportions of obese people in one's county predicts lower levels of bullying or "am I fat?'' questions from those with a normal BMI relative to his/her actual BMI. Most women asking whether they were themselves fat/obese were not actually fat/obese. Both men and women who were actually overweight/obese were significantly more likely in the future to ask for advice about bullying than thinner individuals. Moreover, as mean county-level BMI increased, bullying decreased and then increased again (in a U-shape curve). Regardless of where they lived, posters who asked "am I fat?'' who had a BMI in the healthy range were more likely than other posters to subsequently post on health problems, but the proportions of such posters also declined greatly as county-level BMI increased. Our findings suggest that obese people residing in counties with higher levels of BMI may have better physical and mental health than obese people living in counties with lower levels of BMI by some measures, but these improvements are modest.	[Kuebler, Meghan; Muennig, Peter] Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY 10027 USA; [Yom-Tov, Elad] Microsoft Res Israel, Herzliyya, Israel; [Pelleg, Dan] Yahoo Labs, Haifa, Matam Park, Israel; [Puhl, Rebecca M.] Yale Univ, Rudd Ctr Food Policy & Obes, New Haven, CT USA	Columbia University; Yale University	Kuebler, M (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY 10027 USA.	meghankuebler@gmail.com; pm124@columbia.edu	Puhl, Rebecca/ABE-9260-2021	Muennig, Peter/0000-0002-4234-0498; Yom-Tov, Elad/0000-0002-2380-4584				Ali MM, 2011, SOUTH ECON J, V77, P827, DOI 10.4284/0038-4038-77.4.827; Andreyeva T, 2008, OBESITY, V16, P1129, DOI 10.1038/oby.2008.35; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bluher M, 2010, CURR OPIN LIPIDOL, V21, P38, DOI 10.1097/MOL.0b013e3283346ccc; Bolton-Smith C, 2000, J EPIDEMIOL COMMUN H, V54, P143, DOI 10.1136/jech.54.2.143; Boyes AD, 2009, J SEX MARITAL THER, V35, P282, DOI 10.1080/00926230902851280; BRINDLEY DN, 1989, CLIN SCI, V77, P453, DOI 10.1042/cs0770453; Burke MA, 2010, OBESITY, V18, P1226, DOI 10.1038/oby.2009.369; Center for Disease Control, 2012, DEF OV OB; Centers for Disease Control and Prevention, 2008, COUNT LEV EST OB US; DEURENBERG P, 1991, BRIT J NUTR, V65, P105, DOI 10.1079/BJN19910073; Dietz WH, 1999, AM J CLIN NUTR, V70, p123S; Dodds PS, 2010, J HAPPINESS STUD, V11, P441, DOI 10.1007/s10902-009-9150-9; Falkner NH, 1999, OBES RES, V7, P572, DOI 10.1002/j.1550-8528.1999.tb00716.x; Friedman KE, 2005, OBES RES, V13, P907, DOI 10.1038/oby.2005.105; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Guo S S, 1999, Am J Clin Nutr, V70, p145S, DOI 10.1093/ajcn/70.1.145s; Homan G, 2012, HUM REPROD, V27, P2396, DOI 10.1093/humrep/des176; Jaworowska A, 2009, BIOMED PHARMACOTHER, V63, P679, DOI 10.1016/j.biopha.2008.08.005; Johnson F, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a494; Kaplan AM, 2010, BUS HORIZONS, V53, P59, DOI 10.1016/j.bushor.2009.09.003; Kawachi I, 2010, ANN NY ACAD SCI, V1186, P56, DOI 10.1111/j.1749-6632.2009.05340.x; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; LEMARCHAND L, 1988, AM J EPIDEMIOL, V128, P874, DOI 10.1093/oxfordjournals.aje.a115040; Mackey ER, 2008, J YOUTH ADOLESCENCE, V37, P1097, DOI 10.1007/s10964-008-9299-2; Matthiasdottir E, 2012, EUR J PUBLIC HEALTH, V22, P116, DOI 10.1093/eurpub/ckq178; Maximova K, 2008, INT J OBESITY, V32, P1008, DOI 10.1038/ijo.2008.15; McDowell Margaret A, 2008, Natl Health Stat Report, P1; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Muennig P, 2008, AM J PUBLIC HEALTH, V98, P501, DOI 10.2105/AJPH.2007.114769; Muennig P, 2006, AM J PUBLIC HEALTH, V96, P1662, DOI 10.2105/AJPH.2005.068874; Muennig P, 2010, AM J PUBLIC HEALTH, V100, P1758, DOI 10.2105/AJPH.2009.165019; Muennig P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-128; Muennig P, 2009, STRESS HEALTH, V25, P241, DOI 10.1002/smi.1243; Neuman WL, 2011, SOCIAL RES METHODS Q, V7th; Nieto-Garcia F J, 1990, Epidemiology, V1, P146, DOI 10.1097/00001648-199003000-00011; Nihiser AJ, 2007, J SCHOOL HEALTH, V77, P651, DOI 10.1111/j.1746-1561.2007.00249.x; Ogden CL, 2002, PEDIATRICS, V109, P45, DOI 10.1542/peds.109.1.45; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Pajunen P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-754; Pelleg D, 2013, TOUCH SCREENS TOUCHY; Phillips Katharine A, 2004, World Psychiatry, V3, P12; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; PIRIE P, 1981, J AM DIET ASSOC, V78, P601; Puhl RM, 2008, INT J OBESITY, V32, P992, DOI 10.1038/ijo.2008.22; Puhl RM, 2007, PSYCHOL BULL, V133, P557, DOI 10.1037/0033-2909.133.4.557; Puhl RM, 2011, J SCHOOL HEALTH, V81, P696, DOI 10.1111/j.1746-1561.2011.00646.x; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Rosenberger PH, 2007, OBES SURG, V17, P470, DOI 10.1007/s11695-007-9082-6; Rothman KJ, 2008, INT J OBESITY, V32, pS56, DOI 10.1038/ijo.2008.87; Roy JP, 2004, MED HYPOTHESES, V62, P222, DOI 10.1016/S0306-9877(03)00315-3; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Singleton R.A., 2005, APPROACHES SOCIAL RE; US Bureau of Census, 2001, US CENS POP HOUS 200; Wang J, 2010, J ADOLESCENT HEALTH, V47, P99, DOI 10.1016/j.jadohealth.2009.12.007; Webster M, 2012, SOCIAL MEDIA	57	11	11	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73479	10.1371/journal.pone.0073479	http://dx.doi.org/10.1371/journal.pone.0073479			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	221YD	24058478	Green Published, gold, Green Submitted			2022-12-25	WOS:000324695900015
J	Ay, AS; Benzerdjerb, N; Sevestre, H; Ahidouch, A; Ouadid-Ahidouch, H				Ay, Anne-Sophie; Benzerdjerb, Nazim; Sevestre, Henri; Ahidouch, Ahmed; Ouadid-Ahidouch, Halima			Orai3 Constitutes a Native Store-Operated Calcium Entry That Regulates Non Small Cell Lung Adenocarcinoma Cell Proliferation	PLOS ONE			English	Article							CRAC; CANCER; EXPRESSION; PATHWAYS; CHANNELS; CA2+	Orai channels have been associated with cell proliferation, survival and metastasis in several cancers. The present study investigates the expression and the role of Orai3 in cell proliferation in non-small cell lung cancer (NSCLC). We show that Orai3 is over-expressed in cancer tissues as compared to the non-tumoral ones. Furthermore, Orai3 staining is stronger in high grade tumors. Pharmacological inhibition or knockdown of Orai3 significantly reduced store operated calcium entry (SOCE), inhibited cell proliferation and arrested cells of two NSCLC cell lines in G0/G1 phase. These effects were concomitant with a down-regulation of cyclin D1, cyclin E, CDK4 and CDK2 expression. Moreover, Orai3 silencing decreased Akt phosphorylation levels. In conclusion, Orai3 constitutes a native SOCE pathway in NSCLC that controls cell proliferation and cell cycle progression likely via Akt pathway.	[Ay, Anne-Sophie; Benzerdjerb, Nazim; Sevestre, Henri; Ahidouch, Ahmed; Ouadid-Ahidouch, Halima] UFR Sci, Lab Cellular & Mol Physiol, LPCM EA 4667, SFR CAP SANTE FED 4231, Amiens, France; [Benzerdjerb, Nazim; Sevestre, Henri] Amiens North Hosp, Pathol Anat & Cytol Serv, Amiens, France; [Ahidouch, Ahmed] Ibn Zohr Univ, Dept Biol, Agadir, Morocco	Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Ibn Zohr University of Agadir	Ouadid-Ahidouch, H (corresponding author), UFR Sci, Lab Cellular & Mol Physiol, LPCM EA 4667, SFR CAP SANTE FED 4231, Amiens, France.	ha-sciences@u-picardie.fr			Region Picardie; Ministere de l'Education Nationale (France)	Region Picardie(Region Hauts-de-France); Ministere de l'Education Nationale (France)	This study was supported by the Region Picardie, and by the Ministere de l'Education Nationale (France). The funders had no role in study design, data collection and analysis, in the decision to publish, or in preparation of the manuscript.	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Borowiec AS, 2011, BBA-MOL CELL RES, V1813, P723, DOI 10.1016/j.bbamcr.2011.01.025; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; Ding X, 2010, JNCI-J NATL CANCER I, V102, P1052, DOI 10.1093/jnci/djq217; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; El Boustany C, 2010, CELL CALCIUM, V47, P350, DOI 10.1016/j.ceca.2010.01.006; Faouzi M, 2001, J CELL PHYSL, V226, P542; FERNANDO KC, 1994, BBA-MOL CELL RES, V1222, P383, DOI 10.1016/0167-4889(94)90044-2; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; Kahl CR, 2004, MOL BIOL CELL, V15, P1833, DOI 10.1091/mbc.e03-10-0730; Kurebayashi N, 2001, J PHYSIOL-LONDON, V533, P185, DOI 10.1111/j.1469-7793.2001.0185b.x; Lehen'kyi V, 2007, ONCOGENE, V26, P7380, DOI 10.1038/sj.onc.1210545; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lof C, 2012, MOL ENDOCRINOL, V26, P2046, DOI 10.1210/me.2012-1171; Luo DL, 2001, J BIOL CHEM, V276, P20186, DOI 10.1074/jbc.M100327200; Marinov M, 2007, CRIT REV ONCOL HEMAT, V63, P172, DOI 10.1016/j.critrevonc.2007.04.002; Ogawa A, 2012, AM J PHYSIOL-CELL PH, V302, pC405, DOI 10.1152/ajpcell.00337.2011; Ouadid-Ahidouch H, 2004, AM J PHYSIOL-CELL PH, V287, pC125, DOI 10.1152/ajpcell.00488.2003; Pande G, 1996, CYTOMETRY, V24, P55, DOI 10.1002/(SICI)1097-0320(19960501)24:1<55::AID-CYTO7>3.0.CO;2-H; Prevarskaya N, 2013, EXPERT OPIN THER TAR, V17, P225, DOI 10.1517/14728222.2013.741594; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Shih YW, 2009, FOOD CHEM TOXICOL, V47, P1985, DOI 10.1016/j.fct.2009.05.011; Spirli C, 2012, HEPATOLOGY, V55, P856, DOI 10.1002/hep.24723; Tajeddine N, 2012, J BIOL CHEM, V287, P16146, DOI 10.1074/jbc.M112.340034; Trebak M, 2009, CIRC RES, V104, pE56, DOI 10.1161/CIRCRESAHA.109.196105; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085	28	54	57	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e72889	10.1371/journal.pone.0072889	http://dx.doi.org/10.1371/journal.pone.0072889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058448	gold, Green Published, Green Submitted			2022-12-25	WOS:000324408400008
J	Fan, Q; Huang, ZM; Boucher, M; Shang, XY; Zuo, L; Brinks, H; Lau, WB; Zhang, JK; Chuprun, JK; Gao, EH				Fan, Qian; Huang, Zheng M.; Boucher, Matthieu; Shang, Xiying; Zuo, Lin; Brinks, Henriette; Lau, Wayne Bond; Zhang, Jianke; Chuprun, J. Kurt; Gao, Erhe			Inhibition of Fas-Associated Death Domain-Containing Protein (FADD) Protects against Myocardial Ischemia/Reperfusion Injury in a Heart Failure Mouse Model	PLOS ONE			English	Article							RHEUMATOID SYNOVIOCYTES; SIGNALING COMPLEX; MYOCYTE APOPTOSIS; GENE-THERAPY; CELL-DEATH; RECEPTOR; INFARCTION; CARDIOMYOCYTES; DISEASE; TNF	Aim: As technological interventions treating acute myocardial infarction (MI) improve, post-ischemic heart failure increasingly threatens patient health. The aim of the current study was to test whether FADD could be a potential target of gene therapy in the treatment of heart failure. Methods: Cardiomyocyte-specific FADD knockout mice along with non-transgenic littermates (NLC) were subjected to 30 minutes myocardial ischemia followed by 7 days of reperfusion or 6 weeks of permanent myocardial ischemia via the ligation of left main descending coronary artery. Cardiac function were evaluated by echocardiography and left ventricular (LV) catheterization and cardiomyocyte death was measured by Evans blue-TTC staining, TUNEL staining, and caspase-3, -8, and -9 activities. In vitro, H9C2 cells transfected with ether scramble siRNA or FADD siRNA were stressed with chelerythrin for 30 min and cleaved caspase-3 was assessed. Results: FADD expression was significantly decreased in FADD knockout mice compared to NLC. Ischemia/reperfusion (I/R) upregulated FADD expression in NLC mice, but not in FADD knockout mice at the early time. FADD deletion significantly attenuated I/R-induced cardiac dysfunction, decreased myocardial necrosis, and inhibited cardiomyocyte apoptosis. Furthermore, in 6 weeks long term permanent ischemia model, FADD deletion significantly reduced the infarct size (from 41.20 +/- 3.90% in NLC to 26.83 +/- 4.17% in FADD deletion), attenuated myocardial remodeling, improved cardiac function and improved survival. In vitro, FADD knockdown significantly reduced chelerythrin-induced the level of cleaved caspase-3. Conclusion: Taken together, our results suggest FADD plays a critical role in post-ischemic heart failure. Inhibition of FADD retards heart failure progression. Our data supports the further investigation of FADD as a potential target for genetic manipulation in the treatment of heart failure.	[Fan, Qian; Huang, Zheng M.; Boucher, Matthieu; Shang, Xiying; Zuo, Lin; Brinks, Henriette; Chuprun, J. Kurt; Gao, Erhe] Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA 19122 USA; [Fan, Qian] Beijing Capital Med Univ, Beijing Chaoyang Hosp, Dept Gerontol, Beijing, Peoples R China; [Lau, Wayne Bond] Thomas Jefferson Univ Hosp, Dept Emergency Med, Philadelphia, PA 19107 USA; [Zhang, Jianke] Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Capital Medical University; Jefferson University; Jefferson University	Gao, EH (corresponding author), Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA 19122 USA.	erhe.gao@temple.edu	Boucher, Matthieu/AAV-2538-2021	Fan, Qian/0000-0002-8269-3060; Lau, Wayne Bond/0000-0002-8064-8290	National Institutes of Health (NIH) [P01 HL075443]; American Heart Association post-doctoral fellowship; Fonds de la Recherche en Sante du Quebec postdoctoral scholarship (Quebec, Canada); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL075443] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association post-doctoral fellowship(American Heart Association); Fonds de la Recherche en Sante du Quebec postdoctoral scholarship (Quebec, Canada); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by a National Institutes of Health (NIH) grants P01 HL075443 (Project 1 and Core B) (to Walter J. Koch). Matthieu Boucher was supported by an American Heart Association post-doctoral fellowship (Great Rivers Affiliate) and a Fonds de la Recherche en Sante du Quebec postdoctoral scholarship (Quebec, Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Binah O, 2004, ANN NY ACAD SCI, V1015, P338, DOI 10.1196/annals.1302.030; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Brinks H, 2010, CIRC RES, V107, P1140, DOI 10.1161/CIRCRESAHA.110.221010; Chen M, 2013, CIRC RES, V112, P1121, DOI 10.1161/CIRCRESAHA.112.300754; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Date T, 2003, J MOL CELL CARDIOL, V35, P811, DOI 10.1016/S0022-2828(03)00139-1; Davidson SM, 2003, J MOL CELL CARDIOL, V35, P1359, DOI 10.1016/J.yjmcc.2003.08.001; Fan Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066234; Fang J, 2008, J AM COLL CARDIOL, V52, P428, DOI 10.1016/j.jacc.2008.03.061; Ferrari R, 1999, PHARMACOL RES, V40, P97, DOI 10.1006/phrs.1998.0463; Foo RSY, 2005, J CLIN INVEST, V115, P565, DOI 10.1172/JCI200524569; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Gao E, 2007, AM J PHYSIOL-HEART C, V293, pH60, DOI 10.1152/ajpheart.00227.2007; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Giampietri C, 2008, J HYPERTENS, V26, P1008, DOI 10.1097/HJH.0b013e3282f6a179; Green DR, 2011, MOL CELL, V44, P9, DOI 10.1016/j.molcel.2011.09.003; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Imtiyaz HZ, 2006, J IMMUNOL, V176, P6852, DOI 10.4049/jimmunol.176.11.6852; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kobayashi T, 2000, GENE THER, V7, P527, DOI 10.1038/sj.gt.3301127; Kobayashi T, 2000, ARTHRITIS RHEUM, V43, P1106, DOI 10.1002/1529-0131(200005)43:5<1106::AID-ANR21>3.0.CO;2-F; Kondo S, 1998, HUM GENE THER, V9, P1599, DOI 10.1089/hum.1998.9.11-1599; Lee Y, 2009, APOPTOSIS, V14, P536, DOI 10.1007/s10495-008-0302-x; Liang CS, 2009, J AM COLL CARDIOL, V53, P21, DOI 10.1016/j.jacc.2008.09.026; Mani K, 2003, J AM COLL CARDIOL, V41, P761, DOI 10.1016/S0735-1097(02)02958-3; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Palojoki E, 2001, AM J PHYSIOL-HEART C, V280, pH2726, DOI 10.1152/ajpheart.2001.280.6.H2726; Shilkrut M, 2003, J MOL CELL CARDIOL, V35, P1229, DOI 10.1016/S0022-2828(03)00232-3; Tao L, 2004, P NATL ACAD SCI USA, V101, P11471, DOI 10.1073/pnas.0402941101; Testa M, 1996, J AM COLL CARDIOL, V28, P964, DOI 10.1016/S0735-1097(96)00268-9; Xiao JF, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0239-z; Zhang J, 2001, J BIOL CHEM, V276, P29815, DOI 10.1074/jbc.M103838200; Zhang YH, 2005, J IMMUNOL, V175, P3033, DOI 10.4049/jimmunol.175.5.3033	38	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73537	10.1371/journal.pone.0073537	http://dx.doi.org/10.1371/journal.pone.0073537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058479	Green Published, gold, Green Submitted			2022-12-25	WOS:000324408400028
J	Li, LT; Zhu, YB; Ma, JF; Li, ZY; Dong, ZP				Li, Li-Tao; Zhu, Yan-Bin; Ma, Ji-Fang; Li, Zhi-Yong; Dong, Zhi-Ping			An Analysis of the Athetis lepigone Transcriptome from Four Developmental Stages	PLOS ONE			English	Article							PROTEINS	Athetis lepigone Moschler (Lepidoptera: Noctuidae) has recently become an important insect pest of maize (Zea mays) crops in China. In order to understand the characteristics of the different developmental stages of this pest, we used Illumina short-read sequences to perform de novo transcriptome assembly and gene expression analysis for egg, larva, pupa and adult developmental stages. We obtained 10.08 Gb of raw data from Illumina sequencing and recovered 81,356 unigenes longer than 100 bp through a de novo assembly. The total sequence length reached 49.75 Mb with 858 bp of N50 and an average unigene length of 612 bp. Annotation analysis of predicted proteins indicate that 33,736 unigenes (41.47% of total unigenes) are matches to genes in the Genbank Nr database. The unigene sequences were subjected to GO, COG and KEGG functional classification. A large number of differentially expressed genes were recovered by pairwise comparison of the four developmental stages. The most dramatic differences in gene expression were found in the transitions from one stage to another stage. Some of these differentially expressed genes are related to cuticle and wing formation as well as the growth and development. We identified more than 2,500 microsatellite markers that may be used for population studies of A. lepigone. This study lays the foundation for further research on population genetics and gene function analysis in A. lepigone.	[Li, Li-Tao; Zhu, Yan-Bin; Ma, Ji-Fang; Li, Zhi-Yong; Dong, Zhi-Ping] Hebei Acad Agr & Forestry Sci, Inst Millet Crops, Shijiazhuang, Peoples R China; [Zhu, Yan-Bin] Agr Univ Hebei, Coll Life Sci, Baoding, Peoples R China	Hebei Academy of Agricultural & Forestry Sciences; Hebei Agricultural University	Dong, ZP (corresponding author), Hebei Acad Agr & Forestry Sci, Inst Millet Crops, Shijiazhuang, Peoples R China.	dzping001@163.com			Project of Hebei Department of Science and Technology [11220301D]	Project of Hebei Department of Science and Technology	This study was supported by the Project of Hebei Department of Science and Technology (11220301D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN SO, 1995, INSECT BIOCHEM MOLEC, V25, P153, DOI 10.1016/0965-1748(94)00052-J; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Berger N, 2012, BBA-GENE REGUL MECH, V1819, P863, DOI 10.1016/j.bbagrm.2012.02.022; Chen X, 2012, INSECT BIOCHEM MOLEC, V42, P665, DOI 10.1016/j.ibmb.2012.05.004; Etebari K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-446; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; [姜京宇 Jiang Jingyu], 2008, [植物保护, Plant Protection], V34, P123; Kucharski R, 2007, INSECT BIOCHEM MOLEC, V37, P128, DOI 10.1016/j.ibmb.2006.10.009; Lindeborg Mats, 2008, Entomologisk Tidskrift, V129, P43; Ma J.F., 2012, CHINA PLANT PROTECTI, V32, P37; Ma JF, 2011, J HEBEI AGR SCI, V9, P1; Ma JF, 2012, CHINA PLANT PROTECTI, V32, P16; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nowacki Janusz, 2001, Polskie Pismo Entomologiczne, V70, P271; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Poltavsky A., 2009, ENTOMOL REV, V89, P1072, DOI [10.1134/S0013873809090085, DOI 10.1134/S0013873809090085]; Poltavsky Alexander Nikolaevitch, 2003, Phegea, V31, P167; Sangwan I, 2002, PLANT PHYSIOL, V129, P1788, DOI 10.1104/pp.002618; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Wang YQ, 2011, J HEBEI AGR SCI, V15, P4; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036238; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Zhang FJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-303; Zhang LD, 2006, BMC GENOMICS, V7, DOI [10.1186/1471-2164-7-323, 10.1186/1471-2164-7-153]; Zhang ZL, 2009, SHENYANG INSECT ILLU; Zhu Yan-Bin, 2012, Acta Entomologica Sinica, V55, P457	29	26	37	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73911	10.1371/journal.pone.0073911	http://dx.doi.org/10.1371/journal.pone.0073911			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058501	Green Submitted, Green Published, gold			2022-12-25	WOS:000324408400041
J	Liu, Y; Yu, FL; Huang, HY; Han, JX				Liu, Yi; Yu, Fengling; Huang, Haiyan; Han, Jinxiang			Development of Recombinant Antigen Array for Simultaneous Detection of Viral Antibodies	PLOS ONE			English	Article							PROTEIN MICROARRAY; INFECTION; ASSAY; ENCEPHALITIS; IMMUNOASSAY; VIRUSES; TYPE-1; HSV-1	Protein microarrays have been developed to study antibody reactivity against a large number of antigens, demonstrating extensive perspective for clinical application. We developed a viral antigen array by spotting four recombinant antigens and synthetic peptide, including glycoprotein G of herpes simplex virus (HSV) type 1 and 2, phosphoprotein 150 of cytomegalovirus (CMV), Rubella virus (RV) core plus glycoprotein E1 and E2 as well as a E1 peptide with the optimal concentrations on activated glass slides to simultaneously detect IgG and IgM against HSV1, HSV2, CMV and RV in clinical specimens of sera and cerebrospinal fluids (CSFs). The positive reference sera were initially used to measure the sensitivity and specificity of the array with the optimal conditions. Then clinical specimens of 144 sera and 93 CSFs were tested for IgG and IgM antibodies directed against HSV1, HSV2, CMV and RV by the antigen array. Specificity of the antigen array for viral antibodies detection was satisfying compared to commercial ELISA kits but sensitivity of the array varied relying on quality and antigenic epitopes of the spotting antigens. In short, the recombinant antigen array has potential to simultaneous detect multiple viral antibodies using minute amount (3 mu l) of samples, which holds the particularly advantage to detect viral antibodies in clinical CSFs being suspicious of neonatal meningitis and encephalitis.	[Liu, Yi] Shandong Univ, Pediat Res Inst, Qilu Childrens Hosp, Jinan 250100, Peoples R China; [Yu, Fengling] Shandong Univ, Clin Lab, Qilu Childrens Hosp, Jinan 250100, Peoples R China; [Huang, Haiyan; Han, Jinxiang] Shandong Acad Med Sci, Shandong Med Biotechnol Ctr, Minist Hlth, Key Lab Biotech Drugs, Jinan, Peoples R China	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Han, JX (corresponding author), Shandong Acad Med Sci, Shandong Med Biotechnol Ctr, Minist Hlth, Key Lab Biotech Drugs, Jinan, Peoples R China.	jinxiang.han@yahoo.com			Key Project Foundation of Shandong Province [2004GG2202150]; Natural Science Foundation of Shandong Province [Y2007C072]	Key Project Foundation of Shandong Province; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This study was funded by Key Project Foundation of Shandong Province (2004GG2202150) and Natural Science Foundation of Shandong Province (Y2007C072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardizzoni A, 2009, EUR J CLIN MICROBIOL, V28, P1067, DOI 10.1007/s10096-009-0748-y; Chen JX, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001899; Feron D, 2013, ANAL BIOCHEM, V433, P202, DOI 10.1016/j.ab.2012.10.012; Guo DD, 2006, SHANDONG MED, V46, P13; Hanson KE, 2007, J CLIN MICROBIOL, V45, P721, DOI 10.1128/JCM.01950-06; Jaaskelainen AJ, 2009, J VIROL METHODS, V160, P167, DOI 10.1016/j.jviromet.2009.05.013; James SH, 2009, ANTIVIR RES, V83, P207, DOI 10.1016/j.antiviral.2009.04.010; Kalantari-Dehaghi M, 2012, J VIROL, V86, P4328, DOI 10.1128/JVI.05194-11; Liu Brian C-S, 2012, Expert Opin Med Diagn, V6, P187, DOI 10.1517/17530059.2012.672969; [刘毅 Liu Yi], 2005, [山东大学学报. 医学版, Journal of Shandong University], V43, P473; MacBeath G, 2000, SCIENCE, V289, P1760; Maecker HT, 2012, NAT REV RHEUMATOL, V8, P317, DOI 10.1038/nrrheum.2012.66; Maters AW, 2012, DIAGN MICR INFEC DIS, V73, P273, DOI 10.1016/j.diagmicrobio.2012.03.023; Perkins D, 2007, J CELL MOL MED, V11, P581, DOI 10.1111/j.1582-4934.2007.00045.x; Scheper T, 2010, J VIROL METHODS, V166, P42, DOI 10.1016/j.jviromet.2010.02.015; Singh DD, 2012, CURR MICROBIOL, V65, P290, DOI 10.1007/s00284-012-0154-z; Steiner I, 2011, CURR OPIN NEUROL, V24, P268, DOI 10.1097/WCO.0b013e328346be6f; Tom I, 2013, CURR PROTOC PROTEIN; van der Weiden S, 2011, EARLY HUM DEV, V87, P103, DOI 10.1016/j.earlhumdev.2010.11.005; VORNHAGEN R, 1995, J CLIN MICROBIOL, V33, P1927, DOI 10.1128/JCM.33.7.1927-1930.1995; Wadia PP, 2011, METHODS MOL BIOL, V723, P81, DOI 10.1007/978-1-61779-043-0_7; Wandinger KP, 2011, J VIROL METHODS, V174, P85, DOI 10.1016/j.jviromet.2011.04.001; Wilson KM, 2006, CLIN VACCINE IMMUNOL, V13, P380, DOI 10.1128/CVI.13.3.380-386.2006; Yan H, 2010, J VIROL METHODS, V169, P351, DOI 10.1016/j.jviromet.2010.08.003; Yang J, 2008, PRAC J MED PHARM, V25, P216; Zandi K, 2007, FEMS IMMUNOL MED MIC, V50, P319, DOI 10.1111/j.1574-695X.2007.00247.x; Zhang YF, 2012, ANAL BIOCHEM, V430, P185, DOI 10.1016/j.ab.2012.08.021	27	6	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73842	10.1371/journal.pone.0073842	http://dx.doi.org/10.1371/journal.pone.0073842			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058498	Green Published, gold, Green Submitted			2022-12-25	WOS:000324408400038
J	Lutz, DA; Powell, RL; Silman, MR				Lutz, David A.; Powell, Rebecca L.; Silman, Miles R.			Four Decades of Andean Timberline Migration and Implications for Biodiversity Loss with Climate Change	PLOS ONE			English	Article							FOREST; GRADIENTS; TREELINE; REGENERATION; HOTSPOTS; IMPACTS	Rapid 21st-century climate change may lead to large population decreases and extinction in tropical montane cloud forest species in the Andes. While prior research has focused on species migrations per se, ecotones may respond to different environmental factors than species. Even if species can migrate in response to climate change, if ecotones do not they can function as hard barriers to species migrations, making ecotone migrations central to understanding species persistence under scenarios of climate change. We examined a 42-year span of aerial photographs and high resolution satellite imagery to calculate migration rates of timberline-the grassland-forest ecotone-inside and outside of protected areas in the high Peruvian Andes. We found that timberline in protected areas was more likely to migrate upward in elevation than in areas with frequent cattle grazing and fire. However, rates in both protected (0.24 m yr(-1)) and unprotected (0.05 m yr(-1)) areas are only 0.5-2.3% of the rates needed to stay in equilibrium with projected climate by 2100. These ecotone migration rates are 12.5 to 110 times slower than the observed species migration rates within the same forest, suggesting a barrier to migration for mid-and high-elevation species. We anticipate that the ecotone will be a hard barrier to migration under future climate change, leading to drastic population and biodiversity losses in the region unless intensive management steps are taken.	[Lutz, David A.; Powell, Rebecca L.; Silman, Miles R.] Wake Forest Univ, Ctr Energy Environm & Sustainabil, Winston Salem, NC 27109 USA; [Lutz, David A.; Powell, Rebecca L.; Silman, Miles R.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; [Lutz, David A.] Dartmouth Coll, Environm Studies Program, Hanover, NH 03755 USA	Wake Forest University; Wake Forest University; Dartmouth College	Lutz, DA (corresponding author), Wake Forest Univ, Ctr Energy Environm & Sustainabil, Winston Salem, NC 27109 USA.	David.A.Lutz@dartmouth.edu		Lutz, David/0000-0001-8780-7576	Gordon and Betty Moore Foundation; National Science Foundation Division of Earth Sciences	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation Division of Earth Sciences(National Science Foundation (NSF))	Funding for this research came from the Gordon and Betty Moore Foundation grant "Field Laboratory for Integrated Ecosystem Service Science in Upper Amazonian Peru" and National Science Foundation Division of Earth Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, ENVI VERS 4 7; Bader MY, 2007, ARCT ANTARCT ALP RES, V39, P353, DOI 10.1657/1523-0430(06-055)[BADER]2.0.CO;2; Berisha S, 2009, THESIS WAKE FOREST U; Brown R, 2013, THESIS U GUELEPH; Bush MB, 2004, SCIENCE, V303, P827, DOI 10.1126/science.1090795; Di Pasquale G, 2008, PALAEOGEOGR PALAEOCL, V259, P17, DOI 10.1016/j.palaeo.2006.12.016; ESRI (Environmental Systems Resource Institute), 2009, ARCMAP 9 2; Feeley KJ, 2011, J BIOGEOGR, V38, P783, DOI 10.1111/j.1365-2699.2010.02444.x; Feeley KJ, 2010, GLOBAL CHANGE BIOL, V16, P3215, DOI 10.1111/j.1365-2486.2010.02197.x; Feeley KJ, 2009, P NATL ACAD SCI USA, V106, P12382, DOI 10.1073/pnas.0900698106; Foster P, 2001, EARTH-SCI REV, V55, P73, DOI 10.1016/S0012-8252(01)00056-3; Germino MJ, 2000, PHYSIOL PLANTARUM, V110, P89, DOI 10.1034/j.1399-3054.2000.110112.x; Gibbon A, 2010, ECOSYSTEMS, V13, P1097, DOI 10.1007/s10021-010-9376-8; Hillyer R, 2010, GLOBAL CHANGE BIOL, V16, P3205, DOI 10.1111/j.1365-2486.2010.02268.x; Killeen TJ, 2008, PHILOS T R SOC B, V363, P1881, DOI 10.1098/rstb.2007.0018; Kitayama K, 2002, J ECOL, V90, P37, DOI 10.1046/j.0022-0477.2001.00634.x; Korner C, 1998, OECOLOGIA, V115, P445, DOI 10.1007/s004420050540; Laegaard S, 1992, PARAMO ANDEAN ECOSYS, P151; Maher EL, 2006, ECOSCIENCE, V13, P334, DOI 10.2980/i1195-6860-13-3-334.1; Malhi Y, 2010, GLOBAL CHANGE BIOL, V16, P3171, DOI 10.1111/j.1365-2486.2010.02323.x; Martin PH, 2007, J BIOGEOGR, V34, P1792, DOI 10.1111/j.1365-2699.2007.01726.x; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; R Core Team, 2012, R LANG ENV STAT COMP; SARMIENTO F.O., 1995, TROPICAL MONTANE CLO, P284; Sarmiento FO, 2002, MT RES DEV, V22, P278, DOI 10.1659/0276-4741(2002)022[0278:ACFTL]2.0.CO;2; Sarmiento FO, 1997, ENVIRON CONSERV, V24, P14, DOI 10.1017/S0376892997000052; Smith WK, 2009, BOT REV, V75, P163, DOI 10.1007/s12229-009-9030-3; Still CJ, 1999, NATURE, V398, P608, DOI 10.1038/19293; Tachikawa T, 2011, ASTER GLOBAL DIGITAL; Urrego DH, 2011, J QUATERNARY SCI, V26, P28, DOI 10.1002/jqs.1422; Urrutia R, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011021; Valencia BG, 2010, J BIOGEOGR, V37, P1637, DOI 10.1111/j.1365-2699.2010.02318.x; Vuille M, 2003, CLIMATIC CHANGE, V59, P75, DOI 10.1023/A:1024406427519; Young KR, 2007, PHILOS T R SOC B, V362, P263, DOI 10.1098/rstb.2006.1986; Young KR, 2006, CLIMATIC CHANGE, V78, P63, DOI 10.1007/s10584-006-9091-9; YOUNG KR, 1993, B TORREY BOT CLUB, V120, P1, DOI 10.2307/2996657; Young KR, 1998, MAN BIOSPH, V21, P595; YOUNG KR, 1993, ARCTIC ALPINE RES, V25, P167, DOI 10.2307/1551809; Zimmermann M, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003787	41	40	41	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74496	10.1371/journal.pone.0074496	http://dx.doi.org/10.1371/journal.pone.0074496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040260	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500097
J	van Schaik, CP; Damerius, L; Isler, K				van Schaik, Carel P.; Damerius, Laura; Isler, Karin			Wild Orangutan Males Plan and Communicate Their Travel Direction One Day in Advance	PLOS ONE			English	Article							MENTAL TIME-TRAVEL; FUTURE-NEEDS; CHIMPANZEES; EVOLUTION; COGNITION; ANIMALS; RECALL	The ability to plan for the future beyond immediate needs would be adaptive to many animal species, but is widely thought to be uniquely human. Although studies in captivity have shown that great apes are capable of planning for future needs, it is unknown whether and how they use this ability in the wild. Flanged male Sumatran orangutans (Pongo abelii) emit long calls, which females use to maintain earshot associations with them. We tested whether long calls serve to communicate a male's ever-changing predominant travel direction to facilitate maintaining these associations. We found that the direction in which a flanged male emits his long calls predicts his subsequent travel direction for many hours, and that a new call indicates a change in his main travel direction. Long calls given at or near the night nest indicate travel direction better than random until late afternoon on the next day. These results show that male orangutans make their travel plans well in advance and announce them to conspecifics. We suggest that such a planning ability is likely to be adaptive for great apes, as well as in other taxa.	[van Schaik, Carel P.; Damerius, Laura; Isler, Karin] Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland	University of Zurich	Isler, K (corresponding author), Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland.	kisler@aim.uzh.ch	Isler, Karin/A-9566-2008	Isler, Karin/0000-0002-2391-1523	Universitas Indonesia; Universitas Syiah Kuala; Wildlife Conservation Society (New York); L.S.B. Leakey Foundation; Wenner-Gren Foundation for Anthropological Research; Swiss National Science Foundation	Universitas Indonesia(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); Universitas Syiah Kuala; Wildlife Conservation Society (New York); L.S.B. Leakey Foundation; Wenner-Gren Foundation for Anthropological Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was supported by Universitas Indonesia and Universitas Syiah Kuala, the Wildlife Conservation Society (New York), the L.S.B. Leakey Foundation, the Wenner-Gren Foundation for Anthropological Research and the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Hanna JR, 2010, J NEUROPHYSIOL, V104, P322, DOI 10.1152/jn.00830.2009; [Anonymous], JMP VERS 9 1989 2012; BOESCH C, 1984, Primates, V25, P160, DOI 10.1007/BF02382388; Cheke LG, 2012, BIOL LETTERS, V8, P171, DOI 10.1098/rsbl.2011.0909; Clayton NS, 2003, NAT REV NEUROSCI, V4, P685, DOI 10.1038/nrn1180; Correia SPC, 2007, CURR BIOL, V17, P856, DOI 10.1016/j.cub.2007.03.063; DELGADO RA, 2003, THESIS DUKE U DURHAM; Delgado Roberto A., 2009, P215; Eichenbaum H, 2005, LEARN MOTIV, V36, P190, DOI 10.1016/j.lmot.2005.02.006; Ferkin MH, 2008, ANIM COGN, V11, P147, DOI 10.1007/s10071-007-0101-8; Fox EA, 2004, AM J PHYS ANTHROPOL, V125, P162, DOI 10.1002/ajpa.10386; Fox EA, 2002, BEHAV ECOL SOCIOBIOL, V52, P93, DOI 10.1007/s00265-002-0495-x; GALDIKAS B M F, 1983, Primates, V24, P371, DOI 10.1007/BF02381982; Hanna JB, 2008, SCIENCE, V320, P898, DOI 10.1126/science.1155504; Martin-Ordas G, 2013, CURR BIOL, V23, P1438, DOI 10.1016/j.cub.2013.06.017; Menzel Charles, 2005, P188; MITANI JC, 1985, ANIM BEHAV, V33, P272, DOI 10.1016/S0003-3472(85)80141-X; Setia TM, 2007, FOLIA PRIMATOL, V78, P215, DOI 10.1159/000102317; Mulcahy NJ, 2006, SCIENCE, V312, P1038, DOI 10.1126/science.1125456; Normand E, 2009, ANIM COGN, V12, P797, DOI 10.1007/s10071-009-0239-7; Normand E, 2009, ANIM BEHAV, V77, P1195, DOI 10.1016/j.anbehav.2009.01.025; Osvath M, 2008, ANIM COGN, V11, P661, DOI 10.1007/s10071-008-0157-0; Osvath M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036782; Osvath M, 2009, CURR BIOL, V19, pR190, DOI 10.1016/j.cub.2009.01.010; Pontzer H, 2009, P NATL ACAD SCI USA, V106, P192, DOI 10.1073/pnas.0806105106; Premack D, 2007, P NATL ACAD SCI USA, V104, P13861, DOI 10.1073/pnas.0706147104; Raby CR, 2007, NATURE, V445, P919, DOI 10.1038/nature05575; Reader SM, 2011, PHILOS T R SOC B, V366, P1017, DOI 10.1098/rstb.2010.0342; Rilling JK, 2007, P NATL ACAD SCI USA, V104, P17146, DOI 10.1073/pnas.0705132104; Roberts WA, 2012, LEARN MOTIV, V43, P169, DOI 10.1016/j.lmot.2012.05.005; Roberts WA, 2009, TRENDS COGN SCI, V13, P271, DOI 10.1016/j.tics.2009.03.003; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Rosati AG, 2007, CURR BIOL, V17, P1663, DOI 10.1016/j.cub.2007.08.033; SAS Institute Inc, 2012, JMP STAT GRAPH GUID; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Shettleworth S.J., 2009, COGNITION EVOLUTION; Singleton I, 2001, INT J PRIMATOL, V22, P877, DOI 10.1023/A:1012033919441; Spillmann B, 2010, ETHOLOGY, V116, P385, DOI 10.1111/j.1439-0310.2010.01744.x; Suddendorf T, 1997, GENET SOC GEN PSYCH, V123, P133; Suddendorf T, 2007, BEHAV BRAIN SCI, V30, P335, DOI 10.1017/S0140525X0700221X; Suddendorf T, 2009, PHILOS T R SOC B, V364, P1317, DOI 10.1098/rstb.2008.0301; Tulving E., 2005, MISSING LINK COGNITI, P3, DOI [10.1093/acprof:oso/9780195161564.003.0001, DOI 10.1093/ACPROF:OSO/9780195161564.003.0001]; Utami Atmoko Suci, 2004, P196; van Noordwijk MA, 2009, BEHAV ECOL SOCIOBIOL, V63, P883, DOI 10.1007/s00265-009-0728-3; Van Schaik C, 2004, ORANGUTANS RED APES; van Schaik CP, 1999, PRIMATES, V40, P69, DOI 10.1007/BF02557703; Wartmann FM, 2010, PRIMATES, V51, P119, DOI 10.1007/s10329-009-0186-6; Wiltschko W, 2005, J COMP PHYSIOL A, V191, P675, DOI 10.1007/s00359-005-0627-7; WINKLER LA, 1989, AM J PRIMATOL, V17, P305, DOI 10.1002/ajp.1350170405	49	31	31	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74896	10.1371/journal.pone.0074896	http://dx.doi.org/10.1371/journal.pone.0074896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040357	gold, Green Published, Green Accepted			2022-12-25	WOS:000326734500126
J	Vediyappan, G; Dumontet, V; Pelissier, F; d'Enfert, C				Vediyappan, Govindsamy; Dumontet, Vincent; Pelissier, Franck; d'Enfert, Christophe			Gymnemic Acids Inhibit Hyphal Growth and Virulence in Candida albicans	PLOS ONE			English	Article							ANTISWEET NATURAL-PRODUCTS; GERM TUBE FORMATION; SYLVESTRE R BR; ALLIANCE REGISTRY; MORPHOGENESIS; EPIDEMIOLOGY; RESISTANCE; IDENTIFICATION; PATHOGENESIS; REGULATORS	Candida albicans is an opportunistic and polymorphic fungal pathogen that causes mucosal, disseminated and invasive infections in humans. Transition from the yeast form to the hyphal form is one of the key virulence factors in C. albicans contributing to macrophage evasion, tissue invasion and biofilm formation. Nontoxic small molecules that inhibit C. albicans yeast-to-hypha conversion and hyphal growth could represent a valuable source for understanding pathogenic fungal morphogenesis, identifying drug targets and serving as templates for the development of novel antifungal agents. Here, we have identified the triterpenoid saponin family of gymnemic acids (GAs) as inhibitor of C. albicans morphogenesis. GAs were isolated and purified from Gymnema sylvestre leaves, the Ayurvedic traditional medicinal plant used to treat diabetes. Purified GAs had no effect on the growth and viability of C. albicans yeast cells but inhibited its yeast-to-hypha conversion under several hypha-inducing conditions, including the presence of serum. Moreover, GAs promoted the conversion of C. albicans hyphae into yeast cells under hypha inducing conditions. They also inhibited conidial germination and hyphal growth of Aspergillus sp. Finally, GAs inhibited the formation of invasive hyphae from C. albicans-infected Caenorhabditis elegans worms and rescued them from killing by C. albicans. Hence, GAs could be useful for various antifungal applications due to their traditional use in herbal medicine.	[Vediyappan, Govindsamy] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [Vediyappan, Govindsamy; d'Enfert, Christophe] Inst Pasteur, Unite Biol & Pathogenicite Fong, Dept Genomes & Genet, Paris, France; [Vediyappan, Govindsamy; d'Enfert, Christophe] INRA, USC2019, Paris, France; [Dumontet, Vincent; Pelissier, Franck] CNRS, Inst Chim Subst Nat, Ctr Rech Gif, Gif Sur Yvette, France	Kansas State University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Vediyappan, G (corresponding author), Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA.	gvediyap@ksu.edu		Vediyappan, Govindsamy/0000-0002-0876-9549; d'Enfert, Christophe/0000-0002-6235-3886	NIH from the KINBRE Programs [P20RR016475-10, P20GM103418-13]; Johnson Cancer Research Center, Kansas State University; EURESFUN from the European Commission [LSHM-CT-2005-518199]; Kansas State University Open Access Publishing Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103418] Funding Source: NIH RePORTER	NIH from the KINBRE Programs; Johnson Cancer Research Center, Kansas State University; EURESFUN from the European Commission; Kansas State University Open Access Publishing Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research publication was made possible by the NIH grant numbers P20RR016475-10 and P20GM103418-13 from the KINBRE Programs, and Innovative Research Award from Johnson Cancer Research Center, Kansas State University to GV. This work was supported in part by a grant (EURESFUN, LSHM-CT-2005-518199) from the European Commission to CD. GV was the recipient of a post-doctoral fellowship of the European Commission (EURESFUN, LSHM-CT-2005-518199) during the early phase of this study. Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund to GV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A. K., 2008, Infectious Disorders - Drug Targets, V8, P2; Banerjee M, 2012, EUKARYOTIC CELL; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Braun BR, 2000, GENETICS, V155, P57; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; Brown AJP, 2002, CANDIDA CANDIDIASIS; Brown DH, 1999, LICHENOLOGIST, V31, P1; Carlisle PL, 2009, P NATL ACAD SCI USA, V106, P599, DOI 10.1073/pnas.0804061106; Chauvel M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045912; Coleman JJ, 2010, ACS CHEM BIOL, V5, P321, DOI 10.1021/cb900243b; d'Enfert C, 2006, CURR DRUG TARGETS, V7, P465, DOI 10.2174/138945006776359458; Davis D, 2003, CURR GENET, V44, P58, DOI [10.1007/s00294-003-0415-2, 10.1007/s00294-003-0431-2]; Davis-Hanna A, 2008, MOL MICROBIOL, V67, P47, DOI 10.1111/j.1365-2958.2007.06013.x; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475; Ghosh S, 2009, INFECT IMMUN, V77, P1596, DOI 10.1128/IAI.01452-08; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Hall RA, 2011, EUKARYOT CELL, V10, P1034, DOI 10.1128/EC.05060-11; HOPPS HE, 1963, J IMMUNOL, V91, P416; Horn DL, 2009, CLIN INFECT DIS, V48, P1695, DOI 10.1086/599039; IMOTO T, 1991, J CHROMATOGR, V557, P383, DOI 10.1016/S0021-9673(01)87146-6; Kanetkar P, 2007, J CLIN BIOCHEM NUTR, V41, P77, DOI 10.3164/jcbn.2007010; Konjufca V, 2006, INFECT IMMUN, V74, P6785, DOI 10.1128/IAI.00851-06; Leach MJ, 2007, J ALTERN COMPLEM MED, V13, P977, DOI 10.1089/acm.2006.6387; LIU HM, 1992, CHEM PHARM BULL, V40, P1366; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Marcil A, 2002, INFECT IMMUN, V70, P6319, DOI 10.1128/IAI.70.11.6319-6329.2002; MATTIA E, 1982, J BACTERIOL, V152, P555; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Neofytos D, 2009, CLIN INFECT DIS, V48, P265, DOI 10.1086/595846; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; ODDS FC, 1985, CRC CR REV MICROBIOL, V12, P45, DOI 10.3109/10408418509104425; Oh J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001140; Palmer Glen E, 2011, Commun Integr Biol, V4, P240, DOI 10.4161/cib.4.2.14717; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2010, CRIT REV MICROBIOL, V36, P1, DOI 10.3109/10408410903241444; Porchezhian E, 2003, PHARMAZIE, V58, P5; Pukkila-Worley R, 2009, EUKARYOT CELL, V8, P1750, DOI 10.1128/EC.00163-09; Ramage G, 2009, CRIT REV MICROBIOL, V35, P340, DOI 10.3109/10408410903241436; Roman E, 2007, TRENDS MICROBIOL, V15, P181, DOI 10.1016/j.tim.2007.02.001; Shapiro RS, 2011, MICROBIOL MOL BIOL R, V75, P213, DOI 10.1128/MMBR.00045-10; Shareck J, 2011, EUKARYOT CELL, V10, P1004, DOI 10.1128/EC.05030-11; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; STANLEY VC, 1969, J PATHOL, V97, P357, DOI 10.1002/path.1710970222; STOCKLIN W, 1969, J AGR FOOD CHEM, V17, P704, DOI 10.1021/jf60164a011; TAKECHI M, 1995, PLANTA MED, V61, P76, DOI 10.1055/s-2006-958006; Tampakakis E, 2008, NAT PROTOC, V3, P1925, DOI 10.1038/nprot.2008.193; Thompson DS, 2011, EUKARYOT CELL, V10, P1173, DOI 10.1128/EC.05085-11; van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244; Whiteway M, 2007, ANNU REV MICROBIOL, V61, P529, DOI 10.1146/annurev.micro.61.080706.093341; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Xu DM, 2007, PLOS PATHOG, V3, P835, DOI 10.1371/journal.ppat.0030092; YOSHIKAWA K, 1993, CHEM PHARM BULL, V41, P1730, DOI 10.1248/cpb.41.1730; YOSHIKAWA K, 1989, TETRAHEDRON LETT, V30, P1103, DOI 10.1016/S0040-4039(01)80371-3; YOSHIKAWA K, 1992, CHEM PHARM BULL, V40, P1779, DOI 10.1248/cpb.40.1779; Zeidler U, 2009, FEMS YEAST RES, V9, P126, DOI 10.1111/j.1567-1364.2008.00459.x; Zhao XM, 2004, MICROBIOL-SGM, V150, P2415, DOI 10.1099/mic.0.26943-0	58	57	60	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74189	10.1371/journal.pone.0074189	http://dx.doi.org/10.1371/journal.pone.0074189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040201	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500077
J	Worton, LE; Ausk, BJ; Downey, LM; Bain, SD; Gardiner, EM; Srinivasan, S; Gross, TS; Kwon, RY				Worton, Leah E.; Ausk, Brandon J.; Downey, Leah M.; Bain, Steven D.; Gardiner, Edith M.; Srinivasan, Sundar; Gross, Ted S.; Kwon, Ronald Y.			Systems-Based Identification of Temporal Processing Pathways during Bone Cell Mechanotransduction	PLOS ONE			English	Article							INTERSTITIAL FLUID-FLOW; SHEAR-STRESS; GENE-EXPRESSION; RECOVERY PERIODS; REST; MECHANOSENSITIVITY; INTERMITTENT; ACTIVATION; INCREASES; FREQUENCY	Bone has long been established to be a highly mechanosensitive tissue. When subjected to mechanical loading, bone exhibits profoundly different anabolic responses depending on the temporal pattern in which the stimulus is applied. This phenomenon has been termed temporal processing, and involves complex signal amplification mechanisms that are largely unidentified. In this study, our goal was to characterize transcriptomic perturbations arising from the insertion of intermittent rest periods (a temporal variation with profound effects on bone anabolism) in osteoblastic cells subjected to fluid flow, and assess the utility of these perturbations to identify signaling pathways that are differentially activated by this temporal variation. At the level of the genome, we found that the common and differential alterations in gene expression arising from the two flow conditions were distributionally distinct, with the differential alterations characterized by many small changes in a large number of genes. Using bioinformatics analysis, we identified distinct up-and down-regulation transcriptomic signatures associated with the insertion of rest intervals, and found that the up-regulation signature was significantly associated with MAPK signaling. Confirming the involvement of the MAPK pathway, we found that the insertion of rest intervals significantly elevated flow-induced p-ERK1/2 levels by enabling a second spike in activity that was not observed in response to continuous flow. Collectively, these studies are the first to characterize distinct transcriptomic perturbations in bone cells subjected to continuous and intermittent stimulation, and directly demonstrate the utility of systems-based transcriptomic analysis to identify novel acute signaling pathways underlying temporal processing in bone cells.	[Worton, Leah E.; Ausk, Brandon J.; Downey, Leah M.; Bain, Steven D.; Gardiner, Edith M.; Srinivasan, Sundar; Gross, Ted S.; Kwon, Ronald Y.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Kwon, RY (corresponding author), Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA.	ronkwon@uw.edu			University of Washington Department of Orthopaedics and Sports Medicine; National Institutes of Health [AR056235, AR056652]; Sigvard T. Hansen, Jr. Endowed Chair; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056652, R01AR056235] Funding Source: NIH RePORTER	University of Washington Department of Orthopaedics and Sports Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sigvard T. Hansen, Jr. Endowed Chair; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors would like to acknowledge financial support from the University of Washington Department of Orthopaedics and Sports Medicine (RYK), the National Institutes of Health (SS: AR056235, TSG: AR056652), and the Sigvard T. Hansen, Jr. Endowed Chair (TSG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2005, ANN BIOMED ENG, V33, P52, DOI 10.1007/s10439-005-8962-y; Batra NN, 2005, J BIOMECH, V38, P1909, DOI 10.1016/j.jbiomech.2004.08.009; Berson RE, 2008, ADV EXP MED BIOL, V614, P189, DOI 10.1007/978-0-387-74911-2_22; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chen NX, 2000, AM J PHYSIOL-CELL PH, V278, pC989, DOI 10.1152/ajpcell.2000.278.5.C989; Dardik A, 2005, J VASC SURG, V41, P869, DOI 10.1016/j.jvs.2005.01.020; Donahue SW, 2001, AM J PHYSIOL-CELL PH, V281, pC1635, DOI 10.1152/ajpcell.2001.281.5.C1635; Donahue TLH, 2003, J BIOMECH, V36, P1363, DOI 10.1016/S0021-9290(03)00118-0; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Frolik CA, 2003, BONE, V33, P372, DOI 10.1016/S8756-3282(03)00202-3; GODDARD GV, 1969, EXP NEUROL, V25, P295, DOI 10.1016/0014-4886(69)90128-9; Handcock MS, 1998, SOCIOL METHODOL, V28, P53, DOI 10.1111/0081-1750.00042; Hanson AD, 2009, ANN BIOMED ENG, V2009, P5; HUNG CT, 1995, CLIN ORTHOP RELAT R, P256; Jacobs CR, 2013, INTRODUCTION TO CELL MECHANICS AND MECHANOBIOLOGY, P1; Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6; Kamel MA, 2010, BONE, V47, P872, DOI 10.1016/j.bone.2010.08.007; Kim DH, 2009, ANNU REV BIOMED ENG, V11, P203, DOI 10.1146/annurev-bioeng-061008-124915; Kwon RY, 2007, J BIOMECH, V40, P3162, DOI 10.1016/j.jbiomech.2007.04.003; Kwon RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033336; Kwon RY, 2010, FASEB J, V24, P2859, DOI 10.1096/fj.09-148007; Kwon RY, 2010, J BONE MINER RES, V25, P1798, DOI 10.1002/jbmr.74; Kwon RY, 2010, CELL MOL BIOENG, V3, P296, DOI 10.1007/s12195-010-0129-8; LaMothe JM, 2004, J APPL PHYSIOL, V96, P1788, DOI 10.1152/japplphysiol.01145.2003; LEY K, 1989, BLOOD, V73, P1324; Liu DW, 2008, BONE, V42, P644, DOI 10.1016/j.bone.2007.09.058; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Parikh JR, 2010, NUCLEIC ACIDS RES, V38, pW109, DOI 10.1093/nar/gkq424; Plunkett NA, 2010, TISSUE ENG PT A, V16, P943, DOI 10.1089/ten.TEA.2009.0345; POST RM, 1980, LIFE SCI, V26, P1275, DOI 10.1016/0024-3205(80)90085-5; Riehl BD, 2012, CELLS, V2012, P4; Robling AG, 2001, J EXP BIOL, V204, P3389; Samaha AN, 2008, BIOL PSYCHIAT, V64, P145, DOI 10.1016/j.biopsych.2008.01.010; Sen B, 2011, J BIOMECH, V44, P593, DOI 10.1016/j.jbiomech.2010.11.022; Shinn J.B., 2003, HEAR J, V56, P52, DOI [10.1097/01.HJ.0000292557.52409.67, DOI 10.1097/01.HJ.0000292557.52409.67]; Srinivasan S, 2003, BONE, V33, P946, DOI 10.1016/j.bone.2003.07.009; Srinivasan S, 2002, J BONE MINER RES, V17, P1613, DOI 10.1359/jbmr.2002.17.9.1613; Srinivasan S, 2007, J APPL PHYSIOL, V102, P1945, DOI 10.1152/japplphysiol.00507.2006; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugiyama T, 2008, BONE, V43, P238, DOI 10.1016/j.bone.2008.04.012; Thomas JMD, 2011, BIOTECHNOL PROGR, V27, P460, DOI 10.1002/btpr.507; Umemura Y, 2002, J APPL PHYSIOL, V93, P1345, DOI 10.1152/japplphysiol.00358.2002; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Worton LE, 2013, 2013 P ASME SUMM BIO; You LD, 2001, J BIOMECH, V34, P1375, DOI 10.1016/S0021-9290(01)00107-5; Young SRL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016026; ZENG Y, 1994, ANN BIOMED ENG, V22, P280, DOI 10.1007/BF02368235	48	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74205	10.1371/journal.pone.0074205	http://dx.doi.org/10.1371/journal.pone.0074205			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040202	Green Submitted, Green Published, gold			2022-12-25	WOS:000326734500078
J	Yan, YF; Su, SC; Meng, XR; Ji, XL; Qu, Y; Liu, ZZ; Wang, XY; Cui, YJ; Deng, ZL; Zhou, DS; Jiang, WC; Yang, RF; Han, YP				Yan, Yanfeng; Su, Shanchun; Meng, Xiangrong; Ji, Xiaolan; Qu, Yi; Liu, Zizhong; Wang, Xiaoyi; Cui, Yujun; Deng, Zhongliang; Zhou, Dongsheng; Jiang, Wencan; Yang, Ruifu; Han, Yanping			Determination of sRNA Expressions by RNA-seq in Yersinia pestis Grown In Vitro and during Infection	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; SMALL NONCODING RNAS; REGULATORY SYSTEM; ESCHERICHIA-COLI; VIBRIO-CHOLERAE; BIOVAR MICROTUS; CRP REGULON; VIRULENCE; PLAGUE; BACTERIA	Background: Small non-coding RNAs (sRNAs) facilitate host-microbe interactions. They have a central function in the post-transcriptional regulation during pathogenic lifestyles. Hfq, an RNA-binding protein that many sRNAs act in conjunction with, is required for Y. pestis pathogenesis. However, information on how Yersinia pestis modulates the expression of sRNAs during infection is largely unknown. Methodology and Principal Findings: We used RNA-seq technology to identify the sRNA candidates expressed from Y. pestis grown in vitro and in the infected lungs of mice. A total of 104 sRNAs were found, including 26 previously annotated sRNAs, by searching against the Rfam database with 78 novel sRNA candidates. Approximately 89% (93/104) of these sRNAs from Y. pestis are shared with its ancestor Y. pseudotuberculosis. Ninety-seven percent of these sRNAs (101/104) are shared among more than 80 sequenced genomes of 135 Y. pestis strains. These 78 novel sRNAs include 62 intergenic and 16 antisense sRNAs. Fourteen sRNAs were selected for verification by independent Northern blot analysis. Results showed that nine selected sRNA transcripts were Hfq-dependent. Interestingly, three novel sRNAs were identified as new members of the transcription factor CRP regulon. Semi-quantitative analysis revealed that Y. pestis from the infected lungs induced the expressions of six sRNAs including RyhB1, RyhB2, CyaR/RyeE, 6S RNA, RybB and sR039 and repressed the expressions of four sRNAs, including CsrB, CsrC, 4.5S RNA and sR027. Conclusions and Significance: This study is the first attempt to subject RNA from Y. pestis-infected samples to direct high-throughput sequencing. Many novel sRNAs were identified and the expression patterns of relevant sRNAs in Y. pestis during in vitro growth and in vivo infection were revealed. The annotated sRNAs accounted for the most abundant sRNAs either expressed in bacteria grown in vitro or differentially expressed in the infected lungs. These findings suggested these sRNAs may have important functions in Y. pestis physiology or pathogenesis.	[Yan, Yanfeng; Ji, Xiaolan; Qu, Yi; Liu, Zizhong; Wang, Xiaoyi; Cui, Yujun; Zhou, Dongsheng; Yang, Ruifu; Han, Yanping] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Su, Shanchun; Jiang, Wencan] Sichuan Agr Univ, Microbiol Lab, Yaan, Sichuan Provinc, Peoples R China; [Meng, Xiangrong] Huzhong Hispital, Clin Lab, Guangzhou, Guangdong, Peoples R China; [Deng, Zhongliang] Univ South China, Sch Publ Hlth, Dept Sanit Inspect, Hengyang, Hunan, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Sichuan Agricultural University; University of South China	Yang, RF (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	ruifuyang@gmail.com; yanpinghan@gmail.com	Yang, Ruifu/A-2273-2011	Yang, Ruifu/0000-0003-3219-7269; Su, Shanchun/0000-0001-7723-5156; Zhou, Dongsheng/0000-0003-3827-5969	National Natural Science Foundation of China [31171248, 30930001]; National Basic Research Program of China [2014CB744400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This study was funded by the National Natural Science Foundation of China (31171248 and 30930001) and by the National Basic Research Program of China (2014CB744400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebo P, 2012, RNA, V18, P530, DOI 10.1261/rna.027359.111; Arnvig KB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002342; Bai G, 2010, J BACTERIOL, V192, P4239, DOI 10.1128/JB.00504-10; Beauregard A, 2013, RNA BIOL, V10, P397, DOI 10.4161/rna.23590; Beckmann BM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq437; Bi YJ, 2009, IMMUNOLOGY, V128, pe406, DOI 10.1111/j.1365-2567.2008.02990.x; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Cleri D J, 1997, Semin Respir Infect, V12, P12; De Lay N, 2009, J BACTERIOL, V191, P461, DOI 10.1128/JB.01157-08; Deng ZL, 2012, RES MICROBIOL, V163, P413, DOI 10.1016/j.resmic.2012.05.006; Faucher SP, 2010, P NATL ACAD SCI USA, V107, P7533, DOI 10.1073/pnas.0911764107; Gao H, 2008, J BACTERIOL, V190, P3063, DOI 10.1128/JB.01910-07; Geng J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006213; Gripenland J, 2010, NAT REV MICROBIOL, V8, P857, DOI 10.1038/nrmicro2457; Han Y, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-96; Heroven AK, 2008, MOL MICROBIOL, V68, P1179, DOI 10.1111/j.1365-2958.2008.06218.x; Heroven AK, 2012, RNA BIOL, V9, P379, DOI 10.4161/rna.19333; Johansen J, 2008, J MOL BIOL, V383, P1, DOI 10.1016/j.jmb.2008.06.058; Koo JT, 2011, P NATL ACAD SCI USA, V108, pE709, DOI 10.1073/pnas.1101655108; Kroger C, 2012, P NATL ACAD SCI USA; Lathem WW, 2005, P NATL ACAD SCI USA, V102, P17786, DOI 10.1073/pnas.0506840102; Lenz DH, 2005, MOL MICROBIOL, V58, P1186, DOI 10.1111/j.1365-2958.2005.04902.x; Liu HH, 2009, J BASIC MICROB, V49, P92, DOI 10.1002/jobm.200800027; Liu JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp080; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2003, CURR OPIN MICROBIOL, V6, P120, DOI 10.1016/S1369-5274(03)00027-4; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mraheil MA, 2011, NUCLEIC ACIDS RES, V39, P4235, DOI 10.1093/nar/gkr033; Okan NA, 2010, INFECT IMMUN, V78, P1284, DOI 10.1128/IAI.00976-09; Ortega AD, 2012, RNA BIOL, V9, P469, DOI 10.4161/rna.19317; Papenfort K, 2008, MOL MICROBIOL, V68, P890, DOI 10.1111/j.1365-2958.2008.06189.x; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Qu Y, 2012, FUTURE MICROBIOL, V7, P535, DOI [10.2217/FMB.12.13, 10.2217/fmb.12.13]; Repoila F, 2009, BIOL CELL, V101, P117, DOI 10.1042/BC20070137; STRALEY SC, 1986, INFECT IMMUN, V51, P445, DOI 10.1128/IAI.51.2.445-454.1986; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Trevino J, 2010, MICROBIOL-SGM, V156, P1342, DOI 10.1099/mic.0.036558-0; Trotochaud AE, 2004, J BACTERIOL, V186, P4978, DOI 10.1128/JB.186.15.4978-4985.2004; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Weilbacher T, 2003, MOL MICROBIOL, V48, P657, DOI 10.1046/j.1365-2958.2003.03459.x; Weissenmayer BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017570; Yi Q, 2012, FUTURE MICROBIOL, V7, P535, DOI [10.2217/fmb.12.13, DOI 10.2217/FMB.12.13.PUBMED:22439729]; Zhan LJ, 2008, INFECT IMMUN, V76, P5028, DOI 10.1128/IAI.00370-08; Zheng DL, 2004, NUCLEIC ACIDS RES, V32, P5874, DOI 10.1093/nar/gkh908; Zhou DS, 2006, FEMS MICROBIOL LETT, V258, P9, DOI 10.1111/j.1574-6968.2006.00208.x; Zhou DS, 2005, FEMS MICROBIOL LETT, V250, P85, DOI 10.1016/j.femsle.2005.06.053; Zhou DS, 2004, J BACTERIOL, V186, P5138, DOI [10.1128/JB.186.15.5138-5146.2004, 10.1128/jb.186.15.5138-5146.2004]; Zhou DS, 2004, J BACTERIOL, V186, P5147, DOI 10.1128/jb.186.15.5147-5152.2004	49	49	53	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74495	10.1371/journal.pone.0074495	http://dx.doi.org/10.1371/journal.pone.0074495			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040259	Green Submitted, gold, Green Published			2022-12-25	WOS:000326734500096
J	Metaxakis, A; Partridge, L				Metaxakis, Athanasios; Partridge, Linda			Dietary Restriction Extends Lifespan in Wild-Derived Populations of Drosophila melanogaster	PLOS ONE			English	Article							CALORIC RESTRICTION; NUTRITION; HISTORY	Dietary restriction (DR) can result in lifespan-extension and improved function and health during ageing. Although the impact of DR on lifespan and health has been established in a variety of organisms, most DR experiments are carried out on laboratory strains that have often undergone adaptation to laboratory conditions. The effect of DR on animals recently derived from wild populations is rarely assessed. We measured the DR response of four populations of Drosophila melanogaster within two generations of collection from the wild. All populations responded to DR with an increase in lifespan and a decrease in female fecundity, similarly to a control, laboratory-adapted strain. These effects of DR are thus not a result of adaptation to laboratory conditions, and reflect the characteristics of natural populations.	[Metaxakis, Athanasios; Partridge, Linda] Max Planck Inst Biol Ageing, Cologne, Germany; [Metaxakis, Athanasios; Partridge, Linda] UCL, Inst Healthy Ageing, London, England; [Metaxakis, Athanasios; Partridge, Linda] UCL, Dept Genet Evolut & Environm, London, England	Max Planck Society; University of London; University College London; University of London; University College London	Partridge, L (corresponding author), Max Planck Inst Biol Ageing, Cologne, Germany.	Partridge@age.mpg.de	Partridge, Linda/E-7342-2015	Partridge, Linda/0000-0001-9615-0094	Max Planck grant	Max Planck grant	Max Planck grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass TM, 2007, J GERONTOL A-BIOL, V62, P1071, DOI 10.1093/gerona/62.10.1071; Chapman T, 1996, P ROY SOC B-BIOL SCI, V263, P755, DOI 10.1098/rspb.1996.0113; CHAPMAN T, 1994, J EVOLUTION BIOL, V7, P51, DOI 10.1046/j.1420-9101.1994.7010051.x; CHIPPINDALE AK, 1993, J EVOLUTION BIOL, V6, P171, DOI 10.1046/j.1420-9101.1993.6020171.x; Clancy David J., 2001, Drosophila Information Service, V84, P168; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Grandison RC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004067; Harper JM, 2006, AGING CELL, V5, P441, DOI 10.1111/j.1474-9726.2006.00236.x; Jiang JC, 2000, FASEB J, V14, P2135; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Liao CY, 2010, AGING CELL, V9, P92, DOI 10.1111/j.1474-9726.2009.00533.x; Linnen C, 2001, EVOL ECOL RES, V3, P877; Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Partridge L, 2011, AGING CELL, V10, P5, DOI 10.1111/j.1474-9726.2010.00649.x; Sgro CM, 2001, AM NAT, V158, P657, DOI 10.1086/323592; Sutphin GL, 2008, EXP GERONTOL, V43, P130, DOI 10.1016/j.exger.2007.10.019; Tatar M, 2011, EXP GERONTOL, V46, P363, DOI 10.1016/j.exger.2010.12.002; Weindruch R., 1988, RETARDATION AGING DI; Wong R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006063	24	22	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74681	10.1371/journal.pone.0074681	http://dx.doi.org/10.1371/journal.pone.0074681			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040317	Green Published, Green Submitted, gold			2022-12-25	WOS:000327538600107
J	Sutherland, JS; Lalor, MK; Black, GF; Ambrose, LR; Loxton, AG; Chegou, NN; Kassa, D; Mihret, A; Howe, R; Mayanja-Kizza, H; Gomez, MP; Donkor, S; Franken, K; Hanekom, W; Klein, MR; Parida, SK; Boom, WH; Thiel, BA; Crampin, AC; Ota, M; Walzl, G; Ottenhoff, THM; Dockrell, HM; Kaufmann, SHE				Sutherland, Jayne S.; Lalor, Maeve K.; Black, Gillian F.; Ambrose, Lyn R.; Loxton, Andre G.; Chegou, Novel N.; Kassa, Desta; Mihret, Adane; Howe, Rawleigh; Mayanja-Kizza, Harriet; Gomez, Marie P.; Donkor, Simon; Franken, Kees; Hanekom, Willem; Klein, Michel R.; Parida, Shreemanta K.; Boom, W. Henry; Thiel, Bonnie A.; Crampin, Amelia C.; Ota, Martin; Walzl, Gerhard; Ottenhoff, Tom H. M.; Dockrell, Hazel M.; Kaufmann, Stefan H. E.		GCGH Biomarkers TB Consortium	Analysis of Host Responses to Mycobacterium tuberculosis Antigens in a Multi-Site Study of Subjects with Different TB and HIV Infection States in Sub-Saharan Africa	PLOS ONE			English	Article							INTERFERON-GAMMA; REGULON; CELLS; VACCINATION; DORMANCY; DISEASE	Background: Tuberculosis (TB) remains a global health threat with 9 million new cases and 1.4 million deaths per year. In order to develop a protective vaccine, we need to define the antigens expressed by Mycobacterium tuberculosis (Mtb), which are relevant to protective immunity in high-endemic areas. Methods: We analysed responses to 23 Mtb antigens in a total of 1247 subjects with different HIV and TB status across 5 geographically diverse sites in Africa (South Africa, The Gambia, Ethiopia, Malawi and Uganda). We used a 7-day whole blood assay followed by IFN-gamma ELISA on the supernatants. Antigens included PPD, ESAT-6 and Ag85B (dominant antigens) together with novel resuscitation-promoting factors (rpf), reactivation proteins, latency (Mtb DosR regulon-encoded) antigens, starvation-induced antigens and secreted antigens. Results: There was variation between sites in responses to the antigens, presumably due to underlying genetic and environmental differences. When results from all sites were combined, HIV- subjects with active TB showed significantly lower responses compared to both TST- and TST+ contacts to latency antigens (Rv0569, Rv1733, Rv1735, Rv1737) and the rpf Rv0867; whilst responses to ESAT-6/CFP-10 fusion protein (EC), PPD, Rv2029, TB10.3, and TB10.4 were significantly higher in TST+ contacts (LTBI) compared to TB and TST- contacts fewer differences were seen in subjects with HIV co-infection, with responses to the mitogen PHA significantly lower in subjects with active TB compared to those with LTBI and no difference with any antigen. Conclusions: Our multi-site study design for testing novel Mtb antigens revealed promising antigens for future vaccine development. The IFN-gamma ELISA is a cheap and useful tool for screening potential antigenicity in subjects with different ethnic backgrounds and across a spectrum of TB and HIV infection states. Analysis of cytokines other than IFN-gamma is currently on-going to determine correlates of protection, which may be useful for vaccine efficacy trials.	[Sutherland, Jayne S.; Gomez, Marie P.; Donkor, Simon; Ota, Martin] MRC Unit, Fajara, Gambia; [Lalor, Maeve K.; Crampin, Amelia C.; Dockrell, Hazel M.] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England; [Black, Gillian F.; Loxton, Andre G.; Chegou, Novel N.; Walzl, Gerhard] Univ Stellenbosch, Fac Med & Hlth Sci, Dept Biomed Sci, ZA-7505 Tygerberg, South Africa; [Ambrose, Lyn R.; Crampin, Amelia C.] Karonga Prevent Study, Chilumba, Malawi; [Kassa, Desta] Ethiopian Hlth & Nutr Res Inst, Infect & Noninfect Dis Res Directorate, Addis Ababa, Ethiopia; [Mihret, Adane; Howe, Rawleigh] Armauer Hansen Res Inst, Immunol Unit, Addis Ababa, Ethiopia; [Mayanja-Kizza, Harriet] Makerere Univ, Dept Med, Kampala, Uganda; [Franken, Kees; Klein, Michel R.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [Hanekom, Willem] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Parida, Shreemanta K.; Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Boom, W. Henry; Thiel, Bonnie A.] Case Western Reserve Univ, Cleveland, OH 44106 USA	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Stellenbosch University; Malawi Epidemiology and Intervention Research Unit; Ethiopian Health & Nutrition Research Institute; Makerere University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Cape Town; Max Planck Society; Case Western Reserve University	Sutherland, JS (corresponding author), MRC Unit, Fajara, Gambia.	jsutherland@mrc.gm	Joosten, Simone A/F-1357-2011; Franken, Kees/ABA-7095-2021; van der Spuy, Gian/AAY-7701-2020; Mayanja-Kizza, Harriet/AAM-5372-2020; Joosten, Simone/E-4731-2011; Kaufmann, Stefan HE/I-5454-2014; Walzl, Gerhard/N-6371-2016	Joosten, Simone A/0000-0002-9878-0863; Franken, Kees/0000-0002-4747-6060; van der Spuy, Gian/0000-0002-9067-5903; Mayanja-Kizza, Harriet/0000-0002-9297-6208; Joloba, Moses/0000-0002-0334-9983; Loxton, Andre/0000-0003-0659-9803; Girma, Selfu/0000-0002-1866-0950; Kaufmann, Stefan HE/0000-0001-9866-8268; Parida, Shreemanta K/0000-0003-2129-6691; Hanekom, Willem/0000-0003-3070-6154; Mihret, Adane/0000-0003-3183-4772; Gebremicael, Gebremedhin/0000-0001-6726-9600; Black, Gillian/0000-0002-5081-274X; Jacobsen, Marc/0000-0002-4703-5652; Togun, Toyin/0000-0002-8477-4462; Dockrell, Hazel/0000-0003-1869-9107; du Plessis, Nelita/0000-0001-7881-925X; Walzl, Gerhard/0000-0003-2487-125X; Chegou, Novel N/0000-0002-8690-1699; Kagina, Benjamin/0000-0003-4943-9762; Sutherland, Jayne/0000-0002-7083-4997; Crampin, Amelia/0000-0002-1513-4330	Bill and Melinda Gates Foundation: Grand Challenges in Global Health [37772]; MRC [MC_U190081991, MC_UP_A900_1122, MC_U190071468, MC_U190074190] Funding Source: UKRI; Medical Research Council [MC_U190071468, MC_U190074190, MC_UP_A900_1122, MC_U190081991] Funding Source: researchfish	Bill and Melinda Gates Foundation: Grand Challenges in Global Health(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded through the Bill and Melinda Gates Foundation: Grand Challenges in Global Health grant no. 37772. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BMGF website: http://www.gatesfoundation.org. GCGH website: http://www.biomarkers-for-tb.net	Arlehamn CSL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003130; Black GF, 2001, INT J TUBERC LUNG D, V5, P664; Black GF, 2009, CLIN VACCINE IMMUNOL, V16, P1203, DOI 10.1128/CVI.00111-09; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Chegou NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038501; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Commandeur S, 2013, J IMMUNOL, V190, P1659, DOI 10.4049/jimmunol.1201593; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259; Goldsack L, 2007, TUBERCULOSIS, V87, P465, DOI 10.1016/j.tube.2007.07.001; Inokuchi N, 2003, DIAGN MICR INFEC DIS, V46, P109, DOI 10.1016/S0732-8893(03)00018-X; Leistikow RL, 2010, J BACTERIOL, V192, P1662, DOI 10.1128/JB.00926-09; Leyten EMS, 2006, MICROBES INFECT, V8, P2052, DOI 10.1016/j.micinf.2006.03.018; Macdonald SHF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038488; Odutola AA, 2012, VACCINE, V30, P5591, DOI 10.1016/j.vaccine.2012.06.054; Ottenhoff THM, 2012, TRENDS MICROBIOL, V20, P419, DOI 10.1016/j.tim.2012.06.002; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Ottenhoff THM, 2012, TUBERCULOSIS, V92, pS17, DOI 10.1016/S1472-9792(12)70007-0; Phong WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056037; Santema W, 2013, INFECT IMMUN, V81, P1990, DOI 10.1128/IAI.01121-12; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	23	43	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74080	10.1371/journal.pone.0074080	http://dx.doi.org/10.1371/journal.pone.0074080			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040170	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000327538600068
J	Hazeki, K; Uehara, M; Nigorikawa, K; Hazeki, O				Hazeki, Kaoru; Uehara, Masami; Nigorikawa, Kiyomi; Hazeki, Osamu			PIKfyve Regulates the Endosomal Localization of CpG Oligodeoxynucleotides to Elicit TLR9-Dependent Cellular Responses	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-9; DENDRITIC CELLS; NUCLEIC-ACID; ACTIVATION; DNA; INDUCTION; PATHWAYS; TOLL-LIKE-RECEPTOR-4; INHIBITOR; TRANSPORT	TLR9 is a receptor for oligodeoxynucleotides that contain unmethylated CpG motifs (CpG). Because TLR9 resides in the endoplasmic reticulum during the quiescence state, CpG binding to TLR9 requires membrane trafficking, which includes the maturation of the CpG-containing endosome. In the present study, we examined the role of PIKfyve, a phosphatidylinositol 3-phosphate 5-kinase, in the regulation of TLR9 signaling. The PIKfyve inhibitor YM201636 inhibited co-localization of the CpG-containing endosome with LysoTracker, which stains acidic organelle, and with TLR9. YM201636 increased the co-localization of CpG with the early endosome marker EEA1 but decreased co-localization with the late endosome marker LAMP1. Similar results were obtained in Raw264.7 cells containing shRNA that targets PIKfyve. CpG-mediated phosphorylation but not lipopolysaccharide (LPS)-mediated phosphorylation of IKK, p38 MAPK, JNK and Stat3 was severely impaired by the loss of PIKfyve function. CpG-mediated expression of cytokine mRNA was also decreased in the absence of PIKfyve. These findings demonstrate a novel role of PIKfyve in TLR9 signaling.	[Hazeki, Kaoru; Uehara, Masami; Nigorikawa, Kiyomi; Hazeki, Osamu] Hiroshima Univ, Grad Sch Biomed Sci, Div Mol Med Sci, Hiroshima, Japan	Hiroshima University	Hazeki, K (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Div Mol Med Sci, Hiroshima, Japan.	khazeki@hiroshima-u.ac.jp			Japan Society for the Promotion of Science [23590078, 22590065]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid (Kakenhi) [grant numbers 23590078 (to OH) and 22590065 (to KH)] from the Japan Society for the Promotion of Science. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAIN CC, 1988, J CELL BIOL, V106, P269, DOI 10.1083/jcb.106.2.269; de Lartigue J, 2009, TRAFFIC, V10, P883, DOI 10.1111/j.1600-0854.2009.00915.x; Fukui R, 2009, J EXP MED, V206, P1339, DOI 10.1084/jem.20082316; Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401; Ho CY, 2012, TRAFFIC, V13, P1, DOI 10.1111/j.1600-0854.2011.01246.x; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Ikonomov OC, 2011, J BIOL CHEM, V286, P13404, DOI 10.1074/jbc.M111.222364; Ikonomov OC, 2009, BIOCHEM BIOPH RES CO, V382, P566, DOI 10.1016/j.bbrc.2009.03.063; Ishii KJ, 2002, J EXP MED, V196, P269, DOI 10.1084/jem.20020773; Jang CH, 2006, RHEUMATOLOGY, V45, P703, DOI 10.1093/rheumatology/kei282; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kerkmann M, 2005, J BIOL CHEM, V280, P8086, DOI 10.1074/jbc.M410868200; Kerr MC, 2010, EMBO J, V29, P1331, DOI 10.1038/emboj.2010.28; Kubo H, 2005, BIOCHEM J, V392, P607, DOI 10.1042/BJ20050671; Kuo CC, 2006, J IMMUNOL, V176, P5943, DOI 10.4049/jimmunol.176.10.5943; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Leifer CA, 2006, J BIOL CHEM, V281, P35585, DOI 10.1074/jbc.M607511200; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Mayinger P, 2012, BBA-MOL CELL BIOL L, V1821, P1104, DOI 10.1016/j.bbalip.2012.01.002; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Shisheva A, 2008, CELL BIOL INT, V32, P591, DOI 10.1016/j.cellbi.2008.01.006; Takeshita F, 2004, SEMIN IMMUNOL, V16, P17, DOI 10.1016/j.smim.2003.10.009; Tamura N, 2009, BIOCHEM J, V423, P99, DOI 10.1042/BJ20090687; Wu JY, 2012, J BIOL CHEM, V287, P4323, DOI 10.1074/jbc.M111.295113	31	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73894	10.1371/journal.pone.0073894	http://dx.doi.org/10.1371/journal.pone.0073894			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040108	Green Submitted, Green Published, gold			2022-12-25	WOS:000326405300139
J	Rossignol, M; Fisch, SA; Maurage, P; Joassin, F; Philippot, P				Rossignol, Mandy; Fisch, Sophie-Alexandra; Maurage, Pierre; Joassin, Frederic; Philippot, Pierre			Reduced Processing of Facial and Postural Cues in Social Anxiety: Insights from Electrophysiology	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; ANGRY FACES; SELECTIVE ATTENTION; NEGATIVE EVALUATION; THREATENING FACES; EMOTIONAL FACES; NEURAL SYSTEMS; EYE-TRACKING; GAIN-CONTROL; TIME-COURSE	Social anxiety is characterized by fear of evaluative interpersonal situations. Many studies have investigated the perception of emotional faces in socially anxious individuals and have reported biases in the processing of threatening faces. However, faces are not the only stimuli carrying an interpersonal evaluative load. The present study investigated the processing of emotional body postures in social anxiety. Participants with high and low social anxiety completed an attention-shifting paradigm using neutral, angry and happy faces and postures as cues. We investigated early visual processes through the P100 component, attentional fixation on the P2, structural encoding mirrored by the N170, and attentional orientation towards stimuli to detect with the P100 locked on target occurrence. Results showed a global reduction of P100 and P200 responses to faces and postures in socially anxious participants as compared to non-anxious participants, with a direct correlation between self-reported social anxiety levels and P100 and P200 amplitudes. Structural encoding of cues and target processing were not modulated by social anxiety, but socially anxious participants were slower to detect the targets. These results suggest a reduced processing of social postural and facial cues in social anxiety.	[Rossignol, Mandy; Fisch, Sophie-Alexandra; Maurage, Pierre; Joassin, Frederic; Philippot, Pierre] Catholic Univ Louvain, Inst Rech Psychol, B-1348 Louvain, Belgium	Universite Catholique Louvain	Rossignol, M (corresponding author), Catholic Univ Louvain, Inst Rech Psychol, B-1348 Louvain, Belgium.	mandy.rossignol@uclouvain.be	rossignol, mandy/I-7969-2016	rossignol, mandy/0000-0001-8606-7836; Maurage, Pierre/0000-0003-0197-0810	National Fund for Scientific Research (Belgium)	National Fund for Scientific Research (Belgium)(Fonds de la Recherche Scientifique - FNRS)	MR and PM are supported by grants from the National Fund for Scientific Research (Belgium). No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Amir N, 1998, J ABNORM PSYCHOL, V107, P285, DOI 10.1037/0021-843X.107.2.285; Ashley V, 2004, NEUROREPORT, V15, P211, DOI 10.1097/00001756-200401190-00041; Ball TM, 2012, NEUROIMAGE, V59, P1879, DOI 10.1016/j.neuroimage.2011.08.074; Bannerman RL, 2009, P ROY SOC B-BIOL SCI, V276, P1635, DOI 10.1098/rspb.2008.1744; Bar-Haim Y, 2005, BRAIN COGNITION, V59, P11, DOI 10.1016/j.bandc.2005.03.005; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; BERTRAND O, 1985, ELECTROEN CLIN NEURO, V62, P462, DOI 10.1016/0168-5597(85)90058-9; Blau VC, 2007, BEHAV BRAIN FUNCT, V3; Boraston Z, 2007, J PHYSIOL-LONDON, V581, P893, DOI 10.1113/jphysiol.2007.133587; Buckner JD, 2010, COGNITIVE THER RES, V34, P99, DOI 10.1007/s10608-008-9205-y; Campanella S, 2006, NEUROPHYSIOL CLIN, V36, P71, DOI 10.1016/j.neucli.2006.04.005; Chen YP, 2002, BEHAV RES THER, V40, P677, DOI 10.1016/S0005-7967(01)00086-9; Clark D. M., 1995, SOCIAL PHOBIA DIAGNO, P69, DOI DOI 10.1017/S1352465808004487; Coles ME, 2001, DEPRESS ANXIETY, V14, P145, DOI 10.1002/da.1057; Coles ME, 2008, COGNITION EMOTION, V22, P1159, DOI 10.1080/02699930701685919; Dawson G, 2005, DEV NEUROPSYCHOL, V27, P403, DOI 10.1207/s15326942dn2703_6; de Gelder B, 2009, PHILOS T R SOC B, V364, P3475, DOI 10.1098/rstb.2009.0190; Eimer M, 2000, NEUROREPORT, V11, P2319, DOI 10.1097/00001756-200007140-00050; Eldar S, 2010, BIOL PSYCHOL, V85, P252, DOI 10.1016/j.biopsycho.2010.07.010; Garner M, 2006, J ABNORM PSYCHOL, V115, P760, DOI 10.1037/0021-843X.115.4.760; Heeren A, 2012, CAN J BEHAV SCI, V44, P99, DOI 10.1037/a0026249; Hietanen JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024408; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Holmes A, 2008, BIOL PSYCHOL, V77, P159, DOI 10.1016/j.biopsycho.2007.10.003; Holmes A, 2009, COGN AFFECT BEHAV NE, V9, P323, DOI 10.3758/CABN.9.3.323; Horley K, 2004, PSYCHIAT RES, V127, P43, DOI 10.1016/j.psychres.2004.02.016; Huppert J. D., 2004, COGNITION EMOTION PS, P213, DOI [DOI 10.1017/CBO9780511521263.012, 10.1017/CBO9780511521263.012]; Kadosh KC, 2010, J COGNITIVE NEUROSCI, V22, P903, DOI 10.1162/jocn.2009.21224; Kolassa IT, 2007, COGNITION EMOTION, V21, P1721, DOI 10.1080/02699930701229189; Kolassa IT, 2006, BRAIN RES, V1118, P130, DOI 10.1016/j.brainres.2006.08.019; Kolassa IT, 2009, COGNITION EMOTION, V23, P69, DOI 10.1080/02699930801940461; Krombholz A, 2007, BIOL PSYCHOL, V76, P156, DOI 10.1016/j.biopsycho.2007.07.004; Leary MR., 1995, SOCIAL ANXIETY; Liebowitz M R, 1987, Mod Probl Pharmacopsychiatry, V22, P141; Luck SJ, 1996, J EXP PSYCHOL HUMAN, V22, P725, DOI 10.1037/0096-1523.22.3.725; Mansell W, 1999, COGNITION EMOTION, V13, P673, DOI 10.1080/026999399379032; Maurage P, 2009, ALCOHOL ALCOHOLISM, V44, P476, DOI 10.1093/alcalc/agp037; McTeague LM, 2011, NEUROIMAGE, V54, P1615, DOI 10.1016/j.neuroimage.2010.08.080; Mercado F, 2006, J ANXIETY DISORD, V20, P72, DOI 10.1016/j.janxdis.2004.10.003; Mogg K, 2004, J ABNORM PSYCHOL, V113, P160, DOI 10.1037/0021-843X.113.1.160; Mogg K, 2002, BEHAV RES THER, V40, P1403, DOI 10.1016/S0005-7967(02)00017-7; Moriya J, 2011, J BEHAV THER EXP PSY, V42, P122, DOI 10.1016/j.jbtep.2010.08.001; Moser JS, 2008, BIOL PSYCHOL, V78, P93, DOI 10.1016/j.biopsycho.2008.01.005; Muhlberger A, 2008, CYBERPSYCHOL BEHAV, V11, P425, DOI 10.1089/cpb.2007.0084; Muhlberger A, 2009, J NEURAL TRANSM, V116, P735, DOI 10.1007/s00702-008-0108-6; Mueller EM, 2009, PSYCHOL MED, V39, P1141, DOI 10.1017/S0033291708004820; Mullins DT, 2004, J NONVERBAL BEHAV, V28, P3; Perchet C, 2001, BIOL PSYCHIAT, V50, P44, DOI 10.1016/S0006-3223(00)01119-7; Peschard V, 2013, BIOL PSYCHOL, V93, P88, DOI 10.1016/j.biopsycho.2013.01.009; Pichon S, 2009, NEUROIMAGE, V47, P1873, DOI 10.1016/j.neuroimage.2009.03.084; Pichon S, 2008, SOC NEUROSCI-UK, V3, P199, DOI 10.1080/17470910701394368; Pourtois G, 2004, CEREB CORTEX, V14, P619, DOI 10.1093/cercor/bhh023; Pourtois G, 2005, NEUROIMAGE, V26, P149, DOI 10.1016/j.neuroimage.2005.01.015; Pourtois G, 2006, NEUROIMAGE, V31, P920, DOI 10.1016/j.neuroimage.2005.12.034; Rapee RM, 1997, BEHAV RES THER, V35, P741, DOI 10.1016/S0005-7967(97)00022-3; Rossignol M, 2005, NEUROSCI LETT, V377, P115, DOI 10.1016/j.neulet.2004.11.091; Rossignol M, 2013, BRAIN COGNITION, V82, P344, DOI 10.1016/j.bandc.2013.05.008; Rossignol M, 2012, NEUROSCI LETT, V526, P68, DOI 10.1016/j.neulet.2012.07.045; Rossignol M, 2012, BRAIN RES, V1460, P50, DOI 10.1016/j.brainres.2012.04.034; Roth DA, 2001, PSYCHIAT CLIN N AM, V24, P753, DOI 10.1016/S0193-953X(05)70261-6; Santesso DL, 2008, NEUROPSYCHOLOGIA, V46, P1338, DOI 10.1016/j.neuropsychologia.2007.12.013; Schofield CA, 2012, COGNITION EMOTION, V26, P300, DOI 10.1080/02699931.2011.602050; Schupp HT, 2004, EMOTION, V4, P189, DOI 10.1037/1528-3542.4.2.189; Schupp HT, 2003, NEUROREPORT, V14, P1107, DOI 10.1097/00001756-200306110-00002; Schutter DJLG, 2004, INT J PSYCHOPHYSIOL, V53, P29, DOI 10.1016/j.ijpsycho.2004.01.003; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Spector IP, 2003, J ANXIETY DISORD, V17, P517, DOI 10.1016/S0887-6185(02)00232-3; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Staugaard SR, 2010, CLIN PSYCHOL REV, V30, P669, DOI 10.1016/j.cpr.2010.05.001; Stekelenburg JJ, 2004, NEUROREPORT, V15, P777, DOI 10.1097/00001756-200404090-00007; Straube T, 2005, NEUROPSYCHOBIOLOGY, V52, P163, DOI 10.1159/000087987; Streit M, 1999, COGNITIVE BRAIN RES, V7, P481, DOI 10.1016/S0926-6410(98)00048-2; Thierry G, 2006, NEUROIMAGE, V32, P871, DOI 10.1016/j.neuroimage.2006.03.060; TROWER P, 1989, CLIN PSYCHOL REV, V9, P19, DOI 10.1016/0272-7358(89)90044-5; Valentiner DP, 2011, BEHAV COGN PSYCHOTH, V39, P601, DOI 10.1017/S1352465811000300; van Peer JM, 2010, PSYCHONEUROENDOCRINO, V35, P21, DOI 10.1016/j.psyneuen.2009.09.012; Vassilopoulos SP, 2005, BEHAV COGN PSYCHOTH, V33, P13, DOI 10.1017/S1352465804001730; WATSON D, 1969, J CONSULT CLIN PSYCH, V33, P448, DOI 10.1037/h0027806; Wieser MJ, 2010, PSYCHOPHYSIOLOGY, V47, P271, DOI 10.1111/j.1469-8986.2009.00938.x; Wieser MJ, 2009, J NEURAL TRANSM, V116, P717, DOI 10.1007/s00702-008-0101-0; Wieser MJ, 2009, J ANXIETY DISORD, V23, P93, DOI 10.1016/j.janxdis.2008.04.004	84	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e75234	10.1371/journal.pone.0075234	http://dx.doi.org/10.1371/journal.pone.0075234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	244QV	24040403	gold, Green Published, Green Submitted			2022-12-25	WOS:000326405300201
J	Nakiyingi, L; Bwanika, JM; Kirenga, B; Nakanjako, D; Katabira, C; Lubega, G; Sempa, J; Nyesiga, B; Albert, H; Manabe, YC				Nakiyingi, Lydia; Bwanika, John Mark; Kirenga, Bruce; Nakanjako, Damalie; Katabira, Catherine; Lubega, Gloria; Sempa, Joseph; Nyesiga, Barnabas; Albert, Heidi; Manabe, Yukari C.			Clinical Predictors and Accuracy of Empiric Tuberculosis Treatment among Sputum Smear-Negative HIV-Infected Adult TB Suspects in Uganda	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PULMONARY TUBERCULOSIS; DIAGNOSTIC-ACCURACY; PREVALENCE; MORTALITY; IMPACT; COUNTRIES; SETTINGS; OUTCOMES; THERAPY	Introduction: The existing diagnostic algorithms for sputum smear-negative tuberculosis (TB) are complicated, time-consuming, and often difficult to implement. The decision to initiate TB treatment in resource-limited countries is often largely based on clinical predictors. We sought to determine the clinical predictors and accuracy of empiric TB treatment initiation in HIV-infected sputum smear-negative TB suspects using sputum culture as a reference standard. Setting: Out-patient HIV-TB integrated urban clinic in Kampala, Uganda. Methods: HIV-infected TB suspects were screened using sputum smear microscopy, and mycobacterial sputum liquid and solid cultures were performed. Smear results were made available to the clinician who made a clinical decision on empiric TB treatment initiation for sputum smear-negative patients. Clinic records were reviewed for patients whose sputum smears were negative to collect data on socio-demographics, TB symptomatology, chest X-ray findings, CD4 cell counts and TB treatment initiation. Results: Of 253 smear-negative TB suspects, 56% (142/253) were females, median age 38 IQR (31-44) years, with a median CD4 cell count of 291 IQR (150-482) cells/mm(3). Of the 85 (33.6%) smear-negative patients empirically initiated on TB treatment, 35.3% (n = 30) were sputum culture positive compared to only 18 (10.7%) of the 168 untreated patients (p < 0.001). Abnormal chest X-ray [aOR 10.18, 95% CI (3.14-33.00), p < 0.001] and advanced HIV clinical stage [aOR 3.92, 95% CI (1.20-12.85), p = 0.024] were significantly associated with empiric TB treatment initiation. The sensitivity and specificity of empiric TB treatment initiation in the diagnosis of TB in HIV-infected patients after negative smear microscopy was 62.5% and 73.7% respectively. Conclusion: In resource-limited settings, clinically advanced HIV and abnormal chest X-ray significantly predict a clinical decision to empirically initiate TB treatment in smear-negative HIV-infected patients. Empiric TB treatment initiation correlates poorly with TB cultures. Affordable, accurate and rapid point-of-care diagnostics are needed in resource-limited settings to more accurately determine which HIV-infected TB suspects have smear-negative TB.	[Nakiyingi, Lydia; Bwanika, John Mark; Nakanjako, Damalie; Katabira, Catherine; Lubega, Gloria; Sempa, Joseph; Manabe, Yukari C.] Makerere Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Nakiyingi, Lydia; Kirenga, Bruce; Nakanjako, Damalie] Makerere Univ, Coll Hlth Sci, Sch Med, Kampala, Uganda; [Nyesiga, Barnabas; Albert, Heidi] FIND, Kampala, Uganda; [Manabe, Yukari C.] Johns Hopkins Univ, Dept Med, Div Infect Dis, Baltimore, MD USA	Makerere University; Foundation For Innovative New Diagnostics; Johns Hopkins University	Nakiyingi, L (corresponding author), Makerere Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda.	lydikiyingi@yahoo.com	Nakiyingi, Lydia/ABG-7669-2020; Trajman, Anete/C-7679-2016	Nakiyingi, Lydia/0000-0001-7263-3198; Trajman, Anete/0000-0002-4000-4984; Kirenga, Bruce/0000-0002-2023-2840; Nakanjako, Damalie/0000-0002-0935-2112; Bukulu Sempa, Joseph/0000-0003-1062-0417; Bwanika, John Mark/0000-0002-6745-1274	Gilead Foundation; Medical Education Partnership Initiative program; Johns Hopkins University Center for AIDS Research from the National Institute of Allergy And Infectious Diseases [1P30AI094189]; FOGARTY INTERNATIONAL CENTER [R24TW008886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, P30AI094189] Funding Source: NIH RePORTER	Gilead Foundation(Gilead Sciences); Medical Education Partnership Initiative program; Johns Hopkins University Center for AIDS Research from the National Institute of Allergy And Infectious Diseases; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	LN received financial educational support from Gilead Foundation and the Medical Education Partnership Initiative program. YCM has a developmental award from the Johns Hopkins University Center for AIDS Research (1P30AI094189) from the National Institute of Allergy And Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preperation of the manuscript.	Albert H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015206; [Anonymous], 2012, GLOBAL TUBERCULOSIS, P1; [Anonymous], 2011, GUID INT TUB CAS FIN; Apers L, 2004, INT J TUBERC LUNG D, V8, P945; Arentz M, 2011, INT J TUBERC LUNG D, V15, P1656, DOI 10.5588/ijtld.10.0625; Bakari M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-32; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Davis JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009859; den Boon S, 2006, INT J TUBERC LUNG D, V10, P876; Dimairo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011849; ELLIOTT AM, 1995, T ROY SOC TROP MED H, V89, P78, DOI 10.1016/0035-9203(95)90668-1; ELLIOTT AM, 1993, TUBERCLE LUNG DIS, V74, P191, DOI 10.1016/0962-8479(93)90010-U; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; GORDIN FM, 1989, AM REV RESPIR DIS, V139, P1090, DOI 10.1164/ajrccm/139.5.1090; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P847; Harries AD, 1998, B WORLD HEALTH ORGAN, V76, P651; Harries AD, 2001, INT J TUBERC LUNG D, V5, P1143; Harries AD, 2001, LANCET, V357, P1519, DOI 10.1016/S0140-6736(00)04639-0; Hermans SM, 2012, JAIDS-J ACQ IMM DEF, V60, pE29, DOI 10.1097/QAI.0b013e318251aeb4; Kang'ombe C, 2000, T ROY SOC TROP MED H, V94, P305, DOI 10.1016/S0035-9203(00)90335-3; Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; MacPherson P, 2011, INT J TUBERC LUNG D, V15, P1390, DOI 10.5588/ijtld.11.0056; Meyer-Rath G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036966; Mohammed A, 2004, INT J TUBERC LUNG D, V8, P792; Mosimaneotsile B, 2003, LANCET, V362, P1551, DOI 10.1016/S0140-6736(03)14745-9; Nakiyingi Lydia, 2012, BMC Res Notes, V5, P487, DOI 10.1186/1756-0500-5-487; NUNN PP, 1994, THORAX, V49, P511, DOI 10.1136/thx.49.5.511; Peter JG, 2012, EUR RESPIR J, V40, P1211, DOI 10.1183/09031936.00201711; Raviglione M C, 1997, AIDS, V11 Suppl B, pS115; Siddiqi K, 2003, LANCET INFECT DIS, V3, P288, DOI 10.1016/S1473-3099(03)00609-1; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; Walley J, 2011, JAIDS-J ACQ IMM DEF, V57, pE93, DOI 10.1097/QAI.0b013e3182243a8c; WHO, 2007, WHOHTMHIV200701	37	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e74023	10.1371/journal.pone.0074023	http://dx.doi.org/10.1371/journal.pone.0074023			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040151	gold, Green Published, Green Submitted			2022-12-25	WOS:000324856500072
J	Gao, HJ; Wu, XR; Fossett, N				Gao, Hongjuan; Wu, Xiaorong; Fossett, Nancy			Drosophila E-Cadherin Functions in Hematopoietic Progenitors to Maintain Multipotency and Block Differentiation	PLOS ONE			English	Article							CELL-CELL CONTACT; STEM-CELLS; LYMPH-GLAND; ADHERENS JUNCTIONS; SOMATIC-CELLS; SELF-RENEWAL; FRUIT-FLY; SERPENT; NICHE; MAINTENANCE	A fundamental question in stem cell biology concerns the regulatory strategies that control the choice between multipotency and differentiation. Drosophila blood progenitors or prohemocytes exhibit key stem cell characteristics, including multipotency, quiescence, and niche dependence. As a result, studies of Drosophila hematopoiesis have provided important insights into the molecular mechanisms that control these processes. Here, we show that E-cadherin is an important regulator of prohemocyte fate choice, maintaining prohemocyte multipotency and blocking differentiation. These functions are reminiscent of the role of E-cadherin in mammalian embryonic stem cells. We also show that mis-expression of E-cadherin in differentiating hemocytes disrupts the boundary between these cells and undifferentiated prohemocytes. Additionally, upregulation of E-cadherin in differentiating hemocytes increases the number of intermediate cell types expressing the prohemocyte marker, Patched. Furthermore, our studies indicate that the Drosophila GATA transcriptional co-factor, U-shaped, is required for E-cadherin expression. Consequently, E-cadherin is a downstream target of U-shaped in the maintenance of prohemocyte multipotency. In contrast, we showed that forced expression of the U-shaped GATA-binding partner, Serpent, repressed E-cadherin expression and promoted lamellocyte differentiation. Thus, U-shaped may maintain E-cadherin expression by blocking the inhibitory activity of Serpent. Collectively, these observations suggest that GATA: FOG complex formation regulates E-cadherin levels and, thereby, the choice between multipotency and differentiation. The work presented in this report further defines the molecular basis of prohemocyte cell fate choice, which will provide important insights into the mechanisms that govern stem cell biology.	[Fossett, Nancy] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Fossett, N (corresponding author), Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA.	nfossett@som.umaryland.edu			National Institutes of Health [DK072229]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072229] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Public Health Service grant DK072229 from the National Institutes of Health (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse Herve, 2004, Immunol Rev, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Campbell K, 2011, DEV CELL, V21, P1051, DOI 10.1016/j.devcel.2011.10.005; Chen TT, 2010, STEM CELLS, V28, P1315, DOI 10.1002/stem.456; Crispino JD, 1999, MOL CELL, V3, P219, DOI 10.1016/S1097-2765(00)80312-3; Crispino JD, 2001, GENE DEV, V15, P839, DOI 10.1101/gad.875201; Dearolf CR, 1998, BBA-REV CANCER, V1377, pM13, DOI 10.1016/S0304-419X(97)00031-0; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; Fossett N, 2003, P NATL ACAD SCI USA, V100, P11451, DOI 10.1073/pnas.1635050100; Fossett N, 2001, DIFFERENTIATION, V69, P83, DOI 10.1046/j.1432-0436.2001.690202.x; Fossett N, 2001, TRENDS CARDIOVAS MED, V11, P185, DOI 10.1016/S1050-1738(01)00092-5; Fossett N, 2001, P NATL ACAD SCI USA, V98, P7342, DOI 10.1073/pnas.131215798; Fossett N, 2013, BBA-GEN SUBJECTS, V1830, P2375, DOI 10.1016/j.bbagen.2012.06.005; Frandsen Joel L., 2008, Proceedings of the National Academy of Sciences of the United States of America, V105, P14952, DOI 10.1073/pnas.0808208105; Gao HJ, 2011, GENESIS, V49, P105, DOI 10.1002/dvg.20711; Gao HJ, 2009, MOL CELL BIOL, V29, P6086, DOI 10.1128/MCB.00244-09; Hansson J, 2012, CELL REP, V2, P1579, DOI 10.1016/j.celrep.2012.10.014; Harris TJC, 2012, INT REV CEL MOL BIO, V293, P45, DOI 10.1016/B978-0-12-394304-0.00007-5; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Holz A, 2003, DEVELOPMENT, V130, P4955, DOI 10.1242/dev.00702; Honti V, 2010, MOL IMMUNOL, V47, P1997, DOI 10.1016/j.molimm.2010.04.017; Hsu HJ, 2009, P NATL ACAD SCI USA, V106, P1117, DOI 10.1073/pnas.0809144106; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; Kurucz E, 2007, ACTA BIOL HUNG, V58, P95, DOI 10.1556/ABiol.58.2007.Suppl.8; Kurucz E, 2007, CURR BIOL, V17, P649, DOI 10.1016/j.cub.2007.02.041; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Li L, 2010, STEM CELLS, V28, P247, DOI 10.1002/stem.289; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li ZX, 2010, J PHYS CHEM B, V114, P2894, DOI 10.1021/jp906737q; Lim J, 2011, DEV CELL, V21, P983, DOI 10.1016/j.devcel.2011.11.017; Losick VP, 2011, DEV CELL, V21, P159, DOI 10.1016/j.devcel.2011.06.018; Mandal L, 2004, NAT GENET, V36, P1019, DOI 10.1038/ng1404; Mandal L, 2007, NATURE, V446, P320, DOI 10.1038/nature05585; Martinez-Agosto JA, 2007, GENE DEV, V21, P3044, DOI 10.1101/gad.1602607; Minakhina S, 2010, DEVELOPMENT, V137, P27, DOI 10.1242/dev.043943; Mohamet L, 2011, J ONCOL, V2011, DOI 10.1155/2011/352616; Mondal BC, 2011, CELL, V147, P1589, DOI 10.1016/j.cell.2011.11.041; Muller HM, 1999, J BIOL CHEM, V274, P11727, DOI 10.1074/jbc.274.17.11727; Muratoglu S, 2007, DEV BIOL, V311, P636, DOI 10.1016/j.ydbio.2007.08.015; Muratoglu S, 2006, DEV BIOL, V296, P561, DOI 10.1016/j.ydbio.2006.04.455; NELSON RE, 1994, EMBO J, V13, P3438, DOI 10.1002/j.1460-2075.1994.tb06649.x; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Redmer T, 2011, EMBO REP, V12, P720, DOI 10.1038/embor.2011.88; Rehorn KP, 1996, DEVELOPMENT, V122, P4023; Sam S, 1996, MECH DEVELOP, V60, P197, DOI 10.1016/S0925-4773(96)00615-6; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Sancho-Martinez I, 2013, NATURE, V493, P310, DOI 10.1038/493310b; Sinenko SA, 2009, DEV CELL, V16, P756, DOI 10.1016/j.devcel.2009.03.003; Soncin F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021463; Soncin F, 2009, STEM CELLS, V27, P2069, DOI 10.1002/stem.134; Song XQ, 2002, P NATL ACAD SCI USA, V99, P14813, DOI 10.1073/pnas.232389399; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; Sorrentino RP, 2002, DEV BIOL, V243, P65, DOI 10.1006/dbio.2001.0542; Stinson S., 2011, SCI SIGNAL, V4; Taneyhill LA, 2008, CELL ADHES MIGR, V2, P223, DOI 10.4161/cam.2.4.6835; Tokusumi T, 2009, GENESIS, V47, P771, DOI 10.1002/dvg.20561; Tokusumi Y, 2010, DEVELOPMENT, V137, P3561, DOI 10.1242/dev.053728; Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Waltzer L, 2002, EMBO J, V21, P5477, DOI 10.1093/emboj/cdf545; Ward EJ, 2000, DEVELOPMENT, V127, P4959; Williams MJ, 2007, J IMMUNOL, V178, P4711, DOI 10.4049/jimmunol.178.8.4711; Xie T, 2008, COLD SH Q B, V73, P39, DOI 10.1101/sqb.2008.73.014; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107; Yan W, 2010, J BIOL CHEM, V285, P14042, DOI 10.1074/jbc.M110.105262	71	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74684	10.1371/journal.pone.0074684	http://dx.doi.org/10.1371/journal.pone.0074684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040319	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600143
J	Siwiak, M; Zielenkiewicz, P				Siwiak, Marlena; Zielenkiewicz, Piotr			Transimulation - Protein Biosynthesis Web Service	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; MESSENGER-RNA; ESCHERICHIA-COLI; GENE-EXPRESSION; TRANSLATIONAL CONTROL; GLOBAL ANALYSIS; IN-VIVO; ABUNDANCE; RIBOSOME; REVEALS	Although translation is the key step during gene expression, it remains poorly characterized at the level of individual genes. For this reason, we developed Transimulation - a web service measuring translational activity of genes in three model organisms: Escherichia coli, Saccharomyces cerevisiae and Homo sapiens. The calculations are based on our previous computational model of translation and experimental data sets. Transimulation quantifies mean translation initiation and elongation time (expressed in SI units), and the number of proteins produced per transcript. It also approximates the number of ribosomes that typically occupy a transcript during translation, and simulates their propagation. The simulation of ribosomes' movement is interactive and allows modifying the coding sequence on the fly. It also enables uploading any coding sequence and simulating its translation in one of three model organisms. In such a case, ribosomes propagate according to mean codon elongation times of the host organism, which may prove useful for heterologous expression. Transimulation was used to examine evolutionary conservation of translational parameters of orthologous genes. Transimulation may be accessed at http://nexus.ibb.waw.pl/Transimulation (requires Java version 1.7 or higher). Its manual and source code, distributed under the GPL-2.0 license, is freely available at the website.	[Siwiak, Marlena; Zielenkiewicz, Piotr] Polish Acad Sci, Inst Biochem & Biophys, Dept Bioinformat, Warsaw, Poland; [Zielenkiewicz, Piotr] Warsaw Univ, Fac Biol, Plant Mol Biol Lab, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw	Zielenkiewicz, P (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Dept Bioinformat, Warsaw, Poland.	piotr@ibb.waw.pl		Zielenkiewicz, Piotr/0000-0001-8151-6874	Polish budget funds;  [IP-12-MS]	Polish budget funds; 	This work was supported by Polish budget funds for science in 2012-2013. Grand number: IP-12-MS (http://www.nauka.gov.pl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; BOSTROM K, 1986, J BIOL CHEM, V261, P3800; Bremer H, 1996, ESCHERICHIA COLI SAL; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Fluitt A, 2007, COMPUT BIOL CHEM, V31, P335, DOI 10.1016/j.compbiolchem.2007.07.003; GEHRKE L, 1981, J BIOL CHEM, V256, P2514; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kadner R. J., 1996, ESCHERICHIA COLI SAL, V2nd; Kolkman A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100069; Lewin, 2004, GENES-BASEL; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Lim HN, 2011, P NATL ACAD SCI; LODISH HF, 1972, J BIOL CHEM, V247, P3622; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Mata J, 2005, TRENDS BIOCHEM SCI, V30, P506, DOI 10.1016/j.tibs.2005.07.005; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Miura F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-574; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; NATH K, 1970, J BIOL CHEM, V245, P2889; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Nie L, 2006, BIOCHEM BIOPH RES CO, V339, P603, DOI 10.1016/j.bbrc.2005.11.055; Nilsson M, 1997, BIOTECHNOL BIOENG, V54, P461, DOI 10.1002/(SICI)1097-0290(19970605)54:5<461::AID-BIT6>3.0.CO;2-C; Nissen P, 1999, STRUCTURE, V7, P143, DOI 10.1016/S0969-2126(99)80021-5; OSTLUND G, 2009, NUCL ACIDS RES; PALMITER RD, 1972, J BIOL CHEM, V247, P6770; Percudani R, 1997, J MOL BIOL, V268, P322, DOI 10.1006/jmbi.1997.0942; Pienaar E, 2008, J THEOR BIOL, V251, P616, DOI 10.1016/j.jtbi.2007.12.003; Rajasekhar VK, 2004, ONCOGENE, V23, P3248, DOI 10.1038/sj.onc.1207546; Reshes G, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/4/046001; Sims CE, 2007, LAB CHIP, V7, P423, DOI 10.1039/b615235j; Siwiak M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000865; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tani H, 2012, GENOME RES, V22, P947, DOI 10.1101/gr.130559.111; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; von der Haar T, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-87; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; WOLF SF, 1977, BIOCHEMISTRY-US, V16, P2783, DOI 10.1021/bi00631a031; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zhao L, 2008, NMR BIOMED, V21, P159, DOI 10.1002/nbm.1173	47	30	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73943	10.1371/journal.pone.0073943	http://dx.doi.org/10.1371/journal.pone.0073943			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040122	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600108
J	Wangge, G; Putzeist, M; Knol, MJ; Klungel, OH; Gispen-De Wied, CC; de Boer, A; Hoes, AW; Leufkens, HG; Mantel-Teeuwisse, AK				Wangge, Grace; Putzeist, Michelle; Knol, Mirjam J.; Klungel, Olaf H.; Gispen-De Wied, Christine C.; de Boer, Antonius; Hoes, Arno W.; Leufkens, Hubert G.; Mantel-Teeuwisse, Aukje K.			Regulatory Scientific Advice on Non-Inferiority Drug Trials	PLOS ONE			English	Article							ACTIVE-CONTROL TRIALS	The active-controlled trial with a non-inferiority design has gained popularity in recent years. However, non-inferiority trials present some methodological challenges, especially in determining the non-inferiority margin. Regulatory guidelines provide some general statements on how a non-inferiority trial should be conducted. Moreover, in a scientific advice procedure, regulators give companies the opportunity to discuss critical trial issues prior to the start of the trial. The aim of this study was to identify potential issues that may benefit from more explicit guidance by regulators. To achieve this, we collected and analyzed questions about non-inferiority trials posed by applicants for scientific advice in Europe in 2008 and 2009, as well as the responses given by the European Medicines Agency (EMA). In our analysis we included 156 final letters of advice from 2008 and 2009, addressed to 94 different applicants (manufacturers). Our analysis yielded two major findings: (1) applicants frequently asked questions 'whether' and 'how' to conduct a non-inferiority trial, 26% and 74%, respectively, and (2) the EMA regulators seem mainly concerned about the choice of the non-inferiority margin in non-inferiority trials (36% of total regulatory answers). In 40% of the answers, the EMA recommended using a stricter margin, and in 10% of the answers regarding non-inferiority margins, the EMA questioned the justification of the proposed non-inferiority margin. We conclude that there are still difficulties in selecting the appropriate methodology for non-inferiority trials. Straightforward and harmonized guidance regarding non-inferiority trials is required, for example on whether it is necessary to conduct such a trial and how the non-inferiority margin is determined. It is unlikely that regulatory guidelines can cover all therapeutic areas; therefore, in some cases regulatory scientific advice may be used as an opportunity for tailored advice.	[Wangge, Grace; Putzeist, Michelle; Klungel, Olaf H.; de Boer, Antonius; Leufkens, Hubert G.; Mantel-Teeuwisse, Aukje K.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [Wangge, Grace; Putzeist, Michelle; Gispen-De Wied, Christine C.; Leufkens, Hubert G.] Med Evaluat Board, Utrecht, Netherlands; [Knol, Mirjam J.] Ctr Infect Dis Control Netherlands CIb, Rijksinst Volksgezondheid Milieu RIVM, Natl Inst Publ Hlth & Environm, Epidemiol & Surveillance Unit EPI, Bilthoven, Netherlands; [Hoes, Arno W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Utrecht University; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center	Mantel-Teeuwisse, AK (corresponding author), Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands.	A.K.Mantel@uu.nl	Wangge, Grace/AAS-5241-2020; Mantel-Teeuwisse, Aukje/I-8902-2016	Wangge, Grace/0000-0002-5416-273X; 	Netherlands Organisation for Health Research and Development (ZonMW); Dutch Health Care Insurance Board (CVZ); Royal Dutch Pharmacists Association (KNMP); Top Institute Pharma; EU Innovative Medicines Initiative; Dutch Medicines Evaluation Board; Dutch Ministry of Health and industry; Dutch Top Institute Pharma Escher project [T6-202]	Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Dutch Health Care Insurance Board (CVZ); Royal Dutch Pharmacists Association (KNMP); Top Institute Pharma; EU Innovative Medicines Initiative; Dutch Medicines Evaluation Board; Dutch Ministry of Health and industry; Dutch Top Institute Pharma Escher project	The Department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, has received unrestricted research funding from the Netherlands Organisation for Health Research and Development (ZonMW), the Dutch Health Care Insurance Board (CVZ), the Royal Dutch Pharmacists Association (KNMP), the private-public funded Top Institute Pharma (www.tipharma.nl; includes co-funding from universities, government, and industry), the EU Innovative Medicines Initiative (IMI), EU 7th Framework Program (FP7), the Dutch Medicines Evaluation Board, the Dutch Ministry of Health and industry (including GlaxoSmithKline, Pfizer, and others). This study was funded by the Dutch Top Institute Pharma Escher project (T6-202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown D, 2008, PHARM STAT, V7, P77, DOI 10.1002/pst.337; Center for Drug Evaluation and Research (CDER), 2010, GUID IND ANT DRUG PR; Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER), 2010, GUIDANCE GU IN PRESS; *CHMP, 2005, EMEACPMPEWP215899; Committee for Medicinal Products for Human Use (CHMP), 2011, CPMPEWP55895; Committee for Medicinal Products for Human Use (CHMP), 2011, CPMPEWP108000; Committee for Proprietary Medicinal Products (CPMP), 1995, CPMPEWP55895; Committee for Proprietary Medicinal Products (CPMP), 2000, CPMPEWP48299; European Medicines Agency, 2010, EMEAH426001REV6; Garattini S, 2007, LANCET, V370, P1875, DOI 10.1016/S0140-6736(07)61604-3; ICH Expert Working Group, 2001, CHOIC CONTR GROUP RE, pE; ICH Harmonised Tripartite Guideline, 1998, STAT PRINC CLIN TRIA, pE9; Lewis JA, 2002, STAT MED, V21, P2931, DOI 10.1002/sim.1297; Putzeist M, 2011, EUR J CLIN PHARMACOL, V67, P157, DOI 10.1007/s00228-010-0919-x; Temple R, 2000, ANN INTERN MED, V133, P455, DOI 10.7326/0003-4819-133-6-200009190-00014; van Luijn JCF, 2008, ANN PHARMACOTHER, V42, P1605, DOI 10.1345/aph.1L115; Wangge G, 2010, CLIN PHARMACOL THER, V88, P420, DOI 10.1038/clpt.2010.134; Wangge G, 2013, DRUG DISCOV TODAY, V18, P601, DOI 10.1016/j.drudis.2013.01.003; Wangge G, 2013, THROMB RES, V131, P368, DOI 10.1016/j.thromres.2013.01.013; Wangge G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013550; WHO Collaborating Centre for Drug statistics Methodology, 2012, ATC DDD IND	21	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74818	10.1371/journal.pone.0074818	http://dx.doi.org/10.1371/journal.pone.0074818			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040346	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600149
J	Zhu, Y; Getzin, S; Wiegand, T; Ren, HB; Ma, KP				Zhu, Yan; Getzin, Stephan; Wiegand, Thorsten; Ren, Haibao; Ma, Keping			The Relative Importance of Janzen-Connell Effects in Influencing the Spatial Patterns at the Gutianshan Subtropical Forest	PLOS ONE			English	Article							SPECIES-HABITAT ASSOCIATIONS; BROAD-LEAVED FOREST; DENSITY-DEPENDENCE; TREE; DIVERSITY; RECRUITMENT; LIMITATION; DISPERSAL; DISTRIBUTIONS; CONSEQUENCES	The Janzen-Connell hypothesis is among the most important theories put forward to explain species coexistence in species-rich communities. However, the relative importance of Janzen-Connell effects with respect to other prominent mechanisms of community assembly, such as dispersal limitation, self-thinning due to competition, or habitat association, is largely unresolved. Here we use data from a 24-ha Gutianshan subtropical forest to address it. First we tested for significant associations of adults, juveniles, and saplings with environmental variables. Second we evaluated if aggregation decreased with life stage. In a third analysis we approximately factored out the effect of habitat association and comprehensively analyzed the spatial associations of intraspecific adults and offspring (saplings, juveniles) of 46 common species at continuous neighborhood distances. We found i) that, except for one, all species were associated with at least one environmental variable during at least one of their life stages, but the frequency of significant habitat associations declined with increasing life stage; ii) a decline in aggregation with increasing life stage that was strongest from juveniles to adults; and iii) intraspecific adult-offspring associations were dominated by positive relationships at neighborhood distances up to 10 m. Our results suggest that Janzen-Connell effects were not the dominant mechanisms in structuring the spatial patterns of established trees in the subtropical Gutianshan forest. The spatial patterns may rather reflect the joint effects of size-dependent self-thinning, dispersal limitation and habitat associations. Our findings contribute to a more comprehensive understanding of the relative importance of Janzen-Connell effects in influencing plant community structure under strong topographic heterogeneity.	[Zhu, Yan; Ren, Haibao; Ma, Keping] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China; [Getzin, Stephan; Wiegand, Thorsten] UFZ Helmholtz Ctr Environm Res, Dept Ecol Modelling, Leipzig, Germany	Chinese Academy of Sciences; Institute of Botany, CAS; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Ma, KP (corresponding author), Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China.	kpma@ibcas.ac.cn	Wiegand, Thorsten/H-5877-2016; Wiegand, Thorsten/AAP-9709-2021	Wiegand, Thorsten/0000-0002-3721-2248; Wiegand, Thorsten/0000-0002-3721-2248	National Natural Science Foundation of China [31200342]; Key Innovation Project of CAS [KZCX2-YW-430]; State Key Laboratory of Vegetation and Environmental Change [2011zyts12]; European Research Council (ERC) [233066]; Direct For Biological Sciences [1354741] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Innovation Project of CAS(Chinese Academy of Sciences); State Key Laboratory of Vegetation and Environmental Change; European Research Council (ERC)(European Research Council (ERC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was financially supported by the National Natural Science Foundation of China (31200342), Key Innovation Project of CAS (KZCX2-YW-430) and State Key Laboratory of Vegetation and Environmental Change (2011zyts12). SG was supported by the European Research Council (ERC) Advanced Grant "SpatioDiversity" (grant number 233066) to TW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagchi R, 2011, ECOLOGY, V92, P1723, DOI 10.1890/11-0335.1; BERMAN M, 1986, J R STAT SOC C-APPL, V35, P54; Carson WP., 2008, TROPICAL FOREST COMM, P210; CHAPIN FS, 1989, OECOLOGIA, V79, P412, DOI 10.1007/BF00384322; Chen L, 2010, ECOL LETT, V13, P695, DOI 10.1111/j.1461-0248.2010.01468.x; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Comita LS, 2007, J ECOL, V95, P482, DOI 10.1111/j.1365-2745.2007.01229.x; CONDIT R, 1992, AM NAT, V140, P261, DOI 10.1086/285412; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Condit R, 1996, J ECOL, V84, P549, DOI 10.2307/2261477; CONNELL J H, 1971, P298; Dalling JW, 2002, J ECOL, V90, P714, DOI 10.1046/j.1365-2745.2002.00706.x; Diggle P., 2003, STAT ANAL SPATIAL PO; Du YJ, 2012, ACTA OECOL, V44, P11, DOI 10.1016/j.actao.2011.06.001; Getzin S, 2008, J ECOL, V96, P807, DOI 10.1111/j.1365-2745.2008.01377.x; GILBERT GS, 1994, OECOLOGIA, V98, P100, DOI 10.1007/BF00326095; Gong QQ, 2007, SCI SOIL WATER CONSE, V5, P79; Gunatilleke CVS, 2006, J TROP ECOL, V22, P371, DOI 10.1017/S0266467406003282; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; He FL, 2000, J ECOL, V88, P676, DOI 10.1046/j.1365-2745.2000.00482.x; HilleRisLambers J, 2002, NATURE, V417, P732, DOI 10.1038/nature00809; HUBBELL SP, 1979, SCIENCE, V203, P1299, DOI 10.1126/science.203.4387.1299; Hubbell Stephen P., 2001, V32, pi; Hyatt LA, 2003, OIKOS, V103, P590, DOI 10.1034/j.1600-0706.2003.12235.x; Illian J, 2008, STAT ANAL MODELLING; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Kanagaraj R, 2011, J ECOL, V99, P1441, DOI 10.1111/j.1365-2745.2011.01878.x; Lai JS, 2009, J VEG SCI, V20, P415, DOI 10.1111/j.1654-1103.2009.01065.x; Law R, 2009, J ECOL, V97, P616, DOI 10.1111/j.1365-2745.2009.01510.x; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; Lieberman M, 2007, OIKOS, V116, P377, DOI 10.1111/j.2006.0030-1299.15370.x; Loosmore NB, 2006, ECOLOGY, V87, P1925, DOI 10.1890/0012-9658(2006)87[1925:SIUTGO]2.0.CO;2; McIntire EJB, 2009, ECOLOGY, V90, P46, DOI 10.1890/07-2096.1; Moeur M, 1997, FOREST ECOL MANAG, V94, P175, DOI 10.1016/S0378-1127(96)03976-X; Murrell DJ, 2009, J ECOL, V97, P256, DOI 10.1111/j.1365-2745.2008.01475.x; Nathan R, 2004, J ECOL, V92, P733, DOI 10.1111/j.0022-0477.2004.00914.x; Perry GLW, 2009, OIKOS, V118, P161, DOI 10.1111/j.1600-0706.2008.16947.x; R Development Core Team, 2009, R FDN STAT COMP; Schiffers K, 2008, ECOGRAPHY, V31, P545, DOI 10.1111/j.0906-7590.2008.05374.x; Shen GC, 2009, ECOLOGY, V90, P3033, DOI 10.1890/08-1646.1; Stoyan D., 1994, FRACTALS RANDOM SHAP; Tilman D., 1982, Monographs in Population Biology, pi; Valencia R, 2004, J ECOL, V92, P214, DOI 10.1111/j.0022-0477.2004.00876.x; Wang XG, 2010, J ECOL, V98, P674, DOI 10.1111/j.1365-2745.2010.01644.x; Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x; Wiegand T., 2007, AM NAT, V170, pE67; Wiegand T, 2007, ECOLOGY, V88, P3088, DOI 10.1890/06-1350.1; Wiegand T, 2013, ECOGRAPHY, V36, P92, DOI 10.1111/j.1600-0587.2012.07361.x; Wiegand T, 2012, P ROY SOC B-BIOL SCI, V279, P3312, DOI 10.1098/rspb.2012.0376; Wiegand T, 2009, AM NAT, V174, pE106, DOI 10.1086/605368; Wills C, 1997, P NATL ACAD SCI USA, V94, P1252, DOI 10.1073/pnas.94.4.1252; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Zhang LW, 2011, PLANT SOIL, V347, P211, DOI 10.1007/s11104-011-0839-2; Zhu Yan, 2008, Zhiwu Shengtai Xuebao, V32, P262, DOI 10.3773/j.issn.1005-264x.2008.02.004; Zhu Y, 2010, OIKOS, V119, P109, DOI 10.1111/j.1600-0706.2009.17758.x	57	19	26	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74560	10.1371/journal.pone.0074560	http://dx.doi.org/10.1371/journal.pone.0074560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040283	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600135
J	Wanaguru, M; Crosnier, C; Johnson, S; Rayner, JC; Wright, GJ				Wanaguru, Madushi; Crosnier, Cecile; Johnson, Steven; Rayner, Julian C.; Wright, Gavin J.			Biochemical Analysis of the Plasmodium falciparum Erythrocyte-binding Antigen-175 (EBA175)-Glycophorin-A Interaction IMPLICATIONS FOR VACCINE DESIGN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate-binding Protein; Cell Invasion; Cell Surface Receptor; Infectious Diseases; Malaria; Protein-Protein Interactions; Surface Plasmon Resonance (SPR)	RECEPTOR-BINDING; MALARIA VACCINE; INVASION; EBA-175; PROTEINS; RECOGNIZES; ANTIBODIES	PfEBA175 has an important role in the invasion of human erythrocytes by Plasmodium falciparum and is therefore considered a high priority blood-stage malaria vaccine candidate. PfEBA175 mediates adhesion to erythrocytes through binding of the Duffy-binding-like (DBL) domains in its extracellular domain to Neu5Ac2-3Gal displayed on the O-linked glycans of glycophorin-A (GYPA). Because of the difficulties in expressing active full-length (FL) P. falciparum proteins in a recombinant form, previous analyses of the PfEBA175-GYPA interaction have largely focused on the DBL domains alone, and therefore they have not been performed in the context of the native protein sequence. Here, we express the entire ectodomain of PfEBA175 (PfEBA175 FL) in soluble form, allowing us to compare the biochemical and immunological properties with a fragment containing only the tandem DBL domains (region II, PfEBA175 RII). Recombinant PfEBA175 FL bound human erythrocytes in a trypsin and neuraminidase-sensitive manner and recognized Neu5Ac2-3Gal-containing glycans, confirming its biochemical activity. A quantitative binding analysis showed that PfEBA175 FL interacted with native GYPA with a K-D approximate to 0.26 m and is capable of self-association. By comparison, the RII fragment alone bound GYPA with a lower affinity demonstrating that regions outside of the DBL domains are important for interactions with GYPA; antibodies directed to these other regions also contributed to the inhibition of parasite invasion. These data demonstrate the importance of PfEBA175 regions other than the DBL domains in the interaction with GYPA and merit their inclusion in an EBA175-based vaccine.	[Wanaguru, Madushi; Crosnier, Cecile; Wright, Gavin J.] Wellcome Trust Sanger Inst, Cell Surface Signalling Lab, Cambridge CB10 1HH, England; [Wanaguru, Madushi; Crosnier, Cecile; Rayner, Julian C.; Wright, Gavin J.] Wellcome Trust Sanger Inst, Malaria Programme, Cambridge CB10 1SA, England; [Johnson, Steven] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute; University of Oxford	Wright, GJ (corresponding author), Wellcome Trust Sanger Inst, Cell Surface Signalling Lab, Cambridge CB10 2DP, England.	gw2@sanger.ac.uk	Johnson, Steven J/F-9182-2016	Johnson, Steven J/0000-0002-7877-3543; Wright, Gavin/0000-0003-0537-0863; Rayner, Julian/0000-0002-9835-1014	Wellcome Trust [098051]; MRC [G0900888]; MRC [MR/J002283/1] Funding Source: UKRI; Medical Research Council [MR/J002283/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust Grant 098051 and MRC Grant G0900888.	ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; Bartholdson SJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003031; Batchelor JD, 2011, NAT STRUCT MOL BIOL, V18, P908, DOI 10.1038/nsmb.2088; Birkholtz LM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-197; Bushell KM, 2008, GENOME RES, V18, P622, DOI 10.1101/gr.7187808; Bustamante LY, 2013, VACCINE, V31, P373, DOI 10.1016/j.vaccine.2012.10.106; CAMUS D, 1985, SCIENCE, V230, P553, DOI 10.1126/science.3901257; Crompton PD, 2010, J CLIN INVEST, V120, P4168, DOI 10.1172/JCI44423; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Crosnier C, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-76; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; El Sahly HM, 2010, CLIN VACCINE IMMUNOL, V17, P1552, DOI 10.1128/CVI.00082-10; Geels MJ, 2011, EXPERT REV VACCINES, V10, P1697, DOI [10.1586/erv.11.158, 10.1586/ERV.11.158]; Greenwood BM, 2011, CLIN MICROBIOL INFEC, V17, P1600, DOI 10.1111/j.1469-0691.2011.03612.x; Jakobsen PH, 1998, INFECT IMMUN, V66, P4203; Jiang LB, 2011, P NATL ACAD SCI USA, V108, P7553, DOI 10.1073/pnas.1104050108; KAIN KC, 1993, J EXP MED, V178, P1497, DOI 10.1084/jem.178.5.1497; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Lopaticki S, 2011, INFECT IMMUN, V79, P1107, DOI 10.1128/IAI.01021-10; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Martin MJ, 2005, P NATL ACAD SCI USA, V102, P12819, DOI 10.1073/pnas.0503819102; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Muchmore EA, 1998, AM J PHYS ANTHROPOL, V107, P187, DOI 10.1002/(SICI)1096-8644(199810)107:2<187::AID-AJPA5>3.3.CO;2-M; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; O'Donnell RA, 2006, J CELL BIOL, V174, P1023, DOI 10.1083/jcb.200604136; ORLANDI PA, 1990, MOL BIOCHEM PARASIT, V40, P285, DOI 10.1016/0166-6851(90)90050-V; ORLANDI PA, 1992, J CELL BIOL, V116, P901, DOI 10.1083/jcb.116.4.901; Pandey KC, 2002, MOL BIOCHEM PARASIT, V123, P23, DOI 10.1016/S0166-6851(02)00122-6; Peek LJ, 2006, VACCINE, V24, P5839, DOI 10.1016/j.vaccine.2006.04.067; Rayner JC, 2011, TRENDS PARASITOL, V27, P222, DOI 10.1016/j.pt.2011.01.006; Richards JS, 2010, CLIN INFECT DIS, V51, pE50, DOI 10.1086/656413; Rodriguez LE, 2000, PARASITOLOGY, V120, P225, DOI 10.1017/S003118209900551X; Sim BKL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018393; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Snow RW, 2008, PLOS MED, V5, P1068, DOI 10.1371/journal.pmed.0050142; Theron M, 2010, CYTOM PART A, V77A, P1067, DOI 10.1002/cyto.a.20972; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; TOMITA M, 1975, P NATL ACAD SCI USA, V72, P2964, DOI 10.1073/pnas.72.8.2964; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wright GJ, 2009, MOL BIOSYST, V5, P1405, DOI [10.1039/B903580J, 10.1039/b903580j]; Wright GJ, 2000, IMMUNITY, V13, P233, DOI 10.1016/S1074-7613(00)00023-6; Zhang DM, 2005, INFECT IMMUN, V73, P6530, DOI 10.1128/IAI.73.10.6530-6536.2005	42	35	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32106	32117		10.1074/jbc.M113.484840	http://dx.doi.org/10.1074/jbc.M113.484840			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24043627	Green Published, hybrid			2022-12-25	WOS:000328681700001
J	Fu, XM; Shi, XD; Yan, LX; Zhang, HL; Chang, ZY				Fu, Xinmiao; Shi, Xiaodong; Yan, Linxuan; Zhang, Hanlin; Chang, Zengyi			In Vivo Substrate Diversity and Preference of Small Heat Shock Protein IbpB as Revealed by Using a Genetically Incorporated Photo-cross-linker	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE ALPHA-CRYSTALLIN; MOLTEN GLOBULE STATES; ESCHERICHIA-COLI; MOLECULAR CHAPERONE; MULTICHAPERONE NETWORK; DENATURED PROTEINS; OXIDATIVE STRESS; COMPETENT STATE; DISAGGREGATION; RESISTANCE	Small heat shock proteins (sHSPs), as ubiquitous molecular chaperones found in all forms of life, are known to be able to protect cells against stresses and suppress the aggregation of a variety of model substrate proteins under in vitro conditions. Nevertheless, it is poorly understood what natural substrate proteins are protected by sHSPs in living cells. Here, by using a genetically incorporated photo-cross-linker (p-benzoyl-L-phenylalanine), we identified a total of 95 and 54 natural substrate proteins of IbpB (an sHSP from Escherichia coli) in living cells with and without heat shock, respectively. Functional profiling of these proteins (110 in total) suggests that IbpB, although binding to a wide range of cellular proteins, has a remarkable substrate preference for translation-related proteins (e. g. ribosomal proteins and amino-acyl tRNA synthetases) and moderate preference for metabolic enzymes. Furthermore, these two classes of proteins were found to be more prone to aggregation and/or inactivation in cells lacking IbpB under stress conditions (e. g. heat shock). Together, our in vivo data offer novel insights into the chaperone function of IbpB, or sHSPs in general, and suggest that the preferential protection on the protein synthesis machine and metabolic enzymes may dominantly contribute to the well known protective effect of sHSPs on cell survival against stresses.	[Fu, Xinmiao; Shi, Xiaodong; Yan, Linxuan; Zhang, Hanlin; Chang, Zengyi] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Shi, Xiaodong] Xuzhou Med Coll, Jiangsu Prov Key Lab Anesthesiol, Xuzhou 221002, Peoples R China	Peking University; Xuzhou Medical University	Fu, XM (corresponding author), Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	fuxinmiao@pku.edu.cn; changzy@pku.edu.cn	Fu, Xinmiao/ABE-9050-2020	Fu, Xinmiao/0000-0003-3361-6904; Zhang, Hanlin/0000-0001-9353-6071	National Natural Science Foundation of China [31170738, 31100559, 31270804]; National Basic Research Program of China 973 Program [2012CB917300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China 973 Program(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Research Grants 31170738 (to Z. C.) and 31100559 and 31270804 (to X. F.) and National Basic Research Program of China 973 Program Grant 2012CB917300 (to X. F. and Z. C.).	ARATA S, 1995, J CELL PHYSIOL, V163, P458, DOI 10.1002/jcp.1041630305; Balogi Z, 2008, J BIOL CHEM, V283, P22983, DOI 10.1074/jbc.M710400200; Basha E, 2004, J BIOL CHEM, V279, P7566, DOI 10.1074/jbc.M310684200; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Bepperling A, 2012, P NATL ACAD SCI USA, V109, P20407, DOI 10.1073/pnas.1209565109; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; CARVER JA, 1995, BBA-PROTEIN STRUCT M, V1252, P251, DOI 10.1016/0167-4838(95)00146-L; Carver JA, 2002, J MOL BIOL, V318, P815, DOI 10.1016/S0022-2836(02)00144-4; Cashikar AG, 2005, J BIOL CHEM, V280, P23869, DOI 10.1074/jbc.M502854200; Chang ZY, 1996, J BIOL CHEM, V271, P7218, DOI 10.1074/jbc.271.12.7218; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Clark JI, 2000, CURR OPIN STRUC BIOL, V10, P52, DOI 10.1016/S0959-440X(99)00048-2; Das KP, 1996, J BIOL CHEM, V271, P10449, DOI 10.1074/jbc.271.18.10449; DEJONG WW, 1993, MOL BIOL EVOL, V10, P103; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; FARAHBAKHSH ZT, 1995, BIOCHEMISTRY-US, V34, P509, DOI 10.1021/bi00002a015; Farrelli IS, 2005, NAT METHODS, V2, P377, DOI 10.1038/nmeth0505-377; Fu XM, 2013, J BIOL CHEM, V288, P11897, DOI 10.1074/jbc.M113.450437; Fu XM, 2005, J BIOL CHEM, V280, P6337, DOI 10.1074/jbc.M406319200; Gu LX, 2002, J MOL BIOL, V319, P517, DOI 10.1016/S0022-2836(02)00311-X; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Hu YL, 2012, SCI CHINA LIFE SCI, V55, P927, DOI 10.1007/s11427-012-4388-6; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; Jiao WW, 2008, BIOCHEM J, V410, P63, DOI 10.1042/BJ20071120; Jiao WW, 2005, J MOL BIOL, V347, P871, DOI 10.1016/j.jmb.2005.01.029; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kitagawa M, 2000, FEMS MICROBIOL LETT, V184, P165, DOI 10.1111/j.1574-6968.2000.tb09009.x; Kuczynska-Wisnik D, 2002, MICROBIOL-SGM, V148, P1757, DOI 10.1099/00221287-148-6-1757; Laskowska E, 2010, CURR PHARM BIOTECHNO, V11, P146, DOI 10.2174/138920110790909669; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Leng FW, 2012, SCI CHINA LIFE SCI, V55, P837, DOI 10.1007/s11427-012-4372-1; Lindner RA, 1997, J BIOL CHEM, V272, P27722, DOI 10.1074/jbc.272.44.27722; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Matuszewska E, 2008, MICROBIOL-SGM, V154, P1739, DOI 10.1099/mic.0.2007/014696-0; Matuszewska E, 2009, ACTA BIOCHIM POL, V56, P55; Matuszewska M, 2005, J BIOL CHEM, V280, P12292, DOI 10.1074/jbc.M412706200; MERCK KB, 1993, J BIOL CHEM, V268, P1046; Mogk A, 2003, MOL MICROBIOL, V50, P585, DOI 10.1046/j.1365-2958.2003.03710.x; Mogk A, 2003, J BIOL CHEM, V278, P31033, DOI 10.1074/jbc.M303587200; Mohibullah N, 2008, GENE DEV, V22, P2994, DOI 10.1101/gad.1724408; Moller IM, 2011, J PROTEOMICS, V74, P2228, DOI 10.1016/j.jprot.2011.05.004; Morrow G, 2004, J BIOL CHEM, V279, P43382, DOI 10.1074/jbc.C400357200; Morrow G, 2012, INT J BIOCHEM CELL B, V44, P1613, DOI 10.1016/j.biocel.2012.03.009; Muchowski PJ, 1998, P NATL ACAD SCI USA, V95, P1004, DOI 10.1073/pnas.95.3.1004; Nakamoto H, 2007, CELL MOL LIFE SCI, V64, P294, DOI 10.1007/s00018-006-6321-2; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Nijeholt JALA, 2012, PHILOS T R SOC B, V367, P1016, DOI 10.1098/rstb.2011.0201; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Ratajczak E, 2009, J MOL BIOL, V386, P178, DOI 10.1016/j.jmb.2008.12.009; Richards EH, 1996, CANCER RES, V56, P2446; Rinas U, 2007, J BIOTECHNOL, V127, P244, DOI 10.1016/j.jbiotec.2006.07.004; Salinthone S, 2007, AM J PHYSIOL-LUNG C, V293, pL1194, DOI 10.1152/ajplung.00453.2006; Soto A, 1999, PLANT PHYSIOL, V120, P521, DOI 10.1104/pp.120.2.521; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Torok Z, 2001, P NATL ACAD SCI USA, V98, P3098, DOI 10.1073/pnas.051619498; Treweek TM, 2000, BBA-PROTEIN STRUCT M, V1481, P175, DOI 10.1016/S0167-4838(00)00109-6; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; Waters ER, 2008, GENOME, V51, P177, DOI 10.1139/G07-114; Waters ER, 1999, P NATL ACAD SCI USA, V96, P14394, DOI 10.1073/pnas.96.25.14394; Welker S, 2010, MOL CELL, V39, P507, DOI 10.1016/j.molcel.2010.08.001; Yeh CH, 1997, P NATL ACAD SCI USA, V94, P10967, DOI 10.1073/pnas.94.20.10967; Zhang M, 2011, NAT CHEM BIOL, V7, P671, DOI [10.1038/NCHEMBIO.644, 10.1038/nchembio.644]	65	36	39	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31646	31654		10.1074/jbc.M113.501817	http://dx.doi.org/10.1074/jbc.M113.501817			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24045939	Green Published, hybrid			2022-12-25	WOS:000330596200023
J	Lee, C; Marians, KJ				Lee, Chong; Marians, Kenneth J.			Characterization of the Nucleoid-associated Protein YejK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; ESCHERICHIA-COLI; DNA GYRASE; H-NS; GENES; ACID; FIS	Nucleoid-associated proteins play an important role in condensing chromosomal DNA and regulating gene expression. We report here the characterization of the nucleoid-associated protein YejK, which was detected in a yeast two-hybrid screen using the ParE subunit of topoisomerase IV as bait. The purified protein likely exists in a monomer-dimer equilibrium in solution and can form tetramers. Cross-linking of the protein bound to DNA suggests that the active form could be either a dimer or tetramer. YejK, which is present at about 24,000 copies of monomer per mid-log phase cell, binds double-stranded DNA with a site size of 12-14 base pairs/monomer, does not display a significant preference for either bent compared with straight DNA or supercoiled compared with relaxed DNA, and untwists DNA somewhat as it binds. YejK binds RNA, but not single-stranded DNA, with 65% of the avidity with which it binds DNA. However, cells deleted for yejK do not show defects in either RNA or protein synthesis. YejK interacts with all the subunits of both DNA gyrase and topoisomerase IV and has measurable effects on their activities. In the presence of YejK, relaxation of negatively supercoiled DNA by topoisomerase IV becomes distributive, whereas relaxation of positively supercoiled DNA is stimulated. Relaxation of negatively supercoiled DNA by DNA gyrase is inhibited, whereas the extent of supercoiling of relaxed DNA is limited. A YejK-GFP chimera is an effective marker for the nucleoid in live cell imaging.	[Lee, Chong; Marians, Kenneth J.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Marians, KJ (corresponding author), 1275 York Ave, New York, NY 10065 USA.	kmarians@sloankettering.edu			National Institutes of Health [GM34558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34558 (to K. J. M.).	Arora C, 2004, MOL CELL, V13, P549, DOI 10.1016/S1097-2765(04)00063-2; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Corcoran CP, 2010, J BACTERIOL, V192, P4790, DOI 10.1128/JB.00531-10; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Espeli O, 2003, MOL MICROBIOL, V50, P495, DOI 10.1046/j.1365-2958.2003.03736.x; Ferullo DJ, 2009, METHODS, V48, P8, DOI 10.1016/j.ymeth.2009.02.010; Grainger DC, 2008, MOL MICROBIOL, V68, P1366, DOI 10.1111/j.1365-2958.2008.06253.x; Guo FS, 2007, P NATL ACAD SCI USA, V104, P4309, DOI 10.1073/pnas.0611686104; Keane OM, 2003, MOL GENET GENOMICS, V270, P56, DOI 10.1007/s00438-003-0896-1; KLEVAN L, 1980, BIOCHEMISTRY-US, V19, P5229, DOI 10.1021/bi00564a012; Luijsterburg MS, 2008, CRIT REV BIOCHEM MOL, V43, P393, DOI [10.1080/10409230802528488, 10.1080/10409230802528488 ]; MARIANS KJ, 1987, J BIOL CHEM, V262, P10362; Marie D, 1996, APPL ENVIRON MICROB, V62, P1649, DOI 10.1128/AEM.62.5.1649-1655.1996; McClendon AK, 2005, J BIOL CHEM, V280, P39337, DOI 10.1074/jbc.M503320200; McLeod SM, 2002, J MOL BIOL, V316, P517, DOI 10.1006/jmbi.2001.5391; MENZEL R, 1983, CELL, V34, P105, DOI 10.1016/0092-8674(83)90140-X; Murphy LD, 1999, J BACTERIOL, V181, P3842, DOI 10.1128/JB.181.12.3842-3844.1999; Schneider R, 1999, MOL MICROBIOL, V34, P953, DOI 10.1046/j.1365-2958.1999.01656.x; Takeda Toshiharu, 2011, Int J Evol Biol, V2011, P685015, DOI 10.4061/2011/685015; Vlahovicek K, 2003, NUCLEIC ACIDS RES, V31, P3686, DOI 10.1093/nar/gkg559; WANG Q, 1993, EMBO J, V12, P2495, DOI 10.1002/j.1460-2075.1993.tb05904.x; Weinstein-Fischer D, 2007, MOL MICROBIOL, V63, P1131, DOI 10.1111/j.1365-2958.2006.05569.x; Williams NL, 2001, J MOL BIOL, V306, P969, DOI 10.1006/jmbi.2001.4468	26	9	9	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31503	31516		10.1074/jbc.M113.494237	http://dx.doi.org/10.1074/jbc.M113.494237			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24043617	Green Published, hybrid			2022-12-25	WOS:000330596200010
J	Karki, R; Igwe, OJ				Karki, Rajendra; Igwe, Orisa J.			Toll-Like Receptor 4-Mediated Nuclear Factor Kappa B Activation Is Essential for Sensing Exogenous Oxidants to Propagate and Maintain Oxidative/Nitrosative Cellular Stress	PLOS ONE			English	Article							OXIDATIVE STRESS; NITRIC-OXIDE; ADAPTER MOLECULE; FREE-RADICALS; PEROXYNITRITE; SUPEROXIDE; TLR4; INFLAMMATION; ANTIOXIDANT; IMMUNE	The mechanism(s) by which cells can sense exogenous oxidants that may contribute to intracellular oxidative/nitrosative stress is not clear. The objective of this study was to determine how cells might respond to exogenous oxidants to potentially initiate, propagate and/or maintain inflammation associated with many human diseases through NF-kappa B activation. First, we used HEK-Blue cells that are stably transfected with mouse toll-like receptor 4 (mTLR4) or mouse TLR2. These cells also express optimized secreted embryonic alkaline phosphatase (SEAP) reporter gene under the control of a promoter inducible by NF-kappa B transcription factor. These cells were challenged with their respective receptor-specific ligands, different pro-oxidants and/or inhibitors that act at different levels of the receptor signaling pathways. A neutralizing antibody directed against TLR4 inhibited responses to both TLR4-specific agonist and a prooxidant, which confirmed that both agents act through TLR4. We used the level of SEAP released into the culture media due to NF-kappa B activation as a measure of TLR4 or TLR2 stimulation. Pro-oxidants evoked increased release of SEAP from HEK-Blue mTLR4 cells at a much lower concentration compared with release from the HEK-Blue mTLR2 cells. Specific TLR4 signaling pathway inhibitors and oxidant scavengers (anti-oxidants) significantly attenuated oxidant-induced SEAP release by TLR4 stimulation. Furthermore, a novel pro-oxidant that decays to produce the same reactants as activated phagocytes induced inflammatory pain responses in the mouse orofacial region with increased TLR4 expression, and IL-1 beta and TNF alpha tissue levels. EUK-134, a synthetic serum-stable scavenger of oxidative species decreased these effects. Our data provide in vitro and related in vivo evidence that exogenous oxidants can induce and maintain inflammation by acting mainly through a TLR4-dependent pathway, with implications in many chronic human ailments.	[Karki, Rajendra; Igwe, Orisa J.] Univ Missouri Kansas City, Div Pharmacol & Toxicol, Kansas City, MO USA	University of Missouri System; University of Missouri Kansas City	Igwe, OJ (corresponding author), Univ Missouri Kansas City, Div Pharmacol & Toxicol, Kansas City, MO USA.	igweo@umkc.edu	Karki, Rajendra/H-6647-2019	Karki, Rajendra/0000-0003-4436-9128	National Institutes of Health Grant [NIDCR DE021888]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R15DE021888] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health Grant - NIDCR DE021888. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler V, 1999, ONCOGENE, V18, P6104, DOI 10.1038/sj.onc.1203128; Afanas'ev IB, 2007, MOL BIOTECHNOL, V37, P2, DOI 10.1007/s12033-007-0056-7; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Altug S, 2006, CHRONOBIOL INT, V23, P583, DOI 10.1080/07420520600650703; Ambalavanar R, 2006, NEUROSCI LETT, V399, P249, DOI 10.1016/j.neulet.2006.02.003; Atsu SS, 2006, RHEUMATOL INT, V26, P781, DOI 10.1007/s00296-006-0110-y; BAIRD MB, 1977, CHEM-BIOL INTERACT, V16, P145, DOI 10.1016/0009-2797(77)90124-7; Beal MF, 2002, FREE RADICAL BIO MED, V32, P797, DOI 10.1016/S0891-5849(02)00780-3; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Benoliel R, 2010, CURR PAIN HEADACHE R, V14, P33, DOI 10.1007/s11916-009-0085-y; Bettoni I, 2008, GLIA, V56, P1312, DOI 10.1002/glia.20699; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Coats SR, 2005, J IMMUNOL, V175, P4490, DOI 10.4049/jimmunol.175.7.4490; Cuddy LK, 2012, J NEUROSCI, V32, P5573, DOI 10.1523/JNEUROSCI.5235-11.2012; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Dedon PC, 2004, ARCH BIOCHEM BIOPHYS, V423, P12, DOI 10.1016/j.abb.2003.12.017; Diogenes A, 2011, J DENT RES, V90, P759, DOI 10.1177/0022034511400225; Drew B, 2002, ANN NY ACAD SCI, V959, P66, DOI 10.1111/j.1749-6632.2002.tb02084.x; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; EDWARDS JC, 1982, J LIPID RES, V23, P994; Fan J, 2003, J CLIN INVEST, V112, P1234, DOI 10.1172/JCI200318696; Flohe L, 1997, FREE RADICAL BIO MED, V22, P1115, DOI 10.1016/S0891-5849(96)00501-1; Frantz S, 2001, J BIOL CHEM, V276, P5197, DOI 10.1074/jbc.M009160200; Gill R, 2010, FREE RADICAL BIO MED, V48, P1121, DOI 10.1016/j.freeradbiomed.2010.01.006; Graff-Radford SB, 2009, NEUROLOGIST, V15, P171, DOI 10.1097/NRL.0b013e31819827d8; Hakim AW, 2009, J NEUROPHYSIOL, V102, P1551, DOI 10.1152/jn.00326.2009; HALLIWELL B, 1994, ENVIRON HEALTH PERSP, V102, P5, DOI 10.2307/3432205; Hamada Y, 2006, ORAL SURG ORAL MED O, V102, P596, DOI 10.1016/j.tripleo.2005.11.010; Hawlisch H, 2006, MOL IMMUNOL, V43, P13, DOI 10.1016/j.molimm.2005.06.028; Hensley K, 1997, INT REV NEUROBIOL, V40, P299; HODGSON EK, 1974, BIOCHEMISTRY-US, V13, P3811, DOI 10.1021/bi00715a030; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Ii M, 2006, MOL PHARMACOL, V69, P1288, DOI 10.1124/mol.105.019695; Imbe H, 2001, CELLS TISSUES ORGANS, V169, P238, DOI 10.1159/000047887; Jia Ze-jun, 2012, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V34, P168, DOI 10.3881/j.issn.1000-503X.2012.02.013; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Khattab MM, 2006, EUR J PHARMACOL, V548, P167, DOI 10.1016/j.ejphar.2006.08.007; Kopp EB, 1999, CURR OPIN IMMUNOL, V11, P13, DOI 10.1016/S0952-7915(99)80003-X; Kopp S, 2001, J OROFAC PAIN, V15, P9; Lass A, 1996, BBA-LIPID LIPID MET, V1303, P111, DOI 10.1016/0005-2760(96)00088-4; Lee H, 2013, CURR PROTEIN PEPT SC, V14, P33, DOI 10.2174/1389203711314010006; Li NX, 1999, FASEB J, V13, P1137, DOI 10.1096/fasebj.13.10.1137; Little JW, 2012, AMINO ACIDS, V42, P75, DOI 10.1007/s00726-010-0633-0; Lorne E, 2008, AM J PHYSIOL-CELL PH, V294, pC985, DOI 10.1152/ajpcell.00454.2007; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; McGettrick AF, 2004, MOL IMMUNOL, V41, P577, DOI 10.1016/j.molimm.2004.04.006; MEYER M, 1994, CHEM-BIOL INTERACT, V91, P91, DOI 10.1016/0009-2797(94)90029-9; MEYER M, 1993, EMBO J, V12, P2005, DOI 10.1002/j.1460-2075.1993.tb05850.x; MIESEL R, 1989, INORG CHIM ACTA, V160, P119, DOI 10.1016/S0020-1693(00)85411-0; MIESEL R, 1995, FREE RADICAL RES, V23, P213, DOI 10.3109/10715769509064035; MIESEL R, 1993, INFLAMMATION, V17, P595, DOI 10.1007/BF00914197; MIESEL R, 1995, CLIN EXP RHEUMATOL, V13, P595; Milam SB, 1998, J ORAL MAXIL SURG, V56, P214, DOI 10.1016/S0278-2391(98)90872-2; Minard KI, 2010, BIOCHEMISTRY-US, V49, P6299, DOI 10.1021/bi100825z; Mitchell JA, 2007, J ENDOCRINOL, V193, P323, DOI 10.1677/JOE-07-0067; Miyamoto M, 2011, NEUROSCI LETT, V491, P8, DOI 10.1016/j.neulet.2010.12.060; Nakamura Y, 2002, J BIOL CHEM, V277, P2687, DOI 10.1074/jbc.M109641200; Nicotra L, 2012, EXP NEUROL, V234, P316, DOI 10.1016/j.expneurol.2011.09.038; O'Neill LA, 2003, CURR OPIN PHARMACOL, V3, P396, DOI 10.1016/S1471-4892(03)00080-8; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; PARNHAM MJ, 1991, AGENTS ACTIONS, V32, P4, DOI 10.1007/BF01983300; Paul-Clark MJ, 2008, MOL MED, V14, P238, DOI 10.2119/2007-00098.Paul-Clark; Paul-Clark MJ, 2009, AM J RESP CRIT CARE, V179, P299, DOI 10.1164/rccm.200707-1019OC; Peri F, 2012, BIOTECHNOL ADV, V30, P251, DOI 10.1016/j.biotechadv.2011.05.014; Pham-Huy Lien Ai, 2008, Int J Biomed Sci, V4, P89; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Qureshi N, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P687; Rifkin IR, 2005, IMMUNOL REV, V204, P27, DOI 10.1111/j.0105-2896.2005.00239.x; Rong YQ, 1999, P NATL ACAD SCI USA, V96, P9897, DOI 10.1073/pnas.96.17.9897; Saitoh S, 2004, INT IMMUNOL, V16, P961, DOI 10.1093/intimm/dxh097; Salvemini D, 2006, BIOCHEM SOC T, V34, P965, DOI 10.1042/BST0340965; Saperstein S, 2009, J INTERF CYTOK RES, V29, P273, DOI 10.1089/jir.2008.0076; SCHALKWIJK J, 1987, INT J TISSUE REACT, V9, P39; Sha T, 2007, EUR J PHARMACOL, V571, P231, DOI 10.1016/j.ejphar.2007.06.027; Shoenfelt J, 2009, J LEUKOCYTE BIOL, V86, P303, DOI 10.1189/jlb.1008587; Suzuki YJ, 1997, FREE RADICAL BIO MED, V22, P269, DOI 10.1016/S0891-5849(96)00275-4; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Tanga FY, 2005, P NATL ACAD SCI USA, V102, P5856, DOI 10.1073/pnas.0501634102; Tzortzaki EG, 2012, CHEST, V141, P1243, DOI 10.1378/chest.11-1653; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Wegner H. E. H., 1995, International Urology and Nephrology, V27, P621, DOI 10.1007/BF02564750; Wu FX, 2010, INT J MED SCI, V7, P251; Xiang M, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/916425	86	36	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73840	10.1371/journal.pone.0073840	http://dx.doi.org/10.1371/journal.pone.0073840			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058497	gold, Green Published, Green Submitted			2022-12-25	WOS:000324695900024
J	Hyun, SH; Lee, SY; Sung, GH; Kim, SH; Choi, HK				Hyun, Sun-Hee; Lee, Seok-Young; Sung, Gi-Ho; Kim, Seong Hwan; Choi, Hyung-Kyoon			Metabolic Profiles and Free Radical Scavenging Activity of Cordyceps bassiana Fruiting Bodies According to Developmental Stage	PLOS ONE			English	Article							BEAUVERIA-BASSIANA; MASS-SPECTROMETRY; ABC TRANSPORTERS; ENTOMOPATHOGENIC FUNGI; MILITARIS; IDENTIFICATION; METARHIZIUM; CULTIVATION; TELEOMORPH; MYCOTOXINS	The metabolic profiles of Cordyceps bassiana according to fruiting body developmental stage were investigated using gas chromatography-mass spectrometry. We were able to detect 62 metabolites, including 48 metabolites from 70% methanol extracts and 14 metabolites from 100% n-hexane extracts. These metabolites were classified as alcohols, amino acids, organic acids, phosphoric acids, purine nucleosides and bases, sugars, saturated fatty acids, unsaturated fatty acids, or fatty amides. Significant changes in metabolite levels were found according to developmental stage. Relative levels of amino acids, purine nucleosides, and sugars were higher in development stage 3 than in the other stages. Among the amino acids, valine, isoleucine, lysine, histidine, glutamine, and aspartic acid, which are associated with ABC transporters and aminoacyl-tRNA biosynthesis, also showed higher levels in stage 3 samples. The free radical scavenging activities, which were significantly higher in stage 3 than in the other stages, showed a positive correlation with purine nucleoside metabolites such as adenosine, guanosine, and inosine. These results not only show metabolic profiles, but also suggest the metabolic pathways associated with fruiting body development stages in cultivated C. bassiana.	[Hyun, Sun-Hee; Lee, Seok-Young; Choi, Hyung-Kyoon] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea; [Sung, Gi-Ho] RDA, Mushroom Res Div, Dept Herbal Crop Res, Natl Inst Hort & Herbal Sci, Suwon, South Korea; [Kim, Seong Hwan] Dankook Univ, Dept Microbiol, Cheonan, South Korea	Chung Ang University; National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Dankook University	Choi, HK (corresponding author), Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea.	hykychoi@cau.ac.kr			Rural Development Administration, Republic of Korea [PJ008154]	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ008154), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella M. L., 2006, International Journal of Cosmetic Science, V28, P447, DOI 10.1111/j.1467-2494.2006.00349.x; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Byeon SE, 2011, PHARMAZIE, V66, P58, DOI 10.1691/ph.2011.0668; Byeon SE, 2011, IMMUNOPHARM IMMUNOT, V33, P90, DOI 10.3109/08923973.2010.482137; Chagoyen M, 2012, BRIEF BIOIN IN PRESS; Chagoyen M, 2011, BIOINFORMATICS, V27, P730, DOI 10.1093/bioinformatics/btr001; Choi JN, 2010, J AGR FOOD CHEM, V58, P4258, DOI 10.1021/jf903822e; Cottret L, 2010, NUCLEIC ACIDS RES, V38, pW132, DOI 10.1093/nar/gkq312; DYER PS, 1993, MYCOL RES, V97, P485, DOI 10.1016/S0953-7562(09)80137-8; Eriksson L., 2006, MULTI MEGAVARIATE 1; Frisvad JC, 2007, STUD MYCOL, P31, DOI 10.3114/sim.2007.59.04; Fukushima A, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-1; Gao QA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001264; Garcia-Canaveras JC, 2011, J PROTEOME RES, V10, P4825, DOI 10.1021/pr200629p; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Gudkov SV, 2006, RADIAT RES, V165, P538, DOI 10.1667/RR3552.1; Guenther JC, 2009, MOL PLANT MICROBE IN, V22, P1492, DOI 10.1094/MPMI-22-12-1492; Hendrickx DM, 2012, ANAL CHIM ACTA, V719, P8, DOI 10.1016/j.aca.2011.12.051; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Huang B, 2002, MYCOTAXON, V81, P229; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kirkland BH, 2004, J MED ENTOMOL, V41, P705, DOI 10.1603/0022-2585-41.4.705; Kovalchuk A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-177; Kovatcheva-Apostolova EG, 2008, EUR FOOD RES TECHNOL, V227, P1243, DOI 10.1007/s00217-008-0842-x; LEATHERS TD, 1993, J IND MICROBIOL, V12, P69, DOI 10.1007/BF01569904; Lee Je-O, 2007, Mycobiology, V35, P230, DOI 10.4489/MYCO.2007.35.4.230; Legendre J, 2008, INT J COSMETIC SCI, V30, P74; Lewis RA, 1998, LEWIS DICT TOXICOLOG, P212; Li ZZ, 2001, CHINESE SCI BULL, V46, P751, DOI 10.1007/BF03187215; LOWRY OH, 1971, J BIOL CHEM, V246, P6511; MAPLES KR, 1988, J BIOL CHEM, V263, P1709; Garza-Lopez PM, 2012, WORLD J MICROB BIOT, V28, P353, DOI 10.1007/s11274-011-0827-y; Nielsen KF, 2003, J CHROMATOGR A, V1002, P111, DOI 10.1016/S0021-9673(03)00490-4; Oller-Lopez JL, 2005, ORG BIOMOL CHEM, V3, P1172, DOI 10.1039/b417534d; Park SJ, 2013, METABOLOMICS, V9, P236, DOI 10.1007/s11306-012-0442-4; Quesada-Moraga E, 2004, MYCOL RES, V108, P441, DOI 10.1017/S0953756204009724; Rehner SA, 2011, MYCOLOGIA, V103, P1055, DOI 10.3852/10-302; Sipos G, 2006, CURR DRUG TARGETS, V7, P471, DOI 10.2174/138945006776359403; Smedsgaard J, 1996, J MICROBIOL METH, V25, P5, DOI 10.1016/0167-7012(95)00073-9; Smedsgaard J, 2004, STUD MYCOL, P243; Smith John E., 1995, Natural Toxins, V3, P187, DOI 10.1002/nt.2620030404; Song TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062179; Strasser H, 2000, BIOCONTROL SCI TECHN, V10, P717, DOI 10.1080/09583150020011690; Styczynski MP, 2007, ANAL CHEM, V79, P966, DOI 10.1021/ac0614846; Sung Jae-Mo, 2006, Mycobiology, V34, P1, DOI 10.4489/MYCO.2006.34.1.001; Vey A., 2001, Fungi as biocontrol agents: progress, problems and potential, P311, DOI 10.1079/9780851993560.0311; Wen TC, 2012, AFR J MICROBIOL RES, V6, P5215, DOI 10.5897/AJMR12.522; Woo KH, 2012, J GEN APPL MICROBIOL, V58, P325; Wu G, 2011, J ETHNOPHARMACOL, V134, P504, DOI 10.1016/j.jep.2010.12.012; Xiao GH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00483; Xiong ChengHui, 2010, Mycology - An International Journal on Fungal Biology, V1, P25; Zheng P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r116	52	12	12	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73065	10.1371/journal.pone.0073065	http://dx.doi.org/10.1371/journal.pone.0073065			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058459	Green Published, gold, Green Submitted			2022-12-25	WOS:000324408400017
J	Scranton, K; Stavrinides, M; Mills, NJ; de Valpine, P				Scranton, Katherine; Stavrinides, Menelaos; Mills, Nicholas J.; de Valpine, Perry			Small-Scale Intraspecific Life History Variation in Herbivorous Spider Mites (Tetranychus pacificus) Is Associated with Host Plant Cultivar	PLOS ONE			English	Article							POPULATION-DYNAMICS; INDUCED RESISTANCE; GENETIC DIFFERENTIATION; SYMPATRIC SPECIATION; GENOTYPIC VARIATION; BIOLOGICAL-CONTROL; PHYTOSEIID MITES; AERIAL DISPERSAL; KANZAWAI ACARI; RACE FORMATION	Life history variation is a general feature of arthropod systems, but is rarely included in models of field or laboratory data. Most studies assume that local processes occur identically across individuals, ignoring any genetic or phenotypic variation in life history traits. In this study, we tested whether field populations of Pacific spider mites (Tetranychus pacificus) on grapevines (Vitis vinifera) display significant intraspecific life history variation associated with host plant cultivar. To address this question we collected individuals from sympatric vineyard populations where either Zinfandel or Chardonnay were grown. We then conducted a "common garden experiment" of mites on bean plants (Phaseolus lunatus) in the laboratory. Assay populations were sampled non-destructively with digital photography to quantify development times, survival, and reproductive rates. Two classes of models were fit to the data: standard generalized linear mixed models and a time-to-event model, common in survival analysis, that allowed for interval-censored data and hierarchical random effects. We found a significant effect of cultivar on development time in both GLMM and time-to-event analyses, a slight cultivar effect on juvenile survival, and no effect on reproductive rate. There were shorter development times and a trend towards higher juvenile survival in populations from Zinfandel vineyards compared to those from Chardonnay vineyards. Lines of the same species, originating from field populations on different host plant cultivars, expressed different development times and slightly different survival rates when reared on a common host plant in a common environment.	[Scranton, Katherine; Stavrinides, Menelaos; Mills, Nicholas J.; de Valpine, Perry] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Scranton, Katherine] Yale Univ, New Haven, CT USA; [Stavrinides, Menelaos] Cyprus Univ Technol, Dept Agr Sci Biotechnol & Food Sci, Limassol, Cyprus	University of California System; University of California Berkeley; Yale University; Cyprus University of Technology	Scranton, K (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	katherine.scranton@yale.edu		Stavrinides, Menelaos/0000-0002-6459-1941; Mills, Nicholas/0000-0001-8885-8674	UC Berkeley; van den Bosch fellowship; Direct For Biological Sciences [1021553] Funding Source: National Science Foundation	UC Berkeley; van den Bosch fellowship; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was funded through a combination of institutional grants from UC Berkeley, including the van den Bosch fellowship for graduate student support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2000, ENTOMOL EXP APPL, V96, P39, DOI 10.1023/A:1004073411100; Agrawal AA, 2002, AM NAT, V159, P553, DOI 10.1086/339463; [Anonymous], 2010, R LANG ENV STAT COMP; Bates D., 2010, LINEAR FIXED EFFECTS; Bellamy SL, 2004, STAT MED, V23, P3607, DOI 10.1002/sim.1918; Benton TG, 2001, ECOL LETT, V4, P236, DOI 10.1046/j.1461-0248.2001.00225.x; Berlocher SH, 2002, ANNU REV ENTOMOL, V47, P773, DOI 10.1146/annurev.ento.47.091201.145312; BJORNSTAD ON, 1994, OIKOS, V69, P167, DOI 10.2307/3545298; Bonte D, 2010, PLOS ONE, V5; California Department of Food and Agriculture USDA National Agricultural Statistics Service California Field Office, 2010, CAL GRAP ACR REP 200; Dickey AM, 2010, J EVOLUTION BIOL, V23, P945, DOI 10.1111/j.1420-9101.2010.01962.x; DIEHL SR, 1984, ANNU REV ENTOMOL, V29, P471, DOI 10.1146/annurev.en.29.010184.002351; Dres M, 2002, PHILOS T R SOC B, V357, P471, DOI 10.1098/rstb.2002.1059; Duso C, 1999, EXP APPL ACAROL, V23, P741, DOI 10.1023/A:1006297225577; English-Loeb G, 1998, ENVIRON ENTOMOL, V27, P297, DOI 10.1093/ee/27.2.297; Evans LM, 2008, EVOLUTION, V62, P3027, DOI 10.1111/j.1558-5646.2008.00497.x; FRY JD, 1989, OECOLOGIA, V81, P559, DOI 10.1007/BF00378969; Gilbert M, 2003, J APPL ENTOMOL, V127, P354, DOI 10.1046/j.1439-0418.2003.00757.x; Gomi K, 1996, APPL ENTOMOL ZOOL, V31, P417, DOI 10.1303/aez.31.417; Gotoh T, 2003, APPL ENTOMOL ZOOL, V38, P7, DOI 10.1303/aez.2003.7; GOTOH T, 1993, ENTOMOL EXP APPL, V68, P171, DOI 10.1007/BF02380535; Gotoh T, 2007, INT J ACAROL, V33, P7, DOI 10.1080/01647950708684494; GOULD F, 1979, EVOLUTION, V33, P791, DOI [10.1111/j.1558-5646.1979.tb04735.x, 10.2307/2407646]; Gould JR, 1992, BIOL CONTROL, V2, P257, DOI 10.1016/1049-9644(92)90016-7; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Helle W., 1985, SPIDER MITES THEIR B; Hoddle MS, 1997, J ECON ENTOMOL, V90, P910, DOI 10.1093/jee/90.4.910; Hoddle MS, 1996, FLA ENTOMOL, V79, P464, DOI 10.2307/3495599; Hougaard P, 2000, ANAL MULTIVARIATE SU, P564; HOY MA, 1985, ENTOMOL EXP APPL, V37, P17, DOI 10.1007/BF00366804; Jung CL, 2001, OIKOS, V94, P182, DOI 10.1034/j.1600-0706.2001.11044.x; Kant MR, 2008, P R SOC B, V275, P443, DOI 10.1098/rspb.2007.1277; KARBAN R, 1995, EXP APPL ACAROL, V19, P189, DOI 10.1007/BF00130822; Kennedy GG, 2000, ANNU REV ENTOMOL, V45, P467, DOI 10.1146/annurev.ento.45.1.467; Magalhaes S, 2007, J EVOLUTION BIOL, V20, P2016, DOI 10.1111/j.1420-9101.2007.01365.x; Magalhaes S, 2007, EXP APPL ACAROL, V42, P225, DOI 10.1007/s10493-007-9091-0; Magalhaes S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-182; MILLER RW, 1985, J ECON ENTOMOL, V78, P1379, DOI 10.1093/jee/78.6.1379; Navajas M, 2000, EXP APPL ACAROL, V24, P365, DOI 10.1023/A:1006432604611; Nishimura S, 2005, EXP APPL ACAROL, V35, P59, DOI 10.1007/s10493-004-2005-5; Scranton K, 2012, MIXED EFFECTS UNPUB; Service PM, 2000, AM NAT, V156, P1, DOI 10.1086/303371; Sircom J, 2000, EXP APPL ACAROL, V24, P55, DOI 10.1023/A:1006384715850; Skaloudova B, 2006, COMPUT ELECTRON AGR, V53, P81, DOI 10.1016/j.compag.2006.04.002; Skoracka A, 2008, EVOL ECOL, V22, P607, DOI 10.1007/s10682-007-9185-5; Souissi S, 2001, J PLANKTON RES, V23, P1279, DOI 10.1093/plankt/23.11.1279; Stavrinides MC, 2011, BIOCONTROL, V56, P315, DOI 10.1007/s10526-010-9334-6; Stavrinides MC, 2010, BIOL CONTROL, V55, P126, DOI 10.1016/j.biocontrol.2010.07.006; SUMMY KR, 1985, ENTOMOPHAGA, V30, P107, DOI 10.1007/BF02372242; Teale SA, 2009, ENVIRON ENTOMOL, V38, P1235, DOI 10.1603/022.038.0434; Thaler JS, 1997, AM NAT, V149, P1139, DOI 10.1086/286042; Tien NSH, 2010, EVOLUTION, V64, P2547, DOI 10.1111/j.1558-5646.2010.00996.x; UCHMANSKI J, 1985, PHILOS T ROY SOC B, V310, P1, DOI 10.1098/rstb.1985.0099; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Van Zandt PA, 1998, AM NAT, V152, P595, DOI 10.1086/286192; Vindenes Y, 2008, AM NAT, V171, P455, DOI 10.1086/528965	56	7	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e72980	10.1371/journal.pone.0072980	http://dx.doi.org/10.1371/journal.pone.0072980			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058453	gold, Green Published, Green Submitted			2022-12-25	WOS:000324408400012
J	Xiong, HY; Barker, SC; Burger, TD; Raoult, D; Shao, RF				Xiong, Haoyu; Barker, Stephen C.; Burger, Thomas D.; Raoult, Didier; Shao, Renfu			Heteroplasmy in the Mitochondrial Genomes of Human Lice and Ticks Revealed by High Throughput Sequencing	PLOS ONE			English	Article							TRANSFER-RNA GENES; DNA MUTATIONS; COPY NUMBER; EVOLUTION; ARTHROPODS; DISCOVERY; GENETICS; PROGRAM; REGION	The typical mitochondrial (mt) genomes of bilateral animals consist of 37 genes on a single circular chromosome. The mt genomes of the human body louse, Pediculus humanus, and the human head louse, Pediculus capitis, however, are extensively fragmented and contain 20 minichromosomes, with one to three genes on each minichromosome. Heteroplasmy, i.e. nucleotide polymorphisms in the mt genome within individuals, has been shown to be significantly higher in the mt cox1 gene of human lice than in humans and other animals that have the typical mt genomes. To understand whether the extent of heteroplasmy in human lice is associated with mt genome fragmentation, we sequenced the entire coding regions of all of the mt minichromosomes of six human body lice and six human head lice from Ethiopia, China and France with an Illumina HiSeq platform. For comparison, we also sequenced the entire coding regions of the mt genomes of seven species of ticks, which have the typical mitochondrial genome organization of bilateral animals. We found that the level of heteroplasmy varies significantly both among the human lice and among the ticks. The human lice from Ethiopia have significantly higher level of heteroplasmy than those from China and France (P-t<0.05). The tick, Amblyomma cajennense, has significantly higher level of heteroplasmy than other ticks (P-t<0.05). Our results indicate that heteroplasmy level can be substantially variable within a species and among closely related species, and does not appear to be determined by single factors such as genome fragmentation.	[Xiong, Haoyu; Barker, Stephen C.; Burger, Thomas D.] Univ Queensland, Parasitol Sect, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Raoult, Didier] Aix Marseille Univ, URMITE, Fac Med, UMR CNRS IRD 198 6236, Marseille, France; [Shao, Renfu] Univ Sunshine Coast, GeneCol Res Ctr, Fac Sci Hlth Educ & Engn, Maroochydore, Qld, Australia	University of Queensland; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); University of the Sunshine Coast	Shao, RF (corresponding author), Univ Sunshine Coast, GeneCol Res Ctr, Fac Sci Hlth Educ & Engn, Maroochydore, Qld, Australia.	rshao@usc.edu.au	RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974; Shao, Renfu/0000-0002-1686-4968; Barker, Stephen/0000-0001-9431-8404	Australian Research Council [DP0662755, DP120100240]; Australian Government [ACSRF00980]	Australian Research Council(Australian Research Council); Australian Government(Australian GovernmentCGIAR)	This work was supported by the Australian Research Council (DP0662755 to R. S. and DP120100240 to R. S. and S. C. B) (http://www.arc.gov.au/). R. S. also acknowledges the funding support from the Australian Government for an Australia-China Science & Research Fund Group Mission visit to China (ACSRF00980) (http://www.innovation.gov.au/SCIENCE/INTERNATIONALCOLLABORATION/ACSRF/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Black WC, 1998, MOL BIOL EVOL, V15, P1772, DOI 10.1093/oxfordjournals.molbev.a025903; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; BOYCE TM, 1989, GENETICS, V123, P825; Burger TD, 2012, MOL PHYLOGENET EVOL, V64, P45, DOI 10.1016/j.ympev.2012.03.004; Chiaratti MR, 2010, BIOL REPROD, V83, P1, DOI 10.1095/biolreprod.110.084269; Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9; Doan R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-78; Goto H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r59; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Herd K., 2012, The Open Genomics Journal, V5, P14, DOI 10.2174/1875693X01205010014; Kambhampati S, 1995, INSECT MOL BIOL, V4, P233, DOI 10.1111/j.1365-2583.1995.tb00028.x; Kann LM, 1998, P NATL ACAD SCI USA, V95, P2372, DOI 10.1073/pnas.95.5.2372; Kmiec B, 2006, CURR GENET, V50, P149, DOI 10.1007/s00294-006-0082-1; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lavrov DV, 2007, INTEGR COMP BIOL, V47, P734, DOI 10.1093/icb/icm045; Legros F, 2012, J CELL SCI, V125, P2653; Lemire B, 2005, MITOCHONDRIAL GENETI, DOI [10.1895/wormbook.1.25.1, DOI 10.1895/W0RMB00K.1.25.1]; Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014; Light JE, 2008, J PARASITOL, V94, P1275, DOI 10.1645/GE-1618.1; Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marcade I, 2007, J MOL EVOL, V65, P651, DOI 10.1007/s00239-007-9037-5; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Messenger LA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001584; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Nardi F, 2001, MOL BIOL EVOL, V18, P1293, DOI 10.1093/oxfordjournals.molbev.a003914; Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435; Quinlan AR, 2008, NAT METHODS, V5, P179, DOI 10.1038/NMETH.1172; Rantanen A, 2000, Hum Reprod, V15 Suppl 2, P86; Sachadyn P, 2008, MITOCHONDRION, V8, P358, DOI 10.1016/j.mito.2008.07.007; Santos C, 2008, J MOL EVOL, V67, P191, DOI 10.1007/s00239-008-9138-9; Shao R, 2007, PARASITOLOGY, V134, P153, DOI 10.1017/S0031182006001429; Shao R, 2004, INSECT MOL BIOL, V13, P219, DOI 10.1111/j.0962-1075.2004.00447.x; Shao RF, 2012, GENOME BIOL EVOL, V4, P1088, DOI 10.1093/gbe/evs088; Shao RF, 2009, GENOME RES, V19, P904, DOI 10.1101/gr.083188.108; Shao RF, 2005, MOL BIOL EVOL, V22, P620, DOI 10.1093/molbev/msi047; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Song GJ, 2008, FERTIL STERIL, V90, P2238, DOI 10.1016/j.fertnstert.2007.10.059; Sosa MX, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002737; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Van Leeuwen T, 2008, P NATL ACAD SCI USA, V105, P5980, DOI 10.1073/pnas.0802224105; VOLZLINGENHOHL A, 1992, P NATL ACAD SCI USA, V89, P11528, DOI 10.1073/pnas.89.23.11528	45	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73329	10.1371/journal.pone.0073329	http://dx.doi.org/10.1371/journal.pone.0073329			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058467	Green Published, gold, Green Submitted			2022-12-25	WOS:000324408400021
J	Gaskill, BN; Pritchett-Corning, KR; Gordon, CJ; Pajor, EA; Lucas, JR; Davis, JK; Garner, JP				Gaskill, Brianna N.; Pritchett-Corning, Kathleen R.; Gordon, Christopher J.; Pajor, Edmond A.; Lucas, Jeffrey R.; Davis, Jerry K.; Garner, Joseph P.			Energy Reallocation to Breeding Performance through Improved Nest Building in Laboratory Mice	PLOS ONE			English	Article							ENVIRONMENTAL ENRICHMENT; MUS-MUSCULUS; HOUSE; TEMPERATURE; MOUSE; LACTATION; C57BL/6J; LIMITS; BODY	Mice are housed at temperatures (20-26 degrees C) that increase their basal metabolic rates and impose high energy demands to maintain core temperatures. Therefore, energy must be reallocated from other biological processes to increase heat production to offset heat loss. Supplying laboratory mice with nesting material may provide sufficient insulation to reduce heat loss and improve both feed conversion and breeding performance. Naive C57BL/6, BALB/c, and CD-1breeding pairs were provided with bedding alone, or bedding supplemented with either 8g of Enviro-Dri, 8g of Nestlets, for 6 months. Mice provided with either nesting material built more dome-like nests than controls. Nesting material improved feed efficiency per pup weaned as well as pup weaning weight. The breeding index (pups weaned/dam/week) was higher when either nesting material was provided. Thus, the sparing of energy for thermoregulation of mice given additional nesting material may have been responsible for the improved breeding and growth of offspring.	[Gaskill, Brianna N.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Gaskill, Brianna N.; Pritchett-Corning, Kathleen R.] Charles River, Wilmington, MA USA; [Gordon, Christopher J.] US EPA, Res Triangle Pk, NC 27711 USA; [Pajor, Edmond A.] Univ Calgary, Dept Prod Anim Hlth, Calgary, AB, Canada; [Lucas, Jeffrey R.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Davis, Jerry K.] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Garner, Joseph P.] Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA; [Garner, Joseph P.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Environmental Protection Agency; University of Calgary; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Stanford University; Stanford University	Gaskill, BN (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.	brianna.gaskill@crl.com	Pritchett-Corning, Kathleen R/E-7675-2011; Gaskill, Brianna/F-5950-2011; Garner, Joseph P/C-8422-2009	Pritchett-Corning, Kathleen R/0000-0002-1888-4751; Gaskill, Brianna/0000-0002-1884-803X; 	Professor William Russel Fellowship from the Universities Federation for Animal Welfare	Professor William Russel Fellowship from the Universities Federation for Animal Welfare	This work was supported by the Professor William Russel Fellowship from the Universities Federation for Animal Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], FEST MFWMOUSE GEN IN; BARNETT SA, 1975, J ZOOL, V177, P153, DOI 10.1111/j.1469-7998.1975.tb05975.x; Benaroya-Milshtein N, 2007, J IMMUNOTHER, V30, P517, DOI 10.1097/CJI.0b013e31804efc5e; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BERRY R J, 1970, Field Studies, V3, P219; BERRY RJ, 1992, BIOL REV, V67, P519, DOI 10.1111/j.1469-185X.1992.tb01192.x; Berton F, 1998, PHYSIOL BEHAV, V65, P247, DOI 10.1016/S0031-9384(98)00126-7; Beynen AC, 1993, ANIMAL MODELS PRINCI, P197; Bond TLY, 2002, PHYSIOL BEHAV, V75, P551, DOI 10.1016/S0031-9384(02)00659-5; BROWN RZ, 1953, ECOL MONOGR, V23, P217, DOI 10.2307/1943592; Bult A, 1997, BEHAV GENET, V27, P231, DOI 10.1023/A:1025610130282; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Dahlborn K, 1996, SCAND J LAB ANIM SCI, V23, P97; EEDY J W, 1970, Canadian Journal of Zoology, V48, P1303, DOI 10.1139/z70-221; Eliason HL, 1997, J APPL PHYSIOL, V83, P837, DOI 10.1152/jappl.1997.83.3.837; Gaskill BN, 2013, PHYSIOL BEHAV, V110, P87, DOI 10.1016/j.physbeh.2012.12.018; Gaskill BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032799; Gaskill BN, 2011, J THERM BIOL, V36, P193, DOI 10.1016/j.jtherbio.2011.02.004; Gaskill BN, 2009, APPL ANIM BEHAV SCI, V116, P279, DOI 10.1016/j.applanim.2008.10.002; Gordon C.J., 2004, COMPARATIVE MED, V54, P51; Gordon CJ, 1993, TEMPERATURE REGULATI, DOI 10.1017/CBO9780511565595; Grafen A., 2002, MODERN STAT LIFE SCI, P155; GREENBERG G, 1972, BEHAVIOUR, V42, P119, DOI 10.1163/156853972X00130; Hess SE, 2008, J AM ASSOC LAB ANIM, V47, P25; Krol E, 2003, J EXP BIOL, V206, P4255, DOI 10.1242/jeb.00674; Krol E, 2007, J EXP BIOL, V210, P4233, DOI 10.1242/jeb.009779; Latham N, 2004, APPL ANIM BEHAV SCI, V86, P261, DOI 10.1016/j.applanim.2004.02.006; LISK RD, 1969, ANIM BEHAV, V17, P730, DOI 10.1016/S0003-3472(69)80020-5; LYNCH CB, 1978, ANIM BEHAV, V26, P1136, DOI 10.1016/0003-3472(78)90103-3; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; OGILVIE DM, 1966, CAN J ZOOLOG, V44, P511, DOI 10.1139/z66-055; Rasmussen S, 2009, J AM ASSOC LAB ANIM, V48, P363; SCHNEIDER JE, 1984, J COMP PSYCHOL, V98, P165, DOI 10.1037/0735-7036.98.2.165; Smith TM, 1955, ELEMENTS ECOLOGY; Townsend P, 1997, ANIM WELFARE, V6, P95; Weber EM, 2008, APPL ANIM BEHAV SCI, V114, P1, DOI 10.1016/j.applanim.2008.06.006; Wurbel H, 1998, APPL ANIM BEHAV SCI, V60, P69, DOI 10.1016/S0168-1591(98)00150-6; YAMAUCHI C, 1983, EXP ANIM TOKYO, V32, P1	38	38	38	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74153	10.1371/journal.pone.0074153	http://dx.doi.org/10.1371/journal.pone.0074153			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040193	Green Published, gold, Green Submitted			2022-12-25	WOS:000326734500075
J	Herrero-Barbudo, C; Soldevilla, B; Perez-Sacristan, B; Blanco-Navarro, I; Herrera, M; Granado-Lorencio, F; Dominguez, G				Herrero-Barbudo, Carmen; Soldevilla, Beatriz; Perez-Sacristan, Belen; Blanco-Navarro, Inmaculada; Herrera, Mercedes; Granado-Lorencio, Fernando; Dominguez, Gemma			Modulation of DNA-Induced Damage and Repair Capacity in Humans after Dietary Intervention with Lutein-Enriched Fermented Milk	PLOS ONE			English	Article							PROTECTIVE ROLE; CAROTENOIDS; HEALTHY; SERUM; VEGETABLES	Dietary factors provide protection against several forms of DNA damage. Additionally, consumer demand for natural products favours the development of bioactive food ingredients with health benefits. Lutein is a promising biologically active component in the food industry. The EFSA Panel on Dietetic Products, Nutrition and Allergies considers that protection from oxidative damage may be a beneficial physiological effect but that a cause and effect relationship has not been established. Thus, our aim was to evaluate the safety and potential functional effect of a lutein-enriched milk product using the Comet Assay in order to analyze the baseline, the induced DNA-damage and the repair capacity in the lymphocytes of 10 healthy donors before and after the intake of the mentioned product. Our data suggest that the regular consumption of lutein-enriched fermented milk results in a significant increase in serum lutein levels and this change is associated with an improvement in the resistance of DNA to damage and the capacity of DNA repair in lymphocytes. Our results also support the lack of a genotoxic effect at the doses supplied as well as the absence of interactions and side effects on other nutritional and biochemicals markers.	[Herrero-Barbudo, Carmen; Perez-Sacristan, Belen; Blanco-Navarro, Inmaculada; Granado-Lorencio, Fernando] Hosp Univ Puerta Hierro Majadahonda, Unidad Vitaminas, Madrid, Spain; [Soldevilla, Beatriz; Herrera, Mercedes; Dominguez, Gemma] Hosp Univ Puerta Hierro Majadahonda, Serv Oncol Med, Madrid, Spain; [Blanco-Navarro, Inmaculada; Granado-Lorencio, Fernando] Univ Autonoma Madrid, Fac Med, Serv Bioquim Clin, Madrid, Spain; [Dominguez, Gemma] Univ Autonoma Madrid, Fac Med, Dept Med, Madrid, Spain	Hospital Puerta de Hierro-Majadahonda; Hospital Puerta de Hierro-Majadahonda; Autonomous University of Madrid; Autonomous University of Madrid	Granado-Lorencio, F (corresponding author), Hosp Univ Puerta Hierro Majadahonda, Unidad Vitaminas, Madrid, Spain.	fgranado.hpth@salud.madrid.org; gdominguez.hpth@salud.madrid.org	Granado, Fernando/D-1048-2011; Soldevilla, Beatriz/F-6835-2016	Granado, Fernando/0000-0002-5561-7564; Soldevilla, Beatriz/0000-0002-4831-5402	Cognis Deutschland GmbH Co. and KG; Fundacion para la Investigacion Biomedica Hospital Universitario Puerta de Hierro	Cognis Deutschland GmbH Co. and KG; Fundacion para la Investigacion Biomedica Hospital Universitario Puerta de Hierro	This work was partially funded through a research agreement between Cognis Deutschland GmbH Co. and KG, and Fundacion para la Investigacion Biomedica Hospital Universitario Puerta de Hierro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggett PJ, 2009, EUR J NUTR, V48, pS23, DOI 10.1007/s00394-009-0072-4; BENDICH A, 1989, FASEB J, V3, P1927, DOI 10.1096/fasebj.3.8.2656356; Briviba K, 2008, NUTR CANCER, V60, P164, DOI 10.1080/01635580701621346; Cemeli E, 2009, MUTAT RES-REV MUTAT, V681, P51, DOI 10.1016/j.mrrev.2008.05.002; Collins AR, 2009, MUTAT RES-REV MUTAT, V681, P24, DOI 10.1016/j.mrrev.2007.10.002; Collins AR, 1998, CARCINOGENESIS, V19, P2159, DOI 10.1093/carcin/19.12.2159; EFSA Panel on Dietetic Products Nutrition and Allergies, 2011, EFSA J, V9, P2030, DOI [10.2903/j.efsa.2011.2030, DOI 10.2903/J.EFSA.2011.2030]; Failla M., 2005, TECHNICAL MONOGRAPHS, V3; Granado F, 2003, BRIT J NUTR, V90, P487, DOI 10.1079/BJN2003927; Granado-Lorencio F., 2007, INT J BIOMED PHARM S, V1, P46; Granado-Lorencio F, 2010, J NUTR BIOCHEM, V21, P133, DOI 10.1016/j.jnutbio.2008.12.002; Howlett J, 2008, ILSI EUROPE MONOGRAP; Krinsky NI, 2003, ANNU REV NUTR, V23, P171, DOI 10.1146/annurev.nutr.23.011702.073307; Krinsky Norman I., 2005, Molecular Aspects of Medicine, V26, P459; Maiani G, 2009, MOL NUTR FOOD RES, V53, pS194, DOI 10.1002/mnfr.200800053; Marcon F, 2003, MUTAT RES-GEN TOX EN, V541, P1, DOI 10.1016/S1383-5718(03)00171-2; O'Neill ME, 2001, BRIT J NUTR, V85, P499, DOI 10.1079/BJN2000284; Olmedilla B, 1997, CLIN CHEM, V43, P1066; Olmedilla B, 2001, BRIT J NUTR, V85, P227, DOI 10.1079/BJN2000248; PoolZobel BL, 1997, CARCINOGENESIS, V18, P1847, DOI 10.1093/carcin/18.9.1847; Porrini M, 2005, BRIT J NUTR, V93, P93, DOI 10.1079/BJN20041315; Russell RM, 2006, J NUTR, V136, p2690S, DOI 10.1093/jn/136.10.2690S; Shao A, 2006, REGUL TOXICOL PHARM, V45, P289, DOI 10.1016/j.yrtph.2006.05.007; Singh N.P., 1998, EXP CELL RES, V17, P184, DOI DOI 10.1016/0014-4827(88)90265-0; VANDENBERG H, 1993, INT J VITAM NUTR RES, V63, P247; Watters JL, 2007, CANCER EPIDEM BIOMAR, V16, P1428, DOI 10.1158/1055-9965.EPI-06-1030; Yong LC, 2009, AM J CLIN NUTR, V90, P1402, DOI 10.3945/ajcn.2009.28207; Zhao XF, 2006, AM J CLIN NUTR, V83, P163	28	11	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74135	10.1371/journal.pone.0074135	http://dx.doi.org/10.1371/journal.pone.0074135			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040187	Green Submitted, gold, Green Published			2022-12-25	WOS:000326734500074
J	Millett, ERC; Quint, JK; Smeeth, L; Daniel, RM; Thomas, SL				Millett, Elizabeth R. C.; Quint, Jennifer K.; Smeeth, Liam; Daniel, Rhian M.; Thomas, Sara L.			Incidence of Community-Acquired Lower Respiratory Tract Infections and Pneumonia among Older Adults in the United Kingdom: A Population-Based Study	PLOS ONE			English	Article							PRIMARY-CARE; VACCINE UPTAKE; AGE; CONSULTATIONS; ENGLAND; ILLNESS; GENDER; RATES	Community-acquired lower respiratory tract infections (LRTI) and pneumonia (CAP) are common causes of morbidity and mortality among those aged >= 65 years; a growing population in many countries. Detailed incidence estimates for these infections among older adults in the United Kingdom (UK) are lacking. We used electronic general practice records from the Clinical Practice Research Data link, linked to Hospital Episode Statistics inpatient data, to estimate incidence of community-acquired LRTI and CAP among UK older adults between April 1997-March 2011, by age, sex, region and deprivation quintile. Levels of antibiotic prescribing were also assessed. LRTI incidence increased with fluctuations over time, was higher in men than women aged >= 70 and increased with age from 92.21 episodes/1000 person-years (65-69 years) to 187.91/1000 (85-89 years). CAP incidence increased more markedly with age, from 2.81 to 21.81 episodes/1000 person-years respectively, and was higher among men. For both infection groups, increases over time were attenuated after age-standardisation, indicating that these rises were largely due to population aging. Rates among those in the most deprived quintile were around 70% higher than the least deprived and were generally higher in the North of England. GP antibiotic prescribing rates were high for LRTI but lower for CAP (mostly due to immediate hospitalisation). This is the first study to provide long-term detailed incidence estimates of community-acquired LRTI and CAP in UK older individuals, taking person-time at risk into account. The summary incidence commonly presented for the >= 65 age group considerably underestimates LRTI/CAP rates, particularly among older individuals within this group. Our methodology and findings are likely to be highly relevant to health planners and researchers in other countries with aging populations.	[Millett, Elizabeth R. C.; Quint, Jennifer K.; Smeeth, Liam; Daniel, Rhian M.; Thomas, Sara L.] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Millett, ERC (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	elizabeth.millett@lshtm.ac.uk	quint, jennifer/ABE-3384-2020; Smeeth, Liam/X-5862-2018	Smeeth, Liam/0000-0002-9168-6022; Daniel, Rhian/0000-0001-5649-9320; Quint, Jennifer/0000-0003-0149-4869; Millett, Elizabeth/0000-0002-1342-2339	National Institute for Health Research [CDF 2010-03-32]; Medical Research Council Population Health Scientist Fellowship [G0902135]; Wellcome Trust [098504/Z/12/Z]; MRC [G0902135] Funding Source: UKRI; Medical Research Council [MR/K006584/1, G0902135] Funding Source: researchfish; National Institute for Health Research [CDF-2010-03-32, NF-SI-0510-10090] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council Population Health Scientist Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This report is independent research arising from a Career Development Fellowship supported by the National Institute for Health Research (http://www.nihr.ac.uk), awarded to Dr Thomas (grant number CDF 2010-03-32). The views expressed in this publication are those of the authors and not necessarily those of the UK National Health Service, the National Institute for Health Research or the Department of Health. JKQ is funded on a Medical Research Council Population Health Scientist Fellowship (grant number G0902135). LS is supported by a Wellcome Trust Senior Research Fellowship in Clinical Science (grant number 098504/Z/12/Z). The funders of the study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almirall J, 2000, EUR RESPIR J, V15, P757, DOI 10.1034/j.1399-3003.2000.15d21.x; Ashton Charlotte, 2010, Health Stat Q, P100, DOI 10.1057/hsq.2010.6; Ashworth M, 2006, J CLIN PHARM THER, V31, P461, DOI 10.1111/j.1365-2710.2006.00765.x; Ashworth M, 2005, BRIT J GEN PRACT, V55, P603; Ashworth M, 2004, J PUBLIC HEALTH-UK, V26, P268, DOI 10.1093/pubmed/fdh160; Begum F, 2012, PNEUMOCOCCAL POLYSAC; Bont J, 2007, EUR RESPIR J, V29, P969, DOI 10.1183/09031936.00129706; British Thoracic Society Standards of Care Committee, 2001, THORAX, V56; Davies S. C., 2012, ANN REPORT CHIEF MED, V1; Eurostat, 2013, CAUS DEATH STAT PEOP; Ewig S, 2009, THORAX, V64, P1062, DOI 10.1136/thx.2008.109785; Gulliford M, 2009, J PUBLIC HEALTH-UK, V31, P512, DOI 10.1093/pubmed/fdp081; Gutierrez F, 2006, J INFECTION, V53, P166, DOI 10.1016/j.jinf.2005.11.006; Hak E, 2006, FAM PRACT, V23, P291, DOI 10.1093/fampra/cmi121; Health Protection Agency, 2010, EP REP PAND H1N1 200; Hippisley-Cox JVY, 2009, TRENDS CONSULTATION; Holmes WF, 1999, THORAX, V54, P925, DOI 10.1136/thx.54.10.925; Joint Committee on Vaccination and Immunisation, 2011, JCVI STAT ROUT PNEUM; JOKINEN C, 1993, AM J EPIDEMIOL, V137, P977, DOI 10.1093/oxfordjournals.aje.a116770; Joseph C, 2003, VACCINE, V21, P1137, DOI 10.1016/S0264-410X(02)00505-4; Kaplan V, 2003, ARCH INTERN MED, V163, P317, DOI 10.1001/archinte.163.3.317; Lewis JD, 2005, PHARMACOEPIDEM DR S, V14, P443, DOI 10.1002/pds.1115; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Macfarlane J, 2001, THORAX, V56, P109, DOI 10.1136/thorax.56.2.109; Myles PR, 2009, EPIDEMIOL INFECT, V137, P709, DOI 10.1017/S0950268808001428; National Institute for Health and Care Excellence, 2008, RESP TRACT INF ANT P; Noakes K, 2006, J PUBLIC HEALTH, V28, P242, DOI 10.1093/pubmed/fdl017; Ochoa-Gondar O, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-222; *OFF NAT STAT, 2000, KEY HLTH STAT GEN PR; Office for National Statistics, 2011, STAT B OLD PEOPL DAY; Office for National Statistics, 2012, EN LIF SURV OV REP 2; Petersen I, 2007, BMJ-BRIT MED J, V335, P982, DOI 10.1136/bmj.39345.405243.BE; Public Health England, 2013, INFL VACC UPT MON BE; Public Health England, 2013, 6 MAJ RESP PATH REP; Public Health England, 2013, LAB REP HPA COL INF; Rossi RG, 2004, INT J TUBERC LUNG D, V8, P528; Sapey E, 2006, THORAX, V61, P250, DOI 10.1136/thx.2005.041822; Schnoor M, 2007, J INFECTION, V55, P233, DOI 10.1016/j.jinf.2007.04.355; Sliedrecht A, 2008, THORAX, V63, P817, DOI 10.1136/thx.2007.093013; Winchester CC, 2009, CHEST, V135, P1163, DOI 10.1378/chest.07-2940; Woodhead M, 2011, CLIN MICROBIOL INFEC, V17, P1, DOI 10.1111/j.1469-0691.2011.03602.x	41	123	127	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e75131	10.1371/journal.pone.0075131	http://dx.doi.org/10.1371/journal.pone.0075131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040394	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000326734500135
J	Tang, B; Peng, ZH; Yu, PW; Yu, G; Qian, F; Zeng, DZ; Zhao, YL; Shi, Y; Hao, YX; Luo, HX				Tang, Bo; Peng, Zhi-hong; Yu, Pei-Wu; Yu, Ge; Qian, Feng; Zeng, Dong-zhu; Zhao, Yong-liang; Shi, Yan; Hao, Ying-xue; Luo, Hua-xing			Aberrant Expression of Cx43 Is Associated with the Peritoneal Metastasis of Gastric Cancer and Cx43-Mediated Gap Junction Enhances Gastric Cancer Cell Diapedesis from Peritoneal Mesothelium	PLOS ONE			English	Article							BREAST-CANCER; INTERCELLULAR COMMUNICATION; CONNEXIN-43; INVASION	The process of peritoneal metastasis involves the diapedesis of intra-abdominal exfoliated gastric cancer cells through the mesothelial cell monolayers; however, the related molecular mechanisms for this process are still unclear. Heterocellular gap-junctional intercellular communication (GJIC) between gastric cancer cells and mesothelial cells may play an active role during diapedesis. In this study we detected the expression of connexin 43 (Cx43) in primary gastric cancer tissues, intra-abdominal exfoliated cancer cells, and matched metastatic peritoneal tissues. We found that the expression of Cx43 in primary gastric cancer tissues was significantly decreased; the intra-abdominal exfoliated cancer cells and matched metastatic peritoneal tissues exhibited increasing expression compared with primary gastric cancer tissues. BGC-823 and SGC-7901 human gastric cancer cells were engineered to express Cx43 or Cx43T154A (a mutant protein that only couples gap junctions but provides no intercellular communication) and were co-cultured with human peritoneal mesothelial cells (HPMCs). Heterocellular GJIC and diapedesis through HPMC monolayers on matrigel-coated coverslips were investigated. We found that BGC-823 and SGC-7901 gastric cancer cells expressing Cx43 formed functional heterocellular gap junctions with HPMC monolayers within one hour. A significant increase in diapedesis was observed in engineered Cx43-expressing cells compared with Cx43T154A and control group cells, which suggested that the observed upregulation of diapedesis in Cx43-expressing cells required heterocellular GJIC. Further study revealed that the gastric cancer cells transmigrated through the intercellular space between the mesothelial cells via a paracellular route. Our results suggest that the abnormal expression of Cx43 plays an essential role in peritoneal metastasis and that Cx43-mediated heterocellular GJIC between gastric cancer cells and mesothelial cells may be an important regulatory step during metastasis. Finally, we observed that the diapedesis of exfoliated gastric cancer cells through mesothelial barriers is a viable route of paracellular migration.	[Tang, Bo; Yu, Pei-Wu; Yu, Ge; Qian, Feng; Zeng, Dong-zhu; Zhao, Yong-liang; Shi, Yan; Hao, Ying-xue; Luo, Hua-xing] Third Mil Med Univ, Southwest Hosp, Gen Surg Ctr PLA, Chongqing, Peoples R China; [Peng, Zhi-hong] Third Mil Med Univ, Southwest Hosp, Inst Digest Dis, Chongqing, Peoples R China	Army Medical University; Army Medical University	Yu, PW (corresponding author), Third Mil Med Univ, Southwest Hosp, Gen Surg Ctr PLA, Chongqing, Peoples R China.	tangtbo@sina.cn			National Natural Science Foundation of China [30801097, 81272366]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant No. 30801097 and No. 81272366 from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-31; Bao B, 2011, FASEB J, V25, P255, DOI 10.1096/fj.10-155291; Bates DC, 2007, GLIA, V55, P1554, DOI 10.1002/glia.20569; Beahm DL, 2006, J BIOL CHEM, V281, P7994, DOI 10.1074/jbc.M506533200; Cronier L, 2009, ANTIOXID REDOX SIGN, V11, P323, DOI 10.1089/ars.2008.2153; Edwards JR, 2010, J THEOR BIOL, V263, P45, DOI 10.1016/j.jtbi.2009.12.002; Elzarrad MK, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-20; Ezumi K, 2008, CLIN CANCER RES, V14, P677, DOI 10.1158/1078-0432.CCR-07-1184; Goldberg GS, 2004, BBA-BIOMEMBRANES, V1662, P96, DOI 10.1016/j.bbamem.2003.11.022; Kanczuga-Koda L, 2006, J CLIN PATHOL, V59, P429, DOI 10.1136/jcp.2005.029272; Langlois S, 2010, CANCER RES, V70, P4222, DOI 10.1158/0008-5472.CAN-09-3281; Luiza KK, 2007, CURR SIGNAL TRANSD T, V2, P49, DOI 10.2174/157436207779317074; Matharu G, 2011, BRIT J SURG, V98, P1225, DOI 10.1002/bjs.7586; McLachlan E, 2007, J MEMBRANE BIOL, V218, P107, DOI 10.1007/s00232-007-9052-x; McLachlan E, 2006, CANCER RES, V66, P9886, DOI 10.1158/0008-5472.CAN-05-4302; Mesnil M, 2004, M S-MED SCI, V20, P197, DOI 10.1051/medsci/2004202197; Muller WA, 2009, CIRC RES, V105, P223, DOI 10.1161/CIRCRESAHA.109.200717; Naoi Y, 2007, BREAST CANCER RES TR, V106, P11, DOI 10.1007/s10549-006-9465-8; Naus CC, 2010, NAT REV CANCER, V10, P435, DOI 10.1038/nrc2841; Pollmann MA, 2005, BREAST CANCER RES, V7, pR522, DOI 10.1186/bcr1042; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; Shabir S, 2008, CELL CALCIUM, V44, P453, DOI 10.1016/j.ceca.2008.02.008; Takahashi-Iwanaga H, 2008, J COMP NEUROL, V510, P68, DOI 10.1002/cne.21756; Tang B, 2011, MED ONCOL, V28, P502, DOI 10.1007/s12032-010-9492-5; Wu Jin, 2007, Zhonghua Zhongliu Zazhi, V29, P742; Zhang ZQ, 2004, CARCINOGENESIS, V25, P473, DOI 10.1093/carcin/bgh036; Zhao W, 2011, INT J BIOCHEM CELL B, V43, P1459, DOI 10.1016/j.biocel.2011.06.009	27	35	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74527	10.1371/journal.pone.0074527	http://dx.doi.org/10.1371/journal.pone.0074527			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040271	Green Published, Green Submitted			2022-12-25	WOS:000326734500099
J	Saul, A; Smith, T; Maire, N				Saul, Allan; Smith, Tom; Maire, Nicolas			Stochastic Simulation of Endemic Salmonella enterica Serovar Typhi: The Importance of Long Lasting Immunity and the Carrier State	PLOS ONE			English	Article							CONJUGATE VACCINES; FEVER; CHILDREN; BURDEN; IMMUNOGENICITY; PATHOGENESIS; COUNTRIES; MORTALITY; IMPACT; INDIA	Background: Typhoid fever caused by Salmonella enterica serovar Typhi (S. Typhi) remains a serious burden of disease, especially in developing countries of Asia and Africa. It is estimated that it causes 200,000 deaths per year, mainly in children. S. Typhi is an obligate pathogen of humans and although it has a relatively complex life cycle with a long lived carrier state, the absence of non-human hosts suggests that well targeted control methods should have a major impact on disease. Newer control methods including new generations of vaccines offer hope but their implementation would benefit from quantitative models to guide the most cost effective strategies. This paper presents a quantitative model of Typhoid disease, immunity and transmission as a first step in that process. Methodology/Principal Findings: A stochastic agent-based model has been developed that incorporates known features of the biology of typhoid including probability of infection, the consequences of infection, treatment options, acquisition and loss of immunity as a result of infection and vaccination, the development of the carrier state and the impact of environmental or behavioral factors on transmission. The model has been parameterized with values derived where possible from the literature and where this was not possible, feasible parameters space has been determined by sensitivity analyses, fitting the simulations to age distribution of field data. The model is able to adequately predict the age distribution of typhoid in two settings. Conclusions/Significance: The modeling highlights the importance of variations in the exposure/resistance of infants and young children to infection in different settings, especially as this impacts on design of control programs; it predicts that naturally induced clinical and sterile immunity to typhoid is long lived and highlights the importance of the carrier state especially in areas of low transmission.	[Saul, Allan] Novartis Vaccines Inst Global Hlth, Siena, Italy; [Smith, Tom; Maire, Nicolas] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Smith, Tom; Maire, Nicolas] Univ Basel, Basel, Switzerland	Novartis; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Saul, A (corresponding author), Novartis Vaccines Inst Global Hlth, Siena, Italy.	allan.saul@novartis.com	Smith, Thomas/B-5569-2015; Saul, Allan J/I-6968-2013; Saul, Allan/ABH-2091-2020	Smith, Thomas/0000-0002-3650-9381; Saul, Allan J/0000-0003-0665-4091; Saul, Allan/0000-0003-0665-4091	Novartis; Swiss Tropical and Public Health Institute; Seventh Framework Programme of the European Union, under the GENDRIVAX Grant [251522]	Novartis(Novartis); Swiss Tropical and Public Health Institute; Seventh Framework Programme of the European Union, under the GENDRIVAX Grant	The study received funding from Novartis and the Swiss Tropical and Public Health Institute. Exchange visits between Novartis Vaccines Institute and the Swiss Tropical and Public Health Institute received funding from Seventh Framework Programme of the European Union, under the GENDRIVAX Grant Agreement no 251522 (www.gendrivax.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjuik M, 2006, B WORLD HEALTH ORGAN, V84, P181, DOI 10.2471/BLT.05.026492; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P49; Bhutta ZA, 1996, ARCH DIS CHILD, V75, P214, DOI 10.1136/adc.75.3.214; Bhutta ZA, 2011, ADV EXP MED BIOL, V697, P17, DOI 10.1007/978-1-4419-7185-2_3; CHIN KC, 1986, ARCH DIS CHILD, V61, P1228, DOI 10.1136/adc.61.12.1228; CHUTTANI CS, 1971, B WORLD HEALTH ORGAN, V45, P445; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; CVJETANOVIC B, 1971, B WORLD HEALTH ORGAN, V45, P53; DUGGAN MB, 1975, ARCH DIS CHILD, V50, P67, DOI 10.1136/adc.50.1.67; FERRECCIO C, 1984, J PEDIATR-US, V104, P899, DOI 10.1016/S0022-3476(84)80492-8; Gupta A, 2006, INT J INFECT DIS, V10, P309, DOI 10.1016/j.ijid.2005.06.005; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-187; HORNICK RB, 1970, NEW ENGL J MED, V283, P739, DOI 10.1056/NEJM197010012831406; HORNICK RB, 1970, NEW ENGL J MED, V283, P686, DOI 10.1056/NEJM197009242831306; Karkey A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013988; Klugman KP, 1996, VACCINE, V14, P435, DOI 10.1016/0264-410X(95)00186-5; Kossaczka Z, 1999, INFECT IMMUN, V67, P5806, DOI 10.1128/IAI.67.11.5806-5810.1999; Lauria DT, 2009, VACCINE, V27, P1609, DOI 10.1016/j.vaccine.2008.12.032; LEVINE MM, 1982, J INFECT DIS, V146, P724, DOI 10.1093/infdis/146.6.724; Lin FYC, 2000, AM J TROP MED HYG, V62, P644, DOI 10.4269/ajtmh.2000.62.644; MARMION DE, 1953, J HYG-CAMBRIDGE, V51, P260, DOI 10.1017/S0022172400015680; Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818; Owais A, 2010, PEDIATR INFECT DIS J, V29, P1035, DOI 10.1097/INF.0b013e3181e39f8b; Podda A, 2010, J INFECT DEV COUNTR, V4, P404, DOI 10.3855/jidc.1048; Regional Meterological Center Kolkata, 2013, CLIM KOLK GLANC; Saha SK, 2001, PEDIATR INFECT DIS J, V20, P521, DOI 10.1097/00006454-200105000-00010; Siddiqui FJ, 2006, INT J INFECT DIS, V10, P215, DOI 10.1016/j.ijid.2005.03.010; Sinha A, 1999, LANCET, V354, P734, DOI 10.1016/S0140-6736(98)09001-1; Sur D, 2006, T ROY SOC TROP MED H, V100, P725, DOI 10.1016/j.trstmh.2005.10.019; Sur D, 2009, NEW ENGL J MED, V361, P335, DOI 10.1056/NEJMoa0807521; United Nations Department of Economic and Social Affairs Population Division, 2013, WORLD POP PROSP 2012; van Damme P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025398	32	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74097	10.1371/journal.pone.0074097	http://dx.doi.org/10.1371/journal.pone.0074097			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040177	gold, Green Published, Green Submitted			2022-12-25	WOS:000327538600069
J	Amaike, S; Affeldt, KJ; Yin, WB; Franke, S; Choithani, A; Keller, NP				Amaike, Saori; Affeldt, Katharyn J.; Yin, Wen-Bing; Franke, Stephen; Choithani, Anjali; Keller, Nancy P.			The bZIP Protein MeaB Mediates Virulence Attributes in Aspergillus flavus	PLOS ONE			English	Article							NITROGEN METABOLITE REPRESSION; SECONDARY METABOLISM; AFLATOXIN BIOSYNTHESIS; SCLEROTIAL PRODUCTION; NIDULANS; GENE; PARASITICUS; LAEA; VEA; EXPRESSION	LaeA is a fungal specific virulence factor of both plant and human pathogenic fungi. Transcriptional profiles of laeA mutants have been successfully exploited to identify regulatory mechanisms of secondary metabolism in fungi; here we use laeA mutants as tools to elucidate virulence attributes in Aspergillus flavus. Microarray expression profiles of Delta laeA and overexpression laeA (OE::laeA) were compared to wild type A. flavus. Strikingly, several nitrogen metabolism genes are oppositely mis-regulated in the Delta laeA and OE:: laeA mutants. One of the nitrogen regulatory genes, the bZIP encoding meaB, is up-regulated in Delta laeA. Significantly, over-expression of meaB (OE:: meaB) phenocopies the decreased virulence attributes of a Delta laeA phenotype including decreased colonization of host seed, reduced lipase activity and loss of aflatoxin B1 production in seed. However, a double knock-down of laeA and meaB (KD::laeA, meaB) demonstrated that KD:: laeA, meaB closely resembled Delta laeA rather than wild type or Delta meaB in growth, aflatoxin biosynthesis and sclerotia production thus suggesting that meaB does not contribute to the Delta laeA phenotype. MeaB and LaeA appear to be part of regulatory networks that allow them to have both shared and distinct roles in fungal biology.	[Amaike, Saori; Franke, Stephen] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Affeldt, Katharyn J.; Yin, Wen-Bing; Choithani, Anjali; Keller, Nancy P.] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Keller, Nancy P.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Keller, NP (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA.	npkeller@wisc.edu	Keller, Nancy P./ABC-5911-2021; Yin, Wen-Bing/AAF-4825-2021	Amaike Campen, Saori/0000-0002-7218-1301	United States Department of Agriculture Cooperative State Research, Education and Extension Service (CSREES) project [WIS01200]; National Science Foundation [IOB-0544428, S060039]; National Institutes of Health from National Institute of General Medical Sciences [PO1GM084077]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM084077] Funding Source: NIH RePORTER	United States Department of Agriculture Cooperative State Research, Education and Extension Service (CSREES) project; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health from National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding has been provided for this research from the United States Department of Agriculture Cooperative State Research, Education and Extension Service (CSREES) project (WIS01200), National Science Foundation IOB-0544428, sub-agreement S060039 and National Institutes of Health grant PO1GM084077 from the National Institute of General Medical Sciences to NPK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaike S, 2011, ANNU REV PHYTOPATHOL, V49, P107, DOI 10.1146/annurev-phyto-072910-095221; Amaike S, 2009, EUKARYOT CELL, V8, P1051, DOI 10.1128/EC.00088-09; Andrianopoulos A, 1998, J BACTERIOL, V180, P1973, DOI 10.1128/JB.180.7.1973-1977.1998; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bok Jin Woo, 2012, Methods Mol Biol, V944, P163, DOI 10.1007/978-1-62703-122-6_11; Bok JW, 2006, CHEM BIOL, V13, P31, DOI 10.1016/j.chembiol.2005.10.008; Bok JW, 2005, EUKARYOT CELL, V4, P1574, DOI 10.1128/EC.4.9.1574-1582.2005; CADDICK MX, 1986, EMBO J, V5, P1087, DOI 10.1002/j.1460-2075.1986.tb04326.x; Calvo AM, 2004, APPL ENVIRON MICROB, V70, P4733, DOI 10.1128/AEM.70.8.4733-4739.2004; Calvo AM, 2008, FUNGAL GENET BIOL, V45, P1053, DOI 10.1016/j.fgb.2008.03.014; CHANG PK, 1995, APPL ENVIRON MICROB, V61, P2372, DOI 10.1128/AEM.61.6.2372-2377.1995; Duran RM, 2007, APPL MICROBIOL BIOT, V73, P1158, DOI 10.1007/s00253-006-0581-5; Ehrlich KC, 2002, APPL MICROBIOL BIOT, V60, P174, DOI 10.1007/s00253-002-1094-5; Feng GH, 1998, APPL ENVIRON MICROB, V64, P2275; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; Georgianna DR, 2010, MOL PLANT PATHOL, V11, P213, DOI 10.1111/j.1364-3703.2009.00594.x; He ZM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-104; KACHHOLZ T, 1983, J NAT PROD, V46, P499, DOI 10.1021/np50028a013; Kale SP, 2008, FUNGAL GENET BIOL, V45, P1422, DOI 10.1016/j.fgb.2008.06.009; Klich MA, 2007, MOL PLANT PATHOL, V8, P713, DOI 10.1111/J.1364-3703.2007.00436.X; Lopez-Berges MS, 2010, PLANT CELL, V22, P2459, DOI 10.1105/tpc.110.075937; MATELES RI, 1965, APPL MICROBIOL, V13, P208, DOI 10.1128/AEM.13.2.208-211.1965; McDonald T, 2005, MOL PLANT MICROBE IN, V18, P539, DOI 10.1094/MPMI-18-0539; Merhej J, 2012, MOL PLANT PATHOL, V13, P363, DOI 10.1111/j.1364-3703.2011.00755.x; MILLER BL, 1985, MOL CELL BIOL, V5, P1714, DOI 10.1128/MCB.5.7.1714; Morita H, 2007, FUNGAL GENET BIOL, V44, P330, DOI 10.1016/j.fgb.2006.10.009; Palmer JM, 2010, MICROBIOL-SGM, V156, P3522, DOI 10.1099/mic.0.039255-0; Polly SD, 1996, FEMS LETT, V338, P200; Reverberi M, 2007, FOOD ADDIT CONTAM A, V24, P1070, DOI 10.1080/02652030701553244; Reverberi M, 2012, APPL MICROBIOL BIOT, V95, P1293, DOI 10.1007/s00253-012-3985-4; Robellet X, 2010, CURR GENET, V56, P341, DOI 10.1007/s00294-010-0303-5; Roze LV, 2011, J BIOL CHEM, V286, P35137, DOI 10.1074/jbc.M111.253468; Schrettl M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001124; Shaaban MI, 2010, EUKARYOT CELL, V9, P1816, DOI 10.1128/EC.00189-10; SHAFFER PM, 1984, MOL GEN GENET, V198, P139, DOI 10.1007/BF00328713; Shimizu K, 2001, GENETICS, V157, P591; Soukup AA, 2012, FUNGAL GENET BIOL, V49, P857, DOI 10.1016/j.fgb.2012.09.005; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Tsitsigiannis DI, 2005, INFECT IMMUN, V73, P4548, DOI 10.1128/IAI.73.8.4548-4559.2005; Vallim MA, 2000, MOL MICROBIOL, V36, P290, DOI 10.1046/j.1365-2958.2000.01874.x; Wagner D, 2010, EUKARYOT CELL, V9, P1588, DOI 10.1128/EC.00146-10; Wiemann P, 2010, MOL MICROBIOL, V77, P972, DOI 10.1111/j.1365-2958.2010.07263.x; Wong KH, 2007, MOL MICROBIOL, V66, P534, DOI 10.1111/j.1365-2958.2007.05940.x; Wu DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002542; Xing W, 2010, BIOTECHNOL LETT, V32, P1733, DOI 10.1007/s10529-010-0375-9; Yin WB, 2012, MOL MICROBIOL, V83, P1024, DOI 10.1111/j.1365-2958.2012.07986.x; Yu Jiujiang, 2005, Revista Iberoamericana de Micologia, V22, P194	47	23	29	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74030	10.1371/journal.pone.0074030	http://dx.doi.org/10.1371/journal.pone.0074030			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040154	gold, Green Published, Green Submitted			2022-12-25	WOS:000326405300152
J	Best, LG; Anderson, CM; Saxena, R; Almoguera, B; Chandrupatla, H; Martin, C; Falcon, G; Keplin, K; Pearson, N; Keating, BJ				Best, Lyle G.; Anderson, Cindy M.; Saxena, Richa; Almoguera, Berta; Chandrupatla, Hareesh; Martin, Candelaria; Falcon, Gilbert; Keplin, Kylie; Pearson, Nichole; Keating, Brendan J.			IBC CARe Microarray Allelic Population Prevalences in an American Indian Population	PLOS ONE			English	Article							GENE; ASSOCIATION	Background: The prevalence of variant alleles among single nucleotide polymorphisms (SNPs) is not well known for many minority populations. These population allele frequencies (PAFs) are necessary to guide genetic epidemiology studies and to understand the population specific contribution of these variants to disease risk. Large differences in PAF among certain functional groups of genes could also indicate possible selection pressure or founder effects of interest. The 50K SNP, custom genotyping microarray (CARe) was developed, focusing on about 2,000 candidate genes and pathways with demonstrated pathophysiologic influence on cardiovascular disease (CVD). Methods: The CARe microarray was used to genotype 216 unaffected controls in a study of pre-eclampsia among a Northern Plains, American Indian tribe. The allelic prevalences of 34,240 SNPs suitable for analysis, were determined and compared with corresponding HapMap prevalences for the Caucasian population. Further analysis was conducted to compare the frequency of statistically different prevalences among functionally related SNPs, as determined by the DAVID Bioinformatics Resource. Results: Of the SNPs with PAFs in both datasets, 9.8%, 37.2% and 47.1% showed allele frequencies among the American Indian population greater than, less than and either greater or less than (respectively) the HapMap Caucasian population. The 2,547 genes were divided into 53 functional groups using the highest stringency criteria. While none of these groups reached the Bonferroni corrected p value of 0.00094, there were 7 of these 53 groups with significantly more or less differing PAFs, each with a probability of less than 0.05 and an overall probability of 0.0046. Conclusion: In comparison to the HapMap Caucasian population, there are substantial differences in the prevalence among an American Indian community of SNPs related to CVD. Certain functional groups of genes and related SNPs show possible evidence of selection pressure or founder effects.	[Best, Lyle G.; Martin, Candelaria; Falcon, Gilbert; Keplin, Kylie; Pearson, Nichole] Turtle Mt Community Coll, Dept Sci, Belcourt, ND USA; [Best, Lyle G.] Univ N Dakota, Sch Med & Hlth Sci, Grand Forks, ND 58201 USA; [Anderson, Cindy M.] Univ N Dakota, Coll Nursing, Grand Forks, ND 58201 USA; [Saxena, Richa] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA USA; [Almoguera, Berta; Chandrupatla, Hareesh; Keating, Brendan J.] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA	University of North Dakota Grand Forks; University of North Dakota Grand Forks; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Best, LG (corresponding author), Turtle Mt Community Coll, Dept Sci, Belcourt, ND USA.	lbest@restel.com	Saxena, Richa/AAG-7279-2020	Anderson, Cindy/0000-0002-8276-6557; Saxena, Richa/0000-0003-2233-1065	National Institute of General Medical Sciences of the National Institutes of Health [P20GM12345]; Department of Defense [W911NF-09-1-0016]; NIH NCRR [C06RR022088]; Robert Wood Johnson Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016471, C06RR022088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103442] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Defense(United States Department of Defense); NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM12345, Grant Number W911NF-09-1-0016 from the Department of Defense, NIH NCRR (C06RR022088, Lindseth PI) and the Robert Wood Johnson Foundation, Nurse Faculty Scholar Award (Anderson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Best LG, 2012, AM J REPROD IMMUNOL, V67, P152, DOI 10.1111/j.1600-0897.2011.01076.x; Chang MH, 2009, AM J EPIDEMIOL, V169, P54, DOI 10.1093/aje/kwn286; Cross DS, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-51; Garte S, 2001, CANCER EPIDEM BIOMAR, V10, P1239; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang HY, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-7; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; LEE ET, 1995, DIABETES CARE, V18, P599, DOI 10.2337/diacare.18.5.599; Malhotra A, 2011, OBESITY, V19, P2102, DOI 10.1038/oby.2011.178; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287	14	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e75080	10.1371/journal.pone.0075080	http://dx.doi.org/10.1371/journal.pone.0075080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040389	gold, Green Published, Green Submitted			2022-12-25	WOS:000324856500104
J	Cheng, CS; Jia, KF; Chen, T; Chang, SY; Lin, MS; Yin, HS				Cheng, Chao-Sheng; Jia, Kai-Fan; Chen, Ting; Chang, Shun-Ya; Lin, Ming-Shen; Yin, Hsien-Sheng			Experimentally Validated Novel Inhibitors of Helicobacter pylori Phosphopantetheine Adenylyltransferase Discovered by Virtual High-Throughput Screening	PLOS ONE			English	Article							COENZYME-A; ESCHERICHIA-COLI; DIHYDROFOLATE-REDUCTASE; CRYSTAL-STRUCTURE; SCORING FUNCTION; MECHANISM; METHOTREXATE; PATHOGENESIS; RESISTANCE; PROGRAM	Helicobacter pylori is a major etiologic agent associated with the development and maintenance of human gastritis. The goal of this study was to develop novel antibiotics against H. pylori, and we thus targeted H. pylori phosphopantetheine adenylyltransferase (HpPPAT). PPAT catalyzes the penultimate step in coenzyme A biosynthesis. Its inactivation effectively prevents bacterial viability, making it an attractive target for antibacterial drug discovery. We employed virtual high-throughput screening and the HpPPAT crystal structure to identify compounds in the PubChem database that might act as inhibitors of HpPPAT. D-amethopterin is a potential inhibitor for blocking HpPPAT activity and suppressing H. pylori viability. Following treatment with D-amethopterin, H. pylori exhibited morphological characteristics associated with cell death. D-amethopterin is a mixed inhibitor of HpPPAT activity; it simultaneously occupies the HpPPAT 4'-phosphopantetheine- and ATP-binding sites. Its binding affinity is in the micromolar range, implying that it is sufficiently potent to serve as a lead compound in subsequent drug development. Characterization of the D-amethopterin and HpPPAT interaction network in a docked model will allow us to initiate rational drug optimization to improve the inhibitory efficacy of D-amethopterin. We anticipate that novel, potent, and selective HpPPAT inhibitors will emerge for the treatment of H. pylori infection.	[Cheng, Chao-Sheng; Jia, Kai-Fan; Chen, Ting; Chang, Shun-Ya; Yin, Hsien-Sheng] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Cheng, Chao-Sheng; Jia, Kai-Fan; Chen, Ting; Chang, Shun-Ya; Yin, Hsien-Sheng] Natl Tsing Hua Univ, Coll Life Sci, Hsinchu, Taiwan; [Lin, Ming-Shen] TA Instruments Waters LLC, Taipei, Taiwan	National Tsing Hua University; National Tsing Hua University	Yin, HS (corresponding author), Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan.	hstin@mx.nthu.edu.tw	Chen, Ting/GOE-6981-2022	Chen, Ting/0000-0001-8055-3104	National Science Council, Taiwan (NSC) [NSC-99-2311-B-007-004-MY3, NSC-101-2627-B-007-003, NSC-101-2321-B-007-005-MY2]	National Science Council, Taiwan (NSC)(Ministry of Science and Technology, Taiwan)	The authors acknowledge the support of the National Science Council, Taiwan (NSC grant numbers NSC-99-2311-B-007-004-MY3, NSC-101-2627-B-007-003 and NSC-101-2321-B-007-005-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanian S, 2002, BIOCHEM J, V365, P13, DOI 10.1042/BJ20020569; [Anonymous], 2007, DISCOVERY STUDIO VAS; Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; BARTLETT MS, 1995, ANTIMICROB AGENTS CH, V39, P2436, DOI 10.1128/AAC.39.11.2436; Begley TP, 2001, VITAM HORM, V61, P157; BERG JM, 2007, BIOCHEMISTRY; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cheng CS, 2011, BIOCHEM BIOPH RES CO, V408, P356, DOI 10.1016/j.bbrc.2011.04.058; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Geerlof A, 1999, J BIOL CHEM, V274, P27105, DOI 10.1074/jbc.274.38.27105; GEHLHAAR DK, 1995, CHEM BIOL, V2, P317, DOI 10.1016/1074-5521(95)90050-0; Gerdes SY, 2002, J BACTERIOL, V184, P4555, DOI 10.1128/JB.184.16.4555-4572.2002; Graham DY, 2008, NAT CLIN PRACT GASTR, V5, P321, DOI 10.1038/ncpgasthep1138; HARRIS RE, 1980, CANCER, V46, P2004, DOI 10.1002/1097-0142(19801101)46:9<2004::AID-CNCR2820460918>3.0.CO;2-S; Hirai Y, 1999, JPN J INFECT DIS, V52, P183; Izard T, 1999, EMBO J, V18, P2021, DOI 10.1093/emboj/18.8.2021; Izard T, 2002, J MOL BIOL, V315, P487, DOI 10.1006/jmbi.2001.5272; JACKOWSKI S, 1984, J BACTERIOL, V158, P115, DOI 10.1128/JB.158.1.115-120.1984; JACKOWSKI S, 1981, J BACTERIOL, V148, P926, DOI 10.1128/JB.148.3.926-932.1981; Krammer A, 2005, J MOL GRAPH MODEL, V23, P395, DOI 10.1016/j.jmgm.2004.11.007; Kusters JG, 1997, INFECT IMMUN, V65, P3672, DOI 10.1128/IAI.65.9.3672-3679.1997; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; LIN JT, 1991, CANCER INVEST, V9, P159, DOI 10.3109/07357909109044227; Maple JR, 1998, J COMPUT CHEM, V19, P430, DOI 10.1002/(SICI)1096-987X(199803)19:4<430::AID-JCC5>3.0.CO;2-T; Miller JR, 2007, J BACTERIOL, V189, P8196, DOI 10.1128/JB.00732-07; Miller JR, 2010, CHEM BIOL DRUG DES, V75, P444, DOI 10.1111/j.1747-0285.2010.00957.x; Minakari M, 2010, HELICOBACTER, V15, P154, DOI 10.1111/j.1523-5378.2009.00739.x; Mirbagheri SA, 2006, WORLD J GASTROENTERO, V12, P4888; Morris VK, 2004, PROTEIN SCI, V13, P2547, DOI 10.1110/ps.04816904; Muegge I, 1999, J MED CHEM, V42, P791, DOI 10.1021/jm980536j; Proenca-Modena JL, 2009, FUTURE MICROBIOL, V4, P223, DOI 10.2217/17460913.4.2.223; Rester U, 2008, CURR OPIN DRUG DISC, V11, P559; Rock CO, 2003, J BACTERIOL, V185, P3410, DOI 10.1128/JB.185.11.3410-3415.2003; Rollinger Judith M., 2008, V65; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P586, DOI 10.1021/bi962337c; Shaw WV, 2000, Production and use of antimicrobial agents, Patent No. [Wo0017387, 0017387]; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Smoot DT, 1997, GASTROENTEROLOGY, V113, pS31, DOI 10.1016/S0016-5085(97)80008-X; THILLET J, 1988, J BIOL CHEM, V263, P12500; Venkatachalam CM, 2003, J MOL GRAPH MODEL, V21, P289, DOI 10.1016/S1093-3263(02)00164-X; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang X, 2001, J MED MICROBIOL, V50, P430, DOI 10.1099/0022-1317-50-5-430; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Wubben TJ, 2010, J MOL BIOL, V404, P202, DOI 10.1016/j.jmb.2010.09.002; Zhao LH, 2003, EUR J MED CHEM, V38, P345, DOI 10.1016/S0223-5234(03)00047-3; Zhyvoloup A, 2002, J BIOL CHEM, V277, P22107, DOI 10.1074/jbc.C200195200	49	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74271	10.1371/journal.pone.0074271	http://dx.doi.org/10.1371/journal.pone.0074271			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040220	Green Submitted, gold, Green Published			2022-12-25	WOS:000324481600123
J	Hu, LW; Mei, ZL; Zang, AP; Chen, HY; Dou, XY; Jin, J; Cai, WM				Hu, Liwei; Mei, Zhiling; Zang, Aiping; Chen, Haiying; Dou, Xianying; Jin, Jing; Cai, Weiming			Microarray Analyses and Comparisons of Upper or Lower Flanks of Rice Shoot Base Preceding Gravitropic Bending	PLOS ONE			English	Article							AUXIN TRANSPORT; GENE ONTOLOGY; ARABIDOPSIS; ROOT; GIBBERELLIN; ETHYLENE; TOOL; DISPLAY; GRAVISTIMULATION; BRASSINOSTEROIDS	Gravitropism is a complex process involving a series of physiological pathways. Despite ongoing research, gravitropism sensing and response mechanisms are not well understood. To identify the key transcripts and corresponding pathways in gravitropism, a whole-genome microarray approach was used to analyze transcript abundance in the shoot base of rice (Oryza sativa sp. japonica) at 0.5 h and 6 h after gravistimulation by horizontal reorientation. Between upper and lower flanks of the shoot base, 167 transcripts at 0.5 h and 1202 transcripts at 6 h were discovered to be significantly different in abundance by 2-fold. Among these transcripts, 48 were found to be changed both at 0.5 h and 6 h, while 119 transcripts were only changed at 0.5 h and 1154 transcripts were changed at 6 h in association with gravitropism. MapMan and PageMan analyses were used to identify transcripts significantly changed in abundance. The asymmetric regulation of transcripts related to phytohormones, signaling, RNA transcription, metabolism and cell wall-related categories between upper and lower flanks were demonstrated. Potential roles of the identified transcripts in gravitropism are discussed. Our results suggest that the induction of asymmetrical transcription, likely as a consequence of gravitropic reorientation, precedes gravitropic bending in the rice shoot base.	[Hu, Liwei; Mei, Zhiling; Zang, Aiping; Chen, Haiying; Dou, Xianying; Jin, Jing; Cai, Weiming] Chinese Acad Sci, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Grad Sch, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Cai, WM (corresponding author), Chinese Acad Sci, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Grad Sch, Shanghai, Peoples R China.	wmcai@sibs.ac.cn			National Basic Research Program of China [2011CB710902]; National Natural Science Foundation of China [31070237, 90917009]; National Scientific Program [2012AA101103-04]; Knowledge Innovation Program of the Chinese Academy of Sciences [KJCX2-YW-L08]; China Manned Space Flight Technology Project; National Transgenic Program [2009ZX08004-008B]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Scientific Program; Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); China Manned Space Flight Technology Project; National Transgenic Program	This work was supported by the National Basic Research Program of China (Grant No. 2011CB710902), the National Natural Science Foundation of China (Grant No. 31070237, 90917009), the National Scientific Program (grant 2012AA101103-04), the Knowledge Innovation Program of the Chinese Academy of Sciences (Grant No. KJCX2-YW-L08), the China Manned Space Flight Technology Project and the National Transgenic Program (Grant No. 2009ZX08004-008B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloni R, 2004, PLANTA, V220, P177, DOI 10.1007/s00425-004-1381-8; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bancos S, 2002, PLANT PHYSIOL, V130, P504, DOI 10.1104/pp.005439; Blancaflor EB, 2002, J PLANT GROWTH REGUL, V21, P120, DOI 10.1007/s003440010041; Buer CS, 2006, PLANT PHYSIOL, V140, P1384, DOI 10.1104/pp.105.075671; Buer CS, 2004, PLANT CELL, V16, P1191, DOI 10.1105/tpc.020313; Choe S, 2006, PHYSIOL PLANTARUM, V126, P539, DOI 10.1111/j.1399-3054.2006.00681.x; Clarke R, 2008, NAT REV CANCER, V8, P37, DOI 10.1038/nrc2294; Cui DY, 2005, J EXP BOT, V56, P1327, DOI 10.1093/jxb/eri133; Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; Edelmann HG, 2006, PROTOPLASMA, V229, P183, DOI 10.1007/s00709-006-0205-z; Esmon CA, 2006, P NATL ACAD SCI USA, V103, P236, DOI 10.1073/pnas.0507127103; Fasano JM, 2001, PLANT CELL, V13, P907, DOI 10.1105/tpc.13.4.907; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Fujihira K, 2000, PLANT CELL PHYSIOL, V41, P1193, DOI 10.1093/pcp/pcd046; GIBEAUT DM, 1990, PLANT PHYSIOL, V94, P411, DOI 10.1104/pp.94.2.411; Golan A, 1996, PLANT PHYSIOL, V112, P901, DOI 10.1104/pp.112.3.901; Guo D, 2007, PLANT MOL BIOL, V66, P345; Gutjahr C, 2005, PLANTA, V222, P575, DOI 10.1007/s00425-005-0001-6; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; Hong Z, 2003, PLANT CELL, V15, P2900, DOI 10.1105/tpc.014712; Hu Li Wei, 2009, Fen Zi Xi Bao Sheng Wu Xue Bao, V42, P27; Kamada M., 2005, Biological Sciences in Space, V19, P148, DOI 10.2187/bss.19.148; Kimbrough JM, 2004, PLANT PHYSIOL, V136, P2790, DOI 10.1104/pp.104.044594; Kiss JZ, 2000, CRIT REV PLANT SCI, V19, P551, DOI 10.1016/S0735-2689(01)80008-3; Knauss S, 2003, J BIOL CHEM, V278, P23936, DOI 10.1074/jbc.M212585200; Lewis DR, 2011, PLANT PHYSIOL, V156, P144, DOI 10.1104/pp.111.172502; Li L, 2005, PLANT CELL, V17, P2738, DOI 10.1105/tpc.105.034397; Li PJ, 2007, CELL RES, V17, P402, DOI 10.1038/cr.2007.38; Limbach C, 2005, PLANT PHYSIOL, V139, P1030, DOI 10.1104/pp.105.068106; Lo SF, 2008, PLANT CELL, V20, P2603, DOI 10.1105/tpc.108.060913; Lucas M, 2008, J EXP BOT, V59, P55, DOI 10.1093/jxb/erm171; MacCleery SAKJ, 1999, PLANT PHYSIOL, V120, P10; Martzivanou M, 2003, PHYSIOL PLANTARUM, V118, P221, DOI 10.1034/j.1399-3054.2003.00092.x; MCCLURE BA, 1989, SCIENCE, V243, P91, DOI 10.1126/science.11540631; Morita MT, 2004, CURR OPIN PLANT BIOL, V7, P712, DOI 10.1016/j.pbi.2004.09.001; Moseyko N, 2002, PLANT PHYSIOL, V130, P720, DOI 10.1104/pp.009688; Ottenschlager I, 2003, P NATL ACAD SCI USA, V100, P2987, DOI 10.1073/pnas.0437936100; Palmieri M, 2005, J EXP BOT, V56, P2539, DOI 10.1093/jxb/eri248; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Perera IK, 2001, PLANT PHYSIOL, V125, P1499, DOI 10.1104/pp.125.3.1499; Plieth C, 2002, PLANT PHYSIOL, V129, P786, DOI 10.1104/pp.011007; Rahman A, 2010, PLANT CELL, V22, P1762, DOI 10.1105/tpc.110.075317; Sakamoto T, 2004, PLANT PHYSIOL, V134, P1642, DOI 10.1104/pp.103.033696; Sakamoto T, 2006, J PLANT GROWTH REGUL, V25, P245, DOI 10.1007/s00344-006-0041-6; Schlitt T, 2003, GENOME RES, V13, P2568, DOI 10.1101/gr.1111403; Spartz AK, 2012, PLANT J, V70, P978, DOI 10.1111/j.1365-313X.2012.04946.x; Sugano Mami, 2004, Biol Sci Space, V18, P261, DOI 10.2187/bss.18.261; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; Usadel B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-535; Vandenbussche F, 2011, PLANT PHYSIOL, V156, P1331, DOI 10.1104/pp.111.177873; Wolbang CM, 2007, PHYSIOL PLANTARUM, V131, P140, DOI 10.1111/j.1399-3054.2007.00931.x; Yang HY, 2005, CLIN EXP METASTAS, V22, P593, DOI 10.1007/s10585-005-6244-6; Yoder TI, 2001, PLANT PHYSIOL, V125, P1045, DOI 10.1104/pp.125.2.1045; Zhang YY, 2008, CELL RES, V18, P412, DOI 10.1038/cr.2008.28	56	15	17	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74646	10.1371/journal.pone.0074646	http://dx.doi.org/10.1371/journal.pone.0074646			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040303	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600139
J	Nakazawa, Y; Lash, RR; Carroll, DS; Damon, IK; Karem, KL; Reynolds, MG; Osorio, JE; Rocke, TE; Malekani, JM; Muyembe, JJ; Formenty, P; Peterson, AT				Nakazawa, Yoshinori; Lash, R. Ryan; Carroll, Darin S.; Damon, Inger K.; Karem, Kevin L.; Reynolds, Mary G.; Osorio, Jorge E.; Rocke, Tonie E.; Malekani, Jean M.; Muyembe, Jean-Jacques; Formenty, Pierre; Peterson, A. Townsend			Mapping Monkeypox Transmission Risk through Time and Space in the Congo Basin	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; ECOLOGICAL NICHE; GEOGRAPHIC-DISTRIBUTION; VIRUS; DISTRIBUTIONS; NDVI; SMALLPOX; COVER; TRANSFERABILITY; CONSERVATION	Monkeypox is a major public health concern in the Congo Basin area, with changing patterns of human case occurrences reported in recent years. Whether this trend results from better surveillance and detection methods, reduced proportions of vaccinated vs. non-vaccinated human populations, or changing environmental conditions remains unclear. Our objective is to examine potential correlations between environment and transmission of monkeypox events in the Congo Basin. We created ecological niche models based on human cases reported in the Congo Basin by the World Health Organization at the end of the smallpox eradication campaign, in relation to remotely-sensed Normalized Difference Vegetation Index datasets from the same time period. These models predicted independent spatial subsets of monkeypox occurrences with high confidence; models were then projected onto parallel environmental datasets for the 2000s to create present-day monkeypox suitability maps. Recent trends in human monkeypox infection are associated with broad environmental changes across the Congo Basin. Our results demonstrate that ecological niche models provide useful tools for identification of areas suitable for transmission, even for poorly-known diseases like monkeypox.	[Nakazawa, Yoshinori; Lash, R. Ryan; Carroll, Darin S.; Damon, Inger K.; Karem, Kevin L.; Reynolds, Mary G.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Nakazawa, Yoshinori] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Osorio, Jorge E.] Univ Wisconsin, Sch Vet Med, Dept Pathol Sci, Madison, WI 53706 USA; [Rocke, Tonie E.] USGS Natl Wildlife Hlth Ctr, Madison, WI USA; [Malekani, Jean M.] Univ Kinshasa, Kinshasa, DEM REP CONGO; [Muyembe, Jean-Jacques] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Formenty, Pierre] WHO, Dept Communicable Dis Surveillance & Response, CH-1211 Geneva, Switzerland; [Peterson, A. Townsend] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA	Centers for Disease Control & Prevention - USA; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; University of Wisconsin System; University of Wisconsin Madison; United States Department of the Interior; United States Geological Survey; Universite de Kinshasa; Institute Nacional de Recherche Biomedical; World Health Organization; University of Kansas	Nakazawa, Y (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	ynakazawa@cdc.gov	Peterson, A. Townsend/I-5697-2013; Lash, R. Ryan/ABA-3420-2021	Peterson, A. Townsend/0000-0003-0243-2379; Lash, R. Ryan/0000-0002-7171-2748; Reynolds, Mary/0000-0001-7882-4614; Rocke, Tonie/0000-0003-3933-1563	National Institutes of Health [1R01TW008859-01]; FOGARTY INTERNATIONAL CENTER [R01TW008859] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research was supported by the National Institutes of Health grant 1R01TW008859-01 ("Sylvatic Reservoirs of Human Monkeypox"). Use of trade, product, or firm names does not imply endorsement by the United States Government. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; [Anonymous], P 21 INT C MACH LEAR; Anyamba A, 2002, PHOTOGRAMM ENG REM S, V68, P137; ARITA I, 1968, B WORLD HEALTH ORGAN, V39, P277; Berthet N, 2011, LANCET, V378, P1354, DOI 10.1016/S0140-6736(11)61142-2; Breman JG, 2000, EMERGING INFECT; Carlson TN, 1997, REMOTE SENS ENVIRON, V62, P241, DOI 10.1016/S0034-4257(97)00104-1; Carroll DS, 2011, PLOS ONE, V6, DOI DOI 10.2137/1J0URNAL.P0NE.0023086; Chapman AD, 2006, GLOBAL BIODIVERSITY; Costa GC, 2010, BIODIVERS CONSERV, V19, P883, DOI 10.1007/s10531-009-9746-8; Damon IK, 2006, NEW ENGL J MED, V355, P962, DOI 10.1056/NEJMc060792; DEFRIES RS, 1994, INT J REMOTE SENS, V15, P3567, DOI 10.1080/01431169408954345; Donalisio MR, 2011, ACTA TROP, V119, P125, DOI 10.1016/j.actatropica.2011.04.019; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Ellis CK, 2012, J WILDLIFE DIS, V48, P335, DOI 10.7589/0090-3558-48.2.335; Emerson GL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007666; ESPOSITO JJ, 1985, VIROLOGY, V143, P230, DOI 10.1016/0042-6822(85)90111-4; Formenty P, 2010, EMERG INFECT DIS, V16, P1539, DOI 10.3201/eid1610.100713; Fuller T, 2010, ECOHEALTH, P1, DOI [10.1007/s10393-10010-10355-10395, DOI 10.1007/S10393-10010-10355-10395]; Glass GE, 2007, ECOL APPL, V17, P129, DOI 10.1890/1051-0761(2007)017[0129:PHRAFH]2.0.CO;2; Gonzalez C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000585; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; Hansen MC, 2008, REMOTE SENS ENVIRON, V112, P2495, DOI 10.1016/j.rse.2007.11.012; Holt AC, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-38; Huemmrich KF, 1999, J GEOPHYS RES-ATMOS, V104, P27935, DOI 10.1029/1999JD900164; Jezek Z., 1988, MONOGRAPHS VIROLOGY; KHODAKEVICH L, 1987, TROP GEOGR MED, V39, P56; KHODAKEVICH L, 1986, LANCET, V1, P98; KHODAKEVICH L, 1988, B WORLD HEALTH ORGAN, V66, P747; LADNYJ ID, 1972, B WORLD HEALTH ORGAN, V46, P593; Lash RR, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-23; Learned LA, 2005, AM J TROP MED HYG, V73, P428, DOI 10.4269/ajtmh.2005.73.428; Levine RS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000176; Li Y, 2006, J CLIN VIROL, V36, P194, DOI 10.1016/j.jcv.2006.03.012; Likos AM, 2005, J GEN VIROL, V86, P2661, DOI 10.1099/vir.0.81215-0; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; MACKETT M, 1979, J GEN VIROL, V45, P683, DOI 10.1099/0022-1317-45-3-683; Meyer H, 2002, J CLIN MICROBIOL, V40, P2919, DOI 10.1128/JCM.40.8.2919-2921.2002; Nakazawa Y, 2007, VECTOR-BORNE ZOONOT, V7, P529, DOI 10.1089/vbz.2007.0125; Nakazawa Y, 2013, EMERG INFECT DIS, V19, P237, DOI 10.3201/eid1902.121220; Nakazawa Y, 2010, AM J TROP MED HYG, V82, P912, DOI 10.4269/ajtmh.2010.09-0354; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson A. T., 2006, BIODIVERSITY INFORM, V3, P59, DOI DOI 10.17161/BI.V3I0.29; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000261; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Peterson AT, 2005, T ROY SOC TROP MED H, V99, P647, DOI 10.1016/j.trstmh.2005.02.004; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 2004, EMERG INFECT DIS, V10, P40, DOI 10.3201/eid1001.030125; Peterson AT, 2002, EMERG INFECT DIS, V8, P662, DOI 10.3201/eid0807.010454; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P272, DOI 10.1111/j.0906-7590.2008.5378.x; Polop F, 2008, ECOL RES, V23, P217, DOI 10.1007/s11284-007-0371-2; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Reynolds MG, 2012, CURR OPIN VIROL, V2, P335, DOI 10.1016/j.coviro.2012.02.004; Rimoin AW, 2007, EMERG INFECT DIS, V13, P934, DOI 10.3201/eid1306.061540; Rimoin AW, 2010, P NATL ACAD SCI USA, V107, P16262, DOI 10.1073/pnas.1005769107; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; STOCKWELL DRB, 1992, MATH COMPUT SIMULAT, V33, P385, DOI 10.1016/0378-4754(92)90126-2; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; von Magnus P., 1959, Acta Pathologica et Microbiologica Scandinavica, V46, P156; Williams RAJ, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-47; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x	67	15	15	9	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74816	10.1371/journal.pone.0074816	http://dx.doi.org/10.1371/journal.pone.0074816			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040344	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600147
J	Natarajan, K; Xie, YQ; Burcu, M; Linn, DE; Qiu, Y; Baer, MR				Natarajan, Karthika; Xie, Yingqiu; Burcu, Mehmet; Linn, Douglas E.; Qiu, Yun; Baer, Maria R.			Pim-1 Kinase Phosphorylates and Stabilizes 130 kDa FLT3 and Promotes Aberrant STAT5 Signaling in Acute Myeloid Leukemia with FLT3 Internal Tandem Duplication	PLOS ONE			English	Article							CONSTITUTIVELY ACTIVATED FLT3; UBIQUITIN-PROTEASOME PATHWAY; SERINE/THREONINE KINASES; SUBSTRATE-SPECIFICITY; ENDOPLASMIC-RETICULUM; INHIBITOR; CELLS; PROTEIN; DEGRADATION; RECEPTOR	The type III receptor tyrosine kinase fms-like tyrosine kinase 3 (FLT3) is expressed on both normal hematopoietic stem cells and acute myeloid leukemia (AML) cells and regulates their proliferation. Internal tandem duplication (ITD) mutation of FLT3 is present in a third of AML cases, results in constitutive activation and aberrant signaling of FLT3, and is associated with adverse treatment outcomes. While wild-type (WT) FLT3 is predominantly a 150 kDa complex glycosylated cell surface protein, FLT3-ITD is partially retained in the endoplasmic reticulum as a 130 kDa underglycosylated species associated with the chaperones calnexin and heat shock protein (HSP) 90, and mediates aberrant STAT5 signaling, which upregulates the oncogenic serine/threonine kinase Pim-1. FLT3 contains a Pim-1 substrate consensus serine phosphorylation site, and we hypothesized that it might be a Pim-1 substrate. Pim-1 was indeed found to directly interact with and serine-phosphorylate FLT3. Pim-1 inhibition decreased the expression and half-life of 130 kDa FLT3, with partial abrogation by proteasome inhibition, in association with decreased FLT3 binding to calnexin and HSP90, and increased 150 kDa FLT3 expression and half-life, with abrogation by inhibition of glycosylation. These findings were consistent with Pim-1 stabilizing FLT3-ITD as a 130 kDa species associated with calnexin and HSP90 and inhibiting its glycosylation to form the 150 kDa species. Pim-1 knockdown effects were similar. Pim-1 inhibition also decreased phosphorylation of FLT3 at tyrosine 591 and of STAT5, and expression of Pim-1 itself, consistent with inhibition of the FLT3-ITD-STAT5 signaling pathway. Finally, Pim-1 inhibition synergized with FLT3 inhibition in inducing apoptosis of FLT3-ITD cells. This is, to our knowledge, the first demonstration of a role of Pim-1 in a positive feedback loop promoting aberrant signaling in malignant cells.	[Natarajan, Karthika; Xie, Yingqiu; Burcu, Mehmet; Qiu, Yun; Baer, Maria R.] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Linn, Douglas E.; Qiu, Yun] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA; [Baer, Maria R.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Baer, MR (corresponding author), Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA.	mbaer@umm.edu	Xie, Yingqiu/C-5346-2011; Natarajan, Karthika/G-7206-2012	Natarajan, Karthika/0000-0001-7435-1477	Leukemia and Lymphoma Society Translational Research Award; University of Maryland, Baltimore UMMG Cancer Research [CH 649 CRF]; State of Maryland Department of Health and Mental Hygiene (DHMH) under the Cigarette Restitution Fund Program; NCI Cancer Center [P30 CA134274 (UMGCC)]; NATIONAL CANCER INSTITUTE [P30CA134274] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society Translational Research Award(Leukemia and Lymphoma Society); University of Maryland, Baltimore UMMG Cancer Research; State of Maryland Department of Health and Mental Hygiene (DHMH) under the Cigarette Restitution Fund Program; NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by a Leukemia and Lymphoma Society Translational Research Award (MRB), University of Maryland, Baltimore UMMG Cancer Research Grant #CH 649 CRF, State of Maryland Department of Health and Mental Hygiene (DHMH) under the Cigarette Restitution Fund Program (MRB) and NCI Cancer Center Support Grant P30 CA134274 (UMGCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam M, 2006, CANCER RES, V66, P3828, DOI 10.1158/0008-5472.CAN-05-2309; Aho TLT, 2004, FEBS LETT, V571, P43, DOI 10.1016/j.febslet.2004.06.050; Bachmann M, 2006, INT J BIOCHEM CELL B, V38, P430, DOI 10.1016/j.biocel.2005.10.010; Baek S, 2013, J MOL BIOL, V425, P411, DOI 10.1016/j.jmb.2012.10.019; Bullock AN, 2005, J BIOL CHEM, V280, P41675, DOI 10.1074/jbc.M510711200; Chen LS, 2011, BLOOD, V118, P693, DOI 10.1182/blood-2010-12-323022; Chen XP, 2002, P NATL ACAD SCI USA, V99, P2175, DOI 10.1073/pnas.042035699; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; CUYPERS HT, 1984, CELL, V37, P141; Fathi A, 2011, CURR OPIN HEMATOL, V18, P71, DOI 10.1097/MOH.0b013e3283439a03; Fathi AT, 2012, LEUKEMIA RES, V36, P224, DOI 10.1016/j.leukres.2011.07.011; Fischer T, 2010, J CLIN ONCOL, V28, P4339, DOI 10.1200/JCO.2010.28.9678; George P, 2004, CANCER RES, V64, P3645, DOI 10.1158/0008-5472.CAN-04-0006; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Grundler R, 2009, J EXP MED, V206, P1957, DOI 10.1084/jem.20082074; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Holder S, 2007, MOL CANCER THER, V6, P163, DOI 10.1158/1535-7163.MCT-06-0397; Hospital MA, 2012, BLOOD, V119, P1791, DOI 10.1182/blood-2011-11-393066; Kamemura K, 2003, PROG NUCLEIC ACID RE, V73, P107, DOI 10.1016/S0079-6603(03)01004-3; Kelly LM, 2002, BLOOD, V99, P310, DOI 10.1182/blood.V99.1.310; Kim HR, 2008, J CELL BIOCHEM, V105, P1048, DOI 10.1002/jcb.21906; Kim KT, 2005, BLOOD, V105, P1759, DOI 10.1182/blood-2004-05-2006; Kim KT, 2007, BRIT J HAEMATOL, V138, P603, DOI 10.1111/j.1365-2141.2007.06696.x; Kim KT, 2006, BRIT J HAEMATOL, V134, P500, DOI 10.1111/j.1365-2141.2006.06225.x; Levis M, 2011, BLOOD, V117, P3294, DOI 10.1182/blood-2010-08-301796; Meshinchi S, 2009, CLIN CANCER RES, V15, P4263, DOI 10.1158/1078-0432.CCR-08-1123; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Minami Y, 2002, LEUKEMIA, V16, P1535, DOI 10.1038/sj.leu.2402558; Mochizuki T, 1999, J BIOL CHEM, V274, P18659, DOI 10.1074/jbc.274.26.18659; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Muraski JA, 2008, P NATL ACAD SCI USA, V105, P13889, DOI 10.1073/pnas.0709135105; Oshikawa G, 2011, J BIOL CHEM, V286, P30263, DOI 10.1074/jbc.M111.232348; Palaty CK, 1997, BIOCHEM CELL BIOL, V75, P153, DOI 10.1139/bcb-75-2-153; Qian KC, 2005, J BIOL CHEM, V280, P6130, DOI 10.1074/jbc.M409123200; Quentmeier H, 2003, LEUKEMIA, V17, P120, DOI 10.1038/sj.leu.2402740; Ramos RR, 2007, P NATL ACAD SCI USA, V104, P10470, DOI 10.1073/pnas.0701114104; Ravandi F, 2010, J CLIN ONCOL, V28, P1856, DOI 10.1200/JCO.2009.25.4888; Rocnik JL, 2006, BLOOD, V108, P1339, DOI 10.1182/blood-2005-11-011429; SARIS CJM, 1991, EMBO J, V10, P655, DOI 10.1002/j.1460-2075.1991.tb07994.x; Schmidt-Arras DE, 2005, MOL CELL BIOL, V25, P3690, DOI 10.1128/MCB.25.9.3690-3703.2005; Schmidt-Arras D, 2009, BLOOD, V113, P3568, DOI 10.1182/blood-2007-10-121426; Shay KP, 2005, MOL CANCER RES, V3, P170; Wang XR, 2008, CANCER RES, V68, P7409, DOI 10.1158/0008-5472.CAN-08-1522; Xie Y, 2008, J BIOL CHEM, V283, P3349, DOI 10.1074/jbc.M707773200; Xie YQ, 2010, MOL PHARMACOL, V78, P310, DOI 10.1124/mol.109.061713; Zarrinkar PP, 2009, BLOOD, V114, P2984, DOI 10.1182/blood-2009-05-222034; Zhang Y, 2008, ONCOGENE, V27, P4809, DOI 10.1038/onc.2008.123; Zhang YD, 2007, MOL CANCER RES, V5, P909, DOI 10.1158/1541-7786.MCR-06-0388	48	41	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74653	10.1371/journal.pone.0074653	http://dx.doi.org/10.1371/journal.pone.0074653			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040307	Green Submitted, Green Published, gold			2022-12-25	WOS:000324481600140
J	Opstad, TB; Pettersen, AA; Arnesen, H; Seljeflot, I				Opstad, Trine B.; Pettersen, Alf A.; Arnesen, Harald; Seljeflot, Ingebjorg			The Co-Existence of the IL-18+183 A/G and MMP-9-1562 C/T Polymorphisms Is Associated with Clinical Events in Coronary Artery Disease Patients	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; NF-KAPPA-B; MYOCARDIAL-INFARCTION; FUNCTIONAL POLYMORPHISM; CARDIOVASCULAR-DISEASE; PLAQUE INSTABILITY; METABOLIC SYNDROME; CIRCULATING LEVELS; GENETIC-VARIATION; UNSTABLE ANGINA	Objective: Interleukin (IL)-18 has been associated with severity of atherosclerosis and discussed to predict cardiovascular (CV) events. We have previously shown that the IL-18+183 G-allele significantly reduces IL-18 levels. This study was aimed to investigate the prognostic significance of the IL-18+183 A/G polymorphism (rs5744292), single and in coexistence with the matrix metalloproteinase (MMP)-9-1562 C/T (rs3918242) polymorphism, in patients with stable coronary artery disease (CAD). Serum levels of IL-18, MMP-9 and tissue inhibitor of matrix metalloproteinase (TIMP)-1 were additionally assessed. Methods: 1001 patients with angiographically verified CAD were genotyped and the biomarkers were measured accordingly. After two years follow-up, 10.6% experienced new clinical events; acute myocardial infarction (AMI), stroke, unstable angina pectoris and death. Results: The IL-18+ 183 G-allele associated with 35% risk reduction in composite endpoints after adjusting for potential covariates (p = 0.044). The IL-18+ 183 AA/MMP-9 -1562 CT/TT combined genotypes associated with a significant increase in risk of composite endpoints (OR = 1.87; 95% CI = 1.13-3.11, p = 0.015, adjusted). Patients with clinical events presented with significantly higher IL-18 levels as compared to patients without (p = 0.011, adjusted). The upper tertile of IL-18 levels associated with an increase in risk of AMI as compared to lower tertiles (OR = 2.36; 95% CI = 1.20-4.64, p = 0.013, adjusted). Conclusion: The IL-18+ 183 A/G polymorphism, single and in combination with MMP-9 genotypes, may influence the risk of clinical events in stable CAD patients.	[Opstad, Trine B.; Pettersen, Alf A.; Arnesen, Harald; Seljeflot, Ingebjorg] Oslo Univ Hosp, Dept Cardiol, Ctr Clin Heart Res, Oslo, Norway; [Opstad, Trine B.; Pettersen, Alf A.; Arnesen, Harald; Seljeflot, Ingebjorg] Oslo Univ Hosp, Ctr Heart Failure Res, Oslo, Norway; [Arnesen, Harald; Seljeflot, Ingebjorg] Univ Oslo, Fac Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Opstad, TB (corresponding author), Oslo Univ Hosp, Dept Cardiol, Ctr Clin Heart Res, Oslo, Norway.	trineoa@medisin.uio.no		Pettersen, Alf-Age R/0000-0001-7543-475X	Norwegian Council for Cardiovascular Diseases; Stein Erik Hagen Foundation for Clinical Heart Research, Oslo, Norway	Norwegian Council for Cardiovascular Diseases; Stein Erik Hagen Foundation for Clinical Heart Research, Oslo, Norway	The work was funded by the Norwegian Council for Cardiovascular Diseases and Stein Erik Hagen Foundation for Clinical Heart Research, Oslo, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blankenberg S, 2003, CIRCULATION, V108, P2453, DOI 10.1161/01.CIR.0000099509.76044.A2; Blankenberg S, 2003, CIRCULATION, V107, P1579, DOI 10.1161/01.CIR.0000058700.41738.12; Blankenberg S, 2002, CIRCULATION, V106, P24, DOI 10.1161/01.CIR.0000020546.30940.92; Chalikias GK, 2005, ATHEROSCLEROSIS, V182, P135, DOI 10.1016/j.atherosclerosis.2005.02.002; Chandrasekar B, 2004, BIOCHEM BIOPH RES CO, V319, P304, DOI 10.1016/j.bbrc.2004.04.185; Chandrasekar B, 2006, J BIOL CHEM, V281, P15099, DOI 10.1074/jbc.M600200200; Espinola-Klein C, 2008, EUR J CARDIOV PREV R, V15, P278, DOI 10.1097/HJR.0b013e3282f37a6e; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Gerdes N, 2002, J EXP MED, V195, P245, DOI 10.1084/jem.20011022; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Hartford M, 2010, ARTERIOSCL THROM VAS, V30, P2039, DOI 10.1161/ATVBAHA.109.202697; Hernesniemi JA, 2008, ATHEROSCLEROSIS, V196, P643, DOI 10.1016/j.atherosclerosis.2007.07.018; Hivert MF, 2009, DIABETOLOGIA, V52, P2101, DOI 10.1007/s00125-009-1455-z; Koenig W, 2007, ARTERIOSCL THROM VAS, V27, P15, DOI 10.1161/01.ATV.0000251503.35795.4f; Koh YS, 2008, INT J CARDIOL, V127, P430, DOI 10.1016/j.ijcard.2007.04.107; Mallat Z, 2001, CIRC RES, V89, pE41, DOI 10.1161/hh1901.098735; Mallat Z, 2001, CIRCULATION, V104, P1598, DOI 10.1161/hc3901.096721; Medley TL, 2004, ARTERIOSCL THROM VAS, V24, P1479, DOI 10.1161/01.ATV.0000135656.49158.95; Mizon-Gerard F, 2004, EUR HEART J, V25, P688, DOI 10.1016/j.ehj.2004.01.015; Nold M, 2003, N-S ARCH PHARMACOL, V367, P68, DOI 10.1007/s00210-002-0648-5; Opstad TB, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-110; Opstad TB, 2012, CLIN CHIM ACTA, V413, P113, DOI 10.1016/j.cca.2011.09.004; Oviedo-Orta E, 2008, IMMUNOLOGY, V124, P42, DOI 10.1111/j.1365-2567.2007.02728.x; Pettersen AAR, 2004, SCAND CARDIOVASC J, V38, P353, DOI 10.1080/14017430410024324; Pettersen AAR, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.000703; Rabkin SW, 2009, NAT CLIN PRACT CARD, V6, P192, DOI 10.1038/ncpcardio1453; Sahar S, 2005, CIRC RES, V96, P1064, DOI 10.1161/01.RES.0000168210.10358.f4; Tiret L, 2005, CIRCULATION, V112, P643, DOI 10.1161/CIRCULATIONAHA.104.519702; Troseid M, 2009, DIABETES CARE, V32, P486, DOI 10.2337/dc08-1710; Weiss TW, 2011, WIEN KLIN WOCHENSCHR, V123, P650, DOI 10.1007/s00508-011-0028-6; Whitman SC, 2002, CIRC RES, V90, pE34, DOI 10.1161/hh0202.105292; Zhang BP, 1999, CIRCULATION, V99, P1788, DOI 10.1161/01.CIR.99.14.1788	32	25	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74498	10.1371/journal.pone.0074498	http://dx.doi.org/10.1371/journal.pone.0074498			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040261	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600132
J	Yancey, D; Nelson, KC; Baiz, D; Hassan, S; Flores, A; Pullikuth, A; Karpova, Y; Axanova, L; Moore, V; Sui, GC; Kulik, G				Yancey, Dana; Nelson, Kyle C.; Baiz, Daniele; Hassan, Sazzad; Flores, Anabel; Pullikuth, Ashok; Karpova, Yelena; Axanova, Linara; Moore, Victoria; Sui, Guangchao; Kulik, George			BAD Dephosphorylation and Decreased Expression of MCL-1 Induce Rapid Apoptosis in Prostate Cancer Cells	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; TUMOR SUPPRESSION; GROWTH-FACTOR; CLASS-I; BCL-XL; SURVIVAL; PROTEINS; DEATH; PHOSPHORYLATION; PTEN	PTEN loss and constitutive activation of the PI3K signaling pathway have been associated with advanced androgenin-dependent prostate cancer. PTEN-deficient prostate cancer C42Luc cells survive in serum-free media and show relative resistance to apoptosis even in the presence of the PI3K inhibitor ZSTK474. Yet, when ZSTK474 is combined with the translation inhibitor cycloheximide, C42Luc cells undergo apoptosis within 6 hours. We identified dephosphorylation of BAD (Bcl2-associated death promoter) as a main apoptosis-regulatory molecule downstream from PI3K, and loss of MCL-1 (Myel (o) over bar id c (e) over bar ll leukemi (a) over bar -1) as a major target of cycloheximide. The combination of MCL-1 knockdown and expression of p (h) over bar osphor (y) over bar lation-deficient mutant BAD2SA is sufficient to trigger rapid apoptosis in prostate cancer cells. These results establish the mechanism for the synergistic induction of apoptosis by the combination of a PI3K inhibitor and of a protein synthesis inhibitor in PTEN-deficient prostate cancer cells.	[Yancey, Dana; Nelson, Kyle C.; Baiz, Daniele; Hassan, Sazzad; Flores, Anabel; Pullikuth, Ashok; Karpova, Yelena; Axanova, Linara; Sui, Guangchao; Kulik, George] Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC USA; [Moore, Victoria] Elon Univ, Dept Chem, Elon, NC USA	Wake Forest University; Elon University	Kulik, G (corresponding author), Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC USA.	gkulik@wakehealth.edu	Pullikuth, Ashok/AAT-2717-2020; Pullikuth, Ashok K/M-3100-2018	Pullikuth, Ashok K/0000-0002-0041-3310	National Cancer Institute to George Kulik [R01CA118329]; NATIONAL CANCER INSTITUTE [P30CA012197, R01CA118329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM064249] Funding Source: NIH RePORTER	National Cancer Institute to George Kulik; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by R01CA118329 grant from the National Cancer Institute to George Kulik. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgul C, 2000, FEBS LETT, V478, P72, DOI 10.1016/S0014-5793(00)01809-3; Axanova LS, 2010, PROSTATE, V70, P1658, DOI 10.1002/pros.21201; Ayala G, 2004, CLIN CANCER RES, V10, P6572, DOI 10.1158/1078-0432.CCR-04-0477; Bayascas JR, 2005, MOL CELL, V18, P143, DOI 10.1016/j.molcel.2005.03.020; Bendell JC, 2012, J CLIN ONCOL, V30, P282, DOI 10.1200/JCO.2011.36.1360; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Castilla C, 2006, ENDOCRINOLOGY, V147, P4960, DOI 10.1210/en.2006-0502; Cavarretta IT, 2007, ONCOGENE, V26, P2822, DOI 10.1038/sj.onc.1210097; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Deocampo N D, 2003, Minerva Endocrinol, V28, P145; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Duke University, 2012, BKM120 MET CASTR RES; Dutta S, 2010, J MOL BIOL, V398, P747, DOI 10.1016/j.jmb.2010.03.058; Fang XJ, 1999, ONCOGENE, V18, P6635, DOI 10.1038/sj.onc.1203076; Gao N, 2003, BIOCHEM BIOPH RES CO, V310, P1124, DOI 10.1016/j.bbrc.2003.09.132; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Holmgreen SP, 1999, CELL DEATH DIFFER, V6, P525, DOI 10.1038/sj.cdd.4400519; ISAACS JT, 1992, J ANDROL, V13, P457; Kim MH, 2009, PROSTATE, V69, P1435, DOI 10.1002/pros.20993; Kitada S, 1998, BLOOD, V91, P3379, DOI 10.1182/blood.V91.9.3379; Krajewska M, 1996, AM J PATHOL, V148, P1567; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; McMenamin ME, 1999, CANCER RES, V59, P4291; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Murillo H, 2001, ENDOCRINOLOGY, V142, P4795, DOI 10.1210/en.142.11.4795; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Pourmand Gholamreza, 2007, Urol J, V4, P95; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Sarah Cannon Research Institute, 2012, STUD PI3 KIN MTOR IN; Sastry KSR, 2006, J BIOL CHEM, V281, P20891, DOI 10.1074/jbc.M602928200; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; Shuttleworth SJ, 2011, CURR MED CHEM, V18, P2686; Smith AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006224; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Sui G, 2005, METH MOL B, V309, P205; Suzuki H, 1998, CANCER RES, V58, P204; Tan Y, 2000, J BIOL CHEM, V275, P25865, DOI 10.1074/jbc.M004199200; Tang DG, 1998, CANCER RES, V58, P3466; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wei G, 2012, CANCER CELL, V21, P547, DOI 10.1016/j.ccr.2012.02.028; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; WU HC, 1994, INT J CANCER, V57, P406, DOI 10.1002/ijc.2910570319; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yoshimoto M, 2007, BRIT J CANCER, V97, P678, DOI 10.1038/sj.bjc.6603924; Zenyaku Kogyo Co. Ltd, 2012, PHAS 1B MULT OP LAB; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	58	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74561	10.1371/journal.pone.0074561	http://dx.doi.org/10.1371/journal.pone.0074561			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040284	Green Submitted, Green Published, gold			2022-12-25	WOS:000324481600136
J	Fu, X; Meng, Z; Liang, W; Tian, Y; Wang, X; Han, W; Lou, G; Wang, X; Lou, F; Yen, Y; Yu, H; Jove, R; Huang, W				Fu, X.; Meng, Z.; Liang, W.; Tian, Y.; Wang, X.; Han, W.; Lou, G.; Wang, X.; Lou, F.; Yen, Y.; Yu, H.; Jove, R.; Huang, W.			miR-26a enhances miRNA biogenesis by targeting Lin28B and Zcchc11 to suppress tumor growth and metastasis	ONCOGENE			English	Article						miR-26a; Zcchc11; let-7; miRNA biogenesis; tumorigenesis; metastasis	MICRORNA EXPRESSION; LET-7; TRANSFORMATION; PROLIFERATION; TUMORIGENESIS; MATURATION; REGULATOR; BLOCKADE; ABSENCE; HMGA2	Human cancers often exhibit attenuated microRNA (miRNA) biogenesis and global underexpression of miRNAs; thus, targeting the miRNA biogenesis pathway represents a novel strategy for cancer therapy. Here, we report that miR-26a enhances miRNA biogenesis, which acts as a common mechanism partially accounting for miR-26a function in diverse cancers including melanoma, prostate and liver cancer. miR-26a was broadly reduced in multiple cancers, and overexpression of miR-26a significantly suppressed tumor growth and metastasis both in vitro and in vivo, including melanoma, prostate and liver cancers. Notably, miR-26a overexpression was accompanied by global upregulation of miRNAs, especially let-7, and let-7 expression was concordant with miR-26a expression in cancer cell lines, xenograft tumors and normal human tissues, underscoring their biological relevance. We showed that miR-26a directly targeted Lin28B and Zcchc11-two critical repressors of let-7 maturation. Furthermore, we have demonstrated that Zcchc11 promoted tumor growth and metastasis, and it was prominently overexpressed in human cancers. Our findings thus provide a novel mechanism by which a miRNA acts as a modulator of miRNA biogenesis. These results also define a role of the miR-26a and Zcchc11 in tumorigenesis and metastasis and have implications to develop new strategies for cancer therapy.	[Fu, X.; Meng, Z.; Wang, X.; Han, W.; Lou, G.; Wang, X.; Lou, F.; Huang, W.] City Hope Natl Med Ctr, Beckman Res Inst, Div Mol Diabet Res, Dept Diabet & Metab Dis Res, Duarte, CA 91010 USA; [Meng, Z.; Yen, Y.; Yu, H.; Jove, R.; Huang, W.] City Hope Natl Med Ctr, Beckman Res Inst, Irell & Manella Grad Sch Biol Sci, Duarte, CA 91010 USA; [Liang, W.; Tian, Y.; Jove, R.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA; [Yen, Y.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Pharmacol, Duarte, CA 91010 USA; [Yu, H.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Immunotherapy & Tumor Immunol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Huang, W (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Div Mol Diabet Res, Dept Diabet & Metab Dis Res, 1500 E Duarte Rd, Duarte, CA 91010 USA.	whuang@coh.org	Yen, Yun/H-9591-2016	Fu, Xianghui/0000-0001-9808-3892; YU, Hua/0000-0003-0931-1000	National Cancer Institute [P30 CA033572]; American Cancer Society [RSG-11-132-01-CCE]; NATIONAL CANCER INSTITUTE [R01CA139158, P30CA033572] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs Arthur Riggs and Rama Natarajan for reviewing the manuscript, Dr Kyle Sousa and other members of the Huang laboratory for their helpful discussions and Dr Keely Walker for editing the manuscript. This work was supported by the National Cancer Institute (P30 CA033572) and the American Cancer Society (RSG-11-132-01-CCE).	Blahna MT, 2011, J BIOL CHEM, V286, P42381, DOI 10.1074/jbc.M111.259689; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Guo L, 2013, ONCOGENE, V32, P5272, DOI 10.1038/onc.2012.573; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Hammond SM, 2008, CELL, V135, P1013, DOI 10.1016/j.cell.2008.11.026; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Jiang X, 2012, CANCER CELL, V22, P524, DOI 10.1016/j.ccr.2012.08.028; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; King CE, 2011, ONCOGENE, V30, P4185, DOI 10.1038/onc.2011.131; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Mavrakis KJ, 2011, NAT GENET, V43, P673, DOI 10.1038/ng.858; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Melo SA, 2010, CANCER CELL, V18, P303, DOI 10.1016/j.ccr.2010.09.007; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Meng ZP, 2010, HEPATOLOGY, V52, P2148, DOI 10.1002/hep.23915; Newman MA, 2010, INT J BIOCHEM CELL B, V42, P1330, DOI 10.1016/j.biocel.2009.02.023; Newman MA, 2010, GENE DEV, V24, P1086, DOI 10.1101/gad.1919710; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Ravi A, 2012, CANCER CELL, V21, P848, DOI 10.1016/j.ccr.2012.04.037; Raymond CK, 2005, RNA, V11, P1737, DOI 10.1261/rna.2148705; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Talmadge JE, 2010, METHODS MOL BIOL, V602, P215, DOI 10.1007/978-1-60761-058-8_13; Thornton JE, 2012, TRENDS CELL BIOL, V22, P474, DOI 10.1016/j.tcb.2012.06.001; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557; Yun JU, 2011, EMBO J, V30, P4500, DOI 10.1038/emboj.2011.312; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	46	93	97	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 21	2014	33	34					4296	4306		10.1038/onc.2013.385	http://dx.doi.org/10.1038/onc.2013.385			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AO2MK	24056962	Green Accepted			2022-12-25	WOS:000341156900003
J	Qi, J; Dong, Z; Liu, J; Zhang, JT				Qi, J.; Dong, Z.; Liu, J.; Zhang, J-T			EIF3i promotes colon oncogenesis by regulating COX-2 protein synthesis and beta-catenin activation	ONCOGENE			English	Article						eIF3i; COX-2; beta-catenin; translational control; colon cancer; RNA-binding	INTESTINAL-CELL DIFFERENTIATION; INITIATION-FACTOR EIF3; TRANSLATIONAL CONTROL; MESSENGER-RNA; CANCER; EXPRESSION; SUBUNITS; CYCLOOXYGENASE-2; REVEALS; GROWTH	Translational control of gene expression has recently been recognized as an important mechanism controlling cell proliferation and oncogenesis, and it mainly occurs in the initiation step of protein synthesis that involves multiple eukaryotic initiation factors (eIFs). Many eIFs have been found to have aberrant expression in human tumors and the aberrant expression may contribute to oncogenesis. However, how these previously considered house-keeping proteins are potentially oncogenic remains elusive. In this study, we investigated the expression of eIF3i in human colon cancers, tested its contribution to colon oncogenesis and determined the mechanism of eIF3i action in colon oncogenesis. We found that eIF3i expression was upregulated in both human colon adenocarcinoma and adenoma polyps as well as in model inducible colon tumorigenic cell lines. Overexpression of ectopic eIF3i in intestinal epithelial cells causes oncogenesis by directly upregulating the synthesis of cyclooxygenase-2 (COX-2) protein and activates the beta-catenin/T-cell factor 4 signaling pathway that mediates the oncogenic function of eIF3i. Together, we conclude that eIF3i is a proto-oncogene that drives colon oncogenesis by translationally upregulating COX-2 and activating the beta-catenin signaling pathway. These findings imply that proto-oncogenic eIFs likely exert their tumorigenic function by regulating/altering the synthesis level of downstream tumor suppressor or oncogenes.	Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; Indiana Univ Sch Med, IU Simon Canc Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Zhang, JT (corresponding author), Indiana Univ Sch Med, IU Simon Canc Ctr, Dept Pharmacol & Toxicol, 980 W Walnut St,R3-C510, Indianapolis, IN 46202 USA.	jianzhan@iupui.edu	Zhang, Jian-Ting/L-8334-2015	Zhang, Jian-Ting/0000-0002-2803-9914	NIH grant [R01 CA94961]; NATIONAL CANCER INSTITUTE [R01CA094961] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Hongmiao Sheng for the generous gift of the rat intestinal epithelial cell lines. This work was supported in part by a NIH grant R01 CA94961 (JTZ).	Ahlemann M, 2006, MOL CARCINOGEN, V45, P957, DOI 10.1002/mc.20269; Asano K, 1998, J BIOL CHEM, V273, P18573, DOI 10.1074/jbc.273.29.18573; Bernardini S, 1997, BIOCHEM BIOPH RES CO, V234, P278, DOI 10.1006/bbrc.1997.6626; Block KL, 1998, J BIOL CHEM, V273, P31901, DOI 10.1074/jbc.273.48.31901; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Ding QM, 1998, AM J PHYSIOL-CELL PH, V275, pC1193, DOI 10.1152/ajpcell.1998.275.5.C1193; Dixon DA, 2000, J BIOL CHEM, V275, P11750, DOI 10.1074/jbc.275.16.11750; Dong ZZ, 2006, CRIT REV ONCOL HEMAT, V59, P169, DOI 10.1016/j.critrevonc.2006.03.005; Dong ZZ, 2009, EXP CELL RES, V315, P1889, DOI 10.1016/j.yexcr.2009.03.009; Dong ZZ, 2004, ONCOGENE, V23, P3790, DOI 10.1038/sj.onc.1207465; Dong ZZ, 2003, MOL BIOL CELL, V14, P3942, DOI 10.1091/mbc.E02-12-0784; Gray SG, 2000, INT J MOL MED, V5, P33; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Herrmannova A, 2012, NUCLEIC ACIDS RES, V40, P2294, DOI 10.1093/nar/gkr765; Kikuchi A, 2003, CANCER SCI, V94, P225, DOI 10.1111/j.1349-7006.2003.tb01424.x; Kuroda T, 2006, CANCER RES, V66, P10127, DOI 10.1158/0008-5472.CAN-06-2744; Liu RY, 2011, ONCOGENE, V30, P4814, DOI 10.1038/onc.2011.189; Liu Y, 2006, CANCER RES, V66, P3248, DOI 10.1158/0008-5472.CAN-05-3801; Liu ZQ, 2007, DIFFERENTIATION, V75, P652, DOI 10.1111/j.1432-0436.2007.00165.x; Markowitz AJ, 1995, AM J PHYSIOL-GASTR L, V269, pG925, DOI 10.1152/ajpgi.1995.269.6.G925; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; MATHEWS MB, 2007, TRANSLATIONAL CONTRO; Matsuda S, 2000, CANCER RES, V60, P13; Phan L, 2001, EMBO J, V20, P2954, DOI 10.1093/emboj/20.11.2954; PINTO M, 1983, BIOL CELL, V47, P323; Rauch J, 2004, BIOCHEM BIOPH RES CO, V323, P156, DOI 10.1016/j.bbrc.2004.08.071; SCHNEIDER RJ, 2007, TRANSLATIONAL CONTRO, P401; Shao JY, 2005, J BIOL CHEM, V280, P26565, DOI 10.1074/jbc.M413056200; Sheng HM, 2000, J BIOL CHEM, V275, P6628, DOI 10.1074/jbc.275.9.6628; Sheng HM, 2001, CANCER RES, V61, P2670; Wang Y, 2013, ADV CIV ENG, V2013, DOI 10.1155/2013/189105; Yin JY, 2013, CARCINOGENESIS, V34, P1224, DOI 10.1093/carcin/bgt052; Yin JY, 2011, CLIN CANCER RES, V17, P4600, DOI 10.1158/1078-0432.CCR-10-2591; Yin JY, 2011, BIOSCIENCE REP, V31, P1, DOI 10.1042/BSR20100077; Zhang LL, 2007, J BIOL CHEM, V282, P5790, DOI 10.1074/jbc.M606284200; Zhou M, 2008, P NATL ACAD SCI USA, V105, P18139, DOI 10.1073/pnas.0801313105; Zweibaum A, 1989, ADAPTATION DEV GASTR, P103	39	32	32	0	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 7	2014	33	32					4156	4163		10.1038/onc.2013.397	http://dx.doi.org/10.1038/onc.2013.397			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AN4YK	24056964	Green Accepted, Green Submitted			2022-12-25	WOS:000340595700006
J	Taylor, MS; Ruch, TR; Hsiao, PY; Hwang, Y; Zhang, PF; Dai, LX; Huang, CRL; Berndsen, CE; Kim, MS; Pandey, A; Wolberger, C; Marmorstein, R; Machamer, C; Boeke, JD; Cole, PA				Taylor, Martin S.; Ruch, Travis R.; Hsiao, Po-Yuan; Hwang, Yousang; Zhang, Pingfeng; Dai, Lixin; Huang, Cheng Ran Lisa; Berndsen, Christopher E.; Kim, Min-Sik; Pandey, Akhilesh; Wolberger, Cynthia; Marmorstein, Ronen; Machamer, Carolyn; Boeke, Jef D.; Cole, Philip A.			Architectural Organization of the Metabolic Regulatory Enzyme Ghrelin O-Acyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); Lipids; Membrane Proteins; Metabolism; Peptide Hormones; Enzyme	TRANSMEMBRANE PROTEIN TOPOLOGY; ACYL-COENZYME; ACTIVE-SITE; CHOLESTEROL ACYLTRANSFERASE-1; CONSENSUS PREDICTION; MEMBRANE-PROTEINS; FATTY-ACIDS; PEPTIDE; PALMITOYLATION; IDENTIFICATION	Ghrelin O-acyltransferase (GOAT) is a polytopic integral membrane protein required for activation of ghrelin, a secreted metabolism-regulating peptide hormone. Although GOAT is a potential therapeutic target for the treatment of obesity and diabetes and plays a key role in other physiologic processes, little is known about its structure or mechanism. GOAT is a member of the membrane-bound O-acyltransferase (MBOAT) family, a group of polytopic integral membrane proteins involved in lipid-biosynthetic and lipid-signaling reactions from prokaryotes to humans. Here we use phylogeny and a variety of bioinformatic tools to predict the topology of GOAT. Using selective permeabilization indirect immunofluorescence microscopy in combination with glycosylation shift immunoblotting, we demonstrate that GOAT contains 11 transmembrane helices and one reentrant loop. Development of the V5Glyc tag, a novel, small, and sensitive dual topology reporter, facilitated these experiments. The MBOAT family invariant residue His-338 is in the ER lumen, consistent with other family members, but conserved Asn-307 is cytosolic, making it unlikely that both are involved in catalysis. Photocross-linking of synthetic ghrelin analogs and inhibitors demonstrates binding to the C-terminal region of GOAT, consistent with a role of His-338 in the active site. This knowledge of GOAT architecture is important for a deeper understanding of the mechanism of GOAT and other MBOATs and could ultimately advance the discovery of selective inhibitors for these enzymes.	[Taylor, Martin S.; Hsiao, Po-Yuan; Hwang, Yousang; Cole, Philip A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Taylor, Martin S.; Dai, Lixin; Huang, Cheng Ran Lisa; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Taylor, Martin S.; Dai, Lixin; Huang, Cheng Ran Lisa; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Ruch, Travis R.; Machamer, Carolyn] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Huang, Cheng Ran Lisa; Kim, Min-Sik; Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Berndsen, Christopher E.; Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Berndsen, Christopher E.; Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Zhang, Pingfeng; Marmorstein, Ronen] Wistar Inst Anat & Biol, Program Gene Express & Regulat, Philadelphia, PA 19104 USA; [Marmorstein, Ronen] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; The Wistar Institute; University of Pennsylvania	Machamer, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St,105 WBSB, Baltimore, MD 21205 USA.	machamer@jhmi.edu; jboeke@jhmi.edu; pcole@jhmi.edu	Kim, Min-Sik/N-5010-2018; Kim, Min-Sik/M-3488-2016; Pandey, Akhilesh/B-4127-2009	Kim, Min-Sik/0000-0001-7317-5360; Kim, Min-Sik/0000-0001-7317-5360; Pandey, Akhilesh/0000-0001-9943-6127; Berndsen, Christopher/0000-0002-4285-4341; Wolberger, Cynthia/0000-0001-8578-2969; Taylor, Martin/0000-0003-1560-9276; Boeke, Jef/0000-0001-5322-4946; Taylor, Martin/0000-0001-5824-142X	National Institutes of Health [8U54GM103520, GM62437]; Pfeiffer Foundation; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103520, R37GM062437, R01GM060293, R01GM062437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfeiffer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 8U54GM103520 and GM62437. This work was also supported by funds from the Pfeiffer Foundation.	Arai M, 2004, NUCLEIC ACIDS RES, V32, pW390, DOI 10.1093/nar/gkh380; Baldanzi G, 2002, J CELL BIOL, V159, P1029, DOI 10.1083/jcb.200207165; Barnett BP, 2010, SCIENCE, V330, P1689, DOI 10.1126/science.1196154; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Bosson R, 2006, MOL BIOL CELL, V17, P2636, DOI 10.1091/mbc.E06-02-0104; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; Buglino JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011195; Carlini VP, 2002, BIOCHEM BIOPH RES CO, V299, P739, DOI 10.1016/S0006-291X(02)02740-7; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; CHURCH RFR, 1970, J ORG CHEM, V35, P2465, DOI 10.1021/jo00833a001; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; DESHAIES RJ, 1987, J CELL BIOL, V105, P633, DOI 10.1083/jcb.105.2.633; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egecioglu E, 2010, ADDICT BIOL, V15, P304, DOI 10.1111/j.1369-1600.2010.00216.x; Ejskjaer N, 2013, NEUROGASTROENT MOTIL, V25, pE140, DOI 10.1111/nmo.12064; Goldstein JL, 2011, COLD SH Q B, V76, P121, DOI 10.1101/sqb.2011.76.010447; Guo ZY, 2005, J BIOL CHEM, V280, P37814, DOI 10.1074/jbc.M508384200; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Hardy RY, 2012, J BIOL CHEM, V287, P42881, DOI 10.1074/jbc.M112.426833; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Inlow D., 1989, J TISSUE CULTURE MET, V12, P13; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kim H, 2003, J BIOL CHEM, V278, P10208, DOI 10.1074/jbc.M300163200; Kim H, 2006, P NATL ACAD SCI USA, V103, P11142, DOI 10.1073/pnas.0604075103; Kirchner H, 2009, NAT MED, V15, P741, DOI 10.1038/nm.1997; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Li RL, 2012, J BIOL CHEM, V287, P17942, DOI 10.1074/jbc.M112.358051; Lin S, 2003, MOL BIOL CELL, V14, P2447, DOI 10.1091/mbc.E02-11-0725; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; McFie PJ, 2010, J BIOL CHEM, V285, P37377, DOI 10.1074/jbc.M110.163691; Mitchell LA, 2013, ACS SYNTH BIOL, V2, P473, DOI 10.1021/sb300131w; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Nishi Y, 2005, ENDOCRINOLOGY, V146, P2255, DOI 10.1210/en.2004-0695; Nugent T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-169; Okumura H, 2002, J CARDIOVASC PHARM, V39, P779, DOI 10.1097/00005344-200206000-00001; Ozawa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005426; Pagac M, 2012, MOL MICROBIOL, V86, P1156, DOI 10.1111/mmi.12047; Pagac M, 2011, J BIOL CHEM, V286, P36438, DOI 10.1074/jbc.M111.256511; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petrova E, 2013, NAT CHEM BIOL, V9, P247, DOI [10.1038/NCHEMBIO.1184, 10.1038/nchembio.1184]; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Resh MD, 2012, TRENDS MOL MED, V18, P206, DOI 10.1016/j.molmed.2012.01.007; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwenke DO, 2008, ENDOCRINOLOGY, V149, P5172, DOI 10.1210/en.2008-0472; Sengstag C, 2000, METHOD ENZYMOL, V327, P175, DOI 10.1016/S0076-6879(00)27275-3; Shen HB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002399; Shindou H, 2009, BIOCHEM BIOPH RES CO, V383, P320, DOI 10.1016/j.bbrc.2009.04.013; SWIFT AM, 1991, J CELL BIOL, V115, P19, DOI 10.1083/jcb.115.1.19; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tamaki H, 2007, J BIOL CHEM, V282, P34288, DOI 10.1074/jbc.M704509200; Taylor MS, 2012, METHOD ENZYMOL, V514, P205, DOI 10.1016/B978-0-12-381272-8.00013-1; Trudel L, 2002, AM J PHYSIOL-GASTR L, V282, pG948, DOI 10.1152/ajpgi.00339.2001; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Yang J, 2008, P NATL ACAD SCI USA, V105, P10750, DOI 10.1073/pnas.0805353105; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Yi CX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032100; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895; Yu CJ, 1999, J BIOL CHEM, V274, P36139, DOI 10.1074/jbc.274.51.36139	69	52	52	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32211	32228		10.1074/jbc.M113.510313	http://dx.doi.org/10.1074/jbc.M113.510313			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24045953	Green Published, hybrid			2022-12-25	WOS:000328681700010
J	van Ooij, C; Withers-Martinez, C; Ringel, A; Cockcroft, S; Haldar, K; Blackman, MJ				van Ooij, Christiaan; Withers-Martinez, Chrislaine; Ringel, Alessa; Cockcroft, Shamshad; Haldar, Kasturi; Blackman, Michael J.			Identification of a Plasmodium falciparum Phospholipid Transfer Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL TRANSFER PROTEIN; START DOMAIN PROTEIN; RED-BLOOD-CELL; INFECTED ERYTHROCYTES; MALARIA PARASITE; MEMBRANE NETWORK; HOST ERYTHROCYTE; FOLD RECOGNITION; TRAFFICKING; SURFACE	Infection of erythrocytes by the human malaria parasite Plasmodium falciparum results in dramatic modifications to the host cell, including changes to its antigenic and transport properties and the de novo formation of membranous compartments within the erythrocyte cytosol. These parasite-induced structures are implicated in the transport of nutrients, metabolic products, and parasite proteins, as well as in parasite virulence. However, very few of the parasite effector proteins that underlie remodeling of the host erythrocyte are functionally characterized. Using bioinformatic examination and modeling, we have found that the exported P. falciparum protein PFA0210c belongs to the START domain family, members of which mediate transfer of phospholipids, ceramide, or fatty acids between membranes. In vitro phospholipid transfer assays using recombinant PFA0210 confirmed that it can transfer phosphatidylcholine, phosphatidylinositol, phosphatidylethanolamine, and sphingomyelin between phospholipid vesicles. Furthermore, assays using HL60 cells containing radiolabeled phospholipids indicated that orthologs of PFA0210c can also transfer phosphatidylcholine, phosphatidylinositol, and phosphatidylethanolamine. Biochemical and immunochemical analysis showed that PFA0210c associates with membranes in infected erythrocytes at mature stages of intracellular parasite growth. Localization studies in live parasites revealed that the protein is present in the parasitophorous vacuole during growth and is later recruited to organelles in the parasite. Together these data suggest that PFA0210c plays a role in the formation of the membranous structures and nutrient phospholipid transfer in the malaria-parasitized erythrocyte.	[van Ooij, Christiaan; Withers-Martinez, Chrislaine; Ringel, Alessa; Blackman, Michael J.] MRC Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; [Cockcroft, Shamshad] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6JJ, England; [Haldar, Kasturi] Univ Notre Dame, Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA; [Haldar, Kasturi] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	MRC National Institute for Medical Research; University of London; University College London; University of Notre Dame; University of Notre Dame	van Ooij, C (corresponding author), MRC Natl Inst Med Res, Div Parasitol, Mill Hill, London NW7 1AA, England.	cvanooi@nimr.mrc.ac.uk	Haldar, Kasturi/C-6685-2014; Cockcroft, Shamshad/F-9480-2011	Cockcroft, Shamshad/0000-0002-5731-476X; Ringel, Alessa/0000-0002-6392-6076	National Institutes of Health [R01HL069630, P01 HL 078826]; Wellcome Trust [095836/Z/1/Z]; United Kingdom Medical Research Council [U117532063]; MRC [MC_U117532063] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078826, R01HL069630] Funding Source: NIH RePORTER; Medical Research Council [MC_U117532063] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL069630 and P01 HL 078826 (to K. H.), Wellcome Trust Career Re-entry Fellowship 095836/Z/1/Z (to C. v. O.), and United Kingdom Medical Research Council Grant U117532063 (to M. J. B.).	AIKAWA M, 1971, EXP PARASITOL, V30, P284, DOI 10.1016/0014-4894(71)90094-4; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angeletti S, 2004, BIOCHEM BIOPH RES CO, V314, P181, DOI 10.1016/j.bbrc.2003.12.076; Angeletti S, 2012, BBA-BIOMEMBRANES, V1818, P425, DOI 10.1016/j.bbamem.2011.10.024; Ansorge I, 1996, BIOCHEM J, V315, P307, DOI 10.1042/bj3150307; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; BEHARI R, 1994, EXP PARASITOL, V79, P250, DOI 10.1006/expr.1994.1088; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P35, DOI 10.1016/0166-6851(91)90128-S; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Chang HH, 2008, MOL BIOCHEM PARASIT, V160, P107, DOI 10.1016/j.molbiopara.2008.04.011; Clark BJ, 2012, J ENDOCRINOL, V212, P257, DOI 10.1530/JOE-11-0313; Collins CR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003344; Cooke BM, 2001, ADV PARASIT, V50, P1, DOI 10.1016/S0065-308X(01)50029-9; DELPLACE P, 1985, MOL BIOCHEM PARASIT, V17, P239, DOI 10.1016/0166-6851(85)90021-0; Derre I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002092; Elwell CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002198; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Flores-Martin J, 2013, INT J MOL SCI, V14, P6170, DOI 10.3390/ijms14036170; GEORGE PY, 1985, BIOCHIM BIOPHYS ACTA, V836, P176, DOI 10.1016/0005-2760(85)90064-5; Gruring C, 2012, CELL HOST MICROBE, V12, P717, DOI 10.1016/j.chom.2012.09.010; HIBBS AR, 1994, EXP PARASITOL, V79, P260, DOI 10.1006/expr.1994.1089; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Horibata Y, 2010, J BIOL CHEM, V285, P7358, DOI 10.1074/jbc.M109.056960; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; Kanno K, 2007, BBA-MOL CELL BIOL L, V1771, P654, DOI 10.1016/j.bbalip.2007.04.003; KASPER AM, 1981, BIOCHEMISTRY-US, V20, P146, DOI 10.1021/bi00504a024; Knuepfer E, 2005, MOL BIOCHEM PARASIT, V142, P258, DOI 10.1016/j.molbiopara.2005.04.005; Kriek N, 2003, MOL MICROBIOL, V50, P1215, DOI 10.1046/j.1365-2958.2003.03784.x; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Kulzer S, 2010, CELL MICROBIOL, V12, P1398, DOI 10.1111/j.1462-5822.2010.01477.x; Lauer SA, 1997, SCIENCE, V276, P1122, DOI 10.1126/science.276.5315.1122; Li H, 2002, BBA-MOL CELL BIOL L, V1580, P67, DOI 10.1016/S1388-1981(01)00191-3; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Moon RW, 2013, P NATL ACAD SCI USA, V110, P531, DOI 10.1073/pnas.1216457110; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; NASH GB, 1989, BLOOD, V74, P855, DOI 10.1182/blood.V74.2.855.bloodjournal742855; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Olayioye MA, 2005, J BIOL CHEM, V280, P27436, DOI 10.1074/jbc.M413330200; Otto TD, 2010, MOL MICROBIOL, V76, P12, DOI 10.1111/j.1365-2958.2009.07026.x; Roderick SL, 2002, NAT STRUCT BIOL, V9, P507, DOI 10.1038/nsb812; Roobsoong W, 2011, J PROTEOMICS, V74, P1701, DOI 10.1016/j.jprot.2011.03.035; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Segui B, 2002, BIOCHEM J, V366, P23, DOI 10.1042/BJ20020317; Silvestrini F, 2010, MOL CELL PROTEOMICS, V9, P1437, DOI 10.1074/mcp.M900479-MCP200; Spielmann T, 2010, TRENDS PARASITOL, V26, P6, DOI 10.1016/j.pt.2009.10.001; Spycher C, 2006, MOL CELL BIOL, V26, P4074, DOI 10.1128/MCB.00095-06; Tarr SJ, 2013, MOL MICROBIOL, V87, P835, DOI 10.1111/mmi.12133; Thorsell AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019521; Tilley SJ, 2004, STRUCTURE, V12, P317, DOI 10.1016/j.str.2004.01.013; Chu T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018396; Tremblay JM, 1996, J BIOL CHEM, V271, P21075, DOI 10.1074/jbc.271.35.21075; van Ooij C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000084; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wickert H, 2004, EUR J CELL BIOL, V83, P567, DOI 10.1078/0171-9335-00432; Wickert H, 2003, EUR J CELL BIOL, V82, P271, DOI 10.1078/0171-9335-00319	58	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31971	31983		10.1074/jbc.M113.474189	http://dx.doi.org/10.1074/jbc.M113.474189			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24043620	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000330596200050
J	Huang, YC; Wu, YL; Lee, MH; Lee, JD; Wu, CY; Hsu, HL; Lin, YH; Huang, YC; Huang, WH; Weng, HH; Yang, JT; Lee, M; Ovbiagele, B				Huang, Ying-Chih; Wu, Yi-Ling; Lee, Ming-Hsueh; Lee, Jiann-Der; Wu, Chih-Ying; Hsu, Huan-Lin; Lin, Ya-Hui; Huang, Yen-Chu; Huang, Wen-Hung; Weng, Hsu-Huei; Yang, Jen-Tsung; Lee, Meng; Ovbiagele, Bruce			Association of Renal Biomarkers with 3-Month and 1-Year Outcomes among Critically Ill Acute Stroke Patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; TYPE-2 DIABETIC-PATIENTS; BLOOD-PRESSURE RESEARCH; CARDIOVASCULAR EVENTS; INCIDENT STROKE; HEART-FAILURE; RISK-FACTOR; MICROALBUMINURIA; ALBUMINURIA; PREVALENCE	Background: The comparative relationships of widely recognized biomarkers of renal injury with short-term and long-term outcomes among critically ill acute stroke patients are unknown. We evaluated the impact of baseline albuminuria [urine albumin-creatinine ratio (UACR)>= 30 mg/g] or low estimated glomerular filtration rate (eGFR<60 ml/min per 1.73 m(2)) on stroke patients admitted to the intensive care unit (ICU). Methods: We reviewed data on consecutive stroke patients admitted to a hospital ICU in Taiwan from September 2007 to August 2010 and followed-up for 1 year. Baseline UACR was categorized into <30 mg/g (normal), 30-299 mg/g (microalbuminuria), and >= 300 mg/g (macroalbuminuria), while eGFR was divided into >= 60, 45-59, and <45 ml/min per 1.73 m(2). The outcome measure was death or disability at 3-month and 1-year after stroke onset, assessed by dichotomizing the modified Rankin Scale at 3-6 versus 0-2. Results: Of 184 consecutive patients, 153 (83%) met study entry criteria. Mean age was 67.9 years and median admission NIHSS score was 16. Among the renal biomarkers, only macroalbuminuria was associated with poorer 3-month outcome (OR 8.44, 95% CI 1.38 to 51.74, P = 0.021) and 1-year outcome (OR 18.06, 95% CI 2.59 to 125.94, P = 0.003) after adjustment of relevant covariates. When ischemic and hemorrhagic stroke were analyzed separately, macroalbuminuria was associated with poorer 1-year outcome among ischemic (OR 17.10, 95% CI 1.04 to 280.07, P = 0.047) and hemorrhagic stroke patients (OR 1951.57, 95% CI 1.07 to 3561662.85, P = 0.048), respectively, after adjustment of relevant covariates and hematoma volume. Conclusions: Presence of macroalbuminuria indicates poor 3-month and 1-year outcomes among critically ill acute stroke patients.	[Huang, Ying-Chih; Wu, Yi-Ling; Lee, Jiann-Der; Wu, Chih-Ying; Hsu, Huan-Lin; Lin, Ya-Hui; Huang, Yen-Chu; Lee, Meng] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Neurol, Chiayi, Taiwan; [Lee, Ming-Hsueh; Yang, Jen-Tsung] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Neurosurg, Chiayi, Taiwan; [Huang, Wen-Hung] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Nephrol, Chiayi, Taiwan; [Weng, Hsu-Huei] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Diagnost Radiol, Chiayi, Taiwan; [Ovbiagele, Bruce] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Medical University of South Carolina	Lee, M (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Neurol, Chiayi, Taiwan.	menglee5126@gmail.com	Lee, Ming-Hsueh/H-8034-2015; Huang, Yenchu/AAO-1140-2020; huang, wen/GXW-0661-2022; Weng, Hsu-Huei/N-8329-2014	Lee, Ming-Hsueh/0000-0001-5341-7764; Lee, Jiann-Der/0000-0001-6310-0488; Weng, Hsu-Huei/0000-0002-2020-8912; Wu, Yi-Ling/0000-0001-9254-9399	Chang Gung Medical Research Project Grants, Taiwan [CMRPG 660311, 660312, 660313, CMRPG6B0111]	Chang Gung Medical Research Project Grants, Taiwan	This paper is supported by Chang Gung Medical Research Project Grants (CMRPG 660311, 660312, 660313 and CMRPG6B0111), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar MI, 2010, NEUROLOGY, V75, P1343, DOI 10.1212/WNL.0b013e3181f73638; Ani C, 2010, J NEUROL SCI, V288, P123, DOI 10.1016/j.jns.2009.09.020; Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Asselbergs FW, 2004, CIRCULATION, V110, P2809, DOI 10.1161/01.CIR.0000146378.65439.7A; Brosius FC, 2006, CIRCULATION, V114, P1083, DOI 10.1161/CIRCULATIONAHA.106.177321; de Zeeuw D, 2006, J AM SOC NEPHROL, V17, P2100, DOI 10.1681/ASN.2006050517; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Halbesma N, 2006, J AM SOC NEPHROL, V17, P2582, DOI 10.1681/ASN.2005121352; Hirst JA, 2012, KIDNEY INT, V81, P674, DOI 10.1038/ki.2011.413; Horio M, 2010, AM J KIDNEY DIS, V56, P32, DOI 10.1053/j.ajkd.2010.02.344; Ibsen H, 2005, HYPERTENSION, V45, P198, DOI 10.1161/01.HYP.0000154082.72286.2a; Jackson CE, 2009, LANCET, V374, P543, DOI 10.1016/S0140-6736(09)61378-7; Kumai Y, 2012, NEUROLOGY, V78, P1909, DOI 10.1212/WNL.0b013e318259e110; Lee Meng, 2010, BMJ, V341, pc4249, DOI 10.1136/bmj.c4249; Lee M, 2011, EXPERT REV NEUROTHER, V11, P241, DOI 10.1586/ERN.10.204; Lee M, 2010, STROKE, V41, P2625, DOI 10.1161/STROKEAHA.110.581215; Lee M, 2010, CEREBROVASC DIS, V30, P464, DOI 10.1159/000317069; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Murussi M, 2007, DIABETIC MED, V24, P1136, DOI 10.1111/j.1464-5491.2007.02209.x; Neves AL, 2012, MOL GENET METAB, V106, P359, DOI 10.1016/j.ymgme.2012.04.023; O'Hare AM, 2010, ARCH INTERN MED, V170, P930, DOI 10.1001/archinternmed.2010.129; Ovbiagele B, 2008, J NEUROL SCI, V271, P21, DOI 10.1016/j.jns.2008.04.007; Ovbiagele B, 2011, J NEUROL SCI, V301, P46, DOI 10.1016/j.jns.2010.11.002; Ovbiagele B, 2009, CEREBROVASC DIS, V28, P582, DOI 10.1159/000247602; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Slowik A, 2002, CEREBROVASC DIS, V14, P15, DOI 10.1159/000063718; Terao Y, 2008, J NEUROSURG ANESTH, V20, P163, DOI 10.1097/ANA.0b013e31816f1c05; Terao Y, 2007, INTENS CARE MED, V33, P1000, DOI 10.1007/s00134-007-0617-z; Thorevska N, 2003, CRIT CARE MED, V31, P1075, DOI 10.1097/01.CCM.0000059316.90804.0B; Tsagalis G, 2009, NEPHROL DIAL TRANSPL, V24, P194, DOI 10.1093/ndt/gfn471	34	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e72971	10.1371/journal.pone.0072971	http://dx.doi.org/10.1371/journal.pone.0072971			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058451	Green Published, gold, Green Submitted			2022-12-25	WOS:000324408400010
J	Kaya, HB; Cetin, O; Kaya, H; Sahin, M; Sefer, F; Kahraman, A; Tanyolac, B				Kaya, Hilal Betul; Cetin, Oznur; Kaya, Hulya; Sahin, Mustafa; Sefer, Filiz; Kahraman, Abdullah; Tanyolac, Bahattin			SNP Discovery by Illumina-Based Transcriptome Sequencing of the Olive and the Genetic Characterization of Turkish Olive Genotypes Revealed by AFLP, SSR and SNP Markers	PLOS ONE			English	Article							OLEA-EUROPAEA L.; MICROSATELLITE MARKERS; MOLECULAR CHARACTERIZATION; POPULATION-STRUCTURE; MOROCCAN OLIVE; LINKAGE MAP; DIVERSITY; CULTIVARS; POLYMORPHISM; VARIETIES	Background: The olive tree (Olea europaea L.) is a diploid (2n = 2x = 46) outcrossing species mainly grown in the Mediterranean area, where it is the most important oil-producing crop. Because of its economic, cultural and ecological importance, various DNA markers have been used in the olive to characterize and elucidate homonyms, synonyms and unknown accessions. However, a comprehensive characterization and a full sequence of its transcriptome are unavailable, leading to the importance of an efficient large-scale single nucleotide polymorphism (SNP) discovery in olive. The objectives of this study were (1) to discover olive SNPs using next-generation sequencing and to identify SNP primers for cultivar identification and (2) to characterize 96 olive genotypes originating from different regions of Turkey. Methodology/Principal Findings: Next-generation sequencing technology was used with five distinct olive genotypes and generated cDNA, producing 126,542,413 reads using an Illumina Genome Analyzer IIx. Following quality and size trimming, the high-quality reads were assembled into 22,052 contigs with an average length of 1,321 bases and 45 singletons. The SNPs were filtered and 2,987 high-quality putative SNP primers were identified. The assembled sequences and singletons were subjected to BLAST similarity searches and annotated with a Gene Ontology identifier. To identify the 96 olive genotypes, these SNP primers were applied to the genotypes in combination with amplified fragment length polymorphism (AFLP) and simple sequence repeats (SSR) markers. Conclusions/Significance: This study marks the highest number of SNP markers discovered to date from olive genotypes using transcriptome sequencing. The developed SNP markers will provide a useful source for molecular genetic studies, such as genetic diversity and characterization, high density quantitative trait locus (QTL) analysis, association mapping and map-based gene cloning in the olive. High levels of genetic variation among Turkish olive genotypes revealed by SNPs, AFLPs and SSRs allowed us to characterize the Turkish olive genotype.	[Kaya, Hilal Betul; Tanyolac, Bahattin] Ege Univ, Dept Bioengn, Izmir, Turkey; [Cetin, Oznur; Kaya, Hulya; Sahin, Mustafa; Sefer, Filiz] Olive Res Stn, Izmir, Turkey; [Kahraman, Abdullah] Harran Univ, Dept Field Crops, S Urfa, Turkey	Ege University; Harran University	Tanyolac, B (corresponding author), Ege Univ, Dept Bioengn, Izmir, Turkey.	bahattin.tanyolac@ege.edu.tr	Kahraman, Abdullah/AAB-1400-2020; Tanyolac, Bahattin/AAD-3762-2019; Kahraman, Abdullah/W-1029-2017	Kaya, Hilal Betul/0000-0002-2543-7212; Kahraman, Abdullah/0000-0002-8829-3797	Turkish Technical and Research Council [108G096]	Turkish Technical and Research Council(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This manuscript was funded by Turkish Technical and Research Council with the project number of 108G096. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2011, AFRICAN J AGR RES, V6; Achtak H, 2009, J AM SOC HORTIC SCI, V134, P624, DOI 10.21273/JASHS.134.6.624; Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; Alba V, 2009, SCI HORTIC-AMSTERDAM, V123, P11, DOI 10.1016/j.scienta.2009.07.007; Albertini E, 2011, MOL BREEDING, V27, P533, DOI 10.1007/s11032-010-9452-y; ANDERSON JA, 1993, GENOME, V36, P181, DOI 10.1139/g93-024; Angiolillo A, 1999, THEOR APPL GENET, V98, P411, DOI 10.1007/s001220051087; Annadurai RS, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-663; [Anonymous], 1997, IPGRI TECHNICAL B IPGRI TECHNICAL B; Ashrafi H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-571; Bachlava E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029814; Bahulikar Rahul A., 2004, BMC Ecology, V4, P12, DOI 10.1186/1472-6785-4-12; Baldoni L, 2006, ANN BOT-LONDON, V98, P935, DOI 10.1093/aob/mcl178; Baldoni L, 2009, MOL BREEDING, V24, P213, DOI 10.1007/s11032-009-9285-8; Bandelj D, 2004, EUPHYTICA, V136, P93, DOI 10.1023/B:EUPH.0000019552.42066.10; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-51; Belaj A, 2001, J AM SOC HORTIC SCI, V126, P64, DOI 10.21273/JASHS.126.1.64; Belaj A, 2004, HORTSCIENCE, V39, P1557, DOI 10.21273/HORTSCI.39.7.1557; Belaj A, 2012, TREE GENET GENOMES, V8, P365, DOI 10.1007/s11295-011-0447-6; Belaj A, 2010, SCI HORTIC-AMSTERDAM, V124, P323, DOI 10.1016/j.scienta.2010.01.010; Boskou G, 2006, FOOD CHEM, V94, P558, DOI 10.1016/j.foodchem.2004.12.005; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Bracci T, 2011, PLANT CELL REP, V30, P449, DOI 10.1007/s00299-010-0991-9; Carriero F, 2002, THEOR APPL GENET, V104, P301, DOI 10.1007/s001220100691; Charafi J, 2008, GENET RESOUR CROP EV, V55, P893, DOI 10.1007/s10722-007-9294-6; Cipriani G, 2002, THEOR APPL GENET, V104, P223, DOI 10.1007/s001220100685; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Consolandi C, 2007, J BIOTECHNOL, V129, P565, DOI 10.1016/j.jbiotec.2007.01.025; Corrado G, 2011, J HORTIC SCI BIOTECH, V86, P461, DOI 10.1080/14620316.2011.11512789; Daoud D, 2007, J HORTIC SCI, V82; Dassanayake M, 2009, NEW PHYTOL, V183, P764, DOI 10.1111/j.1469-8137.2009.02913.x; de la Rosa R, 2003, THEOR APPL GENET, V106, P1273, DOI 10.1007/s00122-002-1189-5; De La Rosa R, 2002, MOL ECOL NOTES, V2, P265, DOI 10.1046/j.1471-8286.2002.00217.x; Diaz A, 2006, J AM SOC HORTIC SCI, V131, P250, DOI 10.21273/JASHS.131.2.250; Diez CM, 2012, CROP SCI, V52, P211, DOI 10.2135/cropsci2011.02.0110; Diez CM, 2011, ANN BOT-LONDON, V108, P797, DOI 10.1093/aob/mcr194; do Val ADB, 2012, GENET MOL RES, V11, P556, DOI 10.4238/2012.March.8.4; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edwards D, 2010, PLANT BIOTECHNOL J, V8, P2, DOI 10.1111/j.1467-7652.2009.00459.x; Egan AN, 2012, AM J BOT, V99, P175, DOI 10.3732/ajb.1200020; Ercisli S, 2009, GENET MOL RES, V8, P414, DOI 10.4238/vol8-2gmr576; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; FAOSTAT, 2010, STAT DAT FAOSTAT; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gemas VJV, 2004, GENET RESOUR CROP EV, V51, P501, DOI 10.1023/B:GRES.0000024152.16021.40; Giraldo E, 2008, J AM SOC HORTIC SCI, V133, P69, DOI 10.21273/JASHS.133.1.69; Gouta H, 2010, HEREDITAS, V147, P283, DOI 10.1111/j.1601-5223.2009.02147.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grati-Kamoun N, 2006, GENET RESOUR CROP EV, V53, P265, DOI 10.1007/s10722-004-6130-0; Green P. S., 2002, Kew Bulletin, V57, P91, DOI 10.2307/4110824; Gupta P, 2012, MOL BREEDING, V30, P1325, DOI 10.1007/s11032-012-9719-6; Hakim I. R., 2010, Diversity, V2, P17; Haouane H, 2011, GENETICA, V139, P1083, DOI 10.1007/s10709-011-9608-7; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Henry RJ, 2012, J BIOSCIENCES, V37, P829, DOI 10.1007/s12038-012-9253-z; Huang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038653; Iorizzo M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-389; Ipek A, 2012, SCI AGR, V69, P327, DOI 10.1590/S0103-90162012000500007; Isik N, 2011, CROP SCI, V51, P1646, DOI 10.2135/cropsci2010.11.0625; Jackson Scott, 2006, Plant Cell, V18, P1100; Khadari B, 2008, TREE GENET GENOMES, V4, P213, DOI 10.1007/s11295-007-0102-4; Khadari B, 2005, HORTSCIENCE, V40, P29, DOI 10.21273/HORTSCI.40.1.29; Khadari B, 2003, THEOR APPL GENET, V106, P521, DOI 10.1007/s00122-002-1079-x; Kim S, 2011, INT J DATA MIN BIOIN, V5, P231; Koehmstedt AM, 2011, GENET RESOUR CROP EV, V58, P519, DOI 10.1007/s10722-010-9595-z; Lopes MS, 2004, HORTSCIENCE, V39, P1562, DOI 10.21273/HORTSCI.39.7.1562; Maccaferri M, 2008, GENETICS, V178, P489, DOI 10.1534/genetics.107.077297; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Martins-Lopes P, 2008, J AGR FOOD CHEM, V56, P11786, DOI 10.1021/jf801146z; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mekuria GT, 2002, SCI HORTIC-AMSTERDAM, V94, P91, DOI 10.1016/S0304-4238(01)00375-2; Menini U, 1998, OLIVE GERMPLASM CULT; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Mizrachi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-681; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Munoz-Merida A, 2013, DNA RES, V20, P93, DOI 10.1093/dnares/dss036; Mutz KO, 2013, CURR OPIN BIOTECH, V24, P22, DOI 10.1016/j.copbio.2012.09.004; Omrani-Sabbaghi A, 2007, SCI HORTIC-AMSTERDAM, V112, P439, DOI 10.1016/j.scienta.2006.12.051; Ozkaya MT, 2006, SCI HORTIC-AMSTERDAM, V108, P205, DOI 10.1016/j.scienta.2006.01.016; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Paszkiewicz K, 2012, BIOINFORMATICS FOR HIGH THROUGHPUT SEQUENCING, P231, DOI 10.1007/978-1-4614-0782-9_14; Poljuha D, 2008, SCI HORTIC-AMSTERDAM, V115, P223, DOI 10.1016/j.scienta.2007.08.018; Pritchard JK, 2000, GENETICS, V155, P945; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Reale S, 2006, GENOME, V49, P1193, DOI 10.1139/G06-068; ROHLF F, 2000, NTSYS NUMERICAL TAXO; Saddoud O, 2007, HEREDITAS, V144, P149, DOI 10.1111/j.2007.0018-0661.01967.x; Sanz-Cortes F, 2001, J AM SOC HORTIC SCI, V126, P7, DOI 10.21273/JASHS.126.1.07; Sarri V, 2006, GENOME, V49, P1606, DOI 10.1139/G06-126; Sefc KM, 2000, MOL ECOL, V9, P1171, DOI 10.1046/j.1365-294x.2000.00954.x; Sexton T, 2011, BMC P, V5, pO9; Sexton TR, 2010, AUST FORESTRY, V73, P254, DOI 10.1080/00049158.2010.10676336; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Strickler SR, 2012, AM J BOT, V99, P257, DOI 10.3732/ajb.1100292; Trick M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-14; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; Varshney RK, 2007, PLANT SCI, V173, P638, DOI 10.1016/j.plantsci.2007.08.010; Visioli F, 2002, CRITICAL REV FOOD SC, V42, P3; Vizoso P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-423; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wiesman Z, 1998, J AM SOC HORTIC SCI, V123, P837, DOI 10.21273/JASHS.123.5.837; Wong MML, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-726; You FM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-354; Zhang QX, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2290; Zhou XG, 2010, PROTEIN CELL, V1, P520, DOI 10.1007/s13238-010-0065-3; Zohary D., 2000, Domestication of plants in the Old World: the origin and spread of cultivated plants in West Asia, Europe and the Nile Valley	111	46	50	3	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73674	10.1371/journal.pone.0073674	http://dx.doi.org/10.1371/journal.pone.0073674			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058483	gold, Green Submitted, Green Published			2022-12-25	WOS:000324408400032
J	Blackmore, TM; Dugdale, A; Argo, CM; Curtis, G; Pinloche, E; Harris, PA; Worgan, HJ; Girdwood, SE; Dougal, K; Newbold, CJ; McEwan, NR				Blackmore, Tina M.; Dugdale, Alex; Argo, Caroline McG.; Curtis, Gemma; Pinloche, Eric; Harris, Pat A.; Worgan, Hilary J.; Girdwood, Susan E.; Dougal, Kirsty; Newbold, C. Jamie; McEwan, Neil R.			Strong Stability and Host Specific Bacterial Community in Faeces of Ponies	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; LENGTH-POLYMORPHISM ANALYSIS; EQUINE LARGE-INTESTINE; GASTROINTESTINAL-TRACT; MICROBIAL DIVERSITY; BODY-FAT; HORSES; HINDGUT; DIGESTIBILITY; ACIDOSIS	The horse, as a hindgut fermenter, is reliant on its intestinal bacterial population for efficient diet utilisation. However, sudden disturbance of this population can result in severe colic or laminitis, both of which may require euthanasia. This study therefore aimed to determine the temporal stability of the bacterial population of faecal samples from six ponies maintained on a formulated high fibre diet. Bacterial 16S rRNA terminal restriction fragment length polymorphism (TRFLP) analyses of 10 faecal samples collected from 6 ponies at regular intervals over 72 hour trial periods identified a significant pony-specific profile (P<0.001) with strong stability. Within each pony, a significantly different population was found after 11 weeks on the same diet (P<0.001) and with greater intra-individual similarity. Total short chain fatty acid (SCFA) concentration increased in all ponies, but other changes (such as bacterial population diversity measures, individual major SCFA concentration) were significant and dependent on the individual. This study is the first to report the extent of stability of microbes resident in the intestinal tract as represented with such depth and frequency of faecal sampling. In doing so, this provides a baseline from which future trials can be planned and the extent to which results may be interpreted.	[Blackmore, Tina M.; Pinloche, Eric; Worgan, Hilary J.; Girdwood, Susan E.; Dougal, Kirsty; Newbold, C. Jamie; McEwan, Neil R.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Ceredigion, Wales; [Dugdale, Alex; Argo, Caroline McG.; Curtis, Gemma] Univ Liverpool, Dept Vet Clin Sci, Div Equine Sci, Leahurst, South Wirral, England; [Harris, Pat A.] WALTHAM Ctr Pet Nutr, Equine Studies Grp, Melton Mowbray, Leics, England	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); University of Liverpool; Mars; WALTHAM Petcare Science Institute	McEwan, NR (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Ceredigion, Wales.	nrm@aber.ac.uk		Dugdale, Alexandra/0000-0002-6577-968X; Argo, Caroline/0000-0002-8279-6350; McEwan, Neil/0000-0003-3839-9072	WALTHAM Centre For Pet Nutrition	WALTHAM Centre For Pet Nutrition	The trial was commercially funded by WALTHAM Centre For Pet Nutrition, of which one of the co-authors, Dr Pat Harris, is an employee. The ponies were fed Spillers(r) Happy Hoof for the duration of the trial (detailed in Methods), which is a marketed product of WALTHAM Centre For Pet Nutrition. There are no patents or products in development. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Al Jassim RAM, 2009, VET CLIN N AM-EQUINE, V25, P199, DOI 10.1016/j.cveq.2009.04.005; Alvarado P, 2009, APPL ENVIRON MICROB, V75, P4747, DOI 10.1128/AEM.00568-09; ARGENZIO RA, 1974, AM J PHYSIOL, V226, P1035, DOI 10.1152/ajplegacy.1974.226.5.1035; Costa MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041484; Costa Marcio C., 2012, Animal Health Research Reviews, V13, P121, DOI 10.1017/S1466252312000035; Daly K, 2003, FEMS MICROBIOL ECOL, V44, P243, DOI 10.1016/S0168-6496(03)00032-1; Daly K, 2001, FEMS MICROBIOL ECOL, V38, P141, DOI 10.1111/j.1574-6941.2001.tb00892.x; Daly K, 2012, BRIT J NUTR, V107, P989, DOI 10.1017/S0007114511003825; de Fombelle A, 2003, ANIM SCI, V77, P293; Dougal K., 2005, Proceedings of the British Society of Animal Science annual conference 2005, York, UK. 4th-6th April, 2005, P47; Dougal K, 2012, FEMS MICROBIOL ECOL, V82, P642, DOI 10.1111/j.1574-6941.2012.01441.x; Dugdale AHA, 2011, EQUINE VET J, V43, P562, DOI 10.1111/j.2042-3306.2010.00327.x; Dugdale AHA, 2011, EQUINE VET J, V43, P552, DOI 10.1111/j.2042-3306.2010.00330.x; Dunbar J, 2000, APPL ENVIRON MICROB, V66, P2943, DOI 10.1128/AEM.66.7.2943-2950.2000; Edwards A, 2011, ISME J, V5, P150, DOI 10.1038/ismej.2010.100; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; GARNER HE, 1977, J ANIM SCI, V45, P1037; Gronvold AMR, 2010, VET MICROBIOL, V145, P366, DOI 10.1016/j.vetmic.2010.03.023; Hongoh Y, 2005, APPL ENVIRON MICROB, V71, P6590, DOI 10.1128/AEM.71.11.6590-6599.2005; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Julliand V, 2001, J EQUINE VET SCI, V21, P543, DOI 10.1016/S0737-0806(01)70159-1; Li M, 2009, J APPL MICROBIOL, V107, P1924, DOI 10.1111/j.1365-2672.2009.04376.x; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; MACKIE RI, 1988, APPL ENVIRON MICROB, V54, P2155, DOI 10.1128/AEM.54.9.2155-2160.1988; Marsh TL, 2000, APPL ENVIRON MICROB, V66, P3616, DOI 10.1128/AEM.66.8.3616-3620.2000; Milinovich GJ, 2008, ISME J, V2, P1089, DOI 10.1038/ismej.2008.67; MOORE BE, 1993, J ANIM SCI, V71, P3350, DOI 10.2527/1993.71123350x; Parveen I, 2008, ANIM FEED SCI TECH, V144, P65, DOI 10.1016/j.anifeedsci.2007.10.002; Rajilic-Stojanovic M, 2012, ENV MICROBIOLOGY; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Reece W. O., 2009, FUNCTIONAL ANATOMY P; Sadet-Bourgeteau S, 2010, GUT MICR NEW INS GUT; Schoster Angelika, 2013, BMC Res Notes, V6, P91, DOI 10.1186/1756-0500-6-91; Shepherd ML, 2012, FEMS MICROBIOL LETT, V326, P62, DOI 10.1111/j.1574-6968.2011.02434.x; Steelman SM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-231; Van Weyenberg S, 2006, LIVEST SCI, V99, P3, DOI 10.1016/j.livprodsci.2005.04.008; Varloud M, 2004, ANIM SCI, V79, P61, DOI 10.1017/S1357729800054539; Welkie DG, 2010, ANAEROBE, V16, P94, DOI 10.1016/j.anaerobe.2009.07.002; Willing B, 2009, EQUINE VET J, V41, P908, DOI 10.2746/042516409X447806; Yamano H, 2008, ANIM SCI J, V79, P234, DOI 10.1111/j.1740-0929.2008.00522.x; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	41	47	48	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e75079	10.1371/journal.pone.0075079	http://dx.doi.org/10.1371/journal.pone.0075079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040388	Green Submitted, Green Published, gold			2022-12-25	WOS:000326734500132
J	Migocka, M; Warzybok, A; Papierniak, A; Klobus, G				Migocka, Magdalena; Warzybok, Anna; Papierniak, Anna; Klobus, Grazyna			NO3-/H+ Antiport in the Tonoplast of Cucumber Root Cells Is Stimulated by Nitrate Supply: Evidence for a Reversible Nitrate-Induced Phosphorylation of Vacuolar NO3-/H+ Antiport	PLOS ONE			English	Article							MEMBRANE H+-ATPASE; ANION CHANNEL GENE; PLASMA-MEMBRANE; PROTEIN-KINASE; TRANSPORTER GENE; ION HOMEOSTASIS; COUPLING RATIO; MAIZE ROOTS; PROTON PUMP; BARLEY	Studies in the last few years have shed light on the process of nitrate accumulation within plant cells, achieving molecular identification and partial characterization of the genes and proteins involved in this process. However, contrary to the plasma membrane-localized nitrate transport activities, the kinetics of active nitrate influx into the vacuole and its adaptation to external nitrate availability remain poorly understood. In this work, we have investigated the activity and regulation of the tonoplast-localized H+/NO3- antiport in cucumber roots in response to N starvation and NO3- induction. The time course of nitrate availability strongly influenced H+/NO3- antiport activity at the tonoplast of root cells. However, under N starvation active nitrate accumulation within the vacuole still occurred. Hence, either a constitutive H+-coupled transport system specific for nitrate operates at the tonoplast, or nitrate uses another transport protein of broader specificity to different anions to enter the vacuole via a proton-dependent process. H+/NO3- antiport in cucumber was significantly stimulated in NO3--induced plants that were supplied with nitrate for 24 hours following 6-day-long N starvation. The cytosolic fraction isolated from the roots of NO3--induced plants significantly stimulated H+/NO3- antiport in tonoplast membranes isolated from cucumbers growing on nitrate. The stimulatory effect of the cytosolic fraction was completely abolished by EGTA and the protein kinase inhibitor staurosporine and slightly enhanced by the phosphatase inhibitors okadaic acid and cantharidin. Hence, we conclude that stimulation of H+/NO3- antiport at the tonoplast of cucumber roots in response to nitrate provision may occur through the phosphorylation of a membrane antiporter involving Ca-dependent, staurosporine-sensitive protein kinase.	[Migocka, Magdalena; Warzybok, Anna; Papierniak, Anna; Klobus, Grazyna] Univ Wroclaw, Inst Expt Biol, Dept Plant Mol Physiol, PL-50138 Wroclaw, Poland	University of Wroclaw	Migocka, M (corresponding author), Univ Wroclaw, Inst Expt Biol, Dept Plant Mol Physiol, PL-50138 Wroclaw, Poland.	mmigocka@biol.uni.wroc.pl		Klobus, Grazyna/0000-0001-9337-0745; Papierniak-Wygladala, Anna/0000-0001-9814-2899	National Science Centre (NCN), Krakow, Poland [N N303 818740]	National Science Centre (NCN), Krakow, Poland	The study was financially supported by the grant nom N N303 818740 from National Science Centre (NCN), Krakow, Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; ANDREWS M, 1986, PLANT CELL ENVIRON, V9, P511, DOI 10.1111/j.1365-3040.1986.tb01582.x; ASLAM M, 1992, PLANT PHYSIOL, V99, P1124, DOI 10.1104/pp.99.3.1124; Barbier-Brygoo H, 2011, ANNU REV PLANT BIOL, V62, P25, DOI 10.1146/annurev-arplant-042110-103741; BEHL R, 1988, PLANTA, V176, P235, DOI 10.1007/BF00392450; BLOMZANDSTRA M, 1985, J EXP BOT, V36, P1043, DOI 10.1093/jxb/36.7.1043; BLUMWALD E, 1985, P NATL ACAD SCI USA, V82, P3683, DOI 10.1073/pnas.82.11.3683; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carter C, 2004, PLANT CELL, V16, P3285, DOI 10.1105/tpc.104.027078; Cheng NH, 2003, PLANT CELL, V15, P347, DOI 10.1105/tpc.007385; Chopin F, 2007, PLANT CELL, V19, P1590, DOI 10.1105/tpc.107.050542; Cipriano DJ, 2008, BBA-BIOENERGETICS, V1777, P599, DOI 10.1016/j.bbabio.2008.03.013; DAVIES JM, 1994, P NATL ACAD SCI USA, V91, P8547, DOI 10.1073/pnas.91.18.8547; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; De Angeli A, 2009, PHILOS T R SOC B, V364, P195, DOI 10.1098/rstb.2008.0128; De Angeli A, 2009, J BIOL CHEM, V284, P26526, DOI 10.1074/jbc.M109.005132; Dunkley TPJ, 2006, P NATL ACAD SCI USA, V103, P6518, DOI 10.1073/pnas.0506958103; Endler A, 2006, PLANT PHYSIOL, V141, P196, DOI 10.1104/pp.106.079533; Forde BG, 2000, BBA-BIOMEMBRANES, V1465, P219, DOI 10.1016/S0005-2736(00)00140-1; GALLAGHER SR, 1982, PLANT PHYSIOL, V70, P1335, DOI 10.1104/pp.70.5.1335; Gaxiola RA, 2007, FEBS LETT, V581, P2204, DOI 10.1016/j.febslet.2007.03.050; Geelen D, 2000, PLANT J, V21, P259, DOI 10.1046/j.1365-313x.2000.00680.x; GLASS ADM, 1992, PLANT PHYSIOL, V99, P456, DOI 10.1104/pp.99.2.456; Harada H, 2004, J EXP BOT, V55, P2005, DOI 10.1093/jxb/erh224; Held K, 2011, CELL RES, V21, P1116, DOI 10.1038/cr.2011.50; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; Hu HC, 2009, PLANT J, V57, P264, DOI 10.1111/j.1365-313X.2008.03685.x; Huang NC, 1999, PLANT CELL, V11, P1381, DOI 10.1105/tpc.11.8.1381; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Kabala K, 2001, ACTA PHYSIOL PLANT, V23, P55, DOI 10.1007/s11738-001-0023-z; Kabala K, 2012, PLANT PHYSIOL, V47, P207; Kabala K, 2003, J PLANT PHYSL, V159, P1245; Kettner C, 2003, BIOPHYS J, V85, P3730, DOI 10.1016/S0006-3495(03)74789-4; Kim BG, 2007, PLANT J, V52, P473, DOI 10.1111/j.1365-313X.2007.03249.x; Klobus G, 2004, PHYSIOL PLANTARUM, V121, P84, DOI 10.1111/j.0031-9317.2004.00306.x; Krebs M, 2010, P NATL ACAD SCI USA, V107, P3251, DOI 10.1073/pnas.0913035107; Krouk G, 2010, CURR OPIN PLANT BIOL, V13, P266, DOI 10.1016/j.pbi.2009.12.003; Larsson C, 1990, PLANT PLASMA MEMBRAN, P158; Leran S, 2013, MOL PLANT, V6, P1984, DOI 10.1093/mp/sst068; Li LG, 2006, P NATL ACAD SCI USA, V103, P12625, DOI 10.1073/pnas.0605129103; Li RF, 2009, PROG NAT SCI-MATER, V19, P667, DOI 10.1016/j.pnsc.2008.06.030; Li WB, 2007, PLANT PHYSIOL, V143, P425, DOI 10.1104/pp.106.091223; Liu KH, 2003, EMBO J, V22, P1005, DOI 10.1093/emboj/cdg118; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; Luttge U, 2000, PLANT PHYSIOL, V124, P1335, DOI 10.1104/pp.124.3.1335; Lv QD, 2009, PLANT SCI, V176, P650, DOI 10.1016/j.plantsci.2009.02.006; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; MARTINOIA E, 1981, NATURE, V289, P292, DOI 10.1038/289292a0; Migocka M, 2013, PLANT SOIL, V364, P245, DOI 10.1007/s11104-012-1345-x; Migocka M, 2011, J EXP BOT, V62, P4903, DOI 10.1093/jxb/err180; MILLER AJ, 1992, PLANTA, V187, P554, DOI 10.1007/BF00199977; Miller AJ, 1996, J EXP BOT, V47, P843, DOI 10.1093/jxb/47.7.843; Nakanishi Y, 1998, PLANT PHYSIOL, V116, P589, DOI 10.1104/pp.116.2.589; Nikolic M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-66; Orsel M, 2004, PLANTA, V219, P714, DOI 10.1007/s00425-004-1266-x; Paungfoo-Lonhienne C, 2008, P NATL ACAD SCI USA, V105, P4524, DOI 10.1073/pnas.0712078105; Radcliffe SA, 2005, PLANT CELL ENVIRON, V28, P1379, DOI 10.1111/j.1365-3040.2005.01370.x; RASICALDOGNO F, 1985, PLANT PHYSIOL, V77, P200, DOI 10.1104/pp.77.1.200; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; SANTI S, 1995, PLANT PHYSIOL, V109, P1277, DOI 10.1104/pp.109.4.1277; Santi S, 2003, J EXP BOT, V54, P1851, DOI 10.1093/jxb/erg208; SCHUMAKER KS, 1987, PLANT PHYSIOL, V83, P490, DOI 10.1104/pp.83.3.490; SIDDIQI MY, 1990, PLANT PHYSIOL, V93, P1426, DOI 10.1104/pp.93.4.1426; SIDDIQI MY, 1991, J EXP BOT, V42, P1455, DOI 10.1093/jxb/42.11.1455; SIDDIQI MY, 1989, PLANT PHYSIOL, V90, P806, DOI 10.1104/pp.90.3.806; Sze H, 1999, PLANT CELL, V11, P677, DOI 10.1105/tpc.11.4.677; THAYER JR, 1980, ANAL BIOCHEM, V102, P110, DOI 10.1016/0003-2697(80)90325-5; TSAY YF, 1993, CELL, V72, P705, DOI 10.1016/0092-8674(93)90399-B; Tsay YF, 2007, FEBS LETT, V581, P2290, DOI 10.1016/j.febslet.2007.04.047; ULLRICH WR, 1992, PR PHYT SOC, V33, P121; Vert G, 2009, CELL, V138, P1064, DOI 10.1016/j.cell.2009.09.005; von der Fecht-Bartenbach J, 2010, PLANT CELL PHYSIOL, V51, P960, DOI 10.1093/pcp/pcq062; WANG YZ, 1986, PLANT PHYSIOL, V81, P497, DOI 10.1104/pp.81.2.497; Weichert A, 2012, PLANTA, V235, P311, DOI 10.1007/s00425-011-1508-7; Xu J, 2006, CELL, V125, P1347, DOI 10.1016/j.cell.2006.06.011; Zhuo DG, 1999, PLANT J, V17, P563, DOI 10.1046/j.1365-313X.1999.00396.x; Zou JJ, 2010, PLANT PHYSIOL, V154, P1232, DOI 10.1104/pp.110.157545	77	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73972	10.1371/journal.pone.0073972	http://dx.doi.org/10.1371/journal.pone.0073972			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040130	Green Published, gold, Green Submitted			2022-12-25	WOS:000326734500065
J	Tutken, T; Kaiser, TM; Vennemann, T; Merceron, G				Tuetken, Thomas; Kaiser, Thomas M.; Vennemann, Torsten; Merceron, Gildas			Opportunistic Feeding Strategy for the Earliest Old World Hypsodont Equids: Evidence from Stable Isotope and Dental Wear Proxies	PLOS ONE			English	Article							EARLY VALLESIAN VERTEBRATES; ATZELSDORF LATE MIOCENE; OXYGEN ISOTOPES; MICROWEAR TEXTURE; ENAMEL CARBONATE; C-13/C-12 RATIOS; UNGULATE MAMMALS; BONE PHOSPHATE; WESTERN CAPE; FOSSIL	Background: The equid Hippotherium primigenium, with moderately hypsodont cheek teeth, rapidly dispersed through Eurasia in the early late Miocene. This dispersal of hipparions into the Old World represents a major faunal event during the Neogene. The reasons for this fast dispersal of H. primigenium within Europe are still unclear. Based on its hypsodonty, a high specialization in grazing is assumed although the feeding ecology of the earliest European hipparionines within a pure C-3 plant ecosystem remains to be investigated. Methodology/Principal Findings: A multi-proxy approach, combining carbon and oxygen isotopes from enamel as well as dental meso- and microwear analyses of cheek teeth, was used to characterize the diet of the earliest European H. primigenium populations from four early Late Miocene localities in Germany (Eppelsheim, Howenegg), Switzerland (Charmoille), and France (Soblay). Enamel delta C-13 values indicate a pure C-3 plant diet with small (<1.4%) seasonal variations for all four H. primigenium populations. Dental wear and carbon isotope compositions are compatible with dietary differences. Except for the Howenegg hipparionines, dental microwear data indicate a browse-dominated diet. By contrast, the tooth mesowear patterns of all populations range from low to high abrasion suggesting a wide spectrum of food resources. Conclusions/Significance: Combined dental wear and stable isotope analysis enables refined palaeodietary reconstructions in C-3 ecosystems. Different H. primigenium populations in Europe had a large spectrum of feeding habits with a high browsing component. The combination of specialized phenotypes such as hypsodont cheek teeth with a wide spectrum of diet illustrates a new example of the Liem's paradox. This dietary flexibility associated with the capability to exploit abrasive food such as grasses probably contributed to the rapid dispersal of hipparionines from North America into Eurasia and the fast replacement of the brachydont equid Anchitherium by the hypsodont H. primigenium in Europe.	[Tuetken, Thomas] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany; [Kaiser, Thomas M.] Univ Hamburg, Biozentrum Grindel, Hamburg, Germany; [Vennemann, Torsten] Univ Lausanne, Inst Geochem, Lausanne, Switzerland; [Merceron, Gildas] Univ Poitiers, iPHEP UMR CNRS 7262, Poitiers, France	University of Bonn; University of Hamburg; University of Lausanne; Universite de Poitiers	Tutken, T (corresponding author), Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany.	tuetken@uni-bonn.de	Tütken, Thomas/E-4988-2010; Merceron, Gildas/C-8648-2012; Kaiser, Thomas/G-8883-2015	Merceron, Gildas/0000-0001-5777-7126; Kaiser, Thomas/0000-0002-8154-1751; Tutken, Thomas/0000-0002-2590-8600	Swiss National Science Foundation (SNF) [200021-100530/1]; Deutsche Forschungsgemeinschaft Emmy Noether-Program [TU 148/2, KA-1525 4-1/4-2, KA-1525 9-1, KA 1525 8-1]; Fyssen Foundation (Paris, France)	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Deutsche Forschungsgemeinschaft Emmy Noether-Program(German Research Foundation (DFG)); Fyssen Foundation (Paris, France)	This study was partly financed by the Swiss National Science Foundation (SNF) grant 200021-100530/1 to TV and the Deutsche Forschungsgemeinschaft Emmy Noether-Program TU 148/2 to TT and KA-1525 4-1/4-2 and KA-1525 9-1, KA 1525 8-1 to TMK and is publication no. 44 of the DFG Research Unit 771 "Function and enhanced efficiency in the mammalian dentition-phylogenetic and ontogenetic impact on the masticatory apparatus". The study was further funded by a research grant from the Fyssen Foundation (Paris, France) to GM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRES IM, 1992, PHOTOSYNTHETICA, V26, P323; Andrews Peter, 1999, P454; [Anonymous], SCHRIFTENREIHE DTSCH; AYLIFFE LK, 1990, GEOCHIM COSMOCHIM AC, V54, P2603, DOI 10.1016/0016-7037(90)90246-H; Balasse M, 2002, J ARCHAEOL SCI, V29, P917, DOI 10.1006/jasc.2001.0787; Balasse M, 2002, INT J OSTEOARCHAEOL, V12, P155, DOI 10.1002/oa.601; BECKER D., 2003, GEOFOCUS, V9, P327; Bernor R.L., 1996, P307; Blondel C, 2010, PALAEOGEOGR PALAEOCL, V292, P184, DOI 10.1016/j.palaeo.2010.03.042; Bohme M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036817; Bryant JD, 1996, PALAEOGEOGR PALAEOCL, V126, P75, DOI 10.1016/S0031-0182(96)00071-5; BRYANT JD, 1995, GEOCHIM COSMOCHIM AC, V59, P4523; Cerling T.E., 1997, STABLE ISOTOPES INTE, P363; Cerling TE, 1999, OECOLOGIA, V120, P347, DOI 10.1007/s004420050868; CERLING TE, 1993, NATURE, V361, P344, DOI 10.1038/361344a0; Cerling TE, 2004, OECOLOGIA, V138, P5, DOI 10.1007/s00442-003-1375-4; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Damuth J, 2011, BIOL REV, V86, P733, DOI 10.1111/j.1469-185X.2011.00176.x; DANSGAARD W, 1964, TELLUS, V16, P436; Daxner-Hoeck Gudrun, 2009, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V111A, P557; de Bonis L., 1993, Paleontologia i Evolucio, V24-25, P93; DeGusta D, 2005, J ARCHAEOL SCI, V32, P1115, DOI 10.1016/j.jas.2005.02.011; Deines P, 1980, HDB ENV GEOCHEMISTRY, V1, P239; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Diefendorf AF, 2010, P NATL ACAD SCI USA, V107, P5738, DOI 10.1073/pnas.0910513107; Drucker D, 2003, PALAEOGEOGR PALAEOCL, V195, P375, DOI 10.1016/S0031-0182(03)00366-3; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; Eronen JT, 2010, EVOLUTION, V64, P398, DOI 10.1111/j.1558-5646.2009.00830.x; Feranec RS, 2006, PALEOBIOLOGY, V32, P191, DOI 10.1666/05006.1; Feranec RS, 2003, PALEOBIOLOGY, V29, P230, DOI 10.1666/0094-8373(2003)029<0230:SIHATP>2.0.CO;2; Fortelius M, 2006, PALAEOGEOGR PALAEOCL, V238, P219, DOI 10.1016/j.palaeo.2006.03.042; Fortelius Mikael, 2003, Deinsea (Rotterdam), V10, P1; Fortelius Mikael, 2000, American Museum Novitates, V3301, P1, DOI 10.1206/0003-0082(2000)301<0001:FCOUMU>2.0.CO;2; Franz-Odendaal TA, 2004, GEODIVERSITAS, V26, P675; Franzen Jens Lorenz, 2000, Natur und Museum (Frankfurt am Main), V130, P169; Franzen JL, 2003, EPPELSHEIM 2000 NEW, P217; Fricke HC, 1996, PALAEOGEOGR PALAEOCL, V126, P91, DOI 10.1016/S0031-0182(96)00072-7; Grimm MC., 2005, GEOL JB HESSEN, V132, P79; Gugel IL, 2001, AM J PHYS ANTHROPOL, V114, P124, DOI 10.1002/1096-8644(200102)114:2&lt;124::AID-AJPA1012&gt;3.0.CO;2-S; Harzhauser Mathias, 2009, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V111A, P479; Heaton THE, 1999, J ARCHAEOL SCI, V26, P637, DOI 10.1006/jasc.1998.0381; Hoppe KA, 2004, PALAEOGEOGR PALAEOCL, V203, P299, DOI 10.1016/S0031-0182(03)00688-6; HUERTAS AD, 1995, GEOCHIM COSMOCHIM AC, V59, P4299; Hummel J, 2011, P ROY SOC B-BIOL SCI, V278, P1742, DOI 10.1098/rspb.2010.1939; Janis Christine, 2008, V195, P21, DOI 10.1007/978-3-540-72422-3_2; Jernvall J, 2002, NATURE, V417, P538, DOI 10.1038/417538a; Kahlke RD, 2011, QUATERNARY SCI REV, V30, P1368, DOI 10.1016/j.quascirev.2010.07.020; Kaiser TM, 2011, VERTEBR PALEOBIOL PA, P329, DOI 10.1007/978-90-481-9956-3_16; Kaiser Thomas M., 2000, Journal of Vertebrate Paleontology, V20, p51A; Kaiser TM, 2009, PALAEONTOL Z, V83, P131, DOI 10.1007/s12542-009-0002-z; Kaiser TM, 2003, PALAEOGEOGR PALAEOCL, V198, P381, DOI 10.1016/S0031-0182(03)00480-2; Kaiser TM, 2003, J MORPHOL, V258, P67, DOI 10.1002/jmor.10125; Kalin D, 1997, ECLOGAE GEOL HELV, V90, P97; KAUFMAN PB, 1985, ANN BOT-LONDON, V55, P487, DOI 10.1093/oxfordjournals.aob.a086926; King T, 1999, AM J PHYS ANTHROPOL, V108, P359, DOI 10.1002/(SICI)1096-8644(199903)108:3<359::AID-AJPA10>3.0.CO;2-9; Koch PL, 1997, J ARCHAEOL SCI, V24, P417, DOI 10.1006/jasc.1996.0126; Kohn MJ, 2010, P NATL ACAD SCI USA, V107, P19691, DOI 10.1073/pnas.1004933107; Kohn MJ, 1996, GEOCHIM COSMOCHIM AC, V60, P4811, DOI 10.1016/S0016-7037(96)00240-2; Kohn MJ, 1996, GEOCHIM COSMOCHIM AC, V60, P3889, DOI 10.1016/0016-7037(96)00248-7; Kohn MJ, 1998, CHEM GEOL, V152, P97, DOI 10.1016/S0009-2541(98)00099-0; Laden G, 2005, J HUM EVOL, V49, P482, DOI 10.1016/j.jhevol.2005.05.007; LANNING FC, 1989, ANN BOT-LONDON, V64, P395, DOI 10.1093/oxfordjournals.aob.a087858; LEETHORP JA, 1987, S AFR J SCI, V83, P712; Levin NE, 2006, P NATL ACAD SCI USA, V103, P11201, DOI 10.1073/pnas.0604719103; LIEM KF, 1980, AM ZOOL, V20, P295; LONGINELLI A, 1984, GEOCHIM COSMOCHIM AC, V48, P385, DOI 10.1016/0016-7037(84)90259-X; Lucas PW, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0923; MacFadden B.J., 1992, FOSSIL HORSES SYSTEM; MacFadden BJ, 2005, SCIENCE, V307, P1728, DOI 10.1126/science.1105458; MacFadden BJ, 1999, SCIENCE, V283, P824, DOI 10.1126/science.283.5403.824; MCNAUGHTON SJ, 1985, ECOLOGY, V66, P528, DOI 10.2307/1940401; Menouret Bernard, 2008, Documents des Laboratoires de Geologie Lyon, V165, P1; Merceron G, 2005, PALAIOS, V20, P551, DOI 10.2110/palo.2004.p04-17; Merceron G, 2004, PALAEOGEOGR PALAEOCL, V207, P143, DOI 10.1016/j.palaeo.2004.02.008; Merceron G, 2007, J HUM EVOL, V53, P331, DOI 10.1016/j.jhevol.2007.04.008; Merceron G, 2010, P ROY SOC B-BIOL SCI, V277, P3105, DOI 10.1098/rspb.2010.0523; Merceron G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009542; Mihlbachler Matthew C., 2006, Journal of Mammalian Evolution, V13, P11, DOI 10.1007/s10914-005-9001-3; Mihlbachler Matthew C., 2012, Palaeontologia Electronica, V15, P1; Mihlbachler MC, 2011, SCIENCE, V331, P1178, DOI 10.1126/science.1196166; Munk Wolfgang, 2007, Carolinea, V65, P5; Nelson SV, 2007, PALAEOGEOGR PALAEOCL, V243, P204, DOI 10.1016/j.palaeo.2006.07.017; Nelson SV, 2005, PALAEOGEOGR PALAEOCL, V222, P122, DOI 10.1016/j.palaeo.2005.03.012; Passey BH, 2005, J ARCHAEOL SCI, V32, P1459, DOI 10.1016/j.jas.2005.03.015; Passey BH, 2002, J GEOL, V110, P123, DOI 10.1086/338280; QUADE J, 1992, CHEM GEOL, V94, P183, DOI 10.1016/0168-9622(92)90011-X; QUADE J, 1995, J HUM EVOL, V28, P373, DOI 10.1006/jhev.1995.1029; Ramdarshan A, 2012, PLOS ONE, V6; Rivals F, 2007, J VERTEBR PALEONTOL, V27, P763, DOI 10.1671/0272-4634(2007)27[763:EOODIF]2.0.CO;2; Robinson BW, 1998, AM NAT, V151, P223, DOI 10.1086/286113; Rozanski K., 1993, GEOPHYS MONOGR SER, V78, P1, DOI DOI 10.1029/GM078P0001; Sanson GD, 2007, J ARCHAEOL SCI, V34, P526, DOI 10.1016/j.jas.2006.06.009; Schulz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056167; Scott JR, 2012, MAMMALIA, V76, P157, DOI 10.1515/mammalia-2011-0083; Scott RS, 2012, AM J PHYS ANTHROPOL, V147, P551, DOI 10.1002/ajpa.22007; Semprebon GM, 2007, PALAEOGEOGR PALAEOCL, V253, P332, DOI 10.1016/j.palaeo.2007.06.006; Sharp ZD, 1998, GEOLOGY, V26, P219, DOI 10.1130/0091-7613(1998)026<0219:FIROSC>2.3.CO;2; Simpson G.G., 1951, HORSES; Solounias N, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)366<0001:AITROU>2.0.CO;2; SOLOUNIAS N, 1988, PALEOBIOLOGY, V14, P287, DOI 10.1017/S009483730001201X; SONDAAR P Y, 1974, Geobios (Villeurbanne), V7, P289, DOI 10.1016/S0016-6995(74)80012-4; Sponheimer M, 1999, J ARCHAEOL SCI, V26, P723, DOI 10.1006/jasc.1998.0388; Spotl C, 2003, RAPID COMMUN MASS SP, V17, P1004, DOI 10.1002/rcm.1010; Steininger Fritz F., 1999, P9; Stromberg CAE, 2006, PALEOBIOLOGY, V32, P236, DOI 10.1666/0094-8373(2006)32[236:EOHIET]2.0.CO;2; Stromberg CAE, 2002, PALAEOGEOGR PALAEOCL, V177, P59, DOI 10.1016/S0031-0182(01)00352-2; Stromberg CAE, 2007, PALAEOGEOGR PALAEOCL, V250, P18, DOI 10.1016/j.palaeo.2007.02.012; SULLIVAN CH, 1983, NATURE, V301, P177, DOI 10.1038/301177a0; Swisher CC., 1996, EVOLUTION W EURASIAN, P64; TEAFORD MF, 1989, AM J PHYS ANTHROPOL, V80, P391, DOI 10.1002/ajpa.1330800312; TEAFORD MF, 1989, AM J PHYS ANTHROPOL, V80, P447, DOI 10.1002/ajpa.1330800405; Tieszen Larry L., 1993, MOL ARCHAEOLOGY PREH, P121, DOI DOI 10.1007/978-3-662-02894-0_5; Tutken T, 2006, PALAEOGEOGR PALAEOCL, V241, P457, DOI 10.1016/j.palaeo.2006.04.007; Tutken T, 2009, PALAEONTOL Z, V83, P207, DOI 10.1007/s12542-009-0011-y; Ungar P.S., 2008, TECHNIQUE APPL DENT, P389, DOI DOI 10.1017/CBO9780511542442.017; Ungar Peter S., 2007, Journal of Mammalian Evolution, V14, P163, DOI 10.1007/s10914-007-9050-x; van Dam JA, 2009, PALAEOGEOGR PALAEOCL, V274, P64, DOI 10.1016/j.palaeo.2008.12.022; VANDERMERWE NJ, 1989, GEOCHIM COSMOCHIM AC, V53, P1091, DOI 10.1016/0016-7037(89)90213-5; WALKER A, 1978, SCIENCE, V201, P908, DOI 10.1126/science.684415; Woodburne M.O., 1996, P124; Woodburne Michael O., 2009, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V111A, P585; Yakir D., 1997, STABLE ISOTOPES INTE, P147; Zhang Z-Q, 2002, VERTEBRAT PALASIATIC, V40, P166	123	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74463	10.1371/journal.pone.0074463	http://dx.doi.org/10.1371/journal.pone.0074463			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040254	Green Published, gold, Green Submitted			2022-12-25	WOS:000326734500095
J	Zhu, FL; Li, YL; Zhang, JM; Piao, CM; Liu, TT; Li, HH; Du, J				Zhu, Fuli; Li, Yulin; Zhang, Junmeng; Piao, Chunmei; Liu, Tingting; Li, Hui-Hua; Du, Jie			Senescent Cardiac Fibroblast Is Critical for Cardiac Fibrosis after Myocardial Infarction	PLOS ONE			English	Article							VASCULAR CELL SENESCENCE; PREMATURE SENESCENCE; TUMOR-SUPPRESSOR; INFLAMMATORY RESPONSE; P53; MODEL; DELETION	Senescence is a recognized mechanism of cardiovascular diseases; however, its contribution to myocardial fibrosis and rupture after infarction and the underlying mechanisms remain unclear. Here we showed that senescent cardiac fibroblasts markedly accumulated in heart after myocardial infarction. The expression of key senescence regulators, especially p53, was significantly up-regulated in the infarcted heart or hypoxia-treated fibroblasts. Furthermore, knockdown of endogenous p53 by siRNA in fibroblasts markedly reduced hypoxia-induced cell senescence, cytokine expression but increased collagen expression, whereas increased expression of p53 protein by adenovirus infection had opposite effects. Consistent with in vitro results in cardiac fibroblasts, p53 deficiency in vivo significantly decreased the accumulation of senescent fibroblasts, the infiltration of macrophages and matrix metalloproteinases, but enhanced collagen deposition after myocardial infarction. In conclusion, these results suggest that the p53-mediated fibroblast senescence limits cardiac collagen production, and inhibition of p53 activity could represent a novel therapeutic target to increase reparative fibrosis and to prevent heart rupture after myocardial infarction.	[Zhu, Fuli; Li, Yulin; Zhang, Junmeng; Piao, Chunmei; Liu, Tingting; Du, Jie] Capital Med Univ, Beijing AnZhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Key Lab Remodeling Related Cardiovasc Dis,Minist, Beijing, Peoples R China; [Li, Hui-Hua] Capital Med Univ, Dept Physiol & Pathophysiol, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Du, J (corresponding author), Capital Med Univ, Beijing AnZhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Key Lab Remodeling Related Cardiovasc Dis,Minist, Beijing, Peoples R China.	jdu@bcm.edu	Li, yulin/AGZ-5611-2022	Zhang, Junmeng/0000-0003-4670-0670	Chinese Ministry of Science and Technology [2012CB945104, 2012CB517802]; National Natural Science Foundation of China [81230006, 31090363, 81025001]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Chinese Ministry of Science and Technology (2012CB945104, 2012CB517802), National Natural Science Foundation of China (81230006, 31090363, 81025001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudino TA, 2006, AM J PHYSIOL-HEART C, V291, pH1015, DOI 10.1152/ajpheart.00023.2006; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Coppe JP, 2011, J BIOL CHEM, V286, P36396, DOI 10.1074/jbc.M111.257071; Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9; Frangogiannis NG, 2006, CURR MED CHEM, V13, P1877, DOI 10.2174/092986706777585086; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Gorgoulis VG, 2005, LAB INVEST, V85, P502, DOI 10.1038/labinvest.3700241; Gould KE, 2002, AM J PHYSIOL-HEART C, V282, pH615, DOI 10.1152/ajpheart.00206.2001; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Kiaris H, 2005, CANCER RES, V65, P1627, DOI 10.1158/0008-5472.CAN-04-3791; Kletsas D, 2004, ANN NY ACAD SCI, V1019, P330, DOI 10.1196/annals.1297.056; Komarova EA, 2005, FASEB J, V19, P1030, DOI 10.1096/fj.04-3213fje; Kordinas V, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/154397; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Leontieva OV, 2012, P NATL ACAD SCI USA, V109, P13314, DOI 10.1073/pnas.1205690109; Li YL, 2012, ARTERIOSCL THROM VAS, V32, P1662, DOI 10.1161/ATVBAHA.112.249706; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Long XL, 1997, J CLIN INVEST, V99, P2635, DOI 10.1172/JCI119452; Ma FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035144; Matsusaka H, 2006, CARDIOVASC RES, V70, P457, DOI 10.1016/j.cardiores.2006.02.001; Minamino T, 2004, J MOL CELL CARDIOL, V36, P175, DOI 10.1016/j.yjmcc.2003.11.010; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Mirzayans R, 2005, RADIAT RES, V163, P53, DOI 10.1667/RR3280; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Ren JL, 2009, CELL SIGNAL, V21, P378, DOI 10.1016/j.cellsig.2008.10.011; Ren JY, 2011, AM J HYPERTENS, V24, P701, DOI 10.1038/ajh.2011.42; Sermeus A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.48; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Sutton MS, 1997, CIRCULATION, V96, P3294; Tsai CC, 2011, BLOOD, V117, P459, DOI 10.1182/blood-2010-05-287508; Welford SM, 2011, MOL CANCER RES, V9, P538, DOI 10.1158/1541-7786.MCR-11-0065; Xie P, 2009, J BIOL CHEM, V284, P5488, DOI 10.1074/jbc.M806487200; Yang K, 2012, AM J HYPERTENS, V25, P994, DOI 10.1038/ajh.2012.74; Yang M, 2012, ARTERIOSCL THROM VAS, V32, P1675, DOI 10.1161/ATVBAHA.112.248732; Zhang FX, 2007, ACTA PHARMACOL SIN, V28, P44, DOI 10.1111/j.1745-7254.2007.00488.x; Zhang Tao, 2012, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V26, P796; Zhang TP, 2009, APOPTOSIS, V14, P1245, DOI 10.1007/s10495-009-0391-1; Zhang XL, 2005, BLOOD, V106, P75, DOI 10.1182/blood-2004-08-3033; Zheng SJ, 2005, DIABETES, V54, P1423, DOI 10.2337/diabetes.54.5.1423	44	120	122	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74535	10.1371/journal.pone.0074535	http://dx.doi.org/10.1371/journal.pone.0074535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040275	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500102
J	Skinner, AM; Verghese, SC; Kurre, P				Skinner, Amy M.; Verghese, Santhosh Chakkaramakkil; Kurre, Peter			Cell- Cell Transmission of VSV-G Pseudotyped Lentivector Particles	PLOS ONE			English	Article							LENTIVIRAL VECTORS; IN-VIVO; STABLE TRANSDUCTION; VIRUS-PARTICLES; GENE-THERAPY; T-CELLS; INFECTION; HIV-1; ENTRY; SPREAD	Many replicating viruses, including HIV-1 and HTLV-1, are efficiently transmitted from the cell surface of actively infected cells upon contact with bystander cells. In a previous study, we reported the prolonged cell surface retention of VSV-G replication-deficient pseudotyped lentivector prior to endocytic entry. However, the competing kinetics of cell surface versus dissociation, neutralization or direct transfer to other cells have received comparatively little attention. Here we demonstrate that the relative efficiency of cell-cell surface transmission can outpace "cell-free" transduction at limiting vector input. This coincides with the prolonged half-life of cell bound vector but occurs, unlike HTLV-1, without evidence for particle aggregation. These studies suggest that cell-surface attachment stabilizes particles and alters neutralization kinetics. Our experiments provide novel insight into the underexplored cell-cell transmission of pseudotyped particles.	[Skinner, Amy M.; Verghese, Santhosh Chakkaramakkil; Kurre, Peter] Oregon Hlth & Sci Univ, Dept Pediat, Pape Family Pediat Res Inst, Portland, OR 97201 USA; [Kurre, Peter] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Kurre, P (corresponding author), Oregon Hlth & Sci Univ, Dept Pediat, Pape Family Pediat Res Inst, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA.	kurrepe@ohsu.edu	sourisseau, marion/M-7542-2014		National Heart, Lung, and Blood Institute (NHLBI) [HL90765]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000128] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090765] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was supported by HL90765 (PK) from the National Heart, Lung, and Blood Institute (NHLBI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela IA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002634; Andreadis S, 2000, J VIROL, V74, P1258, DOI 10.1128/JVI.74.3.1258-1266.2000; Beer C, 2007, J VIROL, V81, P8247, DOI 10.1128/JVI.00312-07; Blomer U, 2005, GENE THER, V12, P67, DOI 10.1038/sj.gt.3302384; Cavrois M, 2007, PLOS PATHOG, V3, P38, DOI 10.1371/journal.ppat.0030004; de Witte L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000049; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Galimi F, 2002, BLOOD, V100, P2732, DOI 10.1182/blood-2002-04-1245; Greco G, 2002, J IMMUNOL, V168, P5722, DOI 10.4049/jimmunol.168.11.5722; Haas DL, 2000, MOL THER, V2, P71, DOI 10.1006/mthe.2000.0094; Haim H, 2007, J VIROL, V81, P3525, DOI 10.1128/JVI.02293-06; Jin J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000163; Le Rouzic E, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-11; Logan AC, 2004, HUM GENE THER, V15, P976, DOI 10.1089/hum.2004.15.976; Matrai J, 2010, MOL THER, V18, P477, DOI 10.1038/mt.2009.319; Mazurov D, 2012, J VIROL, V86, P2447, DOI 10.1128/JVI.06993-11; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Monel B, 2012, J VIROL, V86, P3924, DOI 10.1128/JVI.06478-11; Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630; Mothes W, 2010, J VIROL, V84, P8360, DOI 10.1128/JVI.00443-10; Murphy SL, 2008, MOL THER, V16, P138, DOI 10.1038/sj.mt.6300334; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; O'Neill LS, 2010, J GENE MED, V12, P463, DOI 10.1002/jgm.1458; Pais-Correia AM, 2010, NAT MED, V16, P83, DOI 10.1038/nm.2065; Pan YW, 2007, J VIROL, V81, P639, DOI 10.1128/JVI.01089-06; Pizzato M, 2001, GENE THER, V8, P1088, DOI 10.1038/sj.gt.3301494; Platt EJ, 2010, J VIROL, V84, P3106, DOI 10.1128/JVI.01958-09; Sastry L, 2003, MOL THER, V8, P830, DOI 10.1016/j.ymthe.2003.08.003; SATO H, 1992, VIROLOGY, V186, P712, DOI 10.1016/0042-6822(92)90038-Q; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Sharma S, 2000, J VIROL, V74, P10790, DOI 10.1128/JVI.74.22.10790-10795.2000; Sherer NM, 2008, TRENDS CELL BIOL, V18, P414, DOI 10.1016/j.tcb.2008.07.003; Sherer NM, 2010, J VIROL, V84, P3248, DOI 10.1128/JVI.02155-09; Skinner AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006219; Sourisseau M, 2007, J VIROL, V81, P1000, DOI 10.1128/JVI.01629-06; Thoulouze MI, 2011, TRENDS MICROBIOL, V19, P257, DOI 10.1016/j.tim.2011.03.002; VASSALLI JD, 1986, J CELL SCI, V85, P125; Verhoeyen E, 2009, CSHPROTOC; Wiley RD, 2006, P NATL ACAD SCI USA, V103, P738, DOI 10.1073/pnas.0507995103; Willmon C, 2009, MOL THER, V17, P1667, DOI 10.1038/mt.2009.194; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Zhong P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053138	44	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74925	10.1371/journal.pone.0074925	http://dx.doi.org/10.1371/journal.pone.0074925			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040363	gold, Green Published, Green Submitted			2022-12-25	WOS:000327538600121
J	Melis, M; Atzori, E; Cabras, S; Zonza, A; Calo, C; Muroni, P; Nieddu, M; Padiglia, A; Sogos, V; Tepper, BJ; Barbarossa, IT				Melis, Melania; Atzori, Elena; Cabras, Stefano; Zonza, Andrea; Calo, Carla; Muroni, Patrizia; Nieddu, Mariella; Padiglia, Alessandra; Sogos, Valeria; Tepper, Beverly J.; Barbarossa, Iole Tomassini			The Gustin (CA6) Gene Polymorphism, rs2274333 (A/G), as a Mechanistic Link between PROP Tasting and Fungiform Taste Papilla Density and Maintenance	PLOS ONE			English	Article							ANHYDRASE ISOENZYME-VI; BODY-MASS INDEX; BITTER-TASTE; 6-N-PROPYLTHIOURACIL PROP; VEGETABLE INTAKE; SENSITIVITY; TAS2R38; PERCEPTION; PHENYLTHIOCARBAMIDE; PTC	Taste sensitivity to PROP varies greatly among individuals and is associated with polymorphisms in the bitter receptor gene TAS2R38, and with differences in fungiform papilla density on the anterior tongue surface. Recently we showed that the PROP non-taster phenotype is strongly associated with the G variant of polymorphism rs2274333 (A/G) of the gene that controls the salivary trophic factor, gustin. The aims of this study were 1) to investigate the role of gustin gene polymorphism rs2274333 (A/G), in PROP sensitivity and fungiform papilla density and morphology, and 2) to investigate the effect of this gustin gene polymorphism on cell proliferation and metabolic activity. Sixty-four subjects were genotyped for both genes by PCR techniques, their PROP sensitivity was assessed by scaling and threshold methods, and their fungiform papilla density, diameter and morphology were determined. In vitro experiments examined cell proliferation and metabolic activity, following treatment with saliva of individuals with and without the gustin gene mutation, and with isolated protein, in the two iso-forms. Gustin and TAS2R38 genotypes were associated with PROP threshold (p=0.0001 and p=0.0042), but bitterness intensity was mostly determined by TAS2R38 genotypes (p<0.000001). Fungiform papillae densities were associated with both genotypes (p<0.014) (with a stronger effect for gustin; p=0.0006), but papilla morphology was a function of gustin alone (p<0.0012). Treatment of isolated cells with saliva from individuals with the AA form of gustin or direct application of the active iso-form of gustin protein increased cell proliferation and metabolic activity (p<0.0135). These novel findings suggest that the rs2274333 polymorphism of the gustin gene affects PROP sensitivity by acting on fungiform papilla development and maintenance, and could provide the first mechanistic explanation for why PROP super-tasters are more responsive to a broad range of oral stimuli.	[Melis, Melania; Cabras, Stefano; Zonza, Andrea; Muroni, Patrizia; Nieddu, Mariella; Sogos, Valeria; Barbarossa, Iole Tomassini] Univ Cagliari, Dept Biomed Sci, Monserrato, Italy; [Atzori, Elena; Calo, Carla; Padiglia, Alessandra] Univ Cagliari, Dept Life & Environm Sci, Monserrato, Italy; [Tepper, Beverly J.] Rutgers State Univ, Sch Environm & Biol Sci, Dept Food Sci, New Brunswick, NJ 08903 USA	University of Cagliari; University of Cagliari; Rutgers State University New Brunswick	Barbarossa, IT (corresponding author), Univ Cagliari, Dept Biomed Sci, Monserrato, Italy.	tomassin@unica.it	Sogos, Valeria/B-5471-2012	Sogos, Valeria/0000-0002-4021-1043; MELIS, MELANIA/0000-0003-3410-3158; Nieddu, Mariella/0000-0001-8595-7001; Cabras, Stefano/0000-0001-6690-8378; TOMASSINI BARBAROSSA, IOLE/0000-0002-2849-4052	Italian Ministry of University and Research; Fondazione Banco di Sardegna	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Fondazione Banco di Sardegna(Fondazione Banco di Sardegna)	This work was supported by the Italian Ministry of University and Research and "Fondazione Banco di Sardegna". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajec MR, 2008, PHYSIOL BEHAV, V95, P581, DOI 10.1016/j.physbeh.2008.08.009; Baranowski T, 2011, NUTR RES, V31, P594, DOI 10.1016/j.nutres.2011.07.004; Barbarossa IT, 2013, NUTRITION, V29, P531, DOI 10.1016/j.nut.2012.09.018; Bartoshuk LM, 2012, PHYSIOL BEHAV, V107, P516, DOI 10.1016/j.physbeh.2012.06.013; Bartoshuk LM, 1998, ANN NY ACAD SCI, V855, P793, DOI 10.1111/j.1749-6632.1998.tb10660.x; BARTOSHUK LM, 1994, PHYSIOL BEHAV, V56, P1165, DOI 10.1016/0031-9384(94)90361-1; Basson MD, 2005, DIGEST DIS SCI, V50, P483, DOI 10.1007/s10620-005-2462-7; BEIDLER LM, 1965, J CELL BIOL, V27, P263, DOI 10.1083/jcb.27.2.263; Bell KI, 2006, AM J CLIN NUTR, V84, P245, DOI 10.1093/ajcn/84.1.245; Bennick A, 2002, CRIT REV ORAL BIOL M, V13, P184, DOI 10.1177/154411130201300208; Biarnes X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012394; Brehm KE, 2009, J CLIN MICROBIOL, V47, P3156, DOI 10.1128/JCM.00510-09; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Cabras T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030962; Calo C, 2011, PHYSIOL BEHAV, V104, P1065, DOI 10.1016/j.physbeh.2011.06.013; Campbell MC, 2012, MOL BIOL EVOL, V29, P1141, DOI 10.1093/molbev/msr293; Carrai M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020464; Chale-Rush A, 2007, CHEM SENSES, V32, P423, DOI 10.1093/chemse/bjm007; Czekanska EM, 2011, METHODS MOL BIOL, V740, P27, DOI 10.1007/978-1-61779-108-6_5; Dinehart ME, 2006, PHYSIOL BEHAV, V87, P304, DOI 10.1016/j.physbeh.2005.10.018; Dinnella C, 2011, APPETITE, V56, P633, DOI 10.1016/j.appet.2011.02.017; Drayna D, 2003, HUM GENET, V112, P567, DOI 10.1007/s00439-003-0911-y; Drewnowski A, 2007, J AM DIET ASSOC, V107, P1340, DOI 10.1016/j.jada.2007.05.013; Duffy VB, 2000, J AM DIET ASSOC, V100, P647, DOI 10.1016/S0002-8223(00)00191-7; Duffy VB, 2004, ALCOHOL CLIN EXP RES, V28, P1629, DOI 10.1097/01.ALC.0000145789.55183.D4; Essick GK, 2003, PHYSIOL BEHAV, V80, P289, DOI 10.1016/j.physbeh.2003.08.007; FARBMAN AI, 1980, CELL TISSUE KINET, V13, P349, DOI 10.1111/j.1365-2184.1980.tb00474.x; Fox AL, 1932, P NATL ACAD SCI USA, V18, P115, DOI 10.1073/pnas.18.1.115; Genick UK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027745; GLANVILL.EV, 1965, NATURE, V205, P930, DOI 10.1038/205930a0; GREEN BG, 1993, CHEM SENSES, V18, P683, DOI 10.1093/chemse/18.6.683; Guo SW, 2001, ANN HUM BIOL, V28, P111; Hayes JE, 2008, CHEM SENSES, V33, P255, DOI 10.1093/chemse/bjm084; Hayes JE, 2007, CHEM SENSES, V32, P225, DOI 10.1093/chemse/bjl050; HENKIN RI, 1975, P NATL ACAD SCI USA, V72, P488, DOI 10.1073/pnas.72.2.488; Henkin RI, 1999, AM J MED SCI, V318, P392, DOI 10.1097/00000441-199912000-00006; Keller KL, 2002, APPETITE, V38, P3, DOI 10.1006/appe.2001.0441; KHALIFAH RG, 1977, BIOCHEMISTRY-US, V16, P2241, DOI 10.1021/bi00629a031; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Kirkmeyer SV, 2003, CHEM SENSES, V28, P527, DOI 10.1093/chemse/28.6.527; Kivela J, 1997, ACTA PHYSIOL SCAND, V161, P221, DOI 10.1046/j.1365-201X.1997.00217.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leinonen J, 2001, J HISTOCHEM CYTOCHEM, V49, P657, DOI 10.1177/002215540104900513; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lucock M, 2011, FOOD FUNCT, V2, P457, DOI 10.1039/c1fo10054h; Melis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059810; MEYER TS, 1965, BIOCHIM BIOPHYS ACTA, V107, P144, DOI 10.1016/0304-4165(65)90403-4; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; MILLER IJ, 1990, PHYSIOL BEHAV, V47, P1213, DOI 10.1016/0031-9384(90)90374-D; MURAKAMI H, 1987, J BIOL CHEM, V262, P1382; Nosrat IV, 2012, J BIOL CHEM, V287, P16791, DOI 10.1074/jbc.M111.328476; OLSON JM, 1989, GENET EPIDEMIOL, V6, P423, DOI 10.1002/gepi.1370060305; Padiglia A, 2010, AM J CLIN NUTR, V92, P539, DOI 10.3945/ajcn.2010.29418; PARKKILA S, 1995, ACTA PHYSIOL SCAND, V154, P205, DOI 10.1111/j.1748-1716.1995.tb09902.x; PARKKILA S, 1990, J HISTOCHEM CYTOCHEM, V38, P941, DOI 10.1177/38.7.2113069; Prodi DA, 2004, CHEM SENSES, V29, P697, DOI 10.1093/chemse/bjh074; Reed DR, 2010, HUM MOL GENET, V19, P4278, DOI 10.1093/hmg/ddq324; Sandell MA, 2006, CURR BIOL, V16, pR792, DOI 10.1016/j.cub.2006.08.049; Sato K, 2002, ACTA OTO-LARYNGOL, V122, P74, DOI 10.1080/00016480260046445; Shahbake M, 2005, BRAIN RES, V1052, P196, DOI 10.1016/j.brainres.2005.06.031; Sillanpaa MJ, 2004, ANN HUM GENET, V68, P646, DOI 10.1046/j.1529-8817.2004.00122.x; Soares S, 2011, J AGR FOOD CHEM, V59, P5535, DOI 10.1021/jf104975d; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Tan J, 2012, J CHEM INF MODEL, V52, P1875, DOI 10.1021/ci300133a; Tepper BJ, 2008, OBESITY, V16, P2289, DOI 10.1038/oby.2008.357; Tepper BJ, 2008, ANNU REV NUTR, V28, P367, DOI 10.1146/annurev.nutr.28.061807.155458; Tepper BJ, 2011, APPETITE, V56, P104, DOI 10.1016/j.appet.2010.11.144; Tepper BJ, 2009, INT J FOOD SCI NUTR, V60, P35, DOI 10.1080/09637480802304499; Tepper BJ, 1998, ANN NY ACAD SCI, V855, P802, DOI 10.1111/j.1749-6632.1998.tb10662.x; Tepper BJ, 2002, PHYSIOL BEHAV, V75, P305, DOI 10.1016/S0031-9384(01)00664-3; Tepper BJ, 2001, PHYSIOL BEHAV, V73, P571, DOI 10.1016/S0031-9384(01)00500-5; Thornton-Wells TA, 2004, TRENDS GENET, V20, P640, DOI 10.1016/j.tig.2004.09.007; Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268; Timpson NJ, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-51; Timpson NJ, 2005, AM J CLIN NUTR, V81, P1005; Wooding S, 2004, AM J HUM GENET, V74, P637, DOI 10.1086/383092; Yeomans MR, 2007, PHYSIOL BEHAV, V91, P264, DOI 10.1016/j.physbeh.2007.03.011; Yeomans MR, 2009, Q J EXP PSYCHOL, V62, P1648, DOI 10.1080/17470210802557793; Zhang GH, 2009, CHEM SENSES, V34, P93, DOI 10.1093/chemse/bjn059; Zhao LQ, 2003, PHYSIOL BEHAV, V78, P625, DOI 10.1016/S0031-9384(03)00057-X	80	46	47	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74151	10.1371/journal.pone.0074151	http://dx.doi.org/10.1371/journal.pone.0074151			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040192	Green Submitted, Green Published, gold			2022-12-25	WOS:000326405300162
J	Yin, JH; Yang, MN; Zhou, SS; Wang, Y; Feng, J; Xia, ZG				Yin, Jian-hai; Yang, Man-ni; Zhou, Shui-sen; Wang, Yi; Feng, Jun; Xia, Zhi-gui			Changing Malaria Transmission and Implications in China towards National Malaria Elimination Programme between 2010 and 2012	PLOS ONE			English	Article							ANOPHELES-SINENSIS; YONGCHENG CITY; VIVAX MALARIA; PROVINCE	Background: Towards the implementation of national malaria elimination programme in China since 2010, the epidemiology of malaria has changed dramatically, and the lowest malaria burden was achieved yearly. It is time to analyze the changes of malaria situation based on surveillance data from 2010 to 2012 to reconsider the strategies for malaria elimination. Methods and Principal findings: Malaria epidemiological data was extracted from the provincial annual reports in China between 2010 and 2012. The trends of the general, autochthonous and imported malaria were analyzed, and epidemic areas were reclassified according to Action Plan of China Malaria Elimination (2010-2020). As a result, there reported 2743 malaria cases with a continued decline in 2012, and around 7% autochthonous malaria cases accounted. Three hundred and fifty-three individual counties from 19 provincial regions had autochthonous malaria between 2010 and 2012, and only one county was reclassified into Type I (local infections detected in 3 consecutive years and the annual incidences >= 1/10,000) again. However, the imported malaria cases reported of each year were widespread, and 598 counties in 29 provinces were suffered in 2012. Conclusions/Significance: Malaria was reduced significantly from 2010 to 2012 in China, and malaria importation became an increasing challenge. It is necessary to adjust or update the interventions for subsequent malaria elimination planning and resource allocation.	[Yin, Jian-hai; Yang, Man-ni; Zhou, Shui-sen; Wang, Yi; Xia, Zhi-gui] Chinese Ctr Dis Control & Prevent CDC, Natl Inst Parasit Dis, Beijing, Peoples R China; [Yin, Jian-hai; Yang, Man-ni; Zhou, Shui-sen; Wang, Yi; Xia, Zhi-gui] MOH, Key Lab Parasite & Vector Biol, Beijing, Peoples R China; [Yin, Jian-hai; Yang, Man-ni; Zhou, Shui-sen; Wang, Yi; Xia, Zhi-gui] WHO Collaborating Ctr Malaria Schistosomiasis & F, Shanghai, Peoples R China; [Feng, Jun] Guizhou Prov CDC, Guiyang, Peoples R China	Chinese Center for Disease Control & Prevention; World Health Organization	Xia, ZG (corresponding author), Chinese Ctr Dis Control & Prevent CDC, Natl Inst Parasit Dis, Beijing, Peoples R China.	nipdxzhg@163.com	Yin, Jianhai/AAF-5820-2020; Yin, Jianhai/GRS-2880-2022	Yin, Jianhai/0000-0003-1333-8732	National S & T Major Program [2012ZX10004-220, 2012ZX10004-201]	National S & T Major Program	This work was supported by the National S & T Major Program (Grant No. 2012ZX10004-220 and 2012ZX10004-201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MAL PROGR REV MAN RE; [Anonymous], 2010, ACT PLAN CHIN MAL EL; [Anonymous], 2011, PLOS MED; Cotter C, 2013, LANCET; Cui F, 2006, PEST MANAG SCI, V62, P1013, DOI 10.1002/ps.1288; Danis K, 2013, TRAVEL MED INFECT DI, V11, P8, DOI 10.1016/j.tmaid.2013.01.001; Gatton ML, 2013, EVOLUTION, V67, P1218, DOI 10.1111/evo.12063; Gonzalez-Ceron L, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-109; Liu XB, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-58; Liu XB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-221; Liu Ying, 2012, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V30, P309; Ma YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022219; Pan JY, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-136; Petersen E, 2013, TRAVEL MED INFECT DI, V11, P51, DOI 10.1016/j.tmaid.2013.01.003; Qi Gao, 2011, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V23, P347; Sleigh AC, 1998, B WORLD HEALTH ORGAN, V76, P265; Stresman G, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-353; Tang L.H., 1999, ZHONGGUO JI SHENG CH, V17, P3; Tang LH, 2009, GUO JI YI XUE JI SHE, V36, P8; Tatem AJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-133; Ulrich JN, 2013, TRENDS PARASITOL, V29, P104, DOI 10.1016/j.pt.2013.01.002; Wang SB, 2013, TRENDS BIOTECHNOL, V31, P185, DOI 10.1016/j.tibtech.2013.01.001; WHO, 2012, WORLD MALARIA REPORT 2012, P1; World Health Organization, 2007, MAL EL FIELD MAN LOW; World Health Organization, 2012, TEST TREAT TRACK SCA; Xia Zhi-Gui, 2012, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V30, P419; Xiao-Nong Zhou, 2011, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V23, P473; Yin JH, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-130; Zhong DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055475; Zhou SS, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-337; Zhou Shui-Sen, 2011, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V29, P401	31	49	58	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74228	10.1371/journal.pone.0074228	http://dx.doi.org/10.1371/journal.pone.0074228			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040210	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300166
J	Chaudhary, R; Pierre, CC; Nanan, K; Wojtal, D; Morone, S; Pinelli, C; Wood, GA; Robine, S; Daniel, JM				Chaudhary, Roopali; Pierre, Christina C.; Nanan, Kyster; Wojtal, Daria; Morone, Simona; Pinelli, Christopher; Wood, Geoffrey A.; Robine, Sylvie; Daniel, Juliet M.			The POZ-ZF Transcription Factor Kaiso (ZBTB33) Induces Inflammation and Progenitor Cell Differentiation in the Murine Intestine	PLOS ONE			English	Article							ZINC-FINGER PROTEINS; EPITHELIAL-CELLS; BINDING-PROTEIN; METHYLATED DNA; PARTNER KAISO; COLON-CANCER; WNT; PROLIFERATION; GENES; REQUIREMENT	Since its discovery, several studies have implicated the POZ-ZF protein Kaiso in both developmental and tumorigenic processes. However, most of the information regarding Kaiso's function to date has been gleaned from studies in Xenopus laevis embryos and mammalian cultured cells. To examine Kaiso's role in a relevant, mammalian organ-specific context, we generated and characterized a Kaiso transgenic mouse expressing a murine Kaiso transgene under the control of the intestine-specific villin promoter. Kaiso transgenic mice were viable and fertile but pathological examination of the small intestine revealed distinct morphological changes. Kaiso transgenics (Kaiso(Tg/+)) exhibited a crypt expansion phenotype that was accompanied by increased differentiation of epithelial progenitor cells into secretory cell lineages; this was evidenced by increased cell populations expressing Goblet, Paneth and enteroendocrine markers. Paradoxically however, enhanced differentiation in Kaiso(Tg/+) was accompanied by reduced proliferation, a phenotype reminiscent of Notch inhibition. Indeed, expression of the Notch signalling target HES-1 was decreased in Kaiso(Tg/+) animals. Finally, our Kaiso transgenics exhibited several hallmarks of inflammation, including increased neutrophil infiltration and activation, villi fusion and crypt hyperplasia. Interestingly, the Kaiso binding partner and emerging anti-inflammatory mediator p120(ctn) is recruited to the nucleus in Kaiso(Tg/+) mice intestinal cells suggesting that Kaiso may elicit inflammation by antagonizing p120(ctn) function.	[Chaudhary, Roopali; Pierre, Christina C.; Wojtal, Daria; Daniel, Juliet M.] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Nanan, Kyster] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada; [Morone, Simona] Univ Turin, Dept Med Sci, Turin, Italy; [Pinelli, Christopher; Wood, Geoffrey A.] Univ Guelph, Dept Pathol, Guelph, ON N1G 2W1, Canada; [Robine, Sylvie] Inst Curie, CNRS, Dept Morphogenesis & Intracellular Signalling, F-75231 Paris, France	McMaster University; McMaster University; Queens University - Canada; University of Turin; University of Guelph; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Daniel, JM (corresponding author), McMaster Univ, Dept Biol, 1280 Main St W, Hamilton, ON, Canada.	danielj@mcmaster.ca	Wood, Geoffrey/ABB-2052-2021	Wood, Geoffrey/0000-0003-1756-8607; Wojtal, Daria/0000-0002-3401-4641	CIHR [MOP-84320]; Ontario Graduate Scholarship; McMaster Prestige Award	CIHR(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); McMaster Prestige Award	This work was supported by CIHR grant (MOP-84320) to Juliet Daniel. R. Chaudhary was the recipient of an Ontario Graduate Scholarship and C. Pierre was the recipient of a McMaster Prestige Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blattler A, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-13; Caballero IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004315; Cofre J, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-28; Dai SD, 2010, LUNG CANCER, V67, P205, DOI 10.1016/j.lungcan.2009.06.013; Dai SD, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-178; Daniel JM, 2002, NUCLEIC ACIDS RES, V30, P2911, DOI 10.1093/nar/gkf398; Daniel JM, 2007, BBA-MOL CELL RES, V1773, P59, DOI 10.1016/j.bbamcr.2006.08.052; Donaldson NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050398; Donaldson NS, 2012, PLOS ONE IN PRESS; Filion GJP, 2006, MOL CELL BIOL, V26, P169, DOI 10.1128/MCB.26.1.169-181.2006; Goldstein NS, 2006, AM J CLIN PATHOL, V125, P838, DOI 10.1309/4PK0G68M2G1L6X47; Iioka H, 2009, FEBS LETT, V583, P627, DOI 10.1016/j.febslet.2009.01.012; Jacques P, 2008, MUCOSAL IMMUNOL, V1, P364, DOI 10.1038/mi.2008.24; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Jiang GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030303; Jones J, 2012, AM J PATHOL, V181, P1836, DOI 10.1016/j.ajpath.2012.08.008; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Lopes EC, 2008, CANCER RES, V68, P7258, DOI 10.1158/0008-5472.CAN-08-0344; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Ogaki S, 2013, STEM CELLS, V31, P1086, DOI 10.1002/stem.1344; Okamoto R, 2009, AM J PHYSIOL-GASTR L, V296, pG23, DOI 10.1152/ajpgi.90225.2008; Ostanin DV, 2006, AM J PHYSIOL-GASTR L, V290, pG109, DOI 10.1152/ajpgi.00214.2005; Park JI, 2006, DEV CELL, V11, P683, DOI 10.1016/j.devcel.2006.09.022; Park JI, 2005, DEV CELL, V8, P843, DOI 10.1016/j.devcel.2005.04.010; Pinto D, 1999, J BIOL CHEM, V274, P6476, DOI 10.1074/jbc.274.10.6476; Prokhortchouk A, 2006, MOL CELL BIOL, V26, P199, DOI 10.1128/MCB.26.1.199-208.2006; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Rubin DC, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00107; Ruzov A, 2004, DEVELOPMENT, V131, P6185, DOI 10.1242/dev.01549; Ruzov A, 2009, DEVELOPMENT, V136, P729, DOI 10.1242/dev.025569; Ruzov A, 2009, DEVELOPMENT, V136, P723, DOI 10.1242/dev.025577; Saleh M, 2011, NAT REV IMMUNOL, V11, P9, DOI 10.1038/nri2891; Sasai N, 2010, NUCLEIC ACIDS RES, V38, P5015, DOI 10.1093/nar/gkq280; Smalley-Freed WG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019880; Smalley-Freed WG, 2010, J CLIN INVEST, V120, P1824, DOI 10.1172/JCI41414; Spring CM, 2005, EXP CELL RES, V305, P253, DOI 10.1016/j.yexcr.2005.01.007; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; van Roy FM, 2005, NAT REV CANCER, V5, P956, DOI 10.1038/nrc1752; VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763; Vermeulen JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037864; Wang YZ, 2012, TUMOUR BIOL; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yang RY, 2006, CELL CYCLE, V5, P180, DOI 10.4161/cc.5.2.2306; Yoon HG, 2003, MOL CELL, V12, P723, DOI 10.1016/j.molcel.2003.08.008; Zecchini V, 2005, GENE DEV, V19, P1686, DOI 10.1101/gad.341705	45	16	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74160	10.1371/journal.pone.0074160	http://dx.doi.org/10.1371/journal.pone.0074160			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040197	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600120
J	Hargrove, TY; Wawrzak, Z; Alexander, PW; Chaplin, JH; Keenan, M; Charman, SA; Perez, CJ; Waterman, MR; Chatelain, E; Lepesheva, GI				Hargrove, Tatiana Y.; Wawrzak, Zdzislaw; Alexander, Paul W.; Chaplin, Jason H.; Keenan, Martine; Charman, Susan A.; Perez, Catherine J.; Waterman, Michael R.; Chatelain, Eric; Lepesheva, Galina I.			Complexes of Trypanosoma cruzi Sterol 14 alpha-Demethylase (CYP51) with Two Pyridine-based Drug Candidates for Chagas Disease STRUCTURAL BASIS FOR PATHOGEN SELECTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIFUNGAL AGENTS; ERGOSTEROL BIOSYNTHESIS; SUBSTRATE PREFERENCES; SCHIZOTRYPANUM CRUZI; CYTOCHROMES P450; INHIBITION; KETOCONAZOLE; EPIMASTIGOTES; BINDING; TARGET	Chagas disease, caused by the eukaryotic (protozoan) parasite Trypanosoma cruzi, is an alarming emerging global health problem with no clinical drugs available to treat the chronic stage. Azole inhibitors of sterol 14 alpha-demethylase (CYP51) were proven effective against Chagas, and antifungal drugs posaconazole and ravuconazole have entered clinical trials in Spain, Bolivia, and Argentina. Here we present the x-ray structures of T. cruzi CYP51 in complexes with two alternative drug candidates, pyridine derivatives (S)-(4-chlorophenyl)-1-(4-(4-(trifluoromethyl)phenyl)-piperazin-1-yl)-2-(pyridin-3-yl)ethanone (UDO; Protein Data Bank code 3ZG2) and N-[4-(trifluoromethyl)phenyl]-N-[1-[5-(trifluoromethyl)-2-pyridyl]-4-piperidyl]pyridin-3-amine (UDD; Protein Data Bank code 3ZG3). These compounds have been developed by the Drugs for Neglected Diseases initiative (DNDi) and are highly promising antichagasic agents in both cellular and in vivo experiments. The binding parameters and inhibitory effects on sterol 14 alpha-demethylase activity in reconstituted enzyme reactions confirmed UDO and UDD as potent and selective T. cruzi CYP51 inhibitors. Comparative analysis of the pyridine-and azole-bound CYP51 structures uncovered the features that make UDO and UDD T. cruzi CYP51-specific. The structures suggest that although a precise fit between the shape of the inhibitor molecules and T. cruzi CYP51 active site topology underlies their high inhibitory potency, a longer coordination bond between the catalytic heme iron and the pyridine nitrogen implies a weaker influence of pyridines on the iron reduction potential, which may be the basis for the observed selectivity of these compounds toward the target enzyme versus other cytochrome P450s, including human drug-metabolizing P450s. These findings may pave the way for the development of novel CYP51-targeted drugs with optimized metabolic properties that are very much needed for the treatment of human infections caused by eukaryotic microbial pathogens.	[Hargrove, Tatiana Y.; Waterman, Michael R.; Lepesheva, Galina I.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Wawrzak, Zdzislaw] Northwestern Univ, Synchrotron Res Ctr, Life Sci Collaborat Access Team, Argonne, IL 60439 USA; [Alexander, Paul W.; Chaplin, Jason H.; Keenan, Martine] Murdoch Univ, Epichem Pty Ltd, Murdoch, WA 6150, Australia; [Charman, Susan A.] Monash Univ, Monash Inst Pharmaceut Sci, Ctr Drug Candidate Optimisat, Parkville, Vic 3052, Australia; [Perez, Catherine J.] Murdoch Univ, Dept Parasitol & Vet Sci, Murdoch, WA 6150, Australia; [Chatelain, Eric] Drugs Neglected Dis Initiat, CH-1202 Geneva, Switzerland; [Lepesheva, Galina I.] Vanderbilt Ctr Struct Biol, Nashville, TN 37232 USA; [Lepesheva, Galina I.] Inst Global Hlth, Nashville, TN 37232 USA	Vanderbilt University; Northwestern University; Murdoch University; Monash University; Murdoch University	Lepesheva, GI (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 622 RRB,23rd & Pierce, Nashville, TN 37232 USA.	galina.lepesheva@vanderbilt.edu	Charman, Susan A/E-2221-2011	Charman, Susan A/0000-0003-1753-8213	National Institutes of Health [GM 067871]; Department for International Development (DFID), United Kingdom; Reconstruction Credit Institution-Federal Ministry of Education and Research (KfW-BMBF), Germany; Ministry of Foreign and European Affairs (MAEE), France; Spanish Agency for International Development Cooperation (AECID), Spain; Directorate-General for International Cooperation (DGIS), Netherlands; Medecins Sans Frontieres (Doctors without Borders (international)); Swiss foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067871] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department for International Development (DFID), United Kingdom; Reconstruction Credit Institution-Federal Ministry of Education and Research (KfW-BMBF), Germany; Ministry of Foreign and European Affairs (MAEE), France; Spanish Agency for International Development Cooperation (AECID), Spain; Directorate-General for International Cooperation (DGIS), Netherlands(Netherlands Government); Medecins Sans Frontieres (Doctors without Borders (international)); Swiss foundation(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 067871 (to G. I. L.). For synthesis of UDO (EPL-BS1246) and UDD (EPL-BS0967) and their testing in microsomal, cellular experiments and in vivo, DNDi received financial support from the following donors: the Department for International Development (DFID), United Kingdom; the Reconstruction Credit Institution-Federal Ministry of Education and Research (KfW-BMBF), Germany; the Ministry of Foreign and European Affairs (MAEE), France; the Spanish Agency for International Development Cooperation (AECID), Spain; the Directorate-General for International Cooperation (DGIS), Netherlands; Medecins Sans Frontieres (Doctors without Borders (international)); and a Swiss foundation.	Andriani G, 2013, J MED CHEM, V56, P2556, DOI 10.1021/jm400012e; Apt W, 1998, AM J TROP MED HYG, V59, P133, DOI 10.4269/ajtmh.1998.59.133; Araujo MSS, 2000, J ANTIMICROB CHEMOTH, V45, P819, DOI 10.1093/jac/45.6.819; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEACH DH, 1986, BIOCHEM BIOPH RES CO, V136, P851, DOI 10.1016/0006-291X(86)90410-9; BENNETT JE, 1974, NEW ENGL J MED, V290, P320, DOI 10.1056/NEJM197402072900607; Buckner F, 2003, P NATL ACAD SCI USA, V100, P15149, DOI 10.1073/pnas.2535442100; Buckner FS, 2012, ANTIMICROB AGENTS CH, V56, P4914, DOI 10.1128/AAC.06244-11; Buckner FS, 1996, ANTIMICROB AGENTS CH, V40, P2592, DOI 10.1128/AAC.40.11.2592; Bui SH, 2012, J BIOL CHEM, V287, P19699, DOI 10.1074/jbc.M111.319202; Clayton J, 2010, NATURE, V465, pS12, DOI 10.1038/nature09224; Correia MA., 2005, CYTOCHROME P450 STRU, P246; Soeiro MDC, 2013, ANTIMICROB AGENTS CH, V57, P4151, DOI 10.1128/AAC.00070-13; Dobish MC, 2012, ORG LETT, V14, P6322, DOI 10.1021/ol303092v; DOCAMPO R, 1981, MOL BIOCHEM PARASIT, V3, P169, DOI 10.1016/0166-6851(81)90047-5; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Espinel-Ingroff A, 2008, REV IBEROAM MICOL, V25, P101, DOI 10.1016/S1130-1406(08)70027-5; FISCHER RT, 1989, J LIPID RES, V30, P1621; Gubbins PO, 2011, EXPERT OPIN DRUG MET, V7, P1411, DOI 10.1517/17425255.2011.627854; Guengerich FP, 2006, AAPS J, V8, pE101, DOI 10.1208/aapsj080112; Hargrove TY, 2012, INT J PARASITOL-DRUG, V2, P178, DOI 10.1016/j.ijpddr.2012.06.001; Hargrove TY, 2012, J LIPID RES, V53, P311, DOI 10.1194/jlr.M021865; Hargrove TY, 2011, J BIOL CHEM, V286, P26838, DOI 10.1074/jbc.M111.237099; Hucke O, 2005, J MED CHEM, V48, P5415, DOI 10.1021/jm050441z; Kanafani ZA, 2008, CLIN INFECT DIS, V46, P120, DOI 10.1086/524071; Keenan M, 2013, BIOORGAN MED CHEM, V21, P1756, DOI 10.1016/j.bmc.2013.01.050; Keenan M, 2012, J MED CHEM, V55, P4189, DOI 10.1021/jm2015809; Konkle ME, 2009, J MED CHEM, V52, P2846, DOI 10.1021/jm801643b; LAZARDI K, 1990, ANTIMICROB AGENTS CH, V34, P2097, DOI 10.1128/AAC.34.11.2097; Lepesheva GI, 2007, CHEM BIOL, V14, P1283, DOI 10.1016/j.chembiol.2007.10.011; Lepesheva GI, 2007, BBA-GEN SUBJECTS, V1770, P467, DOI 10.1016/j.bbagen.2006.07.018; Lepesheva GI, 2011, CURR TOP MED CHEM, V11, P2060; Lepesheva GI, 2011, ADV PARASIT, V75, P65, DOI 10.1016/B978-0-12-385863-4.00004-6; Lepesheva GI, 2011, BBA-PROTEINS PROTEOM, V1814, P88, DOI 10.1016/j.bbapap.2010.06.006; Lepesheva GI, 2010, J BIOL CHEM, V285, P25582, DOI 10.1074/jbc.M110.133215; Lepesheva GI, 2010, J BIOL CHEM, V285, P1773, DOI 10.1074/jbc.M109.067470; Lepesheva G, 2008, LIPIDS, V43, P1117, DOI 10.1007/s11745-008-3225-y; Lepesheva GI, 2006, J BIOL CHEM, V281, P3577, DOI 10.1074/jbc.M510317200; Lepesheva GI, 2003, BIOCHEMISTRY-US, V42, P9091, DOI 10.1021/bi034663f; Lepesheva GI, 2004, MOL CELL ENDOCRINOL, V215, P165, DOI 10.1016/j.mce.2003.11.016; Lepesheva GI, 2004, BIOCHEMISTRY-US, V43, P10789, DOI 10.1021/bi048967t; Lepesheva GI, 2001, J BIOL CHEM, V276, P28413, DOI 10.1074/jbc.M102767200; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Leslie M, 2011, SCIENCE, V333, P933, DOI 10.1126/science.333.6045.933; Maertens JA, 2004, CLIN MICROBIOL INFEC, V10, P1, DOI 10.1111/j.1470-9465.2004.00841.x; Mast N, 2013, MOL PHARMACOL, V84, P86, DOI 10.1124/mol.113.085902; Molina J, 2000, ANTIMICROB AGENTS CH, V44, P150, DOI 10.1128/AAC.44.1.150-155.2000; NES WR, 1977, BIOCH STEROIDS OTHER, P325; Obach RS, 2006, J PHARMACOL EXP THER, V316, P336, DOI 10.1124/jpet.105.093229; OMURA T, 1964, J BIOL CHEM, V239, P2370; Roberts CW, 2003, MOL BIOCHEM PARASIT, V126, P129, DOI 10.1016/S0166-6851(02)00280-3; Saari TI, 2010, CURR OPIN ANESTHESIO, V23, P441, DOI 10.1097/ACO.0b013e32833a254d; Schuster I, 2007, DRUG METAB REV, V39, P481, DOI 10.1080/03602530701498455; Strushkevich N, 2010, J MOL BIOL, V397, P1067, DOI 10.1016/j.jmb.2010.01.075; TRZASKOS JM, 1984, J BIOL CHEM, V259, P3402; URBINA JA, 1988, ANTIMICROB AGENTS CH, V32, P1237, DOI 10.1128/AAC.32.8.1237; Urbina JA, 2009, MEM I OSWALDO CRUZ, V104, P311, DOI 10.1590/S0074-02762009000900041; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Van den Bossche H, 1988, MODE ACTION PYRIDINE, P79; Villalta F, 2013, J INFECT DIS, V208, P504, DOI 10.1093/infdis/jit042; Zhang WJ, 2002, DRUG METAB DISPOS, V30, P314, DOI 10.1124/dmd.30.3.314	61	70	70	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31602	31615		10.1074/jbc.M113.497990	http://dx.doi.org/10.1074/jbc.M113.497990			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24047900	hybrid, Green Published			2022-12-25	WOS:000330596200019
J	Alam, M; Ahmad, R; Rajabi, H; Kharbanda, A; Kufe, D				Alam, Maroof; Ahmad, Rehan; Rajabi, Hasan; Kharbanda, Akriti; Kufe, Donald			MUC1-C Oncoprotein Activates ERK -> C/EBP beta Signaling and Induction of Aldehyde Dehydrogenase 1A1 in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN-BETA; C/EBP-BETA; TRANSCRIPTION FACTOR; MAMMARY-GLAND; KAPPA-B; ANDROGEN RECEPTOR; REGULATORY LOOP; SIDE POPULATION; DNA-BINDING; STEM-CELLS	Aldehyde dehydrogenase 1A1 (ALDH1A1) activity is used as a marker of breast cancer stem cells; however, little is known about the regulation of ALDH1A1 expression. Mucin 1 (MUC1) is a heterodimeric protein that is aberrantly overexpressed in most human breast cancers. In studies of breast cancer cells stably silenced for MUC1 or overexpressing the oncogenic MUC1-Csubunit, we demonstrate that MUC1-Cis sufficient for induction of MEK -> ERK signaling and that treatment with a MUC1-Cinhibitor suppresses ERK activation. In turn, MUC1-C induces ERK-mediated phosphorylation and activation of the CCAAT/enhancer-binding protein beta (C/EBP beta) transcription factor. The results further show that MUC1-C and C/EBP beta form a complex on the ALDH1A1 gene promoter and activate ALDH1A1 gene transcription. MUC1-C-induced up-regulation of ALDH1A1 expression is associated with increases in ALDH activity and is detectable in stem-like cells when expanded as mammospheres. These findings demonstrate that MUC1-C (i) activates a previously unrecognized ERK -> C/EBP beta -> ALDH1A1 pathway, and (ii) promotes the induction of ALDH activity in breast cancer cells.	[Alam, Maroof; Ahmad, Rehan; Rajabi, Hasan; Kharbanda, Akriti; Kufe, Donald] Harvard Univ, Dana Farber Canc Inst, Sch Med, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Kufe, D (corresponding author), 450 Brookline Ave,Dana 830, Boston, MA 02215 USA.	donald_kufe@dfci.harvard.edu	Rather, R A/J-3509-2019		NCI of the National Institutes of Health [CA97098, CA166480]; NATIONAL CANCER INSTITUTE [R01CA166480, R01CA097098] Funding Source: NIH RePORTER	NCI of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the NCI of the National Institutes of Health under award numbers CA97098 and CA166480. D. K. holds equity in Genus Oncology and is a consultant to the company. The other authors disclosed no potential conflicts of interest.	Ahmad R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001426; Ahmad R, 2009, CANCER RES, V69, P7013, DOI 10.1158/0008-5472.CAN-09-0523; Atwood AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025205; Bundy LM, 2003, ONCOGENE, V22, P869, DOI 10.1038/sj.onc.1206216; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Christgen M, 2007, MOL CELL BIOCHEM, V306, P201, DOI 10.1007/s11010-007-9570-y; Chute JP, 2006, P NATL ACAD SCI USA, V103, P11707, DOI 10.1073/pnas.0603806103; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Douville J, 2009, STEM CELLS DEV, V18, P17, DOI 10.1089/scd.2008.0055; Eaton EM, 2001, J CELL PHYSIOL, V189, P91, DOI 10.1002/jcp.1139; Elizondo G, 2000, J BIOL CHEM, V275, P39747, DOI 10.1074/jbc.M004987200; Engelmann K, 2008, CANCER RES, V68, P2419, DOI 10.1158/0008-5472.CAN-07-2249; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Ginestier C, 2009, CELL CYCLE, V8, P3297, DOI 10.4161/cc.8.20.9761; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Grimm SL, 2003, J MAMMARY GLAND BIOL, V8, P191, DOI 10.1023/A:1025900908026; Hattrup CL, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1515; Jin CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039432; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; Kufe DW, 2013, ONCOGENE, V32, P1073, DOI 10.1038/onc.2012.158; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; LaMarca HL, 2010, STEM CELLS, V28, P535, DOI 10.1002/stem.297; Lee S, 2010, MOL CELL BIOL, V30, P2621, DOI 10.1128/MCB.00782-09; Leng YM, 2007, J BIOL CHEM, V282, P19321, DOI 10.1074/jbc.M703222200; Li YQ, 2003, MOL CANCER RES, V1, P765; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI [10.1517/17425255.4.6.697, 10.1517/17425255.4.6.697 ]; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Niehof M, 2001, J MOL BIOL, V309, P855, DOI 10.1006/jmbi.2001.4708; Panchamoorthy G, 2011, HYBRIDOMA, V30, P531, DOI 10.1089/hyb.2011.0070; PANDEY P, 1995, CANCER RES, V55, P4000; Park SY, 2010, CLIN CANCER RES, V16, P876, DOI 10.1158/1078-0432.CCR-09-1532; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Piwien-Pilipuk G, 2002, J BIOL CHEM, V277, P44557, DOI 10.1074/jbc.M206886200; Raina D, 2004, J BIOL CHEM, V279, P20607, DOI 10.1074/jbc.M310538200; Raina D., 2013, ONCOGENE IN PRESS; Raina D, 2012, INT J ONCOL, V40, P1644, DOI 10.3892/ijo.2011.1308; Raina D, 2011, MOL CANCER THER, V10, P806, DOI 10.1158/1535-7163.MCT-10-1050; Rajabi H., 2013, ONCOGENE IN PRESS; Rajabi H, 2012, PROSTATE, V72, P1659, DOI 10.1002/pros.22519; Rajabi H, 2012, J BIOL CHEM, V287, P10703, DOI 10.1074/jbc.M111.323311; Rajabi H, 2011, PROSTATE, V71, P1299, DOI 10.1002/pros.21344; Ramasamy S, 2007, MOL CELL, V27, P992, DOI 10.1016/j.molcel.2007.07.031; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Relic B, 2004, J BIOL CHEM, V279, P22399, DOI 10.1074/jbc.M314118200; Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907; Rosen JM, 1999, ANNU REV NUTR, V19, P407, DOI 10.1146/annurev.nutr.19.1.407; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; Siroy A, 2013, HUM PATHOL, V44, P2159, DOI 10.1016/j.humpath.2013.04.010; STEIN B, 1993, MOL CELL BIOL, V13, P3964, DOI 10.1128/MCB.13.7.3964; Su WC, 2003, J BIOL CHEM, V278, P51150, DOI 10.1074/jbc.M305501200; Trasino SE, 2007, EXP BIOL MED, V232, P762; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; WILLIAMS SC, 1995, EMBO J, V14, P3170, DOI 10.1002/j.1460-2075.1995.tb07319.x; YANAGAWA Y, 1995, J BIOL CHEM, V270, P17521, DOI 10.1074/jbc.270.29.17521; Yao MY, 2011, LUNG, V189, P453, DOI 10.1007/s00408-011-9327-y; Zahnow CA, 1997, J NATL CANCER I, V89, P1887, DOI 10.1093/jnci/89.24.1887	60	66	69	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					30892	30903		10.1074/jbc.M113.477158	http://dx.doi.org/10.1074/jbc.M113.477158			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24043631	hybrid, Green Published			2022-12-25	WOS:000330778900010
J	Takasu, Y; Sajwan, S; Daimon, T; Osanai-Futahashi, M; Uchino, K; Sezutsu, H; Tamura, T; Zurovec, M				Takasu, Yoko; Sajwan, Suresh; Daimon, Takaaki; Osanai-Futahashi, Mizuko; Uchino, Keiro; Sezutsu, Hideki; Tamura, Toshiki; Zurovec, Michal			Efficient TALEN Construction for Bombyx mori Gene Targeting	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; CLEAVAGE DOMAIN; MUTAGENESIS; DROSOPHILA; GENOME; CELLS; IDENTIFICATION; DISRUPTION; INJECTION; EFFECTORS	Engineered nucleases are artificial enzymes able to introduce double stranded breaks at desired genomic locations. The double stranded breaks start the error-prone repair process of non-homologous end-joining (NHEJ), which eventually leads to the induction of mutations at target sites. We showed earlier that ZFNs and TALENs are able to induce NHEJ mutations in the B. mori genome. In order to optimize our mutagenesis protocol, we modified one of the reported truncated TALEN scaffolds and optimized it for use in the B. mori embryo. We also established a novel B. mori somatic cell assay suitable for the preselection of highly efficient TALENs directly in the B. mori model system. We compared the efficiency of several TALEN pairs based on three different frameworks using the BmBLOS2 gene. The new active TALENs show one order of magnitude higher efficiency than those we used previously. We confirmed the utility of our improved protocol by mutagenesis of the autosomal gene, red egg (Bm-re) and showed that it allows obtaining homozygous mutants in G(1). Our procedure minimizes the chance of failure in B. mori gene targeting experiments.	[Takasu, Yoko; Daimon, Takaaki; Osanai-Futahashi, Mizuko; Uchino, Keiro; Sezutsu, Hideki; Tamura, Toshiki] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Sajwan, Suresh; Zurovec, Michal] Univ South Bohemia, Acad Sci, Ctr Biol, Ceske Budejovice, Czech Republic; [Sajwan, Suresh; Zurovec, Michal] Univ South Bohemia, Fac Nat Sci, Ceske Budejovice, Czech Republic	National Institute of Agrobiological Sciences - Japan; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of South Bohemia Ceske Budejovice	Tamura, T (corresponding author), Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan.	ttamura@affrc.go.jp; zurovec@entu.cas.cz	Zurovec, Michal/H-2562-2014; Zurovec, Michal/AAE-8185-2021	Zurovec, Michal/0000-0002-0913-166X; Zurovec, Michal/0000-0002-0913-166X; Uchino, Keiro/0000-0003-3650-7359; Daimon, Takaaki/0000-0002-8382-1132; Sezutsu, Hideki/0000-0001-8886-1611	KAKENHI from Japan Society for the Promotion of Science [23580083]; Grant Agency of Czech Republic [P305/10/2406]; Grants-in-Aid for Scientific Research [23580083] Funding Source: KAKEN	KAKENHI from Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grant Agency of Czech Republic(Grant Agency of the Czech Republic); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by KAKENHI Grant Number 23580083 from Japan Society for the Promotion of Science and grant P305/10/2406 from the Grant Agency of Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beumer KJ, 2008, P NATL ACAD SCI USA, V105, P19821, DOI 10.1073/pnas.0810475105; Bibikova M, 2002, GENETICS, V161, P1169; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Christian ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045383; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Liu JY, 2012, J GENET GENOMICS, V39, P209, DOI 10.1016/j.jgg.2012.04.003; Ma SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045035; Merlin C, 2013, GENOME RES, V23, P159, DOI 10.1101/gr.145599.112; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Osanai-Futahashi M, 2012, J BIOL CHEM, V287, P17706, DOI 10.1074/jbc.M111.321331; Porteus M, 2010, COLD SPRING HARB PRO; Sajwan S, 2013, INSECT BIOCHEM MOLEC, V43, P17, DOI 10.1016/j.ibmb.2012.10.011; SALLES FJ, 1994, SCIENCE, V266, P1996, DOI 10.1126/science.7801127; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Takasu Y, 2010, INSECT BIOCHEM MOLEC, V40, P759, DOI 10.1016/j.ibmb.2010.07.012; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Watanabe T, 2012, ACTA BIOL HUNG, V63, P58, DOI 10.1556/ABiol.63.2012.Suppl.2.5; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Zhang F, 2011, METHODS MOL BIOL, V701, P167, DOI 10.1007/978-1-61737-957-4_9	26	60	65	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73458	10.1371/journal.pone.0073458	http://dx.doi.org/10.1371/journal.pone.0073458			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058473	gold, Green Published			2022-12-25	WOS:000324695900013
J	Agosta, SJ; Bernardo, J; Ceballos, G; Steele, MA				Agosta, Salvatore J.; Bernardo, Joseph; Ceballos, Gerardo; Steele, Michael A.			A Macrophysiological Analysis of Energetic Constraints on Geographic Range Size in Mammals	PLOS ONE			English	Article							BASAL METABOLIC-RATE; LATITUDINAL DIVERSITY GRADIENT; LARGE SPATIAL SCALES; BODY-SIZE; THERMAL TOLERANCE; GLOBAL PATTERNS; CLIMATE-CHANGE; SPECIES RANGE; NEW-WORLD; ECOLOGICAL IMPLICATIONS	Physiological processes are essential for understanding the distribution and abundance of organisms, and recently, with widespread attention to climate change, physiology has been ushered back to the forefront of ecological thinking. We present a macrophysiological analysis of the energetics of geographic range size using combined data on body size, basal metabolic rate (BMR), phylogeny and range properties for 574 species of mammals. We propose three mechanisms by which interspecific variation in BMR should relate positively to geographic range size: (i) Thermal Plasticity Hypothesis, (ii) Activity Levels/Dispersal Hypothesis, and (iii) Energy Constraint Hypothesis. Although each mechanism predicts a positive correlation between BMR and range size, they can be further distinguished based on the shape of the relationship they predict. We found evidence for the predicted positive relationship in two dimensions of energetics: (i) the absolute, mass-dependent dimension (BMR) and (ii) the relative, mass-independent dimension (MIBMR). The shapes of both relationships were similar and most consistent with that expected from the Energy Constraint Hypothesis, which was proposed previously to explain the classic macroecological relationship between range size and body size in mammals and birds. The fact that this pattern holds in the MIBMR dimension indicates that species with supra-allometric metabolic rates require among the largest ranges, above and beyond the increasing energy demands that accrue as an allometric consequence of large body size. The relationship is most evident at high latitudes north of the Tropics, where large ranges and elevated MIBMR are most common. Our results suggest that species that are most vulnerable to extinction from range size reductions are both large-bodied and have elevated MIBMR, but also, that smaller species with elevated MIBMR are at heightened risk. We also provide insights into the global latitudinal trends in range size and MIBMR and more general issues of phylogenetic and geographic scale.	[Agosta, Salvatore J.] Virginia Commonwealth Univ, Ctr Environm Studies, Richmond, VA 23284 USA; [Agosta, Salvatore J.] Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA; [Bernardo, Joseph] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Bernardo, Joseph] Southern Appalachian Biodivers Inst, Roan Mt, TN USA; [Ceballos, Gerardo] Univ Nacl Autonoma Mexico, Dept Ecol Biodiversidad, Inst Ecol, Mexico City 04510, DF, Mexico; [Steele, Michael A.] Wilkes Univ, Dept Biol, Wilkes Barre, PA 18766 USA	Virginia Commonwealth University; Virginia Commonwealth University; Texas A&M University System; Texas A&M University College Station; Universidad Nacional Autonoma de Mexico; Wilkes University	Agosta, SJ (corresponding author), Virginia Commonwealth Univ, Ctr Environm Studies, Richmond, VA 23284 USA.	sagosta@vcu.edu	Bernardo, Joseph/C-2403-2008	Bernardo, Joseph/0000-0002-5516-4710; Ceballos, Gerardo/0000-0001-8374-2656	Department of Ecology and Evolutionary Biology, University of Toronto; Department of Biology, Wilkes University from the Howard Hughes Medical Institute; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica Proyect from the Universidad Nacional Autonoma de Mexico (UNAM) [IN 211811]; Harvard Forest; H. Fenner Endowment of Wilkes University	Department of Ecology and Evolutionary Biology, University of Toronto(University of Toronto); Department of Biology, Wilkes University from the Howard Hughes Medical Institute; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica Proyect from the Universidad Nacional Autonoma de Mexico (UNAM); Harvard Forest; H. Fenner Endowment of Wilkes University	SJA was supported for portions of this work by postdoctoral research fellowships from the Department of Ecology and Evolutionary Biology, University of Toronto and Department of Biology, Wilkes University through a departmental grant from the Howard Hughes Medical Institute. GC was supported in part by the Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica Proyect No. IN 211811 from the Universidad Nacional Autonoma de Mexico (UNAM). MAS recognizes the support of a Bullard Fellowship from Harvard Forest and the H. Fenner Endowment of Wilkes University. This is contribution No. 8 from the Southern Appalachian Biodiversity Institute. The aforementioned entities had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Bediako A, 2000, P ROY SOC B-BIOL SCI, V267, P739, DOI 10.1098/rspb.2000.1065; Agosta SJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0140; ANDERSON S, 1981, AM MUS NOVIT, P1; ARITA HT, 1990, CONSERV BIOL, V4, P181, DOI 10.1111/j.1523-1739.1990.tb00107.x; AYRES JM, 1992, AM NAT, V140, P531, DOI 10.1086/285427; BENNETT AF, 1979, SCIENCE, V206, P649, DOI 10.1126/science.493968; Bernardo J, 2007, BIOLOGY LETT, V3, P695, DOI 10.1098/rsbl.2007.0259; Bernardo J, 2006, BIOL LETTERS, V2, P135, DOI 10.1098/rsbl.2005.0417; Bininda-Emonds ORP, 2008, NATURE, V456, P274, DOI 10.1038/nature07347; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Blackburn TM, 1996, ECOGRAPHY, V19, P369, DOI 10.1111/j.1600-0587.1996.tb00247.x; Blackburn TM, 1996, PHILOS T R SOC B, V351, P897, DOI 10.1098/rstb.1996.0083; Blomberg SP, 2012, SYST BIOL, V61, P382, DOI 10.1093/sysbio/syr118; Bohning-Gaese K, 2006, AM NAT, V167, P555, DOI 10.1086/501078; Boyer AG, 2012, METABOLIC ECOLOGY SC; Bozinovic F, 2011, ANNU REV ECOL EVOL S, V42, P155, DOI 10.1146/annurev-ecolsys-102710-145055; BRATTSTROM BH, 1968, COMP BIOCHEM PHYSIOL, V24, P93, DOI 10.1016/0010-406X(68)90961-4; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; BROWN JH, 1987, AM NAT, V130, P1, DOI 10.1086/284694; BROWN JH, 1993, AM NAT, V142, P573, DOI 10.1086/285558; BROWN JH, 1989, SCIENCE, V243, P1145, DOI 10.1126/science.243.4895.1145; BROWN JH, 1991, AM NAT, V138, P1478, DOI 10.1086/285297; Brown JH, 1999, J MAMMAL, V80, P333, DOI 10.2307/1383283; Buckley LB, 2012, GLOBAL ECOL BIOGEOGR, V21, P873, DOI 10.1111/j.1466-8238.2011.00737.x; Buckley LB, 2010, P ROY SOC B-BIOL SCI, V277, P2131, DOI 10.1098/rspb.2010.0179; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Calosi P, 2008, J BIOGEOGR, V35, P295, DOI 10.1111/j.1365-2699.2007.01787.x; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Careau V, 2009, FUNCT ECOL, V23, P150, DOI 10.1111/j.1365-2435.2008.01468.x; Ceballos G, 2005, SCIENCE, V309, P603, DOI 10.1126/science.1114015; Ceballos G, 2006, P NATL ACAD SCI USA, V103, P19374, DOI 10.1073/pnas.0609334103; Chown SL, 2004, PLOS BIOL, V2, P1701, DOI 10.1371/journal.pbio.0020406; Chown SL, 2004, FUNCT ECOL, V18, P159, DOI 10.1111/j.0269-8463.2004.00825.x; Chown SL, 2008, P ROY SOC B-BIOL SCI, V275, P1469, DOI 10.1098/rspb.2008.0137; Clarke A, 1999, J ANIM ECOL, V68, P893, DOI 10.1046/j.1365-2656.1999.00337.x; Clarke A, 2010, BIOL REV, V85, P703, DOI 10.1111/j.1469-185X.2010.00122.x; Criddle RS, 2005, PURE APPL CHEM, V77, P1425, DOI 10.1351/pac200577081425; Criddle RS, 2003, RUSS J PLANT PHYSL+, V50, P192, DOI 10.1023/A:1022969029867; Crozier LG, 2008, EVOL APPL, V1, P252, DOI 10.1111/j.1752-4571.2008.00033.x; Crozier LG, 2004, OECOLOGIA, V141, P148, DOI 10.1007/s00442-004-1634-z; Cruz FB, 2005, J EVOLUTION BIOL, V18, P1559, DOI 10.1111/j.1420-9101.2005.00936.x; Darlington P.J., 1957, ZOOGEOGRAPHY GEOGRAP; Darwin C., 1859, ORIGIN SPECIES MEANS; Davies TJ, 2011, PHILOS T R SOC B, V366, P2526, DOI 10.1098/rstb.2011.0018; Diniz JAF, 2005, ACTA OECOL, V27, P25, DOI 10.1016/j.actao.2004.08.006; DUNHAM AE, 1989, PHYSIOL ZOOL, V62, P335, DOI 10.1086/physzool.62.2.30156174; DUNHAM AE, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P95; Estes S, 2007, AM NAT, V169, P227, DOI 10.1086/510633; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fernandez MH, 2005, J BIOGEOGR, V32, P1243, DOI 10.1111/j.1365-2699.2005.01270.x; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; Gaston KJ, 2009, AM NAT, V174, P595, DOI 10.1086/605982; Gaston KJ, 2009, P R SOC B, V276, P1395, DOI 10.1098/rspb.2008.1480; Gaston KJ, 1996, CONSERV BIOL, V10, P638, DOI 10.1046/j.1523-1739.1996.10020638.x; Gaston KJ, 1999, OIKOS, V84, P309, DOI 10.2307/3546727; Gaston KJ, 1996, OIKOS, V75, P479, DOI 10.2307/3545889; Gaston KJ, 2001, GLOBAL ECOL BIOGEOGR, V10, P179, DOI 10.1046/j.1466-822x.2001.00225.x; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Gates D. M., 1980, BIOPHYSICAL ECOLOGY; Gebczynski AK, 2009, J EVOLUTION BIOL, V22, P1212, DOI 10.1111/j.1420-9101.2009.01734.x; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; Grinnell J, 1917, AM NAT, V51, P115, DOI 10.1086/279591; Haag CR, 2005, P ROY SOC B-BIOL SCI, V272, P2449, DOI 10.1098/rspb.2005.3235; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hayes JP, 2010, J EVOLUTION BIOL, V23, P1868, DOI 10.1111/j.1420-9101.2010.02053.x; Hellmann JJ, 2008, OECOLOGIA, V157, P583, DOI 10.1007/s00442-008-1112-0; HUEY RB, 1979, AM ZOOL, V19, P357; HUEY RB, 1991, AM NAT, V137, pS91, DOI 10.1086/285141; Hulbert AJ, 2000, ANNU REV PHYSIOL, V62, P207, DOI 10.1146/annurev.physiol.62.1.207; Hulbert AJ, 2004, PHYSIOL BIOCHEM ZOOL, V77, P869, DOI 10.1086/422768; Humphries MM, 2005, ECOL LETT, V8, P1326, DOI 10.1111/j.1461-0248.2005.00839.x; Institute SAS., 2009, CARY; *INT UN CONS NAT, 2012, IUCN RED LIST CAT CR; IUCN, 2011, GUID US IUCN RED LIS; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jetz W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003261; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Kelt DA, 2001, AM NAT, V157, P637, DOI 10.1086/320621; Kelt DA, 1999, ECOLOGY, V80, P337; KLEIBER MAX, 1932, HILGARDIA, V6, P315; Lampinen R, 1996, ATLAS FLORAE EUROPAE; Le Conte J., 1900, OUTLINES COMP PHYSL; Leger EA, 2009, BASIC APPL ECOL, V10, P279, DOI 10.1016/j.baae.2008.04.001; Lloyd KM, 2003, J BIOGEOGR, V30, P1751, DOI 10.1046/j.1365-2699.2003.00922.x; Lovegrove BG, 2003, J COMP PHYSIOL B, V173, P87, DOI 10.1007/s00360-002-0309-5; Lovegrove BG, 2000, AM NAT, V156, P201, DOI 10.1086/303383; MacArthur R.H., 1972, pvii; MacMillen R.E., 1989, P143; Maurer BA, 1999, UNTANGLING ECOLOGICA; McCain CM, 2009, ECOL LETT, V12, P550, DOI 10.1111/j.1461-0248.2009.01308.x; McNab B.K., 2012, EXTREME MEASURES ECO; McNab BK, 2003, COMP BIOCHEM PHYS A, V135, P357, DOI 10.1016/S1095-6433(03)00090-4; McNab BK, 2005, CURR ZOOL, V51, P535; McNab BK, 2009, MOL MIGRATION PRESSU, P621; Mcnab BK, 2008, COMP BIOCHEM PHYS A, V151, P5, DOI 10.1016/j.cbpa.2008.05.008; Merriam C.H., 1984, NATL GEOGRAPHIC MAGA, V6, P229; Mueller P, 2001, P NATL ACAD SCI USA, V98, P12550, DOI 10.1073/pnas.221456698; Niitepold K, 2009, ECOLOGY, V90, P2223, DOI 10.1890/08-1498.1; O'Connor MP, 2007, AM NAT, V170, P431, DOI 10.1086/519459; O'Connor MP, 2006, INTEGR COMP BIOL, V46, P1093, DOI 10.1093/icb/icl031; Orme CDL, 2006, PLOS BIOL, V4, P1276, DOI 10.1371/journal.pbio.0040208; Osovitz CJ, 2007, COMP BIOCHEM PHYS A, V147, P821, DOI 10.1016/j.cbpa.2007.02.012; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pelini SL, 2009, P NATL ACAD SCI USA, V106, P11160, DOI 10.1073/pnas.0900284106; Pither J, 2003, P ROY SOC B-BIOL SCI, V270, P475, DOI 10.1098/rspb.2002.2275; Porter W.P., 1983, P55; PORTER WP, 1989, PHYSIOL ZOOL, V62, P286, DOI 10.1086/physzool.62.2.30156172; PORTER WP, 1969, ECOL MONOGR, V39, P227, DOI 10.2307/1948545; Porter WP, 1975, PERSPECTIVES BIOPHYS, P347; R DEVELOPMENT CORE TEAM, 2009, R LANG ENV STAT COMP; Raichlen DA, 2010, J COMP PHYSIOL B, V180, P301, DOI 10.1007/s00360-009-0399-4; Rapoport E.H., 1982, AREOGRAPHY, P210; Revell LJ, 2010, METHODS ECOL EVOL, V1, P319, DOI 10.1111/j.2041-210X.2010.00044.x; Rezende EL, 2004, EVOLUTION, V58, P1361; Rodriguez-Serrano E, 2009, GLOBAL CHANGE BIOL, V15, P2116, DOI 10.1111/j.1365-2486.2009.01854.x; ROY K, 1994, P NATL ACAD SCI USA, V91, P8871, DOI 10.1073/pnas.91.19.8871; Rundle SD, 2007, FRESHWATER BIOL, V52, P471, DOI 10.1111/j.1365-2427.2006.01712.x; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Sears MW, 2006, FUNCT ECOL, V20, P97, DOI 10.1111/j.1365-2435.2006.01067.x; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Sieg AE, 2009, AM NAT, V174, P720, DOI 10.1086/606023; Smith FA, 2011, PHILOS T R SOC B, V366, P2364, DOI 10.1098/rstb.2011.0067; Speakman JR, 2004, PHYSIOL BIOCHEM ZOOL, V77, P900, DOI 10.1086/427059; Speakman JR, 2000, ADV ECOL RES, V30, P177; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Stillman JH, 2004, INT CONGR SER, V1275, P267, DOI 10.1016/j.ics.2004.09.034; Stillman JH, 2003, SCIENCE, V301, P65, DOI 10.1126/science.1083073; Stillman JH, 2000, PHYSIOL BIOCHEM ZOOL, V73, P200, DOI 10.1086/316738; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Swanson DL, 2009, EVOLUTION, V63, P184, DOI 10.1111/j.1558-5646.2008.00522.x; WESTOBY M, 1995, J ECOL, V83, P727, DOI 10.2307/2261640; WESTOBY M, 1995, J ECOL, V83, P531, DOI 10.2307/2261605; White CR, 2009, EVOLUTION, V63, P2658, DOI 10.1111/j.1558-5646.2009.00747.x; Willis J.C., 1922, AGE AREA STUDY GEOGR; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Zimmermann Christopher, 1998, P163	138	17	17	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e72731	10.1371/journal.pone.0072731	http://dx.doi.org/10.1371/journal.pone.0072731			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058444	gold, Green Published			2022-12-25	WOS:000324408400006
J	Kanold, AMJ; Svenungsson, E; Gunnarsson, I; Gotherstrom, C; Padyukov, L; Papadogiannakis, N; Uzunel, M; Westgren, M				Kanold, Anna Maria Jonsson; Svenungsson, Elisabet; Gunnarsson, Iva; Gotherstrom, Cecilia; Padyukov, Leonid; Papadogiannakis, Nikos; Uzunel, Mehmet; Westgren, Magnus			A Research Study of the Association between Maternal Microchimerism and Systemic Lupus Erythematosus in Adults: A Comparison between Patients and Healthy Controls Based on Single-Nucleotide Polymorphism Using Quantitative Real-Time PCR	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; UMBILICAL-CORD BLOOD; FETAL MICROCHIMERISM; BILIARY ATRESIA; CHIMERISM; CELLS; SCLEROSIS; CHILDREN; CLASSIFICATION; LYMPHOCYTES	Background: Naturally acquired microchimerism may arise in the mother and her child during pregnancy when bidirectional trafficking of cells occurs through the placental barrier. The occurrence of maternal microchimerism (maternal cells in the offspring) has been associated with several autoimmune diseases, especially in children. Systemic Lupus erythematosus (SLE) is an autoimmune disorder with a resemblance to graft-versus-host disease. The aim of this study was to investigate the association between maternal microchimerism in the blood and SLE. Methodology/Principal Findings: Thirty-two patients with SLE, 17 healthy brothers of the patients, and an additional 12 unrelated healthy men were the subjects in this study. A single-nucleotide polymorphism unique to each mother was identified, and maternal microchimerism in the study group and in the control group was detected using a quantitative real-time polymerase chain reaction technique. No differences in the frequency or the concentration of maternal cells were apparent in the blood of patients with SLE or in that of the controls. Two patients and one control tested positive for maternal microchimerism, but the positive subjects were all negative at a follow-up 16 years later. The sensitivity of the method was estimated to 1/10.000. Conclusions/Significance: These results show no association between SLE and maternal microchimerism. The frequency of maternal microchimerism in the blood of adults overall may be lower than earlier reported.	[Kanold, Anna Maria Jonsson; Gotherstrom, Cecilia; Westgren, Magnus] Karolinska Univ Hosp, Karolinska Inst, Ctr Fetal Med, Dept Obstet & Gynecol, Stockholm, Sweden; [Svenungsson, Elisabet; Gunnarsson, Iva; Padyukov, Leonid] Karolinska Univ Hosp, Karolinska Inst, Rheumatol Unit, Dept Med Solna, Stockholm, Sweden; [Gotherstrom, Cecilia; Uzunel, Mehmet] Karolinska Univ Hosp, Karolinska Inst, Div Clin Immunol & Transfus Med, Stockholm, Sweden; [Papadogiannakis, Nikos] Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Div Pathol,Sect Perinatal Pathol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Kanold, AMJ (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Ctr Fetal Med, Dept Obstet & Gynecol, Stockholm, Sweden.	anna.kanold@karolinska.se	Padyukov, Leonid/A-4890-2009	Padyukov, Leonid/0000-0003-2950-5670; Gotherstrom, Cecilia/0000-0003-3782-0048; Svenungsson, Elisabet/0000-0003-3396-3244	Stockholms County	Stockholms County	Funding provided by grants from Stockholms County. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh M, 2002, BLOOD, V99, P4618, DOI 10.1182/blood.V99.12.4618; Aractingi S, 2002, ARTHRITIS RHEUM-US, V46, P1039, DOI 10.1002/art.10137; Artlett CM, 2001, RHEUMATOLOGY, V40, P1279, DOI 10.1093/rheumatology/40.11.1279; Artlett CM, 2000, LANCET, V356, P2155, DOI 10.1016/S0140-6736(00)03499-1; Azzouz Doua F, 2010, Chimerism, V1, P23, DOI 10.4161/chim.1.1.12648; Berry SM, 2004, PEDIATR RES, V56, P73, DOI 10.1203/01.PDR.0000129656.10005.A6; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; Gammill HS, 2010, BLOOD, V116, P2706, DOI 10.1182/blood-2010-02-270942; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; HALL JM, 1995, BLOOD, V86, P2829; Hayashida M, 2007, J PEDIATR SURG, V42, P2097, DOI 10.1016/j.jpedsurg.2007.08.039; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Hovinga ICLK, 2007, ANN RHEUM DIS, V66, P1568, DOI 10.1136/ard.2007.070516; Hovinga ICLK, 2006, ARTHRITIS RHEUM-US, V54, P2944, DOI 10.1002/art.22038; Invernizzi P, 2000, CLIN EXP IMMUNOL, V122, P418, DOI 10.1046/j.1365-2249.2000.01381.x; Johnson KL, 2001, ARTHRITIS RHEUM, V44, P2107, DOI 10.1002/1529-0131(200109)44:9<2107::AID-ART361>3.0.CO;2-9; Jonsson AM, 2010, PEDIATR RES, V68, P199, DOI 10.1203/00006450-201011001-00387; Jonsson AM, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.047; Khosrotehrani K, 2003, ARTHRITIS RHEUM, V48, P3237, DOI 10.1002/art.11324; Khosrotehrani K, 2006, J INVEST DERMATOL, V126, P345, DOI 10.1038/sj.jid.5700060; Kobayashi H, 2007, J PEDIATR SURG, V42, P987, DOI 10.1016/j.jpedsurg.2007.01.051; Lambert NC, 2004, ARTHRITIS RHEUM-US, V50, P906, DOI 10.1002/art.20200; LIANG MH, 1988, ARTHRITIS RHEUM, V31, P817, DOI 10.1002/art.1780310701; Lo YMD, 1998, BRIT J HAEMATOL, V100, P605; Loubiere LS, 2006, LAB INVEST, V86, P1185, DOI 10.1038/labinvest.3700471; Maloney S, 1999, J CLIN INVEST, V104, P41, DOI 10.1172/JCI6611; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Mosca M, 2003, ANN RHEUM DIS, V62, P651, DOI 10.1136/ard.62.7.651; Muller SM, 2001, BLOOD, V98, P1847, DOI 10.1182/blood.V98.6.1847; Nelson JL, 2007, P NATL ACAD SCI USA, V104, P1637, DOI 10.1073/pnas.0606169104; Nelson JL, 1998, LANCET, V351, P559, DOI 10.1016/S0140-6736(97)08357-8; Ohtsuka T, 2001, ARCH DERMATOL RES, V293, P387, DOI 10.1007/s004030100245; Petit T, 1995, EXP HEMATOL, V23, P1601; POLLACK MS, 1982, NEW ENGL J MED, V307, P662, DOI 10.1056/NEJM198209093071106; PORTANOVA JP, 1988, REV CONCEPTS IMMUNOP, V6, P119; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Reed AM, 2004, J IMMUNOL, V172, P5041, DOI 10.4049/jimmunol.172.8.5041; Reed AM, 2000, LANCET, V356, P2156, DOI 10.1016/S0140-6736(00)03500-5; SOCIE G, 1994, BLOOD, V83, P340; STARZL TE, 1992, LANCET, V339, P1579, DOI 10.1016/0140-6736(92)91840-5; Stevens AM, 2005, ARTHRITIS RHEUM, V52, P2768, DOI 10.1002/art.21256; Stevens AM, 2005, RHEUMATOLOGY, V44, P187, DOI 10.1093/rheumatology/keh453; Stevens AM, 2003, LANCET, V362, P1617, DOI 10.1016/S0140-6736(03)14795-2; Stevens AM, 2009, PEDIATR DEVEL PATHOL, V12, P337, DOI 10.2350/08-07-0499.1; Sunku Chennakesava Cuddapah, 2010, Chimerism, V1, P11, DOI 10.4161/chim.1.1.13098; Suskind David L, 2011, Chimerism, V2, P50, DOI 10.4161/chim.2.2.16556; Suskind DL, 2004, BMC GASTROENTEROL, V4, DOI 10.1186/1471-230X-4-14; Svenungsson E, 2010, ANN RHEUM DIS, V69, P834, DOI 10.1136/ard.2009.115535; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tanaka A, 1999, HEPATOLOGY, V30, P833, DOI 10.1002/hep.510300410; Utter GH, 2007, VOX SANG, V93, P188, DOI 10.1111/j.1423-0410.2007.00954.x; vanDijk BA, 1996, AM J MED GENET, V61, P264, DOI 10.1002/(SICI)1096-8628(19960122)61:3<264::AID-AJMG11>3.0.CO;2-R; Willer CJ, 2006, J NEUROIMMUNOL, V179, P145, DOI 10.1016/j.jneuroim.2006.06.011; Yan Z, 2005, AM J MED, V118, P899, DOI 10.1016/j.amjmed.2005.03.037; Ye Y, 2012, RHEUMATOLOGY, V51, P987, DOI 10.1093/rheumatology/ker430	55	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74534	10.1371/journal.pone.0074534	http://dx.doi.org/10.1371/journal.pone.0074534			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040274	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500101
J	Raina, V; Gupta, S; Yadav, S; Surolia, A				Raina, Varshiesh; Gupta, Sarika; Yadav, Saurabh; Surolia, Avadhesha			Simvastatin Induced Neurite Outgrowth Unveils Role of Cell Surface Cholesterol and Acetyl CoA Carboxylase in SH-SY5Y Cells	PLOS ONE			English	Article							ACTIVATED-PROTEIN-KINASE; PHOSPHATASE 2A; TYROSINE PHOSPHORYLATION; AKT ACTIVITY; STEM-CELLS; ACID; DIFFERENTIATION; ATORVASTATIN; EXPRESSION; AMPK	Statins are known to modulate cell surface cholesterol (CSC) and AMP-activated protein kinase (AMPK) in nonneural cells; however no study demonstrates whether CSC and AMPK may regulate simvastatin induced neuritogenesis (SIN). We found that simvastatin (SIM) maintains CSC as shown by Fillipin III staining, Flotillin-2 protein expression / localization and phosphorylation of various receptor tyrosine kinases (RTKs) in the plasma membrane. Modulation of CSC revealed that SIN is critically dependent on this CSC. Simultaneously, phospho array for mitogen activated protein kinases (MAPKs) revealed PI3K / Akt as intracellular pathway which modulates lipid pathway by inhibiting AMPK activation. Though, SIM led to a transient increase in AMPK phosphorylation followed by a sudden decline; the effect was independent of PI3K. Strikingly, AMPK phosphorylation was regulated by protein phosphatase 2A (PP2A) activity which was enhanced upon SIM treatment as evidenced by increase in threonine phosphorylation. Moreover, it was observed that addition of AMP analogue and PP2A inhibitor inhibited SIN. Biocomposition of neurites shows that lipids form a major part of neurites and AMPK is known to regulate lipid metabolism majorly through acetyl CoA carboxylase (ACC). AMPK activity is negative regulator of ACC activity and we found that phosphorylation of ACC started to decrease after 6 hrs which becomes more pronounced at 12 hrs. Addition of ACC inhibitor showed that SIN is dependent on ACC activity. Simultaneously, addition of Fatty acid synthase (FAS) inhibitor confirmed that endogenous lipid pathway is important for SIN. We further investigated SREBP-1 pathway activation which controls ACC and FAS at transcriptional level. However, SIM did not affect SREBP-1 processing and transcription of its target genes likes ACC1 and FAS. In conclusion, this study highlights a distinct role of CSC and ACC in SIN which might have implication in process of neuronal differentiation induced by other agents.	[Raina, Varshiesh; Gupta, Sarika; Yadav, Saurabh] Natl Inst Immunol, Mol Sci Lab, New Delhi 110067, India; [Surolia, Avadhesha] Indian Inst Sci, Mol Biophys Unit, Bangaluru, Karnataka, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Indian Institute of Science (IISC) - Bangalore	Gupta, S (corresponding author), Natl Inst Immunol, Mol Sci Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	sarika@nii.res.in; surolia@tmbu.iisc.ernet.in			Department of Science and Technology (DST), Government of India	Department of Science and Technology (DST), Government of India(Department of Science & Technology (India))	This work was supported by a grant from the Department of Science and Technology (DST), Government of India. AS holds a JC Bose Fellowship of DST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arazi SS, 2008, CLIN CHIM ACTA, V393, P119, DOI 10.1016/j.cca.2008.03.031; Arthur JR, 2011, J LIPID RES, V52, P1345, DOI 10.1194/jlr.M012633; BEHNKE O, 1984, EUR J CELL BIOL, V35, P189; BRAMHAM J, 1995, J INORG BIOCHEM, V57, P23, DOI 10.1016/0162-0134(94)00010-8; CALDERON RO, 1995, J NEUROCHEM, V64, P424; CHEN J, 1994, J BIOL CHEM, V269, P7957; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Evangelopoulos ME, 2009, J NEUROSCI RES, V87, P2138, DOI 10.1002/jnr.22025; Evangelopoulos ME, 2010, NEUROSCI LETT, V468, P28, DOI 10.1016/j.neulet.2009.10.054; Fernandez-Hernando C, 2005, MOL CELL NEUROSCI, V29, P591, DOI 10.1016/j.mcn.2005.04.012; Gil GA, 2004, MOL BIOL CELL, V15, P1881, DOI 10.1091/mbc.e03-09-0705; Guirland C, 2007, ADV EXP MED BIOL, V621, P144, DOI 10.1007/978-0-387-76715-4_11; GUZMAN M, 1993, LIPIDS, V28, P1087, DOI 10.1007/BF02537075; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; Holmberg E, 2006, J NEUROTRAUM, V23, P1366, DOI 10.1089/neu.2006.23.1366; Hooff GP, 2012, MOL NEUROBIOL, V46, P179, DOI 10.1007/s12035-012-8285-6; Hooff GP, 2010, BBA-MOL CELL BIOL L, V1801, P896, DOI 10.1016/j.bbalip.2010.03.014; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kim KH, 1997, ANNU REV NUTR, V17, P77, DOI 10.1146/annurev.nutr.17.1.77; Ko M, 2005, J BIOL CHEM, V280, P42759, DOI 10.1074/jbc.M509164200; Kou R, 2009, J BIOL CHEM, V284, P14734, DOI 10.1074/jbc.M808664200; Kovacic S, 2003, J BIOL CHEM, V278, P39422, DOI 10.1074/jbc.M305371200; Kretz A, 2006, NEUROBIOL DIS, V21, P421, DOI 10.1016/j.nbd.2005.08.003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ledesma MD, 1998, P NATL ACAD SCI USA, V95, P3966, DOI 10.1073/pnas.95.7.3966; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Liao Y, 2010, AM J TRANSL RES, V2, P19; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Marszalek JR, 2005, ANNU REV CELL DEV BI, V21, P633, DOI 10.1146/annurev.cellbio.21.122303.120624; Marszalek JR, 2004, J BIOL CHEM, V279, P23882, DOI 10.1074/jbc.M313460200; Matsuda T, 2008, J PHARMACOL EXP THER, V327, P130, DOI 10.1124/jpet.108.139659; MUDERHWA JM, 1996, VACCINE RES, V5, P1; Mulder M, 2004, NEUROBIOL DIS, V16, P212, DOI 10.1016/j.nbd.2004.01.015; PFENNINGER KH, 1983, J CELL BIOL, V97, P1038, DOI 10.1083/jcb.97.4.1038; Pooler AM, 2006, J NEUROCHEM, V97, P716, DOI 10.1111/j.1471-4159.2006.03763.x; Rise P, 2007, EUR J PHARMACOL, V571, P97, DOI 10.1016/j.ejphar.2007.06.021; Robson LG, 2010, NEUROBIOL AGING, V31, P678, DOI 10.1016/j.neurobiolaging.2008.05.027; Roglans N, 2002, LIPIDS, V37, P445, DOI 10.1007/s11745-002-0916-0; Saggerson D, 2008, ANNU REV NUTR, V28, P253, DOI 10.1146/annurev.nutr.28.061807.155434; Sasahara Y, 1996, J BIOL CHEM, V271, P25950, DOI 10.1074/jbc.271.42.25950; Sowa Y, 2012, STEM CELLS DEV, V21, P1852, DOI 10.1089/scd.2011.0403; Sponne I, 2004, FASEB J, V18, P836, DOI 10.1096/fj.03-0372fje; Stancu C, 2001, J CELL MOL MED, V5, P378, DOI 10.1111/j.1582-4934.2001.tb00172.x; Strack S, 2002, J BIOL CHEM, V277, P41525, DOI 10.1074/jbc.M203767200; Sun W, 2006, CIRCULATION, V114, P2655, DOI 10.1161/CIRCULATIONAHA.106.630194; Tanabe A, 2012, J CELL PHYSIOL, V227, P618, DOI 10.1002/jcp.22763; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Wang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013662; Williams T, 2011, P NATL ACAD SCI USA, V108, P5849, DOI 10.1073/pnas.1013660108; Wong LL, 2009, INT J ONCOL, V34, P1291, DOI 10.3892/ijo_00000256; Wood WG, 2011, J NEUROCHEM, V116, P684, DOI 10.1111/j.1471-4159.2010.07017.x; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; Zhang Q, 2012, STEM CELLS DEV, V21, P1321, DOI 10.1089/scd.2011.0684; Zhou Xiu-Ping, 2009, Commun Integr Biol, V2, P138	55	5	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74547	10.1371/journal.pone.0074547	http://dx.doi.org/10.1371/journal.pone.0074547			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040277	Green Submitted, gold, Green Published			2022-12-25	WOS:000326734500104
J	Rhee, EJ; Seo, H; Kim, JD; Jeon, WS; Park, SE; Park, CY; Oh, KW; Park, SW; Lee, WY				Rhee, Eun-Jung; Seo, Hae; Kim, Jong Dae; Jeon, Won Seon; Park, Se Eun; Park, Cheol-Young; Oh, Ki-Won; Park, Sung-Woo; Lee, Won-Young			Metabolic Health Is More Closely Associated with Coronary Artery Calcification than Obesity	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; CALCIUM; RISK; PREDICTION; SCORE; MODEL	Background: Recent studies have suggested that metabolic health may contribute more to the atherosclerosis than obesity. The aim of this study is to compare coronary artery calcium scores (CACS) among patients with different metabolic health and obesity status. Methods: A health-screening program of 24,063 participants (mean age 41 years) was conducted, and CACS was assessed by multi-detector computerized tomography (MDCT). Being metabolically healthy was defined as having fewer than two of the following risk factors: high blood pressure, high fasting blood glucose, high triglyceride, low high-density lipoprotein cholesterol, highest decile of homeostasis model assessment-insulin resistance (HOMA-IR) index, and highest decile of high-sensitivity C-reactive protein (hs-CRP). Obesity status was defined as body mass index (BMI) higher than 25 kg/m(2). Analyses were performed in four groups divided according to metabolic health and obesity: metabolically healthy non-obese (MHNO), metabolically healthy obese (MHO), metabolically unhealthy non-obese (MUHNO), and metabolically unhealthy obese (MUHO). Results: Mean values of CACS in the four groups were significantly different, except those between MHNO and MHO and between MUHNO and MUHO. When multinomial logistic regression analysis was performed with five CACS categories as the dependent variables and after adjusting for age, sex, and smoking status, the MHO, MUHNO, and MUHO groups showed significantly increased odds ratio for increasing CACS categories compared with no calcification status (5.221 for CACS > 400 in MUHO group with 95% CI 2.856 similar to 5.032 with MHNO group as the reference). When other variables including the metabolic parameters were included in the same model, the risks were attenuated. Conclusion: Metabolic health is more closely associated with subclinical atherosclerosis than obesity as assessed by CACS.	[Rhee, Eun-Jung; Kim, Jong Dae; Jeon, Won Seon; Park, Se Eun; Park, Cheol-Young; Oh, Ki-Won; Park, Sung-Woo; Lee, Won-Young] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Endocrinol & Metab, Seoul, South Korea; [Seo, Hae] Soonchunhyang Univ, Gumi Hosp, Dept Endocrinol & Metab, Gumi, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Soonchunhyang University	Lee, WY (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Endocrinol & Metab, Seoul, South Korea.	drlwy@hanmail.net	Rhee, Eun-Jung/M-9294-2015; LEE, WON-YOUNG/C-7249-2018; Park, Cheol-Young/C-6690-2018	Rhee, Eun-Jung/0000-0002-6108-7758; LEE, WON-YOUNG/0000-0002-1082-7592; Park, Cheol-Young/0000-0002-9415-9965				Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Bielak LF, 2000, CIRCULATION, V102, P380; Bluher M, 2012, CURR OPIN ENDOCRINOL, V19, P341, DOI 10.1097/MED.0b013e328357f0a3; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Despres JP, 2012, J CLIN ENDOCR METAB, V97, P2283, DOI 10.1210/jc.2012-2081; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Hamer M, 2012, J CLIN ENDOCR METAB, V97, P2482, DOI 10.1210/jc.2011-3475; Johnson AR, 2012, IMMUNOL REV, V249, P218, DOI 10.1111/j.1600-065X.2012.01151.x; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Khan UI, 2011, ATHEROSCLEROSIS, V217, P179, DOI 10.1016/j.atherosclerosis.2011.01.007; Lee SY, 2007, DIABETES RES CLIN PR, V75, P72, DOI 10.1016/j.diabres.2006.04.013; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ortega FB, 2012, EUR HEART J IN PRESS; Peters SAE, 2012, HEART, V98, P177, DOI 10.1136/heartjnl-2011-300747; Rumberger JA, 1999, MAYO CLIN PROC, V74, P243, DOI 10.4065/74.3.243; Steering Committee of the WHO Western Pacific Region IASO & IOTF, 2000, AS PAC PERSP RED OB; Subramanian S, 2012, BBA-MOL CELL BIOL L, V1821, P819, DOI 10.1016/j.bbalip.2011.10.003; Velho S, 2010, EUR J CLIN NUTR, V64, P1043, DOI 10.1038/ejcn.2010.114; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Yu JH, 2013, ENDOCRINOL METAB, V28, P33, DOI 10.3803/EnM.2013.28.1.33	21	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74564	10.1371/journal.pone.0074564	http://dx.doi.org/10.1371/journal.pone.0074564			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040286	Green Submitted, Green Published, gold			2022-12-25	WOS:000326734500105
J	Chan, YS; Takeuchi, R; Jarjour, J; Huen, DS; Stoddard, BL; Russell, S				Chan, Yuk-Sang; Takeuchi, Ryo; Jarjour, Jordan; Huen, David S.; Stoddard, Barry L.; Russell, Steven			The Design and In Vivo Evaluation of Engineered I-OnuI-Based Enzymes for HEG Gene Drive	PLOS ONE			English	Article							HOMING ENDONUCLEASES; DROSOPHILA	The homing endonuclease gene (HEG) drive system, a promising genetic approach for controlling arthropod populations, utilises engineered nucleases to spread deleterious mutations that inactivate individual genes throughout a target population. Previous work with a naturally occurring LAGLIDADG homing endonuclease (I-SceI) demonstrated its feasibility in both Drosophila and Anopheles. Here we report on the next stage of this strategy: the redesign of HEGs with customized specificity in order to drive HEG-induced 'homing' in vivo via break-induced homologous recombination. Variants targeting a sequence within the Anopheles AGAP004734 gene were created from the recently characterized I-OnuI endonuclease, and tested for cleavage activity and frequency of homing using a model Drosophila HEG drive system. We observed cleavage and homing at an integrated reporter for all endonuclease variants tested, demonstrating for the first time that engineered HEGs can cleave their target site in insect germline cells, promoting targeted mutagenesis and homing. However, in comparison to our previously reported work with I-SceI, the engineered I-OnuI variants mediated homing with a reduced frequency, suggesting that site-specific cleavage activity is insufficient by itself to ensure efficient homing. Taken together, our experiments take a further step towards the development of a viable HEG-based population control strategy for insects.	[Chan, Yuk-Sang; Huen, David S.; Russell, Steven] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, Cambs, England; [Takeuchi, Ryo; Stoddard, Barry L.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; [Takeuchi, Ryo; Stoddard, Barry L.] Northwest Genome Engn Consortium, Seattle, WA USA; [Jarjour, Jordan] Pregenen Inc, Seattle, WA USA; [Russell, Steven] Cambridge Syst Biol Ctr, Cambridge, Cambs, England	University of Cambridge; Fred Hutchinson Cancer Center; University of Cambridge	Huen, DS (corresponding author), Wolverhampton Univ, Dept Appl Sci, Wolverhampton WV1 1DJ, W Midlands, England.	david.s.huen@gmail.com	Huen, David/F-3676-2014	Huen, David/0000-0002-9900-2297	Foundation of the National Institutes of Health; Bill and Melinda Gates Foundation; National Institutes of Health [RL1 CA133833, R01 GM49857]; NATIONAL CANCER INSTITUTE [RL1CA133833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049857] Funding Source: NIH RePORTER	Foundation of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Foundation of the National Institutes of Health grant awarded to Prof. Austin Burt via the Grand Challenges in Human Health program funded by the Bill and Melinda Gates Foundation, as well as additional support to BLS from the National Institutes of Health (RL1 CA133833 and R01 GM49857). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker DA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-296; Barzel A, 2011, NUCLEIC ACIDS RES, V39, P6646, DOI 10.1093/nar/gkr242; Bibikova M, 2002, GENETICS, V161, P1169; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; Chan YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054130; Chan YS, 2011, GENETICS, V188, P33, DOI 10.1534/genetics.111.127506; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deredec A, 2008, GENETICS, V179, P2013, DOI 10.1534/genetics.108.089037; Deredec A, 2011, P NATL ACAD SCI USA, V108, pE874, DOI 10.1073/pnas.1110717108; Doyon JB, 2006, J AM CHEM SOC, V128, P2477, DOI 10.1021/ja057519l; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Jarjour J, 2009, NUCLEIC ACIDS RES, V37, P6871, DOI 10.1093/nar/gkp726; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McVey M, 2004, GENETICS, V167, P699, DOI 10.1534/genetics.103.025411; Segal DJ, 2013, ANNU REV GENOM HUM G, V14, P135, DOI 10.1146/annurev-genom-091212-153435; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Takeuchi R, 2011, P NATL ACAD SCI USA, V108, P13077, DOI 10.1073/pnas.1107719108; Taylor GK, 2012, NUCLEIC ACIDS RES, V40, pW110, DOI 10.1093/nar/gks365; Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937	21	32	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74254	10.1371/journal.pone.0074254	http://dx.doi.org/10.1371/journal.pone.0074254			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040217	Green Published, Green Submitted, gold			2022-12-25	WOS:000327538600081
J	Dumas, T; Dubal, S; Attal, Y; Chupin, M; Jouvent, R; Morel, S; George, N				Dumas, Thibaud; Dubal, Stephanie; Attal, Yohan; Chupin, Marie; Jouvent, Roland; Morel, Shasha; George, Nathalie			MEG Evidence for Dynamic Amygdala Modulations by Gaze and Facial Emotions	PLOS ONE			English	Article							NEURONAL POPULATION ACTIVITY; EVENT-RELATED POTENTIALS; NEURAL RESPONSES; SINGLE NEURONS; ELECTROPHYSIOLOGICAL EVIDENCE; NONINVASIVE DETECTION; THETA OSCILLATIONS; TIME-COURSE; ANXIETY; FACE	Background: Amygdala is a key brain region for face perception. While the role of amygdala in the perception of facial emotion and gaze has been extensively highlighted with fMRI, the unfolding in time of amydgala responses to emotional versus neutral faces with different gaze directions is scarcely known. Methodology/Principal Findings: Here we addressed this question in healthy subjects using MEG combined with an original source imaging method based on individual amygdala volume segmentation and the localization of sources in the amygdala volume. We found an early peak of amygdala activity that was enhanced for fearful relative to neutral faces between 130 and 170 ms. The effect of emotion was again significant in a later time range (310-350 ms). Moreover, the amygdala response was greater for direct relative averted gaze between 190 and 350 ms, and this effect was selective of fearful faces in the right amygdala. Conclusion: Altogether, our results show that the amygdala is involved in the processing and integration of emotion and gaze cues from faces in different time ranges, thus underlining its role in multiple stages of face perception.	[Dumas, Thibaud; Attal, Yohan; Chupin, Marie; George, Nathalie] CNRS, UMR 7225, CRICM, Paris, France; [Dumas, Thibaud; Attal, Yohan; Chupin, Marie; George, Nathalie] INSERM, U975, Paris, France; [Dumas, Thibaud; Attal, Yohan; Chupin, Marie; George, Nathalie] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere CRICM, UMR S975, Paris, France; [Dumas, Thibaud; Attal, Yohan; Chupin, Marie; George, Nathalie] Univ Paris 06, Ctr MEG CENIR, Paris, France; [Dumas, Thibaud; Dubal, Stephanie; Jouvent, Roland] Hop La Pitie Salpetriere, CNRS, USR 3246, Paris, France; [Morel, Shasha] Univ Tours, CNRS, UMR 7295, CeRCA, Tours, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Tours	Dumas, T (corresponding author), CNRS, UMR 7225, CRICM, Paris, France.	thibaud.dumas@upmc.fr		GEORGE, Nathalie/0000-0002-1556-973X; Morel, Shasha/0000-0002-5441-2516	Agence National de la Recherche	Agence National de la Recherche(French National Research Agency (ANR))	This research was supported by grants from the Agence National de la Recherche to SD and NG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2003, SCIENCE, V300, P1536, DOI 10.1126/science.1082244; Adams RB, 2012, SOC COGN AFFECT NEUR, V7, P568, DOI 10.1093/scan/nsr038; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; ADOLPHS R, 1995, J NEUROSCI, V15, P5879; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Adolphs R, 2006, PROG BRAIN RES, V156, P363, DOI 10.1016/S0079-6123(06)56020-0; Adolphs R, 2010, ANN NY ACAD SCI, V1191, P42, DOI 10.1111/j.1749-6632.2010.05445.x; Amaral DG, 2003, NEUROSCIENCE, V118, P1099, DOI 10.1016/S0306-4522(02)01001-1; Attal Y, 2009, IRBM, V30, P133, DOI 10.1016/j.irbm.2009.01.005; Attal Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059856; Attal Y, 2012, REV NEUROSCIENCE, V23, P85, DOI [10.1515/RNS.2011.056, 10.1515/rns.2011.056]; Baillet S, 2001, IEEE SIGNAL PROC MAG, V18, P14, DOI 10.1109/79.962275; Bar-Haim Y, 2005, BRAIN COGNITION, V59, P11, DOI 10.1016/j.bandc.2005.03.005; Barbeau EJ, 2008, CEREB CORTEX, V18, P997, DOI 10.1093/cercor/bhm140; Bayle DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008207; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Bishop SJ, 2007, TRENDS COGN SCI, V11, P307, DOI 10.1016/j.tics.2007.05.008; Calder AJ, 2011, PHILOS T R SOC B, V366, P1684, DOI 10.1098/rstb.2010.0362; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Chupin M, 2007, NEUROIMAGE, V34, P996, DOI 10.1016/j.neuroimage.2006.10.035; Cisler JM, 2010, CLIN PSYCHOL REV, V30, P203, DOI 10.1016/j.cpr.2009.11.003; Conty L, 2012, J NEUROSCI, V32, P4531, DOI 10.1523/JNEUROSCI.5636-11.2012; Cornwell BR, 2008, BRAIN RES, V1244, P103, DOI 10.1016/j.brainres.2008.09.068; Cristinzio C, 2010, BRAIN, V133, P248, DOI 10.1093/brain/awp255; Dumas T, 2011, IRBM, V32, P42, DOI 10.1016/j.irbm.2010.11.001; Dumas T, 2010, IFMBE PROC, V28, P330; Eger E, 2003, NEUROPSYCHOLOGIA, V41, P808, DOI 10.1016/S0028-3932(02)00287-7; Eldar S, 2010, BIOL PSYCHOL, V85, P252, DOI 10.1016/j.biopsycho.2010.07.010; Etkin A, 2004, NEURON, V44, P1043, DOI 10.1016/j.neuron.2004.12.006; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Ewbank MP, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00056; Ewbank MP, 2009, NEUROIMAGE, V44, P1144, DOI 10.1016/j.neuroimage.2008.09.056; Felmingham KL, 2003, NEUROREPORT, V14, P777, DOI 10.1097/00001756-200304150-00024; Frenkel TI, 2011, BIOL PSYCHOL, V88, P188, DOI 10.1016/j.biopsycho.2011.08.001; Garnero L, 1999, EEG CL N SU, V50, P183; Garolera M, 2007, NEUROREPORT, V18, P1449, DOI 10.1097/WNR.0b013e3282efa253; George N, 2001, NEUROIMAGE, V13, P1102, DOI 10.1006/nimg.2001.0769; George N., 2013, CAMBRIDGE HDB HUMAN, P171; Hadjikhani N, 2008, BRAIN COGNITION, V68, P1, DOI 10.1016/j.bandc.2008.01.008; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; HARI R, 1988, ELECTROEN CLIN NEURO, V71, P64, DOI 10.1016/0168-5597(88)90020-2; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; Hillebrand A, 2005, HUM BRAIN MAPP, V25, P199, DOI 10.1002/hbm.20102; Holmes A, 2008, BIOL PSYCHOL, V77, P159, DOI 10.1016/j.biopsycho.2007.10.003; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; Hung YW, 2010, NEUROIMAGE, V50, P727, DOI 10.1016/j.neuroimage.2009.12.093; Ishai A, 2005, BRAIN RES BULL, V67, P87, DOI 10.1016/j.brainresbull.2005.05.027; Ishai A, 2008, NEUROIMAGE, V40, P415, DOI 10.1016/j.neuroimage.2007.10.040; Kawashima R, 1999, BRAIN, V122, P779, DOI 10.1093/brain/122.4.779; Klucharev V, 2004, NEUROREPORT, V15, P621, DOI 10.1097/00001756-200403220-00010; Kluver H, 1939, ARCH NEURO PSYCHIATR, V42, P979; Kolassa IT, 2007, COGNITION EMOTION, V21, P1721, DOI 10.1080/02699930701229189; Kolassa IT, 2009, COGNITION EMOTION, V23, P69, DOI 10.1080/02699930801940461; Kreiman G, 2000, NAT NEUROSCI, V3, P946, DOI 10.1038/78868; Krolak-Salmon P, 2004, NEURON, V42, P665, DOI 10.1016/S0896-6273(04)00264-8; Kuraoka K, 2007, J NEUROPHYSIOL, V97, P1379, DOI 10.1152/jn.00464.2006; LeDoux J., 1997, J AM ACAD PSYCHOAN, V25, P525; LeDoux J. E., 1996, EMOTIONAL BRAIN MYST; Lewis S, 2003, NEUROREPORT, V14, P1841, DOI 10.1097/00001756-200310060-00017; Li W, 2008, J COGNITIVE NEUROSCI, V20, P95; Lin FH, 2006, NEUROIMAGE, V31, P160, DOI 10.1016/j.neuroimage.2005.11.054; Liu BC, 1999, BRAIN TOPOGR, V11, P291, DOI 10.1023/A:1022258620435; Liu LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009790; Lundqvist D., 1998, KAROLINSKA DIRECTED; Luo Q, 2007, NEUROIMAGE, V34, P839, DOI 10.1016/j.neuroimage.2006.09.023; Maratos FA, 2009, COGN AFFECT BEHAV NE, V9, P133, DOI 10.3758/CABN.9.2.133; Meletti S, 2012, NEUROPSYCHOLOGIA, V50, P44, DOI 10.1016/j.neuropsychologia.2011.10.020; Mormann F, 2011, NAT NEUROSCI, V14, P1247, DOI 10.1038/nn.2899; Moses SN, 2007, BRAIN RES BULL, V71, P452, DOI 10.1016/j.brainresbull.2006.08.016; Muhlberger A, 2009, J NEURAL TRANSM, V116, P735, DOI 10.1007/s00702-008-0108-6; Mueller EM, 2009, PSYCHOL MED, V39, P1141, DOI 10.1017/S0033291708004820; Munte TF, 1998, NEUROSCI RES, V30, P25, DOI 10.1016/S0168-0102(97)00118-1; N'Diaye K, 2009, EMOTION, V9, P798, DOI 10.1037/a0017845; Okada T, 2008, SOC COGN AFFECT NEUR, V3, P80, DOI 10.1093/scan/nsm027; Pakkenberg B, 1997, J COMP NEUROL, V384, P312, DOI 10.1002/(SICI)1096-9861(19970728)384:2<312::AID-CNE10>3.0.CO;2-K; Pegna AJ, 2008, INT J PSYCHOPHYSIOL, V70, P127, DOI 10.1016/j.ijpsycho.2008.08.007; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Pierce K, 2001, BRAIN, V124, P2059, DOI 10.1093/brain/124.10.2059; Pourtois G, 2010, COGN AFFECT BEHAV NE, V10, P83, DOI 10.3758/CABN.10.1.83; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Ramirez RR, 2010, SPRINGER SER OPTIM A, V38, P127, DOI 10.1007/978-0-387-88630-5_8; Rauch SL, 2003, ANN NY ACAD SCI, V985, P389; Rigato S, 2010, SOC COGN AFFECT NEUR, V5, P88, DOI 10.1093/scan/nsp037; Rolls E. T., 2000, AMYGDALA FUNCTIONAL, P447; Rossignol M, 2012, BRAIN RES, V1460, P50, DOI 10.1016/j.brainres.2012.04.034; Sander D., 2013, CAMBRIDGE HDB HUMAN, P5, DOI [10.1017/CBO9780511843716.003, DOI 10.1017/CBO9780511843716.003]; Sato W, 2004, NEUROIMAGE, V22, P1006, DOI 10.1016/j.neuroimage.2004.02.030; Sato W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028188; Sato W, 2011, NEUROPSYCHOLOGIA, V49, P612, DOI 10.1016/j.neuropsychologia.2010.12.025; Sato W, 2010, NEUROIMAGE, V50, P1658, DOI 10.1016/j.neuroimage.2010.01.049; Schumann CM, 2005, J COMP NEUROL, V491, P320, DOI 10.1002/cne.20704; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Schupp HT, 2006, NEUROREPORT, V17, P365, DOI 10.1097/01.wnr.0000203355.88061.c6; Schupp HT, 2004, EMOTION, V4, P189, DOI 10.1037/1528-3542.4.2.189; Sergerie K, 2008, NEUROSCI BIOBEHAV R, V32, P811, DOI 10.1016/j.neubiorev.2007.12.002; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Sprengelmeyer R, 2006, NEUROPSYCHOLOGIA, V44, P2899, DOI 10.1016/j.neuropsychologia.2006.06.020; Stein MB, 2007, AM J PSYCHIAT, V164, P318, DOI 10.1176/appi.ajp.164.2.318; Straube T, 2010, NEUROIMAGE, V49, P2680, DOI 10.1016/j.neuroimage.2009.10.074; Streit M, 1999, COGNITIVE BRAIN RES, V7, P481, DOI 10.1016/S0926-6410(98)00048-2; Streit M, 2003, NEUROSCI LETT, V342, P101, DOI 10.1016/S0304-3940(03)00274-X; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Tesche CD, 1996, COGNITIVE BRAIN RES, V4, P39, DOI 10.1016/0926-6410(95)00044-5; Tesche CD, 1997, BRAIN RES, V749, P53, DOI 10.1016/S0006-8993(96)01286-3; Tesche CD, 2000, P NATL ACAD SCI USA, V97, P919, DOI 10.1073/pnas.97.2.919; Tikhonov A., 1977, SOLUTION ILL POSED P; Ulloa JL, 2012, SOC COGN AFFECT NEUR, P1749; Vlamings PHJM, 2009, J VISION, V9, DOI 10.1167/9.5.12; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Walentowska W, 2012, INT J PSYCHOPHYSIOL, V85, P27, DOI 10.1016/j.ijpsycho.2011.12.004; WASHBURN MS, 1992, J NEUROSCI, V12, P4066; Whalen P.J., 2009, HUMAN AMYGDALA; Winston JS, 2003, NEUROIMAGE, V20, P84, DOI 10.1016/S1053-8119(03)00303-3; Yang JJ, 2012, NEUROPSYCHOLOGIA, V50, P2566, DOI 10.1016/j.neuropsychologia.2012.07.001	117	42	43	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74145	10.1371/journal.pone.0074145	http://dx.doi.org/10.1371/journal.pone.0074145			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040190	gold, Green Published			2022-12-25	WOS:000327538600072
J	Cammock, CE; Halnon, NJ; Skoczylas, J; Blanchard, J; Bohm, R; Miller, CJ; Lai, C; Krogstad, PA				Cammock, Cheryl E.; Halnon, Nancy J.; Skoczylas, Jill; Blanchard, James; Bohm, Rudolf; Miller, Christopher J.; Lai, Chi; Krogstad, Paul A.			Myocarditis, Disseminated Infection, and Early Viral Persistence Following Experimental Coxsackievirus B Infection of Cynomolgus Monkeys	PLOS ONE			English	Article							DILATED CARDIOMYOPATHY; MOLECULAR DIAGNOSIS; ENTEROVIRUS; RNA; VIRUSES; REPLICATION; PROGNOSIS; SEQUENCES; CHILDREN; MODEL	Coxsackievirus B (CVB) infection is a common cause of acute viral myocarditis. The clinical presentation of myocarditis caused by this enterovirus is highly variable, ranging from mildly symptoms to complete hemodynamic collapse. These variations in initial symptoms and in the immediate and long term outcomes of this disease have impeded development of effective treatment strategies. Nine cynomolgus monkeys were inoculated with myocarditic strains of CVB. Virological studies performed up to 28 days post-inoculation demonstrated the development of neutralizing antibody in all animals, and the presence of CVB in plasma. High dose intravenous inoculation (n = 2) resulted in severe disseminated disease, while low dose intravenous (n = 6) or oral infection (1 animal) resulted in clinically unapparent infection. Transient, minor, echocardiographic abnormalities were noted in several animals, but no animals displayed signs of significant acute cardiac failure. Although viremia rapidly resolved, signs of myocardial inflammation and injury were observed in all animals at the time of necropsy, and CVB was detected in postmortem myocardial specimens up to 28 days PI. This non-human primate system replicates many features of illness in acute coxsackievirus myocarditis and demonstrates that myocardial involvement may be common in enteroviral infection; it may provide a model system for testing of treatment strategies for enteroviral infections and acute coxsackievirus myocarditis.	[Cammock, Cheryl E.] Wake Forest Univ, Bowman Gray Sch Med, Dept Pediat, Winston Salem, NC 27103 USA; [Halnon, Nancy J.; Skoczylas, Jill; Krogstad, Paul A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Lai, Chi] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Krogstad, Paul A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Blanchard, James; Bohm, Rudolf] Tulane Univ, Natl Primate Res Ctr, Dept Vet Med, Covington, LA USA; [Miller, Christopher J.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Miller, Christopher J.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA	Wake Forest University; Wake Forest Baptist Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Tulane University; University of California System; University of California Davis; University of California System; University of California Davis	Krogstad, PA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA.	pkrogstad@mednet.ucla.edu	Krogstad, Paul/AAQ-8495-2020		Tulane National Primate Research Center [5P51RR000164]; Theodore Laubisch Fund at UCLA; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107, P51OD011104] Funding Source: NIH RePORTER	Tulane National Primate Research Center; Theodore Laubisch Fund at UCLA; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Pilot Study Grant from the Tulane National Primate Research Center (5P51RR000164) and a grant from the Theodore Laubisch Fund at UCLA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ferreira Lydia Masako, 2004, Acta Cir. Bras., V19, P1, DOI 10.1590/S0102-86502004000700001; Aretz H T, 1987, Am J Cardiovasc Pathol, V1, P3; Bolten R, 1998, J VIROL, V72, P8578, DOI 10.1128/JVI.72.11.8578-8585.1998; Bowles NE, 2003, J AM COLL CARDIOL, V42, P466, DOI 10.1016/S0735-1097(03)00648-X; BOWLES NE, 1986, LANCET, V1, P1120; Calabrese F, 2002, DIAGN MOL PATHOL, V11, P212, DOI 10.1097/00019606-200212000-00004; Campbell KJ, 2009, IMMUNOGENETICS, V61, P177, DOI 10.1007/s00251-008-0351-x; Centers for Disease Control, 2008, MMWR-MORBID MORTAL W, V57, P553; Chamanza R, 2010, TOXICOL PATHOL, V38, P642, DOI 10.1177/0192623310368981; CHANDY KG, 1980, J MED PRIMATOL, V9, P323; Chapman NM, 2008, CURR TOP MICROBIOL, V323, P275; Cherry JD, 2009, TXB PEDIAT INFECT DI, P2110; Corless CE, 2002, J MED VIROL, V67, P555, DOI 10.1002/jmv.10138; Dennert R, 2008, EUR HEART J, V29, P2073, DOI 10.1093/eurheartj/ehn296; Fairweather D, 2005, REV MED VIROL, V15, P17, DOI 10.1002/rmv.445; Feuer R, 2002, J VIROL, V76, P4430, DOI 10.1128/JVI.76.9.4430-4440.2002; Freund MW, 2010, ARCH DIS CHILD-FETAL, V95, pF206, DOI 10.1136/adc.2009.165183; Fujioka S, 2000, J AM COLL CARDIOL, V36, P1920, DOI 10.1016/S0735-1097(00)00955-4; GWATHMEY JK, 1992, J AM COLL CARDIOL, V19, P864, DOI 10.1016/0735-1097(92)90533-S; HOSHINO T, 1983, JPN CIRC J, V47, P59, DOI 10.1253/jcj.47.59; Jacobsen FW, 2011, J IMMUNOL, V186, P341, DOI 10.4049/jimmunol.1001685; KELLY ME, 1978, J MED PRIMATOL, V7, P119; Knowlton KU, 1996, J VIROL, V70, P7811, DOI 10.1128/JVI.70.11.7811-7818.1996; Krogstad P, 2008, PEDIATR INFECT DIS J, V27, P668, DOI 10.1097/INF.0b013e31816b5d2a; MASON JW, 1995, NEW ENGL J MED, V333, P269, DOI 10.1056/NEJM199508033330501; McCarthy RE, 2000, NEW ENGL J MED, V342, P690, DOI 10.1056/NEJM200003093421003; Myers J. M, 2013, CURR PROTOC IMMUNOL, DOI DOI 10.1002/0471142735.IM1514S101; Nathan M, 2008, ASAIO J, V54, P554, DOI 10.1097/MAT.0b013e3181877fc5; PAQUE RE, 1981, INFECT IMMUN, V31, P470, DOI 10.1128/IAI.31.1.470-479.1981; Pauschinger M, 2004, MED MICROBIOL IMMUN, V193, P65, DOI 10.1007/s00430-003-0213-y; Sagar S, 2012, LANCET, V379, P738, DOI 10.1016/S0140-6736(11)60648-X; Simmonds J, 2008, PEDIATR CARDIOL, V29, P834, DOI 10.1007/s00246-007-9182-z; Sleeper MM, 2008, J AM ASSOC LAB ANIM, V47, P22; Slifka MK, 2001, J VIROL, V75, P2377, DOI 10.1128/JVI.75.5.2377-2387.2001; Spotnitz MD, 2006, PROG CARDIOVASC DIS, V49, P42, DOI 10.1016/j.pcad.2006.06.001; Thibaut HJ, 2012, BIOCHEM PHARMACOL, V83, P185, DOI 10.1016/j.bcp.2011.08.016; Verboon-Maciolek MA, 2002, J MED VIROL, V66, P241, DOI 10.1002/jmv.2136; WHY HJF, 1994, CIRCULATION, V89, P2582, DOI 10.1161/01.CIR.89.6.2582; Zuo J, 2012, ANTIMICROB AGENTS CH, V56, P4838, DOI 10.1128/AAC.00983-12	39	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74569	10.1371/journal.pone.0074569	http://dx.doi.org/10.1371/journal.pone.0074569			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040287	gold, Green Published, Green Submitted			2022-12-25	WOS:000326405300183
J	Lehman, JA; Hauck, PM; Gendron, JM; Batuello, CN; Eitel, JA; Albig, A; Kadakia, MP; Mayo, LD				Lehman, Jason A.; Hauck, Paula M.; Gendron, Jaimie M.; Batuello, Christopher N.; Eitel, Jacob A.; Albig, Allan; Kadakia, Madhavi P.; Mayo, Lindsey D.			Serdemetan Antagonizes the Mdm2-HIF1 alpha Axis Leading to Decreased Levels of Glycolytic Enzymes	PLOS ONE			English	Article							INDUCIBLE FACTOR 1-ALPHA; TUMOR ANGIOGENESIS; HYPOXIA; INDUCTION; HDM2; HIF-1-ALPHA; EXPRESSION; APOPTOSIS; CANCER; MDM2	Serdemetan (JNJ-26854165), an antagonist to Mdm2, was anticipated to promote the activation of p53. While regulation of p53 by Mdm2 is important, Mdm2 also regulates numerous proteins involved in diverse cellular functions. We investigated if Serdemetan would alter the Mdm2-HIF1 alpha axis and affect cell survival in human glioblastoma cells independently of p53. Treatment of cells with Serdemetan under hypoxia resulted in a decrease in HIF1 alpha levels. HIF1a downstream targets, VEGF and the glycolytic enzymes (enolase, phosphoglycerate kinase1/2, and glucose transporter 1), were all decreased in response to Serdemetan. The involvement of Mdm2 in regulating gene expression of glycolytic enzymes raises the possibility of side effects associated with therapeutically targeting Mdm2.	[Lehman, Jason A.; Hauck, Paula M.; Eitel, Jacob A.; Mayo, Lindsey D.] Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN USA; [Gendron, Jaimie M.; Batuello, Christopher N.; Mayo, Lindsey D.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Albig, Allan] Boise State Univ, Dept Biol, Boise, ID 83725 USA; [Kadakia, Madhavi P.] Wright State Univ, Dept Biochem & Mol Biol, Boonshoft Sch Med, Dayton, OH 45435 USA; [Mayo, Lindsey D.] Indiana Univ Sch Med, Indiana Univ Simon Canc Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Idaho; Boise State University; University System of Ohio; Wright State University Dayton; Indiana University System; Indiana University Bloomington	Mayo, LD (corresponding author), Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN USA.	ldmayo@iu.edu			Riley Children's Foundation	Riley Children's Foundation	Riley Children's Foundation for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardos JI, 2004, MOL CELL BIOL, V24, P2905, DOI 10.1128/MCB.24.7.2905-2914.2004; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Cao C, 2006, MOL CANCER THER, V5, P411, DOI 10.1158/1535-7163.MCT-05-0356; Chargari C, 2011, CANCER LETT, V312, P209, DOI 10.1016/j.canlet.2011.08.011; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; Kojima K, 2010, MOL CANCER THER, V9, P2545, DOI 10.1158/1535-7163.MCT-10-0337; LaRusch GA, 2007, CANCER RES, V67, P450, DOI 10.1158/0008-5472.CAN-06-2710; Lee YM, 2009, CARCINOGENESIS, V30, P1768, DOI 10.1093/carcin/bgp196; Lehman JA, 2011, J BIOL CHEM, V286, P36631, DOI 10.1074/jbc.M110.217620; Lim SK, 2011, BMB REP, V44, P158, DOI 10.5483/BMBRep.2011.44.3.158; Nieminen AL, 2005, J CELL PHYSIOL, V204, P364, DOI 10.1002/jcp.20406; Patterson DM, 2011, ANGIOGENESIS, V14, P255, DOI 10.1007/s10456-011-9210-8; Ravi R, 2000, GENE DEV, V14, P34; Tabernero J, 2011, CLIN CANCER RES, V17, P6313, DOI 10.1158/1078-0432.CCR-11-1101; Zagzag D, 2000, CANCER-AM CANCER SOC, V88, P2606, DOI 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W	15	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e74741	10.1371/journal.pone.0074741	http://dx.doi.org/10.1371/journal.pone.0074741			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040331	Green Published, Green Submitted, gold			2022-12-25	WOS:000324856500095
J	Ban, T; Ke, JY; Chen, RZ; Gu, X; Tan, MHE; Zhou, XE; Kang, YY; Melcher, K; Zhu, JK; Xu, HE				Ban, Ting; Ke, Jiyuan; Chen, Runze; Gu, Xin; Tan, M. H. Eileen; Zhou, X. Edward; Kang, Yanyong; Melcher, Karsten; Zhu, Jian-Kang; Xu, H. Eric			Structure of a PLS-class Pentatricopeptide Repeat Protein Provides Insights into Mechanism of RNA Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; IDENTIFICATION; STABILIZATION; CHLAMYDOMONAS; BINDING; TERMINI	Pentatricopeptide repeat (PPR) proteins are sequence-specific RNA-binding proteins that form a pervasive family of proteins conserved in yeast, plants, and humans. The plant PPR proteins are grouped mainly into the P and PLS classes. Here, we report the crystal structure of a PLS-class PPR protein from Arabidopsis thaliana called THA8L (THA8-like) at 2.0 angstrom. THA8L resembles THA8 (thylakoid assembly 8), a protein that is required for the splicing of specific group II introns of genes involved in biogenesis of chloroplast thylakoid membranes. The THA8L structure contains three P-type PPR motifs flanked by one L-type motif and one S-type motif. We identified several putative THA8L-binding sites, enriched with purine sequences, in the group II introns. Importantly, THA8L has strong binding preference for single-stranded RNA over single-stranded DNA or double-stranded RNA. Structural analysis revealed that THA8L contains two extensive patches of positively charged residues next to the residues that are proposed to comprise the RNA-binding codes. Mutations in these two positively charged patches greatly reduced THA8L RNA-binding activity. On the basis of these data, we constructed a model of THA8L-RNA binding that is dependent on two forces: one is the interaction between nucleotide bases and specific amino acids in the PPR motifs (codes), and the other is the interaction between the negatively charged RNA backbone and positively charged residues of PPR motifs. Together, these results further our understanding of the mechanism of PPR protein-RNA interactions.	[Ban, Ting; Zhu, Jian-Kang] Chinese Acad Sci, Shanghai Ctr Plant Stress Biol, Shanghai 200032, Peoples R China; [Ban, Ting; Zhu, Jian-Kang] Chinese Acad Sci, Shanghai Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai 200032, Peoples R China; [Ban, Ting; Chen, Runze; Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, Van Andel Res Inst Shanghai Inst Mat Med ARI SIMM, Ctr Struct & Funct Drug Targets,Key Lab Receptor, Shanghai 201203, Peoples R China; [Ke, Jiyuan; Gu, Xin; Tan, M. H. Eileen; Zhou, X. Edward; Kang, Yanyong; Melcher, Karsten; Xu, H. Eric] Ctr Struct Biol & Drug Discovery, Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Tan, M. H. Eileen] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hosp, Dept Obstet & Gynecol, Singapore 119228, Singapore; [Zhu, Jian-Kang] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47906 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Van Andel Institute; National University of Singapore; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Zhu, JK (corresponding author), Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47906 USA.	zhu132@purdue.edu; eric.xu@vai.org	Melcher, Karsten/AAZ-3861-2020; Zhu, Jian-Kang/F-7658-2011; Xu, H. Eric/ABD-7487-2021; Tan, Min/GQQ-2702-2022	Melcher, Karsten/0000-0002-9125-4027; Zhu, Jian-Kang/0000-0001-5134-731X; Xu, H. Eric/0000-0002-6829-8144	NIDDK NIH HHS [R01 DK071662] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abbas YM, 2013, NATURE, V494, P60, DOI 10.1038/nature11783; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Delannoy E, 2007, BIOCHEM SOC T, V35, P1643, DOI 10.1042/BST0351643; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filipovska A, 2012, MOL BIOSYST, V8, P699, DOI 10.1039/c2mb05392f; Fujii S, 2011, NEW PHYTOL, V191, P37, DOI 10.1111/j.1469-8137.2011.03746.x; Howard MJ, 2012, P NATL ACAD SCI USA, V109, P16149, DOI 10.1073/pnas.1209062109; Johnson X, 2010, PLANT CELL, V22, P234, DOI 10.1105/tpc.109.066266; Jonietz C, 2011, PLANT PHYSIOL, V157, P1430, DOI 10.1104/pp.111.181552; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khrouchtchova A, 2012, RNA, V18, P1197, DOI 10.1261/rna.032623.112; Kobayashi K, 2012, NUCLEIC ACIDS RES, V40, P2712, DOI 10.1093/nar/gkr1084; Loiselay C, 2008, MOL CELL BIOL, V28, P5529, DOI 10.1128/MCB.02056-07; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pfalz J, 2009, EMBO J, V28, P2042, DOI 10.1038/emboj.2009.121; Prikryl J, 2011, P NATL ACAD SCI USA, V108, P415, DOI 10.1073/pnas.1012076108; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Soon FF, 2012, SCIENCE, V335, P85, DOI 10.1126/science.1215106; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286; Zhelyazkova P, 2012, NUCLEIC ACIDS RES, V40, P3092, DOI 10.1093/nar/gkr1137	26	49	51	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31540	31548		10.1074/jbc.M113.496828	http://dx.doi.org/10.1074/jbc.M113.496828			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24047899	Green Published, hybrid			2022-12-25	WOS:000330596200013
J	Zeng, LF; Wang, G; Ummarino, D; Margariti, A; Xu, QH; Xiao, QZ; Wang, W; Zhang, ZY; Yin, XK; Mayr, M; Cockerill, G; Li, JYS; Chien, S; Hu, YH; Xu, QB				Zeng, Lingfang; Wang, Gang; Ummarino, Dario; Margariti, Andriana; Xu, Qihe; Xiao, Qingzhong; Wang, Wen; Zhang, Zhongyi; Yin, Xiaoke; Mayr, Manuel; Cockerill, Gillian; Li, Julie Yi-Shuan; Chien, Shu; Hu, Yanhua; Xu, Qingbo			Histone Deacetylase 3 Unconventional Splicing Mediates Endothelial-to-mesenchymal Transition through Transforming Growth Factor beta 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION; CELLS; PROTEIN; HDAC3; CANCER; HEART; EXPRESSION; GENE; DIFFERENTIATION; PROGRESSION	Histone deacetylase 3 (HDAC3) plays a critical role in the maintenance of endothelial integrity and other physiological processes. In this study, we demonstrated that HDAC3 undergoes unconventional splicing during stem cell differentiation. Four different splicing variants have been identified, designated as HD3 alpha, -beta, -gamma, and -delta, respectively. HD3 alpha was confirmed in stem cell differentiation by specific antibody against the sequences from intron 12. Immunofluorescence staining indicated that the HD3 alpha isoform co-localized with CD31-positive or alpha-smooth muscle actin-positive cells at different developmental stages of mouse embryos. Overexpression of HD3 alpha reprogrammed human aortic endothelial cells into mesenchymal cells featuring an endothelial-to-mesenchymal transition (EndMT) phenotype. HD3 alpha directly interacts with HDAC3 and Akt1 and selectively activates transforming growth factor beta 2 (TGF beta 2) secretion and cleavage. TGF beta 2 functioned as an autocrine and/or paracrine EndMT factor. The HD3 alpha-induced EndMT was both PI3K/Akt- and TGF beta 2-dependent. This study provides the first evidence of the role of HDAC3 splicing in the maintenance of endothelial integrity.	[Zeng, Lingfang; Ummarino, Dario; Margariti, Andriana; Zhang, Zhongyi; Yin, Xiaoke; Mayr, Manuel; Hu, Yanhua; Xu, Qingbo] Kings Coll London, BHF Ctr, Div Cardiovasc, London SE5 9NU, England; [Wang, Gang] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Dept Emergency Med, Xian 710004, Shaanxi, Peoples R China; [Xu, Qihe] Kings Coll London, Dept Renal Med, London SE5 9NU, England; [Xiao, Qingzhong] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England; [Wang, Wen] Queen Mary Univ London, Sch Engn & Mat Sci, Med Engn Div, London E1 4NS, England; [Cockerill, Gillian] St Georges Univ London, Dept Cardiovasc Sci, London SW17 0RE, England; [Li, Julie Yi-Shuan; Chien, Shu] Univ Calif San Diego, Dept Bioengn & Med, La Jolla, CA 92093 USA	University of London; King's College London; Xi'an Jiaotong University; University of London; King's College London; University of London; Queen Mary University London; University of London; Queen Mary University London; St Georges University London; University of California System; University of California San Diego	Zeng, LF (corresponding author), Kings Coll London, BHF Ctr, Div Cardiovasc, 125 Cold Harbour Lane, London SE5 9NU, England.	lingfang.zeng@kcl.ac.uk	Margariti, Andriana/AAH-5318-2019; Yin, Xiaoke/AAZ-2658-2020	Yin, Xiaoke/0000-0002-5172-0935; Mayr, Manuel/0000-0002-0597-829X; Zeng, Lingfang/0000-0002-0390-4561	British Heart Foundation; Oak Foundation; National Natural Science Foundation of China [81300116]; British Heart Foundation [FS/09/044/28007, PG/11/40/28891, FS/13/2/29892] Funding Source: researchfish; Kidney Research UK [IN1/2010] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Oak Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); British Heart Foundation(British Heart Foundation); Kidney Research UK(Kidney Research UK (KRUK))	This work was supported by grants from the British Heart Foundation and the Oak Foundation and National Natural Science Foundation of China Grant 81300116.	Aisagbonhi O, 2011, DIS MODEL MECH, V4, P469, DOI 10.1242/dmm.006510; Alam S, 2011, J BIOL CHEM, V286, P44211, DOI 10.1074/jbc.M111.242289; Arciniegas E, 2007, AM J PHYSIOL-LUNG C, V293, pL1, DOI 10.1152/ajplung.00378.2006; Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Azhar M, 2009, DEV DYNAM, V238, P431, DOI 10.1002/dvdy.21854; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; Chang ACY, 2011, DEV CELL, V21, P288, DOI 10.1016/j.devcel.2011.06.022; Chen PY, 2012, CELL REP, V2, P1684, DOI 10.1016/j.celrep.2012.10.021; Chi JT, 2003, P NATL ACAD SCI USA, V100, P10623, DOI 10.1073/pnas.1434429100; Clayton A, 2007, CANCER RES, V67, P7458, DOI 10.1158/0008-5472.CAN-06-3456; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Emiliani S, 1998, P NATL ACAD SCI USA, V95, P2795, DOI 10.1073/pnas.95.6.2795; Gallinari P, 2007, CELL RES, V17, P195, DOI 10.1038/sj.cr.7310149; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Hatipoglu OF, 2009, J BIOL CHEM, V284, P16325, DOI 10.1074/jbc.M109.001313; Kekatpure VD, 2009, J BIOL CHEM, V284, P7436, DOI 10.1074/jbc.M808999200; Kumarswamy R, 2012, ARTERIOSCL THROM VAS, V32, P361, DOI 10.1161/ATVBAHA.111.234286; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Margariti A, 2010, CIRC RES, V106, P1202, DOI 10.1161/CIRCRESAHA.109.213165; Margariti A, 2009, J CELL SCI, V122, P460, DOI 10.1242/jcs.034850; MARKWALD RR, 1977, AM J ANAT, V148, P85, DOI 10.1002/aja.1001480108; MARKWALD RR, 1975, DEV BIOL, V42, P160, DOI 10.1016/0012-1606(75)90321-8; Meadows Kafi N, 2009, J Angiogenes Res, V1, P2, DOI 10.1186/2040-2384-1-2; Medici D, 2011, BIOCHEM J, V437, P515, DOI 10.1042/BJ20101500; Mihira H, 2012, J BIOCHEM, V151, P145, DOI 10.1093/jb/mvr121; MIYAZONO K, 1991, EMBO J, V10, P1091, DOI 10.1002/j.1460-2075.1991.tb08049.x; Nakajima Y, 2000, ANAT RECORD, V258, P119, DOI 10.1002/(SICI)1097-0185(20000201)258:2<119::AID-AR1>3.0.CO;2-U; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; Potenta S, 2008, BRIT J CANCER, V99, P1375, DOI 10.1038/sj.bjc.6604662; POTTS JD, 1989, DEV BIOL, V134, P392, DOI 10.1016/0012-1606(89)90111-5; Schniewind B, 2007, ONCOGENE, V26, P4850, DOI 10.1038/sj.onc.1210272; Strobl JS, 2007, J PARASITOL, V93, P694, DOI 10.1645/GE-1043R.1; Tabata T, 2009, GENES CELLS, V14, P17, DOI 10.1111/j.1365-2443.2008.01246.x; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Togi S, 2009, BIOCHEM BIOPH RES CO, V379, P616, DOI 10.1016/j.bbrc.2008.12.132; Wang JH, 2010, MOL CANCER RES, V8, P266, DOI 10.1158/1541-7786.MCR-09-0221; Wang JK, 2005, DEV BIOL, V286, P299, DOI 10.1016/j.ydbio.2005.07.035; Xiao QZ, 2006, ARTERIOSCL THROM VAS, V26, P2244, DOI 10.1161/01.ATV.0000240251.50215.50; Zampetaki A, 2010, CIRCULATION, V121, P132, DOI 10.1161/CIRCULATIONAHA.109.890491; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zeng LF, 2006, J CELL BIOL, V174, P1059, DOI 10.1083/jcb.200605113; Zeng LF, 2009, P NATL ACAD SCI USA, V106, P8326, DOI 10.1073/pnas.0903197106; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813	49	28	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31853	31866		10.1074/jbc.M113.463745	http://dx.doi.org/10.1074/jbc.M113.463745			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24045946	Green Published, hybrid			2022-12-25	WOS:000330596200035
J	Lonjedo, M; Poch, E; Mocholi, E; Hernandez-Sanchez, M; Ivorra, C; Franke, TF; Guasch, RM; Perez-Roger, I				Lonjedo, Marta; Poch, Enric; Mocholi, Enric; Hernandez-Sanchez, Marta; Ivorra, Carmen; Franke, Thomas F.; Guasch, Rosa M.; Perez-Roger, Ignacio			The Rho Family Member RhoE Interacts with Skp2 and Is Degraded at the Proteasome during Cell Cycle Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RND PROTEINS; ROCK-I; PROSTATE-CANCER; GTPASES; DEGRADATION; UBIQUITIN; PHOSPHORYLATION; UBIQUITYLATION; PROLIFERATION; CYTOSKELETON	RhoE/Rnd3 is an atypical member of the Rho family of small GTPases. In addition to regulating actin cytoskeleton dynamics, RhoE is involved in the regulation of cell proliferation, survival, and metastasis. We examined RhoE expression levels during cell cycle and investigated mechanisms controlling them. We show that RhoE accumulates during G(1), in contact-inhibited cells, and when the Akt pathway is inhibited. Conversely, RhoE levels rapidly decrease at the G(1)/S transition and remain low for most of the cell cycle. We also show that the half-life of RhoE is shorter than that of other Rho proteins and that its expression levels are regulated by proteasomal degradation. The expression patterns of RhoEoverlap with that of the cell cycle inhibitor p27. Consistently with an involvement of RhoE in cell cycle regulation, RhoE and p27 levels decrease after overexpression of the F-box protein Skp2. We have identified a region between amino acids 231 and 240 of RhoEas the Skp2-interacting domain and Lys(235) as the substrate for ubiquitylation. Based on our results, we propose a mechanism according to which proteasomal degradation of RhoE by Skp2 regulates its protein levels to control cellular proliferation.	[Lonjedo, Marta; Poch, Enric; Mocholi, Enric; Hernandez-Sanchez, Marta; Ivorra, Carmen; Perez-Roger, Ignacio] Univ CEU Cardenal Herrera, Fac Ciencias Salud, Inst Ciencias Biomed, Moncada 46113, Valencia, Spain; [Franke, Thomas F.] NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA; [Franke, Thomas F.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Guasch, Rosa M.] Ctr Invest Principe Felipe, Valencia 46012, Spain	Universidad CEU Cardenal Herrera; New York University; New York University; Prince Felipe Research Center	Poch, E (corresponding author), Univ CEU Cardenal Herrera, Fac Ciencias Salud, Inst Ciencias Biomed, Edif Seminario, Moncada 46113, Valencia, Spain.	epoch@uch.ceu.es; iperez@uch.ceu.es	Guasch, Rosa/B-7520-2014; HERNANDEZ-SANCHEZ, MARTA/M-2307-2014; Poch, Enric/C-5258-2013; GUASCH, ROSA MARIA/ABG-9879-2020; HERNANDEZ-SANCHEZ, MARTA/AAE-9432-2019; Mocholi, Enric/ABH-5275-2020; HERNANDEZ-SANCHEZ, MARTA/AAE-9429-2019; Pérez Roger, Ignacio/K-1346-2014	HERNANDEZ-SANCHEZ, MARTA/0000-0001-8689-0582; GUASCH, ROSA MARIA/0000-0001-8284-786X; HERNANDEZ-SANCHEZ, MARTA/0000-0001-8689-0582; Pérez Roger, Ignacio/0000-0002-5564-6912; Ivorra, Carmen/0000-0002-4699-6689	Instituto de Salud Carlos III; Generalitat Valenciana; Universidad CEU Cardenal Herrera Santander-Copernicus; Universidad CEU Cardenal Herrera	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Universidad CEU Cardenal Herrera Santander-Copernicus; Universidad CEU Cardenal Herrera	This work was supported by grants from the Instituto de Salud Carlos III (to I. P.-R. and R. M. G.), the Generalitat Valenciana (to E. P.), and the Universidad CEU Cardenal Herrera Santander-Copernicus (to I. P.-R.). The work was also supported by fellowships from the Universidad CEU Cardenal Herrera (to M. L. and E. M.) and from the Generalitat Valenciana (to M. H.-S.).	Albero MP, 2010, ONCOGENE, V29, P3276, DOI 10.1038/onc.2010.81; Andreu EJ, 2005, CANCER RES, V65, P3264, DOI 10.1158/0008-5472.CAN-04-1357; Aspenstrom P, 2007, EXP CELL RES, V313, P3673, DOI 10.1016/j.yexcr.2007.07.022; Bektic J, 2005, PROSTATE, V64, P332, DOI 10.1002/pros.20243; Belgiovine C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014154; Boswell SA, 2007, J BIOL CHEM, V282, P4850, DOI 10.1074/jbc.M610532200; Boulter E, 2012, FASEB J, V26, P469, DOI 10.1096/fj.11-192252; Boyer L, 2006, MOL BIOL CELL, V17, P2489, DOI 10.1091/mbc.E05-09-0876; Chan CH, 2012, CELL, V149, P1098, DOI 10.1016/j.cell.2012.02.065; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; Chen YZ, 2009, MOL CELL, V35, P841, DOI 10.1016/j.molcel.2009.09.004; Doye A, 2002, CELL, V111, P553, DOI 10.1016/S0092-8674(02)01132-7; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Foster R, 1996, MOL CELL BIOL, V16, P2689; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Goh LL, 2012, J BIOL CHEM, V287, P31311, DOI 10.1074/jbc.M111.327056; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Lu LF, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-22; Lu ZM, 2010, CELL CYCLE, V9, P2342, DOI 10.4161/cc.9.12.11988; Madigan JP, 2009, BIOCHEM J, V424, P153, DOI 10.1042/BJ20082377; Mocholi E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019236; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Nethe M, 2010, J CELL SCI, V123, P4011, DOI 10.1242/jcs.078360; Nethe M, 2010, J CELL SCI, V123, P1948, DOI 10.1242/jcs.062919; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Ongusaha PP, 2006, CURR BIOL, V16, P2466, DOI 10.1016/j.cub.2006.10.056; Pacary E, 2011, NEURON, V69, P1069, DOI 10.1016/j.neuron.2011.02.018; Perez-Roger I, 1999, EMBO J, V18, P5310, DOI 10.1093/emboj/18.19.5310; Peris B, 2012, J NEUROCHEM, V121, P903, DOI 10.1111/j.1471-4159.2012.07733.x; Pertz O, 2010, J CELL SCI, V123, P1841, DOI 10.1242/jcs.064345; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Poch E, 2007, EXP CELL RES, V313, P719, DOI 10.1016/j.yexcr.2006.11.006; Riento K, 2005, EMBO J, V24, P1170, DOI 10.1038/sj.emboj.7600612; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; Riou P, 2013, CELL, V153, P640, DOI 10.1016/j.cell.2013.03.044; Riou P, 2010, BIOESSAYS, V32, P986, DOI 10.1002/bies.201000060; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Villalonga P, 2004, MOL CELL BIOL, V24, P7829, DOI 10.1128/MCB.24.18.7829-7840.2004; Visvikis O, 2008, FEBS J, V275, P386, DOI 10.1111/j.1742-4658.2007.06209.x; Wang HR, 2006, METHOD ENZYMOL, V406, P437, DOI 10.1016/S0076-6879(06)06032-0; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Zhao H, 2012, TUMOR BIOL, V33, P1363, DOI 10.1007/s13277-012-0384-5; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345	55	15	16	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					30872	30882		10.1074/jbc.M113.511105	http://dx.doi.org/10.1074/jbc.M113.511105			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24045951	Green Published, hybrid			2022-12-25	WOS:000330778900008
J	Kelly, AN; van Heuven, WJB; Pitchford, NJ; Ledgeway, T				Kelly, Andrew N.; van Heuven, Walter J. B.; Pitchford, Nicola J.; Ledgeway, Timothy			Is the Masked Priming Same-Different Task a Pure Measure of Prelexical Processing?	PLOS ONE			English	Article							VISUAL WORD RECOGNITION; BAYESIAN-INFERENCE; PRINTED WORD; MODEL; PROPORTION; PERCEPTION; FREQUENCY; INFORMATION; ORDER	To study prelexical processes involved in visual word recognition a task is needed that only operates at the level of abstract letter identities. The masked priming same-different task has been purported to do this, as the same pattern of priming is shown for words and nonwords. However, studies using this task have consistently found a processing advantage for words over nonwords, indicating a lexicality effect. We investigated the locus of this word advantage. Experiment 1 used conventional visually-presented reference stimuli to test previous accounts of the lexicality effect. Results rule out the use of different strategies, or strength of representations, for words and nonwords. No interaction was shown between prime type and word type, but a consistent word advantage was found. Experiment 2 used novel auditorally-presented reference stimuli to restrict nonword matching to the sublexical level. This abolished scrambled priming for nonwords, but not words. Overall this suggests the processing advantage for words over nonwords results from activation of whole-word, lexical representations. Furthermore, the number of shared open-bigrams between primes and targets could account for scrambled priming effects. These results have important implications for models of orthographic processing and studies that have used this task to investigate prelexical processes.	[Kelly, Andrew N.; van Heuven, Walter J. B.; Pitchford, Nicola J.; Ledgeway, Timothy] Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England	University of Nottingham	van Heuven, WJB (corresponding author), Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England.	walter.vanheuven@nottingham.ac.uk	van Heuven, Walter J B/K-9034-2013	van Heuven, Walter J B/0000-0003-3183-4449; Ledgeway, Timothy/0000-0002-2000-2420	School of Psychology, University of Nottingham	School of Psychology, University of Nottingham	This research was funded by the School of Psychology, University of Nottingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PA, 2009, ATTEN PERCEPT PSYCHO, V71, P281, DOI 10.3758/APP.71.2.281; ANGIOLILLOBENT JS, 1982, J EXP PSYCHOL HUMAN, V8, P392, DOI 10.1037/0096-1523.8.3.392; Bodner GE, 2003, PSYCHON B REV, V10, P645, DOI 10.3758/BF03196527; Bodner GE, 2008, CAN J EXP PSYCHOL, V62, P127, DOI 10.1037/1196-1961.62.2.127; Bodner GE, 2006, MEM COGNITION, V34, P1298, DOI 10.3758/BF03193273; Bodner GE, 2009, PSYCHON B REV, V16, P497, DOI 10.3758/PBR.16.3.497; Bowers JS, 2010, EUR J COGN PSYCHOL, V22, P779, DOI 10.1080/09541440902955900; Brysbaert M, 2009, BEHAV RES METHODS, V41, P977, DOI 10.3758/BRM.41.4.977; CARAMAZZA A, 1990, COGNITION, V37, P243, DOI 10.1016/0010-0277(90)90047-N; CHAMBERS SM, 1975, MEM COGNITION, V3, P549, DOI 10.3758/BF03197530; Coane JH, 2010, Q J EXP PSYCHOL, V63, P2376, DOI 10.1080/17470211003687546; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Davis C.J., 1999, THESIS U NEW S WALES; Davis CJ, 2010, PSYCHOL REV, V117, P713, DOI 10.1037/a0019738; Finkbeiner M, 2009, COGN NEUROPSYCHOL, V26, P1, DOI 10.1080/02643290902905294; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; FORSTER KI, 1984, J EXP PSYCHOL LEARN, V10, P680, DOI 10.1037/0278-7393.10.4.680; Gomez P, 2008, PSYCHOL REV, V115, P577, DOI 10.1037/a0012667; Gorfein DS, 2008, BEHAV RES METHODS, V40, P522, DOI 10.3758/BRM.40.2.522; Grainger J, 2003, MENTAL LEXICON: SOME WORDS TO TALK ABOUT WORDS, P1; Grainger J, 2004, TRENDS COGN SCI, V8, P58, DOI 10.1016/j.tics.2003.11.006; Grainger J, 1996, PSYCHOL REV, V103, P518, DOI 10.1037/0033-295X.103.3.518; Grainger J, 2008, LANG COGNITIVE PROC, V23, P1, DOI 10.1080/01690960701578013; Grainger J, 2006, J EXP PSYCHOL HUMAN, V32, P865, DOI 10.1037/0096-1523.32.4.865; KINOSHITA S, 1987, Q J EXP PSYCHOL-A, V39, P701, DOI 10.1080/14640748708401810; Kinoshita S, 2010, J EXP PSYCHOL LEARN, V36, P1422, DOI 10.1037/a0020609; Kinoshita S, 2009, LANG COGNITIVE PROC, V24, P506, DOI 10.1080/01690960802289213; Kinoshita S, 2008, Q J EXP PSYCHOL, V61, P1873, DOI 10.1080/17470210701781114; Kinoshita S, 2009, J EXP PSYCHOL LEARN, V35, P1, DOI 10.1037/a0014277; MARMUREK HHC, 1989, MEM COGNITION, V17, P483, DOI 10.3758/BF03202622; Marsolek Chad J., 2003, RETHINKING IMPLICIT; Norris D, 2006, PSYCHOL REV, V113, P327, DOI 10.1037/0033-295X.113.2.327; Norris D, 2008, J EXP PSYCHOL GEN, V137, P434, DOI 10.1037/a0012799; Norris D, 2010, J MEM LANG, V62, P254, DOI 10.1016/j.jml.2009.11.002; Perea M, 2011, Q J EXP PSYCHOL, V64, P2065, DOI 10.1080/17470218.2011.582131; Perea M, 2009, ACTA PSYCHOL, V130, P127, DOI 10.1016/j.actpsy.2008.11.001; Rey A, 2009, COGN NEUROPSYCHOL, V26, P7, DOI 10.1080/09541440802176300; Sandra D, 2010, LANG SPEECH, V53, P405, DOI 10.1177/0023830910371459; Whitney C, 2005, J RES READ, V28, P274, DOI 10.1111/j.1467-9817.2005.00270.x; Whitney C, 2001, PSYCHON B REV, V8, P221, DOI 10.3758/BF03196158; WHITNEY C, 2004, THESIS U MARYLAND CO; Whitney C, 2008, LANG COGNITIVE PROC, V23, P143, DOI 10.1080/01690960701579771	42	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e72888	10.1371/journal.pone.0072888	http://dx.doi.org/10.1371/journal.pone.0072888			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	221YD	24058447	Green Published, Green Submitted, gold			2022-12-25	WOS:000324695900004
J	Geng, B; Cai, B; Liao, F; Zheng, Y; Zeng, Q; Fan, XF; Gong, YS; Yang, JC; Cui, QH; Tang, CS; Xu, GH				Geng, Bin; Cai, Bo; Liao, Feng; Zheng, Yang; Zeng, Qiang; Fan, Xiaofang; Gong, Yongsheng; Yang, Jichun; Cui, Qing Hua; Tang, Chaoshu; Xu, Guo Heng			Increase or Decrease Hydrogen Sulfide Exert Opposite Lipolysis, but Reduce Global Insulin Resistance in High Fatty Diet Induced Obese Mice	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; ADIPOSE TRIGLYCERIDE LIPASE; GAMMA-GLUTAMYL-TRANSFERASE; PROTEIN-KINASE; GLUCOSE-UTILIZATION; 3T3L1 ADIPOCYTES; PLASMA CYSTEINE; METABOLISM; PHOSPHORYLATION; ACTIVATION	Objective: Adipose tissue expressed endogenous cystathionine gamma lyase (CSE)/hydrogen sulfide (H2S) system. H2S precursor inhibited catecholamine stimulated lipolysis. Thus, we hypothesized that CSE/H2S system regulates lipolysis which contributed to the pathogenesis of insulin resistance. Methods: We treated rat adipocyte with DL-propargylglycine (PAG, a CSE inhibitor), L-cysteine (an H2S precursor) plus pyridoxial phosphate (co-enzyme) or the H2S chronic release donor GYY4137, then the glycerol level was assayed for assessing the lipolysis. Then, the effects of PAG and GYY4137 on insulin resistance in high fatty diet (HFD) induced obese mice were investigated. Results: Here, we found that PAG time-dependently increased basal or isoproterenol stimulated lipolysis. However, L-cysteine plus pyridoxial phosphate or GYY4137 significantly reduced it. PAG increased phosphorylated protein kinase A substrate, perilipin 1 and hormone sensitive lipase, but L-cysteine and GYY4137 decreased the parameters. In HFD induced obese mice, PAG increased adipose basal lipolysis, thus blunted fat mass increase, resulting in lowering insulin resistance evidenced by reduction of fasting glucose, insulin level, HOMA index, oral glucose tolerance test (OGTT) curve area and elevating the insulin tolerance test (ITT) response. GYY4137 inhibited lipolysis in vivo without increasing fat mass, but also ameliorated the insulin resistance in HFD mice. Conclusion: These results implicated that inhibition endogenous CSE/H2S system in adipocytes increased lipolysis by a protein kinase A-perilipin/hormone-sensitive lipase pathway, thus blunted fat mass increase and reduced insulin resistance in obese mice; giving H2S donor decreased lipolysis, also reduced insulin resistance induced by HFD. Our data showed that increase or decrease H2S induced opposite lipolysis, but had the same effect on insulin resistance. The paradoxical regulation may be resulted from different action of H2S on metabolic and endocrine function in adipocyte.	[Geng, Bin; Cai, Bo; Liao, Feng; Zheng, Yang; Yang, Jichun; Cui, Qing Hua; Tang, Chaoshu; Xu, Guo Heng] Peking Univ, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Beijing 100871, Peoples R China; [Cai, Bo] Guangdong Med Collage, Dept Physiol, Zhan Jiang, Guangdong, Peoples R China; [Zeng, Qiang] Chinese Peoples Liberat Army Gen Hosp, Int Med Ctr, Beijing, Peoples R China; [Fan, Xiaofang; Gong, Yongsheng; Tang, Chaoshu] Wenzhou Med Univ, Inst Hypoxia Med, Wen Zhou, Zhejiang, Peoples R China	Peking University; Guangdong Medical University; Chinese People's Liberation Army General Hospital; Wenzhou Medical University	Geng, B (corresponding author), Peking Univ, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Beijing 100871, Peoples R China.	bingeng@hsc.pku.edu.cn; xug@hsc.pku.edu.cn	Geng, Bin/ABB-6045-2020	Geng, Bin/0000-0001-7573-8710	Major State Basic Research Development Program of the People's Republic of China [2012CB517806, 2009CB941603]; National Natural Science Foundation of the People's Republic China [81170235, 81070114]	Major State Basic Research Development Program of the People's Republic of China(National Basic Research Program of China); National Natural Science Foundation of the People's Republic China(National Natural Science Foundation of China (NSFC))	This work was supported by the Major State Basic Research Development Program of the People's Republic of China (nos. 2012CB517806 and 2009CB941603) and the National Natural Science Foundation of the People's Republic China (nos. 81170235 and 81070114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Chang L, 2008, AMINO ACIDS, V34, P573, DOI 10.1007/s00726-007-0011-8; Commerford SR, 2000, AM J PHYSIOL-ENDOC M, V279, pE875, DOI 10.1152/ajpendo.2000.279.4.E875; CZECH MP, 1972, J BIOL CHEM, V247, P6218; CZECH MP, 1974, J BIOL CHEM, V249, P1001; Dhawan SS, 2011, ATHEROSCLEROSIS, V219, P266, DOI 10.1016/j.atherosclerosis.2011.05.020; EGAN JJ, 1990, J BIOL CHEM, V265, P18769; Elshorbagy AK, 2011, NUTR METAB CARDIOVAS; Elshorbagy AK, 2008, AM J CLIN NUTR, V88, P738, DOI 10.1093/ajcn/88.3.738; Elshorbagy AK, 2009, OBESITY, V17, P1435, DOI 10.1038/oby.2008.671; Enos RT, 2013, J LIPID RES, V54, P152, DOI 10.1194/jlr.M030700; Fang LP, 2009, J HYPERTENS, V27, P2174, DOI 10.1097/HJH.0b013e328330a900; Feng XJ, 2009, BIOCHEM BIOPH RES CO, V380, P153, DOI 10.1016/j.bbrc.2009.01.059; GARTON AJ, 1989, EUR J BIOCHEM, V179, P249, DOI 10.1111/j.1432-1033.1989.tb14548.x; Giral P, 2008, ARTERIOSCL THROM VAS, V28, P587, DOI 10.1161/ATVBAHA.107.157891; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; He JH, 2006, BBA-MOL CELL BIOL L, V1761, P247, DOI 10.1016/j.bbalip.2006.02.001; Hu LF, 2011, ANTIOXID REDOX SIGN, V15, P405, DOI 10.1089/ars.2010.3517; Huang CY, 2012, CELL BIOCH FUNCT; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kawasaki M, 2010, CYTOTECHNOLOGY, V62, P225, DOI 10.1007/s10616-010-9282-0; Kimura H, 2011, AMINO ACIDS, V41, P113, DOI 10.1007/s00726-010-0510-x; Lappas G, 2005, J HYPERTENS, V23, P2251, DOI 10.1097/01.hjh.0000191905.26853.f1; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Londos C, 1996, INT J OBESITY, V20, pS97; Londos C, 1999, ANN NY ACAD SCI, V892, P155, DOI 10.1111/j.1749-6632.1999.tb07794.x; Mani S, 2011, FREE RADICAL BIO MED, V50, P1280, DOI 10.1016/j.freeradbiomed.2011.01.038; Manna P, 2012, J BIOL CHEM, V287, P42324, DOI 10.1074/jbc.M112.407833; Manna P, 2011, J BIOL CHEM, V286, P39848, DOI 10.1074/jbc.M111.270884; OLEFSKY JM, 1979, HORM METAB RES, V11, P209, DOI 10.1055/s-0028-1092709; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; van den Brandhof WE, 2001, ATHEROSCLEROSIS, V157, P403, DOI 10.1016/S0021-9150(00)00724-3; Wueest S, 2009, DIABETOLOGIA, V52, P541, DOI 10.1007/s00125-008-1223-5; Xu C, 2009, MOL ENDOCRINOL, V23, P1161, DOI 10.1210/me.2008-0464; Yong QC, 2008, J MOL CELL CARDIOL, V44, P701, DOI 10.1016/j.yjmcc.2008.01.007; Yu Fang, 2010, Beijing Da Xue Xue Bao Yi Xue Ban, V42, P493; de Pina MZ, 2008, J BIOL CHEM, V283, P12373, DOI 10.1074/jbc.M706832200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zu LX, 2009, J BIOL CHEM, V284, P5915, DOI 10.1074/jbc.M807852200	42	53	58	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73892	10.1371/journal.pone.0073892	http://dx.doi.org/10.1371/journal.pone.0073892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058499	Green Published, gold, Green Submitted			2022-12-25	WOS:000324408400039
J	Olofsson, G; Sparr, E				Olofsson, Gerd; Sparr, Emma			Ionization Constants pK(a) of Cardiolipin	PLOS ONE			English	Article							DILUTE AQUEOUS-SOLUTION; ALPHA-SYNUCLEIN; MITOCHONDRIAL-MEMBRANES; SUPERCOMPLEX FORMATION; APOPTOSIS; ACIDS; NMR	Cardiolipin is a phospholipid found in the inner mitochondrial membrane and in bacteria, and it is associated with many physiological functions. Cardiolipin has a dimeric structure consisting of two phosphatidyl residues connected by a glycerol bridge and four acyl chains, and therefore it can carry two negative charges. The pK(a) values of the phosphate groups have previously been reported to differ widely with pK(a1) = 2.8 and pK(a2) = 7.5-9.5. Still, there are several examples of experimental observations from cardiolipin-containing systems that do not fit with this dissociation behavior. Therefore, we have carried out pH-titration and titration calorimetric experiments on two synthetic cardiolipins, 1,1',2,2'-tetradecanoyl cardiolipin, CL (C14:0), and 1,1',2,2'-tetraoctadecenoyl cardiolipin, CL (C18:1). Our results show that both behave as strong dibasic acids with pK(a1) about the same as the first pK(a) of phosphoric acid, 2.15, and pK(a2) about one unit larger. The characterization of the acidic properties of cardiolipin is crucial for the understanding of the molecular organization in self-assembled systems that contain cardiolipin, and for their biological function.	[Olofsson, Gerd; Sparr, Emma] Lund Univ, Ctr Chem & Chem Engn, Div Phys Chem, S-22100 Lund, Sweden	Lund University	Sparr, E (corresponding author), Lund Univ, Ctr Chem & Chem Engn, Div Phys Chem, S-22100 Lund, Sweden.	emma.sparr@fkem1.lu.se		Sparr, Emma/0000-0001-8343-9657	Swedish Research Council (VR); Linnaeus Center of Excellence "Organizing molecular matter"; Swedish Foundation for Strategic Research (SSF); Knut and Alice Wallenberg's foundation	Swedish Research Council (VR)(Swedish Research Council); Linnaeus Center of Excellence "Organizing molecular matter"; Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg's foundation(Knut & Alice Wallenberg Foundation)	The Swedish Research Council (VR) is gratefully acknowledged for financial support both through regular grants and the Linnaeus Center of Excellence "Organizing molecular matter" (ES). ES acknowledges The Swedish Foundation for Strategic Research (SSF) for financial support. Knut and Alice Wallenberg's foundation funded the acquisition of the ITC equipment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENSON SW, 1958, J AM CHEM SOC, V80, P5151, DOI 10.1021/ja01552a035; Cevc G., 1993, PHOSPHOLIPIDS HDB, V2ZxaucDNWHcC; CHRISTEN.JJ, 1967, J AM CHEM SOC, V89, P213, DOI 10.1021/ja00978a005; COULONMORELEC MJ, 1962, B SOC CHIM BIOL, V44, P171; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; EIBL H, 1979, BIOCHIM BIOPHYS ACTA, V553, P476, DOI 10.1016/0005-2736(79)90303-1; Evans D.F, 1999, COLLOIDAL DOMAIN PHY, V2nd; FEW AV, 1960, BIOCHIM BIOPHYS ACTA, V38, P130, DOI 10.1016/0006-3002(60)91202-6; Gane R, 1931, J CHEM SOC, P2153, DOI 10.1039/jr9310002153; Gorbenko GP, 2006, BIOPHYS J, V90, P4093, DOI 10.1529/biophysj.105.080150; Grey M, 2011, J PARKINSON DIS, V1, P359, DOI 10.3233/JPD-2011-11067; Haines TH, 2009, BBA-BIOMEMBRANES, V1788, P1997, DOI 10.1016/j.bbamem.2009.09.008; HUBNER W, 1991, BIOCHIM BIOPHYS ACTA, V1066, P166, DOI 10.1016/0005-2736(91)90183-9; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; KATES M, 1993, LIPIDS, V28, P877, DOI 10.1007/BF02537494; Kleinschmidt JH, 1998, BIOCHEMISTRY-US, V37, P11579, DOI 10.1021/bi980235b; Korytowski W, 2011, J BIOL CHEM, V286, P26334, DOI 10.1074/jbc.M110.188516; Larson JW, 1982, CAN J CHEM, V60; Lewis RNAH, 2009, BBA-BIOMEMBRANES, V1788, P2069, DOI 10.1016/j.bbamem.2009.03.014; McMillin JB, 2002, BBA-MOL CELL BIOL L, V1585, P97, DOI 10.1016/S1388-1981(02)00329-3; Nichols-Smith S, 2004, BBA-BIOMEMBRANES, V1663, P82, DOI 10.1016/j.bbamem.2004.02.002; PINHEIRO TJT, 1994, BIOCHEMISTRY-US, V33, P4896, DOI 10.1021/bi00182a018; POWELL GL, 1985, BIOCHEMISTRY-US, V24, P2902, DOI 10.1021/bi00333a013; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlattner U, 2013, J BIOL CHEM, V288, P111, DOI 10.1074/jbc.M112.408633; SEDDON JM, 1983, BIOCHIM BIOPHYS ACTA, V734, P347, DOI 10.1016/0005-2736(83)90134-7; Sparagna GC, 2007, J LIPID RES, V48, P1559, DOI 10.1194/jlr.M600551-JLR200; Tarahovsky YS, 2000, BIOPHYS J, V79, P3193, DOI 10.1016/S0006-3495(00)76552-0; Tatulian S. A., 1993, PHOSPHOLIPIDS HDB, P511; Wenz T, 2009, BBA-BIOENERGETICS, V1787, P609, DOI 10.1016/j.bbabio.2009.02.012; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200; Zigoneanu IG, 2012, BBA-BIOMEMBRANES, V1818, P512, DOI 10.1016/j.bbamem.2011.11.024	33	69	69	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73040	10.1371/journal.pone.0073040	http://dx.doi.org/10.1371/journal.pone.0073040			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058458	gold, Green Published, Green Submitted			2022-12-25	WOS:000324408400016
J	Coulthard, TJ; Ramirez, JA; Barton, N; Rogerson, M; Brucher, T				Coulthard, Tom J.; Ramirez, Jorge A.; Barton, Nick; Rogerson, Mike; Bruecher, Tim			Were Rivers Flowing across the Sahara During the Last Interglacial? Implications for Human Migration through Africa	PLOS ONE			English	Article							LATE PLEISTOCENE; EVOLUTION; HOLOCENE; VARIABILITY; SIMULATION; ATMOSPHERE; MONSOON; EVENTS; SYSTEM; REMOTE	Human migration north through Africa is contentious. This paper uses a novel palaeohydrological and hydraulic modelling approach to test the hypothesis that under wetter climates c. 100,000 years ago major river systems ran north across the Sahara to the Mediterranean, creating viable migration routes. We confirm that three of these now buried palaeo river systems could have been active at the key time of human migration across the Sahara. Unexpectedly, it is the most western of these three rivers, the Irharhar river, that represents the most likely route for human migration. The Irharhar river flows directly south to north, uniquely linking the mountain areas experiencing monsoon climates at these times to temperate Mediterranean environments where food and resources would have been abundant. The findings have major implications for our understanding of how humans migrated north through Africa, for the first time providing a quantitative perspective on the probabilities that these routes were viable for human habitation at these times.	[Coulthard, Tom J.; Ramirez, Jorge A.; Rogerson, Mike] Univ Hull, Dept Geog Environm & Earth Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; [Barton, Nick] Univ Oxford, Inst Archaeol, Oxford, England; [Bruecher, Tim] Max Planck Inst Meteorol, D-20146 Hamburg, Germany	University of Hull; University of Oxford; Max Planck Society	Coulthard, TJ (corresponding author), Univ Hull, Dept Geog Environm & Earth Sci, Kingston Upon Hull HU6 7RX, N Humberside, England.	T.Coulthard@hull.ac.uk	Coulthard, Tom/K-7194-2015	Coulthard, Tom/0000-0002-8164-0442; Rogerson, Mike/0000-0001-6016-0549; Ramirez, Jorge/0000-0002-6816-308X	NERC [NE/J014133/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/C508912/1] Funding Source: researchfish; Natural Environment Research Council [NE/J014133/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Abdelsalam MG, 2008, GEOSPHERE, V4, P375, DOI 10.1130/GES00142.1; [Anonymous], 2011, REFERENCE 3D PRODUCT; [Anonymous], 2011, GMTED2010; Bailey SE, 2007, AM J PHYS ANTHROPOL, P67; Balout L, 1955, PREHISTOIRE AFRIQUE; Balter M, 2011, SCIENCE, V331, P20, DOI 10.1126/science.331.6013.20; Bar-Matthews M, 1999, EARTH PLANET SC LETT, V166, P85, DOI 10.1016/S0012-821X(98)00275-1; Bar-Matthews M, 2003, GEOCHIM COSMOCHIM AC, V67, P3181, DOI 10.1016/S0016-7037(02)01031-1; Barton RNE, 2009, QUATERNARY SCI REV, V28, P1914, DOI 10.1016/j.quascirev.2009.03.010; Bastawesy MA, 2008, J AFR EARTH SCI, V52, P73, DOI 10.1016/j.jafrearsci.2008.03.006; Bates PD, 2010, J HYDROL, V387, P33, DOI 10.1016/j.jhydrol.2010.03.027; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI [10.1175/1520-0469(1978)035<2362:LTVODI>2.0.CO;2, 10.1016/0033-5894(78)90064-9]; Beven K, 1997, HYDROL PROCESS, V11, P1069; Beven K.J., 1979, HYDROL SCI B, V24, P43, DOI [DOI 10.1080/02626667909491834, 10.1080/02626667909491834, 10.1080/ 02626667909491834]; Biancamaria S, 2009, J HYDROL, V379, P136, DOI 10.1016/j.jhydrol.2009.09.054; Bouzouggar A., 2012, MODERN ORIGINS N AFR, P93; Brovkin V, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037543; Burns SJ, 2001, GEOLOGY, V29, P623, DOI 10.1130/0091-7613(2001)029<0623:SEFOFC>2.0.CO;2; Castaneda IS, 2009, P NATL ACAD SCI USA, V106, P20159, DOI 10.1073/pnas.0905771106; Causse C, 2003, APPL GEOCHEM, V18, P1691, DOI 10.1016/S0883-2927(03)00043-X; Coulthard T, EARTH SURFACE PROCES; Crevecoeur I, 2009, AM J PHYS ANTHROPOL, V140, P347, DOI 10.1002/ajpa.21080; de Almeida GAM, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011570; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; Drake NA, 2008, PALAEOGEOGR PALAEOCL, V263, P131, DOI 10.1016/j.palaeo.2008.02.005; Drake NA, 2011, P NATL ACAD SCI USA, V108, P458, DOI 10.1073/pnas.1012231108; Fischer N, 2011, CLIM PAST, V7, P1139, DOI 10.5194/cp-7-1139-2011; Fischer N, 2010, CLIM PAST, V6, P155, DOI 10.5194/cp-6-155-2010; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Gasse F, 2002, QUATERNARY SCI REV, V21, P737, DOI 10.1016/S0277-3791(01)00125-1; GRUN R, 1991, ARCHAEOMETRY, V33, P153, DOI 10.1111/j.1475-4754.1991.tb00696.x; Hagemann S, 2003, CLIM DYNAM, V21, P349, DOI 10.1007/s00382-003-0349-x; Hagemann S, 1998, HYDROLOGY EARTH SYST; Harvati K, 2010, J HUM EVOL, V59, P445, DOI 10.1016/j.jhevol.2010.06.005; HIBLER WD, 1979, J PHYS OCEANOGR, V9, P815, DOI 10.1175/1520-0485(1979)009<0815:ADTSIM>2.0.CO;2; Jungclaus JH, 2006, J CLIMATE, V19, P3952, DOI 10.1175/JCLI3827.1; Kleindienst M.R., 2009, NYAME AKUMA, V71, P18; Kutzbach JE, 2008, CLIM DYNAM, V30, P567, DOI 10.1007/s00382-007-0308-z; Lahr Marta Mirazon, 1994, Evolutionary Anthropology, V3, P48, DOI 10.1002/evan.1360030206; Larrasoana JC, 2008, MAR GEOL, V254, P224, DOI 10.1016/j.margeo.2008.06.003; Liu Z, 2007, QUATERNARY SCI REV, V26, P1818, DOI 10.1016/j.quascirev.2007.03.002; Marsland SJ, 2003, OCEAN MODEL, V5, P91, DOI 10.1016/S1463-5003(02)00015-X; Miliaresis GC, 1999, COMPUT GEOSCI, V25, P715, DOI 10.1016/S0098-3004(99)00025-4; Neal J, 2011, J FLOOD RISK MANAG, V4, P88, DOI 10.1111/j.1753-318X.2011.01093.x; Neal J, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR012514; Osborne AH, 2010, QUATERNARY SCI REV, V29, P2473, DOI 10.1016/j.quascirev.2010.05.015; Osborne AH, 2008, P NATL ACAD SCI USA, V105, P16444, DOI 10.1073/pnas.0804472105; Pachur HJ, 1997, REMOTE SENS ENVIRON, V61, P437, DOI 10.1016/S0034-4257(96)00210-6; PACHUR HJ, 1987, SCIENCE, V237, P298, DOI 10.1126/science.237.4812.298; PACHUR HJ, 2006, OSTSAHARA SPATQUARTA; Raddatz TJ, 2007, CLIM DYNAM, V29, P565, DOI 10.1007/s00382-007-0247-8; Reuter HI, 2007, INT J GEOGR INF SCI, V21, P983, DOI 10.1080/13658810601169899; Revel M, 2010, QUATERNARY SCI REV, V29, P1342, DOI 10.1016/j.quascirev.2010.02.006; Roeckner E., 2003, ATMOSPHERIC GEN CIRC; Rohling EJ, 2008, NAT GEOSCI, V1, P38, DOI 10.1038/ngeo.2007.28; Rohling EJ, 2002, EARTH PLANET SC LETT, V202, P61, DOI 10.1016/S0012-821X(02)00775-6; Rudolf B., 2010, GPCC STATUS REPORT D; Shea J.J., 2005, MITEKUFAT HAEVEN J I, V35, P451; Smith JR, 2004, PALAEOGEOGR PALAEOCL, V206, P157, DOI 10.1016/j.palaeo.2004.01.021; Tuenter E, 2003, GLOBAL PLANET CHANGE, V36, P219, DOI 10.1016/S0921-8181(02)00196-0; Tzedakis PC, 2003, GLOBAL PLANET CHANGE, V36, P157, DOI 10.1016/S0921-8181(02)00182-0; Valcke S, 2003, TRGMGC0369; VALLADAS H, 1988, NATURE, V331, P614, DOI 10.1038/331614a0; Vorosmarty C. J, 1996, RIVER DISCHARGE DATA; Wilson M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030156; Zammouri M, 2005, J HYDROL, V314, P125, DOI 10.1016/j.jhydrol.2005.03.011; Ziegler M, 2010, QUATERNARY SCI REV, V29, P1481, DOI 10.1016/j.quascirev.2010.03.011	67	55	55	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74834	10.1371/journal.pone.0074834	http://dx.doi.org/10.1371/journal.pone.0074834			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040347	Green Accepted, Green Published, gold			2022-12-25	WOS:000326734500122
J	Robles, H; Martin, K				Robles, Hugo; Martin, Kathy			Resource Quantity and Quality Determine the Inter-Specific Associations between Ecosystem Engineers and Resource Users in a Cavity-Nest Web	PLOS ONE			English	Article							BRITISH-COLUMBIA; TREE SWALLOWS; COMMUNITIES; CANADA; AVAILABILITY; CONSERVATION; WOODPECKER; ORGANISMS; RESPONSES; SELECTION	While ecosystem engineering is a widespread structural force of ecological communities, the mechanisms underlying the inter-specific associations between ecosystem engineers and resource users are poorly understood. A proper knowledge of these mechanisms is, however, essential to understand how communities are structured. Previous studies suggest that increasing the quantity of resources provided by ecosystem engineers enhances populations of resource users. In a long-term study (1995-2011), we show that the quality of the resources (i.e. tree cavities) provided by ecosystem engineers is also a key feature that explains the inter-specific associations in a tree cavity-nest web. Red-naped sapsuckers (Sphyrapicus nuchalis) provided the most abundant cavities (52% of cavities, 0.49 cavities/ha). These cavities were less likely to be used than other cavity types by mountain bluebirds (Sialia currucoides), but provided numerous nest-sites (41% of nesting cavities) to tree swallows (Tachycineta bicolour). Swallows experienced low reproductive outputs in northern flicker (Colaptes auratus) cavities compared to those in sapsucker cavities (1.1 vs. 2.1 fledglings/nest), but the highly abundant flickers (33% of cavities, 0.25 cavities/ha) provided numerous suitable nest-sites for bluebirds (58%). The relative shortage of cavities supplied by hairy woodpeckers (Picoides villosus) and fungal/insect decay (< 10% of cavities each, < 0.09 cavities/ha) provided fewer breeding opportunities (< 15% of nests), but represented high quality nest-sites for both bluebirds and swallows. Because both the quantity and quality of resources supplied by different ecosystem engineers may explain the amount of resources used by each resource user, conservation strategies may require different management actions to be implemented for the key ecosystem engineer of each resource user. We, therefore, urge the incorporation of both resource quantity and quality into models that assess community dynamics to improve conservation actions and our understanding of ecological communities based on ecosystem engineering.	[Robles, Hugo; Martin, Kathy] Univ British Columbia, Ctr Appl Conservat Res, Dept Forest & Conservat Sci, Vancouver, BC V5Z 1M9, Canada; [Martin, Kathy] Environm Canada, Pacific Wildlife Res Ctr, Delta, BC, Canada	University of British Columbia; Environment & Climate Change Canada; Canadian Wildlife Service; Pacific Wildlife Research Centre	Robles, H (corresponding author), Univ British Columbia, Ctr Appl Conservat Res, Dept Forest & Conservat Sci, Vancouver, BC V5Z 1M9, Canada.	hugo.roblesdiez@ua.ac.be	Robles, Hugo/GLT-7003-2022; Robles, Hugo/AAH-6795-2021	Robles, Hugo/0000-0003-0289-0687	Natural Sciences and Engineering Research Council of Canada (NSERC Special Strategic Grant); Environment Canada, Sustainable Forest Management Network and Forest Renewal B.C. Tolko Industries Limited (Cariboo Woodlands)	Natural Sciences and Engineering Research Council of Canada (NSERC Special Strategic Grant); Environment Canada, Sustainable Forest Management Network and Forest Renewal B.C. Tolko Industries Limited (Cariboo Woodlands)	This research was funded by The Natural Sciences and Engineering Research Council of Canada (NSERC Special Strategic Grant to KM), Environment Canada, Sustainable Forest Management Network and Forest Renewal B.C. Tolko Industries Limited (Cariboo Woodlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamik P, 2008, J ZOOL, V275, P209, DOI 10.1111/j.1469-7998.2008.00415.x; Aitken KEH, 2007, J ORNITHOL, V148, pS425, DOI 10.1007/s10336-007-0166-9; Blakely TJ, 2008, AUSTRAL ECOL, V33, P963, DOI 10.1111/j.1442-9993.2008.01867.x; Blanc LA, 2008, CONDOR, V110, P80, DOI 10.1525/cond.2008.110.1.80; Blanc LA, 2012, FOREST ECOL MANAG, V286, P192, DOI 10.1016/j.foreco.2012.08.021; Boogert NJ, 2006, BIOSCIENCE, V56, P570, DOI 10.1641/0006-3568(2006)56[570:TIONCA]2.0.CO;2; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Calderon-Cortes N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019083; Cardinale BJ, 2004, FUNCT ECOL, V18, P381, DOI 10.1111/j.0269-8463.2004.00865.x; Cully JF, 2010, ECOGRAPHY, V33, P667, DOI 10.1111/j.1600-0587.2009.05746.x; DAILY GC, 1993, P NATL ACAD SCI USA, V90, P592, DOI 10.1073/pnas.90.2.592; Davidson AD, 2007, ECOGRAPHY, V30, P515, DOI 10.1111/j.0906-7590.2007.05032.x; DOBKIN DS, 1995, CONDOR, V97, P694, DOI 10.2307/1369178; Edworthy AB, 2012, ECOL APPL, V22, P1733, DOI 10.1890/11-1594.1; Fisher RJ, 2006, OECOLOGIA, V147, P744, DOI 10.1007/s00442-005-0310-2; Galvez-Bravo L, 2011, J ARID ENVIRON, V75, P779, DOI 10.1016/j.jaridenv.2011.03.015; Haeckler FW, 1948, CONDOR, V50, P216, DOI [10.2307/1364540, DOI 10.2307/1364540]; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Koch AJ, 2012, IBIS, V154, P590, DOI 10.1111/j.1474-919X.2012.01242.x; LOTKA ALFRED J., 1932, JOUR WASHINGTON ACAD SCI, V22, P461; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Machicote M, 2004, OIKOS, V106, P527, DOI 10.1111/j.0030-1299.2004.13139.x; Martin K, 2004, CONDOR, V106, P5, DOI 10.1650/7482; Power H. W., 1996, BIRDS N AM ONLINE; Pringle RM, 2008, ECOLOGY, V89, P26, DOI 10.1890/07-0776.1; Prugh LR, 2012, J ANIM ECOL, V81, P667, DOI 10.1111/j.1365-2656.2011.01930.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAPHAEL MG, 1984, WILDLIFE MONOGR, P1; RENDELL WB, 1989, CONDOR, V91, P875, DOI 10.2307/1368072; Robles H, 2008, AUK, V125, P131, DOI 10.1525/auk.2008.125.1.131; Robles H, 2007, FOREST ECOL MANAG, V242, P343, DOI 10.1016/j.foreco.2007.01.052; Robles H, 2012, FOREST ECOL MANAG, V277, P46, DOI 10.1016/j.foreco.2012.04.017; Robles H, 2011, FOREST ECOL MANAG, V261, P1428, DOI 10.1016/j.foreco.2011.01.029; SAUER JR, 2011, N AM BREEDING BIRD S; STAUFFER D F, 1982, Wilson Bulletin, V94, P329; Waters JR, 1988, THESIS HUMBOLDT STAT; Winkler DW, 2011, BIRDS N AM; Wright JP, 2002, OECOLOGIA, V132, P96, DOI 10.1007/s00442-002-0929-1; Wright JP, 2006, BIOSCIENCE, V56, P203, DOI 10.1641/0006-3568(2006)056[0203:TCOOAE]2.0.CO;2; Zhu X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044346	41	32	33	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74694	10.1371/journal.pone.0074694	http://dx.doi.org/10.1371/journal.pone.0074694			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040324	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500116
J	Chotoo, CK; Silverman, GA; Devor, DC; Luke, CJ				Chotoo, Cavita K.; Silverman, Gary A.; Devor, Daniel C.; Luke, Cliff J.			A Small Conductance Calcium-Activated K+ Channel in C-elegans, KCNL-2, Plays a Role in the Regulation of the Rate of Egg-Laying	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; POTASSIUM CHANNELS; NERVOUS-SYSTEM; SK3; EXPRESSION; AFTERHYPERPOLARIZATION; SUPPRESSION; SUBUNIT; APAMIN; GENES	In the nervous system of mice, small conductance calcium-activated potassium (SK) channels function to regulate neuronal excitability through the generation of a component of the medium afterhyperpolarization that follows action potentials. In humans, irregular action potential firing frequency underlies diseases such as ataxia, epilepsy, schizophrenia and Parkinson's disease. Due to the complexity of studying protein function in the mammalian nervous system, we sought to characterize an SK channel homologue, KCNL-2, in C. elegans, a genetically tractable system in which the lineage of individual neurons was mapped from their early developmental stages. Sequence analysis of the KCNL-2 protein reveals that the six transmembrane domains, the potassium-selective pore and the calmodulin binding domain are highly conserved with the mammalian homologues. We used widefield and confocal fluorescent imaging to show that a fusion construct of KCNL-2 with GFP in transgenic lines is expressed in the nervous system of C. elegans. We also show that a KCNL-2 null strain, kcnl-2(tm1885), demonstrates a mild egg-laying defective phenotype, a phenotype that is rescued in a KCNL-2-dependent manner. Conversely, we show that transgenic lines that overexpress KCNL-2 demonstrate a hyperactive egg-laying phenotype. In this study, we show that the vulva of transgenic hermaphrodites is highly innervated by neuronal processes and by the VC4 and VC5 neurons that express GFP-tagged KCNL-2. We propose that KCNL-2 functions in the nervous system of C. elegans to regulate the rate of egg-laying.	[Chotoo, Cavita K.; Silverman, Gary A.; Devor, Daniel C.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15213 USA; [Silverman, Gary A.; Luke, Cliff J.] Univ Pittsburgh, Dept Pediat, Childrens Hosp Pittsburgh, UPMC, Pittsburgh, PA 15260 USA; [Silverman, Gary A.; Luke, Cliff J.] Magee Womens Hosp, Res Inst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Devor, DC (corresponding author), Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15213 USA.	dd2@pitt.edu; cliff.luke@chp.edu	Silverman, Gary/AAJ-1269-2020		National Institute of Health [HL092157, DK079806, DK081422]; Hartwell Foundation (GAS); NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079806, R01DK081422] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Foundation (GAS); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institute of Health (HL092157 to DCD; DK079806 and DK081422 to GAS) and The Hartwell Foundation (GAS). Some nematode strains used in this work were provided by the NIH-funded Caenorhabditis Genetics Center at the University of Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman JP, 2012, ANNU REV PHYSIOL, V74, P245, DOI 10.1146/annurev-physiol-020911-153336; Bany IA, 2003, J NEUROSCI, V23, P8060; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Bond CT, 2000, SCIENCE, V289, P1942, DOI 10.1126/science.289.5486.1942; Bowden SEH, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-20-j0006.2001; Brahler S, 2009, CIRCULATION, V119, P2323, DOI 10.1161/CIRCULATIONAHA.108.846634; BRENNER S, 1974, GENETICS, V77, P71; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; Dimitriadi M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001172; Empson RM, 2001, NEUROSCIENCE, V102, P297, DOI 10.1016/S0306-4522(00)00494-2; Fanger CM, 2001, J BIOL CHEM, V276, P12249, DOI 10.1074/jbc.M011342200; de Sevilla DF, 2006, J NEUROPHYSIOL, V96, P3028, DOI 10.1152/jn.00434.2006; Gerlach AC, 2004, PFLUG ARCH EUR J PHY, V448, P187, DOI 10.1007/s00424-003-1237-2; Herrera GM, 2003, J PHYSIOL-LONDON, V551, P893, DOI 10.1113/jphysiol.2003.045914; Ishii TM, 1997, J BIOL CHEM, V272, P23195, DOI 10.1074/jbc.272.37.23195; Joiner WJ, 1997, P NATL ACAD SCI USA, V94, P11013, DOI 10.1073/pnas.94.20.11013; Kim J, 2001, GENETICS, V157, P1599; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LARSEN PL, 1995, GENETICS, V139, P1567; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MENDEL JE, 1995, SCIENCE, V267, P1652, DOI 10.1126/science.7886455; Miller MJ, 2001, J BIOL CHEM, V276, P27753, DOI 10.1074/jbc.C100221200; Moresco JJ, 2004, J NEUROSCI, V24, P8522, DOI 10.1523/JNEUROSCI.1915-04.2004; Ringstad N, 2008, NAT NEUROSCI, V11, P1168, DOI 10.1038/nn.2186; Sawin E.R., 1996, SELECTED WORKS MAO T, V151, P135; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; Shakkottai VG, 2004, J CLIN INVEST, V113, P582, DOI 10.1172/JCI200420216; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Singson A, 1998, CELL, V93, P71, DOI 10.1016/S0092-8674(00)81147-2; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; Szatanik M, 2008, NEUROGENETICS, V9, P237, DOI 10.1007/s10048-008-0136-2; Taylor MS, 2003, CIRC RES, V93, P124, DOI 10.1161/01.RES.0000081980.63146.69; Thorneloe KS, 2008, AM J PHYSIOL-REG I, V294, pR1737, DOI 10.1152/ajpregu.00840.2006; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wolfart J, 2001, J NEUROSCI, V21, P3443, DOI 10.1523/JNEUROSCI.21-10-03443.2001; Zhang M, 2008, CURR BIOL, V18, P1445, DOI 10.1016/j.cub.2008.08.047	40	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e75869	10.1371/journal.pone.0075869	http://dx.doi.org/10.1371/journal.pone.0075869			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040423	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000327538600143
J	Newton, RJ; Huse, SM; Morrison, HG; Peake, CS; Sogin, ML; McLellan, SL				Newton, Ryan J.; Huse, Susan M.; Morrison, Hilary G.; Peake, Colin S.; Sogin, Mitchell L.; McLellan, Sandra L.			Shifts in the Microbial Community Composition of Gulf Coast Beaches Following Beach Oiling	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; BACTERIAL COMMUNITIES; OF-MEXICO; DIVERSITY; SEDIMENTS; DYNAMICS; SANDS; SPILL; CORE; HYPOTHESIS	Microorganisms associated with coastal sands serve as a natural biofilter, providing essential nutrient recycling in nearshore environments and acting to maintain coastal ecosystem health. Anthropogenic stressors often impact these ecosystems, but little is known about whether these disturbances can be identified through microbial community change. The blowout of the Macondo Prospect reservoir on April 20, 2010, which released oil hydrocarbons into the Gulf of Mexico, presented an opportunity to examine whether microbial community composition might provide a sensitive measure of ecosystem disturbance. Samples were collected on four occasions, beginning in mid-June, during initial beach oiling, until mid-November from surface sand and surf zone waters at seven beaches stretching from Bay St. Louis, MS to St. George Island, FL USA. Oil hydrocarbon measurements and NOAA shoreline assessments indicated little to no impact on the two most eastern beaches (controls). Sequence comparisons of bacterial ribosomal RNA gene hypervariable regions isolated from beach sands located to the east and west of Mobile Bay in Alabama demonstrated that regional drivers account for markedly different bacterial communities. Individual beaches had unique community signatures that persisted over time and exhibited spatial relationships, where community similarity decreased as horizontal distance between samples increased from one to hundreds of meters. In contrast, sequence analyses detected larger temporal and less spatial variation among the water samples. Superimposed upon these beach community distance and time relationships, was increased variability in bacterial community composition from oil hydrocarbon contaminated sands. The increased variability was observed among the core, resident, and transient community members, indicating the occurrence of community-wide impacts rather than solely an overprinting of oil hydrocarbon-degrading bacteria onto otherwise relatively stable sand population structures. Among sequences classified to genus, Alcanivorax, Alteromonas, Marinobacter, Winogradskyella, and Zeaxanthinibacter exhibited the largest relative abundance increases in oiled sands.	[Newton, Ryan J.; Peake, Colin S.; McLellan, Sandra L.] Univ Wisconsin, Sch Freshwater Sci, Great Lakes WATER Inst, Milwaukee, WI 53201 USA; [Huse, Susan M.; Morrison, Hilary G.; Sogin, Mitchell L.] Marine Biol Lab, Josephine Bay Paul Ctr, Woods Hole, MA 02543 USA	University of Wisconsin System; University of Wisconsin Milwaukee; Marine Biological Laboratory - Woods Hole	McLellan, SL (corresponding author), Univ Wisconsin, Sch Freshwater Sci, Great Lakes WATER Inst, Milwaukee, WI 53201 USA.	mclellan@uwm.edu	Sogin, Mitchell/AAE-7186-2019	Morrison, Hilary/0000-0003-0281-326X; McLellan, Sandra/0000-0003-3283-1151	University of Wisconsin-Milwaukee National Institute of Environmental Health Sciences program [ES-004184]; Alfred P. Sloan Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES004184] Funding Source: NIH RePORTER	University of Wisconsin-Milwaukee National Institute of Environmental Health Sciences program; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Financial support for this work was provided by the University of Wisconsin-Milwaukee National Institute of Environmental Health Sciences program, grant ES-004184 to SLM and the Alfred P. Sloan Foundation's grant for the Rare Biosphere in the Built Environment MLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Gutierrez J, 2009, APPL ENVIRON MICROB, V75, P3407, DOI 10.1128/AEM.01776-08; [Anonymous], 2010, OIL BUDGET CALCULATO; [Anonymous], 2011, EXP FACT HDB 2011 ED; Biers EJ, 2009, APPL ENVIRON MICROB, V75, P2221, DOI 10.1128/AEM.02118-08; Boer SI, 2009, ISME J, V3, P780, DOI 10.1038/ismej.2009.29; Boone PA, 1973, GULF COAST ASS GEOL, V23, P226; Buhring SI, 2005, ENVIRON MICROBIOL, V7, P281, DOI 10.1111/j.1462-2920.2004.00710.x; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Chao A, 2006, BIOMETRICS, V62, P361, DOI 10.1111/j.1541-0420.2005.00489.x; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Coulon F, 2007, ENVIRON MICROBIOL, V9, P177, DOI 10.1111/j.1462-2920.2006.01126.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; Gibson DJ, 1999, J ECOL, V87, P1064, DOI 10.1046/j.1365-2745.1999.00424.x; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; Giovannoni SJ, 2012, SCIENCE, V335, P671, DOI 10.1126/science.1198078; Gobet A, 2012, ISME J, V6, P542, DOI 10.1038/ismej.2011.132; HANSKI I, 1982, OIKOS, V38, P210, DOI 10.2307/3544021; Harayama S, 2004, CURR OPIN BIOTECH, V15, P205, DOI 10.1016/j.copbio.2004.04.002; Hayworth JS, 2011, HYDROL EARTH SYST SC, V15, P3639, DOI 10.5194/hess-15-3639-2011; Head IM, 2006, NAT REV MICROBIOL, V4, P173, DOI 10.1038/nrmicro1348; Hewson I, 2006, MAR ECOL PROG SER, V306, P79, DOI 10.3354/meps306079; Hewson I, 2003, MICROB ECOL, V46, P322, DOI 10.1007/s00248-002-1067-3; Huettel M, 2000, LIMNOL OCEANOGR, V45, P534, DOI 10.4319/lo.2000.45.3.0534; Hunter EM, 2006, APPL ENVIRON MICROB, V72, P5689, DOI 10.1128/AEM.03007-05; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Kostka JE, 2011, APPL ENVIRON MICROB, V77, P7962, DOI 10.1128/AEM.05402-11; Llobet-Brossa E, 1998, APPL ENVIRON MICROB, V64, P2691; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Mills HJ, 2008, APPL ENVIRON MICROB, V74, P4440, DOI 10.1128/AEM.02692-07; Newton RJ, 2011, APPL ENVIRON MICROB, V77, P6972, DOI 10.1128/AEM.05480-11; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Oksanen J., 2016, R PACKAG; Polymenakou PN, 2005, MICROB ECOL, V49, P367, DOI 10.1007/s00248-004-0274-5; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; Sorensen KB, 2007, MAR ECOL PROG SER, V346, P61, DOI 10.3354/meps06996; Urakawa H, 2000, ENVIRON MICROBIOL, V2, P542, DOI 10.1046/j.1462-2920.2000.00137.x; USEPA, 2004, C IMP CONTR CSOS SSO; White P.S., 1985, ECOLOGY NATURAL DIST, P3, DOI 10.1016/B978-0-12-554520-4.50006-X; Yakimov MM, 2007, CURR OPIN BIOTECH, V18, P257, DOI 10.1016/j.copbio.2007.04.006; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	49	53	53	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74265	10.1371/journal.pone.0074265	http://dx.doi.org/10.1371/journal.pone.0074265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040219	Green Submitted, gold, Green Published			2022-12-25	WOS:000327538600082
J	Thiaville, MM; Kim, H; Frey, WD; Kim, J				Thiaville, Michelle M.; Kim, Hana; Frey, Wesley D.; Kim, Joomyeong			Identification of an Evolutionarily Conserved Cis-Regulatory Element Controlling the Peg3 Imprinted Domain	PLOS ONE			English	Article							ANTISENSE TRANSCRIPT; GENE; YY1; BINDING; REGION	The mammalian Peg3 domain harbors more than 20 evolutionarily conserved regions (ECRs) that are spread over the 250-kb genomic interval. The majority of these ECRs are marked with two histone modifications, H3K4me1 and H3K27ac, suggesting potential roles as distant regulatory elements for the transcription of the nearby imprinted genes. In the current study, the chromatin conformation capture (3C) method was utilized to detect potential interactions of these ECRs with the imprinted genes. According to the results, one region, ECR18, located 200-kb upstream of Peg3 interacts with the two promoter regions of Peg3 and Zim2. The observed interaction is most prominent in brain, but was also detected in testis. Histone modification and DNA methylation on ECR18 show no allele bias, implying that this region is likely functional on both alleles. In vitro assays also reveal ECR18 as a potential enhancer or repressor for the promoter of Peg3. Overall, these results indicate that the promoters of several imprinted genes in the Peg3 domain interact with one evolutionarily conserved region, ECR18, and further suggest that ECR18 may play key roles in the transcription and imprinting control of the Peg3 domain as a distant regulatory element.	[Thiaville, Michelle M.; Kim, Hana; Frey, Wesley D.; Kim, Joomyeong] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu		Frey, Wesley/0000-0003-0392-5714	National Institutes of Health [R01-GM066225, R15-ES019118]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R15ES019118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study has been supported by National Institutes of Health (R01-GM066225, R15-ES019118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz LK, 2012, CURR OPIN GENET DEV, V22, P72, DOI 10.1016/j.gde.2011.12.001; Bartolomei MS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002592; Choo JH, 2008, GENE, V409, P28, DOI 10.1016/j.gene.2007.10.036; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Do Kim J, 2006, GENOME RES, V16, P901, DOI 10.1101/gr.5091406; Do Kim J, 2009, NUCLEIC ACIDS RES, V37, P5656, DOI 10.1093/nar/gkp613; Do Kim J, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-108; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Huang JM, 2009, GENE, V445, P1, DOI 10.1016/j.gene.2009.06.002; Ideraabdullah FY, 2008, MUTAT RES-FUND MOL M, V647, P77, DOI 10.1016/j.mrfmmm.2008.08.008; Kim J, 2000, GENOME RES, V10, P1138, DOI 10.1101/gr.10.8.1138; Kim J, 2004, GENOMICS, V84, P47, DOI 10.1016/j.ygeno.2004.02.007; Kim J, 2003, HUM MOL GENET, V12, P233, DOI 10.1093/hmg/ddg028; Kim J, 2001, GENOMICS, V77, P91, DOI 10.1006/geno.2001.6621; KIM J, 2005, RAPIDLY EVOLVING IMP; Kim JD, 2007, GENOMICS, V89, P262, DOI 10.1016/j.ygeno.2006.09.009; Kim J, 2008, EPIGENETICS-US, V3, P115, DOI 10.4161/epi.3.3.6176; Kim J, 2007, GENOMICS, V90, P85, DOI 10.1016/j.ygeno.2007.03.012; Kim J, 2012, HUM MOL GENET, V21, P2677, DOI 10.1093/hmg/dds092; Kim JY, 1999, HUM MOL GENET, V8, P847, DOI 10.1093/hmg/8.5.847; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Miele A, 2006, CURR PROTOC MOL BIOL, V21; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Spahn L, 2003, NAT GENET, V35, P11, DOI 10.1038/ng0903-11; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532	27	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e75417	10.1371/journal.pone.0075417	http://dx.doi.org/10.1371/journal.pone.0075417			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040411	Green Published, Green Submitted, gold			2022-12-25	WOS:000327538600138
J	Patki, G; Allam, FH; Atrooz, F; Dao, AT; Solanki, N; Chugh, G; Asghar, M; Jafri, F; Bohat, R; Alkadhi, KA; Salim, S				Patki, Gaurav; Allam, Farida H.; Atrooz, Fatin; Dao, An T.; Solanki, Naimesh; Chugh, Gaurav; Asghar, Mohammad; Jafri, Faizan; Bohat, Ritu; Alkadhi, Karim A.; Salim, Samina			Grape Powder Intake Prevents Ovariectomy-Induced Anxiety-Like Behavior, Memory Impairment and High Blood Pressure in Female Wistar Rats	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; OXIDATIVE STRESS; COMPLEMENTARY THERAPIES; INSULIN-RESISTANCE; ANIMAL-MODEL; RISK-FACTORS; HYPERTENSION; MENOPAUSE; WOMEN; ANTIOXIDANT	Diminished estrogen influence at menopause is reported to be associated with cognitive decline, heightened anxiety and hypertension. While estrogen therapy is often prescribed to overcome these behavioral and physiological deficits, antioxidants which have been shown beneficial are gaining nutritional intervention and popularity. Therefore, in the present study, utilizing the antioxidant properties of grapes, we have examined effect of 3 weeks of grape powder (GP; 15 g/L dissolved in tap water) treatment on anxiety-like behavior, learning-memory impairment and high blood pressure in ovariectomized (OVX) rats. Four groups of female Wistar rats were used; sham control, sham-GP treated, OVX and OVX+GP treated. We observed a significant increase in systolic and diastolic blood pressure in OVX rats as compared to sham-controls. Furthermore, ovariectomy increased anxiety-like behavior and caused learning and memory impairment in rats as compared to sham-controls. Interestingly, providing grape powder treated water to OVX rats restored both systolic and diastolic blood pressure, decreased anxiety-like behavior and improved memory function. Moreover, OVX rats exhibited an impaired long term potentiation which was restored with grape powder treatment. Furthermore, ovariectomy increased oxidative stress in the brain, serum and urine, selectively decreasing antioxidant enzyme, glyoxalase-1 protein expression in the hippocampus but not in the cortex and amygdala of OVX rats, while grape powder treatment reversed these effects. Other antioxidant enzyme levels, including manganese superoxide dismutase (SOD) and Cu/Zn SOD remained unchanged. We suggest that grape powder by regulating oxidative stress mechanisms exerts its protective effect on blood pressure, learning-memory and anxiety-like behavior. Our study is the first to examine behavioral, biochemical, physiological and electrophysiological outcome of estrogen depletion in rats and to test protective role of grape powder, all in the same study.	[Patki, Gaurav; Allam, Farida H.; Atrooz, Fatin; Dao, An T.; Solanki, Naimesh; Chugh, Gaurav; Asghar, Mohammad; Jafri, Faizan; Bohat, Ritu; Alkadhi, Karim A.; Salim, Samina] Univ Houston, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77204 USA	University of Houston System; University of Houston	Salim, S (corresponding author), Univ Houston, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77204 USA.	ssalim@uh.edu		Atrooz, Fatin/0000-0002-1358-7926	NIH [R15 G103327, R01 AG039836]; NATIONAL INSTITUTE OF MENTAL HEALTH [R15MH093918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG039836] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding for this research was provided in parts by NIH R15 G103327 grant awarded to Samina Salim, NIH R01 AG039836 to Mohammad Asghar. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AM, 2011, CAN J PHYSIOL PHARM, V89, P497, DOI 10.1139/Y11-053; Acosta JI, 2009, ENDOCRINOLOGY, V150, P4248, DOI 10.1210/en.2008-1802; Agarwal A, 2008, AM J REPROD IMMUNOL, V59, P2, DOI 10.1111/j.1600-0897.2007.00559.x; Aleisa AM, 2011, HIPPOCAMPUS, V21, P899, DOI 10.1002/hipo.20806; Alhaider IA, 2010, EUR J NEUROSCI, V31, P1368, DOI 10.1111/j.1460-9568.2010.07175.x; Allam F., 2013, J NUTR; [Anonymous], NEUROBIOLOGICAL BASI; Asghar M, 2009, AM J PHYSIOL-RENAL, V297, pF1543, DOI 10.1152/ajprenal.00366.2009; Banday AA, 2009, AM J PHYSIOL-RENAL, V297, pF397, DOI 10.1152/ajprenal.90729.2008; Becker S, 2005, HIPPOCAMPUS, V15, P722, DOI 10.1002/hipo.20095; Berk M, 2011, NEUROSCI BIOBEHAV R, V35, P804, DOI 10.1016/j.neubiorev.2010.10.001; Bethel-Brown CS, 2010, PHARMACOL BIOCHEM BE, V96, P423, DOI 10.1016/j.pbb.2010.06.014; Bhuiyan MS, 2010, MENOPAUSE, V17, P213, DOI 10.1097/gme.0b013e3181b57489; Borrelli F, 2010, MATURITAS, V66, P333, DOI 10.1016/j.maturitas.2010.05.010; Bowe J, 2006, J ENDOCRINOL, V191, P399, DOI 10.1677/joe.1.06919; Carroll D, 2010, PSYCHOSOM MED, V72, P16, DOI 10.1097/PSY.0b013e3181c4fca1; Chen TS, 2000, MECH AGEING DEV, V120, P127, DOI 10.1016/S0047-6374(00)00214-1; Ciobica A, 2011, PSYCHIAT DANUB, V23, P340; Curtin MLI, 1990, CHRONIC ILLNESS IMPA; Davidge ST, 2001, AM J PHYSIOL-REG I, V280, pR904, DOI 10.1152/ajpregu.2001.280.3.R904; de Oliveira MR, 2008, NEUROCHEM RES, V33, P378, DOI 10.1007/s11064-007-9438-2; Dennehy C, 2010, MATURITAS, V66, P370, DOI 10.1016/j.maturitas.2010.06.003; Di Loreto S, 2008, INT J BIOCHEM CELL B, V40, P245, DOI 10.1016/j.biocel.2007.07.019; Dong HW, 2001, BRAIN RES REV, V38, P192, DOI 10.1016/S0165-0173(01)00079-0; Femenia T, 2012, BRAIN RES, V1476, P58, DOI 10.1016/j.brainres.2012.03.053; Freeman EW, 2011, JAMA-J AM MED ASSOC, V305, P267, DOI 10.1001/jama.2010.2016; Fuhrman B, 2005, J NUTR, V135, P722, DOI 10.1093/jn/135.4.722; Goss PE, 2007, BREAST CANCER RES TR, V103, P293, DOI 10.1007/s10549-006-9381-y; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Hamer M, 2010, HYPERTENSION, V56, P547, DOI 10.1161/HYPERTENSIONAHA.110.153775; Hasenohrl RU, 1999, EXP BRAIN RES, V128, P435, DOI 10.1007/s002210050866; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Huang YH, 2010, BRIT J NUTR, V104, P1297, DOI 10.1017/S0007114510002291; Jacobs U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022925; JIALAL I, 1990, ATHEROSCLEROSIS, V82, P185, DOI 10.1016/0021-9150(90)90039-L; Jialal I, 2001, J NUTR, V131, p389S, DOI 10.1093/jn/131.2.389S; John JH, 2002, LANCET, V359, P1969, DOI 10.1016/S0140-6736(02)98858-6; Jonas BS, 1997, ARCH FAM MED, V6, P43, DOI 10.1001/archfami.6.1.43; Kurzer MS, 2003, J NUTR, V133, p1983S, DOI 10.1093/jn/133.6.1983S; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Lee SD, 2008, MATURITAS, V61, P268, DOI 10.1016/j.maturitas.2008.07.004; Liehr JG, 1996, J LAB CLIN MED, V128, P344, DOI 10.1016/S0022-2143(96)80002-3; Mendoza-Nunez VM, 2011, REJUV RES, V14, P25, DOI 10.1089/rej.2010.1054; Martins DB, 2012, LIFE SCI, V90, P351, DOI 10.1016/j.lfs.2011.12.006; Masood A, 2009, J PHARMACOL EXP THER, V331, P690, DOI 10.1124/jpet.109.156729; Miquel J, 2006, ARCH GERONTOL GERIAT, V42, P289, DOI 10.1016/j.archger.2005.08.005; Moura EG, 2012, J NUTR BIOCH; Moylan S, 2012, MOL PSYCHIAT; Muthusami S, 2005, CLIN CHIM ACTA, V360, P81, DOI 10.1016/j.cccn.2005.04.014; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; ROY EJ, 1990, BRAIN RES BULL, V25, P221, DOI 10.1016/0361-9230(90)90064-7; Salim S, 2010, BRAIN RES, V1359, P178, DOI 10.1016/j.brainres.2010.08.093; Salim S, 2010, BEHAV BRAIN RES, V208, P545, DOI 10.1016/j.bbr.2009.12.039; Seeman MV, 1997, AM J PSYCHIAT, V154, P1641, DOI 10.1176/ajp.154.12.1641; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Sonmez U, 2007, NEUROSCI LETT, V420, P133, DOI 10.1016/j.neulet.2007.04.070; Stahlberg C, 2004, INT J CANCER, V109, P721, DOI 10.1002/ijc.20016; Thompson EA, 2010, MATURITAS, V66, P350, DOI 10.1016/j.maturitas.2010.02.003; Vatassery GT, 2004, J NEUROSCI RES, V75, P845, DOI 10.1002/jnr.20027; Vislocky LM, 2010, NUTR REV, V68, P656, DOI 10.1111/j.1753-4887.2010.00335.x; Vollert C, 2011, BEHAV BRAIN RES, V224, P233, DOI 10.1016/j.bbr.2011.05.010; Walf AA, 2007, PHARMACOL BIOCHEM BE, V86, P407, DOI 10.1016/j.pbb.2006.07.003; Walf AA, 2006, NEUROPSYCHOPHARMACOL, V31, P1097, DOI 10.1038/sj.npp.1301067; Walf AA, 2009, PSYCHONEUROENDOCRINO, V34, P909, DOI [10.1016/j.psyneuen.2009.01.004, 10.1016/j.psyneuen.2009.07.005]; WENGER NK, 1993, NEW ENGL J MED, V329, P247, DOI 10.1056/NEJM199307223290406; Wong VCK, 2009, GYNECOL ENDOCRINOL, V25, P166, DOI 10.1080/09513590802549866; Yanes LL, 2011, AM J HYPERTENS, V24, P740, DOI 10.1038/ajh.2011.71	67	49	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74522	10.1371/journal.pone.0074522	http://dx.doi.org/10.1371/journal.pone.0074522			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040270	gold, Green Submitted, Green Published			2022-12-25	WOS:000326405300179
J	Bergdahl, B; Sandstrom, AG; Borgstrom, C; Boonyawan, T; van Niel, EWJ; Gorwa-Grauslund, MF				Bergdahl, Basti; Sandstrom, Anders G.; Borgstrom, Celina; Boonyawan, Tarinee; van Niel, Ed W. J.; Gorwa-Grauslund, Marie F.			Engineering Yeast Hexokinase 2 for Improved Tolerance Toward Xylose-Induced Inactivation	PLOS ONE			English	Article							UTILIZING SACCHAROMYCES-CEREVISIAE; SNF1 PROTEIN-KINASE; CONTINUOUS-CULTURE; PHOSPHORYLATION; EXPRESSION; CARBON; GENES; MIG1; PHOSPHATASE; MUTAGENESIS	Hexokinase 2 (Hxk2p) from Saccharomyces cerevisiae is a bi-functional enzyme being both a catalyst and an important regulator in the glucose repression signal. In the presence of xylose Hxk2p is irreversibly inactivated through an autophosphorylation mechanism, affecting all functions. Consequently, the regulation of genes involved in sugar transport and fermentative metabolism is impaired. The aim of the study was to obtain new Hxk2p-variants, immune to the autophosphorylation, which potentially can restore the repressive capability closer to its nominal level. In this study we constructed the first condensed, rationally designed combinatorial library targeting the active-site in Hxk2p. We combined protein engineering and genetic engineering for efficient screening and identified a variant with Phe159 changed to tyrosine. This variant had 64% higher catalytic activity in the presence of xylose compared to the wild-type and is expected to be a key component for increasing the productivity of recombinant xylose-fermenting strains for bioethanol production from lignocellulosic feedstocks.	[Bergdahl, Basti; Sandstrom, Anders G.; Borgstrom, Celina; Boonyawan, Tarinee; van Niel, Ed W. J.; Gorwa-Grauslund, Marie F.] Lund Univ, Div Appl Microbiol, Dept Chem, Lund, Sweden	Lund University	Bergdahl, B (corresponding author), Lund Univ, Div Appl Microbiol, Dept Chem, Lund, Sweden.	basti.bergdahl@tmb.lth.se	van Niel, Ed/GQQ-1220-2022; Gorwa-Grauslund, Marie/AAD-4225-2020	Gorwa-Grauslund, Marie F/0000-0002-4810-4082; Borgstrom Tufvegren, Celina/0000-0003-1029-5976	Swedish National Energy Agency [P35350-1]	Swedish National Energy Agency	This work was financially supported by the Swedish National Energy Agency (www.energimyndigheten.se, Project No. P35350-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuatzi D, 2007, J BIOL CHEM, V282, P4485, DOI 10.1074/jbc.M606854200; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bergdahl B, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-34; BRYSON V, 1952, SCIENCE, V116, P48; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; de la Cera T, 2002, J MOL BIOL, V319, P703, DOI 10.1016/S0022-2836(02)00377-7; DeVit MJ, 1999, CURR BIOL, V9, P1231, DOI 10.1016/S0960-9822(99)80503-X; FERNANDEZ R, 1984, ARCH MICROBIOL, V139, P139, DOI 10.1007/BF00401988; FERNANDEZ R, 1986, J GEN MICROBIOL, V132, P3467; Fernandez-Garcia P, 2012, J BIOL CHEM, V287, P42151, DOI 10.1074/jbc.M112.401679; Firth AE, 2005, BIOINFORMATICS, V21, P3314, DOI 10.1093/bioinformatics/bti516; Gietz RD, 2007, NAT PROTOC, V2, P38, DOI 10.1038/nprot.2007.15; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Girio FM, 2010, BIORESOURCE TECHNOL, V101, P4775, DOI 10.1016/j.biortech.2010.01.088; GOSTOMSKI P, 1994, J BIOTECHNOL, V37, P167, DOI 10.1016/0168-1656(94)90008-6; Guerrero C, 2008, P NATL ACAD SCI USA, V105, P13333, DOI 10.1073/pnas.0801870105; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hahn-Hagerdal B, 2007, APPL MICROBIOL BIOT, V74, P937, DOI 10.1007/s00253-006-0827-2; Heidrich K, 1997, BIOCHEMISTRY-US, V36, P1960, DOI 10.1021/bi9623643; Hoog C, 2001, J PHYS CHEM B, V105, P6375, DOI 10.1021/jp0041252; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Jin YS, 2004, APPL ENVIRON MICROB, V70, P6816, DOI 10.1128/AEM.70.11.6816-6825.2004; Johansson B, 2001, THESIS LUND U LUND; Karhumaa K, 2005, YEAST, V22, P359, DOI 10.1002/yea.1216; Klimacek M, 2010, APPL ENVIRON MICROB, V76, P7566, DOI 10.1128/AEM.01787-10; Kraakman LS, 1999, BIOCHEM J, V343, P159, DOI 10.1042/0264-6021:3430159; LOBO Z, 1977, ARCH BIOCHEM BIOPHYS, V182, P639, DOI 10.1016/0003-9861(77)90544-6; Ludin K, 1998, P NATL ACAD SCI USA, V95, P6245, DOI 10.1073/pnas.95.11.6245; Miyazaki Kentaro, 2003, Methods Mol Biol, V231, P23; Moreno F, 2002, FEMS MICROBIOL REV, V26, P83, DOI 10.1111/j.1574-6976.2002.tb00600.x; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Noubhani A, 2009, J BIOL CHEM, V284, P27229, DOI 10.1074/jbc.M109.029454; OZCAN S, 1995, MOL CELL BIOL, V15, P1564; Pelaez R, 2012, J BIOL CHEM, V287, P3518, DOI 10.1074/jbc.M111.317230; Pelaez R, 2010, BIOCHEM J, V432, P181, DOI 10.1042/BJ20100663; Reetz MT, 2008, CHEM COMMUN, P5499, DOI 10.1039/b813388c; Rolland F, 2000, MOL MICROBIOL, V38, P348, DOI 10.1046/j.1365-2958.2000.02125.x; Ronen M, 2006, P NATL ACAD SCI USA, V103, P389, DOI 10.1073/pnas.0509978103; Runquist D, 2009, APPL MICROBIOL BIOT, V82, P123, DOI 10.1007/s00253-008-1773-y; Runquist D, 2010, APPL ENVIRON MICROB, V76, P7796, DOI 10.1128/AEM.01505-10; Runquist D, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-49; Saloheimo A, 2007, APPL MICROBIOL BIOT, V74, P1041, DOI 10.1007/s00253-006-0747-1; Salusjarvi L, 2006, APPL BIOCHEM BIOTECH, V128, P237, DOI 10.1385/ABAB:128:3:237; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sandstrom AG, 2012, P NATL ACAD SCI USA, V109, P78, DOI 10.1073/pnas.1111537108; Sanz P, 2000, MOL CELL BIOL, V20, P1321, DOI 10.1128/MCB.20.4.1321-1328.2000; Sassner P, 2008, BIOMASS BIOENERG, V32, P422, DOI 10.1016/j.biombioe.2007.10.014; Sauer U, 2001, Adv Biochem Eng Biotechnol, V73, P129; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Schuurmans JM, 2008, FEMS YEAST RES, V8, P26, DOI 10.1111/j.1567-1364.2007.00309.x; Schuurmans JM, 2008, FEMS YEAST RES, V8, P195, DOI 10.1111/j.1567-1364.2007.00319.x; Sutherland CM, 2003, CURR BIOL, V13, P1299, DOI 10.1016/S0960-9822(03)00459-7; Traff KL, 2002, YEAST, V19, P1233, DOI 10.1002/yea.913; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; ZAMAN S, 2009, MOL SYST BIOL, V5	57	17	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e75055	10.1371/journal.pone.0075055	http://dx.doi.org/10.1371/journal.pone.0075055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040384	Green Published, gold, Green Submitted			2022-12-25	WOS:000324856500101
J	Brust, JCM; Berman, AR; Zalta, B; Haramati, LB; Ning, YM; Heo, M; van der Merwe, TL; Bamber, S; Moll, AP; Friedland, GH; Shah, NS; Gandhi, NR				Brust, James C. M.; Berman, Andrew R.; Zalta, Benjamin; Haramati, Linda B.; Ning, Yuming; Heo, Moonseong; van der Merwe, Theo L.; Bamber, Sheila; Moll, Anthony P.; Friedland, Gerald H.; Shah, N. Sarita; Gandhi, Neel R.			Chest Radiograph Findings and Time to Culture Conversion in Patients with Multidrug-Resistant Tuberculosis and HIV in Tugela Ferry, South Africa	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; PULMONARY TUBERCULOSIS; RETROSPECTIVE COHORT; TREATMENT OUTCOMES; SPUTUM SMEAR; CT FINDINGS; XDR-TB; PREDICTORS; PATTERNS	Background: The majority of patients with multidrug-resistant tuberculosis (MDR-TB) in South Africa are co-infected with HIV, but the radiographic features of MDR-TB and their relationship with time to sputum culture conversion in the antiretroviral therapy era have not been described. Methods: We reviewed baseline chest radiographs for 56 patients with MDR-TB from a rural area of South Africa. We analyzed the association of cavities, consolidation, pleural effusion and hilar lymphadenopathy with time to sputum culture conversion, adjusting for HIV status, baseline sputum smear and CD4 count. Results: Of the 56 subjects, 49 (88%) were HIV-positive, with a median CD4 count of 136 cells/mm(3) (IQR 65-249). Thirty-two (57%) patients were sputum smear positive. Twenty-two (39%) patients had a cavity and 37 (66%) patients had consolidations. Cavitary disease and consolidations were each associated with longer time to culture conversion on bivariate analysis but not after adjusting for sputum smear status (aORs 1.79 [0.94-3.42] and 1.09 [0.67-1.78], respectively). Positive baseline sputum smear remained independently associated with longer time to conversion (aOR 3.45 [1.39-8.59]). We found no association between pleural effusion or hilar lymphadenopathy and time to conversion. Seventy-nine percent of patients were cured at the end of treatment. Conclusions: Despite high rates of HIV co-infection and advanced immunodeficiency, the majority of patients had severe pathology on baseline chest radiograph. Nevertheless, culture conversion rates were high and treatment outcomes were favorable. Cavitation and consolidation do not appear to have an independent association with time to culture conversion beyond that of baseline sputum smear status.	[Brust, James C. M.; Berman, Andrew R.; Zalta, Benjamin; Haramati, Linda B.; Ning, Yuming; Heo, Moonseong; Shah, N. Sarita; Gandhi, Neel R.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Brust, James C. M.; Berman, Andrew R.; Zalta, Benjamin; Haramati, Linda B.; Ning, Yuming; Heo, Moonseong; Shah, N. Sarita; Gandhi, Neel R.] Montefiore Med Ctr, Bronx, NY 10467 USA; [Berman, Andrew R.] Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA; [van der Merwe, Theo L.; Bamber, Sheila; Moll, Anthony P.] Philanjalo & Church Scotland Hosp, Tugela Ferry, South Africa; [Bamber, Sheila] Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa; [Friedland, Gerald H.] Yale Univ, Sch Med, New Haven, CT USA; [Gandhi, Neel R.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Yale University; Emory University; Rollins School Public Health	Brust, JCM (corresponding author), Albert Einstein Coll Med, Bronx, NY 10467 USA.	jcmbrust@gmail.com		Heo, Moonseong/0000-0001-7711-1209	National Institutes of Health [K23 AI083088]; Doris Duke Charitable Foundation [2007070, 2007071, 2007018]; Gilead Foundation; Irene Diamond Fund [R05130]; United States President's Emergency Plan for AIDS Relief; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI051519, K23AI083088, R01AI087465, R01AI089349] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Gilead Foundation(Gilead Sciences); Irene Diamond Fund; United States President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JCMB is supported by the National Institutes of Health [K23 AI083088]. NRG and NSS are both recipients of the Doris Duke Charitable Foundation Clinical Scientist Development Award [NRG: 2007070, NSS: 2007071]. GHF is also supported by the Doris Duke Charitable Foundation [2007018], the Gilead Foundation, and The Irene Diamond Fund [R05130]. Additional funding for the program was provided by the United States President's Emergency Plan for AIDS Relief. Statistical support was provided by the Center for AIDS Research at Albert Einstein College of Medicine/Montefiore Medical Center [P30 AI051519]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandaiah A, 2011, AM J RESP CRIT CARE, V183, P987, DOI 10.1164/rccm.201008-1246CI; Angthong W, 2011, JPN J RADIOL, V29, P554, DOI 10.1007/s11604-011-0597-3; Brust JCM, 2012, INT J TUBERC LUNG D, V16, P998, DOI 10.5588/ijtld.11.0713; Brust JCM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015841; Cox HS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001126; Department of Health South Africa, 2004, HE S AFR NAT TUB CON; Dominguez-Castellano A, 2003, INT J TUBERC LUNG D, V7, P432; Dorman SE, 2009, AM J RESP CRIT CARE, V180, P273, DOI 10.1164/rccm.200901-0078OC; Fishman JE, 1998, J THORAC IMAG, V13, P65, DOI 10.1097/00005382-199801000-00015; Gandhi NR, 2012, INT J TUBERC LUNG D, V16, P90, DOI 10.5588/ijtld.11.0153; Gandhi NR, 2013, J INFECT DIS, V207, P9, DOI 10.1093/infdis/jis631; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Geng E, 2005, JAMA-J AM MED ASSOC, V293, P2740, DOI 10.1001/jama.293.22.2740; Guler M, 2007, INT J CLIN PRACT, V61, P231, DOI 10.1111/j.1742-1241.2006.01131.x; Haramati LB, 1997, CLIN RADIOL, V52, P31, DOI 10.1016/S0009-9260(97)80302-9; Holtz TH, 2006, ANN INTERN MED, V144, P650, DOI 10.7326/0003-4819-144-9-200605020-00008; Jones BE, 1997, AM J RESP CRIT CARE, V156, P1270, DOI 10.1164/ajrccm.156.4.9609143; KEIPER MD, 1995, CHEST, V107, P74, DOI 10.1378/chest.107.1.74; Keshavjee S, 2008, LANCET, V372, P1403, DOI 10.1016/S0140-6736(08)61204-0; Kliiman K, 2009, EUR RESPIR J, V33, P1085, DOI 10.1183/09031936.00155708; Kwon YS, 2008, CLIN INFECT DIS, V47, P496, DOI 10.1086/590005; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; LONG R, 1991, CHEST, V99, P123, DOI 10.1378/chest.99.1.123; Mac Kenzie WR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018358; Matsuoka S, 2004, CLIN IMAG, V28, P119, DOI 10.1016/S0899-7071(03)00148-7; Palaci M, 2007, J CLIN MICROBIOL, V45, P4064, DOI 10.1128/JCM.01780-07; Perlman DC, 1997, CLIN INFECT DIS, V25, P242, DOI 10.1086/514546; Telzak EE, 1997, CLIN INFECT DIS, V25, P666, DOI 10.1086/513772; World Health Organization, 2011, WHO PROGRESS REPORT	29	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73975	10.1371/journal.pone.0073975	http://dx.doi.org/10.1371/journal.pone.0073975			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040132	Green Published, Green Submitted, gold			2022-12-25	WOS:000324856500069
J	Quintas, M; Neto, JL; Pereira-Monteiro, J; Barros, J; Sequeiros, J; Sousa, A; Alonso, I; Lemos, C				Quintas, Marlene; Neto, Joao Luis; Pereira-Monteiro, Jose; Barros, Jose; Sequeiros, Jorge; Sousa, Alda; Alonso, Isabel; Lemos, Carolina			Interaction between gamma-Aminobutyric Acid A Receptor Genes: New Evidence in Migraine Susceptibility	PLOS ONE			English	Article							MULTIFACTOR-DIMENSIONALITY REDUCTION; GABA(A) RECEPTORS; SEX-DIFFERENCES; TRANSMISSION; ASSOCIATION; EXPRESSION; SELECTION; SUBUNITS; GENETICS; GENOMICS	Migraine is a common neurological episodic disorder with a female-to-male prevalence 3- to 4-fold higher, suggesting a possible X-linked genetic component. Our aims were to assess the role of common variants of gamma-aminobutyric acid A receptor (GABA(A)R) genes, located in the X-chromosome, in migraine susceptibility and the possible interaction between them. An association study with 188 unrelated cases and 286 migraine-free controls age-and ethnic matched was performed. Twenty-three tagging SNPs were selected in three genes (GABRE, GABRA3 and GABRQ). Allelic, genotypic and haplotypic frequencies were compared between cases and controls. We also focused on gene-gene interactions. The AT genotype of rs3810651 of GABRQ gene was associated with an increased risk for migraine (OR: 4.07; 95% CI: 1.71-9.73, p=0.002), while the CT genotype of rs3902802 (OR: 0.41; 95% CI: 0.21-0.78, p=0.006) and GA genotype of rs2131190 of GABRA3 gene (OR: 0.53; 95% CI: 0.32-0.88, p=0.013) seem to be protective factors. All associations were found in the female group and maintained significance after Bonferroni correction. We also found three nominal associations in the allelic analyses although there were no significant results in the haplotypic analyses. Strikingly, we found strong interactions between six SNPs encoding for different subunits of GABA(A)R, all significant after permutation correction. To our knowledge, we show for the first time, the putative involvement of polymorphisms in GABA(A)R genes in migraine susceptibility and more importantly we unraveled a role for novel gene-gene interactions opening new perspectives for the development of more effective treatments.	[Quintas, Marlene; Neto, Joao Luis; Pereira-Monteiro, Jose; Sequeiros, Jorge; Sousa, Alda; Alonso, Isabel; Lemos, Carolina] Univ Porto, Inst Biol Mol Celular, UnIGENe IBMC, P-4100 Porto, Portugal; [Neto, Joao Luis; Pereira-Monteiro, Jose; Barros, Jose; Sequeiros, Jorge; Sousa, Alda; Alonso, Isabel; Lemos, Carolina] Univ Porto, ICBAS, P-4100 Porto, Portugal; [Pereira-Monteiro, Jose; Barros, Jose] Hosp Santo Antonio, Ctr Hosp Porto, Servico Neurol, Porto, Portugal	Universidade do Porto; Universidade do Porto	Lemos, C (corresponding author), Univ Porto, Inst Biol Mol Celular, UnIGENe IBMC, Rua Campo Alegre 823, P-4100 Porto, Portugal.	clclemos@ibmc.up.pt	Sousa, Alda/K-4372-2013; Alonso, Isabel/I-4307-2013; Lemos, Carolina/J-4967-2013; Pereira-Monteiro, José/K-6036-2013; Neto, João/K-8243-2019; Pinho, Marlene/K-7188-2013	Sousa, Alda/0000-0001-5441-1815; Alonso, Isabel/0000-0001-8549-6903; Lemos, Carolina/0000-0001-9803-9584; Neto, João/0000-0003-0863-158X; Sequeiros, Jorge/0000-0002-9846-1037; Quintas, Marlene/0000-0001-5033-8235; Pereira-Monteiro, Jose/0000-0001-8846-0754; Barros, Jose/0000-0001-6183-5050	Fundacao para a Ciencia e Tecnologia, FCT [PEsT]; ERDF; COMPETE; Financiamento Plurianual de Unidades de Investigacao (FCT); Sociedade Portuguesa de Cefaleias, SPC; National Headache Foundation; NHF (U.S.A)	Fundacao para a Ciencia e Tecnologia, FCT [PEsT]; ERDF(European Commission); COMPETE; Financiamento Plurianual de Unidades de Investigacao (FCT)(Portuguese Foundation for Science and Technology); Sociedade Portuguesa de Cefaleias, SPC; National Headache Foundation; NHF (U.S.A)	This study was supported in part by Fundacao para a Ciencia e Tecnologia, FCT [PEsT], co-funded by ERDF and COMPETE; and by Financiamento Plurianual de Unidades de Investigacao (FCT), Sociedade Portuguesa de Cefaleias, SPC and National Headache Foundation, NHF (U.S.A). The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aloisi AM, 2003, CLIN J PAIN, V19, P168, DOI 10.1097/00002508-200305000-00004; Andreou AP, 2010, NEUROBIOL DIS, V37, P314, DOI 10.1016/j.nbd.2009.10.007; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cairns BE, 2009, MATURITAS, V63, P292, DOI 10.1016/j.maturitas.2009.06.004; Charych EI, 2009, NEUROPHARMACOLOGY, V57, P481, DOI 10.1016/j.neuropharm.2009.07.027; Chen T, 2012, J NEUROL SCI, V318, P112, DOI 10.1016/j.jns.2012.03.014; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; de Vries B, 2009, HUM GENET, V126, P115, DOI 10.1007/s00439-009-0684-z; Enna SJ, 2006, ADV PHARMACOL, V54, P1, DOI 10.1016/S1054-3589(06)54001-3; Fernandez F, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-109; Greene CS, 2010, BIOCOMPUT-PAC SYM, P327; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Kelman L, 2007, CEPHALALGIA, V27, P394, DOI 10.1111/j.1468-2982.2007.01303.x; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lemos C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050626; Lemos C, 2010, CEPHALALGIA, V30, P1375, DOI 10.1177/0333102410368443; Lipton RB, 2005, AM J MED, V118, p3S, DOI 10.1016/j.amjmed.2005.01.014; Low NCP, 2007, CEPHALALGIA, V27, P935, DOI 10.1111/j.1468-2982.2007.01378.x; McNally GP, 2008, LEARN MEMORY, V15, P106, DOI 10.1101/lm.806008; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Montagna P, 2008, NEUROL SCI, V29, pS47, DOI 10.1007/s10072-008-0886-5; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Morcillo-Suarez C, 2008, BIOINFORMATICS, V24, P1643, DOI 10.1093/bioinformatics/btn241; Motsinger Alison A., 2006, Human Genomics, V2, P318; Netzer C, 2008, AM J MED GENET B, V147B, P37, DOI 10.1002/ajmg.b.30560; Nyholt DR, 2000, HUM GENET, V107, P18; Nyholt DR, 1998, HUM MOL GENET, V7, P459, DOI 10.1093/hmg/7.3.459; Osawa Y, 2006, AM J PHYSIOL-LUNG C, V291, pL923, DOI 10.1152/ajplung.00185.2006; Oswell G, 2008, AM J MED GENET B, V147B, P33, DOI 10.1002/ajmg.b.30566; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Pereira Monteiro JM, 2000, GENETICS HEADACHE DI, P37; Plummer PN, 2011, GENE, V490, P32, DOI 10.1016/j.gene.2011.08.031; Puppe Anja, 2007, CNS & Neurological Disorders-Drug Targets, V6, P247; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Rudolph U, 2006, CURR OPIN PHARMACOL, V6, P18, DOI 10.1016/j.coph.2005.10.003; Russo L, 2005, AM J HUM GENET, V76, P327, DOI 10.1086/427521; Sarang SS, 2008, J PHARMACOL EXP THER, V324, P376, DOI 10.1124/jpet.107.129957; Sinkkonen ST, 2000, J NEUROSCI, V20, P3588, DOI 10.1523/JNEUROSCI.20-10-03588.2000; Storer RJ, 2001, BRIT J PHARMACOL, V134, P896, DOI 10.1038/sj.bjp.0704325; Striessnig J, 2005, DRUG DISCOV TODAY, V2, P453, DOI [DOI 10.1016/J.DDMEC.2005.11.002, 10.1016/j.ddmec.2005.11.002]; Tomita Y, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-120; Treiman DM, 2001, EPILEPSIA, V42, P8, DOI 10.1046/j.1528-1157.2001.042suppl.3008.x; Wessman M, 2007, LANCET NEUROL, V6, P521, DOI 10.1016/S1474-4422(07)70126-6; Whiting PJ, 2003, DRUG DISCOV TODAY, V8, P445, DOI 10.1016/S1359-6446(03)02703-X; Wong CGT, 2003, ANN NEUROL, V54, pS3, DOI 10.1002/ana.10696; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Yang PY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-524	49	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74087	10.1371/journal.pone.0074087	http://dx.doi.org/10.1371/journal.pone.0074087			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040174	Green Submitted, Green Published, gold			2022-12-25	WOS:000324481600118
J	Akiyama, K; Noguchi, J; Hirose, M; Kajita, S; Katayama, K; Khalaj, M; Tsuji, T; Fairfield, H; Byers, C; Reinholdt, L; Ogura, A; Kunieda, T				Akiyama, Kouyou; Noguchi, Junko; Hirose, Michiko; Kajita, Shimpei; Katayama, Kentaro; Khalaj, Maryam; Tsuji, Takehito; Fairfield, Heather; Byers, Candice; Reinholdt, Laura; Ogura, Atsuo; Kunieda, Tetsuo			A Mutation in the Nuclear Pore Complex Gene Tmem48 Causes Gametogenesis Defects in Skeletal Fusions with Sterility (sks) Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXONIC SPLICING ENHANCERS; SPINDLE POLE BODIES; SACCHAROMYCES-CEREVISIAE; MOUSE SPERMATOCYTES; GERM-CELLS; IN-VITRO; MEIOSIS; NUCLEOPORIN; YEAST; NDC1	Skeletal fusions with sterility (sks) is an autosomal recessive mutation of mouse that results in male and female sterility because of defects in gametogenesis. The mutants also have skeletal malformations with fused vertebrae and ribs. We examined testicular phenotypes of sks/sks mice to investigate the defects in spermatogenesis. Histological and immunocytochemical analyses and expression analyses of the marker genes demonstrated that spermatogenesis is arrested at mid to late pachytene stage of meiotic prophase with defective synapsis of the homologous chromosomes. Next, we determined the precise chromosomal localization of the sks locus on a 0.3-Mb region of mouse chromosome 4 by linkage analysis. By sequencing the positional candidate genes in this region and whole exome sequencing, we found a GG to TT nucleotide substitution in exon 6 of the Tmem48 gene that encodes a putative transmembrane protein with six transmembrane domains. The nucleotide substitution causes aberrant splicing, which deletes exon 6 of the Tmem48 transcript. Specific expression of TMEM48 was observed in germ cells of males and females. Furthermore, the phenotypes of the sks mutant were completely rescued by the transgenesis of a genomic fragment containing the wild-type Tmem48 gene. These findings indicate that the Tmem48 mutation is responsible for the gametogenesis defects and skeletal malformations in the sks mice. The TMEM48 protein is a nuclear membrane protein comprising the nuclear pore complex; its exact function in the nuclear pore complex is still unknown. Our finding suggested that the nuclear pore complex plays an important role in mammalian gametogenesis and skeletal development.	[Akiyama, Kouyou; Tsuji, Takehito; Kunieda, Tetsuo] Okayama Univ, Grad Sch Environm & Life Sci, Okayama 7008530, Japan; [Kajita, Shimpei; Katayama, Kentaro; Khalaj, Maryam] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Noguchi, Junko] Natl Inst Agrobiol Sci, Div Anim Sci, Tsukuba, Ibaraki 9058602, Japan; [Hirose, Michiko; Ogura, Atsuo] RIKEN Bioresource Ctr, Tsukuba, Ibaraki 3050074, Japan; [Fairfield, Heather; Byers, Candice; Reinholdt, Laura] Jackson Lab, Bar Harbor, ME 04609 USA	Okayama University; Okayama University; National Institute of Agrobiological Sciences - Japan; RIKEN; Jackson Laboratory	Kunieda, T (corresponding author), Okayama Univ, Grad Sch Environm & Life Sci, 1-1-1 Tsushima Naka, Okayama 7008530, Japan.	tkunieda@cc.okayama-u.ac.jp	Katayama, Kentaro/O-5296-2019; Ogura, Atsuo/J-3916-2014	Katayama, Kentaro/0000-0002-2859-0423; Ogura, Atsuo/0000-0003-0447-1988; Byers, Candice/0000-0003-2526-2843	Japan Science Society [18-130]; Japan Society for the Promotion of Science; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010972] Funding Source: NIH RePORTER	Japan Science Society; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by Sasakawa Scientific Research Grant 18-130 from the Japan Science Society and grants from the Japan Society for the Promotion of Science.	Akiyama K, 2008, J REPROD DEVELOP, V54, P122, DOI 10.1262/jrd.19186; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; BYERS B, 1978, J CELL SCI, V30, P331; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chatel G, 2011, CELL SIGNAL, V23, P1555, DOI 10.1016/j.cellsig.2011.05.023; Chuma S, 2001, DEV BIOL, V229, P468, DOI 10.1006/dbio.2000.9989; Dix DJ, 1997, DEVELOPMENT, V124, P4595; Fairbrother WG, 2004, NUCLEIC ACIDS RES, V32, pW187, DOI 10.1093/nar/gkh393; Fairfield H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r86; Gigliotti S, 1998, J CELL BIOL, V142, P1195, DOI 10.1083/jcb.142.5.1195; HANDEL MA, 1988, GAMETE RES, V21, P409, DOI 10.1002/mrd.1120210409; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Harper L, 2004, J CELL SCI, V117, P4025, DOI 10.1242/jcs.01363; Hawryluk-Gara LA, 2005, MOL BIOL CELL, V16, P2382, DOI 10.1091/mbc.e04-10-0857; HYAMS JS, 1978, J CELL BIOL, V78, P401, DOI 10.1083/jcb.78.2.401; La Salle S, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095752; Mansfeld J, 2006, MOL CELL, V22, P93, DOI 10.1016/j.molcel.2006.02.015; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Noguchi J, 2008, J REPROD DEVELOP, V54, P203, DOI 10.1262/jrd.19158; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Scherthan H, 2001, NAT REV MOL CELL BIO, V2, P621, DOI 10.1038/35085086; Stavru F, 2006, J CELL BIOL, V173, P509, DOI 10.1083/jcb.200601001; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; Sun FY, 2010, DEVELOPMENT, V137, P1699, DOI 10.1242/dev.043125; THOMAS JH, 1986, CELL, V44, P65, DOI 10.1016/0092-8674(86)90485-X; Vuillaumier-Barrot S, 1999, Hum Mutat, V14, P543, DOI 10.1002/(SICI)1098-1004(199912)14:6<543::AID-HUMU17>3.0.CO;2-S; West RR, 1998, MOL BIOL CELL, V9, P2839, DOI 10.1091/mbc.9.10.2839; WINEY M, 1993, J CELL BIOL, V122, P743, DOI 10.1083/jcb.122.4.743; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	31	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31830	31841		10.1074/jbc.M113.492306	http://dx.doi.org/10.1074/jbc.M113.492306			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24045954	hybrid, Green Published			2022-12-25	WOS:000330596200033
J	Ferreyra, MLF; Rodriguez, E; Casas, MI; Labadie, G; Grotewold, E; Casati, P				Falcone Ferreyra, Maria Lorena; Rodriguez, Eduardo; Casas, Maria Isabel; Labadie, Guillermo; Grotewold, Erich; Casati, Paula			Identification of a Bifunctional Maize C- and O-Glucosyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYL FLAVONOID PHYTOALEXINS; QUANTITATIVE TRAIT LOCI; UV-B; CRYSTAL-STRUCTURES; GLYCOSYLTRANSFERASES; EXPRESSION; LEAVES; MAYSIN; YEAST; L.	Flavonoids accumulate in plant vacuoles usually as O-glycosylated derivatives, but several species can also synthesize flavonoid C-glycosides. Recently, we demonstrated that a flavanone 2-hydroxylase (ZmF2H1, CYP93G5) converts flavanones to the corresponding 2-hydroxy derivatives, which are expected to serve as substrates for C-glycosylation. Here, we isolated ac DNA encoding a UDP-dependent glycosyltransferase (UGT708A6), and its activity was characterized by in vitro and in vivo bioconversion assays. In vitro assays using 2-hydroxyflavanones as substrates and in vivo activity assays in yeast co-expressing ZmF2H1 and UGT708A6 show the formation of the flavones C-glycosides. UGT708A6 can also O-glycosylate flavanones in bioconversion assays in Escherichia coli as well as by in vitro assays with the purified recombinant protein. Thus, UGT708A6 is a bifunctional glycosyltransferase that can produce both C-and O-glycosidated flavonoids, a property not previously described for any other glycosyltransferase.	[Falcone Ferreyra, Maria Lorena; Casati, Paula] Univ Nacl Rosario, Ctr Estudios Fotosintet & Bioquim, RA-2000 Rosario, Santa Fe, Argentina; [Rodriguez, Eduardo] Univ Nacl Rosario, Inst Biol Mol & Celular Rosario, RA-2000 Rosario, Santa Fe, Argentina; [Labadie, Guillermo] Univ Nacl Rosario, Inst Quim Rosario, RA-2000 Rosario, Santa Fe, Argentina; [Casas, Maria Isabel] Ohio State Univ, Mol Cellular & Dev Biol Grad Program, Columbus, OH 43210 USA; [Casas, Maria Isabel; Grotewold, Erich] Ohio State Univ, Ctr Appl Plant Sci, Columbus, OH 43210 USA; [Grotewold, Erich] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Grotewold, Erich] Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA	National University of Rosario; National University of Rosario; National University of Rosario; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Casati, P (corresponding author), Univ Nacl Rosario, Ctr Estudios Fotosintet & Bioquim, S2002LRK, RA-2000 Rosario, Santa Fe, Argentina.	casati@cefobi-conicet.gov.ar	Labadie, Guillermo/I-1401-2015; Casas, Maria/M-2393-2016	Labadie, Guillermo/0000-0003-2467-1573; Casas, Maria/0000-0002-1395-9646; Grotewold, Erich/0000-0002-4720-7290; Falcone Ferreyra, Maria Lorena/0000-0001-5235-3252	United States Department of Agriculture [2010-65115-20408]; National Science Foundation [IOS-1125620]; Fondo para la Investigacion Cientifica y Tecnologica [PICT-2006-00957, PICT-2010-00105]; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Excellence in Plant Molecular Biology/Biotechnology graduate fellowship	United States Department of Agriculture(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF)); Fondo para la Investigacion Cientifica y Tecnologica; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Excellence in Plant Molecular Biology/Biotechnology graduate fellowship	This work was supported in part by United States Department of Agriculture Grant 2010-65115-20408 and National Science Foundation Grant IOS-1125620 (to E. G.), Fondo para la Investigacion Cientifica y Tecnologica Grants PICT-2006-00957 and PICT-2010-00105 (to P. C. and E. G.), and grants from Consejo Nacional de Investigaciones Cientificas y Tecnicas (to L. F. F.).; Supported by an Excellence in Plant Molecular Biology/Biotechnology graduate fellowship.	Abad-Garcia B, 2008, RAPID COMMUN MASS SP, V22, P1834, DOI 10.1002/rcm.3560; Akashi T, 1998, FEBS LETT, V431, P287, DOI 10.1016/S0014-5793(98)00781-9; Bowles D, 2005, CURR OPIN PLANT BIOL, V8, P254, DOI 10.1016/j.pbi.2005.03.007; Bowles D, 2010, ENCY LIFE SCI ELS, DOI [10.1002/9780470015902.a0021537, DOI 10.1002/9780470015902.A0021537]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brazier-Hicks M, 2007, P NATL ACAD SCI USA, V104, P20238, DOI 10.1073/pnas.0706421104; Brazier-Hicks M, 2013, METAB ENG, V16, P11, DOI 10.1016/j.ymben.2012.11.004; Brazier-Hicks M, 2009, J BIOL CHEM, V284, P17926, DOI 10.1074/jbc.M109.009258; Byrne PF, 1996, P NATL ACAD SCI USA, V93, P8820, DOI 10.1073/pnas.93.17.8820; Caasi-Lit MT, 2007, PHOTOCHEM PHOTOBIOL, V83, P1167, DOI 10.1111/j.1751-1097.2007.00125.x; Caputi L, 2012, PLANT J, V69, P1030, DOI 10.1111/j.1365-313X.2011.04853.x; Casati P, 2005, PLANT CELL ENVIRON, V28, P788, DOI 10.1111/j.1365-3040.2005.01329.x; Du YG, 2010, PLANT PHYSIOL, V154, P324, DOI 10.1104/pp.110.161042; Durr C, 2004, ANGEW CHEM INT EDIT, V43, P2962, DOI 10.1002/anie.200453758; El-Alfy Taha S, 2011, Sci Pharm, V79, P963, DOI 10.3797/scipharm.1108-19; Eveland AL, 2010, PLANT PHYSIOL, V154, P1024, DOI 10.1104/pp.110.159673; Ferreyra MLF, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00222; Francisco RM, 2013, PLANT CELL, V25, P1840, DOI 10.1105/tpc.112.102152; FURTEK D, 1988, PLANT MOL BIOL, V11, P473, DOI 10.1007/BF00039028; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Grotewold E, 1998, PLANT CELL, V10, P721, DOI 10.1105/tpc.10.5.721; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Gueldner R. C., 1989, 197 198 NAT M AM CHE, P251; Harborne, 1993, FLAVONOIDS INSECTS; Hassan S, 2012, J EXP BOT, V63, P3429, DOI 10.1093/jxb/err430; KERSCHER F, 1988, J PLANT PHYSIOL, V132, P110, DOI 10.1016/S0176-1617(88)80193-7; KROON J, 1994, PLANT J, V5, P69, DOI 10.1046/j.1365-313X.1994.5010069.x; Kumano T, 2008, BIOORGAN MED CHEM, V16, P8117, DOI 10.1016/j.bmc.2008.07.052; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lee EM, 2010, MOLECULES, V15, P8251, DOI 10.3390/molecules15118251; Markham KR, 1998, PHYTOCHEMISTRY, V49, P1913, DOI 10.1016/S0031-9422(98)00438-5; McMullen MD, 2004, J HERED, V95, P225, DOI 10.1093/jhered/esh042; McMullen MD, 1998, P NATL ACAD SCI USA, V95, P1996, DOI 10.1073/pnas.95.5.1996; McNally DJ, 2003, PHYSIOL MOL PLANT P, V63, P293, DOI 10.1016/j.pmpp.2004.03.005; McNally DJ, 2003, J NAT PROD, V66, P1280, DOI 10.1021/np030150y; Morohashi K, 2012, PLANT CELL, V24, P2745, DOI 10.1105/tpc.112.098004; Nichenametla SN, 2006, CRIT REV FOOD SCI, V46, P161, DOI 10.1080/10408390591000541; Osmani SA, 2009, PHYTOCHEMISTRY, V70, P325, DOI 10.1016/j.phytochem.2008.12.009; Patil BS, 2009, J AGR FOOD CHEM, V57, P8142, DOI 10.1021/jf9000132; Payyavula RS, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-151; Peiru S, 2005, APPL ENVIRON MICROB, V71, P2539, DOI 10.1128/AEM.71.5.2539-2547.2005; RALSTON EJ, 1988, GENETICS, V119, P185; Rozen S, 2000, Methods Mol Biol, V132, P365; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schreiber SL, 2007, NAT CHEM BIOL, V3, P352, DOI 10.1038/nchembio0707-352; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Shao H, 2005, PLANT CELL, V17, P3141, DOI 10.1105/tpc.105.035055; SNOOK ME, 1995, J AGR FOOD CHEM, V43, P2740, DOI 10.1021/jf00058a036; SNOOK ME, 1989, J CHROMATOGR, V477, P439, DOI 10.1016/S0021-9673(01)89654-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tapas AR, 2008, TROP J PHARM RES, V7, P1089; Urban P, 1997, J BIOL CHEM, V272, P19176, DOI 10.1074/jbc.272.31.19176; Vaistij FE, 2009, PLANT-DERIVED NATURAL PRODUCTS: SYNTHESIS, FUNCTION, AND APPLICATION, P209, DOI 10.1007/978-0-387-85498-4_10; Zhang JA, 2007, PLANT PHYSIOL, V144, P741, DOI 10.1104/pp.106.095018	55	91	96	2	61	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31678	31688		10.1074/jbc.M113.510040	http://dx.doi.org/10.1074/jbc.M113.510040			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24045947	Green Published, hybrid			2022-12-25	WOS:000330596200026
J	Chen, IC; Lin, HY; Hsiao, YC; Chen, CM; Wu, YR; Shiau, HC; Shen, YF; Huang, KS; Su, MT; Hsieh-Li, HM; Lee-Chen, GJ				Chen, I-Cheng; Lin, Hsuan-Yuan; Hsiao, Ya-Chin; Chen, Chiung-Mei; Wu, Yih-Ru; Shiau, Hsin-Chieh; Shen, Yu-Fang; Huang, Kuo-Shiu; Su, Ming-Tsan; Hsieh-Li, Hsiu-Mei; Lee-Chen, Guey-Jen			Internal Ribosome Entry Segment Activity of ATXN8 Opposite Strand RNA	PLOS ONE			English	Article							NON-AUG CODONS; TRANSLATION INITIATION; BIDIRECTIONAL EXPRESSION; MESSENGER-RNAS; SCA8; TRANSCRIPT; ISOFORMS; GENES; SITE; DNA	Spinocerebellar ataxia type 8 (SCA8) involves the expansion of CTG/CAG repeats from the overlapping ataxin 8 opposite strand (ATXN8OS) and ataxin 8 (ATXN8) genes located on chromosome 13q21. Although being transcribed, spliced and polyadenylated in the CTG orientation, ATXN8OS does not itself appear to be protein coding, as only small open reading frames (ORFs) were noted. In the present study we investigated the translation of a novel 102 amino acids containing-ORF in the ATXN8OS RNA. Expression of chimeric construct with an in-frame ORF-EGFP gene demonstrated that ATXN8OS RNA is translatable. Using antiserum raised against ORF, ATXN8OS ORF expression was detected in various human cells including lymphoblastoid, embryonic kidney 293, neuroblastoma IMR-32, SK-N-SH, SH-SY5Y cells and human muscle tissue. The biological role of the ATXN8OS ORF and its connection to SCA8 remains to be determined.	[Chen, I-Cheng; Lin, Hsuan-Yuan; Hsiao, Ya-Chin; Shiau, Hsin-Chieh; Shen, Yu-Fang; Huang, Kuo-Shiu; Su, Ming-Tsan; Hsieh-Li, Hsiu-Mei; Lee-Chen, Guey-Jen] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Chen, I-Cheng; Chen, Chiung-Mei; Wu, Yih-Ru] Chang Gung Univ, Coll Med, Dept Neurol, Chang Gung Mem Hosp, Taipei, Taiwan	National Taiwan Normal University; Chang Gung Memorial Hospital; Chang Gung University	Lee-Chen, GJ (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.	t43019@ntnu.edu.tw	Chen, Chiung-Mei/AAL-6260-2020	Chen, I-Cheng/0000-0001-6235-6289	National Science Council, Executive Yuan [NSC95-3112-B-003-002, NSC97-2311-B-003-010-MY3]; National Taiwan Normal University, Taipei, Taiwan [NTNU100-D-02]	National Science Council, Executive Yuan(Ministry of Science and Technology, Taiwan); National Taiwan Normal University, Taipei, Taiwan	This work was supported by grants NSC95-3112-B-003-002 and NSC97-2311-B-003-010-MY3 from the National Science Council, Executive Yuan, and NTNU100-D-02 from National Taiwan Normal University, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benzow KA, 2002, MAMM GENOME, V13, P134, DOI 10.1007/s0033501-2105-2; Bruening W, 1996, J BIOL CHEM, V271, P8646, DOI 10.1074/jbc.271.15.8646; Chen IC, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-9; Daughters RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000600; Gurtu V, 1996, BIOCHEM BIOPH RES CO, V229, P295, DOI 10.1006/bbrc.1996.1795; HANN SR, 1994, GENE DEV, V8, P2441, DOI 10.1101/gad.8.20.2441; He Y, 2006, J NEUROSCI, V26, P9975, DOI 10.1523/JNEUROSCI.2595-06.2006; Ikeda Y, 2008, CEREBELLUM, V7, P150, DOI 10.1007/s12311-008-0010-7; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; Koob MD, 1998, NAT GENET, V18, P72, DOI 10.1038/ng0198-72; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; Kozak M, 1997, EMBO J, V16, P2482, DOI 10.1093/emboj/16.9.2482; LOCK P, 1991, MOL CELL BIOL, V11, P4363, DOI 10.1128/MCB.11.9.4363; Martin MM, 2003, MOL CELL ENDOCRINOL, V212, P51, DOI 10.1016/j.mce.2003.09.017; Mauro VR, 2007, METHOD ENZYMOL, V429, P323, DOI 10.1016/S0076-6879(07)29015-9; Mokrejs M, 2006, NUCLEIC ACIDS RES, V34, pD125, DOI 10.1093/nar/gkj081; Moseley ML, 2006, NAT GENET, V38, P758, DOI 10.1038/ng1827; Mutsuddi M, 2004, CURR BIOL, V14, P302, DOI 10.1016/j.cub.2004.01.034; Nemes JP, 2000, HUM MOL GENET, V9, P1543, DOI 10.1093/hmg/9.10.1543; Ngoka LCM, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-30; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; Ranum LPW, 2004, TRENDS GENET, V20, P506, DOI 10.1016/j.tig.2004.08.004; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; Wegrzyn JL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-232; Wullner U, 2003, DRUGS TODAY, V39, P927, DOI 10.1358/dot.2003.39.12.799411	26	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73885	10.1371/journal.pone.0073885	http://dx.doi.org/10.1371/journal.pone.0073885			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040107	Green Published, gold			2022-12-25	WOS:000326734500061
J	He, CX; Yang, YY; Zhang, MM; Price, JL; Zhao, ZW				He, Chunxia; Yang, Yunyan; Zhang, Mingming; Price, Jeffrey L.; Zhao, Zhangwu			Regulation of Sleep by Neuropeptide Y-Like System in Drosophila melanogaster	PLOS ONE			English	Article							SEXUALLY DIMORPHIC BEHAVIOR; RECEPTOR; NEURONS; HOMEOSTASIS; MODULATION; INSIGHTS; GENE	Sleep is important for maintenance of normal physiology in animals. In mammals, neuropeptide Y (NPY), a homolog of Drosophila neuropeptide F (NPF), is involved in sleep regulation, with different effects in human and rat. However, the function of NPF on sleep in Drosophila melanogaster has not yet been described. In this study, we investigated the effects of NPF and its receptor-neuropeptide F receptor (NPFR1) on Drosophila sleep. Male flies over-expressing NPF or NPFR1 exhibited increased sleep during the nighttime. Further analysis demonstrated that sleep episode duration during nighttime was greatly increased and sleep latency was significantly reduced, indicating that NPF and NPFR1 promote sleep quality, and their action on sleep is not because of an impact of the NPF signal system on development. Moreover, the homeostatic regulation of flies after sleep deprivation was disrupted by altered NPF signaling, since sleep deprivation decreased transcription of NPF in control flies, and there were less sleep loss during sleep deprivation and less sleep gain after sleep deprivation in flies overexpressing NPF and NPFR1 than in control flies, suggesting that NPF system auto-regulation plays an important role in sleep homeostasis. However, these effects did not occur in females, suggesting a sex-dependent regulatory function in sleep for NPF and NPFR1. NPF in D1 brain neurons showed male-specific expression, providing the cellular locus for male-specific regulation of sleep by NPF and NPFR1. This study brings a new understanding into sleep studies of a sexually dimorphic regulatory mode in female and male flies.	[He, Chunxia; Yang, Yunyan; Zhang, Mingming; Zhao, Zhangwu] China Agr Univ, Coll Agr & Biotechnol, Beijing 100094, Peoples R China; [Price, Jeffrey L.] Univ Missouri, Kansas City, MO 64110 USA	China Agricultural University; University of Missouri System; University of Missouri Kansas City	Price, JL (corresponding author), Univ Missouri, Kansas City, MO 64110 USA.	zhaozw@cau.edu.cn			Ministry of Science and Technology of the People's Republic of China [2012CB114100]; National Natural Science Foundation of China [31272371]; Ministry of Education of China [20110008110018]; China Agricultural University [KYCX2011004]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); China Agricultural University	This work was supported by the National Basic Research Program from the Ministry of Science and Technology of the People's Republic of China ("973" Program Grant number 2012CB114100), the National Natural Science Foundation of China (Grant number 31272371), the Doctoral Scientific Fund Project of the Ministry of Education of China (Grant number 20110008110018) to Z. Zhao, and the Innovation Fund for Graduate Students of China Agricultural University (Grant number KYCX2011004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosto J, 2008, NAT NEUROSCI, V11, P354, DOI 10.1038/nn2046; Antonijevic IA, 2000, NEUROPHARMACOLOGY, V39, P1474, DOI 10.1016/S0028-3908(00)00057-5; Belgacem YH, 2002, P NATL ACAD SCI USA, V99, P15154, DOI 10.1073/pnas.232244199; Bushey D, 2011, SCIENCE, V332, P1576, DOI 10.1126/science.1202839; Bushey D, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-56; Catterson JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012062; Caylak E, 2009, AM J MED GENET A, V149A, P2612, DOI 10.1002/ajmg.a.33087; Chiu Joanna C, 2010, J Vis Exp, DOI 10.3791/2157; Cirelli C, 2008, ANN NY ACAD SCI, V1129, P323, DOI 10.1196/annals.1417.017; Cirelli C, 2006, P NATL ACAD SCI USA, V103, P13901, DOI 10.1073/pnas.0606652103; Dierick HA, 2007, NAT GENET, V39, P678, DOI 10.1038/ng2029; Fujii S, 2007, CURR BIOL, V17, P244, DOI 10.1016/j.cub.2006.11.049; Garczynski SF, 2002, PEPTIDES, V23, P773, DOI 10.1016/S0196-9781(01)00647-7; Gatti S, 2000, CURR BIOL, V10, P667, DOI 10.1016/S0960-9822(00)00517-0; Gilestro GF, 2009, BIOINFORMATICS, V25, P1466, DOI 10.1093/bioinformatics/btp237; He C, 2013, INSECT MOL BIOL, V22, P376, DOI 10.1111/imb.12027; Hendricks JC, 2003, J BIOL RHYTHM, V18, P12, DOI 10.1177/0748730402239673; Hermann C, 2012, J COMP NEUROL, V520, P970, DOI 10.1002/cne.22742; Herzog H, 2003, EUR J PHARMACOL, V480, P21, DOI 10.1016/j.ejphar.2003.08.089; Holliday ND, 2004, HANDB EXP PHARM, V162, P45; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; Ishimoto H, 2010, GENETICS, V185, P269, DOI 10.1534/genetics.110.114587; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Keene AC, 2010, CURR BIOL, V20, P1209, DOI 10.1016/j.cub.2010.05.029; LARHAMMAR D, 1993, COMP BIOCHEM PHYS C, V106, P743, DOI 10.1016/0742-8413(93)90236-E; Lee GH, 2006, P NATL ACAD SCI USA, V103, P12580, DOI 10.1073/pnas.0601171103; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lingo PR, 2007, NEUROSCIENCE, V148, P371, DOI 10.1016/j.neuroscience.2007.06.010; McDonald DM, 2010, AGING-US, V2, P519, DOI 10.18632/aging.100181; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Pedrazzini T, 2003, CELL MOL LIFE SCI, V60, P350, DOI 10.1007/s000180300029; Schutt C, 2000, DEVELOPMENT, V127, P667; Shang YH, 2011, NAT NEUROSCI, V14, P889, DOI 10.1038/nn.2860; Thorsell A, 2002, NEUROPEPTIDES, V36, P182, DOI 10.1054/npep.2002.0897; Toth A, 2007, BRAIN RES BULL, V72, P293, DOI 10.1016/j.brainresbull.2007.01.006; Vezzani A, 1999, TRENDS NEUROSCI, V22, P25, DOI 10.1016/S0166-2236(98)01284-3; Wen TQ, 2005, P NATL ACAD SCI USA, V102, P2141, DOI 10.1073/pnas.0406814102; Wu MN, 2009, J NEUROSCI, V29, P11029, DOI 10.1523/JNEUROSCI.1653-09.2009; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9	39	44	46	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74237	10.1371/journal.pone.0074237	http://dx.doi.org/10.1371/journal.pone.0074237			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040211	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500079
J	Leistner, R; Meyer, E; Gastmeier, P; Pfeifer, Y; Eller, C; Dem, P; Schwab, F				Leistner, Rasmus; Meyer, Elisabeth; Gastmeier, Petra; Pfeifer, Yvonne; Eller, Christoph; Dem, Petra; Schwab, Frank			Risk Factors Associated with the Community-Acquired Colonization of Extended-Spectrum Beta-Lactamase (ESBL) Positive Escherichia Coli. An Exploratory Case-Control Study	PLOS ONE			English	Article							FOREIGN TRAVEL; CHICKEN MEAT; ENTEROBACTERIACEAE; EPIDEMIOLOGY; EMERGENCE; DURATION; ANIMALS	Background: The number of extended-spectrum beta-lactamase (ESBL) positive (+) Escherichia coli is increasing worldwide. In contrast with many other multidrug-resistant bacteria, it is suspected that they predominantly spread within the community. The objective of this study was to assess factors associated with community-acquired colonization of ESBL (+) E. coli. Methods: We performed a matched case-control study at the Charite University Hospital Berlin between May 2011 and January 2012. Cases were defined as patients colonized with community-acquired ESBL (+) E. coli identified <72 h after hospital admission. Controls were patients that carried no ESBL-positive bacteria but an ESBL-negative E. coli identified <72 h after hospital admission. Two controls per case were chosen from potential controls according to admission date. Case and control patients completed a questionnaire assessing nutritional habits, travel habits, household situation and language most commonly spoken at home (mother tongue). An additional rectal swab was obtained together with the questionnaire to verify colonization status. Genotypes of ESBL (+) E. coli strains were determined by PCR and sequencing. Risk factors associated with ESBL (+) E. coli colonization were analyzed by a multivariable conditional logistic regression analysis. Results: We analyzed 85 cases and 170 controls, respectively. In the multivariable analysis, speaking an Asian language most commonly at home (OR = 13.4, CI 95% 3.3-53.8; p<0.001) and frequently eating pork (>= 3 meals per week) showed to be independently associated with ESBL colonization (OR = 3.5, CI 95% 1.8-6.6; p<0.001). The most common ESBL genotypes were CTX-M-1 with 44% (n = 37), CTX-M-15 with 28% (n = 24) and CTX-M-14 with 13% (n = 11). Conclusion: An Asian mother tongue and frequently consuming certain types of meat like pork can be independently associated with the colonization of ESBL-positive bacteria. We found neither frequent consumption of poultry nor previous use of antibiotics to be associated with ESBL colonization.	[Leistner, Rasmus; Meyer, Elisabeth; Gastmeier, Petra; Dem, Petra; Schwab, Frank] Charite, Inst Hyg & Environm Med, D-13353 Berlin, Germany; [Leistner, Rasmus; Meyer, Elisabeth; Gastmeier, Petra; Dem, Petra; Schwab, Frank] German Natl Reference Ctr Surveillance Nosocomial, Berlin, Germany; [Pfeifer, Yvonne; Eller, Christoph] Robert Koch Inst, Wernigerode, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Robert Koch Institute	Leistner, R (corresponding author), Charite, Inst Hyg & Environm Med, D-13353 Berlin, Germany.	rasmus.leistner@charite.de		Gastmeier, Petra/0000-0001-5520-4287; Leistner, Rasmus/0000-0002-1225-9023	RESET Project (German Federal Ministry for Education and Research, BMBF) [FKZ01Kl1013H, FKZ01Kl1013E]	RESET Project (German Federal Ministry for Education and Research, BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the RESET Project (FKZ01Kl1013H and FKZ01Kl1013E German Federal Ministry for Education and Research, BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraniak A, 2002, J ANTIMICROB CHEMOTH, V50, P393, DOI 10.1093/jac/dkf151; Birgand G, 2013, AM J INFECT CONTROL, V41, P443, DOI 10.1016/j.ajic.2012.05.015; Choi Bernard C K, 2005, Prev Chronic Dis, V2, pA16; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clinical and Laboratory Standards Institute (CLSI), 2012, M07A9 CLSI, V9, P1; Doernberg SB, 2012, AM J INFECT CONTROL, V40, P123, DOI 10.1016/j.ajic.2011.04.001; ECDC, 2011, ANN EP REP EUR CTR D, P183; ECDC, 2011, ANN REP EUR ANT RES; Enoch DA, 2012, J HOSP INFECT, V81, P270, DOI 10.1016/j.jhin.2012.05.006; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Grobner S, 2009, J MED MICROBIOL, V58, P912, DOI 10.1099/jmm.0.005850-0; Han JH, 2012, ANTIMICROB AGENTS CH, V56, P5575, DOI 10.1128/AAC.01136-12; Hawser SP, 2009, ANTIMICROB AGENTS CH, V53, P3280, DOI 10.1128/AAC.00426-09; Hilty M, 2012, CLIN INFECT DIS, V55, P967, DOI 10.1093/cid/cis581; Kluytmans JA, 2012, CLIN INFECT DIS, DOI 101093/cid/cis929.; Kola A, 2012, J ANTIMICROB CHEMOTH, V67, P2631, DOI 10.1093/jac/dks295; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Li B, 2012, ANTIMICROB AGENTS CH, V56, P4558, DOI 10.1128/AAC.00171-12; Meyer E, 2012, INFECTION, V40, P685, DOI 10.1007/s15010-012-0324-8; Meyer E, 2011, INFECTION, V39, P501, DOI 10.1007/s15010-011-0154-0; Nicolas-Chanoine MH, 2012, J ANTIMICROB CHEMOTH, DOI 101093/jac/dks429.; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Rodriguez-Bano J, 2004, J CLIN MICROBIOL, V42, P1089, DOI 10.1128/JCM.42.3.1089-1094.2004; Tangden T, 2010, ANTIMICROB AGENTS CH, V54, P3564, DOI 10.1128/AAC.00220-10; Tham J, 2012, SCAND J INFECT DIS, V44, P573, DOI 10.3109/00365548.2011.653582; Tian GB, 2012, J MED MICROBIOL, V61, P233, DOI 10.1099/jmm.0.036806-0; Tzouvelekis LS, 2000, INT J ANTIMICROB AG, V14, P137, DOI 10.1016/S0924-8579(99)00165-X; Wickramasinghe NH, 2012, J ANTIMICROB CHEMOTH, V67, P1108, DOI 10.1093/jac/dks018	29	57	59	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74323	10.1371/journal.pone.0074323	http://dx.doi.org/10.1371/journal.pone.0074323			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040229	Green Published, gold, Green Submitted			2022-12-25	WOS:000326734500084
J	Roellig, DM; Gomez-Puerta, LA; Mead, DG; Pinto, J; Ancca-Juarez, J; Calderon, M; Bern, C; Gilman, RH; Cama, VA				Roellig, Dawn M.; Gomez-Puerta, Luis A.; Mead, Daniel G.; Pinto, Jesus; Ancca-Juarez, Jenny; Calderon, Maritza; Bern, Caryn; Gilman, Robert H.; Cama, Vitaliano A.		Chagas Disease Workgrp Arequipa	Hemi-Nested PCR and RFLP Methodologies for Identifying Blood Meals of the Chagas Disease Vector, Triatoma infestans	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; TRYPANOSOMA-CRUZI; FEEDING PATTERNS; REDUVIIDAE; HEMIPTERA; IDENTIFICATION; TRANSMISSION; ARGENTINA; INFECTION; AREQUIPA	Trypanosoma cruzi, the etiologic agent of Chagas disease, is transmitted by hematophagous reduviid bugs within the subfamily Triatominae. These vectors take blood meals from a wide range of hosts, and their feeding behaviors have been used to investigate the ecology and epidemiology of T. cruzi. In this study we describe two PCR-based methodologies that amplify a fragment of the 16S mitochondrial rDNA, aimed to improve the identification of blood meal sources for Triatoma infestans: a.-Sequence analyses of two heminested PCRs that allow the identification of mammalian and avian species, and b.-restriction fragment length polymorphism (RFLP) analysis from the mammalian PCR to identify and differentiate multi-host blood meals. Findings from both methodologies indicate that host DNA could be detected and the host species identified in samples from laboratory reared and field collected triatomines. The implications of this study are two-fold. First, these methods can be used in areas where the fauna diversity and feeding behavior of the triatomines are unknown. Secondly, the RFLP method led to the identification of multi-host DNA from T. infestans gut contents, enhancing the information provided by this assay. These tools are important contributions for ecological and epidemiological studies of vector-borne diseases.	[Roellig, Dawn M.; Bern, Caryn; Cama, Vitaliano A.] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA 30333 USA; [Gomez-Puerta, Luis A.] Univ Nacl Mayor San Marcos, Lima 14, Peru; [Mead, Daniel G.] Univ Georgia, Southeastern Cooperat Wildlife Dis Study, Athens, GA 30602 USA; [Pinto, Jesus; Ancca-Juarez, Jenny; Calderon, Maritza] Univ Peruana Cayetano Heredia, Lima, Peru; [Gilman, Robert H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Centers for Disease Control & Prevention - USA; Universidad Nacional Mayor de San Marcos; University System of Georgia; University of Georgia; Universidad Peruana Cayetano Heredia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Cama, VA (corresponding author), Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA 30333 USA.	vec5@cdc.gov		Bern, Caryn/0000-0001-8195-7303; ANCCA JUAREZ, JENNY MAGALY/0000-0001-6727-4450; Calderon Sanchez, Maritza Mercedes/0000-0001-6582-7306; Gomez-Puerta, Luis/0000-0002-7909-979X	National Institute of Allergy and Infectious Diseases [5P50 AI074285-03, 04, 1K01AI079162-03, 3K01AI079162-02S1]; DPDM PDB Centers for Disease Control and Prevention (CDC); Emerging Infectious Diseases (EID); CDC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI079162, P50AI074285] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DPDM PDB Centers for Disease Control and Prevention (CDC); Emerging Infectious Diseases (EID); CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institute of Allergy and Infectious Diseases projects 5P50 AI074285-03 and 04, 1K01AI079162-03 and 3K01AI079162-02S1, DPDM PDB Centers for Disease Control and Prevention (CDC), and by an appointment (DMR) to the Emerging Infectious Diseases (EID) Fellowship Program administered by the Association of Public Health Laboratories (APHL) and funded by CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1979, B AM MUS NAT HIST, V163, P1; Bosseno MF, 2006, AM J TROP MED HYG, V74, P303, DOI 10.4269/ajtmh.2006.74.303; Bowman NM, 2008, CLIN INFECT DIS, V46, P1822, DOI 10.1086/588299; Bowman NM, 2011, AM J TROP MED HYG, V84, P85, DOI 10.4269/ajtmh.2011.10-0303; Breniere SF, 2004, J MED ENTOMOL, V41, P1015, DOI 10.1603/0022-2585-41.6.1015; CHRISTENSEN HA, 1981, AM J TROP MED HYG, V30, P278, DOI 10.4269/ajtmh.1981.30.278; Giordano R, 2005, MEM I OSWALDO CRUZ, V100, P753, DOI 10.1590/S0074-02762005000700014; Gurtler RE, 1998, AM J TROP MED HYG, V58, P748, DOI 10.4269/ajtmh.1998.58.748; Ibanez-Cervantes G, 2013, PARASITOL INT, V62, P36, DOI 10.1016/j.parint.2012.09.003; Kent R, 2009, J MED ENTOMOL, V46, P380, DOI 10.1603/033.046.0226; Killmaster LF, 2011, VECTOR-BORNE ZOONOT, V11, P559, DOI 10.1089/vbz.2010.0083; Kitano T, 2007, INT J LEGAL MED, V121, P423, DOI 10.1007/s00414-006-0113-y; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Levy MZ, 2006, EMERG INFECT DIS, V12, P1345, DOI 10.3201/eid1209.051662; Lopez A, 1999, ACTA TROP, V73, P275, DOI 10.1016/S0001-706X(99)00039-X; de Souza RDM, 2011, MEM I OSWALDO CRUZ, V106, P16, DOI 10.1590/S0074-02762011000100003; Mota J, 2007, VECTOR-BORNE ZOONOT, V7, P617, DOI 10.1089/vbz.2007.0106; Mukabana WR, 2002, B ENTOMOL RES, V92, P233, DOI 10.1079/BER2002164; Palacios Q, 1960, REV PERU MED EXP SAL, V13, P15; Pan American Health Organization,, 2006, QUANT EST CHAG DIS A; Pellecer MJ, 2013, AM J TROP MED HYG, V88, P638, DOI 10.4269/ajtmh.12-0458; Pinto J, 2012, REV INST MED TROP SP, V54, P83, DOI 10.1590/S0036-46652012000200005; Pizarro Juan Carlos, 2007, Kinetoplastid Biol Dis, V6, P1, DOI 10.1186/1475-9292-6-1; Pizarro JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003585; Stevens L, 2012, EMERG INFECT DIS, V18, P646, DOI 10.3201/eid1804.111396; WISNIVESKYCOLLI C, 1982, J MED ENTOMOL, V19, P645, DOI 10.1093/jmedent/19.6.645; Zeledon R, 2010, MEM I OSWALDO CRUZ, V105, P99, DOI 10.1590/S0074-02762010000100015	28	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74713	10.1371/journal.pone.0074713	http://dx.doi.org/10.1371/journal.pone.0074713			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040328	Green Published, gold, Green Submitted			2022-12-25	WOS:000326734500117
J	Hagan, N; Robins, N; Hsu-Kim, H; Halabi, S; Gonzales, RDE; Richter, DD; Vandenberg, J				Hagan, Nicole; Robins, Nicholas; Hsu-Kim, Heileen; Halabi, Susan; Espinoza Gonzales, Ruben Dario; Richter, Daniel deB.; Vandenberg, John			Residential Mercury Contamination in Adobe Brick Homes in Huancavelica, Peru	PLOS ONE			English	Article							SOILS; SLOVENIA; DISTRICT; SITES; SPAIN; DUST	This is the first study of adobe brick contamination anywhere in the world. Huancavelica, Peru is the site of historic cinnabar refining and one of the most mercury (Hg) contaminated urban areas in the world. Over 80% of homes in Huancavelica are constructed with adobe bricks made from Hg contaminated soil. In this study we measured total Hg concentrations in adobe brick, dirt floor, surface dust, and air samples from the interior of 60 adobe brick houses located in four neighborhoods. Concentrations of total Hg in adobe bricks, dirt floors, and surface dust ranged from 8.00 to 1070 mu g/g, 3.06 to 926 mu g/g, and 0.02 to 9.69 mu g/wipe, respectively, with statistically significant differences between the four neighborhoods. Concentrations of Hg in adobe brick and dirt floor samples in Huancavelica were orders of magnitude higher than in Ayacucho, a non-mining town in Peru. A strong correlation exists between total Hg concentrations in adobe bricks and dirt floors which confirms that adobe bricks were being made on-site and not purchased from an off-site source. A strong correlation between surface dust and adobe bricks and dirt floors indicates that walls and floors serve as indoor sources of Hg contamination. Elemental Hg vapor concentrations were below detection (<0.5 mu g/m(3)) in most homes; however in homes with detectable levels, concentrations up to 5.1 mu g/m3 were observed. No statistically significant differences in Hg vapor measurements were observed between neighborhoods. This study demonstrates that building materials used widely in developing communities, such as adobe bricks, may be a substantial source of residential Hg exposure in silver or gold refining communities where Hg is produced or used for amalgamation in artisanal gold production.	[Hagan, Nicole] Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA; [Robins, Nicholas] N Carolina State Univ, Dept Hist, Raleigh, NC 27695 USA; [Hsu-Kim, Heileen] Duke Univ, Dept Civil & Environm Engn, Durham, NC 27706 USA; [Halabi, Susan] Duke Univ, Dept Biostat & Bioinformat, Durham, NC 27706 USA; [Espinoza Gonzales, Ruben Dario] Environm Hlth Council, Huancavelica, Peru; [Richter, Daniel deB.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Vandenberg, John] US EPA, Off Res & Dev, Res Triangle Pk, NC 27711 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University; Duke University; Duke University; Duke University; United States Environmental Protection Agency	Hagan, N (corresponding author), Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA.	nhagan@live.unc.edu	Richter, D.D./AAN-4583-2021; Halabi, Susan/AAG-7938-2022; Halabi, Susan/AFL-7973-2022; Hsu-Kim, Heileen/A-5409-2008	Halabi, Susan/0000-0003-4135-2777; Halabi, Susan/0000-0003-4135-2777; Hsu-Kim, Heileen/0000-0003-0675-4308; Vandenberg, John/0000-0003-2619-9460	Duke Global Health Institute; Oak Ridge Institute Science and Education fellowships at the U.S. EPA National Center for Environmental Assessment, Office of Research and Development; EPA/UNC [CR-83515201-0]; Curriculum in Toxicology, University of North Carolina at Chapel Hill	Duke Global Health Institute; Oak Ridge Institute Science and Education fellowships at the U.S. EPA National Center for Environmental Assessment, Office of Research and Development; EPA/UNC(United States Environmental Protection Agency); Curriculum in Toxicology, University of North Carolina at Chapel Hill	This research was supported by a grant from the Duke Global Health Institute. Nicholas Robins and Nicole Hagan would jointly like to acknowledge support from Oak Ridge Institute Science and Education fellowships at the U.S. EPA National Center for Environmental Assessment, Office of Research and Development. Nicole Hagan would also like to acknowledge support from the EPA/UNC Toxicology Training Agreement CR-83515201-0, with the Curriculum in Toxicology, University of North Carolina at Chapel Hill. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, CHILD SPEC EXP FACT; Cooke CA, 2009, P NATL ACAD SCI USA, V106, P8830, DOI 10.1073/pnas.0900517106; Gnamus A, 2000, ENVIRON SCI TECHNOL, V34, P3337, DOI 10.1021/es991419w; Gosar M, 2006, SCI TOTAL ENVIRON, V369, P150, DOI 10.1016/j.scitotenv.2006.05.006; Hagan N, 2011, ATMOS ENVIRON, V45, P7619, DOI 10.1016/j.atmosenv.2010.10.009; Higueras P, 2006, SCI TOTAL ENVIRON, V356, P112, DOI 10.1016/j.scitotenv.2005.04.042; Lemus R., 1996, Reviews on Environmental Health, V11, P179; Mendoza J, 2012, 86 5 CASAS HUANCAVEL; Molina JA, 2006, ENVIRON GEOCHEM HLTH, V28, P487, DOI 10.1007/s10653-006-9058-9; Rasmussen PE, 2001, SCI TOTAL ENVIRON, V267, P125, DOI 10.1016/S0048-9697(00)00775-0; Robins NA, 2012, SCI TOTAL ENVIRON, V426, P146, DOI 10.1016/j.scitotenv.2012.03.082; Robins NA, 2012, ENVIRON HEALTH PERSP, V120, P627, DOI 10.1289/ehp.1104192; Robins Nicholas A., 2011, MERCURY MINING EMPIR; US EPA (US Environmental Protection Agency), 1995, MERC CHLOR; Usepa, 2002, 1631 USEPA	15	11	11	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e75179	10.1371/journal.pone.0075179	http://dx.doi.org/10.1371/journal.pone.0075179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040399	Green Published, Green Submitted, gold			2022-12-25	WOS:000327538600132
J	Wang, MY; Zhu, ML; He, J; Shi, TY; Li, QX; Wang, YN; Li, J; Zhou, XY; Sun, MH; Wang, XF; Yang, YJ; Wang, JC; Jin, L; Wei, QY				Wang, Meng-Yun; Zhu, Mei-Ling; He, Jing; Shi, Ting-Yan; Li, Qiao-Xin; Wang, Ya-Nong; Li, Jin; Zhou, Xiao-Yan; Sun, Meng-Hong; Wang, Xiao-Feng; Yang, Ya-Jun; Wang, Jiu-Cun; Jin, Li; Wei, Qing-Yi			Potentially Functional Polymorphisms in the CASP7 Gene Contribute to Gastric Adenocarcinoma Susceptibility in an Eastern Chinese Population	PLOS ONE			English	Article							CASPASE-7; CANCER; RISK; ASSOCIATION; APOPTOSIS; SITE; EXPRESSION	Background: Caspase 7 (CASP7) is an important regulator and executioner in the apoptosis pathway and plays a crucial role in cancer development and progression. However, few studies have evaluated associations between functional single nucleotide polymorphisms (SNPs) in the 3' untranslational region (UTR) of CASP7 and risk of gastric cancer. Methods: In a case-control study of 1117 patients with gastric cancer and 1146 cancer-free controls with frequency matching on age and sex, we genotyped four potentially functional SNPs (rs4353229T>C, rs10787498T>G, rs1127687G>A and rs12247479G>A) located in the microRNA binding sites of the CASP7 3' UTR by using Taqman assays and evaluated their associations with risk of gastric cancer by using logistic regression analyses as well as multifactorial dimension reduction (MDR) analysis. Results: In the single-locus analysis, only the CASP7 rs4353229 TT genotype was associated with 0.83-fold decreased risk (95% confidence interval [CI] = 0.70-0.98) of gastric cancer under a recessive model, compared with the CT/CC genotypes. In the combined analysis of all four SNPs, we found that the risk of gastric cancer decreased by 19% in those carrying any of the risk genotypes (adjusted odds ratio = 0.81, 95% CI = 0.68-0.96), compared with those carrying zero risk genotypes, and this risk was more evident in subgroups of younger age (<59 years), females, non-smokers, non-drinkers and patients with non-gastric cardia adenocarcinoma. Further MDR analysis suggested some evidence of interactions between the combined genotypes and other risk factors for gastric cancer. Conclusions: Potentially functional CASP7 variants may contribute to risk of gastric cancer. Larger studies with different ethnic populations are warranted to validate our findings.	[Wang, Meng-Yun; Zhu, Mei-Ling; He, Jing; Shi, Ting-Yan; Li, Qiao-Xin; Wei, Qing-Yi] Fudan Univ, Shanghai Canc Ctr, Inst Canc, Shanghai 200433, Peoples R China; [Wang, Meng-Yun; Zhu, Mei-Ling; He, Jing; Shi, Ting-Yan; Li, Qiao-Xin; Wei, Qing-Yi] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Wang, Ya-Nong] Fudan Univ, Shanghai Canc Ctr, Dept Abdominal Surg, Shanghai 200433, Peoples R China; [Li, Jin] Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China; [Zhou, Xiao-Yan; Sun, Meng-Hong] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China; [Wang, Xiao-Feng; Yang, Ya-Jun; Wang, Jiu-Cun; Jin, Li] Fudan Univ, Sch Life Sci, Key Lab Contemporary Anthropol, Minist Educ,State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Wang, Xiao-Feng; Yang, Ya-Jun; Wang, Jiu-Cun; Jin, Li] Fudan Taizhou Inst Hlth Sci, Taizhou, Jiangsu, Peoples R China; [Wei, Qing-Yi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; University of Texas System; UTMD Anderson Cancer Center	Wei, QY (corresponding author), Fudan Univ, Shanghai Canc Ctr, Inst Canc, Shanghai 200433, Peoples R China.	weiqingyi@yahoo.com	Jin, Li/M-5063-2019; He, Jing/M-5774-2015; Jin, Li/C-1468-2009; Wang, Jiucun/J-8744-2012	He, Jing/0000-0002-1954-2892; Jin, Li/0000-0002-4546-2415; Wang, Jiucun/0000-0003-2765-0620	China Recruitment Program of Global Experts at Fudan University; Shanghai Committee of Science and Technology, China [12DZ2260100]; Ministry of Science and Technology [2011BAI09B00]; Ministry of Health [201002007]	China Recruitment Program of Global Experts at Fudan University; Shanghai Committee of Science and Technology, China(Shanghai Science & Technology Committee); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health	This study was supported by the funds from China Recruitment Program of Global Experts at Fudan University, the Shanghai Committee of Science and Technology, China (Grant No. 12DZ2260100), Ministry of Science and Technology (2011BAI09B00) and Ministry of Health (201002007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Ai X, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.91; Babu SR, 2003, ANN NY ACAD SCI, V1005, P340, DOI 10.1196/annals.1288.054; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Favaloro B, 2012, AGING-US, V4, P330, DOI 10.18632/aging.100459; Galvan A, 2010, TRENDS GENET, V26, P132, DOI 10.1016/j.tig.2009.12.008; Garcia-Lozano JR, 2007, RHEUMATOLOGY, V46, P1243, DOI 10.1093/rheumatology/kem096; He J, 2012, HUM GENET, V131, P1235, DOI 10.1007/s00439-012-1152-8; Holm K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-600; Hu Zhibin, 2007, Gastrointest Cancer Res, V1, P12; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Ladeiras-Lopes R, 2008, CANCER CAUSE CONTROL, V19, P689, DOI 10.1007/s10552-008-9132-y; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lamkanfi M, 2009, BLOOD, V113, P2742, DOI 10.1182/blood-2008-09-178038; Lee WK, 2009, LUNG CANCER, V65, P19, DOI 10.1016/j.lungcan.2008.10.022; Liu CY, 2010, CARCINOGENESIS, V31, P1259, DOI 10.1093/carcin/bgq092; Liu L, 2011, CARCINOGENESIS, V32, P336, DOI 10.1093/carcin/bgq264; Liu ZS, 2011, CARCINOGENESIS, V32, P1668, DOI 10.1093/carcin/bgr209; Palli Domenico, 2000, Journal of Gastroenterology, V35, P84; Palmerini F, 2001, HUM PATHOL, V32, P461, DOI 10.1053/hupa.2001.24328; Park C, 2012, HUM IMMUNOL, V73, P736, DOI 10.1016/j.humimm.2012.04.017; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Soung YH, 2003, ONCOGENE, V22, P8048, DOI 10.1038/sj.onc.1206727; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031932; Xu HL, 2009, CANCER EPIDEM BIOMAR, V18, P2114, DOI 10.1158/1055-9965.EPI-09-0152; Yoo NJ, 2004, APMIS, V112, P330; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395	37	5	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74041	10.1371/journal.pone.0074041	http://dx.doi.org/10.1371/journal.pone.0074041			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040159	Green Submitted, Green Published, gold			2022-12-25	WOS:000327538600063
J	Blas, MM; Alva, IE; Garcia, PJ; Carcamo, C; Montano, SM; Mori, N; Munante, R; Zunt, JR				Blas, Magaly M.; Alva, Isaac E.; Garcia, Patricia J.; Carcamo, Cesar; Montano, Silvia M.; Mori, Nicanor; Munante, Ricardo; Zunt, Joseph R.			High Prevalence of Human T-Lymphotropic Virus Infection in Indigenous Women from the Peruvian Amazon	PLOS ONE			English	Article							I HTLV-I; PREGNANT-WOMEN; CELL LEUKEMIA; RETROVIRAL INFECTION; NORWEGIAN SCABIES; TYPE-1 INFECTION; ENDEMIC AREA; RISK-FACTORS; SEROPREVALENCE; ANTIBODY	Background: In an earlier study, we detected an association between human T-cell lymphotropic virus (HTLV) infection and cervical human papillomavirus (HPV) in indigenous Amazonian Peruvian women of the Shipibo-Konibo ethnic group. As both HTLV and HPV can be transmitted sexually, we now report a population-based study examining the prevalence and risk factors for HTLV-1 and HTLV-2 infection in this population. Methods: Between July and December 2010, we conducted a comprehensive screening for HTLV among Shipibo-Konibo women 15 to 39 years of age living in two communities located in Lima and in 17 communities located within four hours by car or boat from the Amazonian city of Pucallpa in Peru. Results: We screened 1,253 Shipibo-Konibo women for HTLV infection 74 (5.9%) tested positive for HTLV-1, 47 (3.8%) for HTLV-2 infection, and 4 (0.3%) had indeterminate results. In the multivariate analysis, factors associated with HTLV-1 infection included: older age (Prevalence Ratio (PR): 1.04, 95% CI 1.00-1.08), primary education or less (PR: 2.01, 95% CI: 1.25-3.24), younger or same age most recent sex partner (PR: 1.66, 95% CI: 1.00-2.74), and having a most recent sex partner who worked at a logging camp (PR: 1.73, 95% CI: 1.09-2.75). The only factor associated with HTLV-2 infection was older age (PR: 1.08, 95% CI: 1.03-1.12). Conclusion: HTLV infection is endemic among Shipibo-Konibo women. Two characteristics of the sexual partner (younger age and labor history) were associated with infection in women. These results suggest the need for implementation of both HTLV screening during the antenatal healthcare visits of Shipibo-Konibo women, and counseling about the risk of HTLV transmission through prolonged breastfeeding in infected women. We also recommend the implementation of prevention programs to reduce sexual transmission of these viruses.	[Blas, Magaly M.; Alva, Isaac E.; Garcia, Patricia J.; Carcamo, Cesar] Univ Peruana Cayetano Heredia, Epidemiol STD & HIV Unit, Sch Publ Hlth & Adm, Lima, Peru; [Montano, Silvia M.; Mori, Nicanor] US Naval Med Res Unit 6 NAMRU 6, Callao, Peru; [Munante, Ricardo] Minist Hlth, Ucayali Reg Hlth Directorate, Ucayali, Peru; [Zunt, Joseph R.] Univ Washington, Sch Publ Hlth & Community Med, Dept Neurol, Seattle, WA 98195 USA; [Zunt, Joseph R.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Zunt, Joseph R.] Univ Washington, Dept Med, Seattle, WA 98195 USA	Universidad Peruana Cayetano Heredia; Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Blas, MM (corresponding author), Univ Peruana Cayetano Heredia, Epidemiol STD & HIV Unit, Sch Publ Hlth & Adm, Lima, Peru.	magaly.blas@upch.pe	Zunt, Joseph/ABD-2886-2021	Mori, Nicanor/0000-0002-2270-1663	International Clinical Research Fellows Program at Vanderbilt University [R24 TW007988]; Fogarty International Center/National Institutes of Health (FIC/NIH) [R01 TW008398, RO1 NS055627]; Merck Investigator-Initiated Studies Program of Merck Co., Inc.; FOGARTY INTERNATIONAL CENTER [R24TW007988, R01TW008398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055627] Funding Source: NIH RePORTER	International Clinical Research Fellows Program at Vanderbilt University; Fogarty International Center/National Institutes of Health (FIC/NIH); Merck Investigator-Initiated Studies Program of Merck Co., Inc.; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the International Clinical Research Fellows Program at Vanderbilt University (R24 TW007988), by the Fogarty International Center/National Institutes of Health (FIC/NIH) grant R01 TW008398 to Magaly Blas, RO1 NS055627 to Joseph R. Zunt and supported in part by a research grant from the Merck Investigator-Initiated Studies Program of Merck & Co., Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon JO, 2006, JAIDS-J ACQ IMM DEF, V42, P604, DOI 10.1097/01.qai.0000221680.52563.d5; Alva IE, 2012, AM J TROP MED HYG, V87, P954, DOI 10.4269/ajtmh.2012.12-0289; Amano M, 2011, INT J DERMATOL, V50, P915, DOI 10.1111/j.1365-4632.2011.04882.x; Armah HB, 2006, J MED MICROBIOL, V55, P765, DOI 10.1099/jmm.0.46426-0; Bittencourt AL, 2001, J ACQ IMMUN DEF SYND, V26, P490, DOI 10.1097/00126334-200104150-00016; Blas M, 2005, AM J TROP MED HYG, V72, P855, DOI 10.4269/ajtmh.2005.72.855; Blas MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044240; Brites C, 2002, AIDS, V16, P1292, DOI 10.1097/00002030-200206140-00015; Calattini S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-30; Dourado I, 2003, JAIDS-J ACQ IMM DEF, V34, P527, DOI 10.1097/00126334-200312150-00013; Fujiyoshi T, 1999, AIDS RES HUM RETROV, V15, P1235, DOI 10.1089/088922299310124; Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388; Goncalves DU, 2010, CLIN MICROBIOL REV, V23, P577, DOI 10.1128/CMR.00063-09; GOTUZZO E, 1994, J INFECT DIS, V169, P754, DOI 10.1093/infdis/169.4.754; IJICHI S, 1995, INTERNAL MED, V34, P713, DOI 10.2169/internalmedicine.34.713; KALYANARAMAN VS, 1982, SCIENCE, V218, P571, DOI 10.1126/science.6981847; La Rosa AM, 2009, CLIN INFECT DIS, V49, P112, DOI 10.1086/599609; LAGRENADE L, 1990, LANCET, V336, P1345; Marinho J, 2005, JAIDS-J ACQ IMM DEF, V40, P625, DOI 10.1097/01.qai.0000174252.73516.7a; Medeot S, 1999, AM J TROP MED HYG, V60, P623, DOI 10.4269/ajtmh.1999.60.623; MOCHIZUKI M, 1992, AM J OPHTHALMOL, V114, P123, DOI 10.1016/S0002-9394(14)73974-1; MOROFUJIHIRATA M, 1993, AM J EPIDEMIOL, V137, P43, DOI 10.1093/oxfordjournals.aje.a116600; Moxoto I, 2007, REV SOC BRAS MED TRO, V40, P37, DOI 10.1590/S0037-86822007000100007; MURPHY EL, 1991, AM J EPIDEMIOL, V133, P1114, DOI 10.1093/oxfordjournals.aje.a115824; Murphy EL, 1996, INT J EPIDEMIOL, V25, P1083, DOI 10.1093/ije/25.5.1083; MURPHY EL, 1989, ANN INTERN MED, V111, P555, DOI 10.7326/0003-4819-111-7-555; NAKADA K, 1984, LANCET, V1, P633; Orellana ER, 2013, QUALITATIVE HLT 0807; Pedral-Sampaio, 1997, Braz J Infect Dis, V1, P31; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Pouliquen JF, 2004, J CLIN MICROBIOL, V42, P2020, DOI 10.1128/JCM.42.5.2020-2026.2004; Rafatpanah H, 2011, J CLIN VIROL, V52, P172, DOI 10.1016/j.jcv.2011.07.004; Roucoux DF, 2004, AIDS REV, V6, P144; Sanchez-Palacios C., 2003, International Journal of Infectious Diseases, V7, P132, DOI 10.1016/S1201-9712(03)90009-9; Takatsuki K, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-16; Wolfe ND, 2005, P NATL ACAD SCI USA, V102, P7994, DOI 10.1073/pnas.0501734102; Zunt JR, 2006, AM J TROP MED HYG, V74, P922, DOI 10.4269/ajtmh.2006.74.922; Zurita S, 1997, AM J TROP MED HYG, V56, P561, DOI 10.4269/ajtmh.1997.56.561	38	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73978	10.1371/journal.pone.0073978	http://dx.doi.org/10.1371/journal.pone.0073978			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040133	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600109
J	Chi, MH; Craven, KD				Chi, Myoung-Hwan; Craven, Kelly D.			Oxygen and an Extracellular Phase Transition Independently Control Central Regulatory Genes and Conidiogenesis in Aspergillus fumigatus	PLOS ONE			English	Article							ASEXUAL DEVELOPMENT; CONIDIOPHORE DEVELOPMENT; NIDULANS; SPORULATION; BRLA; DNA; DIFFERENTIATION; INITIATION; EXPRESSION; PATHOGEN	Conidiogenesis is the primary process for asexual reproduction in filamentous fungi. As the conidia resulting from the conidiogenesis process are primarily disseminated via air currents and/or water, an outstanding question has been how fungi recognize aerial environments suitable for conidial development. In this study, we documented the somewhat complex development of the conidia-bearing structures, termed conidiophores, from several Aspergillus species in a subsurface (gel-phase) layer of solid media. A subset of the isolates studied was able to develop conidiophores in a gel-phase environment, but exposure to the aeriform environment was required for the terminal developmental transition from phialide cells to conidia. The remaining Aspergilli could not initiate the conidiogenesis process until they were exposed to the aeriform environment. Our observations of conidiophore development in high or low oxygen conditions in both aeriform and gel-phase environments revealed that oxygen and the aeriform state are positive environmental factors for inducing conidiogenesis in most of the aspergilli tested in this study. Transcriptional analysis using A. fumigatus strain AF293 confined to either the aeriform or gel-phase environments revealed that expression of a key regulatory gene for conidiophore development (AfubrlA) is facilitated by oxygen while expression of another regulatory gene controlling conidia formation from phialides (AfuabaA) was repressed regardless of oxygen levels in the gel-embedded environment. Furthermore, by comparing the developmental behavior of conidiation-defective mutants lacking genes controlling various regulatory checkpoints throughout the conidiogenesis pathway, we propose that this aerial response by the fungus requires both oxygen and the phase transition (solid to aeriform), with these environmental signals integrating into the upstream regulatory pathway and central regulatory pathway of conidiogenesis, respectively. Our findings provide not only novel insight into how fungi respond to an aerial environment to trigger development for airborne conidia production but also the relationship between environmental factors and conidiogenesis regulation in aspergilli.	[Chi, Myoung-Hwan; Craven, Kelly D.] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK USA	Noble Research Institute	Craven, KD (corresponding author), Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK USA.	kdcraven@noble.org			Samuel Roberts Noble Foundation	Samuel Roberts Noble Foundation	This research is funded internally by the Samuel Roberts Noble Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS TH, 1988, CELL, V54, P353, DOI 10.1016/0092-8674(88)90198-5; Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; Aguirre J, 2005, TRENDS MICROBIOL, V13, P111, DOI 10.1016/j.tim.2005.01.007; ANDERSON JG, 1971, T BRIT MYCOL SOC, V56, P9, DOI 10.1016/S0007-1536(71)80103-1; Anderson MJ, 1996, J CLIN MICROBIOL, V34, P87, DOI 10.1128/JCM.34.1.87-93.1996; ANDRIANOPOULOS A, 1994, MOL CELL BIOL, V14, P2503, DOI 10.1128/MCB.14.4.2503; AXELROD DE, 1973, DEV BIOL, V34, P9, DOI 10.1016/0012-1606(73)90335-7; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bayram OS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001226; Rodriguez-Urra AB, 2012, ACS CHEM BIOL, V7, P599, DOI 10.1021/cb200455u; CHANG YC, 1993, GENETICS, V133, P29; DEnfert C, 1996, INFECT IMMUN, V64, P4401, DOI 10.1128/IAI.64.10.4401-4405.1996; Denning DW, 1997, ANTIMICROB AGENTS CH, V41, P1364, DOI 10.1128/AAC.41.6.1364; DENNING DW, 1990, J INFECT DIS, V162, P1151, DOI 10.1093/infdis/162.5.1151; Denning DW, 1997, J ANTIMICROB CHEMOTH, V40, P401, DOI 10.1093/jac/40.3.401; Etxebeste O, 2008, EUKARYOT CELL, V7, P38, DOI 10.1128/EC.00207-07; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; GALBRAITH JC, 1969, J GEN MICROBIOL, V59, P31, DOI 10.1099/00221287-59-1-31; Han KH, 2003, J MICROBIOL, V41, P34; Hedayati MT, 2007, MICROBIOL-SGM, V153, P1677, DOI 10.1099/mic.0.2007/007641-0; Hong SB, 2005, MYCOLOGIA, V97, P1316, DOI 10.3852/mycologia.97.6.1316; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Kikuma T, 2006, EUKARYOT CELL, V5, P1328, DOI 10.1128/EC.00024-06; Kwon NJ, 2010, FUNGAL GENET BIOL, V47, P981, DOI 10.1016/j.fgb.2010.08.009; Kwon NJ, 2010, MOL MICROBIOL, V77, P1203, DOI 10.1111/j.1365-2958.2010.07282.x; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; LEE BN, 1994, GENE DEV, V8, P641, DOI 10.1101/gad.8.6.641; LEE BN, 1994, MOL MICROBIOL, V14, P323, DOI 10.1111/j.1365-2958.1994.tb01293.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mah JH, 2006, EUKARYOT CELL, V5, P1585, DOI 10.1128/EC.00192-06; MARSHALL MA, 1991, MOL CELL BIOL, V11, P55, DOI 10.1128/MCB.11.1.55; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; MIMS CW, 1988, PROTOPLASMA, V144, P132, DOI 10.1007/BF01637246; MIRABITO PM, 1989, CELL, V57, P859, DOI 10.1016/0092-8674(89)90800-3; Ni M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000970; Ni M, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P559; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; O'Gorman CM, 2009, NATURE, V457, P471, DOI 10.1038/nature07528; Pain A, 2004, FUNGAL GENET BIOL, V41, P443, DOI 10.1016/j.fgb.2003.12.003; Paoletti M, 2005, CURR BIOL, V15, P1242, DOI 10.1016/j.cub.2005.05.045; Park HS, 2012, CURR OPIN MICROBIOL, V15, P669, DOI 10.1016/j.mib.2012.09.006; Park HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045935; Park HS, 2012, MOL MICROBIOLOGY; Peterson SW, 2008, MYCOLOGIA, V100, P205, DOI 10.3852/mycologia.100.2.205; Seo JA, 2006, GENETICS, V172, P1535, DOI 10.1534/genetics.105.052258; SEWALL TC, 1990, DEV BIOL, V138, P499, DOI 10.1016/0012-1606(90)90215-5; SEWALL TC, 1990, PLANT CELL, V2, P731, DOI 10.1105/tpc.2.8.731; Shimizu K, 2001, GENETICS, V157, P591; SKROMNE I, 1995, MICROBIOL-SGM, V141, P21, DOI 10.1099/00221287-141-1-21; Tao L, 2011, MICROBIOL-SGM, V157, P313, DOI 10.1099/mic.0.044271-0; WIESER J, 1994, CURR GENET, V27, P62, DOI 10.1007/BF00326580; WIESER J, 1995, GENE DEV, V9, P491, DOI 10.1101/gad.9.4.491; Xiao P, 2010, EUKARYOT CELL, V9, P1711, DOI 10.1128/EC.00198-10; Yu JH, 2006, EUKARYOT CELL, V5, P1577, DOI 10.1128/EC.00193-06; Yu JH, 1996, EMBO J, V15, P5184, DOI 10.1002/j.1460-2075.1996.tb00903.x	56	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74805	10.1371/journal.pone.0074805	http://dx.doi.org/10.1371/journal.pone.0074805			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040343	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600146
J	Gardai, SJ; Mao, WX; Schule, B; Babcock, M; Schoebel, S; Lorenzana, C; Alexander, J; Kim, S; Glick, H; Hilton, K; Fitzgerald, JK; Buttini, M; Chiou, SS; McConlogue, L; Anderson, JP; Schenk, DB; Bard, F; Langston, JW; Yednock, T; Johnston, JA				Gardai, Shyra J.; Mao, Wenxian; Schuele, Birgitt; Babcock, Michael; Schoebel, Sue; Lorenzana, Carlos; Alexander, Jeff; Kim, Sam; Glick, Heather; Hilton, Kathryn; Fitzgerald, J. Kent; Buttini, Manuel; Chiou, San-San; McConlogue, Lisa; Anderson, John P.; Schenk, Dale B.; Bard, Frederique; Langston, J. William; Yednock, Ted; Johnston, Jennifer A.			Elevated Alpha-Synuclein Impairs Innate Immune Cell Function and Provides a Potential Peripheral Biomarker for Parkinson's Disease	PLOS ONE			English	Article							APOPTOTIC CELLS; NEURODEGENERATIVE DISEASES; ARACHIDONIC-ACID; IN-VIVO; PHAGOCYTOSIS; CLEARANCE; MICE; EXPRESSION; EXOCYTOSIS; SECRETION	Alpha-synuclein protein is strongly implicated in the pathogenesis Parkinson's disease. Increased expression of alpha-synuclein due to genetic multiplication or point mutations leads to early onset disease. While alpha-synuclein is known to modulate membrane vesicle dynamics, it is not clear if this activity is involved in the pathogenic process or if measurable physiological effects of alpha-synuclein over-expression or mutation exist in vivo. Macrophages and microglia isolated from BAC alpha-synuclein transgenic mice, which overexpress alpha-synuclein under regulation of its own promoter, express alpha-synuclein and exhibit impaired cytokine release and phagocytosis. These processes were affected in vivo as well, both in peritoneal macrophages and microglia in the CNS. Extending these findings to humans, we found similar results with monocytes and fibroblasts isolated from idiopathic or familial Parkinson's disease patients compared to age-matched controls. In summary, this paper provides 1) a new animal model to measure alpha-synuclein dysfunction; 2) a cellular system to measure synchronized mobilization of alpha-synuclein and its functional interactions; 3) observations regarding a potential role for innate immune cell function in the development and progression of Parkinson's disease and other human synucleinopathies; 4) putative peripheral biomarkers to study and track these processes in human subjects. While altered neuronal function is a primary issue in PD, the widespread consequence of abnormal alpha-synuclein expression in other cell types, including immune cells, could play an important role in the neurodegenerative progression of PD and other synucleinopathies. Moreover, increased alpha-synuclein and altered phagocytosis may provide a useful biomarker for human PD.	[Gardai, Shyra J.; Mao, Wenxian; Babcock, Michael; Schoebel, Sue; Lorenzana, Carlos; Alexander, Jeff; Glick, Heather; Hilton, Kathryn; Fitzgerald, J. Kent; Buttini, Manuel; Chiou, San-San; McConlogue, Lisa; Anderson, John P.; Schenk, Dale B.; Bard, Frederique; Yednock, Ted; Johnston, Jennifer A.] Elan Pharmaceut, Res, San Francisco, CA USA; [Schuele, Birgitt; Kim, Sam; Langston, J. William] Parkinsons Inst, Sunnyvale, CA USA		Gardai, SJ (corresponding author), Elan Pharmaceut, Res, San Francisco, CA USA.	sgardai@gmail.com		Johnston, Jennifer/0000-0002-4867-9230; Buttini, Manuel/0000-0003-1805-0279; Schuele, Birgitt/0000-0002-9952-5776	Elan Pharmaceuticals; Parkinson Alliance	Elan Pharmaceuticals; Parkinson Alliance	All authors were employees of either Elan Pharmaceuticals or The Parkinson's Institute. Work accomplished at Elan was supported by Elan Pharmaceuticals. B. Shulle, J. Langston, and S. Kim were supported by Parkinson Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Austin SA, 2006, J NEUROSCI, V26, P10558, DOI 10.1523/JNEUROSCI.1799-06.2006; Braun V, 2006, BIOL CELL, V98, P195, DOI 10.1042/BC20050021; Brighina L, 2010, NEUROBIOL AGING, V31, P884, DOI 10.1016/j.neurobiolaging.2008.06.010; Burgalossi A, 2010, NEURON, V68, P473, DOI 10.1016/j.neuron.2010.09.019; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Carr J, 2003, PARKINSONISM RELAT D, V9, P201, DOI 10.1016/S1353-8020(02)00048-2; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Darios F, 2010, EMBO REP, V11, P528, DOI 10.1038/embor.2010.66; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Erwig LP, 2007, AM J PATHOL, V171, P2, DOI 10.2353/ajpath.2007.070135; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Frank-Cannon TC, 2008, J NEUROSCI, V28, P10825, DOI 10.1523/JNEUROSCI.3001-08.2008; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gu XL, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-12; Hackam DJ, 1998, P NATL ACAD SCI USA, V95, P11691, DOI 10.1073/pnas.95.20.11691; Halliday GM, 2011, MOVEMENT DISORD, V26, P6, DOI 10.1002/mds.23455; Hasegawa Y, 2000, ACTA NEUROL SCAND, V101, P159, DOI 10.1034/j.1600-0404.2000.101003159.x; Huynh KK, 2007, PHYSIOLOGY, V22, P366, DOI 10.1152/physiol.00028.2007; Ikemura M, 2008, J NEUROPATH EXP NEUR, V67, P945, DOI 10.1097/NEN.0b013e318186de48; Jellinger KA, 2011, J NEUROL SCI, V310, P107, DOI 10.1016/j.jns.2011.04.012; Kim KS, 2010, J BIOL CHEM, V285, P21416, DOI 10.1074/jbc.M110.103499; Kuo YM, 2010, HUM MOL GENET, V19, P1633, DOI 10.1093/hmg/ddq038; Lacy P, 2011, BLOOD; Lee SJ, 2008, J MOL NEUROSCI, V34, P17, DOI 10.1007/s12031-007-0012-9; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; Liu J, 2003, GENE, V308, P1, DOI 10.1016/S0378-1119(03)00453-0; Lotharius J, 2002, HUM MOL GENET, V11, P2395, DOI 10.1093/hmg/11.20.2395; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Lucking CB, 2000, CELL MOL LIFE SCI, V57, P1894, DOI 10.1007/PL00000671; Miklossy J, 2006, J NEUROPATH EXP NEUR, V65, P953, DOI 10.1097/01.jnen.0000235121.98052.54; Mukundan L, 2009, NAT MED, V15, P1266, DOI 10.1038/nm.2048; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Murray RZ, 2005, SCIENCE, V310, P1492, DOI 10.1126/science.1120225; Nagatsu T, 2000, ADV RES NEURODEGENER, V8, P277; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Norsworthy PJ, 2004, J IMMUNOL, V172, P3406, DOI 10.4049/jimmunol.172.6.3406; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Palokangas H, 1997, J CELL SCI, V110, P1767; Reichmann H, 2011, J NEUROL SCI, V310, P9, DOI 10.1016/j.jns.2011.04.016; Rickman C, 2005, CHEM BIOL, V12, P545, DOI 10.1016/j.chembiol.2005.03.004; Roodveldt C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013481; Roszer T, 2011, J IMMUNOL, V186, P621, DOI 10.4049/jimmunol.1002230; Scalzo P, 2010, J NEUROL, V257, P540, DOI 10.1007/s00415-009-5357-2; Schiesling C, 2008, NEUROPATH APPL NEURO, V34, P255, DOI 10.1111/j.1365-2990.2008.00952.x; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Solano RM, 2008, J NEUROSCI, V28, P598, DOI 10.1523/JNEUROSCI.4609-07.2008; Stuart LM, 2005, J IMMUNOL, V174, P3220, DOI 10.4049/jimmunol.174.6.3220; Tan EK, 2010, NEUROLOGY, V75, P508, DOI 10.1212/WNL.0b013e3181eccfcd; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; Uversky VN, 2008, CURR PROTEIN PEPT SC, V9, P507, DOI 10.2174/138920308785915218; van Horssen J, 2010, FREE RADICAL BIO MED, V49, P1283, DOI 10.1016/j.freeradbiomed.2010.07.013; Wakabayashi K, 2010, ACTA NEUROPATHOL, V120, P1, DOI 10.1007/s00401-010-0706-x; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	60	67	74	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e71634	10.1371/journal.pone.0071634	http://dx.doi.org/10.1371/journal.pone.0071634			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24058406	Green Published, gold, Green Submitted			2022-12-25	WOS:000324403200014
J	La Sala, MS; Hurtado, MD; Brown, AR; Bohorquez, DV; Liddle, RA; Herzog, H; Zolotukhin, S; Dotson, CD				La Sala, Michael S.; Hurtado, Maria D.; Brown, Alicia R.; Bohorquez, Diego V.; Liddle, Rodger A.; Herzog, Herbert; Zolotukhin, Sergei; Dotson, Cedrick D.			Modulation of taste responsiveness by the satiation hormone peptide YY	FASEB JOURNAL			English	Article						endocrine signaling; hormonal signaling; fat intake; behavior; gustation	GASTRIC BYPASS-SURGERY; SWEET TASTE; NEUROPEPTIDE-Y; WEIGHT-LOSS; PANCREATIC-POLYPEPTIDE; STRAIN DIFFERENCES; FLAVOR PREFERENCE; LEPTIN LEVELS; FOOD-INTAKE; OBESE RATS	It has been hypothesized that the peripheral taste system may be modulated in the context of an animal's metabolic state. One purported mechanism for this phenomenon is that circulating gastrointestinal peptides modulate the functioning of the peripheral gustatory system. Recent evidence suggests endocrine signaling in the oral cavity can influence food intake (FI) and satiety. We hypothesized that these hormones may be affecting FI by influencing taste perception. We used immunohistochemistry along with genetic knockout models and the specific reconstitution of peptide YY (PYY) in saliva using gene therapy protocols to identify a role for PYY signaling in taste. We show that PYY is expressed in subsets of taste cells in murine taste buds. We also show, using brief-access testing with PYY knockouts, that PYY signaling modulates responsiveness to bitter-tasting stimuli, as well as to lipid emulsions. We show that salivary PYY augmentation, via viral vector therapy, rescues behavioral responsiveness to a lipid emulsion but not to bitter stimuli and that this response is likely mediated via activation of Y2 receptors localized apically in taste cells. Our findings suggest distinct functions for PYY produced locally in taste cells vs. that circulating systemically.	[La Sala, Michael S.; Hurtado, Maria D.; Zolotukhin, Sergei] Univ Florida, Dept Pediat, Coll Med, Gainesville, FL 32611 USA; [Brown, Alicia R.; Dotson, Cedrick D.] Univ Florida, Dept Neurosci, Coll Med, Gainesville, FL 32611 USA; [Dotson, Cedrick D.] Univ Florida, Dept Psychiat, Coll Med, Div Addict Med, Gainesville, FL 32611 USA; [Dotson, Cedrick D.] Univ Florida, Ctr Smell & Taste, Gainesville, FL 32611 USA; [Bohorquez, Diego V.; Liddle, Rodger A.] Duke Univ, Dept Med, Durham, NC USA; [Bohorquez, Diego V.; Liddle, Rodger A.] Vet Affairs Med Ctr, Durham, NC USA; [Herzog, Herbert] Garvan Inst Med Res, Sydney, NSW, Australia	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Garvan Institute of Medical Research	Dotson, CD (corresponding author), Univ Florida, McKnight Brain Inst, Dept Neurosci, 1149 Newell Dr,Box 100244, Gainesville, FL 32611 USA.	c.dotson@mbi.ufl.edu	Brown, Alicia/C-6478-2008; Herzog, Herbert/B-8294-2008	Brown, Alicia/0000-0001-6602-7917; Dotson, Cedrick/0000-0003-0992-1191; , Herbert/0000-0002-1713-1029	U.S. National Institutes of Health [P30-DC010763, R01-DK62302, R01-DC012819]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091946, R01DK098796, F32DK094704, R01DK062302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC010763, R01DC012819] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002230] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank Megan Doheny for assistance in data collection and Andres Acosta for technical assistance. This work was supported by the U.S. National Institutes of Health, grants P30-DC010763 and R01-DK62302 (to S.Z.) and R01-DC012819 (to C.D.D).	Acosta A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026137; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Batterham RL, 2003, NEW ENGL J MED, V349, P941, DOI 10.1056/NEJMoa030204; Boey D, 2006, DIABETOLOGIA, V49, P1360, DOI 10.1007/s00125-006-0237-0; Bohorquez DV, 2011, J MOL HISTOL, V42, P3, DOI 10.1007/s10735-010-9302-6; Bueter M, 2011, PHYSIOL BEHAV, V104, P709, DOI 10.1016/j.physbeh.2011.07.025; Chen CH, 1997, NEUROGASTROENT MOTIL, V9, P109, DOI 10.1046/j.1365-2982.1997.d01-26.x; Chen K, 2010, BRAIN RES, V1325, P53, DOI 10.1016/j.brainres.2010.02.026; Dotson CD, 2005, PHYSIOL BEHAV, V85, P655, DOI 10.1016/j.physbeh.2005.06.010; Dotson CD, 2005, CHEM SENSES, V30, P593, DOI 10.1093/chemse/bji053; Dotson CD, 2004, CHEM SENSES, V29, P489, DOI 10.1093/chemse/bjh051; Dramane G, 2011, CURR MED CHEM, V18, P3417, DOI 10.2174/092986711796504655; Dvoryanchikov G, 2009, J COMP NEUROL, V517, P1, DOI 10.1002/cne.22152; Ekblad E, 2002, PEPTIDES, V23, P251, DOI 10.1016/S0196-9781(01)00601-5; Elson AET, 2010, FASEB J, V24, P3960, DOI 10.1096/fj.10-158105; Gilbertson TA, 1998, ANN NY ACAD SCI, V855, P165, DOI 10.1111/j.1749-6632.1998.tb10560.x; Glendinning JI, 2008, PHYSIOL BEHAV, V95, P476, DOI 10.1016/j.physbeh.2008.07.017; Hajnal A, 2010, AM J PHYSIOL-GASTR L, V299, pG967, DOI 10.1152/ajpgi.00070.2010; HARTEL S, 1988, HISTOCHEMISTRY, V89, P151, DOI 10.1007/BF00489918; Hastings JA, 2001, BRAIN RES, V890, P32, DOI 10.1016/S0006-8993(00)02874-2; Hofer D, 1999, HISTOCHEM CELL BIOL, V112, P79, DOI 10.1007/s004180050394; Horio N, 2010, J PHARMACOL SCI, V112, P8, DOI 10.1254/jphs.09R07FM; Hurtado MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046358; Jyotaki M, 2010, ENDOCR J, V57, P467, DOI 10.1507/endocrj.K10E-095; Katano H, 2006, GENE THER, V13, P594, DOI 10.1038/sj.gt.3302691; Kawai K, 2000, P NATL ACAD SCI USA, V97, P11044, DOI 10.1073/pnas.190066697; le Roux CW, 2011, AM J PHYSIOL-REG I, V301, pR1057, DOI 10.1152/ajpregu.00139.2011; LEIBOWITZ SF, 1991, PEPTIDES, V12, P1251, DOI 10.1016/0196-9781(91)90203-2; Martin B, 2009, ANN NY ACAD SCI, V1170, P98, DOI 10.1111/j.1749-6632.2009.03920.x; Michel MC, 2008, N-S ARCH PHARMACOL, V377, P205, DOI 10.1007/s00210-008-0280-0; Michel MC, 1998, PHARMACOL REV, V50, P143; Michlig S, 2007, J COMP NEUROL, V502, P1003, DOI 10.1002/cne.21354; Miras AD, 2010, CURR OPIN GASTROEN, V26, P140, DOI 10.1097/MOG.0b013e328333e94a; Morimoto R, 2008, NUTRITION, V24, P878, DOI 10.1016/j.nut.2008.06.011; Nakamura Y, 2008, DIABETES, V57, P2661, DOI 10.2337/db07-1103; Nelson TM, 2003, CHEM SENSES, V28, P695, DOI 10.1093/chemse/bjg062; Nguyen AD, 2011, CURR OPIN ENDOCRINOL, V18, P56, DOI 10.1097/MED.0b013e3283422f0a; Olbers T, 2006, ANN SURG, V244, P715, DOI 10.1097/01.sla.0000218085.25902.f8; Padley F., 1986, LIPID HDB, P88; Panek-Scarborough LM, 2012, PHYSIOL BEHAV, V105, P1242, DOI 10.1016/j.physbeh.2012.01.001; Sclafani A, 2007, PHYSIOL BEHAV, V90, P602, DOI 10.1016/j.physbeh.2006.11.012; Shigemura N, 2004, ENDOCRINOLOGY, V145, P839, DOI 10.1210/en.2003-0602; Shin AC, 2011, AM J PHYSIOL-REG I, V301, pR1267, DOI 10.1152/ajpregu.00314.2011; Shin YK, 2008, J NEUROCHEM, V106, P455, DOI 10.1111/j.1471-4159.2008.05397.x; Smith BK, 2001, AM J PHYSIOL-REG I, V281, pR596, DOI 10.1152/ajpregu.2001.281.2.R596; Smith JC, 2001, APPETITE, V36, P93, DOI 10.1006/appe.2000.0372; Stefanie B., 2013, BIOL CHEM, V394, P921; Stewart JE, 2011, PROG LIPID RES, V50, P225, DOI 10.1016/j.plipres.2011.02.002; Stewart JE, 2010, BRIT J NUTR, V104, P145, DOI 10.1017/S0007114510000267; Tichansky DS, 2011, SURG ENDOSC, V25, P1176, DOI 10.1007/s00464-010-1335-0; Umabiki M, 2010, TOHOKU J EXP MED, V220, P267, DOI 10.1620/tjem.220.267; Vona-Davis LC, 2007, CURR TOP MED CHEM, V7, P1710, DOI 10.2174/156802607782340966; Zhang L, 2011, PHARMACOL THERAPEUT, V131, P91, DOI 10.1016/j.pharmthera.2011.03.011; Zhang XJ, 2011, ACTA HISTOCHEM, V113, P663, DOI 10.1016/j.acthis.2010.09.007; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	55	34	34	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2013	27	12					5022	5033		10.1096/fj.13-228064	http://dx.doi.org/10.1096/fj.13-228064			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	293UK	24043261	Green Published			2022-12-25	WOS:000329999000035
J	Dhruv, H; Loftus, JC; Narang, P; Petit, JL; Fameree, M; Burton, J; Tchegho, G; Chow, D; Yin, H; Al-Abed, Y; Berens, ME; Tran, NL; Meurice, N				Dhruv, Harshil; Loftus, Joseph C.; Narang, Pooja; Petit, Joachim L.; Fameree, Maureen; Burton, Julien; Tchegho, Giresse; Chow, Donald; Yin, Holly; Al-Abed, Yousef; Berens, Michael E.; Tran, Nhan L.; Meurice, Nathalie			Structural Basis and Targeting of the Interaction between Fibroblast Growth Factor-inducible 14 and Tumor Necrosis Factor-like Weak Inducer of Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Cell Signaling; Cell Surface Receptor; Docking; Drug Development; Drug Discovery; Drug Screening; Protein-Protein Interactions	CYSTEINE-RICH DOMAIN; SMALL-MOLECULE INHIBITION; TWEAK/FN14 PATHWAY; KAPPA-B; MULTIFUNCTIONAL CYTOKINE; CELL MIGRATION; FN14; RECEPTOR; PROTEIN; TNF	Deregulation of the TNF-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling pathway is observed in many diseases, including inflammation, autoimmune diseases, and cancer. Activation of Fn14 signaling by TWEAK binding triggers cell invasion and survival and therefore represents an attractive pathway for therapeutic intervention. Based on structural studies of the TWEAK-binding cysteine-rich domain of Fn14, several homology models of TWEAK were built to investigate plausible modes of TWEAK-Fn14 interaction. Two promising models, centered on different anchoring residues of TWEAK (tyrosine 176 and tryptophan 231), were prioritized using a data-driven strategy. Site-directed mutagenesis of TWEAK at Tyr(176), but not Trp(231), resulted in the loss of TWEAK binding to Fn14 substantiating Tyr(176) as the anchoring residue. Importantly, mutation of TWEAK at Tyr(176) did not disrupt TWEAK trimerization but failed to induce Fn14-mediated nuclear factor -light chain enhancer of activated B cell (NF-B) signaling. The validated structural models were utilized in a virtual screen to design a targeted library of small molecules predicted to disrupt the TWEAK-Fn14 interaction. 129 small molecules were screened iteratively, with identification of molecules producing up to 37% inhibition of TWEAK-Fn14 binding. In summary, we present a data-driven in silico study revealing key structural elements of the TWEAK-Fn14 interaction, followed by experimental validation, serving as a guide for the design of small molecule inhibitors of the TWEAK-Fn14 ligand-receptor interaction. Our results validate the TWEAK-Fn14 interaction as a chemically tractable target and provide the foundation for further exploration utilizing chemical biology approaches focusing on validating this system as a therapeutic target in invasive cancers.	[Dhruv, Harshil; Fameree, Maureen; Burton, Julien; Tchegho, Giresse; Chow, Donald; Yin, Holly; Berens, Michael E.; Tran, Nhan L.] Translat Genom Res Inst, Phoenix, AZ 85004 USA; [Loftus, Joseph C.; Narang, Pooja; Petit, Joachim L.; Meurice, Nathalie] Mayo Clin, Scottsdale, AZ 85259 USA; [Al-Abed, Yousef] Feinstein Inst Med Res, Ctr Mol Innovat, Manhasset, NY 11030 USA	Translational Genomics Research Institute; Mayo Clinic; Mayo Clinic Phoenix; Northwell Health	Tran, NL (corresponding author), Translat Genom Res Inst, 445 N 5th St, Phoenix, AZ 85004 USA.	ntran@tgen.org; meurice.nathalie@mayo.edu			National Institutes of Health from NIEHS [ES06694]; NCI [CA023074]; BIO5 Institute of the University of Arizona; NATIONAL CANCER INSTITUTE [R01CA130940, P30CA015083, P50CA108961, P30CA023074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC2MH090878] Funding Source: NIH RePORTER	National Institutes of Health from NIEHS; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BIO5 Institute of the University of Arizona; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Dr. Gerald M. Maggiora for fruitful discussions and Dr. Jeffrey Winkles (University of Maryland) for the HEK293-Fn14-NF kappa B luciferase cells. Surface plasmon resonance data were acquired by the Arizona Proteomics Consortium supported by National Institutes of Health Grant ES06694 from NIEHS to the Southwest Environmental Health Sciences Center and Grant CA023074 from NCI to the Arizona Cancer Center, and by the BIO5 Institute of the University of Arizona.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Benicchi T, 2012, J BIOMOL SCREEN, V17, P933, DOI 10.1177/1087057112447873; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhatnagar S, 2012, CURR MOL MED, V12, P3, DOI 10.2174/156652412798376107; Bhattacharjee M., 2012, J SIGNAL TRANSDUCT, V2012; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Brockmann MA, 2003, NEUROSURGERY, V52, P1391, DOI 10.1227/01.NEU.0000064806.87785.AB; Brown SAN, 2006, BIOCHEM J, V397, P297, DOI 10.1042/BJ20051362; Brown SAN, 2010, J BIOL CHEM, V285, P17432, DOI 10.1074/jbc.M110.131979; Burkly LC, 2007, CYTOKINE, V40, P1, DOI 10.1016/j.cyto.2007.09.007; Burkly LC, 2011, IMMUNOL REV, V244, P99, DOI 10.1111/j.1600-065X.2011.01054.x; Campbell S, 2006, J IMMUNOL, V176, P1889, DOI 10.4049/jimmunol.176.3.1889; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Dixon SL, 2006, CHEM BIOL DRUG DES, V67, P370, DOI 10.1111/j.1747-0285.2006.00384.x; Feng SLY, 2000, AM J PATHOL, V156, P1253, DOI 10.1016/S0002-9440(10)64996-6; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Frostell-Karlsson A, 2000, J MED CHEM, V43, P1986, DOI 10.1021/jm991174y; Han HY, 2002, CANCER RES, V62, P2890; Harada N, 2002, BIOCHEM BIOPH RES CO, V299, P488, DOI 10.1016/S0006-291X(02)02670-0; He F, 2009, PROTEIN SCI, V18, P650, DOI 10.1002/pro.49; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Hymowitz SG, 2005, J BIOL CHEM, V280, P7218, DOI 10.1074/jbc.M411714200; Jain M, 2009, CIRCULATION, V119, P2058, DOI 10.1161/CIRCULATIONAHA.108.837286; Kolfschoten GA, 2003, BIOCHEM PHARMACOL, V66, P1427, DOI 10.1016/S0006-2952(03)00493-3; Kolzsch J, 1990, Z Arztl Fortbild (Jena), V84, P1199; Lammens A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062697; Lamszus K, 1998, INT J CANCER, V75, P19, DOI 10.1002/(SICI)1097-0215(19980105)75:1<19::AID-IJC4>3.0.CO;2-4; Meighan-Mantha RL, 1999, J BIOL CHEM, V274, P33166, DOI 10.1074/jbc.274.46.33166; Meireles LMC, 2010, NUCLEIC ACIDS RES, V38, pW407, DOI 10.1093/nar/gkq502; Molecular Operating Environment, 2010, MOL OP ENV VERS 2010; NEMETHY G, 1992, J PHYS CHEM-US, V96, P6472, DOI 10.1021/j100194a068; Pellegrini M, 2013, FEBS J, V280, P1818, DOI 10.1111/febs.12206; Polek TC, 2003, J BIOL CHEM, V278, P32317, DOI 10.1074/jbc.M302518200; Ramachandran N, 2004, SCIENCE, V305, P86, DOI 10.1126/science.1097639; Schneider P, 1999, EUR J IMMUNOL, V29, P1785, DOI 10.1002/(SICI)1521-4141(199906)29:06<1785::AID-IMMU1785>3.0.CO;2-U; Silvian LF, 2011, ACS CHEM BIOL, V6, P636, DOI 10.1021/cb2000346; Tansey MG, 2009, DRUG DISCOV TODAY, V14, P1082, DOI 10.1016/j.drudis.2009.10.002; Tran NL, 2006, CANCER RES, V66, P9535, DOI 10.1158/0008-5472.CAN-06-0418; Tran NL, 2005, J BIOL CHEM, V280, P3483, DOI 10.1074/jbc.M409906200; Tran NL, 2003, AM J PATHOL, V162, P1313, DOI 10.1016/S0002-9440(10)63927-2; Watts GS, 2007, INT J CANCER, V121, P2132, DOI 10.1002/ijc.22898; Watts KS, 2010, J CHEM INF MODEL, V50, P534, DOI 10.1021/ci100015j; Whitsett TG, 2012, AM J PATHOL, V181, P111, DOI 10.1016/j.ajpath.2012.03.026; Wiley SR, 2003, CYTOKINE GROWTH F R, V14, P241, DOI 10.1016/S1359-6101(03)00019-4; Willis AL, 2008, MOL CANCER RES, V6, P725, DOI 10.1158/1541-7786.MCR-08-0005; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Yoriki R, 2011, EXP THER MED, V2, P103, DOI 10.3892/etm.2010.181; Zheng TS, 2008, J LEUKOCYTE BIOL, V84, P338, DOI 10.1189/jlb.0308165	50	17	19	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32261	32276		10.1074/jbc.M113.493536	http://dx.doi.org/10.1074/jbc.M113.493536			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24056367	Green Published, hybrid			2022-12-25	WOS:000328681700014
J	Kam, RKT; Shi, WL; Chan, SO; Chen, YL; Xu, G; Lau, CBS; Fung, KP; Chan, WY; Zhao, H				Kam, Richard Kin Ting; Shi, Weili; Chan, Sun On; Chen, Yonglong; Xu, Gang; Lau, Clara Bik-San; Fung, Kwok Pui; Chan, Wood Yee; Zhao, Hui			Dhrs3 Protein Attenuates Retinoic Acid Signaling and Is Required for Early Embryonic Patterning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-EMBRYOS; GASTRULATION MOVEMENTS; ZEBRAFISH PRONEPHROS; CELL MOVEMENTS; GENE XLIM-1; EXPRESSION; MESODERM; INDUCTION; SPECIFICATION; LAEVIS	All-trans-retinoic acid (atRA) is an important morphogen involved in many developmental processes, including neural differentiation, body axis formation, and organogenesis. During early embryonic development, atRA is synthesized from all-trans-retinal (atRAL) in an irreversible reaction mainly catalyzed by retinal dehydrogenase 2 (aldh1a2), whereas atRAL is converted from all-trans-retinol via reversible oxidation by retinol dehydrogenases, members of the short-chain dehydrogenase/reductase family. atRA is degraded by cytochrome P450, family 26 (cyp26). We have previously identified a short-chain dehydrogenase/reductase 3 (dhrs3), which showed differential expression patterns in Xenopus embryos. We show here that the expression of dhrs3 was induced by atRA treatment and overexpression of Xenopus nodal related 1 (xnr1) in animal cap assay. Overexpression of dhrs3 enhanced the phenotype of excessive cyp26a1. In embryos overexpressing aldh1a2 or retinol dehydrogenase 10 (rdh10) in the presence of their respective substrates, Dhrs3 counteracted the action of Aldh1a2 or Rdh10, indicating that retinoic acid signaling is attenuated. Knockdown of Dhrs3 by antisense morpholino oligonucleotides resulted in a phenotype of shortened anteroposterior axis, reduced head structure, and perturbed somitogenesis, which were also found in embryos treated with an excess of atRA. Examination of the expression of brachyury, not, goosecoid, and papc indicated that convergent extension movement was defective in Dhrs3 morphants. Taken together, these studies suggest that dhrs3 participates in atRA metabolism by reducing atRAL levels and is required for proper anteroposterior axis formation, neuroectoderm patterning, and somitogenesis.	[Kam, Richard Kin Ting; Fung, Kwok Pui; Zhao, Hui] Chinese Univ Hong Kong, Minist Educ, Key Lab Regenerat Med, Hong Kong, Hong Kong, Peoples R China; [Chan, Sun On; Chan, Wood Yee] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Chen, Yonglong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, Guangzhou 510663, Guangdong, Peoples R China; [Zhao, Hui] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen 518057, Peoples R China; [Shi, Weili; Xu, Gang] Chinese Univ Hong Kong, Fac Med, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Lau, Clara Bik-San] Chinese Univ Hong Kong, Inst Chinese Med, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese University of Hong Kong, Shenzhen; Chinese University of Hong Kong; Chinese University of Hong Kong	Chan, WY (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.	wy-chan@cuhk.edu.hk; zhaohui@cuhk.edu.hk	Chan, Sun-On/R-6547-2018; Zhao, Hui/B-8429-2016; Fung, Kwok Pui/R-9708-2018; Lau, Clara Bik-San/AAF-3989-2020; Chan, Wood Yee/R-6692-2018	Chan, Sun-On/0000-0002-3221-3786; Zhao, Hui/0000-0001-8160-6415; Fung, Kwok Pui/0000-0001-6214-5123; Lau, Clara Bik-San/0000-0002-7409-1270; Chan, Wood Yee/0000-0002-7114-1463	Research Grants Council of Hong Kong [CUHK480709, N_CUHK413/12]; Key Project of Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-YW-R-083]; National Natural Science Foundation of China [81270438]; Chinese University of Hong Kong	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Key Project of Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese University of Hong Kong(Chinese University of Hong Kong)	This work was supported in part by Grants CUHK480709 and N_CUHK413/12 from the Research Grants Council of Hong Kong (to H. Z.), in part by Key Project of Knowledge Innovation Program of the Chinese Academy of Sciences Grant KSCX2-YW-R-083 (to Y. L. C.), and National Natural Science Foundation of China Grant 81270438 (to G. X.).; Supported by graduate studentships from the Chinese University of Hong Kong.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Aulehla A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000869; Bollig F, 2009, DEVELOPMENT, V136, P2883, DOI 10.1242/dev.031773; Brent AE, 2004, DEVELOPMENT, V131, P3885, DOI 10.1242/dev.01275; Caneparo L, 2007, GENE DEV, V21, P465, DOI 10.1101/gad.406007; Cartry J, 2006, DEV BIOL, V299, P35, DOI 10.1016/j.ydbio.2006.06.047; Cerignoli F, 2002, CANCER RES, V62, P1196; Chen F, 2007, DEVELOPMENT, V134, P2969, DOI 10.1242/dev.006221; Chen Y, 2003, MECH DEVELOP, V120, P277, DOI 10.1016/S0925-4773(02)00460-4; Chen YL, 2004, DEV BIOL, V271, P144, DOI 10.1016/j.ydbio.2004.03.030; CHEN YP, 1994, DEV BIOL, V161, P70, DOI 10.1006/dbio.1994.1008; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Duester G, 2003, CHEM-BIOL INTERACT, V143, P201, DOI 10.1016/S0009-2797(02)00204-1; Duester Gregg, 2007, Birth Defects Research, V81, P84, DOI 10.1002/bdrc.20092; Esteban-Pretel G, 2010, J NUTR BIOCHEM, V21, P227, DOI 10.1016/j.jnutbio.2008.12.007; Feng L, 2010, DEV BIOL, V338, P1, DOI 10.1016/j.ydbio.2009.10.029; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Harada Y, 2007, BIOCHEM BIOPH RES CO, V358, P968, DOI 10.1016/j.bbrc.2007.04.208; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HARVEY RP, 1992, MECH DEVELOP, V37, P141, DOI 10.1016/0925-4773(92)90076-V; Hollemann T, 1998, EMBO J, V17, P7361, DOI 10.1093/emboj/17.24.7361; Hukriede NA, 2003, DEV CELL, V4, P83, DOI 10.1016/S1534-5807(02)00398-2; ISAACS HV, 1994, EMBO J, V13, P4469, DOI 10.1002/j.1460-2075.1994.tb06769.x; Ishibashi H, 2008, MECH DEVELOP, V125, P58, DOI 10.1016/j.mod.2007.10.005; Janssens S, 2010, INT J DEV BIOL, V54, P1435, DOI 10.1387/ijdb.092985sj; JONES CM, 1995, DEVELOPMENT, V121, P3651; Kam RKT, 2010, INT J DEV BIOL, V54, P1355, DOI 10.1387/ijdb.092984rk; Kam RKT, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-11; Kim SH, 1998, DEVELOPMENT, V125, P4681; Kolm PJ, 1997, DEV BIOL, V192, P1, DOI 10.1006/dbio.1997.8754; KOLM PJ, 1995, DEV BIOL, V167, P34, DOI 10.1006/dbio.1995.1005; Kuroda H, 2002, DEV BIOL, V244, P267, DOI 10.1006/dbio.2002.0589; Latinkic BV, 1997, GENE DEV, V11, P3265, DOI 10.1101/gad.11.23.3265; Lee SJ, 2010, MECH DEVELOP, V127, P49, DOI 10.1016/j.mod.2009.11.001; Lee YM, 2008, J BIOL CHEM, V283, P33969, DOI 10.1074/jbc.M804469200; Luxardi G, 2010, DEVELOPMENT, V137, P417, DOI 10.1242/dev.039735; Mansukhani A, 2005, J CELL BIOL, V168, P1065, DOI 10.1083/jcb.200409182; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; Mic FA, 2002, DEVELOPMENT, V129, P2271; Mizuseki K, 1998, DEVELOPMENT, V125, P579; Niederreither K, 2001, DEVELOPMENT, V128, P1019; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Ryckebusch L, 2008, P NATL ACAD SCI USA, V105, P2913, DOI 10.1073/pnas.0712344105; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Strate I, 2009, DEVELOPMENT, V136, P461, DOI 10.1242/dev.024901; Tada M, 2012, DEVELOPMENT, V139, P3897, DOI 10.1242/dev.073007; TAIRA M, 1994, DEVELOPMENT, V120, P1525; TAIRA M, 1992, GENE DEV, V6, P356, DOI 10.1101/gad.6.3.356; Tanibe M, 2008, INT J DEV BIOL, V52, P893, DOI 10.1387/ijdb.082683mt; Uehara M, 2009, GENE DEV, V23, P1689, DOI 10.1101/gad.1776209; Wessely O, 2002, NEURON, V33, P489, DOI 10.1016/S0896-6273(02)00596-2; White RJ, 2008, DEV DYNAM, V237, P2775, DOI 10.1002/dvdy.21695; WILLIAMS BA, 1994, DEVELOPMENT, V120, P785; Wingert RA, 2007, PLOS GENET, V3, P1922, DOI 10.1371/journal.pgen.0030189; Zhao H, 2001, INT J DEV BIOL, V45, P817	56	39	40	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31477	31487		10.1074/jbc.M113.514984	http://dx.doi.org/10.1074/jbc.M113.514984			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24045938	hybrid, Green Published			2022-12-25	WOS:000330596200007
J	Perdomo-Morales, R; Montero-Alejo, V; Corzo, G; Besada, V; Vega-Hurtado, Y; Gonzalez-Gonzalez, Y; Perera, E; Porto-Verdecia, M				Perdomo-Morales, Rolando; Montero-Alejo, Vivian; Corzo, Gerardo; Besada, Vladimir; Vega-Hurtado, Yamile; Gonzalez-Gonzalez, Yamile; Perera, Erick; Porto-Verdecia, Marlene			The Trypsin Inhibitor Panulirin Regulates the Prophenoloxidase-activating System in the Spiny Lobster Panulirus argus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANDUCA-SEXTA SERPIN-4; BLACK TIGER SHRIMP; SERINE PROTEINASE; PHENOLOXIDASE ACTIVITY; PROTEASE INHIBITORS; OXIDASE ACTIVATION; PROTEOLYTIC-ENZYMES; CATIONIC PEPTIDE; CDNA CLONING; ACTIVE-SITE	The melanization reaction promoted by the prophenoloxidase- activating system is an essential defense response in invertebrates subjected to regulatory mechanisms that are still not fully understood. We report here the finding and characterization of a novel trypsin inhibitor, named panulirin, isolated from the hemocytes of the spiny lobster Panulirus argus with regulatory functions on the melanization cascade. Panulirin is a cationic peptide (pI 9.5) composed of 48 amino acid residues (5.3 kDa), with six cysteine residues forming disulfide bridges. Its primary sequence was determined by combining Edman degradation/N-terminal sequencing and electrospray ionization-MS/MS spectrometry. The low amino acid sequence similarity with known proteins indicates that it represents a new family of peptidase inhibitors. Panulirin is a competitive and reversible tight-binding inhibitor of trypsin (K-i = 8.6 nM) with a notable specificity because it does not inhibit serine peptidases such as subtilisin, elastase, chymotrypsin, thrombin, and plasmin. The removal of panulirin from the lobster hemocyte lysate leads to an increase in phenoloxidase response to LPS. Likewise, the addition of increasing concentrations of panulirin to a lobster hemocyte lysate, previously depleted of trypsin-inhibitory activity, decreased the phenoloxidase response to LPS in a concentration-dependent fashion. These results indicate that panulirin is implicated in the regulation of the melanization cascade in P. argus by inhibiting peptidase(s) in the pathway toward the activation of the prophenoloxidase enzyme.	[Perdomo-Morales, Rolando; Montero-Alejo, Vivian; Vega-Hurtado, Yamile; Porto-Verdecia, Marlene] Ctr Pharmaceut Res & Dev, Dept Biochem, Havana 10400, Cuba; [Corzo, Gerardo] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca 62250, Morelos, Mexico; [Besada, Vladimir] Ctr Genet Engn & Biotechnol, Dept Prote, Havana 10600, Cuba; [Gonzalez-Gonzalez, Yamile] Univ Fed Sao Paulo, Dept Biochem, BR-04044020 Sao Paulo, Brazil; [Perera, Erick] Univ Havana, Ctr Marine Res, Havana 11300, Cuba	Universidad Nacional Autonoma de Mexico; Centro de Ingenieria Genetica y Biotecnologia; Universidade Federal de Sao Paulo (UNIFESP); Universidad de la Habana	Perdomo-Morales, R (corresponding author), Ctr Pharmaceut Res & Dev, Dept Biochem, Ave 26 1605 E Ave 51 & Boyeros, Havana 10400, Cuba.	rolando.perdomo@infomed.sld.cu	Perera, Erick/F-2917-2012; Perera, Erick/E-9908-2018; Corzo, Gerardo/B-3778-2014; Montero-Alejo, Vivian/AAY-1316-2020; Perdomo-Morales, Rolando/AAC-8280-2020	Perera, Erick/0000-0001-6108-1340; Perera, Erick/0000-0001-6108-1340; Corzo, Gerardo/0000-0002-9513-1622; Montero-Alejo, Vivian/0000-0002-0089-7925; Perdomo-Morales, Rolando/0000-0001-5598-6864; Besada, Vladimir/0000-0003-3584-7714				An CJ, 2010, INSECT BIOCHEM MOLEC, V40, P683, DOI 10.1016/j.ibmb.2010.07.001; Corral-Rodriguez MA, 2009, INSECT BIOCHEM MOLEC, V39, P579, DOI 10.1016/j.ibmb.2009.07.003; Apostoluk W, 1998, PROTEINS, V32, P459, DOI 10.1002/(SICI)1097-0134(19980901)32:4<459::AID-PROT5>3.0.CO;2-B; ASHIDA M, 1984, COMP BIOCHEM PHYS B, V77, P21, DOI 10.1016/0305-0491(84)90217-7; ASPAN A, 1990, INSECT BIOCHEM, V20, P485, DOI 10.1016/0020-1790(90)90030-X; ASPAN A, 1991, INSECT BIOCHEM, V21, P363, DOI 10.1016/0020-1790(91)90002-V; Ballin JD, 2004, NUCLEIC ACIDS RES, V32, P3271, DOI 10.1093/nar/gkh646; BIETH JG, 1995, METHOD ENZYMOL, V248, P59; Bode W, 2000, BBA-PROTEIN STRUCT M, V1477, P241, DOI 10.1016/S0167-4838(99)00276-9; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Breugelmans B, 2009, PEPTIDES, V30, P622, DOI 10.1016/j.peptides.2008.07.026; Cardenas W, 1997, FISH SHELLFISH IMMUN, V7, P283, DOI 10.1006/fsim.1997.0083; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Cerenius L, 2010, TRENDS BIOCHEM SCI, V35, P575, DOI 10.1016/j.tibs.2010.04.006; Cerenius L, 2010, J INVERTEBR PATHOL, V103, P21, DOI 10.1016/j.jip.2009.09.006; CHASE T, 1967, BIOCHEM BIOPH RES CO, V29, P508, DOI 10.1016/0006-291X(67)90513-X; Christeller JT, 2005, FEBS J, V272, P5710, DOI 10.1111/j.1742-4658.2005.04975.x; Copeland R. A., 2000, PRACTICAL INTRO STRU, P305; ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X; Franssens V, 2008, PEPTIDES, V29, P235, DOI 10.1016/j.peptides.2007.07.032; Gai YC, 2008, FISH SHELLFISH IMMUN, V25, P657, DOI 10.1016/j.fsi.2008.08.013; Garcia-Molina F, 2007, J AGR FOOD CHEM, V55, P9739, DOI 10.1021/jf0712301; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Grzesiak A, 2000, J MOL BIOL, V301, P205, DOI 10.1006/jmbi.2000.3935; Gubb D, 2010, BIOCHIMIE, V92, P1749, DOI 10.1016/j.biochi.2010.09.004; HANSPAL JS, 1983, ANAL BIOCHEM, V132, P288, DOI 10.1016/0003-2697(83)90010-6; HAZES B, 1988, PROTEIN ENG, V2, P119, DOI 10.1093/protein/2.2.119; HERGENHAHN HG, 1987, BIOCHEM J, V248, P223, DOI 10.1042/bj2480223; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Jiang HB, 2003, INSECT BIOCHEM MOLEC, V33, P1049, DOI 10.1016/S0965-1748(03)00123-1; Jiang HB, 2003, J BIOL CHEM, V278, P3552, DOI 10.1074/jbc.M205743200; Jiang N, 2007, NAT IMMUNOL, V8, P1114, DOI 10.1038/ni1501; Jiang R, 2009, J BIOL CHEM, V284, P35652, DOI 10.1074/jbc.M109.071001; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9; Kelly CA, 2005, PROTEIN PEPTIDE LETT, V12, P465, DOI 10.2174/0929866054395383; Krowarsch D, 2005, PROTEIN PEPTIDE LETT, V12, P403, DOI 10.2174/0929866054395275; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; LABOUESSE J, 1967, EUR J BIOCHEM, V2, P215, DOI 10.1111/j.1432-1033.1967.tb00127.x; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Laskowski Jr. M., 2000, PROTEIN PROTEIN RECO, P228; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Laskowski M, 2000, BBA-PROTEIN STRUCT M, V1477, P324, DOI 10.1016/S0167-4838(99)00284-8; Laskowski M Jr, 1986, Adv Exp Med Biol, V199, P1; Liang ZC, 1997, P NATL ACAD SCI USA, V94, P6682, DOI 10.1073/pnas.94.13.6682; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu ZQ, 2007, INSECT BIOCHEM MOLEC, V37, P478, DOI 10.1016/j.ibmb.2007.02.004; Montero-Alejo V, 2012, FISH SHELLFISH IMMUN, V33, P872, DOI 10.1016/j.fsi.2012.07.013; Nagase H., 2001, FINDING PURIFICATION, V2nd ed., P131; Nappi A, 2009, ADV PARASIT, V70, P99, DOI 10.1016/S0065-308X(09)70004-1; OHTA T, 1994, J MOL EVOL, V39, P614, DOI 10.1007/BF00160406; Otlewski J, 2005, EMBO J, V24, P1303, DOI 10.1038/sj.emboj.7600611; Perazzolo LM, 1997, DEV COMP IMMUNOL, V21, P385, DOI 10.1016/S0145-305X(97)00022-0; Perdomo-Morales R, 2007, FISH SHELLFISH IMMUN, V23, P1187, DOI 10.1016/j.fsi.2007.04.001; Perdomo-Morales R, 2008, BBA-GEN SUBJECTS, V1780, P652, DOI 10.1016/j.bbagen.2008.01.001; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; Pisuttharachai D, 2009, DEV COMP IMMUNOL, V33, P434, DOI 10.1016/j.dci.2008.11.007; Pisuttharachai D, 2009, FISHERIES SCI, V75, P195, DOI 10.1007/s12562-008-0027-3; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; Rawlings ND, 2010, BIOCHIMIE, V92, P1463, DOI 10.1016/j.biochi.2010.04.013; Rimphanitchayakit V, 2010, DEV COMP IMMUNOL, V34, P377, DOI 10.1016/j.dci.2009.12.004; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Simonet G, 2003, PEPTIDES, V24, P1633, DOI 10.1016/j.peptides.2003.07.014; Simonet G, 2002, COMP BIOCHEM PHYS B, V132, P247, DOI 10.1016/S1096-4959(01)00530-9; SMITH VJ, 1991, DEV COMP IMMUNOL, V15, P251, DOI 10.1016/0145-305X(91)90018-T; Soderhall I, 2009, J BIOL CHEM, V284, P6301, DOI 10.1074/jbc.M806764200; SODERHALL K, 1984, BIOCHIM BIOPHYS ACTA, V797, P99, DOI 10.1016/0304-4165(84)90387-8; Somnuk S, 2012, FISH SHELLFISH IMMUN, V33, P332, DOI 10.1016/j.fsi.2012.05.005; Sritunyalucksana K, 1999, DEV COMP IMMUNOL, V23, P179, DOI 10.1016/S0145-305X(99)00005-1; Sugumaran H, 2002, PIGM CELL RES, V15, P2, DOI 10.1034/j.1600-0749.2002.00056.x; Sugumaran M, 2000, BIOCHEM BIOPH RES CO, V268, P379, DOI 10.1006/bbrc.2000.2138; Tong YR, 2005, J BIOL CHEM, V280, P14932, DOI 10.1074/jbc.M500532200; Tong YR, 2005, J BIOL CHEM, V280, P14923, DOI 10.1074/jbc.M500531200; TSUKAMOTO T, 1992, BIOCHEM BIOPH RES CO, V184, P86, DOI 10.1016/0006-291X(92)91161-I; Wang SY, 2012, FISH SHELLFISH IMMUN, V32, P331, DOI 10.1016/j.fsi.2011.11.025; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1; Zhang W, 1996, P NATL ACAD SCI USA, V93, P2511, DOI 10.1073/pnas.93.6.2511; Zhao MY, 2005, J BIOL CHEM, V280, P24744, DOI 10.1074/jbc.M504173200; Zhu YF, 2003, J BIOL CHEM, V278, P46556, DOI 10.1074/jbc.M309682200; Zou Z, 2005, J BIOL CHEM, V280, P14341, DOI 10.1074/jbc.M500570200	82	6	7	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31867	31879		10.1074/jbc.M113.464297	http://dx.doi.org/10.1074/jbc.M113.464297			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24047891	Green Published, hybrid			2022-12-25	WOS:000330596200036
J	Heimer, SR; Evans, DJ; Stern, ME; Barbieri, JT; Yahr, T; Fleiszig, SMJ				Heimer, Susan R.; Evans, David J.; Stern, Michael E.; Barbieri, Joseph T.; Yahr, Timothy; Fleiszig, Suzanne M. J.			Pseudomonas aeruginosa Utilizes the Type III Secreted Toxin ExoS to Avoid Acidified Compartments within Epithelial Cells	PLOS ONE			English	Article							ADP-RIBOSYLATION DOMAIN; EXOENZYME-S; INTRACELLULAR-LOCALIZATION; BURKHOLDERIA-CENOCEPACIA; IN-VIVO; VACUOLES; MACROPHAGES; MATURATION; SURVIVAL; EXSA	Invasive Pseudomonas aeruginosa (PA) can enter epithelial cells wherein they mediate formation of plasma membrane bleb-niches for intracellular compartmentalization. This phenotype, and capacity for intracellular replication, requires the ADP-ribosyltransferase (ADPr) activity of ExoS, a PA type III secretion system (T3SS) effector protein. Thus, PA T3SS mutants lack these capacities and instead traffic to perinuclear vacuoles. Here, we tested the hypothesis that the T3SS, via the ADPr activity of ExoS, allows PA to evade acidic vacuoles that otherwise suppress its intracellular viability. The acidification state of bacteria-occupied vacuoles within infected corneal epithelial cells was studied using LysoTracker to visualize acidic, lysosomal vacuoles. Steady state analysis showed that within cells wild-type PAO1 localized to both membrane bleb-niches and vacuoles, while both exsA (transcriptional activator) and popB (effector translocation) T3SS mutants were only found in vacuoles. The acidification state of occupied vacuoles suggested a relationship with ExoS expression, i.e. vacuoles occupied by the exsA mutant (unable to express ExoS) were more often acidified than either popB mutant or wild-type PAO1 occupied vacuoles (p < 0.001). An exoS-gfp reporter construct pJNE05 confirmed that high exoS transcriptional output coincided with low occupation of acidified vacuoles, and vice versa, for both popB mutants and wild-type bacteria. Complementation of a triple effector null mutant of PAO1 with exoS (pUCPexoS) reduced the number of acidified bacteria-occupied vacuoles per cell; pUCPexoSE381D which lacks ADPr activity did not. The H+-ATPase inhibitor bafilomycin rescued intracellular replication to wild-type levels for exsA mutants, showing its viability is suppressed by vacuolar acidification. Taken together, the data show that the mechanism by which ExoS ADPr activity allows intracellular replication by PA involves suppression of vacuolar acidification. They also show that variability in ExoS expression by wild-type PA inside cells can differentially influence the fate of individual intracellular bacteria, even within the same cell.	[Heimer, Susan R.; Evans, David J.; Fleiszig, Suzanne M. J.] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Heimer, Susan R.; Evans, David J.] Touro Univ Calif, Coll Pharm, Vallejo, CA USA; [Stern, Michael E.] Allergan Pharmaceut Inc, Irvine, CA USA; [Barbieri, Joseph T.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Yahr, Timothy] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Fleiszig, Suzanne M. J.] Univ Calif Berkeley, Grad Grp Vis Sci, Berkeley, CA 94720 USA; [Fleiszig, Suzanne M. J.] Univ Calif Berkeley, Grad Grp Microbiol, Berkeley, CA 94720 USA; [Fleiszig, Suzanne M. J.] Univ Calif Berkeley, Grad Grp Infect Dis & Immun, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Touro University California; AbbVie; Allergan; Medical College of Wisconsin; University of Iowa; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Fleiszig, SMJ (corresponding author), Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.	fleiszig@berkeley.edu		Fleiszig, Suzanne/0000-0001-6324-3462; Yahr, Timothy/0000-0001-9054-8704; Evans, David/0000-0002-6885-2053	National Institutes of Health (NIH) [AI079192, AI030162, AI055042]; Allergan Inc.; University of California, Berkeley; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030162, R01AI055042, R01AI079192, R56AI055042] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allergan Inc.(AbbVieAllergan); University of California, Berkeley(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institutes of Health (NIH) AI079192 (SMJF), AI030162 (JTB) and AI055042 (TY). Funding from Allergan Inc. was provided under a research agreement with the University of California, Berkeley. The NIH had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Stern is a paid employee of Allergan Inc., and contributed to conception of the project idea. No other external funding was received for this work.	Agodi A, 2010, J HOSP INFECT, V74, P258, DOI 10.1016/j.jhin.2009.08.015; Alix E, 2011, J CELL BIOL, V195, P943, DOI 10.1083/jcb.201105019; Angus AA, 2008, INFECT IMMUN, V76, P1992, DOI 10.1128/IAI.01221-07; Angus AA, 2010, INFECT IMMUN, V78, P4500, DOI 10.1128/IAI.00417-10; Barbieri JT, 2005, REV PHYSIOL BIOCH P, V152, P79, DOI 10.1007/s10254-004-0031-7; Beauregard KE, 1997, J EXP MED, V186, P1159, DOI 10.1084/jem.186.7.1159; Bloemberg GV, 1997, APPL ENVIRON MICROB, V63, P4543, DOI 10.1128/AEM.63.11.4543-4551.1997; Brutinel ED, 2008, MOL MICROBIOL, V68, P657, DOI 10.1111/j.1365-2958.2008.06179.x; Cisz M, 2008, J BACTERIOL, V190, P2726, DOI 10.1128/JB.01553-07; Deng Q, 2008, TRAFFIC, V9, P1948, DOI 10.1111/j.1600-0854.2008.00808.x; Eber MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025298; Fleiszig SMJ, 1997, INFECT IMMUN, V65, P579, DOI 10.1128/IAI.65.2.579-586.1997; Ganesan AK, 1998, J BIOL CHEM, V273, P7332, DOI 10.1074/jbc.273.13.7332; Ghigo E, 2012, ADV EXP MED BIOL, V984, P141, DOI 10.1007/978-94-007-4315-1_8; Gomes MS, 1999, INFECT IMMUN, V67, P3199, DOI 10.1128/IAI.67.7.3199-3206.1999; Holden DW, 2002, TRAFFIC, V3, P161, DOI 10.1034/j.1600-0854.2002.030301.x; Hritonenko V, 2012, MICROBES INFECT, V14, P1366, DOI 10.1016/j.micinf.2012.08.007; Itani KMF, 2011, AM J INFECT CONTROL, V39, P42, DOI 10.1016/j.ajic.2010.03.018; Keen EF, 2010, BURNS, V36, P819, DOI 10.1016/j.burns.2009.10.013; Keith KE, 2009, MICROBIOL-SGM, V155, P1004, DOI 10.1099/mic.0.026781-0; Knodler LA, 2003, TRAFFIC, V4, P587, DOI 10.1034/j.1600-0854.2003.00118.x; Koulenti D, 2009, CRIT CARE MED, V37, P2360, DOI 10.1097/CCM.0b013e3181a037ac; Lamothe J, 2007, CELL MICROBIOL, V9, P40, DOI 10.1111/j.1462-5822.2006.00766.x; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Lee EJ, 2003, INVEST OPHTH VIS SCI, V44, P5220, DOI 10.1167/iovs.03-0229; Lee EJ, 2003, INVEST OPHTH VIS SCI, V44, P3892, DOI 10.1167/iovs.02-1302; Logsdon LK, 2011, MBIO, V2, DOI 10.1128/mBio.00332-10; Maresso AW, 2004, J BIOL CHEM, V279, P38402, DOI 10.1074/jbc.M405707200; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; McColley SA, 2012, PEDIATR PULM, V47, P966, DOI 10.1002/ppul.22519; McNeil PL, 2002, J CELL SCI, V115, P873; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Ogawa M, 2006, AUTOPHAGY, V2, P171, DOI 10.4161/auto.2829; Pederson KJ, 2000, MOL MICROBIOL, V37, P287, DOI 10.1046/j.1365-2958.2000.01990.x; Rietsch A, 2006, MOL MICROBIOL, V59, P807, DOI 10.1111/j.1365-2958.2005.04990.x; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Roy D, 2004, SCIENCE, V304, P1515, DOI 10.1126/science.1098371; Shaver CM, 2004, INFECT IMMUN, V72, P6969, DOI 10.1128/IAI.72.12.6969-6977.2004; Singer JT, 2010, APPL ENVIRON MICROB, V76, P3467, DOI 10.1128/AEM.01679-09; Smith AC, 2007, J CELL BIOL, V176, P263, DOI 10.1083/jcb.200611056; Stapleton F, 2012, EYE, V26, P185, DOI 10.1038/eye.2011.288; Urbanowski ML, 2007, INFECT IMMUN, V75, P4432, DOI 10.1128/IAI.00664-07; Vallis AJ, 1999, INFECT IMMUN, V67, P914, DOI 10.1128/IAI.67.2.914-920.1999; Vance RE, 2005, INFECT IMMUN, V73, P1706, DOI 10.1128/IAI.73.3.1706-1713.2005; Yahr TL, 1997, J BACTERIOL, V179, P7165, DOI 10.1128/jb.179.22.7165-7168.1997; YAHR TL, 1994, J BACTERIOL, V176, P3832, DOI 10.1128/JB.176.13.3832-3838.1994; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Zhang Y, 2007, J BIOL CHEM, V282, P13022, DOI 10.1074/jbc.M606305200; Zolfaghar I, 2006, INFECT IMMUN, V74, P3880, DOI 10.1128/IAI.01891-05	49	34	38	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73111	10.1371/journal.pone.0073111	http://dx.doi.org/10.1371/journal.pone.0073111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058462	gold, Green Published, Green Submitted			2022-12-25	WOS:000324695900008
J	Hernandez, SM; Mattsson, BJ; Peters, VE; Cooper, RJ; Carroll, CR				Hernandez, Sonia M.; Mattsson, Brady J.; Peters, Valerie E.; Cooper, Robert J.; Carroll, C. Ron			Coffee Agroforests Remain Beneficial for Neotropical Bird Community Conservation across Seasons	PLOS ONE			English	Article							COSTA-RICA; BROWN JAY; BIODIVERSITY CONSERVATION; SHADE COFFEE; FOREST; OCCUPANCY; PLANTATIONS; DIVERSITY; DYNAMICS; PATTERNS	Coffee agroforestry systems and secondary forests have been shown to support similar bird communities but comparing these habitat types are challenged by potential biases due to differences in detectability between habitats. Furthermore, seasonal dynamics may influence bird communities differently in different habitat types and therefore seasonal effects should be considered in comparisons. To address these issues, we incorporated seasonal effects and factors potentially affecting bird detectability into models to compare avian community composition and dynamics between coffee agroforests and secondary forest fragments. In particular, we modeled community composition and community dynamics of bird functional groups based on habitat type (coffee agroforest vs. secondary forest) and season while accounting for variation in capture probability (i.e. detectability). The models we used estimated capture probability to be similar between habitat types for each dietary guild, but omnivores had a lower capture probability than frugivores and insectivores. Although apparent species richness was higher in coffee agroforest than secondary forest, model results indicated that omnivores and insectivores were more common in secondary forest when accounting for heterogeneity in capture probability. Our results largely support the notion that shade-coffee can serve as a surrogate habitat for secondary forest with respect to avian communities. Small coffee agroforests embedded within the typical tropical countryside matrix of secondary forest patches and small-scale agriculture, therefore, may host avian communities that resemble those of surrounding secondary forest, and may serve as viable corridors linking patches of forest within these landscapes. This information is an important step toward effective landscape-scale conservation in Neotropical agricultural landscapes.	[Hernandez, Sonia M.; Peters, Valerie E.; Carroll, C. Ron] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Mattsson, Brady J.; Cooper, Robert J.] Univ Georgia, Daniel B Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Hernandez, SM (corresponding author), Univ Georgia, Daniel B Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA.	shernz@uga.edu; brady.mattsson@gmail.com	Mattsson, Brady/K-1688-2015	Mattsson, Brady/0000-0002-3182-9538	UGA San Luis Research Station; UGA Costa Rica office; National Science Foundation Graduate Research Fellowship	UGA San Luis Research Station; UGA Costa Rica office; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	The authors thank the staff at the UGA San Luis Research Station, and the UGA Costa Rica office for logistical and financial support. This work was funded by the National Science Foundation Graduate Research Fellowship (Hernandez). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bakermans MH, 2009, BIOL CONSERV, V142, P2476, DOI 10.1016/j.biocon.2009.05.018; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Blake JG, 2000, AUK, V117, P663, DOI 10.1642/0004-8038(2000)117[0663:DOBAAE]2.0.CO;2; Carlo TA, 2003, OECOLOGIA, V134, P119, DOI 10.1007/s00442-002-1087-1; FLEMING TH, 1987, ANNU REV ECOL SYST, V18, P91, DOI 10.1146/annurev.ecolsys.18.1.91; Garrigues R., 2007, BIRDS COSTA RICA FIE; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Greenberg R, 1997, BIOTROPICA, V29, P501, DOI 10.1111/j.1744-7429.1997.tb00044.x; GREENBERG R, 2000, ANIMAL CONSERVATION, V3, P1367; Guindon C. F., 1996, FOREST PATCHES TROPI; Haber W. A., 2000, MONTEVERDE ECOLOGY C, P39; Harvey CA, 2007, BIODIVERS CONSERV, V16, P2257, DOI 10.1007/s10531-007-9194-2; Hernandez-Divers SM, 2008, INVESTIGATING DIFFER; Hines JE, 1999, BIRD STUDY, V46, P209; Janzen D, 1998, SCIENCE, V279, P1312, DOI 10.1126/science.279.5355.1312; KARR JR, 1991, ECOL APPL, V1, P66, DOI 10.2307/1941848; Koens Jacobus Franciscus, 2009, Environment Development and Sustainability, V11, P1225, DOI 10.1007/s10668-009-9214-3; Komar O, 2006, BIRD CONSERV INT, V16, P1, DOI 10.1017/S0959270906000074; LAWTON MF, 1985, CONDOR, V87, P192, DOI 10.2307/1366883; LAWTON MF, 1980, AUK, V97, P631; LAWTON MF, 1981, CONDOR, V83, P27, DOI 10.2307/1367595; Moguel P, 1999, CONSERV BIOL, V13, P11, DOI 10.1046/j.1523-1739.1999.97153.x; Moore JE, 2005, J WILDLIFE MANAGE, V69, P933, DOI 10.2193/0022-541X(2005)069[0933:MPOBFR]2.0.CO;2; Mordecai RS, 2011, J APPL ECOL, V48, P56, DOI 10.1111/j.1365-2664.2010.01921.x; Nadkarni NM., 2000, MONTEVERDE ECOLOGY C, P15; PELTONEN A, 1991, ECOLOGY, V72, P1698, DOI 10.2307/1940969; Perfecto I, 1996, BIOSCIENCE, V46, P598, DOI 10.2307/1312989; Perfecto I, 2008, ANN NY ACAD SCI, V1134, P173, DOI 10.1196/annals.1439.011; Perfecto I, 2007, ENVIRON SCI ENG, P227; Peters VE, 2010, J ANIM ECOL, V79, P824, DOI 10.1111/j.1365-2656.2010.01699.x; POWELL GVN, 1995, CONSERV BIOL, V9, P354, DOI 10.1046/j.1523-1739.1995.9020354.x; RALPH CJ, 2004, MONITORING BIRD POPU; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Ruiz-Gutierrez V, 2010, J APPL ECOL, V47, P621, DOI 10.1111/j.1365-2664.2010.01811.x; Sanchez-Azofeifa GA, 2007, CONSERV BIOL, V21, P1165, DOI 10.1111/j.1523-1739.2007.00751.x; Sekercioglu CH, 2012, J ORNITHOL, V153, pS153, DOI 10.1007/s10336-012-0869-4; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Stiles G., 1989, GUIDE BIRDS COSTA RI; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Wassenaar T, 2007, GLOBAL ENVIRON CHANG, V17, P86, DOI 10.1016/j.gloenvcha.2006.03.007; Young BE, 2000, MONTEVERDE ECOLOGY C, P179; Zipkin EF, 2009, J APPL ECOL, V46, P815, DOI 10.1111/j.1365-2664.2009.01664.x	42	21	21	1	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e65101	10.1371/journal.pone.0065101	http://dx.doi.org/10.1371/journal.pone.0065101			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058437	Green Published, gold, Green Submitted			2022-12-25	WOS:000324695900001
J	Mielke, MM; Maetzler, W; Haughey, NJ; Bandaru, VVR; Savica, R; Deuschle, C; Gasser, T; Hauser, AK; Graber-Sultan, S; Schleicher, E; Berg, D; Liepelt-Scarfone, I				Mielke, Michelle M.; Maetzler, Walter; Haughey, Norman J.; Bandaru, Veera V. R.; Savica, Rodolfo; Deuschle, Christian; Gasser, Thomas; Hauser, Ann-Kathrin; Graeber-Sultan, Susanne; Schleicher, Erwin; Berg, Daniela; Liepelt-Scarfone, Inga			Plasma Ceramide and Glucosylceramide Metabolism Is Altered in Sporadic Parkinson's Disease and Associated with Cognitive Impairment: A Pilot Study	PLOS ONE			English	Article							SOCIETY TASK-FORCE; LEWY BODY DISEASE; GLUCOCEREBROSIDASE MUTATIONS; ALZHEIMER-DISEASE; GAUCHER-DISEASE; DEMENTIA; RELEVANCE; INCREASE; DEATH; CELLS	Background: Mutations in the gene coding for glucocerebrosidase (GBA), which metabolizes glucosylceramide (a monohexosylceramide) into glucose and ceramide, is the most common genetic risk factor for sporadic Parkinson's disease (PD). GBA mutation carriers are more likely to have an earlier age of onset and to develop cognitive impairment and dementia. We hypothesized that plasma levels of lipids involved in ceramide metabolism would also be altered in PD non-GBA mutation carriers and associated with worse cognition. Methods: Plasma ceramide, monohexosylceramide, and lactosylceramide levels in 26 cognitively normal PD patients, 26 PD patients with cognitive impairment or dementia, and 5 cognitively normal non-PD controls were determined by LC/ESI/MS/MS. Results: Levels of all lipid species were higher in PD patients versus controls. Among PD patients, levels of ceramide C16:0, C18:0, C20:0, C22:0, and C24:1 and monohexosylceramide C16:0, C20:0 and C24: 0 species were higher (all P, 0.05) in those with versus without cognitive impairment. Conclusion: These results suggest that plasma ceramide and monohexosylceramide metabolism is altered in PD non-GBA mutation carriers and that higher levels are associated with worse cognition. Additional studies with larger sample sizes, including cognitively normal controls, are needed to confirm these findings.	[Mielke, Michelle M.; Savica, Rodolfo] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Mielke, Michelle M.; Savica, Rodolfo] Mayo Clin, Dept Neurol, Rochester, MN USA; [Maetzler, Walter; Deuschle, Christian; Gasser, Thomas; Hauser, Ann-Kathrin; Graeber-Sultan, Susanne; Berg, Daniela; Liepelt-Scarfone, Inga] Univ Tubingen, Ctr Neurol, Hertie Inst Clin Brain Res, Tubingen, Germany; [Maetzler, Walter; Deuschle, Christian; Gasser, Thomas; Hauser, Ann-Kathrin; Graeber-Sultan, Susanne; Berg, Daniela; Liepelt-Scarfone, Inga] German Ctr Neurodegenerat Dis, DZNE, Tubingen, Germany; [Haughey, Norman J.; Bandaru, Veera V. R.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD USA; [Schleicher, Erwin] Univ Tubingen, Dept Internal Med, Tubingen, Germany	Mayo Clinic; Mayo Clinic; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Johns Hopkins University; Eberhard Karls University of Tubingen	Mielke, MM (corresponding author), Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA.	mielke.michelle@mayo.edu	Maetzler, Walter/A-6796-2011; Berg, Daniela/A-8728-2019; Gasser, Thomas/GNH-5293-2022; Maetzler, Walter/AAE-5831-2020	Maetzler, Walter/0000-0002-5945-4694; Berg, Daniela/0000-0001-5796-5442; Gasser, Thomas/0000-0002-1069-1146; Maetzler, Walter/0000-0002-5945-4694; Mielke, Michelle/0000-0001-7177-1185	National Institute on Aging [U01 AG37526]; Novartis; International Parkinson Fonds (Deutschland) gGmbH (IPD); German Ministry for Education and Research (BMBF); NATIONAL INSTITUTE ON AGING [U01AG037526] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Novartis(Novartis); International Parkinson Fonds (Deutschland) gGmbH (IPD); German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institute on Aging (U01 AG37526) and from George P. Mitchell and the late Cynthia W. Mitchell. The DEMPARK study was funded by an unrestricted grant from Novartis and a grant from the International Parkinson Fonds (Deutschland) gGmbH (IPD). The continuation of the study (LANDSCAPE) is funded by the German Ministry for Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2010, J NEUROL SCI, V289, P18, DOI 10.1016/j.jns.2009.08.034; Alcalay RN, 2012, NEUROLOGY, V78, P1434, DOI 10.1212/WNL.0b013e318253d54b; Balzer-Geldsetzer M, 2011, NEUROEPIDEMIOLOGY, V37, P168, DOI 10.1159/000331490; Bandaru VVR, 2007, NEUROLOGY, V68, P1481, DOI 10.1212/01.wnl.0000260610.79853.47; BEUTLER E, 1992, SCIENCE, V256, P794, DOI 10.1126/science.1589760; Bras J, 2008, FEBS J, V275, P5767, DOI 10.1111/j.1742-4658.2008.06709.x; Brockmann K, 2011, NEUROLOGY, V77, P276, DOI 10.1212/WNL.0b013e318225ab77; da Costa CA, 2000, J BIOL CHEM, V275, P24065, DOI 10.1074/jbc.M002413200; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; Dubois B, 2007, MOVEMENT DISORD, V22, P2314, DOI 10.1002/mds.21844; FranceLanord V, 1997, J NEUROCHEM, V69, P1612; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Gracia-Garcia P, 2011, J NEUROPSYCH CLIN N, V23, P215, DOI 10.1176/appi.neuropsych.23.2.215; Haughey NJ, 2004, ANN NEUROL, V55, P257, DOI 10.1002/ana.10828; Hunot S, 1997, P NATL ACAD SCI USA, V94, P7531, DOI 10.1073/pnas.94.14.7531; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Lee YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015946; Levenson CW, 2004, EXP NEUROL, V190, P506, DOI 10.1016/j.expneurol.2004.08.014; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Mielke MM, 2012, NEUROLOGY, V79, P633, DOI 10.1212/WNL.0b013e318264e380; Mielke MM, 2010, NEUROBIOL AGING, V31, P17, DOI 10.1016/j.neurobiolaging.2008.03.011; Neumann J, 2009, BRAIN, V132, P1783, DOI 10.1093/brain/awp044; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Sofic E, 2001, J NEURAL TRANSM, V108, P541, DOI 10.1007/s007020170055; Tsuang D, 2012, NEUROLOGY, V79, P1944, DOI 10.1212/WNL.0b013e3182735e9a; Yap TL, 2011, J BIOL CHEM, V286, P28080, DOI 10.1074/jbc.M111.237859	28	137	138	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73094	10.1371/journal.pone.0073094	http://dx.doi.org/10.1371/journal.pone.0073094			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058461	Green Published, Green Submitted, gold			2022-12-25	WOS:000324695900007
J	Pinto, F; Mielewczik, M; Liebisch, F; Walter, A; Greven, H; Rascher, U				Pinto, Francisco; Mielewczik, Michael; Liebisch, Frank; Walter, Achim; Greven, Hartmut; Rascher, Uwe			Non-Invasive Measurement of Frog Skin Reflectivity in High Spatial Resolution Using a Dual Hyperspectral Approach	PLOS ONE			English	Article							EUROPEAN TREE FROG; HYPEROLIUS-VIRIDIFLAVUS AMPHIBIA; MATE CHOICE; ULTRAVIOLET REFLECTANCE; ARID ENVIRONMENT; VISUAL PIGMENTS; HYLA-ARBOREA; COLOR-VISION; ADAPTATIONS; HEMOGLOBIN	Background: Most spectral data for the amphibian integument are limited to the visible spectrum of light and have been collected using point measurements with low spatial resolution. In the present study a dual camera setup consisting of two push broom hyperspectral imaging systems was employed, which produces reflectance images between 400 and 2500 nm with high spectral and spatial resolution and a high dynamic range. Methodology/Principal Findings: We briefly introduce the system and document the high efficiency of this technique analyzing exemplarily the spectral reflectivity of the integument of three arboreal anuran species (Litoria caerulea, Agalychnis callidryas and Hyla arborea), all of which appear green to the human eye. The imaging setup generates a high number of spectral bands within seconds and allows non-invasive characterization of spectral characteristics with relatively high working distance. Despite the comparatively uniform coloration, spectral reflectivity between 700 and 1100 nm differed markedly among the species. In contrast to H. arborea, L. caerulea and A. callidryas showed reflection in this range. For all three species, reflectivity above 1100 nm is primarily defined by water absorption. Furthermore, the high resolution allowed examining even small structures such as fingers and toes, which in A. callidryas showed an increased reflectivity in the near infrared part of the spectrum. Conclusion/Significance: Hyperspectral imaging was found to be a very useful alternative technique combining the spectral resolution of spectrometric measurements with a higher spatial resolution. In addition, we used Digital Infrared/Red-Edge Photography as new simple method to roughly determine the near infrared reflectivity of frog specimens in field, where hyperspectral imaging is typically difficult.	[Pinto, Francisco; Mielewczik, Michael; Walter, Achim; Rascher, Uwe] Forschungszentrum Julich GmbH, Inst Bio & Geosci Plant Sci IBG 2, Julich, Germany; [Mielewczik, Michael; Liebisch, Frank; Walter, Achim] Eidgenoss Tech Hsch ETH Zurich, Inst Agr Sci, Zurich, Switzerland; [Greven, Hartmut] Univ Dusseldorf, Inst Zellbiol, D-40225 Dusseldorf, Germany	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf	Mielewczik, M (corresponding author), Forschungszentrum Julich GmbH, Inst Bio & Geosci Plant Sci IBG 2, Julich, Germany.	michaemi@ethz.ch	Walter, Achim/N-8392-2013; Rascher, Uwe/D-5457-2009; Mielewczik, Michael/H-6491-2015	Rascher, Uwe/0000-0002-9993-4588; Mielewczik, Michael/0000-0002-3796-4183; Liebisch, Frank/0000-0003-0000-7491; Walter, Achim/0000-0001-7753-9643; Pinto, Francisco/0000-0003-3000-9084	DAAD/CONICYT fellowship	DAAD/CONICYT fellowship	This work has been made possible by the funding support of the DAAD/CONICYT fellowship to Francisco Pinto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelopoulou E, 2001, PROC SPIE, V4299, P243, DOI 10.1117/12.429495; Bagnara J, 1986, BIOL INTEGUMENT, V2, P136, DOI DOI 10.1007/978-3-662-00989-5_8; Bagnara J.T., 1976, P1; Bagnara JT, 2003, PIGM CELL RES, V16, P510, DOI 10.1034/j.1600-0749.2003.00075.x; BAKKEN GS, 1978, SCIENCE, V200, P321, DOI 10.1126/science.200.4339.321; BENNETT ATD, 1994, VISION RES, V34, P1471, DOI 10.1016/0042-6989(94)90149-X; Bokhorst S, 2012, ENVIRON EXP BOT, V81, P18, DOI 10.1016/j.envexpbot.2012.02.011; Bowmaker JK, 2005, J COMP PHYSIOL A, V191, P925, DOI 10.1007/s00359-005-0014-4; Buttemer W. A., 1996, Australian Zoologist, V30, P134; CAREY C, 1978, OECOLOGIA, V35, P197, DOI 10.1007/BF00344732; Chiao CC, 2000, VISION RES, V40, P3257, DOI 10.1016/S0042-6989(00)00156-5; Chiao CC, 2011, P NATL ACAD SCI USA, V108, P9148, DOI 10.1073/pnas.1019090108; Cott H, 1956, ZOOLOGICAL PHOTOGRAP; Cott H. B., 1966, ADAPTIVE COLOURATION; DODD CK, 1981, BIOTROPICA, V13, P161, DOI 10.2307/2388120; Eiden M, 2007, 10 ISPMSRS C MARCH 1, P473; EMERSON SB, 1990, FUNCT ECOL, V4, P47, DOI 10.2307/2389651; Engelmann WE, 1993, LURCHE KRIECHTIERE E; Feilhauer H, 2010, J QUANT SPECTROSC RA, V111, P1947, DOI 10.1016/j.jqsrt.2010.03.007; Garbulsky MF, 2011, REMOTE SENS ENVIRON, V115, P281, DOI 10.1016/j.rse.2010.08.023; Gates D. M., 1980, BIOPHYSICAL ECOLOGY; GATES DM, 1965, APPL OPTICS, V4, P11, DOI 10.1364/AO.4.000011; Gehring Philip-Sebastian, 2007, Salamandra, V43, P43; GIBSON H. LOU, 1965, J BIOL PHOTOGR ASS, V33, P1; Gomez D, 2011, BEHAV ECOL, V22, P889, DOI 10.1093/beheco/arr039; Gomez D, 2010, BEHAVIOUR, V147, P1753, DOI 10.1163/000579510X534227; Gomez D, 2009, P ROY SOC B-BIOL SCI, V276, P2351, DOI 10.1098/rspb.2009.0168; Gray AR, 2011, NOTES HYBRIDIZATION; HAMADA K, 1964, J BIOCHEM-TOKYO, V55, P636, DOI 10.1093/oxfordjournals.jbchem.a127937; Hoffman EA, 2000, BIOL J LINN SOC, V70, P633, DOI 10.1006/bijl.1999.0421; Hostert P, 2005, NEW STRATEGIES FOR EUROPEAN REMOTE SENSING, P645; HUTCHISON VH, 1960, ECOLOGY, V41, P199, DOI 10.2307/1931954; Hutchison Victor H., 1992, P206; Jacobs GH, 2012, ADV EXP MED BIOL, V739, P156, DOI 10.1007/978-1-4614-1704-0_10; Kim A, 2011, OPTICAL THERMAL RESPONSE OF LASER-IRRADIATED TISSUE, SECOND EDITION, P267, DOI 10.1007/978-90-481-8831-4_8; KNIPLING E B, 1970, Remote Sensing of Environment, V1, P155; KOBELT F, 1992, J COMP PHYSIOL B, V162, P314; KOBELT F, 1986, OECOLOGIA, V68, P533, DOI 10.1007/BF00378768; Krempels D, 1989, THESIS U MIAMI MIAMI; Land M F, 1972, Prog Biophys Mol Biol, V24, P75, DOI 10.1016/0079-6107(72)90004-1; LAND MF, 1966, J EXP BIOL, V45, P433; Mahlein AK, 2013, REMOTE SENS ENVIRON, V128, P21, DOI 10.1016/j.rse.2012.09.019; Mielewczik M., 2012, ENTOMOLOGIE BEUTE, V24, P183; Molina-Borja M, 2006, J ZOOL, V268, P193, DOI 10.1111/j.1469-7998.2005.00008.x; NIELSEN HI, 1978, GEN COMP ENDOCR, V36, P543, DOI 10.1016/0016-6480(78)90094-1; NIELSEN HI, 1978, CELL TISSUE RES, V194, P405; NIELSEN HI, 1980, J EXP ZOOL, V211, P143, DOI 10.1002/jez.1402110204; NIELSEN HI, 1982, J ZOOL, V198, P363; NIELSEN HI, 1978, J EXP ZOOL, V205, P79, DOI 10.1002/jez.1402050111; Osorio D, 2008, VISION RES, V48, P2042, DOI 10.1016/j.visres.2008.06.018; PORTER WP, 1967, ECOL MONOGR, V37, P273, DOI 10.2307/1942325; PROVENCIO I, 1992, VISION RES, V32, P2201, DOI 10.1016/0042-6989(92)90084-V; Rascher U, 2007, PHOTOGRAMM ENG REM S, V73, P45, DOI 10.14358/PERS.73.1.45; Robertson JM, 2008, J BIOGEOGR, V35, P830, DOI 10.1111/j.1365-2699.2007.01824.x; Robertson JM, 2011, J BIOGEOGR, V38, P2122, DOI 10.1111/j.1365-2699.2011.02548.x; Robertson JM, 2009, J HERED, V100, P715, DOI 10.1093/jhered/esp041; Romer C, 2012, FUNCT PLANT BIOL, V39, P878, DOI 10.1071/FP12060; Rogers CG, 1906, BIOL BULL-US, V10, P165, DOI 10.2307/1535847; Savage JM, 2002, AMPHIBIANS REPTILES, P281; Schwalm P, 1981, THESIS; SCHWALM PA, 1980, J MORPHOL, V163, P37, DOI 10.1002/jmor.1051630106; SCHWALM PA, 1977, SCIENCE, V196, P1225, DOI 10.1126/science.860137; Spotila James R., 1992, P59; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Summers K, 2003, J BIOGEOGR, V30, P35, DOI 10.1046/j.1365-2699.2003.00795.x; TRACY CR, 1976, ECOL MONOGR, V46, P293, DOI 10.2307/1942256; Troy TL, 2001, J BIOMED OPT, V6, P167, DOI 10.1117/1.1344191; Tyler MJ, 2011, FIELD GUIDE FROGS AU; WALTON BM, 1993, PHYSIOL ZOOL, V66, P270, DOI 10.1086/physzool.66.2.30163690; Wells KD, 2007, ECOLOGY BEHAV AMPHIB, P146; WOOLLEY JT, 1971, PLANT PHYSIOL, V47, P656, DOI 10.1104/pp.47.5.656; Xie YC, 2008, J PLANT ECOL, V1, P9, DOI 10.1093/jpe/rtm005; Zonios G, 2001, J INVEST DERMATOL, V117, P1452, DOI 10.1046/j.0022-202x.2001.01577.x; Zug G.R., 2011, HERPETOLOGY INTRO BI; Zuzak KJ, 2001, CIRCULATION, V104, P2905, DOI 10.1161/hc4901.100525	75	7	7	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73234	10.1371/journal.pone.0073234	http://dx.doi.org/10.1371/journal.pone.0073234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058464	gold, Green Published			2022-12-25	WOS:000324695900009
J	Li, WP; Gao, Z; Yang, CH; Li, JH; Li, L; Lv, R; Liu, Z				Li, Wuping; Gao, Zhan; Yang, Chunhui; Li, Jiahu; Li, Ling; Lv, Rong; Liu, Zhong			The Estimation of Prevalence, Incidence, and Residual Risk of Transfusion-Transmitted Human Hepatitis B Infection from Blood Donated at the Anhui Blood Center, China, from 2009 to 2011	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; C VIRUS; VIRAL-INFECTIONS; DONORS; IMPACT	Background: The high prevalence of hepatitis B virus (HBV) among the Chinese population poses a threat to blood safety; however, few studies have examined epidemiological data regarding HBV infection of Chinese blood donors. The present study investigated the demographic characteristics of blood donors at the Anhui blood center in China, the prevalence, incidence, and residual risk (RR) associated with hepatitis B surface antigen (HBsAg) expression in terms of transfusion transmitted HBV (TTHBV) infections. Methods: The demographic characteristics and HBV status of people who donated blood at the Anhui blood center between 2009 and 2011 were retrospectively analyzed. The incidence of HBV was estimated through HBsAg yield approach. The window period model was then used to estimate the RR of TTHBV infection. Results: The typical donor at the Anhui blood center was a first-time volunteer, aged less than 25 years, unmarried, of Han ethnicity, and with an education below high school level. The prevalence of HBV infection among repeat donors, first-time donors, and all donors was 28.9, 127.2 and 82.1 per 100,000, respectively. The incidence estimate was 333.9 per 105 person-years. Using an infectious window period of 59 days, the RR for HBV was estimated to be 1 in 1853 between 2009 and 2011. Conclusions: The incidence and RR of HBV in Chinese blood donors are much higher than those of donors in developed countries. This is because sensitive ELISAs and nucleic acid tests are not available in China. Further work is needed to improve both the safety and availability of blood products in China.	[Li, Wuping] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Li, Wuping; Gao, Zhan; Yang, Chunhui; Liu, Zhong] Peking Union Med Coll, Beijing 100021, Peoples R China; [Li, Wuping; Gao, Zhan; Yang, Chunhui; Liu, Zhong] Chinese Acad Med Sci, Inst Blood Transfus, Beijing 100730, Peoples R China; [Li, Jiahu; Li, Ling; Lv, Rong; Liu, Zhong] Anhui Blood Ctr, Hefei, Anhui, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Blood Transfusion - CAMS	Li, WP (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.	lwpzhr@sina.com; liuzhong@yahoo.cn	Liu, Zhong/ABH-8584-2020	liu, zhong/0000-0001-8173-9656	Institute of Pathogen Biology, Chinese Academy of Medical Sciences [2011IPB106]	Institute of Pathogen Biology, Chinese Academy of Medical Sciences	This study was supported by the basic grant of Institute of Pathogen Biology, Chinese Academy of Medical Sciences (grant NO: 2011IPB106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain JP, 2004, VOX SANG, V86, P83, DOI 10.1111/j.0042-9007.2004.00406.x; Alter HJ, 2000, NAT MED, V6, P1082, DOI 10.1038/80394; Candotti D, 2009, J HEPATOL, V51, P798, DOI 10.1016/j.jhep.2009.05.020; *DEC INC, 2000, CRYST BALL SOFTW 200; Dodd RY, 2002, TRANSFUSION, V42, P975, DOI 10.1046/j.1537-2995.2002.00174.x; Dodd RY, 2004, INT J HEMATOL, V80, P301, DOI 10.1532/IJH97.04123; Dodd RY, 2002, TRANSFUSION, V42, P1240, DOI 10.1046/j.1537-2995.2002.00231.x; Glynn SA, 1998, TRANSFUSION, V38, P350, DOI 10.1046/j.1537-2995.1998.38498257373.x; Kleinman SH, 2006, J CLIN VIROL, V36, pS23, DOI 10.1016/S1386-6532(06)80005-3; Li CQ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-176; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liang XF, 2009, J INFECT DIS, V200, P39, DOI 10.1086/599332; Liu Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-193; Mine H, 2003, J VIROL METHODS, V112, P145, DOI 10.1016/S0166-0934(03)00215-5; Niederhauser C, 2011, J BLOOD MED, V2, P91, DOI 10.2147/JBM.S12899; Ren FR, 2011, TRANSFUSION, V51, P2588, DOI 10.1111/j.1537-2995.2011.03215.x; *SAS I, 1989, SAS STAT US GUID VER; Schreiber GB, 1996, NEW ENGL J MED, V334, P1685, DOI 10.1056/NEJM199606273342601; Seed CR, 2005, INTERN MED J, V35, P592, DOI 10.1111/j.1445-5994.2005.00926.x; Shang G, 2007, TRANSFUSION, V47, P529, DOI 10.1111/j.1537-2995.2006.01146.x; Wang J., 2012, INTERNAL MED, V2, P1, DOI [10.4172/2165-8048.1000113, DOI 10.4172/2165-8048.1000113]; Zou SM, 2009, TRANSFUSION, V49, P1609, DOI 10.1111/j.1537-2995.2009.02195.x	22	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73472	10.1371/journal.pone.0073472	http://dx.doi.org/10.1371/journal.pone.0073472			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058476	Green Published, gold, Green Submitted			2022-12-25	WOS:000324408400026
J	Sagredo, A; del Campo, L; Martorell, A; Navarro, R; Martin, MC; Blanco-Rivero, J; Ferrer, M				Sagredo, Ana; del Campo, Lara; Martorell, Aina; Navarro, Rocio; Martin, Maria C.; Blanco-Rivero, Javier; Ferrer, Mercedes			Ovariectomy Increases the Participation of Hyperpolarizing Mechanisms in the Relaxation of Rat Aorta	PLOS ONE			English	Article							NITRIC-OXIDE RELEASE; ACETYLCHOLINE-INDUCED RELAXATION; DEPENDENT PROTEIN-KINASE; FEMALE SEX-HORMONES; SUPEROXIDE-DISMUTASE; HYDROGEN-PEROXIDE; K+ CHANNELS; VASODILATION; METABOLISM; MODULATION	This study examines the downstream NO release pathway and the contribution of different vasodilator mediators in the acetylcholine-induced response in rat aorta 5-months after the loss of ovarian function. Aortic segments from ovariectomized and control female Sprague-Dawley rats were used to measure: the levels of superoxide anion, the superoxide dismutases (SODs) activity, the cGMP formation, the cGMP-dependent protein kinase (PKG) activity and the involvement of NO, cGMP, hydrogen peroxide and hyperpolarizing mechanisms in the ACh-induced relaxation. The results showed that ovariectomy did not alter ACh-induced relaxation; incubation with L-NAME, a NO synthase inhibitor, decreased the ACh-induced response to a lesser extent in aorta from ovariectomized than from control rats, while ODQ, a guanylate cyclase inhibitor, decreased that response to a similar extent; the blockade of hyperpolarizing mechanisms, by precontracting arteries with KCl, decreased the ACh-induced response to a greater extent in aortas from ovariectomized than those from control rats; catalase, that decomposes hydrogen peroxide, decreased the ACh-induced response only in aorta from ovariectomized rats. In addition, ovariectomy increased superoxide anion levels and SODs activity, decreased cGMP formation and increased PKG activity. Despite the increased superoxide anion and decreased cGMP in aorta from ovariectomized rats, ACh-induced relaxation is maintained by the existence of hyperpolarizing mechanisms in which hydrogen peroxide participates. The greater contribution of hydrogen peroxide in ACh-induced relaxation is due to increased SOD activity, in an attempt to compensate for increased superoxide anion formation. Increased PKG activity could represent a redundant mechanism to ensure vasodilator function in the aorta of ovariectomized rats.	[Sagredo, Ana; del Campo, Lara; Martorell, Aina; Navarro, Rocio; Martin, Maria C.; Blanco-Rivero, Javier; Ferrer, Mercedes] Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain; [del Campo, Lara; Blanco-Rivero, Javier; Ferrer, Mercedes] Inst Invest Sanitarias IdiPAZ, Madrid, Spain	Autonomous University of Madrid	Ferrer, M (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain.	mercedes.ferrer@uam.es	del Campo, Lara/A-8317-2015; Parra, Mercedes Ferrer/AAE-1746-2020; del Campo Milán, Lara/ABD-4219-2021; Navarro, Rocío/N-5505-2016; Rivero, Javier Blanco/ABE-8749-2020; Ferrer, Mercedes/E-3556-2018; Blanco-Rivero, Javier/J-6118-2014	del Campo, Lara/0000-0002-0394-116X; Parra, Mercedes Ferrer/0000-0002-4670-7146; del Campo Milán, Lara/0000-0002-0394-116X; Navarro, Rocío/0000-0002-0083-7711; Rivero, Javier Blanco/0000-0001-7232-2314; Blanco-Rivero, Javier/0000-0001-7232-2314; Martin, Carmen/0000-0001-8785-4225	Fondo de Investigaciones Sanitarias [PI1100406]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	This work was supported by grants (to MF) from the Fondo de Investigaciones Sanitarias (PI1100406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres S, 1998, AM J PHYSIOL-ENDOC M, V274, pE1002, DOI 10.1152/ajpendo.1998.274.6.E1002; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Blanco-Rivero J, 2007, J ENDOCRINOL, V192, P189, DOI 10.1677/joe.1.07079; Blanco-Rivero J, 2006, J ENDOCRINOL, V190, P771, DOI 10.1677/joe.1.06887; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; Castillo C, 2005, BIOGERONTOLOGY, V6, P49, DOI 10.1007/s10522-004-7383-x; Chen GF, 1996, CIRC RES, V79, P827, DOI 10.1161/01.RES.79.4.827; Cornwell TL, 2001, BIOL REPROD, V64, P857, DOI 10.1095/biolreprod64.3.857; Dikalov SI, 2008, FREE RADICAL BIO MED, V45, P1340, DOI 10.1016/j.freeradbiomed.2008.08.013; Ding EL, 2007, DIABETOLOGIA, V50, P2076, DOI 10.1007/s00125-007-0785-y; Feletou M, 2009, CLIN SCI, V117, P139, DOI 10.1042/CS20090096; Ferrer M, 1999, CLIN SCI, V97, P625, DOI 10.1042/CS19990102; Ferrer M, 1999, GEN PHARMACOL, V33, P35, DOI 10.1016/S0306-3623(98)00259-6; FURCHGOTT RF, 1989, FASEB J, V3, P2007, DOI 10.1096/fasebj.3.9.2545495; Camporez JPG, 2011, J PHYSIOL-LONDON, V589, P2585, DOI 10.1113/jphysiol.2011.206078; Ghanam K, 1998, BIOCHEM BIOPH RES CO, V249, P858, DOI 10.1006/bbrc.1998.9238; Gorodeski GI, 2000, ENDOCRINOLOGY, V141, P1658, DOI 10.1210/en.141.5.1658; GRYGLEWSKI RJ, 1986, NATURE, V320, P454, DOI 10.1038/320454a0; KHAN SA, 1993, J PHARMACOL EXP THER, V267, P1327; Kobayashi Seiichi, 2002, J Atheroscler Thromb, V9, P184; Leung SWS, 2007, CLIN EXP PHARMACOL P, V34, P822, DOI 10.1111/j.1440-1681.2007.04686.x; Lincoln TM, 2001, J APPL PHYSIOL, V91, P1421, DOI 10.1152/jappl.2001.91.3.1421; Martin MD, 2005, NITRIC OXIDE-BIOL CH, V12, P163, DOI 10.1016/j.niox.2005.02.003; Martorell A, 2009, CARDIOVASC RES, V84, P300, DOI 10.1093/cvr/cvp214; Meurer S, 2005, J BIOL CHEM, V280, P33149, DOI 10.1074/jbc.M507565200; Miller VM, 2007, TRENDS PHARMACOL SCI, V28, P263, DOI 10.1016/j.tips.2007.04.004; Minoves N, 2002, CLIN SCI, V103, P239, DOI 10.1042/cs1030239; Munzel T, 2003, CIRCULATION, V108, P2172, DOI 10.1161/01.CIR.0000094403.78467.C3; Murad F, 1997, CIRCULATION, V95, P1101; Ng Martin K C, 2007, Heart Lung Circ, V16, P185, DOI 10.1016/j.hlc.2007.02.108; NIELSEN KC, 1971, BRAIN RES, V27, P33, DOI 10.1016/0006-8993(71)90370-2; Oishi A, 2004, BIOCHEM BIOPH RES CO, V324, P193, DOI 10.1016/j.bbrc.2004.09.032; Oury TD, 1996, LAB INVEST, V75, P617; Reyna-Neyra A, 2007, J NEUROENDOCRINOL, V19, P418, DOI 10.1111/j.1365-2826.2007.01546.x; RUBANYI GM, 1986, AM J PHYSIOL, V250, pH815, DOI 10.1152/ajpheart.1986.250.5.H815; Sagredo A, 2011, JOINT M EUR SOC MICR; SAGREDO A, 2007, P 8 C EUR ASS CLIN P; Strehlow K, 2003, CIRC RES, V93, P170, DOI 10.1161/01.RES.0000082334.17947.11; Tanaka M, 2005, HYPERTENS RES, V28, P67, DOI 10.1291/hypres.28.67; Teede H, 2001, CLIN SCI, V100, P473, DOI 10.1042/CS20000170; Teede HJ, 2007, CLIN EXP PHARMACOL P, V34, P672, DOI 10.1111/j.1440-1681.2007.04658.x; Thengchaisri N, 2003, AM J PHYSIOL-HEART C, V285, pH2255, DOI 10.1152/ajpheart.00487.2003; Wei EP, 1996, AM J PHYSIOL-HEART C, V271, pH1262, DOI 10.1152/ajpheart.1996.271.3.H1262; Wolin MS, 2002, J VASC RES, V39, P191, DOI 10.1159/000063685	46	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73474	10.1371/journal.pone.0073474	http://dx.doi.org/10.1371/journal.pone.0073474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058477	Green Published, gold, Green Submitted			2022-12-25	WOS:000324408400027
J	De Cadiz, AE; Jeelani, G; Nakada-Tsukui, K; Caler, E; Nozaki, T				De Cadiz, Aleyla Escueta; Jeelani, Ghulam; Nakada-Tsukui, Kumiko; Caler, Elisabet; Nozaki, Tomoyoshi			Transcriptome Analysis of Encystation in Entamoeba invadens	PLOS ONE			English	Article							PROTEIN-KINASE-C; CYSTEINE PROTEINASES; HISTOLYTICA GENOME; GENE-EXPRESSION; HEAT-SHOCK; IDENTIFICATION; FAMILY; GIARDIA; AMEBIASIS; GROWTH	Encystation is an essential differentiation process for the completion of the life cycle of a group of intestinal protozoa including Entamoeba histolytica, the causative agent of intestinal and extraintestinal amebiasis. However, regulation of gene expression during encystation is poorly understood. To comprehensively understand the process at the molecular level, the transcriptomic profiles of E. invadens, which is a related reptilian species that causes an invasive disease similar to that of E. histolytica, was investigated during encystation. Using a custom-generated Affymetrix platform microarray, we performed time course (0.5, 2, 8, 24, 48, and 120 h) gene expression analysis of encysting E. invadens. ANOVA analysis revealed that a total of 1,528 genes showed >= 3 fold up-regulation at one or more time points, relative to the trophozoite stage. Of these modulated genes, 8% (116 genes) were up-regulated at the early time points (0.5, 2 and 8h), while 63% (962 genes) were up-regulated at the later time points (24, 48, and 120 h). Twenty nine percent (450 genes) are either up-regulated at 2 to 5 time points or constitutively up-regulated in both early and late stages. Among the up-regulated genes are the genes encoding transporters, cytoskeletal proteins, proteins involved in vesicular trafficking (small GTPases), Myb transcription factors, cysteine proteases, components of the proteasome, and enzymes for chitin biosynthesis. This study represents the first kinetic analysis of gene expression during differentiation from the invasive trophozoite to the dormant, infective cyst stage in Entamoeba. Functional analysis on individual genes and their encoded products that are modulated during encystation may lead to the discovery of targets for the development of new chemotherapeutics that interfere with stage conversion of the parasite.	[De Cadiz, Aleyla Escueta; Jeelani, Ghulam; Nakada-Tsukui, Kumiko; Nozaki, Tomoyoshi] Natl Inst Infect Dis, Dept Parasitol, Tokyo, Japan; [De Cadiz, Aleyla Escueta] Univ Philippines Mindanao, Coll Sci & Math, Dept Biol Sci & Environm Studies, Davao, Philippines; [Caler, Elisabet] J Craig Venter Inst, Rockville, MD USA; [Nozaki, Tomoyoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	National Institute of Infectious Diseases (NIID); University of the Philippines System; University of the Philippines Mindanao; J. Craig Venter Institute; University of Tsukuba	Nozaki, T (corresponding author), Natl Inst Infect Dis, Dept Parasitol, Tokyo, Japan.	nozaki@nih.go.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [18GS0314, 18050006, 18073001, 20390119, 23390099]; MEXT of Japan [3308]; Ministry of Health, Labour and Welfare of Japan [H20-Shinkosaiko-ippan-016, H23-Shinkosaiko-ippan-014]; Japan Health Sciences Foundation [KAA1551, KHA1101]; Global COE Program (Global COE for Human Metabolomic Systems Biology) from MEXT, Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Health Sciences Foundation; Global COE Program (Global COE for Human Metabolomic Systems Biology) from MEXT, Japan	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (18GS0314, 18050006, 18073001, 20390119, 23390099), a Grant-in-Aid for Scientific Research on Innovative Areas from MEXT of Japan ("Matryoshka-type evolution", 3308), a grant for research on emerging and re-emerging infectious diseases from the Ministry of Health, Labour and Welfare of Japan (H20-Shinkosaiko-ippan-016, H23-Shinkosaiko-ippan-014), a grant for research to promote the development of anti-AIDS pharmaceuticals from the Japan Health Sciences Foundation (KAA1551, KHA1101), and by Global COE Program (Global COE for Human Metabolomic Systems Biology) from MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeijon C, 1997, TRENDS BIOCHEM SCI, V22, P203, DOI 10.1016/S0968-0004(97)01053-0; Barron-Gonzalez MP, 2005, EXP PARASITOL, V110, P318, DOI 10.1016/j.exppara.2005.03.021; Beck DL, 2005, EUKARYOT CELL, V4, P722, DOI 10.1128/EC.4.4.722-732.2005; Biller L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-63; Boettner DR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040008; Bruchhaus I, 2003, EUKARYOT CELL, V2, P501, DOI 10.1128/EC.2.3.501-509.2003; Bulik DA, 2000, J BIOL CHEM, V275, P14722, DOI 10.1074/jbc.275.19.14722; Buss SN, 2010, INT J PARASITOL, V40, P833, DOI 10.1016/j.ijpara.2009.12.007; Byers J, 2005, CELL MICROBIOL, V7, P269, DOI [10.1111/.j.1462-5822.2004.00457.x, 10.1111/j.1462-5822.2004.00457.x]; Campos-Gongora E, 2000, ARCH MED RES, V31, P162, DOI 10.1016/S0188-4409(00)00054-0; Chatterjee A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000498; Chia MY, 2009, VET PATHOL, V46, P673, DOI 10.1354/vp.08-VP-0224-P-CR; Clark CG, 2007, ADV PARASIT, V65, P51, DOI 10.1016/S0065-308X(07)65002-7; Coppi A, 1999, MOL BIOCHEM PARASIT, V102, P67, DOI 10.1016/S0166-6851(99)00085-7; DAS S, 1991, BIOCHEM J, V280, P641, DOI 10.1042/bj2800641; Das S, 2006, MOL BIOCHEM PARASIT, V148, P86, DOI 10.1016/j.molbiopara.2006.03.002; Davis PH, 2006, MOL BIOCHEM PARASIT, V145, P111, DOI 10.1016/j.molbiopara.2005.08.017; DONALDSON M, 1975, AM J VET RES, V36, P807; DuBois KN, 2008, J BIOL CHEM, V283, P18024, DOI 10.1074/jbc.M802133200; Ebert F, 2008, PARASITOL INT, V57, P521, DOI 10.1016/j.parint.2008.07.002; Ehrenkaufer GM, 2007, CELL MICROBIOL, V9, P1426, DOI 10.1111/j.1462-5822.2006.00882.x; Ehrenkaufer GM, 2009, CELL MICROBIOL, V11, P898, DOI 10.1111/j.1462-5822.2009.01300.x; Eichinger D, 1997, BIOESSAYS, V19, P633, DOI 10.1002/bies.950190714; Eichinger D, 2001, CURR OPIN MICROBIOL, V4, P421, DOI 10.1016/S1369-5274(00)00229-0; Field J, 2000, J EUKARYOT MICROBIOL, V47, P511, DOI 10.1111/j.1550-7408.2000.tb00083.x; Gallego E, 2007, PARASITOL RES, V101, P1, DOI 10.1007/s00436-007-0458-2; Ghosh SK, 1999, INFECT IMMUN, V67, P3073, DOI 10.1128/IAI.67.6.3073-3081.1999; Gilchrist CA, 2006, MOL BIOCHEM PARASIT, V147, P163, DOI 10.1016/j.molbiopara.2006.02.007; Gonzalez J, 1999, EUR J BIOCHEM, V264, P897, DOI 10.1046/j.1432-1327.1999.00682.x; Gonzalez-Salazar F, 2000, ARCH MED RES, V31, pS192, DOI 10.1016/S0188-4409(00)00193-4; He C, 2010, J BIOL CHEM, V285, P18516, DOI 10.1074/jbc.M109.086181; Hon CC, 2010, ANAEROBIC PARASITIC PROTOZOA: GENOMICS AND MOLECULAR BIOLOGY, P81; Ikegami A, 2004, INFECT IMMUN, V72, P4619, DOI 10.1128/IAI.72.8.4619-4627.2004; Inagaki S, 2006, INFECT IMMUN, V74, P5023, DOI 10.1128/IAI.00062-06; Jeelani G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037740; Kojimoto A, 2001, J VET MED SCI, V63, P1365, DOI 10.1292/jvms.63.1365; Kriebel PW, 2004, IUBMB LIFE, V56, P541, DOI 10.1080/15216540400013887; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lopez  AB, 2003, MOL BIOCHEM PARASIT, V128, P51, DOI 10.1016/S0166-6851(03)00049-5; Lorenzi HA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000716; MacFarlane RC, 2006, INFECT IMMUN, V74, P340, DOI 10.1128/IAI.74.1.340-351.2006; Makioka A, 2000, EXP PARASITOL, V95, P288, DOI 10.1006/expr.2000.4538; Makioka A, 2003, PARASITOL RES, V91, P204, DOI 10.1007/s00436-003-0955-x; Makioka A, 2000, PARASITOL RES, V86, P599, DOI 10.1007/PL00008536; Makioka A, 2001, PARASITOL RES, V87, P371, DOI 10.1007/s004360000339; McGugan GC, 2003, MOL BIOCHEM PARASIT, V129, P137, DOI 10.1016/S0166-6851(03)00115-4; Meneses E, 2010, GENE, V455, P32, DOI 10.1016/j.gene.2010.02.004; Moncada D, 2003, INFECT IMMUN, V71, P838, DOI 10.1128/IAI.71.2.838-844.2003; Nakada-Tsukui K, 2011, GENOMES OF FOODBORNE AND WATERBORNE PATHOGENS, P321; Nakada-Tsukui K, 2010, EXP PARASITOL, V126, P337, DOI 10.1016/j.exppara.2010.04.014; Nakada-Tsukui K, 2009, CELL MICROBIOL, V11, P1471, DOI 10.1111/j.1462-5822.2009.01341.x; Noel CJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-99; Nozaki T, 2006, ARCH MED RES, V37, P277, DOI 10.1016/j.arcmed.2005.09.010; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Picazarri K, 2008, INFECT IMMUN, V76, P278, DOI 10.1128/IAI.00636-07; Que XC, 2000, CLIN MICROBIOL REV, V13, P196, DOI 10.1128/CMR.13.2.196-206.2000; Rosinski JA, 1998, J MOL EVOL, V46, P74, DOI 10.1007/PL00006285; Said-Fernandez S, 2001, J PARASITOL, V87, P919, DOI 10.2307/3285156; SANCHEZ L, 1994, MOL BIOCHEM PARASIT, V67, P125, DOI 10.1016/0166-6851(94)90102-3; SHIOZAKI K, 1994, CELL MOL BIOL RES, V40, P241; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; Tillack M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-170; Ulrich HD, 2005, TRENDS CELL BIOL, V15, P525, DOI 10.1016/j.tcb.2005.08.002; Van Dellen KL, 2006, EUKARYOT CELL, V5, P836, DOI 10.1128/EC.5.5.836-848.2006; Vicente JB, 2009, CELL MICROBIOL, V11, P51, DOI 10.1111/j.1462-5822.2008.01236.x; Wang Z, 2003, MOL BIOCHEM PARASIT, V129, P23, DOI 10.1016/S0166-6851(03)00073-2; Weber C, 2006, EUKARYOT CELL, V5, P871, DOI 10.1128/EC.5.5.871-875.2006	67	37	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74840	10.1371/journal.pone.0074840	http://dx.doi.org/10.1371/journal.pone.0074840			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040350	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500125
J	Wild, AL; Marsh, PM; Whitfield, JB				Wild, Alexander L.; Marsh, Paul M.; Whitfield, James B.			Fast-Evolving Homoplastic Traits Are Best for Species Identification in a Group of Neotropical Wasps	PLOS ONE			English	Article							SUBFAMILY DORYCTINAE HYMENOPTERA; PHYLOGENY	Biological characters can be employed for both taxonomy and phylogenetics, but is conscripting characters for double duty a good idea? We explore the evolution of characters designed for taxonomic diagnosis in Costa Rican heterospiline wasps, a hyperdiverse lineage of parasitoid Braconidae, by mapping them to a robust multi-locus molecular phylogeny. We discover a strong positive relationship between the amount of evolutionary change a character undergoes and how broadly useful the characters are in the context of an interactive identification key-e. g., how evenly the character states are distributed among taxa. The empirical finding that fast characters are the most useful for species identification supports the idea that characters designed for taxonomic diagnoses are likely to underperform- or be positively misleading-in phylogenetic analyses.	[Wild, Alexander L.; Whitfield, James B.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Wild, AL (corresponding author), Univ Illinois, Dept Entomol, Urbana, IL 61801 USA.	alwild@myrmecos.net			NSF [0717365]	NSF(National Science Foundation (NSF))	This research was wholly funded by NSF grant #0717365 to JBW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belokobylskij SA, 2004, ZOOL J LINN SOC-LOND, V142, P369, DOI 10.1111/j.1096-3642.2004.00133.x; Cabrera BJ, 2002, PAN-PAC ENTOMOL, V78, P7; CBIT (Queensland), 2009, LUC 3 4; CHARNOV EL, 1981, NATURE, V289, P27, DOI 10.1038/289027a0; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Givnish Thomas J., 1997, P55; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HETZ M, 1988, J STORED PROD RES, V24, P131, DOI 10.1016/0022-474X(88)90010-0; Jenner RA, 2004, SYST BIOL, V53, P333, DOI 10.1080/10635150490423962; LaSalle J., 1991, Redia, V74, P315; Maddison WP, 2017, MESQUITE MODULAR SYS; Marsh Paul M., 2002, Memoirs of the American Entomological Institute (Gainesville), V70, P1; Marsh Paul M., 1999, Journal of Hymenoptera Research, V8, P13; Nylander J, 2004, MR MODELTEST V2 PROG; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Packer L, 2009, MOL ECOL RESOUR, V9, P42, DOI 10.1111/j.1755-0998.2009.02631.x; Patterson C., 1987, MOL MORPHOLOGY EVOLU; Rambaut A, 2014, TRACER V1 6; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Scotland RW, 2003, SYST BIOL, V52, P539, DOI 10.1080/10635150390223613; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; SWOFFORD DL, 1991, PHYLOGENETIC ANALYSIS OF DNA SEQUENCES, P295; Wheeler TJ, 2007, BIOINFORMATICS, V23, pI559, DOI 10.1093/bioinformatics/btm226; Wiens JJ, 2004, SYST BIOL, V53, P653, DOI 10.1080/10635150490472959; Wild AL, 2008, MOL PHYLOGENET EVOL, V48, P877, DOI 10.1016/j.ympev.2008.05.023; Winston JE, 1999, DESCRIBING SPECIES P; Wley EO, 1981, PHYLOGENETICS THEORY; Zaldivar-Riveron A, 2008, INVERTEBR SYST, V22, P345, DOI 10.1071/IS07028; Zaldivar-Riveron A, 2010, MITOCHONDR DNA, V21, P18, DOI 10.3109/19401736.2010.523701	29	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74837	10.1371/journal.pone.0074837	http://dx.doi.org/10.1371/journal.pone.0074837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040349	Green Submitted, Green Published, gold			2022-12-25	WOS:000326734500124
J	Zins, K; Lucas, T; Reichl, P; Abraham, D; Aharinejad, S				Zins, Karin; Lucas, Trevor; Reichl, Patrick; Abraham, Dietmar; Aharinejad, Seyedhossein			A Rac1/Cdc42 GTPase-Specific Small Molecule Inhibitor Suppresses Growth of Primary Human Prostate Cancer Xenografts and Prolongs Survival in Mice	PLOS ONE			English	Article							MAMMARY ADENOCARCINOMA CELLS; RESPONSE MEDIATOR PROTEIN-1; RHO-GTPASES; CYCLIN D1; BAD PHOSPHORYLATION; SIGNAL-TRANSDUCTION; TUMOR XENOGRAFTS; PI3K/AKT PATHWAY; LEADING-EDGE; RAC	Deregulated Rho GTPases Rac1 and Cdc42 have been discovered in various tumors, including prostate and Rac protein expression significantly increases in prostate cancer. The Rac and Cdc42 pathways promote the uncontrolled proliferation, invasion and metastatic properties of human cancer cells. We synthesized the novel compound AZA1 based on structural information of the known Rac1 inhibitor NSC23766. In the current study we investigated the effects of inhibition of these pathways by AZA1 on prostate tumorigenicity by performing preclinical studies using a xenograft mouse model of prostate cancer. In androgen-independent prostate cancer cells, AZA1 inhibited both Rac1 and Cdc42 but not RhoA GTPase activity in a dose-dependent manner and blocked cellular migration and proliferation. Cyclin D1 expression significantly decreased following Rac1/Cdc42 inhibition in prostate cancer cells. AZA1 treatment also down-regulated PAK and AKT activity in prostate cancer cells, associated with induction of the pro-apoptotic function of BAD by suppression of serine-112 phosphorylation. Daily systemic administration of AZA1 for 2 weeks reduced growth of human 22Rv1 prostate tumor xenografts in mice and improved the survival of tumor-bearing animals significantly. These data suggest a role of AZA1 in blocking Rac1/Cdc42-dependent cell cycle progression, cancer cell migration and increase of cancer cell apoptosis involving down-regulation of the AKT and PAK signaling pathway in prostate cancer cells. We therefore propose that a small-molecule inhibitor therapy targeting Rac1/Cdc42 Rho GTPase signaling pathways may be used as a novel treatment for patients with advanced prostate cancer.	[Zins, Karin; Lucas, Trevor; Reichl, Patrick; Abraham, Dietmar; Aharinejad, Seyedhossein] Med Univ Vienna, Cardiovasc Res Labs, Vienna, Austria	Medical University of Vienna	Abraham, D (corresponding author), Med Univ Vienna, Cardiovasc Res Labs, Vienna, Austria.	dietmar.abraham@meduniwien.ac.at		Abraham, Dietmar/0000-0001-6337-0058; Zins, Karin/0000-0002-0202-2364; Lucas, Trevor/0000-0002-5114-8035	PRIZE project [Z080347]; Austria Wirtschaftsservice Ges.m.b.H (aws)	PRIZE project; Austria Wirtschaftsservice Ges.m.b.H (aws)	PRIZE project number: Z080347; Austria Wirtschaftsservice Ges.m.b.H (aws). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharinejad S, 2004, CANCER RES, V64, P5378, DOI 10.1158/0008-5472.CAN-04-0961; Aharinejad S, 2002, CANCER RES, V62, P5317; Angelucci A, 2006, ENDOCR-RELAT CANCER, V13, P197, DOI 10.1677/erc.1.01100; Antonarakis ES, CANC LETT, V291, P1; Arias-Romero LE, ONCOGENE, V29, P5839; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Berardi R, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-8; Bosco EE, BLOOD, V115, P3320; Bradley EW, 2008, J CELL PHYSIOL, V217, P752, DOI 10.1002/jcp.21550; Chan AY, 1998, J CELL SCI, V111, P199; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chen Y, 1998, ONCOGENE, V16, P1913, DOI 10.1038/sj.onc.1201719; Cooperberg MR, 2005, J CLIN ONCOL, V23, P8146, DOI 10.1200/JCO.2005.02.9751; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Drobnjak M, 2000, CLIN CANCER RES, V6, P1891; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Engers R, 2007, ENDOCR-RELAT CANCER, V14, P245, DOI 10.1677/ERC-06-0036; Ferri N, 2009, J MED CHEM, V52, P4087, DOI 10.1021/jm8015987; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Gajewski TF, 1996, CELL, V87, P589, DOI 10.1016/S0092-8674(00)81377-X; Gao H, 2006, P NATL ACAD SCI USA, V103, P14477, DOI 10.1073/pnas.0606836103; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gera JF, 2004, J BIOL CHEM, V279, P2737, DOI 10.1074/jbc.M309999200; Han EKH, 1998, PROSTATE, V35, P95, DOI 10.1002/(SICI)1097-0045(19980501)35:2<95::AID-PROS2>3.0.CO;2-F; Hayakawa J, 2000, CANCER RES, V60, P5988; Higuchi M, 2008, NAT CELL BIOL, V10, P1356, DOI 10.1038/ncb1795; Huang Q, 2005, CELL MOL LIFE SCI, V62, P1167, DOI 10.1007/s00018-005-5050-2; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jaffe AB, 2002, ADV CANCER RES, V84, P57, DOI 10.1016/S0065-230X(02)84003-9; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jordan P, 1999, ONCOGENE, V18, P6835, DOI 10.1038/sj.onc.1203233; Joyce D, 1999, J BIOL CHEM, V274, P25245, DOI 10.1074/jbc.274.36.25245; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Kim JK, 2009, J CELL PHYSIOL, V220, P292, DOI 10.1002/jcp.21791; Klein EA, 2007, CELL CYCLE, V6, P1115, DOI 10.4161/cc.6.9.4147; Lee JT, 2008, CELL CYCLE, V7, P1745, DOI 10.4161/cc.7.12.6166; Liu M, INT J CANC, V128, P1269; Meshki J, 2010, J BIOL CHEM, V285, P26033, DOI 10.1074/jbc.M110.128371; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Pan SH, 2011, J CLIN INVEST, V121, P3189, DOI 10.1172/JCI42975; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Rul W, 2002, ANN NY ACAD SCI, V973, P145, DOI 10.1111/j.1749-6632.2002.tb04624.x; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sardana G, 2008, CLIN CHEM, V54, P1951, DOI 10.1373/clinchem.2008.110668; Sarker D, 2009, CLIN CANCER RES, V15, P4799, DOI 10.1158/1078-0432.CCR-08-0125; Sastry KSR, 2006, J BIOL CHEM, V281, P20891, DOI 10.1074/jbc.M602928200; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Segall JE, 1996, CLIN EXP METASTAS, V14, P61, DOI 10.1007/BF00157687; Shi HY, 2007, CELL MOTIL CYTOSKEL, V64, P338, DOI 10.1002/cm.20187; Shih JY, 2001, JNCI-J NATL CANCER I, V93, P1392, DOI 10.1093/jnci/93.18.1392; Shih JY, 2003, CLIN EXP METASTAS, V20, P69, DOI 10.1023/A:1022598604565; Stengel K, CELL SIGNAL, V23, P1415; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Westwick JK, 1997, MOL CELL BIOL, V17, P1324, DOI 10.1128/MCB.17.3.1324; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang L, 2006, MOL BIOL CELL, V17, P4675, DOI 10.1091/mbc.E06-05-0466; Yuan L, CLIN EXP METASTASIS; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zins K, 2007, CANCER RES, V67, P1038, DOI 10.1158/0008-5472.CAN-06-2295	66	66	68	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74924	10.1371/journal.pone.0074924	http://dx.doi.org/10.1371/journal.pone.0074924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040362	Green Submitted, Green Published, gold			2022-12-25	WOS:000326734500128
J	Ashmole, I; Duffy, SM; Leyland, ML; Bradding, P				Ashmole, Ian; Duffy, S. Mark; Leyland, Mark L.; Bradding, Peter			The Contribution of Orai(CRACM)1 and Orai( CRACM)2 Channels in Store-Operated Ca2+ Entry and Mediator Release in Human Lung Mast Cells	PLOS ONE			English	Article							CALCIUM CURRENT; PORE SUBUNIT	Background: The influx of extracellular Ca2+ into mast cells is critical for the Fc epsilon R1-dependent release of preformed granule-derived mediators and newly synthesised autacoids and cytokines. The Orai(CRACM) ion channel family provide the major pathway through which this Ca2+ influx occurs. However the individual role of each of the three members of the Orai channel family in Ca2+ influx and mediator release has not been defined in human mast cells. Objective: To assess whether there might be value in targeting individual Orai family members for the inhibition of Fc epsilon RI-dependent human lung mast cells (HLMC) mediator release. Methods: We used an adenoviral delivery system to transduce HLMCs with shRNAs targeted against Orai1 and Orai2 or with cDNAs directing the expression of dominant-negative mutations of the three known Orai channels. Results: shRNA-mediated knockdown of Orai1 resulted in a significant reduction of approximately 50% in Ca2+ influx and in the release of beta-hexosaminidase (a marker of degranulation) and newly synthesized LTC4 in activated HLMCs. In contrast shRNA knockdown of Orai2 resulted in only marginal reductions of Ca2+ influx, degranulation and LTC4 release. Transduced dominant-negative mutants of Orai1, -2 and -3 markedly reduced Orai currents and completely inhibited HLMC degranulation suggesting that Orai channels form heteromultimers in HLMCs, and that Orai channels comprise the dominant Ca2+ influx pathway following FceRI-dependent HLMC activation. Inhibition of Orai currents did not alter HLMC survival. In addition we observed a significant down-regulation of the level of CRACM3 mRNA transcripts together with a small increase in the level of CRACM1 and CRACM2 transcripts following a period of sustained HLMC activation. Conclusion and Clinical Relevance: Orai1 plays an important role in Ca2+ influx and mediator release from HLMCs. Strategies which target Orai1 will effectively inhibit Fc epsilon RI-dependent HLMC activation, but spare off-target inhibition of Orai2 in other cells and body systems.	[Ashmole, Ian; Duffy, S. Mark; Bradding, Peter] Univ Leicester, Inst Lung Hlth, Dept Infect Immun & Inflammat, Glenfield Hosp, Leicester, Leics, England; [Leyland, Mark L.] Univ Leicester, Dept Biochem, Leicester, Leics, England	University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Leicester	Bradding, P (corresponding author), Univ Leicester, Inst Lung Hlth, Dept Infect Immun & Inflammat, Glenfield Hosp, Leicester, Leics, England.	pbradding@hotmail.com		Bradding, Peter/0000-0001-8403-0319	Wellcome Trust, UK [087499]; ERDF [05567]; National Institute for Health Research Leicester Respiratory Biomedical Research Unit	Wellcome Trust, UK(Wellcome Trust); ERDF(European Commission); National Institute for Health Research Leicester Respiratory Biomedical Research Unit	This work was supported by project grant no. 087499 from the Wellcome Trust, UK and was conducted in laboratories part-funded by ERDF #05567. The work was also supported in part by the National Institute for Health Research Leicester Respiratory Biomedical Research Unit. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashmole I, 2012, J ALLERGY CLIN IMMUN, V129, P1628, DOI 10.1016/j.jaci.2012.01.070; Bogeski I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000672; Bradding P, 2006, J ALLERGY CLIN IMMUN, V117, P1277, DOI 10.1016/j.jaci.2006.02.039; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Duffy SM, 2003, J ALLERGY CLIN IMMUN, V112, P965, DOI 10.1016/j.jaci.2003.07.004; Duffy SM, 2001, J IMMUNOL, V167, P4261, DOI 10.4049/jimmunol.167.8.4261; Faouzi M, 2011, J CELL PHYSIOL, V226, P542, DOI 10.1002/jcp.22363; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Freichel M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00150; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Motiani RK, 2010, J BIOL CHEM, V285, P19173, DOI 10.1074/jbc.M110.102582; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Sanmugalingam D, 2000, J LEUKOCYTE BIOL, V68, P38; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wykes RCE, 2007, J IMMUNOL, V179, P4045, DOI 10.4049/jimmunol.179.6.4045; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	26	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74895	10.1371/journal.pone.0074895	http://dx.doi.org/10.1371/journal.pone.0074895			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040356	Green Published, Green Submitted, gold			2022-12-25	WOS:000327538600119
J	Li, ZY; Chen, W; Su, YL; Zhang, Q; Hou, ZY; Pan, JS; Zhang, YZ				Li, Zhiyong; Chen, Wei; Su, Yanling; Zhang, Qi; Hou, Zhiyong; Pan, Jinshe; Zhang, Yingze			The Application of Closed Reduction Internal Fixation and Iliac Bone Block Grafting in the Treatment of Acute Displaced Femoral Neck Fractures	PLOS ONE			English	Article							INTRACAPSULAR HIP-FRACTURES; COMPRESSION SCREW FIXATION; SUBCAPITAL FRACTURES; HEALING COMPLICATIONS; YOUNG-ADULTS; END-RESULT; FEMUR; NONUNION; PRESSURE; HEAD	Objective: This study aimed to evaluate the preliminary clinical and radiographic outcomes of acute displaced femoral neck fracture treated by closed reduction and internal fixation (CRIF) with free iliac bone block grafting with comparison to a routine protocol of CRIF without bone grafting. Methods: From December 2008 to February 2010, 220 adult patients with acute displaced femoral neck fractures were enrolled in this study. In study group, there were 124 patients (57 males, 67 females) with a mean age of 44.8 years (range, 20-64 years). There were 70 transcervical fractures and 54 subcapital fractures. The patients were treated by CRIF and free iliac bone block grafting. The control group consisted of 96 adult patients (46 males, 50 females) with a mean age of 46.3 years (range, 23-64 years). There were 61 transcervical fractures and 35 subcapital fractures. The patients in control group were treated by CRIF without bone grafting. Results: In study group, 112 patients were followed up for an average of 27.4 months (range, 24-34 months). All fractures healed within 5 months. However, 10 patients presented AVN of the femoral heads. The mean Harris score was 88.6 (range, 41-100). In control group, 68 patients were followed up for an average of 31.2 months (range, 24-42 months). The rates of AVN of the femoral head and fracture nonunion in control group were 26.5% (18/68) and 16.2% (11/68), respectively, significantly higher than those in study group (both P<0.05). The mean Harris score in control group was 83.8 (41-100), significantly lower than that in study group (P<0.05). Conclusion: Acute displaced femoral neck fractures can be treated by CRIF and free iliac bone block grafting in a minimally invasive manner. This technique can guarantee uneventful fracture healing and significantly reduce the rate of femoral head osteonecrosis.	[Li, Zhiyong; Chen, Wei; Su, Yanling; Zhang, Qi; Hou, Zhiyong; Pan, Jinshe; Zhang, Yingze] Hebei Med Univ, Hosp 3, Dept Orthopaed Surg, Shijiazhuang, Hebei, Peoples R China	Hebei Medical University	Zhang, YZ (corresponding author), Hebei Med Univ, Hosp 3, Dept Orthopaed Surg, Shijiazhuang, Hebei, Peoples R China.	dryzzhang@126.com	Chen, Wei/GRX-2231-2022	Hou, Zhiyong/0000-0001-5838-4025				Aminian A, 2007, J ORTHOP TRAUMA, V21, P544, DOI 10.1097/BOT.0b013e31814b822e; ARNOLD WD, 1974, J BONE JOINT SURG AM, VA 56, P254, DOI 10.2106/00004623-197456020-00003; BANKS HH, 1974, ORTHOP CLIN N AM, V5, P865; BARNES R, 1976, J BONE JOINT SURG BR, V58, P2, DOI 10.1302/0301-620X.58B1.1270491; BONFIGLIO M, 1968, J BONE JOINT SURG AM, VA 50, P48, DOI 10.2106/00004623-196850010-00003; Chang MC, 1999, ORTHOPEDICS, V22, P493; CHAPMAN MW, 1975, J BONE JOINT SURG BR, V57, P735; Chapman MW, 2001, CHAPMANS ORTHOPAEDIC, P617; CHRISTIE J, 1988, J BONE JOINT SURG BR, V70, P199, DOI 10.1302/0301-620X.70B2.3346287; CRAWFURD EJP, 1988, J BONE JOINT SURG BR, V70, P195, DOI 10.1302/0301-620X.70B2.3279041; Damany DS, 2005, INJURY, V36, P131, DOI 10.1016/j.injury.2004.05.023; DEDRICK DK, 1986, J TRAUMA, V26, P932, DOI 10.1097/00005373-198610000-00013; DICKSON JA, 1953, J BONE JOINT SURG AM, V35-A, P805, DOI 10.2106/00004623-195335040-00001; FIELDING JW, 1974, J BONE JOINT SURG AM, VA 56, P1464, DOI 10.2106/00004623-197456070-00015; Frihagen F, 2007, BMJ-BRIT MED J, V335, P1251, DOI 10.1136/bmj.39399.456551.25; GAERTNER RL, 1977, SOUTH MED J, V70, P1039, DOI 10.1097/00007611-197709000-00008; GARDEN R S, 1971, Journal of Bone and Joint Surgery British Volume, V53, P183; GARDEN RS, 1964, J BONE JOINT SURG BR, V46, P630, DOI 10.1302/0301-620X.46B4.630; GERBER C, 1993, CLIN ORTHOP RELAT R, P77; Haidukewych GJ, 2004, J BONE JOINT SURG AM, V86A, P1711, DOI 10.2106/00004623-200408000-00015; HARPER WM, 1991, J BONE JOINT SURG BR, V73, P73, DOI 10.1302/0301-620X.73B1.1991780; HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012; Henderson MS, 1940, J BONE JOINT SURG, V22, P97; Huang HK, 2010, ORTHOPEDICS, V33, DOI 10.3928/01477447-20101021-15; Itadera Eichi, 2003, J Orthop Sci, V8, P155, DOI 10.1007/s007760300026; Keating J, 2010, ROCKWOOD TP AND GREE, P1562; Keating JF, 2006, J BONE JOINT SURG AM, V88A, P249, DOI 10.2106/JBJS.E.00215; Khan M, 2011, INDIAN J ORTHOP, V45, P23, DOI 10.4103/0019-5413.73658; KOFOED H, 1982, INJURY, V14, P146, DOI 10.1016/0020-1383(82)90049-3; Kuntz AF, 2011, FRACTURES IN THE ELD, P244; LeCroy CM, 2002, J ORTHOP TRAUMA, V16, P464, DOI 10.1097/00005131-200208000-00004; Lee CH, 2003, ARCH ORTHOP TRAUM SU, V123, P527, DOI 10.1007/s00402-003-0579-8; Liporace F, 2008, J BONE JOINT SURG AM, V90A, P1654, DOI 10.2106/JBJS.G.01353; LUYAO GL, 1994, J BONE JOINT SURG AM, V76A, P15, DOI 10.2106/00004623-199401000-00003; MADSEN F, 1987, ACTA ORTHOP SCAND, V58, P212, DOI 10.3109/17453678709146468; Mak JCS, 2010, MED J AUSTRALIA, V192, P37, DOI 10.5694/j.1326-5377.2010.tb03400.x; MARTENS M, 1979, CLIN ORTHOP RELAT R, P199; Maruenda JI, 1997, CLIN ORTHOP RELAT R, P172; MEYERS MH, 1973, J BONE JOINT SURG AM, VA 55, P257, DOI 10.2106/00004623-197355020-00002; NAGI ON, 1986, J BONE JOINT SURG BR, V68, P387, DOI 10.1302/0301-620X.68B3.3733802; NILSSON LT, 1993, ACTA ORTHOP SCAND, V64, P175, DOI 10.3109/17453679308994564; Parker MJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001708.pub2; Parker M J, 1994, Injury, V25 Suppl 2, pB3; Parker MJ, 2007, CLIN ORTHOP RELAT R, P175, DOI 10.1097/BLO.0b013e3180325a42; PARKER MJ, 1991, J BONE JOINT SURG BR, V73, P826, DOI 10.1302/0301-620X.73B5.1894675; PROTZMAN RR, 1976, J BONE JOINT SURG AM, V58, P689, DOI 10.2106/00004623-197658050-00020; REHNBERG L, 1989, ACTA ORTHOP SCAND, V60, P579, DOI 10.3109/17453678909150126; REHNBERG L, 1989, J BONE JOINT SURG BR, V71, P173, DOI 10.1302/0301-620X.71B2.2925729; Roshan A, 2008, CLIN MED RES, V6, P33, DOI 10.3121/cmr.2008.752; RUBIN R, 1981, J TRAUMA, V21, P1036, DOI 10.1097/00005373-198112000-00006; SKINNER PW, 1986, J BONE JOINT SURG BR, V68, P78, DOI 10.1302/0301-620X.68B1.3941145; Stankewich CJ, 1996, J ORTHOP TRAUMA, V10, P248, DOI 10.1097/00005131-199605000-00005; Su YL, 2011, INJURY, V42, P140, DOI 10.1016/j.injury.2010.05.008; SWIONTKOWSKI MF, 1994, J BONE JOINT SURG AM, V76A, P129, DOI 10.2106/00004623-199401000-00019; SWIONTKOWSKI MF, 1984, J BONE JOINT SURG AM, V66A, P837, DOI 10.2106/00004623-198466060-00003; SWIONTKOWSKI MF, 1986, CLIN ORTHOP RELAT R, P248; Swiontkowski MF, 1992, SKELETAL TRAUMA, P1384; Upadhyay A, 2004, J BONE JOINT SURG BR, V86B, P1035, DOI 10.1302/0301-620X.86B7.15047; Wei J, 2000, CHIN J TRAUMATOL, V16, P142; Xu B, 2012, CHIN J TRAUMA, V28, P131; ZETTERBERG CH, 1982, ACTA ORTHOP SCAND, V53, P427, DOI 10.3109/17453678208992237	61	5	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e75479	10.1371/journal.pone.0075479	http://dx.doi.org/10.1371/journal.pone.0075479			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040414	Green Published, gold, Green Submitted			2022-12-25	WOS:000327538600141
J	Lopes, FB; Magnabosco, CU; Paulini, F; da Silva, MC; Miyagi, ES; Lobo, RB				Lopes, Fernando Brito; Magnabosco, Claudio Ulhoa; Paulini, Fernanda; da Silva, Marcelo Correa; Miyagi, Eliane Sayuri; Lobo, Raysildo Barbosa			Genetic Analysis of Growth Traits in Polled Nellore Cattle Raised on Pasture in Tropical Region Using Bayesian Approaches	PLOS ONE			English	Article							WEANING WEIGHT; BEEF-CATTLE; (CO)VARIANCE COMPONENTS; REPRODUCTIVE TRAITS; TABAPUA CATTLE; ANIMAL-MODELS; PARAMETERS; TRENDS; BIRTH; SELECTION	Components of (co)variance and genetic parameters were estimated for adjusted weights at ages 120 (W120), 240 (W240), 365 (W365) and 450 (W450) days of Polled Nellore cattle raised on pasture and born between 1987 and 2010. Analyses were performed using an animal model, considering fixed effects: herd-year-season of birth and calf sex as contemporary groups and the age of cow as a covariate. Gibbs Samplers were used to estimate (co) variance components, genetic parameters and additive genetic effects, which accounted for great proportion of total variation in these traits. High direct heritability estimates for the growth traits were revealed and presented mean 0.43, 0.61, 0.72 and 0.67 for W120, W240, W365 and W450, respectively. Maternal heritabilities were 0.07 and 0.08 for W120 and W240, respectively. Direct additive genetic correlations between the weight at 120, 240, 365 and 450 days old were strong and positive. These estimates ranged from 0.68 to 0.98. Direct-maternal genetic correlations were negative for W120 and W240. The estimates ranged from -0.31 to -0.54. Estimates of maternal heritability ranged from 0.056 to 0.092 for W120 and from 0.064 to 0.096 for W240. This study showed that genetic progress is possible for the growth traits we studied, which is a novel and favorable indicator for an upcoming and promising Polled Zebu breed in Tropical regions. Maternal effects influenced the performance of weight at 120 and 240 days old. These effects should be taken into account in genetic analyses of growth traits by fitting them as a genetic or a permanent environmental effect, or even both. In general, due to a medium-high estimate of environmental (co) variance components, management and feeding conditions for Polled Nellore raised at pasture in tropical regions of Brazil needs improvement and growth performance can be enhanced.	[Lopes, Fernando Brito] Embrapa Cerrados Capes, Goiania, Go, Brazil; [Magnabosco, Claudio Ulhoa] Embrapa Cerrados, Brasilia, DF, Brazil; [Paulini, Fernanda] Univ Brasilia, Inst Biol Sci, Dept Physiol Sci, Postgrad Program Anim Biol, Brasilia, DF, Brazil; [da Silva, Marcelo Correa; Miyagi, Eliane Sayuri] Univ Fed Goias, Postgrad Program Anim Sci, Goiania, Go, Brazil; [Lobo, Raysildo Barbosa] Brazilian Soc Breeders & Researchers, Ribeirao Preto, SP, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Brasilia; Universidade Federal de Goias	Lopes, FB (corresponding author), Embrapa Cerrados Capes, Goiania, Go, Brazil.	camult@gmail.com	Silva, Marcelo/AAE-4532-2021; Paulini, Fernanda/L-5032-2016; Magnabosco, Cláudio Ulhoa/ABC-4494-2021	Silva, Marcelo/0000-0002-7599-1967; Paulini, Fernanda/0000-0003-4490-9614; Magnabosco, Cláudio Ulhoa/0000-0002-7274-0134; MIYAGI, ELIANE/0000-0003-0900-2515				Bertazzo RP, 2004, REV BRAS ZOOTECN, V33, P1118, DOI 10.1590/S1516-35982004000500003; Bijma P, 2006, J ANIM SCI, V84, P800, DOI 10.2527/2006.844800x; Boligon AA, 2010, J ANIM SCI, V88, P849, DOI 10.2527/jas.2008-1511; Boligon AA, 2008, REV BRAS ZOOTECN, V37, P596, DOI 10.1590/S1516-35982008000400002; Brasil, 2011, PROJ AGR MUND BRAS; Cabrera M. E., 2001, Livestock Research for Rural Development, V13, P1; Cardoso FF, 2001, REV BRAS ZOOTECN, V30, P41, DOI 10.1590/S1516-35982001000100008; CASELLA G, 1992, AM STAT, V46, P167, DOI 10.2307/2685208; de Albuquerque LG, 2001, J ANIM BREED GENET, V118, P83, DOI 10.1046/j.1439-0388.2001.00279.x; de Faria CU, 2009, REV BRAS ZOOTECN, V38, P1191, DOI 10.1590/S1516-35982009000700005; Santos Geneíldes Cristina de Jesus, 2012, Acta Sci., Anim. Sci., V34, P97, DOI 10.4025/actascianimsci.v34i1.12172; Dias LT, 2006, REV BRAS ZOOTECN, V35, P1915, DOI 10.1590/S1516-35982006000700006; Dias LT, 2005, REV BRAS ZOOTECN, V34, P1914, DOI 10.1590/S1516-35982005000600015; Dodenhoff J, 1999, J ANIM SCI, V77, P840; Eler JP, 2000, REV BRAS ZOOTECN, V29, P1642, DOI 10.1590/S1516-35982000000600007; Elzo MA, 1998, J ANIM SCI, V76, P1539; Faria CU, 2008, CIENCIA ANIMAL BRASI, V9, P598; Ferraz Filho P. B., 2002, Archives of Veterinary Science, V7, P65; Ferraz José Bento Sterman, 2010, R. Bras. Zootec., V39, P216, DOI 10.1590/S1516-35982010001300024; Ferraz PB, 2002, REV BRAS ZOOTECN, V31, P635, DOI 10.1590/S1516-35982002000300013; Forni S, 2007, J ANIM SCI, V85, P3189, DOI 10.2527/jas.2006-677; Forni S, 2009, J ANIM SCI, V87, P496, DOI 10.2527/jas.2008-0845; Garnero AD, 2013, CIENC RURAL, V43, P702, DOI 10.1590/S0103-84782013005000029; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; Lopes F. B., 2011, Revista Brasileira de Saude e Producao Animal, V12, P607; Lopes FB, 2012, REV CIENC AGRON, V43, P362, DOI 10.1590/S1806-66902012000200020; Malhado C. H. M., 2002, Archives of Veterinary Science, V7, P71; Maniatis N, 2002, SMALL RUMINANT RES, V45, P235, DOI 10.1016/S0921-4488(02)00114-1; Mercadante MEZ, 1997, REV SOC BRAS ZOOTECN, V26, P1124; MEYER K, 1992, LIVEST PROD SCI, V31, P179, DOI 10.1016/0301-6226(92)90017-X; MEYER K, 1993, J ANIM SCI, V71, P2614, DOI 10.2527/1993.71102614x; Meyer K, 1997, LIVEST PROD SCI, V52, P187, DOI 10.1016/S0301-6226(97)00144-9; Ndofor-Foleng H. M., 2012, African Journal of Biotechnology, V11, P14410; Nephawe KA, 2004, S AFR J ANIM SCI, V34, P166; Plasse Dieter, 2002, Genetics and Molecular Research, V1, P282; R Development Core Team, 2012, R LANG ENV STAT COMP; Ribeiro MN, 2001, REV BRAS ZOOTECN, V30, P1224, DOI 10.1590/S1516-35982001000500014; Robinson DL, 1996, LIVEST PROD SCI, V45, P1, DOI 10.1016/0301-6226(95)00083-6; Robinson DL, 1996, LIVEST PROD SCI, V45, P111, DOI 10.1016/0301-6226(96)00002-4; Rosales-Alday J., 2004, Tecnica Pecuaria en Mexico, V42, P333; SAS Institute, 2002, STAT AN SYST US GUID; Silva JAI, 2005, REV BRAS ZOOTECN, V34, P1568, DOI 10.1590/S1516-35982005000500017; Sorensen DA., 2002, STAT BIOL HEALTH; Souza J.C., 2011, Arch. zootec., V60, P457, DOI 10.4321/s0004-05922011000300035; Souza J.C., 2008, ARCH LATINOAMERICANO, V16, P85; Suarez MJ, 2011, J ANIM SCI, V89, P3859, DOI 10.2527/jas.2010-3810; TAWAH CL, 1993, ANIM PROD, V57, P73, DOI 10.1017/S0003356100006620; VAN KAAM J.B.C.H.M., 1997, GIBANAL ANAL PROGRAM; VanTassell CP, 1996, J ANIM SCI, V74, P2586; Vergara OD, 2009, J ANIM SCI, V87, P516, DOI 10.2527/jas.2007-0636; Wasike CB, 2009, TROP ANIM HEALTH PRO, V41, P741, DOI 10.1007/s11250-008-9246-y; WILLHAM RL, 1972, J ANIM SCI, V35, P1288	52	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e75423	10.1371/journal.pone.0075423	http://dx.doi.org/10.1371/journal.pone.0075423			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040412	Green Published, Green Submitted, gold			2022-12-25	WOS:000327538600139
J	Scroggins, SM; Olivier, AK; Meyerholz, DK; Schlueter, AJ				Scroggins, Sabrina M.; Olivier, Alicia K.; Meyerholz, David K.; Schlueter, Annette J.			Characterization of Regulatory Dendritic Cells That Mitigate Acute Graft-versus-Host Disease in Older Mice Following Allogeneic Bone Marrow Transplantation	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE RECEPTORS; T-CELLS; PD-1; PROTECT; INFLAMMATION; PREVENTION; INFLUENZA; CYTOKINES; SURVIVAL; LIGANDS	Despite improvements in human leukocyte antigen matching and pharmacologic prophylaxis, acute graft-versus-host disease (GVHD) is often a fatal complication following hematopoietic stem cell transplant (HSCT). Older HSCT recipients experience significantly increased morbidity and mortality compared to young recipients. Prophylaxis with syngeneic regulatory dendritic cells (DCreg) in young bone marrow transplanted (BMT) mice has been shown to decrease GVHD-associated mortality. To evaluate this approach in older BMT recipients, young (3-4 months) and older (14-18 months) DCreg were generated using GM-CSF, IL-10, and TGF beta. Analysis of young versus older DCreg following culture revealed no differences in phenotype. The efficacy of DCreg treatment in older BMT mice was evaluated in a BALB/c -> C57Bl/6 model of GVHD; on day 2 post-BMT (d + 2), mice received syngeneic, age-matched DCreg. Although older DCreg-treated BMT mice showed decreased morbidity and mortality compared to untreated BMT mice (all of which died), there was a small but significant decrease in the survival of older DCreg-treated BMT mice (75% survival) compared to young DCreg-treated BMT mice (90% survival). To investigate differences between dendritic cells (DC) in young and older DCreg-treated BMT mice that may play a role in DCreg function in vivo, DC phenotypes were assessed following DCreg adoptive transfer. Transferred DCreg identified in older DCreg-treated BMT mice at d + 3 showed significantly lower expression of PD-L1 and PIR B compared to DCreg from young DCreg-treated BMT mice. In addition, donor DC identified in d + 21 DCreg-treated BMT mice displayed increased inhibitory molecule and decreased co-stimulatory molecule expression compared to d + 3, suggesting induction of a regulatory phenotype on the donor DC. In conclusion, these data indicate DCreg treatment is effective in the modulation of GVHD in older BMT recipients and provide evidence for inhibitory pathways that DCreg and donor DC may utilize to induce and maintain tolerance to GVHD.	[Scroggins, Sabrina M.; Schlueter, Annette J.] Univ Iowa, Grad Coll, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA; [Scroggins, Sabrina M.; Olivier, Alicia K.; Meyerholz, David K.; Schlueter, Annette J.] Univ Iowa, Coll Med, Dept Pathol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Schlueter, AJ (corresponding author), Univ Iowa, Grad Coll, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA.	annette-schlueter@uiowa.edu	Meyerholz, David/J-8131-2019	Meyerholz, David/0000-0003-1552-3253; Schlueter, Annette/0000-0003-2442-7079; Scroggins, Sabrina/0000-0001-5842-0575	NIH [5T32AI007485]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007485] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the aiming for a cure grant, aimingforacure.com. SMS was supported in part by a NIH Predoctoral Training Grant in Immunology, Award No. 5T32AI007485. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarnath S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000302; ASCHAN J, 1994, CLIN TRANSPLANT, V8, P258; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Belz GT, 2000, J VIROL, V74, P3486, DOI 10.1128/JVI.74.8.3486-3493.2000; Blazar BR, 2012, NAT REV IMMUNOL, V12, P443, DOI 10.1038/nri3212; Bryson JS, 1997, BONE MARROW TRANSPL, V19, P721, DOI 10.1038/sj.bmt.1700719; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Chorny A, 2005, P NATL ACAD SCI USA, V102, P13562, DOI 10.1073/pnas.0504484102; Chorny A, 2006, BLOOD, V107, P3787, DOI 10.1182/blood-2005-11-4495; del Rio ML, 2010, IMMUNOL REV, V234, P268, DOI 10.1111/j.0105-2896.2009.00874.x; Duffner UA, 2004, J IMMUNOL, V172, P7393, DOI 10.4049/jimmunol.172.12.7393; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Fife BT, 2011, ANN NY ACAD SCI, V1217, P45, DOI 10.1111/j.1749-6632.2010.05919.x; Fujita S, 2006, BLOOD, V107, P3656, DOI 10.1182/blood-2005-10-4190; Fujita S, 2008, J ALLERGY CLIN IMMUN, V121, P95, DOI 10.1016/j.jaci.2007.08.038; Fujita S, 2007, BLOOD, V110, P3793, DOI 10.1182/blood-2007-04-086470; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Guleria I, 2005, J EXP MED, V202, P231, DOI 10.1084/jem.20050019; Hadeiba H, 2008, NAT IMMUNOL, V9, P1253, DOI 10.1038/ni.1658; Hahn T, 2008, J CLIN ONCOL, V26, P5728, DOI 10.1200/JCO.2008.17.6545; Johnston L, 2008, BEST PRACT RES CL HA, V21, P177, DOI 10.1016/j.beha.2008.02.006; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Keir ME, 2007, CURR OPIN IMMUNOL, V19, P309, DOI 10.1016/j.coi.2007.04.012; Kubagawa H, 1999, J EXP MED, V189, P309, DOI 10.1084/jem.189.2.309; Kunisaki KM, 2009, LANCET INFECT DIS, V9, P493, DOI 10.1016/S1473-3099(09)70175-6; Lan YY, 2006, J IMMUNOL, V177, P5868, DOI 10.4049/jimmunol.177.9.5868; Li J, 2011, BIOL BLOOD MARROW TR, V17, P962, DOI 10.1016/j.bbmt.2011.01.018; Li WZ, 2012, J SURG RES, V176, pE79, DOI 10.1016/j.jss.2011.12.009; Matte CC, 2004, NAT MED, V10, P987, DOI 10.1038/nm1089; Meyerholz DK, 2010, AM J RESP CRIT CARE, V182, P1251, DOI 10.1164/rccm.201004-0643OC; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Mou Hai-bo, 2004, J Zhejiang Univ Sci, V5, P1239, DOI 10.1631/jzus.2004.1239; Nakamura A, 2004, NAT IMMUNOL, V5, P623, DOI 10.1038/ni1074; Nervi B, 2007, EXP HEMATOL, V35, P1823, DOI 10.1016/j.exphem.2007.06.007; Ordemann R, 2002, J CLIN INVEST, V109, P1249, DOI 10.1172/JCI200214793; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Pasquini MC, 2008, BEST PRACT RES CL HA, V21, P193, DOI 10.1016/j.beha.2008.02.011; Pasquini Marcelo C, 2010, Clin Transpl, P87; Ruane DT, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00025; Ruffner MA, 2009, EUR J IMMUNOL, V39, P3084, DOI 10.1002/eji.200939407; Sato K, 2003, IMMUNITY, V18, P367, DOI 10.1016/S1074-7613(03)00055-4; Sato K, 2003, BLOOD, V101, P3581, DOI 10.1182/blood-2002-09-2712; Sato K, 2009, BLOOD, V113, P4780, DOI 10.1182/blood-2008-10-183145; Scott CL, 2011, TRENDS IMMUNOL, V32, P412, DOI 10.1016/j.it.2011.06.003; Shin T, 2003, J EXP MED, V198, P31, DOI 10.1084/jem.20030242; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; SULLIVAN KM, 1989, NEW ENGL J MED, V320, P828, DOI 10.1056/NEJM198903303201303; Takai T, 2005, IMMUNOLOGY, V115, P433, DOI 10.1111/j.1365-2567.2005.02177.x; Torres-Aguilar H, 2010, J IMMUNOL, V184, P1765, DOI 10.4049/jimmunol.0902133; Ujike A, 2002, NAT IMMUNOL, V3, P542, DOI 10.1038/ni801; Wang XJ, 2011, BLOOD, V118, P6426, DOI 10.1182/blood-2011-06-358747; Wolf D, 2012, BLOOD, V119, P16, DOI 10.1182/blood-2011-08-339465; Yi TS, 2011, J IMMUNOL, V186, P2739, DOI 10.4049/jimmunol.1002939; Zhang XS, 2008, CLIN IMMUNOL, V127, P313, DOI 10.1016/j.clim.2008.01.013; Zhao JA, 2010, ACTA HAEMATOL-BASEL, V124, P134, DOI 10.1159/000315553	56	10	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e75158	10.1371/journal.pone.0075158	http://dx.doi.org/10.1371/journal.pone.0075158			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040397	Green Submitted, gold, Green Published			2022-12-25	WOS:000327538600130
J	Soong, K; Chiu, ST; Chen, CNN				Soong, Keryea; Chiu, Shau-Ting; Chen, Ching-Nen Nathan			Novel Seed Adaptations of a Monocotyledon Seagrass in the Wavy Sea	PLOS ONE			English	Article							ECOSYSTEMS; EVOLUTION	Returning to the sea, just like invasion of land, has occurred in many groups of animals and plants. For flowering plants, traits adapted to the terrestrial environments have to change or adopt a new function to allow the plants to survive and prosper in the sea where water motion tends to rotate and move seeds. In this investigation, how seeds of the seagrass Thalassia hemprichii (Hydrocharitaceae), a common monocotyledon in the Indo-Pacific, adapt to the wavy environment was studied. Mature seeds were collected from Dongsha Atoll in South China Sea. The effects of light qualities on seed germination, the seed morphology, the unipolar distribution of starch granules in the endosperms and growth of root hair-like filamentous cells from basal surface of the seeds were all found to differ from those of terrestrial monocotyledons. Physiologically, germination of the seeds was stimulated by blue light rather than red light. Morphologically, the bell-shaped seeds coupled with the unipolar distribution of starch granules in the enlarged bases helped maintain their upright posture on the tidal seafloor. Growth of root hair-like filamentous cells from the basal surface of the seeds prior to primary root growth served to attach onto sediments, providing leverage and attachment required by the primary roots to insert into sediments. These filamentous cells grasped coral sand but not silicate sand, demonstrating a habitat preference of this species.	[Soong, Keryea; Chen, Ching-Nen Nathan] Natl Sun Yat Sen Univ, Inst Marine Biol, Kaohsiung 80424, Taiwan; [Chiu, Shau-Ting] Natl Museum Nat Sci, Dept Biol, Taichung, Taiwan; [Soong, Keryea; Chen, Ching-Nen Nathan] Natl Sun Yat Sen Univ, Asia Pacific Ocean Res Ctr, Kaohsiung 80424, Taiwan	National Sun Yat Sen University; National Sun Yat Sen University	Chen, CNN (corresponding author), Natl Sun Yat Sen Univ, Inst Marine Biol, Kaohsiung 80424, Taiwan.	nathanc@mail.nsysu.edu.tw			Asian-Pacific Ocean Study Center of National Sun Yat-sen University; National Science Council, Taiwan [NSC 101-2119-M-110-004-MY5]; Dongsha Atoll Research Station	Asian-Pacific Ocean Study Center of National Sun Yat-sen University; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Dongsha Atoll Research Station	This work was financed in part by a grant from Asian-Pacific Ocean Study Center of National Sun Yat-sen University and a grant NSC 101-2119-M-110-004-MY5 from National Science Council, Taiwan. This project was also supported by Dongsha Atoll Research Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1984, PLANT HISTOCHEMISTRY; Becraft PW, 2011, J EXP BOT, V62, P1669, DOI 10.1093/jxb/erq372; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Hashiguchi Y, 2013, AM J BOT, V100, P91, DOI 10.3732/ajb.1200315; Janssen T, 2004, BOT J LINN SOC, V146, P385, DOI 10.1111/j.1095-8339.2004.00345.x; JOHANSEN D.A., 1940, PLANT MICROTECHNIQUE; Lalli CM, 1993, BIOL OCEANOGRAPHY IN, P25; Les DH, 1997, SYST BOT, V22, P443, DOI 10.2307/2419820; Losi A, 2011, PHOTOCHEM PHOTOBIOL, V87, P491, DOI 10.1111/j.1751-1097.2011.00913.x; Lucas C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029987; Pollard PC, 2013, J BIOSCIENCES, V38, P157, DOI 10.1007/s12038-013-9299-6; Ruzin S.E., 1999, PLANT MICROTECHNIQUE; Short F, 2007, J EXP MAR BIOL ECOL, V350, P3, DOI 10.1016/j.jembe.2007.06.012; Short F.T., 2010, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2010.e.T153538A45166753.RLTS.T153538A4516675.en., DOI 10.2305/IUCN.UK.2010.E]; Short FT, 2011, BIOL CONSERV, V144, P1961, DOI 10.1016/j.biocon.2011.04.010; Taiz L, 2006, PLANT PHYSIOL, P417; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wissler L, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-8	19	10	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74143	10.1371/journal.pone.0074143	http://dx.doi.org/10.1371/journal.pone.0074143			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040188	gold, Green Published, Green Submitted			2022-12-25	WOS:000326405300160
J	Tennakoon, JB; Wang, HR; Coarfa, C; Cooney, AJ; Gunaratne, PH				Tennakoon, Jayantha B.; Wang, Hongran; Coarfa, Cristian; Cooney, Austin J.; Gunaratne, Preethi H.			Chromatin Changes in Dicer-Deficient Mouse Embryonic Stem Cells in Response to Retinoic Acid Induced Differentiation	PLOS ONE			English	Article							NUCLEAR FACTOR; RNA INTERFERENCE; METHYLATION; MICRORNAS; RIBONUCLEASE; MECHANISM; GERMLINE; GENES; OCT4	Loss of Dicer, an enzyme critical for microRNA biogenesis, results in lethality due to a block in mouse embryonic stem cell (mES) differentiation. Using ChIP-Seq we found increased H3K9me2 at over 900 CpG islands in the Dicer(-/-)ES epigenome. Gene ontology analysis revealed that promoters of chromatin regulators to be among the most impacted by increased CpG island H3K9me2 in ES (Dicer(-/-)). We therefore, extended the study to include H3K4me3 and H3K27me3 marks for selected genes. We found that the ES (Dicer(-/-)) mutant epigenome was characterized by a shift in the overall balance between transcriptionally favorable (H3K4me3) and unfavorable (H3K27me3) marks at key genes regulating ES cell differentiation. Pluripotency genes Oct4, Sox2 and Nanog were not impacted in relation to patterns of H3K27me3 and H3K4me3 and showed no changes in the rates of transcript down-regulation in response to RA. The most striking changes were observed in regards to genes regulating differentiation and the transition from self-renewal to differentiation. An increase in H3K4me3 at the promoter of Lin28b was associated with the down-regulation of this gene at a lower rate in Dicer(-/-)ES as compared to wild type ES. An increase in H3K27me3 in the promoters of differentiation genes Hoxa1 and Cdx2 in Dicer(-/-)ES cells was coincident with an inability to upregulate these genes at the same rate as ES upon retinoic acid (RA)-induced differentiation. We found that siRNAs Ezh2 and post-transcriptional silencing of Ezh2 by let-7g rescued this effect suggesting that Ezh2 up-regulation is in part responsible for increased H3K27me3 and decreased rates of up-regulation of differentiation genes in Dicer(-/-)ES.	[Tennakoon, Jayantha B.; Gunaratne, Preethi H.] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Wang, Hongran; Coarfa, Cristian; Cooney, Austin J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Gunaratne, Preethi H.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Gunaratne, Preethi H.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	University of Houston System; University of Houston; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Cooney, AJ (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	acooney@bcm.edu; phgunaratne@uh.edu			National Institute of General Medical Sciences (NIGMS) [P01 GM081627]; NIGMS [P01 GM081627]	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences (NIGMS)- P01 GM081627 pilot grant to PHG and NIGMS- P01 GM081627 grant to AJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bao N, 2004, DEV CELL, V7, P653, DOI 10.1016/j.devcel.2004.10.003; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Coarfa C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-572; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; Gan JH, 2006, CELL, V124, P355, DOI 10.1016/j.cell.2005.11.034; Gu PL, 2011, STEM CELLS, V29, P1041, DOI 10.1002/stem.652; Huff JT, 2010, NAT STRUCT MOL BIOL, V17, P1495, DOI 10.1038/nsmb.1924; Hummelke GC, 2001, FRONT BIOSCI, V6, pD1186, DOI 10.2741/Hummelke; Jenuwein H, 2002, SCIENCE, V297, P2215, DOI 10.1126/science.1077903; Jenuwein T, 2006, FEBS J, V273, P3121, DOI 10.1111/j.1742-4658.2006.05343.x; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Shohet JM, 2011, CANCER RES, V71, P3841, DOI 10.1158/0008-5472.CAN-10-4391; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040	27	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74556	10.1371/journal.pone.0074556	http://dx.doi.org/10.1371/journal.pone.0074556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040281	gold, Green Published, Green Submitted			2022-12-25	WOS:000326405300181
J	Raju, J; Roberts, J; Sondagar, C; Kapal, K; Aziz, SA; Caldwell, D; Mehta, R				Raju, Jayadev; Roberts, Jennifer; Sondagar, Chandni; Kapal, Kamla; Aziz, Syed A.; Caldwell, Don; Mehta, Rekha			Negligible Colon Cancer Risk from Food-Borne Acrylamide Exposure in Male F344 Rats and Nude (nu/nu) Mice-Bearing Human Colon Tumor Xenografts	PLOS ONE			English	Article							DIETARY ACRYLAMIDE; COLORECTAL-CANCER; CARCINOGENESIS; ONCOGENICITY; GLYCIDAMIDE; TOXICITY; MODEL	Acrylamide, a possible human carcinogen, is formed in certain carbohydrate-rich foods processed at high temperature. We evaluated if dietary acrylamide, at doses (0.5, 1.0 or 2.0 mg/kg diet) reflecting upper levels found in human foods, modulated colon tumorigenesis in two rodent models. Male F344 rats were randomized to receive diets without (control) or with acrylamide. 2-weeks later, rats in each group received two weekly subcutaneous injections of either azoxymethane (AOM) or saline, and were killed 20 weeks post-injections; colons were assessed for tumors. Male athymic nude (nu/nu) mice bearing HT-29 human colon adenocarcinoma cells-derived tumor xenografts received diets without (control) or with acrylamide; tumor growth was monitored and mice were killed 4 weeks later. In the F344 rat study, no tumors were found in the colons of the saline-injected rats. However, the colon tumor incidence was 54.2% and 66.7% in the control and the 2 mg/kg acrylamide-treated AOM-injected groups, respectively. While tumor multiplicity was similar across all diet groups, tumor size and burden were higher in the 2 mg/kg acrylamide group compared to the AOM control. These results suggest that acrylamide by itself is not a "complete carcinogen", but acts as a "co-carcinogen" by exacerbating the effects of AOM. The nude mouse study indicated no differences in the growth of human colon tumor xenografts between acrylamide-treated and control mice, suggesting that acrylamide does not aid in the progression of established tumors. Hence, food-borne acrylamide at levels comparable to those found in human foods is neither an independent carcinogen nor a tumor promoter in the colon. However, our results characterize a potential hazard of acrylamide as a colon co-carcinogen in association with known and possibly other environmental tumor initiators/promoters.	[Raju, Jayadev; Roberts, Jennifer; Sondagar, Chandni; Kapal, Kamla; Aziz, Syed A.; Mehta, Rekha] Hlth Canada, Toxicol Res Div, Bur Chem Safety Food Directorate, Hlth Prod & Food Branch, Ottawa, ON K1A 0L2, Canada; [Caldwell, Don] Hlth Canada, Sci Serv Div, Bur Chem Safety Food Directorate, Hlth Prod & Food Branch, Ottawa, ON K1A 0L2, Canada	Health Canada; Health Canada	Raju, J (corresponding author), Hlth Canada, Toxicol Res Div, Bur Chem Safety Food Directorate, Hlth Prod & Food Branch, Ottawa, ON K1A 0L2, Canada.	jayadev.raju@hc-sc.gc.ca	Aziz, Syed/AAS-6550-2020		Chemicals Management Plan, Health Canada, Government of Canada	Chemicals Management Plan, Health Canada, Government of Canada	Financial support for this research was provided from the Chemicals Management Plan, Health Canada, Government of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2481; Becalski A, 2004, J AGR FOOD CHEM, V52, P3801, DOI 10.1021/jf0349376; Benedikte H, 2007, ANTICANCER RES, V27, P3855; BIRD RP, 1987, CANCER LETT, V37, P147, DOI 10.1016/0304-3835(87)90157-1; Bird RP, 1996, CANCER RES, V56, P2896; BULL RJ, 1984, CANCER RES, V44, P107; BULL RJ, 1984, CANCER LETT, V24, P209, DOI 10.1016/0304-3835(84)90138-1; Choi YM, 2009, J TOXICOL SCI, V34, P407, DOI 10.2131/jts.34.407; Doerge DR, 2005, TOXICOL APPL PHARM, V208, P199, DOI 10.1016/j.taap.2005.03.003; FRIEDMAN MA, 1995, FUND APPL TOXICOL, V27, P95, DOI 10.1006/faat.1995.1112; Gargas ML, 2009, FOOD CHEM TOXICOL, V47, P760, DOI 10.1016/j.fct.2008.12.032; Hamilton SR, 2000, PATHOLOGY GENETICS T, P101; Health Canada, 2012, HLTH CAN REV EXP ASS; Health Canada, 2009, ACR LEV SEL CAN FOOD; Imai T, 2005, CANCER LETT, V230, P25, DOI 10.1016/j.canlet.2004.12.019; Imai T, 2014, J APPL TOXICOL, V34, P57, DOI 10.1002/jat.2831; JOHNSON KA, 1986, TOXICOL APPL PHARM, V85, P154, DOI 10.1016/0041-008X(86)90109-2; Larsson SC, 2009, EUR J CANCER, V45, P513, DOI 10.1016/j.ejca.2008.12.001; Mojska H, 2012, FOOD CHEM TOXICOL, V50, P2722, DOI 10.1016/j.fct.2012.05.023; Mucci LA, 2006, INT J CANCER, V118, P169, DOI 10.1002/ijc.21309; Mucci LA, 2009, JNCI-J NATL CANCER I, V101, P618, DOI 10.1093/jnci/djp080; National Toxicology Program, 2012, Natl Toxicol Program Tech Rep Ser, P1; Pelucchi C, 2011, ANN ONCOL, V22, P1487, DOI 10.1093/annonc/mdq610; Raju J, 2011, FOOD CHEM TOXICOL, V49, P1373, DOI 10.1016/j.fct.2011.03.022; Raju J, 2008, WORLD J GASTROENTERO, V14, P6632, DOI 10.3748/wjg.14.6632; Reddy BS, 2004, ENVIRON MOL MUTAGEN, V44, P26, DOI 10.1002/em.20026; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Shipp A, 2006, CRIT REV TOXICOL, V36, P481, DOI 10.1080/10408440600851377; Stadler RH, 2002, NATURE, V419, P449, DOI 10.1038/419449a; Swedish National Food Administration, 2002, ACR FOOD; Von Tungeln LS, 2012, INT J CANCER, V131, P2008, DOI 10.1002/ijc.27493; Whiteley LO, 1996, GUIDES TOXICOLOGIC P, P1; WHO INT AGCY RES CANC, 1994, IARC MONOG EVAL CARC, V60, P389; World Health Organisation (WHO), 1996, TRAC EL HUM NUTR HLT; Zhang X, 2009, TOXICOL IND HEALTH, V25, P101, DOI 10.1177/0748233709102948; Zhang XC, 2009, TOXICOL MECH METHOD, V19, P285, DOI 10.1080/15376510802637670	36	7	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73916	10.1371/journal.pone.0073916	http://dx.doi.org/10.1371/journal.pone.0073916			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040114	Green Submitted, gold, Green Published			2022-12-25	WOS:000324481600106
J	Forrest, MP; Waite, AJ; Martin-Rendon, E; Blake, DJ				Forrest, Marc P.; Waite, Adrian J.; Martin-Rendon, Enca; Blake, Derek J.			Knockdown of Human TCF4 Affects Multiple Signaling Pathways Involved in Cell Survival, Epithelial to Mesenchymal Transition and Neuronal Differentiation	PLOS ONE			English	Article							HELIX-LOOP-HELIX; PITT-HOPKINS-SYNDROME; SEVERE MENTAL-RETARDATION; TRANSCRIPTION FACTOR; EPSILON-SARCOGLYCAN; MISSENSE MUTATIONS; GENE-EXPRESSION; FRAGILE-X; KAPPA-B; SCHIZOPHRENIA	Haploinsufficiency of TCF4 causes Pitt-Hopkins syndrome (PTHS): a severe form of mental retardation with phenotypic similarities to Angelman, Mowat-Wilson and Rett syndromes. Genome-wide association studies have also found that common variants in TCF4 are associated with an increased risk of schizophrenia. Although TCF4 is transcription factor, little is known about TCF4-regulated processes in the brain. In this study we used genome-wide expression profiling to determine the effects of acute TCF4 knockdown on gene expression in SH-SY5Y neuroblastoma cells. We identified 1204 gene expression changes (494 upregulated, 710 downregulated) in TCF4 knockdown cells. Pathway and enrichment analysis on the differentially expressed genes in TCF4-knockdown cells identified an over-representation of genes involved in TGF-beta signaling, epithelial to mesenchymal transition (EMT) and apoptosis. Among the most significantly differentially expressed genes were the EMT regulators, SNAI2 and DEC1 and the proneural genes, NEUROG2 and ASCL1. Altered expression of several mental retardation genes such as UBE3A (Angelman Syndrome), ZEB2 (Mowat-Wilson Syndrome) and MEF2C was also found in TCF4-depleted cells. These data suggest that TCF4 regulates a number of convergent signaling pathways involved in cell differentiation and survival in addition to a subset of clinically important mental retardation genes.	[Forrest, Marc P.; Waite, Adrian J.; Blake, Derek J.] Cardiff Univ, Inst Psychol Med & Clin Neurosci, MRC Ctr Neuropsychiat Genet & Genom, Sch Med, Cardiff CF10 3AX, S Glam, Wales; [Martin-Rendon, Enca] Univ Oxford, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, Oxford, England; [Martin-Rendon, Enca] John Radcliffe Hosp, Stem Cell Res Lab, NHS Blood & Transplant, Oxford OX3 9DU, England	Cardiff University; University of Oxford; University of Oxford	Blake, DJ (corresponding author), Cardiff Univ, Inst Psychol Med & Clin Neurosci, MRC Ctr Neuropsychiat Genet & Genom, Sch Med, Cardiff CF10 3AX, S Glam, Wales.	blakedj@cardiff.ac.uk	Forrest, Marc/AAD-7335-2021; Martin-Rendon, Enca/K-6457-2016	Forrest, Marc/0000-0002-9280-7850; 	Medical Research Council; MRC	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a Medical Research Council (http://www.mrc.ac.uk/index.htm) studentship (MPF) and an MRC Centenary Award (DJB, MPF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Amiel J, 2007, AM J HUM GENET, V80, P988, DOI 10.1086/515582; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Armani R, 2012, AM J MED GENET A, V158A, P713, DOI 10.1002/ajmg.a.34206; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bhakar AL, 2012, ANNU REV NEUROSCI, V35, P417, DOI 10.1146/annurev-neuro-060909-153138; Bhattacharya A, 2012, NEURON, V76, P325, DOI 10.1016/j.neuron.2012.07.022; Blake DJ, 2010, SCHIZOPHRENIA BULL, V36, P443, DOI 10.1093/schbul/sbq035; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Bond AM, 2012, DEV NEUROBIOL, V72, P1068, DOI 10.1002/dneu.22022; Bracko O, 2012, J NEUROSCI, V32, P3376, DOI 10.1523/JNEUROSCI.4248-11.2012; Brockschmidt A, 2007, HUM MOL GENET, V16, P1488, DOI 10.1093/hmg/ddm099; Brzozka MM, 2010, BIOL PSYCHIAT, V68, P33, DOI 10.1016/j.biopsych.2010.03.015; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; Cobaleda C, 2007, ANNU REV GENET, V41, P41, DOI 10.1146/annurev.genet.41.110306.130146; de Pontual L, 2009, HUM MUTAT, V30, P669, DOI 10.1002/humu.20935; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Esapa CT, 2007, HUM MOL GENET, V16, P327, DOI 10.1093/hmg/ddl472; Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209; Flora A, 2007, P NATL ACAD SCI USA, V104, P15382, DOI 10.1073/pnas.0707456104; Forrest M, 2012, HUM MUTAT, V33, P1676, DOI 10.1002/humu.22160; Garavelli L, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-42; Gutierrez H, 2011, TRENDS NEUROSCI, V34, P316, DOI 10.1016/j.tins.2011.03.001; HENTHORN P, 1990, SCIENCE, V247, P467, DOI 10.1126/science.2105528; Hoffmann R, 2008, NAT GENET, V40, P1047, DOI 10.1038/ng.f.217; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hyman BT, 2012, NAT REV NEUROSCI, V13, P395, DOI 10.1038/nrn3228; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Le Meur N, 2010, J MED GENET, V47, P22, DOI 10.1136/jmg.2009.069732; Li SQ, 2012, J NEUROSCI, V32, P7791, DOI 10.1523/JNEUROSCI.1309-12.2012; Liu Y, 1998, J BIOL CHEM, V273, P19269, DOI 10.1074/jbc.273.30.19269; Locke M, 2009, HUM MOL GENET, V18, P2344, DOI 10.1093/hmg/ddp167; Mabb AM, 2011, TRENDS NEUROSCI, V34, P293, DOI 10.1016/j.tins.2011.04.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Murre C, 2005, NAT IMMUNOL, V6, P1079, DOI 10.1038/ni1260; Navarrete K, 2013, AM J MED GENET B, V162B, P1, DOI 10.1002/ajmg.b.32109; Panchision DM, 2001, GENE DEV, V15, P2094, DOI 10.1101/gad.894701; Peippo M, 2011, MOL SYNDROMOL, V2, P171, DOI 10.1159/000335287; Powell LM, 2008, CURR OPIN GENET DEV, V18, P411, DOI 10.1016/j.gde.2008.07.012; Qin ZH, 2007, ACTA PHARMACOL SIN, V28, P1859, DOI 10.1111/j.1745-7254.2007.00741.x; Quednow BB, 2011, J NEUROSCI, V31, P6684, DOI 10.1523/JNEUROSCI.0526-11.2011; Reizis B, 2010, CURR OPIN IMMUNOL, V22, P206, DOI 10.1016/j.coi.2010.01.005; Remacle JE, 1999, EMBO J, V18, P5073, DOI 10.1093/emboj/18.18.5073; Schmeisser MJ, 2012, J NEUROSCI, V32, P5688, DOI 10.1523/JNEUROSCI.0111-12.2012; Segklia A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034088; Sepp M, 2012, HUM MOL GENET, V21, P2873, DOI 10.1093/hmg/dds112; Sepp M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022138; Sobrado VR, 2009, J CELL SCI, V122, P1014, DOI 10.1242/jcs.028241; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Tropea D, 2009, P NATL ACAD SCI USA, V106, P2029, DOI 10.1073/pnas.0812394106; Van Balkom IDC, 2012, DEV MED CHILD NEUROL, V54, P925, DOI 10.1111/j.1469-8749.2012.04339.x; Waite A, 2011, HUM MUTAT, V32, P1246, DOI 10.1002/humu.21561; Wirgenes KV, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.39; Wu YH, 2012, DERMATOL SIN, V30, P1, DOI 10.1016/j.dsi.2012.02.004; Zhu XH, 2013, NEUROPSYCHOPHARMACOL, V38, P683, DOI 10.1038/npp.2012.234; Zweier C, 2007, AM J HUM GENET, V80, P994, DOI 10.1086/515583; Zweier M, 2011, MOL SYNDROMOL, V2, P164, DOI 10.1159/000337496	61	70	73	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e73169	10.1371/journal.pone.0073169	http://dx.doi.org/10.1371/journal.pone.0073169			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24058414	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000324403200043
J	Muller, B; Chihota, VN; Pillay, M; Klopper, M; Streicher, EM; Coetzee, G; Trollip, A; Hayes, C; Bosman, ME; Gey van Pittius, NC; Victor, TC; Gagneux, S; van Helden, PD; Warren, RM				Mueller, Borna; Chihota, Violet N.; Pillay, Manormoney; Klopper, Marisa; Streicher, Elizabeth M.; Coetzee, Gerrit; Trollip, Andre; Hayes, Cindy; Bosman, Marlein E.; Gey van Pittius, Nicolaas C.; Victor, Thomas C.; Gagneux, Sebastien; van Helden, Paul D.; Warren, Robin M.			Programmatically Selected Multidrug-Resistant Strains Drive the Emergence of Extensively Drug-Resistant Tuberculosis in South Africa	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; WESTERN-CAPE; POPULATION-STRUCTURE; BEIJING STRAIN; SPREAD; MUTATIONS; EVOLUTION; EPIDEMIOLOGY; SURVEILLANCE; PYRAZINAMIDE	Background: South Africa shows one of the highest global burdens of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB). Since 2002, MDR-TB in South Africa has been treated by a standardized combination therapy, which until 2010 included ofloxacin, kanamycin, ethionamide, ethambutol and pyrazinamide. Since 2010, ethambutol has been replaced by cycloserine or terizidone. The effect of standardized treatment on the acquisition of XDR-TB is not currently known. Methods: We genetically characterized a random sample of 4,667 patient isolates of drug-sensitive, MDR and XDR-TB cases collected from three South African provinces, namely, the Western Cape, Eastern Cape and KwaZulu-Natal. Drug resistance patterns of a subset of isolates were analyzed for the presence of commonly observed resistance mutations. Results: Our analyses revealed a strong association between distinct strain genotypes and the emergence of XDR-TB in three neighbouring provinces of South Africa. Strains predominant in XDR-TB increased in proportion by more than 20-fold from drug-sensitive to XDR-TB and accounted for up to 95% of the XDR-TB cases. A high degree of clustering for drug resistance mutation patterns was detected. For example, the largest cluster of XDR-TB associated strains in the Eastern Cape, affecting more than 40% of all MDR patients in this province, harboured identical mutations concurrently conferring resistance to isoniazid, rifampicin, pyrazinamide, ethambutol, streptomycin, ethionamide, kanamycin, amikacin and capreomycin. Conclusions: XDR-TB associated genotypes in South Africa probably were programmatically selected as a result of the standard treatment regimen being ineffective in preventing their transmission. Our findings call for an immediate adaptation of standard treatment regimens for M/XDR-TB in South Africa.	[Mueller, Borna; Chihota, Violet N.; Klopper, Marisa; Streicher, Elizabeth M.; Trollip, Andre; Gey van Pittius, Nicolaas C.; Victor, Thomas C.; van Helden, Paul D.; Warren, Robin M.] Univ Stellenbosch, Fac Med & Hlth Sci, Div Mol Biol & Human Genet,MRC Ctr Mol & Cellular, DST NRF Ctr Excellence Biomed TB Res, Cape Town, South Africa; [Mueller, Borna; Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Mueller, Borna; Gagneux, Sebastien] Univ Basel, Basel, Switzerland; [Chihota, Violet N.] Aurum Inst Hlth Res, Johannesburg, South Africa; [Pillay, Manormoney] Univ KwaZulu Natal, Med Microbiol & Infect Control, Durban, South Africa; [Coetzee, Gerrit] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Natl TB Reference Lab, Johannesburg, South Africa; [Hayes, Cindy] Natl Hlth Lab Serv, Port Elizabeth, South Africa; [Bosman, Marlein E.] Natl Hlth Lab Serv, Cape Town, South Africa	National Research Foundation - South Africa; Stellenbosch University; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Kwazulu Natal; National Health Laboratory Service; National Institute for Communicable Diseases (NICD)	Warren, RM (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, Div Mol Biol & Human Genet,MRC Ctr Mol & Cellular, DST NRF Ctr Excellence Biomed TB Res, Cape Town, South Africa.	rw1@sun.ac.za	Streicher, Elizabeth/O-9597-2019; Klopper, Marisa/U-9887-2018; Müller, Borna/AAS-9471-2020; Gagneux, Sebastien/ABE-7909-2020; Streicher, Elizabeth M/I-7780-2018; van Pittius, Nicolaas C Gey/D-3434-2015; Chihota, Violet/DWH-9372-2022	Streicher, Elizabeth/0000-0003-3901-1981; Streicher, Elizabeth M/0000-0003-3901-1981; van Pittius, Nicolaas C Gey/0000-0002-8807-4105; Gagneux, Sebastien/0000-0001-7783-9048; Warren, Robin/0000-0001-5741-7358; Klopper, Marisa/0000-0002-9318-8289; Chihota, Violet/0000-0003-1444-9266	Harry-Crossley foundation; Medical Research Council of South Africa; Department of Science and Technology/National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research; Novartis foundation; Wellcome trust [01680/Z/00/Z]; NIH Fogarty ICORTA TB/AIDS [5U2RTW007370, 5U2RTW007373]; National Research Foundation	Harry-Crossley foundation; Medical Research Council of South Africa(South African Medical Research Council); Department of Science and Technology/National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research(Department of Science & Technology (India)); Novartis foundation(Novartis); Wellcome trust(Wellcome Trust); NIH Fogarty ICORTA TB/AIDS; National Research Foundation	This project received financial support from the Harry-Crossley foundation, the Medical Research Council of South Africa and the Department of Science and Technology/National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research. BM was partly funded by the Novartis foundation. VNC was funded by the Wellcome trust grant 01680/Z/00/Z and NIH Fogarty ICORTA TB/AIDS (grants 5U2RTW007370 and 5U2RTW007373). MP was funded by the National Research Foundation and the Medical Research Council of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MULTIDRUG EXTENSIVEL; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Chihota VN, 2012, J CLIN MICROBIOL, V50, P995, DOI 10.1128/JCM.05832-11; Cox HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013901; Devaux I, 2010, EUROSURVEILLANCE, V15, P15; Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8; Farley JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020436; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Georghiou SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033275; Hanekom M, 2007, J CLIN MICROBIOL, V45, P1483, DOI 10.1128/JCM.02191-06; Hoek KGP, 2009, SAMJ S AFR MED J, V99, P785; Ioerger TR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-670; Ioerger TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007778; Iwamoto T, 2008, ANTIMICROB AGENTS CH, V52, P3805, DOI 10.1128/AAC.00579-08; Johnson R, 2006, INT J TUBERC LUNG D, V10, P1412; Johnson R, 2006, INT J TUBERC LUNG D, V10, P68; Johnson R, 2010, INT J TUBERC LUNG D, V14, P119; Jugheli L, 2009, ANTIMICROB AGENTS CH, V53, P5064, DOI 10.1128/AAC.00851-09; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Klopper M, 2013, EMERG INFECT DIS, V19, P449, DOI [10.3201/EID1903.120246, 10.3201//EID1903.120246]; Louw GE, 2006, INT J TUBERC LUNG D, V10, P802; Morlock GP, 2003, ANTIMICROB AGENTS CH, V47, P3799, DOI 10.1128/AAC.47.12.3799-3805.2003; Muller B, 2011, INT J TUBERC LUNG D, V15, P344; Muller B, 2013, TRENDS GENET, V29, P160, DOI 10.1016/j.tig.2012.11.005; Muller B, 2012, PROGR RESP RES, P96; National Institute for Communicable Diseases, 2015, COMM DIS COMM, V14; Niemann S, 2010, J CLIN MICROBIOL, V48, P3544, DOI 10.1128/JCM.00715-10; Perdigao J, 2010, J ANTIMICROB CHEMOTH, V65, P224, DOI 10.1093/jac/dkp452; Pillay M, 2007, CLIN INFECT DIS, V45, P1409, DOI 10.1086/522987; PORTEOUS J B, 1959, S Afr Med J, V33, P265; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Sirgel FA, 2012, J ANTIMICROB CHEMOTH, V67, P1088, DOI 10.1093/jac/dks033; Sirgel FA, 2012, MICROB DRUG RESIST, V18, P193, DOI 10.1089/mdr.2011.0063; Strauss OJ, 2008, J CLIN MICROBIOL, V46, P1514, DOI 10.1128/JCM.01938-07; Streicher EM, 2007, J CLIN MICROBIOL, V45, P237, DOI 10.1128/JCM.01429-06; Streicher EM, 2012, ANTIMICROB AGENTS CH, V56, P2420, DOI 10.1128/AAC.05905-11; Streicher EM, 2012, INFECT GENET EVOL, V12, P686, DOI 10.1016/j.meegid.2011.07.019; van Rie A, 1999, J INFECT DIS, V180, P1608, DOI 10.1086/315054; Victor T. C., 1999, Tubercle and Lung Disease, V79, P343, DOI 10.1054/tuld.1999.0222; Victor TC, 2007, INT J TUBERC LUNG D, V11, P195; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO-IUTALD Global Project on anti-tuberculosis drug resistance surveillance, 2008, 4 WHOIUTALD GLOB PRO; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789; Zignol M, 2012, B WORLD HEALTH ORGAN, V90, P111, DOI 10.2471/BLT.11.092585; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	51	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e70919	10.1371/journal.pone.0070919	http://dx.doi.org/10.1371/journal.pone.0070919			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24058399	Green Submitted, gold, Green Published			2022-12-25	WOS:000324403200003
J	Ishikawa, Y; Bachinger, HP				Ishikawa, Yoshihiro; Baechinger, Hans Peter			An Additional Function of the Rough Endoplasmic Reticulum Protein Complex Prolyl 3-Hydroxylase 1.Cartilage-associated Protein.Cyclophilin B THE CXXXC MOTIF REVEALS DISULFIDE ISOMERASE ACTIVITY IN VITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECESSIVE OSTEOGENESIS IMPERFECTA; BASEMENT-MEMBRANE COLLAGEN; CHICK TENDON COLLAGEN; CIS-TRANS-ISOMERASE; CYCLOPHILIN-B; TRIPLE-HELIX; STRUCTURAL BASIS; BOND FORMATION; MUTATIONS; PROCOLLAGEN	Collagen biosynthesis occurs in the rough endoplasmic reticulum, and many molecular chaperones and folding enzymes are involved in this process. The folding mechanism of type I procollagen has been well characterized, and protein disulfide isomerase (PDI) has been suggested as a key player in the formation of the correct disulfide bonds in the noncollagenous carboxyl-terminal and amino-terminal propeptides. Prolyl 3-hydroxylase 1 (P3H1) forms a hetero-trimeric complex with cartilage-associated protein and cyclophilin B (CypB). This complex is a multifunctional complex acting as a prolyl 3-hydroxylase, a peptidyl prolyl cis-trans isomerase, and a molecular chaperone. Two major domains are predicted from the primary sequence of P3H1: an amino-terminal domain and a carboxyl-terminal domain corresponding to the 2-oxoglutarate-and iron-dependent dioxygenase domains similar to the alpha-subunit of prolyl 4-hydroxylase and lysyl hydroxylases. The amino-terminal domain contains four CXXXC sequence repeats. The primary sequence of cartilage-associated protein is homologous to the amino-terminal domain of P3H1 and also contains four CXXXC sequence repeats. However, the function of the CXXXC sequence repeats is not known. Several publications have reported that short peptides containing a CXC or a CXXC sequence show oxido-reductase activity similar to PDI in vitro. We hypothesize that CXXXC motifs have oxido-reductase activity similar to the CXXC motif in PDI. We have tested the enzyme activities on model substrates in vitro using a GCRALCG peptide and the P3H1 complex. Our results suggest that this complex could function as a disulfide isomerase in the rough endoplasmic reticulum.	Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97239 USA	Oregon Health & Science University	Bachinger, HP (corresponding author), Shriners Hosp Children, Res Dept, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	hpb@shcc.org		Ishikawa, Yoshihiro/0000-0003-2013-0518	Shriners Hospitals for Children	Shriners Hospitals for Children	This work was supported by grants from Shriners Hospitals for Children (to H. P. B.).	Araki K, 2011, J BIOL CHEM, V286, P32705, DOI 10.1074/jbc.M111.227181; BACHINGER HP, 1993, AM J MED GENET, V45, P152, DOI 10.1002/ajmg.1320450204; BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x; BACHINGER HP, 1978, EUR J BIOCHEM, V90, P605, DOI 10.1111/j.1432-1033.1978.tb12641.x; Bachinger HP, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 5: AMINO ACIDS, PEPTIDES AND PROTEINS, P469; Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; Barnes AM, 2010, NEW ENGL J MED, V362, P521, DOI 10.1056/NEJMoa0907705; Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Bottomley MJ, 2001, CURR BIOL, V11, P1114, DOI 10.1016/S0960-9822(01)00317-7; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Cabrele C, 2002, CHEM BIOL, V9, P731, DOI 10.1016/S1074-5521(02)00152-7; Castagnola P, 1997, J CELL SCI, V110, P1351; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P14985, DOI 10.1021/bi970071j; Choi JW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000750; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Ettema TJG, 2003, TRENDS BIOCHEM SCI, V28, P170, DOI 10.1016/S0968-0004(03)00037-9; Eyre DR, 2013, CALCIFIED TISSUE INT, V93, P338, DOI 10.1007/s00223-013-9723-9; Gorres KL, 2010, CRIT REV BIOCHEM MOL, V45, P106, DOI 10.3109/10409231003627991; GRYDER RM, 1975, J BIOL CHEM, V250, P2470; Hagiwara M, 2011, MOL CELL, V41, P432, DOI 10.1016/j.molcel.2011.01.021; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI 10.1089/ARS.2009.2466; HAWKINS HC, 1991, BIOCHEM J, V275, P335, DOI 10.1042/bj2750335; Holster T, 2007, J BIOL CHEM, V282, P2512, DOI 10.1074/jbc.M606608200; Horibe T, 2004, J BIOL CHEM, V279, P4604, DOI 10.1074/jbc.M310922200; Horibe T, 2002, J BIOCHEM, V132, P401, DOI 10.1093/oxfordjournals.jbchem.a003236; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Ishikawa Y, 2013, BBA-MOL CELL RES, V1833, P2479, DOI 10.1016/j.bbamcr.2013.04.008; Ishikawa Y, 2012, J BIOL CHEM, V287, P22253, DOI 10.1074/jbc.M111.333336; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; JIMENEZ S, 1973, BIOCHEM BIOPH RES CO, V52, P106, DOI 10.1016/0006-291X(73)90960-1; JOHN DCA, 1993, EMBO J, V12, P1587, DOI 10.1002/j.1460-2075.1993.tb05803.x; KEFALIDES NA, 1975, J INVEST DERMATOL, V65, P85, DOI 10.1111/1523-1747.ep12598062; Kikuchi M, 2002, J BIOCHEM, V132, P451, DOI 10.1093/oxfordjournals.jbchem.a003242; Kim JH, 1998, P NATL ACAD SCI USA, V95, P2997, DOI 10.1073/pnas.95.6.2997; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Klappa P, 2000, J BIOL CHEM, V275, P13213, DOI 10.1074/jbc.275.18.13213; Koehler CM, 2006, ANTIOXID REDOX SIGN, V8, P813, DOI 10.1089/ars.2006.8.813; Koehler CM, 2004, TRENDS BIOCHEM SCI, V29, P1, DOI 10.1016/j.tibs.2003.11.003; Koide T, 2005, TOP CURR CHEM, V247, P85, DOI 10.1007/b103820; Kozlov G, 2010, J BIOL CHEM, V285, P35551, DOI 10.1074/jbc.M110.160101; KRESINA TF, 1979, BIOCHEMISTRY-US, V18, P3089, DOI 10.1021/bi00581a028; LAMBERT N, 1983, BIOCHEM J, V213, P225, DOI 10.1042/bj2130225; LAMBERT N, 1983, BIOCHEM J, V213, P235, DOI 10.1042/bj2130235; LUNDSTROM J, 1993, BIOCHEMISTRY-US, V32, P6649, DOI 10.1021/bi00077a018; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; Marini JC, 2007, CELL CYCLE, V6, P1675, DOI 10.4161/cc.6.14.4474; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Mokranjac D, 2009, BBA-MOL CELL RES, V1793, P33, DOI 10.1016/j.bbamcr.2008.06.021; MOORE EC, 1964, J BIOL CHEM, V239, P3453; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Ochs RL, 1996, MOL BIOL CELL, V7, P1015, DOI 10.1091/mbc.7.7.1015; Pirneskoski A, 2001, J BIOL CHEM, V276, P11287, DOI 10.1074/jbc.M010656200; Pyott SM, 2011, HUM MOL GENET, V20, P1595, DOI 10.1093/hmg/ddr037; ROSENBLO.J, 1973, ARCH BIOCHEM BIOPHYS, V158, P478, DOI 10.1016/0003-9861(73)90539-0; Sato Y, 2012, FEBS J, V279, P2262, DOI 10.1111/j.1742-4658.2012.08593.x; Satoh M, 2005, CELL STRESS CHAPERON, V10, P211, DOI 10.1379/CSC-109R.1; SIEDLER F, 1993, BIOCHEMISTRY-US, V32, P7488, DOI 10.1021/bi00080a021; SMITH T, 1995, J BIOL CHEM, V270, P18323, DOI 10.1074/jbc.270.31.18323; STEINMANN B, 1991, J BIOL CHEM, V266, P1299; Takagi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036809; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Valli M, 2012, CLIN GENET, V82, P453, DOI 10.1111/j.1399-0004.2011.01794.x; Van Dijk FS, 2009, EUR J HUM GENET, V17, P1560, DOI 10.1038/ejhg.2009.75; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Vranka JA, 2010, J BIOL CHEM, V285, P17253, DOI 10.1074/jbc.M110.102228; Wagner K, 2009, BBA-MOL CELL RES, V1793, P52, DOI 10.1016/j.bbamcr.2008.05.026; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Willaert A, 2009, J MED GENET, V46, P233, DOI 10.1136/jmg.2008.062729; Wilson R, 1998, J BIOL CHEM, V273, P9637, DOI 10.1074/jbc.273.16.9637; Wouters MA, 2010, ANTIOXID REDOX SIGN, V12, P53, DOI [10.1089/ars.2009.2510, 10.1089/ARS.2009.2510]; Woycechowsky KJ, 1999, CHEM BIOL, V6, P871, DOI 10.1016/S1074-5521(00)80006-X; Woycechowsky KJ, 2003, BIOCHEMISTRY-US, V42, P5387, DOI 10.1021/bi026993q; Zito E, 2012, MOL CELL, V48, P39, DOI 10.1016/j.molcel.2012.08.010	80	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31437	31446		10.1074/jbc.M113.498063	http://dx.doi.org/10.1074/jbc.M113.498063			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24043621	Green Published, hybrid			2022-12-25	WOS:000330596200003
J	Liu, WJ; Li, XL; Zhao, YS; Meng, XM; Wan, C; Yang, BX; Lan, HY; Lin, HY; Xia, Y				Liu, Wenjing; Li, Xiaoling; Zhao, Yueshui; Meng, Xiao-Ming; Wan, Chao; Yang, Baoxue; Lan, Hui-Yao; Lin, Herbert Y.; Xia, Yin			Dragon (Repulsive Guidance Molecule RGMb) Inhibits E-cadherin Expression and Induces Apoptosis in Renal Tubular Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MORPHOGENETIC PROTEIN CORECEPTOR; REGULATES HEPCIDIN EXPRESSION; FIBROSIS; KIDNEY; NEOGENIN; INJURY; RECEPTORS; INFLAMMATION; TRANSITION; MECHANISMS	Dragon is one of the three members of the repulsive guidance molecule (RGM) family, i.e. RGMa, RGMb (Dragon), and RGMc (hemojuvelin). We previously identified the RGM members as bone morphogenetic protein (BMP) co-receptors that enhance BMP signaling. Our previous studies found that Dragon is highly expressed in the tubular epithelial cells of mouse kidneys. However, the roles of Dragon in renal epithelial cells are yet to be defined. We now show that overexpression of Dragon increased cell death induced by hypoxia in association with increased cleaved poly(ADP-ribose) polymerase and cleaved caspase-3 levels in mouse inner medullary collecting duct (IMCD3) cells. Dragon also inhibited E-cadherin expression but did not affect epithelial-to-mesenchymal transition induced by TGF-beta in IMCD3 cells. Previous studies suggest that the three RGM members can function as ligands for the receptor neogenin. Interestingly, our present study demonstrates that the Dragon actions on apoptosis and E-cadherin expression in IMCD3 cells were mediated by the neogenin receptor but not through the BMP pathway. Dragon expression in the kidney was up-regulated by unilateral ureteral obstruction in mice. Compared with wild-type mice, heterozygous Dragon knock-out mice exhibited 45-66% reduction in Dragon mRNA expression, decreased epithelial apoptosis, and increased tubular E-cadherin expression and had attenuated tubular injury after unilateral ureteral obstruction. Our results suggest that Dragon may impair tubular epithelial integrity and induce epithelial apoptosis both in vitro and in vivo.	[Liu, Wenjing; Li, Xiaoling; Zhao, Yueshui; Wan, Chao; Xia, Yin] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Key Lab Regenerat Med,Minist Educ, Hong Kong, Hong Kong, Peoples R China; [Wan, Chao; Xia, Yin] Chinese Univ Hong Kong, Shenzhen Res Inst, Sch Biomed Sci Core Lab, Shenzhen 518057, Peoples R China; [Lin, Herbert Y.] Harvard Univ, Ctr Syst Biol,Med Sch, Massachusetts Gen Hosp,Program Membrane Biol, Program Anemia Signaling Res,Div Nephrol,Dept Med, Boston, MA 02114 USA; [Meng, Xiao-Ming; Lan, Hui-Yao] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Meng, Xiao-Ming; Lan, Hui-Yao] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Yang, Baoxue] Peking Univ, Sch Basic Med Sci, Dept Pharmacol, Beijing 100191, Peoples R China; [Yang, Baoxue] Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing 100191, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; Harvard University; Harvard Medical School; Massachusetts General Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong; Peking University	Lin, HY (corresponding author), Richard B Simches Res Ctr, Program Membrane Biol, 185 Cambridge St,CPZN-8216, Boston, MA 02114 USA.	Lin.Herbert@mgh.harvard.edu; Xia.Yin@cuhk.edu.hk	Liu, Wenjing/ACS-5787-2022; Wan, Chao/J-9277-2013; Lan, Hui Yao/C-9734-2015; Xia, Yin/M-5440-2018	Wan, Chao/0000-0001-6780-2006; Lan, Hui Yao/0000-0003-4283-9755; Xia, Yin/0000-0003-0315-7532; ZHAO, YUESHUI/0000-0002-1972-6130; Meng, Xiao-ming/0000-0002-1166-561X	Hong Kong Research Grant Council (RGC) [N_CUHK432/12, 81261160507]; National Natural Science Foundation of China (NSFC) [N_CUHK432/12, 81261160507]; Chinese University of Hong Kong; RGC/General Research Fund (GRF) [CUHK477311]; CUHK [2041603, 2041747]; Shenzhen Science and Technology Research and Development Funding [SZRI-C.02.12.006]; National Institute of Health [RO1 DK-069533, RO1 DK-071837]; Chinese University of Hong Kong postgraduate scholarships; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069533, R01DK071837] Funding Source: NIH RePORTER	Hong Kong Research Grant Council (RGC)(Hong Kong Research Grants Council); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese University of Hong Kong(Chinese University of Hong Kong); RGC/General Research Fund (GRF); CUHK(Chinese University of Hong Kong); Shenzhen Science and Technology Research and Development Funding; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese University of Hong Kong postgraduate scholarships; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Hong Kong Research Grant Council (RGC) and National Natural Science Foundation of China (NSFC) joint grants N_CUHK432/12 and 81261160507 (to Y. X. and B. Y.), the startup fund offered by The Chinese University of Hong Kong (to Y. X.), RGC/General Research Fund (GRF) grant CUHK477311 (to Y. X.), CUHK direct grants 2041603 and 2041747 (to Y. X.), Shenzhen Science and Technology Research and Development Funding SZRI-C.02.12.006 (to Y. X.), and National Institute of Health Grants RO1 DK-069533 and RO1 DK-071837 (to H. Y. L.).; Supported by Chinese University of Hong Kong postgraduate scholarships.	Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2005, J BIOL CHEM, V280, P29820, DOI 10.1074/jbc.M503511200; Bascands JL, 2005, KIDNEY INT, V68, P925, DOI 10.1111/j.1523-1755.2005.00486.x; Bell CH, 2013, SCIENCE, V341, P77, DOI 10.1126/science.1232322; Cain JE, 2008, DIFFERENTIATION, V76, P831, DOI 10.1111/j.1432-0436.2008.00265.x; Chung ACK, 2011, J AM SOC NEPHROL, V22, P802, DOI 10.1681/ASN.2010050510; Conrad S, 2010, MOL CELL NEUROSCI, V43, P222, DOI 10.1016/j.mcn.2009.11.003; Daemen MARC, 1999, J CLIN INVEST, V104, P541, DOI 10.1172/JCI6974; Dendooven A, 2011, AM J PATHOL, V178, P1069, DOI 10.1016/j.ajpath.2010.12.005; Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, pF4, DOI 10.1152/ajprenal.00045.2005; Gould SE, 2002, KIDNEY INT, V61, P51, DOI 10.1046/j.1523-1755.2002.00103.x; Hotter G, 2004, LAB INVEST, V84, P213, DOI 10.1038/labinvest.3700026; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Khan S, 1999, LAB INVEST, V79, P1089; Li L, 2010, AM J PATHOL, V176, P1767, DOI 10.2353/ajpath.2010.090345; Li VSW, 2009, GASTROENTEROLOGY, V137, P176, DOI 10.1053/j.gastro.2009.03.005; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Meng XM, 2013, CLIN SCI, V124, P243, DOI 10.1042/CS20120252; Mirakaj V, 2011, P NATL ACAD SCI USA, V108, P6555, DOI 10.1073/pnas.1015605108; Muramatsu R, 2011, NAT MED, V17, P488, DOI 10.1038/nm.2321; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Samad TA, 2005, J BIOL CHEM, V280, P14122, DOI 10.1074/jbc.M410034200; Shin GJ, 2008, J MOL HISTOL, V39, P105, DOI 10.1007/s10735-007-9138-x; Truong LD, 1996, KIDNEY INT, V50, P200, DOI 10.1038/ki.1996.303; Wang WW, 2009, AM J NEPHROL, V30, P186, DOI 10.1159/000213503; Xia Y, 2008, BLOOD, V111, P5195, DOI 10.1182/blood-2007-09-111567; Xia Y, 2007, J BIOL CHEM, V282, P18129, DOI 10.1074/jbc.M701679200; Xia Y, 2011, J IMMUNOL, V186, P1369, DOI 10.4049/jimmunol.1002047; Xia Y, 2010, J AM SOC NEPHROL, V21, P666, DOI 10.1681/ASN.2009050511; Yanagita M, 2006, J CLIN INVEST, V116, P70, DOI 10.1172/JCI25445; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Yang YL, 2009, ENDOCRINOLOGY, V150, P727, DOI 10.1210/en.2008-0090; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1247, DOI 10.1681/ASN.2010060616	38	17	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31528	31539		10.1074/jbc.M113.517573	http://dx.doi.org/10.1074/jbc.M113.517573			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24052264	Green Published, hybrid			2022-12-25	WOS:000330596200012
J	Walentek, P; Schneider, I; Schweickert, A; Blum, M				Walentek, Peter; Schneider, Isabelle; Schweickert, Axel; Blum, Martin			Wnt11b Is Involved in Cilia-Mediated Symmetry Breakage during Xenopus Left-Right Development	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; PLANAR CELL POLARITY; LEFT-RIGHT AXIS; GENE-EXPRESSION; KUPFFERS VESICLE; BETA-CATENIN; CONVERGENT EXTENSION; FOXJ1 EXPRESSION; NODAL CILIA; FLOW	Breakage of bilateral symmetry in amphibian embryos depends on the development of a ciliated epithelium at the gastrocoel roof during early neurulation. Motile cilia at the gastrocoel roof plate (GRP) give rise to leftward flow of extracellular fluids. Flow is required for asymmetric gene expression and organ morphogenesis. Wnt signaling has previously been involved in two steps, Wnt/beta-catenin mediated induction of Foxj1, a regulator of motile cilia, and Wnt/planar cell polarity (PCP) dependent cilia polarization to the posterior pole of cells. We have studied Wnt11b in the context of laterality determination, as this ligand was reported to activate canonical and non-canonical Wnt signaling. Wnt11b was found to be expressed in the so-called superficial mesoderm (SM), from which the GRP derives. Surprisingly, Foxj1 was only marginally affected in loss-of-function experiments, indicating that another ligand acts in this early step of laterality specification. Wnt11b was required, however, for polarization of GRP cilia and GRP morphogenesis, in line with the known function of Wnt/PCP in cilia-driven leftward flow. In addition Xnr1 and Coco expression in the lateral-most GRP cells, which sense flow and generate the first asymmetric signal, was attenuated in morphants, involving Wnt signaling in yet another process related to symmetry breakage in Xenopus.	[Walentek, Peter; Schneider, Isabelle; Schweickert, Axel; Blum, Martin] Univ Hohenheim, Inst Zool, Stuttgart, Baden Wurttembe, Germany	University Hohenheim	Blum, M (corresponding author), Univ Hohenheim, Inst Zool, Stuttgart, Baden Wurttembe, Germany.	martin.blum@uni-hohenheim.de		Walentek, Peter/0000-0002-2332-6068	DFG [BL285/9-1]; Landesgraduiertenforderung Baden-Wurttemberg	DFG(German Research Foundation (DFG)); Landesgraduiertenforderung Baden-Wurttemberg	This work was supported by DFG Grant BL285/9-1 to MB. PW was recipient of a PhD fellowship from the Landesgraduiertenforderung Baden-Wurttemberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DS, 2006, DEVELOPMENT, V133, P1657, DOI 10.1242/dev.02341; Alten L, 2012, DEVELOPMENT, V139, P1276, DOI 10.1242/dev.072728; Antic D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008999; Bajoghli B, 2007, DEV BIOL, V303, P347, DOI 10.1016/j.ydbio.2006.11.020; Basu B, 2008, CURR TOP DEV BIOL, V85, P151, DOI 10.1016/S0070-2153(08)00806-5; Beyer T, 2012, CURR BIOL, V22, P33, DOI 10.1016/j.cub.2011.11.027; Blum M, 2007, DIFFERENTIATION, V75, P133, DOI 10.1111/j.1432-0436.2006.00124.x; Blum M, 2009, SEMIN CELL DEV BIOL, V20, P464, DOI 10.1016/j.semcdb.2008.11.005; Blum M, 2009, DEV DYNAM, V238, P1215, DOI 10.1002/dvdy.21855; Borovina A, 2010, NAT CELL BIOL, V12, P407, DOI 10.1038/ncb2042; Bowes JB, 2010, NUCLEIC ACIDS RES, V38, pD607, DOI 10.1093/nar/gkp953; Buechling T, 2010, CURR BIOL, V20, P1263, DOI 10.1016/j.cub.2010.05.028; Caron A, 2012, DEVELOPMENT, V139, P514, DOI 10.1242/dev.071746; Cha SW, 2008, DEVELOPMENT, V135, P3719, DOI 10.1242/dev.029025; Cha SW, 2009, CURR BIOL, V19, P1573, DOI 10.1016/j.cub.2009.07.062; CHRISTIAN JL, 1991, DEVELOPMENT, V111, P1045; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; DANOS MC, 1995, DEVELOPMENT, V121, P1467; Deardorff' MA, 1998, DEVELOPMENT, V125, P2687; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Flaherty MP, 2008, TRENDS CARDIOVAS MED, V18, P260, DOI 10.1016/j.tcm.2008.12.001; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Garriock RJ, 2005, DEV BIOL, V279, P179, DOI 10.1016/j.ydbio.2004.12.013; Garriock RJ, 2007, DEV BIOL, V304, P127, DOI 10.1016/j.ydbio.2006.12.020; Hashimoto M, 2010, CURR OPIN GENET DEV, V20, P433, DOI 10.1016/j.gde.2010.04.002; Hatayama M, 2011, BIOCHEM BIOPH RES CO, V410, P520, DOI 10.1016/j.bbrc.2011.06.014; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Hojo M, 2007, DEV GROWTH DIFFER, V49, P395, DOI 10.1111/j.1440-169x.2007.00937.x; Itoh K, 1998, MECH DEVELOP, V74, P145, DOI 10.1016/S0925-4773(98)00076-8; Kofron M, 2007, DEVELOPMENT, V134, P503, DOI 10.1242/dev.02739; Kreiling JA, 2008, MECH DEVELOP, V125, P396, DOI 10.1016/j.mod.2008.02.004; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Lai SL, 2012, DEVELOPMENT, V139, P4439, DOI 10.1242/dev.081745; Li Y, 2008, GENE DEV, V22, P3050, DOI 10.1101/gad.1687308; Lin XY, 2009, DEVELOPMENT, V136, P207, DOI 10.1242/dev.029561; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mahaffey JP, 2013, DEVELOPMENT, V140, P1262, DOI 10.1242/dev.085316; Marques S, 2004, GENE DEV, V18, P2342, DOI 10.1101/gad.306504; Matthews HK, 2008, DEV DYNAM, V237, P3404, DOI 10.1002/dvdy.21758; Miller JR, 1997, J CELL BIOL, V139, P229, DOI 10.1083/jcb.139.1.229; Moulton Jon D, 2008, Curr Protoc Mol Biol, VChapter 26, DOI 10.1002/0471142727.mb2608s83; Nakaya MA, 2005, DEVELOPMENT, V132, P5425, DOI 10.1242/dev.02149; Nascone N, 1997, DEV BIOL, V189, P68, DOI 10.1006/dbio.1997.8635; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Niehrs C, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3134pe26; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Oteiza P, 2010, DEVELOPMENT, V137, P3459, DOI 10.1242/dev.049981; Rodriguez-Esteban C, 2001, DEVELOPMENT, V128, P3189; Ryan AK, 1998, NATURE, V394, P545, DOI 10.1038/29004; Satow R, 2004, BIOCHEM BIOPH RES CO, V321, P487, DOI 10.1016/j.bbrc.2004.06.166; Schneider I, 2008, DEVELOPMENT, V135, P75, DOI 10.1242/dev.004713; Schneider I, 2010, DEV BIOL, V348, P22, DOI 10.1016/j.ydbio.2010.08.040; Schweickert A, 2001, MECH DEVELOP, V107, P191, DOI 10.1016/S0925-4773(01)00461-0; Schweickert A, 2007, CURR BIOL, V17, P60, DOI 10.1016/j.cub.2006.10.067; Schweickert A, 2012, DIFFERENTIATION, V83, pS67, DOI 10.1016/j.diff.2011.11.005; Schweickert A, 2010, CURR BIOL, V20, P738, DOI 10.1016/j.cub.2010.02.061; Shiratori H, 2001, MOL CELL, V7, P137, DOI 10.1016/S1097-2765(01)00162-9; Shook DR, 2004, DEV BIOL, V270, P163, DOI 10.1016/j.ydbio.2004.02.021; Smith JC, 2000, PHILOS T ROY SOC B, V355, P923, DOI 10.1098/rstb.2000.0627; Song H, 2010, NATURE, V466, P378, DOI 10.1038/nature09129; Stubbs JL, 2008, NAT GENET, V40, P1454, DOI 10.1038/ng.267; Sugimura R, 2010, BIRTH DEFECTS RES C, V90, P243, DOI 10.1002/bdrc.20195; Sykes TG, 1998, DEVELOPMENT, V125, P4595; Tada M, 2000, DEVELOPMENT, V127, P2227; Tahinci E, 2007, DEVELOPMENT, V134, P4095, DOI 10.1242/dev.010272; Takao D, 2013, DEV BIOL, V376, P23, DOI 10.1016/j.ydbio.2013.01.018; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; Tetelin S, 2010, DEV DYNAM, V239, P148, DOI 10.1002/dvdy.22012; Ulmer B, 2013, CELL REP, V3, P615, DOI 10.1016/j.celrep.2013.02.015; Uysal-Onganer P, 2012, ACTA PHYSIOL, V204, P52, DOI 10.1111/j.1748-1716.2011.02297.x; Vick P, 2009, DEV BIOL, V331, P281, DOI 10.1016/j.ydbio.2009.05.547; VONDASSOW G, 1993, GENE DEV, V7, P355, DOI 10.1101/gad.7.3.355; Vonica A, 2007, DEV BIOL, V303, P281, DOI 10.1016/j.ydbio.2006.09.039; Walentek P, 2012, CELL REP, V1, P516, DOI 10.1016/j.celrep.2012.03.005; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Yanai I, 2011, DEV CELL, V20, P483, DOI 10.1016/j.devcel.2011.03.015; Yang YZ, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-14; Zhang M, 2012, DEVELOPMENT, V139, P2009, DOI 10.1242/dev.074435; Zhang Y, 2009, GENESIS, V47, P719, DOI 10.1002/dvg.20551	80	26	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73646	10.1371/journal.pone.0073646	http://dx.doi.org/10.1371/journal.pone.0073646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058481	gold, Green Published, Green Submitted			2022-12-25	WOS:000324408400030
J	Henderson, G; Cox, F; Kittelmann, S; Miri, VH; Zethof, M; Noel, SJ; Waghorn, GC; Janssen, PH				Henderson, Gemma; Cox, Faith; Kittelmann, Sandra; Miri, Vahideh Heidarian; Zethof, Michael; Noel, Samantha J.; Waghorn, Garry C.; Janssen, Peter H.			Effect of DNA Extraction Methods and Sampling Techniques on the Apparent Structure of Cow and Sheep Rumen Microbial Communities	PLOS ONE			English	Article							BACTERIAL DIVERSITY; FECAL SAMPLES; DAIRY-COWS; PCR-DGGE; DIETS; ARCHAEA; PASTURE; CATTLE; DEER	Molecular microbial ecology techniques are widely used to study the composition of the rumen microbiota and to increase understanding of the roles they play. Therefore, sampling and DNA extraction methods that result in adequate yields of microbial DNA that also accurately represents the microbial community are crucial. Fifteen different methods were used to extract DNA from cow and sheep rumen samples. The DNA yield and quality, and its suitability for downstream PCR amplifications varied considerably, depending on the DNA extraction method used. DNA extracts from nine extraction methods that passed these first quality criteria were evaluated further by quantitative PCR enumeration of microbial marker loci. Absolute microbial numbers, determined on the same rumen samples, differed by more than 100-fold, depending on the DNA extraction method used. The apparent compositions of the archaeal, bacterial, ciliate protozoal, and fungal communities in identical rumen samples were assessed using 454 Titanium pyrosequencing. Significant differences in microbial community composition were observed between extraction methods, for example in the relative abundances of members of the phyla Bacteroidetes and Firmicutes. Microbial communities in parallel samples collected from cows by oral stomach-tubing or through a rumen fistula, and in liquid and solid rumen digesta fractions, were compared using one of the DNA extraction methods. Community representations were generally similar, regardless of the rumen sampling technique used, but significant differences in the abundances of some microbial taxa such as the Clostridiales and the Methanobrevibacter ruminantium clade were observed. The apparent microbial community composition differed between rumen sample fractions, and Prevotellaceae were most abundant in the liquid fraction. DNA extraction methods that involved phenol-chloroform extraction and mechanical lysis steps tended to be more comparable. However, comparison of data from studies in which different sampling techniques, different rumen sample fractions or different DNA extraction methods were used should be avoided.	[Henderson, Gemma; Cox, Faith; Kittelmann, Sandra; Miri, Vahideh Heidarian; Zethof, Michael; Noel, Samantha J.; Janssen, Peter H.] AgResearch Ltd, Palmerston North, New Zealand; [Noel, Samantha J.] Massey Univ, Palmerston North, New Zealand; [Waghorn, Garry C.] DairyNZ, Hamilton, New Zealand	AgResearch - New Zealand; Massey University; DairyNZ	Henderson, G (corresponding author), AgResearch Ltd, Palmerston North, New Zealand.	gemma.henderson@agresearch.co.nz	Noel, Samantha/AAM-4090-2021	Kittelmann, Sandra/0000-0002-6019-9854; Henderson, Gemma/0000-0002-8258-2811; Janssen, Peter/0000-0002-1022-3502	AgResearch	AgResearch	Work at AgResearch was carried out under contract to the Pastoral Greenhouse Gas Research Consortium (PGgRc; www.pggrc.co.nz). The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The authors required PGgRc approval to publish.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ariefdjohan MW, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-23; Bergmann I, 2010, SYST APPL MICROBIOL, V33, P78, DOI 10.1016/j.syapm.2009.11.004; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; de Menezes AB, 2011, FEMS MICROBIOL ECOL, V78, P256, DOI 10.1111/j.1574-6941.2011.01151.x; Dridi B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007063; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fouts DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048289; Geishauser T, 1996, SMALL RUMINANT RES, V21, P63, DOI 10.1016/0921-4488(95)00810-1; Janssen PH, 2008, APPL ENVIRON MICROB, V74, P3619, DOI 10.1128/AEM.02812-07; Jeyanathan J, 2011, FEMS MICROBIOL ECOL, V76, P311, DOI 10.1111/j.1574-6941.2011.01056.x; Johnson DE, 1996, ENVIRON MONIT ASSESS, V42, P113, DOI [10.1007/BF00394045, DOI 10.1007/BF00394045]; Kim M, 2011, FEMS MICROBIOL ECOL, V76, P49, DOI 10.1111/j.1574-6941.2010.01029.x; Kittelmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047879; Kittelmann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036866; Kittelmann S, 2011, FEMS MICROBIOL ECOL, V75, P468, DOI 10.1111/j.1574-6941.2010.01022.x; Kontanis EJ, 2006, J FORENSIC SCI, V51, P795, DOI 10.1111/j.1556-4029.2006.00182.x; Krsek M, 1999, J MICROBIOL METH, V39, P1, DOI 10.1016/S0167-7012(99)00093-7; Lodge-Ivey SL, 2009, J ANIM SCI, V87, P2333, DOI 10.2527/jas.2008-1472; Lueders T, 2004, ENVIRON MICROBIOL, V6, P73, DOI 10.1046/j.1462-2920.2003.00536.x; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McOrist AL, 2002, J MICROBIOL METH, V50, P131, DOI 10.1016/S0167-7012(02)00018-0; McSweeney CS, 2001, ANIM FEED SCI TECH, V91, P83, DOI 10.1016/S0377-8401(01)00232-2; Miller MEB, 2012, ENVIRON MICROBIOL, V14, P207, DOI 10.1111/j.1462-2920.2011.02593.x; O Cuiv P, 2010, MICROB ECOL, V61, P353; Olson Nathan D, 2012, BMC Res Notes, V5, P668, DOI 10.1186/1756-0500-5-668; Paul K, 2012, APPL ENVIRON MICROB, V78, P8245, DOI 10.1128/AEM.02193-12; Pitta DW, 2010, MICROB ECOL, V59, P511, DOI 10.1007/s00248-009-9609-6; Rius AG, 2012, J DAIRY SCI, V95, P5024, DOI 10.3168/jds.2012-5392; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Shen JS, 2012, J DAIRY SCI, V95, P5978, DOI 10.3168/jds.2012-5499; Willner D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034605; Wright ADG, 1997, J EUKARYOT MICROBIOL, V44, P61, DOI 10.1111/j.1550-7408.1997.tb05693.x; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	34	216	224	2	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74787	10.1371/journal.pone.0074787	http://dx.doi.org/10.1371/journal.pone.0074787			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040342	Green Submitted, Green Published, gold			2022-12-25	WOS:000326734500120
J	Howe, JD; Barry, NP; Bretscher, MS				Howe, Jonathan D.; Barry, Nicholas P.; Bretscher, Mark S.			How Do Amoebae Swim and Crawl?	PLOS ONE			English	Article							GIANT HELA-CELLS; PLASMA-MEMBRANE; RECEPTORS; DICTYOSTELIUM	The surface behaviour of swimming amoebae was followed in cells bearing a cAR1-paGFP (cyclic AMP receptor fused to a photoactivatable-GFP) construct. Sensitized amoebae were placed in a buoyant medium where they could swim toward a chemoattractant cAMP source. paGFP, activated at the cell's front, remained fairly stationary in the cell's frame as the cell advanced; the label was not swept rearwards. Similar experiments with chemotaxing cells attached to a substratum gave the same result. Furthermore, if the region around a lateral projection near a crawling cell's front is marked, the projection and the labelled cAR1 behave differently. The label spreads by diffusion but otherwise remains stationary in the cell's frame; the lateral projection moves rearwards on the cell (remaining stationary with respect to the substrate), so that it ends up outside the labelled region. Furthermore, as cAR1-GFP cells move, they occasionally do so in a remarkably straight line; this suggests they do not need to snake to move on a substratum. Previously, we suggested that the surface membrane of a moving amoeba flows from front to rear as part of a polarised membrane trafficking cycle. This could explain how swimming amoebae are able to exert a force against the medium. Our present results indicate that, in amoebae, the suggested surface flow does not exist: this implies that they swim by shape changes.	[Howe, Jonathan D.; Barry, Nicholas P.; Bretscher, Mark S.] MRC, Mol Biol Lab, Div Cell Biol, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Bretscher, MS (corresponding author), MRC, Mol Biol Lab, Div Cell Biol, Hills Rd, Cambridge CB2 2QH, England.	msb@mrc-lmb.cam.ac.uk			Medical Research Council (MRC); MRC [MC_U105178788] Funding Source: UKRI; Medical Research Council [MC_U105178788] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council (MRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado-Velasco C, 1999, MOL BIOL CELL, V10, P4419, DOI 10.1091/mbc.10.12.4419; Barry NP, 2010, P NATL ACAD SCI USA, V107, P11376, DOI 10.1073/pnas.1006327107; BRETSCHER MS, 1983, P NATL ACAD SCI-BIOL, V80, P454, DOI 10.1073/pnas.80.2.454; Bretscher MS, 1999, EXP CELL RES, V248, P552, DOI 10.1006/excr.1999.4439; BRETSCHER MS, 1983, EMBO J, V2, P599, DOI 10.1002/j.1460-2075.1983.tb01469.x; HOPKINS CR, 1994, J CELL BIOL, V125, P1265, DOI 10.1083/jcb.125.6.1265; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Traynor D, 2007, J CELL SCI, V120, P2318, DOI 10.1242/jcs.007732; Ueda M, 2001, SCIENCE, V294, P864, DOI 10.1126/science.1063951; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001	10	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74382	10.1371/journal.pone.0074382	http://dx.doi.org/10.1371/journal.pone.0074382			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040237	Green Submitted, gold, Green Published			2022-12-25	WOS:000326734500089
J	Ridge, PG; Koop, A; Maxwell, TJ; Bailey, MH; Swerdlow, RH; Kauwe, JSK; Honea, RA				Ridge, Perry G.; Koop, Andre; Maxwell, Taylor J.; Bailey, Matthew H.; Swerdlow, Russell H.; Kauwe, John S. K.; Honea, Robyn A.		Alzheimer's Dis Neuroimaging Initi	Mitochondrial Haplotypes Associated with Biomarkers for Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; GENOME-WIDE ASSOCIATION; MATERNAL FAMILY-HISTORY; PHYSICAL-ACTIVITY; DNA HAPLOGROUPS; HIPPOCAMPAL ATROPHY; CASCADE HYPOTHESIS; NORMAL INDIVIDUALS; ONSET ALZHEIMERS; HUMAN-EVOLUTION	Various studies have suggested that the mitochondrial genome plays a role in late-onset Alzheimer's disease, although results are mixed. We used an endophenotype-based approach to further characterize mitochondrial genetic variation and its relationship to risk markers for Alzheimer's disease. We analyzed longitudinal data from non-demented, mild cognitive impairment, and late-onset Alzheimer's disease participants in the Alzheimer's Disease Neuroimaging Initiative with genetic, brain imaging, and behavioral data. We assessed the relationship of structural MRI and cognitive biomarkers with mitochondrial genome variation using TreeScanning, a haplotype-based approach that concentrates statistical power by analyzing evolutionarily meaningful groups (or clades) of haplotypes together for association with a phenotype. Four clades were associated with three different endophenotypes: whole brain volume, percent change in temporal pole thickness, and left hippocampal atrophy over two years. This is the first study of its kind to identify mitochondrial variation associated with brain imaging endophenotypes of Alzheimer's disease. Our results provide additional evidence that the mitochondrial genome plays a role in risk for Alzheimer's disease.	[Ridge, Perry G.; Bailey, Matthew H.; Kauwe, John S. K.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Ridge, Perry G.] ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA; [Koop, Andre; Swerdlow, Russell H.; Honea, Robyn A.] Univ Kansas, Alzheimers Dis Ctr, Dept Neurol, Sch Med, Kansas City, KS 66103 USA; [Maxwell, Taylor J.] Univ Texas Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX USA	Brigham Young University; Utah System of Higher Education; University of Utah; ARUP Laboratories; University of Kansas; University of Kansas Medical Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Honea, RA (corresponding author), Univ Kansas, Alzheimers Dis Ctr, Dept Neurol, Sch Med, Kansas City, KS 66103 USA.	rhonea@kumc.edu	Kauwe, John/AAC-6646-2021	Kauwe, John/0000-0001-8641-2468; Bailey, Matthew H./0000-0003-4526-9727	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; National Institutes of Health [P30 AG010129, K01 AG030514, R01AG042611, K01 AG035042]; Alzheimer's Association [MNIRG-11-205368]; Brigham Young University Gerontology Program; University of Kansas Alzheimer's Disease Center [P30AG035982]; NATIONAL INSTITUTE ON AGING [P30AG010129, U01AG024904, R01AG042611, K01AG030514, K01AG035042, U24AG021886, P30AG035982] Funding Source: NIH RePORTER	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Brigham Young University Gerontology Program; University of Kansas Alzheimer's Disease Center; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N. V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129 and K01 AG030514. JSKK is supported by the National Institutes of Health (R01AG042611), the Alzheimer's Association (MNIRG-11-205368) and the Brigham Young University Gerontology Program. RAH is supported by NIH grants K01 AG035042 and P30 AG010129. RHS is supported by the University of Kansas Alzheimer's Disease Center (P30AG035982). Data used in preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (adni.loni.ucla.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.ucla.edu/wpcontent/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrawis JP, 2012, NEUROBIOL AGING, V33, P856, DOI 10.1016/j.neurobiolaging.2010.07.020; ARNOLD SE, 1994, ARCH NEUROL-CHICAGO, V51, P145, DOI 10.1001/archneur.1994.00540140051014; Biffi A, 2010, ARCH NEUROL-CHICAGO, V67, P677, DOI 10.1001/archneurol.2010.108; Bonilla E, 1999, BBA-BIOENERGETICS, V1410, P171, DOI 10.1016/S0005-2728(98)00165-0; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cardoso SM, 2004, J NEUROCHEM, V89, P1417, DOI 10.1111/j.1471-4159.2004.02438.x; Carrieri G, 2001, HUM GENET, V108, P194, DOI 10.1007/s004390100463; Chinnery PF, 2000, NEUROLOGY, V55, P302, DOI 10.1212/WNL.55.2.302; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coskun P, 2011, BIOCH BIOPHYS ACTA, DOI 10:1016/j.bbagen. 2011.08.008; Coto E, 2011, NEUROGENETICS, V12, P345, DOI 10.1007/s10048-011-0295-4; Desikan RS, 2009, BRAIN, V132, P2048, DOI 10.1093/brain/awp123; Desikan RS, NEUROBIOL AGING, V31, P1364; Etnier JL, 2007, MED SCI SPORT EXER, V39, P199, DOI 10.1249/01.mss.0000239399.85955.5e; Fesahat F, 2007, CELL MOL NEUROBIOL, V27, P329, DOI 10.1007/s10571-006-9126-9; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Frisoni GB, 2009, ALZHEIMERS DEMENT, V5, P307, DOI 10.1016/j.jalz.2009.04.1235; Heister D, 2011, NEUROLOGY, V77, P1619, DOI 10.1212/WNL.0b013e3182343314; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Hibar DP, 2012, TWIN RES HUM GENET, V15, P286, DOI 10.1017/thg.2012.15; Hibar DP, 2011, NEUROIMAGE, V56, P1875, DOI 10.1016/j.neuroimage.2011.03.077; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Holland D, 2009, P NATL ACAD SCI USA, V106, P20954, DOI 10.1073/pnas.0906053106; Honea RA, 2010, NEUROLOGY, V74, P113, DOI 10.1212/WNL.0b013e3181c918cb; Honea RA, 2012, J ALZHEIMERS DIS, V31, P659, DOI 10.3233/JAD-2012-120676; Honea RA, 2011, NEUROLOGY, V76, P822, DOI 10.1212/WNL.0b013e31820e7b74; Honea RA, 2009, J ALZHEIMERS DIS, V18, P553, DOI 10.3233/JAD-2009-1163; Hua X, 2008, NEUROIMAGE, V41, P19, DOI 10.1016/j.neuroimage.2008.02.010; Hudson G, 2012, NEUROLOGY, V78, P1038, DOI 10.1212/WNL.0b013e31824e8f1d; Hudson G, 2012, NEUROLOGY; Ingman M, 2001, J HERED, V92, P454, DOI 10.1093/jhered/92.6.454; Jack CR, 2004, NEUROLOGY, V62, P591, DOI 10.1212/01.WNL.0000110315.26026.EF; Kruger J, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-8; Lakatos A, 2010, NEUROBIOL AGING, V31, P1355, DOI 10.1016/j.neurobiolaging.2010.04.031; Mancuso M, 2007, NEUROL SCI, V28, P142, DOI 10.1007/s10072-007-0807-z; Maruszak A, 2009, NEUROBIOL AGING, V30, P1749, DOI 10.1016/j.neurobiolaging.2008.01.004; Mosconi L, 2009, NEUROLOGY, V72, P513, DOI 10.1212/01.wnl.0000333247.51383.43; Mosconi L, 2010, P NATL ACAD SCI USA, V107, P5949, DOI 10.1073/pnas.0914141107; Orth M, 2001, AM J MED GENET, V106, P27, DOI 10.1002/ajmg.1425; PARKER WD, 1990, NEUROLOGY, V40, P1302, DOI 10.1212/WNL.40.8.1302; Peper JS, 2007, HUM BRAIN MAPP, V28, P464, DOI 10.1002/hbm.20398; Podewils LJ, 2005, AM J EPIDEMIOL, V161, P639, DOI 10.1093/aje/kwi092; Posada D, 2005, BIOINFORMATICS, V21, P2130, DOI 10.1093/bioinformatics/bti293; Potkin SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006501; Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417; Reiman EM, 2007, ANN NY ACAD SCI, V1097, P94, DOI 10.1196/annals.1379.011; Ridge PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045134; Rovio S, 2005, LANCET NEUROL, V4, P705, DOI 10.1016/S1474-4422(05)70198-8; Santoro A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012037; Schuff N, 2009, BRAIN, V132, P1067, DOI 10.1093/brain/awp007; Schuit AJ, 2001, MED SCI SPORT EXER, V33, P772; Silver M, 2012, NEUROIMAGE, V63, P1681, DOI 10.1016/j.neuroimage.2012.08.002; Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250; Stein JL, 2010, NEUROIMAGE, V53, P1160, DOI 10.1016/j.neuroimage.2010.02.032; Stein JL, 2010, NEUROIMAGE, V51, P542, DOI 10.1016/j.neuroimage.2010.02.068; Swerdlow RH, 1997, NEUROLOGY, V49, P918, DOI 10.1212/WNL.49.4.918; Swerdlow RH, 2004, MED HYPOTHESES, V63, P8, DOI 10.1016/j.mehy.2003.12.045; Swerdlow RH, 2007, J NEUROSCI RES, V85, P3416, DOI 10.1002/jnr.21167; Swerdlow RH, 2010, J ALZHEIMERS DIS, V20, pS265, DOI 10.3233/JAD-2010-100339; Swerdlow RH, 2009, EXP NEUROL, V218, P308, DOI 10.1016/j.expneurol.2009.01.011; Takasaki S, 2009, J BIOENERG BIOMEMBR, V41, P407, DOI 10.1007/s10863-009-9240-8; Templeton AR, 2005, GENETICS, V169, P441, DOI 10.1534/genetics.104.030080; van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Zsurka G, 1998, BIOL PSYCHIAT, V44, P371, DOI 10.1016/S0006-3223(97)00461-7	69	22	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74158	10.1371/journal.pone.0074158	http://dx.doi.org/10.1371/journal.pone.0074158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040196	gold, Green Published			2022-12-25	WOS:000326734500076
J	Warnes, SL; Keevil, CW				Warnes, Sarah L.; Keevil, C. William			Inactivation of Norovirus on Dry Copper Alloy Surfaces	PLOS ONE			English	Article							HUMAN ENTERIC VIRUSES; INTENSIVE-CARE-UNIT; CLOSTRIDIUM-DIFFICILE; CROSS-CONTAMINATION; FELINE CALICIVIRUS; HOSPITAL SURFACES; STAINLESS-STEEL; METAL-SURFACES; SURVIVAL; GASTROENTERITIS	Noroviruses (family Caliciviridae) are the primary cause of viral gastroenteritis worldwide. The virus is highly infectious and touching contaminated surfaces can contribute to infection spread. Although the virus was identified over 40 years ago the lack of methods to assess infectivity has hampered the study of the human pathogen. Recently the murine virus, MNV-1, has successfully been used as a close surrogate. Copper alloys have previously been shown to be effective antimicrobial surfaces against a range of bacteria and fungi. We now report rapid inactivation of murine norovirus on alloys, containing over 60% copper, at room temperature but no reduction of infectivity on stainless steel dry surfaces in simulated wet fomite and dry touch contamination. The rate of inactivation was initially very rapid and proportional to copper content of alloy tested. Viral inactivation was not as rapid on brass as previously observed for bacteria but copper-nickel alloy was very effective. The use of chelators and quenchers of reactive oxygen species (ROS) determined that Cu(II) and especially Cu(I) ions are still the primary effectors of toxicity but quenching superoxide and hydroxyl radicals did not confer protection. This suggests Fenton generation of ROS is not important for the inactivation mechanism. One of the targets of copper toxicity was the viral genome and a reduced copy number of the gene for a viral encoded protein, VPg (viral-protein-genome-linked), which is essential for infectivity, was observed following contact with copper and brass dry surfaces. The use of antimicrobial surfaces containing copper in high risk closed environments such as cruise ships and care facilities could help to reduce the spread of this highly infectious and costly pathogen.	[Warnes, Sarah L.; Keevil, C. William] Univ Southampton, Ctr Biol Sci, Southampton, Hants, England	University of Southampton	Warnes, SL (corresponding author), Univ Southampton, Ctr Biol Sci, Southampton, Hants, England.	s.l.warnes@soton.ac.uk		Keevil, Charles/0000-0003-1917-7706	Copper Development Association, NY; International Copper Association, NY	Copper Development Association, NY; International Copper Association, NY	The research was funded by the Copper Development Association, NY and the International Copper Association, NY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAD FX, 1994, APPL ENVIRON MICROB, V60, P3704, DOI 10.1128/AEM.60.10.3704-3710.1994; ABAD FX, 1994, APPL ENVIRON MICROB, V60, P2377, DOI 10.1128/AEM.60.7.2377-2383.1994; Baert L, 2008, APPL ENVIRON MICROB, V74, P543, DOI 10.1128/AEM.01039-07; Barker J, 2004, J HOSP INFECT, V58, P42, DOI 10.1016/j.jhin.2004.04.021; Beersma MFC, 2012, J CLIN MICROBIOL, V50, P3040, DOI 10.1128/JCM.00908-12; Casey AL, 2010, J HOSP INFECT, V74, P72, DOI 10.1016/j.jhin.2009.08.018; Clay S, 2006, AM J INFECT CONTROL, V34, P41, DOI 10.1016/j.ajic.2005.05.013; D'Souza DH, 2006, INT J FOOD MICROBIOL, V108, P84, DOI 10.1016/j.ijfoodmicro.2005.10.024; Donaldson EF, 2010, NAT REV MICROBIOL, V8, P231, DOI 10.1038/nrmicro2296; Duizer E, 2004, J GEN VIROL, V85, P79, DOI 10.1099/vir.0.19478-0; Gerhardts A, 2012, J APPL MICROBIOL, V112, P614, DOI 10.1111/j.1365-2672.2012.05234.x; Giammanco GM, 2012, INFECT GENET EVOL, V12, P169, DOI 10.1016/j.meegid.2011.10.021; Gibson KE, 2012, APPL ENVIRON MICROB, V78, P3037, DOI 10.1128/AEM.00027-12; Goodfellow I, 2011, CURR OPIN VIROL, V1, P355, DOI 10.1016/j.coviro.2011.09.003; Griffiths PD, 2012, REV MED VIROL, V22, P67, DOI 10.1002/rmv.1705; Hamza IA, 2011, INT J HYG ENVIR HEAL, V214, P424, DOI 10.1016/j.ijheh.2011.07.014; Kawada JI, 2012, MICROBIOL IMMUNOL, V56, P756, DOI 10.1111/j.1348-0421.2012.00498.x; Lee N, 2007, EMERG INFECT DIS, V13, P1399, DOI 10.3201/eid1309.061535; Li JY, 2011, APPL ENVIRON MICROB, V77, P6878, DOI 10.1128/AEM.05661-11; Lopman B, 2012, CURR OPIN VIROL, V2, P96, DOI 10.1016/j.coviro.2011.11.005; McFadden N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002413; Ministry of Health, 2012, GUID HANDL CLUST CAS; Noyce JO, 2007, APPL ENVIRON MICROB, V73, P2748, DOI 10.1128/AEM.01139-06; Noyce JO, 2006, J HOSP INFECT, V63, P289, DOI 10.1016/j.jhin.2005.12.008; Noyce JO, 2006, APPL ENVIRON MICROB, V72, P4239, DOI 10.1128/AEM.02532-05; Rodriguez-Lazaro D, 2012, FEMS MICROBIOL REV, V36, P786, DOI 10.1111/j.1574-6976.2011.00306.x; Sagripanti JL, 1997, ANTIMICROB AGENTS CH, V41, P812, DOI 10.1128/AAC.41.4.812; Salgado CD, 2013, INFECT CONT HOSP EP, V34, P479, DOI 10.1086/670207; Schmidt MG, 2012, J CLIN MICROBIOL, V50, P2217, DOI 10.1128/JCM.01032-12; Seitz SR, 2011, APPL ENVIRON MICROB, V77, P6884, DOI 10.1128/AEM.05806-11; Sharps CP, 2012, J FOOD PROTECT, V75, P1437, DOI 10.4315/0362-028X.JFP-12-052; Shionoiri N, 2012, J BIOSCI BIOENG, V113, P580, DOI 10.1016/j.jbiosc.2011.12.006; Takahashi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021951; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; Thornley CN, 2011, CLIN INFECT DIS, V53, P515, DOI 10.1093/cid/cir465; Turcios-Ruiz RM, 2008, J PEDIATR-US, V153, P339, DOI 10.1016/j.jpeds.2008.04.015; Warnes SL, 2012, ENVIRON MICROBIOL, V14, P1730, DOI 10.1111/j.1462-2920.2011.02677.x; Warnes SL, 2011, APPL ENVIRON MICROB, V77, P6049, DOI 10.1128/AEM.00597-11; Warnes SL, 2010, APPL ENVIRON MICROB, V76, P5390, DOI 10.1128/AEM.03050-09; Warnes S.L., 2012, MBIO, V3, DOI DOI 10.1128/MBI0.00489-12; Weaver L, 2008, J HOSP INFECT, V68, P145, DOI 10.1016/j.jhin.2007.11.011; Weaver L, 2010, LETT APPL MICROBIOL, V50, P18, DOI 10.1111/j.1472-765X.2009.02753.x; Weber DJ, 2010, AM J INFECT CONTROL, V38, pS25, DOI 10.1016/j.ajic.2010.04.196; Wilks SA, 2005, INT J FOOD MICROBIOL, V105, P445, DOI 10.1016/j.ijfoodmicro.2005.04.021; Wilks SA, 2006, INT J FOOD MICROBIOL, V111, P93, DOI 10.1016/j.ijfoodmicro.2006.04.037; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Wobus CE, 2006, J VIROL, V80, P5104, DOI 10.1128/JVI.02346-05	47	104	107	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e75017	10.1371/journal.pone.0075017	http://dx.doi.org/10.1371/journal.pone.0075017			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040380	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000326405300199
J	Ho, PWL; Tse, ZHM; Liu, HF; Lu, S; Ho, JWM; Kung, MHW; Ramsden, DB; Ho, SL				Ho, Philip Wing-Lok; Tse, Zero Ho-Man; Liu, Hui-Fang; Lu, Song; Ho, Jessica Wing-Man; Kung, Michelle Hiu-Wai; Ramsden, David Boyer; Ho, Shu-Leong			Assessment of Cellular Estrogenic Activity Based on Estrogen Receptor-Mediated Reduction of Soluble-Form Catechol-O-Methyltransferase (COMT) Expression in an ELISA-Based System	PLOS ONE			English	Article							DOWN-REGULATION; XENOESTROGENS; METABOLISM; MECHANISMS; EXPOSURE; DISEASE; MCF-7	Xenoestrogens are either natural or synthetic compounds that mimic the effects of endogenous estrogen. These compounds, such as bisphenol-A (BPA), and phthalates, are commonly found in plastic wares. Exposure to these compounds poses major risk to human health because of the potential to cause endocrine disruption. There is huge demand for a wide range of chemicals to be assessed for such potential for the sake of public health. Classical in vivo assays for endocrine disruption are comprehensive but time-consuming and require sacrifice of experimental animals. Simple preliminary in vitro screening assays can reduce the time and expense involved. We previously demonstrated that catechol-O-methyltransferase (COMT) is transcriptionally regulated by estrogen via estrogen receptor (ER). Therefore, detecting corresponding changes of COMT expression in estrogen-responsive cells may be a useful method to estimate estrogenic effects of various compounds. We developed a novel cell-based ELISA to evaluate cellular response to estrogenicity by reduction of soluble-COMT expression in ER-positive MCF-7 cells exposed to estrogenic compounds. In contrast to various existing methods that only detect bioactivity, this method elucidates direct physiological effect in a living cell in response to a compound. We validated our assay using three well-characterized estrogenic plasticizers -BPA, benzyl butyl phthalate (BBP), and di-n-butyl phthalate (DBP). Cells were exposed to either these plasticizers or 17 beta-estradiol (E2) in estrogen-depleted medium with or without an ER-antagonist, ICI 182,780, and COMT expression assayed. Exposure to each of these plasticizers (10(-9)-10(-7)M) dose-dependently reduced COMT expression (p<0.05), which was blocked by ICI 182,780. Reduction of COMT expression was readily detectable in cells exposed to picomolar level of E2, comparable to other in vitro assays of similar sensitivity. To satisfy the demand for in vitro assays targeting different cellular components, a cell-based COMT assay provides useful initial screening to supplement the current assessments of xenoestrogens for potential estrogenic activity.	[Ho, Philip Wing-Lok; Tse, Zero Ho-Man; Liu, Hui-Fang; Lu, Song; Ho, Jessica Wing-Man; Kung, Michelle Hiu-Wai; Ho, Shu-Leong] Univ Hong Kong, Dept Med, Div Neurol, Hong Kong, Hong Kong, Peoples R China; [Ramsden, David Boyer] Univ Birmingham, Sch Med, Birmingham, W Midlands, England; [Ramsden, David Boyer] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Ho, Philip Wing-Lok; Lu, Song; Ho, Shu-Leong] Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Birmingham; University of Birmingham; University of Hong Kong	Ho, SL (corresponding author), Univ Hong Kong, Dept Med, Div Neurol, Hong Kong, Hong Kong, Peoples R China.	slho@hku.hk	Ho, Philip Wing-Lok/K-5814-2013; Ho, Shu-Leong/AFK-8146-2022	Ho, Philip Wing-Lok/0000-0001-7794-0146; 	Henry G Leong Professorship in Neurology; Donation Fund for Neurology Research; Technology Transfer Seed Funding, Technology Transfer Office (TTO), University of Hong Kong; Seed Funding Program for Applied Research [201002160001]; University of Hong Kong	Henry G Leong Professorship in Neurology; Donation Fund for Neurology Research; Technology Transfer Seed Funding, Technology Transfer Office (TTO), University of Hong Kong; Seed Funding Program for Applied Research; University of Hong Kong(University of Hong Kong)	This project is financially supported by the Henry G Leong Professorship in Neurology (SLH); the Donation Fund for Neurology Research (SLH); Technology Transfer Seed Funding, Technology Transfer Office (TTO), University of Hong Kong; Seed Funding Program for Applied Research (PWL Ho; 201002160001, HKU). PWL Ho is supported by a Research Assistant Professorship, JWM Ho and HF Liu are supported by Postdoctoral Fellowships from the University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonifacio MJ, 2007, CNS DRUG REV, V13, P352, DOI 10.1111/j.1527-3458.2007.00020.x; Carvan Michael J. III, 2000, Annals of the New York Academy of Sciences, V919, P133; Dawling S, 2001, CANCER RES, V61, P6716; Frye CA, 2012, J NEUROENDOCRINOL, V24, P144, DOI 10.1111/j.1365-2826.2011.02229.x; Ho PWL, 2008, CURR DRUG METAB, V9, P304, DOI 10.2174/138920008784220600; Ho PWL, 2008, CURR DRUG METAB, V9, P276, DOI 10.2174/138920008784220628; Houston MC, 2007, ALTERN THER HEALTH M, V13, P128; Jiang H, 2003, NEUROPHARMACOLOGY, V45, P1011, DOI 10.1016/S0028-3908(03)00286-7; Jorgensen M, 2000, ENVIRON HEALTH PERSP, V108, P403, DOI 10.2307/3454380; Kim KH, 2009, TOXICOL APPL PHARM, V237, P168, DOI 10.1016/j.taap.2009.03.002; Lawson C, 2011, BIOL REPROD, V84, P79, DOI 10.1095/biolreprod.110.084814; Levenson AS, 1997, CANCER RES, V57, P3071; Lewandowski KE, 2007, HARVARD REV PSYCHIAT, V15, P233, DOI 10.1080/10673220701650409; Melzer D, 2011, ENVIRON HEALTH PERSP, V119, P1788, DOI 10.1289/ehp.1103809; OECD, 2001, TEST NO 416 2 GEN RE, DOI [10.1787/9789264070868-en, DOI 10.1787/9789264070868-EN]; SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.1289/ehp.95103s7113; Soto AM, 2006, BEST PRACT RES CL EN, V20, P15, DOI 10.1016/j.beem.2005.09.001; Strunck E, 2000, J STEROID BIOCHEM, V74, P73, DOI 10.1016/S0960-0760(00)00092-3; Tom T, 1998, DRUG AGING, V12, P55, DOI 10.2165/00002512-199812010-00006; Waring RH, 2008, J STEROID BIOCHEM, V108, P213, DOI 10.1016/j.jsbmb.2007.09.007; Welshons WV, 1999, TOXICOL IND HEALTH, V15, P12, DOI 10.1191/074823399678846745; Willhite CC, 2008, J TOXICOL ENV HEAL B, V11, P69, DOI 10.1080/10937400701724303; Xie T, 1999, MOL PHARMACOL, V56, P31, DOI 10.1124/mol.56.1.31; Yager JD, 1996, ANNU REV PHARMACOL, V36, P203, DOI 10.1146/annurev.pa.36.040196.001223; Zhu BT, 2002, CURR DRUG METAB, V3, P321, DOI 10.2174/1389200023337586	25	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e74065	10.1371/journal.pone.0074065	http://dx.doi.org/10.1371/journal.pone.0074065			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040167	Green Submitted, gold, Green Published			2022-12-25	WOS:000324856500073
J	Bargut, TCL; Ferreira, TPT; Daleprane, JB; Martins, MA; Silva, PMR; Aguila, MB				Lonzetti Bargut, Thereza Cristina; Teixeira Ferreira, Tatiana Paula; Daleprane, Julio Beltrame; Martins, Marco Aurelio; Rodrigues Silva, Patricia Machado; Aguila, Marcia Barbosa			Fish Oil Has Beneficial Effects on Allergen-Induced Airway Inflammation and Hyperreactivity in Mice	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATED-RECEPTOR-GAMMA; CD4(+) T-CELLS; MURINE MODEL; DOCOSAHEXAENOIC ACID; PROSTAGLANDIN D-2; MOUSE MODEL; CYTOKINE; HYPERRESPONSIVENESS; INHIBITION	Background: Fish oil (FO) is rich in n-3 polyunsaturated fatty acids (PUFA), which have been suggested to be anti-inflammatory and are associated with improvement of several inflammatory diseases. In this study, we investigated the influence of FO on allergen-induced lung inflammation and airway hyperreactivity in mice. Methods: Male A/J mice were fed either a standard-chow (SC) or a FO diet (FO) for 8 weeks. After 4 weeks, each group was further randomized for ovalbumin (SC-OVA and FO-OVA) or saline (SC-SAL and FO-SAL) challenge. Resistance and elastance were measured at baseline and after aerosolized methacholine, 24h after the last challenge. Bronchoalveolar lavage (BAL) was performed for leukocyte counts. Lung tissue mucus deposition, peribronchiolar matrix deposition and eosinophil infiltration were quantified. Serum immunoglobulin E (IgE) and IgG1 (ref 2.2), lung IL-4, IL-5, IL-10, IL-13, IL-17, INF gamma and eotaxin-1 and 2 were detected by ELISA and nuclear factor kappa B (NF kappa B), GATA-3 and peroxisome proliferator-activated receptor gamma (PPAR gamma) expression was measured by Western blot. Results: Levels of serum IgE and IgG1 were significantly higher in OVA sensitized mice. OVA challenge resulted in increased eosinophil infiltration, increased inflammatory cytokine production, peribronchiolar matrix and mucus deposition and airway hyperreactivity to aerosolized methacholine. Elevated lung NF kappa B and GATA-3 expression was noted in OVA-challenged mice. These changes were attenuated in mice fed with FO diet. Higher PPAR gamma expression was also detected in the lungs from the FO-fed groups. Conclusion: Our results demonstrate that FO intake attenuated classical asthma features by suppressing the systemic sensitization, thus providing evidence that FO might be a prophylactic alternative for asthma prevention.	[Lonzetti Bargut, Thereza Cristina; Aguila, Marcia Barbosa] Univ Estado Rio De Janeiro, Lab Morphometry Metab & Cardiovasc Dis, Biomed Ctr, Inst Biol, Rio De Janeiro, Brazil; [Teixeira Ferreira, Tatiana Paula; Daleprane, Julio Beltrame; Martins, Marco Aurelio; Rodrigues Silva, Patricia Machado] Oswaldo Cruz Fdn FIOCRUZ, Lab Inflammat, Inst Oswaldo Cruz, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz	Aguila, MB (corresponding author), Univ Estado Rio De Janeiro, Lab Morphometry Metab & Cardiovasc Dis, Biomed Ctr, Inst Biol, Rio De Janeiro, Brazil.	marciaguila@gmail.com	Bargut, Thereza/AAK-4649-2020; Aguila, Marcia/P-2349-2019; Daleprane, Julio/H-2597-2012; Mandarim-de-Lacerda, Carlos A/F-7125-2012; SILVA, PATRICIA MACHADO RODRIGUES E/AAS-4906-2020; Aguila, Marcia Barbosa/ABF-6505-2020	Daleprane, Julio/0000-0002-3493-1386; Aguila, Marcia Barbosa/0000-0003-3994-4589; Bargut, Thereza/0000-0001-9218-3104	CNPq; Faperj; PAPES4/Fiocruz	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faperj(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); PAPES4/Fiocruz	The research was supported by CNPq, Faperj and PAPES4/Fiocruz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguila MB, 2010, OLIVES AND OLIVE OIL IN HEALTH AND DISEASE PREVENTION, P787, DOI 10.1016/B978-0-12-374420-3.00082-6; Aguila MB, 2005, PROSTAG OTH LIPID M, V76, P74, DOI 10.1016/j.prostaglandins.2004.12.003; Al Biltagi M, 2009, ACTA PAEDIATR, V98, P737, DOI 10.1111/j.1651-2227.2008.01213.x; Al-Muhsen S, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-34; Antunes MA, 2010, J APPL PHYSIOL, V109, P855, DOI 10.1152/japplphysiol.00333.2010; Arantes-Costa FM, 2008, TOXICOL PATHOL, V36, P680, DOI 10.1177/0192623308317427; Bhattacharya A, 2005, J NUTR, V135, P1124, DOI 10.1093/jn/135.5.1124; Bhavsar PK, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-71; Bilal S, 2011, BBA-MOL BASIS DIS, V1812, P1164, DOI 10.1016/j.bbadis.2011.05.002; Bringhenti I, 2011, J NUTR BIOCHEM, V22, P1009, DOI 10.1016/j.jnutbio.2010.08.013; Calder PC, 2012, J NUTR, V142, p592S, DOI 10.3945/jn.111.155259; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Chai OH, 2011, EXP MOL MED, V43, P35, DOI 10.3858/emm.2011.43.1.004; Churg A, 2004, AM J RESP CRIT CARE, V170, P492, DOI 10.1164/rccm.200404-511OC; Covar R, 2010, CLIN EXP ALLERGY, V40, P1163, DOI 10.1111/j.1365-2222.2010.03523.x; Crapster-Pregont M, 2012, J ALLERGY CLIN IMMUN, V129, P1621, DOI 10.1016/j.jaci.2012.01.052; Dawczynski C, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-130; de Matos OG, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/236564; Durrani SR, 2011, J ALLERGY CLIN IMMUN, V128, P439, DOI 10.1016/j.jaci.2011.06.002; Galli C, 2009, ANN NUTR METAB, V55, P123, DOI 10.1159/000228999; Ghosh S, 2012, J IMMUNOL, V189, P1322, DOI 10.4049/jimmunol.1200138; Girodet PO, 2011, PHARMACOL THERAPEUT, V130, P325, DOI 10.1016/j.pharmthera.2011.02.001; Hawrylowicz CM, 2005, NAT REV IMMUNOL, V5, P271, DOI 10.1038/nri1589; Hulbert AJ, 2005, BIOL REV, V80, P155, DOI 10.1017/S1464793104006578; JIANG H, 2012, J PHARM EXP THER; Kaplan C, 2002, ARTHRITIS RES, V4, P54, DOI 10.1186/ar383; Kong WM, 2011, BRAIN BEHAV IMMUN, V25, P872, DOI 10.1016/j.bbi.2010.09.012; Larsson AK, 2011, EUR J PHARMACOL, V669, P136, DOI 10.1016/j.ejphar.2011.07.046; Lee KS, 2006, J IMMUNOL, V177, P5248, DOI 10.4049/jimmunol.177.8.5248; Lim H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052666; Lu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019889; Mickleborough TD, 2006, CHEST, V129, P39, DOI 10.1378/chest.129.1.39; Nabe T, 2012, EUR J PHARMACOL, V677, P154, DOI 10.1016/j.ejphar.2011.12.020; Novak TE, 2003, AM J PHYSIOL-LUNG C, V284, pL84, DOI 10.1152/ajplung.00077.2002; Ochkur SI, 2007, J IMMUNOL, V178, P7879, DOI 10.4049/jimmunol.178.12.7879; Oliphant CJ, 2011, IMMUNOLOGY, V134, P378, DOI 10.1111/j.1365-2567.2011.03499.x; Olsen PC, 2011, CLIN EXP ALLERGY, V41, P250, DOI 10.1111/j.1365-2222.2010.03580.x; Peebles RS, 2005, J IMMUNOL, V175, P8253, DOI 10.4049/jimmunol.175.12.8253; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pettipher R, 2012, J PHARMACOL EXP THER, V340, P473, DOI 10.1124/jpet.111.187203; Queto T, 2011, LIFE SCI, V88, P830, DOI 10.1016/j.lfs.2011.03.001; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Saraiva SA, 2011, RESP PHYSIOL NEUROBI, V177, P141, DOI 10.1016/j.resp.2011.03.019; Serra MF, 2012, ANESTHESIOLOGY, V117, P580, DOI 10.1097/ALN.0b013e31826687d5; Shin IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045734; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; Takeda K, 2001, AM J PHYSIOL-LUNG C, V281, pL394, DOI 10.1152/ajplung.2001.281.2.L394; Tull SP, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000177; Uhm TG, 2012, ALLERGY ASTHMA IMMUN, V4, P68, DOI 10.4168/aair.2012.4.2.68; Vanden Berghe W, 2003, ADV EXP MED BIOL, V544, P181; Volkov A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060565; Weise C, 2011, J NUTR BIOCHEM, V22, P269, DOI 10.1016/j.jnutbio.2010.02.004; Woerly G, 2003, J EXP MED, V198, P411, DOI 10.1084/jem.20021384; Wood LG, 2010, CLIN EXP ALLERGY, V40, P1785, DOI 10.1111/j.1365-2222.2010.03503.x; Xue L, 2009, CLIN EXP IMMUNOL, V156, P126, DOI 10.1111/j.1365-2249.2008.03871.x; Yin HY, 2009, FREE RADICAL BIO MED, V47, P622, DOI 10.1016/j.freeradbiomed.2009.05.033; Zosky GR, 2009, AM J PHYSIOL-LUNG C, V297, pL373, DOI 10.1152/ajplung.00053.2009; 2011, GLOB ASTHM REP 2011	58	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e75059	10.1371/journal.pone.0075059	http://dx.doi.org/10.1371/journal.pone.0075059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040386	gold, Green Published, Green Submitted			2022-12-25	WOS:000324856500102
J	Stevenson, PA; Rillich, J				Stevenson, Paul A.; Rillich, Jan			Isolation Associated Aggression - A Consequence of Recovery from Defeat in a Territorial Animal	PLOS ONE			English	Article							AGONISTIC BEHAVIOR; SOCIAL-ISOLATION; GRYLLUS-BIMACULATUS; MALE CRICKETS; ACHETA-DOMESTICUS; FIELD CRICKET; MICE; EXPERIENCE; OCTOPAMINE; STRESS	Population density has profound influences on the physiology and behaviour of many animal species. Social isolation is generally reported to lead to increased aggressiveness, while grouping lowers it. We evaluated the effects of varying degrees of isolation and grouping on aggression in a territorial insect, the Mediterranean field cricket, Gryllus bimaculatus. Substantiating early observations, we show that dyadic contests between weight-matched, adult male crickets taken from groups rarely escalate beyond threat displays, whereas interactions between pairs of previously isolated crickets typically escalate to physical fights lasting several seconds. No significant differences were found between 1, 2 and 6-day isolates, or between individuals grouped for a few hours or lifelong. Unexpectedly, crickets grouped in immediate proximity within individual mesh cages that precluded fighting while permitting visual, olfactory and mechanical, antennal contact, were as aggressive as free isolates. This suggests that reduced aggression of grouped animals may be an acquired result of fighting. Supporting this notion, isolated crickets initially engage in vigorous fights when first grouped, but fighting intensity and duration rapidly decline to the level of life-long grouped crickets within only 10 min. Furthermore, grouped crickets become as aggressive as life-long isolates after only 3 hours of isolation, and on the same time course required for crickets to regain their aggressiveness after social defeat. We conclude that the reduced aggressiveness of grouped crickets is a manifestation of the loser effect resulting from social subjugation, while isolation allows recovery to a state of heightened aggressiveness, which in crickets can be considered as the default condition. Given the widespread occurrence of the loser effect in the Animal Kingdom, many effects generally attributed to social isolation are likely to be a consequence of recovery from social subjugation.	[Stevenson, Paul A.] Univ Leipzig, Inst Biol, D-04109 Leipzig, Germany; [Rillich, Jan] Free Univ Berlin, Inst Neurobiol, Berlin, Germany	Leipzig University; Free University of Berlin	Stevenson, PA (corresponding author), Univ Leipzig, Inst Biol, D-04109 Leipzig, Germany.	stevenson@rz.uni-leipzig.de	Stevenson, Paul A/A-2048-2010		German Research Foundation; DFG Research Group 1363 [STE 714/4-1]	German Research Foundation; DFG Research Group 1363	Funding by the German Research Foundation http://www.dfg.de/en/; DFG Research Group 1363, grant STE 714/4-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMO SA, 1995, ANIM BEHAV, V49, P1491, DOI 10.1016/0003-3472(95)90070-5; Adamo SA, 2011, HORM BEHAV, V60, P478, DOI 10.1016/j.yhbeh.2011.07.015; Agis-Balboa RC, 2007, P NATL ACAD SCI USA, V104, P18736, DOI 10.1073/pnas.0709419104; ALEXANDER RICHARD D., 1961, BEHAVIOUR, V17, P130, DOI 10.1163/156853961X00042; Amsalem E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018238; Anstey ML, 2009, SCIENCE, V323, P627, DOI 10.1126/science.1165939; Bartolomucci A, 2009, SCAND J LAB ANIM SCI, V36, P87; BENTON D, 1979, BEHAV PROCESS, V4, P211, DOI 10.1016/0376-6357(79)90002-0; BERNSTEIN IS, 1974, FOLIA PRIMATOL, V21, P81, DOI 10.1159/000155607; BERRY RJ, 1992, BIOL REV, V67, P519, DOI 10.1111/j.1469-185X.1992.tb01192.x; Briffa M, 2008, ANIM BEHAV, V75, P1053, DOI 10.1016/j.anbehav.2007.08.016; Brown WD, 2007, ETHOLOGY, V113, P457, DOI 10.1111/j.1439-0310.2007.01357.x; Burrows Malcolm, 2011, Neural Syst Circuits, V1, P11, DOI 10.1186/2042-1001-1-11; Cacioppo JT, 2009, TRENDS COGN SCI, V13, P447, DOI 10.1016/j.tics.2009.06.005; Carnevali L, 2012, PHYSIOL BEHAV, V106, P142, DOI 10.1016/j.physbeh.2012.01.022; Certel SJ, 2007, P NATL ACAD SCI USA, V104, P4706, DOI 10.1073/pnas.0700328104; CLAYTON FL, 1968, BEHAVIOUR, V30, P96, DOI 10.1163/156853968X00207; Cullen DA, 2010, J INSECT PHYSIOL, V56, P937, DOI 10.1016/j.jinsphys.2010.04.023; Cunningham RL, 2008, J NEUROENDOCRINOL, V20, P997, DOI 10.1111/j.1365-2826.2008.01756.x; D'Amato FR, 2001, PHYSIOL BEHAV, V73, P421, DOI 10.1016/S0031-9384(01)00460-7; Desjardins JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032781; DiRienzo N, 2012, ANIM BEHAV, V84, P861, DOI 10.1016/j.anbehav.2012.07.007; DIXON KA, 1986, ANIM BEHAV, V34, P340, DOI 10.1016/S0003-3472(86)80102-6; Earley RL, 2006, PHYSIOL BEHAV, V88, P353, DOI 10.1016/j.physbeh.2006.04.002; FRANCK D, 1985, BEHAV PROCESS, V10, P415, DOI 10.1016/0376-6357(85)90041-5; Ghosal K, 2010, ARCH INSECT BIOCHEM, V74, P38, DOI 10.1002/arch.20360; Ghosal K, 2009, J EXP BIOL, V212, P2044, DOI 10.1242/jeb.026682; GOLDSMITH JF, 1976, AGGRESSIVE BEHAV, V2, P307, DOI 10.1002/1098-2337(1976)2:4<307::AID-AB2480020407>3.0.CO;2-I; Gomez-Laplaza LM, 2000, MAR FRESHW BEHAV PHY, V33, P63, DOI 10.1080/10236240009387083; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; HALPERIN JRP, 1993, BEHAV PROCESS, V28, P123, DOI 10.1016/0376-6357(93)90087-8; HEILIGENBERG W, 1972, J COMP PHYSIOL PSYCH, V77, P332, DOI 10.1007/BF00696433; HOFMANN H, 1997, THESIS U LEIPZIG LEI; Hofmann HA, 2000, NATURE, V403, P613, DOI 10.1038/35001137; Hofmann HA, 2001, ANIM BEHAV, V62, P337, DOI 10.1006/anbe.2001.1746; Hsu YY, 2006, BIOL REV, V81, P33, DOI 10.1017/S146479310500686X; Iba M, 1995, ZOOL SCI, V12, P695, DOI 10.2108/zsj.12.695; Issa FA, 1999, J EXP BIOL, V202, P3497; Iwasaki M, 2008, COMP BIOCHEM PHYS A, V149, P306, DOI 10.1016/j.cbpa.2008.01.008; Iwasaki M, 2006, ZOOL SCI, V23, P863, DOI 10.2108/zsj.23.863; Johnson O, 2009, NEUROSCIENCE, V158, P1292, DOI 10.1016/j.neuroscience.2008.10.055; Judge KA, 2010, BEHAV ECOL SOCIOBIOL, V64, P1971, DOI 10.1007/s00265-010-1008-y; Khazraie K, 1999, BEHAV PROCESS, V44, P341, DOI 10.1016/S0376-6357(98)00058-8; Killian KA, 2008, J INSECT BEHAV, V21, P535, DOI 10.1007/s10905-008-9148-x; KOYAMA S, 1993, J ETHOL, V11, P117, DOI 10.1007/BF02350045; Krohn TC, 2006, ANIM WELFARE, V15, P343; LAGERSPETZ KM, 1971, SCAND J PSYCHOL, V12, P241, DOI 10.1111/j.1467-9450.1971.tb00627.x; Lihoreau M, 2009, BEHAV PROCESS, V82, P81, DOI 10.1016/j.beproc.2009.03.008; Lorenz K., 1966, AGGRESSION; LUI W, 2010, NAT NEUROSCI, V14, P896; Maleszka J, 2009, J COMP PHYSIOL A, V195, P733, DOI 10.1007/s00359-009-0449-0; Matsuda Toshio, 2001, Japanese Journal of Neuropsychopharmacology, V21, P71; Matsumoto K, 2005, STRESS, V8, P85, DOI 10.1080/10253890500159022; Miczek KA, 2011, BEHAV GENET, V41, P787, DOI 10.1007/s10519-011-9462-5; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Nagamoto J, 2005, ZOOL SCI, V22, P1079, DOI 10.2108/zsj.22.1079; O'Connell LA, 2011, J COMP NEUROL, V519, P3599, DOI 10.1002/cne.22735; Ott SR, 2010, P ROY SOC B-BIOL SCI, V277, P3087, DOI 10.1098/rspb.2010.0694; PARMIGIANI S, 1983, BEHAV PROCESS, V8, P45, DOI 10.1016/0376-6357(83)90042-6; PAYNE AP, 1985, PHYSIOL BEHAV, V34, P911, DOI 10.1016/0031-9384(85)90013-7; PFENNIG DW, 1989, ETHOLOGY, V80, P1; Rillich J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028891; Rillich J, 2011, P ROY SOC B-BIOL SCI, V278, P1873, DOI 10.1098/rspb.2010.2099; Rogers SM, 2004, J EXP BIOL, V207, P3603, DOI 10.1242/jeb.01183; Schiller L, 2006, PROG NEURO-PSYCHOPH, V30, P492, DOI 10.1016/j.pnpbp.2005.11.008; SIMMONS LW, 1986, ANIM BEHAV, V34, P567, DOI 10.1016/S0003-3472(86)80126-9; SIMPSON JS, 2009, PHENOTYPIC PLASTICIT, P147; SIMPSON SJ, 2013, OXFORD HDB IN PRESS; Sokolowski MB, 2010, NEURON, V65, P780, DOI 10.1016/j.neuron.2010.03.007; Stevenson PA, 2000, J NEUROBIOL, V43, P107; Stevenson PA, 2005, J NEUROSCI, V25, P1431, DOI 10.1523/JNEUROSCI.4258-04.2005; Stevenson PA, 2013, CURR OPIN NEUROBIOL, V23, P318, DOI 10.1016/j.conb.2013.03.002; Stevenson PA, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00118; Tanner CJ, 2008, ANIM BEHAV, V76, P1335, DOI 10.1016/j.anbehav.2008.04.022; Technau GM, 2007, J NEUROGENET, V21, P183, DOI 10.1080/01677060701695359; Verlinden H, 2010, J INSECT PHYSIOL, V56, P868, DOI 10.1016/j.jinsphys.2010.03.003; Wada-Katsumata A, 2011, J EXP BIOL, V214, P1707, DOI 10.1242/jeb.051565; Wang LM, 2010, NATURE, V463, P227, DOI 10.1038/nature08678; Welch B. L., 1969, P188; ZHOU C, 2008, NAT NEUROSCI; Zwarts L, 2012, FLY, V6, P35, DOI 10.4161/fly.19249	81	38	38	18	1014	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e74965	10.1371/journal.pone.0074965	http://dx.doi.org/10.1371/journal.pone.0074965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040368	Green Submitted, Green Published, gold			2022-12-25	WOS:000324856500098
J	Roh-Johnson, M; Bravo-Cordero, JJ; Patsialou, A; Sharma, VP; Guo, P; Liu, H; Hodgson, L; Condeelis, J				Roh-Johnson, M.; Bravo-Cordero, J. J.; Patsialou, A.; Sharma, V. P.; Guo, P.; Liu, H.; Hodgson, L.; Condeelis, J.			Macrophage contact induces RhoA GTPase signaling to trigger tumor cell intravasation	ONCOGENE			English	Article						cancer; tumor cell intravasation; macrophages; RhoA biosensor; invadopodia; heterotypic cell contact	EXTRACELLULAR-MATRIX DEGRADATION; TRANSENDOTHELIAL MIGRATION; E-SELECTIN; ENDOTHELIAL-CELLS; CANCER-CELLS; MAMMARY-TUMORS; BREAST-CANCER; IN-VIVO; TYROSINE PHOSPHORYLATION; MELANOMA-CELLS	Most cancer patients die as a result of metastasis, thus it is important to understand the molecular mechanisms of dissemination, including intra- and extravasation. Although the mechanisms of extravasation have been vastly studied in vitro and in vivo, the process of intravasation is still unclear. Furthermore, how cells in the tumor microenvironment facilitate tumor cell intravasation is still unknown. Using high-resolution imaging, we found that macrophages enhance tumor cell intravasation upon physical contact. Macrophage and tumor cell contact induce RhoA activity in tumor cells, triggering the formation of actin-rich degradative protrusions called invadopodia, enabling tumor cells to degrade and break through matrix barriers during tumor cell transendothelial migration. Interestingly, we show that macrophage-induced invadopodium formation and tumor cell intravasation also occur in patient-derived tumor cells and in vivo models, revealing a conserved mechanism of tumor cell intravasation. Our results illustrate a novel heterotypic cell contact-mediated signaling role for RhoA, as well as yield mechanistic insight into the ability of cells within the tumor microenvironment to facilitate steps of the metastatic cascade.	[Roh-Johnson, M.; Bravo-Cordero, J. J.; Patsialou, A.; Sharma, V. P.; Guo, P.; Hodgson, L.; Condeelis, J.] Yeshiva Univ Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Roh-Johnson, M.; Bravo-Cordero, J. J.; Patsialou, A.; Sharma, V. P.; Guo, P.; Hodgson, L.; Condeelis, J.] Gruss Lipper Biophoton Ctr, Bronx, NY USA; [Liu, H.] Univ Chicago, Ben May Dept Canc Res, Chicago, IL USA	Yeshiva University; Albert Einstein College of Medicine; University of Chicago	Roh-Johnson, M (corresponding author), Yeshiva Univ Albert Einstein Coll Med, 1300 Morris Pk Ave,Price Ctr 208, Bronx, NY 10461 USA.	minna.roh@einstein.yu.edu	Guo, Peng/E-9858-2015	Bravo-Cordero, Jose Javier/0000-0001-9481-1231; Liu, Huiping/0000-0003-4822-7995; Sharma, Ved P/0000-0001-9998-5070; Hodgson, Louis/0000-0001-9188-7580	NIH [CA150344, CA100324, GM093121, CA159663]; Susan G. Komen for the Cure(C) [KG111405]; FOGARTY INTERNATIONAL CENTER [D43TW001429] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA150344, P01CA100324, U54CA163131, P30CA013330, F32CA159663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093121] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen for the Cure(C); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Brian Beaty for advice regarding invadopodium experiments; David Entenberg, Vera Desmarais, Jeffrey Wyckoff and the Analytical Imaging Facility for help with microscopy; Richard Stanley, Fernando Macian, Esther Arwert, Allison Harney and Veronika Micolski for guidance and reagents; Yarong Wang for help with animal injections; and the Albert Einstein shRNA Core, the Flow Cytometry Core facility and the Histology and Comparative Pathology Core for help with experiments. We also thank Jeffrey Segall, Dianne Cox, Anne Bresnick and Aviv Bergmann for helpful discussions, and the Condeelis, Segall, Cox and Hodgson labs for advice and reagents. This work was funded by NIH CA150344 (JC), NIH CA100324 (AP), NIH GM093121 (LH and JJB-C), Post-doctoral fellowship from Susan G. Komen for the Cure (c) KG111405 (VPS) and NIH CA159663 (MRJ).	Arthur WT, 2002, BIOL RES, V35, P239, DOI 10.4067/S0716-97602002000200016; Beaty BT, 2013, MOL BIOL CELL, V24, P1661, DOI 10.1091/mbc.E12-12-0908; Blouw B, 2008, EUR J CELL BIOL, V87, P555, DOI 10.1016/j.ejcb.2008.02.008; Bowden ET, 1999, ONCOGENE, V18, P4440, DOI 10.1038/sj.onc.1202827; Bravo-Cordero JJ, 2007, EMBO J, V26, P1499, DOI 10.1038/sj.emboj.7601606; Bravo-Cordero JJ, 2011, CURR BIOL, V21, P635, DOI 10.1016/j.cub.2011.03.039; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Clark ES, 2007, CANCER RES, V67, P4227, DOI 10.1158/0008-5472.CAN-06-3928; DAS SK, 1981, BLOOD, V58, P630; Gil-Henn H, 2013, ONCOGENE, V32, P2622, DOI 10.1038/onc.2012.284; Gligorijevic B, 2012, J CELL SCI, V125, P724, DOI 10.1242/jcs.092726; Haidari M, 2012, J BIOL CHEM, V287, P32981, DOI 10.1074/jbc.M112.395905; Haidari M, 2011, CARDIOVASC RES, V92, P456, DOI 10.1093/cvr/cvr240; Hu YY, 2001, J BIOL CHEM, V276, P48549, DOI 10.1074/jbc.M105513200; Hu YY, 2000, J IMMUNOL, V165, P2142, DOI 10.4049/jimmunol.165.4.2142; Jin FY, 2012, MOL CANCER RES, V10, P1021, DOI 10.1158/1541-7786.MCR-11-0498; KOOP S, 1995, CANCER RES, V55, P2520; KRAMER RH, 1979, P NATL ACAD SCI USA, V76, P5704, DOI 10.1073/pnas.76.11.5704; Laferriere J, 2001, J BIOL CHEM, V276, P33762, DOI 10.1074/jbc.M008564200; Lessey EC, 2012, BIOCHEMISTRY-US, V51, P7420, DOI 10.1021/bi300758e; Li B, 2006, FEBS LETT, V580, P4252, DOI 10.1016/j.febslet.2006.06.056; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Lipschutz JH, 2001, CURR PROTOC CELL BIO; Liu HP, 2010, P NATL ACAD SCI USA, V107, P18115, DOI 10.1073/pnas.1006732107; Lovett DH, 2010, BIOCHEM BIOPH RES CO, V398, P482, DOI 10.1016/j.bbrc.2010.06.104; Mader CC, 2011, CANCER RES, V71, P1730, DOI 10.1158/0008-5472.CAN-10-1432; Magalhaes MAO, 2011, J CELL BIOL, V195, P903, DOI 10.1083/jcb.201103045; McGhee Ewan J, 2011, Small GTPases, V2, P239; Nethe M, 2012, J CELL SCI, V125, P3430, DOI 10.1242/jcs.100925; NICOLSON GL, 1982, J HISTOCHEM CYTOCHEM, V30, P214, DOI 10.1177/30.3.7061823; OHIGASHI H, 1989, JPN J CANCER RES, V80, P818, DOI 10.1111/j.1349-7006.1989.tb01720.x; Omelchenko T, 2012, CURR BIOL, V22, P278, DOI 10.1016/j.cub.2012.01.014; Oser M, 2010, J CELL SCI, V123, P3662, DOI 10.1242/jcs.068163; Patsialou A, 2013, INTRAVITAL IN PRESS; Patsialou A, 2009, CANCER RES, V69, P9498, DOI 10.1158/0008-5472.CAN-09-1868; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Ponik SM, 2013, MOL BIOL CELL, V24, P1688, DOI 10.1091/mbc.E12-05-0386; Proebstl D, 2012, J EXP MED, V209, P1219, DOI 10.1084/jem.20111622; Reymond N, 2012, J CELL BIOL, V199, P653, DOI 10.1083/jcb.201205169; Reymond N, 2012, METHODS MOL BIOL, V827, P123, DOI 10.1007/978-1-61779-442-1_9; Robinson BD, 2009, CLIN CANCER RES, V15, P2433, DOI 10.1158/1078-0432.CCR-08-2179; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Roussos ET, 2011, J CELL SCI, V124, P2120, DOI 10.1242/jcs.086231; Sakurai-Yageta M, 2008, J CELL BIOL, V181, P985, DOI 10.1083/jcb.200709076; Saltel F, 2011, EUR J CELL BIOL, V90, P100, DOI 10.1016/j.ejcb.2010.05.011; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; Sharma VP, 2008, J LEUKOCYTE BIOL, V84, P440, DOI 10.1189/jlb.0907636; Sharma VP, 2013, METHODS MOL BIOL, V1046, P343, DOI 10.1007/978-1-62703-538-5_21; Spiering D, 2012, METHODS MOL BIOL, V827, P215, DOI 10.1007/978-1-61779-442-1_15; Stoletov K, 2007, P NATL ACAD SCI USA, V104, P17406, DOI 10.1073/pnas.0703446104; Timpson P, 2011, CANCER RES, V71, P747, DOI 10.1158/0008-5472.CAN-10-2267; Tremblay PL, 2006, ONCOGENE, V25, P6563, DOI 10.1038/sj.onc.1209664; Voura EB, 1998, MICROSC RES TECHNIQ, V43, P265, DOI 10.1002/(SICI)1097-0029(19981101)43:3<265::AID-JEMT9>3.0.CO;2-Z; Voura EB, 1998, CELL TISSUE RES, V293, P375, DOI 10.1007/s004410051129; WALZ G, 1990, SCIENCE, V250, P1132, DOI 10.1126/science.1701275; Weiss TW, 2004, J MOL CELL CARDIOL, V36, P539, DOI 10.1016/j.yjmcc.2004.02.001; Witzel S, 2006, J CELL BIOL, V175, P791, DOI 10.1083/jcb.200606017; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Yamaguchi H, 2012, EUR J CELL BIOL, V91, P902, DOI 10.1016/j.ejcb.2012.04.005; Yoshida M, 2003, ARTERIOSCL THROM VAS, V23, P783, DOI 10.1161/01.ATV.0000067427.40133.59; Yu WF, 2008, J LEUKOCYTE BIOL, V84, P852, DOI 10.1189/jlb.0308171; Zervantonakis IK, 2012, P NATL ACAD SCI USA, V109, P13515, DOI 10.1073/pnas.1210182109	63	109	112	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 14	2014	33	33					4203	4212		10.1038/onc.2013.377	http://dx.doi.org/10.1038/onc.2013.377			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AO2MB	24056963	Green Accepted			2022-12-25	WOS:000341155800002
J	Lawson, KA; Teteak, CJ; Zou, JH; Hacquebord, J; Ghatan, A; Zielinska-Kwiatkowska, A; Fernandes, RJ; Chansky, HA; Yang, L				Lawson, Kevin A.; Teteak, Colin J.; Zou, Junhui; Hacquebord, Jacques; Ghatan, Andrew; Zielinska-Kwiatkowska, Anna; Fernandes, Russell J.; Chansky, Howard A.; Yang, Liu			Mesenchyme-specific Knockout of ESET Histone Methyltransferase Causes Ectopic Hypertrophy and Terminal Differentiation of Articular Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arthritis; Articular cartilage; Cartilage biology; Chondrocytes; Differentiation; Epigenetics; Gene Knockout; Histone methylation	CELL NUCLEAR ANTIGEN; ALKALINE-PHOSPHATASE; OSTEOARTHRITIC CARTILAGE; DNA FRAGMENTATION; GROWTH-PLATE; MOUSE LIMB; EXPRESSION; JOINT; APOPTOSIS; GENE	The exact molecular mechanisms governing articular chondrocytes remain unknown in skeletal biology. In this study, we have found that ESET (an ERG-associated protein with a SET domain, also called SETDB1) histone methyltransferase is expressed in articular cartilage. To test whether ESET regulates articular chondrocytes, we carried out mesenchyme-specific deletion of the ESET gene in mice. ESET knock-out did not affect generation of articular chondrocytes during embryonic development. Two weeks after birth, there was minimal qualitative difference at the knee joints between wild-type and ESET knock-out animals. At 1 month, ectopic hypertrophy, proliferation, and apoptosis of articular chondrocytes were seen in the articular cartilage of ESET-null animals. At 3 months, additional signs of terminal differentiation such as increased alkaline phosphatase activity and an elevated level of matrix metalloproteinase (MMP)-13 were found in ESET-null cartilage. Staining for type II collagen and proteoglycan revealed that cartilage degeneration became progressively worse from 2 weeks to 12 months at the knee joints of ESET knock-out mutants. Analysis of over 14 pairs of age- and sex-matched wild-type and knock-out mice indicated that the articular chondrocyte phenotype in ESET-null mutants is 100% penetrant. Our results demonstrate that expression of ESET plays an essential role in the maintenance of articular cartilage by preventing articular chondrocytes from terminal differentiation and may have implications in joint diseases such as osteoarthritis.	[Lawson, Kevin A.; Teteak, Colin J.; Zou, Junhui; Hacquebord, Jacques; Ghatan, Andrew; Zielinska-Kwiatkowska, Anna; Fernandes, Russell J.; Chansky, Howard A.; Yang, Liu] Univ Washington, Dept Orthoped & Sports Med, Seattle, WA 98108 USA; [Chansky, Howard A.; Yang, Liu] Vet Affairs Puget Sound Hlth Care Syst, Res & Dev Program, Seattle, WA 98108 USA	University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Yang, L (corresponding author), Univ Washington, Dept Orthoped & Sports Med, 1660 S Columbian Way,GMR 151, Seattle, WA 98108 USA.	lyang@u.washington.edu		Lawson, Kevin/0000-0002-2931-5263; , jacques/0000-0003-1829-1195	National Institutes of Health [RO1 AR051455, RO1 AR057025]; Merit Review Award from the United States Department of Veterans Affairs, Office of Research and Development Biomedical Laboratory Research Program; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057025, R01AR051455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merit Review Award from the United States Department of Veterans Affairs, Office of Research and Development Biomedical Laboratory Research Program; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by National Institutes of Health Grant RO1 AR051455 (to L. Y.). This work was also supported by a Merit Review Award from the United States Department of Veterans Affairs, Office of Research and Development Biomedical Laboratory Research Program (to H. A. C.).; Supported by National Institutes of Health Grant RO1 AR057025.	AYDELOTTE MB, 1988, CONNECT TISSUE RES, V18, P205, DOI 10.3109/03008208809016808; Berenbaum F, 2013, OSTEOARTHR CARTILAGE, V21, P16, DOI 10.1016/j.joca.2012.11.012; Blackburn ML, 2003, BBA-GENE STRUCT EXPR, V1629, P8, DOI 10.1016/S0167-4781(03)00155-6; Chen CG, 2012, ARTHRITIS RHEUM-US, V64, P3278, DOI 10.1002/art.34566; Dy P, 2010, DEV BIOL, V341, P346, DOI 10.1016/j.ydbio.2010.02.024; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Goldring MB, 2012, THER ADV MUSCULOSKEL, V4, P269, DOI 10.1177/1759720X12448454; HALL PA, 1990, J PATHOL, V162, P285, DOI 10.1002/path.1711620403; Hyde G, 2007, DEV BIOL, V304, P825, DOI 10.1016/j.ydbio.2007.01.026; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Iwamoto M, 2007, DEV BIOL, V305, P40, DOI 10.1016/j.ydbio.2007.01.037; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kamekura S, 2006, ARTHRITIS RHEUM, V54, P2462, DOI 10.1002/art.22041; Kouzarides T, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.005; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Miao DS, 2002, J HISTOCHEM CYTOCHEM, V50, P333, DOI 10.1177/002215540205000305; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; Pfander D, 2001, AM J PATHOL, V159, P1777, DOI 10.1016/S0002-9440(10)63024-6; Pitsillides AA, 2011, NAT REV RHEUMATOL, V7, P654, DOI 10.1038/nrrheum.2011.129; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Quinn TM, 2005, OSTEOARTHR CARTILAGE, V13, P672, DOI 10.1016/j.joca.2005.04.011; Rodova M, 2011, J BONE MINER RES, V26, P1974, DOI 10.1002/jbmr.397; van der Kraan PM, 2012, OSTEOARTHR CARTILAGE, V20, P223, DOI 10.1016/j.joca.2011.12.003; Wang XB, 2004, OSTEOARTHR CARTILAGE, V12, P963, DOI 10.1016/j.joca.2004.08.008; Weng JJ, 2013, BBA-GEN SUBJECTS, V1830, P2839, DOI 10.1016/j.bbagen.2012.12.021; Xia Y, 2002, OSTEOARTHR CARTILAGE, V10, P370, DOI 10.1053/joca.2002.0523; Yang CL, 1997, EXP CELL RES, V235, P370, DOI 10.1006/excr.1997.3692; Yang L, 2013, DEV BIOL, V380, P99, DOI 10.1016/j.ydbio.2013.04.031	28	16	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32119	32125		10.1074/jbc.M113.473827	http://dx.doi.org/10.1074/jbc.M113.473827			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24056368	Green Published, hybrid			2022-12-25	WOS:000328681700002
J	Samanta, S; Martin, CT				Samanta, Satamita; Martin, Craig T.			Insights into the Mechanism of Initial Transcription in Escherichia coli RNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAC UV5 PROMOTER; ABORTIVE INITIATION; STRUCTURAL BASIS; IN-VITRO; DNA HYBRID; OPEN COMPLEX; ANGSTROM RESOLUTION; T7-RNA POLYMERASE; SIGMA(70) SUBUNIT; CLEAVAGE FACTORS	It has long been known that during initial transcription of the first 8-10 bases of RNA, complexes are relatively unstable, leading to the release of short abortive RNA transcripts. An early "stressed intermediate" model led to a more specific mechanistic model proposing "scrunching" stress as the basis for the instability. Recent studies in the single subunit T7 RNA polymerase have argued against scrunching as the energetic driving force and instead argue for a model in which pushing of the RNA-DNA hybrid against a protein element associated with promoter binding, while likely driving promoter release, reciprocally leads to instability of the hybrid. In this study, we test these models in the structurally unrelated multisubunit bacterial RNA polymerase. Via the targeted introduction of mismatches and nicks in the DNA, we demonstrate that neither downstream bubble collapse nor compaction/scrunching of either the single-stranded template or nontemplate strands is a major force driving abortive instability (although collapse from the downstream end of the bubble does contribute significantly to the instability of artificially halted complexes). In contrast, pushing of the hybrid against a mobile protein element (sigma(3.2) in the bacterial enzyme) results in substantially increased abortive instability and is likely the primary energetic contributor to abortive cycling. The results suggest that abortive instability is a by-product of the mechanistic need to couple the energy of nucleotide addition (RNA chain growth) to driving the timed release of promoter contacts during initial transcription.	[Samanta, Satamita; Martin, Craig T.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Martin, CT (corresponding author), Univ Massachusetts, Dept Chem, 710 N Pleasant St,LGRT 104, Amherst, MA 01003 USA.	cmartin@chem.umass.edu	Martin, Craig T/L-3596-2013	Martin, Craig T/0000-0003-1029-5239	National Institutes of Health [1RO1 GM55002]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055002] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1RO1 GM55002.	BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; CARPOUSIS AJ, 1980, BIOCHEMISTRY-US, V19, P3245, DOI 10.1021/bi00555a023; Cashel M, 2003, J BIOL CHEM, V278, P5539, DOI 10.1074/jbc.M211430200; Chander M, 2007, BIOCHEMISTRY-US, V46, P12687, DOI 10.1021/bi701236f; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 1998, COLD SPRING HARB SYM, V63, P263, DOI 10.1101/sqb.1998.63.263; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; DeHaseth PL, 1998, J BACTERIOL, V180, P3019, DOI 10.1128/JB.180.12.3019-3025.1998; DEUSCHLE U, 1986, EMBO J, V5, P2987, DOI 10.1002/j.1460-2075.1986.tb04596.x; Durniak KJ, 2008, SCIENCE, V322, P553, DOI 10.1126/science.1163433; Gong P, 2006, J BIOL CHEM, V281, P23533, DOI 10.1074/jbc.M604023200; GRALLA JD, 1980, BIOCHEMISTRY-US, V19, P5864, DOI 10.1021/bi00566a031; Guo Y, 1998, P NATL ACAD SCI USA, V95, P11655, DOI 10.1073/pnas.95.20.11655; Hernandez VJ, 1996, J BIOL CHEM, V271, P18775, DOI 10.1074/jbc.271.31.18775; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; Hsu LM, 2006, BIOCHEMISTRY-US, V45, P8841, DOI 10.1021/bi060247u; Hsu LM, 2009, METHODS, V47, P25, DOI 10.1016/j.ymeth.2008.10.010; Hsu LLM, 2003, BIOCHEMISTRY-US, V42, P3777, DOI 10.1021/bi026954e; HSU LM, 1995, P NATL ACAD SCI USA, V92, P11588, DOI 10.1073/pnas.92.25.11588; JIN DJ, 1994, J MOL BIOL, V236, P72, DOI 10.1006/jmbi.1994.1119; KAMMERER W, 1986, EMBO J, V5, P2995, DOI 10.1002/j.1460-2075.1986.tb04597.x; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kireeva ML, 2000, J MOL BIOL, V299, P325, DOI 10.1006/jmbi.2000.3755; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Kulbachinskiy A, 2006, J BIOL CHEM, V281, P18273, DOI 10.1074/jbc.C600060200; Li XY, 1998, J BIOL CHEM, V273, P23558, DOI 10.1074/jbc.273.36.23558; Liu X, 2011, SCIENCE, V333, P633, DOI 10.1126/science.1206629; Marr MT, 2001, P NATL ACAD SCI USA, V98, P8972, DOI 10.1073/pnas.161253298; Martin CT, 2005, PROG NUCLEIC ACID RE, V80, P323, DOI 10.1016/S0079-6603(05)80008-X; MARTIN CT, 1988, BIOCHEMISTRY-US, V27, P3966, DOI 10.1021/bi00411a012; MASLAK M, 1993, BIOCHEMISTRY-US, V32, P4281, DOI 10.1021/bi00067a017; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; Mekler V, 2011, J BIOL CHEM, V286, P22600, DOI 10.1074/jbc.M111.247080; Mekler V, 2011, J BIOL CHEM, V286, P270, DOI 10.1074/jbc.M110.174102; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; MINKLEY EG, 1973, J MOL BIOL, V77, P255, DOI 10.1016/0022-2836(73)90335-5; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; Naryshkina T, 2006, J MOL BIOL, V361, P634, DOI 10.1016/j.jmb.2006.05.034; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Opalka N, 2003, CELL, V114, P335, DOI 10.1016/S0092-8674(03)00600-7; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Palangat M, 2001, J MOL BIOL, V311, P265, DOI 10.1006/jmbi.2001.4842; Ramirez-Tapia LE, 2012, J BIOL CHEM, V287, P37352, DOI 10.1074/jbc.M112.370643; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; Santangelo TJ, 2007, J MOL BIOL, V367, P344, DOI 10.1016/j.jmb.2006.12.069; Sen R, 1998, J BIOL CHEM, V273, P9872, DOI 10.1074/jbc.273.16.9872; STRANEY DC, 1987, J MOL BIOL, V193, P267, DOI 10.1016/0022-2836(87)90218-X; Toulokhonov I, 2006, J MOL BIOL, V361, P644, DOI 10.1016/j.jmb.2006.06.071; Ujvari A, 1996, BIOCHEMISTRY-US, V35, P14574, DOI 10.1021/bi961165g; Vahia AV, 2011, BIOCHEMISTRY-US, V50, P7015, DOI 10.1021/bi200620q; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786	56	25	26	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31993	32003		10.1074/jbc.M113.497669	http://dx.doi.org/10.1074/jbc.M113.497669			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24047893	Green Published, hybrid			2022-12-25	WOS:000330596200052
J	Tsutsui, Y; Ramakrishnan, B; Qasba, PK				Tsutsui, Yuko; Ramakrishnan, Boopathy; Qasba, Pradman K.			Crystal Structures of beta-1,4-Galactosyltransferase 7 Enzyme Reveal Conformational Changes and Substrate Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EHLERS-DANLOS-SYNDROME; HEPARAN-SULFATE; COMPLEX; PROTEOGLYCANS; RECOGNITION; SNAPSHOTS; DONOR	The beta-1,4-galactosyltransferase 7 (beta 4GalT7) enzyme is involved in proteoglycan synthesis. In the presence of a manganese ion, it transfers galactose from UDP-galactose to xylose on a proteoglycan acceptor substrate. We present here the crystal structures of human beta 4GalT7 in open and closed conformations. A comparison of these crystal structures shows that, upon manganese and UDP or UDP-Gal binding, the enzyme undergoes conformational changes involving a small and a long loop. We also present the crystal structures of Drosophila wild-type beta 4GalT7 and D211N beta 4GalT7 mutant enzymes in the closed conformation in the presence of the acceptor substrate xylobiose and the donor substrate UDP-Gal, respectively. To understand the catalytic mechanism, we have crystallized the ternary complex of D211N beta 4GalT7 mutant enzyme in the presence of manganese with the donor and the acceptor substrates together in the same crystal structure. The galactose moiety of the bound UDP-Gal molecule forms seven hydrogen bonds with the protein molecule. The nonreducing end of the xylose moiety of xylobiose binds to the hydrophobic acceptor sugar binding pocket created by the conformational changes, whereas its extended xylose moiety forms hydrophobic interactions with a Tyr residue. In the ternary complex crystal structure, the nucleophile O4 oxygen atom of the xylose molecule is found in close proximity to the C1 and O5 atoms of the galactose moiety. This is the first time that a Michaelis complex of a glycosyltransferase has been described, and it clearly suggests an S(N)2 type catalytic mechanism for the beta 4GalT7 enzyme.	NCI, Struct Glycobiol Sect, NIH, Frederick, MD 21702 USA; NCI, Basic Res Program, SAIC Frederick Inc, Nanobiol Program,Ctr Canc Res,NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Qasba, PK (corresponding author), Frederick Natl Lab Canc Res, Struct Glycobiol Sect, Bldg 469,Rm 221,POB B, Frederick, MD 21702 USA.	qasba@helix.nih.gov			National Cancer Institute, National Institutes of Health [HHSN261200800001E]; Intramural Research Program of the National Institutes of Health, NCI, National Institutes of Health	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the National Institutes of Health, NCI, National Institutes of Health	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract HHSN261200800001E (to P. K. Q.). This research was supported (in part) by the Intramural Research Program of the National Institutes of Health, NCI, National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afratis N, 2012, FEBS J, V279, P1177, DOI 10.1111/j.1742-4658.2012.08529.x; Almeida R, 1999, J BIOL CHEM, V274, P26165, DOI 10.1074/jbc.274.37.26165; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Boix E, 2001, J BIOL CHEM, V276, P48608, DOI 10.1074/jbc.M108828200; Chiodoni C, 2010, CANCER METAST REV, V29, P295, DOI 10.1007/s10555-010-9221-8; Daligault F, 2009, BIOCHEM J, V418, P605, DOI 10.1042/BJ20081093; DeLano WL, 2010, PYMOL MOL GRAPH SYST; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esko JD, 1996, CURR OPIN STRUC BIOL, V6, P663, DOI 10.1016/S0959-440X(96)80034-0; Garcia-Garcia JF, 2011, MOL BIOSYST, V7, P1312, DOI 10.1039/c0mb00206b; FRITZ TA, 1994, J BIOL CHEM, V269, P300; Gunasekaran K, 2003, BIOCHEMISTRY-US, V42, P3674, DOI 10.1021/bi034046r; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Krupicka M, 2009, J PHYS CHEM B, V113, P11314, DOI 10.1021/jp904716t; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lazarus MB, 2012, NAT CHEM BIOL, V8, P966, DOI [10.1038/nchembio.1109, 10.1038/NCHEMBIO.1109]; LUGEMWA FN, 1991, J BIOL CHEM, V266, P6674; Okajima T, 1999, J BIOL CHEM, V274, P28841, DOI 10.1074/jbc.274.41.28841; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pasek M, 2010, BIOCHEM BIOPH RES CO, V394, P679, DOI 10.1016/j.bbrc.2010.03.051; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rahuel-Clermont S, 2010, BIOCHEM J, V432, P303, DOI 10.1042/BJ20100921; Ramakrishnan B, 2006, J MOL BIOL, V357, P1619, DOI 10.1016/j.jmb.2006.01.088; Ramakrishnan B, 2004, BIOCHEMISTRY-US, V43, P12513, DOI 10.1021/bi049007+; Ramakrishnan B, 2002, J MOL BIOL, V318, P491, DOI 10.1016/S0022-2836(02)00020-7; Ramakrishnan B, 2010, CURR OPIN STRUC BIOL, V20, P536, DOI 10.1016/j.sbi.2010.07.004; Ramakrishnan B, 2010, J BIOL CHEM, V285, P15619, DOI 10.1074/jbc.M109.099564; Raman K, 2011, BIOCHEM BIOPH RES CO, V404, P86, DOI 10.1016/j.bbrc.2010.11.069; Ramasamy V, 2003, J MOL BIOL, V331, P1065, DOI 10.1016/S0022-2836(03)00790-3; RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369; Seidler DG, 2006, J MOL MED, V84, P583, DOI 10.1007/s00109-006-0046-4; Talhaoui I, 2010, J BIOL CHEM, V285, P37342, DOI 10.1074/jbc.M110.151951; Tremblay LV, 2010, BIOCHEMISTRY-US, V49, P9685, DOI 10.1021/bi1015088; Varki A., 1999, ESSENTIALS GLYCOBIOL	37	31	32	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31963	31970		10.1074/jbc.M113.509984	http://dx.doi.org/10.1074/jbc.M113.509984			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24052259	Green Published, hybrid			2022-12-25	WOS:000330596200049
J	Wolny, M; Colegrave, M; Colman, L; White, E; Knight, PJ; Peckham, M				Wolny, Marcin; Colegrave, Melanie; Colman, Lucy; White, Ed; Knight, Peter J.; Peckham, Michelle			Cardiomyopathy Mutations in the Tail of beta-Cardiac Myosin Modify the Coiled-coil Structure and Affect Integration into Thick Filaments in Muscle Sarcomeres in Adult Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN GENE; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; REGULATORY PHOSPHORYLATION SITE; CONTRACTILE KINETICS; MOLECULAR-BASIS; BINDING-SITE; AMINO-ACID; SKELETAL; DOMAIN; PROTEIN	It is unclear why mutations in the filament-forming tail of myosin heavy chain (MHC) cause hypertrophic or dilated cardiomyopathy as these mutations should not directly affect contraction. To investigate this, we first investigated the impact of five hypertrophic cardiomyopathy-causing (N1327K, E1356K, R1382W, E1555K, and R1768K) and one dilated cardiomyopathy-causing (R1500W) tail mutations on their ability to incorporate into muscle sarcomeres in vivo. We used adenoviral delivery to express full-length wild type or mutant enhanced GFP-MHC in isolated adult cardiomyocytes. Three mutations (N1327K, E1356K, and E1555K) reduced enhanced GFP-MHC incorporation into muscle sarcomeres, whereas the remainder had no effect. No mutations significantly affected contraction. Fluorescence recovery after photobleaching showed that fluorescence recovery for the mutation that incorporated least well (N1327K) was significantly faster than that of WT with half-times of 25.1 +/- 1.8 and 32.2 +/- 2.5 min (mean +/- S.E.), respectively. Next, we determined the effects of each mutation on the helical properties of wild type and seven mutant peptides (7, 11, or 15 heptads long) from the myosin tail by circular dichroism. R1382W and E1768K slightly increased the alpha-helical nature of peptides. The remaining mutations reduced alpha-helical content, with N1327K showing the greatest reduction. Only peptides containing residues 1301-1329 were highly alpha-helical suggesting that this region helps in initiation of coiled coil. These results suggest that small effects of mutations on helicity translate into a reduced ability to incorporate into sarcomeres, which may elicit compensatory hypertrophy.	[Wolny, Marcin; Colegrave, Melanie; Colman, Lucy; Knight, Peter J.; Peckham, Michelle] Univ Leeds, Sch Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [White, Ed] Univ Leeds, Sch Biomed Sci, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [White, Ed] Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England	University of Leeds; University of Leeds; University of Leeds	Peckham, M (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Fac Biol Sci, Miall Bldg, Leeds LS2 9JT, W Yorkshire, England.	m.peckham@leeds.ac.uk	Colegrave, Melanie/AAB-1590-2020; Peckham, Michelle/J-4991-2015	Peckham, Michelle/0000-0002-3754-2028	British Heart Foundation [PG/07/061/23277]; Biotechnology and Biological Sciences Research Council [BB/I007423/1]; Biotechnology and Biological Sciences Research Council; BBSRC [BB/I007423/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by British Heart Foundation Grant PG/07/061/23277 and Biotechnology and Biological Sciences Research Council Grant BB/I007423/1 (to M. P., P. J. K., and M. W.).; Recipient of a Biotechnology and Biological Sciences Research Council-funded studentship. Present address: Karus Therapeutics Ltd., Abingdon, Oxfordshire OX14 4RZ, United Kingdom.	Armel TZ, 2010, J MOL CELL CARDIOL, V48, P1007, DOI 10.1016/j.yjmcc.2009.10.011; Armel TZ, 2010, BIOCHEM BIOPH RES CO, V391, P352, DOI 10.1016/j.bbrc.2009.11.062; ATKINSON SJ, 1992, J MOL BIOL, V226, P7, DOI 10.1016/0022-2836(92)90118-4; Baboolal TG, 2009, P NATL ACAD SCI USA, V106, P22193, DOI [10.1073/pnas.0909851106, 10.1073/pnas.09098S1106]; Becker KD, 1997, J CELL BIOL, V137, P131, DOI 10.1083/jcb.137.1.131; Blair E, 2002, CIRC RES, V90, P263, DOI 10.1161/hh0302.104532; Buvoli M, 2012, J MOL BIOL, V415, P807, DOI 10.1016/j.jmb.2011.11.042; Cohen C, 1998, J STRUCT BIOL, V122, P180, DOI 10.1006/jsbi.1998.3983; CRAIG R, 1976, J MOL BIOL, V102, P325, DOI 10.1016/S0022-2836(76)80057-5; Flashman E, 2007, BIOCHEM J, V401, P97, DOI 10.1042/BJ20060500; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Herron TJ, 2007, CIRC RES, V100, P1182, DOI 10.1161/01.RES.0000264102.00706.4e; Ho CY, 2012, CIRCULATION, V125, P1432, DOI 10.1161/CIRCULATIONAHA.110.017277; Hougs L, 2005, EUR J HUM GENET, V13, P161, DOI 10.1038/sj.ejhg.5201310; Jung HS, 2008, MOL BIOL CELL, V19, P3234, DOI 10.1091/mbc.E08-02-0206; Karkkainen S, 2004, EUR J HEART FAIL, V6, P861, DOI 10.1016/j.ejheart.2004.04.017; Leach RN, 2005, CELL CALCIUM, V38, P515, DOI 10.1016/j.ceca.2005.07.006; Lee DL, 2001, J MOL BIOL, V306, P539, DOI 10.1006/jmbi.2000.4351; Locher MR, 2011, AM J PHYSIOL-HEART C, V300, pH869, DOI 10.1152/ajpheart.00452.2010; Maggs AM, 2000, J MUSCLE RES CELL M, V21, P101, DOI 10.1023/A:1005639229497; Maron Barry J, 2010, Am J Cardiol, V105, P1164, DOI 10.1016/j.amjcard.2009.12.021; Maron BJ, 2009, CIRC-CARDIOVASC GENE, V2, P81, DOI 10.1161/CIRCGENETICS.108.788703; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Maron BJ, 2004, CIRCULATION, V109, P2807, DOI 10.1161/01.CIR.0000128363.85581.E1; McCrossan ZA, 2004, CARDIOVASC RES, V63, P283, DOI 10.1016/j.cardiores.2004.04.013; MCLACHLAN AD, 1982, NATURE, V299, P226, DOI 10.1038/299226a0; McNally EM, 2002, CIRC RES, V90, P246, DOI 10.1161/res.90.3.246; Meredith C, 2004, AM J HUM GENET, V75, P703, DOI 10.1086/424760; Miller G, 2003, J PHYSIOL-LONDON, V548, P167, DOI 10.1113/jphysiol.2002.031922; Obermann WMJ, 1997, EMBO J, V16, P211, DOI 10.1093/emboj/16.2.211; Obermann WMJ, 1998, MOL BIOL CELL, V9, P829, DOI 10.1091/mbc.9.4.829; OFFER G, 1990, J MOL BIOL, V216, P213, DOI 10.1016/S0022-2836(05)80309-2; OFFER G, 1995, J MOL BIOL, V249, P967, DOI 10.1006/jmbi.1995.0352; Papageorgopoulos C, 2002, ANAL BIOCHEM, V309, P1, DOI 10.1016/S0003-2697(02)00253-1; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Peckham M, 2009, SOFT MATTER, V5, P2493, DOI 10.1039/b822339d; Perrot A, 2005, J MOL MED-JMM, V83, P468, DOI 10.1007/s00109-005-0635-7; Picard B, 2011, ELECTROPHORESIS, V32, P1804, DOI 10.1002/elps.201100118; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Sanger JW, 2009, CELL MOTIL CYTOSKEL, V66, P556, DOI 10.1002/cm.20365; Snapp Erik L, 2003, Curr Protoc Cell Biol, VChapter 21, DOI 10.1002/0471143030.cb2101s19; Steinmetz MO, 2007, P NATL ACAD SCI USA, V104, P7062, DOI 10.1073/pnas.0700321104; Taylor MRG, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-27; Van der Ven PFM, 1999, J MUSCLE RES CELL M, V20, P569, DOI 10.1023/A:1005569225773; Van Driest SL, 2004, J AM COLL CARDIOL, V44, P602, DOI 10.1016/j.jacc.2004.04.039; Vandenboom R, 2011, AM J PHYSIOL-HEART C, V300, pH574, DOI 10.1152/ajpheart.00786.2009; Waldmuller S, 2002, HUM MUTAT, V19, P560, DOI 10.1002/humu.10074; Wang Q, 2003, J CELL SCI, V116, P4227, DOI 10.1242/jcs.00709; WENDEROTH MP, 1987, J CELL BIOL, V105, P2771, DOI 10.1083/jcb.105.6.2771; Willis MS, 2013, NEW ENGL J MED, V368, P455, DOI 10.1056/NEJMra1106180; Xu Q, 2010, J MOL CELL CARDIOL, V48, P899, DOI 10.1016/j.yjmcc.2010.03.005	53	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31952	31962		10.1074/jbc.M113.513291	http://dx.doi.org/10.1074/jbc.M113.513291			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24047955	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000330596200047
J	Muromoto, R; Nakajima, M; Hirashima, K; Hirao, T; Kon, S; Shimoda, K; Oritani, K; Matsuda, T				Muromoto, Ryuta; Nakajima, Maiko; Hirashima, Koki; Hirao, Toru; Kon, Shigeyuki; Shimoda, Kazuya; Oritani, Kenji; Matsuda, Tadashi			Jun Activation Domain-binding Protein 1 (JAB1) Is Required for the Optimal Response to Interferons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULLIN UBIQUITIN LIGASES; COP9 SIGNALOSOME CSN; KAPPA-B-ALPHA; NEDD8-ACTIVATING ENZYME; FUNCTIONAL INTERACTIONS; NEDD8 MODIFICATION; DOWN-REGULATION; RECEPTOR; MOTIF; CELLS	Degradation of IFN receptor (IFNR) protein is one of the mechanisms to limit the extent of cellular responses to interferons. Tyrosine kinase 2 (TYK2), a JAK family kinase, has been reported to bind to and stabilize IFNR, indicating that TYK2 is a fundamental component of IFNR complex. Herein, we identified Jun activation domain-binding protein 1 (JAB1) as a new TYK2 binding partner and investigated its role in the regulation of IFN responses. siRNA knockdown of JAB1 resulted in suppression of IFN-induced phosphorylation of STAT proteins and their transcriptional activation. Importantly, JAB1 knockdown induced the activation of SCF ubiquitin ligase complex containing Cullin 1 (CUL1), as judged by the enhancement of covalent modification of CUL1 with the ubiquitin-like protein NEDD8, and markedly reduced the basal protein level of IFNR. In contrast, NEDD8 knockdown or inhibition of NEDD8 modification by NEDD8-activating enzyme inhibitor resulted in increased IFNR protein concomitantly with a reduction of NEDD8-modified CUL1. Furthermore, NEDD8-activating enzyme inhibitor treatment enhanced the susceptibility to IFN-alpha in HeLa cells. These data suggest that the NEDD8 modification pathway is involved in the proteolysis of IFNR and that JAB1 acts as a positive regulator of IFN responses by stabilizing IFNR through antagonizing the NEDD8 pathway.	[Muromoto, Ryuta; Nakajima, Maiko; Hirashima, Koki; Hirao, Toru; Kon, Shigeyuki; Matsuda, Tadashi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Immunol, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Shimoda, Kazuya] Miyazaki Univ, Fac Med, Dept Gastroenterol & Hematol, Miyazaki 8891692, Japan; [Oritani, Kenji] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Osaka 5650871, Japan	Hokkaido University; University of Miyazaki; Osaka University	Matsuda, T (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Immunol, Kita Ku, Kita 12 Nishi 6, Sapporo, Hokkaido 0600812, Japan.	tmatsuda@pharm.hokudai.ac.jp	Matsuda, Tadashi/A-3835-2012; Muromoto, Ryuta/E-4203-2012	Matsuda, Tadashi/0000-0002-3089-3757; Muromoto, Ryuta/0000-0002-7474-493X	Japan Society for the Promotion of Science; Northern Advancement Center for Science and Technology by the Takeda Science Foundation; Uehara Memorial Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Northern Advancement Center for Science and Technology by the Takeda Science Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported in part by Grant-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science, by the Northern Advancement Center for Science and Technology by the Takeda Science Foundation and by the Uehara Memorial Foundation.	Ahmed CM, 2013, J NEUROIMMUNOL, V254, P101, DOI 10.1016/j.jneuroim.2012.10.006; Bhattacharya S, 2010, J BIOL CHEM, V285, P2318, DOI 10.1074/jbc.M109.071498; Blank JL, 2013, CANCER RES, V73, P225, DOI 10.1158/0008-5472.CAN-12-1729; Bush KT, 1997, J BIOL CHEM, V272, P9086; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; CONSTANTINESCU SN, 1994, P NATL ACAD SCI USA, V91, P9602, DOI 10.1073/pnas.91.20.9602; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Denti S, 2006, J BIOL CHEM, V281, P32188, DOI 10.1074/jbc.M604746200; Furukawa M, 2000, MOL CELL BIOL, V20, P8185, DOI 10.1128/MCB.20.21.8185-8197.2000; Gauzzi MC, 1997, P NATL ACAD SCI USA, V94, P11839, DOI 10.1073/pnas.94.22.11839; Haro T, 2004, J IMMUNOL, V173, P1151, DOI 10.4049/jimmunol.173.2.1151; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kumar KGS, 2008, J BIOL CHEM, V283, P18566, DOI 10.1074/jbc.M800991200; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Kumar KGS, 2003, EMBO J, V22, P5480; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Lin JJ, 2010, CANCER RES, V70, P10310, DOI 10.1158/0008-5472.CAN-10-2062; Liu J, 2008, BIOCHEM BIOPH RES CO, V367, P388, DOI 10.1016/j.bbrc.2007.12.137; Liu JH, 2009, CELL HOST MICROBE, V5, P72, DOI 10.1016/j.chom.2008.11.008; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Menon S, 2007, NAT IMMUNOL, V8, P1236, DOI 10.1038/ni1514; Milhollen MA, 2011, CANCER RES, V71, P3042, DOI 10.1158/0008-5472.CAN-10-2122; Minakshi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008342; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Morimoto M, 2003, BIOCHEM BIOPH RES CO, V301, P392, DOI 10.1016/S0006-291X(02)03051-6; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Muromoto R, 2006, FEBS LETT, V580, P93, DOI 10.1016/j.febslet.2005.11.057; Muromoto R, 2004, J IMMUNOL, V172, P2985, DOI 10.4049/jimmunol.172.5.2985; Muromoto R, 2006, J IMMUNOL, V177, P1160, DOI 10.4049/jimmunol.177.2.1160; Pearce C, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-31; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Ragimbeau J, 2001, J BIOL CHEM, V276, P30812, DOI 10.1074/jbc.M103559200; Ragimbeau J, 2003, EMBO J, V22, P537, DOI 10.1093/emboj/cdg038; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Schwechheimer C, 2004, BBA-MOL CELL RES, V1695, P45, DOI 10.1016/j.bbamcr.2004.09.023; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Schweitzer K, 2007, EMBO J, V26, P1532, DOI 10.1038/sj.emboj.7601600; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; Soucy TA, 2009, CLIN CANCER RES, V15, P3912, DOI 10.1158/1078-0432.CCR-09-0343; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Welteke V, 2009, EMBO REP, V10, P642, DOI 10.1038/embor.2009.64; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wolf DA, 2003, NAT CELL BIOL, V5, P1029, DOI 10.1038/ncb1203-1029; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Yamakami M, 2003, J BIOL CHEM, V278, P52865, DOI 10.1074/jbc.M306740200	54	6	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					30969	30979		10.1074/jbc.M113.485847	http://dx.doi.org/10.1074/jbc.M113.485847			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24043623	Green Published, hybrid			2022-12-25	WOS:000330778900016
J	Saito, MM; Imoto, S; Yamaguchi, R; Tsubokura, M; Kami, M; Nakada, H; Sato, H; Miyano, S; Higuchi, T				Saito, Masaya M.; Imoto, Seiya; Yamaguchi, Rui; Tsubokura, Masaharu; Kami, Masahiro; Nakada, Haruka; Sato, Hiroki; Miyano, Satoru; Higuchi, Tomoyuki			Enhancement of Collective Immunity in Tokyo Metropolitan Area by Selective Vaccination against an Emerging Influenza Pandemic	PLOS ONE			English	Article							STRATEGIES	Vaccination is a preventive measure against influenza that does not require placing restrictions on social activities. However, since the stockpile of vaccine that can be prepared before the arrival of an emerging pandemic strain is generally quite limited, one has to select priority target groups to which the first stockpile is distributed. In this paper, we study a simulation-based priority target selection method with the goal of enhancing the collective immunity of the whole population. To model the region in which the disease spreads, we consider an urban area composed of suburbs and central areas connected by a single commuter train line. Human activity is modelled following an agent-based approach. The degree to which collective immunity is enhanced is judged by the attack rate in unvaccinated people. The simulation results show that if students and office workers are given exclusive priority in the first three months, the attack rate can be reduced from 30% in the baseline case down to 1-2%. In contrast, random vaccination only slightly reduces the attack rate. It should be noted that giving preference to active social groups does not mean sacrificing those at high risk, which corresponds to the elderly in our simulation model. Compared with the random administration of vaccine to all social groups, this design successfully reduces the attack rate across all age groups.	[Saito, Masaya M.; Higuchi, Tomoyuki] Inst Stat Math, Tachikawa, Tokyo, Japan; [Imoto, Seiya; Yamaguchi, Rui; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Minato Ku, Tokyo, Japan; [Tsubokura, Masaharu; Kami, Masahiro; Nakada, Haruka] Univ Tokyo, Inst Med Sci, Div Social Commun Syst Adv Clin Res, Minato Ku, Tokyo, Japan; [Sato, Hiroki] Natl Def Med Coll, Dept Prevent Med & Publ Hlth, Tokorozawa, Saitama 359, Japan	Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan; University of Tokyo; University of Tokyo; National Defense Medical College - Japan	Saito, MM (corresponding author), Inst Stat Math, Tachikawa, Tokyo, Japan.	saitohm@ism.ac.jp	Tsubokura, Masaharu/AAV-4364-2021; Tsubokura, Masaharu/D-7300-2017	Tsubokura, Masaharu/0000-0001-8027-202X; Tsubokura, Masaharu/0000-0001-8027-202X; Sato, Hiroki/0000-0002-6061-1511; Nakada, Haruka/0000-0003-1856-4640; Miyano, Satoru/0000-0002-1753-6616	Grants-in-Aid for Scientific Research [23650143] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Cooley P, 2011, J URBAN HEALTH, V88, P982, DOI 10.1007/s11524-011-9603-4; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DICK EC, 1987, J INFECT DIS, V156, P442, DOI 10.1093/infdis/156.3.442; DUGUID JP, 1946, J HYG-CAMBRIDGE, V44, P471, DOI 10.1017/S0022172400019288; FEIGIN RD, 1982, NEW ENGL J MED, V307, P1255, DOI 10.1056/NEJM198211113072007; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Inaida S, 2011, JPN J INFECT DIS, V64, P473; Jefferson T, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004879.pub3; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub3; Jefferson Tom, 2010, COCHRANE DB SYST REV, V2010, P7; Kerkhove MDV, 2011, PLOS MED, P8; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Ministry of Health Labour and Welfare Japan, 2012, STUD COMM REP DISTR; Ministry of Health Labour and Welfare Japan, 2009, CURR STAND VACC SCHE; Ministry of Health Labour and Welfare Japan, 2010, STUD COMM ADV REACT; Sato H, 2010, EUROSURVEILLANCE, P15; Sha Li, 2011, Zhonghua Er Ke Za Zhi, V49, P539; Siegel JD, 2007, 2007 GUIDELINE ISOLA; Tokyo metropolitan government, 2008, TOK STAT YB; Weinberg GA, 2010, J INFECT DIS, V201, P1607, DOI 10.1086/652404; World Health Organization, 2011, GLOB AL RESP GAR	24	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e72866	10.1371/journal.pone.0072866	http://dx.doi.org/10.1371/journal.pone.0072866			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058445	Green Published, Green Submitted, gold			2022-12-25	WOS:000324695900003
J	Wulff, AS; Hollingsworth, PM; Ahrends, A; Jaffre, T; Veillon, JM; L'Huillier, L; Fogliani, B				Wulff, Adrien S.; Hollingsworth, Peter M.; Ahrends, Antje; Jaffre, Tanguy; Veillon, Jean-Marie; L'Huillier, Laurent; Fogliani, Bruno			Conservation Priorities in a Biodiversity Hotspot: Analysis of Narrow Endemic Plant Species in New Caledonia	PLOS ONE			English	Article							IUCN RED LIST; CUNONIACEAE; MAQUIS; PATTERNS; CRITERIA; RARITY; SOILS; FLORA; GENUS	New Caledonia is a global biodiversity hotspot facing extreme environmental degradation. Given the urgent need for conservation prioritisation, we have made a first-pass quantitative assessment of the distribution of Narrow Endemic Species (NES) in the flora to identify species and sites that are potentially important for conservation action. We assessed the distributional status of all angiosperm and gymnosperm species using data from taxonomic descriptions and herbarium samples. We characterised species as being NES if they occurred in 3 or fewer locations. In total, 635 of the 2930 assessed species were classed as NES, of which only 150 have been subjected to the IUCN conservation assessment. As the distributional patterns of un-assessed species from one or two locations correspond well with assessed species which have been classified as Critically Endangered or Endangered respectively, we suggest that our distributional data can be used to prioritise species for IUCN assessment. We also used the distributional data to produce a map of "Hotspots of Plant Narrow Endemism'' (HPNE). Combined, we used these data to evaluate the coincidence of NES with mining activities (a major source of threat on New Caledonia) and also areas of conservation protection. This is to identify species and locations in most urgent need of further conservation assessment and subsequent action. Finally, we grouped the NES based on the environments they occurred in and modelled the habitat distribution of these groups with a Maximum Entropy Species Distribution Model (MaxEnt). The NES were separable into three different groups based primarily on geological differences. The distribution of the habitat types for each group coincide partially with the HPNE described above and also indicates some areas which have high habitat suitability but few recorded NES. Some of these areas may represent under-sampled hotspots of narrow endemism and are priorities for further field work.	[Wulff, Adrien S.] Univ Nouvelle Caledonie, Lab Insulaire Vivant & Environm LIVE EA 4243, Noumea, New Caledonia; [Wulff, Adrien S.; L'Huillier, Laurent; Fogliani, Bruno] Inst Agron Neo Caledonien IAC, Paita, New Caledonia; [Hollingsworth, Peter M.; Ahrends, Antje] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland; [Jaffre, Tanguy; Veillon, Jean-Marie] Inst Rech Dev, UMR AMAP, Herbarium NOU, Lab Bot & Ecol Vegetale Appl, Noumea, New Caledonia	Universite Nouvelle Caledonie; Institut de Recherche pour le Developpement (IRD)	Wulff, AS (corresponding author), Univ Nouvelle Caledonie, Lab Insulaire Vivant & Environm LIVE EA 4243, Noumea, New Caledonia.	wulff@iac.nc		Hollingsworth, Peter/0000-0003-0602-0654; FOGLIANI, Bruno/0000-0003-2178-1689	Government of New Caledonia; Agronomic Institute of New Caledonia	Government of New Caledonia; Agronomic Institute of New Caledonia	The authors are grateful to the Government of New Caledonia (www.gouv.nc) and the Agronomic Institute of New Caledonia (www.iac.nc) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrends A, 2011, BIOL CONSERV, V144, P131, DOI 10.1016/j.biocon.2010.08.008; Anacker BL, 2011, SERPENTINE: THE EVOLUTION AND ECOLOGY OF A MODEL SYSTEM, P49; Barrabe L, 2011, ADANSONIA, V33, P135, DOI 10.5252/a2011n1a9; Benichou P., 1987, METEOROLOGIE, V7, P23; BOUCHET P, 1995, BIODIVERS CONSERV, V4, P415, DOI 10.1007/BF00058425; Bradford J, 2004, BIODIVERS CONSERV, V13, P2253, DOI 10.1023/B:BIOC.0000047901.33761.3c; Callmander MW, 2005, TAXON, V54, P1047, DOI 10.2307/25065491; Crain BJ, 2011, BIODIVERS CONSERV, V20, P3489, DOI 10.1007/s10531-011-0137-6; Dhar U, 2002, CURR SCI INDIA, V82, P141; DTSI (Direction des Technologies et Services de l'Information)/SGT/DIMENC/SGNC, 2006, CART SURF DEGR ACT M; Dudley N., 2008, GUIDELINES APPL PROT, DOI [10.2305/IUCN.CH.2008.PAPS.2.en, DOI 10.2305/IUCN.CH.2008.PAPS.2.EN]; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Gargominy O, 1996, REV ECOL-TERRE VIE, V51, P375; Gouvernement de la Nouvelle-Caledonie, 2011, RES NAT NOUV CAL; GRASS Development Team, 2011, GEOGR RES AN SUPP SY; Grosjean P, 2011, AURELHY R PACKAGE IM; Henning C, 2010, FPC FLEXIBLE PROCEDU; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; IUCN Standards and Petitions Subcommittee, 2011, GUID US IUCN RED LIS; Jaffre T, 1996, COLLOQ SEMI, P137; Jaffre T, 1998, BIODIVERS CONSERV, V7, P109, DOI 10.1023/A:1008815930865; JAFFRE T, 1987, Bulletin du Museum National d'Histoire Naturelle Section B Adansonia Botanique Phytochimie, V9, P365; JAFFRE T., 1997, ECOLOGIE MILIEUX ROC, P163; Jaffre T., 1994, BOIS FOR TROP, V242, P7; Jaffre T., 1992, PLANTES NOUVELLE CAL; Jaffre T, 2010, BIODIVERS CONSERV, V19, P1485, DOI 10.1007/s10531-010-9780-6; Jaffru T., 1993, BIODIVERSITY LETT, V1, P82, DOI DOI 10.2307/2999751; Jarvis A, 2008, HOLE FILLED SRTM GLO; KINDT R, 2011, FOREST LANDSCAPE WOR, V5; KRUCKEBERG AR, 1985, ANNU REV ECOL SYST, V16, P447, DOI 10.1146/annurev.es.16.110185.002311; Kumar S., 2009, J ECOLOGY NATURAL EN, V1, P94, DOI 10.5897/ JENE.9000071; Legendre P., 2015, COMMUNITY ECOLOGY PA; LHuillier L., 2010, MINES ENV NOUVELLE C, P21; LHuillier L., 2010, MINES ENV NOUVELLE C, P147; Maechler M., 2011, CLUSTER CLUSTER ANAL; Maurizot P, 2005, HARMONISATION COUVER; McCoy S, 1999, J BIOGEOGR, V26, P579, DOI 10.1046/j.1365-2699.1999.00309.x; McPherson G, 2004, ANN MO BOT GARD, V91, P260; MEYER JY, 2006, ESPECES ENVAHISSANTE, P50, DOI DOI 10.4000/BOOKS.IRDEDITIONS.7658; MITASOVA H, 1993, MATH GEOL, V25, P641, DOI 10.1007/BF00893171; Morat P, 1999, B SOC BOT SUD OUEST, V19, P129; Morat P, 2012, ADANSONIA, V34, P179, DOI 10.5252/a2012n2a1; Mulligan M, 2006, GLOBAL GRIDDED 1 KM; Munzinger J, 2008, BOT J LINN SOC, V157, P775, DOI 10.1111/j.1095-8339.2008.00804.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers N, 1988, Environmentalist, V8, P187, DOI 10.1007/BF02240252; Pascal M, 2008, CONSERV BIOL, V22, P498, DOI 10.1111/j.1523-1739.2008.00889.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pillon Y, 2010, J ECOL, V98, P1108, DOI 10.1111/j.1365-2745.2010.01689.x; Pillon Yohan, 2008, Kew Bulletin, V63, P419, DOI 10.1007/s12225-008-9045-7; Pillon Y, 2009, ADANSONIA, V31, P191, DOI 10.5252/a2009n1a13; Pintaud JC, 2001, CR ACAD SCI III-VIE, V324, P453, DOI 10.1016/S0764-4469(01)01312-9; Pitman NCA, 2002, SCIENCE, V298, P989, DOI 10.1126/science.298.5595.989; Province Nord, 2008, COD ENV PROV NORD; Province Sud, 2009, COD ENV PROV SUD; R Core Team, 2016, R FDN STAT COMP; Robbirt KM, 2006, BIODIVERS CONSERV, V15, P1903, DOI 10.1007/s10531-005-4307-2; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Saerkinen Tiina, 2011, BMC Ecology, V11, P27, DOI 10.1186/1472-6785-11-27; Tribsch A, 2003, TAXON, V52, P477, DOI 10.2307/3647447; Venter S, 2007, NEW ZEAL J BOT, V45, P503	63	75	77	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73371	10.1371/journal.pone.0073371	http://dx.doi.org/10.1371/journal.pone.0073371			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058470	Green Submitted, gold, Green Published			2022-12-25	WOS:000324695900012
J	Moraga, AR; Ahrazem, O; Rambla, JL; Granell, A; Gomez, LG				Rubio Moraga, Angela; Ahrazem, Oussama; Luis Rambla, Jose; Granell, Antonio; Gomez Gomez, Lourdes			Crocins with High Levels of Sugar Conjugation Contribute to the Yellow Colours of Early-Spring Flowering Crocus Tepals	PLOS ONE			English	Article							CAROTENOID CLEAVAGE DIOXYGENASE; ARBUSCULAR MYCORRHIZAL FUNGI; C-27 APOCAROTENOIDS; GENE-EXPRESSION; IN-VITRO; SATIVUS; SAFFRON; ACCUMULATION; CROCETIN; GLUCOSYLTRANSFERASE	Crocus sativus is the source of saffron spice, the processed stigma which accumulates glucosylated apocarotenoids known as crocins. Crocins are found in the stigmas of other Crocuses, determining the colourations observed from pale yellow to dark red. By contrast, tepals in Crocus species display a wider diversity of colours which range from purple, blue, yellow to white. In this study, we investigated whether the contribution of crocins to colour extends from stigmas to the tepals of yellow Crocus species. Tepals from seven species were analysed by UPLC-PDA and ESI-Q-TOF-MS/MS revealing for the first time the presence of highly glucosylated crocins in this tissue. beta-carotene was found to be the precursor of these crocins and some of them were found to contain rhamnose, never before reported. When crocin profiles from tepals were compared with those from stigmas, clear differences were found, including the presence of new apocarotenoids in stigmas. Furthermore, each species showed a characteristic profile which was not correlated with the phylogenetic relationship among species. While gene expression analysis in tepals of genes involved in carotenoid metabolism showed that phytoene synthase was a key enzyme in apocarotenoid biosynthesis in tepals. Expression of a crocetin glucosyltransferase, previously identified in saffron, was detected in all the samples. The presence of crocins in tepals is compatible with the role of chromophores to attract pollinators. The identification of tepals as new sources of crocins is of special interest given their wide range of applications in medicine, cosmetics and colouring industries.	[Rubio Moraga, Angela; Gomez Gomez, Lourdes] Univ Castilla La Mancha, Fac Farm, Albacete, Spain; [Rubio Moraga, Angela; Ahrazem, Oussama; Gomez Gomez, Lourdes] Univ Castilla La Mancha, Inst Bot, Albacete, Spain; [Ahrazem, Oussama] Fdn Parque Cient & Tecnol Castilla La Mancha, Albacete, Spain; [Luis Rambla, Jose; Granell, Antonio] Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, Consejo Super Invest Cient, E-46071 Valencia, Spain	Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Gomez, LG (corresponding author), Univ Castilla La Mancha, Fac Farm, Campus Univ S-N, Albacete, Spain.	marialourdes.gomez@uclm.es	Gomez-Gomez, Lourdes/AAF-2371-2020; Granell, Antonio/G-3664-2010; Ahrazem, oussama/AAV-1392-2021; Rambla, José L./B-5881-2011; Ahrazem, Oussama/E-5602-2016	Gomez-Gomez, Lourdes/0000-0003-2586-4457; Ahrazem, oussama/0000-0001-9183-9319; Rambla, José L./0000-0003-4704-2534; Ahrazem, Oussama/0000-0001-9183-9319; Rubio-Moraga, Angela/0000-0002-2162-2314	Spanish Ministerio de Ciencia e Innovacion [BIO2009-07803]; FPCYTA through the INCRECYT Programme	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FPCYTA through the INCRECYT Programme	The laboratory is supported by the Spanish Ministerio de Ciencia e Innovacion (BIO2009-07803) and participates in the IBERCAROT network (112RT0445). Dr. Ahrazem was funded by FPCYTA through the INCRECYT Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev FI, 2004, CANCER DETECT PREV, V28, P426, DOI 10.1016/j.cdp.2004.09.002; Ahrazem O, 2012, J EXP BOT, V63, P681, DOI 10.1093/jxb/err293; Ahrazem O, 2010, J EXP BOT, V61, P105, DOI 10.1093/jxb/erp283; Akiyama K, 2007, BIOSCI BIOTECH BIOCH, V71, P1405, DOI 10.1271/bbb.70023; Almeida ERA, 2008, CURR GENET, V53, P129, DOI 10.1007/s00294-007-0170-x; Auldridge ME, 2006, CURR OPIN PLANT BIOL, V9, P315, DOI 10.1016/j.pbi.2006.03.005; Bathaie SZ, 2010, CRIT REV FOOD SCI NU, V50, P25; Brandi F, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-24; Campbell R, 2010, PLANT PHYSIOL, V154, P656, DOI 10.1104/pp.110.158733; Castillo R, 2005, PLANT PHYSIOL, V139, P674, DOI 10.1104/pp.105.067827; Cooper CM, 2009, J AGR FOOD CHEM, V57, P1513, DOI 10.1021/jf802610p; Cooper CM, 2003, J AGR FOOD CHEM, V51, P2384, DOI 10.1021/jf026007c; Dufresne C, 1997, PLANTA MED, V63, P150, DOI 10.1055/s-2006-957633; Dufresne C, 1999, ENZYME MICROBIAL TEC, V24, P9; Feizzadeh Behzad, 2008, Urol J, V5, P161; Fester T, 2002, PLANTA, V216, P148, DOI 10.1007/s00425-002-0917-z; Floss DS, 2008, PLANT PHYSIOL, V148, P1267, DOI 10.1104/pp.108.125062; G?mez-G?mez L., 2010, FUNC PLANT SCI BIOTE, V4, P56; Giaccio M, 2004, CRIT REV FOOD SCI, V44, P155, DOI 10.1080/10408690490441433; Gomez-Miranda B, 1981, CURRENT MICROBIOLOGY, V6, P3; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Harpke D, 2013, MOL PHYLOGENET EVOL, V66, P617, DOI 10.1016/j.ympev.2012.10.007; Hosseinzadeh H, 2013, PHYTOTHER RES, V27, P475, DOI 10.1002/ptr.4784; Howes MJR, 2011, DRUG AGING, V28, P439, DOI 10.2165/11591310-000000000-00000; Ilg A, 2010, PLANTA, V232, P691, DOI 10.1007/s00425-010-1205-y; Jacobsen N, 1997, NEW PLANTSMAN, V4, P32; Jella P, 1998, J AGR FOOD CHEM, V46, P242, DOI 10.1021/jf9702149; Kachanovsky DE, 2012, P NATL ACAD SCI USA, V109, P19021, DOI 10.1073/pnas.1214808109; Karrer P, 1929, HELV CHIM ACTA, V12, P2; Kishimoto S, 2005, BIOSCI BIOTECH BIOCH, V69, P2122, DOI 10.1271/bbb.69.2122; KLINGNER A, 1995, PHYTOCHEMISTRY, V38, P53, DOI 10.1016/0031-9422(94)00538-5; Laine RA, 1972, GAS LIQUID CHROMATOG, V28, P8; Lendzemo VW, 2007, PLANT SIGNAL BEHAV, V2, P58, DOI 10.4161/psb.2.1.3884; Lu S, 2006, PLANT CELL, V18, P3594, DOI 10.1105/tpc.106.046417; Lundmark M, 2009, J EXP BOT, V60, P2203, DOI 10.1093/jxb/erp103; Mathew B, 1982, CROCUSES REVISION GE; Moraga A, 2004, PLANTA, V219, P955, DOI 10.1007/s00425-004-1299-1; Norbaek R, 2002, PHYTOCHEMISTRY, V60, P357, DOI 10.1016/S0031-9422(02)00055-9; Ochiai T, 2007, BBA-GEN SUBJECTS, V1770, P578, DOI 10.1016/j.bbagen.2006.11.012; Ohmiya A, 2011, JAPAN AGR RES Q, V45, P8; Ohmiya A, 2009, J JAPAN SOC HORT SCI, V78, P6; Ohmiya A, 2006, PLANT PHYSIOL, V142, P1193, DOI 10.1104/pp.106.087130; Ootani S, 1982, RES I EVOLUT BIOL SC, V1, P6; Pfander H, 1982, PHYTOCHEMISTRY, V21, P4; Pfister S, 1996, J AGR FOOD CHEM, V44, P2612, DOI 10.1021/jf950713e; Pfrander H, 1976, PURE APPL CHEM, V47, P7; Rubio A, 2008, J BIOL CHEM, V283, P24816, DOI 10.1074/jbc.M804000200; Moraga AR, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-109; Moraga AR, 2009, PHYTOCHEMISTRY, V70, P1009, DOI 10.1016/j.phytochem.2009.04.022; Rubio-Moraga A, 2010, PHYTOCHEMISTRY, V71, P1506, DOI 10.1016/j.phytochem.2010.05.026; Rychener M, 1984, HELV CHIM ACTA, V67, P5; Schliemann W, 2006, PHYTOCHEMISTRY, V67, P1196, DOI 10.1016/j.phytochem.2006.05.005; Schmidt M, 2007, WIEN MED WOCHENSCHR, V157, P315, DOI 10.1007/s10354-007-0428-4; Schwartz SH, 2001, J BIOL CHEM, V276, P25208, DOI 10.1074/jbc.M102146200; TARANTILIS PA, 1995, J CHROMATOGR A, V699, P107, DOI 10.1016/0021-9673(95)00044-N; Trapero-Mozos A, 2012, PLANT PHYSL; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Van Uden W, 1992, PLANTA MED S, V1, P2; Wakelin AM, 2003, INT J PLANT SCI, V164, P867, DOI 10.1086/378825; Walter MH, 2000, PLANT J, V21, P571, DOI 10.1046/j.1365-313x.2000.00708.x; Walter MH, 2011, NAT PROD REP; Walter MH, 2010, PLANTA, V232, P1, DOI 10.1007/s00425-010-1156-3; YOKOYAMA H, 1966, PHYTOCHEMISTRY, V5, P1159, DOI 10.1016/S0031-9422(00)86110-5; Zhang Z, 2013, PHARM BIOL; Zhu CF, 2010, ARCH BIOCHEM BIOPHYS, V504, P132, DOI 10.1016/j.abb.2010.07.028	65	23	23	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e71946	10.1371/journal.pone.0071946	http://dx.doi.org/10.1371/journal.pone.0071946			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058441	Green Published, Green Submitted, gold			2022-12-25	WOS:000324408400003
J	Djukic, TI; Savic-Radojevic, AR; Pekmezovic, TD; Matic, MG; Pljesa-Ercegovac, MS; Coric, VM; Radic, TM; Suvakov, SR; Krivic, BN; Dragicevic, DP; Simic, TP				Djukic, Tatjana I.; Savic-Radojevic, Ana R.; Pekmezovic, Tatjana D.; Matic, Marija G.; Pljesa-Ercegovac, Marija S.; Coric, Vesna M.; Radic, Tanja M.; Suvakov, Sonja R.; Krivic, Biljana N.; Dragicevic, Dejan P.; Simic, Tatjana P.			Glutathione S-Transferase T1, O1 and O2 Polymorphisms Are Associated with Survival in Muscle Invasive Bladder Cancer Patients	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; URINARY-BLADDER; BREAST-CANCER; EXPRESSION; GENE; M1; P1; TUMORS; DAMAGE; GSTT1	Objective: To examine the association of six glutathione transferase (GST) gene polymorphisms (GSTT1, GSTP1/rs1695, GSTO1/rs4925, GSTO2/rs156697, GSTM1, GSTA1/rs3957357) with the survival of patients with muscle invasive bladder cancer and the genotype modifying effect on chemotherapy. Patients and Methods: A total of 105 patients with muscle invasive bladder cancer were included in the study. The follow-up lasted 5 years. The effect of GSTs polymorphisms on predicting mortality was analyzed by the Cox proportional hazard models, while Kaplan-Meier analysis was performed to assess differences in survival. Results: GSTT1 active, GSTO1 Asp140Asp or GSTO2 Asp142Asp genotypes were independent predictors of a higher risk of death among bladder cancer patients (HR = 2.5, P = 0.028; HR = 2.9, P = 0.022; HR = 3.9, P = 0.001; respectively) and significantly influenced the overall survival. There was no association between GSTP1, GSTM1 and GSTA1 gene variants with overall mortality. Only GSTO2 polymorphism showed a significant effect on the survival in the subgroup of patients who received chemotherapy (P = 0.006). Conclusion: GSTT1 active genotype and GSTO1 Asp140Asp and GSTO2 Asp142Asp genotypes may have a prognostic/pharmacogenomic role in patients with muscle invasive bladder cancer.	[Djukic, Tatjana I.; Savic-Radojevic, Ana R.; Matic, Marija G.; Pljesa-Ercegovac, Marija S.; Coric, Vesna M.; Radic, Tanja M.; Suvakov, Sonja R.; Simic, Tatjana P.] Univ Belgrade, Fac Med, Inst Med & Clin Biochem, Belgrade, Serbia; [Pekmezovic, Tatjana D.] Univ Belgrade, Fac Med, Inst Epidemiol, Belgrade, Serbia; [Krivic, Biljana N.] Clin Ctr Serbia, Urol Clin, Belgrade, Serbia; [Dragicevic, Dejan P.] Univ Belgrade, Fac Med, Clin Ctr Serbia, Urol Clin, Belgrade, Serbia	University of Belgrade; University of Belgrade; Clinical Centre of Serbia; Clinical Centre of Serbia; University of Belgrade	Simic, TP (corresponding author), Univ Belgrade, Fac Med, Inst Med & Clin Biochem, Belgrade, Serbia.	tatjanasimic@med.bg.ac.rs	Pljesa-Ercegovac, Marija/AFS-8309-2022	Simic, Tatjana/0000-0001-8683-5129; Coric, Vesna/0000-0003-0227-821X; Djukic, Tatjana/0000-0003-1959-5115	Serbian Ministry of Education, Science and Technological Development [175052]	Serbian Ministry of Education, Science and Technological Development	This work was supported by the Serbian Ministry of Education, Science and Technological Development [grant 175052]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-13; Berendsen CL, 1997, UROLOGY, V49, P644, DOI 10.1016/S0090-4295(96)00575-4; Catani MV, 2002, BIOCHEM J, V364, P441, DOI 10.1042/BJ20011713; Chung CJ, 2011, SCI TOTAL ENVIRON, V409, P465, DOI 10.1016/j.scitotenv.2010.10.053; Diedrich A, 2006, HISTOL HISTOPATHOL, V21, P1199, DOI 10.14670/HH-21.1199; Fang J, 2007, J DRUG TARGET, V15, P475, DOI 10.1080/10611860701498286; Ha YS, 2010, DIS MARKERS, V29, P81, DOI [10.3233/DMA-2010-0729, 10.1155/2010/816149]; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Johansson K, 2011, MOL PHARMACEUT, V8, P1698, DOI 10.1021/mp2000692; Lesseur C, 2012, TOXICOL LETT, V210, P100, DOI 10.1016/j.toxlet.2012.01.015; Li Y, 2007, J NUTR, V137, P2171, DOI 10.1093/jn/137.10.2171; Manevich Y, 2013, FREE RADICAL BIO MED, V54, P62, DOI 10.1016/j.freeradbiomed.2012.10.556; Marahatta SB, 2006, CANCER LETT, V236, P276, DOI 10.1016/j.canlet.2005.05.020; Norskov MS, 2011, PHARMACOGENOMICS J, V11, P292, DOI 10.1038/tpj.2010.38; Pljesa-Ercegovac M, 2011, UROL ONCOL-SEMIN ORI, V29, P70, DOI 10.1016/j.urolonc.2008.10.019; Romero A, 2012, ANN ONCOL, V23, P1750, DOI 10.1093/annonc/mdr483; Salinas-Souza C, 2010, PHARMACOGENET GENOM, V20, P507, DOI 10.1097/FPC.0b013e32833caa45; Savic-Radojevic A, 2007, EUR UROL, V52, P470, DOI 10.1016/j.eururo.2007.01.046; Simic T, 2005, UROLOGY, V65, P1035, DOI 10.1016/j.urology.2005.01.005; Simic T, 2009, NAT REV UROL, V6, P281, DOI 10.1038/nrurol.2009.49; Stearns V, 2004, PHARMACOGENOMICS J, V4, P143, DOI 10.1038/sj.tpj.6500242; Stoehlmacher J, 2002, J NATL CANCER I, V94, P936; Suvakov S, 2013, NEPHROL DIAL TRANSPL, V28, P202, DOI 10.1093/ndt/gfs369; Turella P, 2005, CANCER RES, V65, P3751, DOI 10.1158/0008-5472.CAN-04-3903; Valachis A, 2011, INT J MED SCI, V8, P492, DOI 10.7150/ijms.8.492; Whitbread AK, 2005, METHOD ENZYMOL, V401, P78, DOI 10.1016/S0076-6879(05)01005-0	26	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74724	10.1371/journal.pone.0074724	http://dx.doi.org/10.1371/journal.pone.0074724			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040330	Green Published, gold, Green Submitted			2022-12-25	WOS:000326734500118
J	Kanemaki, N; Tchedre, KT; Imayasu, M; Kawarai, S; Sakaguchi, M; Yoshino, A; Itoh, N; Meguro, A; Mizuki, N				Kanemaki, Nobuyuki; Tchedre, Kissaou T.; Imayasu, Masaki; Kawarai, Shinpei; Sakaguchi, Masahiro; Yoshino, Atsushi; Itoh, Norihiko; Meguro, Akira; Mizuki, Nobuhisa			Dogs and Humans Share a Common Susceptibility Gene SRBD1 for Glaucoma Risk	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; GENOME-WIDE ASSOCIATION; CYP1B1 MUTATIONS; ELOVL5; POPULATION; MYOCILIN; BEAGLES; DISEASE; CLONING; CDNA	Glaucoma is a degenerative optic neuropathy that is associated with elevated intraocular pressure. Primary open angle glaucoma is the most common type of glaucoma in canines, and its highest incidence among dog breeds has been reported in Shiba-Inus, followed by Shih-Tzus. These breeds are known to have an abnormal iridocorneal angle and dysplastic prectinate ligament. However, the hereditary and genetic backgrounds of these dogs have not yet been clarified. In this study, we investigated the association between polymorphisms of the glaucoma candidate genes, SRBD1, ELOVL5, and ADAMTS10, and glaucoma in Shiba-Inus and Shih-Tzus. We analyzed 11 polymorphisms in these three genes using direct DNA sequencing. Three SRBD1 SNPs, rs8655283, rs22018514 and rs22018513 were significantly associated with glaucoma in Shiba-Inus, while rs22018513, a synonymous SNP in exon 4, showed the strongest association (P = 0.00039, OR = 3.03). Conditional analysis revealed that rs22018513 could account for most of the association of these SNPs with glaucoma in Shiba-Inus. In Shih-Tzus, only rs9172407 in the SRBD1 intron 1 was significantly associated with glaucoma (P = 0.0014, OR = 5.25). There were no significant associations between the ELOVL5 or ADAMTS10 polymorphisms and glaucoma in Shiba-Inus and Shih-Tzus. The results showed that SRBD1 polymorphisms play an important role in glaucoma pathology in both Shiba-Inus and Shih-Tzus. SRBD1 polymorphisms have also been associated with normal- and high-tension glaucomas in humans. Therefore, SRBD1 may be a common susceptibility gene for glaucoma in humans and dogs. We anticipate that the nucleotide sequencing data from this study can be used in genetic testing to determine for the first time, the genetic status and susceptibility of glaucoma in dogs, with high precision. Moreover, canine glaucoma resulting from SRBD1 polymorphisms could be a useful animal model to study human glaucoma.	[Kanemaki, Nobuyuki] Azabu Univ, Vet Teaching Hosp, Sagamihara, Kanagawa, Japan; [Tchedre, Kissaou T.; Imayasu, Masaki] Menicon Co Ltd, Cent R&D Lab, Kasugai, Aichi, Japan; [Kawarai, Shinpei; Sakaguchi, Masahiro] Azabu Univ, Sch Vet Med, Dept Vet Microbiol, Sagamihara, Kanagawa, Japan; [Yoshino, Atsushi; Itoh, Norihiko; Meguro, Akira; Mizuki, Nobuhisa] Yokohama City Univ, Sch Med, Dept Ophthalmol, Yokohama, Kanagawa 232, Japan	Azabu University; Azabu University; Yokohama City University	Mizuki, N (corresponding author), Yokohama City Univ, Sch Med, Dept Ophthalmol, Yokohama, Kanagawa 232, Japan.	mizunobu@med.yokohama-cu.ac.jp	Ito, Norihiko/ABD-3147-2021; Kawarai, Shinpei/AAA-5122-2019	Kawarai, Shinpei/0000-0002-1654-960X; Kanemaki, Nobuyuki/0000-0002-8736-6720	MEXT	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barragan I, 2005, INT J MOL MED, V16, P1163; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BEDFORD PGC, 1975, J SMALL ANIM PRACT, V16, P217, DOI 10.1111/j.1748-5827.1975.tb05739.x; Bycroft M, 1997, CELL, V88, P235, DOI 10.1016/S0092-8674(00)81844-9; COTTRELL BD, 1988, J SMALL ANIM PRACT, V29, P185, DOI 10.1111/j.1748-5827.1988.tb02276.x; EKLUND EA, 1995, GENE, V155, P231, DOI 10.1016/0378-1119(94)00898-3; Fan BJ, 2005, MOL VIS, V11, P625; GELATT KN, 1977, INVEST OPHTH VIS SCI, V16, P1135; GELATT KN, 1981, AM J VET RES, V42, P1691; Kato K, 2009, MOL VIS, V15, P2470; Kato K, 2007, VET OPHTHALMOL, V10, P53, DOI 10.1111/j.1463-5224.2007.00530.x; Kato K, 2006, J VET MED SCI, V68, P853, DOI 10.1292/jvms.68.853; Kuchtey J, 2013, INVEST OPHTH VIS SCI, V54, P1881, DOI 10.1167/iovs.12-10796; Kuchtey J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001306; Kumar A, 2007, MOL VIS, V13, P667; LOVEKIN LG, 1964, J AM VET MED ASSOC, V145, P1081; Mabuchi F, 2011, INVEST OPHTH VIS SCI, V52, P4626, DOI 10.1167/iovs.11-7382; MARTIN CL, 1978, VET CLIN N AM, V8, P257, DOI 10.1016/S0091-0279(78)50033-6; Meguro A, 2010, OPHTHALMOLOGY, V117, P1331, DOI 10.1016/j.ophtha.2009.12.001; Moon YA, 2009, J LIPID RES, V50, P412, DOI 10.1194/jlr.M800383-JLR200; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Nakano M, 2009, P NATL ACAD SCI USA, V106, P12838, DOI 10.1073/pnas.0906397106; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; QUIGLEY HA, 1993, NEW ENGL J MED, V328, P1097, DOI 10.1056/NEJM199304153281507; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Sitorus R, 2003, J Med Genet, V40, pe9, DOI 10.1136/jmg.40.1.e9; SUBRAMANIAN AR, 1983, PROG NUCLEIC ACID RE, V28, P101, DOI 10.1016/S0079-6603(08)60085-9; Wang D, 2011, PHARMACOGENOMICS J, V11, P274, DOI 10.1038/tpj.2010.28; Yang M, 2009, MOL VIS, V15, P432	29	13	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74372	10.1371/journal.pone.0074372	http://dx.doi.org/10.1371/journal.pone.0074372			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040232	Green Submitted, Green Published, gold			2022-12-25	WOS:000326734500085
J	Khusainov, R; Kuipers, OP				Khusainov, Rustem; Kuipers, Oscar P.			The Presence of Modifiable Residues in the Core Peptide Part of Precursor Nisin Is Not Crucial for Precursor Nisin Interactions with NisB- and NisC	PLOS ONE			English	Article							MODIFICATION ENZYMES NISB; LEADER PEPTIDE; LIPID-II; LANTIBIOTIC NISIN; POSTTRANSLATIONAL MODIFICATION; PORE FORMATION; BIOSYNTHESIS; MECHANISM; PRENISIN; TARGET	Precursor nisin is a model posttranslationally modified precursor lantibiotic that can be structurally divided into a leader peptide sequence and a modifiable core peptide part. The nisin core peptide clearly plays an important role in the precursor nisin - nisin modification enzymes interactions, since it has previously been shown that the construct containing only the nisin leader sequence is not sufficient to pull-down the nisin modification enzymes NisB and NisC. Serines and threonines in the core peptide part are the residues that NisB specifically dehydrates, and cysteines are the residues that NisC stereospecifically couples to the dehydrated amino acids. Here, we demonstrate that increasing the number of negatively charged residues in the core peptide part of precursor nisin, which are absent in wild-type nisin, does not abolish binding of precursor nisin to the modification enzymes NisB and NisC, but dramatically decreases the antimicrobial potency of these nisin mutants. An unnatural precursor nisin variant lacking all serines and threonines in the core peptide part and an unnatural precursor nisin variant lacking all cysteines in the core peptide part still bind the nisin modification enzymes NisB and NisC, suggesting that these residues are not essential for direct interactions with the nisin modification enzymes NisB and NisC. These results are important for lantibiotic engineering studies.	[Khusainov, Rustem; Kuipers, Oscar P.] Univ Groningen, Dept Mol Genet, Groningen, Netherlands; [Kuipers, Oscar P.] Kluyver Ctr Genom Ind Fermentat, Groningen, Netherlands; [Khusainov, Rustem; Kuipers, Oscar P.] Univ Groningen, Synthet Biol Ctr, Groningen, Netherlands	University of Groningen; University of Groningen	Kuipers, OP (corresponding author), Univ Groningen, Dept Mol Genet, Groningen, Netherlands.	o.p.kuipers@rug.nl	Kuipers, Oscar/B-6752-2009	Kuipers, Oscar/0000-0001-5596-7735	Dutch Science Council [ALW: ALW 816.02.005]	Dutch Science Council	Rustem Khusainov received financial support from the Dutch Science Council ALW: ALW 816.02.005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bierbaum G, 1996, APPL ENVIRON MICROB, V62, P385, DOI 10.1128/AEM.62.2.385-392.1996; Breukink E, 1997, BIOCHEMISTRY-US, V36, P6968, DOI 10.1021/bi970008u; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; Chan WC, 1996, FEBS LETT, V390, P129, DOI 10.1016/0014-5793(96)00638-2; Chatterjee C, 2006, CHEM BIOL, V13, P1109, DOI 10.1016/j.chembiol.2006.08.015; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Field D, 2008, MOL MICROBIOL, V69, P218, DOI 10.1111/j.1365-2958.2008.06279.x; Garg N, 2013, P NATL ACAD SCI USA, V110, P7258, DOI 10.1073/pnas.1222488110; Gut IM, 2011, ACS CHEM BIOL, V6, P744, DOI 10.1021/cb1004178; Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818; Hsu ST, 2002, BIOCHEMISTRY-US, V41, P7670, DOI 10.1021/bi025679t; Hsu STD, 2004, NAT STRUCT MOL BIOL, V11, P963, DOI 10.1038/nsmb830; Khusainov R, 2013, FEBS OPEN BIO, V3, P237, DOI 10.1016/j.fob.2013.05.001; Khusainov R, 2012, CHEMBIOCHEM, V13, P2433, DOI 10.1002/cbic.201200437; Khusainov R, 2011, MOL MICROBIOL, V82, P706, DOI 10.1111/j.1365-2958.2011.07846.x; Kluskens LD, 2005, BIOCHEMISTRY-US, V44, P12827, DOI 10.1021/bi050805p; Krawczyk B, 2012, J AM CHEM SOC, V134, P9922, DOI 10.1021/ja3040224; Kuipers A, 2004, J BIOL CHEM, V279, P22176, DOI 10.1074/jbc.M312789200; Kuipers A, 2008, APPL ENVIRON MICROB, V74, P6591, DOI 10.1128/AEM.01334-08; Kuipers OP, 1996, ANTON LEEUW INT J G, V69, P161, DOI 10.1007/BF00399421; Lee MV, 2009, J AM CHEM SOC, V131, P12258, DOI 10.1021/ja9033507; Levengood MR, 2007, J AM CHEM SOC, V129, P10314, DOI 10.1021/ja072967+; Lubelski J, 2008, CELL MOL LIFE SCI, V65, P455, DOI 10.1007/s00018-007-7171-2; Lubelski J, 2009, J BIOL CHEM, V284, P25962, DOI 10.1074/jbc.M109.026690; Majchrzykiewicz JA, 2010, ANTIMICROB AGENTS CH, V54, P1498, DOI 10.1128/AAC.00883-09; Molloy EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058530; Plat A, 2013, CURR PROTEIN PEPT SC, V14, P85, DOI 10.2174/1389203711314020001; Plat A, 2011, APPL ENVIRON MICROB, V77, P604, DOI 10.1128/AEM.01503-10; RAYMAN MK, 1981, APPL ENVIRON MICROB, V41, P375, DOI 10.1128/AEM.41.2.375-380.1981; Rink R, 2005, BIOCHEMISTRY-US, V44, P8873, DOI 10.1021/bi050081h; Rink R, 2007, BIOCHEMISTRY-US, V46, P13179, DOI 10.1021/bi700106z; Rink R, 2007, APPL ENVIRON MICROB, V73, P5809, DOI 10.1128/AEM.01104-07; Sambrook J, 2001, MOL CLONING LAB MANU; Siezen RJ, 1996, ANTON LEEUW INT J G, V69, P171, DOI 10.1007/BF00399422; van Kraaij C, 2000, EUR J BIOCHEM, V267, P901, DOI 10.1046/j.1432-1327.2000.01075.x; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Zhang XG, 2007, J AM CHEM SOC, V129, P2212, DOI 10.1021/ja067672v	37	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74890	10.1371/journal.pone.0074890	http://dx.doi.org/10.1371/journal.pone.0074890			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040355	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300193
J	McAlinden, A; Varghese, N; Wirthlin, L; Chang, LW				McAlinden, Audrey; Varghese, Nobish; Wirthlin, Louisa; Chang, Li-Wei			Differentially Expressed MicroRNAs in Chondrocytes from Distinct Regions of Developing Human Cartilage	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ARTICULAR-CARTILAGE; OSTEOGENIC DIFFERENTIATION; GENE-EXPRESSION; MESSENGER-RNA; GROWTH-PLATE; AMINO PROPEPTIDE; IIA PROCOLLAGEN; SYNOVIAL JOINT; MOUSE LIMB	There is compelling in vivo evidence from reports on human genetic mutations and transgenic mice that some microRNAs (miRNAs) play an important functional role in regulating skeletal development and growth. A number of published in vitro studies also point toward a role for miRNAs in controlling chondrocyte gene expression and differentiation. However, information on miRNAs that may regulate a specific phase of chondrocyte differentiation (i.e. production of progenitor, differentiated or hypertrophic chondrocytes) is lacking. To attempt to bridge this knowledge gap, we have investigated miRNA expression patterns in human embryonic cartilage tissue. Specifically, a developmental time point was selected, prior to endochondral ossification in the embryonic limb, to permit analysis of three distinct populations of chondrocytes. The location of chondroprogenitor cells, differentiated chondrocytes and hypertrophic chondrocytes in gestational day 54-56 human embryonic limb tissue sections was confirmed both histologically and by specific collagen expression patterns. Laser capture microdissection was utilized to separate the three chondrocyte populations and a miRNA profiling study was carried out using TaqMan (R) OpenArray (R) Human MicroRNA Panels (Applied Biosystems (R)). Here we report on abundantly expressed miRNAs in human embryonic cartilage tissue and, more importantly, we have identified miRNAs that are significantly differentially expressed between precursor, differentiated and hypertrophic chondrocytes by 2-fold or more. Some of the miRNAs identified in this study have been described in other aspects of cartilage or bone biology, while others have not yet been reported in chondrocytes. Finally, a bioinformatics approach was applied to begin to decipher developmental cellular pathways that may be regulated by groups of differentially expressed miRNAs during distinct stages of chondrogenesis. Data obtained from this work will serve as an important resource of information for the field of cartilage biology and will enhance our understanding of miRNA-driven mechanisms regulating cartilage and endochondral bone development, regeneration and repair.	[McAlinden, Audrey; Wirthlin, Louisa] Washington Univ, Dept Orthopaed Surg, St Louis, MO 63130 USA; [McAlinden, Audrey] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO USA; [Varghese, Nobish; Chang, Li-Wei] Washington Univ, Dept Pathol & Immunol, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	McAlinden, A (corresponding author), Washington Univ, Dept Orthopaed Surg, St Louis, MO 63130 USA.	mcalindena@wustl.edu		McAlinden, Audrey/0000-0001-8433-4224	Children's Discovery Institute at Washington University; St Louis Children's Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD000836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235] Funding Source: NIH RePORTER	Children's Discovery Institute at Washington University; St Louis Children's Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding for this work was provided by the Children's Discovery Institute at Washington University and St Louis Children's Hospital (to AM) (http://www.childrensdiscovery.org/content/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander S, 2007, ARTHRITIS RHEUM, V56, P3715, DOI 10.1002/art.22953; Ambros V, 2011, CURR OPIN GENET DEV, V21, P511, DOI 10.1016/j.gde.2011.04.003; Asli NS, 2010, DEV BIOL, V344, P857, DOI 10.1016/j.ydbio.2010.06.003; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Becerra J, 2010, TISSUE ENG PART B-RE, V16, P617, DOI [10.1089/ten.teb.2010.0191, 10.1089/ten.TEB.2010.0191]; Carroll AP, 2013, J MOL CELL BIOL, V5, P73, DOI 10.1093/jmcb/mjt004; Chong JJH, 2013, STEM CELLS DEV, V22, P1932, DOI 10.1089/scd.2012.0542; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r127; Coskun E, 2011, LEUKEMIA RES, V35, P208, DOI 10.1016/j.leukres.2010.05.007; Cremer M A, 1988, Int Rev Immunol, V4, P65, DOI 10.3109/08830188809044771; de Faria Omar Jr., 2013, Frontiers in Genetics, V3, P311, DOI 10.3389/fgene.2012.00311; de Pontual L, 2011, NAT GENET, V43, P1026, DOI 10.1038/ng.915; Dews M, 2010, CANCER RES, V70, P8233, DOI 10.1158/0008-5472.CAN-10-2412; Diaz-Prado S, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-144; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Dorn GW, 2011, TRANSL RES, V157, P226, DOI 10.1016/j.trsl.2010.12.013; Dudek KA, 2010, J BIOL CHEM, V285, P24381, DOI 10.1074/jbc.M110.111328; Dunn W, 2009, ARTHRITIS RHEUM-US, V60, P2333, DOI 10.1002/art.24678; Ehlen Harald W. A., 2006, Birth Defects Research, V78, P267, DOI 10.1002/bdrc.20076; Enquobahrie DA, 2011, J MATERN-FETAL NEO M, V24, P1002, DOI 10.3109/14767058.2010.538454; Eskildsen T, 2011, P NATL ACAD SCI USA, V108, P6139, DOI 10.1073/pnas.1016758108; Fabbri M, 2013, CURR MOL MED; Fang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018067; Friedman JM, 2009, SWISS MED WKLY, V139, P466, DOI smw-12794; Friedman LM, 2009, MAMM GENOME, V20, P581, DOI 10.1007/s00335-009-9230-5; Funaba M, 1996, ENDOCRINOLOGY, V137, P4250, DOI 10.1210/en.137.10.4250; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Gibson G, 2013, J ORTHOP RES, V31, P1333, DOI 10.1002/jor.22397; Gkountela S, 2013, NAT CELL BIOL, V15, P113, DOI 10.1038/ncb2638; Grigorenko EV, 2011, METHODS MOL BIOL, V676, P101, DOI 10.1007/978-1-60761-863-8_8; Gu Shuo, 2010, Silence, V1, P11, DOI 10.1186/1758-907X-1-11; Guan YJ, 2011, FASEB J, V25, P4457, DOI 10.1096/fj.11-185132; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He XJ, 2011, DEV BIOL, V357, P463, DOI 10.1016/j.ydbio.2011.07.014; Heras FL, 2012, ORTHOP CLIN N AM, V43, P155, DOI 10.1016/j.ocl.2012.01.003; Hjorten R, 2007, BONE, V41, P535, DOI 10.1016/j.bone.2007.06.024; Hong E, 2013, TISSUE ENG PT A, V19, P1015, DOI [10.1089/ten.tea.2012.0055, 10.1089/ten.TEA.2012.0055]; Hyde G, 2007, DEV BIOL, V304, P825, DOI 10.1016/j.ydbio.2007.01.026; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Iwamoto M, 2007, DEV BIOL, V305, P40, DOI 10.1016/j.ydbio.2007.01.037; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jones SW, 2009, OSTEOARTHR CARTILAGE, V17, P464, DOI 10.1016/j.joca.2008.09.012; Jude JA, 2012, AM J PHYSIOL-LUNG C, V303, pL460, DOI 10.1152/ajplung.00041.2012; Kaluza D, 2013, ARTERIOSCL THROM VAS, V33, P533, DOI 10.1161/ATVBAHA.112.300415; Karlsen TA, 2011, TISSUE ENG PART C-ME, V17, P219, DOI [10.1089/ten.tec.2010.0200, 10.1089/ten.TEC.2010.0200]; Kawasaki H, 2004, NATURE, V431, P211, DOI 10.1038/nature02889; Kim YJ, 2009, J BONE MINER RES, V24, P816, DOI 10.1359/JBMR.081230; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Koyama E, 2008, DEV BIOL, V316, P62, DOI 10.1016/j.ydbio.2008.01.012; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kuhnert F, 2010, BLOOD, V115, P4631, DOI 10.1182/blood-2010-03-276428; Le LTT, 2013, ARTHRITIS RHEUM-US, V65, P1963, DOI 10.1002/art.37990; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Li X, 2011, GENE, V480, P34, DOI 10.1016/j.gene.2011.03.003; Lin L, 2011, J ORTHOP RES, V29, P1578, DOI 10.1002/jor.21423; Liu GQ, 2010, ACTA BIOCH BIOPH SIN, V42, P662, DOI 10.1093/abbs/gmq072; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P705, DOI 10.1002/art.33388; Lorda-Diez CI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024546; Luo W, 2013, J GENET GENOMICS, V40, P107, DOI 10.1016/j.jgg.2013.02.002; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Martinez-Sanchez A, 2012, J BIOL CHEM, V287, P916, DOI 10.1074/jbc.M111.302430; Matkovich SJ, 2011, CIRC RES, V108, P18, DOI 10.1161/CIRCRESAHA.110.233528; McGlinn E, 2009, P NATL ACAD SCI USA, V106, P18610, DOI 10.1073/pnas.0910374106; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Miyaki S, 2012, NAT REV RHEUMATOL, V8, P543, DOI 10.1038/nrrheum.2012.128; Miyaki S, 2010, GENE DEV, V24, P1173, DOI 10.1101/gad.1915510; Nahar MS, 2013, J BIOCHEM MOL TOXIC, V27, P116, DOI 10.1002/jbt.21459; Nakamura Y, 2011, MOL CELL BIOL, V31, P3019, DOI 10.1128/MCB.05178-11; Oganesian A, 1997, J HISTOCHEM CYTOCHEM, V45, P1469, DOI 10.1177/002215549704501104; Pacifici M, 2006, ANN NY ACAD SCI, V1068, P74, DOI 10.1196/annals.1346.010; Pando R, 2012, J NUTR BIOCHEM, V23, P1474, DOI 10.1016/j.jnutbio.2011.09.010; Park CY, 2012, CELL REP, V1, P385, DOI 10.1016/j.celrep.2012.02.008; Poulet B, 2012, ARTHRITIS RHEUM-US, V64, P3256, DOI 10.1002/art.34572; Ross JA, 2010, MOL CARCINOGEN, V49, P320, DOI 10.1002/mc.20620; RYAN MC, 1990, J BIOL CHEM, V265, P10334; SANDELL LJ, 1994, DEV DYNAM, V199, P129, DOI 10.1002/aja.1001990206; Satish L, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-15; Sehm T, 2009, DEV BIOL, V334, P468, DOI 10.1016/j.ydbio.2009.08.008; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Simon D, 2010, HUM MOL GENET, V19, P2015, DOI 10.1093/hmg/ddq083; Staines KA, 2012, CELL BIOCHEM FUNCT, V30, P633, DOI 10.1002/cbf.2852; Steck E, 2012, J MOL MED, V90, P1185, DOI 10.1007/s00109-012-0895-y; Suomi S, 2008, GENE REGUL SYST BIO, V2, P177; Swingler TE, 2012, ARTHRITIS RHEUM-US, V64, P1909, DOI 10.1002/art.34314; Tardif G, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-148; Tome M, 2011, CELL DEATH DIFFER, V18, P985, DOI 10.1038/cdd.2010.167; Tong AW, 2008, CANCER GENE THER, V15, P341, DOI 10.1038/cgt.2008.8; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Yamane S, 2007, TISSUE ENG, V13, P2163, DOI 10.1089/ten.2006.0431; Yamasaki K, 2009, ARTHRITIS RHEUM-US, V60, P1035, DOI 10.1002/art.24404; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021679; Yang L, 2013, DEV BIOL, V380, P99, DOI 10.1016/j.ydbio.2013.04.031; Yang Z, 2011, STEM CELLS DEV, V20, P259, DOI 10.1089/scd.2010.0072; Ye D, 2012, STEM CELLS, V30, P1645, DOI 10.1002/stem.1149; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yin RT, 2013, J VASC RES, V50, P157, DOI 10.1159/000345697; Yu T, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-64; Zhang J, 2011, J BONE MINER RES, V26, P1953, DOI 10.1002/jbmr.377; Zhang ZJ, 2012, J CELL BIOCHEM, V113, P888, DOI 10.1002/jcb.23418; Zhang ZN, 2013, CLIN CHEM, V59, P1175, DOI 10.1373/clinchem.2012.197335; Zhu Y, 1999, J CELL BIOL, V144, P1069, DOI 10.1083/jcb.144.5.1069	107	37	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e75012	10.1371/journal.pone.0075012	http://dx.doi.org/10.1371/journal.pone.0075012			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040378	Green Submitted, Green Published, gold			2022-12-25	WOS:000326405300198
J	Shannahan, JH; Lai, XY; Ke, PC; Podila, R; Brown, JM; Witzmann, FA				Shannahan, Jonathan H.; Lai, Xianyin; Ke, Pu Chun; Podila, Ramakrishna; Brown, Jared M.; Witzmann, Frank A.			Silver Nanoparticle Protein Corona Composition in Cell Culture Media	PLOS ONE			English	Article							LUNG EPITHELIAL-CELLS; SILICA NANOPARTICLES; SURFACE-PROPERTIES; STATISTICAL-MODEL; ADSORPTION; TOXICITY; CYTOTOXICITY; IMPACT; SERUM; TRANSFERRIN	The potential applications of nanomaterials as drug delivery systems and in other products continue to expand. Upon introduction into physiological environments and driven by energetics, nanomaterials readily associate proteins forming a protein corona (PC) on their surface. This PC influences the nanomaterial's surface characteristics and may impact their interaction with cells. To determine the biological impact of nanomaterial exposure as well as nanotherapeutic applications, it is necessary to understand PC formation. Utilizing a label-free mass spectrometry-based proteomics approach, we examined the composition of the PC for a set of four silver nanoparticles (AgNPs) including citrate-stabilized and polyvinlypyrrolidone-stabilized (PVP) colloidal silver (20 or 110 nm diameter). To simulate cell culture conditions, AgNPs were incubated for 1 h in Dulbecco's Modified Eagle Medium supplemented with 10% fetal bovine serum, washed, coronal proteins solubilized, and proteins identified and quantified by label-free LC-MS/MS. To determine which attributes influence PC formation, the AgNPs were characterized in both water and cell culture media with 10% FBS. All AgNPs associated a common subset of 11 proteins including albumin, apolipoproteins, keratins, and other serum proteins. 110 nm citrate-and PVP-stabilized AgNPs were found to bind the greatest number of proteins (79 and 85 respectively) compared to 20 nm citrate-and PVP-stabilized AgNPs (45 and 48 respectively), suggesting a difference in PC formation based on surface curvature. While no relationships were found for other protein parameters (isoelectric point or aliphatic index), the PC on 20 nm AgNPs (PVP and citrate) consisted of more hydrophobic proteins compared to 110 nm AgNPs implying that this class of proteins are more receptive to curvature-induced folding and crowding in exchange for an increased hydration in the aqueous environment. These observations demonstrate the significance of electrostatic and hydrophobic interactions in the formation of the PC which may have broad biological and toxicological implications.	[Shannahan, Jonathan H.; Brown, Jared M.] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Anschutz Med Campus, Aurora, CO USA; [Lai, Xianyin; Witzmann, Frank A.] Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46204 USA; [Ke, Pu Chun; Podila, Ramakrishna] Clemson Univ, Dept Phys & Astron, Clemson, SC 29634 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Indiana University System; Indiana University-Purdue University Indianapolis; Clemson University	Witzmann, FA (corresponding author), Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46204 USA.	fwitzman@iupui.edu	Podila, Ramakrishna/H-6226-2012; Ke, Pu Chun/N-6707-2019; Ke, Pu Chun/K-2805-2013	Podila, Ramakrishna/0000-0003-0472-2361; Ke, Pu Chun/0000-0003-2134-0859; Ke, Pu Chun/0000-0003-2134-0859	NIH [ES019311, ES019525, ES018810, GM082518]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [RC2ES018810, R01ES019311, U19ES019525] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grants ES019311 (JMB), ES019525 (JMB), ES018810 (FAW) and GM082518 (FAW). In addition, the authors would like to acknowledge the National Centers for Nanotechnology Health Implications Consortium (NCNHIR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvizo RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033650; Beduneau A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004343; BLUNK T, 1993, ELECTROPHORESIS, V14, P1382, DOI 10.1002/elps.11501401214; Casals E, 2010, ACS NANO, V4, P3623, DOI 10.1021/nn901372t; Clift MJD, 2010, TOXICOL LETT, V198, P358, DOI 10.1016/j.toxlet.2010.08.002; Deng ZJ, 2011, NAT NANOTECHNOL, V6, P39, DOI [10.1038/nnano.2010.250, 10.1038/NNANO.2010.250]; Ehrenberg MS, 2009, BIOMATERIALS, V30, P603, DOI 10.1016/j.biomaterials.2008.09.050; El Badawy AM, 2011, ENVIRON SCI TECHNOL, V45, P283, DOI 10.1021/es1034188; Foldbjerg R, 2012, TOXICOL SCI, V130, P145, DOI 10.1093/toxsci/kfs225; Huynh KA, 2011, ENVIRON SCI TECHNOL, V45, P5564, DOI 10.1021/es200157h; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Lai XY, 2008, PROTEOM CLIN APPL, V2, P1140, DOI 10.1002/prca.200780140; Lartigue L, 2012, ACS NANO, V6, P2665, DOI 10.1021/nn300060u; Lesniak A, 2013, J AM CHEM SOC, V135, P1438, DOI 10.1021/ja309812z; Lesniak A, 2012, ACS NANO, V6, P5845, DOI 10.1021/nn300223w; Lesniak A, 2010, BIOMATERIALS, V31, P9511, DOI 10.1016/j.biomaterials.2010.09.049; Lin JJ, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/6/065102; Liu HL, 2013, J HAZARD MATER, V248, P478, DOI 10.1016/j.jhazmat.2013.01.046; Liu JY, 2012, ACS NANO, V6, P9887, DOI 10.1021/nn303449n; Lundqvist M, 2004, LANGMUIR, V20, P10639, DOI 10.1021/la0484725; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Lynch I, 2007, ADV COLLOID INTERFAC, V134-35, P167, DOI 10.1016/j.cis.2007.04.021; Mahon E, 2012, J CONTROL RELEASE, V161, P164, DOI 10.1016/j.jconrel.2012.04.009; Maiorano G, 2010, ACS NANO, V4, P7481, DOI 10.1021/nn101557e; Martinez-Gutierrez F, 2013, FUTURE MICROBIOL, V8, P403, DOI [10.2217/FMB.13.5, 10.2217/fmb.13.5]; Milani S, 2012, ACS NANO, V6, P2532, DOI 10.1021/nn204951s; Monopoli MP, 2011, J AM CHEM SOC, V133, P2525, DOI 10.1021/ja107583h; Monroe ME, 2008, COMPUT BIOL CHEM, V32, P215, DOI 10.1016/j.compbiolchem.2008.02.006; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Panas A, 2013, NANOTOXICOLOGY, V7, P259, DOI 10.3109/17435390.2011.652206; Park J, 2011, CHEM COMMUN, V47, P4382, DOI 10.1039/c1cc10357a; Park MVDZ, 2011, BIOMATERIALS, V32, P9810, DOI 10.1016/j.biomaterials.2011.08.085; Podila R, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4772509; Rosen BP, 2002, COMP BIOCHEM PHYS A, V133, P689, DOI 10.1016/S1095-6433(02)00201-5; Salvati A, 2013, NAT NANOTECHNOL, V8, P137, DOI [10.1038/nnano.2012.237, 10.1038/NNANO.2012.237]; Shannahan JH, 2013, SMALL; Singh RP, 2012, TOXICOL LETT, V213, P249, DOI 10.1016/j.toxlet.2012.07.009; Sotiriou GA, 2013, SMALL; Tedja R, 2012, ACS NANO, V6, P4083, DOI 10.1021/nn3004845; Tenzer S, 2011, ACS NANO, V5, P7155, DOI 10.1021/nn201950e; Walkey CD, 2012, CHEM SOC REV, V41, P2780, DOI 10.1039/c1cs15233e; Wang F, 2013, NANOMEDICINE; Yin N, 2013, SMALL; Zhang HZ, 2011, PROTEOMICS, V11, P4569, DOI 10.1002/pmic.201100037	45	155	155	4	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74001	10.1371/journal.pone.0074001	http://dx.doi.org/10.1371/journal.pone.0074001			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040142	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300148
J	Xie, JG; Xu, ZL; Zhou, SB; Pan, XC; Cai, SX; Yang, L; Mei, H				Xie, Jiangan; Xu, Zhiling; Zhou, Shangbo; Pan, Xianchao; Cai, Shaoxi; Yang, Li; Mei, Hu			The VHSE-Based Prediction of Proteasomal Cleavage Sites	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; 20 S PROTEASOME; ANTIGENIC PEPTIDES; COMPLEX; MOTIFS; PROTEINS; IMMUNOPROTEASOME; IDENTIFICATION; GENERATION; ALGORITHM	Prediction of proteasomal cleavage sites has been a focus of computational biology. Up to date, the predictive methods are mostly based on nonlinear classifiers and variables with little physicochemical meanings. In this paper, the physicochemical properties of 14 residues both upstream and downstream of a cleavage site are characterized by VHSE (principal component score vector of hydrophobic, steric, and electronic properties) descriptors. Then, the resulting VHSE descriptors are employed to construct prediction models by support vector machine (SVM). For both in vivo and in vitro datasets, the performance of VHSE-based method is comparatively better than that of the well-known PAProC, MAPPP, and NetChop methods. The results reveal that the hydrophobic property of 10 residues both upstream and downstream of the cleavage site is a dominant factor affecting in vivo and in vitro cleavage specificities, followed by residue's electronic and steric properties. Furthermore, the difference in hydrophobic potential between residues flanking the cleavage site is proposed to favor substrate cleavages. Overall, the interpretable VHSE-based method provides a preferable way to predict proteasomal cleavage sites.	[Xie, Jiangan; Zhou, Shangbo] Minist Educ, Key Lab Dependence Serv Comp Cyber Phys Soc, Chongqing, Peoples R China; [Xie, Jiangan; Zhou, Shangbo] Chongqing Univ, Coll Comp Sci, Chongqing 630044, Peoples R China; [Xu, Zhiling; Pan, Xianchao; Cai, Shaoxi; Yang, Li; Mei, Hu] Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing, Peoples R China; [Xu, Zhiling; Pan, Xianchao; Cai, Shaoxi; Yang, Li; Mei, Hu] Chongqing Univ, Coll Bioengn, Chongqing 630044, Peoples R China	Chongqing University; Chongqing University	Mei, H (corresponding author), Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing, Peoples R China.	meihu@cqu.edu.cn		Xie, Jiangan/0000-0003-0958-3364	National Natural Science Foundation of China [61073135]; "111" project of "Introducing Talents of Discipline to Universities"	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "111" project of "Introducing Talents of Discipline to Universities"	This research was supported by the National Natural Science Foundation of China (No 61073135) and the "111" project of "Introducing Talents of Discipline to Universities". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuvia Y, 2000, J MOL BIOL, V295, P879, DOI 10.1006/jmbi.1999.3392; Angeles A, 2012, FRONT BIOSCI-LANDMRK, V17, P1904, DOI 10.2741/4027; Ayyoub M, 2002, J IMMUNOL, V168, P1717, DOI 10.4049/jimmunol.168.4.1717; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Ehring B, 1996, EUR J BIOCHEM, V235, P404, DOI 10.1111/j.1432-1033.1996.00404.x; Falk K, 2006, J IMMUNOL, V177, P2741; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gubler B, 1998, MOL IMMUNOL, V35, P427, DOI 10.1016/S0161-5890(98)00059-5; Hakenberg Jorg, 2003, Appl Bioinformatics, V2, P155; Holzhutter HG, 1999, J MOL BIOL, V286, P1251, DOI 10.1006/jmbi.1998.2530; Hsu C. W., 2003, PRACTICAL GUIDE SUPP; Joachims T, 1999, SVMLIGHT SUPPORT VEC; Kawahara M, 2009, J IMMUNOL, V183, P6069, DOI 10.4049/jimmunol.0803564; Kesmir C, 2002, PROTEIN ENG, V15, P287, DOI 10.1093/protein/15.4.287; Kim E, 2009, J IMMUNOL, V183, P7379, DOI 10.4049/jimmunol.0901489; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Konstantinova IM, 2008, INT REV CEL MOL BIO, V267, P59, DOI 10.1016/S1937-6448(08)00602-3; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Kuttler C, 2000, J MOL BIOL, V298, P417, DOI 10.1006/jmbi.2000.3683; Lucchiari-Hartz M, 2000, J EXP MED, V191, P239, DOI 10.1084/jem.191.2.239; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Mei H, 2005, BIOPOLYMERS, V80, P775, DOI 10.1002/bip.20296; Morel S, 2000, IMMUNITY, V12, P107, DOI 10.1016/S1074-7613(00)80163-6; Niedermann G, 1996, P NATL ACAD SCI USA, V93, P8572, DOI 10.1073/pnas.93.16.8572; Nussbaum AK, 2001, IMMUNOGENETICS, V53, P87, DOI 10.1007/s002510100300; Nussbaum AK, 1998, P NATL ACAD SCI USA, V95, P12504, DOI 10.1073/pnas.95.21.12504; Orlowski M, 2000, ARCH BIOCHEM BIOPHYS, V383, P1, DOI 10.1006/abbi.2000.2036; Pardo M, 2005, SENSOR ACTUAT B-CHEM, V107, P730, DOI 10.1016/j.snb.2004.12.005; Ponomarenko J, 2011, NUCLEIC ACIDS RES, V39, pD1164, DOI 10.1093/nar/gkq888; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Sanchez VD, 2003, NEUROCOMPUTING, V55, P5, DOI 10.1016/S0925-2312(03)00373-4; Saxova P, 2003, INT IMMUNOL, V15, P781, DOI 10.1093/intimm/dxg084; Schneider M, 2009, J PROTEOMICS, V72, P567, DOI 10.1016/j.jprot.2008.11.010; Stadtmueller BM, 2012, J BIOL CHEM, V287, P37371, DOI 10.1074/jbc.M112.367003; Strehl B, 2005, IMMUNOL REV, V207, P19, DOI 10.1111/j.0105-2896.2005.00308.x; Strehl B, 2008, J BIOL CHEM, V283, P17891, DOI 10.1074/jbc.M710042200; Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1; Toseland Christopher P, 2005, Immunome Res, V1, P4, DOI 10.1186/1745-7580-1-4	41	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74506	10.1371/journal.pone.0074506	http://dx.doi.org/10.1371/journal.pone.0074506			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040264	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300177
J	Donovan, C; Royce, SG; Esposito, J; Tran, J; Ibrahim, ZA; Tang, MLK; Bailey, S; Bourke, JE				Donovan, Chantal; Royce, Simon G.; Esposito, James; Tran, Jenny; Ibrahim, Zaridatul Aini; Tang, Mimi L. K.; Bailey, Simon; Bourke, Jane E.			Differential Effects of Allergen Challenge on Large and Small Airway Reactivity in Mice	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; CUT LUNG SLICES; PULMONARY-DISEASE; SENSITIZED RATS; MURINE MODEL; IN-VITRO; HYPERRESPONSIVENESS; ASTHMA; BRONCHIOLES; DYNAMICS	The relative contributions of large and small airways to hyperresponsiveness in asthma have yet to be fully assessed. This study used a mouse model of chronic allergic airways disease to induce inflammation and remodelling and determine whether in vivo hyperresponsiveness to methacholine is consistent with in vitro reactivity of trachea and small airways. Balb/C mice were sensitised (days 0, 14) and challenged (3 times/week, 6 weeks) with ovalbumin. Airway reactivity was compared with saline-challenged controls in vivo assessing whole lung resistance, and in vitro measuring the force of tracheal contraction and the magnitude/rate of small airway narrowing within lung slices. Increased airway inflammation, epithelial remodelling and fibrosis were evident following allergen challenge. In vivo hyperresponsiveness to methacholine was maintained in isolated trachea. In contrast, methacholine induced slower narrowing, with reduced potency in small airways compared to controls. In vitro incubation with IL-1/TNF alpha did not alter reactivity. The hyporesponsiveness to methacholine in small airways within lung slices following chronic ovalbumin challenge was unexpected, given hyperresponsiveness to the same agonist both in vivo and in vitro in tracheal preparations. This finding may reflect the altered interactions of small airways with surrounding parenchymal tissue after allergen challenge to oppose airway narrowing and closure.	[Donovan, Chantal; Esposito, James; Tran, Jenny; Ibrahim, Zaridatul Aini; Bailey, Simon; Bourke, Jane E.] Univ Melbourne, Dept Pharmacol & Therapeut, Lung Hlth Res Ctr, Parkville, Vic 3052, Australia; [Royce, Simon G.; Tang, Mimi L. K.] Univ Melbourne, Dept Pediat, Parkville, Vic 3052, Australia; [Royce, Simon G.; Tang, Mimi L. K.] Royal Childrens Hosp, Dept Allergy & Immunol, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Bailey, Simon] Univ Melbourne, Fac Vet Sci, Parkville, Vic 3052, Australia	University of Melbourne; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Bourke, JE (corresponding author), Univ Melbourne, Dept Pharmacol & Therapeut, Lung Hlth Res Ctr, Parkville, Vic 3052, Australia.	jane.bourke@unimelb.edu.au	Bailey, Simon/H-7606-2019; Tang, Mimi/ABD-8350-2020; Ibrahim, Zaridatul Aini/N-2626-2017; Bourke, Jane E/K-2596-2019	Tang, Mimi/0000-0002-3839-5293; Ibrahim, Zaridatul Aini/0000-0001-7829-2160; Bourke, Jane E/0000-0001-7314-9234; Bailey, Simon/0000-0001-9348-5497	University of Melbourne Faculty Research Grant Scheme; NHMRC [509239, 1041575]; Australian Postgraduate Award	University of Melbourne Faculty Research Grant Scheme; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government)	This work was supported by the University of Melbourne Faculty Research Grant Scheme and NHMRC Project Grants (509239, 1041575). CD is supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SS, 2007, EUR RESPIR J, V29, P834, DOI 10.1183/09031936.00112606; Bai Y, 2006, AM J PHYSIOL-LUNG C, V291, pL208, DOI 10.1152/ajplung.00494.2005; Bergner A, 2006, EUR J MED RES, V11, P77; BRAMLEY AM, 1995, AM J RESP CRIT CARE, V152, P1513, DOI 10.1164/ajrccm.152.5.7582286; Brown RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010332; Burgel PR, 2011, EUR RESPIR REV, V20, P23, DOI 10.1183/09059180.00010410; Chen H, 2003, J APPL PHYSIOL, V95, P864, DOI 10.1152/japplphysiol.00140.2003; Chew AD, 2008, EUR RESPIR J, V31, P532, DOI 10.1183/09031936.00079307; Chiba Y, 2004, INFLAMM RES, V53, P636, DOI 10.1007/s00011-004-1305-x; Gavett SH, 1999, J CLIN INVEST, V104, P721, DOI 10.1172/JCI6890; Henjakovic M, 2008, TOXICOL APPL PHARM, V231, P68, DOI 10.1016/j.taap.2008.04.003; Keramidaris E, 2001, J ALLERGY CLIN IMMUN, V107, P734, DOI 10.1067/mai.2001.114050; Khan MA, 2010, AM J PHYSIOL-LUNG C, V299, pL98, DOI 10.1152/ajplung.00011.2010; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Liberati TA, 2010, EXPERT REV MOL DIAGN, V10, P501, DOI [10.1586/erm.10.21, 10.1586/ERM.10.21]; Locke NR, 2007, AM J RESP CELL MOL, V36, P625, DOI 10.1165/rcmb.2006-0083OC; Martin C, 2001, AM J RESP CELL MOL, V24, P139, DOI 10.1165/ajrcmb.24.2.3545; McVicker CG, 2007, AM J RESP CELL MOL, V36, P721, DOI 10.1165/rcmb.2006-0409OC; Mechiche H, 2003, CLIN EXP ALLERGY, V33, P887, DOI 10.1046/j.1365-2222.2003.01696.x; Moir LM, 2003, AM J PHYSIOL-LUNG C, V284, pL148, DOI 10.1152/ajplung.00105.2002; Palmans E, 2000, AM J RESP CRIT CARE, V161, P627, DOI 10.1164/ajrccm.161.2.9902094; Perez JF, 2005, J GEN PHYSIOL, V125, P535, DOI 10.1085/jgp.200409216; Sanderson MJ, 2011, PULM PHARMACOL THER, V24, P452, DOI 10.1016/j.pupt.2011.05.001; Shin YS, 2009, ALLERGY ASTHMA IMMUN, V1, P10, DOI 10.4168/aair.2009.1.1.10; Sturton G, 2008, TRENDS PHARMACOL SCI, V29, P340, DOI 10.1016/j.tips.2008.04.003; Sukkar M B, 2001, Respirology, V6, P199, DOI 10.1046/j.1440-1843.2001.00334.x; Wagner EM, 1998, AM J RESP CRIT CARE, V157, P447, DOI 10.1164/ajrccm.157.2.9611043; Ward JE, 2006, PULM PHARMACOL THER, V19, P39, DOI 10.1016/j.pupt.2005.02.005; Witzenrath M, 2008, EXP TOXICOL PATHOL, V60, P9, DOI 10.1016/j.etp.2008.03.002; WOOLCOCK AJ, 1991, AM REV RESPIR DIS, V143, P1438, DOI 10.1164/ajrccm/143.6.1438; YANAI M, 1992, J APPL PHYSIOL, V72, P1016, DOI 10.1152/jappl.1992.72.3.1016	31	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e74101	10.1371/journal.pone.0074101	http://dx.doi.org/10.1371/journal.pone.0074101			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040180	gold, Green Published, Green Submitted			2022-12-25	WOS:000324856500077
J	Bam, K; Thapa, R; Newman, MS; Bhatt, LP; Bhatta, SK				Bam, Kiran; Thapa, Rajshree; Newman, Marielle Sophia; Bhatt, Lokesh Prasad; Bhatta, Shree Krishna			Sexual Behavior and Condom Use among Seasonal Dalit Migrant Laborers to India from Far West, Nepal: A Qualitative Study	PLOS ONE			English	Article							HIV/AIDS; RISK	Background: Around 41% of Human Immunodeficiency Virus (HIV) cases in Nepal occur in seasonal migrant laborers. Dalit migrant laborers represent the largest proportion of reported HIV cases in the Far Western Region (Sudur Pashchimanchal, or Far West), Nepal. The study's objectives were to assess sexual behavior, condom use status and HIV risk perception among Dalit migrant laborers to India from Far West Region, Nepal. Methods: The study was conducted among Dalit male migrant laborers aged 15 years and above who had migrated for at least six months of the last two years to India. For the sampling the village development committees (VDCs) from Achham, Doti and Kanchanpur districts of Nepal were purposively selected. The data were collected in March and April 2011 via ten in-depth interviews and four focus group discussions and analyzed using content analysis. Results: Poor socio-economic status, caste-related discrimination, and lack of employment opportunities push large groups of young Dalits to migrate to India for employment, where they engage in sex with female sex workers (FSWs). The participants described unmarried status, peer influence, alcohol use, low-priced sex with FSWs and unwillingness to use condoms as common factors of their migration experience. Lack of awareness on HIV/AIDS was common among study participants. Awareness of HIV/AIDS and faithful, monogamous partnerships are reported as factors influencing safer sexual behavior. Conclusions: Dalits are an especially vulnerable population among migrant laborers and may be over-represented in new HIV infections in Nepal. Comprehensive surveying and health promotion programs targeted to this population are urgently needed and potent methods of stopping HIV spread.	[Bam, Kiran] Dist Hlth Off, Dist AIDS Coordinat Comm DACC, Silgadhi, Doti, Nepal; [Thapa, Rajshree] Assoc Med Doctors Asia AMDA Nepal, Damak, Jhapa, Nepal; [Newman, Marielle Sophia] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Bhatt, Lokesh Prasad] HAMI Project, Assoc Med Doctors Asia, Kathmandu, Nepal; [Bhatta, Shree Krishna] Far Western Reg Hlth Directorate, Rajpur, Doti, Nepal	Bangladesh Rural Advancement Committee BRAC; BRAC University	Bam, K (corresponding author), BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh.	bam.kiran@gmail.com		Thapa, Rajshree/0000-0003-1442-793X	The Samata Foundation (Dalit led organization), Lalitpur, Nepal	The Samata Foundation (Dalit led organization), Lalitpur, Nepal	The Samata Foundation (Dalit led organization), Lalitpur, Nepal provided funds to conduct this research and helped during data collection. The Samata Foundation had no role in study design or protocol development, data analysis, report writing or the decision to publish this research data in a peer-reviewed article.	[Anonymous], [No title captured]; Bam K, 2011, AJMS, V2, P3, DOI 10.3126/ajms.v2i1.4290; Bishwakarma P, 2004, SITUATION ANAL DALIT; Bondurant T, 2001, HIV STI PREVENTION C; Brokerhoff M, 1998, POLICY RES DIVISION, V111; CARE, 2004, PIL IN UND PEOPL LIV; *CENTR BUR STAT, 2004, NEP LIV STAND SURV 2, V2; *CENTR BUR STAT, 2004, NEP LIV STAND SURV 2, V1; Central Bureau of Statistics, 2001, POP CENS NEP; Central Bureau of Statistics, 2008, NEP KATHM; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012948; Entz AT, 2000, AIDS, V14, P1027, DOI 10.1097/00002030-200005260-00015; GECAS V, 1983, SOC PSYCHOL QUART, V46, P77, DOI 10.2307/3033844; International Labor Organization, 2005, DAL LAB NEP; Marshall C., 2010, DESIGNING QUALITATIV; Ministry of Health and Population, 2007, NCASC NAT HIV AIDS S; Ministry of Health and Population New ERA and Macro International Inc, 2006, NEP DEM HLTH SURV; Morris M, 1996, AIDS, V10, P1265, DOI 10.1097/00002030-199609000-00013; NCASC, 2004, HIV AIDS EP SIT NEP; NCASC, 2007, NAT EST HIV INF; NCASC, 2006, SEX TRANSM INF NAT P; Population Council, 2011, MIGR HIV IND; PROTHERO RM, 1977, INT J EPIDEMIOL, V6, P259, DOI 10.1093/ije/6.3.259; Puri M, 2006, J ADOLESCENT HEALTH, V38, P237, DOI 10.1016/j.jadohealth.2004.10.001; Smith-Estelle A, 2003, REPROD HEALTH MATTER, V11, P142, DOI 10.1016/S0968-8080(03)02292-4; Srivastava A, 2009, FRAMEWORK ANAL QUALI, DOI DOI 10.1002/JIA2.25572; Success Search Option Intrepid Nepal, 2010, INT BIOB SURV MAL LA; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; United Nations, 2010, UNGASS UN GEN ASS SP; Viswanathan M, 2004, AHRQ PUBLICATION	31	21	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74903	10.1371/journal.pone.0074903	http://dx.doi.org/10.1371/journal.pone.0074903			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219CG	24040359	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600151
J	Chakraborty, P; Banerjee, S; Saha, P; Nandi, SS; Sharma, S; Goswami, SK; Chakravarty, B; Kabir, SN				Chakraborty, Pratip; Banerjee, Sayani; Saha, Piyali; Nandi, Shyam Sundar; Sharma, Sunita; Goswami, Sourendra K.; Chakravarty, Baidyanath; Kabir, Syed N.			Aspirin and Low-Molecular Weight Heparin Combination Therapy Effectively Prevents Recurrent Miscarriage in Hyperhomocysteinemic Women	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; PREGNANCY LOSS; INSULIN-RESISTANCE; ANTIPHOSPHOLIPID SYNDROME; CONTROLLED-TRIAL; PLUS HEPARIN; 1ST-TRIMESTER; COMPLICATIONS; THROMBOPHILIA; ANTIBODIES	The management of recurrent pregnancy loss (RPL) still remains a great challenge, and women with polycystic ovarian syndrome (PCOS) are at a greater risk for spontaneous abortion. Treatment with low-molecular-weight heparin (LMWH) has become an accepted treatment option for women with RPL; however, the subgroup of women, who are likely to respond to LMWH, has not been precisely identified. The present study evaluated the efficacy of LMWH with reference to PCOS and associated metabolic phenotypes including hyperhomocysteinemia (HHcy), insulin resistance (IR) and obesity. This prospective observational study was conducted at Institute of Reproductive Medicine, Kolkata, India. A total of 967 women with history of 2 or more consecutive first trimester abortions were screened and 336 were selected for the study. The selected patients were initially divided on the basis of presence or absence of PCOS, while subsequent stratification was based on HHcy, IR and/or obesity. The subjects had treatment with aspirin during one conception cycle and aspirin-LMWH combined anticoagulant therapy for the immediate next conception cycle, if the first treated cycle was unsuccessful. Pregnancy salvage was the sole outcome measure. The overall rate of pregnancy salvage following aspirin therapy was 43.15%, which was mostly represented by normohomocysteinemic women, while the salvage rate was lower in the HHcy populations irrespective of the presence or absence of PCOS, IR, or obesity. By contrast, aspirin-LMWH combined therapy could rescue 66.84% pregnancies in the aspirin-failed cases. Logistic regression analyses showed that HHcy remained a significant factor in predicting salvage rates in the PCOS, IR, and obese subpopulations controlled for other confounding factors. With regard to pregnancy salvage, combined anticoagulant therapy with aspirin and LMWH conferred added benefit to those with HHcy phenotype.	[Chakraborty, Pratip; Sharma, Sunita; Goswami, Sourendra K.; Chakravarty, Baidyanath] Inst Reprod Med, Dept Infertil, Kolkata, W Bengal, India; [Banerjee, Sayani; Saha, Piyali; Nandi, Shyam Sundar; Kabir, Syed N.] Indian Inst Chem Biol, CSIR, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Kabir, SN (corresponding author), Indian Inst Chem Biol, CSIR, Kolkata, W Bengal, India.	snkabir@iicb.res.in	Nandi, Shyam Sundar/H-8612-2019	Nandi, Shyam Sundar/0000-0001-6422-2540				Baek KH, 2007, TRENDS MOL MED, V13, P310, DOI 10.1016/j.molmed.2007.05.005; Brenner B, 2005, FERTIL STERIL, V84, P770, DOI 10.1016/j.fertnstert.2005.03.048; Carp HJA, 2004, CURR OPIN OBSTET GYN, V16, P129, DOI 10.1097/00001703-200404000-00006; Chakraborty P, 2013, BIOL TRACE ELEM RES, V152, P9, DOI 10.1007/s12011-012-9592-5; Check JH, 2012, AM J REPROD IMMUNOL, V67, P326, DOI 10.1111/j.1600-0897.2012.01119.x; Chen Y, 2012, FERTIL STERIL, V97, P764, DOI 10.1016/j.fertnstert.2011.12.002; Craven CM, 1999, AM J OBSTET GYNECOL, V181, P455, DOI 10.1016/S0002-9378(99)70578-8; D'Uva M, 2008, BIOL-TARGETS THER, V2, P897; Darvall KAL, 2007, EUR J VASC ENDOVASC, V33, P223, DOI 10.1016/j.ejvs.2006.10.006; Deruelle P, 2006, EUR J OBSTET GYN R B, V127, P73, DOI 10.1016/j.ejogrb.2005.09.010; Diamanti-Kandarakis Evanthia, 2007, Hormones (Athens), V6, P210; Dimitrakakis C, 2000, HAEMOSTASIS, V30, P243; Empson M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002859.pub2; Farquharson RG, 2002, OBSTET GYNECOL, V100, P408, DOI 10.1016/S0029-7844(02)02165-8; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Ford Holly B, 2009, Rev Obstet Gynecol, V2, P76; Greer IA, 2005, BLOOD, V106, P401, DOI 10.1182/blood-2005-02-0626; Heit JA, 2005, ANN INTERN MED, V143, P697, DOI 10.7326/0003-4819-143-10-200511150-00006; Jauniaux E, 2006, HUM REPROD, V21, P2216, DOI 10.1093/humrep/del150; Junqueira DR, 2012, COCHRANE DB SYST REV, V12; Kaandorp SP, 2010, NEW ENGL J MED, V362, P1586, DOI 10.1056/NEJMoa1000641; Kupferminc Michael J, 2003, Reprod Biol Endocrinol, V1, P111, DOI 10.1186/1477-7827-1-111; Kwak-Kim J, 2009, J OBSTET GYNAECOL RE, V35, P609, DOI 10.1111/j.1447-0756.2009.01079.x; Lashen H, 2004, HUM REPROD, V19, P1644, DOI 10.1093/humrep/deh277; Laskin CA, 2009, J RHEUMATOL, V36, P279, DOI [10.3899/jrheum.080763), 10.3899/jrheum.080763]; Lee RM, 2000, SEMIN REPROD MED, V18, P433, DOI 10.1055/s-2000-13733; Lockshin MD, 1999, THROMB HAEMOSTASIS, V82, P641; Mak A, 2010, RHEUMATOLOGY, V49, P281, DOI 10.1093/rheumatology/kep373; Matthiesen L, 2012, AM J REPROD IMMUNOL, V67, P334, DOI 10.1111/j.1600-0897.2012.01121.x; Metwally M, 2010, FERTIL STERIL, V94, P290, DOI 10.1016/j.fertnstert.2009.03.021; Nelen WLDM, 2000, FERTIL STERIL, V74, P1196, DOI 10.1016/S0015-0282(00)01595-8; Nelson SM, 2008, HUM REPROD UPDATE, V14, P623, DOI 10.1093/humupd/dmn031; Pacchiarotti A, 2007, J ASSIST REPROD GEN, V24, P459, DOI 10.1007/s10815-007-9165-2; Pritchand D., 2006, UPDATE RELATION COMM; Rai R, 2000, HUM REPROD, V15, P612, DOI 10.1093/humrep/15.3.612; Rai R, 1997, BRIT MED J, V314, P253, DOI 10.1136/bmj.314.7076.253; Raziel A, 2001, AM J REPROD IMMUNOL, V45, P65, DOI 10.1111/j.8755-8920.2001.450201.x; Rodger MA, 2008, OBSTET GYNECOL, V112, P320, DOI 10.1097/AOG.0b013e31817e8acc; Rushton DI, 1988, EARLY PREGNANCY LOSS, P149; Schachter M, 2003, HUM REPROD, V18, P721, DOI 10.1093/humrep/deg190; Shlebak A, 2009, HEART, V95, P1643, DOI 10.1136/hrt.2009.171553; Tian L, 2007, J CLIN ENDOCR METAB, V92, P1430, DOI 10.1210/jc.2006-1123; TULPPALA M, 1991, LANCET, V337, P879, DOI 10.1016/0140-6736(91)90205-4; Unfried G, 2002, OBSTET GYNECOL, V99, P614, DOI 10.1016/S0029-7844(01)01789-6; WHO, 2000, WHO TECHNICAL REPORT, V894; Wijeyaratne CN, 2004, CLIN ENDOCRINOL, V60, P560, DOI 10.1111/j.1365-2265.2004.02019.x	46	16	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74155	10.1371/journal.pone.0074155	http://dx.doi.org/10.1371/journal.pone.0074155			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040195	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600119
J	Arnault, E; Barrau, C; Nanteau, C; Gondouin, P; Bigot, K; Vienot, F; Gutman, E; Fontaine, V; Villette, T; Cohen-Tannoudji, D; Sahel, JA; Picaud, S				Arnault, Emilie; Barrau, Coralie; Nanteau, Celine; Gondouin, Pauline; Bigot, Karine; Vienot, Francoise; Gutman, Emmanuel; Fontaine, Valerie; Villette, Thierry; Cohen-Tannoudji, Denis; Sahel, Jose-Alain; Picaud, Serge			Phototoxic Action Spectrum on a Retinal Pigment Epithelium Model of Age-Related Macular Degeneration Exposed to Sunlight Normalized Conditions	PLOS ONE			English	Article							LIGHT-INDUCED APOPTOSIS; BLUE-LIGHT; LIPOFUSCIN FLUOROPHORE; PHOTOCHEMICAL DAMAGE; OPTICAL-DENSITY; RISK-FACTORS; PREVALENCE; BARRIER; CELLS; A2E	Among the identified risk factors of age-related macular degeneration, sunlight is known to induce cumulative damage to the retina. A photosensitive derivative of the visual pigment, N-retinylidene-N-retinylethanolamine (A2E), may be involved in this phototoxicity. The high energy visible light between 380 nm and 500 nm (blue light) is incriminated. Our aim was to define the most toxic wavelengths in the blue-green range on an in vitro model of the disease. Primary cultures of porcine retinal pigment epithelium cells were incubated for 6 hours with different A2E concentrations and exposed for 18 hours to 10 nm illumination bands centered from 380 to 520 nm in 10 nm increments. Light irradiances were normalized with respect to the natural sunlight reaching the retina. Six hours after light exposure, cell viability, necrosis and apoptosis were assessed using the Apotox-Glo Triplex (TM) assay. Retinal pigment epithelium cells incubated with A2E displayed fluorescent bodies within the cytoplasm. Their absorption and emission spectra were similar to those of A2E. Exposure to 10 nm illumination bands induced a loss in cell viability with a dose dependence upon A2E concentrations. Irrespective of A2E concentration, the loss of cell viability was maximal for wavelengths from 415 to 455 nm. Cell viability decrease was correlated to an increase in cell apoptosis indicated by caspase-3/7 activities in the same spectral range. No light-elicited necrosis was measured as compared to control cells maintained in darkness. Our results defined the precise spectrum of light retinal toxicity in physiological irradiance conditions on an in vitro model of age-related macular degeneration. Surprisingly, a narrow bandwidth in blue light generated the greatest phototoxic risk to retinal pigment epithelium cells. This phototoxic spectrum may be advantageously valued in designing selective photoprotection ophthalmic filters, without disrupting essential visual and non-visual functions of the eye.	[Arnault, Emilie; Nanteau, Celine; Gondouin, Pauline; Bigot, Karine; Gutman, Emmanuel; Fontaine, Valerie; Sahel, Jose-Alain; Picaud, Serge] Univ Paris 06, Inst Vis, UMR S 968, Paris, France; [Arnault, Emilie; Nanteau, Celine; Gondouin, Pauline; Bigot, Karine; Gutman, Emmanuel; Fontaine, Valerie; Sahel, Jose-Alain; Picaud, Serge] INSERM, U968, Paris, France; [Arnault, Emilie; Nanteau, Celine; Gondouin, Pauline; Bigot, Karine; Gutman, Emmanuel; Fontaine, Valerie; Sahel, Jose-Alain; Picaud, Serge] CNRS, UMR 7210, Paris, France; [Barrau, Coralie; Villette, Thierry; Cohen-Tannoudji, Denis] Essilor Inc Corp, Charenton Le Pont, France; [Vienot, Francoise] Museum Natl Hist Nat, F-75231 Paris, France; [Sahel, Jose-Alain] INSERM DHOS CIC 503, Ctr Hosp Natl Ophtalmol Quinze Vingts, Paris, France; [Sahel, Jose-Alain] UCL, Inst Ophthalmol, London, England; [Sahel, Jose-Alain; Picaud, Serge] Fdn Ophtalmol Adolphe Rothschild, Paris, France; [Sahel, Jose-Alain] Acad Sci Inst France, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Essilor International; Museum National d'Histoire Naturelle (MNHN); CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of London; University College London; Fondation Adolphe de Rothschild	Picaud, S (corresponding author), Univ Paris 06, Inst Vis, UMR S 968, Paris, France.	serge.picaud@inserm.fr	Picaud, Serge/H-4012-2014; Sahel, Jose-Alain/F-3172-2017	Picaud, Serge/0000-0002-0548-5145; Sahel, Jose-Alain/0000-0002-4831-1153; CARNEIRO, Emilie/0000-0002-5235-6557; Villette, Thierry/0000-0003-3354-8155	OSEO (DESCARTES project); INSERM; Universite Pierre et Marie Curie (Paris VI); CNRS; Fondation Ophtalmologique A. de Rothschild (Paris); Federation des Aveugles de France; City of Paris; Regional Council of Ile-de-France; ESSILOR International; French state funds [ANR-10-LABX-65, ANR-11-IDEX-0004-02]	OSEO (DESCARTES project); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Pierre et Marie Curie (Paris VI); CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation Ophtalmologique A. de Rothschild (Paris); Federation des Aveugles de France; City of Paris(Region Ile-de-France); Regional Council of Ile-de-France(Region Ile-de-France); ESSILOR International; French state funds	This research programm received French public subsidies from OSEO (DESCARTES project) and was also supported by INSERM, Universite Pierre et Marie Curie (Paris VI), CNRS, the Fondation Ophtalmologique A. de Rothschild (Paris), the Federation des Aveugles de France, the City of Paris, the Regional Council of Ile-de-France and ESSILOR International. This work performed in the frame of the LABEX LIFESENSES [reference ANR-10-LABX-65] was also supported by French state funds managed by the ANR within the Investissements d'Avenir programme under reference ANR-11-IDEX-0004-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augood CA, 2006, ARCH OPHTHALMOL-CHIC, V124, P529, DOI 10.1001/archopht.124.4.529; BAZAN HEP, 1990, INVEST OPHTH VIS SCI, V31, P1433; Ben-Shabat S, 2002, ANGEW CHEM INT EDIT, V41, P814, DOI 10.1002/1521-3773(20020301)41:5<814::AID-ANIE814>3.0.CO;2-2; Boettner EA, 1962, INVESTIGATIVE OPHTHA, V1; Boettner EA, 1967, SPECTRAL TRANSMISSIO; Butt AL, 2011, OPHTHALMOLOGY, V118, P1380, DOI 10.1016/j.ophtha.2010.11.007; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Cruickshanks KJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P246; Davies S, 2001, FREE RADICAL BIO MED, V31, P256, DOI 10.1016/S0891-5849(01)00582-2; Fletcher AE, 2008, ARCH OPHTHALMOL-CHIC, V126, P1396, DOI 10.1001/archopht.126.10.1396; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gellermann W, 2002, J OPT SOC AM A, V19, P1172, DOI 10.1364/JOSAA.19.001172; GORGELS TGMF, 1995, INVEST OPHTH VIS SCI, V36, P851; Grimm C, 2000, NAT GENET, V25, P63, DOI 10.1038/75614; Grimm C, 2001, INVEST OPHTH VIS SCI, V42, P497; Hafezi F, 1997, EXP EYE RES, V64, P963, DOI 10.1006/exer.1997.0288; Hunter JJ, 2012, PROG RETIN EYE RES, V31, P28, DOI 10.1016/j.preteyeres.2011.11.001; Kaya S, 2012, ACTA OPHTHALMOL, V90, pe399, DOI 10.1111/j.1755-3768.2012.02423.x; Klein R, 2010, ARCH OPHTHALMOL-CHIC, V128, P750, DOI 10.1001/archophthalmol.2010.92; Lawwill T, 1982, Trans Am Ophthalmol Soc, V80, P517; Le Grand Y, 1972, OPTIQUE PHYSL, V2; Lund DJ, 2006, HEALTH PHYS, V90, P477, DOI 10.1097/01.HP.0000190115.83416.cb; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2009, INVEST OPHTH VIS SCI, V50, P5435, DOI 10.1167/iovs.09-3944; Maeda T, 2009, INVEST OPHTH VIS SCI, V50, P4917, DOI 10.1167/iovs.09-3581; Mainster MA, 2010, SURV OPHTHALMOL, V55, P272, DOI 10.1016/j.survophthal.2009.07.006; Maiti P, 2006, BIOCHEMISTRY-US, V45, P852, DOI 10.1021/bi0518545; Mitchell P, 1998, OPHTHALMOLOGY, V105, P1359, DOI 10.1016/S0161-6420(98)98013-7; Ng KP, 2008, MOL CELL PROTEOMICS, V7, P1397, DOI 10.1074/mcp.M700525-MCP200; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; PUTTING BJ, 1993, GRAEF ARCH CLIN EXP, V231, P600, DOI 10.1007/BF00936526; PUTTING BJ, 1992, EXP EYE RES, V54, P133, DOI 10.1016/0014-4835(92)90077-6; PUTTING BJ, 1992, INVEST OPHTH VIS SCI, V33, P3385; PUTTING BJ, 1994, EXP EYE RES, V58, P31, DOI 10.1006/exer.1994.1192; Raman R, 2011, INVEST OPHTH VIS SCI, V52, P7910, DOI 10.1167/iovs.11-7636; Rein DB, 2009, ARCH OPHTHALMOL-CHIC, V127, P533, DOI 10.1001/archophthalmol.2009.58; Rezai KA, 2008, GRAEF ARCH CLIN EXP, V246, P671, DOI 10.1007/s00417-006-0484-2; Sabour-Pickett S, 2012, MOL NUTR FOOD RES, V56, P270, DOI 10.1002/mnfr.201100219; Sanchez-Ramos C, 2010, ADV EXP MED BIOL, V664, P159, DOI 10.1007/978-1-4419-1399-9_19; Schutt F, 2000, INVEST OPHTH VIS SCI, V41, P2303; Seddon JM, 2011, OPHTHALMOLOGY, V118, P2203, DOI 10.1016/j.ophtha.2011.04.029; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Sparrow JR, 2010, J LIPID RES, V51, P247, DOI 10.1194/jlr.R000687; Sparrow JR, 1999, INVEST OPHTH VIS SCI, V40, P2988; Sparrow JR, 2004, J CATARACT REFR SURG, V30, P873, DOI 10.1016/j.jcrs.2004.01.031; Sparrow JR, 2002, INVEST OPHTH VIS SCI, V43, P1222; Sparrow JR, 2001, INVEST OPHTH VIS SCI, V42, P1356; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; Sui GY, 2013, BRIT J OPHTHALMOL, V97, P389, DOI 10.1136/bjophthalmol-2012-302281; Tanito M, 2006, EXP EYE RES, V83, P1493, DOI 10.1016/j.exer.2006.08.006; TAYLOR HR, 1992, ARCH OPHTHALMOL-CHIC, V110, P99, DOI 10.1001/archopht.1992.01080130101035; Ueda T, 2009, EXP EYE RES, V89, P863, DOI 10.1016/j.exer.2009.07.018; van Norren D, 2011, PHOTOCHEM PHOTOBIOL, V87, P747, DOI 10.1111/j.1751-1097.2011.00921.x; vanBest JA, 1997, MICROSC RES TECHNIQ, V36, P77, DOI 10.1002/(SICI)1097-0029(19970115)36:2<77::AID-JEMT1>3.0.CO;2-S; VANNORREN D, 1990, VISION RES, V30, P1517, DOI 10.1016/0042-6989(90)90032-G; Vojnikovic B, 2010, COLLEGIUM ANTROPOL, V34, P57; Weigert G, 2011, INVEST OPHTH VIS SCI, V52, P8174, DOI 10.1167/iovs.11-7522; Westlund B, 2009, APOPTOSIS, V14, P31, DOI 10.1007/s10495-008-0285-7; Wihlmark U, 1997, FREE RADICAL BIO MED, V22, P1229, DOI 10.1016/S0891-5849(96)00555-2; YOUNG RW, 1992, J NATL MED ASSOC, V84, P353; Zhou JL, 2011, OPTOMETRY VISION SCI, V88, P759, DOI 10.1097/OPX.0b013e3182158cdd	61	75	84	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e71398	10.1371/journal.pone.0071398	http://dx.doi.org/10.1371/journal.pone.0071398			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24058402	Green Published, Green Submitted, gold			2022-12-25	WOS:000324403200007
J	Villegas-Rios, D; Alonso-Fernandez, A; Fabeiro, M; Banon, R; Saborido-Rey, F				Villegas-Rios, David; Alonso-Fernandez, Alexandre; Fabeiro, Marina; Banon, Rafael; Saborido-Rey, Fran			Demographic Variation between Colour Patterns in a Temperate Protogynous Hermaphrodite, the Ballan Wrasse Labrus bergylta	PLOS ONE			English	Article							GREAT-BARRIER-REEF; REPRODUCTIVE-BIOLOGY; AGE-STRUCTURE; GROWTH; SIZE; VALIDATION; SPECIATION; OTOLITHS; HISTORY; FISHES	Fish populations are often treated as homogeneous units in typical fishery management, thereby tacitly ignoring potential intraspecific variation which can lead to imprecise management rules. However, intraspecific variation in life-history traits is widespread and related to a variety of factors. We investigated the comparative age-based demography of the two main colour patterns of Labrus bergylta (plain and spotted, which coexist in sympatry), a commercially valuable resource in the NE Atlantic. Individuals were aged based on otolith readings after validating the annual periodicity of annuli deposition. The relationships between the otolith weight and fish age and between otolith length and fish length were strong but differed between colour patterns. The fit of the growth models to the age and length data resulted in divergent growth curves between colour morphotypes and between sexes. Males and spotted individuals attained larger mean asymptotic sizes (L-inf) than females and plain individuals, respectively, but converged to them more slowly (smaller k). Estimates of mortality based on catch curves from two independent datasets provided a global total mortality (Z) of 0.35 yr(-1), although Z was larger in plain and female individuals. Overall, the results of this research have direct implications for management of L. bergylta and, as a precautionary measure, we recommend considering both colour patterns as two different management units.	[Villegas-Rios, David; Alonso-Fernandez, Alexandre; Fabeiro, Marina; Saborido-Rey, Fran] Inst Marine Res IIM CSIC, Dept Ecol & Marine Resources, Vigo, Pontevedra, Spain; [Banon, Rafael] Conselleri Mar & Medio Rural Xunta de Galicia, Direcc Xeral Desenvolvemento Pesqueiro, Serv Planificacio, Santiago De Compostela, A Coruna, Spain; [Saborido-Rey, Fran] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); King Abdullah University of Science & Technology	Villegas-Rios, D (corresponding author), Inst Marine Res IIM CSIC, Dept Ecol & Marine Resources, Vigo, Pontevedra, Spain.	villegas@iim.csic.es	Bañón, Rafael/F-2748-2015; Saborido-Rey, Fran/A-8440-2008; Villegas Ríos, David/G-3091-2016; Bañón, Rafael/AAD-1171-2019; Alonso-Fernández, Alexandre/C-9916-2012	Bañón, Rafael/0000-0001-6038-9335; Saborido-Rey, Fran/0000-0002-2760-8169; Villegas Ríos, David/0000-0001-5660-5322; Bañón, Rafael/0000-0001-6038-9335; Alonso-Fernández, Alexandre/0000-0002-0793-2738; Villegas Rios, David/0000-0001-6384-687X	project Artevigo [09MMA022402PR]; Regional Government of Galicia (Xunta de Galicia), Spain	project Artevigo; Regional Government of Galicia (Xunta de Galicia), Spain(Xunta de Galicia)	This work was supported by the project Artevigo (Ref: 09MMA022402PR), funded by the Regional Government of Galicia (Xunta de Galicia), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Fernandez A, 2011, MAR COAST FISH, V3, P145, DOI 10.1080/19425120.2011.556927; Alonzo SH, 2004, FISH B-NOAA, V102, P1; Artuz M. L., 2005, HIDROBIOLOGICA, V3, P17; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Barreto FS, 2008, EVOLUTION, V62, P226, DOI 10.1111/j.1558-5646.2007.00285.x; Baty F, 2011, NLSTOOLS TOOLS NONLI; BEAMISH RJ, 1981, CAN J FISH AQUAT SCI, V38, P982, DOI 10.1139/f81-132; Bernatchez L, 1996, EVOLUTION, V50, P624, DOI [10.2307/2410836, 10.1111/j.1558-5646.1996.tb03873.x]; Berumen ML, 2012, CORAL REEFS, V31, P169, DOI 10.1007/s00338-011-0838-z; Beverton RJH, 1957, DYNAMICS EXPLOTED 2, VXIX; Caldow C, 2003, MAR ECOL PROG SER, V265, P185, DOI 10.3354/meps265185; Campana SE, 2001, J FISH BIOL, V59, P197, DOI 10.1006/jfbi.2001.1668; CAMPANA SE, 1985, CAN J FISH AQUAT SCI, V42, P1014, DOI 10.1139/f85-127; Cappo M, 2000, FISH B-NOAA, V98, P474; Caselle JE, 2011, CAN J FISH AQUAT SCI, V68, P288, DOI 10.1139/F10-140; CHAPMAN DG, 1960, BIOMETRICS, V16, P354, DOI 10.2307/2527687; Choat JH, 2006, MAR ECOL PROG SER, V318, P237, DOI 10.3354/meps318237; Choat JH, 1996, MAR ECOL PROG SER, V145, P33, DOI 10.3354/meps145033; Choat JH, 2003, MAR ECOL PROG SER, V246, P265, DOI 10.3354/meps246265; Choat JH, 1996, MAR ECOL PROG SER, V134, P15, DOI 10.3354/meps134015; Choat JH, 2012, BIOL J LINN SOC, V107, P529, DOI 10.1111/j.1095-8312.2012.01959.x; Committee of Age Reading Experts, 2006, MAN GEN AG DET PROC, V52; Cossington S, 2010, J FISH BIOL, V77, P600, DOI 10.1111/j.1095-8649.2010.02706.x; Costello M.J., 1991, Progress in Underwater Science, V16, P29; Craig P, 2005, NAGA, V22, P28; DIPPER FA, 1979, J ZOOL, V187, P97; DIPPER FA, 1977, J FISH BIOL, V11, P105, DOI 10.1111/j.1095-8649.1977.tb04103.x; Elmer KR, 2009, EVOLUTION, V63, P2750, DOI 10.1111/j.1558-5646.2009.00736.x; FOWLER AJ, 1990, MAR ECOL PROG SER, V64, P25, DOI 10.3354/meps064025; FRANCIS RICC, 1988, CAN J FISH AQUAT SCI, V45, P936, DOI 10.1139/f88-115; Gordoa A, 2000, FISH RES, V45, P43, DOI 10.1016/S0165-7836(99)00094-6; Gust N, 2002, MAR BIOL, V140, P1039, DOI 10.1007/s00227-001-0773-6; Hamilton SL, 2007, ECOL APPL, V17, P2268, DOI 10.1890/06-1930.1; ICES, 2006, WORKSH AG DET REDF W; JONSSON B, 1993, REV FISH BIOL FISHER, V3, P348, DOI 10.1007/BF00043384; KIMURA DK, 1980, FISH B-NOAA, V77, P765; Linde M, 2011, ENVIRON BIOL FISH, V92, P337, DOI 10.1007/s10641-011-9844-9; Meekan MG, 2001, MAR ECOL PROG SER, V212, P223, DOI 10.3354/meps212223; Morita K, 2009, ECOL RES, V24, P711, DOI 10.1007/s11284-008-0579-9; MULLIGAN TJ, 1992, CAN J FISH AQUAT SCI, V49, P632, DOI 10.1139/f92-072; Munch SB, 2009, P NATL ACAD SCI USA, V106, P13860, DOI 10.1073/pnas.0900300106; Munoz RC, 2004, BEHAV ECOL, V15, P129, DOI 10.1093/beheco/arg086; Nogueira E, 1997, ESTUAR COAST SHELF S, V44, P285, DOI 10.1006/ecss.1996.0119; Ogle D., 2016, FSA FISHERIES STOCK; PALUMBI SR, 1992, TRENDS ECOL EVOL, V7, P114, DOI 10.1016/0169-5347(92)90144-Z; Panfili J, 2002, MANUAL FISH SCLEROCH; Pauly D., 1984, ICLARM Technical Reports, P1; Pears RJ, 2006, MAR ECOL PROG SER, V307, P259, DOI 10.3354/meps307259; Pilling GM, 2002, CAN J FISH AQUAT SCI, V59, P424, DOI 10.1139/F02-022; Planes S, 1997, MAR BIOL, V130, P109, DOI 10.1007/s002270050230; Porteiro Felipe Mora, 1996, Arquipelago Boletim da Universidade dos Acores Ciencias Biologicas e Marinhas, V14A, P23; Puebla O, 2009, J FISH BIOL, V75, P960, DOI 10.1111/j.1095-8649.2009.02358.x; Puebla O, 2007, P ROY SOC B-BIOL SCI, V274, P1265, DOI 10.1098/rspb.2006.0435; R Development Core Team, 2011, R LANG ENV STAT COMP; Rhodes KL, 2011, MAR ECOL PROG SER, V421, P183, DOI 10.3354/meps08904; ROFF DA, 1983, CAN J FISH AQUAT SCI, V40, P1395, DOI 10.1139/f83-161; SADOVY Y, 1987, COPEIA, P136, DOI 10.2307/1446046; Sherwood GD, 2010, ICES J MAR SCI, V67, P1640, DOI 10.1093/icesjms/fsq094; Sjolander S., 1972, Revue Comport Anim, V6, P43; Stearns S.C., 1992, pi; Talbot C, 2012, 54 SCOTT SALM PROD O, P54; Thorson JT, 2011, T AM FISH SOC, V140, P356, DOI 10.1080/00028487.2011.557016; Trip EL, 2008, MAR ECOL PROG SER, V373, P97, DOI 10.3354/meps07755; Villegas-Rios D, MAR FRESHW IN PRESS; Villegas-Rios D, 2013, J SEA RES, V80, P61, DOI 10.1016/j.seares.2013.02.009; Wakefield CB, 2010, ICES J MAR SCI, V67, P1164, DOI 10.1093/icesjms/fsq021; Williams Ashley J., 2009, Endangered Species Research, V9, P67, DOI 10.3354/esr00237; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	68	21	21	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e71591	10.1371/journal.pone.0071591	http://dx.doi.org/10.1371/journal.pone.0071591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24058404	Green Published, Green Submitted, gold			2022-12-25	WOS:000324403200012
J	Sabit, H; Mallajosyula, SS; MacKerell, AD; Swaan, PW				Sabit, Hairat; Mallajosyula, Sairam S.; MacKerell, Alexander D., Jr.; Swaan, Peter W.			Transmembrane Domain II of the Human Bile Acid Transporter SLC10A2 Coordinates Sodium Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drug Transport; Membrane Proteins; Membrane Transport; Site-directed Mutagenesis; Transporters	MOLECULAR-DYNAMICS SIMULATIONS; SUBSTRATE TRANSLOCATION; ASBT SLC10A2; HASBT; MUTAGENESIS; INHIBITORS; TOPOLOGY; PROTEINS; RESIDUES; PATHWAY	Human apical sodium-dependent bile acid transporter (hASBT, SLC10A2) is responsible for intestinal reabsorption of bile acids and plays a key role in cholesterol homeostasis. We used a targeted and systematic approach to delineate the role of highly conserved transmembrane helix 2 on the expression and function of hASBT. Cysteine mutation significantly depressed transport activity for >60% of mutants without affecting cell surface localization of the transporter. All mutants were inaccessible toward chemical modification by membrane-impermeant MTSET reagent, strongly suggesting that transmembrane 2 (TM2) plays an indirect role in bile acid substrate translocation. Both bile acid uptake and sodium dependence of TM2 mutants revealed a distinct -helical periodicity. Kinetic studies with conservative and non-conservative mutants of sodium sensitive residues further underscored the importance of Gln(75), Phe(76), Met(79), Gly(83), Leu(86), Phe(90), and Asp(91) in hASBT function. Computational analysis indicated that Asp(91) may coordinate with sodium during the transport cycle. Combined, our data propose that a consortium of sodium-sensitive residues along with previously reported residues (Thr(134), Leu(138), and Thr(149)) from TM3 may form the sodium binding and translocation pathway. Notably, residues Gln(75), Met(79), Thr(82), and Leu(86) from TM2 are highly conserved in TM3 of a putative remote bacterial homologue (ASBT(NM)), suggesting a universal mechanism for the SLC10A transporter family.	[Sabit, Hairat; Mallajosyula, Sairam S.; MacKerell, Alexander D., Jr.; Swaan, Peter W.] Univ Maryland, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Swaan, PW (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, 20 Penn St, Baltimore, MD 21201 USA.	pswaan@rx.umaryland.edu	MacKerell, Alex/Y-2469-2019; MacKerell, Alex/AAA-2560-2020	MacKerell, Alex/0000-0001-8287-6804; Swaan, Peter/0000-0003-1767-1487	National Science Foundation [OCI-1053575]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061425] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Tatiana Claro da Silva for excellent advice during the course of this work. We also thank Dr. Robyn Moore for critical reading of the manuscript. This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation Grant OCI-1053575. We also acknowledge the use of computational facilities at computer aided drug design (CADD), University of Maryland Baltimore.	Balakrishnan A, 2006, MOL PHARMACEUT, V3, P223, DOI 10.1021/mp060022d; Banerjee A, 2006, BIOCHEMISTRY-US, V45, P943, DOI 10.1021/bi052202j; Banerjee A, 2005, BIOCHEMISTRY-US, V44, P8908, DOI 10.1021/bi050553s; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; da Silva TC, 2011, J BIOL CHEM, V286, P27322, DOI 10.1074/jbc.M110.217802; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dawson PA, 2011, HANDB EXP PHARMACOL, V201, P169, DOI 10.1007/978-3-642-14541-4_4; Dawson PA, 2009, J LIPID RES, V50, P2340, DOI 10.1194/jlr.R900012-JLR200; Gibbs N, 1997, BIOPHYS J, V72, P2490, DOI 10.1016/S0006-3495(97)78893-3; Gonzalez PM, 2012, PHARM RES-DORDR, V29, P1821, DOI 10.1007/s11095-012-0706-8; Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6; Hu NJ, 2011, NATURE, V478, P408, DOI 10.1038/nature10450; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hussainzada N, 2008, J BIOL CHEM, V283, P20653, DOI 10.1074/jbc.M802885200; Hussainzada N, 2008, MOL PHARMACOL, V73, P305, DOI 10.1124/mol.107.041640; Hussainzada N, 2006, MOL PHARMACOL, V70, P1565, DOI 10.1124/mol.106.028647; Hussainzada N, 2009, BIOCHEMISTRY-US, V48, P8528, DOI 10.1021/bi900616w; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Khantwal CM, 2008, BIOCHEMISTRY-US, V47, P3606, DOI 10.1021/bi702498w; Kitayama K, 2006, EUR J PHARMACOL, V539, P89, DOI 10.1016/j.ejphar.2006.04.005; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Lionarons DA, 2012, J LIPID RES, V53, P1535, DOI 10.1194/jlr.M025726; LOO TW, 1993, J BIOL CHEM, V268, P3143; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Moore RH, 2013, BIOCHEMISTRY-US, V52, P5117, DOI 10.1021/bi400028q; Rais R, 2011, J PHARM SCI-US, V100, P1184, DOI 10.1002/jps.22332; Ray A, 2006, BIOORG MED CHEM LETT, V16, P1473, DOI 10.1016/j.bmcl.2005.12.050; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Tremont SJ, 2005, J MED CHEM, V48, P5837, DOI 10.1021/jm040215+; Weinman SA, 1998, J BIOL CHEM, V273, P34691, DOI 10.1074/jbc.273.52.34691; Zhang EY, 2004, BIOCHEMISTRY-US, V43, P11380, DOI 10.1021/bi049270a	34	7	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32394	32404		10.1074/jbc.M113.518555	http://dx.doi.org/10.1074/jbc.M113.518555			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24045943	hybrid, Green Published			2022-12-25	WOS:000328681700024
J	Gupta, S; Bhar, A; Chatterjee, M; Das, S				Gupta, Sumanti; Bhar, Anirban; Chatterjee, Moniya; Das, Sampa			Fusarium oxysporum f.sp ciceri Race 1 Induced Redox State Alterations Are Coupled to Downstream Defense Signaling in Root Tissues of Chickpea (Cicer arietinum L.)	PLOS ONE			English	Article							F-SP CICERIS; REACTIVE OXYGEN; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; INCOMPATIBLE INTERACTIONS; INOCULUM DENSITY; TRANSPORTER GENE; PROTEIN-KINASE; JASMONIC ACID; HIGH-SALINITY	Reactive oxygen species are known to play pivotal roles in pathogen perception, recognition and downstream defense signaling. But, how these redox alarms coordinate in planta into a defensive network is still intangible. Present study illustrates the role of Fusarium oxysporum f.sp ciceri Race1 (Foc1) induced redox responsive transcripts in regulating downstream defense signaling in chickpea. Confocal microscopic studies highlighted pathogen invasion and colonization accompanied by tissue damage and deposition of callose degraded products at the xylem vessels of infected roots of chickpea plants. Such depositions led to the clogging of xylem vessels in compatible hosts while the resistant plants were devoid of such obstructions. Lipid peroxidation assays also indicated fungal induced membrane injury. Cell shrinkage and gradual nuclear adpression appeared as interesting features marking fungal ingress. Quantitative real time polymerase chain reaction exhibited differential expression patterns of redox regulators, cellular transporters and transcription factors during Foc1 progression. Network analysis showed redox regulators, cellular transporters and transcription factors to coordinate into a well orchestrated defensive network with sugars acting as internal signal modulators. Respiratory burst oxidase homologue, cationic peroxidase, vacuolar sorting receptor, polyol transporter, sucrose synthase, and zinc finger domain containing transcription factor appeared as key molecular candidates controlling important hubs of the defense network. Functional characterization of these hub controllers may prove to be promising in understanding chickpea-Foc1 interaction and developing the case study as a model for looking into the complexities of wilt diseases of other important crop legumes.	[Gupta, Sumanti; Bhar, Anirban; Chatterjee, Moniya; Das, Sampa] Bose Inst, Div Plant Biol, Kolkata, W Bengal, India	Department of Science & Technology (India); Bose Institute	Das, S (corresponding author), Bose Inst, Div Plant Biol, Kolkata, W Bengal, India.	sampa@mail.jcbose.ac.in	Bhar, Anirban/ADE-5445-2022	BHAR, ANIRBAN/0000-0002-7535-3447	Department of Biotechnology, Government of India [BT/PR9593/AGR/02/444/2007]; Council of Scientific and Industrial Research, India [09/015(0378)/2009-EMR-1]; Council of Scientific and Industrial Research-NMITLI, India [5/258/53/2006-NMITLI]; Bose Institute, Department of Science and technology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research-NMITLI, India; Bose Institute, Department of Science and technology, Government of India(Department of Science & Technology (India))	This work was supported by the grant provided to SG by Department of Biotechnology, Government of India (Grant number: BT/PR9593/AGR/02/444/2007), to AB by Council of Scientific and Industrial Research, India (Grant number: 09/015(0378)/2009-EMR-1) and to MC by Council of Scientific and Industrial Research-NMITLI, India (Grant number: 5/258/53/2006-NMITLI). SD was supported by funds provided by Bose Institute, Department of Science and technology, Government of India. The funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersson E, 2005, PLANT MOL BIOL, V59, P469, DOI 10.1007/s11103-005-0352-1; Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Anil VS, 2008, J BIOL CHEM, V283, P3497, DOI 10.1074/jbc.M700766200; Ashraf N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-415; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Avila EL, 2008, J EXP BOT, V59, P1149, DOI 10.1093/jxb/ern025; BAILEY BA, 1990, PLANT PHYSIOL, V94, P1849, DOI 10.1104/pp.94.4.1849; Barabutis N, 2008, P NATL ACAD SCI USA, V105, P20470, DOI 10.1073/pnas.0811209106; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Benz JP, 2010, TRENDS PLANT SCI, V15, P608, DOI 10.1016/j.tplants.2010.08.008; Bhadauria V, 2010, BIOTECH HISTOCHEM, V85, P99, DOI [10.3109/10520290903132196, 10.1080/10520290903132196]; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; Bourdel-Marchasson I, 2001, AGE AGEING, V30, P235, DOI 10.1093/ageing/30.3.235; BRODY JDY, 2006, NAT IMMUNOL, V7, P1243; Campbell EJ, 2003, PLANT PHYSIOL, V133, P1272, DOI 10.1104/pp.103.024182; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Cheng ZW, 2011, MOL PLANT, V4, P279, DOI 10.1093/mp/ssq073; Chow PS, 2004, TREE PHYSIOL, V24, P1129, DOI 10.1093/treephys/24.10.1129; Coego A, 2005, PLANT CELL, V17, P2123, DOI 10.1105/tpc.105.032375; Couee I, 2006, J EXP BOT, V57, P449, DOI 10.1093/jxb/erj027; Dangl JL, 2007, SCIENCE, V315, P1088, DOI 10.1126/science.1138991; Davletova S, 2005, PLANT PHYSIOL, V139, P847, DOI 10.1104/pp.105.068254; De Smet I, 2003, PLANT J, V33, P543, DOI 10.1046/j.1365-313X.2003.01652.x; Dean JD, 2005, J EXP BOT, V56, P1525, DOI 10.1093/jxb/eri145; Denness L, 2011, PLANT PHYSIOL, V156, P1364, DOI 10.1104/pp.111.175737; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dos Santos CV, 2006, TRENDS PLANT SCI, V11, P329, DOI 10.1016/j.tplants.2006.05.005; Eichhorn H, 2006, J EXP BOT, V57, P2193, DOI 10.1093/jxb/erj179; Elmore JM, 2011, MOL PLANT, V4, P416, DOI 10.1093/mp/ssq083; GALATIS B, 2010, PLANT SIGNAL BEHAV, V5, pE11; Garcia-Brugger A, 2006, MOL PLANT MICROBE IN, V19, P711, DOI 10.1094/MPMI-19-0711; Garcia-Limones C, 2002, PHYSIOL MOL PLANT P, V61, P325, DOI 10.1006/pmpp.2003.0445; Garg R, 2010, BIOCHEM BIOPH RES CO, V396, P283, DOI 10.1016/j.bbrc.2010.04.079; Genre A, 2008, PLANT CELL, V20, P1407, DOI 10.1105/tpc.108.059014; Gilmour SJ, 2000, PLANT PHYSIOL, V124, P1854, DOI 10.1104/pp.124.4.1854; Giri AP, 1998, PLANT PATHOL, V47, P693, DOI 10.1046/j.1365-3059.1998.00299.x; Gu Y, 2008, P NATL ACAD SCI USA, V105, P18064, DOI 10.1073/pnas.0808652105; Gupta S, 2010, PLOS ONE, V5, P1; Gupta S, 2009, PHYTOPATHOLOGY, V99, P1245, DOI 10.1094/PHYTO-99-11-1245; Hardham AR, 2007, CURR OPIN PLANT BIOL, V10, P342, DOI 10.1016/j.pbi.2007.05.001; HAWARE MP, 1982, PLANT DIS, V66, P809, DOI 10.1094/PD-66-809; Heath MC, 1997, NEW PHYTOL, V135, P689, DOI 10.1046/j.1469-8137.1997.00710.x; Heller J, 2011, ANNU REV PHYTOPATHOL, V49, P369, DOI 10.1146/annurev-phyto-072910-095355; Hwang I, 2000, P NATL ACAD SCI USA, V97, P6224, DOI 10.1073/pnas.97.11.6224; Jelic M, 2003, BIOCHEMISTRY-US, V42, P5906, DOI 10.1021/bi034001q; Jeong J, 2009, PLANT SCI, V176, P709, DOI 10.1016/j.plantsci.2009.02.011; Jimenez-Fernandez D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061360; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kachroo A, 2009, ANNU REV PHYTOPATHOL, V47, P153, DOI 10.1146/annurev-phyto-080508-081820; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; Khatib M, 2004, NEW PHYTOL, V162, P501, DOI 10.1111/j.1469-8137.2004.01043.x; Kiraly L., 2006, Acta Phytopathologica et Entomologica Hungarica, V41, P11, DOI 10.1556/APhyt.41.2006.1-2.2; Klepek YS, 2005, PLANT CELL, V17, P204, DOI 10.1105/tpc.104.026641; Kwak KJ, 2007, PLANT CELL PHYSIOL, V48, P221, DOI 10.1093/pcp/pcl057; Laskowski MJ, 2002, PLANT PHYSIOL, V128, P578, DOI 10.1104/pp.010581; Law AHY, 2012, PROTOPLASMA, V249, P269, DOI 10.1007/s00709-011-0295-0; Levitan A, 2004, J BIOL CHEM, V279, P20002, DOI 10.1074/jbc.M312877200; Lin F, 2009, J EXP BOT, V60, P3221, DOI 10.1093/jxb/erp157; Liu XM, 2010, PLANT PHYSIOL, V152, P985, DOI 10.1104/pp.109.150656; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manavella PA, 2008, PLANT J, V56, P376, DOI 10.1111/j.1365-313X.2008.03604.x; Martin G, 2004, RNA, V10, P899, DOI 10.1261/rna.5242304; Mengiste T, 2003, PLANT CELL, V15, P2551, DOI 10.1105/tpc.014167; Miller G, 2006, ANN BOT-LONDON, V98, P279, DOI 10.1093/aob/mcl107; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Nagaoka S, 2003, J EXP BOT, V54, P2231, DOI 10.1093/jxb/erg241; Navas-Cortes JA, 2000, EUR J PLANT PATHOL, V106, P135, DOI 10.1023/A:1008727815927; Navas-Cortes JA, 2007, PHYTOPATHOLOGY, V97, P564, DOI 10.1094/PHYTO-97-5-0564; O'Connell RJ, 2006, NEW PHYTOL, V171, P699, DOI 10.1111/j.1469-8137.2006.01829.x; Okubara PA, 2005, PLANT SOIL, V274, P215, DOI 10.1007/s11104-004-7328-9; Oliver RP, 2004, MOL PLANT PATHOL, V5, P347, DOI 10.1111/j.1364-3703.2004.00228.x; Pauwels L, 2008, PLANT SIGNAL BEHAV, V3, P846, DOI 10.4161/psb.3.10.5993; Perez-Gomez J, 2007, CURR BIOL, V17, pR217, DOI 10.1016/j.cub.2007.01.045; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Proels RK, 2010, MOL PLANT MICROBE IN, V23, P1143, DOI 10.1094/MPMI-23-9-1143; Raffaele S, 2008, PLANT CELL, V20, P752, DOI 10.1105/tpc.107.054858; Reinders A, 2005, J BIOL CHEM, V280, P1594, DOI 10.1074/jbc.M410831200; Rivas S, 2004, EMBO J, V23, P2156, DOI 10.1038/sj.emboj.7600224; Ronald PC, 2010, SCIENCE, V330, P1061, DOI 10.1126/science.1189468; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Sakamoto H, 2004, PLANT PHYSIOL, V136, P2734, DOI 10.1104/pp.104.046599; Sayanova O, 1997, P NATL ACAD SCI USA, V94, P4211, DOI 10.1073/pnas.94.8.4211; Slewinski TL, 2011, MOL PLANT, V4, P641, DOI 10.1093/mp/ssr051; STANGHELLINI ME, 1993, PHYTOPATHOLOGY, V83, P1498, DOI 10.1094/Phyto-83-1498; STRITTMATTER P, 1965, J BIOL CHEM, V240, P4481; Strompen G, 2005, PLANT J, V41, P125, DOI 10.1111/j.1365-313X.2004.02283.x; Summerell BA, 2003, PLANT DIS, V87, P117, DOI 10.1094/PDIS.2003.87.2.117; Talbot NJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000308; Tamura K, 2010, PLANT CELL, V22, P4084, DOI 10.1105/tpc.110.079947; Thomma BPHJ, 2011, PLANT CELL, V23, P4, DOI 10.1105/tpc.110.082602; Truernit E, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-15; Tsuda K, 2010, CURR OPIN PLANT BIOL, V13, P459, DOI 10.1016/j.pbi.2010.04.006; Tsuda K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000772; Tuteja Narendra, 2008, Physiology and Molecular Biology of Plants, V14, P101, DOI 10.1007/s12298-008-0009-z; Van Breusegem F, 2008, PLANT PHYSIOL, V147, P978, DOI 10.1104/pp.108.122325; Van den Ende W, 2009, J EXP BOT, V60, P9, DOI 10.1093/jxb/ern297; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; van Doorn WG, 2011, CELL DEATH DIFFER, V18, P1241, DOI 10.1038/cdd.2011.36; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Vellosillo T, 2010, PLANT PHYSIOL, V154, P444, DOI 10.1104/pp.110.161273; Wang W, 2003, ELECTROPHORESIS, V24, P2369, DOI 10.1002/elps.200305500; WEI ZM, 1992, SCIENCE, V257, P85, DOI 10.1126/science.1621099; Wise RP, 2007, ANNU REV PHYTOPATHOL, V45, P329, DOI 10.1146/annurev.phyto.45.011107.143944; YOUNG SA, 1995, PLANT PHYSIOL, V107, P1333, DOI 10.1104/pp.107.4.1333; YUN BW, 2011, BIOCH BIOPH IN PRESS; Zabotin AI, 2002, RUSS J PLANT PHYSL+, V49, P792, DOI 10.1023/A:1020969730151; Zhang K, 1996, PLANTA, V200, P2; Zhu HY, 2005, PLANT PHYSIOL, V137, P1189, DOI 10.1104/pp.104.058891; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	112	31	31	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73163	10.1371/journal.pone.0073163	http://dx.doi.org/10.1371/journal.pone.0073163			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058463	Green Submitted, Green Published, gold			2022-12-25	WOS:000324408400019
J	Bilardi, JE; Walker, S; Temple-Smith, M; McNair, R; Mooney-Somers, J; Bellhouse, C; Fairley, CK; Chen, MY; Bradshaw, C				Bilardi, Jade E.; Walker, Sandra; Temple-Smith, Meredith; McNair, Ruth; Mooney-Somers, Julie; Bellhouse, Clare; Fairley, Christopher K.; Chen, Marcus Y.; Bradshaw, Catriona			The Burden of Bacterial Vaginosis: Women's Experience of the Physical, Emotional, Sexual and Social Impact of Living with Recurrent Bacterial Vaginosis	PLOS ONE			English	Article							TRANSMITTED INFECTIONS; PRETERM DELIVERY; PREVALENCE; LESBIANS; INTERVIEWS; BEHAVIORS; TRACT; HPV	Background: Bacterial vaginosis is a common vaginal infection, causing an abnormal vaginal discharge and/or odour in up to 50% of sufferers. Recurrence is common following recommended treatment. There are limited data on women's experience of bacterial vaginosis, and the impact on their self-esteem, sexual relationships and quality of life. The aim of this study was to explore the experiences and impact of recurrent bacterial vaginosis on women. Methods: A social constructionist approach was chosen as the framework for the study. Thirty five women with male and/or female partners participated in semi-structured interviews face-to-face or by telephone about their experience of recurrent bacterial vaginosis. Results: Recurrent bacterial vaginosis impacted on women to varying degrees, with some women reporting it had little impact on their lives but most reporting it had a moderate to severe impact. The degree to which it impacted on women physically, emotionally, sexually and socially often depended on the frequency of episodes and severity of symptoms. Women commonly reported that symptoms of bacterial vaginosis made them feel embarrassed, ashamed, 'dirty' and very concerned others may detect their malodour and abnormal discharge. The biggest impact of recurrent bacterial vaginosis was on women's self-esteem and sex lives, with women regularly avoiding sexual activity, in particular oral sex, as they were too embarrassed and self-conscious of their symptoms to engage in these activities. Women often felt confused about why they were experiencing recurrent bacterial vaginosis and frustrated at their lack of control over recurrence. Conclusion: Women's experience of recurrent bacterial vaginosis varied broadly and significantly in this study. Some women reported little impact on their lives but most reported a moderate to severe impact, mainly on their self-esteem and sex life. Further support and acknowledgement of these impacts are required when managing women with recurrent bacterial vaginosis.	[Bilardi, Jade E.; Bradshaw, Catriona] Monash Univ, Dept Epidemiol & Preventat Med, Melbourne, Vic 3004, Australia; [Bilardi, Jade E.; Walker, Sandra; Bellhouse, Clare; Fairley, Christopher K.; Chen, Marcus Y.; Bradshaw, Catriona] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Temple-Smith, Meredith; McNair, Ruth] Univ Melbourne, Gen Practice & Primary Hlth Care Acad Ctr, Melbourne, Vic, Australia; [Mooney-Somers, Julie] Univ Sydney, Ctr Values Eth & Law Med, Sydney, NSW 2006, Australia; [Mooney-Somers, Julie] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Bilardi, Jade E.; Walker, Sandra; Fairley, Christopher K.; Chen, Marcus Y.; Bradshaw, Catriona] Alfred Hlth, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia	Monash University; University of Melbourne; University of Melbourne; University of Sydney; University of Sydney	Bilardi, JE (corresponding author), Monash Univ, Dept Epidemiol & Preventat Med, Melbourne, Vic 3004, Australia.	jbilardi@mshc.org.au	McNair, Ruth P/B-3027-2012; Mooney-Somers, Julie/D-1824-2010	Mooney-Somers, Julie/0000-0003-4047-3403; Bilardi, Jade/0000-0003-0461-2605; Christopher, Fairley/0000-0001-9081-1664; Temple-Smith, Meredith/0000-0003-1296-9591; bradshaw, catriona/0000-0002-6643-5678; McNair, Ruth/0000-0002-4738-8781	Australian Lesbian Medical Association; ACON; National Health and Medical Research Centre (NHMRC) [GNT1013135]	Australian Lesbian Medical Association; ACON; National Health and Medical Research Centre (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	In the conduct of this study a small grant was utilised from the Australian Lesbian Medical Association (www.almas.org.au) and ACON (www.acon.org.au). Dr Jade Bilardi is in receipt of a National Health and Medical Research Centre (NHMRC) Early Career Fellowship GNT1013135. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsworth JE, 2007, OBSTET GYNECOL, V109, P114, DOI 10.1097/01.AOG.0000247627.84791.91; [Anonymous], 2008, NORD REV, DOI [DOI 10.1515/nor-2017-0181, DOI 10.1177/0022146510383495]; Bailey JV, 2004, SEX TRANSM DIS, V31, P691, DOI 10.1097/01.olq.0000143093.70899.68; Berger BJ, 1995, CLIN INFECT DIS, V21, P1402, DOI 10.1093/clinids/21.6.1402; Bradshaw CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057688; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; Bradshaw CS, 2011, WOMEN WHO HAVE SEX W; Braun V., 2006, MAY, V3, P77, DOI 10.1191/1478088706qp063oa; Carter Stacy M, 2009, N S W Public Health Bull, V20, P105, DOI 10.1071/NB09018; Chapple A, 2000, J REPROD INFANT PSYC, V18, P309, DOI 10.1080/713683045; Chico RM, 2012, JAMA-J AM MED ASSOC, V307, P2079, DOI 10.1001/jama.2012.3428; Conrad P., 1987, RES SOCIOLOGY HLTH C, V6, P1; Daley EM, 2010, J HEALTH PSYCHOL, V15, P279, DOI 10.1177/1359105309351249; Darlaston-Jones D, 2007, AUST COMMUNITY PSYCH, V19, P19; Duncan B, 2001, BRIT MED J, V322, P195, DOI 10.1136/bmj.322.7280.195; EASMON CSF, 1992, GENITOURIN MED, V68, P134; Evans AL, 2007, SEX TRANSM INFECT, V83, P470, DOI 10.1136/sti.2006.022277; Fethers K, 2000, SEX TRANSM INFECT, V76, P345, DOI 10.1136/sti.76.5.345; Fethers KA, 2008, CLIN INFECT DIS, V47, P1426, DOI 10.1086/592974; Fethers KA, 2009, J INFECT DIS, V200, P1662, DOI 10.1086/648092; Gribch C, 2013, QUALITATIVE DATA ANA; HAY PE, 1994, BRIT MED J, V308, P295, DOI 10.1136/bmj.308.6924.295; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Holzman C, 2001, AM J PUBLIC HEALTH, V91, P1664, DOI 10.2105/AJPH.91.10.1664; Hutchinson KB, 2007, SEX TRANSM DIS, V34, P671, DOI 10.1097/01.olq.0000258435.34879.da; Irving G, 1998, SEX TRANSM INFECT, V74, P334, DOI 10.1136/sti.74.5.334; Karasz A, 2003, SOC SCI MED, V56, P1013, DOI 10.1016/S0277-9536(02)00092-8; Marrazzo JM, 2010, SEX TRANSM DIS, V37, P335, DOI 10.1097/OLQ.0b013e3181ca3cac; McCaffery K, 2006, SEX TRANSM INFECT, V82, P169, DOI 10.1136/sti.2005.016436; Ness RB, 2002, OBSTET GYNECOL, V100, P765, DOI 10.1016/S0029-7844(02)02184-1; Newton DC, 2008, J HEALTH PSYCHOL, V13, P864, DOI 10.1177/1359105308095058; Newton Danielle C, 2005, Sex Health, V2, P63, DOI 10.1071/SH04015; Novick G, 2008, RES NURS HEALTH, V31, P391, DOI 10.1002/nur.20259; Payne SC, 2010, J AM ACAD NURSE PRAC, V22, P101, DOI 10.1111/j.1745-7599.2009.00474.x; Sewankambo N, 1997, LANCET, V350, P546, DOI 10.1016/S0140-6736(97)01063-5; Sobel JD, 1997, NEW ENGL J MED, V337, P1896, DOI 10.1056/NEJM199712253372607; Sturges JE., 2004, QUAL RES, V4, P107, DOI [DOI 10.1177/1468794104041110, 10.1177/1468794104041110]; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042	38	87	94	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74378	10.1371/journal.pone.0074378	http://dx.doi.org/10.1371/journal.pone.0074378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	248VW	24040236	Green Published, gold			2022-12-25	WOS:000326734500088
J	Cinner, JE; Huchery, C; Darling, ES; Humphries, AT; Graham, NAJ; Hicks, CC; Marshall, N; McClanahan, TR				Cinner, Joshua E.; Huchery, Cindy; Darling, Emily S.; Humphries, Austin T.; Graham, Nicholas A. J.; Hicks, Christina C.; Marshall, Nadine; McClanahan, Tim R.			Evaluating Social and Ecological Vulnerability of Coral Reef Fisheries to Climate Change	PLOS ONE			English	Article							RESILIENCE; IMPACTS; COMANAGEMENT; PERSPECTIVE; COMMUNITIES; ADAPTATION; MANAGEMENT; FISH	There is an increasing need to evaluate the links between the social and ecological dimensions of human vulnerability to climate change. We use an empirical case study of 12 coastal communities and associated coral reefs in Kenya to assess and compare five key ecological and social components of the vulnerability of coastal social-ecological systems to temperature induced coral mortality [specifically: 1) environmental exposure; 2) ecological sensitivity; 3) ecological recovery potential; 4) social sensitivity; and 5) social adaptive capacity]. We examined whether ecological components of vulnerability varied between government operated no-take marine reserves, community-based reserves, and openly fished areas. Overall, fished sites were marginally more vulnerable than community-based and government marine reserves. Social sensitivity was indicated by the occupational composition of each community, including the importance of fishing relative to other occupations, as well as the susceptibility of different fishing gears to the effects of coral bleaching on target fish species. Key components of social adaptive capacity varied considerably between the communities. Together, these results show that different communities have relative strengths and weaknesses in terms of social-ecological vulnerability to climate change.	[Cinner, Joshua E.; Huchery, Cindy; Graham, Nicholas A. J.; Hicks, Christina C.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Darling, Emily S.] Simon Fraser Univ, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada; [Humphries, Austin T.] Rhodes Univ, Coastal Res Grp, ZA-6140 Grahamstown, South Africa; [Humphries, Austin T.] Wildlife Conservat Soc, Coral Reef Conservat Project, Mombasa, Kenya; [Marshall, Nadine] Commonwealth Sci & Ind Res Org, Ecosyst Sci, Townsville, Qld, Australia; [McClanahan, Tim R.] Wildlife Conservat Soc, Marine Programs, Bronx, NY USA	James Cook University; Simon Fraser University; Rhodes University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Wildlife Conservation Society	Cinner, JE (corresponding author), James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	joshua.cinner@jcu.edu.au	McClanahan, Tim/K-4998-2019; Graham, Nicholas AJ/C-8360-2014; Marshall, Nadine/D-9339-2011; Cinner, Joshua e/E-8966-2011; Hicks, Christina/M-6182-2015; Cinner, Joshua/AAA-6823-2021	Graham, Nicholas AJ/0000-0002-0304-7467; Marshall, Nadine/0000-0003-4463-3558; Cinner, Joshua e/0000-0003-2675-9317; Hicks, Christina/0000-0002-7399-4603; Darling, Emily/0000-0002-1048-2838; McClanahan, Timothy/0000-0001-5821-3584; huchery, cindy/0000-0002-5657-7584	Australian Research Council; United Nations Food and Agricultural Organization (FAO)	Australian Research Council(Australian Research Council); United Nations Food and Agricultural Organization (FAO)	The Australian Research Council and the United Nations Food and Agricultural Organization (FAO) funded this research. This paper is based on an unpublished report to FAO led by JEC titled "Social-ecological vulnerability of coral reef fisheries to climatic shocks." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006; Adger WN, 2005, CR GEOSCI, V337, P399, DOI 10.1016/j.crte.2004.11.004; Adger WN, 2000, PROG HUM GEOG, V24, P347, DOI 10.1191/030913200701540465; Adger WN, 2005, SCIENCE, V309, P1036, DOI 10.1126/science.1112122; Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; [Anonymous], 2009, CLIMATE CHANGE IMPLI; Ateweberhan M, 2011, CORAL REEFS, V30, P739, DOI 10.1007/s00338-011-0775-x; Badjeck MC, 2010, MAR POLICY, V34, P375, DOI 10.1016/j.marpol.2009.08.007; Bell, 2011, VULNERABILITY TROPIC; Bene C, 2011, GLOBAL ENVIRON CHANG, V21, P1173, DOI 10.1016/j.gloenvcha.2011.07.002; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Cinner JE, 2012, GLOBAL ENVIRON CHANG, V22, P651, DOI 10.1016/j.gloenvcha.2012.03.002; Cinner JE, 2012, GLOBAL ENVIRON CHANG, V22, P12, DOI 10.1016/j.gloenvcha.2011.09.018; Cinner JE, 2012, P NATL ACAD SCI USA, V109, P5219, DOI 10.1073/pnas.1121215109; Cinner JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011999; Cinner JE, 2009, J APPL ECOL, V46, P724, DOI 10.1111/j.1365-2664.2009.01648.x; Cutter SL, 1996, PROG HUM GEOG, V20, P529, DOI 10.1177/030913259602000407; Daw TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031460; Donner SD, 2007, BIOSCIENCE, V57, P214, DOI 10.1641/B570302; Elsner JB, 2008, NATURE, V455, P92, DOI 10.1038/nature07234; Folke C, 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI 10.1016/j.gloenvcha.2006.04.002; Gallopin GC, 2006, GLOBAL ENVIRON CHANG, V16, P293, DOI 10.1016/j.gloenvcha.2006.02.004; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Grandcourt EM, 2003, FISH RES, V60, P539, DOI 10.1016/S0165-7836(02)00173-X; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes S, 2012, ENVIRON SCI POLICY, V23, P95, DOI 10.1016/j.envsci.2012.07.012; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; IPCC Working Group I Four Assessment Report, 2007, CLIMATE CHANGE 2001; Kelly PM, 2000, CLIMATIC CHANGE, V47, P325, DOI 10.1023/A:1005627828199; MacNeil MA, 2010, GLOBAL ECOL BIOGEOGR, V19, P412, DOI 10.1111/j.1466-8238.2009.00515.x; Madin JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046637; Maina J, 2008, ECOL MODEL, V212, P180, DOI 10.1016/j.ecolmodel.2007.10.033; Maina J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023064; Marshall NA., 2010, FRAMEWORK SOCIAL ADA; Marshall N, 2013, ECOSYSTEMS, V16, P797, DOI 10.1007/s10021-013-9651-6; McClanahan TR, 2008, CONSERV LETT, V1, P53, DOI 10.1111/j.1755-263X.2008.00008_1.x; McClanahan TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042884; McClanahan TR, 2009, REV FISH BIOL FISHER, V19, P33, DOI 10.1007/s11160-008-9088-8; Mills D, 2011, J INT DEV, V23, P308, DOI 10.1002/jid.1638; Nakamura N, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049877; Nelson DR, 2007, ANNU REV ENV RESOUR, V32, P395, DOI 10.1146/annurev.energy.32.051807.090348; Ostrom E, 2007, P NATL ACAD SCI USA, V104, P15181, DOI 10.1073/pnas.0702288104; Ostrovskaya E. Y., 2010, EKONOMIKA 21 VEKA, P1; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Paulay G, 1997, DIVERSITY DISTRIBUTI, P298; Pratchett Morgan S., 2011, Diversity, V3, P424, DOI 10.3390/d3030424; Reaka-Kudla Marjorie L., 1997, P83; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43854; Schwarz AM, 2011, GLOBAL ENVIRON CHANG, V21, P1128, DOI 10.1016/j.gloenvcha.2011.04.011; Smit B, 2006, GLOBAL ENVIRON CHANG, V16, P282, DOI 10.1016/j.gloenvcha.2006.03.008; Sumaila U.R., 2011, NATURE CLIMATE CHANG; Westmacott S, 2000, COLLECTED ESSAYS EC, P94	53	153	155	13	188	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74321	10.1371/journal.pone.0074321	http://dx.doi.org/10.1371/journal.pone.0074321			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	248VW	24040228	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000326734500083
J	Jung, J; Lifland, AW; Alonas, EJ; Zurla, C; Santangelo, PJ				Jung, Jeenah; Lifland, Aaron W.; Alonas, Eric J.; Zurla, Chiara; Santangelo, Philip J.			Characterization of mRNA-Cytoskeleton Interactions In Situ Using FMTRIP and Proximity Ligation	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BETA-ACTIN; DEPENDENT LOCALIZATION; GENE-EXPRESSION; PROTEIN; TRANSPORT; HYBRIDIZATION; COMPARTMENTS; TRANSLATION; TRANSCRIPTS	Many studies have demonstrated an association between the cytoskeleton and mRNA, as well as the asymmetric distribution of mRNA granules within the cell in response to various signaling events. It is likely that the extensive cytoskeletal network directs mRNA transport and localization, with different cytoskeletal elements having their own specific roles. In order to understand the spatiotemporal changes in the interactions between the mRNA and the cytoskeleton as a response to a stimulus, a technique that can visualize and quantify these changes across a population of cells while capturing cell-to-cell variations is required. Here, we demonstrate a method for imaging and quantifying mRNA-cytoskeleton interactions on a per cell basis with single-interaction sensitivity. Using a proximity ligation assay with flag-tagged multiply-labeled tetravalent RNA imaging probes (FMTRIP), we quantified interactions between mRNAs and beta-tubulin, vimentin, or filamentous actin (F-actin) for two different mRNAs, poly(A) + and beta-actin mRNA, in two different cell types, A549 cells and human dermal fibroblasts (HDF). We found that the mRNAs interacted predominantly with F-actin (>50% in HDF, >20% in A549 cells), compared to beta-tubulin (< 5%) and vimentin (11-13%). This likely reflects differences in mRNA management by the two cell types. We then quantified changes in these interactions in response to two perturbations, F-actin depolymerization and arsenite-induced oxidative stress, both of which alter either the cytoskeleton itself and mRNA localization. Both perturbations led to a decrease in poly(A) + mRNA interactions with F-actin and an increase in the interactions with microtubules, in a time dependent manner.	[Santangelo, Philip J.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; Emory Univ, Atlanta, GA 30322 USA	University System of Georgia; Georgia Institute of Technology; Emory University	Santangelo, PJ (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	philip.santangelo@bme.gatech.edu			National Institutes of Health [CA147922, GM094198, EB009455]; NATIONAL CANCER INSTITUTE [R21CA147922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB009455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094198, T32GM008169] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health, grants CA147922, GM094198, EB009455. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSELL GJ, 1994, J CELL BIOL, V126, P863, DOI 10.1083/jcb.126.4.863; Bassell GJ, 1998, J NEUROSCI, V18, P251; Beach DL, 1999, CURR BIOL, V9, P569, DOI 10.1016/S0960-9822(99)80260-7; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bukrinskaya A, 1998, J EXP MED, V188, P2113, DOI 10.1084/jem.188.11.2113; Carson JH, 1997, CELL MOTIL CYTOSKEL, V38, P318, DOI 10.1002/(SICI)1097-0169(1997)38:4<318::AID-CM2>3.0.CO;2-#; Chou I N, 1989, Biomed Environ Sci, V2, P358; Condeelis J, 2005, BIOL CELL, V97, P97; Escuin D, 2005, CANCER RES, V65, P9021, DOI 10.1158/0008-5472.CAN-04-4095; Glotzer JB, 1997, CURR BIOL, V7, P326, DOI 10.1016/S0960-9822(06)00156-4; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Heckman C, 2008, PROTOCOL EXCHANGE; HEINLEIN M, 1995, SCIENCE, V270, P1983, DOI 10.1126/science.270.5244.1983; HESKETH JE, 1991, BIOCHEM J, V277, P1; HESKETH JE, 1991, BIOCHEM J, V274, P607, DOI 10.1042/bj2740607; HILL MA, 1994, J CELL BIOL, V126, P1221, DOI 10.1083/jcb.126.5.1221; HILL MA, 1993, J CELL BIOL, V122, P825, DOI 10.1083/jcb.122.4.825; Jambhekar A, 2007, RNA, V13, P625, DOI 10.1261/rna.262607; Jansen RP, 2001, NAT REV MOL CELL BIO, V2, P247, DOI 10.1038/35067016; Johnsson AK, 2010, EUR J CELL BIOL, V89, P394, DOI 10.1016/j.ejcb.2009.10.020; Jonson L, 2007, MOL CELL PROTEOMICS, V6, P798, DOI 10.1074/mcp.M600346-MCP200; Jung J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks837; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; LI WD, 1992, TOXICOL APPL PHARM, V114, P132, DOI 10.1016/0041-008X(92)90105-2; Lifland AW, 2011, TRAFFIC, V12, P1000, DOI 10.1111/j.1600-0854.2011.01209.x; Ling SC, 2004, P NATL ACAD SCI USA, V101, P17428, DOI 10.1073/pnas.0408114101; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Mathias RA, 2009, BBA-PROTEINS PROTEOM, V1794, P1325, DOI 10.1016/j.bbapap.2009.05.001; Nemerow GR, 1999, MICROBIOL MOL BIOL R, V63, P725, DOI 10.1128/MMBR.63.3.725-734.1999; Oyanagi J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053209; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Pirozzi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021548; Raju CS, 2011, MOL BIOL CELL, V22, P1864, DOI 10.1091/mbc.E10-11-0904; Ratti A, 2006, J CELL SCI, V119, P1442, DOI 10.1242/jcs.02852; Rodriguez AJ, 2006, J CELL BIOL, V175, P67, DOI 10.1083/jcb.200512137; SAGER PR, 1989, TOXICOL APPL PHARM, V97, P141, DOI 10.1016/0041-008X(89)90063-X; Santangelo PJ, 2009, NAT METHODS, V6, P347, DOI [10.1038/nmeth.1316, 10.1038/NMETH.1316]; Sene KH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-85; Shulman JM, 2000, CELL, V101, P377, DOI 10.1016/S0092-8674(00)80848-X; Slobodin B, 2010, RNA, V16, P2277, DOI 10.1261/rna.2091710; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; SUNDELL CL, 1991, SCIENCE, V253, P1275, DOI 10.1126/science.1891715; Suon S, 2004, STEM CELLS DEV, V13, P625, DOI 10.1089/scd.2004.13.625; Swanger SA, 2011, METHODS MOL BIOL, V714, P103, DOI 10.1007/978-1-61779-005-8_7; Takizawa PA, 1997, NATURE, V389, P90, DOI 10.1038/38015; THEURKAUF WE, 1992, DEVELOPMENT, V115, P923; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Xing L, 2013, TRAFFIC, V14, P2, DOI 10.1111/tra.12004; Zimber A, 2004, CELL SIGNAL, V16, P1085, DOI 10.1016/j.cellsig.2004.03.020; Zimyanin VL, 2008, CELL, V134, P843, DOI 10.1016/j.cell.2008.06.053; Zurla C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019727	51	12	12	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74598	10.1371/journal.pone.0074598	http://dx.doi.org/10.1371/journal.pone.0074598			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040294	gold, Green Submitted, Green Published			2022-12-25	WOS:000326734500106
J	Brautigam, C; Raggioli, A; Winter, J				Braeutigam, Christien; Raggioli, Angelo; Winter, Jennifer			The Wnt/beta-Catenin Pathway Regulates the Expression of the miR-302 Cluster in Mouse ESCs and P19 Cells	PLOS ONE			English	Article							BETA-CATENIN; MICRORNA EXPRESSION; STEM; TCF3; CANCER; DIFFERENTIATION; PLURIPOTENCY; MUTATIONS; INDUCTION; CIRCUITRY	MicroRNAs of the miR-302 cluster are involved in early embryonic development and somatic cell reprogramming. Expression of the miR-302 gene is regulated by the binding of the pluripotency factors Oct4, Sox2 and Nanog to the miR-302 promoter. The specific expression pattern of the miR-302 gene suggested that additional transcription factors might be involved in its regulation. Here, we show that the miR-302 promoter is a direct target of the Wnt/beta-catenin signaling pathway. We found that the miR-302 promoter contains three different functional Tcf/Lef binding sites. Two of the three sites were located within the cluster of Oct4/Sox2/Nanog binding sites and were essential for Wnt/beta-catenin-mediated regulation of the miR-302 gene. Tcf3, the only Tcf/Lef factor that bound to the miR-302 promoter, acted as a repressor of miR-302 transcription. Interestingly, mutations in the two Tcf/Lef binding sites and the Oct4/Nanog binding sites abolished miR-302 promoter responsiveness to Wnt signaling, suggesting that the Tcf/Lef and the Oct4/Nanog sites interact genetically.	[Braeutigam, Christien; Raggioli, Angelo; Winter, Jennifer] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Winter, Jennifer] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Human Genet, D-55122 Mainz, Germany; [Braeutigam, Christien; Raggioli, Angelo] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany	Max Planck Society; Johannes Gutenberg University of Mainz; University of Freiburg	Winter, J (corresponding author), Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany.	jewinter@uni-mainz.de		Raggioli, Angelo/0000-0002-6748-0307	Max-Planck Society	Max-Planck Society(Max Planck Society)	This work was supported by the Max-Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Auerbach W, 2000, BIOTECHNIQUES, V29, P1024, DOI 10.2144/00295st04; Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Currier N, 2010, GENESIS, V48, P183, DOI 10.1002/dvg.20604; Evans P, 2010, TLS-TIMES LIT SUPPL, P30; Friedel RH, 2011, METHODS MOL BIOL, V693, P205, DOI 10.1007/978-1-60761-974-1_12; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Hikasa H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.185280; Hikasa H, 2010, DEV CELL, V19, P521, DOI 10.1016/j.devcel.2010.09.005; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Hohjoh H, 2007, BIOCHEM BIOPH RES CO, V362, P360, DOI 10.1016/j.bbrc.2007.07.189; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Huang B, 2009, ACTA BIOCH BIOPH SIN, V41, P231, DOI 10.1093/abbs/gmp006; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Jesus ABD, 2009, CELL CYCLE, V8, P394; Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010; Kuhl SJ, 2013, BBA-GEN SUBJECTS, V1830, P2297, DOI 10.1016/j.bbagen.2012.08.010; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Liu HY, 2011, MOL BIOL REP, V38, P2155, DOI 10.1007/s11033-010-0343-4; Mansukhani A, 2005, J CELL BIOL, V168, P1065, DOI 10.1083/jcb.200409182; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Marikawa Y, 2006, SEMIN CELL DEV BIOL, V17, P175, DOI 10.1016/j.semcdb.2006.04.003; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; MCBURNEY MW, 1982, DEV BIOL, V89, P503, DOI 10.1016/0012-1606(82)90338-4; Merrill BJ, 2004, DEVELOPMENT, V131, P263, DOI 10.1242/dev.00935; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Mohamed OA, 2004, DEV DYNAM, V231, P416, DOI 10.1002/dvdy.20135; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Pereira L, 2006, MOL CELL BIOL, V26, P7479, DOI 10.1128/MCB.00368-06; Rosa A, 2009, DEV CELL, V16, P517, DOI 10.1016/j.devcel.2009.02.007; Rudloff S, 2012, DEVELOPMENT, V139, P3711, DOI 10.1242/dev.085597; Stadler B, 2010, STEM CELLS DEV, V19, P935, DOI 10.1089/scd.2009.0426; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Viswanathan SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006143; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Yakulov T, 2013, MOL CELL PROTEOMICS; Yi F, 2008, STEM CELLS, V26, P1951, DOI 10.1634/stemcells.2008-0229; Zhou AD, 2012, ONCOGENE, V31, P2968, DOI 10.1038/onc.2011.461	44	30	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e75315	10.1371/journal.pone.0075315	http://dx.doi.org/10.1371/journal.pone.0075315			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040406	Green Published, Green Submitted, gold			2022-12-25	WOS:000327538600135
J	Clancy, JP; Szczesniak, RD; Ashlock, MA; Ernst, SE; Fan, LJ; Hornick, DB; Karp, PH; Khan, U; Lymp, J; Ostmann, AJ; Rezayat, A; Starner, TD; Sugandha, SP; Sun, HT; Quinney, N; Donaldson, SH; Rowe, SM; Gabriel, SE				Clancy, John P.; Szczesniak, Rhonda D.; Ashlock, Melissa A.; Ernst, Sarah E.; Fan, Lijuan; Hornick, Douglas B.; Karp, Philip H.; Khan, Umer; Lymp, James; Ostmann, Alicia J.; Rezayat, Amir; Starner, Timothy D.; Sugandha, Shajan P.; Sun, Hongtao; Quinney, Nancy; Donaldson, Scott H.; Rowe, Steven M.; Gabriel, Sherif E.			Multicenter Intestinal Current Measurements in Rectal Biopsies from CF and Non-CF Subjects to Monitor CFTR Function	PLOS ONE			English	Article							NASAL POTENTIAL DIFFERENCE; CYSTIC-FIBROSIS GENE; DELTA-F508 HOMOZYGOUS TWINS; BIOAVAILABLE COMPOUND; STOP MUTATION; CONDUCTANCE; IDENTIFICATION; PATHOGENESIS; SUPPRESSION; EXPRESSION	Intestinal current measurements (ICM) from rectal biopsies are a sensitive means to detect cystic fibrosis transmembrane conductance regulator (CFTR) function, but have not been optimized for multicenter use. We piloted multicenter standard operating procedures (SOPs) to detect CFTR activity by ICM and examined key questions for use in clinical trials. SOPs for ICM using human rectal biopsies were developed across three centers and used to characterize ion transport from non-CF and CF subjects (two severe CFTR mutations). All data were centrally evaluated by a blinded interpreter. SOPs were then used across four centers to examine the effect of cold storage on CFTR currents and compare CFTR currents in biopsies from one subject studied simultaneously either at two sites (24 hours post-biopsy) or when biopsies were obtained by either forceps or suction. Rectal biopsies from 44 non-CF and 17 CF subjects were analyzed. Mean differences (mu A/cm(2); 95% confidence intervals) between CF and non-CF were forskolin/IBMX=102.6(128.0 to 81.1), carbachol=96.3(118.7 to 73.9), forskolin/IBMX+carbachol=200.9(243.1 to 158.6), and bumetanide=-44.6 (-33.7 to -55.6) (P<0.005, CF vs non-CF for all parameters). Receiver Operating Characteristic curves indicated that each parameter discriminated CF from non-CF subjects (area under the curve of 0.94-0.98). CFTR dependent currents following 18-24 hours of cold storage for forskolin/IBMX, carbachol, and forskolin/IBMX+carbachol stimulation (n=17 non-CF subjects) were 44%, 47.5%, and 47.3%, respectively of those in fresh biopsies. CFTR-dependent currents from biopsies studied after cold storage at two sites simultaneously demonstrated moderate correlation (n=14 non-CF subjects, Pearson correlation coefficients 0.389, 0.484, and 0.533). Similar CFTR dependent currents were detected from fresh biopsies obtained by either forceps or suction (within-subject comparisons, n=22 biopsies from three non-CF subjects). Multicenter ICM is a feasible CFTR outcome measure that discriminates CF from non-CF ion transport, offers unique advantages over other CFTR bioassays, and warrants further development as a potential CFTR biomarker.	[Clancy, John P.; Szczesniak, Rhonda D.; Ostmann, Alicia J.; Rezayat, Amir; Sun, Hongtao] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Clancy, John P.; Szczesniak, Rhonda D.; Ostmann, Alicia J.; Rezayat, Amir; Sun, Hongtao] Univ Cincinnati, Cincinnati, OH USA; [Ashlock, Melissa A.] Cyst Fibrosis Fdn, Bethesda, MD USA; [Ernst, Sarah E.; Hornick, Douglas B.; Karp, Philip H.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Fan, Lijuan] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Khan, Umer] Seattle Childrens Hosp, Dept Biostat, Seattle, WA USA; [Lymp, James] Genentech Inc, San Francisco, CA 94080 USA; [Starner, Timothy D.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Sugandha, Shajan P.; Rowe, Steven M.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Quinney, Nancy; Donaldson, Scott H.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Gabriel, Sherif E.] N30 Pharmaceut, Aurora, CO USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cystic Fibrosis Foundation; University of Iowa; University of Alabama System; University of Alabama Birmingham; Seattle Children's Hospital; Roche Holding; Genentech; University of Iowa; University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill	Clancy, JP (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA.	john.clancy@cchmc.org	Donaldson, Scott H./ABG-5157-2021; Szczesniak, Rhonda/M-4446-2015	Donaldson, Scott H./0000-0003-4802-0388; Szczesniak, Rhonda/0000-0003-0705-715X; Starner, Timothy/0000-0002-1933-7477; Hornick, Douglas/0000-0003-4545-8456	National Institutes of Health [P30 DK065988, P30 DK072482, U UL1025777, U01 HL102288]; Cystic Fibrosis Foundation; Cystic Fibrosis Foundation Therapeutics [AMIN09YO, R457-CR11, CLANCY05Y0, GABRIE08AO]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL102288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK065988, P30DK072482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institutes of Health (grants P30 DK065988 to SHD, SEG, and NLQ, P30 DK072482 and U UL1025777 to LF and SMR, and U01 HL102288 to DBH, PHK, and TDS) and the Cystic Fibrosis Foundation and Cystic Fibrosis Foundation Therapeutics (grants AMIN09YO and R457-CR11 to JPC, CLANCY05Y0 to SMR and LF, and GABRIE08AO to SHD, SEG, and NLQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Ahrens RC, 2002, PEDIATR PULM, V33, P142, DOI 10.1002/ppul.10043; Barreto C, 2004, PEDIATR PULM, P243, DOI 10.1002/ppul.70118; BARTKO JJ, 1966, PSYCHOL REP, V19, P3, DOI 10.2466/pr0.1966.19.1.3; Bebok Z, 2001, AM J PHYSIOL-CELL PH, V280, pC135, DOI 10.1152/ajpcell.2001.280.1.C135; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Boucher RC, 2002, ADV DRUG DELIVER REV, V54, P1359, DOI 10.1016/S0169-409X(02)00144-8; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; Bronsveld I, 2001, J CLIN INVEST, V108, P1705; Bronsveld I, 2000, GASTROENTEROLOGY, V119, P32, DOI 10.1053/gast.2000.8524; Charizopoulou N, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-18; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Collawn JF, 2009, AM J RESP CELL MOL, V40, P385, DOI 10.1165/rcmb.2008-0006ED; De Jonge Hugo R, 2004, J Cyst Fibros, V3 Suppl 2, P159, DOI 10.1016/j.jcf.2004.05.034; Derichs N, 2010, THORAX, V65, P594, DOI 10.1136/thx.2009.125088; Du M, 2002, J MOL MED, V80, P595, DOI 10.1007/s00109-002-0363-1; Du M, 2008, P NATL ACAD SCI USA, V105, P2064, DOI 10.1073/pnas.0711795105; Du M, 2006, J MOL MED, V84, P573, DOI 10.1007/s00109-006-0045-5; Du M, 2009, J BIOL CHEM, V284, P6885, DOI 10.1074/jbc.M806728200; Farkas K, 2011, INFLAMM BOWEL DIS, V17, P884, DOI 10.1002/ibd.21432; French PJ, 1996, J CLIN INVEST, V98, P1304, DOI 10.1172/JCI118917; Greger R, 2000, ANNU REV PHYSIOL, V62, P467, DOI 10.1146/annurev.physiol.62.1.467; Harrington MA, 2002, BIOPHYS J, V82, P1278, DOI 10.1016/S0006-3495(02)75484-2; Hirtz S, 2004, GASTROENTEROLOGY, V127, P1085, DOI 10.1053/j.gastro.2004.07.006; Hug MJ, 2011, METHODS MOL BIOL, V741, P87, DOI 10.1007/978-1-61779-117-8_7; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kerem E, 2008, LANCET, V372, P719, DOI 10.1016/S0140-6736(08)61168-X; KNOWLES MR, 1995, HUM GENE THER, V6, P445, DOI 10.1089/hum.1995.6.4-445; KOPITO RR, 1999, PHYSIOL REV, V79, P167; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; LIU B, 2010, PEDIAT PULMONOLOLOGY, V303, pA247; Mall M, 2004, GASTROENTEROLOGY, V126, P32, DOI 10.1053/j.gastro.2003.10.049; Mall M, 1998, AM J PHYSIOL-GASTR L, V275, pG1274, DOI 10.1152/ajpgi.1998.275.6.G1274; Meyerholz DK, 2010, AM J PATHOL, V176, P1377, DOI 10.2353/ajpath.2010.090849; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; RIORDAN JR, 1989, SCIENCE, V245, P1066; Robert R, 2010, MOL PHARMACOL, V77, P922, DOI 10.1124/mol.109.062679; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Rowe Steven M, 2007, Proc Am Thorac Soc, V4, P387, DOI 10.1513/pats.200703-043BR; Rubenstein RC, 1998, AM J RESP CRIT CARE, V157, P484, DOI 10.1164/ajrccm.157.2.9706088; Rubenstein Ronald C., 1998, Current Opinion in Pediatrics, V10, P250, DOI 10.1097/00008480-199806000-00005; Scholte Bob J, 2004, J Cyst Fibros, V3 Suppl 2, P183, DOI 10.1016/j.jcf.2004.05.039; Schuler Daniel, 2004, J Cyst Fibros, V3 Suppl 2, P151, DOI 10.1016/j.jcf.2004.05.032; Sermet-Gaudelus I, 2010, AM J RESP CRIT CARE, V182, P1262, DOI 10.1164/rccm.201001-0137OC; Solomon GM, 2010, CHEST, V138, P919, DOI 10.1378/chest.10-0179; Sousa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047708; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928; Umar S, 2000, AM J PHYSIOL-GASTR L, V278, pG753, DOI 10.1152/ajpgi.2000.278.5.G753; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Varga K, 2008, BIOCHEM J, V410, P555, DOI 10.1042/BJ20071420; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wilke M, 2011, J CYST FIBROS, V10, pS152, DOI 10.1016/S1569-1993(11)60020-9; Wilschanski M, 2003, NEW ENGL J MED, V349, P1433, DOI 10.1056/NEJMoa022170; Xiao F, 2012, J PHYSIOL-LONDON, V590, P5317, DOI 10.1113/jphysiol.2012.232124	56	35	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73905	10.1371/journal.pone.0073905	http://dx.doi.org/10.1371/journal.pone.0073905			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040112	Green Published, Green Submitted, gold			2022-12-25	WOS:000327538600051
J	Marenne, G; Chanock, SJ; Malats, N; Genin, E				Marenne, Gaelle; Chanock, Stephen J.; Malats, Nuria; Genin, Emmanuelle			Advantage of Using Allele-Specific Copy Numbers When Testing for Association in Regions with Common Copy Number Variants	PLOS ONE			English	Article							HIDDEN-MARKOV MODEL; SUSCEPTIBILITY; NUCLEOTIDE; RESOLUTION	Copy number variants (CNV) can be called from SNP-arrays; however, few studies have attempted to combine both CNV and SNP calls to test for association with complex diseases. Even when SNPs are located within CNVs, two separate association analyses are necessary, to compare the distribution of bi-allelic genotypes in cases and controls (referred to as SNP-only strategy) and the number of copies of a region (referred to as CNV-only strategy). However, when disease susceptibility is actually associated with allele specific copy-number states, the two strategies may not yield comparable results, raising a series of questions about the optimal analytical approach. We performed simulations of the performance of association testing under different scenarios that varied genotype frequencies and inheritance models. We show that the SNP-only strategy lacks power under most scenarios when the SNP is located within a CNV; frequently it is excluded from analysis as it does not pass quality control metrics either because of an increased rate of missing calls or a departure from fitness for Hardy-Weinberg proportion. The CNV-only strategy also lacks power because the association testing depends on the allele which copy number varies. The combined strategy performs well in most of the scenarios. Hence, we advocate the use of this combined strategy when testing for association with SNPs located within CNVs.	[Marenne, Gaelle; Genin, Emmanuelle] Univ Paris Diderot, INSERM, UMR S946, Inst Univ Hematol, Paris, France; [Marenne, Gaelle; Malats, Nuria] Spanish Natl Canc Res Ctr CNIO, Genet & Mol Epidemiol Grp, Madrid, Spain; [Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Genin, Emmanuelle] Univ Bretagne Occidentale, INSERM, UMR 1078, Brest, France; [Genin, Emmanuelle] Ctr Hosp Reg Univ Brest, Brest, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centro Nacional de Investigaciones Oncologicas (CNIO); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; CHU Brest	Genin, E (corresponding author), Univ Paris Diderot, INSERM, UMR S946, Inst Univ Hematol, Paris, France.	gaelle.marenne@gmail.com	Genin, Emmanuelle/C-4974-2013; Malats, Nuria/H-7041-2015; Garcia-Closas, Montserrat/AAZ-6930-2021; Marenne, Gaelle/AAU-8338-2020	Genin, Emmanuelle/0000-0003-4117-2813; Malats, Nuria/0000-0003-2538-3784; Garcia-Closas, Montserrat/0000-0003-1033-2650; Marenne, Gaelle/0000-0002-4363-7170	Instituto de Salud Carlos III (ISCIII) [FI09/00205]; Spanish Ministry of Science and Innovation; Acciones Integradas / Picasso program for collaboration between French and Spanish groups [HF2008-0069]; Region Ile-De-France	Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Acciones Integradas / Picasso program for collaboration between French and Spanish groups; Region Ile-De-France(Region Ile-de-France)	This work was supported by a FIS grant (FI09/00205) from Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Science and Innovation, by the Acciones Integradas / Picasso program for collaboration between French and Spanish groups (HF2008-0069) and by the Region Ile-De-France for travel grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JS, 2008, BIOCHEM BIOPH RES CO, V373, P593, DOI 10.1016/j.bbrc.2008.06.083; Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Hindorff LA, CATALOG PUBLISHED GE; Irvin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024052; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lee S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003906; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marenne G, 2011, HUM MUTAT, V32, P240, DOI 10.1002/humu.21398; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rothman N, 2010, NAT GENET, V42, P978, DOI 10.1038/ng.687; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Staaf J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-409; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217	21	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e75350	10.1371/journal.pone.0075350	http://dx.doi.org/10.1371/journal.pone.0075350			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040408	gold, Green Submitted, Green Published			2022-12-25	WOS:000327538600137
J	Stuart, SA; Robertson, JD; Marrion, NV; Robinson, ESJ				Stuart, Sarah A.; Robertson, James D.; Marrion, Neil V.; Robinson, Emma S. J.			Chronic Pravastatin but Not Atorvastatin Treatment Impairs Cognitive Function in Two Rodent Models of Learning and Memory	PLOS ONE			English	Article							BRAIN CHOLESTEROL-SYNTHESIS; REDUCTASE INHIBITORS; HIPPOCAMPAL-LESIONS; OBJECT-RECOGNITION; SPATIAL MEMORY; SIMVASTATIN; STATINS; CORTEX; RAT; METABOLISM	Statins are some of the most commonly prescribed drugs and are used to reduce blood cholesterol. Recent evidence suggests that, in some patients, they may adversely influence cognitive function including causing memory impairments. These clinical observations have led to statin prescriptions now including a warning about possible cognitive impairments. In order to better understand the relationship between statin treatment and cognitive function, studies in animals are needed. The present study investigated the effects of chronic treatment with two statins, pravastatin and atorvastatin, in two rodent models of learning and memory. Adult rats were treated once daily with pravastatin (10mg/kg, orally) or atorvostatin (10mg/kg, orally) for 18 days. Before, during and after treatment, animals were tested in a simple discrimination and reversal learning task. On the last day of treatment and following one week withdrawal, animals were also tested in a task of novel object discrimination. Pravastatin tended to impair learning over the last few days of treatment and this effect was fully reversed once treatment ceased. In the novel object discrimination task, pravastatin significantly impaired object recognition memory. No effects were observed for atorvostatin in either task. These data suggest that chronic treatment with pravastatin impairs working and recognition memory in rodents. The reversibility of the effects on cessation of treatment is similar to what has been observed in patients, but the lack of effect of atorvostatin suggests that lipophilicity may not be a major factor influencing statin-induced cognitive impairments.	[Stuart, Sarah A.; Robertson, James D.; Marrion, Neil V.; Robinson, Emma S. J.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England	University of Bristol	Robinson, ESJ (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England.	pmesjr@bris.ac.uk	; Robinson, Emma/A-4572-2010	Robertson, James/0000-0002-9961-0073; Robinson, Emma/0000-0002-1299-6541	RCUK academic fellowship; British Pharmacological Society Integrative Pharmacology Fund; Wellcome Trust [084621/Z/08/Z]; BBSRC Industrial CASE studentship; Pfizer, UK [BB/H530762/1]; Pfizer; BBSRC CASE studentship for Sarah Stuart	RCUK academic fellowship(UK Research & Innovation (UKRI)); British Pharmacological Society Integrative Pharmacology Fund; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC Industrial CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Pfizer, UK(Pfizer); Pfizer(Pfizer); BBSRC CASE studentship for Sarah Stuart(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was carried out as an undergraduate student project funded by an RCUK academic fellowship awarded to ESJR with additional financial support provided by the British Pharmacological Society Integrative Pharmacology Fund and the Wellcome Trust (reference number 084621/Z/08/Z). SAS is funded by a BBSRC Industrial CASE studentship with Pfizer, UK (reference number BB/H530762/1). Funding from Pfizer was only associated with the BBSRC CASE studentship for Sarah Stuart and supported a project independent of the work described here. Pfizer were not directly involved financially or academically in the work published here. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson EE, 2009, ANN NEUROL, V66, P407, DOI 10.1002/ana.21731; AGGLETON JP, 1986, BEHAV BRAIN RES, V19, P133, DOI 10.1016/0166-4328(86)90011-2; Barker GRI, 2007, J NEUROSCI, V27, P2948, DOI 10.1523/JNEUROSCI.5289-06.2007; Baytan SH, 2008, TOHOKU J EXP MED, V214, P341, DOI 10.1620/tjem.214.341; Birrell JM, 2000, J NEUROSCI, V20, P4320; BOTTI RE, 1991, CLIN NEUROPHARMACOL, V14, P256, DOI 10.1097/00002826-199106000-00010; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; Dales M, 2000, INT MED NEWS, V1, P55; Davidson MH, 2001, DRUGS, V61, P197, DOI 10.2165/00003495-200161020-00005; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; Douma TN, 2011, PSYCHOPHARMACOLOGY, V216, P537, DOI 10.1007/s00213-011-2245-0; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Etminan M, 2003, PHARMACOTHERAPY, V23, P726, DOI 10.1592/phco.23.6.726.32184; Evans MA, 2009, PHARMACOTHERAPY, V29, P800, DOI 10.1592/phco.29.7.800; Fassbender K, 2002, NEUROLOGY, V59, P1257, DOI 10.1212/WNL.59.8.1257; FDA. Drug Safety Communication, 2012, DRUG SAF COMM IMP SA; Feldman HH, 2010, NEUROLOGY, V74, P956, DOI 10.1212/WNL.0b013e3181d6476a; Ghittoni R, 2006, EUR J IMMUNOL, V36, P2885, DOI 10.1002/eji.200636567; Haag MDM, 2009, J NEUROL NEUROSUR PS, V80, P13, DOI 10.1136/jnnp.2008.150433; Hering H, 2003, J NEUROSCI, V23, P3262; HSU I, 1995, ANN PHARMACOTHER, V29, P743, DOI 10.1177/106002809502907-818; Idris NF, 2005, PSYCHOPHARMACOLOGY, V179, P336, DOI 10.1007/s00213-004-2058-5; Javadi-Paydar M, 2011, BRAIN RES, V1386, P89, DOI 10.1016/j.brainres.2011.02.057; Jentsch JD, 2001, NEUROPSYCHOPHARMACOL, V24, P66, DOI 10.1016/S0893-133X(00)00174-3; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Johnson-Anuna LN, 2005, J PHARMACOL EXP THER, V312, P786, DOI 10.1124/jpet.104.075028; JONES GH, 1991, BEHAV BRAIN RES, V43, P35, DOI 10.1016/S0166-4328(05)80050-6; Jones P, 1998, AM J CARDIOL, V81, P582, DOI 10.1016/S0002-9149(97)00965-X; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1113/expphysiol.2010.053793, 10.1113/jphysiol.2010.192278]; King DS, 2003, PHARMACOTHERAPY, V23, P1663, DOI 10.1592/phco.23.15.1663.31953; Kusuhara H, 1999, J BIOL CHEM, V274, P13675, DOI 10.1074/jbc.274.19.13675; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lutjohann D, 2004, STEROIDS, V69, P431, DOI 10.1016/j.steroids.2004.03.012; MACKINTO.NJ, 1969, CAN J PSYCHOLOGY, V23, P335, DOI 10.1037/h0082821; Mans RA, 2010, NEUROSCIENCE, V166, P435, DOI 10.1016/j.neuroscience.2009.12.062; McTaggart F, 2001, AM J CARDIOL, V87, p28B; MCTAVISH D, 1991, DRUGS, V42, P65, DOI 10.2165/00003495-199142010-00005; Muldoon MF, 2004, AM J MED, V117, P823, DOI 10.1016/j.amjmed.2004.07.041; Mumby DG, 2007, BEHAV BRAIN RES, V185, P82, DOI 10.1016/j.bbr.2007.07.026; Oldfield S, 2009, MOL PHARMACOL, V76, P1279, DOI 10.1124/mol.109.058008; Padala KP, 2006, ANN PHARMACOTHER, V40, P1880, DOI 10.1345/aph.1H014; Pfrieger FW, 2011, PROG LIPID RES, V50, P357, DOI 10.1016/j.plipres.2011.06.002; Pfrieger FW, 2003, BBA-BIOMEMBRANES, V1610, P271, DOI 10.1016/S0005-2736(03)00024-5; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; Rosenson Robert S, 2003, Expert Rev Cardiovasc Ther, V1, P495, DOI 10.1586/14779072.1.4.495; Schachter M, 2005, FUND CLIN PHARMACOL, V19, P117, DOI 10.1111/j.1472-8206.2004.00299.x; Shepherd J, 2003, AM J CARDIOL, V91, p11C, DOI 10.1016/S0002-9149(03)00004-3; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Takeda M, 2004, EUR J PHARMACOL, V483, P133, DOI 10.1016/j.ejphar.2003.10.017; Takemoto M, 2001, ARTERIOSCL THROM VAS, V21, P1712, DOI 10.1161/hq1101.098486; Thelen KM, 2006, J PHARMACOL EXP THER, V316, P1146, DOI 10.1124/jpet.105.094136; Tinsley CJ, 2012, HIPPOCAMPUS, V22, P466, DOI 10.1002/hipo.20913; TSUJI A, 1993, J PHARMACOL EXP THER, V267, P1085; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Vecka M, 2004, TOHOKU J EXP MED, V204, P299, DOI 10.1620/tjem.204.299; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Warburton EC, 2003, NEURON, V38, P987, DOI 10.1016/S0896-6273(03)00358-1; Winters BD, 2004, J NEUROSCI, V24, P5901, DOI 10.1523/JNEUROSCI.1346-04.2004; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Zhou Z, 2006, AM HEART J, V151, P273, DOI 10.1016/j.ahj.2005.04.003	61	39	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e75467	10.1371/journal.pone.0075467	http://dx.doi.org/10.1371/journal.pone.0075467			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040413	Green Published, Green Submitted, gold			2022-12-25	WOS:000327538600140
J	Wang, YQ; Huang, YM; Guan, F; Xiao, Y; Deng, J; Chen, HY; Chen, XL; Li, JR; Huang, HJ; Shi, CW				Wang, Yueqin; Huang, Yimin; Guan, Fei; Xiao, Yan; Deng, Jing; Chen, Huoying; Chen, Xiaolin; Li, Jianrong; Huang, Hanju; Shi, Chunwei			Hypoxia-Inducible Factor-1alpha and MAPK Co-Regulate Activation of Hepatic Stellate Cells upon Hypoxia Stimulation	PLOS ONE			English	Article							GROWTH-FACTOR; IN-VITRO; ANGIOGENESIS; EXPRESSION; FIBROGENESIS; PROMOTES; PATHWAY; LEPTIN; CANCER; GENES	Background: Hepatic stellate cell (HSC) plays a key role in pathogenesis of liver fibrosis. During liver injury, hypoxia in local micro-environment is inevitable. Hif-1 alpha is the key transcriptional regulation factor that induces cell's adaptive responses to hypoxia. Recently, it was reported that MAPK is involved in regulation of Hif-1 alpha activity. Aims: To explore whether Hif-1 alpha regulates HSC activation upon hypoxia, and whether MAPK affects Hif-1 alpha-regulated signaling cascades, thus providing new targets for preventing liver fibrosis. Methods: Hif-1 alpha expression in livers of Schistosoma japonicum infected BALB/c mice was detected with western blot and immunohistochemistry. A rat cell line of HSC, HSC-T6, was cultured in 1% oxygen. HSC activation, including F-actin reorganization, increase of vimentin and alpha-SMA, was detected with western blot or immunocytochemistry. Cells were transfected with specific siRNA to Hif-1 alpha, expression of activation markers, transcription of fibrosis-promoting cytokines, secretion of collagen I were detected with western blot, Real Time PCR and ELISA. Lysate from HSC-T6 cells pretreated with PD98059, a specific MEK1 pharmacological inhibitor, was subjected to detect Hif-1 alpha ubiquitination and nuclear translocation with western blot and immunoprecipitation. Results and Conclusions: Hif-1 alpha apparently increased in liver tissues of Schistosoma japonicum infected mice. 1% O-2 induced F-actin reorganization, increase of Hif-1 alpha, vimentin and alpha-SMA in HSC-T6 cells. Hif-1 alpha Knockdown inhibited HSC-T6 activation, transcription of IL-6, TGF-beta and CTGF and secretion of collagen I from HSC-T6 cells upon hypoxia. Inhibition of MAPK phosphorylation enhanced Hif-1 alpha ubiquitination, and inhibited Hif-1 alpha translocation into nucleus. Conclusively, Hif-1 alpha and MAPK participate in HSC activation upon hypoxia.	[Wang, Yueqin; Huang, Yimin; Deng, Jing; Chen, Huoying; Chen, Xiaolin; Li, Jianrong; Shi, Chunwei] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pathogen Biol, Wuhan 430074, Hubei, Peoples R China; [Guan, Fei; Xiao, Yan] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Parasitol, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Shi, CW (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pathogen Biol, Wuhan 430074, Hubei, Peoples R China.	chunweishi@mail.hust.edu.cn		Huang, Yimin/0000-0003-4348-5688	National Natural Science Foundation of China [31101007]; Natural Science Foundation of Hubei Province [2011CDB364]; Independent Innovation Foundation of Huazhong University of Science and Technology [2013QN173, 2010109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province); Independent Innovation Foundation of Huazhong University of Science and Technology	Supported by grants of National Natural Science Foundation of China (No.31101007, to Shi C), Natural Science Foundation of Hubei Province (No.2011CDB364, to CS), Independent Innovation Foundation of Huazhong University of Science and Technology (No.2013QN173, to CS; No.2010109, to YH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2012, SAUDI J GASTROENTERO, V18, P155, DOI 10.4103/1319-3767.96445; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Brugarolas J, 2004, CANCER CELL, V6, P7, DOI 10.1016/j.ccr.2004.06.020; Chen QR, 2012, TISSUE ANTIGENS, V79, P33, DOI 10.1111/j.1399-0039.2011.01809.x; Choi SS, 2010, J BIOL CHEM, V285, P36551, DOI 10.1074/jbc.M110.168542; Copple BL, 2011, LIVER INT, V31, P230, DOI 10.1111/j.1478-3231.2010.02347.x; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Gressner Olav A, 2007, Comp Hepatol, V6, P7, DOI 10.1186/1476-5926-6-7; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Liu YD, 2011, ALCOHOL CLIN EXP RES, V35, P921, DOI 10.1111/j.1530-0277.2010.01422.x; Meindl-Beinker NM, 2008, J GASTROEN HEPATOL, V23, pS122, DOI 10.1111/j.1440-1746.2007.05297.x; Mylonis I, 2008, J BIOL CHEM, V283, P27620, DOI 10.1074/jbc.M803081200; Nath B, 2012, HEPATOLOGY, V55, P622, DOI 10.1002/hep.25497; Nieto, 2007, HEPATOLOGY, V45, P546, DOI 10.1002/hep.21542; Novo E, 2007, AM J PATHOL, V170, P1942, DOI 10.2353/ajpath.2007.060887; Presser LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056367; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Riser BL, 2009, AM J PATHOL, V174, P1725, DOI 10.2353/ajpath.2009.080241; Rosmorduc O, 2010, SEMIN LIVER DIS, V30, P258, DOI 10.1055/s-0030-1255355; Shi CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021482; Troeger JS, 2011, LIVER INT, V31, P143, DOI 10.1111/j.1478-3231.2010.02426.x; Wang YQ, 2004, BIOCHEM BIOPH RES CO, V317, P358, DOI 10.1016/j.bbrc.2004.03.050; Xia C, 2008, J APPL MICROBIOL, V105, P1720, DOI 10.1111/j.1365-2672.2008.03896.x; Yu B, 2009, CANCER RES, V69, P7704, DOI 10.1158/0008-5472.CAN-09-0808; Zhong H, 2000, CANCER RES, V60, P1541	31	32	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74051	10.1371/journal.pone.0074051	http://dx.doi.org/10.1371/journal.pone.0074051			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040163	gold, Green Published, Green Submitted			2022-12-25	WOS:000327538600066
J	Horta, BL; Gigante, DP; Lima, RC; Barros, FC; Victora, CG				Horta, Bernardo L.; Gigante, Denise P.; Lima, Rosangela C.; Barros, Fernando C.; Victora, Cesar G.			Birth by Caesarean Section and Prevalence of Risk Factors for Non-Communicable Diseases in Young Adults: A Birth Cohort Study	PLOS ONE			English	Article							NONFASTING TRIGLYCERIDES; EARLY DETERMINANTS; GUT MICROBIOTA; BLOOD-PRESSURE; DELIVERY; OBESITY; CHILDHOOD; PELOTAS; HEALTH; METAANALYSIS	Background: Conflicting findings on the risk of obesity among subjects born by caesarean section have been published. Caesarean section should also increase the risk of obesity related cardiovascular risk factors if type of delivery is associated with obesity later in life. This study was aimed at assessing the effect of type of delivery on metabolic cardiovascular risk factors in early adulthood. Methodology and Principal Findings: In 1982, maternity hospitals in Pelotas, southern Brazil, were visited and those livebirths whose family lived in the urban area of the city have been followed. In 2000, when male subjects undertook the Army entrance examination (n=2200), fat mass and fat free mass were estimated through bioimpedance. In 2004-2005, we attempted to follow the whole cohort (n=4297), and the following outcomes were studied: blood pressure; HDL cholesterol; triglycerides; random blood glucose, C-reactive protein, waist circumference and body mass index. The estimates were adjusted for the following confounders: family income at birth; maternal schooling; household assets index in childhood; maternal skin color; birth order; maternal age; maternal prepregnancy weight; maternal height; maternal smoking during pregnancy; birthweight and family income at early adulthood. Results: In the crude analyses, blood pressure (systolic, diastolic and mean arterial pressure) and body mass index were higher among subjects who were delivered through caesarean section. After controlling for confounders, systolic blood pressure was 1.15 mmHg (95% confidence interval: 0.05; 2.25) higher among subjects delivered by caesarean section, and BMI 0.40 kg/m(2) (95% confidence interval: 0.08; 0.71). After controlling for BMI the effect on systolic blood pressure dropped to 0.60 mmHg (95% confidence interval: -0.47; 1.67). Fat mass at 18 years of age was also higher among subjects born by caesarean section. Conclusion: Caesarean section was associated with a small increased in systolic blood pressure, body mass index and fat mass.	[Horta, Bernardo L.; Gigante, Denise P.; Victora, Cesar G.] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, RS, Brazil; [Lima, Rosangela C.] Fundacao Univ Fed Grande Dourados, Dourados, MS, Brazil; [Barros, Fernando C.] Univ Catolica Pelotas, Postgrad Program Hlth & Behav, Pelotas, RS, Brazil	Universidade Federal de Pelotas; Universidade Federal da Grande Dourados; Universidade Catolica de Pelotas; Universidade Federal de Pelotas	Horta, BL (corresponding author), Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, RS, Brazil.	blhorta@gmail.com	Victora, Cesar Gomes/Y-2455-2019; Horta, Bernardo/A-7604-2008; Victora, Cesar G/D-4476-2013; Barros, Fernando C/D-4857-2013; Gigante, Denise/G-9285-2015	Victora, Cesar Gomes/0000-0002-2465-2180; Horta, Bernardo/0000-0001-9843-412X; Victora, Cesar G/0000-0002-2465-2180; Gigante, Denise/0000-0001-7309-5838	Wellcome Trust; Rio Grande do Sul State Research; National Research Council - Brazil	Wellcome Trust(Wellcome TrustEuropean Commission); Rio Grande do Sul State Research; National Research Council - Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Wellcome Trusts initiative entitled Major Awards for Latin America on Health Consequences of Population Change, Rio Grande do Sul State Research Support Foundation and National Research Council - Brazil. Earlier phases of the 1982 cohort study were funded by the International Development Research Center (Canada), the World Health Organization (Department of Child and Adolescent Health and Development, and Human Reproduction Programme), the Overseas Development Administration (United Kingdom), the United Nations Development Fund for Women, the National Program for Centers of Excellence (Brazil), the National Research Council (Brazil) and the Ministry of Health (Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajslev TA, 2011, INT J OBESITY, V35, P522, DOI 10.1038/ijo.2011.27; Andersen LG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014126; Bager P, 2008, CLIN EXP ALLERGY, V38, P634, DOI 10.1111/j.1365-2222.2008.02939.x; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Barros FC, 2012, AM J CLIN NUTR, V95, P465, DOI 10.3945/ajcn.111.026401; Barros FC, 2008, REV SAUDE PUBL, V42, P7, DOI 10.1590/S0034-89102008000900003; Biasucci G, 2008, J NUTR, V138, p1796S, DOI 10.1093/jn/138.9.1796S; Bjorksten B, 2001, J ALLERGY CLIN IMMUN, V108, P516, DOI 10.1067/mai.2001.118130; Cardwell CR, 2008, DIABETOLOGIA, V51, P726, DOI 10.1007/s00125-008-0941-z; Decker E, 2010, PEDIATRICS, V125, pE1433, DOI 10.1542/peds.2009-2260; FOLSOM AR, 1983, CLIN CHEM, V29, P505; Gigante DP, 2008, REV SAUDE PUBL, V42, P42, DOI 10.1590/S0034-89102008000900007; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Goldani HAS, 2011, AM J CLIN NUTR, V93, P1344, DOI 10.3945/ajcn.110.010033; Gronlund MM, 1999, J PEDIATR GASTR NUTR, V28, P19, DOI 10.1097/00005176-199901000-00007; Horta BL, 2008, REV SAUDE PUBL, V42, P86, DOI 10.1590/S0034-89102008000900012; Horta BL, 2008, REV SAUDE PUBL, V42, P93, DOI 10.1590/S0034-89102008000900013; Huh SY, 2012, ARCH DIS CHILD, V97, P610, DOI 10.1136/archdischild-2011-301141; Huurre A, 2008, NEONATOLOGY, V93, P236, DOI 10.1159/000111102; Hyde MJ, 2012, BIOL REV, V87, P229, DOI 10.1111/j.1469-185X.2011.00195.x; Hyde MJ, 2010, CLIN SCI, V118, P47, DOI 10.1042/CS20090169; Kalliomaki M, 2008, AM J CLIN NUTR, V87, P534, DOI 10.1093/ajcn/87.3.534; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Martin Joyce A, 2011, Natl Vital Stat Rep, V60, P1; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Neu J, 2011, CLIN PERINATOL, V38, P321, DOI 10.1016/j.clp.2011.03.008; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Sesso HD, 2000, HYPERTENSION, V36, P801, DOI 10.1161/01.HYP.36.5.801; Stavrou EP, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-8; Thavagnanam S, 2008, CLIN EXP ALLERGY, V38, P629, DOI 10.1111/j.1365-2222.2007.02780.x; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; WELLS JCK, 2003, INT J BODY COMPOSITI, V1, P1; Williams MJA, 2004, INT J OBESITY, V28, P998, DOI 10.1038/sj.ijo.0802713; WILLIAMS RL, 1982, OBSTET GYNECOL, V59, P624; Zhou LS, 2011, EUR J PEDIATR, V170, P1401, DOI 10.1007/s00431-011-1416-7	35	29	30	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74301	10.1371/journal.pone.0074301	http://dx.doi.org/10.1371/journal.pone.0074301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040224	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300168
J	Premi, E; Gazzina, S; Bozzali, M; Archetti, S; Alberici, A; Cercignani, M; Bianchetti, A; Gasparotti, R; Turla, M; Caltagirone, C; Padovani, A; Borroni, B				Premi, Enrico; Gazzina, Stefano; Bozzali, Marco; Archetti, Silvana; Alberici, Antonella; Cercignani, Mara; Bianchetti, Angelo; Gasparotti, Roberto; Turla, Marinella; Caltagirone, Carlo; Padovani, Alessandro; Borroni, Barbara			Cognitive Reserve in Granulin-Related Frontotemporal Dementia: from Preclinical to Clinical Stages	PLOS ONE			English	Article							RESTING-STATE NETWORKS; BEHAVIORAL VARIANT; LOBAR DEGENERATION; BRAIN; CONNECTIVITY; OCCUPATION; EDUCATION; DISCONNECTION; DECLINE; ATROPHY	Objective: Consistent with the cognitive reserve hypothesis, higher education and occupation attainments may help persons with neurodegenerative dementias to better withstand neuropathology before developing cognitive impairment. We tested here the cognitive reserve hypothesis in patients with frontotemporal dementia (FTD), with or without pathogenetic granulin mutations (GRN+ and GRN-), and in presymptomatic GRN mutation carriers (aGRN+). Methods: Education and occupation attainments were assessed and combined to define Reserve Index (RI) in 32 FTD patients, i.e. 12 GRN+ and 20 GRN-, and in 17 aGRN+. Changes in functional connectivity were estimated by resting state fMRI, focusing on the salience network (SN), executive network (EN) and bilateral frontoparietal networks (FPNs). Cognitive status was measured by FTD-modified Clinical Dementia Rating Scale. Results: In FTD patients higher level of premorbid cognitive reserve was associated with reduced connectivity within the SN and the EN. EN was more involved in FTD patients without GRN mutations, while SN was more affected in GRN pathology. In aGRN+, cognitive reserve was associated with reduced SN. Conclusions: This study suggests that cognitive reserve modulates functional connectivity in patients with FTD, even in monogenic disease. In GRN inherited FTD, cognitive reserve mechanisms operate even in presymptomatic to clinical stages.	[Premi, Enrico; Gazzina, Stefano; Alberici, Antonella; Padovani, Alessandro; Borroni, Barbara] Univ Brescia, Ctr Neurodegenerat Disorders, Brescia, Italy; [Bozzali, Marco] Santa Lucia Fdn IRCCS, Neuroimaging Lab, Rome, Italy; [Archetti, Silvana] Brescia Hosp, Lab Anal 3, Brescia, Italy; [Cercignani, Mara] Univ Sussex, Brighton & Sussex Med Sch, Clin Imaging Ctr, Brighton, E Sussex, England; [Bianchetti, Angelo] Geriatr Res Grp, Brescia, Italy; [Gasparotti, Roberto] Univ Brescia, Neuroradiol Unit, Brescia, Italy; [Turla, Marinella] ValleCamonica Hosp, Neurol Unit, Brescia, Italy; [Caltagirone, Carlo] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy	University of Brescia; IRCCS Santa Lucia; Hospital Spedali Civili Brescia; University of Brighton; University of Sussex; University of Brescia; University of Rome Tor Vergata	Borroni, B (corresponding author), Univ Brescia, Ctr Neurodegenerat Disorders, Brescia, Italy.	bborroni@inwind.it	Premi, Enrico/J-9854-2018; Padovani, Alessandro/ABI-7312-2020; Alberici, Antonella/K-2038-2018; Gasparotti, Roberto/K-5165-2018; Borroni, Barbara/AAN-4105-2020; Bozzali, Marco/AAC-1031-2022	Premi, Enrico/0000-0002-4342-6963; Padovani, Alessandro/0000-0002-0119-3639; Gasparotti, Roberto/0000-0002-2591-2415; Bozzali, Marco/0000-0002-0568-2026; BIANCHETTI, ANGELO/0000-0002-2914-0627; Cercignani, Mara/0000-0002-4550-2456				Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bastin C, 2012, NEUROIMAGE, V63, P713, DOI 10.1016/j.neuroimage.2012.06.074; Borroni B, 2008, REJUV RES, V11, P585, DOI 10.1089/rej.2007.0623; Borroni B, 2011, NEURODEGENER DIS, V8, P289, DOI 10.1159/000322790; Borroni B, 2009, DEMENT GERIATR COGN, V28, P130, DOI 10.1159/000235575; Borroni B, 2012, NEUROBIOL AGING, V33, P2506, DOI 10.1016/j.neurobiolaging.2011.10.031; Bozzali M, 2011, CURR MED CHEM, V18, P2452, DOI 10.2174/092986711795843263; Bozzali M, 2008, MAGN RESON IMAGING, V26, P1065, DOI 10.1016/j.mri.2008.01.044; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Dopper EGP, 2013, NEUROLOGY, V80, P814, DOI 10.1212/WNL.0b013e31828407bc; Filippi M, 2013, CORTEX, V49, P2389, DOI 10.1016/j.cortex.2012.09.017; Garibotto V, 2008, NEUROLOGY, V71, P1342, DOI 10.1212/01.wnl.0000327670.62378.c0; Garibotto V, 2012, NEUROL SCI, V33, P1037, DOI 10.1007/s10072-011-0889-5; Gili T, 2011, J NEUROL NEUROSUR PS, V82, P58, DOI 10.1136/jnnp.2009.199935; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Meng XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038268; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; PERNECZKY R, 2007, EUR J NUCL MED MOL I, V34, P1082, DOI DOI 10.1007/s00259-006-0323-z; Premi E, 2012, DEMENT GERIATR COGN, V33, P372, DOI 10.1159/000339366; Ptak R, 2012, NEUROSCIENTIST, V18, P502, DOI 10.1177/1073858411409051; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Seeley WW, 2008, ARCH NEUROL-CHICAGO, V65, P249, DOI 10.1001/archneurol.2007.38; Serra L, 2011, REJUV RES, V14, P143, DOI 10.1089/rej.2010.1103; Spreng RN, 2011, NEUROPSYCHOLOGIA, V49, P3699, DOI 10.1016/j.neuropsychologia.2011.09.025; Steffener J, 2012, BBA-MOL BASIS DIS, V1822, P467, DOI 10.1016/j.bbadis.2011.09.012; Stern Y, 1999, NEUROLOGY, V53, P1942, DOI 10.1212/WNL.53.9.1942; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Sumowski JF, 2010, BRAIN, V133, P362, DOI 10.1093/brain/awp307; Thompson PM, 2010, CURR OPIN NEUROL, V23, P368, DOI 10.1097/WCO.0b013e32833b764c; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075	40	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74762	10.1371/journal.pone.0074762	http://dx.doi.org/10.1371/journal.pone.0074762			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040338	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000326405300191
J	Novo, M; Mangado, A; Quiros, M; Morales, P; Salvado, Z; Gonzalez, R				Novo, Maite; Mangado, Ana; Quiros, Manuel; Morales, Pilar; Salvado, Zoel; Gonzalez, Ramon			Genome-Wide Study of the Adaptation of Saccharomyces cerevisiae to the Early Stages of Wine Fermentation	PLOS ONE			English	Article							YEAST GENE-EXPRESSION; ALCOHOLIC FERMENTATION; DELETION MUTANTS; TRANSCRIPTIONAL RESPONSE; ETHANOL TOLERANCE; MAXIMAL TOLERANCE; STRESS-RESPONSE; 1ST HOURS; IDENTIFICATION; PROFILES	This work was designed to identify yeast cellular functions specifically affected by the stress factors predominating during the early stages of wine fermentation, and genes required for optimal growth under these conditions. The main experimental method was quantitative fitness analysis by means of competition experiments in continuous culture of whole genome barcoded yeast knockout collections. This methodology allowed the identification of haploinsufficient genes, and homozygous deletions resulting in growth impairment in synthetic must. However, genes identified as haploproficient, or homozygous deletions resulting in fitness advantage, were of little predictive power concerning optimal growth in this medium. The relevance of these functions for enological performance of yeast was assessed in batch cultures with single strains. Previous studies addressing yeast adaptation to winemaking conditions by quantitative fitness analysis were not specifically focused on the proliferative stages. In some instances our results highlight the importance of genes not previously linked to winemaking. In other cases they are complementary to those reported in previous studies concerning, for example, the relevance of some genes involved in vacuolar, peroxisomal, or ribosomal functions. Our results indicate that adaptation to the quickly changing growth conditions during grape must fermentation require the function of different gene sets in different moments of the process. Transport processes and glucose signaling seem to be negatively affected by the stress factors encountered by yeast in synthetic must. Vacuolar activity is important for continued growth during the transition to stationary phase. Finally, reduced biogenesis of peroxisomes also seems to be advantageous. However, in contrast to what was described for later stages, reduced protein synthesis is not advantageous for the early (proliferative) stages of the fermentation process. Finally, we found adenine and lysine to be in short supply for yeast growth in some natural grape musts.	[Novo, Maite; Mangado, Ana; Quiros, Manuel; Morales, Pilar; Salvado, Zoel; Gonzalez, Ramon] Univ La Rioja, CSIC, Inst Ciencias Vid & Vino, Gobierno de La Rioja, Logrono, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-CAR-UR - Instituto de Ciencias de la Vid y del Vino (ICVV); Universidad de La Rioja	Gonzalez, R (corresponding author), Univ La Rioja, CSIC, Inst Ciencias Vid & Vino, Gobierno de La Rioja, Logrono, Spain.	rgonzalez@icvv.es	González, Ramón/G-9281-2011; Novo, Maite/G-2002-2016; Salvado, Zoel/G-2014-2016; Gonzalez, Ramon/Y-5961-2019; Morales, Pilar/H-5289-2015	González, Ramón/0000-0001-7388-1660; Novo, Maite/0000-0002-2454-1990; Salvado, Zoel/0000-0003-4412-1421; Gonzalez, Ramon/0000-0001-7388-1660; Morales, Pilar/0000-0002-0130-6111	Spanish Ministry of Economy and Competitivity [AGL 2009-07327, AGL2012-32064]; CSIC; European Social Fund of the EU; Spanish Ministry of Economy and Competitiveness	Spanish Ministry of Economy and Competitivity(Spanish Government); CSIC; European Social Fund of the EU(European Social Fund (ESF)); Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was funded by the grants AGL 2009-07327 and AGL2012-32064 from the Spanish Ministry of Economy and Competitivity. MN and MQ were partially funded by CSIC training JAE-Doc contracts co-funded by the European Social Fund of the EU. AM is the recipient of a PhD training grant from the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando A, 2006, FEMS YEAST RES, V6, P249, DOI 10.1111/j.1567-1364.2006.00035.x; Auesukaree C, 2009, J APPL GENET, V50, P301, DOI 10.1007/BF03195688; Balakrishnan R, 2012, DATABASE-OXFORD, DOI 10.1093/database/bar062; Beltran G, 2006, FEMS YEAST RES, V6, P1167, DOI 10.1111/j.1567-1364.2006.00106.x; BELY M, 1990, J FERMENT BIOENG, V70, P246, DOI 10.1016/0922-338X(90)90057-4; Birrell GW, 2002, P NATL ACAD SCI USA, V99, P8778, DOI 10.1073/pnas.132275199; Delneri D, 2008, NAT GENET, V40, P113, DOI 10.1038/ng.2007.49; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fujita K, 2006, FEMS YEAST RES, V6, P744, DOI 10.1111/j.1567-1364.2006.00040.x; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gonzalez R, 2011, MOLECULAR WINE MICROBIOLOGY, P279, DOI 10.1016/B978-0-12-375021-1.10011-6; Harsch MJ, 2010, FEMS YEAST RES, V10, P72, DOI 10.1111/j.1567-1364.2009.00580.x; Kumar GR, 2008, AM J ENOL VITICULT, V59, P401; Marks VD, 2008, FEMS YEAST RES, V8, P35, DOI 10.1111/j.1567-1364.2007.00338.x; Novo M, 2007, FEMS YEAST RES, V7, P304, DOI 10.1111/j.1567-1364.2006.00175.x; Perez-Torrado R, 2002, SYST APPL MICROBIOL, V25, P153, DOI 10.1078/0723-2020-00087; Pierce SE, 2007, NAT PROTOC, V2, P2958, DOI 10.1038/nprot.2007.427; Piggott N, 2011, G3-GENES GENOM GENET, V1, P353, DOI 10.1534/g3.111.000836; Rossignol T, 2003, YEAST, V20, P1369, DOI 10.1002/yea.1046; Rossignol T, 2006, APPL MICROBIOL BIOT, V71, P699, DOI 10.1007/s00253-006-0398-2; Rossouw D, 2009, APPL ENVIRON MICROB, V75, P6600, DOI 10.1128/AEM.01251-09; Salvado Z, 2008, FEMS YEAST RES, V8, P1137, DOI 10.1111/j.1567-1364.2008.00389.x; Smith AM, 2009, GENOME RES, V19, P1836, DOI 10.1101/gr.093955.109; Tai SL, 2007, MICROBIOL-SGM, V153, P877, DOI 10.1099/mic.0.2006/002873-0; Teixeira MC, 2010, OMICS, V14, P201, DOI 10.1089/omi.2009.0149; Teixeira MC, 2009, APPL ENVIRON MICROB, V75, P5761, DOI 10.1128/AEM.00845-09; Trabalzini L, 2003, BIOCHEM J, V370, P35, DOI 10.1042/BJ20020140; van Voorst F, 2006, YEAST, V23, P351, DOI 10.1002/yea.1359; Varela C, 2005, YEAST, V22, P369, DOI 10.1002/yea.1217; Varela C, 2004, APPL ENVIRON MICROB, V70, P3392, DOI 10.1128/AEM.70.6.3392-3400.2004; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yazawa H, 2007, YEAST, V24, P551, DOI 10.1002/yea.1492; Yoshikawa K, 2009, FEMS YEAST RES, V9, P32, DOI 10.1111/j.1567-1364.2008.00456.x	33	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74086	10.1371/journal.pone.0074086	http://dx.doi.org/10.1371/journal.pone.0074086			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040173	Green Submitted, Green Published, gold			2022-12-25	WOS:000324481600117
J	van Sluijs, EMF; McMinn, AM; Inskip, HM; Ekelund, U; Godfrey, KM; Harvey, NC; Griffin, SJ				van Sluijs, Esther M. F.; McMinn, Alison M.; Inskip, Hazel M.; Ekelund, Ulf; Godfrey, Keith M.; Harvey, Nicholas C.; Griffin, Simon J.			Correlates of Light and Moderate-to-Vigorous Objectively Measured Physical Activity in Four-Year Old Children	PLOS ONE			English	Article							PRESCHOOL-CHILDREN; HEART-RATE; VALIDATION; PARENTS; HEALTH; ADOLESCENTS; FITNESS; OBESITY; WEIGHT	Background: Correlates of physical activity (PA) are hypothesized to be context and behaviour specific, but there is limited evidence of this in young children. The aim of the current study is to investigate associations between personal, social and environmental factors and objectively measured light and moderate-to-vigorous PA (LPA and MVPA, respectively) in four-year-old children. Methods: Cross-sectional data were used from the Southampton Women's Survey, a UK population-based longitudinal study. Four-year old children (n = 487, 47.0% male) had valid PA data assessed using accelerometry (Actiheart) and exposure data collected with a validated maternal questionnaire (including data on child personality, family demographics, maternal behaviour, rules and restrictions, and perceived local environment). Linear regression modelling was used to analyse associations with LPA and MVPA separately, interactions with sex were explored. Results: LPA minutes were greater in children whose mothers reported more PA (vs. inactive: regression coefficient +/- standard error: 6.70 +/- 2.94 minutes), and without other children in the neighbourhood to play with (26.33 +/- 2.44). MVPA minutes were greater in children with older siblings (vs. none: 5.81 +/- 2.80) and those whose mothers used active transport for short trips (vs. inactive: 6.24 +/- 2.95). Children accumulated more MVPA in spring (vs. winter: 9.50 +/- 4.03) and, in boys only, less MVPA with availability of other children in the neighbourhood (23.98 +/- 1.70). Discussion: Young children's LPA and MVPA have differing associations with a number of social and environmental variables. Interventions targeting PA promotion in young children outside of formal care settings should consider including intensity specific factors.	[van Sluijs, Esther M. F.; McMinn, Alison M.; Ekelund, Ulf; Griffin, Simon J.] MRC, Epidemiol Unit, Cambridge, England; [van Sluijs, Esther M. F.; McMinn, Alison M.; Griffin, Simon J.] UKCRC Ctr Diet & Activ Res CEDAR, Cambridge, England; [Inskip, Hazel M.; Godfrey, Keith M.; Harvey, Nicholas C.] MRC, Lifecourse Epidemiol Unit, Southampton, Hants, England; [Ekelund, Ulf] Norwegian Sch Sport Sci, Dept Sport Med, Oslo, Norway; [Godfrey, Keith M.] Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Godfrey, Keith M.] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England	University of Cambridge; Norwegian School of Sport Sciences; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust	van Sluijs, EMF (corresponding author), MRC, Epidemiol Unit, Cambridge, England.	esther.vansluijs@mrc-epid.cam.ac.uk	Ekelund, Ulf/AAE-8471-2019; Griffin, Simon/K-3106-2013; Inskip, Hazel/L-5467-2018	Ekelund, Ulf/0000-0003-2115-9267; Harvey, Nicholas/0000-0002-8194-2512; Griffin, Simon/0000-0002-2157-4797; Inskip, Hazel/0000-0001-8897-1749; Godfrey, Keith/0000-0002-4643-0618; van Sluijs, Esther/0000-0001-9141-9082	Medical Research Council [MC_U106179474, MC_U106179473, MC_UP_1001/2]; Centre for Diet and Activity Research (CEDAR); UKCRC Public Health Research Centre of Excellence; British Heart Foundation; Department of Health, Economic and Social Research Council; Medical Research Council; Wellcome Trust under UK Clinical Research Collaboration; Arthritis Research Campaign; National Osteoporosis Society; International Osteoporosis Foundation; Cohen Trust; NIHR Southampton Biomedical Research Centre; NIHR Musculoskeletal Biomedical Research Unit; Oxford; Commission of the European Community; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MC_U106179473, MC_UP_A620_1017, MC_U106179474, MC_UU_12015/7, MC_UP_1001/2, MC_UU_12015/3, MC_UU_12011/4, MC_UU_12015/4] Funding Source: UKRI; British Heart Foundation [RG/07/009/23120] Funding Source: researchfish; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MC_UU_12015/3, MC_UU_12015/7, MC_UU_12015/4, MC_UP_A620_1017, MC_UU_12011/4] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Centre for Diet and Activity Research (CEDAR); UKCRC Public Health Research Centre of Excellence; British Heart Foundation(British Heart Foundation); Department of Health, Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust under UK Clinical Research Collaboration(Wellcome Trust); Arthritis Research Campaign(Versus Arthritis); National Osteoporosis Society; International Osteoporosis Foundation; Cohen Trust; NIHR Southampton Biomedical Research Centre; NIHR Musculoskeletal Biomedical Research Unit; Oxford; Commission of the European Community(European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Participants were drawn from a cohort study funded by the Medical Research Council and the Dunhill Medical Trust. This work was supported by the Medical Research Council [Unit Programme numbers MC_U106179474, MC_U106179473, MC_UP_1001/2]. The work of EMFvS, AMM and SJG was supported by the Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence. Funding from the British Heart Foundation, Department of Health, Economic and Social Research Council, Medical Research Council, and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The Southampton Women's Survey and the work of HMI, NCH and KMG were supported by grants from Medical Research Council, British Heart Foundation, the Arthritis Research Campaign, National Osteoporosis Society, International Osteoporosis Foundation, Cohen Trust, NIHR Southampton Biomedical Research Centre, NIHR Musculoskeletal Biomedical Research Unit, Oxford, and the Commission of the European Community, specific RTD Programme "Quality of Life and Management of Living Resources", within the 7th Framework Programme, research grant no. FP7/2007-13 (EarlyNutrition Project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph AL, 2012, J PHYS ACT HEALTH, V9, P944, DOI 10.1123/jpah.9.7.944; Andersen LB, 2011, BRIT J SPORT MED, V45, P871, DOI 10.1136/bjsports-2011-090333; Berge JM, 2011, PEDIATRICS, V127, P881, DOI 10.1542/peds.2010-3218; Biddle SJH, 2011, BRIT J SPORT MED, V45, P886, DOI 10.1136/bjsports-2011-090185; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Cliff DP, 2009, J SCI MED SPORT, V12, P557, DOI 10.1016/j.jsams.2008.10.008; Cole TJ, 1998, STAT MED, V17, P407, DOI 10.1002/(SICI)1097-0258(19980228)17:4&lt;407::AID-SIM742&gt;3.0.CO;2-L; Collings PJ, 2013, AM J CLIN NUTR, V97, P1020, DOI 10.3945/ajcn.112.045088; Corder K, 2005, MED SCI SPORT EXER, V37, P1761, DOI 10.1249/01.mss.0000176466.78408.cc; Department of Health, 2011, UK PHYS ACT GUID; Dwyer GM, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-66; Fitzgerald A, 2012, J ADOLESCENCE, V35, P941, DOI 10.1016/j.adolescence.2012.01.002; Fitzgibbon ML, 2005, J PEDIATR-US, V146, P618, DOI 10.1016/j.jpeds.2004.12.019; Harvey NC, 2012, OSTEOPOROSIS INT, V23, P121, DOI 10.1007/s00198-011-1641-y; Harvey-Berino J, 2003, OBES RES, V11, P606; Hills AP, 2011, BRIT J SPORT MED, V45, P866, DOI 10.1136/bjsports-2011-090199; Hinkley T, 2008, AM J PREV MED, V34, P435, DOI 10.1016/j.amepre.2008.02.001; Hinkley T, 2012, AM J PREV MED, V43, P159, DOI 10.1016/j.amepre.2012.04.020; Hinkley T, 2011, FAM COMMUNITY HEALTH, V34, P39, DOI 10.1097/FCH.0b013e31820590d6; Inskip HM, 2006, INT J EPIDEMIOL, V35, P42, DOI 10.1093/ije/dyi202; Irwin JD, 2005, CAN J PUBLIC HEALTH, V96, P299, DOI 10.1007/BF03405170; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Kreichauf S, 2012, OBES REV, V13, P96, DOI 10.1111/j.1467-789X.2011.00973.x; McMinn AM, 2008, PEDIATR EXERC SCI, V20, P319, DOI 10.1123/pes.20.3.319; McMinn AM, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-81; Pate RR, 2006, OBESITY, V14, P2000, DOI 10.1038/oby.2006.234; Puder JJ, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6195; Reilly J, 2011, MAKING CASE UK PHYS; Reilly JJ, 2008, ARCH DIS CHILD, V93, P614, DOI 10.1136/adc.2007.133272; Reilly JJ, 2006, BMJ-BRIT MED J, V333, P1041, DOI 10.1136/bmj.38979.623773.55; Ridgway CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016125; Sallis JF, 2004, HLTH BEHAV HLTH ED T, P403; Shaw B, 2013, CHILDRENS INDEPENDEN; Singh A, 2012, ARCH PEDIAT ADOL MED, V166, P49, DOI 10.1001/archpediatrics.2011.716; Skelton JA, 2012, INT J OBESITY, V36, P891, DOI 10.1038/ijo.2012.56; Tremblay MS, 2012, APPL PHYSIOL NUTR ME, V37, P357, DOI [10.1139/h2012-026, 10.1139/H2012-026, 10.1139/H2012-018, 10.1139/h2012-018]; Vale S, 2009, PEDIAT EXERC SCI, V21; Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35	39	23	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74934	10.1371/journal.pone.0074934	http://dx.doi.org/10.1371/journal.pone.0074934			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040365	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000324481600152
J	Bedel, A; Pasquet, JM; Lippert, E; Taillepierre, M; Lagarde, V; Dabernat, S; Dubus, P; Charaf, L; Beliveau, F; de Verneuil, H; Richard, E; Mahon, FX; Moreau-Gaudry, F				Bedel, Aurelie; Pasquet, Jean-Max; Lippert, Eric; Taillepierre, Miguel; Lagarde, Valerie; Dabernat, Sandrine; Dubus, Pierre; Charaf, Lucie; Beliveau, Francois; de Verneuil, Hubert; Richard, Emmanuel; Mahon, Francois-Xavier; Moreau-Gaudry, Francois			Variable Behavior of iPSCs Derived from CML Patients for Response to TKI and Hematopoietic Differentiation	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; PLURIPOTENT STEM-CELLS; IMATINIB; DISCONTINUATION; GENERATION; APOPTOSIS; THERAPY	Chronic myeloid leukemia disease (CML) found effective therapy by treating patients with tyrosine kinase inhibitors (TKI), which suppress the BCR-ABL1 oncogene activity. However, the majority of patients achieving remission with TKI still have molecular evidences of disease persistence. Various mechanisms have been proposed to explain the disease persistence and recurrence. One of the hypotheses is that the primitive leukemic stem cells (LSCs) can survive in the presence of TKI. Understanding the mechanisms leading to TKI resistance of the LSCs in CML is a critical issue but is limited by availability of cells from patients. We generated induced pluripotent stem cells (iPSCs) derived from CD34(+) blood cells isolated from CML patients (CML-iPSCs) as a model for studying LSCs survival in the presence of TKI and the mechanisms supporting TKI resistance. Interestingly, CML-iPSCs resisted to TKI treatment and their survival did not depend on BCR-ABL1, as for primitive LSCs. Induction of hematopoietic differentiation of CML-iPSC clones was reduced compared to normal clones. Hematopoietic progenitors obtained from iPSCs partially recovered TKI sensitivity. Notably, different CML-iPSCs obtained from the same CML patients were heterogeneous, in terms of BCR-ABL1 level and proliferation. Thus, several clones of CML-iPSCs are a powerful model to decipher all the mechanisms leading to LSC survival following TKI therapy and are a promising tool for testing new therapeutic agents.	[Bedel, Aurelie; Pasquet, Jean-Max; Lippert, Eric; Taillepierre, Miguel; Dabernat, Sandrine; Charaf, Lucie; Beliveau, Francois; de Verneuil, Hubert; Richard, Emmanuel; Mahon, Francois-Xavier; Moreau-Gaudry, Francois] INSERM, U1035, Bordeaux, France; [Dubus, Pierre] Univ Bordeaux, EA 2406, Bordeaux, France; [Bedel, Aurelie; Lippert, Eric; Lagarde, Valerie; Dabernat, Sandrine; Dubus, Pierre; de Verneuil, Hubert; Richard, Emmanuel; Mahon, Francois-Xavier; Moreau-Gaudry, Francois] Univ Bordeaux Segalen, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Mahon, FX (corresponding author), INSERM, U1035, Bordeaux, France.	Francois-Xavier.Mahon@u-bordeaux2.fr; fgaudry@u-bordeaux2.fr	PASQUET, JEAN-MAX/I-9702-2014; PASQUET, JEAN-MAX/T-4906-2019	PASQUET, JEAN-MAX/0000-0002-1345-3776; Moreau-Gaudry, Francois/0000-0003-1813-3939; Beliveau, Francois/0000-0001-6324-2363; Dubus, Pierre/0000-0003-1803-4711	Fondation de France; Novartis pharmaceutical company	Fondation de France(Fondation de France); Novartis pharmaceutical company	This work was supported by grants from Fondation de France and from Novartis pharmaceutical company. The authors thank Novartis for providing them with imatinib. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedel A, 2012, AM J HUM GENET, V91, P109, DOI 10.1016/j.ajhg.2012.05.026; Belloc F, 2009, LEUKEMIA, V23, P679, DOI 10.1038/leu.2008.364; Carette JE, 2010, BLOOD, V115, P4039, DOI 10.1182/blood-2009-07-231845; Coppo P, 2009, CELL SIGNAL, V21, P52, DOI 10.1016/j.cellsig.2008.09.006; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; Desplat V, 2005, CANCER-AM CANCER SOC, V103, P102, DOI 10.1002/cncr.20758; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Gioia R, 2011, BLOOD, V118, P2211, DOI 10.1182/blood-2010-10-313692; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Hamilton A, 2012, BLOOD, V119, P1501, DOI 10.1182/blood-2010-12-326843; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hu KJ, 2011, BLOOD, V117, pE109, DOI 10.1182/blood-2010-07-298331; Hughes TP, 2003, NEW ENGL J MED, V349, P1423, DOI 10.1056/NEJMoa030513; Kumano K, 2012, BLOOD, V119, P6234, DOI 10.1182/blood-2011-07-367441; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; O'Hare T, 2012, NAT REV CANCER, V12, P513, DOI 10.1038/nrc3317; Onder TT, 2012, CURR OPIN GENET DEV, V22, P500, DOI 10.1016/j.gde.2012.05.005; Ramos-Mejia V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035824; Ramos-Mejia V, 2012, TRENDS MOL MED, V18, P245, DOI 10.1016/j.molmed.2012.04.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang M, 2012, HAEMATOL-HEMATOL J, V97, P1553, DOI 10.3324/haematol.2012.062844; Winkler T, 2013, J CLIN INVEST, V123, P1952, DOI 10.1172/JCI67146; Woods NB, 2011, STEM CELLS, V29, P1158, DOI 10.1002/stem.657; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	26	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e71596	10.1371/journal.pone.0071596	http://dx.doi.org/10.1371/journal.pone.0071596			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24058405	Green Published, Green Submitted, gold			2022-12-25	WOS:000324403200013
J	Nolde, MJ; Cheng, EC; Guo, SQ; Lin, HF				Nolde, Mona J.; Cheng, Ee-chun; Guo, Shangqin; Lin, Haifan			Piwi Genes Are Dispensable for Normal Hematopoiesis in Mice	PLOS ONE			English	Article							STEM-CELLS; SMALL RNAS; HIWI GENE; PIRNA PATHWAY; DROSOPHILA; EXPRESSION; PROGENITOR; GERMLINE; FAMILY; METHYLATION	Hematopoietic stem cells (HSC) must engage in a life-long balance between self-renewal and differentiation to sustain hematopoiesis. The highly conserved PIWI protein family regulates proliferative states of stem cells and their progeny in diverse organisms. A Human piwi gene (for clarity, the non-italicized "piwi" refers to the gene subfamily), HIWI (PIWIL1), is expressed in CD34(+) stem/progenitor cells and transient expression of HIWI in a human leukemia cell line drastically reduces cell proliferation, implying the potential function of these proteins in hematopoiesis. Here, we report that one of the three piwi genes in mice, Miwi2 (Piwil4), is expressed in primitive hematopoetic cell types within the bone marrow. Mice with a global deletion of all three piwi genes, Miwi, Mili, and Miwi2, are able to maintain long-term hematopoiesis with no observable effect on the homeostatic HSC compartment in adult mice. The PIWI-deficient hematopoetic cells are capable of normal lineage reconstitution after competitive transplantation. We further show that the three piwi genes are dispensable during hematopoietic recovery after myeloablative stress by 5-FU. Collectively, our data suggest that the function of the piwi gene subfamily is not required for normal adult hematopoiesis.	[Nolde, Mona J.; Cheng, Ee-chun; Guo, Shangqin; Lin, Haifan] Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT 06520 USA; [Nolde, Mona J.; Cheng, Ee-chun; Lin, Haifan] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Guo, Shangqin] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Lin, HF (corresponding author), Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT 06520 USA.	haifan.lin@yale.edu	Guo, Shangqin/AAL-7580-2020; Guo, Shangqin/Q-4088-2019	Guo, Shangqin/0000-0003-1157-0423; 	NIH [R01HD42012]; Mathers Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD042012] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042012] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the NIH (R01HD42012) and an Award from Mathers Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Attema JL, 2007, P NATL ACAD SCI USA, V104, P12371, DOI 10.1073/pnas.0704468104; BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chen L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000293; CIVIN CI, 1984, J IMMUNOL, V133, P157; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Grochola LF, 2008, BRIT J CANCER, V99, P1083, DOI 10.1038/sj.bjc.6604653; He G, 2010, AM J TRANSL RES, V2, P156; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Kim VN, 2006, GENE DEV, V20, P1993, DOI 10.1101/gad.1456106; KRAUSE DS, 1994, BLOOD, V84, P691; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee JH, 2010, CANCER RES, V70, P4569, DOI 10.1158/0008-5472.CAN-09-2670; Lee JH, 2006, HUM MOL GENET, V15, P201, DOI 10.1093/hmg/ddi430; LERNER C, 1990, EXP HEMATOL, V18, P114; Lin HF, 2007, SCIENCE, V316, P397, DOI 10.1126/science.1137543; Liu JJ, 2010, INT J CLIN EXP PATHO, V3, P328; Liu XY, 2006, INT J CANCER, V118, P1922, DOI 10.1002/ijc.21575; O'Donnell KA, 2007, CELL, V129, P37, DOI 10.1016/j.cell.2007.03.028; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Qiao D, 2002, ONCOGENE, V21, P3988, DOI 10.1038/sj.onc.1205505; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Sasaki T, 2003, GENOMICS, V82, P323, DOI 10.1016/S0888-7543(03)00129-0; Sharma AK, 2001, BLOOD, V97, P426, DOI 10.1182/blood.V97.2.426; Siddiqi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033711; Sugimoto K, 2007, BIOCHEM BIOPH RES CO, V359, P497, DOI 10.1016/j.bbrc.2007.05.136; Taubert H, 2007, ONCOGENE, V26, P1098, DOI 10.1038/sj.onc.1209880; VANZANT G, 1984, J EXP MED, V159, P679, DOI 10.1084/jem.159.3.679; Williams RT, 2008, COLD SH Q B, V73, P461, DOI 10.1101/sqb.2008.73.039; Ye Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013406; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263	40	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e71950	10.1371/journal.pone.0071950	http://dx.doi.org/10.1371/journal.pone.0071950			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24058407	Green Published, Green Submitted, gold			2022-12-25	WOS:000324403200016
J	Cheung, HNM; Dunbar, C; Morotz, GM; Cheng, WH; Chan, HYE; Miller, CCJ; Lau, KF				Cheung, Hei Nga Maggie; Dunbar, Charlotte; Morotz, Gabor M.; Cheng, Wai Hang; Chan, Ho Yin Edwin; Miller, Christopher C. J.; Lau, Kwok-Fai			FE65 interacts with ADP-ribosylation factor 6 to promote neurite outgrowth	FASEB JOURNAL			English	Article						ARF6; amyloid-; A4 precursor protein-binding family B member 1; neurons; Rac1	AMYLOID PRECURSOR PROTEIN; RECEPTOR-RELATED PROTEIN; PHOSPHOTYROSINE-BINDING DOMAIN; ADAPTER PROTEIN; NUCLEAR TRANSLOCATION; DOWNSTREAM ACTIVATION; DEPENDENT ACTIVATION; APOE RECEPTOR; GROWTH CONES; AXON GROWTH	FE65 is an adaptor protein that binds to the amyloid precursor protein (APP). As such, FE65 has been implicated in the pathogenesis of Alzheimer's disease. In addition, evidence suggests that FE65 is involved in brain development. It is generally believed that FE65 participates in these processes by recruiting various interacting partners to form functional complexes. Here, we show that via its first phosphotyrosine binding (PTB) domain, FE65 binds to the small GTPase ADP-ribosylation factor 6 (ARF6). FE65 preferentially binds to ARF6-GDP, and they colocalize in neuronal growth cones. Interestingly, FE65 stimulates the activation of both ARF6 and its downstream GTPase Rac1, a regulator of actin dynamics, and functions in growth cones to stimulate neurite outgrowth. We show that transfection of FE65 and/or ARF6 promotes whereas small interfering RNA knockdown of FE65 or ARF6 inhibits neurite outgrowth in cultured neurons as compared to the mock-transfected control cells. Moreover, knockdown of ARF6 attenuates FE65 stimulation of neurite outgrowth and defective neurite outgrowth seen in FE65-deficient neurons is partially corrected by ARF6 overexpression. Notably, the stimulatory effect of FE65 and ARF6 on neurite outgrowth is abrogated either by dominant-negative Rac1 or knockdown of Rac1. Thus, we identify FE65 as a novel regulator of neurite outgrowth via controlling ARF6-Rac1 signaling.Cheung, H. N., Dunbar, C., Morotz, G. M., Cheng, W. H., Chan, H. Y., Miller, C. C., Lau, K.-.F. FE65 interacts with ADP-ribosylation factor 6 to promote neurite outgrowth.	[Cheung, Hei Nga Maggie; Cheng, Wai Hang; Chan, Ho Yin Edwin; Lau, Kwok-Fai] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Dunbar, Charlotte; Morotz, Gabor M.; Miller, Christopher C. J.] Kings Coll London, Inst Psychiat, Ctr Neurodegenerat Res, Dept Neurosci, London, England	Chinese University of Hong Kong; University of London; King's College London	Lau, KF (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	kflau@cuhk.edu.hk	Chan, Edwin/A-9478-2011; Mórotz, Gábor Miklós/C-7979-2013	Chan, Edwin/0000-0003-4307-474X; Mórotz, Gábor Miklós/0000-0003-4223-7009; Cheng, Wai Hang/0000-0002-3408-9184; Miller, Christopher/0000-0002-5130-1845; Lau, Kwok-Fai/0000-0002-0193-1152	Research Grant Council Hong Kong [CUHK467712]; CUHK Direct Grant Scheme [2030443]; United College Endowment Fund [CA11156, CA11188]; Wellcome Trust; Medical Research Council (UK); Alzheimer's Research UK; BBSRC [BB/L019299/1] Funding Source: UKRI; MRC [G0501573] Funding Source: UKRI; Alzheimers Research UK [ARUK-PhD2012-1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/L019299/1] Funding Source: researchfish; Medical Research Council [G0501573] Funding Source: researchfish	Research Grant Council Hong Kong(Hong Kong Research Grants Council); CUHK Direct Grant Scheme; United College Endowment Fund; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by funds from the Research Grant Council Hong Kong (CUHK467712); the CUHK Direct Grant Scheme (2030443); United College Endowment Fund (CA11156 and CA11188); Wellcome Trust; Medical Research Council (UK); and Alzheimer's Research UK. The authors thank Ka Ming Vincent Tam for technical assistance.	Albertinazzi C, 2003, MOL BIOL CELL, V14, P1295, DOI 10.1091/mbc.E02-07-0406; Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Boshans RL, 2000, MOL CELL BIOL, V20, P3685, DOI 10.1128/MCB.20.10.3685-3694.2000; Bryan B, 2004, J BIOL CHEM, V279, P45824, DOI 10.1074/jbc.M406216200; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chen LH, 2012, J BIOL CHEM, V287, P26104, DOI 10.1074/jbc.M112.360206; Chen PW, 2013, J BIOL CHEM, V288, P5849, DOI 10.1074/jbc.M112.415778; Chow WNV, 2012, BIOCHEM J, V443, P681, DOI 10.1042/BJ20112175; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; De Curtis I, 2008, DEV NEUROSCI-BASEL, V30, P47, DOI 10.1159/000109851; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; Dumanis SB, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-9; Ermekova KS, 1997, J BIOL CHEM, V272, P32869, DOI 10.1074/jbc.272.52.32869; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Eva R, 2012, J NEUROSCI, V32, P10352, DOI 10.1523/JNEUROSCI.1409-12.2012; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; Flynn KC, 2012, NEURON, V76, P1091, DOI 10.1016/j.neuron.2012.09.038; Frey D, 2000, J CELL BIOL, V149, P1443, DOI 10.1083/jcb.149.7.1443; Guenette S, 2006, EMBO J, V25, P420, DOI 10.1038/sj.emboj.7600926; Hao CY, 2011, BIOCHEM J, V436, P631, DOI 10.1042/BJ20110145; Hernandez-Deviez DJ, 2004, MOL BIOL CELL, V15, P111, DOI 10.1091/mbc.E03-06-0410; Hoe HS, 2006, J BIOL CHEM, V281, P24521, DOI 10.1074/jbc.M600728200; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; Jaworski J, 2007, EUR J CELL BIOL, V86, P513, DOI 10.1016/j.ejcb.2007.04.007; Kanoh H, 1997, J BIOL CHEM, V272, P5421, DOI 10.1074/jbc.272.9.5421; Kesavapany S, 2002, NEUROSCIENCE, V115, P951, DOI 10.1016/S0306-4522(02)00422-0; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; Lau KF, 2000, NEUROREPORT, V11, P3607, DOI 10.1097/00001756-200011090-00041; Lau KF, 2008, J BIOL CHEM, V283, P34728, DOI 10.1074/jbc.M801874200; Leemhuis J, 2010, J NEUROSCI, V30, P14759, DOI 10.1523/JNEUROSCI.4036-10.2010; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lu W, 2013, CURR BIOL, V23, P1018, DOI 10.1016/j.cub.2013.04.050; Lundquist EA, 2003, CURR OPIN NEUROBIOL, V13, P384, DOI 10.1016/s0959-4388(03)00071-0; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Ma QH, 2008, NAT CELL BIOL, V10, P283, DOI 10.1038/ncb1690; Ma Z, 2007, CURR BIOL, V17, P722, DOI 10.1016/j.cub.2007.03.014; Macia E, 2004, J CELL SCI, V117, P2389, DOI 10.1242/jcs.01090; MARSH L, 1984, J CELL BIOL, V99, P2041, DOI 10.1083/jcb.99.6.2041; May V, 2002, J NEUROSCI, V22, P6980; McLoughlin DM, 1998, BIOCHEM SOC T, V26, P497, DOI 10.1042/bst0260497; McLoughlin DM, 1996, FEBS LETT, V397, P197; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Menetrey J, 2000, NAT STRUCT BIOL, V7, P466; Minopoli G, 2001, J BIOL CHEM, V276, P6545, DOI 10.1074/jbc.M007340200; Minopoli G, 2012, IUBMB LIFE, V64, P936, DOI 10.1002/iub.1094; Mo J, 2012, BIOCHEM BIOPH RES CO, V422, P250, DOI 10.1016/j.bbrc.2012.04.136; Monteleon CL, 2012, MOL BIOL CELL, V23, P4495, DOI 10.1091/mbc.E12-03-0246; Montenegro-Venegas C, 2010, MOL BIOL CELL, V21, P3518, DOI 10.1091/mbc.E09-08-0709; Mulvihill MM, 2011, BIOCHEMISTRY-US, V50, P6208, DOI 10.1021/bi200508f; Myers KR, 2008, TRENDS CELL BIOL, V18, P184, DOI 10.1016/j.tcb.2008.02.002; Nakaya T, 2008, J BIOL CHEM, V283, P19119, DOI 10.1074/jbc.M801827200; Nekhoroshkova E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004647; Nikolic M, 2002, INT J BIOCHEM CELL B, V34, P731, DOI 10.1016/S1357-2725(01)00167-4; Pasqualato S, 2001, EMBO REP, V2, P234, DOI 10.1093/embo-reports/kve043; Perez RG, 1997, J NEUROSCI, V17, P9407; Perkinton MS, 2004, J BIOL CHEM, V279, P22084, DOI 10.1074/jbc.M311479200; Pietrzik CU, 2004, J NEUROSCI, V24, P4259, DOI 10.1523/JNEUROSCI.5451-03.2004; Radhakrishna H, 1999, J CELL SCI, V112, P855; Rama N, 2012, J BIOL CHEM, V287, P30014, DOI 10.1074/jbc.M111.324780; Sabo SL, 2003, J NEUROSCI, V23, P5407; Sabo SL, 2001, J CELL BIOL, V153, P1403, DOI 10.1083/jcb.153.7.1403; Sabo SL, 1999, J BIOL CHEM, V274, P7952, DOI 10.1074/jbc.274.12.7952; Sannerud R, 2011, P NATL ACAD SCI USA, V108, pE559, DOI 10.1073/pnas.1100745108; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Schweitzer JK, 2011, SEMIN CELL DEV BIOL, V22, P39, DOI 10.1016/j.semcdb.2010.09.002; Sepp KJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000111; Sheridan AM, 2001, MOL CELL BIOL, V21, P4470, DOI 10.1128/MCB.21.14.4470-4481.2001; Stante M, 2009, P NATL ACAD SCI USA, V106, P5093, DOI 10.1073/pnas.0810869106; Stiles TL, 2013, J CELL SCI, V126, P209, DOI 10.1242/jcs.113191; Tahirovic S, 2010, J NEUROSCI, V30, P6930, DOI 10.1523/JNEUROSCI.5395-09.2010; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Tsai SC, 1998, J BIOL CHEM, V273, P20697, DOI 10.1074/jbc.273.33.20697; Tudor EL, 2010, NEUROSCIENCE, V167, P774, DOI 10.1016/j.neuroscience.2010.02.035; Tudor EL, 2005, J BIOL CHEM, V280, P34735, DOI 10.1074/jbc.M506216200; Turner AJ, 2011, EMBO REP, V12, P180, DOI 10.1038/embor.2011.25; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Vagnoni A, 2012, HUM MOL GENET, V21, P2845, DOI 10.1093/hmg/dds109; Wang BP, 2004, J NEUROSCI RES, V75, P12, DOI 10.1002/jnr.10834; Wang PL, 2011, NEUROREPORT, V22, P716, DOI 10.1097/WNR.0b013e32834aca9d; Wang Y, 2009, LEARN MEMORY, V16, P537, DOI 10.1101/lm.1499309; Williams KL, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-24; YAMADA KM, 1970, P NATL ACAD SCI USA, V66, P1206, DOI 10.1073/pnas.66.4.1206; Yamazaki T, 1997, J NEUROSCI, V17, P1004; Zambrano N, 1998, J BIOL CHEM, V273, P20128, DOI 10.1074/jbc.273.32.20128	91	30	30	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					337	349		10.1096/fj.13-232694	http://dx.doi.org/10.1096/fj.13-232694			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24056087	Green Accepted			2022-12-25	WOS:000333526100032
J	Ladeveze, S; Tarquis, L; Cecchini, DA; Bercovici, J; Andre, I; Topham, CM; Morel, S; Laville, E; Monsan, P; Lombard, V; Henrissat, B; Potocki-Veronese, G				Ladeveze, Simon; Tarquis, Laurence; Cecchini, Davide A.; Bercovici, Juliette; Andre, Isabelle; Topham, Christopher M.; Morel, Sandrine; Laville, Elisabeth; Monsan, Pierre; Lombard, Vincent; Henrissat, Bernard; Potocki-Veronese, Gabrielle			Role of Glycoside Phosphorylases in Mannose Foraging by Human Gut Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Metabolism; Enzyme Mechanisms; Glycoprotein; Intestinal Epithelium; Phosphorylase; GH130; N-Glycan; Human Gut	ENDO-BETA-MANNOSIDASE; SUBSTRATE-SPECIFICITY; N-GLYCAN; BACTEROIDES-THETAIOTAOMICRON; DISACCHARIDE PHOSPHORYLASES; CHEMOENZYMATIC SYNTHESIS; TREHALOSE PHOSPHORYLASE; MOLECULAR-CLONING; METABOLISM; MANNAN	To metabolize both dietary fiber constituent carbohydrates and host glycans lining the intestinal epithelium, gut bacteria produce a wide range of carbohydrate-active enzymes, of which glycoside hydrolases are the main components. In this study, we describe the ability of phosphorylases to participate in the breakdown of human N-glycans, from an analysis of the substrate specificity of UhgbMP, a mannoside phosphorylase of the GH130 protein family discovered by functional metagenomics. UhgbMP is found to phosphorolyze -d-Manp-1,4--d-GlcpNAc-1,4-d-GlcpNAc and is also a highly efficient enzyme to catalyze the synthesis of this precious N-glycan core oligosaccharide by reverse phosphorolysis. Analysis of sequence conservation within family GH130, mapped on a three-dimensional model of UhgbMP and supported by site-directed mutagenesis results, revealed two GH130 subfamilies and allowed the identification of key residues responsible for catalysis and substrate specificity. The analysis of the genomic context of 65 known GH130 sequences belonging to human gut bacteria indicates that the enzymes of the GH130_1 subfamily would be involved in mannan catabolism, whereas the enzymes belonging to the GH130_2 subfamily would rather work in synergy with glycoside hydrolases of the GH92 and GH18 families in the breakdown of N-glycans. The use of GH130 inhibitors as therapeutic agents or functional foods could thus be considered as an innovative strategy to inhibit N-glycan degradation, with the ultimate goal of protecting, or restoring, the epithelial barrier.	[Ladeveze, Simon; Tarquis, Laurence; Cecchini, Davide A.; Bercovici, Juliette; Andre, Isabelle; Topham, Christopher M.; Morel, Sandrine; Laville, Elisabeth; Monsan, Pierre; Potocki-Veronese, Gabrielle] Univ Toulouse, Inst Natl Sci Appl, Univ Toulouse 3, Lab Ingn Syst Biol & Proc,Inst Natl Polytech, F-31077 Toulouse, France; [Ladeveze, Simon; Tarquis, Laurence; Cecchini, Davide A.; Bercovici, Juliette; Andre, Isabelle; Topham, Christopher M.; Morel, Sandrine; Laville, Elisabeth; Monsan, Pierre; Potocki-Veronese, Gabrielle] CNRS, UMR5504, F-31400 Toulouse, France; [Ladeveze, Simon; Tarquis, Laurence; Cecchini, Davide A.; Bercovici, Juliette; Andre, Isabelle; Topham, Christopher M.; Morel, Sandrine; Laville, Elisabeth; Monsan, Pierre; Potocki-Veronese, Gabrielle] INRA, Ingn Syst Biol & Proc UMR792, F-31400 Toulouse, France; [Lombard, Vincent; Henrissat, Bernard] Aix Marseille Univ, CNRS UMR 7257, F-13288 Marseille, France	Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Potocki-Veronese, G (corresponding author), Inst Natl Rech Agron UMR792, CNRS UMR5504, Inst Natl Sci Appl, Lab Ingn Syst Biol & Proc, 135 Ave Rangueil, F-31077 Toulouse, France.	veronese@insa-toulouse.fr	Veronese, Gabrielle/GTF-3473-2022; Henrissat, Bernard/J-2475-2012	Henrissat, Bernard/0000-0002-3434-8588; Topham, Christopher/0000-0002-9147-0184; Lombard, Vincent/0000-0002-9684-7067	Region Midi-Pyrenees; European Regional Development Fund; SICOVAL; Infrastructures en Biologie Sante et Agronomie (IBiSa, France); CNRS; Institut National de la Recherche Agronomique	Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); European Regional Development Fund(European Commission); SICOVAL; Infrastructures en Biologie Sante et Agronomie (IBiSa, France); CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Recherche Agronomique	We cordially thank Nelly Monties for technical assistance. MetaToul (Metabolomics & Fluxomics Facitilies, Toulouse, France) is gratefully acknowledged for access to NMR facilities. MetaToul is supported by grants from the Region Midi-Pyrenees, the European Regional Development Fund, the SICOVAL, the Infrastructures en Biologie Sante et Agronomie (IBiSa, France), the CNRS, and the Institut National de la Recherche Agronomique.	Aerts D, 2011, CARBOHYD RES, V346, P1860, DOI 10.1016/j.carres.2011.06.024; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Brett C. T., 1996, PHYSL BIOCH PLANT CE, P222; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Desmet T, 2012, PROCESS BIOCHEM, V47, P11, DOI 10.1016/j.procbio.2011.10.039; DEY PM, 1978, ADV CARBOHYD CHEM BI, V35, P341; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; Dilokpimol A, 2011, BBA-PROTEINS PROTEOM, V1814, P1720, DOI 10.1016/j.bbapap.2011.08.003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eneyskaya EV, 2009, BIOCHIMIE, V91, P632, DOI 10.1016/j.biochi.2009.03.009; Englyst KN, 2005, BRIT J NUTR, V94, P1, DOI 10.1079/BJN20051457; Erickson AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049138; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gloster TM, 2008, CHEM BIOL, V15, P1058, DOI 10.1016/j.chembiol.2008.09.005; Han SE, 2003, PROTEIN EXPRES PURIF, V30, P194, DOI 10.1016/S1046-5928(03)00104-9; Heinken A, 2013, GUT MICROBES, V4, P28, DOI 10.4161/gmic.22370; Hidaka M, 2004, STRUCTURE, V12, P937, DOI 10.1016/j.str.2004.03.027; Hu L, 2011, INT J CHEM INT J QUA, V3, P68; Hughes CV, 2003, ORAL MICROBIOL IMMUN, V18, P309, DOI 10.1034/j.1399-302X.2003.00091.x; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Ishimizu T, 2004, J BIOL CHEM, V279, P38555, DOI 10.1074/jbc.M406886200; Kawahara R, 2012, J BIOL CHEM, V287, P42389, DOI 10.1074/jbc.M112.390336; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Luley-Goedl C, 2010, BIOTECHNOL J, V5, P1324, DOI 10.1002/biot.201000217; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; Moran AP, 2011, GUT, V60, P1412, DOI 10.1136/gut.2010.212704; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Motomura K, 2011, FEMS MICROBIOL LETT, V320, P25, DOI 10.1111/j.1574-6968.2011.02285.x; Murata T, 1997, BIOSCI BIOTECH BIOCH, V61, P1059, DOI 10.1271/bbb.61.1059; Nakai H, 2013, CURR OPIN CHEM BIOL, V17, P301, DOI 10.1016/j.cbpa.2013.01.006; Nakajima M, 2008, APPL ENVIRON MICROB, V74, P6333, DOI 10.1128/AEM.02846-07; Nihira T, 2013, J BIOL CHEM, V288, P27366, DOI 10.1074/jbc.M113.469080; Ottman N, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00104; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rathore RS, 2009, CRIT REV BIOTECHNOL, V29, P214, DOI 10.1080/07388550902926063; Revers L, 1999, BBA-GEN SUBJECTS, V1428, P88, DOI 10.1016/S0304-4165(99)00048-3; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Salinardi TC, 2010, J NUTR, V140, P1943, DOI 10.3945/jn.110.128207; Sasaki A, 2005, J BIOCHEM, V137, P87, DOI 10.1093/jb/mvi008; Segel, 1975, ENZYME KINETICS BEHA, P274; Senoura T, 2011, BIOCHEM BIOPH RES CO, V408, P701, DOI 10.1016/j.bbrc.2011.04.095; Sheng YH, 2012, J GASTROEN HEPATOL, V27, P28, DOI 10.1111/j.1440-1746.2011.06909.x; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Tailford LE, 2007, J BIOL CHEM, V282, P11291, DOI 10.1074/jbc.M610964200; Tasse L, 2010, GENOME RES, V20, P1605, DOI 10.1101/gr.108332.110; Thompson AJ, 2012, P NATL ACAD SCI USA, V109, P781, DOI 10.1073/pnas.1111482109; USUI T, 1994, GLYCOCONJUGATE J, V11, P105, DOI 10.1007/BF00731150; Van der Borght J, 2011, APPL ENVIRON MICROB, V77, P6939, DOI 10.1128/AEM.05190-11; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Zhao YX, 1999, CARBOHYD RES, V319, P184, DOI 10.1016/S0008-6215(99)00116-0; Zhu YP, 2010, NAT CHEM BIOL, V6, P125, DOI [10.1038/NCHEMBIO.278, 10.1038/nchembio.278]	59	35	37	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32370	32383		10.1074/jbc.M113.483628	http://dx.doi.org/10.1074/jbc.M113.483628			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24043624	Green Published, hybrid			2022-12-25	WOS:000328681700022
J	Zhang, XR; Zhu, J; Li, YM; Lin, T; Siclari, VA; Chandra, A; Candela, EM; Koyama, E; Enomoto-Iwamoto, M; Qin, L				Zhang, Xianrong; Zhu, Ji; Li, Yumei; Lin, Tiao; Siclari, Valerie A.; Chandra, Abhishek; Candela, Elena M.; Koyama, Eiki; Enomoto-Iwamoto, Motomi; Qin, Ling			Epidermal Growth Factor Receptor (EGFR) Signaling Regulates Epiphyseal Cartilage Development through beta-Catenin-dependent and -independent Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Beta-Catenin; Cartilage Biology; Epidermal Growth Factor Receptor (EGFR); Extracellular Matrix; Matrix Metalloproteinase (MMP); Cartilage Matrix Degradation; Secondary Ossification Center	MATRIX METALLOPROTEINASES; TRANSCRIPTIONAL ACTIVITY; CHONDROCYTE MATURATION; BONE-DEVELOPMENT; MICE LACKING; EXPRESSION; TRANSACTIVATION; PROLIFERATION; OSSIFICATION; ANGIOGENESIS	The epidermal growth factor receptor (EGFR) is an essential player in the development of multiple organs during embryonic and postnatal stages. To understand its role in epiphyseal cartilage development, we generated transgenic mice with conditionally inactivated EGFR in chondrocytes. Postnatally, these mice exhibited a normal initiation of cartilage canals at the perichondrium, but the excavation of these canals into the cartilage was strongly suppressed, resulting in a delay in the formation of the secondary ossification center (SOC). This delay was accompanied by normal chondrocyte hypertrophy but decreased mineralization and apoptosis of hypertrophic chondrocytes and reduced osteoclast number at the border of marrow space. Immunohistochemical analyses demonstrated that inactivation of chondrocyte-specific EGFR signaling reduced the amounts of matrix metalloproteinases (MMP9, -13, and -14) and RANKL (receptor activator of NF-B ligand) in the hypertrophic chondrocytes close to the marrow space and decreased the cartilage matrix degradation in the SOC. Analyses of EGFR downstream signaling pathways in primary epiphyseal chondrocytes revealed that up-regulation of MMP9 and RANKL by EGFR signaling was partially mediated by the canonical Wnt/-catenin pathway, whereas EGFR-enhanced MMP13 expression was not. Further biochemical studies suggested that EGFR signaling stimulates the phosphorylation of LRP6, increases active -catenin level, and induces its nuclear translocation. In line with these in vitro studies, deficiency in chondrocyte-specific EGFR activity reduced -catenin amount in hypertrophic chondrocytes in vivo. In conclusion, our work demonstrates that chondrocyte-specific EGFR signaling is an important regulator of cartilage matrix degradation during SOC formation and epiphyseal cartilage development and that its actions are partially mediated by activating the -catenin pathway.	[Zhang, Xianrong; Zhu, Ji; Li, Yumei; Lin, Tiao; Siclari, Valerie A.; Chandra, Abhishek; Koyama, Eiki; Enomoto-Iwamoto, Motomi; Qin, Ling] Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA; [Zhang, Xianrong] Wuhan Univ, Sch Basic Med Sci, Dept Physiol, Wuhan 430072, Hubei Province, Peoples R China; [Li, Yumei] Shanghai Univ Tradit Chinese Med, Shanghai Municipal Hosp Tradit Chinese Med, Shanghai 201203, Peoples R China; [Lin, Tiao; Candela, Elena M.] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Orthopaed Surg, Hangzhou 310009, Zhejiang, Peoples R China; [Koyama, Eiki; Enomoto-Iwamoto, Motomi] Childrens Hosp Philadelphia, Dept Surg, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Wuhan University; Shanghai University of Traditional Chinese Medicine; Zhejiang University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Qin, L (corresponding author), Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, 424 Stemmler Hall,36th St & Hamilton Walk, Philadelphia, PA 19104 USA.	qinling@mail.med.upenn.edu	Chandra, Abhishek/AAG-8781-2020		National Institutes of Health [AR060991, AR062908]; Penn Center for Musculoskeletal Disorders [P30AR050950]; American Society for Bone and Mineral Research (ASBMR) Research Career Enhancement Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062908, P30AR050950, R03AR060991] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn Center for Musculoskeletal Disorders; American Society for Bone and Mineral Research (ASBMR) Research Career Enhancement Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR060991 (to L. Q.) and AR062908 (to M. E. I.) and Penn Center for Musculoskeletal Disorders Grant P30AR050950. This study was also supported by American Society for Bone and Mineral Research (ASBMR) Research Career Enhancement Award (to L. Q.).	Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Alvarez J, 2005, CELL TISSUE RES, V320, P501, DOI 10.1007/s00441-004-1034-z; Alvarez J, 2005, J BONE MINER RES, V20, P1011, DOI 10.1359/JBMR.050204; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Blumer MJF, 2008, ANN ANAT, V190, P305, DOI 10.1016/j.aanat.2008.02.004; Blumer MJF, 2012, MECH DEVELOP, V129, P162, DOI 10.1016/j.mod.2012.04.003; Cervenka I, 2011, MOL CELL BIOL, V31, P179, DOI 10.1128/MCB.00550-10; Chun JS, 2008, BMB REP, V41, P485, DOI 10.5483/BMBRep.2008.41.7.485; Civenni G, 2003, EMBO REP, V4, P166, DOI 10.1038/sj.embor.embor735; Dao DY, 2012, J BONE MINER RES, V27, P1680, DOI 10.1002/jbmr.1639; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Edwards JR, 2011, NAT REV RHEUMATOL, V7, P235, DOI 10.1038/nrrheum.2011.23; Enomoto-Iwamoto M, 2002, DEV BIOL, V251, P142, DOI 10.1006/dbio.2002.0802; Fosang AJ, 2013, OSTEOARTHR CARTILAGE, V21, P401, DOI 10.1016/j.joca.2012.11.013; Guo XZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006067; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hu TH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-236; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Koyama E, 2007, DEVELOPMENT, V134, P2159, DOI 10.1242/dev.001586; Krane SM, 2008, BONE, V43, P7, DOI 10.1016/j.bone.2008.03.020; Krejci P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035826; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lee CH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-64; Lee D, 2004, MAMM GENOME, V15, P525, DOI 10.1007/s00335-004-2384-2; Lee ER, 2001, DEV DYNAM, V222, P52, DOI 10.1002/dvdy.1168; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Mackie EJ, 2011, J ENDOCRINOL, V211, P109, DOI 10.1530/JOE-11-0048; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Ortega N, 2004, TRENDS CELL BIOL, V14, P86, DOI 10.1016/j.tcb.2003.12.003; Ortega N, 2010, DIS MODEL MECH, V3, P224, DOI 10.1242/dmm.004226; Pines G, 2010, FEBS LETT, V584, P2699, DOI 10.1016/j.febslet.2010.04.019; Renkiewicz R, 2003, ARTHRITIS RHEUM, V48, P1742, DOI 10.1002/art.11030; Schlange T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1769; Schneider MR, 2009, TRENDS ENDOCRIN MET, V20, P517, DOI 10.1016/j.tem.2009.06.008; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Tamamura Y, 2005, J BIOL CHEM, V280, P19185, DOI 10.1074/jbc.M414275200; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Usmani SE, 2012, BONE, V51, P131, DOI 10.1016/j.bone.2012.04.012; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wuelling M, 2011, ENDOCR DEV, V21, P1, DOI 10.1159/000328081; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Yasuhara R, 2011, LAB INVEST, V91, P1739, DOI 10.1038/labinvest.2011.144; Zhang XR, 2011, J BONE MINER RES, V26, P2622, DOI 10.1002/jbmr.502; Zhang XR, 2011, J BONE MINER RES, V26, P1022, DOI 10.1002/jbmr.295; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	50	47	49	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32229	32240		10.1074/jbc.M113.463554	http://dx.doi.org/10.1074/jbc.M113.463554			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24047892	hybrid, Green Published			2022-12-25	WOS:000328681700011
J	Zhao, H; Liu, JN; Pan, SN; Sun, YW; Li, Q; Li, F; Ma, L; Guo, QY				Zhao, Heng; Liu, Jiani; Pan, Shinong; Sun, Yingwei; Li, Qi; Li, Fei; Ma, Li; Guo, Qiyong			SOD mRNA and MDA Expression in Rectus Femoris Muscle of Rats with Different Eccentric Exercise Programs and Time Points	PLOS ONE			English	Article							PROTECTS VULNERABLE NEURONS; SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; SKELETAL-MUSCLE; ISCHEMIC DAMAGE; GENE-EXPRESSION; REACTIVE OXYGEN; FREE-RADICALS; ENDURANCE; OVEREXPRESSION	Purpose: Although superoxide dismutase (SOD) and malondialdehyde (MDA) affect Delayed Onset Muscle Soreness (DOMS), their effects are unclear in rectus femoris muscles (RFM) of rats with different eccentric exercise programs and time points. The purpose of this study is to investigate the effects of the various eccentric exercise programs at different time points on the SOD mRNA expression and MDA using rat as the animal model. Methods: 248 male rats were randomly divided into 4 groups: control group (CTL, n = 8), once-only exercise group (OEG, n = 80), continuous exercise group (CEG, n = 80), and intermittent exercise group (IEG, n = 80). Each exercise group was divided into 10 subgroups that exercised 0.5 h, 6 h, 12 h, 24 h, 48 h, 72 h, 96 h, 120 h, 144 h, or 168 h. Rats were sacrificed and their SOD mRNA expression, and MDA concentrations of skeletal muscle tissue were measured. Results: The specimen in all eccentric exercise programs showed increased RFM SOD1 mRNA expression levels at 0.5 h (P < 0.05), and decreased RFM SOD3 mRNA expression at 0.5 h (P < 0.05). The continuous eccentric exercise (CE) significantly enhanced muscle SOD2 mRNA level at 0.5 h (P < 0.05). After once-only eccentric exercise (OE), SOD1, SOD2, and SOD3 mRNA expression significantly increased at 96 h, whereas MDA concentrations decreased at 96 h. After CE, the correlation coefficients of SOD1, SOD2, SOD3 mRNA expression levels and MDA concentrations were -0.814, -0.763, -0.845 (all P < 0.05) at 12 h. Conclusion: Regular eccentric exercise, especially CE could enhance SOD1 and SOD2 mRNA expression in acute stage and the SOD2 mRNA expression correlates to MDA concentration in vivo, which may improve the oxidative adaption ability of skeletal muscles.	[Zhao, Heng; Liu, Jiani; Pan, Shinong; Sun, Yingwei; Li, Qi; Li, Fei; Guo, Qiyong] China Med Univ, Shengjing Hosp, Dept Radiol, Shenyang, Peoples R China; [Ma, Li] China Med Univ, Shengjing Hosp, Cent Lab, Shenyang, Peoples R China	China Medical University; China Medical University	Pan, SN (corresponding author), China Med Univ, Shengjing Hosp, Dept Radiol, Shenyang, Peoples R China.	cjr.panshinong@vip.163.com	赵, 衡/AAQ-9925-2021	Zhao, Heng/0000-0001-6549-4644	National Natural Science Foundation of China [30871211, 81271538]; Outstanding Scientific Fund of Shengjing Hospital [201208]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Scientific Fund of Shengjing Hospital	This work was supported by National Natural Science Foundation of China(30871211, 81271538), Outstanding Scientific Fund of Shengjing Hospital (NO. 201208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7; Anttila K, 2007, ACTA HISTOCHEM CYTOC, V40, P35, DOI 10.1267/ahc.06028; Atig F, 2012, INT J BIOL SCI, V8, P139, DOI 10.7150/ijbs.8.139; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chan PH, 1998, J NEUROSCI, V18, P8292, DOI 10.1523/jneurosci.18-20-08292.1998; Cleak MJ, 1992, J SPORT SCI, V10, P325, DOI 10.1080/02640419208729932; Close GL, 2004, EUR J APPL PHYSIOL, V91, P615, DOI 10.1007/s00421-003-1012-2; Pimenta AD, 2007, EUR J APPL PHYSIOL, V102, P119, DOI 10.1007/s00421-007-0542-4; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Garcia-Lopez D, 2007, MED SCI SPORT EXER, V39, P653, DOI 10.1249/mss.0b013e31802f04f6; Habbout A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056981; Hitomi Y, 2008, REDOX REP, V13, P213, DOI 10.1179/135100008X308894; Hollander J, 2001, PFLUG ARCH EUR J PHY, V442, P426, DOI 10.1007/s004240100539; Hootman JM, 2002, MED SCI SPORT EXER, V34, P838, DOI 10.1097/00005768-200205000-00017; Itoh M, 2004, AM J PHYSIOL-REG I, V287, pR33, DOI 10.1152/ajpregu.00598.2003; Jackson MJ, 2008, FREE RADICAL BIO MED, V44, P132, DOI 10.1016/j.freeradbiomed.2007.06.003; Jeffcoate W, 2004, DIABETOLOGIA, V47, P1488, DOI 10.1007/s00125-004-1477-5; Ji LL, 2004, FASEB J, V18, P1499, DOI 10.1096/fj.04-1846com; Ji LL, 2002, ANN NY ACAD SCI, V959, P82, DOI 10.1111/j.1749-6632.2002.tb02085.x; Ji LL, 1999, P SOC EXP BIOL MED, V222, P283, DOI 10.1046/j.1525-1373.1999.d01-145.x; Kerksick C, 2008, MED SCI SPORT EXER, V40, P1772, DOI 10.1249/MSS.0b013e31817d1cce; Koyama H, 2013, MOLECULES, V18, P1383, DOI 10.3390/molecules18021383; KUIPERS H, 1994, INT J SPORTS MED, V15, P132, DOI 10.1055/s-2007-1021034; LAI CC, 1994, FREE RADICAL BIO MED, V16, P613, DOI 10.1016/0891-5849(94)90061-2; Lima-Cabello E, 2010, J APPL PHYSIOL, V108, P575, DOI 10.1152/japplphysiol.00816.2009; Liu WY, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/780719; Liu XG, 2009, PHOTOMED LASER SURG, V27, P863, DOI 10.1089/pho.2008.2443; Lustgarten MS, 2009, AM J PHYSIOL-CELL PH, V297, pC1520, DOI 10.1152/ajpcell.00372.2009; McLeay Y, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-19; Molines L, 2010, DIABETES METAB, V36, P251, DOI 10.1016/j.diabet.2010.04.002; Murase S, 2010, J NEUROSCI, V30, P3752, DOI 10.1523/JNEUROSCI.3803-09.2010; Nakao C, 2000, J APPL PHYSIOL, V88, P649, DOI 10.1152/jappl.2000.88.2.649; Noor Rana, 2002, Med Sci Monit, V8, pRA210; Nozik-Grayck E, 2008, AM J PHYSIOL-LUNG C, V295, pL422, DOI 10.1152/ajplung.90293.2008; OhIshi S, 1995, MECH AGEING DEV, V84, P65, DOI 10.1016/0047-6374(95)01637-F; Ohishi S, 1997, CLIN EXP PHARMACOL P, V24, P326, DOI 10.1111/j.1440-1681.1997.tb01196.x; Papiez MA, 2009, PROG NEURO-PSYCHOPH, V33, P596, DOI 10.1016/j.pnpbp.2009.02.015; Powers SK, 2011, J PHYSIOL-LONDON, V589, P2129, DOI 10.1113/jphysiol.2010.201327; Qiao D, 2006, BRIT J SPORT MED, V40, P214, DOI 10.1136/bjsm.2005.020099; Radak Z, 2012, NITRIC OXIDE-BIOL CH, V26, P89, DOI 10.1016/j.niox.2011.12.005; Ringholm S, 2011, AM J PHYSIOL-ENDOC M, V301, pE649, DOI 10.1152/ajpendo.00230.2011; Sakellariou GK, 2011, AGING CELL, V10, P749, DOI 10.1111/j.1474-9726.2011.00709.x; SALMINEN A, 1983, ACTA PHYSIOL SCAND, V117, P109, DOI 10.1111/j.1748-1716.1983.tb07184.x; Stepto NK, 2009, MED SCI SPORT EXER, V41, P546, DOI 10.1249/MSS.0b013e31818c6be9; Stupka N, 2000, J APPL PHYSIOL, V89, P2325, DOI 10.1152/jappl.2000.89.6.2325; Sugawara T, 2002, J NEUROSCI, V22, P209, DOI 10.1523/JNEUROSCI.22-01-00209.2002; Tamura I, 2011, J CLIN ENDOCR METAB, V96, pE1073, DOI 10.1210/jc.2010-2489; Thau N, 2012, NEUROBIOL DIS, V47, P248, DOI 10.1016/j.nbd.2012.04.008; Tomiya A, 2004, AM J SPORT MED, V32, P503, DOI 10.1177/0095399703258788; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wang YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058659; Westerterp M, 2006, J LIPID RES, V47, P1203, DOI 10.1194/jlr.M500434-JLR200; Xu Y, 2009, STROKE, V40, P2512, DOI 10.1161/STROKEAHA.109.548453; Yang JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057186; Yu TS, 2010, INT J LEGAL MED, V124, P397, DOI 10.1007/s00414-010-0465-1; Zheng JA, 2010, CLIN EXP PHARMACOL P, V37, P955, DOI 10.1111/j.1440-1681.2010.05415.x	56	13	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73634	10.1371/journal.pone.0073634	http://dx.doi.org/10.1371/journal.pone.0073634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058480	Green Published, gold, Green Submitted			2022-12-25	WOS:000324408400029
J	Dillon, LW; Pierce, LCT; Lehman, CE; Nikiforov, YE; Wang, YH				Dillon, Laura W.; Pierce, Levi C. T.; Lehman, Christine E.; Nikiforov, Yuri E.; Wang, Yuh-Hwa			DNA Topoisomerases Participate in Fragility of the Oncogene RET	PLOS ONE			English	Article							2ND MALIGNANT NEOPLASMS; HUMAN-CHROMOSOME 7; THYROID-CANCER; MOLECULAR-GENETICS; BETULINIC ACID; UNITED-STATES; IN-VITRO; COMMON; REPLICATION; SITE	Fragile site breakage was previously shown to result in rearrangement of the RET oncogene, resembling the rearrangements found in thyroid cancer. Common fragile sites are specific regions of the genome with a high susceptibility to DNA breakage under conditions that partially inhibit DNA replication, and often coincide with genes deleted, amplified, or rearranged in cancer. While a substantial amount of work has been performed investigating DNA repair and cell cycle checkpoint proteins vital for maintaining stability at fragile sites, little is known about the initial events leading to DNA breakage at these sites. The purpose of this study was to investigate these initial events through the detection of aphidicolin (APH)-induced DNA breakage within the RET oncogene, in which 144 APH-induced DNA breakpoints were mapped on the nucleotide level in human thyroid cells within intron 11 of RET, the breakpoint cluster region found in patients. These breakpoints were located at or near DNA topoisomerase I and/or II predicted cleavage sites, as well as at DNA secondary structural features recognized and preferentially cleaved by DNA topoisomerases I and II. Co-treatment of thyroid cells with APH and the topoisomerase catalytic inhibitors, betulinic acid and merbarone, significantly decreased APH-induced fragile site breakage within RET intron 11 and within the common fragile site FRA3B. These data demonstrate that DNA topoisomerases I and II are involved in initiating APH-induced common fragile site breakage at RET, and may engage the recognition of DNA secondary structures formed during perturbed DNA replication.	[Dillon, Laura W.; Wang, Yuh-Hwa] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27106 USA; [Pierce, Levi C. T.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Lehman, Christine E.] Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC USA; [Nikiforov, Yuri E.] Univ Pittsburgh, Dept Pathol & Lab Med, Pittsburgh, PA 15260 USA	Wake Forest University; University of California System; University of California San Diego; Wake Forest University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, YH (corresponding author), Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27106 USA.	ywang@wakehealth.edu			National Institutes of Health [CA113863, T32GM095440]; NATIONAL CANCER INSTITUTE [R01CA113863, P30CA012197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM095440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (CA113863 to YHW and YEN and T32GM095440 to LWD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurashidova G, 2007, EMBO J, V26, P998, DOI 10.1038/sj.emboj.7601578; Allan JM, 2005, NAT REV CANCER, V5, P943, DOI 10.1038/nrc1749; ANDERSON S, 1979, J BIOL CHEM, V254, P1495; Arlt MF, 2010, DNA REPAIR, V9, P678, DOI 10.1016/j.dnarep.2010.03.005; Bar FMA, 2009, J NAT PROD, V72, P1643, DOI 10.1021/np900312u; BEEN MD, 1984, NUCLEIC ACIDS RES, V12, P3097, DOI 10.1093/nar/12.7.3097; BEEN MD, 1984, J MOL BIOL, V180, P515, DOI 10.1016/0022-2836(84)90025-1; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; BOFFETTA P, 1994, ACTA ONCOL, V33, P591, DOI 10.3109/02841869409121767; Bongarzone I, 1997, GENOMICS, V42, P252, DOI 10.1006/geno.1997.4685; Burrow AA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-59; Capranico G, 1998, BBA-GENE STRUCT EXPR, V1400, P185, DOI 10.1016/S0167-4781(98)00135-3; Caudill CM, 2005, J CLIN ENDOCR METAB, V90, P2364, DOI 10.1210/jc.2004-1811; Chen AY, 2009, CANCER-AM CANCER SOC, V115, P3801, DOI 10.1002/cncr.24416; CHENG CH, 1993, BIOCHEMISTRY-US, V32, P8568, DOI 10.1021/bi00084a025; Corbin S, 2002, CANCER RES, V62, P3477; de Vathaire F, 1999, BRIT J CANCER, V79, P1884, DOI 10.1038/sj.bjc.6690300; Dillon LW, 2010, CURR GENOMICS, V11, P326, DOI 10.2174/138920210791616699; DILLON LW, 2013, HUM MOL GENET; DRAKE FH, 1989, CANCER RES, V49, P2578; DROLET M, 1994, J BIOL CHEM, V269, P2068; Durkin SG, 2008, P NATL ACAD SCI USA, V105, P246, DOI 10.1073/pnas.0708097105; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Enewold L, 2009, CANCER EPIDEM BIOMAR, V18, P784, DOI 10.1158/1055-9965.EPI-08-0960; Fortune JM, 1998, J BIOL CHEM, V273, P17643, DOI 10.1074/jbc.273.28.17643; FROELICHAMMON SJ, 1994, J BIOL CHEM, V269, P7719; Gandhi M, 2010, ONCOGENE, V29, P2272, DOI 10.1038/onc.2009.502; Ganguly A, 2007, CANCER RES, V67, P11848, DOI 10.1158/0008-5472.CAN-07-1615; Garcia-Carbonero R, 2002, CLIN CANCER RES, V8, P641; Glover TW, 2006, CANCER LETT, V232, P4, DOI 10.1016/j.canlet.2005.08.032; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; Gow KW, 2003, J PEDIATR SURG, V38, P1574, DOI 10.1016/S0022-3468(03)00563-3; Grabczyk E, 2007, NUCLEIC ACIDS RES, V35, P5351, DOI 10.1093/nar/gkm589; Hande KR, 2008, UPDATE CANC THERAPEU, V3, P13, DOI DOI 10.1016/J.UCT.2008.02.001; Handt O, 2000, CHROMOSOME RES, V8, P677, DOI 10.1023/A:1026737203447; HAY RT, 1982, CELL, V28, P767, DOI 10.1016/0092-8674(82)90056-3; Hellman A, 2000, MOL CELL BIOL, V20, P4420, DOI 10.1128/MCB.20.12.4420-4427.2000; Helmrich A, 2011, MOL CELL, V44, P966, DOI 10.1016/j.molcel.2011.10.013; JHIANG SM, 1992, ONCOGENE, V7, P1331; Jonstrup AT, 2008, NUCLEIC ACIDS RES, V36, P6165, DOI 10.1093/nar/gkn640; Kim MS, 2008, J KOREAN MED SCI, V23, P149, DOI 10.3346/jkms.2008.23.1.149; Klugbauer S, 2001, GENOMICS, V73, P149, DOI 10.1006/geno.2000.6434; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Le Beau MM, 1998, HUM MOL GENET, V7, P755, DOI 10.1093/hmg/7.4.755; LEMOINE NR, 1989, BRIT J CANCER, V60, P897, DOI 10.1038/bjc.1989.387; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Lin YF, 2011, CELL CYCLE, V10, P611, DOI 10.4161/cc.10.4.14729; Lin YF, 2010, P NATL ACAD SCI USA, V107, P692, DOI 10.1073/pnas.0909740107; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; LONG BH, 1985, CANCER RES, V45, P3106; McAvoy S, 2007, CYTOGENET GENOME RES, V118, P260, DOI 10.1159/000108309; Mishmar D, 1998, P NATL ACAD SCI USA, V95, P8141, DOI 10.1073/pnas.95.14.8141; Mulvihill DJ, 2004, GENOME RES, V14, P1350, DOI 10.1101/gr.2304404; Nikiforov YE, 2002, ENDOCR PATHOL, V13, P3, DOI 10.1385/EP:13:1:03; Nikiforov YE, 1999, ONCOGENE, V18, P6330, DOI 10.1038/sj.onc.1203019; Nikiforov YE, 2011, NAT REV ENDOCRINOL, V7, P569, DOI 10.1038/nrendo.2011.142; Nikiforova MN, 2008, EXPERT REV MOL DIAGN, V8, P83, DOI 10.1586/14737159.8.1.83; Pelliccia F, 2008, CYTOGENET GENOME RES, V121, P196, DOI 10.1159/000138885; Pondarre C, 1997, NUCLEIC ACIDS RES, V25, P4111, DOI 10.1093/nar/25.20.4111; Postow L, 2001, P NATL ACAD SCI USA, V98, P8219, DOI 10.1073/pnas.111006998; Reddy K, 2011, NUCLEIC ACIDS RES, V39, P1749, DOI 10.1093/nar/gkq935; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Shah SN, 2010, NUCLEIC ACIDS RES, V38, P1149, DOI 10.1093/nar/gkp1131; SMANIK PA, 1995, HUM MOL GENET, V4, P2313, DOI 10.1093/hmg/4.12.2313; SMITH MB, 1993, J PEDIATR SURG, V28, P1342, DOI 10.1016/S0022-3468(05)80325-2; Sutherland GR, 2003, CYTOGENET GENOME RES, V100, P77, DOI 10.1159/000072840; SWERDLOW AJ, 1993, BRIT J CANCER, V68, P1006, DOI 10.1038/bjc.1993.470; Syrovets T, 2000, MOL PHARMACOL, V58, P71, DOI 10.1124/mol.58.1.71; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Travis LB, 1997, JNCI-J NATL CANCER I, V89, P1429, DOI 10.1093/jnci/89.19.1429; Tuduri S, 2009, NAT CELL BIOL, V11, P1315, DOI 10.1038/ncb1984; VANE D, 1984, J PEDIATR SURG, V19, P855, DOI 10.1016/S0022-3468(84)80384-X; Venkitaraman R, 2008, ACTA ONCOL, V47, P469, DOI 10.1080/02841860701864676; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wada S, 2005, CHEM BIODIVERS, V2, P689, DOI 10.1002/cbdv.200590045; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WU HY, 1988, CELL, V53, P433, DOI 10.1016/0092-8674(88)90163-8; Zhang H, 2007, MOL CELL, V27, P367, DOI 10.1016/j.molcel.2007.06.012; Zlotorynski E, 2003, MOL CELL BIOL, V23, P7143, DOI 10.1128/MCB.23.20.7143-7151.2003; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	81	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e75741	10.1371/journal.pone.0075741	http://dx.doi.org/10.1371/journal.pone.0075741			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040417	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000326734500142
J	Liu, YL; Huang, ZD; Ao, Y; Li, W; Zhang, ZX				Liu, Yulin; Huang, Zhedong; Ao, Yan; Li, Wei; Zhang, Zhixiang			Transcriptome Analysis of Yellow Horn (Xanthoceras sorbifolia Bunge): A Potential Oil-Rich Seed Tree for Biodiesel in China	PLOS ONE			English	Article							CARRIER PROTEIN SYNTHASE; GENE DISCOVERY; EXPRESSION; ESTERS; OPPORTUNITIES; CARBOXYLASE; ANNOTATION; GENERATION; BIOFUELS; PLATFORM	Background: Yellow horn (Xanthoceras sorbifolia Bunge) is an oil-rich seed shrub that grows well in cold, barren environments and has great potential for biodiesel production in China. However, the limited genetic data means that little information about the key genes involved in oil biosynthesis is available, which limits further improvement of this species. In this study, we describe sequencing and de novo transcriptome assembly to produce the first comprehensive and integrated genomic resource for yellow horn and identify the pathways and key genes related to oil accumulation. In addition, potential molecular markers were identified and compiled. Methodology/Principal Findings: Total RNA was isolated from 30 plants from two regions, including buds, leaves, flowers and seeds. Equal quantities of RNA from these tissues were pooled to construct a cDNA library for 454 pyrosequencing. A total of 1,147,624 high-quality reads with total and average lengths of 530.6 Mb and 462 bp, respectively, were generated. These reads were assembled into 51,867 unigenes, corresponding to a total of 36.1 Mb with a mean length, N50 and median of 696, 928 and 570 bp, respectively. Of the unigenes, 17,541 (33.82%) were unmatched in any public protein databases. We identified 281 unigenes that may be involved in de novo fatty acid (FA) and triacylglycerol (TAG) biosynthesis and metabolism. Furthermore, 6,707 SSRs, 16,925 SNPs and 6,201 InDels with high-confidence were also identified in this study. Conclusions: This transcriptome represents a new functional genomics resource and a foundation for further studies on the metabolic engineering of yellow horn to increase oil content and modify oil composition. The potential molecular markers identified in this study provide a basis for polymorphism analysis of Xanthoceras, and even Sapindaceae; they will also accelerate the process of breeding new varieties with better agronomic characteristics.	[Liu, Yulin; Li, Wei] Beijing Forest Univ, Coll Biol Sci & Biotechnol, Beijing, Peoples R China; [Huang, Zhedong; Zhang, Zhixiang] Beijing Forest Univ, Coll Nat Conservat, Lab Systemat Evolut & Biogeog Woody Plants, Beijing, Peoples R China; [Ao, Yan; Zhang, Zhixiang] Beijing Forest Univ, Acad Forest, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University; Beijing Forestry University	Li, W (corresponding author), Beijing Forest Univ, Coll Biol Sci & Biotechnol, Beijing, Peoples R China.	bjfuliwei@bjfu.edu.cn; zxzhang@bjfu.edu.cn			Chinese Key Technology Research and Development Program of Twelfth Five-Year Plan [2011BAD22B08]; Forestry Public Benefit Research Program [201004001]	Chinese Key Technology Research and Development Program of Twelfth Five-Year Plan; Forestry Public Benefit Research Program	This research was financially supported by the Chinese Key Technology Research and Development Program of Twelfth Five-Year Plan (2011BAD22B08), and the Forestry Public Benefit Research Program (201004001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates PD, 2013, CURR OPIN PLANT BIOL, V16, P358, DOI 10.1016/j.pbi.2013.02.015; Baud S, 2009, PLANT J, V60, P933, DOI 10.1111/j.1365-313X.2009.04011.x; Beule T, 2011, TREE GENET GENOMES, V7, P169, DOI 10.1007/s11295-010-0323-9; Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; Dehesh K, 2001, PLANT PHYSIOL, V125, P1103, DOI 10.1104/pp.125.2.1103; Dorado MP, 2006, RENEW ENERG, V31, P1231, DOI 10.1016/j.renene.2005.06.010; Durrett TP, 2008, PLANT J, V54, P593, DOI 10.1111/j.1365-313X.2008.03442.x; Edwards CE, 2012, DNA RES, V19, P1, DOI 10.1093/dnares/dsr037; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Fairless D, 2007, NATURE, V449, P652, DOI 10.1038/449652a; Frandsen GI, 2001, PHYSIOL PLANTARUM, V112, P301, DOI 10.1034/j.1399-3054.2001.1120301.x; Fu HW, 2010, J NAT MED-TOKYO, V64, P80, DOI 10.1007/s11418-009-0359-z; Fu YJ, 2008, CHROMATOGRAPHIA, V67, P9, DOI 10.1365/s10337-007-0471-8; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Guimaraes PM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-387; Gupta V, 2004, THEOR APPL GENET, V108, P743, DOI 10.1007/s00122-003-1481-z; HARRINGTON KJ, 1986, BIOMASS, V9, P1, DOI 10.1016/0144-4565(86)90008-9; He M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042081; Hills MJ, 2004, CURR OPIN PLANT BIOL, V7, P302, DOI 10.1016/j.pbi.2004.03.003; Hu XY, 2006, THEOR APPL GENET, V113, P497, DOI 10.1007/s00122-006-0315-1; HUANG AHC, 1992, ANNU REV PLANT PHYS, V43, P177, DOI 10.1146/annurev.pp.43.060192.001141; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Huang YH, 2008, RENEW SUST ENERG REV, V12, P1176, DOI 10.1016/j.rser.2007.01.009; Jain RK, 2000, BIOCHEM SOC T, V28, P958, DOI 10.1042/BST0280958; Jako C, 2001, PLANT PHYSIOL, V126, P861, DOI 10.1104/pp.126.2.861; JAWORSKI JG, 1989, PLANT PHYSIOL, V90, P41, DOI 10.1104/pp.90.1.41; Jha JK, 2007, PLANT PHYSIOL BIOCH, V45, P490, DOI 10.1016/j.plaphy.2007.03.001; [孔维宝 Kong Weibao], 2011, [中国油脂, China Oils and Fats], V36, P67; Lardizabal K, 2008, PLANT PHYSIOL, V148, P89, DOI 10.1104/pp.108.123042; Li HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030987; Li J, 2012, BIORESOURCE TECHNOL, V108, P112, DOI 10.1016/j.biortech.2011.12.129; Li S, 2004, BIOINFORMATICS, V20, P2865, DOI 10.1093/bioinformatics/bth302; Li XF, 2010, ENVIRON MANAGE, V46, P579, DOI 10.1007/s00267-010-9443-0; Li-Beisson Y, 2013, ACYL LIPID METABOLIS; Lin LJ, 2002, PLANT PHYSIOL, V128, P1200, DOI 10.1104/pp.010928; Madoka Y, 2002, PLANT CELL PHYSIOL, V43, P1518, DOI 10.1093/pcp/pcf172; Mazur B, 1999, SCIENCE, V285, P372, DOI 10.1126/science.285.5426.372; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Mundry M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031410; MURATA N, 1992, PLANT CELL PHYSIOL, V33, P933; Naested H, 2000, PLANT MOL BIOL, V44, P463, DOI 10.1023/A:1026564411918; Natarajan P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-191; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Nookaew I, 2012, NUCLEIC ACIDS RES, V40, P10084, DOI 10.1093/nar/gks804; O'Malley D. M., 1994, Forest Genetics, V1, P207; Ohlrogge J., 2011, BIOCHEMISTRY-US, V33, P34, DOI [10.1042/BIO03302034, DOI 10.1042/BIO03302034]; Padham AK, 2007, PLANT PHYSIOL, V143, P1372, DOI 10.1104/pp.106.090811; Palaniswamy SK, 2006, PLANT PHYSIOL, V140, P818, DOI 10.1104/pp.105.072280; Pidkowich MS, 2007, P NATL ACAD SCI USA, V104, P4742, DOI 10.1073/pnas.0611141104; Pinzi S, 2009, ENERG FUEL, V23, P2325, DOI 10.1021/ef801098a; Rismani-Yazdi H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-148; Roesler K, 1997, PLANT PHYSIOL, V113, P75, DOI 10.1104/pp.113.1.75; Shimada TL, 2010, BIOL PHARM BULL, V33, P360, DOI 10.1248/bpb.33.360; SHIMAKATA T, 1983, ARCH BIOCHEM BIOPHYS, V220, P39, DOI 10.1016/0003-9861(83)90384-3; SLABAS AR, 1992, PLANT MOL BIOL, V19, P169, DOI 10.1007/BF00015613; Sloan DB, 2012, MOL ECOL RESOUR, V12, P333, DOI 10.1111/j.1755-0998.2011.03079.x; Tan HL, 2011, PLANT PHYSIOL, V156, P1577, DOI 10.1104/pp.111.175000; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; Tasaka Y, 1996, EMBO J, V15, P6416, DOI 10.1002/j.1460-2075.1996.tb01033.x; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; Voelker T, 2001, ANNU REV PLANT PHYS, V52, P335, DOI 10.1146/annurev.arplant.52.1.335; Wang F, 2009, IN VITRO CELL DEV-PL, V45, P342, DOI 10.1007/s11627-009-9209-7; Wang HY, 2007, PLANTA, V226, P773, DOI 10.1007/s00425-007-0524-0; Wang R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060449; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Xiao S, 2011, PROG LIPID RES, V50, P141, DOI 10.1016/j.plipres.2010.11.002; Yao ZY, 2013, RENEW SUST ENERG REV, V24, P57, DOI 10.1016/j.rser.2013.03.047; Yao ZY, 2009, CLEAN-SOIL AIR WATER, V37, P642, DOI 10.1002/clen.200900093; [于海燕 YU Haiyan], 2009, [中国油脂, China Oils and Fats], V34, P43; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90; Zhang JianFeng, 2012, African Journal of Biotechnology, V11, P9302; Zhang S, 2010, BIORESOURCE TECHNOL, V101, P2537, DOI 10.1016/j.biortech.2009.11.082; Zhang S, 2010, BIORESOURCE TECHNOL, V101, P931, DOI 10.1016/j.biortech.2009.08.069; Zheng P, 2008, NAT GENET, V40, P367, DOI 10.1038/ng.85; Zou JT, 1997, PLANT CELL, V9, P909, DOI 10.1105/tpc.9.6.909; Zu YG, 2009, EUR FOOD RES TECHNOL, V229, P43, DOI 10.1007/s00217-009-1024-1	77	21	27	4	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74441	10.1371/journal.pone.0074441	http://dx.doi.org/10.1371/journal.pone.0074441			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040247	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500094
J	Ma, YX; Wang, SX; Tian, YH; Chen, L; Li, GY; Mao, JR				Ma, Yuxin; Wang, Shuxing; Tian, Yinghong; Chen, Lucy; Li, Guoying; Mao, Jianren			Disruption of Persistent Nociceptive Behavior in Rats with Learning Impairment	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ASPARTATE RECEPTOR ANTAGONIST; COGNITIVELY INTACT; SELECTIVE IMPAIRMENT; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; PROTEIN-SYNTHESIS; GLUTAMATE UPTAKE; PAIN ASSESSMENT; SPATIAL MEMORY	Despite the subjective nature of pain experience with cognitive and affective dimensions, preclinical pain research has largely focused on its sensory dimension. Here, we examined the relationship between learning/memory and nociceptive behavior in rats with combined learning impairment and persistent nociception. Learning impairment was induced by bilateral hippocampal injection of a mixed A beta solution, whereas persistent nociception produced in these rats by complete Freund's adjuvant-induced ankle inflammation. Those rats with learning impairment showed a diminished development of thermal hyperalgesia and mechanical allodynia and a shorter time course of nociceptive behavior without alteration of their baseline nociceptive threshold. In rats with pre-established hyperalgesia and allodynia due to ankle inflammation, bilateral intra-hippocampal injection of cycloheximide (a protein synthesis inhibitor) promoted the earlier recovery of nociceptive behavior. Moreover, expression of A beta, NR1 subunit of the N-methyl-D-aspartate receptor, and protein kinase C gamma was upregulated, whereas the choline acetyl transferase expression was downregulated, in the hippocampus, thalamus, amygdala, and/or spinal cord of rats with combined learning impairment and persistent nociception. The data indicate that learning impairment could disrupt the response to a state of persistent nociception, suggesting an important role for cognitive maladaptation in the mechanisms of chronic pain. These results also suggest that a preclinical model of combined learning impairment and persistent nociception may be useful to explore the brain mechanisms underlying the transition from acute to chronic pain.	[Ma, Yuxin; Wang, Shuxing; Tian, Yinghong; Chen, Lucy; Mao, Jianren] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med,MGH Ctr Tran, Boston, MA 02115 USA; [Ma, Yuxin; Li, Guoying] Guangdong Pharmaceut Univ, Sch Basic Med, Dept Anat, Guangzhou, Guangdong, Peoples R China; [Ma, Yuxin] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Anat, Guangzhou 510275, Guangdong, Peoples R China	Harvard University; Harvard Medical School; Massachusetts General Hospital; Guangdong Pharmaceutical University; Sun Yat Sen University	Mao, JR (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med,MGH Ctr Tran, Boston, MA 02115 USA.	jmao@partners.org		Chen, Lucy/0000-0002-9956-8194	NIH [R01 DE022901, P20 DA26002, R01 DE18538]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P20DA026002] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by NIH grants R01 DE022901, P20 DA26002 and R01 DE18538. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri NT, 2004, P NATL ACAD SCI USA, V101, P3656, DOI 10.1073/pnas.0400385101; BARKER RA, 1988, INT J NEUROSCI, V41, P29, DOI 10.3109/00207458808985739; Benedetti F, 2004, PAIN, V111, P22, DOI 10.1016/j.pain.2004.05.015; CARLESIMO GA, 1992, NEUROPSYCHOL REV, V3, P119, DOI 10.1007/BF01108841; CHATANI K, 1995, SPINE, V20, P277, DOI 10.1097/00007632-199502000-00004; Chin JH, 2007, J NEUROSCI, V27, P9262, DOI 10.1523/JNEUROSCI.1843-07.2007; Cook AKR, 1999, INT J GERIATR PSYCH, V14, P421, DOI 10.1002/(SICI)1099-1166(199906)14:6<421::AID-GPS932>3.0.CO;2-Y; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Farrell MJ, 1996, PAIN, V67, P7, DOI 10.1016/0304-3959(96)03041-2; Fernandez-Tome P, 2004, NEUROBIOL DIS, V15, P580, DOI 10.1016/j.nbd.2003.12.006; FERRELL BA, 1995, ANN INTERN MED, V123, P681, DOI 10.7326/0003-4819-123-9-199511010-00007; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Flint RW, 2007, NEUROSCIENCE, V148, P833, DOI 10.1016/j.neuroscience.2007.07.022; Fodale V, 2006, BRIT J ANAESTH, V97, P445, DOI 10.1093/bja/ael233; Frampton M, 2003, AGE AGEING, V32, P248, DOI 10.1093/ageing/32.3.248; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hernstadt H, 2009, BRAIN RES, V1286, P42, DOI 10.1016/j.brainres.2009.06.043; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Kelly S, 2007, J PAIN, V8, P307, DOI 10.1016/j.jpain.2006.08.010; Lathe R, 2001, J ENDOCRINOL, V169, P205, DOI 10.1677/joe.0.1690205; LAWLOR BA, 1992, BIOL PSYCHIAT, V31, P337, DOI 10.1016/0006-3223(92)90227-Q; LITVIN OO, 1997, NEUROSCI BEHAV PHYSL, V30, P671; Loeb JL, 1999, AM J NURS, V99, P48, DOI 10.2307/3471995; Manabe T, 1998, NATURE, V394, P577, DOI 10.1038/29073; Mao JR, 2009, J PAIN, V10, P1001, DOI 10.1016/j.jpain.2009.06.002; MAO JR, 1995, NEUROSCI LETT, V198, P75, DOI 10.1016/0304-3940(95)11975-3; MAO JR, 1993, J NEUROSCI, V13, P2689, DOI 10.1523/JNEUROSCI.13-06-02689.1993; MAO JR, 1992, BRAIN RES, V588, P144, DOI 10.1016/0006-8993(92)91354-H; Mao JR, 2002, PAIN, V97, P183, DOI 10.1016/S0304-3959(02)00109-4; MAO JR, 1995, PAIN, V61, P353, DOI 10.1016/0304-3959(95)00022-K; Marzinski L R, 1991, J Gerontol Nurs, V17, P25; Matos M, 2008, NEUROSCIENCE, V156, P898, DOI 10.1016/j.neuroscience.2008.08.022; Meiri N, 1998, BRAIN RES, V789, P48, DOI 10.1016/S0006-8993(97)01528-X; MISHKIN M, 1978, NATURE, V273, P297, DOI 10.1038/273297a0; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Morrison RS, 2000, J PAIN SYMPTOM MANAG, V19, P240, DOI 10.1016/S0885-3924(00)00113-5; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Prediger RDS, 2008, NEUROSCIENCE, V151, P631, DOI 10.1016/j.neuroscience.2007.11.009; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Ryu JK, 2008, NEUROREPORT, V19, P1715, DOI 10.1097/WNR.0b013e3283179333; Scherder E, 2005, J ADV NURS, V52, P151, DOI 10.1111/j.1365-2648.2005.03577.x; Scherder E, 2005, BMJ-BRIT MED J, V330, P461, DOI 10.1136/bmj.330.7489.461; Scherder E, 2001, DEMENT GERIATR COGN, V12, P400, DOI 10.1159/000051287; Scherder EJA, 2008, GERONTOLOGY, V54, P50, DOI 10.1159/000113216; SENGSTAKEN EA, 1993, J AM GERIATR SOC, V41, P541, DOI 10.1111/j.1532-5415.1993.tb01892.x; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Srivareerat M, 2009, BIOL PSYCHIAT, V65, P918, DOI 10.1016/j.biopsych.2008.08.021; Stephan A, 2001, J NEUROSCI, V21, P5703, DOI 10.1523/JNEUROSCI.21-15-05703.2001; Treede RD, 2000, PAIN, V87, P113, DOI 10.1016/S0304-3959(00)00350-X; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; Wang SX, 2005, PAIN, V116, P87, DOI 10.1016/j.pain.2005.03.044; Wynne CF, 2000, GERIATR NURS, V21, P20, DOI 10.1067/mgn.2000.105793; YAMAMOTO KK, 1990, BIOCHEMISTRY-US, V29, P11029, DOI 10.1021/bi00502a003	55	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74533	10.1371/journal.pone.0074533	http://dx.doi.org/10.1371/journal.pone.0074533			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040273	Green Submitted, Green Published, gold			2022-12-25	WOS:000326734500100
J	Gu, CH; Xing, Y; Jiang, L; Chen, M; Xu, M; Yin, Y; Li, C; Yang, Z; Yu, L; Ma, H				Gu, Chunhu; Xing, Yuan; Jiang, Li; Chen, Mai; Xu, Ming; Yin, Yue; Li, Chen; Yang, Zheng; Yu, Lu; Ma, Heng			Impaired Cardiac SIRT1 Activity by Carbonyl Stress Contributes to Aging-Related Ischemic Intolerance	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE 2; OXIDATIVE STRESS; PROTEIN; METABOLISM; ACTIVATION; RESISTANCE; INJURY; DAMAGE; GENE	Reactive aldehydes can initiate protein oxidative damage which may contribute to heart senescence. Sirtuin 1 (SIRT1) is considered to be a potential interventional target for I/R injury management in the elderly. We hypothesized that aldehyde mediated carbonyl stress increases susceptibility of aged hearts to ischemia/reperfusion (I/R) injury, and elucidate the underlying mechanisms with a focus on SIRT1. Male C57BL/6 young (4-6 mo) and aged (22-24 mo) mice were subjected to myocardial I/R. Cardiac aldehyde dehydrogenase (ALDH2), SIRT1 activity and protein carbonyls were assessed. Our data revealed that aged heart exhibited increased endogenous aldehyde/carbonyl stress due to impaired ALDH2 activity concomitant with blunted SIRT1 activity (P<0.05). Exogenous toxic aldehydes (4-HNE) exposure in isolated cardiomyocyte verified that aldehyde-induced carbonyl modification on SIRT1 impaired SIRT1 activity leading to worse hypoxia/reoxygenation (H/R) injury, which could all be rescued by Alda-1 (ALDH2 activator) (all P<0.05). However, SIRT1 inhibitor blocked the protective effect of Alda-1 on H/R cardiomyocyte. Interestingly, myocardial I/R leads to higher carbonylation but lower activity of SIRT1 in aged hearts than that seen in young hearts (P<0.05). The application of Alda-1 significantly reduced the carbonylation on SIRT1 and markedly improved the tolerance to in vivo I/R injury in aged hearts, but failed to protect Sirt1(+/-) knockout mice against myocardial I/R injury. This was verified by Alda-1 treatment improved postischemic contractile function recovery in ex vivo perfused aged but not in Sirt1(+/-) hearts. Thus, aldehyde/carbonyl stress is accelerated in aging heart. These results provide a new insight that impaired cardiac SIRT1 activity by carbonyl stress plays a critical role in the increased susceptibility of aged heart to I/R injury. ALDH2 activation can restore this aging-related myocardial ischemic intolerance.	[Gu, Chunhu] Fourth Mil Med Univ, Dept Cardiovasc Surg, Xijing Hosp, Xian 710032, Peoples R China; [Xing, Yuan; Xu, Ming; Yin, Yue; Li, Chen; Yang, Zheng; Ma, Heng] Fourth Mil Med Univ, Tangdu Hosp, Dept Physiol, Xian 710032, Peoples R China; [Jiang, Li] Fourth Mil Med Univ, Tangdu Hosp, Dept Plast & Burns, Xian 710032, Peoples R China; [Chen, Mai] Fourth Mil Med Univ, Dept Cardiol, Xijing Hosp, Xian 710032, Peoples R China; [Yu, Lu] Fourth Mil Med Univ, Dept Pathol, Xijing Hosp, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Yu, L (corresponding author), Fourth Mil Med Univ, Dept Pathol, Xijing Hosp, Xian 710032, Peoples R China.	yuhuiq@fmmu.edu.cn; hengma@fmmu.edu.cn		xu, ming/0000-0001-5234-2203	National Natural Science Foundation of China [81170108, 31201037, 81071276, 81000062]; Science and Technology Research and Development Program of Shaanxi Province, China [2011KJXX66]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Research and Development Program of Shaanxi Province, China	This work was supported by the following grants: National Natural Science Foundation of China No.81170108 (to Dr. Ma), No.31201037 (to Dr. Yu), No.81071276 (to Dr. Gu) and No.81000062 (to Dr. Chen) and The Science and Technology Research and Development Program of Shaanxi Province, China, No. 2011KJXX66 (Dr. Ma). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Ayyadevara S, 2005, AGING CELL, V4, P257, DOI 10.1111/j.1474-9726.2005.00168.x; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194; Budas GR, 2009, TRENDS CARDIOVAS MED, V19, P158, DOI 10.1016/j.tcm.2009.09.003; Caito S, 2010, FASEB J, V24, P3145, DOI 10.1096/fj.09-151308; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Chen CH, 2010, CARDIOVASC RES, V88, P51, DOI 10.1093/cvr/cvq192; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Conklin D, 2007, MOL BIOSYST, V3, P136, DOI 10.1039/b612702a; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Ferrara N, 2008, REJUV RES, V11, P139, DOI 10.1089/rej.2007.0576; Grimsrud PA, 2008, J BIOL CHEM, V283, P21837, DOI 10.1074/jbc.R700019200; Guarente L, 2011, COLD SH Q B, V76, P81, DOI 10.1101/sqb.2011.76.010629; Hoshi H, 2012, J BONE MINER RES, V27, P2015, DOI 10.1002/jbmr.1634; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Li J, 2008, CRIT CARE MED, V36, P1551, DOI 10.1097/CCM.0b013e3181782335; Li SY, 2004, J BIOL CHEM, V279, P11244, DOI 10.1074/jbc.M308011200; Ma H, 2011, EUR HEART J, V32, P1025, DOI 10.1093/eurheartj/ehq253; Ma H, 2010, CIRCULATION, V122, P282, DOI 10.1161/CIRCULATIONAHA.110.953208; Ma H, 2010, J MOL CELL CARDIOL, V49, P322, DOI 10.1016/j.yjmcc.2010.03.017; Ma H, 2009, J AM COLL CARDIOL, V54, P2187, DOI 10.1016/j.jacc.2009.04.100; Murtaza I, 2008, J BIOL CHEM, V283, P5996, DOI 10.1074/jbc.M706466200; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Perez-Miller S, 2010, NAT STRUCT MOL BIOL, V17, P159, DOI 10.1038/nsmb.1737; Stadtman ER, 2001, ANN NY ACAD SCI, V928, P22; Sun LH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002067; Takagi S, 2002, HYPERTENS RES, V25, P677; Tong C, 2012, FASEB J, DOI [10.1096/fj.12-216473, DOI 10.1096/FJ.12-216473.PUBMED:23024374]; Wang Y, 2013, J HUM HYPERTENS, V27, P181, DOI 10.1038/jhh.2012.15; Wenzel P, 2008, CARDIOVASC RES, V80, P280, DOI 10.1093/cvr/cvn182; Wenzel P, 2008, BIOCHEM BIOPH RES CO, V367, P137, DOI 10.1016/j.bbrc.2007.12.089; Xu F, 2010, HYPERTENS RES, V33, P49, DOI 10.1038/hr.2009.178; Yin DZ, 2005, EXP GERONTOL, V40, P455, DOI 10.1016/j.exger.2005.03.012; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009	35	44	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74050	10.1371/journal.pone.0074050	http://dx.doi.org/10.1371/journal.pone.0074050			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040162	gold, Green Published, Green Submitted			2022-12-25	WOS:000327538600065
J	Wang, W; Chen, ZX; Billiar, TR; Stang, MT; Gao, WT				Wang, Wei; Chen, Zhixia; Billiar, Timothy R.; Stang, Michael T.; Gao, Wentao			The Carboxyl-Terminal Amino Acids Render Pro-Human LC3B Migration Similar to Lipidated LC3B in SDS-PAGE	PLOS ONE			English	Article							AUTOPHAGY; PROTEIN; DEGRADATION; EXPRESSION; PATHWAYS; SYSTEM; FAMILY	LC3 is widely used marker for macroautophagy assays. After translation pro-LC3 is processed by Atg4 to expose C-terminal glycine residue for downstream conjugation reactions to accomplish the conversion of LC3-I to LC3-II. SDS-PAGE based Western blot (Wb) is generally utilized to quantify LC3-II levels where the LC3-I band migrates slower than LC3-II. We found that pro-human LC3B migrated at similar rate as LC3B-II in SDS-PAGE. The carboxyl-terminal five amino acids, particularly Lysine(122) and Leucine(123) of human LC3B play a major role in the faster migration of unprocessed LC3B, rendering it indistinguishable from LC3B-II in Wb assays. The unique faster migration of unprocessed LC3B than LC3B-I is also revealed in mouse LC3B, rat LC3B and rat LC3 but not in human LC3C. Our findings for the first time define pro-LC3 migration patterns for LC3 family member from human, mouse and rat species in SDS-PAGE. These findings provide a reference for pro-LC3 band patterns when Atg4 function is inhibited.	[Wang, Wei] Jilin Univ, Coll Anim Sci & Vet Med, Jilin, Peoples R China; [Chen, Zhixia; Billiar, Timothy R.; Stang, Michael T.; Gao, Wentao] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15213 USA	Jilin University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Stang, MT (corresponding author), Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15213 USA.	stangmt@upmc.edu; gaowent@pitt.edu			National Institutes of Health [3P30CA047904-21S5]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health grant (3P30CA047904-21S5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai H, 2012, ONCOGENE, V31, P4397, DOI 10.1038/onc.2011.613; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; He H, 2003, J BIOL CHEM, V278, P29278, DOI 10.1074/jbc.M303800200; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Ketteler R, 2008, AUTOPHAGY, V4, P801, DOI 10.4161/auto.6401; Kim J, 2001, J CELL BIOL, V152, P51, DOI 10.1083/jcb.152.1.51; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kocher T, 2005, ANAL CHEM, V77, P172, DOI 10.1021/ac0489115; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Li M, 2012, AUTOPHAGY, V8, P401, DOI 10.4161/auto.18777; Marino G, 2003, J BIOL CHEM, V278, P3671, DOI 10.1074/jbc.M208247200; Marino G, 2010, J CLIN INVEST, V120, P2331, DOI 10.1172/JCI42601; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Rose TL, 2006, BIOL CELL, V98, P53, DOI 10.1042/BC20040516; Scherz-Shouval R, 2003, J BIOL CHEM, V278, P14053, DOI 10.1074/jbc.M212108200; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; SHAPIRO AL, 1967, BIOCHEM BIOPH RES CO, V28, P815, DOI 10.1016/0006-291X(67)90391-9; Shu CW, 2010, AUTOPHAGY, V6, P936, DOI 10.4161/auto.6.7.13075; Tanida I, 2004, J BIOL CHEM, V279, P47704, DOI 10.1074/jbc.M407016200; von Muhlinen N, 2012, MOL CELL, V48, P329, DOI 10.1016/j.molcel.2012.08.024; Yoshimura K, 2006, AUTOPHAGY, V2, P200, DOI 10.4161/auto.2744; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	27	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74222	10.1371/journal.pone.0074222	http://dx.doi.org/10.1371/journal.pone.0074222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040206	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000327538600077
J	Chu, PY; Ke, GM; Chen, PC; Liu, LT; Tsai, YC; Tsai, JJ				Chu, Pei-Yu; Ke, Guan-Ming; Chen, Po-Chih; Liu, Li-Teh; Tsai, Yen-Chun; Tsai, Jih-Jin			Spatiotemporal Dynamics and Epistatic Interaction Sites in Dengue Virus Type 1: A Comprehensive Sequence-Based Analysis	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; NUCLEAR-LOCALIZATION; POPULATION-DYNAMICS; PROTEIN-STRUCTURE; FLAVIVIRUS; EVOLUTION; SELECTION; RNA; EMERGENCE; IMPACT	The continuing threat of dengue fever necessitates a comprehensive characterisation of its epidemiological trends. Phylogenetic and recombination events were reconstructed based on 100 worldwide dengue virus (DENV) type 1 genome sequences with an outgroup (prototypes of DENV2-4). The phylodynamic characteristics and site-specific variation were then analysed using data without the outgroup. Five genotypes (GI-GV) and a ladder-like structure with short terminal branch topology were observed in this study. Apparently, the transmission of DENV1 was geographically random before gradual localising with human activity as GI-GIII in South Asia, GIV in the South Pacific, and GV in the Americas. Genotypes IV and V have recently shown higher population densities compared to older genotypes. All codon regions and all tree branches were skewed toward a negative selection, which indicated that their variation was restricted by protein function. Notably, multi-epistatic interaction sites were found in both PrM 221 and NS3 1730. Recombination events accumulated in regions E, NS3-NS4A, and particularly in region NS5. The estimated coevolution pattern also highlights the need for further study of the biological role of protein PrM 221 and NS3 1730. The recent transmission of emergent GV sublineages into Central America and Europe mandates closely monitoring of genotype interaction and succession.	[Chu, Pei-Yu; Chen, Po-Chih] Kaohsiung Med Univ, Coll Hlth Sci, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Chu, Pei-Yu; Chen, Po-Chih] Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan; [Ke, Guan-Ming] Natl Pingtung Univ Sci & Technol, Grad Inst Anim Vaccine Technol, Neipu, Pingtung, Taiwan; [Chen, Po-Chih; Tsai, Yen-Chun; Tsai, Jih-Jin] Kaohsiung Med Univ Hosp, Trop Med Ctr, Kaohsiung, Taiwan; [Liu, Li-Teh] Chung Hwa Univ Med Technol, Coll Med & Life Sci, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan; [Tsai, Jih-Jin] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan; [Tsai, Jih-Jin] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Internal Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Pingtung University Science & Technology; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Chung Hua University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Tsai, JJ (corresponding author), Kaohsiung Med Univ Hosp, Trop Med Ctr, Kaohsiung, Taiwan.	jijits@cc.kmu.edu.tw	TSAI, JIH-JIN/GOP-2776-2022	TSAI, JIH-JIN/0000-0003-2226-8916; Liu, Li-Teh/0000-0002-7993-7263	National Science Council, Taiwan [NSC99-2745-B-037-001-, NSC101-2320-B-037-040-]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was funded by grants NSC99-2745-B-037-001- and NSC101-2320-B-037-040- from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Áñez Germán, 2007, Invest. clín, V48, P273; Bennett SN, 2010, MOL BIOL EVOL, V27, P811, DOI 10.1093/molbev/msp285; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200; Caceres C, 2008, ARCH VIROL, V153, P1967, DOI 10.1007/s00705-008-0200-0; Chu PY, 2001, ARCH VIROL, V146, P589, DOI 10.1007/s007050170164; COOPER PD, 1974, J GEN VIROL, V23, P41, DOI 10.1099/0022-1317-23-1-41; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Domingo C, 2011, J TRAVEL MED, V18, P183, DOI 10.1111/j.1708-8305.2011.00501.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drumond BP, 2012, ARCH VIROL, V157, P2061, DOI 10.1007/s00705-012-1393-9; Dunham EJ, 2007, J MOL EVOL, V64, P656, DOI 10.1007/s00239-006-0278-5; Farfan-Ale JA, 2009, AM J TROP MED HYG, V80, P85, DOI 10.4269/ajtmh.2009.80.85; Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799; Goncalvez AP, 2002, VIROLOGY, V303, P110, DOI 10.1006/viro.2002.1686; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Hill AW, 2010, ECOGRAPHY, V33, P633, DOI 10.1111/j.1600-0587.2010.06312.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUHTAMO E, 2013, EUROSURVEILLANCE, V18; Hwang KP, 2003, J MED VIROL, V70, P404, DOI 10.1002/jmv.10410; Intergovernmental Panel on Climate Change, 2022, CLIM CHANG 2022 IMP, P1; Jackson GW, 2008, J MOL DIAGN, V10, P135, DOI 10.2353/jmoldx.2008.070130; Johansson MA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000382; JORGE LMJ, 2013, EMERG INFECT DIS, V19, P652, DOI DOI 10.3201/EID1904.121295.PUBMED:23632064; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Kuhnert D, 2011, INFECT GENET EVOL, V11, P1825, DOI 10.1016/j.meegid.2011.08.005; Kukreti H, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lindenbach BD, 2007, FIELDS VIROLOGY, V1, P1101, DOI DOI 10.1016/0038-092X(88)90131-4; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Massad E, 2011, LANCET, V377, P1630, DOI 10.1016/S0140-6736(11)60470-4; Medin CL, 2005, J VIROL, V79, P11053, DOI 10.1128/JVI.79.17.11053-11061.2005; Osman O, 2009, J GEN VIROL, V90, P678, DOI 10.1099/vir.0.005306-0; Pond SLK, 2011, MOL BIOL EVOL, V28, P3033, DOI 10.1093/molbev/msr125; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, MOL BIOL EVOL, V22, P478, DOI 10.1093/molbev/msi031; Poon AFY, 2007, PLOS COMPUT BIOL, V3, P2279, DOI 10.1371/journal.pcbi.0030231; Poon AFY, 2008, BIOINFORMATICS, V24, P1949, DOI 10.1093/bioinformatics/btn313; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Raghwani J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002064; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503; Shepard DS, 2004, VACCINE, V22, P1275, DOI 10.1016/j.vaccine.2003.09.019; Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614; Singleton MR, 2002, J BACTERIOL, V184, P1819, DOI 10.1128/JB.184.7.1819-1826.2002; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Twiddy SS, 2003, INFECT GENET EVOL, V3, P87, DOI 10.1016/S1567-1348(02)00153-3; Twiddy SS, 2003, MOL BIOL EVOL, V20, P122, DOI 10.1093/molbev/msg010; Uchil PD, 2006, J VIROL, V80, P5451, DOI 10.1128/JVI.01982-05; Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595; Volz EM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002947; Walczak AM, 2012, GENETICS, V190, P753, DOI 10.1534/genetics.111.134544; Wang EY, 2000, J VIROL, V74, P3227, DOI 10.1128/JVI.74.7.3227-3234.2000; *WHO W, 2012, DENG SEV DEN FACT SH; *WHO W, 2009, DENGUE DENGUE HAEMOR; Wu WL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-322; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548	65	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74165	10.1371/journal.pone.0074165	http://dx.doi.org/10.1371/journal.pone.0074165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040199	Green Published, Green Submitted, gold			2022-12-25	WOS:000326405300164
J	Haga, T; Hirakawa, H; Nagamune, T				Haga, Tomoaki; Hirakawa, Hidehiko; Nagamune, Teruyuki			Fine Tuning of Spatial Arrangement of Enzymes in a PCNA-Mediated Multienzyme Complex Using a Rigid Poly-L-Proline Linker	PLOS ONE			English	Article							PEPTIDE LINKERS; REDUCED PUTIDAREDOXIN; ELECTRON-TRANSFER; ENERGY-TRANSFER; PROTEIN; FUSION; POLYPROLINE; SCAFFOLDS; DISTRIBUTIONS; REDUCTASE	Inspired by natural multienzyme complexes, many types of artificial multienzyme complexes have recently been constructed. We previously constructed a self-assembled complex of a bacterial cytochrome P450 and its ferredoxin and ferredoxin reductase partners using heterotrimerization of proliferating cell nuclear antigen (PCNA) from Sulfolobus solfataricus. In this study, we inserted different peptide linkers between ferredoxin and the PCNA subunit, and examined the effect on activity of the self-assembled multienzyme complex. Although the activity was affected by the lengths of both the rigid poly-L-proline-rich linkers and the flexible Gly(4)-Ser repeating linkers, the poly-L-prolinerich linkers provided the greatest activity enhancement. The optimized poly-L-proline-rich linker enhanced the activity 1.9-fold compared with the GGGGSLVPRGSGGGGS linker used in the previously reported complex, while the Gly(4)-Ser repeating linkers, (G(4)S)(n) (n = 1-6), did not yield higher activity than the maximum activity by the optimized poly-L-proline linker. Both the rigidity/flexibility and length of the peptide linker were found to be important for enhancing the overall activity of the multienzyme complex.	[Haga, Tomoaki; Hirakawa, Hidehiko; Nagamune, Teruyuki] Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Tokyo, Japan; [Nagamune, Teruyuki] Univ Tokyo, Sch Engn, Dept Bioengn, Tokyo, Japan	University of Tokyo; University of Tokyo	Hirakawa, H (corresponding author), Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Tokyo, Japan.	hirakawa@bio.t.u-tokyo.ac.jp; nagamune@bioeng.t.u-tokyo.ac.jp	Nagamune, Teruyuki/R-7708-2017; Hirakawa, Hidehiko/A-3089-2013	Nagamune, Teruyuki/0000-0002-2435-0270; Hirakawa, Hidehiko/0000-0003-0623-8573	Ministry of Education, Culture, Sports, Science and Technology [21760633]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology (#21760633). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapakis Christina M, 2010, J Biol Eng, V4, P3, DOI 10.1186/1754-1611-4-3; Albertsen L, 2011, APPL ENVIRON MICROB, V77, P1033, DOI 10.1128/AEM.01361-10; Anthis NJ, 2013, J AM CHEM SOC, V135, P9648, DOI 10.1021/ja4051422; Arai R, 2004, PROTEINS, V57, P829, DOI 10.1002/prot.20244; Arai R, 2001, PROTEIN ENG, V14, P529, DOI 10.1093/protein/14.8.529; Arora PS, 2002, J AM CHEM SOC, V124, P13067, DOI 10.1021/ja0208355; Best RB, 2007, P NATL ACAD SCI USA, V104, P18964, DOI 10.1073/pnas.0709567104; Blanco-Canosa JB, 2010, J AM CHEM SOC, V132, P10027, DOI 10.1021/ja910988d; BREWER CB, 1988, J BIOL CHEM, V263, P791; Carlsson H, 1996, BBA-PROTEIN STRUCT M, V1293, P154, DOI 10.1016/0167-4838(95)00240-5; Caspi J, 2009, APPL ENVIRON MICROB, V75, P7335, DOI 10.1128/AEM.01241-09; Chen X, 2013, ADV DRUG DELIV REV, DOI [10.1016/j.addr.2012.09.039, DOI 10.1016/J.ADDR.2012.09.039.PUBMED:23026637]; Conrado RJ, 2012, NUCLEIC ACIDS RES, V40, P1879, DOI 10.1093/nar/gkr888; COWAN PM, 1955, NATURE, V176, P501, DOI 10.1038/176501a0; Delebecque CJ, 2011, SCIENCE, V333, P470, DOI 10.1126/science.1206938; Dionne I, 2003, MOL CELL, V11, P275, DOI 10.1016/S1097-2765(02)00824-9; Dionne I, 2008, MOL MICROBIOL, V68, P216, DOI 10.1111/j.1365-2958.2008.06150.x; Doose S, 2007, P NATL ACAD SCI USA, V104, P17400, DOI 10.1073/pnas.0705605104; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Erkelenz M, 2011, J AM CHEM SOC, V133, P16111, DOI 10.1021/ja204993s; Evers TH, 2006, BIOCHEMISTRY-US, V45, P13183, DOI 10.1021/bi061288t; Fu JL, 2012, J AM CHEM SOC, V134, P5516, DOI 10.1021/ja300897h; Hanson JA, 2012, CHEM PHYS, V396, P61, DOI 10.1016/j.chemphys.2011.06.014; Hirakawa H, 2013, BIOTECHNOL BIOENG, V110, P1858, DOI 10.1002/bit.24861; Hirakawa H, 2010, CHEMBIOCHEM, V11, P1517, DOI 10.1002/cbic.201000226; Hlinkova V, 2008, ACTA CRYSTALLOGR D, V64, P941, DOI 10.1107/S0907444908021665; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; Krishnamurthy VM, 2007, J AM CHEM SOC, V129, P1312, DOI 10.1021/ja066780e; Kuznetsov VY, 2006, BIOCHEMISTRY-US, V45, P11934, DOI 10.1021/bi0611154; Lu P, 2008, APPL MICROBIOL BIOT, V79, P579, DOI 10.1007/s00253-008-1468-4; Muller J, 2008, BIOCHEM BIOPH RES CO, V377, P62, DOI 10.1016/j.bbrc.2008.09.078; ROOME PW, 1988, ARCH BIOCHEM BIOPHYS, V266, P41, DOI 10.1016/0003-9861(88)90234-2; Sato S, 2007, J AM CHEM SOC, V129, P873, DOI 10.1021/ja0655643; Schoffelen S, 2012, SOFT MATTER, V8, P1736, DOI 10.1039/c1sm06452e; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Tanaka T, 2010, J AM CHEM SOC, V132, P15899, DOI 10.1021/ja107447w; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Watkins LP, 2006, J PHYS CHEM A, V110, P5191, DOI 10.1021/jp055886d; Wilner OI, 2009, NAT NANOTECHNOL, V4, P249, DOI [10.1038/NNANO.2009.50, 10.1038/nnano.2009.50]; Wriggers W, 2005, BIOPOLYMERS, V80, P736, DOI 10.1002/bip.20291; You C, 2013, ACS SYNTH BIOL, V2, P102, DOI 10.1021/sb300068g; You C, 2012, ANGEW CHEM INT EDIT, V51, P8787, DOI 10.1002/anie.201202441	42	28	31	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e75114	10.1371/journal.pone.0075114	http://dx.doi.org/10.1371/journal.pone.0075114			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040392	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600156
J	Jiang, ZG; Dinov, ID; Labus, J; Shi, YG; Zamanyan, A; Gupta, A; Ashe-McNalley, C; Hong, JY; Tillisch, K; Toga, AW; Mayer, EA				Jiang, Zhiguo; Dinov, Ivo D.; Labus, Jennifer; Shi, Yonggang; Zamanyan, Alen; Gupta, Arpana; Ashe-McNalley, Cody; Hong, Jui-Yang; Tillisch, Kirsten; Toga, Arthur W.; Mayer, Emeran A.			Sex-Related Differences of Cortical Thickness in Patients with Chronic Abdominal Pain	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; BRAIN GRAY-MATTER; NOCICEPTIVE NEURONS; ABNORMALITIES; VALIDATION; DISORDERS; SYMPTOMS; VOLUME; ENVIRONMENT; SENSITIVITY	Background & Aims: Regional reductions in gray matter (GM) have been reported in several chronic somatic and visceral pain conditions, including irritable bowel syndrome (IBS) and chronic pancreatitis. Reported GM reductions include insular and anterior cingulate cortices, even though subregions are generally not specified. The majority of published studies suffer from limited sample size, heterogeneity of populations, and lack of analyses for sex differences. We aimed to characterize regional changes in cortical thickness (CT) in a large number of well phenotyped IBS patients, taking into account the role of sex related differences. Methods: Cortical GM thickness was determined in 266 subjects (90 IBS [70 predominantly premenopausal female] and 176 healthy controls (HC) [155 predominantly premenopausal female]) using the Laboratory of Neuro Imaging (LONI) Pipeline. A combined region of interest (ROI) and whole brain approach was used to detect any sub-regional and vertex-level differences after removing effects of age and total GM volume. Correlation analyses were performed on behavioral data. Results: While IBS as a group did not show significant differences in CT compared to HCs, sex related differences were observed both within the IBS and the HC groups. When female IBS patients were compared to female HCs, whole brain analysis showed significant CT increase in somatosensory and primary motor cortex, as well as CT decrease in bilateral subgenual anterior cingulate cortex (sgACC). The ROI analysis showed significant regional CT decrease in bilateral subregions of insular cortex, while CT decrease in cingulate was limited to left sgACC, accounting for the effect of age and GM volume. Several measures of IBS symptom severity showed significant correlation with CT changes in female IBS patients. Conclusions: Significant, sex related differences in CT are present in both HCs and in IBS patients. The biphasic neuroplastic changes in female IBS patients are related to symptom severity.	[Jiang, Zhiguo; Labus, Jennifer; Gupta, Arpana; Ashe-McNalley, Cody; Hong, Jui-Yang; Tillisch, Kirsten; Mayer, Emeran A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Gail & Gerald Oppenheimer Family Ctr Neurobiol St, Los Angeles, CA 90095 USA; [Jiang, Zhiguo] Kessler Fdn, Res Ctr, Human Performance & Engn Lab, W Orange, NJ USA; [Jiang, Zhiguo] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA; [Dinov, Ivo D.; Shi, Yonggang; Zamanyan, Alen; Toga, Arthur W.] Univ Calif Los Angeles, Lab NeuroImaging LONI, Los Angeles, CA USA; [Mayer, Emeran A.] Univ Calif Los Angeles, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA USA; [Dinov, Ivo D.] Univ Michigan, Ann Arbor, MI 48109 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Kessler Institute for Rehabilitation; New Jersey Institute of Technology; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Michigan System; University of Michigan	Mayer, EA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Gail & Gerald Oppenheimer Family Ctr Neurobiol St, Los Angeles, CA 90095 USA.	emayer@ucla.edu	Jiang, Zhiguo/A-1347-2014; Labus, Jennifer S/M-4567-2017; Tillisch, Kirsten/ABE-2174-2020	Labus, Jennifer S/0000-0002-6634-2551; Jiang, Zhiguo/0000-0002-4415-0401; Dinov, Ivo/0000-0003-3825-4375	National Institutes of Health through the Oppenheimer Center for Neurobiology of Stress [K08 DK071626, R03 DK084169, K23DK073451, R01 AT007137, T32 DK007180, P50 DK064539, R01 DK048351]; LONI [NIBIB 9P41EB015922-15, NCRR 2-P41-RR-013642-15, NCRR U54 RR021813, U24-RR025736, U24-RR021992]; National Science Foundation [0716055, 1023115]; National Center for Complementary & Integrative Health [R01AT007137] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR021813, U24RR021992, P41RR013642, U24RR025736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK084169, T32DK007180, P50DK064539, K08DK071626, R01DK048351, K23DK073451] Funding Source: NIH RePORTER; Division Of Undergraduate Education [1022560] Funding Source: National Science Foundation	National Institutes of Health through the Oppenheimer Center for Neurobiology of Stress(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LONI; National Science Foundation(National Science Foundation (NSF)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Division Of Undergraduate Education(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	This work was funded in part by the National Institutes of Health through the Oppenheimer Center for Neurobiology of Stress Grants: K08 DK071626 (JSL), R03 DK084169 (JSL), K23DK073451 (KT), R01 AT007137 (KT), T32 DK007180 (CH), P50 DK064539 (EAM), R01 DK048351 (EAM), and LONI Grants: NIBIB 9P41EB015922-15, NCRR 2-P41-RR-013642-15, NCRR U54 RR021813, U24-RR025736, U24-RR021992, and National Science Foundation grants 0716055 and 1023115. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BJ, 2011, DEV PSYCHOBIOL, V53, P456, DOI 10.1002/dev.20563; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson S, 2012, EUR J PAIN, V16, P349, DOI 10.1002/j.1532-2149.2011.00027.x; Biedermann S, 2012, NEUROIMAGE, V61, P1206, DOI 10.1016/j.neuroimage.2012.04.010; Blalock EM, 2011, J CHEM NEUROANAT, V42, P118, DOI 10.1016/j.jchemneu.2011.06.007; Blankstein U, 2010, GASTROENTEROLOGY, V138, P1783, DOI 10.1053/j.gastro.2009.12.043; Burgmer M, 2009, PSYCHOSOM MED, V71, P566, DOI 10.1097/PSY.0b013e3181a32da0; Bushnell EMC, 2009, FUNCTIONAL PAIN DISO; Chang L, 2002, GASTROENTEROLOGY, V123, P1686, DOI 10.1053/gast.2002.36603; Chang L, 2000, PAIN, V84, P297, DOI 10.1016/S0304-3959(99)00215-8; Chu A, 2009, J STAT SOFTW, V30, P1; Chung MK, 2005, NEUROIMAGE, V25, P1256, DOI 10.1016/j.neuroimage.2004.12.052; Chung MK, 2010, NEUROIMAGE, V53, P491, DOI 10.1016/j.neuroimage.2010.06.032; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Costafreda Sergi G, 2009, Front Neuroinform, V3, P33, DOI 10.3389/neuro.11.033.2009; Dinov I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013070; Dinov ID, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-304; Dinov Ivo D, 2009, Front Neuroinform, V3, P22, DOI 10.3389/neuro.11.022.2009; Ellingson B, PAIN IN PRESS; Elsenbruch S, 2010, GASTROENTEROLOGY, V139, P1310, DOI 10.1053/j.gastro.2010.06.054; Erpelding N, 2012, PAIN, V153, P1602, DOI 10.1016/j.pain.2012.03.012; Farmer MA, 2011, J UROLOGY, V186, P117, DOI 10.1016/j.juro.2011.03.027; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Gerstner G, 2011, J OROFAC PAIN, V25, P99; Hagler DJ, 2006, NEUROIMAGE, V33, P1093, DOI 10.1016/j.neuroimage.2006.07.036; Heise V, 2011, MOL PSYCHIATR, V16, P908, DOI 10.1038/mp.2010.90; Henningsen P, 2004, SCHMERZ, V18, P136, DOI 10.1007/s00482-003-0299-6; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; Kenshalo DR, 2000, J NEUROPHYSIOL, V84, P719, DOI 10.1152/jn.2000.84.2.719; KENSHALO DR, 1988, BRAIN RES, V454, P378, DOI 10.1016/0006-8993(88)90841-4; KENSHALO DR, 1983, J NEUROPHYSIOL, V50, P1479, DOI 10.1152/jn.1983.50.6.1479; Labus J, 2013, ALIMENT PHARM THER, V37, P304, DOI 10.1111/apt.12171; Labus JS, 2008, NEUROIMAGE, V41, P1032, DOI 10.1016/j.neuroimage.2008.03.009; Labus JS, 2007, PSYCHOSOM MED, V69, P89, DOI 10.1097/PSY.0b013e31802e2f24; Longstreth GL, 2006, ROME 3 FUNCTIONAL GA; Makris N, 2008, NEURON, V60, P174, DOI 10.1016/j.neuron.2008.08.011; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; May A, 2012, PAIN, V153, P1551, DOI 10.1016/j.pain.2012.04.012; May A, 2011, NEUROSCIENTIST, V17, P209, DOI 10.1177/1073858410396220; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; McEwen BS, 2010, ANN NY ACAD SCI, V1204, pE38, DOI 10.1111/j.1749-6632.2010.05568.x; Moayedi M, 2012, PAIN, V153, P1467, DOI 10.1016/j.pain.2012.04.003; Moayedi M, 2012, BRAIN RES, V1456, P82, DOI 10.1016/j.brainres.2012.03.040; Moayedi M, 2011, NEUROIMAGE, V55, P277, DOI 10.1016/j.neuroimage.2010.12.013; Naliboff BD, 2003, GASTROENTEROLOGY, V124, P1738, DOI 10.1016/S0016-5085(03)00400-1; Price DD, 2009, NEUROIMAGE, V47, P995, DOI 10.1016/j.neuroimage.2009.04.028; ROSENSTIEL AK, 1983, PAIN, V17, P33, DOI 10.1016/0304-3959(83)90125-2; Schmulson M, 2000, AM J GASTROENTEROL, V95, P152; Schweinhardt P, 2008, PAIN, V140, P411, DOI 10.1016/j.pain.2008.09.014; Seminowicz DA, 2010, GASTROENTEROLOGY, V139, P48, DOI 10.1053/j.gastro.2010.03.049; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shi YG, 2011, LECT NOTES COMPUT SC, V6892, P327, DOI 10.1007/978-3-642-23629-7_40; Sperber AD, 2011, ALIMENT PHARM THER, V33, P514, DOI 10.1111/j.1365-2036.2010.04561.x; Spiller RC, 2003, GASTROENTEROLOGY, V124, P1662, DOI 10.1016/S0016-5085(03)00324-X; Stabell N, 2013, PAIN, V154, P385, DOI 10.1016/j.pain.2012.11.012; TALLEY NJ, 1995, AUST NZ J MED, V25, P302, DOI 10.1111/j.1445-5994.1995.tb01894.x; Teutsch S, 2008, NEUROIMAGE, V42, P845, DOI 10.1016/j.neuroimage.2008.05.044; Thompson WG, 1999, GUT, V45, P43; Tillisch K, 2005, GUT, V54, P1396, DOI 10.1136/gut.2004.058685; Tillisch K, 2012, ALIMENT PHARM THER, V35, P360, DOI 10.1111/j.1365-2036.2011.04958.x; Torri F, 2012, GENES-BASEL, V3, P545, DOI 10.3390/genes3030545; Valfre W, 2008, HEADACHE, V48, P109, DOI 10.1111/j.1526-4610.2007.00723.x; Whitehead WE, 2002, GASTROENTEROLOGY, V122, P1140, DOI 10.1053/gast.2002.32392; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Zhang Z, 2011, NAT MED, V17, P1448, DOI 10.1038/nm.2442	65	55	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73932	10.1371/journal.pone.0073932	http://dx.doi.org/10.1371/journal.pone.0073932			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040118	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600107
J	Palma, P; Cuadros, M; Conde-Muino, R; Olmedo, C; Cano, C; Segura-Jimenez, I; Blanco, A; Bueno, P; Ferron, JA; Medina, P				Palma, Pablo; Cuadros, Marta; Conde-Muino, Raquel; Olmedo, Carmen; Cano, Carlos; Segura-Jimenez, Inmaculada; Blanco, Armando; Bueno, Pablo; Ferron, J. Antonio; Medina, Pedro			Microarray Profiling of Mononuclear Peripheral Blood Cells Identifies Novel Candidate Genes Related to Chemoradiation Response in Rectal Cancer	PLOS ONE			English	Article							FACTOR MESSENGER-RNA; PREOPERATIVE CHEMORADIATION; EXPRESSION PROFILES; CHEMORADIOTHERAPY; RADIOTHERAPY; REGRESSION; TRIAL	Preoperative chemoradiation significantly improves oncological outcome in locally advanced rectal cancer. However there is no effective method of predicting tumor response to chemoradiation in these patients. Peripheral blood mononuclear cells have emerged recently as pathology markers of cancer and other diseases, making possible their use as therapy predictors. Furthermore, the importance of the immune response in radiosensivity of solid organs led us to hypothesized that microarray gene expression profiling of peripheral blood mononuclear cells could identify patients with response to chemoradiation in rectal cancer. Thirty five 35 patients with locally advanced rectal cancer were recruited initially to perform the study. Peripheral blood samples were obtained before neaodjuvant treatment. RNA was extracted and purified to obtain cDNA and cRNA for hybridization of microarrays included in Human WG CodeLink bioarrays. Quantitative real time PCR was used to validate microarray experiment data. Results were correlated with pathological response, according to Mandards criteria and final UICC Stage (patients with tumor regression grade 1-2 and downstaging being defined as responders and patients with grade 3-5 and no downstaging as non-responders). Twenty seven out of 35 patients were finally included in the study. We performed a multiple t-test using Significance Analysis of Microarrays, to find those genes differing significantly in expression, between responders (n = 11) and non-responders (n = 16) to CRT. The differently expressed genes were: BC 035656.1, CIR, PRDM2, CAPG, FALZ, HLA-DPB2, NUPL2, and ZFP36. The measurement of FALZ (p = 0.029) gene expression level determined by qRT-PCR, showed statistically significant differences between the two groups. Gene expression profiling reveals novel genes in peripheral blood samples of mononuclear cells that could predict responders and non-responders to chemoradiation in patients with locally advanced rectal cancer. Moreover, our investigation added further evidence to the importance of mononuclear cells' mediated response in the neoadjuvant treatment of rectal cancer.	[Palma, Pablo; Conde-Muino, Raquel; Segura-Jimenez, Inmaculada; Ferron, J. Antonio] HUVN, Div Colon & Rectal Surg, Granada, Spain; [Cuadros, Marta; Medina, Pedro] Univ Granada, Dept Biochem, Dept Mol Biol, Granada, Spain; [Cuadros, Marta; Medina, Pedro] Univ Granada, Dept Immunol, Granada, Spain; [Olmedo, Carmen; Bueno, Pablo] HUVN, Dept Surg Res, Granada, Spain; [Cano, Carlos; Blanco, Armando] Univ Granada, Dept Comp Sci & Artificial Intelligence, Granada, Spain	Hospital Universitario Virgen de las Nieves; University of Granada; University of Granada; Hospital Universitario Virgen de las Nieves; University of Granada	Palma, P (corresponding author), HUVN, Div Colon & Rectal Surg, Granada, Spain.	pablopalma@andaluciajunta.es	Vico, Pedro Pablo Medina/D-1688-2013; Gutierrez, Carlos Cano/ABH-2343-2020; Cuadros, Marta/K-1576-2014	Vico, Pedro Pablo Medina/0000-0002-7834-7093; Cuadros, Marta/0000-0002-8329-4854; Palma, Pablo/0000-0003-1084-5982; Conde Muino, Raquel/0000-0002-9163-9410	Fundacion Investigacion Biomedica Mutua Madrilena; Junta de Andalucia [P08-TIC-4299, CTS2200]; DGICT, Madrid [TIN2009-13489]; University of Granada [GREIB PYR_2010-02, 2010_05]	Fundacion Investigacion Biomedica Mutua Madrilena; Junta de Andalucia(Junta de Andalucia); DGICT, Madrid; University of Granada	This investigation was supported by the Fundacion Investigacion Biomedica Mutua Madrilena. MC, CC and AB were supported by projects P08-TIC-4299 and CTS2200 of Junta de Andalucia, TIN2009-13489 of DGICT, Madrid, and GREIB PYR_2010-02 and 2010_05 of University of Granada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Baine MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017014; Bandres E, 2007, ONCOL REP, V17, P1089; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bluth M, 2008, ARCH SURG-CHICAGO, V143, P227, DOI 10.1001/archsurg.2007.73; Ciais D, 2004, ONCOGENE, V23, P8673, DOI 10.1038/sj.onc.1207939; Crane CH, 2003, CANCER-AM CANCER SOC, V97, P517, DOI 10.1002/cncr.11075; Demaria S, 2007, INT J RADIAT BIOL, V83, P819, DOI 10.1080/09553000701481816; DePrimo SE, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-3; Edwards CJ, 2007, MOL MED, V13, P40, DOI 10.2119/2006-000056.Edwards; Essafi-Benkhadir K, 2007, MOL BIOL CELL, V18, P4648, DOI 10.1091/mbc.E07-06-0570; Gerard JP, 2010, J CLIN ONCOL, V28, P1638, DOI 10.1200/JCO.2009.25.8376; Ghadimi BM, 2005, J CLIN ONCOL, V23, P1826, DOI 10.1200/JCO.2005.00.406; Glynne-Jones R, 2007, ONCOLOGIST, V12, P1309, DOI 10.1634/theoncologist.12-11-1309; Hansen CN, 2009, APMIS, V117, P53, DOI 10.1111/j.1600-0463.2008.00015.x; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Hu N, 2005, CANCER RES, V65, P2542, DOI 10.1158/0008-5472.CAN-04-3247; Ishihara S, 2012, ANN SURG ONCOL, V19, P1192, DOI 10.1245/s10434-011-2057-9; Janjan NA, 1999, INT J RADIAT ONCOL, V44, P1027, DOI 10.1016/S0360-3016(99)00099-1; Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580; Kim JS, 2002, INT J RADIAT ONCOL, V54, P403, DOI 10.1016/S0360-3016(02)02856-0; Kitayama J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-64; Lorimore SA, 2001, ONCOGENE, V20, P7085, DOI 10.1038/sj.onc.1204903; Molling JW, 2007, J CLIN ONCOL, V25, P862, DOI 10.1200/JCO.2006.08.5787; Nelson H, 2001, NEW ENGL J MED, V345, P690, DOI 10.1056/NEJM200108303450910; Nesslinger NJ, 2007, CLIN CANCER RES, V13, P1493, DOI 10.1158/1078-0432.CCR-06-1772; Rodel C, 2005, J CLIN ONCOL, V23, P8688, DOI 10.1200/JCO.2005.02.1329; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Schaue D, 2008, CLIN CANCER RES, V14, P4883, DOI 10.1158/1078-0432.CCR-07-4462; Stepkowski TM, 2011, FREE RADICAL BIO MED, V50, P1186, DOI 10.1016/j.freeradbiomed.2011.01.033; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Twine NC, 2003, CANCER RES, V63, P6069; Valentini V, 2002, INT J RADIAT ONCOL, V53, P664, DOI 10.1016/S0360-3016(02)02764-5; Vincenzi B, 2007, PHARMACOGENOMICS, V8, P319, DOI 10.2217/14622416.8.4.319	34	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74034	10.1371/journal.pone.0074034	http://dx.doi.org/10.1371/journal.pone.0074034			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040155	gold, Green Submitted, Green Published			2022-12-25	WOS:000324481600114
J	Iwagawa, T; Tanaka, Y; Iida, A; Itoh, T; Watanabe, S				Iwagawa, Toshiro; Tanaka, Yo; Iida, Atsumi; Itoh, Toshio; Watanabe, Sumiko			Enhancer/Promoter Activities of the Long/Middle Wavelength-Sensitive Opsins of Vertebrates Mediated by Thyroid Hormone Receptor beta 2 and COUP-TFII	PLOS ONE			English	Article							HUMAN COLOR-VISION; CONE PHOTORECEPTORS; MOLECULAR-GENETICS; CELL-LINE; EXPRESSION; GENES; GREEN; EVOLUTION; RED; GRADIENT	Cone photopigments (opsins) are crucial elements of, and the first detection module in, color vision. Individual opsins have different wavelength sensitivity patterns, and the temporal and spatial expression patterns of opsins are unique and stringently regulated. Long and middle wavelength-sensitive (L/M) opsins are of the same phylogenetic type. Although the roles of thyroid hormone/TRss2 and COUP-TFs in the transcriptional regulation of L/M opsins have been explored, the detailed mechanisms, including the target sequence in the enhancer of L/M opsins, have not been revealed. We aimed to reveal molecular mechanisms of L/M opsins in vertebrates. Using several human red opsin enhancer/promoter-luciferase reporter constructs, we found that TR beta 2 increased luciferase activities through the 59-UTR and intron 3-4 region, whereas the presence of T3 affected only the intron 3-4 region-dependent luciferase activity. Furthermore, COUP-TFII suppressed intron 3-4 region-dependent luciferase activities. However, luciferase expression driven by the mouse M opsin intron 3-4 region was only slightly increased by TR beta 2, and rather enhanced by COUP-TFII. To determine whether these differential responses reflect differences between primates and rodents, we examined the enhancer/promoter region of the red opsin of the common marmoset. Interestingly, while TR beta 2 increased 59-UTR-or intron 3-4 region-driven luciferase expression, as observed for the human red opsin, expression of the latter luciferase was not suppressed by COUP-TFII. In fact, immunostaining of common marmoset retinal sections revealed expression of COUP-TFII and red opsin in the cone cells.	[Iwagawa, Toshiro; Tanaka, Yo; Iida, Atsumi; Watanabe, Sumiko] Univ Tokyo, Inst Med Sci, Div Mol & Dev Biol, Tokyo, Japan; [Itoh, Toshio] Cent Inst Expt Anim, Marmoset Res Dept, Kawasaki, Kanagawa, Japan	University of Tokyo	Watanabe, S (corresponding author), Univ Tokyo, Inst Med Sci, Div Mol & Dev Biol, Tokyo, Japan.	sumiko@ims.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work is supported by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; Auricchio A, 2001, HUM MOL GENET, V10, P3075, DOI 10.1093/hmg/10.26.3075; Bruhn SL, 1996, J NEUROSCI, V16, P1430; DARTNALL HJA, 1983, PROC R SOC SER B-BIO, V220, P115, DOI 10.1098/rspb.1983.0091; Deeb SS, 2006, CURR OPIN GENET DEV, V16, P301, DOI 10.1016/j.gde.2006.04.002; Fernandez-Rachubinski F, 2001, EUR J BIOCHEM, V268, P620, DOI 10.1046/j.1432-1327.2001.01915.x; Glaschke A, 2011, J NEUROSCI, V31, P4844, DOI 10.1523/JNEUROSCI.6181-10.2011; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Green ES, 2003, DEVELOPMENT, V130, P539, DOI 10.1242/dev.00275; JACOBS GH, 1987, VISION RES, V27, P2089, DOI 10.1016/0042-6989(87)90123-4; Koso H., 2009, INVEST OPHTH VIS SCI, V5411-5418, P5411; Liu Y, 2007, VISION RES, V47, P2314, DOI 10.1016/j.visres.2007.04.023; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Onishi A, 2010, NAT NEUROSCI, V13, P1059, DOI 10.1038/nn.2618; REID TW, 1974, J NATL CANCER I, V53, P347, DOI 10.1093/jnci/53.2.347; Roberts MR, 2006, P NATL ACAD SCI USA, V103, P6218, DOI 10.1073/pnas.0509981103; Roberts MR, 2005, INVEST OPHTH VIS SCI, V46, P2897, DOI 10.1167/iovs.05-0093; Satoh S, 2009, J NEUROSCI, V29, P12401, DOI 10.1523/JNEUROSCI.0951-09.2009; SJOBERG M, 1995, MOL CELL BIOL, V15, P4718; Surridge AK, 2002, MOL ECOL, V11, P2157, DOI 10.1046/j.1365-294X.2002.01597.x; Swain PK, 2001, J BIOL CHEM, V276, P36824, DOI 10.1074/jbc.M105855200; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Szel A, 1996, MICROSC RES TECHNIQ, V35, P445; Takechi M, 2005, J EXP BIOL, V208, P1337, DOI 10.1242/jeb.01532; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; VOLLRATH D, 1988, SCIENCE, V240, P1669, DOI 10.1126/science.2837827; Weiss AH, 2012, OPHTHALMIC GENETICS, P1; WILLIAMS AJ, 1992, EMBO J, V11, P2039, DOI 10.1002/j.1460-2075.1992.tb05261.x; Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1; Yokoyama S, 2001, GENETICS, V158, P1697	31	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72065	10.1371/journal.pone.0072065	http://dx.doi.org/10.1371/journal.pone.0072065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24058409	Green Published, gold, Green Submitted			2022-12-25	WOS:000324403200018
J	Nair, R; Roden, DL; Teo, WS; McFarland, A; Junankar, S; Ye, S; Nguyen, A; Yang, J; Nikolic, I; Hui, M; Morey, A; Shah, J; Pfefferle, AD; Usary, J; Selinger, C; Baker, LA; Armstrong, N; Cowley, MJ; Naylor, MJ; Ormandy, CJ; Lakhani, SR; Herschkowitz, JI; Perou, CM; Kaplan, W; O'Toole, SA; Swarbrick, A				Nair, R.; Roden, D. L.; Teo, W. S.; McFarland, A.; Junankar, S.; Ye, S.; Nguyen, A.; Yang, J.; Nikolic, I.; Hui, M.; Morey, A.; Shah, J.; Pfefferle, A. D.; Usary, J.; Selinger, C.; Baker, L. A.; Armstrong, N.; Cowley, M. J.; Naylor, M. J.; Ormandy, C. J.; Lakhani, S. R.; Herschkowitz, J. I.; Perou, C. M.; Kaplan, W.; O'Toole, S. A.; Swarbrick, A.			c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer	ONCOGENE			English	Article						Her2; ERBB2; Myc; cancer stem cell; transcriptomics; oncogene cooperation	EPITHELIAL-MESENCHYMAL TRANSITION; BASAL-LIKE PHENOTYPE; LIPOPROTEIN-LIPASE; TRANSGENIC MICE; CELL-PROLIFERATION; MAMMARY-CARCINOMA; EXPRESSION; IDENTIFICATION; AMPLIFICATION; ONCOGENE	The HER2 (ERBB2) and MYC genes are commonly amplified in breast cancer, yet little is known about their molecular and clinical interaction. Using a novel chimeric mammary transgenic approach and in vitro models, we demonstrate markedly increased self-renewal and tumour-propagating capability of cells transformed with Her2 and c-Myc. Coexpression of both oncoproteins in cultured cells led to the activation of a c-Myc transcriptional signature and acquisition of a self-renewing phenotype independent of an epithelial-mesenchymal transition programme or regulation of conventional cancer stem cell markers. Instead, Her2 and c-Myc cooperated to induce the expression of lipoprotein lipase, which was required for proliferation and self-renewal in vitro. HER2 and MYC were frequently coamplified in breast cancer, associated with aggressive clinical behaviour and poor outcome. Lastly, we show that in HER2(+) breast cancer patients receiving adjuvant chemotherapy (but not targeted anti-Her2 therapy), MYC amplification is associated with a poor outcome. These findings demonstrate the importance of molecular and cellular context in oncogenic transformation and acquisition of a malignant stem-like phenotype and have diagnostic and therapeutic consequences for the clinical management of HER2(+) breast cancer.	[Nair, R.; Roden, D. L.; Teo, W. S.; McFarland, A.; Junankar, S.; Ye, S.; Nguyen, A.; Yang, J.; Nikolic, I.; Hui, M.; Cowley, M. J.; Naylor, M. J.; Ormandy, C. J.; O'Toole, S. A.; Swarbrick, A.] Garvan Inst Med Res, Kinghorn Canc Ctr, Canc Res Div, Darlinghurst, NSW 2010, Australia; [Nair, R.; Roden, D. L.; Teo, W. S.; McFarland, A.; Junankar, S.; Ye, S.; Nguyen, A.; Yang, J.; Nikolic, I.; Hui, M.; Cowley, M. J.; Naylor, M. J.; Ormandy, C. J.; O'Toole, S. A.; Swarbrick, A.] Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia; [Teo, W. S.; Junankar, S.; Ye, S.; Morey, A.; Naylor, M. J.; Ormandy, C. J.; Kaplan, W.; O'Toole, S. A.; Swarbrick, A.] Univ New S Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW, Australia; [Morey, A.] St Vincents Hosp, Dept Anat Pathol, Darlinghurst, NSW 2010, Australia; [Shah, J.] Univ New S Wales, Sch Med Sci, Camperdown, NSW, Australia; [Pfefferle, A. D.; Perou, C. M.] Dept Pathol & Lab Med, Chapel Hill, NC USA; [Pfefferle, A. D.; Usary, J.; Perou, C. M.] Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Shah, J.; Perou, C. M.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Selinger, C.; O'Toole, S. A.] Royal Prince Alfred Hosp, Deptt Tissue Pathol & Diagnost Oncol, Camperdown, NSW 2050, Australia; [Baker, L. A.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Armstrong, N.] Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia; [Cowley, M. J.; Kaplan, W.] Garvan Inst Med Res, Peter Wills Bioinformat Ctr, Darlinghurst, NSW 2010, Australia; [Naylor, M. J.] Univ Sydney, Sch Med Sci, Discipline Physiol, Sydney, NSW 2006, Australia; [Naylor, M. J.] Univ Sydney, Sch Med Sci, Bosch Inst, Sydney, NSW 2006, Australia; [Lakhani, S. R.] Univ Queensland, UQ Ctr Clin Res, Sch Med & Pathol Queensland, Royal Brisbane & Womens Hosp, Herston, Qld, Australia; [Herschkowitz, J. I.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [O'Toole, S. A.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	Garvan Institute of Medical Research; Garvan Institute of Medical Research; University of New South Wales Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney; University of North Carolina; University of North Carolina Chapel Hill; University of Sydney; University of New South Wales Sydney; University of Sydney; Garvan Institute of Medical Research; University of Sydney; University of Sydney; Royal Brisbane & Women's Hospital; University of Queensland; Baylor College of Medicine; University of Sydney	Swarbrick, A (corresponding author), Garvan Inst Med Res, Kinghorn Canc Ctr, Canc Res Div, 370 Victoria St, Darlinghurst, NSW 2010, Australia.	a.swarbrick@garvan.org.au	Cowley, Mark/K-8731-2019; Swarbrick, Alexander/E-6107-2010; Lakhani, Sunil R/I-1970-2018; Armstrong, Nicola J./AAF-3045-2021; Junankar, Simon/O-2009-2019; Perou, Charles M/H-9934-2014; Junankar, Simon/B-7677-2019; Yang, Jean/D-2920-2015	Cowley, Mark/0000-0002-9519-5714; Swarbrick, Alexander/0000-0002-3051-5676; Lakhani, Sunil R/0000-0003-4067-2760; Armstrong, Nicola J./0000-0002-4477-293X; Junankar, Simon/0000-0002-3965-8278; Perou, Charles M/0000-0001-9827-2247; Nair, Radhika/0000-0002-6585-3384; Ormandy, Christopher/0000-0002-2504-7919; Shah, Jaynish/0000-0002-1089-7355; Yang, Jean/0000-0002-5271-2603; Nikolic, Iva/0000-0002-0141-5975; Morey, Adrienne/0000-0002-7823-8276	International Postgraduate Research Scholarship (IPRS); Beth Yarrow Memorial Award in Medical Science; Victoria Taylor, Sydney Breast Cancer Foundation; CCNSW; Colin Biggers & Paisley, Sydney; Early Career Fellowship from the National Breast Cancer Foundation Australia; Cancer Institute NSW Clinical Research Fellowship [10-CRF 1-07]	International Postgraduate Research Scholarship (IPRS)(Australian Government); Beth Yarrow Memorial Award in Medical Science; Victoria Taylor, Sydney Breast Cancer Foundation; CCNSW; Colin Biggers & Paisley, Sydney; Early Career Fellowship from the National Breast Cancer Foundation Australia; Cancer Institute NSW Clinical Research Fellowship	We thank Professor JM Bishop and The GW Hooper Foundation (UCSF); Nikki Ailing and Alice Boulghourjian for technical assistance with Flow cytometry and Immunohistochemistry, respectively; and Aurelie Cazet for proof reading the manuscript. WST is a recipient of an International Postgraduate Research Scholarship (IPRS) and the Beth Yarrow Memorial Award in Medical Science. We would like to acknowledge funding from Victoria Taylor, Sydney Breast Cancer Foundation, CCNSW and Colin Biggers & Paisley, Sydney. This research was supported by an Early Career Fellowship from the National Breast Cancer Foundation Australia. AS is a Career Development Fellow of the National Health and Medical Research Council of Australia. SOT is funded by the Cancer Institute NSW Clinical Research Fellowship 10-CRF 1-07.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alonso SR, 2007, CANCER RES, V67, P3450, DOI 10.1158/0008-5472.CAN-06-3481; Axelrod R, 2006, P NATL ACAD SCI USA, V103, P13474, DOI 10.1073/pnas.0606053103; Bagaria SP, 2012, ANN SURG ONCOL, V19, P935, DOI 10.1245/s10434-011-2032-5; BARGMANN CI, 1988, P NATL ACAD SCI USA, V85, P5394, DOI 10.1073/pnas.85.15.5394; Bilban M, 2006, LEUKEMIA, V20, P1080, DOI 10.1038/sj.leu.2404220; Brummer T, 2006, J BIOL CHEM, V281, P626, DOI 10.1074/jbc.M509567200; Carter SA, 2012, BRIT J CANCER, V107, P739, DOI 10.1038/bjc.2012.301; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; Danilo C, 2012, CURR OPIN PHARMACOL, V12, P677, DOI 10.1016/j.coph.2012.07.009; Deming SL, 2000, BRIT J CANCER, V83, P1688, DOI 10.1054/bjoc.2000.1522; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Felsher DW, 1999, P NATL ACAD SCI USA, V96, P3940, DOI 10.1073/pnas.96.7.3940; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hardy KM, 2010, J MAMMARY GLAND BIOL, V15, P191, DOI 10.1007/s10911-010-9172-2; Heintel D, 2005, LEUKEMIA, V19, P1216, DOI 10.1038/sj.leu.2403748; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Herschkowitz JI, 2012, P NATL ACAD SCI USA, V109, P2778, DOI 10.1073/pnas.1018862108; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Hynes NE, 2001, J MAMMARY GLAND BIOL, V6, P141, DOI 10.1023/A:1009528918064; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kim YH, 2006, ONCOGENE, V25, P130, DOI 10.1038/sj.onc.1208997; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Laudadio J, 2007, EXPERT REV MOL DIAGN, V7, P53, DOI 10.1586/14737159.7.1.53; Lee T, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000013; Liu H, 2008, HUM PATHOL, V39, P167, DOI 10.1016/j.humpath.2007.06.012; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; Llaverias G, 2011, AM J PATHOL, V178, P402, DOI 10.1016/j.ajpath.2010.11.005; Lo PK, 2012, ONCOGENE, V31, P2614, DOI [10.1038/onc.2011.439, 10.1038/onc.2012.147]; Lopez-Knowles E, 2010, INT J CANCER, V126, P1121, DOI 10.1002/ijc.24831; Lopez-Knowles E, 2010, CANCER EPIDEM BIOMAR, V19, P301, DOI 10.1158/1055-9965.EPI-09-0741; Magnifico A, TUMOR INITIATING CEL; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Millar EKA, 2009, BRIT J CANCER, V100, P123, DOI 10.1038/sj.bjc.6604809; Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; O'Toole SA, 2011, CANCER RES, V71, P4002, DOI 10.1158/0008-5472.CAN-10-3738; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Park K, 2005, HUM PATHOL, V36, P634, DOI 10.1016/j.humpath.2005.04.016; Perez E, 2009, CANC RES S, V69, P56; Perez EA, 2011, J CLIN ONCOL, V29, P651, DOI 10.1200/JCO.2010.30.2125; Persons DL, 1997, MODERN PATHOL, V10, P720; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Roberts PJ, 2012, CLIN CANCER RES, V18, P5290, DOI 10.1158/1078-0432.CCR-12-0563; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Shachaf CM, 2008, CANCER RES, V68, P5132, DOI 10.1158/0008-5472.CAN-07-6192; Singh SK, 2003, CANCER RES, V63, P5821; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; STEWART TA, 1984, CELL, V38, P627, DOI 10.1016/0092-8674(84)90257-5; Stoelzle Tina, 2009, BMC Biol, V7, P63, DOI 10.1186/1741-7007-7-63; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swarbrick A, 2008, P NATL ACAD SCI USA, V105, P5402, DOI 10.1073/pnas.0801505105; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Welm AL, 2005, P NATL ACAD SCI USA, V102, P4324, DOI 10.1073/pnas.0500470102; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wolfer A, 2010, P NATL ACAD SCI USA, V107, P3698, DOI 10.1073/pnas.0914203107; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Zhang WZ, 2010, P NATL ACAD SCI USA, V107, P18956, DOI 10.1073/pnas.1013420107	82	64	68	0	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 24	2014	33	30					3992	4002		10.1038/onc.2013.368	http://dx.doi.org/10.1038/onc.2013.368			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL8NA	24056965				2022-12-25	WOS:000339394700011
J	Genz, C; Fundakowski, J; Hermesh, O; Schmid, M; Jansen, RP				Genz, Christian; Fundakowski, Julia; Hermesh, Orit; Schmid, Maria; Jansen, Ralf-Peter			Association of the Yeast RNA-binding Protein She2p with the Tubular Endoplasmic Reticulum Depends on Membrane Curvature	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); Membrane; RNA Binding Protein; RNA Transport; Yeast	ASH1 MESSENGER-RNA; ASYMMETRIC LOCALIZATION; SUBCELLULAR MEMBRANES; TRANSLATIONAL CONTROL; INHERITANCE; MYO4P; TRANSLOCATION; TRANSPORT; REVEALS; DOMAINS	Localization of mRNAs contributes to the generation and maintenance of cellular asymmetry in a wide range of organisms. In Saccharomyces cerevisiae, the so-called locasome complex with its core components Myo4p, She2p, and She3p localizes more than 30 mRNAs to the yeast bud tip. A significant fraction of these mRNAs encodes membrane or secreted proteins. Their localization requires, besides the locasome, a functional segregation apparatus of the cortical endoplasmic reticulum (ER), including the machinery that is involved in the movement of ER tubules into the bud. Colocalization of RNA-containing particles with these tubules suggests a coordinated transport of localized mRNAs and the cortical ER to the bud. Association of localized mRNAs to the ER requires the presence of the locasome component She2p. Here we report that She2p is not only an RNA-binding protein but can specifically bind to ER-derived membranes in a membrane curvature-dependent manner in vitro. Although it does not contain any known curvature recognizing motifs, the protein shows a binding preference for liposomes with a diameter resembling that of yeast ER tubules. In addition, membrane binding depends on tetramerization of She2p. In an in vivo membrane-tethering assay, She2p can target a viral peptide GFP fusion protein to the cortical ER, indicating that a fraction of She2p associates with the ER in vivo. Combining RNA- and membrane-binding features makes She2p an ideal coordinator of ER tubule and mRNA cotransport.	[Genz, Christian; Fundakowski, Julia; Hermesh, Orit; Jansen, Ralf-Peter] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Schmid, Maria] Univ Munich, Gene Ctr, D-81377 Munich, Germany	Eberhard Karls University of Tubingen; University of Munich	Jansen, RP (corresponding author), IFIB, Hoppe Seyler Str 4, D-72076 Tubingen, Germany.	ralf.jansen@uni-tuebingen.de			Deutsche Forschungsgesellschaft [DFG JA696/7-1]	Deutsche Forschungsgesellschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgesellschaft Grant DFG JA696/7-1 (to R. P. J.).	Aronov S, 2007, MOL CELL BIOL, V27, P3441, DOI 10.1128/MCB.01643-06; Barrowman J, 2000, EMBO J, V19, P862, DOI 10.1093/emboj/19.5.862; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Bohl F, 2000, EMBO J, V19, P5514, DOI 10.1093/emboj/19.20.5514; BRODSKY JL, 1993, J CELL BIOL, V123, P1355, DOI 10.1083/jcb.123.6.1355; BROUILLETTE CG, 1982, BIOCHEMISTRY-US, V21, P4569, DOI 10.1021/bi00262a009; Colomina N, 2008, J BIOL CHEM, V283, P28670, DOI 10.1074/jbc.M804604200; Cui XYA, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001336; DAUM G, 1982, J BIOL CHEM, V257, P3075; Deshler JO, 1998, CURR BIOL, V8, P489, DOI 10.1016/S0960-9822(98)70200-3; Du TG, 2008, EMBO REP, V9, P781, DOI 10.1038/embor.2008.112; Du TG, 2007, SEMIN CELL DEV BIOL, V18, P171, DOI 10.1016/j.semcdb.2007.01.010; Du YR, 2004, J CELL SCI, V117, P2871, DOI 10.1242/jcs.01286; Estrada P, 2003, J CELL BIOL, V163, P1255, DOI 10.1083/jcb.200304030; Frey S, 2001, J BIOL CHEM, V276, P15905, DOI 10.1074/jbc.M009430200; Fundakowski J, 2012, TRAFFIC, V13, P1642, DOI 10.1111/tra.12011; Graham J. M., 2001, PURIFICATION CRUDE M; Gu W, 2004, GENE DEV, V18, P1452, DOI 10.1101/gad.1189004; Hermesh O, 2013, BBA-MOL CELL RES, V1833, P2519, DOI 10.1016/j.bbamcr.2013.01.013; Heuck A, 2010, J CELL BIOL, V189, P497, DOI 10.1083/jcb.201002076; Hodges AR, 2008, J BIOL CHEM, V283, P6906, DOI 10.1074/jbc.M708865200; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Irie K, 2002, EMBO J, V21, P1158, DOI 10.1093/emboj/21.5.1158; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kraut-Cohen J, 2010, TRENDS BIOCHEM SCI, V35, P459, DOI 10.1016/j.tibs.2010.02.006; Lang BD, 2001, NUCLEIC ACIDS RES, V29, P2567, DOI 10.1093/nar/29.12.2567; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Long RM, 2001, J CELL BIOL, V153, P307, DOI 10.1083/jcb.153.2.307; Long RM, 2000, EMBO J, V19, P6592, DOI 10.1093/emboj/19.23.6592; Madsen KL, 2010, FEBS LETT, V584, P1848, DOI 10.1016/j.febslet.2010.01.053; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Merklinger E, 2012, BIOCHEM J, V442, P381, DOI 10.1042/BJ20111363; Muller M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000611; Muller M, 2009, RNA, V15, P2002, DOI 10.1261/rna.1753309; Niessing D, 2004, CELL, V119, P491, DOI 10.1016/j.cell.2004.10.018; Oeffinger M, 2007, NAT METHODS, V4, P951, DOI 10.1038/NMETH1101; Peabody DS, 1996, NUCLEIC ACIDS RES, V24, P2352, DOI 10.1093/nar/24.12.2352; Pyhtila B, 2008, RNA, V14, P445, DOI 10.1261/rna.721108; Qbadou S, 2003, J CELL SCI, V116, P837, DOI 10.1242/jcs.00291; Reid DW, 2012, J BIOL CHEM, V287, P5518, DOI 10.1074/jbc.M111.312280; ROTHBLATT JA, 1986, CELL, V44, P619, DOI 10.1016/0092-8674(86)90271-0; Schmid M, 2006, CURR BIOL, V16, P1538, DOI 10.1016/j.cub.2006.06.025; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Shen ZF, 2010, GENE DEV, V24, P1914, DOI 10.1101/gad.1937510; Shen Z, 2009, MOL BIOL CELL, V20, P2265, DOI 10.1091/mbc.E08-11-1151; Shepard KA, 2003, P NATL ACAD SCI USA, V100, P11429, DOI 10.1073/pnas.2033246100; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Tuller G, 1999, YEAST, V15, P1555, DOI 10.1002/(SICI)1097-0061(199910)15:14<1555::AID-YEA479>3.0.CO;2-Z; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Waizengger T, 2005, EMBO REP, V6, P57, DOI 10.1038/sj.embor.7400318; Wang C, 2008, PLANT J, V55, P443, DOI 10.1111/j.1365-313X.2008.03516.x; West M, 2011, J CELL BIOL, V193, P333, DOI 10.1083/jcb.201011039; Wu CH, 2011, J CELL BIOL, V193, P521, DOI 10.1083/jcb.201006023	54	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32384	32393		10.1074/jbc.M113.486431	http://dx.doi.org/10.1074/jbc.M113.486431			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24056370	Green Published, hybrid			2022-12-25	WOS:000328681700023
J	Deakyne, JS; Huang, F; Negri, J; Tolliday, N; Cocklin, S; Mazin, AV				Deakyne, Julianna S.; Huang, Fei; Negri, Joseph; Tolliday, Nicola; Cocklin, Simon; Mazin, Alexander V.			Analysis of the Activities of RAD54, a SWI2/SNF2 Protein, Using a Specific Small-molecule Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA STRAND EXCHANGE; ANTITUMOR ANTIBIOTIC STREPTONIGRIN; CHROMATIN-REMODELING ENZYME; RECOMBINATION FACTORS RAD51; HOMOLOGOUS RECOMBINATION; NUCLEOPROTEIN FILAMENT; SACCHAROMYCES-CEREVISIAE; HOLLIDAY JUNCTION; GENOMIC STABILITY; BRANCH MIGRATION	RAD54, an important homologous recombination protein, is a member of the SWI2/SNF2 family of ATPase-dependent DNA translocases. In vitro, RAD54 stimulates RAD51-mediated DNA strand exchange and promotes branch migration of Holliday junctions. It is thought that an ATPase-dependent DNA translocation is required for both of these RAD54 activities. Here we identified, by high-throughput screening, a specific RAD54 inhibitor, streptonigrin (SN), and used it to investigate the mechanisms of RAD54 activities. We found that SN specifically targets the RAD54 ATPase, but not DNA binding, through direct interaction with RAD54 and generation of reactive oxygen species. Consistent with the dependence of branch migration (BM) on the ATPase-dependent DNA translocation of RAD54, SN inhibited RAD54 BM. Surprisingly, the ability of RAD54 to stimulate RAD51 DNA strand exchange was not significantly affected by SN, indicating a relatively smaller role of RAD54 DNA translocation in this process. Thus, the use of SN enabled us to identify important differences in the effect of the RAD54 ATPase and DNA translocation on two major activities of RAD54, BM of Holliday junctions and stimulation of DNA pairing.	[Deakyne, Julianna S.; Huang, Fei; Cocklin, Simon; Mazin, Alexander V.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA; [Negri, Joseph; Tolliday, Nicola] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA	Drexel University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Mazin, AV (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA.	amazin@drexelmed.edu			National Institutes of Health [CA100839, DA033981, MH097512, 1R21AI087388]; KECK Foundation; Leukemia and Lymphoma Society Scholar Award [1054-09]; NATIONAL CANCER INSTITUTE [R56CA100839, R01CA100839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH097512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA033981] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KECK Foundation(W.M. Keck Foundation); Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants CA100839, DA033981, and MH097512 (to A. V. M.) and 1R21AI087388 (to S. C.). This work was also supported by a KECK Foundation award and by Leukemia and Lymphoma Society Scholar Award 1054-09 (to A. V. M.).	Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; Anderberg PI, 2004, J INORG BIOCHEM, V98, P720, DOI 10.1016/j.jinorgbio.2003.10.011; Ariyoshi M, 2000, P NATL ACAD SCI USA, V97, P8257, DOI 10.1073/pnas.140212997; Bolzan AD, 2001, MUTAT RES-REV MUTAT, V488, P25, DOI 10.1016/S1383-5742(00)00062-4; Bravman T, 2006, ANAL BIOCHEM, V358, P281, DOI 10.1016/j.ab.2006.08.005; Bugreev D. V., 2006, NAT PROTOC, DOI [10.1038/nprot.2006.217, DOI 10.1038/NPR0T.2006.217]; Bugreev DV, 2007, NAT STRUCT MOL BIOL, V14, P746, DOI 10.1038/nsmb1268; Bugreev DV, 2006, NATURE, V442, P590, DOI 10.1038/nature04889; Bugreev DV, 2009, J BIOL CHEM, V284, P26349, DOI 10.1074/jbc.M109.029371; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; CAPRANICO G, 1994, J BIOL CHEM, V269, P25004; Chi P, 2007, GENE DEV, V21, P1747, DOI 10.1101/gad.1563007; Clever B, 1997, EMBO J, V16, P2535, DOI 10.1093/emboj/16.9.2535; DAVIES KJA, 1987, J BIOL CHEM, V262, P9895; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Essers J, 2000, EMBO J, V19, P1703, DOI 10.1093/emboj/19.7.1703; Firman K, 2000, EMBO J, V19, P2094, DOI 10.1093/emboj/19.9.2094; GAME JC, 1993, SEMIN CANCER BIOL, V4, P73; Godson GN, 2000, BIOCHEMISTRY-US, V39, P332, DOI 10.1021/bi9916628; Golub EI, 1997, NUCLEIC ACIDS RES, V25, P4106, DOI 10.1093/nar/25.20.4106; Goulart MOF, 2003, BIOELECTROCHEMISTRY, V59, P85, DOI 10.1016/S1567-5394(03)00005-7; HAJDU J, 1981, J AM CHEM SOC, V103, P232, DOI 10.1021/ja00391a061; HARRIS MN, 1965, CANCER, V18, P49, DOI 10.1002/1097-0142(196501)18:1<49::AID-CNCR2820180109>3.0.CO;2-#; Haseltine CA, 2009, NUCLEIC ACIDS RES, V37, P2757, DOI 10.1093/nar/gkp068; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; IYPE LE, 1994, J BIOL CHEM, V269, P24967; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; Jiang H, 1996, J BIOL CHEM, V271, P33181, DOI 10.1074/jbc.271.52.33181; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; Kowalczykowski SC, 2008, NATURE, V453, P463, DOI 10.1038/453463a; KREMER WILLIAM B., 1967, CANCER CHEMOTHER REP, V51, P19; LATUASAN HE, 1961, BIOCHIM BIOPHYS ACTA, V52, P502, DOI 10.1016/0006-3002(61)90408-5; Liu YL, 2004, NAT REV MOL CELL BIO, V5, P937, DOI 10.1038/nrm1502; Long GV, 1997, ANTI-CANCER DRUG DES, V12, P453; LOWN JW, 1983, MOL CELL BIOCHEM, V55, P17, DOI 10.1007/BF00229240; Matsuda M, 1999, ONCOGENE, V18, P3427, DOI 10.1038/sj.onc.1202692; Mazin AV, 2010, DNA REPAIR, V9, P286, DOI 10.1016/j.dnarep.2009.12.006; Mazin AV, 2000, MOL CELL, V6, P583, DOI 10.1016/S1097-2765(00)00057-5; Mazin AV, 2003, J BIOL CHEM, V278, P14029, DOI 10.1074/jbc.M212779200; Mazina OM, 2007, J BIOL CHEM, V282, P21068, DOI 10.1074/jbc.M701992200; Mazina OM, 2004, J BIOL CHEM, V279, P52042, DOI 10.1074/jbc.M410244200; MILLER DS, 1967, CANCER RES, V27, P632; Modesti M, 2007, MOL CELL, V28, P468, DOI 10.1016/j.molcel.2007.08.025; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Petukhova G, 1999, J BIOL CHEM, V274, P29453, DOI 10.1074/jbc.274.41.29453; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Pezza RJ, 2007, GENE DEV, V21, P1758, DOI 10.1101/gad.1562907; PITTILLO RF, 1974, ANTIMICROB AGENTS CH, V5, P82, DOI 10.1128/AAC.5.1.82; POWIS G, 1989, FREE RADICAL BIO MED, V6, P63, DOI 10.1016/0891-5849(89)90162-7; Ristic D, 2001, P NATL ACAD SCI USA, V98, P8454, DOI 10.1073/pnas.151056798; Rossi MJ, 2010, METHODS, V51, P336, DOI 10.1016/j.ymeth.2010.02.010; Sanchez-Cruz P, 2009, CHEM RES TOXICOL, V22, P818, DOI 10.1021/tx800392j; Schmuckli-Maurer J, 2003, NUCLEIC ACIDS RES, V31, P1013, DOI 10.1093/nar/gkg190; Sigurdsson S, 2002, J BIOL CHEM, V277, P42790, DOI 10.1074/jbc.M208004200; Sigurdsson S, 2001, J BIOL CHEM, V276, P8798, DOI 10.1074/jbc.M010011200; SMITH GMR, 1967, BRIT J CANCER, V21, P295, DOI 10.1038/bjc.1967.32; Solinger JA, 2002, MOL CELL, V10, P1175, DOI 10.1016/S1097-2765(02)00743-8; Solinger JA, 2001, J MOL BIOL, V307, P1207, DOI 10.1006/jmbi.2001.4555; SUGIURA Y, 1984, BIOCHIM BIOPHYS ACTA, V782, P254, DOI 10.1016/0167-4781(84)90060-5; SULLIVAN RD, 1963, CANCER CHEMOTH REP, P27; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Tan TLR, 1999, CURR BIOL, V9, P325, DOI 10.1016/S0960-9822(99)80142-0; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; Whitehouse I, 2003, MOL CELL BIOL, V23, P1935, DOI 10.1128/MCB.23.6.1935-1945.2003; Wiese C, 2007, MOL CELL, V28, P482, DOI 10.1016/j.molcel.2007.08.027; Wolner B, 2005, J BIOL CHEM, V280, P10855, DOI 10.1074/jbc.M414388200; Wondrak GT, 2009, ANTIOXID REDOX SIGN, V11, P3013, DOI [10.1089/ars.2009.2541, 10.1089/ARS.2009.2541]; YAMASHITA Y, 1990, CANCER RES, V50, P5841	70	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31567	31580		10.1074/jbc.M113.502195	http://dx.doi.org/10.1074/jbc.M113.502195			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24043618	Green Published, hybrid			2022-12-25	WOS:000330596200016
J	Jamshidiha, M; Ishida, H; Sutherland, C; Gifford, JL; Walsh, MP; Vogel, HJ				Jamshidiha, Mostafa; Ishida, Hiroaki; Sutherland, Cindy; Gifford, Jessica L.; Walsh, Michael P.; Vogel, Hans J.			Structural Analysis of a Calmodulin Variant from Rice THE C-TERMINAL EXTENSION OF OsCaM61 REGULATES ITS CALCIUM BINDING AND ENZYME ACTIVATION PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESIDUAL DIPOLAR COUPLINGS; SWISS-MODEL WORKSPACE; LIGHT-CHAIN KINASE; NMR-SPECTROSCOPY; BINDING PROTEINS; RELAXATION MEASUREMENTS; ARABIDOPSIS-THALIANA; SECONDARY STRUCTURE; PRENYLATION STATUS; PLASMA-MEMBRANE	OsCaM61 is one of five calmodulins known to be present in Oryza sativa that relays the increase of cytosolic [Ca2+] to down-stream targets. OsCaM61 bears a unique C-terminal extension with a prenylation site. Using nuclear magnetic resonance (NMR) spectroscopy we studied the behavior of the calmodulin (CaM) domain and the C-terminal extension of OsCaM61 in the absence and presence of Ca2+. NMR dynamics data for OsCaM61 indicate that the two lobes of the CaM domain act together unlike the independent behavior of the lobes seen in mammalian CaM and soybean CaM4. Also, data demonstrate that the positively charged nuclear localization signal region in the tail in apo-OsCaM61 is helical, whereas it becomes flexible in the Ca2+-saturated protein. The extra helix in apo-OsCaM61 provides additional interactions in the C-lobe and increases the structural stability of the closed apo conformation. This leads to a decrease in the Ca2+ binding affinity of EF-hands III and IV in OsCaM61. In Ca2+-OsCaM61, the basic nuclear localization signal cluster adopts an extended conformation, exposing the C-terminal extension for prenylation or enabling OsCaM61 to be transferred to the nucleus. Moreover, Ser(172) and Ala(173), residues in the tail, interact with different regions of the protein. These interactions affect the ability of OsCaM61 to activate different target proteins. Altogether, our data show that the tail is not simply a linker between the prenyl group and the protein but that it also provides a new regulatory mechanism that some plants have developed to fine-tune Ca2+ signaling events.	[Jamshidiha, Mostafa; Ishida, Hiroaki; Gifford, Jessica L.; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Sutherland, Cindy; Walsh, Michael P.] Univ Calgary, Dept Biochem & Mol Biol, Smooth Muscle Res Grp, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Vogel, HJ (corresponding author), Univ Calgary, Dept Biol Sci, Struct Biol Res Grp, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	vogel@ucalgary.ca			Natural Science and Engineering Research Council of Canada	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by an operating grant from the Natural Science and Engineering Research Council of Canada.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; Batistic O, 2012, BBA-GEN SUBJECTS, V1820, P1283, DOI 10.1016/j.bbagen.2011.10.012; Benjamins R, 2003, PLANT PHYSIOL, V132, P1623, DOI 10.1104/pp.103.019943; Biekofsky RR, 1998, FEBS LETT, V439, P101, DOI 10.1016/S0014-5793(98)01349-0; Boonburapong B, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-4; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bouche N, 2005, ANNU REV PLANT BIOL, V56, P435, DOI 10.1146/annurev.arplant.56.032604.144224; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dong AW, 2002, PLANT MOL BIOL, V48, P203, DOI 10.1023/A:1013380814919; FISCHER R, 1988, J BIOL CHEM, V263, P17055; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; HARMON AC, 1994, BIOCHEMISTRY-US, V33, P7278, DOI 10.1021/bi00189a032; Harmon AC, 2000, TRENDS PLANT SCI, V5, P154, DOI 10.1016/S1360-1385(00)01577-6; Hashimoto K, 2011, BIOCHIMIE, V93, P2054, DOI 10.1016/j.biochi.2011.05.019; Huang H, 2011, J BIOL CHEM, V286, P17181, DOI 10.1074/jbc.M110.179028; Hwang YS, 1999, PLANT MOL BIOL, V40, P911, DOI 10.1023/A:1006241811136; Ishida H, 2008, J BIOL CHEM, V283, P14619, DOI 10.1074/jbc.M801398200; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Katou S, 2007, PLANT CELL PHYSIOL, V48, P332, DOI 10.1093/pcp/pcm007; Kim BG, 2007, PLANT J, V52, P473, DOI 10.1111/j.1365-313X.2007.03249.x; Koo SC, 2009, MOL CELLS, V27, P563, DOI 10.1007/s10059-009-0081-4; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LEE SH, 1995, J BIOL CHEM, V270, P21806, DOI 10.1074/jbc.270.37.21806; Lee SH, 2000, BIOCHEM J, V350, P299, DOI 10.1042/0264-6021:3500299; Li DF, 2006, FEBS LETT, V580, P4325, DOI 10.1016/j.febslet.2006.06.090; Liao BR, 1996, ARCH BIOCHEM BIOPHYS, V327, P53, DOI 10.1006/abbi.1996.0092; Magnan F, 2008, PLANT J, V56, P575, DOI 10.1111/j.1365-313X.2008.03622.x; Mal TK, 2002, BIOCHEMISTRY-US, V41, P12899, DOI 10.1021/bi0264162; McCormack E, 2005, TRENDS PLANT SCI, V10, P383, DOI 10.1016/j.tplants.2005.07.001; NGAI PK, 1984, BIOCHEM J, V218, P863, DOI 10.1042/bj2180863; Oravecz A, 2006, PLANT CELL, V18, P1975, DOI 10.1105/tpc.105.040097; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; PATO MD, 1983, J BIOL CHEM, V258, P7047; Prestegard JH, 2004, CHEM REV, V104, P3519, DOI 10.1021/cr030419i; Rodriguez-Concepcion M, 1999, EMBO J, V18, P1996, DOI 10.1093/emboj/18.7.1996; Rodriguez-Concepcion M, 1999, PLANT MOL BIOL, V39, P865, DOI 10.1023/A:1006170020836; Rodriguez-Concepcion M, 2000, PLANT J, V24, P775, DOI 10.1046/j.1365-313x.2000.00924.x; Sanders D, 1999, PLANT CELL, V11, P691, DOI 10.1105/tpc.11.4.691; SCOTTWOO GC, 1988, BIOCHEM J, V252, P463, DOI 10.1042/bj2520463; Tjandra N, 1996, J BIOMOL NMR, V8, P273, DOI 10.1007/BF00410326; TJANDRA N, 1995, EUR J BIOCHEM, V230, P1014, DOI 10.1111/j.1432-1033.1995.tb20650.x; Tsai YC, 2007, PLANT SIGNAL BEHAV, V2, P446, DOI 10.4161/psb.2.6.4695; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; VOGEL HJ, 1983, FEBS LETT, V157, P241, DOI 10.1016/0014-5793(83)80554-7; VOGEL HJ, 1994, BIOCHEM CELL BIOL, V72, P357, DOI 10.1139/o94-049; Walsh Michael P, 2002, Methods Mol Biol, V173, P339; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Xiao C, 1999, DNA Res, V6, P179, DOI 10.1093/dnares/6.3.179; Yamniuk AP, 2006, J BIOL CHEM, V281, P26455, DOI 10.1074/jbc.M603963200; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Ye SF, 2009, PLANT MOL BIOL, V70, P311, DOI 10.1007/s11103-009-9475-0; Zielinski RE, 2002, PLANTA, V214, P446, DOI 10.1007/s004250100636; Zielinski RE, 1998, ANNU REV PLANT PHYS, V49, P697, DOI 10.1146/annurev.arplant.49.1.697; Zweckstetter M, 2002, J BIOMOL NMR, V23, P127, DOI 10.1023/A:1016316415261	56	3	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					32036	32049		10.1074/jbc.M113.491076	http://dx.doi.org/10.1074/jbc.M113.491076			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24052265	Green Published, hybrid			2022-12-25	WOS:000330596200055
J	Kuwabara, H; Yamasue, H; Koike, S; Inoue, H; Kawakubo, Y; Kuroda, M; Takano, Y; Iwashiro, N; Natsubori, T; Aoki, Y; Kano, Y; Kasai, K				Kuwabara, Hitoshi; Yamasue, Hidenori; Koike, Shinsuke; Inoue, Hideyuki; Kawakubo, Yuki; Kuroda, Miho; Takano, Yosuke; Iwashiro, Norichika; Natsubori, Tatsunobu; Aoki, Yuta; Kano, Yukiko; Kasai, Kiyoto			Altered Metabolites in the Plasma of Autism Spectrum Disorder: A Capillary Electrophoresis Time-of-Flight Mass Spectroscopy Study	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; ANTIOXIDANT DEFENSES; OXIDATIVE DAMAGE; NITRIC-OXIDE; METABOLOMICS; ASSOCIATION; BIOMARKERS; SCHIZOPHRENIA; INTERVIEW; CHILDREN	Clinical diagnosis and severity of autism spectrum disorders (ASD) are determined by trained clinicians based on clinical evaluations of observed behaviors. As such, this approach is inevitably dependent on the expertise and subjective assessment of those administering the clinical evaluations. There is a need to identify objective biological markers associated with diagnosis or clinical severity of the disorder. To identify novel candidate metabolites as potential biomarkers for ASD, the current study applied capillary electrophoresis time-of-flight mass spectroscopy (CE-TOFMS) for high-throughput profiling of metabolite levels in the plasma of 25 psychotropic-naive adult males with high-functioning ASD and 28 age-matched typically-developed control subjects. Ten ASD participants and ten age-matched controls were assigned in the first exploration set, while 15 ASD participants and 18 controls were included in the second replication set. By CE-TOFMS analysis, a total of 143 metabolites were detected in the plasma of the first set. Of these, 17 metabolites showed significantly different relative areas between the ASD participants and the controls (p<0.05). Of the 17 metabolites, we consistently found that the ASD participants had significantly high plasma levels of arginine (p = 0.024) and taurine (p = 0.018), and significantly low levels of 5-oxoproline (p<0.001) and lactic acid (p = 0.031) compared with the controls in the second sample set. Further confirmatory analysis using quantification of absolute metabolite concentrations supported the robustness of high arginine (p = 0.001) and low lactic acid (p = 0.003) in the combined sample (n = 53). The present study identified deviated plasma metabolite levels associated with oxidative stress and mitochondrial dysfunction in individuals with ASD.	[Kuwabara, Hitoshi; Kawakubo, Yuki; Kuroda, Miho; Kano, Yukiko] Univ Tokyo, Grad Sch Med, Dept Child Neuropsychiat, Bunkyo Ku, Tokyo 113, Japan; [Yamasue, Hidenori; Koike, Shinsuke; Inoue, Hideyuki; Takano, Yosuke; Iwashiro, Norichika; Natsubori, Tatsunobu; Aoki, Yuta; Kasai, Kiyoto] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Bunkyo Ku, Tokyo 113, Japan; [Yamasue, Hidenori] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1028666, Japan; [Koike, Shinsuke] Univ Tokyo, Off Mental Hlth Support, Div Counseling & Support, Bunkyo Ku, Tokyo 113, Japan; [Kuroda, Miho] Shukutoku Univ, Fac Integrated Human & Social Welf, Dept Psychol, Chiba, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo	Yamasue, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Bunkyo Ku, Tokyo 113, Japan.	yamasue-tky@umin.ac.jp	Koike, Shinsuke/AIC-4690-2022	Kasai, Kiyoto/0000-0002-4443-4535; Koike, Shinsuke/0000-0002-3375-236X; aoki, yuta/0000-0001-5617-4948	CREST; Japan Science and Technology Agency; Development of biomarker candidates for social behavior; Grants-in-Aid for Scientific Research [24791199, 25461751] Funding Source: KAKEN	CREST(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Development of biomarker candidates for social behavior; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	A part of this study was supported by CREST, Japan Science and Technology Agency, and the "Development of biomarker candidates for social behavior'' carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. to funding.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Aoki Y, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.108; Baran R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-530; Baron-Cohen S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001081; Cai HL, 2012, J PROTEOME RES, V11, P4338, DOI 10.1021/pr300459d; Correia C, 2006, J AUTISM DEV DISORD, V36, P1137, DOI 10.1007/s10803-006-0138-6; Delwing D, 2008, BRAIN RES, V1193, P120, DOI 10.1016/j.brainres.2007.11.052; Emond P, 2013, ANAL BIOANAL CHEM, V405, P5291, DOI 10.1007/s00216-013-6934-x; Filiano JJ, 2002, J CHILD NEUROL, V17, P435, DOI 10.1177/088307380201700607; Filipek PA, 2003, ANN NEUROL, V53, P801, DOI 10.1002/ana.10596; Geier DA, 2009, NEUROCHEM RES, V34, P386, DOI 10.1007/s11064-008-9782-x; Giulivi C, 2010, JAMA-J AM MED ASSOC, V304, P2389, DOI 10.1001/jama.2010.1706; Good P, 2011, MED HYPOTHESES, V77, P1015, DOI 10.1016/j.mehy.2011.08.038; Good P, 2011, NEUROPSYCHOL REV, V21, P66, DOI 10.1007/s11065-011-9157-y; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Iwata K, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-16; Johannesen JK, 2012, SCHIZOPHR B; Kaiser MD, 2010, P NATL ACAD SCI USA, V107, P21223, DOI 10.1073/pnas.1010412107; Kern JK, 2011, MED SCI MONITOR, V17, pCR677, DOI 10.12659/MSM.882125; Kim HW, 2009, AM J MED GENET B, V150B, P300, DOI 10.1002/ajmg.b.30798; Lecavalier L, 2006, AM J MENT RETARD, V111, P199, DOI 10.1352/0895-8017(2006)111[199:VOTADI]2.0.CO;2; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; MACCIARDI F, 1990, PSYCHIAT RES, V32, P63, DOI 10.1016/0165-1781(90)90136-S; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Matsuoka K., 2006, JAPANESE ADULT READI; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; MEISTER A, 1991, PHARMACOL THERAPEUT, V51, P155, DOI 10.1016/0163-7258(91)90076-X; Ming X, 2012, J PROTEOME RES, V11, P5856, DOI 10.1021/pr300910n; Moreno-Fuenmayor H, 1996, Invest Clin, V37, P113; Nakamura K, 2008, INT J NEUROPSYCHOPH, V11, P1073, DOI 10.1017/S1461145708009036; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Oliveira G, 2005, DEV MED CHILD NEUROL, V47, P185, DOI 10.1017/S0012162205000332; Ooga T, 2011, MOL BIOSYST, V7, P1217, DOI 10.1039/c0mb00141d; Pederzolli CD, 2007, METAB BRAIN DIS, V22, P51, DOI 10.1007/s11011-006-9041-2; Pederzolli CD, 2010, METAB BRAIN DIS, V25, P145, DOI 10.1007/s11011-010-9190-1; Pilling S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4082; Quinones MP, 2009, NEUROBIOL DIS, V35, P165, DOI 10.1016/j.nbd.2009.02.019; Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136; Saransaari P, 2000, AMINO ACIDS, V19, P509, DOI 10.1007/s007260070003; Schicho R, 2012, J PROTEOME RES; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shimmura C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025340; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Soga T, 2011, J HEPATOL, V55, P896, DOI 10.1016/j.jhep.2011.01.031; Sugimoto M, 2010, ELECTROPHORESIS, V31, P2311, DOI 10.1002/elps.200900584; Suzuki K, 2010, INT J NEUROPSYCHOPH, V13, P529, DOI 10.1017/S1461145709990952; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Tsuchiya KJ, 2013, J AUTISM DEV DISORD, V43, P643, DOI 10.1007/s10803-012-1606-9; Tu WJ, 2012, J CLIN BIOCHEM NUTR, V51, P248, DOI 10.3164/jcbn.12-45; Watanabe T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039561; Wechsler D., 1997, WAIS 3 WECHSLER ADUL, V3rd, DOI 10.1111/j.1749-6632.1989.tb21005.x; Wechsler D., 1997, WECHSLER ADULT INTEL; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Xu XH, 2012, NEUROSCI BULL, V28, P641, DOI 10.1007/s12264-012-1272-0; Yamasue H, 2009, PSYCHIAT CLIN NEUROS, V63, P129, DOI 10.1111/j.1440-1819.2009.01944.x; Yap IKS, 2010, J PROTEOME RES, V9, P2996, DOI 10.1021/pr901188e; Zheng P, 2012, J PROTEOME RES, V11, P1741, DOI 10.1021/pr2010082; Zoroglu SS, 2003, CELL BIOCHEM FUNCT, V21, P55, DOI 10.1002/cbf.989	59	47	49	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73814	10.1371/journal.pone.0073814	http://dx.doi.org/10.1371/journal.pone.0073814			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058493	Green Published, gold, Green Submitted			2022-12-25	WOS:000324695900023
J	Lindsey, PA; Balme, GA; Funston, P; Henschel, P; Hunter, L; Madzikanda, H; Midlane, N; Nyirenda, V				Lindsey, Peter Andrew; Balme, Guy Andrew; Funston, Paul; Henschel, Philipp; Hunter, Luke; Madzikanda, Hilary; Midlane, Neil; Nyirenda, Vincent			The Trophy Hunting of African Lions: Scale, Current Management Practices and Factors Undermining Sustainability	PLOS ONE			English	Article							PANTHERA-LEO; CONSERVATION; POPULATION; INDUSTRY; IMPACT	The trophy hunting of lions Panthera leo is contentious due to uncertainty concerning conservation impacts and because of highly polarised opinions about the practice. African lions are hunted across at least similar to 558,000 km(2), which comprises 27-32% of the lion range in countries where trophy hunting of the species is permitted. Consequently, trophy hunting has potential to impart significant positive or negative impacts on lions. Several studies have demonstrated that excessive trophy harvests have driven lion population declines. There have been several attempts by protectionist non-governmental organisations to reduce or preclude trophy hunting via restrictions on the import and export of lion trophies. We document the management of lion hunting in Africa and highlight challenges which need addressing to achieve sustainability. Problems include: unscientific bases for quota setting; excessive quotas and off-takes in some countries; fixed quotas which encourage over-harvest; and lack of restrictions on the age of lions that can be hunted. Key interventions needed to make lion hunting more sustainable, include implementation of: enforced age restrictions; improved trophy monitoring; adaptive management of quotas and a minimum length of lion hunts of at least 21 days. Some range states have made important steps towards implementing such improved management and off-takes have fallen steeply in recent years. For example age restrictions have been introduced in Tanzania and in Niassa in Mozambique, and are being considered for Benin and Zimbabwe, several states have reduced quotas, and Zimbabwe is implementing trophy monitoring. However, further reforms are needed to ensure sustainability and reduce conservation problems associated with the practice while allowing retention of associated financial incentives for conservation.	[Lindsey, Peter Andrew; Balme, Guy Andrew; Funston, Paul; Henschel, Philipp; Hunter, Luke] Panthera, Lion Program, New York, NY USA; [Lindsey, Peter Andrew] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0002 Pretoria, Gauteng, South Africa; [Balme, Guy Andrew; Midlane, Neil] Univ Cape Town, Dept Biol Sci, ZA-7925 Cape Town, Western Cape, South Africa; [Madzikanda, Hilary] Zimbabwe Parks & Wildlife Management Author, Harare, Mashonaland Eas, Zimbabwe; [Nyirenda, Vincent] Zambia Wildlife Author, Chilanga, Lusaka Province, Zambia	University of Pretoria; University of Cape Town	Lindsey, PA (corresponding author), Panthera, Lion Program, New York, NY USA.	plindsey@Panthera.org	Hunter, Luke T.B./H-3324-2019; Lindsey, Peter A/J-8368-2012	Hunter, Luke T.B./0000-0001-9653-6544; Lindsey, Peter A/0000-0002-9197-2897; Nyirenda, Vincent Raphael/0000-0002-3506-3912	Panthera	Panthera	This research was funded by Panthera. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, RECREATIONAL HUNTING; Balme GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035209; Bauer H, 2004, ORYX, V38, P26, DOI 10.1017/S0030605304000055; Becker MS, 2013, J WILDLIFE MANAGE, V77, P128, DOI 10.1002/jwmg.446; Begg C, 2010, MONITORING LION LEOP; Booth VR, 2009, COMP PRICES HUNTING; Brink H., 2010, THESIS IMPERIAL COLL; CENAGREF, 2013, PLAN ACT CONS LION B; Central African Republic, 1984, ORD 84 045 PORT PROT; Chardonnet P., 2002, CONSERVATION AFRICAN; Chardonnet P., 2011, CONSERVATION STATUS; Chardonnet P, 2009, CONSERVATION STATUS; Croes BM, 2011, BIOL CONSERV, V144, P3064, DOI 10.1016/j.biocon.2011.09.013; Davidson Z, 2011, BIOL CONSERV, V144, P114, DOI 10.1016/j.biocon.2010.08.005; Di Silvestre I., 2002, DENOMBREMENT G UNPUB; Ferreira S, 2010, S AFR J WILDL RES, V40, P1, DOI 10.3957/056.040.0103; Frank L, 2006, LIONS CONFLICT CONSE; Funston PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059044; Group ICS, 2006, CONSERVATION STRATEG; Henschel P., 2012, IMPROVING STATUS LIO; IUCN, 2022, IUCN RED LIST THREAT; IUCN/PACO, 2009, GRAND CHASS AFR OUES; Lindsey P, 2012, S AFR J WILDL RES, V42, P11, DOI 10.3957/056.042.0103; Lindsey PA, 2007, BIOL CONSERV, V134, P455, DOI 10.1016/j.biocon.2006.09.005; Lindsey PA, 2006, ANIM CONSERV, V9, P283, DOI 10.1111/j.1469-1795.2006.00034.x; Lindsey P. A., 2010, CURRENT CONSERVATION, V3, P23; Lindsey PA, 2007, CONSERV BIOL, V21, P880, DOI 10.1111/j.1523-1739.2006.00594.x; Lindsey PA, 2013, BIOL CONSERV, V160, P80, DOI 10.1016/j.biocon.2012.12.020; Lindsey PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029332; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Loveridge AJ, 2009, RECREATIONAL HUNTING, P108; Mesochina P, 2010, CONSERVATION STATUS; MINFOF/SDIAF/SC, 2012, HUNT AR CAM; Nelson F, 2013, ORYX, V47, P509, DOI 10.1017/S0030605313001178; Norton-Griffiths M., 2007, WORLD ECON, V8, P41; Nowell K, 2004, CAT NEWS, V41, P29; Packer C, 2005, NATURE, V436, P927, DOI 10.1038/436927a; Packer C, 2011, CONSERV BIOL, V25, P142, DOI 10.1111/j.1523-1739.2010.01576.x; PACKER C, 1990, AM NAT, V136, P1, DOI 10.1086/285079; Packer C, 2006, HUNTERS GUIDE AGING; Pellerin M., 2009, STATUT CONSERVATION; Ray J.C., 2005, 24 WILDL CONS SOC; Riggio J., 2011, AFRICAN LION PANTHER; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Roulet P.A, 2004, CHASSEUR BLANC COEUR; Simasiku P, 2008, IMPACT WILDLIFE MANA; SMUTS GL, 1980, J ZOOL, V190, P365; Tanzania Wildlife Division, 2012, COMM ESA STAT REV AF; Taylor R, 2009, BIODIVERS CONSERV, V18, P2563, DOI 10.1007/s10531-009-9612-8; Weaver C., 2011, CITES CBNRM, P1; Whitman K, 2004, NATURE, V428, P175, DOI 10.1038/nature02395; Whitman KL, 2007, CONSERV BIOL, V21, P591, DOI 10.1111/j.1523-1739.2007.00700.x; World Resources Institute, 2010, INT FOR ATL CENTR AF	53	45	45	3	218	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73808	10.1371/journal.pone.0073808	http://dx.doi.org/10.1371/journal.pone.0073808			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058491	Green Published, gold, Green Submitted			2022-12-25	WOS:000324695900021
J	Ward-Paige, CA; Davis, B; Worm, B				Ward-Paige, Christine A.; Davis, Brendal; Worm, Boris			Global Population Trends and Human Use Patterns of Manta and Mobula Rays	PLOS ONE			English	Article							ALFREDI KREFFT; SHARKS; BYCATCH; CONSERVATION; AUSTRALIA; RECOVERY; FISHERY; BIOLOGY; OPTIONS; OCEAN	Despite being the world's largest rays and providing significant revenue through dive tourism, little is known about the population status, exploitation and trade volume of the Mobulidae (mobulids; Manta and Mobula spp.). There is anecdotal evidence, however, that mobulid populations are declining, largely due to the recent emergence of a widespread trade for their gill rakers, which is reflected in increasing Food and Agriculture Organization landings trends. Here, we present results from two dedicated diver surveys, one from the eManta project, which includes summary observations from ninety 10 degrees x10 degrees regions with similar to 200-62,000 dives per region, and the other from the Reef Environmental Education Foundation, which includes spatially more detailed observations from 3 regions with similar to 4,000-118,000 dives per region. We show that mobulids as a group, which includes eleven species, have globally and regionally restricted distributions, typically have low sighting frequency (< 1% of dives) and aggregate in only a few locations. Of the regions surveyed by divers, almost half (47%) report declining mobulid sightings over the last decade. Divers indicate that although mobulid ecotourism occurs in many regions (45% of those reported, n = 41) they are considered protected in only 32% of the regions. Mobulids being fished or sold in local markets were reported from 16% and 12% of regions, respectively, with most being adjacent to mobulid abundance hotspot and ecotourism regions (e.g. Sri Lanka, Indonesia, east Africa). Identification of regions where ecotourism and exploitation are at odds could help prioritize conservation efforts. Vulnerability analysis, using life history characteristics, indicates that Manta spp. are vulnerable to exploitation, tolerating only low fishing mortality rates; data limitations prohibited such analysis for Mobula spp. Our analyses support previous studies in showing the need for improved conservation and monitoring efforts, and suggest that international and enforceable management policies are required to prevent further population decline.	[Ward-Paige, Christine A.; Davis, Brendal; Worm, Boris] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Dalhousie University	Ward-Paige, CA (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	CWard.Paige@gmail.com		Ward-Paige, Christine A./0000-0002-2394-9898; Worm, Boris/0000-0002-5742-8716	National Science and Engineering Research Council of Canada	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this study was provided by the National Science and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alava M, 1997, P INT SEM WORKSH SAB, V8, p[xv, 258, 132]; Amande MJ, 2010, AQUAT LIVING RESOUR, V23, P353, DOI 10.1051/alr/2011003; Anderson Charles, 2001, Shark News, V13, P1; Anderson R. C., 2010, Tourism in Marine Environments, V7, P15, DOI 10.3727/154427310X12826772784793; Arzoumanian Z, 2005, J APPL ECOL, V42, P999, DOI 10.1111/j.1365-2664.2005.01117.x; Bansemer CS, 2010, MAR FRESHWATER RES, V61, P97, DOI 10.1071/MF08362; Couturier LIE, 2012, J FISH BIOL, V80, P1075, DOI 10.1111/j.1095-8649.2012.03264.x; Couturier LIE, 2011, MAR FRESHWATER RES, V62, P628, DOI 10.1071/MF10148; Deakos MH, 2011, MAR ECOL PROG SER, V429, P245, DOI 10.3354/meps09085; Dewar H., 2002, PRELIMINARY REPORT M; FAO, 2011, FISHSTATJ UN SOFTW F; Fernando D, 2011, MANTA TRUST, P1; Graham RT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036834; HOENIG JM, 1983, FISH B-NOAA, V81, P898; Kaschner K, 2010, AQUAMAPS PREDICTED R; Kashiwagi Tom, 2011, Marine Biodiversity Records, V4; Kitchen-Wheeler AM, 2012, ENVIRON BIOL FISH, V93, P557, DOI 10.1007/s10641-011-9950-8; MacCarthy M, 2006, SERV IND J, V26, P537, DOI 10.1080/02642060600722841; Marshall A, 2011, IUCN 2012 IUCN RED L; Marshall A, 2011, IUCN 2012 ICUN RED L; Marshall AD, 2011, MAR BIOL, V158, P1111, DOI 10.1007/s00227-011-1634-6; Marshall AD, 2009, ZOOTAXA, P1; Notarbartolo Di Sciara G, 2006, IUCN 2012 IUCN RED L; Notarbartolo Di Sciara G, 1987, 5 S BIOL MAR U AUT B, P109; O'Malley MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065051; Pollard D., 2009, IUCN 2012 IUCN RED L, DOI 10.2305/IUCN.UK.2009-2; Romanov EV, 2002, FISH B-NOAA, V100, P90; Smith SE, 1998, MAR FRESHWATER RES, V49, P663, DOI 10.1071/MF97135; Storai T, 2011, FISH RES, V109, P74, DOI 10.1016/j.fishres.2011.01.018; Ward-Paige CA, 2012, J FISH BIOL, V80, P1844, DOI 10.1111/j.1095-8649.2012.03246.x; Ward-Paige CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025609; Ward-Paige CA, 2011, ENVIRON BIOL FISH, V90, P263, DOI 10.1007/s10641-010-9739-1; Ward-Paige CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011968; White WT, 2006, FISH RES, V82, P65, DOI 10.1016/j.fishres.2006.08.008; Wilson SG, 2002, MAR FRESHWATER RES, V53, P1005, DOI 10.1071/MF01229; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034	36	60	63	1	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74835	10.1371/journal.pone.0074835	http://dx.doi.org/10.1371/journal.pone.0074835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040348	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500123
J	Xie, GQ; Myint, PK; Zaman, MJS; Li, Y; Zhao, LC; Shi, P; Ren, FX; Wu, YF				Xie, Gaoqiang; Myint, Phyo Kyaw; Zaman, M. Justin S.; Li, Ying; Zhao, Liancheng; Shi, Ping; Ren, Fuxiu; Wu, Yangfeng			Relationship of Serum Interleukin-10 and Its Genetic Variations with Ischemic Stroke in a Chinese General Population	PLOS ONE			English	Article							POLYMORPHISMS; CORONARY; ASSOCIATION; COMBINATION; EVENTS; SHESIS; IL-10; RISK	Background and Purpose: Anti-inflammatory cytokine and its genetic variations may play an important role in the process of atherosclerosis. We assessed whether serum interleukin-10 (IL-10) and its genetic variations are associated with ischemic stroke in a Chinese general population. Methods: An epidemiological survey on cardiovascular diseases and their risk factors was carried in a general population in Beijing in 2005. Serum IL-10, IL-6, p-selectin, soluble intercellular adhesion molecule-1 and C-reactive protein were analyzed using ELISA kits, while three IL-10 Single Nucleotide Polymorphisms (SNP) (rs1800872, rs1554286 and rs3021094) were genotyped in 1475 participants. Results: A high serum IL-10 (top tertile) was significantly associated with ischemic stroke (multivariable adjusted odds ratio (OR) =0.50; 95% CI 0.31-0.81). Rs1800872 (AA vs. AC+CC genotype, OR=1.60; 1.06-2.39), rs1554286(TT vs. CT+CC genotype, OR=1.59; 1.06-2.39), and rs3021094 (CC/CA vs. AA genotype, OR=1.64; 1.04-2.60) were all significantly associated with ischemic stroke even after controlling for age, sex, smoking, systolic blood pressure, total cholesterol, glucose, body mass index and serum IL-10. The SNP score (a summary index of these SNPs) and IL-10 (top tertile) together significantly improved the discriminative power in predicting ischemic stroke by 3.3% (95% CI: 0.2-6.4, p=0.0398) compared to predictions based on conventional risk factors alone. Conclusions: The lower serum IL-10 concentration and its selected genetic variations were significantly associated with an increased likelihood of ischemic stroke in this cross-sectional study. Our results suggest that more prospective studies should be conducted to provide stronger evidence justifying the use of IL-10 and its SNPs as new biomarkers to identify a predisposition towards ischemic stroke.	[Xie, Gaoqiang; Wu, Yangfeng] Peking Univ, Clin Res Inst, Beijing 100871, Peoples R China; [Myint, Phyo Kyaw] Univ Aberdeen, Sch Med & Dent, Inst Appl Hlth Sci, Aberdeen, Scotland; [Myint, Phyo Kyaw; Zaman, M. Justin S.] Univ E Anglia, Norwich Res Pk Cardiovasc Res Grp, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Myint, Phyo Kyaw] Univ Cambridge, Dept Publ Hlth & Primary Care, Clin Gerontol Unit, Cambridge, England; [Myint, Phyo Kyaw] Norfolk & Norwich Univ Hosp, Stroke Res Grp, Norwich, Norfolk, England; [Zaman, M. Justin S.] James Paget Univ Hosp, Dept Cardiol, Great Yarmouth, England; [Li, Ying; Zhao, Liancheng] Chinese Acad Med Sci, Cardiovasc Inst, Beijing, Peoples R China; [Li, Ying; Zhao, Liancheng] Chinese Acad Med Sci, Fuwai Hosp, Beijing, Peoples R China; [Li, Ying; Zhao, Liancheng] Peking Union Med Coll, Beijing, Peoples R China; [Shi, Ping; Ren, Fuxiu] Shijingshan Ctr Dis Control & Prevent, Beijing, Peoples R China; [Wu, Yangfeng] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China; [Wu, Yangfeng] George Inst, Beijing, Peoples R China	Peking University; University of Aberdeen; University of East Anglia; University of Cambridge; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking University	Xie, GQ (corresponding author), Peking Univ, Clin Res Inst, Beijing 100871, Peoples R China.	gqxie72@163.com; zhaolch@163.com			Young Researchers Foundation of Fuwai Hospital [2006-yq-006]; National Natural Science Foundation of China [30471494, 30872168]; People's Republic of China National 10th Five-Year Plan Science and Technology Key Projects [2001BA703B01]	Young Researchers Foundation of Fuwai Hospital; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); People's Republic of China National 10th Five-Year Plan Science and Technology Key Projects	This study was supported by grants 2006-yq-006 of the Young Researchers Foundation of Fuwai Hospital, grants 30471494 and 30872168 of the National Natural Science Foundation of China, and grants 2001BA703B01 of the People's Republic of China National 10th Five-Year Plan Science and Technology Key Projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; de Craen AJM, 2005, GENES IMMUN, V6, P167, DOI 10.1038/sj.gene.6364162; DICKSON RC, 1975, SCIENCE, V187, P27, DOI 10.1126/science.1088926; Donger C, 2001, EUR J CLIN INVEST, V31, P9, DOI 10.1046/j.1365-2362.2001.00754.x; Heeschen C, 2003, CIRCULATION, V107, P2109, DOI 10.1161/01.CIR.0000065232.57371.25; IRVING S, 1992, CIRCULATION, V85, P1083; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Mallat Z, 1999, CIRC RES, V85, pE17, DOI 10.1161/01.RES.85.8.e17; Oslund LJP, 1999, ARTERIOSCL THROM VAS, V19, P2847, DOI 10.1161/01.ATV.19.12.2847; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Stoica AL, 2010, J VASC SURG, V52, P103, DOI 10.1016/j.jvs.2010.01.088; Trompet S, 2007, ANN NY ACAD SCI, V1100, P189, DOI 10.1196/annals.1395.018; van Exel E, 2002, STROKE, V33, P1135, DOI 10.1161/01.STR.0000014206.05597.9E; Weng KP, 2010, CIRC J, V74, P983, DOI 10.1253/circj.CJ-09-0801; Xie GQ, 2010, INT J CARDIOL, V143, P102, DOI 10.1016/j.ijcard.2008.11.173; Xie GQ, 2005, CHEST, V128, P2448, DOI 10.1378/chest.128.4.2448; Xie WX, 2011, HEART, V97, P1326, DOI 10.1136/hrt.2011.223032; Ying BW, 2011, MOL BIOL REP, V38, P379, DOI 10.1007/s11033-010-0119-x; Ying SY, 2005, BIOCHEM BIOPH RES CO, V326, P515, DOI 10.1016/j.bbrc.2004.10.215	22	28	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74126	10.1371/journal.pone.0074126	http://dx.doi.org/10.1371/journal.pone.0074126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040186	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500073
J	Ayyanath, MM; Cutler, GC; Scott-Dupree, CD; Sibley, PK				Ayyanath, Murali-Mohan; Cutler, G. Christopher; Scott-Dupree, Cynthia D.; Sibley, Paul K.			Transgenerational Shifts in Reproduction Hormesis in Green Peach Aphid Exposed to Low Concentrations of Imidacloprid	PLOS ONE			English	Article							SUBLETHAL CONCENTRATIONS; DEFINING HORMESIS; HORMOLIGOSIS; AZADIRACHTIN; INSECTICIDES; STIMULATION; EXPECTATION; ARTHROPODS; HOMOPTERA; FRAMEWORK	Hormesis is a biphasic phenomenon that in toxicology is characterized by low-dose stimulation and high-dose inhibition. It has been observed in a wide range of organisms in response to many chemical stressors, including insects exposed to pesticides, with potential repercussions for agriculture and pest management. To address questions related to the nature of the dose-response and potential consequences on biological fitness, we examined transgenerational hormesis in the green peach aphid, Myzus persicae, when exposed to sublethal concentrations of the insecticide imidacloprid. A hormetic response in the form of increased reproduction was consistently observed and a model previously developed to test for hormesis adequately fit some of our data. However, the nature of the dose-response differed within and across generations depending upon the duration and mode of exposure. Decreased reproduction in intermediate generations confirmed that fitness tradeoffs were a consequence of the hormetic response. However, recovery to levels of reproduction equal to that of controls in subsequent generations and significantly greater total reproduction after four generations suggested that biological fitness was increased by exposure to low concentrations of the insecticide, even when insects were continuously exposed to the stressor. This was especially evident in a greenhouse experiment where the instantaneous rate of population increase almost doubled and total aphid production more than quadrupled when aphids were exposed to potato plants systemically treated with low amounts of imidacloprid. Our results show that although fitness tradeoffs do occur with hormetic responses, this does not necessarily compromise overall biological fitness.	[Ayyanath, Murali-Mohan; Cutler, G. Christopher] Dalhousie Univ, Dept Environm Sci, Fac Agr, Truro, NS, Canada; [Ayyanath, Murali-Mohan; Scott-Dupree, Cynthia D.; Sibley, Paul K.] Univ Guelph, Sch Environm Sci, Ontario Agr Coll, Guelph, ON N1G 2W1, Canada	Dalhousie University; University of Guelph	Cutler, GC (corresponding author), Dalhousie Univ, Dept Environm Sci, Fac Agr, Agr Campus, Truro, NS, Canada.	chris.cutler@dal.ca		Sibley, Paul/0000-0002-2622-266X; Cutler, Chris/0000-0002-4666-9987	Ontario Graduate Scholarship Program; Natural Sciences and Engineering Research Council of Canada	Ontario Graduate Scholarship Program(Ontario Graduate Scholarship); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Financial support for this project was through the Ontario Graduate Scholarship Program, and several University of Guelph internal scholarship donors (scholarships to M-M.A.), and the Natural Sciences and Engineering Research Council of Canada (Discovery Grant to G. C. C.). No additional external funding was received for this study, and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belz RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033432; Calabrese EJ, 2008, ENVIRON TOXICOL CHEM, V27, P1451, DOI [10.1897/07-541.1, 10.1897/07-541]; Calabrese EJ, 2007, TOXICOL APPL PHARM, V222, P122, DOI 10.1016/j.taap.2007.02.015; Calabrese EJ, 2005, ENVIRON POLLUT, V138, P378, DOI 10.1016/j.envpol.2004.10.001; Calabrese EJ, 2002, HUM EXP TOXICOL, V21, P91, DOI 10.1191/0960327102ht217oa; Campos B, 2012, AQUAT TOXICOL, V109, P100, DOI 10.1016/j.aquatox.2011.12.003; Carelli G, 2002, HUM EXP TOXICOL, V21, P103, DOI 10.1191/0960327102ht219oa; Cedergreen N, 2005, ENVIRON TOXICOL CHEM, V24, P3166, DOI 10.1897/05-014R.1; CHELLIAH S, 1980, ENVIRON ENTOMOL, V9, P778, DOI 10.1093/ee/9.6.778; Cohen E, 2006, PESTIC BIOCHEM PHYS, V85, P21, DOI 10.1016/j.pestbp.2005.09.002; Costantini D, 2010, ECOL LETT, V13, P1435, DOI 10.1111/j.1461-0248.2010.01531.x; Cutler GC, 2013, DOSE-RESPONSE, V11, P154, DOI 10.2203/dose-response.12-008.Cutler; Cutler GC, 2009, PEST MANAG SCI, V65, P205, DOI 10.1002/ps.1669; DITTRICH V, 1974, ENVIRON ENTOMOL, V3, P534, DOI 10.1093/ee/3.3.534; Forbes VE, 2000, FUNCT ECOL, V14, P12, DOI 10.1046/j.1365-2435.2000.00392.x; Gressel J, 2011, PEST MANAG SCI, V67, P253, DOI 10.1002/ps.2071; Guedes NMP, 2010, J APPL ENTOMOL, V134, P142, DOI 10.1111/j.1439-0418.2009.01462.x; Guedes RNC, 2009, J ECON ENTOMOL, V102, P170, DOI 10.1603/029.102.0124; Guo RX, 2012, J ENVIRON SCI HEAL B, V47, P883, DOI 10.1080/03601234.2012.693869; Jager T, 2012, ECOTOXICOLOGY, P1; Janmaat A, 2011, PEST MANAG SCI, V67, P719, DOI 10.1002/ps.2113; LOWERY DT, 1986, J ECON ENTOMOL, V79, P1530, DOI 10.1093/jee/79.6.1530; LUCKEY TD, 1968, J ECON ENTOMOL, V61, P7, DOI 10.1093/jee/61.1.7; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; Morse JG, 1998, HUM EXP TOXICOL, V17, P266, DOI 10.1191/096032798678908738; MORSE JG, 1991, J ECON ENTOMOL, V84, P1169, DOI 10.1093/jee/84.4.1169; MUKHERJEE SN, 1993, EXPERIENTIA, V49, P557, DOI 10.1007/BF01955163; Parsons PA, 2001, Q REV BIOL, V76, P459, DOI 10.1086/420541; Parsons PA, 2000, J APPL TOXICOL, V20, P103, DOI 10.1002/(SICI)1099-1263(200003/04)20:2<103::AID-JAT639>3.0.CO;2-O; Ramanaidu K, 2013, PEST MANAG SCI, V69, P949, DOI 10.1002/ps.3456; SAS, 2008, ONLINEDOC 9 2; Schaible R, 2011, EXP GERONTOL, V46, P794, DOI 10.1016/j.exger.2011.06.004; Sinkkonen A, 2011, DOSE-RESPONSE, V9, P130, DOI 10.2203/dose-response.09-045.Sinkkonen; SMIRNOFF WA, 1983, CROP PROT, V2, P225, DOI 10.1016/0261-2194(83)90048-0; Stark JD, 2003, ANNU REV ENTOMOL, V48, P505, DOI 10.1146/annurev.ento.48.091801.112621; Suhett AL, 2011, ENVIRON SCI POLLUT R, V18, P1004, DOI 10.1007/s11356-011-0455-y; Velini ED, 2008, PEST MANAG SCI, V64, P489, DOI 10.1002/ps.1562; Walthall WK, 1997, ENVIRON TOXICOL CHEM, V16, P1068, DOI 10.1002/etc.5620160529; Yu YS, 2010, PESTIC BIOCHEM PHYS, V98, P238, DOI 10.1016/j.pestbp.2010.06.013; Zalizniak L, 2006, ECOTOX ENVIRON SAFE, V64, P207, DOI 10.1016/j.ecoenv.2005.03.015; Zanuncio TV, 2003, CROP PROT, V22, P941, DOI 10.1016/S0261-2194(03)00094-2	41	83	87	3	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e74532	10.1371/journal.pone.0074532	http://dx.doi.org/10.1371/journal.pone.0074532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040272	Green Published, gold, Green Submitted			2022-12-25	WOS:000324856500085
J	Torreggiani, E; Matthews, BG; Pejda, S; Matic, I; Horowitz, MC; Grcevic, D; Kalajzic, I				Torreggiani, Elena; Matthews, Brya G.; Pejda, Slavica; Matic, Igor; Horowitz, Mark C.; Grcevic, Danka; Kalajzic, Ivo			Preosteocytes/Osteocytes Have the Potential to Dedifferentiate Becoming a Source of Osteoblasts	PLOS ONE			English	Article							DENTIN MATRIX PROTEIN-1; MESENCHYMAL STEM-CELLS; BONE-MARROW; IN-VIVO; OSTEOCYTE APOPTOSIS; TRANSGENIC MICE; EXPRESSION; DIFFERENTIATION; LINEAGE; GFP	Presently there is no clear evidence for the ability of mature osteogenic lineage cells to dedifferentiate. In order to identify and trace mature osteogenic lineage cells, we have utilized transgenic mouse models in which the dentin matrix protein 1 (Dmp1) promoter drives expression of GFP (active marker) or Cre recombinase (historic label) in preosteocytes/osteocytes. In long bone chip outgrowth cultures, in which cells on the bone surface were enzymatically removed, cells with previous activity of the Dmp1 promoter migrated onto plastic and down-regulated Dmp1-GFP expression. Dmp1Cre-labeled cells from these cultures had the potential to re-differentiate into the osteogenic lineage, while the negative population showed evidence of adipogenesis. We observed numerous Dmp1Cre-labeled osteoblasts on the surface of bone chips following their in vivo transplantation. Our data indicate that cells embedded in bone matrix are motile, and once given access to the extra bony milieu will migrate out of their lacunae. This population of cells is phenotypically and functionally heterogeneous in vitro. Once the preosteocytes/osteocytes leave lacunae, they can dedifferentiate, potentially providing an additional source of functional osteoblasts.	[Torreggiani, Elena; Matthews, Brya G.; Pejda, Slavica; Matic, Igor; Kalajzic, Ivo] Univ Connecticut, Ctr Hlth, Dept Reconstruct Sci, Farmington, CT 06032 USA; [Horowitz, Mark C.] Yale Univ, Sch Med, Dept Orthopaed & Rehabil, New Haven, CT 06510 USA; [Grcevic, Danka] Univ Sch Med, Dept Physiol & Immunol, Zagreb, Croatia	University of Connecticut; Yale University	Kalajzic, I (corresponding author), Univ Connecticut, Ctr Hlth, Dept Reconstruct Sci, Farmington, CT 06032 USA.	ikalaj@neuron.uchc.edu	Grcevic, Danka/AAS-1666-2021; Torreggiani, Elena/J-6404-2016; Matthews, Brya/B-9812-2013	Grcevic, Danka/0000-0002-2365-8249; Torreggiani, Elena/0000-0001-7874-2002; Matthews, Brya/0000-0002-4145-4696	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [1R21AR059315, 1R01AR055607]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR059315, R01AR055607] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under award numbers 1R21AR059315 and 1R01AR055607. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armani A, 2010, J CELL BIOCHEM, V110, P564, DOI 10.1002/jcb.22598; Aubin JE, 1996, MICROSC RES TECHNIQ, V33, P128, DOI 10.1002/(SICI)1097-0029(19960201)33:2<128::AID-JEMT4>3.0.CO;2-P; Bonyadi M, 2003, P NATL ACAD SCI USA, V100, P5840, DOI 10.1073/pnas.1036475100; Dallas SL, 2010, ANN NY ACAD SCI, V1192, P437, DOI 10.1111/j.1749-6632.2009.05246.x; Echeverri K, 2001, DEV BIOL, V236, P151, DOI 10.1006/dbio.2001.0312; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Feng JQ, 2003, J DENT RES, V82, P776, DOI 10.1177/154405910308201003; Fisher LW, 2003, CONNECT TISSUE RES, V44, P33, DOI 10.1080/03008200390152061; He G, 2004, J BIOL CHEM, V279, P11649, DOI 10.1074/jbc.M309296200; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; Jilka RL, 1998, J BONE MINER RES, V13, P793, DOI 10.1359/jbmr.1998.13.5.793; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Kalajzic I, 2005, J BIOL CHEM, V280, P24618, DOI 10.1074/jbc.M413834200; Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15; Kalajzic I, 2004, BONE, V35, P74, DOI 10.1016/j.bone.2004.03.006; Kalajzic Z, 2008, BONE, V43, P501, DOI 10.1016/j.bone.2008.04.023; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Liu YL, 2010, BONE, V47, P916, DOI 10.1016/j.bone.2010.07.022; LO DC, 1993, P NATL ACAD SCI USA, V90, P7230, DOI 10.1073/pnas.90.15.7230; Lu Y, 2007, J DENT RES, V86, P320, DOI 10.1177/154405910708600404; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Matsumoto T, 2008, J CELL PHYSIOL, V215, P210, DOI 10.1002/jcp.21304; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Nobusue H, 2008, CELL TISSUE RES, V332, P435, DOI 10.1007/s00441-008-0593-9; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; Plotkin LI, 2005, AM J PHYSIOL-CELL PH, V289, pC633, DOI 10.1152/ajpcell.00278.2004; Plotkin LI, 2002, J BIOL CHEM, V277, P8648, DOI 10.1074/jbc.M108625200; Plotkin LI, 2007, J BIOL CHEM, V282, P24120, DOI 10.1074/jbc.M611435200; Poloni A, 2012, STEM CELLS, V30, P965, DOI 10.1002/stem.1067; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Powell WF, 2011, J ENDOCRINOL, V209, P21, DOI 10.1530/JOE-10-0308; Qian H, 2012, J BIOL CHEM, V287, P25795, DOI 10.1074/jbc.M112.339622; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; Ruchon AF, 2000, J BONE MINER RES, V15, P1440, DOI 10.1359/jbmr.2000.15.8.1440; Rutherford RB, 2002, TISSUE ENG, V8, P441, DOI 10.1089/107632702760184709; Song L, 2004, FASEB J, V18, P980, DOI 10.1096/fj.03-1100fje; Toyosawa S, 2001, J BONE MINER RES, V16, P2017, DOI 10.1359/jbmr.2001.16.11.2017; Veno PA, 2007, J BONE MINER RES, V22, pS13; Wang YH, 2005, J BONE MINER RES, V20, P5, DOI 10.1359/JBMR.041016; Webster DJ, 2013, BONE; Xiao ZS, 2011, FASEB J, V25, P2418, DOI 10.1096/fj.10-180299; Yang WC, 2005, J BIOL CHEM, V280, P20680, DOI 10.1074/jbc.M500104200; Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238	46	32	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e75204	10.1371/journal.pone.0075204	http://dx.doi.org/10.1371/journal.pone.0075204			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040401	Green Submitted, Green Published, gold			2022-12-25	WOS:000324856500106
J	Appasamy, D; Ramlan, EI; Firdaus-Raih, M				Appasamy, D.; Ramlan, Effirul Ikhwan; Firdaus-Raih, Mohd			Comparative Sequence and Structure Analysis Reveals the Conservation and Diversity of Nucleotide Positions and Their Associated Tertiary Interactions in the Riboswitches	PLOS ONE			English	Article							RNA APTAMER COMPLEX; S-ADENOSYLMETHIONINE; GENE-EXPRESSION; MOLECULAR RECOGNITION; LYSINE RIBOSWITCH; LOOP INTERACTION; MESSENGER-RNAS; REGULATORY RNA; FOLDING MOTIF; VIRUS GENOME	The tertiary motifs in complex RNA molecules play vital roles to either stabilize the formation of RNA 3D structure or to provide important biological functionality to the molecule. In order to better understand the roles of these tertiary motifs in riboswitches, we examined 11 representative riboswitch PDB structures for potential agreement of both motif occurrences and conservations. A total of 61 unique tertiary interactions were found in the reference structures. In addition to the expected common A-minor motifs and base-triples mainly involved in linking distant regions the riboswitch structures three highly conserved variants of A-minor interactions called G-minors were found in the SAM-I and FMN riboswitches where they appear to be involved in the recognition of the respective ligand's functional groups. From our structural survey as well as corresponding structure and sequence alignments, the agreement between motif occurrences and conservations are very prominent across the representative riboswitches. Our analysis provide evidence that some of these tertiary interactions are essential components to form the structure where their sequence positions are conserved despite a high degree of diversity in other parts of the respective riboswitches sequences. This is indicative of a vital role for these tertiary interactions in determining the specific biological function of riboswitch.	[Appasamy, D.; Firdaus-Raih, Mohd] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Biosci & Biotechnol, Bangi 43600, Selangor, Malaysia; [Ramlan, Effirul Ikhwan] Univ Malaya, Fac Comp Sci & Informat Technol, Dept Artificial Intelligence, Kuala Lumpur, Malaysia; [Firdaus-Raih, Mohd] Univ Kebangsaan Malaysia, Inst Syst Biol, Bangi 43600, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Malaya; Universiti Kebangsaan Malaysia	Firdaus-Raih, M (corresponding author), Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Biosci & Biotechnol, Bangi 43600, Selangor, Malaysia.	firdaus@mfrlab.org	Firdaus-Raih, Mohd/A-9217-2011; Ramlan, Effirul I/B-5264-2010; Appasamy, Sri Devan/GOV-5499-2022; Firdaus-Raih, Mohd/H-3286-2019	Firdaus-Raih, Mohd/0000-0003-4275-4663; Ramlan, Effirul I/0000-0002-8150-4782; Appasamy, Sri Devan/0000-0001-6609-3535; Firdaus-Raih, Mohd/0000-0003-4275-4663	Universiti Kebangsaan Malaysia; Ministry of Higher Education Malaysia [UKM-ST-06-FRGS0006-2009, UKM-DLP-2012-018, ERGS/1/2012/STG08/UKM/02/5]; Ministry of Science, Technology and Innovation Malaysia; High Impact Research Grant; University of Malaya [UM-HIR-MOHE-FCSIT-002]; Ministry of Higher Education	Universiti Kebangsaan Malaysia; Ministry of Higher Education Malaysia(Ministry of Education, Malaysia); Ministry of Science, Technology and Innovation Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); High Impact Research Grant; University of Malaya(Universiti Malaya); Ministry of Higher Education(Science and Technology Development Fund (STDF)Ministry of Higher Education & Scientific Research (MHESR))	This work was supported by the Universiti Kebangsaan Malaysia and Ministry of Higher Education Malaysia grants UKM-ST-06-FRGS0006-2009, UKM-DLP-2012-018 and ERGS/1/2012/STG08/UKM/02/5. SDA gratefully acknowledges funding from the Ministry of Science, Technology and Innovation Malaysia through the National Science Fellowship award. EIR was supported by the High Impact Research Grant jointly funded by the Ministry of Higher Education and University of Malaya (UM-HIR-MOHE-FCSIT-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Almakarem AS, 2012, NUCLEIC ACIDS RES, V40, P1407, DOI 10.1093/nar/gkr810; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blouin S, 2007, RNA, V13, P1256, DOI 10.1261/rna.560307; Blouin S, 2011, NUCLEIC ACIDS RES, V39, P3373, DOI 10.1093/nar/gkq1247; Brodsky AS, 1997, J MOL BIOL, V267, P624, DOI 10.1006/jmbi.1996.0879; Butcher SE, 2011, ACCOUNTS CHEM RES, V44, P1302, DOI 10.1021/ar200098t; CALNAN BJ, 1991, SCIENCE, V252, P1167, DOI 10.1126/science.252.5009.1167; CHANG KY, 1994, P NATL ACAD SCI USA, V91, P8705, DOI 10.1073/pnas.91.18.8705; Corbino KA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r70; COSTA M, 1995, EMBO J, V14, P1276, DOI 10.1002/j.1460-2075.1995.tb07111.x; Dann CE, 2007, CELL, V130, P878, DOI 10.1016/j.cell.2007.06.051; Fan P, 1996, J MOL BIOL, V258, P480, DOI 10.1006/jmbi.1996.0263; Firdaus-Raih M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S13-S2; Flinders J, 2004, CHEMBIOCHEM, V5, P62, DOI 10.1002/cbic.200300701; Friebe P, 2005, J VIROL, V79, P380, DOI 10.1128/JVI.79.1.380-392.2005; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Garst AD, 2009, BBA-GENE REGUL MECH, V1789, P584, DOI 10.1016/j.bbagrm.2009.06.004; Gate JH, 1996, SCIENCE, V273, P1696, DOI 10.1126/science.273.5282.1696; Geary C, 2008, NUCLEIC ACIDS RES, V36, P1138, DOI 10.1093/nar/gkm1048; Gilbert SD, 2008, NAT STRUCT MOL BIOL, V15, P177, DOI 10.1038/nsmb.1371; Gilbert SD, 2007, BIOCHEMISTRY-US, V46, P13297, DOI 10.1021/bi700410g; Gilbert SD, 2006, CHEM BIOL, V13, P805, DOI 10.1016/j.chembiol.2006.08.002; Guo F, 2004, MOL CELL, V16, P351, DOI 10.1016/S1097-2765(04)00592-1; Hamdani HY, 2012, NUCL ACIDS RES; Henkin TM, 2008, GENE DEV, V22, P3383, DOI 10.1101/gad.1747308; Jang SB, 2004, ACTA CRYSTALLOGR D, V60, P829, DOI 10.1107/S0907444904003804; Keating KS, 2008, J MOL BIOL, V383, P475, DOI 10.1016/j.jmb.2008.08.043; Klein DJ, 2009, NAT STRUCT MOL BIOL, V16, P343, DOI 10.1038/nsmb.1563; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Krasilnikov AS, 2003, RNA, V9, P640, DOI 10.1261/rna.2202703; Kwon MY, 2008, RNA, V14, P25, DOI 10.1261/rna.771608; Lu C, 2008, NAT STRUCT MOL BIOL, V15, P1076, DOI 10.1038/nsmb.1494; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Mandal M, 2004, NAT REV MOL CELL BIO, V5, P451, DOI 10.1038/nrm1403; Mandal M, 2004, SCIENCE, V306, P275, DOI 10.1126/science.1100829; McDaniel BA, 2005, MOL MICROBIOL, V57, P1008, DOI 10.1111/j.1365-2958.2005.04740.x; Miranda-Rios J, 2007, STRUCTURE, V15, P259, DOI 10.1016/j.str.2007.02.001; Montange RK, 2006, NATURE, V441, P1172, DOI 10.1038/nature04819; Moore T, 2004, STRUCTURE, V12, P807, DOI 10.1016/j.str.2004.02.033; Mulhbacher J, 2007, NUCLEIC ACIDS RES, V35, P5568, DOI 10.1093/nar/gkm572; Nagaswamy U, 2002, RNA, V8, P1112, DOI 10.1017/S135583820202006X; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PLEIJ CWA, 1985, NUCLEIC ACIDS RES, V13, P1717, DOI 10.1093/nar/13.5.1717; Ramesh A, 2011, J MOL BIOL, V407, P556, DOI 10.1016/j.jmb.2011.01.049; Roth A, 2007, NAT STRUCT MOL BIOL, V14, P308, DOI 10.1038/nsmb1224; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Serganov A, 2008, NATURE, V455, P1263, DOI 10.1038/nature07326; Serganov A, 2009, CURR OPIN STRUC BIOL, V19, P251, DOI 10.1016/j.sbi.2009.02.002; Serganov A, 2009, NATURE, V458, P233, DOI 10.1038/nature07642; Serganov A, 2006, NATURE, V441, P1167, DOI 10.1038/nature04740; Smith KD, 2010, BIOCHEMISTRY-US, V49, P7351, DOI 10.1021/bi100671e; Spitale RC, 2009, J BIOL CHEM, V284, P11012, DOI 10.1074/jbc.C900024200; Staple DW, 2005, PLOS BIOL, V3, P956, DOI 10.1371/journal.pbio.0030213; Tamura M, 2002, J MOL BIOL, V320, P455, DOI 10.1016/S0022-2836(02)00515-6; Thore S, 2006, SCIENCE, V312, P1208, DOI 10.1126/science.1128451; Tucker BJ, 2005, CURR OPIN STRUC BIOL, V15, P342, DOI 10.1016/j.sbi.2005.05.003; Wachter A, 2007, PLANT CELL, V19, P3437, DOI 10.1105/tpc.107.053645; Wakeman CA, 2007, TRENDS BIOCHEM SCI, V32, P415, DOI 10.1016/j.tibs.2007.08.005; Wang JX, 2008, BIOCHEM CELL BIOL, V86, P157, DOI 10.1139/O08-008; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Xin YR, 2008, RNA, V14, P2465, DOI 10.1261/rna.1249208; Yang HW, 2003, NUCLEIC ACIDS RES, V31, P3450, DOI 10.1093/nar/gkg529; Ye XM, 1995, CHEM BIOL, V2, P827, DOI 10.1016/1074-5521(95)90089-6; Ye XM, 1996, NAT STRUCT BIOL, V3, P1026, DOI 10.1038/nsb1296-1026; Zimmermann GR, 1997, NAT STRUCT BIOL, V4, P644, DOI 10.1038/nsb0897-644	72	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e73984	10.1371/journal.pone.0073984	http://dx.doi.org/10.1371/journal.pone.0073984			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040136	Green Submitted, Green Published, gold			2022-12-25	WOS:000324481600111
J	Huang, LL; Shi, Y; Lu, F; Zheng, H; Liu, XQ; Gong, B; Yang, JY; Lin, Y; Cheng, J; Ma, S; Lin, H; Yang, ZL				Huang, Lulin; Shi, Yi; Lu, Fang; Zheng, Hong; Liu, Xiaoqi; Gong, Bo; Yang, Jiyun; Lin, Ying; Cheng, Jing; Ma, Shi; Lin, He; Yang, Zhenglin			Association Study of Polymorphisms in Selenoprotein Genes and Kashin-Beck Disease and Serum Selenium/Iodine Concentration in a Tibetan Population	PLOS ONE			English	Article							GPX1 PRO198LEU POLYMORPHISM; BREAST-CANCER RISK; FUNGAL CONTAMINATION; ALCOHOL-CONSUMPTION; DRINKING-WATER; IODINE; DEFICIENCY; SELENOCYSTEINE	Background: Kashin-Beck disease is a kind of degenerative osteoarthropathy. Genetic factors may play an important role in the pathogenesis of KBD. Objective: To investigate the association of the selenoprotein genes GPX1 (rs1050450, rs1800668, and rs3811699), TrxR2 (rs5748469), and DIO2 (rs225014) with Kashin-Beck disease (KBD) in a Tibetan population and to investigate the association of these SNPs with the serum iodine/selenium concentration in the Tibetan population. Design: Five SNPs including rs1050450, rs1800668, and rs3811699 in the GPX1 gene, rs5748469 in the TrxR2 gene, and rs225014 in the DIO2 gene were analyzed in Tibetan KBD patients and controls using the SNaPshot method. P trend values of the SNPs were calculated using an additive model. Results: None of the five SNPs in the three genes showed a significant association with KBD. Haplotypes TCC, TTC and TTT of rs1050450, rs1800668 and rs3811699 in GPX1 showed a significant association with KBD and controls with P value of 0.0421, 5.0E-4 and 0.0066, respectively. The GPX1 gene (rs1050450) showed a potential significant association with the iodine concentration in the Tibetan study population (P=0.02726). However, no such association was detected with the selenium concentration (P=0.2849). Conclusion(s): In this study, we showed that single SNPs in the genes GPX1 (rs1050450, rs1800668 and rs3811699), TrxR2 (rs5748469), and DIO2 (rs225014) may not be significantly associated with KBD in a Tibetan population. However, haplotype analysis of SNPs rs1050450, rs1800668 and rs3811699 in GPX1 gene showed a significant association with KBD. The results suggested that GPX1 gene play a protective role in the susceptivity of KBD in Tibetans. Furthermore, the GPX1 gene (rs1050450) may be significantly associated with the serum iodine concentration in Tibetans.	[Huang, Lulin; Shi, Yi; Lu, Fang; Zheng, Hong; Liu, Xiaoqi; Gong, Bo; Yang, Jiyun; Lin, Ying; Cheng, Jing; Ma, Shi; Lin, He; Yang, Zhenglin] Sichuan Acad Med Sci, Ctr Human Mol Biol & Genet, Inst Lab Med, Chengdu, Sichuan, Peoples R China; [Huang, Lulin; Shi, Yi; Lu, Fang; Zheng, Hong; Liu, Xiaoqi; Gong, Bo; Yang, Jiyun; Lin, Ying; Cheng, Jing; Ma, Shi; Lin, He; Yang, Zhenglin] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China; [Huang, Lulin; Shi, Yi; Lu, Fang; Zheng, Hong; Liu, Xiaoqi; Gong, Bo; Yang, Jiyun; Lin, Ying; Cheng, Jing; Ma, Shi; Lin, He; Yang, Zhenglin] Chinese Acad Sci, Sichuan Translat Res Hosp, Chengdu, Sichuan, Peoples R China	Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Chinese Academy of Sciences	Yang, ZL (corresponding author), Sichuan Acad Med Sci, Ctr Human Mol Biol & Genet, Inst Lab Med, Chengdu, Sichuan, Peoples R China.	zliny@yahoo.com	Yang, Jiyun/AAS-3937-2020		Department of Science and Technology of China [2007BAI25B02]; Department of Science and Technology of Sichuan Province [08ZC0479]; Health Department of Sichuan Province [110196]; China's Post-doctoral Scientific Fund of the 49 Projects [1612]	Department of Science and Technology of China; Department of Science and Technology of Sichuan Province; Health Department of Sichuan Province; China's Post-doctoral Scientific Fund of the 49 Projects	Supported by Department of Science and Technology of China (2007BAI25B02) and Department of Science and Technology of Sichuan Province (08ZC0479) (to Z. Yang); Health Department of Sichuan Province (110196) and China's Post-doctoral Scientific Fund of the 49 Projects funded On-oriented (Serial No. 1612) (to L. Huang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsova-Sarafinovska Z, 2009, INT UROL NEPHROL, V41, P63, DOI 10.1007/s11255-008-9407-y; Bhatti P, 2009, CANCER EPIDEM BIOMAR, V18, P1841, DOI 10.1158/1055-9965.EPI-09-0197; BOCK A, 1991, MOL MICROBIOL, V5, P515, DOI 10.1111/j.1365-2958.1991.tb00722.x; Chasseur C, 1997, LANCET, V350, P1074, DOI 10.1016/S0140-6736(05)70453-0; Cox DG, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-217; Fairweather-Tait SJ, 2011, ANTIOXID REDOX SIGNA; FORCHHAMMER K, 1991, BIOCHIMIE, V73, P1481, DOI 10.1016/0300-9084(91)90181-Y; Greulich WW., 1959, RADIOGRAPH ATLAS SKE, V2; Hinsenkamp M, 2001, INT ORTHOP, V25, P142, DOI 10.1007/s002640100236; Kohrle J, 2009, BEST PRACT RES CL EN, V23, P815, DOI 10.1016/j.beem.2009.08.002; Kohrle J, 2005, ENDOCR REV, V26, P944, DOI 10.1210/er.2001-0034; KOLSTEREN P, 1992, ANN SOC BELG MED TR, V72, P81; Li SJ, 2007, SPECTROSC SPECT ANAL, V27, P585; MARASAS WFO, 1986, S AFR MED J, V69, P369; Moreno-Reyes R, 2003, AM J CLIN NUTR, V78, P137, DOI 10.1093/ajcn/78.1.137; Moreno-Reyes R, 1998, NEW ENGL J MED, V339, P1112, DOI 10.1056/NEJM199810153391604; Moreno-Reyes R, 2001, J BONE MINER RES, V16, P1556, DOI 10.1359/jbmr.2001.16.8.1556; Pasteels JL, 2001, INT ORTHOP, V25, P151, DOI 10.1007/s002640000190; Patrick L, 2008, ALTERN MED REV, V13, P116; PENG A, 1992, J TOXICOL ENV HEALTH, V35, P79, DOI 10.1080/15287399209531597; Peng X, 2000, BIOL TRACE ELEM RES, V77, P193, DOI 10.1385/BTER:77:3:193; Raaschou-Nielsen O, 2007, CANCER LETT, V247, P293, DOI 10.1016/j.canlet.2006.05.006; Ravn-Haren G, 2006, CARCINOGENESIS, V27, P820, DOI 10.1093/carcin/bgi267; Shi Y, 2011, ARTHRITIS RHEUM; Shi Y, 2011, ARTHRITIS RHEUM-US, V63, P3408, DOI 10.1002/art.30526; Steinbrecher A, 2010, CANCER EPIDEM BIOMAR, V19, P2958, DOI 10.1158/1055-9965.EPI-10-0364; Stone R, 2009, SCIENCE, V324, P1378, DOI 10.1126/science.324_1378; Utiger RD, 1998, NEW ENGL J MED, V339, P1156, DOI 10.1056/NEJM199810153391611; WRIGHT GC, 1987, FUND APPL TOXICOL, V9, P595, DOI 10.1016/0272-0590(87)90040-6; Xiong YM, 2010, OSTEOARTHR CARTILAGE, V18, P817, DOI 10.1016/j.joca.2010.02.004; Ying Guiying, 2007, Wei Sheng Yan Jiu, V36, P238; Zhang WH, 2001, INT ORTHOP, V25, P188, DOI 10.1007/s002640100242; Zhang YZ, 2009, ANN EPIDEMIOL, V19, P560, DOI 10.1016/j.annepidem.2009.04.007; Zou K, 2009, OSTEOARTHR CARTILAGE, V17, P144, DOI 10.1016/j.joca.2008.06.011	34	21	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e71411	10.1371/journal.pone.0071411	http://dx.doi.org/10.1371/journal.pone.0071411			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24058403	Green Published, gold, Green Submitted			2022-12-25	WOS:000324403200008
J	Wang, W; Zeng, WJ; Chen, WL; Zeng, H; Fang, JY				Wang, Wei; Zeng, Wenjing; Chen, Weile; Zeng, Hui; Fang, Jingyun			Soil Respiration and Organic Carbon Dynamics with Grassland Conversions to Woodlands in Temperate China	PLOS ONE			English	Article							WOODY PLANT ENCROACHMENT; LAND-USE CHANGES; SHRUB ENCROACHMENT; CLIMATE-CHANGE; VEGETATION; CO2; EXCHANGE; PHOTOSYNTHESIS; SENSITIVITY; ECOSYSTEMS	Soils are the largest terrestrial carbon store and soil respiration is the second-largest flux in ecosystem carbon cycling. Across China's temperate region, climatic changes and human activities have frequently caused the transformation of grasslands to woodlands. However, the effect of this transition on soil respiration and soil organic carbon (SOC) dynamics remains uncertain in this area. In this study, we measured in situ soil respiration and SOC storage over a two-year period (Jan. 2007-Dec. 2008) from five characteristic vegetation types in a forest-steppe ecotone of temperate China, including grassland (GR), shrubland (SH), as well as in evergreen coniferous (EC), deciduous coniferous (DC) and deciduous broadleaved forest (DB), to evaluate the changes of soil respiration and SOC storage with grassland conversions to diverse types of woodlands. Annual soil respiration increased by 3%, 6%, 14%, and 22% after the conversion from GR to EC, SH, DC, and DB, respectively. The variation in soil respiration among different vegetation types could be well explained by SOC and soil total nitrogen content. Despite higher soil respiration in woodlands, SOC storage and residence time increased in the upper 20 cm of soil. Our results suggest that the differences in soil environmental conditions, especially soil substrate availability, influenced the level of annual soil respiration produced by different vegetation types. Moreover, shifts from grassland to woody plant dominance resulted in increased SOC storage. Given the widespread increase in woody plant abundance caused by climate change and large-scale afforestation programs, the soils are expected to accumulate and store increased amounts of organic carbon in temperate areas of China.	[Wang, Wei; Zeng, Wenjing; Chen, Weile; Fang, Jingyun] Peking Univ, Minist Educ, Dept Ecol, Coll Urban & Environm Sci, Beijing 100871, Peoples R China; [Wang, Wei; Zeng, Wenjing; Chen, Weile; Fang, Jingyun] Peking Univ, Minist Educ, Key Lab Earth Surface Proc, Beijing 100871, Peoples R China; [Zeng, Wenjing; Chen, Weile; Zeng, Hui] Peking Univ, Shenzhen Grad Sch, Key Lab Urban Habitat Environm Sci & Technol, Shenzhen, Peoples R China	Peking University; Peking University; Peking University; University Town of Shenzhen	Wang, W (corresponding author), Peking Univ, Minist Educ, Dept Ecol, Coll Urban & Environm Sci, Beijing 100871, Peoples R China.	wangw@urban.pku.edu.cn	Zeng, Wen/GPS-8058-2022		National Basic Research Program of China [2012CB956303, 2010CB950600]; National Natural Science Foundation of China [31222011, 31270363, 31070428]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [31021001]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Basic Research Program of China (No. 2012CB956303 and 2010CB950600), projects of the National Natural Science Foundation of China (31222011, 31270363 and 31070428), and projects supported by the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (No. 31021001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrends HE, 2009, CLIM RES, V39, P261, DOI 10.3354/cr00811; Arora VK, 2010, GLOBAL CHANGE BIOL, V16, P3327, DOI 10.1111/j.1365-2486.2010.02202.x; Bahn M, 2008, ECOSYSTEMS, V11, P1352, DOI 10.1007/s10021-008-9198-0; Bahn M, 2009, NEW PHYTOL, V182, P451, DOI 10.1111/j.1469-8137.2008.02755.x; Barger NN, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001506; Berthrong ST, 2009, ECOL APPL, V19, P2228, DOI 10.1890/08-1730.1; Bond-Lamberty B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050441; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Boutton T.W., 2009, SOIL CARBON SEQUESTR, P181; Browning DM, 2008, ECOL APPL, V18, P928, DOI 10.1890/07-1559.1; Carbone MS, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000611; Creamer CA, 2011, SOIL BIOL BIOCHEM, V43, P1678, DOI 10.1016/j.soilbio.2011.04.013; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Don A, 2011, GLOBAL CHANGE BIOL, V17, P1658, DOI 10.1111/j.1365-2486.2010.02336.x; Aguiar APD, 2012, GLOBAL CHANGE BIOL, V18, P3346, DOI 10.1111/j.1365-2486.2012.02782.x; Eclesia RP, 2012, GLOBAL CHANGE BIOL, V18, P3237, DOI 10.1111/j.1365-2486.2012.02761.x; Elberling B, 2007, SOIL BIOL BIOCHEM, V39, P646, DOI 10.1016/j.soilbio.2006.09.017; Eldridge DJ, 2011, ECOL LETT, V14, P709, DOI 10.1111/j.1461-0248.2011.01630.x; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; GAMON JA, 1995, ECOL APPL, V5, P28, DOI 10.2307/1942049; Gill RA, 1999, OECOLOGIA, V121, P551, DOI 10.1007/s004420050962; Gimeno TE, 2012, ECOSYSTEMS, V15, P564, DOI 10.1007/s10021-012-9529-z; Henry HAL, 2008, CLIMATIC CHANGE, V87, P421, DOI 10.1007/s10584-007-9322-8; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Hogberg P, 2009, FOREST ECOL MANAG, V257, P1764, DOI 10.1016/j.foreco.2009.01.036; Houghton RA, 2010, TELLUS B, V62, P337, DOI 10.1111/j.1600-0889.2010.00473.x; Houghton RA, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001970; IPCC, 2007, CLIM CHANG 2007 PHYS; Iqbal J, 2008, SOIL BIOL BIOCHEM, V40, P2324, DOI 10.1016/j.soilbio.2008.05.010; Jackson RB, 2002, NATURE, V418, P623, DOI 10.1038/nature00910; Jakubauskas ME, 2001, PHOTOGRAMM ENG REM S, V67, P461; Jenkins M, 2010, GLOBAL CHANGE BIOL, V16, P209, DOI 10.1111/j.1365-2486.2009.01954.x; Kirschbaum MUF, 2004, GLOBAL CHANGE BIOL, V10, P1870, DOI 10.1111/j.1365-2486.2004.00852.x; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; Kurganova I, 2003, TELLUS B, V55, P338, DOI 10.1034/j.1600-0889.2003.00047.x; Lai LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048011; Leifeld J, 2005, GEODERMA, V124, P143, DOI 10.1016/j.geoderma.2004.04.009; Li HM, 2008, FOREST ECOL MANAG, V255, P16, DOI 10.1016/j.foreco.2007.06.051; Liu F, 2011, GLOBAL CHANGE BIOL, V17, P1119, DOI 10.1111/j.1365-2486.2010.02251.x; Liu H, 2008, AGR ECOSYST ENVIRON, V124, P125, DOI 10.1016/j.agee.2007.09.002; Livesley SJ, 2009, GLOBAL CHANGE BIOL, V15, P425, DOI 10.1111/j.1365-2486.2008.01759.x; Marin-Spiotta E, 2013, GLOBAL ECOL BIOGEOGR, V22, P105, DOI 10.1111/j.1466-8238.2012.00788.x; McCulley RL, 2004, ECOLOGY, V85, P2804, DOI 10.1890/03-0645; McKinley DC, 2008, ECOSYSTEMS, V11, P454, DOI 10.1007/s10021-008-9133-4; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Perez-Quezada JF, 2012, J ARID ENVIRON, V83, P45, DOI 10.1016/j.jaridenv.2012.03.015; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Poeplau C, 2013, GEODERMA, V192, P189, DOI 10.1016/j.geoderma.2012.08.003; Raich JW, 2000, BIOGEOCHEMISTRY, V48, P71, DOI 10.1023/A:1006112000616; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Richardson AD, 2009, ECOL APPL, V19, P1417, DOI 10.1890/08-2022.1; Saner P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029642; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; Schindlbacher A, 2009, GLOBAL CHANGE BIOL, V15, P901, DOI 10.1111/j.1365-2486.2008.01757.x; Sheng H, 2010, GLOBAL CHANGE BIOL, V16, P1107, DOI 10.1111/j.1365-2486.2009.01988.x; Smith DL, 2004, ECOLOGY, V85, P3348, DOI 10.1890/03-0576; Smith P, 2012, GLOBAL CHANGE BIOL, V18, P2089, DOI 10.1111/j.1365-2486.2012.02689.x; Tang XL, 2006, GLOBAL CHANGE BIOL, V12, P546, DOI 10.1111/j.1365-2486.2006.01109.x; Throop HL, 2008, GLOBAL CHANGE BIOL, V14, P2420, DOI 10.1111/j.1365-2486.2008.01650.x; van der Werf GR, 2009, NAT GEOSCI, V2, P829, DOI 10.1038/ngeo720; Wang W, 2010, PLANT SOIL, V333, P391, DOI 10.1007/s11104-010-0354-x; Wang W, 2010, SOIL BIOL BIOCHEM, V42, P1236, DOI 10.1016/j.soilbio.2010.04.013; Wei XR, 2009, BIOGEOCHEMISTRY, V96, P149, DOI 10.1007/s10533-009-9350-8; Wheeler CW, 2007, ECOL APPL, V17, P1911, DOI 10.1890/06-1580.1; Wiesmeier M, 2012, GLOBAL CHANGE BIOL, V18, P2233, DOI 10.1111/j.1365-2486.2012.02699.x; You L., 2002, METEOROLOGY J INNER, V4, P14; Zhang YK, 2010, J PLANT RES, V123, P543, DOI 10.1007/s10265-010-0311-z; Zhou RL, 2008, GEODERMA, V145, P370, DOI 10.1016/j.geoderma.2008.04.003	70	29	33	16	136	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e71986	10.1371/journal.pone.0071986	http://dx.doi.org/10.1371/journal.pone.0071986			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24058408	Green Published, Green Submitted, gold			2022-12-25	WOS:000324403200017
J	Haenzi, B; Bonny, O; Masson, R; Lienhard, S; Dey, JH; Kuro-o, M; Hynes, NE				Haenzi, Barbara; Bonny, Olivier; Masson, Regis; Lienhard, Susanne; Dey, Julien H.; Kuro-o, Makoto; Hynes, Nancy E.			Loss of Memo, a novel FGFR regulator, results in reduced lifespan	FASEB JOURNAL			English	Article						vitamin D; 1; 25-dihydroxyvitamin D-3; 1; 25(OH)(2)D; calcium; mineral homeostasis; kidney; insulin sensitivity	KLOTHO; ABLATION; HYPERPHOSPHATEMIA; PHOSPHATE; RECEPTOR	Memo is a widely expressed 33-kDa protein required for heregulin (HRG)-, epidermal growth factor (EGF)-, and fibroblast growth factor (FGF)-induced cell motility. Studies in mouse embryonic fibroblasts, wild-type or knockout for Memo, were performed to further investigate the role of Memo downstream of FGFR. We demonstrated that Memo associates with the FGFR signalosome and is necessary for optimal activation of signaling. To uncover Memo's physiological role, Memo conditional-knockout mice were generated. These animals showed a reduced life span, increased insulin sensitivity, small stature, graying hair, alopecia, kyphosis, loss of subcutaneous fat, and loss of spermatozoa in the epididymis. Memo-knockout mice also have elevated serum levels of active vitamin D, 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D), and calcium compared to control littermates expressing Memo. In summary, the results from in vivo and in vitro models support the hypothesis that Memo is a novel regulator of FGFR signaling with a role in controlling 1,25(OH)(2)D production and normal calcium homeostasis.Haenzi, B., Bonny, O., Masson, R., Lienhard, S., Dey, J. H., Kuro-o, M., Hynes, N. E. Loss of Memo, a novel FGFR regulator, results in reduced lifespan.	[Haenzi, Barbara; Masson, Regis; Lienhard, Susanne; Dey, Julien H.; Hynes, Nancy E.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Haenzi, Barbara; Dey, Julien H.; Hynes, Nancy E.] Univ Basel, Basel, Switzerland; [Bonny, Olivier] Univ Lausanne, Dept Pharmacol & Toxicol, Lausanne, Switzerland; [Kuro-o, Makoto] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	Friedrich Miescher Institute for Biomedical Research; University of Basel; University of Lausanne; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hynes, NE (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	nancy.hynes@fmi.ch		bonny, olivier/0000-0003-4123-4279	Swiss National Fond [SNF 31003A-121574]; European Molecular Biology Organization (EMBO) [ASTF 332-2208]; Swiss National Foundation [PP00P3-133648]; Transfog FP6 IP [LSHC-CT-2004-503438]; Friedrich Miescher Institute for Biochemical Research	Swiss National Fond(Swiss National Science Foundation (SNSF)); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Transfog FP6 IP; Friedrich Miescher Institute for Biochemical Research	The authors thank Gwen MacDonald, Simon Woehrle, and other members of the N.E.H. laboratory for inspiring discussions; Debby Hynx, Dmitri Firsov, and Candice Stoudmann for technical advice and help; and Jurg Biber (University of Zurich, Zurich, Switzerland) for the anti-NaPi2a antibody. The work of B. H. was partially supported by the Swiss National Fond (SNF 31003A-121574) and a European Molecular Biology Organization (EMBO) short-term fellowship (ASTF 332-2208). O.B. is supported by a Swiss National Foundation professorship (PP00P3-133648). The work of R. M. was partially supported by Transfog FP6 IP (LSHC-CT-2004-503438). The laboratory of N.E.H. is supported by the Friedrich Miescher Institute for Biochemical Research. The authors declare no conflicts of interest.	Andrukhova O, 2012, BONE, V51, P621, DOI 10.1016/j.bone.2012.05.015; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Biber J, 2007, NAT PROTOC, V2, P1356, DOI 10.1038/nprot.2007.156; Bibert S, 2009, AM J PHYSIOL-RENAL, V297, pF612, DOI 10.1152/ajprenal.00139.2009; Bryant MR, 2009, GLIA, V57, P935, DOI 10.1002/glia.20818; de Groot T, 2008, KIDNEY INT, V74, P1241, DOI 10.1038/ki.2008.320; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Guo CY, 2002, GENESIS, V32, P8, DOI 10.1002/gene.10021; Hesse M, 2007, MATRIX BIOL, V26, P75, DOI 10.1016/j.matbio.2006.10.003; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Kuro-o M, 2010, MECH AGEING DEV, V131, P270, DOI 10.1016/j.mad.2010.02.008; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Lengner CJ, 2004, J CELL PHYSIOL, V200, P327, DOI 10.1002/jcp.20118; Marone R, 2004, NAT CELL BIOL, V6, P515, DOI 10.1038/ncb1134; Meira M, 2009, J CELL SCI, V122, P787, DOI 10.1242/jcs.032094; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Prie D, 2010, CLIN J AM SOC NEPHRO, V5, P1717, DOI 10.2215/CJN.02680310; Schlatter ID, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032501; Schonig K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf134; Segawa H, 2007, AM J PHYSIOL-RENAL, V292, pF769, DOI 10.1152/ajprenal.00248.2006; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Sitara D, 2004, MATRIX BIOL, V23, P421, DOI 10.1016/j.matbio.2004.09.007; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Zaoui K, 2008, J CELL BIOL, V183, P401, DOI 10.1083/jcb.200805107	26	16	17	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					327	336		10.1096/fj.13-228320	http://dx.doi.org/10.1096/fj.13-228320			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24056085				2022-12-25	WOS:000333526100031
J	Razinia, Z; Baldassarre, M; Cantelli, G; Calderwood, DA				Razinia, Ziba; Baldassarre, Massimiliano; Cantelli, Gaia; Calderwood, David A.			ASB2 alpha, an E3 Ubiquitin Ligase Specificity Subunit, Regulates Cell Spreading and Triggers Proteasomal Degradation of Filamins by Targeting the Filamin Calponin Homology 1 Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING DOMAIN; LEUKEMIA-CELLS; ALPHA-ACTININ; MUTATIONS; DIFFERENTIATION; MIGRATION; PROTEIN; DIMERIZATION; MYOPATHY; HEMATOPOIESIS	Filamins are actin-binding and cross-linking proteins that organize the actin cytoskeleton and anchor transmembrane proteins to the cytoskeleton and scaffold signaling pathways. During hematopoietic cell differentiation, transient expression of ASB2 alpha, the specificity subunit of an E3-ubiquitin ligase complex, triggers acute proteasomal degradation of filamins. This led to the proposal that ASB2 alpha regulates hematopoietic cell differentiation by modulating cell adhesion, spreading, and actin remodeling through targeted degradation of filamins. Here, we show that the calponin homology domain 1 (CH1), within the filamin A (FLNa) actin-binding domain, is the minimal fragment sufficient for ASB2 alpha-mediated degradation. Combining an in-depth flow cytometry analysis with mutagenesis of lysine residues within CH1, we find that arginine substitution at each of a cluster of three lysines (Lys-42, Lys-43, and Lys-135) renders FLNa resistant to ASB2 alpha-mediated degradation without altering ASB2 alpha binding. These lysines lie within previously predicted actin-binding sites, and the ASB2 alpha-resistant filamin mutant is defective in targeting to F-actin-rich structures in cells. However, by swapping CH1 with that of alpha-actinin1, which is resistant to ASB2 alpha-mediated degradation, we generated an ASB2 alpha-resistant chimeric FLNa with normal subcellular localization. Notably, this chimera fully rescues the impaired cell spreading induced by ASB2 alpha expression. Our data therefore reveal ubiquitin acceptor sites in FLNa and establish that ASB2 alpha-mediated effects on cell spreading are due to loss of filamins.	[Razinia, Ziba; Calderwood, David A.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Baldassarre, Massimiliano; Cantelli, Gaia; Calderwood, David A.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Calderwood, David A.] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Calderwood, DA (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St,SHM B395C, New Haven, CT 06520 USA.	david.calderwood@yale.edu	Calderwood, David A/AAC-6954-2019; Baldassarre, Massimiliano/E-6236-2011; Baldassarre, Massimiliano/AAI-6581-2021	Calderwood, David A/0000-0002-0791-4142; Baldassarre, Massimiliano/0000-0002-2498-4767; Baldassarre, Massimiliano/0000-0002-2498-4767; Cantelli, Gaia/0000-0003-2650-6280	National Institutes of Health [RO1 GM-068600]; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM-068600 (to D. A. C.). This work was also supported by an award from the American Heart Association (to Z. R.).	Baldassarre M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007830; Bello NF, 2009, CELL DEATH DIFFER, V16, P921, DOI 10.1038/cdd.2009.27; Bicknell LS, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.029967; Carugo KD, 1997, NAT STRUCT BIOL, V4, P175, DOI 10.1038/nsb0397-175; Chiba N, 1997, ONCOGENE, V14, P2543, DOI 10.1038/sj.onc.1201109; Clark AR, 2009, HUM MOL GENET, V18, P4791, DOI 10.1093/hmg/ddp442; Coffman JA, 2003, CELL BIOL INT, V27, P315, DOI 10.1016/S1065-6995(03)00018-0; Connelly JT, 2008, J CELL PHYSIOL, V217, P145, DOI 10.1002/jcp.21484; Duff RM, 2011, AM J HUM GENET, V88, P729, DOI 10.1016/j.ajhg.2011.04.021; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Guibal FC, 2002, J BIOL CHEM, V277, P218, DOI 10.1074/jbc.M108476200; Heuze ML, 2008, BLOOD, V112, P5130, DOI 10.1182/blood-2007-12-128744; Heuze ML, 2005, J BIOL CHEM, V280, P5468, DOI 10.1074/jbc.M413040200; Huang G, 2001, EMBO J, V20, P723, DOI 10.1093/emboj/20.4.723; Johnson K, 2012, SCIENCE, V336, P717, DOI 10.1126/science.1215157; Kley RA, 2007, BRAIN, V130, P3250, DOI 10.1093/brain/awm271; Kohroki J, 2005, FEBS LETT, V579, P6796, DOI 10.1016/j.febslet.2005.11.016; Kohroki J, 2001, FEBS LETT, V505, P223, DOI 10.1016/S0014-5793(01)02829-0; Krakow D, 2004, NAT GENET, V36, P405, DOI 10.1038/ng1319; Lamsoul I, 2013, BLOOD, V122, P533, DOI 10.1182/blood-2012-11-466649; Lamsoul I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043798; Lamsoul I, 2011, J BIOL CHEM, V286, P30571, DOI 10.1074/jbc.M111.220921; Lu J, 2007, HUM MOL GENET, V16, P1661, DOI 10.1093/hmg/ddm114; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; MCGOUGH A, 1994, J CELL BIOL, V126, P433, DOI 10.1083/jcb.126.2.433; Nakamura A, 2005, BIOCHEM BIOPH RES CO, V328, P838, DOI 10.1016/j.bbrc.2005.01.035; Nie L, 2011, CELL RES, V21, P754, DOI 10.1038/cr.2010.165; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Okuda T, 2001, INT J HEMATOL, V74, P252, DOI 10.1007/BF02982057; Pudas R, 2005, STRUCTURE, V13, P111, DOI 10.1016/j.str.2004.10.014; Razinia Z, 2012, ANNU REV BIOPHYS, V41, P227, DOI 10.1146/annurev-biophys-050511-102252; Razinia Z, 2011, J CELL SCI, V124, P2631, DOI 10.1242/jcs.084343; Robertson SP, 2003, NAT GENET, V33, P487, DOI 10.1038/ng1119; Robertson SP, 2005, CURR OPIN GENET DEV, V15, P301, DOI 10.1016/j.gde.2005.04.001; Ruskamo S, 2009, ACTA CRYSTALLOGR D, V65, P1217, DOI 10.1107/S0907444909037330; Sarkisian MR, 2008, TRENDS NEUROSCI, V31, P54, DOI 10.1016/j.tins.2007.11.009; Sawyer GM, 2009, J MOL BIOL, V390, P1030, DOI 10.1016/j.jmb.2009.06.009; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; van der Flier A, 2002, J CELL BIOL, V156, P361, DOI 10.1083/jcb.200103037; Vorgerd M, 2005, AM J HUM GENET, V77, P297, DOI 10.1086/431959; Wang JY, 2012, BLOOD, V119, P1151, DOI 10.1182/blood-2011-06-362079; WAY M, 1992, J CELL BIOL, V119, P835, DOI 10.1083/jcb.119.4.835; WINDER SJ, 1995, J CELL SCI, V108, P63; Wu W, 2011, J BIOL CHEM, V286, P41153, DOI 10.1074/jbc.M111.273755; Yoshida N, 2005, MOL CELL BIOL, V25, P1003, DOI 10.1128/MCB.25.3.1003-1012.2005; Zheng L, 2007, J CELL BIOL, V178, P121, DOI 10.1083/jcb.200703113; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001; Zhou X, 2007, TRENDS CARDIOVAS MED, V17, P222, DOI 10.1016/j.tcm.2007.08.001	52	14	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					32093	32105		10.1074/jbc.M113.496604	http://dx.doi.org/10.1074/jbc.M113.496604			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24052262	Green Published, hybrid			2022-12-25	WOS:000330596200059
J	Cheng, WF; Chang, MC; Sun, WZ; Jen, YW; Liao, CW; Chen, YY; Chen, CA				Cheng, Wen-Fang; Chang, Ming-Cheng; Sun, Wei-Zen; Jen, Yu-Wei; Liao, Chao-Wei; Chen, Yun-Yuan; Chen, Chi-An			Fusion Protein Vaccines Targeting Two Tumor Antigens Generate Synergistic Anti-Tumor Effects	PLOS ONE			English	Article							IMMUNOLOGICAL RESPONSES; CANCER-IMMUNOTHERAPY; MAGE-3 PROTEIN; T-LYMPHOCYTES; IMMUNE-RESPONSES; CELLS; VACCINATION; VIRUS; ENHANCEMENT; INDUCTION	Introduction: Human papillomavirus (HPV) has been consistently implicated in causing several kinds of malignancies, and two HPV oncogenes, E6 and E7, represent two potential target antigens for cancer vaccines. We developed two fusion protein vaccines, PE(Delta III)/E6 and PE(Delta III)/E7 by targeting these two tumor antigens to test whether a combination of two fusion proteins can generate more potent anti-tumor effects than a single fusion protein. Materials and Methods: In vivo antitumor effects including preventive, therapeutic, and antibody depletion experiments were performed. In vitro assays including intracellular cytokine staining and ELISA for Ab responses were also performed. Results: PE(Delta III)/E6+PE(Delta III)/E7 generated both stronger E6 and E7-specific immunity. Only 60% of the tumor protective effect was observed in the PE(Delta III)/E6 group compared to 100% in the PE(Delta III)/E7 and PE(Delta III)/E6+PE(Delta III)/E7 groups. Mice vaccinated with the PE(Delta III)/E6+PE(Delta III)/E7 fusion proteins had a smaller subcutaneous tumor size than those vaccinated with PE(Delta III)/E6 or PE(Delta III)/E7 fusion proteins alone. Conclusion: Fusion protein vaccines targeting both E6 and E7 tumor antigens generated more potent immunotherapeutic effects than E6 or E7 tumor antigens alone. This novel strategy of targeting two tumor antigens together can promote the development of cancer vaccines and immunotherapy in HPV-related malignancies.	[Cheng, Wen-Fang; Chang, Ming-Cheng; Jen, Yu-Wei; Chen, Yun-Yuan; Chen, Chi-An] Natl Taiwan Univ, Coll Med, Dept Obstet & Gynecol, Taipei 10764, Taiwan; [Cheng, Wen-Fang] Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei 10764, Taiwan; [Cheng, Wen-Fang] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Sun, Wei-Zen] Natl Taiwan Univ, Coll Med, Dept Anesthesiol, Taipei 10764, Taiwan; [Liao, Chao-Wei] Anim Technol Inst Taiwan, Miaoli, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Chen, CA (corresponding author), Natl Taiwan Univ, Coll Med, Dept Obstet & Gynecol, Taipei 10764, Taiwan.	chianchen@ntu.edu.tw		CHEN, CHI-AN/0000-0001-6670-7939; CHENG, WEN-FANG/0000-0002-3282-6304; SUN, WEI-ZEN/0000-0001-8543-2600	HealthBanks Biotech Company [NTUH97A126]	HealthBanks Biotech Company	This was a cooperative study sponsored by HealthBanks Biotech Company (NTUH97A126). This study received funding from the HealthBanks Biotech Company. The funder had no role in the study design, collection, analyses and interpretation of data, writing of the report, and the decision to submit the paper for publication.	Brossart P, 1999, BLOOD, V93, P4309, DOI 10.1182/blood.V93.12.4309.412k19_4309_4317; Chen CA, 2009, GENE THER, V16, P776, DOI 10.1038/gt.2009.31; Chen CH, 1998, J BIOMED SCI, V5, P231, DOI 10.1159/000025336; Chen CA, 2010, MOL THER, V18, P1233, DOI 10.1038/mt.2010.34; Cheng WF, 2008, GENE THER, V15, P1007, DOI 10.1038/gt.2008.25; Cheng WF, 2006, MOL THER, V13, P203, DOI 10.1016/j.ymthe.2005.06.479; Cheng WF, 2005, MOL THER, V12, P960, DOI 10.1016/j.ymthe.2005.04.020; Cheng WF, 2005, IMMUNOLOGY, V115, P136, DOI 10.1111/j.1365-2567.2005.02126.x; Cheng WF, 2004, EUR J IMMUNOL, V34, P1892, DOI 10.1002/eji.200424877; Cheng WF, 2002, HUM GENE THER, V13, P553, DOI 10.1089/10430340252809847; Cheng WF, 2001, HUM GENE THER, V12, P235, DOI 10.1089/10430340150218387; Cheng WF, 2001, J CLIN INVEST, V108, P669, DOI 10.1172/JCI200112346; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; FELTKAMP MCW, 1995, IMMUNOL LETT, V47, P1, DOI 10.1016/0165-2478(95)00052-7; Fominaya J, 1998, GENE THER, V5, P521, DOI 10.1038/sj.gt.3300614; HAUSEN HZ, 1991, VIROLOGY, V184, P9, DOI 10.1016/0042-6822(91)90816-T; HOWLEY PM, 1991, CANCER RES, V51, pS5019; Hsieh CY, 2007, MOL THER, V15, P1890, DOI 10.1038/sj.mt.6300243; Huang CY, 2007, GYNECOL ONCOL, V107, P404, DOI 10.1016/j.ygyno.2007.06.031; Hung CF, 2001, CANCER RES, V61, P1080; International Agency for Research on Cancer, 1995, MON CANC HUM PAP; King CA, 1998, NAT MED, V4, P1281, DOI 10.1038/3266; Liao CW, 2005, CANCER RES, V65, P9089, DOI 10.1158/0008-5472.CAN-05-0958; Lin KY, 1996, CANCER RES, V56, P21; LORINCZ AT, 1992, OBSTET GYNECOL, V79, P328, DOI 10.1097/00006250-199203000-00002; Marchand M, 2003, EUR J CANCER, V39, P70, DOI 10.1016/S0959-8049(02)00479-3; Marshall JL, 2000, J CLIN ONCOL, V18, P3964, DOI 10.1200/JCO.2000.18.23.3964; NASSERI M, 1991, VIROLOGY, V184, P131, DOI 10.1016/0042-6822(91)90829-Z; Nichols WW, 1995, ANN NY ACAD SCI, V772, P30, DOI 10.1111/j.1749-6632.1995.tb44729.x; Peng SW, 2004, J VIROL, V78, P8468, DOI 10.1128/JVI.78.16.8468-8476.2004; SCHWARZ E, 1985, NATURE, V314, P111, DOI 10.1038/314111a0; Vantomme V, 2004, J IMMUNOTHER, V27, P124, DOI 10.1097/00002371-200403000-00006; Vonderheide RH, 1999, IMMUNITY, V10, P673, DOI 10.1016/S1074-7613(00)80066-7; Walter S, 2002, NAT MED, V18; YASUMOTO S, 1986, J VIROL, V57, P572, DOI 10.1128/JVI.57.2.572-577.1986; Zhang Y, 2003, J IMMUNOL, V171, P219, DOI 10.4049/jimmunol.171.1.219	36	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e71216	10.1371/journal.pone.0071216	http://dx.doi.org/10.1371/journal.pone.0071216			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058440	gold, Green Published, Green Submitted			2022-12-25	WOS:000324408400002
J	Black, SL; Dawson, A; Ward, FB; Allen, RJ				Black, S. Lucas; Dawson, Angela; Ward, F. Bruce; Allen, Rosalind J.			Genes Required for Growth at High Hydrostatic Pressure in Escherichia coli K-12 Identified by Genome-Wide Screening	PLOS ONE			English	Article							ENTEROBACTERIAL COMMON ANTIGEN; TOL-PAL COMPLEX; IN-VIVO; BACTERIAL MOTILITY; CELL MORPHOLOGY; SOS RESPONSE; CHI SUBUNIT; O-ANTIGEN; DEEP-SEA; PROTEIN	Despite the fact that much of the global microbial biosphere is believed to exist in high pressure environments, the effects of hydrostatic pressure on microbial physiology remain poorly understood. We use a genome-wide screening approach, combined with a novel high-throughput high-pressure cell culture method, to investigate the effects of hydrostatic pressure on microbial physiology in vivo. The Keio collection of single-gene deletion mutants in Escherichia coli K-12 was screened for growth at a range of pressures from 0.1 MPa to 60 MPa. This led to the identification of 6 genes, rodZ, holC, priA, dnaT, dedD and tatC, whose products were required for growth at 30 MPa and a further 3 genes, tolB, rffT and iscS, whose products were required for growth at 40 MPa. Our results support the view that the effects of pressure on cell physiology are pleiotropic, with DNA replication, cell division, the cytoskeleton and cell envelope physiology all being potential failure points for cell physiology during growth at elevated pressure.	[Black, S. Lucas; Dawson, Angela; Allen, Rosalind J.] Univ Edinburgh, SUPA Sch Phys & Astron, Edinburgh, Midlothian, Scotland; [Black, S. Lucas; Ward, F. Bruce] Univ Edinburgh, Sch Biol Sci, Inst Cell Biol, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Allen, RJ (corresponding author), Univ Edinburgh, SUPA Sch Phys & Astron, Edinburgh, Midlothian, Scotland.	rosalind.allen@ed.ac.uk	Allen, Rosalind/M-5222-2017; Allen, Rosalind/M-5222-2017	Allen, Rosalind/0000-0003-4110-2962; Allen, Rosalind/0000-0003-3163-6354; Black, Lucas/0000-0002-4463-6911	Royal Society of Edinburgh Research Fellowship; Royal Society University Research Fellowship; Royal Society Research grant; EPSRC DTA studentship; EPSRC [EP/J007404/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J007404/1] Funding Source: researchfish	Royal Society of Edinburgh Research Fellowship; Royal Society University Research Fellowship(Royal Society of London); Royal Society Research grant(Royal Society of London); EPSRC DTA studentship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	R.J.A. was funded by a Royal Society of Edinburgh Research Fellowship, by a Royal Society University Research Fellowship and by a Royal Society Research grant. S. L. B. was funded by an EPSRC DTA studentship. None of these grants have specific numbers associated with them. The funders websites are: http://www.royalsoced.org.uk; http://royalsociety.org; http://www.epsrc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe F, 2008, GENETICS, V178, P851, DOI 10.1534/genetics.107.083063; Aertsen A, 2005, MOL MICROBIOL, V58, P1381, DOI 10.1111/j.1365-2958.2005.04903.x; Aertsen A, 2005, APPL ENVIRON MICROB, V71, P2226, DOI 10.1128/AEM.71.5.2226-2231.2005; Aertsen A, 2004, J BACTERIOL, V186, P6133, DOI 10.1128/jb.186.18.6133-6141.2004; Aertsen A, 2004, APPL ENVIRON MICROB, V70, P2660, DOI 10.1128/AEM.70.5.2660-2666.2004; Aertsen A, 2009, TRENDS BIOTECHNOL, V27, P434, DOI 10.1016/j.tibtech.2009.04.001; Alyahya SA, 2009, P NATL ACAD SCI USA, V106, P1239, DOI 10.1073/pnas.0810794106; Arends SJR, 2010, J BACTERIOL, V192, P242, DOI 10.1128/JB.01244-09; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bartlett DH, 2002, BBA-PROTEIN STRUCT M, V1595, P367, DOI 10.1016/S0167-4838(01)00357-0; Bendezu FO, 2009, EMBO J, V28, P193, DOI 10.1038/emboj.2008.264; Bernadac A, 1998, J BACTERIOL, V180, P4872, DOI 10.1128/JB.180.18.4872-4878.1998; Bernhardt TG, 2003, MOL MICROBIOL, V48, P1171, DOI 10.1046/j.1365-2958.2003.03511.x; Bidle KA, 1999, J BACTERIOL, V181, P2330, DOI 10.1128/JB.181.8.2330-2337.1999; Black SL, 2009, 191 BMG LABT; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; BOURNS B, 1988, CELL MOTIL CYTOSKEL, V10, P380, DOI 10.1002/cm.970100305; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002; Cascales E, 2000, MOL MICROBIOL, V38, P904, DOI 10.1046/j.1365-2958.2000.02190.x; Crenshaw HC, 1996, EXP CELL RES, V227, P285, DOI 10.1006/excr.1996.0278; Danese PN, 1998, J BACTERIOL, V180, P5875, DOI 10.1128/JB.180.22.5875-5884.1998; Dubuisson JF, 2005, MICROBIOL-SGM, V151, P3337, DOI 10.1099/mic.0.28237-0; El-Hajj ZW, 2009, J BACTERIOL, V191, P6383, DOI 10.1128/JB.00576-09; Gerdes K, 2009, EMBO J, V28, P171, DOI 10.1038/emboj.2008.287; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; Gerding MA, 2009, J BACTERIOL, V191, P7383, DOI 10.1128/JB.00811-09; GROSS M, 1990, FEBS LETT, V267, P239, DOI 10.1016/0014-5793(90)80934-B; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; HEREMANS K, 1982, ANNU REV BIOPHYS BIO, V11, P1, DOI 10.1146/annurev.bb.11.060182.000245; Ishii A, 2005, EXTREMOPHILES, V9, P65, DOI 10.1007/s00792-004-0414-3; Ishii A, 2004, MICROBIOL-SGM, V150, P1965, DOI 10.1099/mic.0.26962-0; Ize B, 2003, MOL MICROBIOL, V48, P1183, DOI 10.1046/j.1365-2958.2003.03504.x; Kelman Z, 1998, EMBO J, V17, P2436, DOI 10.1093/emboj/17.8.2436; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; KUHN HM, 1988, FEMS MICROBIOL LETT, V54, P195, DOI 10.1111/j.1574-6968.1988.tb02743.x; Lammer H, 2009, ASTRON ASTROPHYS REV, V17, P181, DOI 10.1007/s00159-009-0019-z; LARK CA, 1978, J BACTERIOL, V136, P1008, DOI 10.1128/JB.136.3.1008-1017.1978; Lauhon CT, 2002, J BACTERIOL, V184, P6820, DOI 10.1128/JB.184.24.6820-6829.2002; Lauro FM, 2008, J BACTERIOL, V190, P1699, DOI 10.1128/JB.01176-07; Lazzaroni JC, 1999, FEMS MICROBIOL LETT, V177, P191, DOI 10.1016/S0378-1097(99)00293-1; Lee PA, 2006, ANNU REV MICROBIOL, V60, P373, DOI 10.1146/annurev.micro.60.080805.142212; Llamas MA, 2000, J BACTERIOL, V182, P4764, DOI 10.1128/JB.182.17.4764-4772.2000; Lopper M, 2007, MOL CELL, V26, P781, DOI 10.1016/j.molcel.2007.05.012; Mackey BM, 2008, HIGH PRESSURE MICROB; Manas P, 2004, APPL ENVIRON MICROB, V70, P1545, DOI 10.1128/AEM.70.3.1545-1554.2004; MARQUIS RE, 1987, BAROPHYSIOLOGY PROKA; MASAI H, 1986, P NATL ACAD SCI USA, V83, P1256, DOI 10.1073/pnas.83.5.1256; McCool JD, 2004, GENETICS, V167, P569, DOI 10.1534/genetics.103.025296; Meersman F, 2006, CHEM SOC REV, V35, P908, DOI 10.1039/b517761h; Meersman F, 2008, HIGH-PRESSURE MICROBIOLOGY, P1; MEGANATHAN R, 1973, NATURE, V246, P525, DOI 10.1038/246525a0; MEIERDIETER U, 1990, J BIOL CHEM, V265, P13490; MEIERDIETER U, 1992, J BIOL CHEM, V267, P746; Mihara H, 2002, APPL MICROBIOL BIOT, V60, P12, DOI 10.1007/s00253-002-1107-4; Mozhaev VV, 1996, PROTEINS, V24, P81, DOI 10.1002/(SICI)1097-0134(199601)24:1<81::AID-PROT6>3.0.CO;2-R; NAKASHIMA K, 1995, BIOSCI BIOTECH BIOCH, V59, P130, DOI 10.1271/bbb.59.130; Nishiyama M, 2012, BIOPHYS J, V102, P1872, DOI 10.1016/j.bpj.2012.03.033; OHTA M, 1991, MOL MICROBIOL, V5, P1853, DOI 10.1111/j.1365-2958.1991.tb00809.x; Peters NT, 2011, J BACTERIOL, V193, P4973, DOI 10.1128/JB.00316-11; POLLARD EC, 1966, BIOCHIM BIOPHYS ACTA, V112, P573, DOI 10.1016/0926-6585(66)90261-5; POPE DH, 1975, J BACTERIOL, V121, P753, DOI 10.1128/JB.121.3.753-758.1975; SALMON ED, 1975, J CELL BIOL, V65, P603, DOI 10.1083/jcb.65.3.603; SCHMIDT G, 1976, J BACTERIOL, V127, P755, DOI 10.1128/JB.127.2.755-762.1976; SCHULZ E, 1976, FEBS LETT, V64, P40, DOI 10.1016/0014-5793(76)80243-8; Shiomi D, 2008, EMBO J, V27, P3081, DOI 10.1038/emboj.2008.234; SILVA JL, 1993, ANNU REV PHYS CHEM, V44, P89, DOI 10.1146/annurev.pc.44.100193.000513; Stanley NR, 2001, J BACTERIOL, V183, P139, DOI 10.1128/JB.183.1.139-144.2001; Tamegai H, 1997, EXTREMOPHILES, V1, P207, DOI 10.1007/s007920050035; VANBOGELEN RA, 1990, P NATL ACAD SCI USA, V87, P5589, DOI 10.1073/pnas.87.15.5589; Vass H, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3427224; Vines ED, 2005, J BACTERIOL, V187, P3359, DOI 10.1128/JB.187.10.3359-3368.2005; WELCH TJ, 1993, J BACTERIOL, V175, P7170, DOI 10.1128/JB.175.22.7170-7177.1993; Winter R, 2009, SOFT MATTER, V5, P3157, DOI 10.1039/b901690b; Witte G, 2003, NUCLEIC ACIDS RES, V31, P4434, DOI 10.1093/nar/gkg498; YAYANOS AA, 1969, BIOPHYS J, V9, P1464, DOI 10.1016/S0006-3495(69)86466-0; Yeh YC, 2010, J BACTERIOL, V192, P4847, DOI 10.1128/JB.00607-10; ZOBELL CE, 1964, J BACTERIOL, V87, P710, DOI 10.1128/JB.87.3.710-719.1964; ZOBELL CE, 1962, J BACTERIOL, V84, P1228, DOI 10.1128/JB.84.6.1228-1236.1962; ZOBELL CE, 1949, J BACTERIOL, V57, P179, DOI 10.1128/JB.57.2.179-189.1949	80	26	26	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e73995	10.1371/journal.pone.0073995	http://dx.doi.org/10.1371/journal.pone.0073995			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040140	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500066
J	McGilligan, VE; Gregory-Ksander, MS; Li, DY; Moore, JE; Hodges, RR; Gilmore, MS; Moore, TCB; Dartt, DA				McGilligan, Victoria E.; Gregory-Ksander, Meredith S.; Li, Dayu; Moore, Jonathan E.; Hodges, Robin R.; Gilmore, Michael S.; Moore, Tara C. B.; Dartt, Darlene A.			Staphylococcus aureus Activates the NLRP3 Inflammasome in Human and Rat Conjunctival Goblet Cells	PLOS ONE			English	Article							INTERLEUKIN-1-BETA SECRETION; CASPASE-1 ACTIVATION; MONOCYTIC CELLS; P2X7 RECEPTOR; EXPRESSION; DISEASE; RECOGNITION; REQUIREMENT; KERATITIS; PATHOGEN	The conjunctiva is a moist mucosal membrane that is constantly exposed to an array of potential pathogens and triggers of inflammation. The NACHT, leucine rich repeat (LRR), and pyrin domain-containing protein 3 (NLRP3) is a Nod-like receptor that can sense pathogens or other triggers, and is highly expressed in wet mucosal membranes. NLRP3 is a member of the multi-protein complex termed the NLRP3 inflammasome that activates the caspase 1 pathway, inducing the secretion of biologically active IL-1 beta, a major initiator and promoter of inflammation. The purpose of this study was to: (1) determine whether NLRP3 is expressed in the conjunctiva and (2) determine whether goblet cells specifically contribute to innate mediated inflammation via secretion of IL-1 beta. We report that the receptors known to be involved in the priming and activation of the NLRP3 inflammasome, the purinergic receptors P2X4 and P2X7 and the bacterial Toll-like receptor 2 are present and functional in conjunctival goblet cells. Toxin-containing Staphylococcus aureus (S. aureus), which activates the NLRP3 inflammasome, increased the expression of the inflammasome proteins NLRP3, ASC and pro- and mature caspase 1 in conjunctival goblet cells. The biologically active form of IL-1 beta was detected in goblet cell culture supernatants in response to S. aureus, which was reduced when the cells were treated with the caspase 1 inhibitor Z-YVAD. We conclude that the NLRP3 inflammasome components are present in conjunctival goblet cells. The NRLP3 inflammasome appears to be activated in conjunctival goblet cells by toxin-containing S. aureus via the caspase 1 pathway to secrete mature IL1-beta. Thus goblet cells contribute to the innate immune response in the conjunctiva by activation of the NLRP3 inflammasome.	[McGilligan, Victoria E.; Gregory-Ksander, Meredith S.; Li, Dayu; Hodges, Robin R.; Dartt, Darlene A.] Harvard Univ, Sch Med, Schepens Eye Res Inst, Massachusetts Eye & Ear, Boston, MA 02115 USA; [McGilligan, Victoria E.; Gregory-Ksander, Meredith S.; Li, Dayu; Hodges, Robin R.; Gilmore, Michael S.; Dartt, Darlene A.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [McGilligan, Victoria E.; Moore, Jonathan E.; Moore, Tara C. B.] Univ Ulster, Ctr Mol Biosci, Coleraine BT52 1SA, Londonderry, North Ireland; [Moore, Jonathan E.] Cathedral Eye Clin, Belfast, Antrim, North Ireland; [Gilmore, Michael S.] Harvard Univ, Sch Med, Dept Microbiol, Boston, MA USA; [Gilmore, Michael S.] Harvard Univ, Sch Med, Dept Immunobiol, Boston, MA USA; [Gilmore, Michael S.] Massachusetts Eye & Ear, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Ulster University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary	Dartt, DA (corresponding author), Harvard Univ, Sch Med, Schepens Eye Res Inst, Massachusetts Eye & Ear, Boston, MA 02115 USA.	darlene.dartt@schepens.harvard.edu	Gregory-Ksander, Meredith/AAG-1413-2019	Gregory-Ksander, Meredith/0000-0002-7193-0032; McGilligan, Victoria/0000-0003-1013-3504; Moore, Tara/0000-0002-7659-9326; Moore, Johnny/0000-0001-8451-9421	United States Department of Defense [FY08 W91XWH-09-2-0091]; National Eye Institute [R01EY 017381]; Parkinson's Disease Society UK; NATIONAL EYE INSTITUTE [R01EY017381, R01EY022415] Funding Source: NIH RePORTER; Parkinson&quot;s UK [K-0907] Funding Source: researchfish	United States Department of Defense(United States Department of Defense); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Parkinson's Disease Society UK(Parkinson's UK); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Parkinson&quot;s UK(Parkinson&apos;s UK)	This work was supported by the United States Department of Defense Grant: FY08 W91XWH-09-2-0091, National Eye Institute R01EY 017381 and the Parkinson's Disease Society UK. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alexandrakis G, 2000, OPHTHALMOLOGY, V107, P1497, DOI 10.1016/S0161-6420(00)00179-2; Anders HJ, 2011, J AM SOC NEPHROL, V22, P1007, DOI 10.1681/ASN.2010080798; Anderson JP, 2004, GENE, V338, P25, DOI 10.1016/j.gene.2004.05.002; Ayna G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040069; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Benko S, 2008, MOL VIS, V14, P1575; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Carta S, 2011, J BIOL CHEM, V286, P27069, DOI 10.1074/jbc.M110.203398; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; Dartt DA, 2011, J IMMUNOL, V186, P4455, DOI 10.4049/jimmunol.1000833; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; FENTON MJ, 1988, J IMMUNOL, V140, P2267; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Gonzalez-Benitez JF, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/614345; Graham Joanna E, 2007, Invest Ophthalmol Vis Sci, V48, P5616; Heimer SR, 2010, VIRULENCE, V1, P223, DOI 10.4161/viru.1.4.11466; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; HUANG AJW, 1988, INVEST OPHTH VIS SCI, V29, P969; Kahlenberg JM, 2005, J IMMUNOL, V175, P7611, DOI 10.4049/jimmunol.175.11.7611; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; Keller JF, 2010, IMMUNOBIOLOGY, V215, P53, DOI 10.1016/j.imbio.2009.01.009; Kessing SV, 1968, ACTA OPHTHALMOL S95; Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; Lemp MA, 2007, OCUL SURF, V5, P75; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mariathasan S, 2007, MICROBES INFECT, V9, P664, DOI 10.1016/j.micinf.2007.01.017; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Moore JE, 2011, INVEST OPHTH VIS SCI, V52, P6174, DOI 10.1167/iovs.10-7022; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Schumann RR, 1998, BLOOD, V91, P577, DOI 10.1182/blood.V91.2.577.577_577_584; Seil M, 2010, PURINERG SIGNAL, V6, P405, DOI 10.1007/s11302-010-9205-8; Shatos MA, 2003, INVEST OPHTH VIS SCI, V44, P2477, DOI 10.1167/iovs.02-0550; Shatos MA, 2001, INVEST OPHTH VIS SCI, V42, P1455; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Yeh DL, 2006, AM J OPHTHALMOL, V142, P1066, DOI 10.1016/j.ajo.2006.06.056	40	51	55	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74010	10.1371/journal.pone.0074010	http://dx.doi.org/10.1371/journal.pone.0074010			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040145	gold, Green Published, Green Submitted			2022-12-25	WOS:000327538600058
J	Wu, SY; Li, MH; Ko, FC; Wu, GC; Huang, KL; Chu, SJ				Wu, Shu-Yu; Li, Min-Hui; Ko, Fu-Chang; Wu, Geng-Chin; Huang, Kun-Lun; Chu, Shi-Jye			Protective Effect of Hypercapnic Acidosis in Ischemia-Reperfusion Lung Injury Is Attributable to Upregulation of Heme Oxygenase-1	PLOS ONE			English	Article							ACTIVATION; MONOXIDE; INFLAMMATION; INHIBITION; MECHANISM; PULMONARY; ADHESION; CELLS	Hypercapnic acidosis (HCA) has protective effects in animal models of acute lung injury, but the mechanism underlying the effect of HCA is unclear. Heme oxygenase-1 (HO-1) is an antioxidant enzyme that protects tissue from inflammation injury. We investigated whether HO-1 contributes to the protective effects of HCA in ischemia-reperfusion (IR)-induced lung injury. Typical acute lung injury in rats was successfully induced by 40 min of ischemia and 90 min of reperfusion in an isolated perfused lung model. The rat lungs were randomly assigned to the control group, IR group or IR + HCA group with or without zinc protoporphyrin IX (ZnPP), an HO-1 activity inhibitor. At the end of the experiment, bronchoalveolar lavage fluid (BALF) and lung tissues were collected to evaluate the degree of lung injury. In in vitro experiments, HO-1 siRNA transfected A549 cells were exposed to a normoxic or hypoxia-reoxygenation (H/R) environment in the presence or absence of HCA. IR caused significant increases in the pulmonary arterial pressure, lung weight to body weight and wet/dry ratios, lung weight gain, capillary filtration coefficient, lung injury scores, neutrophil infiltration, and concentrations of protein and TNF-alpha in the BALF. IR also induced degradation of inhibitor of nuclear factor (NF)kappa B-alpha, increased I kappa B kinase (IKK)-beta phosphorylation and nuclear translocation of NF-kappa B, and up-regulated HO-1 expression and activity. Furthermore, IR decreased Bcl-2 protein expression and increased the number of active caspase-3 stained cells. HCA treatment enhanced HO-1 expression and activity, and accordingly reduced IKK-NF-kappa B signaling, inhibited apoptosis, and significantly attenuated IR-induced changes. Treatment with ZnPP partially blocked the protective effect of HCA. In addition, HO-1 siRNA significantly reversed HCA-mediated inhibition of NF-kappa B signaling in A549 cells subjected to H/R. In conclusion, the protective effect of HCA in IR lung injury in rats was mediated in part by the anti-inflammatory and anti-apoptotic action of HO-1.	[Wu, Shu-Yu; Li, Min-Hui; Huang, Kun-Lun] Natl Def Med Ctr, Inst Aerosp & Undersea Med, Taipei, Taiwan; [Ko, Fu-Chang; Wu, Geng-Chin; Chu, Shi-Jye] Taoyuan Armed Forces Gen Hosp, Dept Internal Med, Tao Yuan, Taiwan; [Chu, Shi-Jye] Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Internal Med, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital	Chu, SJ (corresponding author), Taoyuan Armed Forces Gen Hosp, Dept Internal Med, Tao Yuan, Taiwan.	d1204812@mail.ndmctsh.edu.tw	Chu, Shi-Jye/AFS-7472-2022	Chu, Shi-Jye/0000-0002-2723-9375	National Science Council [NSC100-2314-B-282-001]; Taoyuan Armed Forces General Hospital [10132, 10133, 1037]; National Defense Medical Center, Taipei, Taiwan [MAB101-62, MAB101-63]	National Science Council(Ministry of Science and Technology, Taiwan); Taoyuan Armed Forces General Hospital; National Defense Medical Center, Taipei, Taiwan	The study was supported, in part, by grant NSC100-2314-B-282-001 from the National Science Council, grants 10132, 10133 and 1037 from Taoyuan Armed Forces General Hospital and grants MAB101-62 and MAB101-63 from the National Defense Medical Center, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellezza I, 2012, J NUTR BIOCHEM, V23, P1583, DOI 10.1016/j.jnutbio.2011.10.012; Chu SJ, 2002, CRIT CARE MED, V30, P1605, DOI 10.1097/00003246-200207000-00034; Constantin M, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/859235; Contreras M, 2012, CRIT CARE MED, V40, P2622, DOI 10.1097/CCM.0b013e318258f8b4; Freitas A, 2006, BRIT J PHARMACOL, V149, P345, DOI 10.1038/sj.bjp.0706882; Ijland MM, 2010, CRIT CARE, V14, DOI 10.1186/cc9238; Katori M, 2002, TRANSPLANTATION, V73, P287, DOI 10.1097/00007890-200201270-00023; Kim JH, 2006, J AM SOC NEPHROL, V17, P1373, DOI 10.1681/ASN.2005091001; Kregenow DA, 2006, CRIT CARE MED, V34, P1, DOI 10.1097/01.CCM.0000194533.75481.03; Laffey JG, 2000, AM J RESP CRIT CARE, V162, P2287, DOI 10.1164/ajrccm.162.6.2003066; Laffey JG, 2004, INTENS CARE MED, V30, P347, DOI 10.1007/s00134-003-2051-1; Li MH, 2009, BRIT J PHARMACOL, V157, P244, DOI 10.1111/j.1476-5381.2009.00139.x; Li QF, 2009, ACTA PHARMACOL SIN, V30, P228, DOI 10.1038/aps.2008.19; Liu SF, 2006, AM J PHYSIOL-LUNG C, V290, pL622, DOI 10.1152/ajplung.00477.2005; Morse D, 2009, FREE RADICAL BIO MED, V47, P1, DOI 10.1016/j.freeradbiomed.2009.04.007; Park HJ, 2012, ACTA PHYSIOL, V205, P61, DOI 10.1111/j.1748-1716.2012.02425.x; Peng CK, 2011, PULM PHARMACOL THER, V24, P153, DOI 10.1016/j.pupt.2010.07.002; Peng TC, 2011, J SURG RES, V167, pE245, DOI 10.1016/j.jss.2010.06.010; Ryter SW, 2007, AM J RESP CELL MOL, V36, P175, DOI 10.1165/rcmb.2006-0333TR; Ryter SW, 2000, METH MOL B, V99, P369; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; SARDANA MK, 1987, P NATL ACAD SCI USA, V84, P2464, DOI 10.1073/pnas.84.8.2464; Seldon MP, 2007, J IMMUNOL, V179, P7840, DOI 10.4049/jimmunol.179.11.7840; Tang PS, 2008, AM J PHYSIOL-LUNG C, V294, pL632, DOI 10.1152/ajplung.00262.2007; The Acute Respiratory Distress Syndrome Network, 2000, N ENGL J MED, V342; Wu SY, 2012, CRIT CARE MED, V40, P553, DOI 10.1097/CCM.0b013e318232d776; Xia ZW, 2007, AM J PATHOL, V171, P1904, DOI 10.2353/ajpath.2007.070096; Xu B, 2011, J SURG RES, V166, pE157, DOI 10.1016/j.jss.2010.11.902; Zhang XC, 2004, J BIOL CHEM, V279, P10677, DOI 10.1074/jbc.M312941200	29	26	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74742	10.1371/journal.pone.0074742	http://dx.doi.org/10.1371/journal.pone.0074742			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040332	Green Published, Green Submitted, gold			2022-12-25	WOS:000327538600110
J	Yu, YL; Su, KJ; Hsieh, YH; Lee, HL; Chen, TY; Hsiao, PC; Yang, SF				Yu, Yung-Luen; Su, Kuo-Jung; Hsieh, Yi-Hsien; Lee, Hsiang-Lin; Chen, Tzy-Yen; Hsiao, Pei-Ching; Yang, Shun-Fa			Effects of EZH2 Polymorphisms on Susceptibility to and Pathological Development of Hepatocellular Carcinoma	PLOS ONE			English	Article							COLORECTAL-CANCER; PROTEIN EZH2; RISK-FACTORS; GENE; ASSOCIATION; REPRESSION; BREAST; REGION; CELLS	Background: The enhancer of zeste 2 (EZH2) gene encodes the histone methyltransferase that is the catalytic component of the polycomb repressive complex-2, which initiates epigenetic silencing of genes. The expression level of EZH2 in hepatocellular carcinoma (HCC) is highly correlated with tumor progression; however, it has not been determined if specific EZH2 genetic variants are associated with the risk of HCC. This study investigated the potential associations of EZH2 single-nucleotide polymorphisms with HCC susceptibility and its clinicopathologic characteristics. Methodology/Principal Findings: A total of 220 HCC patients and 552 cancer-free controls were analyzed for four EZH2 single-nucleotide polymorphisms (rs6950683, rs2302427, rs3757441, and rs41277434) using real-time PCR genotyping. After adjusting for other co-variants, the individuals carrying at least one C allele at EZH2 rs6950683 and rs3757441 had a 0.611-fold and a 0.660-fold lower risk of developing HCC than did wild-type (TT) carriers, respectively. The CCCA or CCTA haplotype among the four EZH2 sites (rs6950683, rs2302427, rs3757441, and rs41277434), respectively, was also associated with a reduced risk of HCC. Furthermore, HCC patients who carried at least one C allele at rs6950683 or rs3757441 had a higher lymph-node-metastasis risk but a lower liver-cirrhosis risk than did patients carrying the wild-type allele. Conclusions: The rs6950683 and rs3757441 polymorphic genotypes of EZH2 might contribute to the prediction of susceptibility to and pathological development of HCC. This is the first study to provide insight into risk factors associated with EZH2 variants in carcinogenesis of HCC in Taiwan.	[Yu, Yung-Luen] China Med Univ, Grad Inst Canc Biol & Ctr Mol Med, Taichung, Taiwan; [Yu, Yung-Luen; Su, Kuo-Jung] China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung, Taiwan; [Yu, Yung-Luen] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Hsieh, Yi-Hsien] Chung Shan Med Univ, Sch Med, Inst Biochem & Biotechnol, Taichung, Taiwan; [Lee, Hsiang-Lin; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Lee, Hsiang-Lin] Chung Shan Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Chen, Tzy-Yen; Hsiao, Pei-Ching] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, Tzy-Yen; Hsiao, Pei-Ching] Chung Shan Med Univ Hosp, Dept Internal Med, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital	Yang, SF (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	ysf@csmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927	National Science Council, Taiwan [NSC99-2320-B-039-030-MY3, NSC101-2321-B-039-004]; National Health Research Institutes, Taiwan [NHRI-EX102-10245BI]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This study was supported by research grant from National Science Council, Taiwan (NSC99-2320-B-039-030-MY3, NSC101-2321-B-039-004) and a grant from National Health Research Institutes, Taiwan (NHRI-EX102-10245BI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkiz H, 2009, CANCER EPIDEMIOL, V33, P261, DOI 10.1016/j.canep.2009.06.001; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Cardoso C, 2000, EUR J HUM GENET, V8, P174, DOI 10.1038/sj.ejhg.5200439; Chang CC, 2009, CLIN CHEM LAB MED, V47, P412, DOI 10.1515/CCLM.2009.092; Chen CJ, 1997, J GASTROEN HEPATOL, V12, pS294, DOI 10.1111/j.1440-1746.1997.tb00513.x; Chen THH, 2002, INT J CANCER, V98, P257, DOI 10.1002/ijc.10122; Chen TY, 2011, ANN SURG ONCOL, V18, P2348, DOI 10.1245/s10434-011-1574-x; Crea F, 2012, ANN ONCOL, V23, P1207, DOI 10.1093/annonc/mdr387; Department of Health RoC, 2007, HLTH STAT; Dukers DF, 2004, AM J PATHOL, V164, P873, DOI 10.1016/S0002-9440(10)63175-6; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Firpi Roberto J, 2006, Hematology Am Soc Hematol Educ Program, P375; Heyn H, 2013, CANCER CELL, V23, P563, DOI 10.1016/j.ccr.2013.04.028; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Lafaro KJ, 2015, SURG ONCOL CLIN N AM, V24, P1, DOI 10.1016/j.soc.2014.09.001; Lipkin SM, 2010, CANCER PREV RES, V3, P597, DOI 10.1158/1940-6207.CAPR-10-0007; Ren G, 2012, CANCER RES, V72, P3091, DOI 10.1158/0008-5472.CAN-11-3546; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Shastry BS, 2002, J HUM GENET, V47, P561, DOI 10.1007/s100380200086; Shen Z, 2010, J CELL MOL MED, V14, P226, DOI 10.1111/j.1582-4934.2008.00370.x; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Vauthey JN, 2002, J CLIN ONCOL, V20, P1527, DOI 10.1200/JCO.20.6.1527; Weng CJ, 2010, ANN SURG ONCOL, V17, P3394, DOI 10.1245/s10434-010-1124-y; Weng CJ, 2010, ANN SURG ONCOL, V17, P1808, DOI 10.1245/s10434-009-0904-8; Yano Y, 2006, LIVER INT, V26, P789, DOI 10.1111/j.1478-3231.2006.01310.x; Yoon KA, 2010, J THORAC ONCOL, V5, P10, DOI 10.1097/JTO.0b013e3181c422d9; Zhang W, 2011, ANN ONCOL, V22, P104, DOI 10.1093/annonc/mdq315	28	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74870	10.1371/journal.pone.0074870	http://dx.doi.org/10.1371/journal.pone.0074870			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040354	Green Published, Green Submitted, gold			2022-12-25	WOS:000327538600118
J	Yue, YY; Yuan, YG; Hou, ZH; Jiang, WH; Bai, F; Zhang, ZJ				Yue, Yingying; Yuan, Yonggui; Hou, Zhenghua; Jiang, Wenhao; Bai, Feng; Zhang, Zhijun			Abnormal Functional Connectivity of Amygdala in Late-Onset Depression Was Associated with Cognitive Deficits	PLOS ONE			English	Article							MAJOR DEPRESSION; ANTIDEPRESSANT TREATMENT; GERIATRIC DEPRESSION; UNIPOLAR DEPRESSION; BOLD RESPONSES; NEURAL BASIS; HEAD MOTION; BRAIN; STATE; VOLUME	Background: Major depressive disorder (MDD) is associated with decreased function of cortico-limbic circuits, which play important roles in the pathogenesis of MDD. Abnormal functional connectivity (FC) with the amygdala, which is involved in cortico-limbic circuits, has also been observed in MDD. However, little is known about connectivity alterations in late-onset depression (LOD) or whether disrupted connectivity is correlated with cognitive impairment in LOD. Methods and Results: A total of twenty-two LOD patients and twenty-two matched healthy controls (HC) underwent neuropsychological tests and resting state functional magnetic resonance imaging (rs-fMRI). Regional homogeneity (ReHo) and FC with bilateral amygdala seeds were used to analyze blood oxygen level-dependent fMRI data between two groups. Compared with HC, LOD patients showed decreased ReHo in the right middle frontal gyrus and left superior frontal gyrus. In the LOD group, the left amygdala had decreased FC with the right middle frontal gyrus and the left superior frontal gyrus in the amygdala positive network, and it had increased FC with the right post-central gyrus in the amygdala negative network. However, significantly reduced FC with the right amygdala was observed in the right middle occipital gyrus in the amygdala negative network. Further correlative analyses revealed that decreased FC between the amygdala and the right middle occipital gyrus was negatively correlated with the verbal fluency test (VFT, r = -0.485, P = 0.022) and the digit span test (DST, r = -0.561, P = 0.007). Conclusions: Our findings of reduced activity of the prefrontal gyrus and abnormal FC with the bilateral amygdala may be key markers of cognitive dysfunction in LOD patients.	[Yue, Yingying; Yuan, Yonggui; Jiang, Wenhao; Bai, Feng; Zhang, Zhijun] Southeast Univ, Affiliated ZhongDa Hosp, Dept Neuropsychiat, Nanjing, Jiangsu, Peoples R China; [Yue, Yingying; Yuan, Yonggui; Jiang, Wenhao; Bai, Feng; Zhang, Zhijun] Southeast Univ, Inst Neuropsychiat, Nanjing, Jiangsu, Peoples R China; [Hou, Zhenghua] 4th Peoples Hosp Wuhu City, Dept Psychiat, Wuhu, Peoples R China	Southeast University - China; Southeast University - China	Yuan, YG (corresponding author), Southeast Univ, Affiliated ZhongDa Hosp, Dept Neuropsychiat, Nanjing, Jiangsu, Peoples R China.	yygylh2000@sina.com.cn	Yuan, Yonggui/AFA-0807-2022	Yuan, Yonggui/0000-0001-6496-3998	National Natural Science Foundation of China [30970814]; Natural Science Foundation of Jiangsu Province [BK2009050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This research was supported by the National Natural Science Foundation of China (30970814), for which the URL is http://www.most.gov.cn/index.htm, and Natural Science Foundation of Jiangsu Province (BK2009050 Yonggui Yuan), for which the URL is http://www.jstd.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexapoulos GS, 2005, LANCET, V365, P1961, DOI 10.1016/S0140-6736(05)66665-2; Alexopoulos GS, 2002, AM J GERIAT PSYCHIAT, V10, P687, DOI 10.1176/appi.ajgp.10.6.687; Almeida OP, 2003, PSYCHOL MED, V33, P675, DOI 10.1017/S003329170300758X; Anand A, 2005, BIOL PSYCHIAT, V57, P1079, DOI 10.1016/j.biopsych.2005.02.021; Bai F, 2009, BIOL PSYCHIAT, V65, P951, DOI 10.1016/j.biopsych.2008.10.017; Beesdo K, 2009, ARCH GEN PSYCHIAT, V66, P275, DOI 10.1001/archgenpsychiatry.2008.545; Bennett C.M., 2010, J SERENDIPITOUS UNEX, V1, P1, DOI [DOI 10.1016/S1053-8119(09)71202-9, 10.1016/S1053-8119(09)71202-9]; Blazer D, 1989, Annu Rev Gerontol Geriatr, V9, P197; Burke J, 2011, AM J GERIAT PSYCHIAT, V19, P771, DOI 10.1097/JGP.0b013e318211069a; Butters Meryl A, 2008, Dialogues Clin Neurosci, V10, P345; Carballedo A, 2011, J AFFECT DISORDERS, V134, P272, DOI 10.1016/j.jad.2011.06.021; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Drevets WC, 2000, BIOL PSYCHIAT, V48, P813, DOI 10.1016/S0006-3223(00)01020-9; Drevets WC, 1998, ANNU REV MED, V49, P341, DOI 10.1146/annurev.med.49.1.341; Drevets WC, 2003, ANN NY ACAD SCI, V985, P420, DOI 10.1111/j.1749-6632.2003.tb07098.x; Egger K, 2008, PSYCHIAT RES-NEUROIM, V164, P237, DOI 10.1016/j.pscychresns.2007.12.018; Elliott R, 2002, ARCH GEN PSYCHIAT, V59, P597, DOI 10.1001/archpsyc.59.7.597; Fitzgerald PB, 2006, PSYCHIAT RES-NEUROIM, V148, P33, DOI 10.1016/j.pscychresns.2006.04.006; Fujimoto T, 2008, PSYCHIAT RES-NEUROIM, V164, P48, DOI 10.1016/j.pscychresns.2007.03.010; Garrett A, 2011, AM J PSYCHIAT, V168, P173, DOI 10.1176/appi.ajp.2010.09121718; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Grimm S, 2009, NEUROPSYCHOPHARMACOL, V34, P932, DOI 10.1038/npp.2008.81; Hou ZH, 2012, BEHAV BRAIN RES, V227, P30, DOI 10.1016/j.bbr.2011.10.025; Johansen-Berg H, 2008, CEREB CORTEX, V18, P1374, DOI 10.1093/cercor/bhm167; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Kennedy SH, 2001, AM J PSYCHIAT, V158, P899, DOI 10.1176/appi.ajp.158.6.899; Ketter TA, 1996, NEUROSCIENTIST, V2, P55, DOI 10.1177/107385849600200113; Laks J, 2008, CURR OPIN PSYCHIATR, V21, P562, DOI 10.1097/YCO.0b013e32830ef725; Laks J, 2010, CNS NEUROSCI THER, V16, P374, DOI 10.1111/j.1755-5949.2010.00196.x; Liu F, 2012, PROG NEURO-PSYCHOPH, V39, P326, DOI 10.1016/j.pnpbp.2012.07.004; Lloyd AJ, 2004, BRIT J PSYCHIAT, V184, P488, DOI 10.1192/bjp.184.6.488; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Luking KR, 2011, J AM ACAD CHILD PSY, V50, P1027, DOI 10.1016/j.jaac.2011.07.019; Lyness JM, 2002, AM J GERIAT PSYCHIAT, V10, P275, DOI 10.1176/appi.ajgp.10.3.275; Maciag D, 2010, BIOL PSYCHIAT, V67, P465, DOI 10.1016/j.biopsych.2009.10.027; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Mehta KM, 2003, J GERONTOL A-BIOL, V58, P461; Mitchell AJ, 2005, AM J PSYCHIAT, V162, P1588, DOI 10.1176/appi.ajp.162.9.1588; Murphy FC, 1999, PSYCHOL MED, V29, P1307, DOI 10.1017/S0033291799001233; Nebes RD, 2003, J PSYCHIATR RES, V37, P99, DOI 10.1016/S0022-3956(02)00085-7; Northoff G, 2011, NEUROSCI BIOBEHAV R, V35, P1929, DOI 10.1016/j.neubiorev.2010.12.007; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Petrella JR, 2006, RADIOLOGY, V240, P177, DOI 10.1148/radiol.2401050739; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Power JD, 2012, NEUROIMAGE, V13; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Rapp MA, 2005, AM J PSYCHIAT, V162, P691, DOI 10.1176/appi.ajp.162.4.691; Rogers MA, 2004, NEUROSCI RES, V50, P1, DOI 10.1016/j.neures.2004.05.003; Roy AK, 2009, NEUROIMAGE, V45, P614, DOI 10.1016/j.neuroimage.2008.11.030; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Schlosser RGM, 2008, NEUROIMAGE, V43, P645, DOI 10.1016/j.neuroimage.2008.08.002; Sheline YI, 2001, BIOL PSYCHIAT, V50, P651, DOI 10.1016/S0006-3223(01)01263-X; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Siegle GJ, 2002, BIOL PSYCHIAT, V51, P693, DOI 10.1016/S0006-3223(02)01314-8; Siegle GJ, 2007, BIOL PSYCHIAT, V61, P198, DOI 10.1016/j.biopsych.2006.05.048; Steffens DC, 2008, PSYCHOL MED, V38, P163, DOI 10.1017/S003329170700102X; Tononi G, 1998, NEUROIMAGE, V7, P133, DOI 10.1006/nimg.1997.0313; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; van Eijndhoven P, 2009, BIOL PSYCHIAT, V65, P812, DOI 10.1016/j.biopsych.2008.10.027; Weniger G, 2006, J AFFECT DISORDERS, V94, P219, DOI 10.1016/j.jad.2006.04.017; Xie CM, 2012, HUM BRAIN MAPP, V33, P1352, DOI 10.1002/hbm.21291; Yuan YG, 2010, J AFFECT DISORDERS, V121, P273, DOI 10.1016/j.jad.2009.07.003; Yuan YG, 2008, J AFFECT DISORDERS, V111, P145, DOI 10.1016/j.jad.2008.02.016; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059	68	58	64	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e75058	10.1371/journal.pone.0075058	http://dx.doi.org/10.1371/journal.pone.0075058			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259PK	24040385	Green Published, gold, Green Submitted			2022-12-25	WOS:000327538600126
J	Grasmeijer, N; de Waard, H; Hinrichs, WLJ; Frijlink, HW				Grasmeijer, Niels; de Waard, Hans; Hinrichs, Wouter L. J.; Frijlink, Henderik W.			A User-Friendly Model for Spray Drying to Aid Pharmaceutical Product Development	PLOS ONE			English	Article							GLASS-TRANSITION TEMPERATURE; PROTEIN STABILIZATION; MOLECULAR-WEIGHT; NATIVE STRUCTURE; TREHALOSE; WATER; PRESERVATION; OPTIMIZATION; PERFORMANCE; MECHANISMS	The aim of this study was to develop a user-friendly model for spray drying that can aid in the development of a pharmaceutical product, by shifting from a trial-and-error towards a quality-by-design approach. To achieve this, a spray dryer model was developed in commercial and open source spreadsheet software. The output of the model was first fitted to the experimental output of a Buchi B-290 spray dryer and subsequently validated. The predicted outlet temperatures of the spray dryer model matched the experimental values very well over the entire range of spray dryer settings that were tested. Finally, the model was applied to produce glassy sugars by spray drying, an often used excipient in formulations of biopharmaceuticals. For the production of glassy sugars, the model was extended to predict the relative humidity at the outlet, which is not measured in the spray dryer by default. This extended model was then successfully used to predict whether specific settings were suitable for producing glassy trehalose and inulin by spray drying. In conclusion, a spray dryer model was developed that is able to predict the output parameters of the spray drying process. The model can aid the development of spray dried pharmaceutical products by shifting from a trial-and-error towards a quality-by-design approach.	[Grasmeijer, Niels; de Waard, Hans; Hinrichs, Wouter L. J.; Frijlink, Henderik W.] Univ Groningen, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands	University of Groningen	Grasmeijer, N (corresponding author), Univ Groningen, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands.	n.grasmeijer@rug.nl	Hinrichs, Wouter/J-3893-2019; Frijlink, Henderik Willem/AAD-7382-2020	Frijlink, Henderik Willem/0000-0001-7901-8198; Hinrichs, Wouter/0000-0002-1481-2769	Project P3.02 DESIRE of the research program of the BioMedical Materials institute; Dutch Ministry of Economic Affairs, Agriculture and Innovation	Project P3.02 DESIRE of the research program of the BioMedical Materials institute; Dutch Ministry of Economic Affairs, Agriculture and Innovation	This research forms part of the Project P3.02 DESIRE of the research program of the BioMedical Materials institute, co-funded by the Dutch Ministry of Economic Affairs, Agriculture and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, PHARM DEV Q8 QUAL RI; Baldinger A, 2012, PHARM DEV TECHNOL, V17, P389, DOI 10.3109/10837450.2010.550623; Brown AM, 2001, COMPUT METH PROG BIO, V65, P191, DOI 10.1016/S0169-2607(00)00124-3; Chang LQ, 2009, J PHARM SCI-US, V98, P2886, DOI 10.1002/jps.21825; Chang LQ, 2005, J PHARM SCI-US, V94, P1427, DOI 10.1002/jps.20364; Chen R, 2004, CHEM PHARM BULL, V52, P1066, DOI 10.1248/cpb.52.1066; Chen TN, 2000, CRYOBIOLOGY, V40, P277, DOI 10.1006/cryo.2000.2244; Costantino HR, 1998, J PHARM SCI, V87, P1406, DOI 10.1021/js9800679; Crowe LM, 1996, BIOPHYS J, V71, P2087, DOI 10.1016/S0006-3495(96)79407-9; de Waard H, 2009, EUR J PHARM SCI, V38, P224, DOI 10.1016/j.ejps.2009.07.005; Dobry DE, 2009, J PHARM INNOV, V4, P133, DOI 10.1007/s12247-009-9064-4; Francia F, 2008, J AM CHEM SOC, V130, P10240, DOI 10.1021/ja801801p; Geeraedts F, 2010, AAPS J, V12, P215, DOI 10.1208/s12248-010-9179-z; Giovambattista N, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.047801; GORDON M, 1952, J APPL CHEM, V2, P493, DOI 10.1002/jctb.5010020901; Goula AM, 2003, DRY TECHNOL, V21, P1273, DOI 10.1081/DRT-120023180; Grasmeijer N, 2013, BBA-PROTEINS PROTEOM, V1834, P763, DOI 10.1016/j.bbapap.2013.01.020; HANCOCK BC, 1995, PHARMACEUT RES, V12, P799, DOI 10.1023/A:1016292416526; Hinrichs WLJ, 2001, INT J PHARMACEUT, V215, P163, DOI 10.1016/S0378-5173(00)00677-3; Ivey JW, 2010, COMPUT CHEM ENG, V34, P1036, DOI 10.1016/j.compchemeng.2010.02.031; Kawai K, 2011, CARBOHYD POLYM, V83, P934, DOI 10.1016/j.carbpol.2010.09.001; Kemmer G, 2010, NAT PROTOC, V5, P267, DOI 10.1038/nprot.2009.182; Lai MC, 1999, J PHARM SCI-US, V88, P489, DOI 10.1021/js980374e; Lebrun P, 2012, EUR J PHARM BIOPHARM, V80, P226, DOI 10.1016/j.ejpb.2011.09.014; Liao YH, 2002, PHARM RES-DORDR, V19, P1847, DOI 10.1023/A:1021445608807; Mezhericher M, 2010, CHEM ENG PROCESS, V49, P1205, DOI 10.1016/j.cep.2010.09.002; MILLER AA, 1969, SCIENCE, V163, P1325, DOI 10.1126/science.163.3873.1325; ROOS YH, 1993, CARBOHYD RES, V238, P39, DOI 10.1016/0008-6215(93)87004-C; Sampedro JG, 2004, MOL CELL BIOCHEM, V256, P319, DOI 10.1023/B:MCBI.0000009878.21929.eb; US Food and Drug Administration, 2015, PHARM QUAL 21 CENT R; Velikov V, 2001, SCIENCE, V294, P2335, DOI 10.1126/science.1061757; YAWS CL, 1989, HYDROCARB PROCESS, V68, P65	32	17	17	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74403	10.1371/journal.pone.0074403	http://dx.doi.org/10.1371/journal.pone.0074403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040240	Green Submitted, Green Published, gold			2022-12-25	WOS:000326405300170
J	Liu, BT; Yang, QE; Li, L; Sun, J; Liao, XP; Fang, LX; Yang, SS; Deng, H; Liu, YH				Liu, Bao-Tao; Yang, Qiu-E; Li, Liang; Sun, Jian; Liao, Xiao-Ping; Fang, Liang-Xing; Yang, Shou-Shen; Deng, Hui; Liu, Ya-Hong			Dissemination and Characterization of Plasmids Carrying oqxAB-bla(CTX-M) Genes in Escherichia coli Isolates from Food-Producing Animals	PLOS ONE			English	Article							MEDIATED QUINOLONE RESISTANCE; CTX-M; BETA-LACTAMASE; KLEBSIELLA-PNEUMONIAE; TRANSFERABLE PLASMID; MULTIDRUG-RESISTANCE; CLINICAL ISOLATE; EFFLUX PUMP; PREVALENCE; CHINA	Background: The association of PMQR and ESBLs in negative-bacteria isolates has been of great concern. The present study was performed to investigate the prevalence of co-transferability of oqxAB and bla(CTX-M) genes among the 696 Escherichia coli (E. coli) isolates from food-producing animals in South China, and to characterize these plasmids. Methods: The ESBL-encoding genes (bla(CTX-M), bla(TEM) and bla(SHV)), and PMQR (qnrA, qnrB, qnrS, qnrC, qnrD, aac(6')-Ib-cr, qepA, and oqxAB) of these 696 isolates were determined by PCR and sequenced directionally. Conjugation, S1 nuclease pulsed-field gel electrophoresis (PFGE) and Southern blotting experiments were performed to investigate the co-transferability and location of oqxAB and bla(CTX-M). The EcoRI digestion profiles of the plasmids with oqxAB-bla(CTX-M) were also analyzed. The clonal relatedness was investigated by PFGE. Results: Of the 696 isolates, 429 harbored at least one PMQR gene, with oqxAB (328) being the most common type; 191 carried bla(CTX-M), with bla(CTX-M-14) the most common. We observed a significant higher prevalence of bla(CTX-M) among the oqxAB-positive isolates (38.7%) than that (17.4%) in the oqxAB-negative isolates. Co-transferability of oqxAB and bla(CTX-M) was found in 18 of the 127 isolates carrying oqxAB-bla(CTX-M). These two genes were located on the same plasmid in all the 18 isolates, with floR being on these plasmids in 13 isolates. The co-dissemination of these genes was mainly mediated by F33: A-: B- and HI2 plasmids with highly similar EcoRI digestion profiles. Diverse PFGE patterns indicated the high prevalence of oqxAB was not caused by clonal dissemination. Conclusion: bla(CTX-M) was highly prevalent among the oqxAB-positive isolates. The co-dissemination of oqxAB-bla(CTX-M) genes in E. coli isolates from food-producing animals is mediated mainly by similar F33: A-: B-and HI2 plasmids. This is the first report of the co-existence of oqxAB, bla(CTX-M), and floR on the same plasmids in E. coli.	[Liu, Bao-Tao; Yang, Qiu-E; Li, Liang; Sun, Jian; Liao, Xiao-Ping; Fang, Liang-Xing; Yang, Shou-Shen; Deng, Hui; Liu, Ya-Hong] South China Agr Univ, Coll Vet Med, Natl Reference Lab Vet Drug Residues SCAU, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Liu, YH (corresponding author), South China Agr Univ, Coll Vet Med, Natl Reference Lab Vet Drug Residues SCAU, Guangzhou, Guangdong, Peoples R China.	gale@scau.edu.cn	Li, Liang/O-6270-2016	Li, Liang/0000-0003-3571-8058	National Science Fund for Distinguished Young Scholars [31125026]; Special Fund for Agro-scientific Research in the Public Interest [201203040]; National Natural Science Foundation of China [U1201214]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Fund for Distinguished Young Scholars (Grant No. 31125026), the Special Fund for Agro-scientific Research in the Public Interest (Grant No.201203040) and the National Natural Science Foundation of China (Grant No. U1201214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnedahl J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005958; Brinas L, 2003, ANTIMICROB AGENTS CH, V47, P2056, DOI 10.1128/AAC.47.6.2056-2058.2003; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Cavaco LM, 2009, ANTIMICROB AGENTS CH, V53, P603, DOI 10.1128/AAC.00997-08; Chen L, 2007, J ANTIMICROB CHEMOTH, V59, P880, DOI 10.1093/jac/dkm065; Chen X, 2012, ANTIMICROB AGENTS CH, V56, P3423, DOI 10.1128/AAC.06191-11; CLSI, 2012, M100S22 CLSI; Gautom RK, 1997, J CLIN MICROBIOL, V35, P2977, DOI 10.1128/JCM.35.11.2977-2980.1997; Hansen LH, 2007, J ANTIMICROB CHEMOTH, V60, P145, DOI 10.1093/jac/dkm167; Hata M, 2005, ANTIMICROB AGENTS CH, V49, P801, DOI 10.1128/AAC.49.2.801-803.2005; Ho PL, 2011, J ANTIMICROB CHEMOTH, V66, P765, DOI 10.1093/jac/dkq539; Jacoby GA, 2006, ANTIMICROB AGENTS CH, V50, P1178, DOI 10.1128/AAC.50.4.1178-1182.2006; Kim HB, 2009, ANTIMICROB AGENTS CH, V53, P3582, DOI 10.1128/AAC.01574-08; Li B, 2011, SCAND J INFECT DIS, V43, P170, DOI 10.3109/00365548.2010.538856; Liu BT, 2013, MICROB DRUG RESIST, V19, P237, DOI 10.1089/mdr.2012.0179; Liu BT, 2012, J MED MICROBIOL, V61, P1591, DOI 10.1099/jmm.0.043307-0; Liu BT, 2011, J ANTIMICROB CHEMOTH, V66, P1638, DOI 10.1093/jac/dkr172; Liu JH, 2007, INT J ANTIMICROB AG, V29, P576, DOI 10.1016/j.ijantimicag.2006.12.015; Liu WE, 2009, J ANTIMICROB CHEMOTH, V63, P895, DOI 10.1093/jac/dkp068; Ma JY, 2009, ANTIMICROB AGENTS CH, V53, P519, DOI 10.1128/AAC.00886-08; Manian FA, 2003, CLIN INFECT DIS, V36, pE26, DOI 10.1086/344772; Martinez-Martinez L, 1998, LANCET, V351, P797, DOI 10.1016/S0140-6736(97)07322-4; Norcia LJL, 1999, J ANTIBIOT, V52, P52, DOI 10.7164/antibiotics.52.52; Park KS, 2012, ANN CLIN LAB SCI, V42, P191; Pomba C, 2009, ANTIMICROB AGENTS CH, V53, P327, DOI 10.1128/AAC.00896-08; Randall LP, 2011, J ANTIMICROB CHEMOTH, V66, P86, DOI 10.1093/jac/dkq396; Robicsek A, 2006, NAT MED, V12, P83, DOI 10.1038/nm1347; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347; Wang MH, 2009, ANTIMICROB AGENTS CH, V53, P1892, DOI 10.1128/AAC.01400-08; Wang Y, 2012, VET MICROBIOL, V159, P53, DOI 10.1016/j.vetmic.2012.03.009; Weill FX, 2004, J CLIN MICROBIOL, V42, P5767, DOI 10.1128/JCM.42.12.5767-5773.2004; Yamane K, 2007, ANTIMICROB AGENTS CH, V51, P3354, DOI 10.1128/AAC.00339-07; Yuan JY, 2012, J ANTIMICROB CHEMOTH, V67, P1655, DOI 10.1093/jac/dks086; Yue L, 2008, VET MICROBIOL, V132, P414, DOI 10.1016/j.vetmic.2008.05.009; Zhang YJ, 2012, MICROB DRUG RESIST, V18, P465, DOI 10.1089/mdr.2012.0016; Zhao JJ, 2010, ANTIMICROB AGENTS CH, V54, P4219, DOI 10.1128/AAC.00139-10; Zheng HQ, 2012, INT J ANTIMICROB AG, V39, P305, DOI 10.1016/j.ijantimicag.2011.12.001; [No title captured]	39	86	87	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73947	10.1371/journal.pone.0073947	http://dx.doi.org/10.1371/journal.pone.0073947			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040123	Green Submitted, Green Published, gold			2022-12-25	WOS:000326405300143
J	Pires-Neto, RC; Kawaguchi, YMF; Hirota, AS; Fu, C; Tanaka, C; Caruso, P; Park, M; Carvalho, CRR				Pires-Neto, Ruy Camargo; Fogaca Kawaguchi, Yurika Maria; Hirota, Adriana Sayuri; Fu, Carolina; Tanaka, Clarice; Caruso, Pedro; Park, Marcelo; Ribeiro Carvalho, Carlos Roberto			Very Early Passive Cycling Exercise in Mechanically Ventilated Critically Ill Patients: Physiological and Safety Aspects - A Case Series	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; CARDIAC-OUTPUT; MOBILITY; THERAPY	Introduction: Early mobilization can be performed in critically ill patients and improves outcomes. A daily cycling exercise started from day 5 after ICU admission is feasible and can enhance functional capacity after hospital discharge. In the present study we verified the physiological changes and safety of an earlier cycling intervention (<< 72 hrs of mechanical ventilation) in critical ill patients. Methods: Nineteen hemodynamically stable and deeply sedated patients within the first 72 hrs of mechanical ventilation were enrolled in a single 20 minute passive leg cycling exercise using an electric cycle ergometer. A minute-by-minute evaluation of hemodynamic, respiratory and metabolic variables was undertaken before, during and after the exercise. Analyzed variables included the following: cardiac output, systemic vascular resistance, central venous blood oxygen saturation, respiratory rate and tidal volume, oxygen consumption, carbon dioxide production and blood lactate levels. Results: We enrolled 19 patients (42% male, age 55 +/- 17 years, SOFA = 6 +/- 3, SAPS3 score = 58 +/- 13, PaO2/FIO2 = 223 +/- 75). The median time of mechanical ventilation was 1 day (02), and 68% (n=13) of our patients required norepinephrine (maximum concentration = 0.47 mu g. kg(-1). min(-1)). There were no clinically relevant changes in any of the analyzed variables during the exercise, and two minor adverse events unrelated to hemodynamic instability were observed. Conclusions: In our study, this very early passive cycling exercise in sedated, critically ill, mechanically ventilated patients was considered safe and was not associated with significant alterations in hemodynamic, respiratory or metabolic variables even in those requiring vasoactive agents.	[Pires-Neto, Ruy Camargo; Fogaca Kawaguchi, Yurika Maria; Hirota, Adriana Sayuri; Fu, Carolina; Tanaka, Clarice] Univ Sao Paulo Sao Paulo ICHC FMUSP, Fac Med, Inst Cent Hosp Clin, Phys Therapy Serv, Sao Paulo, Brazil; [Pires-Neto, Ruy Camargo] Univ Sao Paulo, Fac Med, Dept Pathol, Sao Paulo, Brazil; [Fu, Carolina; Tanaka, Clarice] Univ Sao Paulo, Fac Med, Dept Phys Therapy Speech Pathologist Therapist &, Sao Paulo, Brazil; [Caruso, Pedro; Ribeiro Carvalho, Carlos Roberto] Univ Sao Paulo, Fac Med, Hosp Clin, Div Pulm & Crit Care,Heart Inst InCor, Sao Paulo, Brazil; [Park, Marcelo] Univ Sao Paulo ICHC FMUSP, Fac Med, Med Emergency ICU Hosp Clin, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Pires-Neto, RC (corresponding author), Univ Sao Paulo Sao Paulo ICHC FMUSP, Fac Med, Inst Cent Hosp Clin, Phys Therapy Serv, Sao Paulo, Brazil.	ruy@usp.br	Pires-Neto, Ruy/G-5520-2013; Caruso, Pedro/B-6054-2016; Fu, Carolina/D-6572-2012; Caruso, Pedro/AAY-8176-2021; Park, Marcelo/H-7851-2016; Carvalho, Carlos Roberto R/N-9827-2018; Tanaka, Clarice/J-5075-2016	Caruso, Pedro/0000-0002-1051-8458; Carvalho, Carlos Roberto R/0000-0002-1618-8509; Tanaka, Clarice/0000-0003-3900-5944	Respiratory and Medical Emergency ICU Research Fund - Hospital das Cl nicas (ICHC/FMUSP)	Respiratory and Medical Emergency ICU Research Fund - Hospital das Cl nicas (ICHC/FMUSP)	This study was supported by the Respiratory and Medical Emergency ICU Research Fund - Hospital das Cl nicas (ICHC/FMUSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARC Clinical Practice guideline, 2004, RESP CARE, V49, P1073; Bailey P, 2007, CRIT CARE MED, V35, P139, DOI 10.1097/01.CCM.0000251130.69568.87; Ballaz L, 2007, ARCH PHYS MED REHAB, V88, P471, DOI 10.1016/j.apmr.2007.01.011; Bourdin G, 2010, RESP CARE, V55, P400; Burtin C, 2009, CRIT CARE MED, V37, P2499, DOI 10.1097/CCM.0b013e3181a38937; De Backer D, 2011, INTENS CARE MED, V37, P233, DOI 10.1007/s00134-010-2098-8; Gosselink R, 2008, INTENS CARE MED, V34, P1188, DOI 10.1007/s00134-008-1026-7; Hodgin KE, 2009, CRIT CARE MED, V37, P561, DOI 10.1097/CCM.0b013e3181957449; Horiuchi K, 1997, CRIT CARE MED, V25, P1347, DOI 10.1097/00003246-199708000-00022; Kho ME, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.08.017; Kobayashi M, 2008, EXPERT REV MED DEVIC, V5, P311, DOI 10.1586/17434440.5.3.311; Luetz A, 2012, CURR OPIN ANESTHESIO, V25, P164, DOI 10.1097/ACO.0b013e32834f8ce7; McLellan S, 2002, INTENS CARE MED, V28, P870, DOI 10.1007/s00134-002-1323-5; Monnet X, 2012, BRIT J ANAESTH, V108, P615, DOI 10.1093/bja/aer491; Morris PE, 2008, CRIT CARE MED, V36, P2238, DOI 10.1097/CCM.0b013e318180b90e; Morris PE, 2007, CRIT CARE CLIN, V23, P1, DOI 10.1016/j.ccc.2006.11.003; Morris PE, 2011, AM J MED SCI, V341, P373, DOI 10.1097/MAJ.0b013e31820ab4f6; Norrenberg M, 2000, INTENS CARE MED, V26, P988, DOI 10.1007/s001340051292; Norrenberg M, 1999, CLIN INTENSIVE CARE, V10, P1, DOI DOI 10.3109/tcic.10.1.1.6; Riker RR, 2001, INTENS CARE MED, V27, P853, DOI 10.1007/s001340100912; Salluh JIF, 2009, J CRIT CARE, V24, P556, DOI 10.1016/j.jcrc.2009.04.004; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Stockley RC, 2010, PHYSIOTHERAPY, V96, P228, DOI 10.1016/j.physio.2009.11.014; Thomsen GE, 2008, CRIT CARE MED, V36, P1119, DOI 10.1097/CCM.0b013e318168f986; van Lieshout JJ, 2001, BRIT J ANAESTH, V86, P467, DOI 10.1093/bja/86.4.467	25	49	49	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74182	10.1371/journal.pone.0074182	http://dx.doi.org/10.1371/journal.pone.0074182			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040200	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300165
J	Zhang, WM; Lv, T; Li, M; Wu, QL; Yang, LS; Liu, H; Sun, DF; Sun, LM; Zhuang, ZH; Wang, DY				Zhang, Weiming; Lv, Ting; Li, Min; Wu, Qiuli; Yang, Linsong; Liu, Hui; Sun, Dafeng; Sun, Lingmei; Zhuang, Ziheng; Wang, Dayong			Beneficial Effects of Wheat Gluten Hydrolysate to Extend Lifespan and Induce Stress Resistance in Nematode Caenorhabditis elegans	PLOS ONE			English	Article							OXIDATIVE STRESS; RELEVANT CONCENTRATIONS; REPRODUCTIVE TOXICITY; ROS-GENERATOR; EXPOSURE; PEPTIDE; TRANSLOCATION; PRETREATMENT; ASSOCIATION; LONGEVITY	Previous studies have showed that wheat gluten hydrolysate (WGH) has the anti-oxidative property. In the present study, we examined the possible safety property of WGH and the beneficial effects of WGH to extend lifespan and induce stress resistance using nematode Caenorhabditis elegans as the in vivo assay system. We found that WGH at concentrations of 0.1-1 mg/mL did not cause lethality, influence development, alter locomotion behavior and brood size, and induce significant intestinal autofluorescence and reactive oxygen species (ROS) production in young adults. Treatment with 0.1-1 mg/mL of WGH significantly extended lifespans of nematodes under the normal conditions. Moreover, WGH treatment significantly inhibited the induction of intestinal autofluorescence and suppressed the decrease in locomotion behavior during the aging process of nematodes. Furthermore, pre-treatment with 1 mg/mL of WGH significantly suppressed the adverse effects caused by heat-stress or oxidative stress on nematodes as indicated by the alterations of both lifespan and intestinal ROS production. Therefore, WGH treatment is relatively safe and has beneficial effects on nematodes under both the normal conditions and the stress conditions.	[Zhang, Weiming; Lv, Ting] Nanjing Normal Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China; [Zhang, Weiming; Lv, Ting; Sun, Dafeng] Nanjing Inst Comprehens Utilizat Wild Plants, Nanjing, Jiangsu, Peoples R China; [Li, Min; Yang, Linsong; Liu, Hui; Zhuang, Ziheng] Changzhou Univ, Sch Pharmaceut Engn & Life Sci, Changzhou, Peoples R China; [Wu, Qiuli; Sun, Lingmei; Wang, Dayong] Southeast Univ, Sch Med, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University; Changzhou University; Southeast University - China	Zhuang, ZH (corresponding author), Changzhou Univ, Sch Pharmaceut Engn & Life Sci, Changzhou, Peoples R China.	cczuzzh@163.com; dayongw@seu.edu.cn			Scientific Starting Fund from Changzhou University [ZMF11020011]; National High Technology Research and Development Program of China (863 Program) [2011AA100802]; National Agricultural Achievements Transformation Fund Project [03EFN217200345]; National Science and Technology Support Program [2011BAD33B03]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20120092120064]; National Natural Science Foundation of China [81172698, 81202233]	Scientific Starting Fund from Changzhou University; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Agricultural Achievements Transformation Fund Project; National Science and Technology Support Program; Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Scientific Starting Fund from Changzhou University (ZMF11020011), National High Technology Research and Development Program of China (863 Program, 2011AA100802), National Agricultural Achievements Transformation Fund Project (03EFN217200345), National Science and Technology Support Program (2011BAD33B03), Specialized Research Fund for the Doctoral Program of Higher Education of China (20120092120064), and National Natural Science Foundation of China (No. 81172698, 81202233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2012, EXP THER MED, V3, P969, DOI 10.3892/etm.2012.539; BRENNER S, 1974, GENETICS, V77, P71; DONKIN SG, 1995, ENVIRON TOXICOL CHEM, V14, P2139, DOI 10.1002/etc.5620141218; Evason K, 2005, SCIENCE, V307, P258, DOI 10.1126/science.1105299; Fan D, 2011, FOOD CHEM, V124, P195, DOI 10.1016/j.foodchem.2010.06.008; Hartwig K, 2009, GENES NUTR, V4, P59, DOI 10.1007/s12263-009-0113-x; Heidler T, 2010, BIOGERONTOLOGY, V11, P183, DOI 10.1007/s10522-009-9239-x; Higaki-Sato N, 2006, J AGR FOOD CHEM, V54, P6984, DOI 10.1021/jf0611421; Horiguchi N, 2005, BIOSCI BIOTECH BIOCH, V69, P2445, DOI 10.1271/bbb.69.2445; Jiang B, 2011, J BIOL INORG CHEM, V16, P267, DOI 10.1007/s00775-010-0723-1; Koikawa N, 2009, NUTRITION, V25, P493, DOI 10.1016/j.nut.2008.11.001; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Li YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044688; Li YX, 2013, NANOTOXICOLOGY, V7, P1004, DOI 10.3109/17435390.2012.689884; Liu PD, 2012, ECOTOX ENVIRON SAFE, V79, P90, DOI 10.1016/j.ecoenv.2011.12.007; Lublin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027762; Murakami H, 2005, J NEUROSCI, V25, P10894, DOI 10.1523/JNEUROSCI.3600-04.2005; Nouara A, 2013, NANOSCALE, V5, P6088, DOI 10.1039/c3nr00847a; Park EY, 2012, J AGR FOOD CHEM, V60, P7483, DOI 10.1021/jf301532e; Pincus Z, 2010, DEV DYNAM, V239, P1306, DOI 10.1002/dvdy.22224; Rui Q, 2009, FRONT MED-PRC, V3, P76; Sampayo JN, 2003, AGING CELL, V2, P319, DOI 10.1046/j.1474-9728.2003.00063.x; Sangha JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043990; Sato K, 2013, J AGR FOOD CHEM, V61, P6304, DOI 10.1021/jf400914e; Shashikumar S, 2011, INDIAN J BIOCHEM BIO, V48, P191; Shen LL, 2010, NEUROSCI BULL, V26, P91, DOI 10.1007/s12264-010-0162-6; Shen Lu-Lu, 2007, Neurosci Bull, V23, P21, DOI 10.1007/s12264-007-0003-4; Shen LL, 2010, MECH AGEING DEV, V131, P732, DOI 10.1016/j.mad.2010.10.005; Shen LL, 2009, ENVIRON TOXICOL PHAR, V28, P125, DOI 10.1016/j.etap.2009.03.009; Shibamura A, 2009, MECH AGEING DEV, V130, P652, DOI 10.1016/j.mad.2009.06.008; Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53; Wang DY, 2013, METHODS MOL BIOL, V1048, P65, DOI 10.1007/978-1-62703-556-9_6; Wang DY, 2010, ENVIRON TOXICOL PHAR, V29, P213, DOI 10.1016/j.etap.2010.01.002; Wang DY, 2010, ECOTOX ENVIRON SAFE, V73, P423, DOI 10.1016/j.ecoenv.2009.12.014; Wang DY, 2009, ENVIRON TOXICOL PHAR, V28, P459, DOI 10.1016/j.etap.2009.07.008; Wang JS, 2007, J FOOD SCI, V72, pC103, DOI 10.1111/j.1750-3841.2006.00247.x; Wu QL, 2011, ENVIRON TOXICOL PHAR, V32, P175, DOI 10.1016/j.etap.2011.04.009; Wu QL, 2012, CHEMOSPHERE, V87, P1281, DOI 10.1016/j.chemosphere.2012.01.035; Ye HY, 2008, NEUROBIOL LEARN MEM, V90, P10, DOI 10.1016/j.nlm.2007.12.001; Yu SH, 2011, ENVIRON TOXICOL PHAR, V32, P233, DOI 10.1016/j.etap.2011.05.008; Zhao YL, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/564093; Zhao YL, 2013, RSC ADV, V3, P5741, DOI 10.1039/c2ra22798c	42	26	27	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74553	10.1371/journal.pone.0074553	http://dx.doi.org/10.1371/journal.pone.0074553			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040279	Green Submitted, Green Published, gold			2022-12-25	WOS:000326405300180
J	Li, XY; Kong, XL; Kong, XN; Wang, Y; Yan, S; Yang, QF				Li, Xiaoyan; Kong, Xiaoli; Kong, Xiangnan; Wang, Yang; Yan, Shi; Yang, Qifeng			53BP1 Sensitizes Breast Cancer Cells to 5-Fluorouracil	PLOS ONE			English	Article							DIHYDROPYRIMIDINE DEHYDROGENASE GENE; HAPLOINSUFFICIENT TUMOR-SUPPRESSOR; INDUCED DOWN-REGULATION; THYMIDYLATE SYNTHASE; THYMIDINE PHOSPHORYLASE; COLORECTAL-CANCER; LOCAL RECURRENCE; EXPRESSION; P53; FLUOROURACIL	Chemoresistance of breast cancer is a worldwide problem for breast cancer and the resistance to chemotherapeutic agents frequently led to the subsequent recurrence and metastasis. In our previous study, we have found that 53BP1 showed a gradual decrease during the progression of breast cancer and loss of 53BP1 was associated with metastasis and poor prognosis in breast cancer. Here we aimed to reveal whether 53BP1 could sensitize breast cancer to 5-Fu. We found that ectopic expression of 53BP1 can significantly sensitize breast cancer cells to 5-Fu while knockdown of 53BP1 conferred the resistance. The in vivo experiments confirmed that overexpression of 53BP1 in combination with 5-Fu markedly inhibited growth of xenotransplanted tumors in nude mice when compared to either agent alone. Furthermore, we demonstrated that 53BP1 regulated the sensitivity to 5-Fu through thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPYD). The present studies provide a new clue that combination of 5-Fu and 53BP1 could be a potential novel targeted strategy for overcoming breast cancer chemoresistance.	[Li, Xiaoyan; Kong, Xiaoli; Kong, Xiangnan; Wang, Yang; Yang, Qifeng] Shandong Univ, Dept Breast Surg, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Yan, Shi] Shandong Univ, Dept Obstet & Gynecol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	Yang, QF (corresponding author), Shandong Univ, Dept Breast Surg, Qilu Hosp, Jinan 250100, Shandong, Peoples R China.	qifengy@gmail.com	yang, qiang/GYJ-0971-2022	Yang, Qifeng/0000-0003-0576-8513	National Natural Science Foundation of China [81072150, 81172529, 81272903]; Shandong Science and Technology Development Plan [2012GZC22115]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Science and Technology Development Plan	This work was supported by National Natural Science Foundation of China (No. 81072150; No. 81172529; No. 81272903) and Shandong Science and Technology Development Plan (No. 2012GZC22115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amstutz U, 2011, PHARMACOGENOMICS, V12, P1321, DOI [10.2217/pgs.11.72, 10.2217/PGS.11.72]; Benson JR, 2012, FUTURE ONCOL, V8, P697, DOI [10.2217/fon.12.61, 10.2217/FON.12.61]; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; COPUR S, 1995, BIOCHEM PHARMACOL, V49, P1419, DOI 10.1016/0006-2952(95)00067-A; Edler D, 2002, J CLIN ONCOL, V20, P1721, DOI 10.1200/JCO.2002.07.039; Ferguson PJ, 2001, BRIT J PHARMACOL, V134, P1437, DOI 10.1038/sj.bjp.0704394; Hong SH, 2012, ONCOL REP, V27, P1251, DOI 10.3892/or.2012.1641; Horiguchi J, 2002, BRIT J CANCER, V86, P222, DOI 10.1038/sj.bjc.6600040; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Iwabuchi K, 1998, J BIOL CHEM, V273, P26061, DOI 10.1074/jbc.273.40.26061; Kakimoto M, 2005, CANCER LETT, V223, P103, DOI 10.1016/j.canlet.2004.09.020; Kong XL, 2012, CANCER BIOL THER, V13, P43, DOI 10.4161/cbt.13.1.18868; Li L.H., 2013, EUR J CANC; Li XA, 2011, CANCER SCI, V102, P1151, DOI 10.1111/j.1349-7006.2011.01919.x; Li XY, 2012, CARCINOGENESIS, V33, P2593, DOI 10.1093/carcin/bgs298; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Loo WTY, 2009, ANTICANCER RES, V29, P2525; Morales JC, 2006, P NATL ACAD SCI USA, V103, P3310, DOI 10.1073/pnas.0511259103; Mori K, 2000, INT J ONCOL, V17, P33; Neboori HJR, 2012, INT J RADIAT ONCOL, V83, pE677, DOI 10.1016/j.ijrobp.2012.01.089; Okabe T, 2008, MOL CANCER THER, V7, P599, DOI 10.1158/1535-7163.MCT-07-0567; Rahman L, 2004, CANCER CELL, V5, P341, DOI 10.1016/S1535-6108(04)00080-7; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Squatrito M, 2012, CANCER RES, V72, P5250, DOI 10.1158/0008-5472.CAN-12-0045; SWAIN SM, 1989, J CLIN ONCOL, V7, P890, DOI 10.1200/JCO.1989.7.7.890; Tanaka K, 2012, J SURG ONCOL, V105, P529, DOI 10.1002/jso.22123; Wakai T, 2011, INT J ONCOL, V38, P1227, DOI 10.3892/ijo.2011.959; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Ward IM, 2005, MOL CELL BIOL, V25, P10079, DOI 10.1128/MCB.25.22.10079-10086.2005; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Yoshinare K, 2003, CANCER SCI, V94, P633, DOI 10.1111/j.1349-7006.2003.tb01495.x; Zhang N, 2013, J BIOL CHEM	32	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e74928	10.1371/journal.pone.0074928	http://dx.doi.org/10.1371/journal.pone.0074928			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040364	Green Published, Green Submitted, gold			2022-12-25	WOS:000324856500097
J	Wolf, RJ; Hilger, RA; Hoheisel, JD; Werner, J; Holtrup, F				Wolf, Robert J.; Hilger, Ralf A.; Hoheisel, Joerg D.; Werner, Jens; Holtrup, Frank			In Vivo Activity and Pharmacokinetics of Nemorosone on Pancreatic Cancer Xenografts	PLOS ONE			English	Article							ST-JOHNS-WORT; PREGNANE-X RECEPTOR; NUCLEAR RECEPTORS; DRUG-INTERACTIONS; HYPERFORIN; METABOLISM; ACTIVATION; APOPTOSIS; CELLS; GEMCITABINE	Pancreatic cancer is one of the leading cancer-related causes of death in the western world with an urgent need for new treatment strategies. Recently, hyperforin and nemorosone have been described as promising anti-cancer lead compounds. While hyperforin has been thoroughly investigated in vitro and in vivo, in vivo data for nemorosone are still missing. Thus, we investigated the growth-inhibitory potential of nemorosone on pancreatic cancer xenografts in NMRI nu/nu mice and determined basic pharmacokinetic parameters. Xenograft tumors were treated with nemorosone and gemcitabine, the current standard of care. Tumor sections were subjected to H&E as well as caspase 3 and Ki-67 staining. Nemorosone plasma kinetics were determined by HPLC and mass spectrometry. Induction of CYP3A4 and other metabolizing enzymes by nemorosone and hyperforin was tested on primary hepatocytes using qRT-PCR. At a dose of 50 mg/kg nemorosone per day, a significant growth-inhibitory effect was observed in pancreatic cancer xenografts. The compound was well tolerated and rapidly absorbed into the bloodstream with a half-life of approximately 30 min. Different metabolites were detected, possibly resembling CYP3A4-independent oxidation products. It is concluded that nemorosone is a potential anti-cancer lead compound with good bioavailability, little side-effects and promising growth-inhibitory effects, thus representing a valuable compound for a combination therapy approach.	[Wolf, Robert J.; Hoheisel, Joerg D.; Holtrup, Frank] German Canc Res Ctr, Div Funct Genome Anal, Heidelberg, Germany; [Hilger, Ralf A.] Univ Hosp Essen, Dept Internal Med Canc Res, Essen, Germany; [Wolf, Robert J.; Werner, Jens] Heidelberg Univ, Dept Gen Surg, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); University of Duisburg Essen; Ruprecht Karls University Heidelberg	Holtrup, F (corresponding author), German Canc Res Ctr, Div Funct Genome Anal, Heidelberg, Germany.	f.holtrup@gmail.com			Helmholtz International Graduate School for Cancer Research; German Federal Ministry of Education and Research, NGFN PaCaNet consortium	Helmholtz International Graduate School for Cancer Research; German Federal Ministry of Education and Research, NGFN PaCaNet consortium	This work was financially supported by a 3 year research fellowship from the Helmholtz International Graduate School for Cancer Research to FH. Funding from the German Federal Ministry of Education and Research as part of the NGFN PaCaNet consortium is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biber A, 1998, PHARMACOPSYCHIATRY, V31, P36, DOI 10.1055/s-2007-979344; BOVEN E, 1993, BRIT J CANCER, V68, P52, DOI 10.1038/bjc.1993.285; Burris H, 1997, EUR J CANCER, V33, pS18, DOI 10.1016/S0959-8049(96)00324-3; Ciochina R, 2006, CHEM REV, V106, P3963, DOI 10.1021/cr0500582; Cui YY, 2004, DRUG METAB DISPOS, V32, P28, DOI 10.1124/dmd.32.1.28; Cui YY, 2002, J CHROMATOGR B, V780, P129, DOI 10.1016/S1570-0232(02)00439-7; Diaz-Carballo D, 2008, INT J CLIN PHARM TH, V46, P428; Diaz-Carballo D, 2008, J CELL MOL MED, V12, P2598, DOI 10.1111/j.1582-4934.2008.00232.x; Dona M, 2004, CANCER RES, V64, P6225, DOI 10.1158/0008-5472.CAN-04-0280; Gerhauser C, 2005, EUR J CANCER, V41, P1941, DOI 10.1016/j.ejca.2005.04.012; Holtrup F, 2011, BRIT J PHARMACOL, V162, P1045, DOI 10.1111/j.1476-5381.2010.01125.x; Honkakoski P, 2000, BIOCHEM J, V347, P321, DOI 10.1042/0264-6021:3470321; Hostanska K, 2003, EUR J PHARM BIOPHARM, V56, P121, DOI 10.1016/S0939-6411(03)00046-8; Iyer M, 2006, EXPERT OPIN DRUG MET, V2, P381, DOI 10.1517/17425255.2.3.381; Keleg Shereen, 2003, Mol Cancer, V2, P14, DOI 10.1186/1476-4598-2-14; Kivisto KT, 1995, BRIT J CLIN PHARMACO, V40, P523, DOI 10.1111/j.1365-2125.1995.tb05796.x; Leuner K, 2007, FASEB J, V21, P4101, DOI 10.1096/fj.07-8110com; Madabushi R, 2006, EUR J CLIN PHARMACOL, V62, P225, DOI 10.1007/s00228-006-0096-0; Moore LB, 2000, P NATL ACAD SCI USA, V97, P7500, DOI 10.1073/pnas.130155097; Schempp CM, 2002, ONCOGENE, V21, P1242, DOI 10.1038/sj.onc.1205190; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Simpkins NS, 2012, BIOORG MED CHEM LETT, V22, P6144, DOI 10.1016/j.bmcl.2012.08.023; Takegoshi S, 2009, PATHOL INT, V59, P61, DOI 10.1111/j.1440-1827.2008.02330.x; TANSWELL P, 1993, INT J CLIN PHARM TH, V31, P514; Tompkins LM, 2007, J BIOCHEM MOL TOXIC, V21, P176, DOI 10.1002/jbt.20180; Watkins RE, 2003, BIOCHEMISTRY-US, V42, P1430, DOI 10.1021/bi0268753	26	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74555	10.1371/journal.pone.0074555	http://dx.doi.org/10.1371/journal.pone.0074555			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040280	Green Published, gold, Green Submitted			2022-12-25	WOS:000324481600134
J	Burska, UL; Harle, VJ; Coffey, K; Darby, S; Ramsey, H; O'Neill, D; Logan, IR; Gaughan, L; Robson, CN				Burska, Urszula L.; Harle, Victoria J.; Coffey, Kelly; Darby, Steven; Ramsey, Hollie; O'Neill, Daniel; Logan, Ian R.; Gaughan, Luke; Robson, Craig N.			Deubiquitinating Enzyme Usp12 Is a Novel Co-activator of the Androgen Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Androgen; Androgen Receptor; Chromatin Immunoprecipitation (ChIP); Deubiquitination; Prostate Cancer; uaf-1; usp12; wdr20	HISTONE DEACETYLASE-1; PROTEIN; DEGRADATION; TIP60	The androgen receptor (AR), a member of the nuclear receptor family, is a transcription factor involved in prostate cell growth, homeostasis, and transformation. AR is a key protein in growth and development of both normal and malignant prostate, making it a common therapeutic target in prostate cancer. AR is regulated by an interplay of multiple post-translational modifications including ubiquitination. We and others have shown that the AR is ubiquitinated by a number of E3 ubiquitin ligases, including MDM2, CHIP, and NEDD4, which can result in its proteosomal degradation or enhanced transcriptional activity. As ubiquitination of AR causes a change in AR activity or stability and impacts both survival and growth of prostate cancer cells, deubiquitination of these sites has an equally important role. Hence, deubiquitinating enzymes could offer novel therapeutic targets. We performed an siRNA screen to identify deubiquitinating enzymes that regulate AR; in that screen ubiquitin-specific protease 12 (Usp12) was identified as a novel positive regulator of AR. Usp12 is a poorly characterized protein with few known functions and requires the interaction with two cofactors, Uaf-1 and WDR20, for its enzymatic activity. In this report we demonstrate that Usp12, in complex with Uaf-1 and WDR20, deubiquitinates the AR to enhance receptor stability and transcriptional activity. Our data show that Usp12 acts in a pro-proliferative manner by stabilizing AR and enhancing its cellular function.	[Burska, Urszula L.; Harle, Victoria J.; Coffey, Kelly; Darby, Steven; Ramsey, Hollie; O'Neill, Daniel; Logan, Ian R.; Gaughan, Luke; Robson, Craig N.] Newcastle Univ, Sch Med, Solid Tumour Target Discovery Lab, Newcastle Canc Ctr,Northern Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Robson, CN (corresponding author), Newcastle Univ, Sch Med, Solid Tumour Target Discovery Lab, Newcastle Canc Ctr,Northern Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	c.n.robson@ncl.ac.uk	Coffey, Kelly/AAZ-4433-2020	Coffey, Kelly/0000-0003-0502-2914; darby, steven/0000-0002-7226-8634; McClurg, Urszula/0000-0003-2631-4174	Prostate Cancer United Kingdom, Cancer Research UK; Medical Research Council; Cancer Research UK [12415] Funding Source: researchfish; Medical Research Council [G0800889, G0900871, G0601123] Funding Source: researchfish; National Institute for Health Research [ACF-2012-01-002] Funding Source: researchfish; Prostate Cancer UK [G2011/14, PG09-23] Funding Source: researchfish; MRC [G0601123, G0900871, G0800889] Funding Source: UKRI	Prostate Cancer United Kingdom, Cancer Research UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Prostate Cancer UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Prostate Cancer United Kingdom, Cancer Research UK, and the Medical Research Council.	Brady ME, 1999, J BIOL CHEM, V274, P17599, DOI 10.1074/jbc.274.25.17599; Cardozo CP, 2003, ARCH BIOCHEM BIOPHYS, V410, P134, DOI 10.1016/S0003-9861(02)00680-X; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen SY, 2009, J BIOL CHEM, V284, P25576, DOI 10.1074/jbc.M109.043133; Chymkowitch P, 2011, EMBO J, V30, P468, DOI 10.1038/emboj.2010.337; Coffey K, 2013, NUCLEIC ACIDS RES, V41, P4433, DOI 10.1093/nar/gkt106; Coffey K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045539; Coffey K, 2012, J ENDOCRINOL, V215, P221, DOI 10.1530/JOE-12-0238; Cohn MA, 2009, J BIOL CHEM, V284, P5343, DOI 10.1074/jbc.M808430200; Culig Z, 2003, UROLOGY, V62, P21, DOI 10.1016/S0090-4295(03)00698-8; Dirac AMG, 2010, MOL CANCER RES, V8, P844, DOI 10.1158/1541-7786.MCR-09-0424; Draker R, 2011, NUCLEIC ACIDS RES, V39, P3529, DOI 10.1093/nar/gkq1352; Faesen AC, 2011, CHEM BIOL, V18, P1550, DOI 10.1016/j.chembiol.2011.10.017; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Fu MF, 2006, MOL CELL BIOL, V26, P8122, DOI 10.1128/MCB.00289-06; Gaughan L, 2005, NUCLEIC ACIDS RES, V33, P13, DOI 10.1093/nar/gki141; Gaughan L, 2002, J BIOL CHEM, V277, P25904, DOI 10.1074/jbc.M203423200; He B, 2004, J BIOL CHEM, V279, P30643, DOI 10.1074/jbc.M403117200; Joo HY, 2011, J BIOL CHEM, V286, P7190, DOI 10.1074/jbc.M110.158311; Kee Y, 2010, J BIOL CHEM, V285, P11252, DOI 10.1074/jbc.M109.095141; Kouranti I, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000471; Li HY, 2008, J BIOL CHEM, V283, P28988, DOI 10.1074/jbc.M710528200; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Logan IR, 2006, MOL CELL BIOL, V26, P6502, DOI 10.1128/MCB.00147-06; Logan IR, 2009, NUCLEIC ACIDS RES, V37, P2962, DOI 10.1093/nar/gkp180; Lu S, 1999, ENDOCRINOLOGY, V140, P5054, DOI 10.1210/en.140.11.5054; Nishida T, 2002, J BIOL CHEM, V277, P41311, DOI 10.1074/jbc.M206741200; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Palazzolo I, 2007, HUM MOL GENET, V16, P1593, DOI 10.1093/hmg/ddm109; Ryan CJ, 2006, UROLOGY, V68, P834, DOI 10.1016/j.urology.2006.04.016; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Xu KX, 2009, CANCER CELL, V15, P270, DOI 10.1016/j.ccr.2009.02.021	32	59	60	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32641	32650		10.1074/jbc.M113.485912	http://dx.doi.org/10.1074/jbc.M113.485912			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24056413	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000328681700049
J	Zhu, L; Zhong, MH; Zhao, JY; Rhee, H; Caesar, I; Knight, EM; Volpicelli-Daley, L; Bustos, V; Netzer, W; Liu, LJ; Lucast, L; Ehrlich, ME; Robakis, NK; Gandy, SE; Cai, DM				Zhu, Li; Zhong, Minghao; Zhao, Jiaying; Rhee, Hannah; Caesar, Ina; Knight, Elysse M.; Volpicelli-Daley, Laura; Bustos, Victor; Netzer, William; Liu, Lijuan; Lucast, Louise; Ehrlich, Michelle E.; Robakis, Nikolaos K.; Gandy, Samuel E.; Cai, Dongming			Reduction of Synaptojanin 1 Accelerates A beta Clearance and Attenuates Cognitive Deterioration in an Alzheimer Mouse Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-PRECURSOR-PROTEIN; GAMMA-SECRETASE; IN-VIVO; PRESENILIN-MUTATIONS; EARLY ENDOSOMES; DOWN-SYNDROME; DISEASE; METABOLISM; MICE; PHOSPHORYLATION	Recent studies link synaptojanin 1 (synj1), the main phosphoinositol (4,5)-biphosphate phosphatase (PI(4,5)P-2-degrading enzyme) in the brain and synapses, to Alzheimer disease. Here we report a novel mechanism by which synj1 reversely regulates cellular clearance of amyloid-beta (A beta). Genetic down-regulation of synj1 reduces both extracellular and intracellular A beta levels in N2a cells stably expressing the Swedish mutant of amyloid precursor protein (APP). Moreover, synj1 haploinsufficiency in an Alzheimer disease transgenic mouse model expressing the Swedish mutant APP and the presenilin-1 mutant Delta E9 reduces amyloid plaque load, as well as A beta(40) and A beta(42) levels in hippocampus of 9-month-old animals. Reduced expression of synj1 attenuates cognitive deficits in these transgenic mice. However, reduction of synj1 does not affect levels of full-length APP and the C-terminal fragment, suggesting that A beta generation by beta- and gamma-secretase cleavage is not affected. Instead, synj1 knockdown increases A beta uptake and cellular degradation through accelerated delivery to lysosomes. These effects are partially dependent upon elevated PI(4,5)P-2 with synj1 down-regulation. In summary, our data suggest a novel mechanism by which reduction of a PI(4,5)P-2-degrading enzyme, synj1, improves amyloid-induced neuropathology and behavior deficits through accelerating cellular A beta clearance.	[Zhu, Li; Zhao, Jiaying; Rhee, Hannah; Caesar, Ina; Knight, Elysse M.; Ehrlich, Michelle E.; Gandy, Samuel E.; Cai, Dongming] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Zhu, Li; Zhao, Jiaying; Rhee, Hannah; Caesar, Ina; Knight, Elysse M.; Ehrlich, Michelle E.; Gandy, Samuel E.; Cai, Dongming] Icahn Sch Med Mt Sinai, Alzheimers Dis Res Ctr, New York, NY 10029 USA; [Robakis, Nikolaos K.] Icahn Sch Med Mt Sinai, Dept Psychiat Neurosci & Expt Therapeut, New York, NY 10029 USA; [Zhu, Li; Zhao, Jiaying; Rhee, Hannah; Caesar, Ina; Knight, Elysse M.; Ehrlich, Michelle E.; Gandy, Samuel E.; Cai, Dongming] James J Peters Vet Affairs Med Ctr, Bronx, NY 10468 USA; [Zhong, Minghao] New York Med Coll, Dept Pathol, Vahalla, NY 10595 USA; [Volpicelli-Daley, Laura; Liu, Lijuan; Lucast, Louise] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06519 USA; [Volpicelli-Daley, Laura; Liu, Lijuan; Lucast, Louise] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06519 USA; [Bustos, Victor; Netzer, William] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10065 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; New York Medical College; Yale University; Yale University; Rockefeller University	Cai, DM (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA.	dongming.cai@mssm.edu	Robakis, Nikolaos/AAA-1838-2021	Cai, Dongming/0000-0002-0601-6826; knight, Elysse/0000-0001-8372-1214	National Institutes of Health [NS047229]; Department of Neurology and Friedman Brain Institute of Icahn Mount Sinai School of Medicine; Ellison Foundation; National Institutes of Health-National Cancer Institute Shared Resources Grant [5R24CA095823-04]; National Science Foundation Major Research Instrumentation Grant [DBI-9724504]; National Institutes of Health Shared Instrumentation Grant [1S10RR09145-01]; NATIONAL CANCER INSTITUTE [R24CA095823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047229] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Neurology and Friedman Brain Institute of Icahn Mount Sinai School of Medicine; Ellison Foundation(Lawrence Ellison Foundation); National Institutes of Health-National Cancer Institute Shared Resources Grant; National Science Foundation Major Research Instrumentation Grant(National Science Foundation (NSF)); National Institutes of Health Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS047229 (to N.R.). This work was also supported by a seed fund provided to Dongming Cai by the Department of Neurology and Friedman Brain Institute of Icahn Mount Sinai School of Medicine, funds from the Ellison Foundation (to P.D.), National Institutes of Health-National Cancer Institute Shared Resources Grant 5R24CA095823-04, National Science Foundation Major Research Instrumentation Grant DBI-9724504, and National Institutes of Health Shared Instrumentation Grant 1S10RR09145-01.	ABRAHAMS JP, 1993, EMBO J, V12, P1775, DOI 10.1002/j.1460-2075.1993.tb05825.x; Aslund A, 2009, ACS CHEM BIOL, V4, P673, DOI 10.1021/cb900112v; Barthet G, 2012, PROG NEUROBIOL, V98, P166, DOI 10.1016/j.pneurobio.2012.05.006; Berg I, 2010, NAT PROTOC, V5, P935, DOI 10.1038/nprot.2010.41; Berman DE, 2008, NAT NEUROSCI, V11, P547, DOI 10.1038/nn.2100; BUXBAUM JD, 1990, P NATL ACAD SCI USA, V87, P6003, DOI 10.1073/pnas.87.15.6003; Cacquevel M, 2008, J NEUROCHEM, V104, P210, DOI 10.1111/j.1471-4159.2007.05041.x; Cai DM, 2006, P NATL ACAD SCI USA, V103, P1941, DOI 10.1073/pnas.0510708103; Calhoun ME, 1998, NEUROBIOL AGING, V19, P599, DOI 10.1016/S0197-4580(98)00098-0; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Cataldo AM, 1997, J NEUROSCI, V17, P6142; Chaufty J, 2012, J NEUROSCI, V32, P9613, DOI 10.1523/JNEUROSCI.0602-12.2012; Cherra SJ, 2010, NEUROPATH APPL NEURO, V36, P125, DOI [10.1111/j.1365-2990.2009.01062.x, 10.1111/j.1365-2990.2010.01062.x]; Cossec JC, 2012, HUM MOL GENET, V21, P3156, DOI 10.1093/hmg/dds142; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Frere Samuel G, 2012, Subcell Biochem, V59, P131, DOI 10.1007/978-94-007-3015-1_5; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Howlett DR, 2004, BRAIN RES, V1017, P130, DOI 10.1016/j.brainres.2004.05.029; Ihara Y, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006361; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Jaskolski F, 2005, J NEUROSCI METH, V146, P42, DOI 10.1016/j.jneumeth.2005.01.012; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kim ML, 2008, J NEUROSCI, V28, P12052, DOI 10.1523/JNEUROSCI.2913-08.2008; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Landman N, 2006, P NATL ACAD SCI USA, V103, P19524, DOI 10.1073/pnas.0604954103; Lane RF, 2010, J NEUROSCI, V30, P13110, DOI 10.1523/JNEUROSCI.3872-10.2010; Lanz TA, 2003, J PHARMACOL EXP THER, V305, P864, DOI 10.1124/jpet.102.048280; Lee S, 2011, AUTOPHAGY, V7, P1562, DOI 10.4161/auto.7.12.17956; Li J, 2012, J BIOL CHEM, V287, P44593, DOI 10.1074/jbc.M112.420224; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; McIntire LBJ, 2012, J NEUROSCI, V32, P15271, DOI 10.1523/JNEUROSCI.2034-12.2012; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Nixon RA, 2008, AUTOPHAGY, V4, P590, DOI 10.4161/auto.6259; Nixon RA, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P277; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Prabhu Y, 2012, MOL BIOL CELL, V23, P2339, DOI 10.1091/mbc.E11-11-0944; Shamir L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000974; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Vieira SI, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-40; Vingtdeux V, 2012, J NEUROCHEM, V120, P34, DOI 10.1111/j.1471-4159.2011.07477.x; Voronov SV, 2008, P NATL ACAD SCI USA, V105, P9415, DOI 10.1073/pnas.0803756105; Zhang H, 2012, J NEUROCHEM, V120, P9, DOI 10.1111/j.1471-4159.2011.07519.x; Zhu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045033; Zinchuk Vadim, 2011, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0419s52	48	49	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					32050	32063		10.1074/jbc.M113.504365	http://dx.doi.org/10.1074/jbc.M113.504365			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24052255	Green Published, hybrid			2022-12-25	WOS:000330596200056
J	Glass, TJ; Hui, SK; Blazar, BR; Lund, TC				Glass, Tiffany J.; Hui, Susanta K.; Blazar, Bruce R.; Lund, Troy C.			Effect of Radiation Dose-Rate on Hematopoietic Cell Engraftment in Adult Zebrafish	PLOS ONE			English	Article							TOTAL-BODY IRRADIATION; BONE-MARROW-TRANSPLANTATION; INDUCED DNA-DAMAGE; GENE-EXPRESSION; IN-VIVO; CHEMOKINE RECEPTOR; IONIZING-RADIATION; ENDOTHELIAL-CELLS; STEM-CELLS; THERAPY	Although exceptionally high radiation dose-rates are currently attaining clinical feasibility, there have been relatively few studies reporting the biological consequences of these dose-rates in hematopoietic cell transplant (HCT). In zebrafish models of HCT, preconditioning before transplant is typically achieved through radiation alone. We report the comparison of outcomes in adult zebrafish irradiated with 20Gy at either 25 or 800 cGy/min in the context of experimental HCT. In non-transplanted irradiated fish we observed no substantial differences between dose-rate groups as assessed by fish mortality, cell death in the kidney, endogenous hematopoietic reconstitution, or gene expression levels of p53 and ddb2 (damage-specific DNA binding protein 2) in the kidney. However, following HCT, recipients conditioned with the higher dose rate showed significantly improved donor-derived engraftment at 9 days post transplant (p <= 0.0001), and improved engraftment persisted at 31 days post transplant. Analysis for sdf-1a expression, as well as transplant of hematopoietic cells from cxcr4b -/- zebrafish, (odysseus), cumulatively suggest that the sdf-1a/cxcr4b axis is not required of donor-derived cells for the observed dose-rate effect on engraftment. Overall, the adult zebrafish model of HCT indicates that exceptionally high radiation dose-rates can impact HCT outcome, and offers a new system for radiobiological and mechanistic interrogation of this phenomenon. Key words: Radiation dose rate, Total Marrow Irradiation (TMI), Total body irradiation (TBI), SDF-1, Zebrafish, hematopoietic cell transplant.	[Glass, Tiffany J.] Univ Minnesota, Sch Med, Dept Mol Cellular Dev Biol & Genet, Minneapolis, MN 55455 USA; [Hui, Susanta K.] Univ Minnesota, Sch Med, Dept Therapeut Radiol Radiat Oncol, Minneapolis, MN 55455 USA; [Blazar, Bruce R.; Lund, Troy C.] Univ Minnesota, Sch Med, Dept Pediat, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Lund, TC (corresponding author), Univ Minnesota, Sch Med, Dept Pediat, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA.	lundx072@umn.edu			National Institutes of Health from the University of Minnesota [1R01CA154491]; Brainstorm translational grant from the University of Minnesota; Joseph E. Wargo cancer research fund from the University of Minnesota; NIH/NHLBI [K08 HL108998]; PHS Cancer Center Support Grant [P30 CA77398]; NATIONAL CANCER INSTITUTE [R01CA154491, R01CA077398] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL108998] Funding Source: NIH RePORTER	National Institutes of Health from the University of Minnesota; Brainstorm translational grant from the University of Minnesota(University of Minnesota System); Joseph E. Wargo cancer research fund from the University of Minnesota; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Institutes of Health (grant #1R01CA154491), Brainstorm translational grant, Joseph E. Wargo cancer research fund from the University of Minnesota; K08 HL108998 NIH/NHLBI; PHS Cancer Center Support Grant P30 CA77398. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson SA, 2004, CANCER RES, V64, P6368, DOI 10.1158/0008-5472.CAN-04-1883; Amundson SA, 2003, HEALTH PHYS, V85, P36, DOI 10.1097/00004032-200307000-00009; [Anonymous], 2011, THOMAS HEMATOPOIETIC; Bastianutto C, 2007, CANCER RES, V67, P10112, DOI 10.1158/0008-5472.CAN-07-2192; Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950; Bertrand JY, 2008, DEVELOPMENT, V135, P1853, DOI 10.1242/dev.015297; Cheng JC, 2008, INT J RADIAT ONCOL, V71, P1436, DOI 10.1016/j.ijrobp.2007.12.009; Collis SJ, 2004, J BIOL CHEM, V279, P49624, DOI 10.1074/jbc.M409600200; Collis SJ, 2004, RADIAT RES, V162, P48, DOI 10.1667/RR3197; DOWN JD, 1991, BLOOD, V77, P661; Egawa T, 2001, IMMUNITY, V15, P323, DOI 10.1016/S1074-7613(01)00185-6; Gaugler MH, 2001, BRIT J HAEMATOL, V113, P940, DOI 10.1046/j.1365-2141.2001.02852.x; Gillette-Ferguson I, 2003, ADV SPACE RES-SERIES, V32, P1641, DOI 10.1016/S0273-1177(03)90405-4; Glass T, 2011, BLOOD; Hui SK, 2007, ACTA ONCOL, V46, P250, DOI 10.1080/02841860601042449; Hwang M, 2007, CURR GENOMICS, V8, P360, DOI 10.2174/138920207783406497; Khaled S, 2012, RADIAT RES, V177, P594, DOI 10.1667/RR2557.1; Knaut H, 2003, NATURE, V421, P279, DOI 10.1038/nature01338; Kobayashi I, 2010, BLOOD, V115, pE1, DOI 10.1182/blood-2009-07-232322; Lataillade JJ, 2000, BLOOD, V95, P756, DOI 10.1182/blood.V95.3.756; LEHNERT S, 1985, BRIT J RADIOL, V58, P745, DOI 10.1259/0007-1285-58-692-745; Lyons SE, 2002, P NATL ACAD SCI USA, V99, P5454, DOI 10.1073/pnas.082695299; McAleer MF, 2005, INT J RADIAT ONCOL, V61, P10, DOI 10.1016/j.ijrobp.2004.09.046; Nagasawa T, 2000, INT J HEMATOL, V72, P408; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Pauls S, 2001, DEV GENES EVOL, V211, P603, DOI 10.1007/s00427-001-0196-x; Pei DS, 2012, MUTAT RES; PETERS LJ, 1979, RADIOLOGY, V131, P243, DOI 10.1148/131.1.243; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Somlo G, 2011, CLIN CANCER RES, V17, P174, DOI 10.1158/1078-0432.CCR-10-1912; Soza-Ried C, 2010, P NATL ACAD SCI USA, V107, P17304, DOI 10.1073/pnas.1004640107; Stachura DL, 2011, BLOOD, V118, P1274, DOI 10.1182/blood-2011-01-331199; Traver D, 2004, BLOOD, V104, P1298, DOI 10.1182/blood-2004-01-0100; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; TRAVIS EL, 1985, RADIOTHER ONCOL, V4, P341, DOI 10.1016/S0167-8140(85)80122-5; VANOS R, 1993, INT J RADIAT BIOL, V64, P761, DOI 10.1080/09553009314552011; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Wong JYC, 2006, BIOL BLOOD MARROW TR, V12, P306, DOI 10.1016/j.bbmt.2005.10.026; Zeng ZQ, 2009, ZEBRAFISH, V6, P405, DOI 10.1089/zeb.2009.0611	41	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e73745	10.1371/journal.pone.0073745	http://dx.doi.org/10.1371/journal.pone.0073745			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24058487	gold, Green Submitted, Green Published			2022-12-25	WOS:000324695900018
J	Perez-Rial, S; del Puerto-Nevado, L; Terron-Exposito, R; Giron-Martinez, A; Gonzalez-Mangado, N; Peces-Barba, G				Perez-Rial, Sandra; del Puerto-Nevado, Laura; Terron-Exposito, Raul; Giron-Martinez, Alvaro; Gonzalez-Mangado, Nicolas; Peces-Barba, German			Role of Recently Migrated Monocytes in Cigarette Smoke-Induced Lung Inflammation in Different Strain of Mice	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; OBSTRUCTIVE PULMONARY-DISEASE; MACROPHAGE SUICIDE TECHNIQUE; CONNECTIVE-TISSUE BREAKDOWN; ALVEOLAR MACROPHAGES; BLOOD MONOCYTES; INDUCED EMPHYSEMA; DEPLETION; MOUSE; VIVO	This study investigates the role of proinflammatory monocytes recruited from blood circulation and recovered in bronchoalveolar lavage (BAL) fluid in mediating the lung damage in a model of acute cigarette smoke (CS)-induced lung inflammation in two strains of mice with different susceptibility to develop emphysema (susceptible -C57BL/6J and non susceptible -129S2/SvHsd). Exposure to whole-body CS for 3 consecutive research cigarettes in one single day induced acute inflammation in the lung of mice. Analysis of BAL fluid showed more influx of recently migrated monocytes at 72 h after CS-exposition in susceptible compared to non susceptible mice. It correlated with an increase in MMP-12 and TNF-alpha protein levels in the lung tissue, and with an increment of NF-kappa B translocation to the nucleus measured by electrophoretic mobility shift assay in C57BL/6J mice. To determine the functional role of these proinflammatory monocytes in mediating CS-induced airway inflammation, alveolar macrophages and blood monocytes were transiently removed by pretreatment with intratracheal and intravenous liposome-encapsulated CL2MDP, given 2 and 4 days prior to CS exposure and their repopulation was studied. Monocytes/macrophages were maximally depleted 48 h after last liposome application and subsequently recently migrated monocytes reappeared in BAL fluid of susceptible mice at 72 h after CS exposure. Recently migrated monocytes influx to the lung correlated with an increase in the MMP-12 protein level in the lung tissue, indicating that the increase in proinflammatory monocytes is associated with a major tissue damaging. Therefore our data confirm that the recruitment of proinflammatory recently migrated monocytes from the blood are responsible for the increase in MMP-12 and has an important role in the pathogenesis of lung disease induced by acute lung inflammation. These results could contribute to understanding the different susceptibility to CS of these strains of mice.	[Perez-Rial, Sandra; del Puerto-Nevado, Laura; Terron-Exposito, Raul; Giron-Martinez, Alvaro; Gonzalez-Mangado, Nicolas; Peces-Barba, German] IIS FJD CIBERES, Resp Res Grp, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Fundacion Jimenez Diaz	Perez-Rial, S (corresponding author), IIS FJD CIBERES, Resp Res Grp, Madrid, Spain.	sperezr@fjd.es	Perez Rial, Sandra/C-6809-2019	Perez Rial, Sandra/0000-0002-7349-7682	Spanish "Ministry of Science and Innovation" [SAF2008-05412-C02]; Spanish Society of Pneumology and Thoracic Surgery [SEPAR-1002]	Spanish "Ministry of Science and Innovation"(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Society of Pneumology and Thoracic Surgery	The work presented was supported by the Spanish "Ministry of Science and Innovation" (SAF2008-05412-C02) and "Spanish Society of Pneumology and Thoracic Surgery" (SEPAR-1002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES PJ, 2004, J COPD, V1, P59; Cavarra E, 2001, AM J RESP CRIT CARE, V164, P886, DOI 10.1164/ajrccm.164.5.2010032; Churg A, 2004, AM J RESP CRIT CARE, V170, P492, DOI 10.1164/rccm.200404-511OC; Churg A, 2003, AM J RESP CRIT CARE, V167, P1083, DOI 10.1164/rccm.200212-1396OC; Churg A, 2002, AM J RESP CRIT CARE, V166, P849, DOI 10.1164/rccm.200202-097OC; Churg A, 2002, AM J RESP CELL MOL, V27, P368, DOI 10.1165/rcmb.4791; CLAASSEN I, 1990, J IMMUNOL METHODS, V134, P153, DOI 10.1016/0022-1759(90)90376-7; Demedts IK, 2006, THORAX, V61, P196, DOI 10.1136/thx.2005.042432; Duan M, J IMMUNOL, V189, P946; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Guerassimov A, 2004, AM J RESP CRIT CARE, V170, P974, DOI 10.1164/rccm.200309-1270oc; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Henderson RB, 2003, BLOOD, V102, P328, DOI 10.1182/blood-2002-10-3228; HIRSCH S, 1983, IMMUNOGENETICS, V18, P229, DOI 10.1007/BF00952962; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Landsman L, 2007, J IMMUNOL, V179, P3488, DOI 10.4049/jimmunol.179.6.3488; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Lofdahl JM, 2006, CLIN EXP IMMUNOL, V145, P428, DOI 10.1111/j.1365-2249.2006.03154.x; Maus U, 2002, AM J RESP CRIT CARE, V165, P95, DOI 10.1164/ajrccm.165.1.2106148; Maus UA, 2006, AM J RESP CELL MOL, V35, P227, DOI 10.1165/rcmb.2005-0241OC; Moodie FM, 2004, FASEB J, V18, P1897, DOI 10.1096/fj.04-1506fje; Morris A, 2008, J PHARMACOL EXP THER, V327, P851, DOI 10.1124/jpet.108.140848; Muller WA, 2001, J EXP MED, V194, pF47, DOI 10.1084/jem.194.9.f47; Murphy J, 2008, AM J RESP CELL MOL, V38, P380, DOI 10.1165/rcmb.2007-0224RC; Perez-Rial S, 2011, MOL IMAGING, V10, P398, DOI 10.2310/7290.2011.00010; Rosas M, 2010, J LEUKOCYTE BIOL, V88, P169, DOI 10.1189/jlb.0809548; Sato A, 2008, J PHARMACOL EXP THER, V325, P380, DOI 10.1124/jpet.107.134007; SEKHON HS, 1994, AM J PHYSIOL-LUNG C, V267, pL557, DOI 10.1152/ajplung.1994.267.5.L557; Sen S, 2010, AM J MED SCI, V340, P427, DOI 10.1097/MAJ.0b013e3181ef712d; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Taylor PR, 2003, EUR J IMMUNOL, V33, P2090, DOI 10.1002/eji.200324003; Tetley TD, 2002, CHEST, V121, p156S, DOI 10.1378/chest.121.5_suppl.156S; THEPEN T, 1989, J EXP MED, V170, P499, DOI 10.1084/jem.170.2.499; van Rooijen N, 2003, METHOD ENZYMOL, V373, P3; vanRooijen N, 1997, TRENDS BIOTECHNOL, V15, P178, DOI 10.1016/S0167-7799(97)01019-6; VANROOIJEN N, 1990, CELL TISSUE RES, V260, P215, DOI 10.1007/BF00318625; vanRooijen N, 1996, J IMMUNOL METHODS, V193, P93, DOI 10.1016/0022-1759(96)00056-7; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; VANROOIJEN N, 1989, J IMMUNOL METHODS, V124, P1, DOI 10.1016/0022-1759(89)90178-6; Vecchio D, AM J PHYSL LUNG CELL, V298, pL704; Wilson MR, 2009, AM J RESP CRIT CARE, V179, P914, DOI 10.1164/rccm.200806-877OC; Yao HW, 2008, AM J PHYSIOL-LUNG C, V294, pL1174, DOI 10.1152/ajplung.00439.2007	42	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e72975	10.1371/journal.pone.0072975	http://dx.doi.org/10.1371/journal.pone.0072975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058452	Green Published, Green Submitted, gold			2022-12-25	WOS:000324408400011
J	Terasaki, N; Goodier, JL; Cheung, LE; Wang, YJ; Kajikawa, M; Kazazian, HH; Okada, N				Terasaki, Natsuko; Goodier, John L.; Cheung, Ling E.; Wang, Yue J.; Kajikawa, Masaki; Kazazian, Haig H., Jr.; Okada, Norihiro			In Vitro Screening for Compounds That Enhance Human L1 Mobilization	PLOS ONE			English	Article							INDEPENDENT LINE-1 RETROTRANSPOSITION; INTERSPERSED NUCLEOTIDE ELEMENT-1; HIGH-FREQUENCY RETROTRANSPOSITION; HUMAN TRANSPOSABLE ELEMENT; REVERSE TRANSCRIPTION; GAUSSIA LUCIFERASE; MAMMALIAN-CELLS; GENE-EXPRESSION; CULTURED-CELLS; INDICATOR GENE	The Long interspersed element 1 (LINE1 or L1) retrotransposon constitutes 17% of the human genome. There are currently 80-100 human L1 elements that are thought to be active in any diploid human genome. These elements can mobilize into new locations of the genome, resulting in changes in genomic information. Active L1s are thus considered to be a type of endogenous mutagen, and L1 insertions can cause disease. Certain stresses, such as gamma radiation, oxidative stress, and treatment with some agents, can induce transcription and/or mobilization of retrotransposons. In this study, we used a reporter gene assay in HepG2 cells to screen compounds for the potential to enhance the transcription of human L1. We assessed 95 compounds including genotoxic agents, substances that induce cellular stress, and commercially available drugs. Treatment with 15 compounds increased the L1 promoter activity by > 1.5-fold (p < 0.05) after 6 or 24 hours of treatment. In particular, genotoxic agents (benzo[a] pyrene, camptothecin, cytochalasin D, merbarone, and vinblastine), PPAR alpha agonists (bezafibrate and fenofibrate), and non-steroidal anti-inflammatory drugs (diflunisal, flufenamic acid, salicylamide, and sulindac) induced L1 promoter activity. To examine their effects on L1 retrotransposition, we developed a high-throughput real-time retrotransposition assay using a novel secreted Gaussia luciferase reporter cassette. Three compounds (etomoxir, WY-14643, and salicylamide) produced a significant enhancement in L1 retrotransposition. This is the first study to report the effects of a wide variety of compounds on L1 transcription and retrotransposition. These results suggest that certain chemical- and drug-induced stresses might have the potential to cause genomic mutations by inducing L1 mobilization. Thus, the risk of induced L1 transcription and retrotransposition should be considered during drug safety evaluation and environmental risk assessments of chemicals.	[Terasaki, Natsuko; Kajikawa, Masaki; Okada, Norihiro] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Sci, Yokohama, Kanagawa 227, Japan; [Goodier, John L.; Cheung, Ling E.; Wang, Yue J.; Kazazian, Haig H., Jr.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Okada, Norihiro] Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan	Tokyo Institute of Technology; Johns Hopkins University; National Cheng Kung University	Okada, N (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Sci, Yokohama, Kanagawa 227, Japan.	nokada@bio.titech.ac.jp		Wang, Yue/0000-0003-2641-6904	US Department of Defense Breast Cancer Research Program [W81XWH-06-1-0456]; MEXT/JSPS KAKENHI [23114006, 23770004]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107632] Funding Source: NIH RePORTER	US Department of Defense Breast Cancer Research Program(United States Department of Defense); MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US Department of Defense Breast Cancer Research Program Award Number W81XWH-06-1-0456 to JLG and MEXT/JSPS KAKENHI Grant Numbers 23114006 and 23770004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELRAHMAN MS, 1991, CAN J PHYSIOL PHARM, V69, P1436, DOI 10.1139/y91-215; An WF, 2006, P NATL ACAD SCI USA, V103, P18662, DOI 10.1073/pnas.0605300103; An WF, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-2; Banaz-Yasar F, 2012, DNA CELL BIOL, V31, P1458, DOI 10.1089/dna.2012.1676; Beck CR, 2011, ANNU REV GENOM HUM G, V12, P187, DOI 10.1146/annurev-genom-082509-141802; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; BECKER KG, 1993, HUM MOL GENET, V2, P1697, DOI 10.1093/hmg/2.10.1697; Belancio VP, 2010, NUCLEIC ACIDS RES, V38, P3909, DOI 10.1093/nar/gkq132; Belancio VP, 2009, GENOME MED, V1, DOI 10.1186/gm97; BOEKE JD, 1985, CELL, V40, P491, DOI 10.1016/0092-8674(85)90197-7; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; BROEKEMEIER KM, 1989, J BIOL CHEM, V264, P7826; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Brouha B, 2002, AM J HUM GENET, V71, P327, DOI 10.1086/341722; Chen JM, 2005, HUM GENET, V117, P411, DOI 10.1007/s00439-005-1321-0; Cost GJ, 2002, EMBO J, V21, P5899, DOI 10.1093/emboj/cdf592; Dai LX, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-18; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; Farkash EA, 2006, NUCLEIC ACIDS RES, V34, P1196, DOI 10.1093/nar/gkj522; Farkash EA, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/37285; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Feng Y, 2003, P NATL ACAD SCI USA, V100, P6469, DOI 10.1073/pnas.0631766100; FREEMAN JD, 1994, BIOTECHNIQUES, V17, P46; GERONDAES P, 1988, BIOCHEM J, V253, P169, DOI 10.1042/bj2530169; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Giorgi G, 2011, CELL TISSUE RES, V346, P383, DOI 10.1007/s00441-011-1289-0; Goodier JL, 2013, NUCL ACIDS IN PRESS; Goodier JL, 2007, MOL CELL BIOL, V27, P6469, DOI 10.1128/MCB.00332-07; Hagan CR, 2003, NAT GENET, V35, P219, DOI 10.1038/ng1259; Han JS, 2004, NATURE, V429, P314, DOI 10.1038/nature02535; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Harris CR, 2009, ONCOGENE, V28, P3857, DOI 10.1038/onc.2009.246; HEIDMANN T, 1988, P NATL ACAD SCI USA, V85, P2219, DOI 10.1073/pnas.85.7.2219; HOLMES SE, 1994, NAT GENET, V7, P143, DOI 10.1038/ng0694-143; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Kale Shubha P, 2005, Int J Environ Res Public Health, V2, P14, DOI 10.3390/ijerph2005010014; Kazazian HH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-62; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; Kimberland ML, 1999, HUM MOL GENET, V8, P1557, DOI 10.1093/hmg/8.8.1557; Kroutter EN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000458; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; LIU WM, 1995, NUCLEIC ACIDS RES, V23, P1758, DOI 10.1093/nar/23.10.1758; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; Mine M, 2007, HUM MUTAT, V28, P137, DOI 10.1002/humu.20449; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Morrish TA, 2007, NATURE, V446, P208, DOI 10.1038/nature05560; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muotri AR, 2009, HIPPOCAMPUS, V19, P1002, DOI 10.1002/hipo.20564; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Nakajima Y, 2004, BIOSCI BIOTECH BIOCH, V68, P565, DOI 10.1271/bbb.68.565; NELSON WG, 1994, MOL CELL BIOL, V14, P1815, DOI 10.1128/MCB.14.3.1815; Okudaira N, 2011, CANCER SCI, V102, P2000, DOI 10.1111/j.1349-7006.2011.02060.x; Okudaira N, 2010, P NATL ACAD SCI USA, V107, P18487, DOI 10.1073/pnas.1001252107; Ostertag EM, 2000, NUCLEIC ACIDS RES, V28, P1418, DOI 10.1093/nar/28.6.1418; Pogribny IP, 2007, MUTAT RES-FUND MOL M, V625, P62, DOI 10.1016/j.mrfmmm.2007.05.004; Rangwala SH, 2009, METHODS, V49, P219, DOI 10.1016/j.ymeth.2009.04.012; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; SCOTT A F, 1987, Genomics, V1, P113, DOI 10.1016/0888-7543(87)90003-6; SKOWRONSKI J, 1988, MOL CELL BIOL, V8, P1385, DOI 10.1128/MCB.8.4.1385; Solyom S, 2012, GENOME RES, V22, P2328, DOI 10.1101/gr.145235.112; Solyom S, 2012, HUM MUTAT, V33, P369, DOI 10.1002/humu.21663; Stribinskis V, 2006, CANCER RES, V66, P2616, DOI 10.1158/0008-5472.CAN-05-3478; Suzuki J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000461; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Tchenio T, 2000, NUCLEIC ACIDS RES, V28, P411, DOI 10.1093/nar/28.2.411; Teneng I, 2007, GENES CELLS, V12, P1101, DOI 10.1111/j.1365-2443.2007.01117.x; Verhaegen M, 2002, ANAL CHEM, V74, P4378, DOI 10.1021/ac025742k; Wallace NA, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-22; Wilkins AS, 2010, BIOESSAYS, V32, P856, DOI 10.1002/bies.201000008; Xie Y, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1076; Yang N, 2003, NUCLEIC ACIDS RES, V31, P4929, DOI 10.1093/nar/gkg663; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	76	17	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74629	10.1371/journal.pone.0074629	http://dx.doi.org/10.1371/journal.pone.0074629			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040300	Green Submitted, Green Published, gold			2022-12-25	WOS:000326734500108
J	Verma, SC; Cai, QL; Kreider, E; Lu, J; Robertson, ES				Verma, Subhash C.; Cai, Qiliang; Kreider, Edward; Lu, Jie; Robertson, Erle S.			Comprehensive Analysis of LANA Interacting Proteins Essential for Viral Genome Tethering and Persistence	PLOS ONE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; RESONANCE ENERGY-TRANSFER; LATENT NUCLEAR ANTIGEN; MOBILITY-GROUP PROTEINS; SPLIT GFP SYSTEM; HISTONE H1; MITOTIC CHROMOSOMES; CHROMATIN-BINDING; MOLECULAR-BIOLOGY; TERMINAL REPEATS	Kaposi's sarcoma associated herpesvirus is tightly linked to multiple human malignancies including Kaposi's sarcoma (KS), Primary Effusion Lymphoma (PEL) and Multicentric Castleman's Disease (MCD). KSHV like other herpesviruses establishes life-long latency in the infected host by persisting as chromatin and tethering to host chromatin through the virally encoded protein Latency Associated Nuclear Antigen (LANA). LANA, a multifunctional protein, is capable of binding to a large number of cellular proteins responsible for transcriptional regulation of various cellular and viral pathways involved in blocking cell death and promoting cell proliferation. This leads to enhanced cell division and replication of the viral genome, which segregates faithfully in the dividing tumor cells. The mechanism of genome segregation is well known and the binding of LANA to nucleosomal proteins, throughout the cell cycle, suggests that these interactions play an important role in efficient segregation. Various biochemical methods have identified a large number of LANA binding proteins, including histone H2A/H2B, histone H1, MeCP2, DEK, CENP-F, NuMA, Bub1, HP-1, and Brd4. These nucleosomal proteins may have various functions in tethering of the viral genome during specific phases of the viral life cycle. Therefore, we performed a comprehensive analysis of their interaction with LANA using a number of different assays. We show that LANA binds to core nucleosomal histones and also associates with other host chromatin proteins including histone H1 and high mobility group proteins (HMGs). We used various biochemical assays including co-immunoprecipitation and in-vivo localization by split GFP and fluorescence resonance energy transfer (FRET) to demonstrate their association.	[Verma, Subhash C.] Univ Nevada, Sch Med, Dept Microbiol & Immunol, Reno, NV 89557 USA; [Cai, Qiliang] Fudan Univ, Sch Basic Med, MOE & MOH Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Kreider, Edward; Lu, Jie; Robertson, Erle S.] Univ Penn, Perelman Sch Med, Abramson Comprehens Canc Ctr, Dept Microbiol, Philadelphia, PA 19104 USA; [Kreider, Edward; Lu, Jie; Robertson, Erle S.] Univ Penn, Perelman Sch Med, Abramson Comprehens Canc Ctr, Tumor Virol Program, Philadelphia, PA 19104 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Fudan University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Verma, SC (corresponding author), Univ Nevada, Sch Med, Dept Microbiol & Immunol, Reno, NV 89557 USA.	scverma@medicine.nevada.edu; erle@mail.med.upenn.edu	Kreider, Edward/GSD-5998-2022	Kreider, Edward/0000-0003-2330-8430	National Cancer Institute [5R01CA091792-08, 5R01CA108461-05, 1R01CA137894-01, 1R01CA138434-01A209];  [K99/R00 CA126182]; NATIONAL CANCER INSTITUTE [R01CA138434, R01CA108461, K99CA126182, R01CA171979, R01CA091792, R01CA137894] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute 5R01CA091792-08, 5R01CA108461-05, 1R01CA137894-01 and 1R01CA138434-01A209 (ESR) and pathways to independence award, K99/R00 CA126182 to SCV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins NL, 2011, BIOCHEM CELL BIOL, V89, P1, DOI 10.1139/O10-112; Alexiadis V, 2000, GENE DEV, V14, P1308; Ballestas ME, 1999, SCIENCE, V284, P641, DOI 10.1126/science.284.5414.641; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Barbera AJ, 2006, SCIENCE, V311, P856, DOI 10.1126/science.1120541; Barbera AJ, 2008, BLOOD, V111, P4425, DOI 10.1182/blood-2008-02-136036; Barbera AJ, 2006, CELL CYCLE, V5, P1048, DOI 10.4161/cc.5.10.2768; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Borah S, 2004, J VIROL, V78, P10336, DOI 10.1128/JVI.78.19.10336-10347.2004; Boumba VA, 2004, PROTEIN PEPTIDE LETT, V11, P515, DOI 10.2174/0929866043406193; Brown DT, 2003, BIOCHEM CELL BIOL, V81, P221, DOI 10.1139/o03-049; Bustin M, 2001, TRENDS BIOCHEM SCI, V26, P431, DOI 10.1016/S0968-0004(01)01855-2; Cai Q, 2007, J VIROL, V81, P10413, DOI 10.1128/JVI.00611-07; Cai QL, 2010, ADV VIRUS RES, V78, P87, DOI 10.1016/S0065-3527(10)78003-9; Carey M, 2007, CSH PROTOC, V2007; Catez F, 2006, NAT STRUCT MOL BIOL, V13, P305, DOI 10.1038/nsmb1077; Catez F, 2004, MOL CELL BIOL, V24, P4321, DOI 10.1128/MCB.24.10.4321-4328.2004; Catez F, 2002, EMBO REP, V3, P760, DOI 10.1093/embo-reports/kvf156; Cotter MA, 1999, VIROLOGY, V264, P254, DOI 10.1006/viro.1999.9999; CRIPPA MP, 1992, J MOL BIOL, V228, P442, DOI 10.1016/0022-2836(92)90833-6; Cuddapah S, 2011, MOL CELL BIOL, V31, P700, DOI 10.1128/MCB.00740-10; Didenko VV, 2001, BIOTECHNIQUES, V31, P1106, DOI 10.2144/01315rv02; Du QS, 2002, CURR BIOL, V12, P1928, DOI 10.1016/S0960-9822(02)01298-8; Flore O, 1998, NATURE, V394, P588, DOI 10.1038/29093; Friborg J, 1999, NATURE, V402, P889, DOI 10.1038/47266; Fujimuro M, 2003, NAT MED, V9, P300, DOI 10.1038/nm829; Godfrey A, 2005, BLOOD, V105, P2510, DOI 10.1182/blood-2004-08-3052; Guo N, 2000, J CELL SCI, V113, P3085; Hachet-Haas M, 2006, MICROSC RES TECHNIQ, V69, P941, DOI 10.1002/jemt.20376; Haren L, 2002, J CELL SCI, V115, P1815; Horn PJ, 2002, SCIENCE, V297, P1824, DOI 10.1126/science.1074200; Izumi K M, 2001, Methods Mol Biol, V174, P249; Kaddoum L, 2010, BIOTECHNIQUES, V49, P727, DOI 10.2144/000113512; Kang H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002140; Kang H, 2009, J VIROL, V83, P6199, DOI 10.1128/JVI.00052-09; Kaul R, 2007, VIROLOGY, V364, P317, DOI 10.1016/j.virol.2007.03.010; Kelley-Clarke B, 2007, VIROLOGY, V357, P149, DOI 10.1016/j.virol.2006.07.052; Kline-Smith SL, 2005, CURR OPIN CELL BIOL, V17, P35, DOI 10.1016/j.ceb.2004.12.009; Krithivas A, 2000, J VIROL, V74, P9637, DOI 10.1128/JVI.74.20.9637-9645.2000; Krithivas A, 2002, J VIROL, V76, P11596, DOI 10.1128/JVI.76.22.11596-11604.2002; KUEHL L, 1984, J CELL BIOL, V99, P648, DOI 10.1083/jcb.99.2.648; Liang CY, 2008, SEMIN CANCER BIOL, V18, P423, DOI 10.1016/j.semcancer.2008.09.003; Lim C, 2003, J BIOL CHEM, V278, P7397, DOI 10.1074/jbc.M211912200; Lindman S, 2010, P NATL ACAD SCI USA, V107, P19826, DOI 10.1073/pnas.1005689107; Lindman S, 2009, PROTEIN SCI, V18, P1221, DOI 10.1002/pro.131; Lu F, 2012, J VIROL, V86, P5752, DOI 10.1128/JVI.07216-11; Lu J, 2009, J VIROL, V83, P7129, DOI 10.1128/JVI.00397-09; Magliery TJ, 2005, J AM CHEM SOC, V127, P146, DOI 10.1021/ja046699g; Matsumura S, 2010, J VIROL, V84, P2318, DOI 10.1128/JVI.01097-09; Mattsson K, 2002, J GEN VIROL, V83, P179, DOI 10.1099/0022-1317-83-1-179; McBride AA, 2004, TRENDS MICROBIOL, V12, P527, DOI 10.1016/j.tim.2004.10.002; Means RE, 2002, CURR TOP MICROBIOL, V269, P187; Moore P S, 1998, J Natl Cancer Inst Monogr, P65; Moore PS, 2003, ANNU REV MICROBIOL, V57, P609, DOI 10.1146/annurev.micro.57.030502.090824; Ottinger M, 2006, J VIROL, V80, P10772, DOI 10.1128/JVI.00804-06; Park SH, 2000, METHOD ENZYMOL, V328, P251, DOI 10.1016/S0076-6879(00)28401-2; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Pfleger KDG, 2006, NAT PROTOC, V1, P337, DOI 10.1038/nprot.2006.52; Piolot T, 2001, J VIROL, V75, P3948, DOI 10.1128/JVI.75.8.3948-3959.2001; Platt GM, 1999, J VIROL, V73, P9789, DOI 10.1128/JVI.73.12.9789-9795.1999; Pollok BA, 1999, TRENDS CELL BIOL, V9, P57, DOI 10.1016/S0962-8924(98)01434-2; Radkov SA, 2000, NAT MED, V6, P1121, DOI 10.1038/80459; Rainbow L, 1997, J VIROL, V71, P5915, DOI 10.1128/JVI.71.8.5915-5921.1997; Rattner BP, 2009, MOL CELL, V34, P620, DOI 10.1016/j.molcel.2009.04.014; Renne R, 1998, J VIROL, V72, P5182, DOI 10.1128/JVI.72.6.5182-5188.1998; Renne R, 1996, J VIROL, V70, P8151, DOI 10.1128/JVI.70.11.8151-8154.1996; Rochman M, 2009, MOL CELL, V35, P642, DOI 10.1016/j.molcel.2009.07.002; Sakakibara S, 2004, J VIROL, V78, P7299, DOI 10.1128/JVI.78.14.7299-7310.2004; Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948; Shinohara H, 2002, J VIROL, V76, P12917, DOI 10.1128/JVI.76.24.12917-12924.2002; Shirakawa H, 2000, J BIOL CHEM, V275, P37937, DOI 10.1074/jbc.M000989200; Si HX, 2008, J VIROL, V82, P6734, DOI 10.1128/JVI.00342-08; Skalsky RL, 2007, J VIROL, V81, P9825, DOI 10.1128/JVI.00842-07; Terme JM, 2011, J BIOL CHEM, V286, P35347, DOI 10.1074/jbc.M111.281923; Verma SC, 2007, CURR TOP MICROBIOL, V312, P101; Verma SC, 2006, J VIROL, V80, P2243, DOI 10.1128/JVI.80.5.2243-2256.2006; Verma SC, 2004, J VIROL, V78, P10348, DOI 10.1128/JVI.78.19.10348-10359.2004; Verma SC, 2007, CELL HOST MICROBE, V2, P106, DOI 10.1016/j.chom.2007.07.002; Verma SC, 2007, J VIROL, V81, P3402, DOI 10.1128/JVI.01607-06; Verma SC, 2006, J VIROL, V80, P11178, DOI 10.1128/JVI.01334-06; Verma SC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002365; Viejo-Borbolla A, 2005, J VIROL, V79, P13618, DOI 10.1128/JVI.79.21.13618-13629.2005; Viejo-Borbolla A, 2003, J VIROL, V77, P7093, DOI 10.1128/JVI.77.12.7093-7100.2003; Villalobos V, 2007, ANNU REV BIOMED ENG, V9, P321, DOI 10.1146/annurev.bioeng.9.060906.152044; WEISBROD S, 1982, NATURE, V297, P289, DOI 10.1038/297289a0; Wilson CG, 2004, NAT METHODS, V1, P255, DOI 10.1038/nmeth1204-255; Woodcock CL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000596; Xiao BY, 2010, J VIROL, V84, P9718, DOI 10.1128/JVI.00713-10; Xiao BT, 2012, MOL BIOL CELL, V23, P4864, DOI 10.1091/mbc.E12-07-0518; Ye FC, 2004, J VIROL, V78, P11121, DOI 10.1128/JVI.78.20.11121-11129.2004; You JX, 2006, J VIROL, V80, P8909, DOI 10.1128/JVI.00502-06; Yu HT, 2005, CELL CYCLE, V4, P262; Zhang QC, 2008, BBA-PROTEINS PROTEOM, V1784, P1159, DOI 10.1016/j.bbapap.2008.04.028; Zhong WD, 1996, P NATL ACAD SCI USA, V93, P6641, DOI 10.1073/pnas.93.13.6641	94	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74662	10.1371/journal.pone.0074662	http://dx.doi.org/10.1371/journal.pone.0074662			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040311	Green Published, Green Submitted, gold			2022-12-25	WOS:000326734500113
J	Hann, S; Kvenvold, L; Newby, BN; Hong, M; Warman, ML				Hann, Steven; Kvenvold, Laura; Newby, Brittney N.; Hong, Minh; Warman, Matthew L.			A Wisp3 Cre-knockin Allele Produces Efficient Recombination in Spermatocytes during Early Prophase of Meiosis I	PLOS ONE			English	Article							PROGRESSIVE PSEUDORHEUMATOID DYSPLASIA; TISSUE GROWTH-FACTOR; INFLAMMATORY BREAST-CANCER; FAMILY-MEMBER WISP3; GERM-CELLS; GENE; MUTATIONS; MICE; EXPRESSION; DIFFERENTIATION	Individuals with the autosomal recessive skeletal disorder Progressive Pseudorheumatoid Dysplasia have loss-of-function mutations in WISP3, and aberrant WISP3 expression has been detected in tumors from patients with colon and breast cancer. In mice however, neither absence nor over-expression of WISP3 was found to cause a phenotype, and endogenous Wisp3 expression has been difficult to detect. To confirm that Wisp3 knockout mice have no phenotype and to identify potential sites of endogenous Wisp3 expression, we generated mice with a knockin allele (Wisp3(GFP-Cre)) designed to express Green Fluorescent Protein (GFP) and Cre-recombinase instead of WISP3. Heterozygous and homozygous knockin mice were fertile and indistinguishable from their wild-type littermates, confirming that mice lacking Wisp3 have no phenotype. We could not detect GFP-expression from the knockin allele, but we could detect Cre-expression after crossing mice with the knockin allele to Cre-reporter mice; the double heterozygous offspring had evidence of Cre-mediated recombination in several tissues. The only tissue that had high levels of Cre-mediated recombination was the testis, where recombination in spermatocytes occurred by early prophase of meiosis I. As a consequence, males that were double heterozygous for a Wisp3(GFP-Cre) and a floxed allele only contributed a recombined allele to their offspring. We detected no evidence of Cre-mediated recombination in the female ovary, although when double heterozygous females contributed the reporter allele to their offspring it had recombined similar to 7% of the time. Wisp3(GFP-Cre) expression therefore occurs less frequently and most likely at a later stage of oocyte development in female mice compared to male mice. We conclude that although WISP3 is dispensable in mice, male mice with a Wisp3(GFP-Cre) allele (Jackson Laboratory stock # 017685) will be useful for studying early prophase of meiosis I and for efficiently recombining floxed alleles that are passed to offspring.	[Hann, Steven; Kvenvold, Laura; Newby, Brittney N.; Hong, Minh; Warman, Matthew L.] Boston Childrens Hosp, Dept Orthopaed Surg, Orthopaed Res Labs, Boston, MA USA; [Warman, Matthew L.] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA USA; [Warman, Matthew L.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Hann, S (corresponding author), Boston Childrens Hosp, Dept Orthopaed Surg, Orthopaed Res Labs, Boston, MA USA.	steven.hann@childrens.harvard.edu		Newby, Brittney/0000-0001-8648-4349	Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR062326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104937] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study received funding from the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando H, 2000, BIOCHEM BIOPH RES CO, V272, P125, DOI 10.1006/bbrc.2000.2762; Borg CL, 2010, HUM REPROD UPDATE, V16, P205, DOI 10.1093/humupd/dmp032; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; Dalal A, 2012, AM J MED GENET A, V158A, P2820, DOI 10.1002/ajmg.a.35620; Delague V, 2005, AM J MED GENET A, V138A, P118, DOI 10.1002/ajmg.a.30906; Grotendorst GR, 2005, FASEB J, V19, P729, DOI 10.1096/fj.04-3217com; Hammond SS, 2009, GENESIS, V47, P617, DOI 10.1002/dvg.20539; Hunt PA, 2008, TRENDS GENET, V24, P86, DOI 10.1016/j.tig.2007.11.010; Hurvitz JR, 1999, NAT GENET, V23, P94, DOI 10.1038/12699; Inselman AL, 2010, GENESIS, V48, P114, DOI 10.1002/dvg.20588; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Kido T, 2005, GENESIS, V42, P263, DOI 10.1002/gene.20147; Kleer CG, 2004, NEOPLASIA, V6, P179, DOI 10.1593/neo.03316; Kleer CG, 2002, ONCOGENE, V21, P3172, DOI 10.1038/sj.onc.1205462; Kutz WE, 2005, MOL CELL BIOL, V25, P414, DOI 10.1128/MCB.25.1.414-421.2005; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Nakamura Y, 2007, J CLIN INVEST, V117, P3075, DOI 10.1172/JCI32001; Nakamura Y, 2009, J CELL COMMUN SIGNAL, V3, P105, DOI 10.1007/s12079-009-0040-z; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Perbal B, 2013, J CELL COMMUN SIGNAL; PETERS H, 1970, PHILOS T R SOC B, V259, P91, DOI 10.1098/rstb.1970.0048; Rempe D, 2006, GENESIS, V44, P44, DOI 10.1002/gene.20183; Segarra NG, 2012, AM J MED GENET C, V160C, P217, DOI 10.1002/ajmg.c.31333; Smith L, 2011, REPRODUCTION, V141, P151, DOI 10.1530/REP-10-0404; Teves ME, 2013, ANDROLOGY-US, V1, P37, DOI 10.1111/j.2047-2927.2012.00001.x; Thorstensen L, 2005, NEOPLASIA, V7, P99, DOI 10.1593/neo.04448; Thorstensen L, 2003, GASTROENTEROLOGY, V124, P270, DOI 10.1053/gast.2003.50034; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09	29	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e75116	10.1371/journal.pone.0075116	http://dx.doi.org/10.1371/journal.pone.0075116			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040393	Green Submitted, gold, Green Published			2022-12-25	WOS:000327538600127
J	Schwab, S; Wurmle, O; Razavi, N; Muri, RM; Altorfer, A				Schwab, Simon; Wurmle, Othmar; Razavi, Nadja; Muri, Rene M.; Altorfer, Andreas			Eye-Head Coordination Abnormalities in Schizophrenia	PLOS ONE			English	Article							SMOOTH-PURSUIT; MOVEMENT ABNORMALITIES; ANTISACCADE TASK; HIGH-RISK; PERFORMANCE; SCHIZOTYPY; RELATIVES; TRACKING; DEFICITS; MARKER	Background: Eye-movement abnormalities in schizophrenia are a well-established phenomenon that has been observed in many studies. In such studies, visual targets are usually presented in the center of the visual field, and the subject's head remains fixed. However, in every-day life, targets may also appear in the periphery. This study is among the first to investigate eye and head movements in schizophrenia by presenting targets in the periphery of the visual field. Methodology/Principal Findings: Two different visual recognition tasks, color recognition and Landolt orientation tasks, were presented at the periphery (at a visual angle of 55 degrees from the center of the field of view). Each subject viewed 96 trials, and all eye and head movements were simultaneously recorded using video-based oculography and magnetic motion tracking of the head. Data from 14 patients with schizophrenia and 14 controls were considered. The patients had similar saccadic latencies in both tasks, whereas controls had shorter saccadic latencies in the Landolt task. Patients performed more head movements, and had increased eye-head offsets during combined eye-head shifts than controls. Conclusions/Significance: Patients with schizophrenia may not be able to adapt to the two different tasks to the same extent as controls, as seen by the former's task-specific saccadic latency pattern. This can be interpreted as a specific oculomotoric attentional dysfunction and may support the hypothesis that schizophrenia patients have difficulties determining the relevance of stimuli. Patients may also show an uneconomic over-performance of head-movements, which is possibly caused by alterations in frontal executive function that impair the inhibition of head shifts. In addition, a model was created explaining 93% of the variance of the response times as a function of eye and head amplitude, which was only observed in the controls, indicating abnormal eye-head coordination in patients with schizophrenia.	[Schwab, Simon; Wurmle, Othmar; Razavi, Nadja; Altorfer, Andreas] Univ Hosp Psychiat, Dept Psychiat Neurophysiol, Bern, Switzerland; [Schwab, Simon; Wurmle, Othmar; Razavi, Nadja; Muri, Rene M.; Altorfer, Andreas] Univ Bern, Bern, Switzerland; [Schwab, Simon; Muri, Rene M.] Univ Bern, Ctr Cognit Learning & Memory, Bern, Switzerland; [Muri, Rene M.] Inselspital Bern, Dept Neurol, Percept & Eye Movement Lab, Bern, Switzerland; [Muri, Rene M.] Inselspital Bern, Dept Clin Res, Percept & Eye Movement Lab, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Schwab, S (corresponding author), Univ Hosp Psychiat, Dept Psychiat Neurophysiol, Bern, Switzerland.	schwab@puk.unibe.ch	Müri, René M/E-9320-2012; Schwab, Simon/ABI-8495-2020	Müri, René M/0000-0001-6990-4188; Schwab, Simon/0000-0002-1588-2689; Altorfer, Andreas/0000-0002-7221-7829				Altorfer A., 2008, SCHIZOPHR RES, V98, P20, DOI [10.1016/j.schres.2007.12.040, DOI 10.1016/J.SCHRES.2007.12.040]; BARTZ AE, 1966, SCIENCE, V152, P1644, DOI 10.1126/science.152.3729.1644; Beedie SA, 2012, WORLD J BIOL PSYCHIA, V13, P200, DOI 10.3109/15622975.2011.566628; Beedie SA, 2011, J PSYCHIATR NEUROSCI, V36, P150, DOI 10.1503/jpn.090169; Benson PJ, 2007, J PSYCHIATR NEUROSCI, V32, P267; Benson PJ, 2012, BIOL PSYCHIAT, V72, P716, DOI 10.1016/j.biopsych.2012.04.019; Bestelmeyer PEG, 2006, SCHIZOPHR RES, V87, P212, DOI 10.1016/j.schres.2006.06.015; Bhugra D, 2005, PLOS MED, V2, P372, DOI 10.1371/journal.pmed.0020151; Butler PD, 2005, CURR OPIN PSYCHIATR, V18, P151, DOI 10.1097/00001504-200503000-00008; Crawford TJ, 1998, AM J PSYCHIAT, V155, P1703, DOI 10.1176/ajp.155.12.1703; Ettinger U, 2005, BIOL PSYCHOL, V68, P61, DOI 10.1016/j.biopsycho.2004.03.014; FUKUSHIMA J, 1988, BIOL PSYCHIAT, V23, P670, DOI 10.1016/0006-3223(88)90050-9; Fukushima J, 1990, J Vestib Res, V1, P171; Gray NS, 2005, NEUROSCI BIOBEHAV R, V29, P989, DOI 10.1016/j.neubiorev.2005.01.006; Green MJ, 2008, J PSYCHIATR NEUROSCI, V33, P34; Guyader N, 2010, PSYCHOL RES-PSYCH FO, V74, P12, DOI 10.1007/s00426-008-0218-7; HOLZMAN PS, 1974, ARCH GEN PSYCHIAT, V31, P143; Hutton SB, 2006, PSYCHOPHYSIOLOGY, V43, P302, DOI 10.1111/j.1469-8986.2006.00403.x; Kafkas A, 2011, Q J EXP PSYCHOL, V64, P1971, DOI 10.1080/17470218.2011.588335; Kang SS, 2011, PSYCHOPHYSIOLOGY, V48, P350, DOI 10.1111/j.1469-8986.2010.01074.x; Kojima T, 2001, SCHIZOPHR RES, V52, P203, DOI 10.1016/S0920-9964(00)00181-X; KOLADA SJ, 1983, BIOL PSYCHIAT, V18, P675; Koning JPF, 2010, SCHIZOPHRENIA BULL, V36, P723, DOI 10.1093/schbul/sbn146; Kraehenmann R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045884; Leask SJ, 2012, THERAPEUTIC ADV 1025; Lencer R, 2008, ARCH GEN PSYCHIAT, V65, P1146, DOI 10.1001/archpsyc.65.10.1146; Lenzenweger MF, 2006, J ABNORM PSYCHOL, V115, P779, DOI 10.1037/0021-843X.115.4.779; Levy DL, 2008, BRAIN COGNITION, V68, P462, DOI 10.1016/j.bandc.2008.08.027; Matsushima E, 1998, J PSYCHIAT RES, V32, P289, DOI 10.1016/S0022-3956(98)00019-3; Minassian A, 2005, SCHIZOPHR RES, V74, P69, DOI 10.1016/j.schres.2004.07.008; Mitropoulou V, 2011, PSYCHIAT RES, V186, P18, DOI 10.1016/j.psychres.2010.08.004; Mittal VA, 2008, ARCH GEN PSYCHIAT, V65, P165, DOI 10.1001/archgenpsychiatry.2007.23; Nagel M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038494; Nakayama H, 2003, PSYCHIAT CLIN NEUROS, V57, P169, DOI 10.1046/j.1440-1819.2003.01097.x; Nieman D, 2007, SCHIZOPHR RES, V95, P54, DOI 10.1016/j.schres.2007.06.022; Nishiura S, 2007, PSYCHIAT CLIN NEUROS, V61, P487, DOI 10.1111/j.1440-1819.2007.01697.x; Nkam I, 2001, SCHIZOPHR RES, V48, P145, DOI 10.1016/S0920-9964(99)00165-6; Nkam I, 2010, BIOL PSYCHIAT, V67, P992, DOI 10.1016/j.biopsych.2009.11.029; O'Driscoll GA, 1998, ARCH GEN PSYCHIAT, V55, P837, DOI 10.1001/archpsyc.55.9.837; Obayashi S, 2003, PSYCHIAT CLIN NEUROS, V57, P409, DOI 10.1046/j.1440-1819.2003.01140.x; Obayashi S, 2001, EUR ARCH PSY CLIN N, V251, P211, DOI 10.1007/s004060170029; Olevitch BA, 1996, INT J NEUROSCI, V88, P249, DOI 10.3109/00207459609000618; Pappa S, 2009, PSYCHOL MED, V39, P1065, DOI 10.1017/S0033291708004716; Peirce JW, 2009, FRONT NEUROINFORM, V2, DOI 10.3389/neuro.11.010.2008; Petrovsky N, 2008, J PSYCHIATR RES, V43, P291, DOI 10.1016/j.jpsychires.2008.05.005; Proudlock FA, 2007, PROG RETIN EYE RES, V26, P486, DOI 10.1016/j.preteyeres.2007.03.004; Reilly JL, 2008, BIOL PSYCHIAT, V63, P776, DOI 10.1016/j.biopsych.2007.11.009; Reilly JL, 2008, BRAIN COGNITION, V68, P415, DOI 10.1016/j.bandc.2008.08.026; Reuter B, 2005, PSYCHIAT RES, V135, P1, DOI 10.1016/j.psychres.2004.12.006; Roberts EO, 2013, SCHIZOPHRENIA BULL, V39, P896, DOI 10.1093/schbul/sbr191; Ross RG, 2002, PSYCHOPHYSIOLOGY, V39, P809, DOI 10.1111/1469-8986.3960809; Ryu H, 2001, ACTA NEUROL SCAND, V104, P369, DOI 10.1034/j.1600-0404.2001.00279.x; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Schwab S, 2012, J EYE MOVEMENT RES, V5; SCHWARTZ BD, 1995, SCHIZOPHR RES, V17, P211, DOI 10.1016/0920-9964(94)00089-Q; Sharot T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002884; SIEVER LJ, 1984, AM J PSYCHIAT, V141, P1560; SIEVER LJ, 1994, AM J PSYCHIAT, V151, P1209; Smyrnis N, 2007, EXP BRAIN RES, V179, P397, DOI 10.1007/s00221-006-0797-8; Smyrnis N, 2011, SCHIZOPHRENIA BULL, V37, P822, DOI 10.1093/schbul/sbp150; Stahl JS, 2001, EXP BRAIN RES, V139, P201, DOI 10.1007/s002210100749; Stahl JS, 1999, EXP BRAIN RES, V126, P41, DOI 10.1007/s002210050715; STANDING L, 1973, Q J EXP PSYCHOL, V25, P207, DOI 10.1080/14640747308400340; Suzuki M, 2009, EUR ARCH PSY CLIN N, V259, P186, DOI 10.1007/s00406-008-0850-7; Takahashi S, 2008, PSYCHIAT CLIN NEUROS, V62, P487, DOI 10.1111/j.1440-1819.2008.01840.x; Thaker GK, 2000, SCHIZOPHR RES, V45, P235, DOI 10.1016/S0920-9964(99)00193-0; Toh WL, 2011, COMPR PSYCHIAT, V52, P567, DOI 10.1016/j.comppsych.2010.12.005; Tonoya Y, 2002, EUR ARCH PSY CLIN N, V252, P255, DOI 10.1007/s00406-002-0390-5; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; van Tricht MJ, 2010, BRAIN COGNITION, V73, P215, DOI 10.1016/j.bandc.2010.05.005; WILLIAMS DP, 1988, ARCH NEUROL-CHICAGO, V45, P1022, DOI 10.1001/archneur.1988.00520330112019; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607	72	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74845	10.1371/journal.pone.0074845	http://dx.doi.org/10.1371/journal.pone.0074845			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259PK	24040351	Green Published, gold, Green Submitted			2022-12-25	WOS:000327538600116
J	Wang, B; Li, ZL; Wang, C; Chen, M; Xiao, JF; Wu, XY; Xiao, WF; Song, Y; Wang, XY				Wang, Bin; Li, Zhiling; Wang, Chao; Chen, Man; Xiao, Jianfeng; Wu, Xiaoyan; Xiao, Wanfen; Song, Yu; Wang, Xiaoyan			Zygotic G2/M Cell Cycle Arrest Induced by ATM/Chk1 Activation and DNA Repair in Mouse Embryos Fertilized with Hydrogen Peroxide-Treated Epididymal Mouse Sperm	PLOS ONE			English	Article							HUMAN-SPERMATOZOA; GENE-EXPRESSION; CRYOPRESERVATION; ATM; CHECKPOINT; MOTILITY; DAMAGE; CHK1; APOPTOSIS; KINASES	Human sperm cryopreservation for assisted reproduction is compromised by ROS-induced sperm cryodamage. Our previous model study in which mouse sperm were treated with H2O2 to simulate sperm DNA-damage caused by cryopreservation-induced ROS have discovered that mouse embryos fertilized with treated sperm showed a delay in cleavage that might be associated with cell cycle arrest. The DNA-damage checkpoint pathway underlying the delay remained elusive. Moreover, our previous study have also indicated that gamma H2AX, the DNA-damage repair marker, was functional in mouse embryos similarly fertilized, but the completeness and correctness are unknown and warrant more studies because insufficiency of completeness and correctness of DNA repair would otherwise trigger apoptosis. Based on the aforementioned model, we used embryo culture, inverted microscope, BrdU incorporation and immunofluorescence to explore the cell cycle phase that arrest occurred and the underlying DNA-damage checkpoint pathway in mouse zygotes fertilized with H2O2-treated sperm. We also adopted Tunel to investigate the apoptosis of mouse embryos similarly fertilized at different developmental stages to testify the completeness and correctness of sperm-derived DNA-damage repair. We found G2/M cell cycle arrest in zygotes fertilized with H2O2-treated sperm. ATM (pSer-1981) and Chk1 (pSer-345) activations, rather than ATR (pSer-428) and Chk2 (pThr-68), were detected in zygotes of the treated group. The apoptosis of embryos of different developmental stages of the treated group weren't different from those of the untreated group. In conclusions, ATM (pSer-1981)-Chk1 (pSer-345) cascade might have mediated G2/M cell cycle arrest and allowed time to facilitate sperm-derived DNA-damage repair in mouse zygotes fertilized with oxygen-stressed sperm, and the DNA-damage repair might be effective.	[Wang, Bin; Li, Zhiling; Chen, Man; Xiao, Jianfeng; Wu, Xiaoyan; Xiao, Wanfen; Song, Yu; Wang, Xiaoyan] Shantou Univ, Coll Med, Reprod Ctr, Affiliated Hosp 1, Shantou, Guangdong, Peoples R China; [Wang, Chao] Jining Med Coll, Affiliated Hosp, Reprod Ctr, Jining, Shandong, Peoples R China	Shantou University; Jining Medical University	Li, ZL (corresponding author), Shantou Univ, Coll Med, Reprod Ctr, Affiliated Hosp 1, Shantou, Guangdong, Peoples R China.	stlizhiling@126.com			National Natural Science Foundation of China [81070542, 30872771]; Natural Science Foundation of Guangdong Province of China [10151503102000020, 81515031102000010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province)	This study was supported by the National Natural Science Foundation of China (No. 81070542 and No. 30872771), the Natural Science Foundation of Guangdong Province of China (No. 10151503102000020 and No. 81515031102000010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; AITKEN J, 1994, BIOESSAYS, V16, P259, DOI 10.1002/bies.950160409; ALVAREZ JG, 1993, J ANDROL, V14, P199; Ashwood-Smith MJ, 1996, MOL HUM REPROD, V2, P46, DOI 10.1093/molehr/2.1.46; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; BRANDRIFF B, 1981, SCIENCE, V211, P1431, DOI 10.1126/science.7466400; Chatterjee S, 2001, MOL REPROD DEV, V59, P451, DOI 10.1002/mrd.1052; CRITSER JK, 1987, FERTIL STERIL, V47, P980; Donnelly ET, 2001, FERTIL STERIL, V76, P892, DOI 10.1016/S0015-0282(01)02834-5; Gatei M, 2003, J BIOL CHEM, V278, P14806, DOI 10.1074/jbc.M210862200; Groth A, 2003, EMBO J, V22, P1676, DOI 10.1093/emboj/cdg151; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Herman-Antosiewicz A, 2005, J BIOL CHEM, V280, P28519, DOI 10.1074/jbc.M501443200; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; HOWLETT SK, 1985, J EMBRYOL EXP MORPH, V87, P175; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Li ZL, 2010, J ANDROL, V31, P437, DOI 10.2164/jandrol.109.007849; Liu SZ, 2005, MOL REPROD DEV, V72, P48, DOI 10.1002/mrd.20332; MACK SR, 1987, GAMETE RES, V18, P375, DOI 10.1002/mrd.1120180411; MCLAUGHLIN EA, 1992, J REPROD FERTIL, V95, P749; Medeiros CMO, 2002, THERIOGENOLOGY, V57, P327, DOI 10.1016/S0093-691X(01)00674-4; Moore GD, 1996, MOL REPROD DEV, V45, P264, DOI 10.1002/(SICI)1098-2795(199611)45:3&lt;264::AID-MRD2&gt;3.0.CO;2-Q; O'Connell M, 2002, HUM REPROD, V17, P704, DOI 10.1093/humrep/17.3.704; Sahu RP, 2009, BRIT J CANCER, V100, P1425, DOI 10.1038/sj.bjc.6605039; Schiller J, 2000, CHEM PHYS LIPIDS, V106, P145, DOI 10.1016/S0009-3084(00)00148-1; Shi Hong-Yan, 2005, Acta Zoologica Sinica, V51, P1151; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Thomson LK, 2009, HUM REPROD, V24, P2061, DOI 10.1093/humrep/dep214; Tyagi A, 2005, CARCINOGENESIS, V26, P1978, DOI 10.1093/carcin/bgi165; Wang WZ, 2008, FEBS LETT, V582, P2689, DOI 10.1016/j.febslet.2008.06.048; Wang XM, 2008, J CELL BIOCHEM, V104, P1181, DOI 10.1002/jcb.21693; Xiao JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038742; Yukawa M, 2007, BIOCHEM BIOPH RES CO, V358, P578, DOI 10.1016/j.bbrc.2007.04.162	36	18	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e73987	10.1371/journal.pone.0073987	http://dx.doi.org/10.1371/journal.pone.0073987			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040138	Green Submitted, Green Published, gold			2022-12-25	WOS:000327538600057
J	Breckel, TPK; Thiel, CM; Bullmore, ET; Zalesky, A; Patel, AX; Giessing, C				Breckel, Thomas P. K.; Thiel, Christiane M.; Bullmore, Edward T.; Zalesky, Andrew; Patel, Ameera X.; Giessing, Carsten			Long-Term Effects of Attentional Performance on Functional Brain Network Topology	PLOS ONE			English	Article							RESTING-STATE NETWORKS; FREQUENCY BOLD FLUCTUATIONS; SUSTAINED ATTENTION; GLUCOSE CONSUMPTION; DEFAULT MODE; CONNECTIVITY; VIGILANCE; MEMORY; ACETYLCHOLINE; ORGANIZATION	Individuals differ in their cognitive resilience. Less resilient people demonstrate a greater tendency to vigilance decrements within sustained attention tasks. We hypothesized that a period of sustained attention is followed by prolonged changes in the organization of "resting state" brain networks and that individual differences in cognitive resilience are related to differences in post-task network reorganization. We compared the topological and spatial properties of brain networks as derived from functional MRI data (N = 20) recorded for 6 mins before and 12 mins after the performance of an attentional task. Furthermore we analysed changes in brain topology during task performance and during the switches between rest and task conditions. The cognitive resilience of each individual was quantified as the rate of increase in response latencies over the 32-minute time course of the attentional paradigm. On average, functional networks measured immediately post-task demonstrated significant and prolonged changes in network organization compared to pre-task networks with higher connectivity strength, more clustering, less efficiency, and shorter distance connections. Individual differences in cognitive resilience were significantly correlated with differences in the degree of recovery of some network parameters. Changes in network measures were still present in less resilient individuals in the second half of the post-task period (i.e. 6-12 mins after task completion), while resilient individuals already demonstrated significant reductions of functional connectivity and clustering towards pre-task levels. During task performance brain topology became more integrated with less clustering and higher global efficiency, but linearly decreased with ongoing time-on-task. We conclude that sustained attentional task performance has prolonged, "hang-over" effects on the organization of post-task resting-state brain networks; and that more cognitively resilient individuals demonstrate faster rates of network recovery following a period of attentional effort.	[Breckel, Thomas P. K.; Thiel, Christiane M.; Giessing, Carsten] Carl von Ossietzky Univ Oldenburg, Dept Psychol, Biol Psychol Lab, D-26111 Oldenburg, Germany; [Bullmore, Edward T.; Patel, Ameera X.; Giessing, Carsten] Univ Cambridge, Behav & Clin Neurosci Inst, Brain Mapping Unit, Cambridge, England; [Bullmore, Edward T.] GlaxoSmithKline, Addenbrookes Ctr Clin Invest, Clin Unit Cambridge, Cambridge, England; [Bullmore, Edward T.] Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England; [Zalesky, Andrew] Univ Melbourne, Natl Neurosci Facil, Melbourne, Vic, Australia	Carl von Ossietzky Universitat Oldenburg; University of Cambridge; GlaxoSmithKline; University of Melbourne	Breckel, TPK (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Psychol, Biol Psychol Lab, D-26111 Oldenburg, Germany.	thomas.breckel@uni-oldenburg.de	Bullmore, Ed/C-1706-2012	Bullmore, Ed/0000-0002-8955-8283; Patel, Ameera/0000-0002-4157-2705; ZALESKY, ANDREW/0000-0003-2298-9908; , Christiane/0000-0003-4788-4301	Deutsche Forschungsgemeinschaft [DFG-TH766/6-1]; Wellcome Trust; University of Cambridge MB/PhD programme; Medical Research Council [G1000183B, G0001354B, G0001354] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Cambridge MB/PhD programme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was supported by the 'Deutsche Forschungsgemeinschaft' (DFG-TH766/6-1). AXP was supported by the Wellcome Trust Translational Medicine and Therapeutics programme, and the University of Cambridge MB/PhD programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Albert NB, 2009, CURR BIOL, V19, P1023, DOI 10.1016/j.cub.2009.04.028; Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; Barnes A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006626; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; Berardi A, 2001, EXP AGING RES, V27, P19, DOI 10.1080/03610730126014; BLOMQVIST G, 1994, ACTA PHYSIOL SCAND, V151, P29, DOI 10.1111/j.1748-1716.1994.tb09718.x; Breckel TPK, 2011, NEUROIMAGE, V55, P1754, DOI 10.1016/j.neuroimage.2011.01.025; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Duff EP, 2008, HUM BRAIN MAPP, V29, P778, DOI 10.1002/hbm.20601; Ferri R, 2007, CLIN NEUROPHYSIOL, V118, P449, DOI 10.1016/j.clinph.2006.10.021; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; Giessing C, 2013, J NEUROSCI, V33, P5903, DOI 10.1523/JNEUROSCI.4854-12.2013; Ginestet CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021570; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Helton WS, 2008, ACTA PSYCHOL, V129, P18, DOI 10.1016/j.actpsy.2008.04.002; HODDES E, 1972, PSYCHOPHYSIOLOGY, V9, P150; HOLLAND PW, 1977, COMMUN STAT A-THEOR, V6, P813, DOI 10.1080/03610927708827533; Holmes A, 1998, NEUROIMAGE, V7; Horovitz SG, 2008, HUM BRAIN MAPP, V29, P671, DOI 10.1002/hbm.20428; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; Kitzbichler MG, 2011, J NEUROSCI, V31, P8259, DOI 10.1523/JNEUROSCI.0440-11.2011; Kozak R, 2006, CEREB CORTEX, V16, P9, DOI 10.1093/cercor/bhi079; Larson-Prior LJ, 2009, P NATL ACAD SCI USA, V106, P4489, DOI 10.1073/pnas.0900924106; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Lim J, 2010, NEUROIMAGE, V49, P3426, DOI 10.1016/j.neuroimage.2009.11.020; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; MADSEN PL, 1995, J CEREBR BLOOD F MET, V15, P485, DOI 10.1038/jcbfm.1995.60; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; MISCHEL W, 1973, PSYCHOL REV, V80, P252, DOI 10.1037/h0035002; NEWSHOLME EA, 1992, BRIT MED BULL, V48, P477, DOI 10.1093/oxfordjournals.bmb.a072558; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; Oken BS, 2006, CLIN NEUROPHYSIOL, V117, P1885, DOI 10.1016/j.clinph.2006.01.017; Parasuraman R, 1998, BRAIN SYSTEMS VIGILA, P221; Park CH, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.08.003; Paus T, 1997, J COGNITIVE NEUROSCI, V9, P392, DOI 10.1162/jocn.1997.9.3.392; Percival D.B., 2006, WAVELET METHODS TIME; Pinheiro J, 2001, MIXED EFFECTS MODELS; Portas CM, 1998, J NEUROSCI, V18, P8979; Power JD, 2011, NEUROIMAGE; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rasmusson DD, 2000, BEHAV BRAIN RES, V115, P205, DOI 10.1016/S0166-4328(00)00259-X; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Sarter M, 2006, BRAIN RES REV, V51, P145, DOI 10.1016/j.brainresrev.2005.11.002; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Stevens WD, 2010, CEREB CORTEX, V20, P1997, DOI 10.1093/cercor/bhp270; Tambini A, 2010, NEURON, V65, P280, DOI 10.1016/j.neuron.2010.01.001; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Waites AB, 2005, HUM BRAIN MAPP, V24, P59, DOI 10.1002/hbm.20069; Wang L, 2010, NEUROIMAGE, V50, P862, DOI 10.1016/j.neuroimage.2010.01.044; Wang L, 2009, HUM BRAIN MAPP, V30, P638, DOI 10.1002/hbm.20530; Warm JS, 2008, HUM FACTORS, V50, P433, DOI 10.1518/001872008X312152; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zou QH, 2009, HUM BRAIN MAPP, V30, P3066, DOI 10.1002/hbm.20728	69	37	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74125	10.1371/journal.pone.0074125	http://dx.doi.org/10.1371/journal.pone.0074125			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040185	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300159
J	Chen, CG; Cheng, GY; Hao, HH; Dai, MH; Wang, X; Huang, LL; Liu, ZL; Yuan, ZH				Chen, Chigang; Cheng, Guyue; Hao, Haihong; Dai, Menghong; Wang, Xu; Huang, Lingli; Liu, Zhenli; Yuan, Zonghui			Mechanism of Porcine Liver Xanthine Oxidoreductase Mediated N-Oxide Reduction of Cyadox as Revealed by Docking and Mutagenesis Studies	PLOS ONE			English	Article							SUBSTRATE ORIENTATION; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; DEHYDROGENASE; PROTEIN; RAT; METABOLISM; IDENTIFICATION; PERFORMANCE; MOLYBDENUM	Xanthine oxidoreductase (XOR) is a cytoplasmic molybdenum-containing oxidoreductase, catalyzing both endogenous purines and exogenous compounds. It is suggested that XOR in porcine hepatocytes catalyzes the N-oxide reduction of quinoxaline 1,4-di-N-oxides (QdNOs). To elucidate the molecular mechanism underlying this metabolism, the cDNA of porcine XOR was cloned and heterologously expressed in Spodoptera frugiperda insect cells. The bovine XOR, showing sequence identity of 91% to porcine XOR, was employed as template for homology modeling. By docking cyadox, a representative compound of QdNOs, into porcine XOR model, eight amino acid residues, Gly47, Asn352, Ser360, Arg427, Asp430, Asp431, Ser1227 and Lys1230, were located at distances of less than 4 angstrom to cyadox. Site-directed mutagenesis was performed to analyze their catalytic functions. Compared with wild type porcine XOR, G47A, S360P, D431A, S1227A, and K1230A displayed altered kinetic parameters in cyadox reduction, similarly to that in xanthine oxidation, indicating these mutations influenced electron-donating process of xanthine before subsequent electron transfer to cyadox to fulfill the N-oxide reduction. Differently, R427E and D430H, both located in the 424-434 loop, exhibited a much lower K-m and a decreased V-max respectively in cyadox reduction. Arg427 may be related to the substrate binding of porcine XOR to cyadox, and Asp430 is suggested to be involved in the transfer of electron to cyadox. This study initially reveals the possible catalytic mechanism of porcine XOR in cyadox metabolism, providing with novel insights into the structure-function relationship of XOR in the reduction of exogenous di-N-oxides.	[Yuan, Zonghui] Huazhong Agr Univ, Natl Reference Lab Vet Drug Residues HZAU, Wuhan, Hubei, Peoples R China; Huazhong Agr Univ, MOA Key Lab Detect Vet Drug Residues Foods, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Yuan, ZH (corresponding author), Huazhong Agr Univ, Natl Reference Lab Vet Drug Residues HZAU, Wuhan, Hubei, Peoples R China.	yuan5802@mail.hzau.edu.cn	DAI, M/GPS-8291-2022; yuan, zonghui/A-1158-2017; Hao, Haihong/E-2789-2019	Hao, Haihong/0000-0003-0199-5700	National Basic Research Program of China [2009CB118800]; National High Technology Research and Development Program of China [2011AA10A214]; National Natural Science Foundation of China [31272614]; Fundamental Research Funds for the Central Universities [2013QC002]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Basic Research Program of China (grant no. 2009CB118800), the National High Technology Research and Development Program of China (grant no. 2011AA10A214), the National Natural Science Foundation of China (grant no. 31272614) and the Fundamental Research Funds for the Central Universities (program no. 2013QC002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ali HI, 2010, J COMPUT AID MOL DES, V24, P57, DOI 10.1007/s10822-009-9314-z; AMAYA Y, 1990, J BIOL CHEM, V265, P14170; Asai R, 2007, J BIOCHEM, V141, P525, DOI 10.1093/jb/mvm054; BARBER MJ, 1982, BIOCHEMISTRY-US, V21, P1638, DOI 10.1021/bi00536a026; BEEDHAM C, 1985, DRUG METAB REV, V16, P119, DOI 10.3109/03602538508991432; Berglund L, 1996, J DAIRY SCI, V79, P198, DOI 10.3168/jds.S0022-0302(96)76351-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao HN, 2010, J BIOL CHEM, V285, P28044, DOI 10.1074/jbc.M110.128561; Carta A, 2005, CURR MED CHEM, V12, P2259, DOI 10.2174/0929867054864831; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Ekser B, 2009, TRANSPL IMMUNOL, V21, P87, DOI 10.1016/j.trim.2008.10.005; Enroth C, 2000, P NATL ACAD SCI USA, V97, P10723, DOI 10.1073/pnas.97.20.10723; Fang GJ, 2006, FOOD CHEM TOXICOL, V44, P36, DOI 10.1016/j.fct.2005.06.003; Ganley B, 2001, BIOORGAN MED CHEM, V9, P2395, DOI 10.1016/S0968-0896(01)00163-8; He QH, 2006, PHOTODERMATOL PHOTO, V22, P100, DOI 10.1111/j.1600-0781.2006.00199.x; HUNT J, 1993, J BIOL CHEM, V268, P18685; ICHIDA K, 1993, GENE, V133, P279; Ishikita H, 2012, J AM CHEM SOC, V134, P999, DOI 10.1021/ja207173p; Iwasaki T, 2000, J BIOCHEM, V127, P771, DOI 10.1093/oxfordjournals.jbchem.a022669; Kanth BK, 2010, COMPUT BIOL CHEM, V34, P226, DOI 10.1016/j.compbiolchem.2010.08.002; KING J, 1971, J MOL BIOL, V62, P465, DOI 10.1016/0022-2836(71)90148-3; Kitamura S, 2006, DRUG METAB PHARMACOK, V21, P83, DOI 10.2133/dmpk.21.83; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lengauer T, 1996, CURR OPIN STRUC BIOL, V6, P402, DOI 10.1016/S0959-440X(96)80061-3; Liu ZY, 2009, RAPID COMMUN MASS SP, V23, P2026, DOI 10.1002/rcm.4106; Matsumoto K, 2011, J PHARMACOL EXP THER, V336, P95, DOI 10.1124/jpet.110.174540; MURRAY KN, 1966, J BIOL CHEM, V241, P4798; NABUURS MJA, 1990, J VET MED A, V37, P68, DOI 10.1111/j.1439-0442.1990.tb00877.x; Nishino T, 2002, J BIOCHEM, V132, P597, DOI 10.1093/oxfordjournals.jbchem.a003262; Nishino T, 2000, J INORG BIOCHEM, V82, P43, DOI 10.1016/S0162-0134(00)00165-3; Nishino T, 2008, FEBS J, V275, P3278, DOI 10.1111/j.1742-4658.2008.06489.x; Okamoto K, 2003, J BIOL CHEM, V278, P1848, DOI 10.1074/jbc.M208307200; Pauff JM, 2008, J BIOL CHEM, V283, P4818, DOI 10.1074/jbc.M707918200; Pauff JM, 2009, J BIOL CHEM, V284, P8751, DOI 10.1074/jbc.M804517200; SESTAKOVA I, 1988, TALANTA, V35, P816, DOI 10.1016/0039-9140(88)80192-9; TERAO M, 1992, BIOCHEM J, V283, P863, DOI 10.1042/bj2830863; Tsuchida S, 2001, J VET MED SCI, V63, P353, DOI 10.1292/jvms.63.353; Wang X, 2011, REGUL TOXICOL PHARM, V59, P324, DOI 10.1016/j.yrtph.2010.11.004; Wu HX, 2012, J PHARMACEUT BIOMED, V67-68, P175, DOI 10.1016/j.jpba.2012.04.004; Xu N, 2011, RAPID COMMUN MASS SP, V25, P2333, DOI 10.1002/rcm.5119; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zheng M, 2011, XENOBIOTICA, V41, P964, DOI 10.3109/00498254.2011.593207; ZIMMERMAN BJ, 1994, AM J MED SCI, V307, P284, DOI 10.1097/00000441-199404000-00009	43	10	10	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73912	10.1371/journal.pone.0073912	http://dx.doi.org/10.1371/journal.pone.0073912			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040113	Green Published, gold, Green Submitted			2022-12-25	WOS:000326405300140
J	Shibata, Y; Inoue, S; Igarashi, A; Yamauchi, K; Abe, S; Aida, Y; Nunomiya, K; Sato, M; Nakano, H; Sato, K; Watanabe, T; Konta, T; Ueno, Y; Kato, T; Kayama, T; Kubota, I				Shibata, Yoko; Inoue, Sumito; Igarashi, Akira; Yamauchi, Keiko; Abe, Shuichi; Aida, Yasuko; Nunomiya, Keiko; Sato, Masamichi; Nakano, Hiroshi; Sato, Kento; Watanabe, Tetsu; Konta, Tuneo; Ueno, Yoshiyuki; Kato, Takeo; Kayama, Takamasa; Kubota, Isao			Elevated Serum Iron Is a Potent Biomarker for Spirometric Resistance to Cigarette Smoke among Japanese Males: The Takahata Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; GENOME-WIDE ASSOCIATION; HEME OXYGENASE-1; SUSCEPTIBILITY; COPD; LUNG; HOMEOSTASIS; VARIANTS; DECLINE	Chronic obstructive pulmonary disease is a common disability among elderly subjects with a heavy cigarette smoking habit. In contrast to the population that is susceptible to smoking, in whom pulmonary function worsens with the length of exposure to cigarette smoke, there are elderly individuals whose pulmonary function is not impaired. However, to date, the characteristics of this resistant smoking population have not been investigated. We aimed to identify a biomarker in individuals in whom lung health is maintained despite smoking. Blood sampling and spirometry were performed on 3,257 subjects who participated in a community-based annual health check in Takahata, Japan, from 2004 to 2006. We selected 117 elderly smokers (age >= 70, Brinkman index >= 600, smoking years >= 30). The 'smoking resistant' group met the following criteria: FEV1/FVC >= 0.7, and FEV(1%)predicted >= 80. Spirometry was re-evaluated in 147 male, current smokers in 2009. Baseline serum iron (sFe) levels were higher in the smoke resistant group compared with the non-resistant group. In those with low sFe levels, FEV1/FVC was reduced in male subjects. These spirometric measures were positively associated with sFe levels in men. Multiple linear regression analysis revealed that sFe levels were predictive for spirometric values, independent of other clinical factors. In addition, sFe levels were predictive for a decline in FEV1.Serum iron levels may be a biomarker for the spirometric susceptibility of individuals to cigarette smoke.	[Shibata, Yoko; Inoue, Sumito; Igarashi, Akira; Yamauchi, Keiko; Abe, Shuichi; Aida, Yasuko; Nunomiya, Keiko; Sato, Masamichi; Nakano, Hiroshi; Sato, Kento; Watanabe, Tetsu; Konta, Tuneo; Kubota, Isao] Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 99023, Japan; [Ueno, Yoshiyuki; Kato, Takeo; Kayama, Takamasa] Yamagata Univ, Sch Med, Global Ctr Excellence Program Study Grp, Yamagata 99023, Japan	Yamagata University; Yamagata University	Shibata, Y (corresponding author), Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 99023, Japan.	shibata@med.id.yamagata-u.ac.jp	Ueno, Yoshiyuki/R-9242-2019	Ueno, Yoshiyuki/0000-0001-5623-4250	Ministry of Education, Culture, Sports, Science and Technology, Japan [18590835, 18790530, 19590880, 20590892]; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [24700963] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant-in-aid from the Global COE program of the Japan Society for the Promotion of Science and grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (18590835, 18790530, 19590880, and 20590892). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida Y, 2011, INT J MED SCI, V8, P470, DOI 10.7150/ijms.8.470; American Lung Association, 2020, GUID PULM FUNCT TEST; Bae Yun-Jung, 2008, Nutr Res Pract, V2, P184, DOI 10.4162/nrp.2008.2.3.184; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Cho MH, 2012, HUM MOL GENET, V21, P947, DOI 10.1093/hmg/ddr524; DIMARCO AT, 1988, NEW ENGL J MED, V319, P874; Fredenburgh LE, 2007, AM J RESP CELL MOL, V36, P158, DOI 10.1165/rcmb.2006-0331TR; Ghio AJ, 2008, AM J RESP CRIT CARE, V178, P1130, DOI 10.1164/rccm.200802-334OC; GOLD-Global Initiative for Chronic Obstructive Lung Disease, 2011, GLOB STRAT DIAGN MAN; Guo Y, 2011, BIOCHEM BIOPH RES CO, V415, P284, DOI 10.1016/j.bbrc.2011.10.042; Lundback B, 2003, RESP MED, V97, P115, DOI 10.1053/rmed.2003.1446; Maestrelli P, 2003, EUR RESPIR J, V21, P971, DOI 10.1183/09031936.03.00098203; McKeever TM, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-67; Meneghini R, 1997, FREE RADICAL BIO MED, V23, P783, DOI 10.1016/S0891-5849(97)00016-6; Mostert V, 2007, DRUG METAB REV, V39, P619, DOI 10.1080/03602530701468342; Nunomiya K, 2013, EUR RESPIR J, V42, P18, DOI 10.1183/09031936.00066212; Obeidat M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019382; Osaka D, 2010, INTERNAL MED, V49, P1489, DOI 10.2169/internalmedicine.49.3364; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Sato M, 2013, INT J MED SCI, V10, P1, DOI 10.7150/ijms.5003; Wilk JB, 2012, AM J RESP CRIT CARE, V186, P622, DOI 10.1164/rccm.201202-0366OC; Yamada N, 2000, AM J HUM GENET, V66, P187, DOI 10.1086/302729; Young RP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016476; Zhou XB, 2012, HUM MOL GENET, V21, P1325, DOI 10.1093/hmg/ddr569	24	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e74020	10.1371/journal.pone.0074020	http://dx.doi.org/10.1371/journal.pone.0074020			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24040149	gold, Green Submitted, Green Published			2022-12-25	WOS:000326405300151
J	de la Serrana, DG; Johnston, IA				de la Serrana, Daniel Garcia; Johnston, Ian A.			Expression of Heat Shock Protein (Hsp90) Paralogues Is Regulated by Amino Acids in Skeletal Muscle of Atlantic Salmon	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; GROWTH; INHIBITION; EVOLUTION; DYNAMICS; NETWORK; TARGET	Heat shock proteins 90 (Hsp90) have an essential role in sarcomere formation and differentiation in skeletal muscle and also act as molecular chaperones during protein folding impacting a wide range of physiological processes. We characterised and provided a phylogenetically consistent nomenclature for the complete repertoire of six Hsp90 paralogues present in duplicated salmonid fish genomes (Hsp90 alpha 1a, Hsp90 alpha 1b, Hsp90 alpha 2a, Hsp90 alpha 2b, Hsp90 beta 1a and Hsp90 beta 1b). The expression of paralogues in fast skeletal muscle was investigated using in vivo fasting-feeding experiments and primary myogenic cultures. Fasted juvenile Atlantic salmon (Salmo salar) showed a transient 2 to 8-fold increase in the expression of all 4 Hsp90 alpha paralogues within 24h of satiation feeding. Hsp90 alpha 1a and hsp90 alpha 1b also showed a pronounced secondary increase in expression after 10 days, concomitant with muscle differentiation and the expression of myogenin and sarcomeric proteins (mlc2, myhc). Hsp90 beta 1b was constitutively expressed whereas Hsp90 beta 1a expression was downregulated 10-fold between fasted and fed individuals. Hsp90 alpha 1a and Hsp90 alpha 1b were upregulated 10 to 15-fold concomitant with myotube formation and muscle differentiation in vitro whereas other Hsp90 paralogues showed no change in expression. In cells starved of amino acid (AA) and serum for 72h the addition of AA, but not insulin-like growth factor 1, increased phosphorylation of mTor and expression of all 4 hsp90 alpha paralogues and associated co-chaperones including hsp30, tbcb, pdia4, pdia6, stga and fk504bp1, indicating a general activation of the protein folding response. In contrast, Hsp90 beta 1a expression in vitro was unresponsive to AA treatment indicating that some other as yet uncharacterised signal(s) regulate its expression in response to altered nutritional state.	[de la Serrana, Daniel Garcia; Johnston, Ian A.] Univ St Andrews, Scottish Oceans Inst, Sch Biol, St Andrews KY16 9AJ, Fife, Scotland	University of St Andrews	de la Serrana, DG (corresponding author), Univ St Andrews, Scottish Oceans Inst, Sch Biol, St Andrews KY16 9AJ, Fife, Scotland.	dgdlsc@st-andrews.ac.uk; iaj@st-andrews.ac.uk	Johnston, Ian A./AAE-2044-2019; Garcia de la serrana, Daniel/R-9956-2018; Johnston, Ian A/D-6592-2013	Garcia de la serrana, Daniel/0000-0001-6630-3379; Johnston, Ian A/0000-0002-7796-5754	European Community [222719-LIFECYCLE]	European Community(European Commission)	This research was funded by the European Community's Seventh Framework program (FP7/2007-2013) under grant agreement No 222719-LIFECYCLE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDORF FW, 1984, EVOL GENET, P55; Amaral IPG, 2011, J EXP BIOL, V214, P2125, DOI 10.1242/jeb.053298; Baos R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034716; Basu N, 2002, GENE, V295, P173, DOI 10.1016/S0378-1119(02)00687-X; Bower NI, 2010, PHYSIOL GENOMICS, V42A, P114, DOI 10.1152/physiolgenomics.00065.2010; Bower NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011100; Bower NI, 2010, AM J PHYSIOL-REG I, V298, pR1615, DOI 10.1152/ajpregu.00114.2010; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Chen B, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-156; Chou SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039679; da Silva VCH, 2012, J PROTEOMICS, V75, P2790, DOI 10.1016/j.jprot.2011.12.028; Du SJ, 2008, P NATL ACAD SCI USA, V105, P554, DOI 10.1073/pnas.0707330105; Hawkins TA, 2008, DEVELOPMENT, V135, P1147, DOI 10.1242/dev.018150; Johnson JL, 2012, BBA-MOL CELL RES, V1823, P607, DOI 10.1016/j.bbamcr.2011.09.020; Kanelakis KC, 1999, J BIOL CHEM, V274, P34134, DOI 10.1074/jbc.274.48.34134; KRONE PH, 1994, BIOCHEM BIOPH RES CO, V204, P746, DOI 10.1006/bbrc.1994.2522; Lele Z, 1999, DEV BIOL, V210, P56, DOI 10.1006/dbio.1999.9262; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Lian J, 2008, MOL NUTR FOOD RES, V52, P393, DOI 10.1002/mnfr.200700005; Liu L, 2008, J BIOL CHEM, V283, P13185, DOI 10.1074/jbc.M800757200; Macqueen DJ, 2013, MOL BIOL EVOL, V30, P1060, DOI 10.1093/molbev/mst017; Manchado M, 2008, GENE, V416, P77, DOI 10.1016/j.gene.2008.03.007; Meyer P, 2004, EMBO J, V23, P511, DOI 10.1038/sj.emboj.7600060; Millson SH, 2007, FEBS J, V274, P4453, DOI 10.1111/j.1742-4658.2007.05974.x; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Penn O, 2010, MOL BIOL EVOL, V27, P1759, DOI 10.1093/molbev/msq066; Presser A, 2008, P NATL ACAD SCI USA, V105, P950, DOI 10.1073/pnas.0707293105; Rescan PY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-438; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sawai A, 2008, CANCER RES, V68, P589, DOI 10.1158/0008-5472.CAN-07-1570; Sreeramulu S, 2009, J BIOL CHEM, V284, P3885, DOI 10.1074/jbc.M806715200; Stechmann A, 2004, J EUKARYOT MICROBIOL, V51, P364, DOI 10.1111/j.1550-7408.2004.tb00580.x; Street TO, 2012, J MOL BIOL, V415, P3, DOI 10.1016/j.jmb.2011.10.038; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Valente LMP, 2012, BRIT J NUTR, V108, P2148, DOI 10.1017/S0007114512000396; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wernersson R, 2006, NUCLEIC ACIDS RES, V34, pW385, DOI 10.1093/nar/gkl252; Wohlgemuth SL, 2007, DEV BIOL, V303, P483, DOI 10.1016/j.ydbio.2006.11.027; Wu CX, 2012, FISH SHELLFISH IMMUN, V33, P42, DOI 10.1016/j.fsi.2012.03.033; Yun BG, 2005, CELL SIGNAL, V17, P1477, DOI 10.1016/j.cellsig.2005.03.006; Yun BG, 2005, EXP CELL RES, V307, P212, DOI 10.1016/j.yexcr.2005.03.003	42	35	35	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e74295	10.1371/journal.pone.0074295	http://dx.doi.org/10.1371/journal.pone.0074295			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040223	Green Published, gold			2022-12-25	WOS:000324856500081
J	Sato-Nishiwaki, M; Aida, Y; Abe, S; Shibata, Y; Kimura, T; Yamauchi, K; Kishi, H; Igarashi, A; Inoue, S; Sato, M; Nakajima, O; Kubota, I				Sato-Nishiwaki, Michiko; Aida, Yasuko; Abe, Shuichi; Shibata, Yoko; Kimura, Tomomi; Yamauchi, Keiko; Kishi, Hiroyuki; Igarashi, Akira; Inoue, Sumito; Sato, Masamichi; Nakajima, Osamu; Kubota, Isao			Reduced Number and Morphofunctional Change of Alveolar Macrophages in MafB Gene-Targeted Mice	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; COLONY-STIMULATING FACTOR; CIGARETTE-SMOKE EXPOSURE; RHO-GTPASES; GM-CSF; EXPRESSION; DIFFERENTIATION; APOPTOSIS; CELLS; LUNG	Alveolar macrophages (AMs) play an important role in the pathogenesis of chronic obstructive pulmonary disease (COPD). We previously demonstrated that the transcription factor, MafB, increased in the AMs of mice exposed to cigarette smoke, and in those of human patients with COPD. The aim of this study was to evaluate the role of MafB in AMs using newly established transgenic (TG) mice that specifically express dominant negative (DN) MafB in macrophages under the control of macrophage scavenger receptor (MSR) enhancer-promoter. We performed cell differential analyses in bronchoalveolar lavage cells, morphological analyses with electron microscopy, and flow cytometry-based analyses of surface markers and a phagocytic capacity assay in macrophages. AM number in the TG mice was significantly decreased compared with wild-type (WT) mice. Morphologically, the high electron density area in the nucleus increased, the shape of pseudopods on the AMs was altered, and actin filament was less localized in the pseudopods of AMs of TG mice, compared with WT mice. The expression of surface markers, F4/80 and CD11b, on peritoneal macrophages in TG mice was reduced compared with WT mice, while those on AMs remained unchanged. Phagocytic capacity was decreased in AMs from TG mice, compared with WT mice. In conclusion, MafB regulates the phenotype of macrophages with respect to the number of alveolar macrophages, the nuclear compartment, cellular shape, surface marker expression, and phagocytic function. MSR-DN MafB TG mice may present a useful model to clarify the precise role of MafB in macrophages.	[Sato-Nishiwaki, Michiko; Aida, Yasuko; Abe, Shuichi; Shibata, Yoko; Kimura, Tomomi; Yamauchi, Keiko; Kishi, Hiroyuki; Igarashi, Akira; Inoue, Sumito; Sato, Masamichi; Kubota, Isao] Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 99023, Japan; [Nakajima, Osamu] Yamagata Univ, Sch Med, Mol Genet Res Lab, Yamagata 99023, Japan	Yamagata University; Yamagata University	Shibata, Y (corresponding author), Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 99023, Japan.	shibata@med.id.yamagata-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [19590880, 20590892, 23390220]; Grants-in-Aid for Scientific Research [24700963] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (19590880, 20590892, and 23390220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoshiba K, 2001, AM J PHYSIOL-LUNG C, V281, pL1392, DOI 10.1152/ajplung.2001.281.6.L1392; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Aziz A, 2006, MOL CELL BIOL, V26, P6808, DOI 10.1128/MCB.00245-06; Bariety J, 1998, KIDNEY INT, V53, P918, DOI 10.1111/j.1523-1755.1998.00845.x; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Berclaz PY, 2002, BLOOD, V100, P4193, DOI 10.1182/blood-2002-04-1102; Blanchi B, 2005, TRENDS MOL MED, V11, P23, DOI 10.1016/j.molmed.2004.11.005; Blanchi B, 2003, NAT NEUROSCI, V6, P1091, DOI 10.1038/nn1129; Cockell M, 1999, CURR OPIN GENET DEV, V9, P199, DOI 10.1016/S0959-437X(99)80030-6; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Hodge SJ, 2003, AM J PHYSIOL-LUNG C, V285, pL492, DOI 10.1152/ajplung.00428.2002; HORVAI A, 1995, P NATL ACAD SCI USA, V92, P5391, DOI 10.1073/pnas.92.12.5391; IMAM SH, 1992, CURR MICROBIOL, V25, P1, DOI 10.1007/BF01570075; JIN DI, 1995, MOL CELL BIOL, V15, P693; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; KATAOKA K, 1994, MOL CELL BIOL, V14, P7581, DOI 10.1128/MCB.14.11.7581; Kelly LM, 2000, EMBO J, V19, P1987, DOI 10.1093/emboj/19.9.1987; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Machiya J, 2007, AM J RESP CELL MOL, V36, P418, DOI 10.1165/rcmb.2006-0248OC; Marques LJ, 1997, AM J RESP CRIT CARE, V156, P1700, DOI 10.1164/ajrccm.156.5.9611052; Moriguchi T, 2006, MOL CELL BIOL, V26, P5715, DOI 10.1128/MCB.00001-06; MORRIS L, 1991, DEVELOPMENT, V112, P517; Naito Makoto, 2004, Medical Electron Microscopy, V37, P16, DOI 10.1007/s00795-003-0228-x; Naylor LH, 1999, BIOCHEM PHARMACOL, V58, P749, DOI 10.1016/S0006-2952(99)00096-9; Niedergang F, 2005, CURR TOP MICROBIOL, V291, P43; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Sato M, 2010, AM J RESP CRIT CARE, V181; Sato M, 2011, RESPIROLOGY, V16, P124, DOI 10.1111/j.1440-1843.2010.01886.x; Senft AP, 2007, AM J PHYSIOL-LUNG C, V292, pL469, DOI 10.1152/ajplung.00297.2006; Shapiro SD, 2005, NEW ENGL J MED, V352, P2016, DOI 10.1056/NEJMe058044; Shapiro SD, 1999, AM J RESP CRIT CARE, V160, pS29, DOI 10.1164/ajrccm.160.supplement_1.9; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; Sieweke MH, 1996, CELL, V85, P49, DOI 10.1016/S0092-8674(00)81081-8; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; Tamura T, 2000, IMMUNITY, V13, P155, DOI 10.1016/S1074-7613(00)00016-9; Tomita K, 2002, AM J RESP CRIT CARE, V166, P724, DOI 10.1164/rccm.2104010; VASILIEV JM, 1991, J CELL SCI, V98, P1; Whitney M, 2002, J BIOMOL SCREEN, V7, P149, DOI 10.1177/108705710200700208; Wolffe AP, 1996, CELL, V84, P817, DOI 10.1016/S0092-8674(00)81059-4; Yamamoto T, 2008, CELL TISSUE RES, V332, P245, DOI 10.1007/s00441-008-0586-8	40	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73963	10.1371/journal.pone.0073963	http://dx.doi.org/10.1371/journal.pone.0073963			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	24040127	Green Published, gold, Green Submitted			2022-12-25	WOS:000324856500067
J	Baselga, A; Gomez-Rodriguez, C; Novoa, F; Vogler, AP				Baselga, Andres; Gomez-Rodriguez, Carola; Novoa, Francisco; Vogler, Alfried P.			Rare Failures of DNA Bar Codes to Separate Morphologically Distinct Species in a Biodiversity Survey of Iberian Leaf Beetles	PLOS ONE			English	Article							MITOCHONDRIAL; NUCLEAR; COLEOPTERA; EVOLUTION; UTILITY	During a survey of genetic and species diversity patterns of leaf beetle (Coleoptera: Chrysomelidae) assemblages across the Iberian Peninsula we found a broad congruence between morphologically delimited species and variation in the cytochrome oxidase (cox1) gene. However, one species pair each in the genera Longitarsus Berthold and Pachybrachis Chevrolat was inseparable using molecular methods, whereas diagnostic morphological characters (including male or female genitalia) unequivocally separated the named species. Parsimony haplotype networks and maximum likelihood trees built from cox1 showed high genetic structure within each species pair, but no correlation with the morphological types and neither with geographic distributions. This contrasted with all analysed congeneric species, which were recovered as monophyletic. A limited number of specimens were sequenced for the nuclear 18S rRNA gene, which showed no or very limited variation within the species pair and no separation of morphological types. These results suggest that processes of lineage sorting for either group are lagging behind the clear morphological and presumably reproductive separation. In the Iberian chrysomelids, incongruence between DNA-based and morphological delimitations is a rare exception, but the discovery of these species pairs may be useful as an evolutionary model for studying the process of speciation in this ecological and geographical setting. In addition, the study of biodiversity patterns based on DNA requires an evolutionary understanding of these incongruences and their potential causes.	[Baselga, Andres; Gomez-Rodriguez, Carola; Novoa, Francisco] Univ Santiago de Compostela, Fac Biol, Dept Zool, Santiago De Compostela, Spain; [Gomez-Rodriguez, Carola; Vogler, Alfried P.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Vogler, Alfried P.] Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot, Berks, England	Universidade de Santiago de Compostela; Natural History Museum London; Imperial College London	Baselga, A (corresponding author), Univ Santiago de Compostela, Fac Biol, Dept Zool, Santiago De Compostela, Spain.	andres.baselga@usc.es	Gómez-Rodríguez, Carola/B-6823-2016; Baselga, Andres/A-6740-2008	Gómez-Rodríguez, Carola/0000-0002-2019-7176; Baselga, Andres/0000-0001-7914-7109	Spanish Ministry of Science and Innovation [CGL2009-10111]; Xunta de Galicia [POS-A/2012/052]; Natural Environment Research Council [NE/C510908/1] Funding Source: researchfish	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	AB was funded by the Spanish Ministry of Science and Innovation (grant CGL2009-10111). CGR is funded by the Xunta de Galicia(postdoctoral fellowship POS-A/2012/052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baselga A, 2006, BIODIVERS CONSERV, V15, P205, DOI 10.1007/s10531-004-6904-x; Baselga A, 1998, B ASOCIACION ESPANOL, P246; Baselga A, 2002, B ASOCIACION ESPANOL, P57; Baselga A, 2007, BIODIVERS CONSERV, V16, P1409, DOI 10.1007/s10531-006-6738-9; Baselga Andres, 2003, Nouvelle Revue d'Entomologie, V20, P117; Baselga A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2881; Baselga A, 2011, MOL ECOL, V20, P5060, DOI 10.1111/j.1365-294X.2011.05342.x; Bastazo G, 1997, THESIS U GRANADA; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Biondi M, 1991, ECOS REVTA ESP ENTOM, V66, P161; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cracraft J, 1983, P NATO ADV STUD I NU, P1; Doguet S, 1994, COLEOPTERES CHRYSOME, V2, P80; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gomez-Zurita J, 2006, J MOL EVOL, V62, P421, DOI 10.1007/s00239-004-0329-8; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hendrich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014448; Isambert B, 2011, BIOL CONSERV, V144, P1902, DOI 10.1016/j.biocon.2011.04.016; Legendre P, 1998, NUMERICAL ECOLOGY; Marske KA, 2012, EVOLUTION, V66, P1862, DOI 10.1111/j.1558-5646.2011.01538.x; Miller WJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001214; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Panchal M, 2007, BIOINFORMATICS, V23, P509, DOI 10.1093/bioinformatics/btl614; Papadopoulou A, 2011, AM NAT, V178, P560, DOI 10.1086/662555; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Petitpierre E, 2000, COLEOPTERA CHRYSOMEL; Petitpierre E, 1999, ALTICINAE B I CATALA, V67, P91; Petitpierre Eduard, 1998, Nouvelle Revue d'Entomologie, V15, P13; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; R Core Team, 2021, R LANG ENV STAT COMP; Ribera I, 2004, MOL ECOL, V13, P179, DOI 10.1046/j.1365-294X.2003.02035.x; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shull VL, 2001, SYST BIOL, V50, P945, DOI 10.1080/106351501753462894; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sota T, 2006, SYST BIOL, V55, P329, DOI 10.1080/10635150500541607; Sota T, 2001, SYST BIOL, V50, P39, DOI 10.1080/713849547; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Uhagon S, 1887, TERCERA PARTE ANALES, V16, P373; Warchalowski A., 2003, CHRYSOMELIDAE LEAF B	43	11	11	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74854	10.1371/journal.pone.0074854	http://dx.doi.org/10.1371/journal.pone.0074854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040352	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600150
J	Zhou, S; Xu, SC; Tao, HH; Zhen, ZW; Chen, GL; Zhang, ZQ; Yang, YQ				Zhou, Shuang; Xu, Shuchang; Tao, Huihong; Zhen, Zhiwei; Chen, Guolin; Zhang, Zhiqiang; Yang, Yaoqin			CCR7 Expression and Intratumoral FOXP3(+) Regulatory T Cells are Correlated with Overall Survival and Lymph Node Metastasis in Gastric Cancer	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CCR7; HEPATOCELLULAR-CARCINOMA; TISSUE MICROARRAYS; PREVALENCE; PROGNOSIS; LOCATION	The aim of this study was to investigate the prognostic value of chemokine receptor CCR7 expression and intratumoral FOXP3(+) regulatory T cells (Tregs) in gastric cancer. CCR7(+) tumor cells and FOXP3(+) Tregs were assessed by immunohistochemistry in tissue microarrays containing gastric cancer from 133 patients. Prognostic effects of low or high CCR7 and FOXP3 expression were evaluated by Cox regression and Kaplan-Meier analysis, as well as the correlation between CCR7 positive score and intratumoral FOXP3(+) cell number in a longitudinal assessment. The analysis showed that the high expression levels of CCR7 and FOXP3 were detected in 69.9% and 65.4% of cases, respectively. High CCR7 expression in gastric cancer cells was significantly associated with poor overall survival (OS) (P = 0.010) and lymph node metastasis (P = 0.009), and was an independent factor for worse OS (P = 0.023) by multivariate analysis. High numbers of intratumoral FOXP3(+) Tregs significantly correlated with shorter OS (P = 0.021) and lymph node metastasis (P = 0.024), and was also an independent factor for adverse OS (P = 0.035). Furthermore, there was a significantly positive correlation between CCR7 positive score and intratumoral FOXP3(+) cell number (r = 0.949, P<0.001). These results revealed that CCR7 expression in gastric cancer cells and intratumoral FOXP3(+) Tregs could be considered as a co-indicator of clinical prognosis of gastric cancer.	[Zhou, Shuang; Tao, Huihong; Zhen, Zhiwei; Chen, Guolin; Yang, Yaoqin] Tongji Univ, Sch Med, Dept Histol & Embryol, Shanghai 200092, Peoples R China; [Xu, Shuchang] Tongji Univ, Tongji Hosp, Sch Med, Dept Gastroenterol, Shanghai 200092, Peoples R China; [Zhang, Zhiqiang] Tongji Univ, Sch Med, Dept Prevent Med, Shanghai 200092, Peoples R China	Tongji University; Tongji University; Tongji University	Zhou, S (corresponding author), Tongji Univ, Sch Med, Dept Histol & Embryol, Shanghai 200092, Peoples R China.	shuangzhou@tongji.edu.cn; yaoqiny@163.com	Chen, Long/H-4268-2019	Chen, Long/0000-0002-2979-5033	National Natural Science Foundation of China [31000527]; Shanghai Health Bureau Research Fund for young investigator; Hong Kong Scholar program [XJ2011025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Health Bureau Research Fund for young investigator; Hong Kong Scholar program	This work was supported by National Natural Science Foundation of China (No. 31000527), Shanghai Health Bureau Research Fund for young investigator (to Dr. Shuang Zhou) and Hong Kong Scholar program (No. XJ2011025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkwill F, 2003, SEMIN IMMUNOL, V15, P49, DOI 10.1016/S1044-5323(02)00127-6; Banham AH, 2006, EUR J IMMUNOL, V36, P2832, DOI 10.1002/eji.200636459; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Byrne WL, 2011, CANCER RES, V71, P6915, DOI 10.1158/0008-5472.CAN-11-1156; Cabioglu N, 2005, CLIN CANCER RES, V11, P5686, DOI 10.1158/1078-0432.CCR-05-0014; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; deLeeuw RJ, 2012, CLIN CANCER RES, V18, P3022, DOI 10.1158/1078-0432.CCR-11-3216; Ding YZ, 2003, CLIN CANCER RES, V9, P3406; Fu JL, 2007, GASTROENTEROLOGY, V132, P2328, DOI 10.1053/j.gastro.2007.03.102; Gabriela C, 2000, IMMUNITY, V13, P759; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Griffiths RW, 2007, CANCER IMMUNOL IMMUN, V56, P1743, DOI 10.1007/s00262-007-0318-z; Heimberger AB, 2008, CLIN CANCER RES, V14, P5166, DOI 10.1158/1078-0432.CCR-08-0320; Hiraoka N, 2006, CLIN CANCER RES, V12, P5423, DOI 10.1158/1078-0432.CCR-06-0369; Hori S, 2004, MICROBES INFECT, V6, P745, DOI 10.1016/j.micinf.2004.02.020; Kakinuma T, 2006, J LEUKOCYTE BIOL, V79, P639, DOI 10.1189/jlb.1105633; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lee AM, 2006, J CLIN ONCOL, V24, P5052, DOI 10.1200/JCO.2006.06.4642; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Mashino K, 2002, CANCER RES, V62, P2937; Mizukami Y, 2008, BRIT J CANCER, V98, P148, DOI 10.1038/sj.bjc.6604149; Nasman A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038711; Oliveira-Neto HH, 2013, TUMOR BIOL, V34, P65, DOI 10.1007/s13277-012-0511-3; Perrone G, 2008, EUR J CANCER, V44, P1875, DOI 10.1016/j.ejca.2008.05.017; Petersen RP, 2006, CANCER-AM CANCER SOC, V107, P2866, DOI 10.1002/cncr.22282; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schimanski CC, 2006, ONCOL REP, V16, P109; Svensson H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030695; Takanami I, 2003, INT J CANCER, V105, P186, DOI 10.1002/ijc.11063; Takeuchi H, 2004, CLIN CANCER RES, V10, P2351, DOI 10.1158/1078-0432.CCR-03-0195; Wiley HE, 2001, J NATL CANCER I, V93, P1638, DOI 10.1093/jnci/93.21.1638; Xu Y, 2012, J ENG FIBER FABR, V7, P7; Xu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021119; Yanagihara S, 1998, J IMMUNOL, V161, P3096; Yang XH, 2006, J HEPATOL, V45, P254, DOI 10.1016/j.jhep.2006.01.036; Yoon HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042274; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	40	42	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74430	10.1371/journal.pone.0074430	http://dx.doi.org/10.1371/journal.pone.0074430			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	24040244	Green Published, Green Submitted, gold			2022-12-25	WOS:000324481600128
J	Stoop, R; Nuesch, P; Stoop, RL; Bunimovich, LA				Stoop, Ruedi; Nueesch, Patrick; Stoop, Ralph Lukas; Bunimovich, Leonid A.			At Grammatical Faculty of Language, Flies Outsmart Men	PLOS ONE			English	Article							NATURAL-LANGUAGE	Using a symbolic dynamics and a surrogate data approach, we show that the language exhibited by common fruit flies Drosophila ('D.') during courtship is as grammatically complex as the most complex human-spoken modern languages. This finding emerges from the study of fifty high-speed courtship videos (generally of several minutes duration) that were visually frame-by-frame dissected into 37 fundamental behavioral elements. From the symbolic dynamics of these elements, the courtship-generating language was determined with extreme confidence (significance level > 0.95). The languages categorization in terms of position in Chomsky's hierarchical language classification allows to compare Drosophila's body language not only with computer's compiler languages, but also with human-spoken languages. Drosophila's body language emerges to be at least as powerful as the languages spoken by humans.	[Stoop, Ruedi; Nueesch, Patrick; Stoop, Ralph Lukas] Univ Zurich, Inst Neuroinformat, Zurich, Switzerland; [Stoop, Ruedi; Nueesch, Patrick; Stoop, Ralph Lukas] Swiss Fed Inst Technol, Zurich, Switzerland; [Bunimovich, Leonid A.] Georgia Inst Technol, Sch Math, Atlanta, GA 30332 USA	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University System of Georgia; Georgia Institute of Technology	Stoop, R (corresponding author), Univ Zurich, Inst Neuroinformat, Zurich, Switzerland.	ruedi@ini.phys.ethz.ch		Stoop, Ralph/0000-0002-5138-8020				CHOMSKY N, 1956, IRE T INFORM THEOR, V2, P113; Chomsky N., 1986, KNOWLEDGE LANGUAGE I; Chomsky N, 1963, STUDIES LOGIC FDN MA, V35, P118; Chomsky Noam, 1988, LANGUAGE PROBLEMS KN; Finch T, 2010, EVOLUTIONS HUMAN LAN; Hagiwara R, 2004, J PHYS A-MATH GEN, V37, P10545, DOI 10.1088/0305-4470/37/44/006; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hofstadter D.R, 1979, GODEL ESCHER BACH ET; Hopcroft J. E., 2007, INTRO AUTOMATA THEOR, V3rd; PINKER S, 1990, BEHAV BRAIN SCI, V13, P707, DOI 10.1017/S0140525X00081061; PULLUM GK, 1982, LINGUIST PHILOS, V4, P471, DOI 10.1007/BF00360802; SHIEBER SM, 1985, LINGUIST PHILOS, V8, P333, DOI 10.1007/BF00630917; Shinbrot T, 2008, ANAT REC, V291, P1278, DOI 10.1002/ar.20731; Stoop R, 2011, CHAOS, V21, DOI 10.1063/1.3553643; Stoop R, 2008, CHAOS, V18, DOI 10.1063/1.2918912	15	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e70284	10.1371/journal.pone.0070284	http://dx.doi.org/10.1371/journal.pone.0070284			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24058398	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000324403200002
J	Kumar, R; Chaterjee, P; Sharma, PK; Singh, AK; Gupta, A; Gill, K; Tripathi, M; Dey, AB; Dey, S				Kumar, Rahul; Chaterjee, Prasun; Sharma, Prakash K.; Singh, Abhay K.; Gupta, Abhishek; Gill, Kamaldeep; Tripathi, Manjari; Dey, Aparajit B.; Dey, Sharmistha			Sirtuin1: A Promising Serum Protein Marker for Early Detection of Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; CALORIE RESTRICTION; NEURODEGENERATION; PLASMA; BLOOD	Sirtuin (SIRT) pathway has a crucial role in Alzheimer's disease (AD). The present study evaluated the alterations in serum sirtuin1 (SIRT1) concentration in healthy individuals (young and old) and patients with AD and mild cognitive impairment (MCI). Blood samples were collected from 40 AD and 9 MCI patients as cases and 22 young healthy adults and 22 healthy elderly individuals as controls. Serum SIRT1 was estimated by Surface Plasmon Resonance (SPR), Western Blot and Enzyme Linked Immunosorbent Assay (ELISA). A significant (p < 0.0001) decline in SIRT1 concentration was observed in patients with AD (2.27 +/- 0.46 ng/mu l) and MCI (3.64 +/- 0.15 ng/mu l) compared to healthy elderly individuals (4.82 +/- 0.4 ng/mu l). The serum SIRT1 concentration in healthy elderly was also significantly lower (p < 0.0001) compared to young healthy controls (8.16 +/- 0.87 ng/mu l). This study, first of its kind, has demonstrated, decline in serum concentration of SIRT1 in healthy individuals as they age. In patients with AD and MCI the decline was even more pronounced, which provides an opportunity to develop this protein as a predictive marker of AD in early stages with suitable cut off values.	[Kumar, Rahul; Singh, Abhay K.; Gupta, Abhishek; Gill, Kamaldeep; Dey, Sharmistha] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India; [Chaterjee, Prasun; Sharma, Prakash K.; Dey, Aparajit B.] All India Inst Med Sci, Dept Geriatr Med, New Delhi 110029, India; [Tripathi, Manjari] All India Inst Med Sci, Dept Neurol, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Dey, S (corresponding author), All India Inst Med Sci, Dept Biophys, New Delhi 110029, India.	sharmistha_d@hotmail.com	Kumar, Rahul/AGB-1290-2022; Ferosekhan, Shajahan/E-5051-2010; Kothari, Dushyant/G-3646-2013	Kumar, Rahul/0000-0002-3603-7572; Kumar, Prakash/0000-0002-8230-2867; GUPTA, ABHISHEK/0000-0003-1056-8479; Gupta, Subodh/0000-0002-9420-480X; Ferosekhan, Shajahan/0000-0003-4662-8306; Kothari, Dushyant/0000-0003-0448-4164; Jadhao, Sanjay/0000-0003-2859-8529	Council of Scientific and Industrial Research	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	Authors acknowledge Council of Scientific and Industrial Research for the fellowship of Rahul kumar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albani D, 2010, J ALZHEIMERS DIS, V19, P11, DOI 10.3233/JAD-2010-1215; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; [Anonymous], 2010, PREV IMP COSTS SERV; Bonda DJ, 2011, LANCET NEUROL, V10, P275, DOI 10.1016/S1474-4422(11)70013-8; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; FLICKER C, 1991, NEUROLOGY, V41, P1006, DOI 10.1212/WNL.41.7.1006; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; JORM AF, 1991, EUR ARCH PSY CLIN N, V240, P218, DOI 10.1007/BF02189530; Julien C, 2009, J NEUROPATH EXP NEUR, V68, P48, DOI 10.1097/NEN.0b013e3181922348; Kemnitz JW, 2011, ILAR J, V52, P66, DOI 10.1093/ilar.52.1.66; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Luis CA, 2009, AGING NEUROPSYCHOL C, V16, P203, DOI 10.1080/13825580802411766; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Patel NV, 2005, NEUROBIOL AGING, V26, P995, DOI 10.1016/j.neurobiolaging.2004.09.014; Petersen RC, 1995, NEUROLOGIST, V1, P326; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Prinzen C, 2005, FASEB J, V19, P1522, DOI 10.1096/fj.04-3619fje; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Rahul Kumar, 2012, International Journal of Molecular Biology, V3, P49; Schneider P, 2009, CNS NEUROSCI THER, V15, P358, DOI 10.1111/j.1755-5949.2009.00104.x; TAYLOR WH, 1969, BRIT J ANAESTH, V41, P227, DOI 10.1093/bja/41.3.227; Thadikkaran L, 2005, PROTEOMICS, V5, P3019, DOI 10.1002/pmic.200402053; Vlassenko AG, 2010, P NATL ACAD SCI USA, V107, P17763, DOI 10.1073/pnas.1010461107	26	107	111	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e61560	10.1371/journal.pone.0061560	http://dx.doi.org/10.1371/journal.pone.0061560			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	24040333	Green Published, gold, Green Submitted			2022-12-25	WOS:000317893400075
J	Singh, NK; Kumar, KRR; Kumar, D; Shukla, P; Kirti, PB				Singh, Naveen Kumar; Kumar, Koppolu Raja Rajesh; Kumar, Dilip; Shukla, Pawan; Kirti, P. B.			Characterization of a Pathogen Induced Thaumatin-Like Protein Gene AdTLP from Arachis diogoi, a Wild Peanut	PLOS ONE			English	Article							OSMOTIN-LIKE PROTEIN; ANTIFREEZE PROTEINS; ANTIFUNGAL PROTEIN; ENHANCES RESISTANCE; BINDING PROTEINS; EXPRESSION; WHEAT; OVEREXPRESSION; INHIBITOR; TOLERANCE	Peanut (Arachis hypogaea L) is one of the widely cultivated and leading oilseed crops of the world and its yields are greatly affected by various biotic and abiotic stresses. Arachis diogoi, a wild relative of peanut, is an important source of genes for resistance against various stresses that affect peanut. In our previous study a thaumatin-like protein gene was found to be upregulated in a differential expression reverse transcription PCR (DDRT-PCR) study using the conidial spray of the late leaf spot pathogen, Phaeoisariopsis personata. In the present study, the corresponding full length cDNA was cloned using RACE-PCR and has been designated as AdTLP. It carried an open reading frame of 726 bp potentially capable of encoding a polypeptide of 241 amino acids with 16 conserved cysteine residues. The semi-quantitative RT-PCR analysis showed that the transcript level of AdTLP increased upon treatment with the late leaf spot pathogen of peanut, P. personata and various hormone treatments indicating its involvement in both, biotic and abiotic stresses. The antifungal activity of the purified recombinant protein was checked against different fungal pathogens, which showed enhanced anti-fungal activity compared to many other reported TLP proteins. The recombinant AdTLP-GFP fusion protein was found to be predominantly localized to extracellular spaces. Transgenic tobacco plants ectopically expressing AdTLP showed enhanced resistance to fungal pathogen, Rhizoctonia solani. The seedling assays showed enhanced tolerance of AdTLP transgenic plants against salt and oxidative stress. The transcript analysis of various defense related genes highlighted constitutively higher level expression of PR1a, PI-I and PI-II genes in transgenic plants. These results suggest that the AdTLP is a good candidate gene for enhancing stress resistance in crop plants.	[Singh, Naveen Kumar; Kumar, Koppolu Raja Rajesh; Kumar, Dilip; Shukla, Pawan; Kirti, P. B.] Univ Hyderabad, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Singh, NK (corresponding author), Univ Hyderabad, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India.	naveenks11@gmail.com	König, Simone/B-6504-2008; KUMAR, DINESH/GRJ-5448-2022; Kirti, P.B./R-1504-2019; Mani, Kannan/AFT-0678-2022; Kumar, Dilip/GQB-0364-2022; Krishnan, Muthukalingan/AAA-5953-2021	König, Simone/0000-0003-0672-7246; KUMAR, DINESH/0000-0002-9641-6662; Mani, Kannan/0000-0002-0897-8842; Kumar, Dilip/0000-0003-3721-4718; Kumar, Dilip/0000-0003-4566-1446; Singh, Naveen Kumar/0000-0001-7673-0198; PRASAD, TULIKA/0000-0003-1617-8375; Kumar, Koppolu Raja Rajesh/0000-0001-5153-6671	Council of Scientific and Industrial Research [38-1290/11/EMR-II]; Government of India; UGC	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Government of India; UGC(University Grants Commission, India)	This work was supported by a grant from the Council of Scientific and Industrial Research (grant no. 38-1290/11/EMR-II), Government of India. KRRK was supported by Dr. D. S. Kothari postdoctoral fellowship from UGC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya K, 2013, MOL BIOTECHNOL, V54, P609, DOI 10.1007/s12033-012-9603-y; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Chu KT, 2003, BIOCHEM BIOPH RES CO, V301, P364, DOI 10.1016/S0006-291X(02)02998-4; CORNELISSEN BJC, 1986, NATURE, V321, P531, DOI 10.1038/321531a0; Dafoe NJ, 2009, J PROTEOME RES, V8, P2341, DOI 10.1021/pr800968r; Das M, 2011, TRANSGENIC RES, V20, P231, DOI 10.1007/s11248-010-9405-6; Datta K, 1999, THEOR APPL GENET, V98, P1138, DOI 10.1007/s001220051178; Doxey AC, 2006, NAT BIOTECHNOL, V24, P852, DOI 10.1038/nbt1224; El-Kereamy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017973; Ferreira RB, 2007, MOL PLANT PATHOL, V8, P677, DOI [10.1111/j.1364-3703.2007.00419.x, 10.1111/J.1364-3703.2007.00419.X]; Fierens E, 2007, BIOCHEM J, V403, P583, DOI 10.1042/BJ20061291; Fierens E, 2009, J ENZYM INHIB MED CH, V24, P646, DOI 10.1080/14756360802321831; Franco OL, 2002, EUR J BIOCHEM, V269, P397, DOI 10.1046/j.0014-2956.2001.02656.x; Fu DL, 2005, PLANT SCI, V168, P671, DOI 10.1016/j.plantsci.2004.09.032; Gao LL, 2007, MOL PLANT MICROBE IN, V20, P82, DOI 10.1094/MPMI-20-0082; Garcia-Casado C, 2000, PHYSIOL PLANTARUM, V110, P172; Goel D, 2010, PROTOPLASMA, V245, P133, DOI 10.1007/s00709-010-0158-0; Gomez-Leyva JF, 2001, J PLANT PHYSIOL, V158, P177, DOI 10.1078/0176-1617-00191; Grenier J, 2000, MYCOLOGIA, V92, P841, DOI 10.2307/3761579; Grenier J, 1999, PLANT J, V19, P473, DOI 10.1046/j.1365-313X.1999.00551.x; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Ho VSM, 2007, PEPTIDES, V28, P760, DOI 10.1016/j.peptides.2007.01.005; HON WC, 1995, PLANT PHYSIOL, V109, P879, DOI 10.1104/pp.109.3.879; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Jami SK, 2007, J PLANT PHYSIOL, V164, P238, DOI 10.1016/j.jplph.2006.01.006; Johnson ET, 2011, MOL GENET GENOMICS, V285, P517, DOI 10.1007/s00438-011-0626-z; Kempema LA, 2007, PLANT PHYSIOL, V143, P849, DOI 10.1104/pp.106.090662; Kim BG, 2009, PHYSIOL MOL PLANT P, V74, P3, DOI 10.1016/j.pmpp.2009.07.001; Kim MJ, 2005, PLANT MOL BIOL, V59, P981, DOI 10.1007/s11103-005-2619-y; Kobayashi K, 2000, PLANT CELL PHYSIOL, V41, P148, DOI 10.1093/pcp/41.2.148; Kombrink E., 1997, PLANT RELATIONSHIPS, DOI [10.1007/978-3-662-10370-8_7, DOI 10.1007/978-3-662-10370-8_7]; Kumar KRR, 2011, PLANT MOL BIOL, V75, P497, DOI 10.1007/s11103-011-9747-3; Kuwabara C, 2002, PHYSIOL PLANTARUM, V115, P101, DOI 10.1034/j.1399-3054.2002.1150112.x; Ladyzhenskaia E P, 2006, Prikl Biokhim Mikrobiol, V42, P462; Liu JJ, 2010, PLANT CELL REP, V29, P419, DOI 10.1007/s00299-010-0826-8; Looze Y, 2009, PHYTOCHEMISTRY, V70, P970, DOI 10.1016/j.phytochem.2009.05.005; Mackintosh CA, 2007, PLANT CELL REP, V26, P479, DOI 10.1007/s00299-006-0265-8; Munis MFH, 2010, BIOCHEM BIOPH RES CO, V393, P38, DOI 10.1016/j.bbrc.2010.01.069; Ogoshi A, 1996, RHIZOCTONIA SPECIES: TAXONOMY, MOLECULAR BIOLOGY, ECOLOGY, PATHOLOGY AND DISEASE CONTROL, P1; Pande S, 2001, PLANT DIS, V85, P851, DOI 10.1094/PDIS.2001.85.8.851; Pressey R, 1997, PHYTOCHEMISTRY, V44, P1241, DOI 10.1016/S0031-9422(96)00667-X; Rajam MV, 2007, BIOL PLANTARUM, V51, P135, DOI 10.1007/s10535-007-0026-8; Rao NK, 2003, GENET RESOUR CROP EV, V50, P707, DOI 10.1023/A:1025055018954; ROBERTS WK, 1990, J GEN MICROBIOL, V136, P1771, DOI 10.1099/00221287-136-9-1771; Sakamoto Y, 2006, PLANT PHYSIOL, V141, P793, DOI 10.1104/pp.106.076679; Seo PJ, 2008, PLANT CELL PHYSIOL, V49, P334, DOI 10.1093/pcp/pcn011; Song XM, 2005, PLANT MOL BIOL, V57, P13, DOI 10.1007/s11103-004-6637-y; Tachi H, 2009, PLANT PHYSIOL BIOCH, V47, P73, DOI 10.1016/j.plaphy.2008.09.012; Takemoto D, 1997, PLANT CELL PHYSIOL, V38, P441, DOI 10.1093/oxfordjournals.pcp.a029187; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Velazhahan R, 2003, BIOL PLANTARUM, V47, P347, DOI 10.1023/B:BIOP.0000023876.55053.5e; Velazhahan R, 1999, PATHOGENESIS-RELATED PROTEINS IN PLANTS, P107; Vijayan S, 2008, APPL MICROBIOL BIOT, V80, P1023, DOI 10.1007/s00253-008-1648-2; Vitali A, 2006, PLANT PHYSIOL BIOCH, V44, P604, DOI 10.1016/j.plaphy.2006.09.008; Wang QH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016930; Wang XJ, 2010, PHYSIOL PLANTARUM, V139, P27, DOI 10.1111/j.1399-3054.2009.01338.x; Ye XY, 1999, BIOCHEM BIOPH RES CO, V263, P130, DOI 10.1006/bbrc.1999.1166; Yeh S, 2000, PLANT PHYSIOL, V124, P1251, DOI 10.1104/pp.124.3.1251; Zarate SI, 2007, PLANT PHYSIOL, V143, P866, DOI 10.1104/pp.106.090035	61	79	97	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e83963	10.1371/journal.pone.0083963	http://dx.doi.org/10.1371/journal.pone.0083963			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	24367621	gold, Green Published, Green Submitted			2022-12-25	WOS:000328741900026
J	Muller, L; Goncalves, GL; Cordeiro-Estrela, P; Marinho, JR; Althoff, SL; Testoni, AF; Gonzalez, EM; Freitas, TRO				Mueller, Livia; Goncalves, Gislene L.; Cordeiro-Estrela, Pedro; Marinho, Jorge R.; Althoff, Sergio L.; Testoni, Andre F.; Gonzalez, Enrique M.; Freitas, Thales R. O.			DNA Barcoding of Sigmodontine Rodents: Identifying Wildlife Reservoirs of Zoonoses	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; TRYPANOSOMA-CRUZI; SPECIES DELIMITATION; DELTAMYS-KEMPI; HANTAVIRUS; GENUS; TRANSMISSION; CRICETIDAE; MAMMALS; AREAS	Species identification through DNA barcoding is a tool to be added to taxonomic procedures, once it has been validated. Applying barcoding techniques in public health would aid in the identification and correct delimitation of the distribution of rodents from the subfamily Sigmodontinae. These rodents are reservoirs of etiological agents of zoonoses including arenaviruses, hantaviruses, Chagas disease and leishmaniasis. In this study we compared distance-based and probabilistic phylogenetic inference methods to evaluate the performance of cytochrome c oxidase subunit I (COI) in sigmodontine identification. A total of 130 sequences from 21 field-trapped species (13 genera), mainly from southern Brazil, were generated and analyzed, together with 58 GenBank sequences (24 species; 10 genera). Preliminary analysis revealed a 9.5% rate of misidentifications in the field, mainly of juveniles, which were reclassified after examination of external morphological characters and chromosome numbers. Distance and model-based methods of tree reconstruction retrieved similar topologies and monophyly for most species. Kernel density estimation of the distance distribution showed a clear barcoding gap with overlapping of intraspecific and interspecific densities < 1% and 21 species with mean intraspecific distance < 2%. Five species that are reservoirs of hantaviruses could be identified through DNA barcodes. Additionally, we provide information for the description of a putative new species, as well as the first COI sequence of the recently described genus Drymoreomys. The data also indicated an expansion of the distribution of Calomys tener. We emphasize that DNA barcoding should be used in combination with other taxonomic and systematic procedures in an integrative framework and based on properly identified museum collections, to improve identification procedures, especially in epidemiological surveillance and ecological assessments.	[Mueller, Livia; Goncalves, Gislene L.; Cordeiro-Estrela, Pedro; Freitas, Thales R. O.] Univ Fed Rio Grande do Sul, Dept Genet, Lab Citogenet & Evolucao, Porto Alegre, RS, Brazil; [Mueller, Livia; Goncalves, Gislene L.; Cordeiro-Estrela, Pedro; Freitas, Thales R. O.] Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil; [Cordeiro-Estrela, Pedro] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol & Parasitol Mamiferos Silvestres Reserva, Rio De Janeiro, Brazil; [Cordeiro-Estrela, Pedro] Univ Fed Paraiba, Dept Sistemat & Ecol, Lab Mamiferos, BR-58059900 Joao Pessoa, Paraiba, Brazil; [Marinho, Jorge R.] Univ Reg Integrada Alto Uruguai & Missoes, Erechim, RS, Brazil; [Althoff, Sergio L.; Testoni, Andre F.] Fundacao Univ Reg Blumenau, Blumenau, SC, Brazil; [Gonzalez, Enrique M.] Museo Nacl Hist Nat, Montevideo, Uruguay	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Fundacao Oswaldo Cruz; Universidade Federal da Paraiba; Universidade Regional Integrada do Alto Uruguai e das Missoes (URI); Universidade Regional de Blumenau (FURB)	Cordeiro-Estrela, P (corresponding author), Univ Fed Rio Grande do Sul, Dept Genet, Lab Citogenet & Evolucao, Porto Alegre, RS, Brazil.	pedroestrela@yahoo.com	Goncalves, Gislene Lopes/D-3567-2013; Köstler, Herbert/B-2089-2010; Cordeiro-Estrela, Pedro/A-2913-2015; Freitas, Thales Renato Ochotorena de/G-1160-2012; Marinho, Jorge/AAC-1097-2019; Althoff, Sérgio Luiz/AAE-5820-2020; Nichols, Thomas E./N-9902-2017	Goncalves, Gislene Lopes/0000-0002-1459-4888; Köstler, Herbert/0000-0001-6207-9226; Freitas, Thales Renato Ochotorena de/0000-0002-1019-9303; Nichols, Thomas E./0000-0002-4516-5103; Althoff, Sergio Luiz/0000-0002-0877-5156; Testoni, Andre Filipe/0000-0002-4680-0092; Cordeiro-Estrela, Pedro/0000-0003-3383-571X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); CAPES-CNPq-PROTAX; PDJ CNPq FIOCRUZ [500091/2010-2]; CNPq [141604/2007-7]; BrBOL: Brazilian Barcoding of Life under project Tetrapoda	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES-CNPq-PROTAX(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PDJ CNPq FIOCRUZ; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); BrBOL: Brazilian Barcoding of Life under project Tetrapoda	This research was financially supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). PCE was funded by CAPES-CNPq-PROTAX and by PDJ CNPq FIOCRUZ 500091/2010-2. G. L. Goncalves received CNPq fellowship (141604/2007-7). This study was supported by BrBOL: Brazilian Barcoding of Life under project Tetrapoda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrellos R, 2012, ZOOTAXA, P1; Almeida FC, 2007, MOL PHYLOGENET EVOL, V42, P449, DOI 10.1016/j.ympev.2006.07.005; Badzinski C, 2012, CHECK LIST, V8, P264, DOI DOI 10.15560/8.2.264; Bonvicino CR, 2010, ZOOTAXA, P19, DOI 10.11646/zootaxa.2336.1.2; Bonvicino CR, 2008, GUIA ROEDORES BRASIL; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; Castro E.C., 1991, Cytobios, V68, P153; Chu YK, 2006, AM J TROP MED HYG, V75, P1127, DOI 10.4269/ajtmh.2006.75.1127; Chu YK, 2009, EMERG INFECT DIS, V15, P1977, DOI 10.3201/eid1512.090338; D'Elia G, 2003, CLADISTICS, V19, P307, DOI 10.1016/S0748-3007(03)00071-9; de Oliveira JA, 2002, ACTA THERIOL, V47, P307, DOI 10.1007/BF03194149; de Oliveira RC, 2012, MEM I OSWALDO CRUZ, V107, P424, DOI 10.1590/S0074-02762012000300020; DEFRONZA TMLG, 1981, CARYOLOGIA, V34, P457, DOI 10.1080/00087114.1981.10796914; DeSalle R, 2006, CONSERV BIOL, V20, P1545, DOI 10.1111/j.1523-1739.2006.00543.x; Donalisio MR, 2011, ACTA TROP, V119, P125, DOI 10.1016/j.actatropica.2011.04.019; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Ebach MC, 2005, NATURE, V434, P697, DOI 10.1038/434697b; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fichet-Calvet E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000388; Firth C, 2012, J VIROL, V86, P13756, DOI 10.1128/JVI.02341-12; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Goncalves Pablo Rodrigues, 2007, MISCELLANEOUS PUBLICATIONS MUSEUM OF ZOOLOGY UNIVERSITY OF MICHIGAN, P1; Goncalves PR, 2005, MAMM BIOL, V70, P46, DOI 10.1078/1616-5047-00175; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haag T, 2007, J MAMMAL, V88, P769, DOI 10.1644/05-MAMM-A-319R1.1; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Herrera HM, 2011, T ROY SOC TROP MED H, V105, P380, DOI 10.1016/j.trstmh.2011.04.008; Ittig REG, 2004, HEREDITY, V93, P535, DOI 10.1038/sj.hdy.6800546; Jayat J. Pablo, 2010, Zootaxa, V2409, P1; Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09; KIMURA M, 1980, P NATL ACAD SCI-BIOL, V77, P522, DOI 10.1073/pnas.77.1.522; Lowenstein JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007866; Nagy Zoltan T, 2012, PLoS One, V7, pe34506, DOI 10.1371/journal.pone.0034506; Nicolas V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036586; Nylander J.A.A., 2004, MRAIC PL; Oliveira RC, 2011, VECTOR-BORNE ZOONOT, V3, P301; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Percequillo AR, 2011, ZOOL J LINN SOC-LOND, V161, P357, DOI 10.1111/j.1096-3642.2010.00643.x; Percequillo AR, 2008, AM MUS NOVIT, P1, DOI 10.1206/495.1; Percequillo AR, 2005, J MAMMAL, V86, P873, DOI 10.1644/1545-1542(2005)86[873:ANSONI]2.0.CO;2; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Porcasi Ximena, 2005, Mastozool. neotrop., V12, P199; Puillandre N, 2012, MOL ECOL, V21, P2671, DOI 10.1111/j.1365-294X.2012.05559.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; R Core Team, 2021, R LANG ENV STAT COMP; Raboni SM, 2012, AM J TROP MED HYG, V87, P371, DOI 10.4269/ajtmh.2012.11-0762; Raboni SM, 2009, J GEN VIROL, V90, P2166, DOI 10.1099/vir.0.011585-0; Rambaut A., 2006, FIGTREE TREE FIGURE; Rivera PC, 2007, ZOOL SCR, V36, P231, DOI 10.1111/j.1463-6409.2007.00273.x; Rocha FL, 2013, PARASITOLOGY, V140, P160, DOI 10.1017/S0031182012001539; Rocha Rita G., 2011, Zootaxa, V2789, P1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roque ALR, 2008, AM J TROP MED HYG, V79, P742, DOI 10.4269/ajtmh.2008.79.742; Salazar-Bravo J, 2002, INFECT GENET EVOL, V1, P191, DOI 10.1016/S1567-1348(02)00026-6; Sambrook J., 1989, MOL CLONING LAB MANU; SBALQUEIRO IJ, 1984, CYTOGENET CELL GENET, V38, P50, DOI 10.1159/000132029; Sirovich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009266; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Smith Margaret F., 1999, Journal of Mammalian Evolution, V6, P89, DOI 10.1023/A:1020668004578; Stahls G, 2008, MOL PHYLOGENET EVOL, V46, P82, DOI 10.1016/j.ympev.2007.09.009; Steiner-Souza F, 2008, ZOOTAXA, P28, DOI 10.11646/zootaxa.1824.1.3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; da Rosa EST, 2012, EMERG INFECT DIS, V18, P982, DOI 10.3201/eid1806.110948; Ventura K, 2011, CYTOGENET GENOME RES, V135, P126, DOI 10.1159/000331584; Weksler M, 2003, MOL PHYLOGENET EVOL, V29, P331, DOI 10.1016/S1055-7903(03)00132-5; Weksler M., 2005, ARQUIVOS MUSEU NACL, V63, P113; Weksler M, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3537[1:TNGOOR]2.0.CO;2; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Wilson D.E., 2005, MAMMAL SPECIES WORLD; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Zou SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026619	73	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80282	10.1371/journal.pone.0080282	http://dx.doi.org/10.1371/journal.pone.0080282			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24040262	Green Published, gold, Green Submitted			2022-12-25	WOS:000327221600200
J	Singh, NK; Pakkianathan, BC; Kumar, M; Prasad, T; Kannan, M; Konig, S; Krishnan, M				Singh, Nitin Kumar; Pakkianathan, Britto Cathrin; Kumar, Manish; Prasad, Tulika; Kannan, Mani; Koenig, Simone; Krishnan, Muthukalingan			Vitellogenin from the Silkworm, Bombyx mori: An Effective Anti-Bacterial Agent	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTOR; PURIFICATION; PROTEIN; HEMOLYMPH; BINDING; IDENTIFICATION; LIPOPROTEINS; LEPIDOPTERA; EXPRESSION; PHOSVITIN	Silkworm, Bombyx mori, vitellogenin (Vg) was isolated from perivisceral fat body of day 3 of pupa. Both Vg subunits were co-purified as verified by mass spectrometry and immunoblot. Purified Vg responded to specific tests for major posttranslational modifications on native gels indicating its nature as lipo-glyco-phosphoprotein. The Vg fraction had strong antibacterial activity against Gram negative bacterium Escherichia coli and Gram positive bacterium Bacillus subtilis. Microscopic images showed binding of Vg to bacterial cells and their destruction. When infected silkworm larvae were treated with purified Vg they survived the full life cycle in contrast to untreated animals. This result showed that Vg has the ability to inhibit the proliferation of bacteria in the silkworm fluid system without disturbing the regular metabolism of the host.	[Singh, Nitin Kumar; Pakkianathan, Britto Cathrin; Kannan, Mani; Krishnan, Muthukalingan] Bharathidasan Univ, Dept Environm Biotechnol, Tiruchirappalli, Tamil Nadu, India; [Kumar, Manish; Prasad, Tulika] Jawaharlal Nehru Univ, Adv Instrumentat Res Facil, New Delhi 110067, India; [Koenig, Simone] Univ Munster, Interdisciplinary Ctr Clin Res, D-48149 Munster, Germany	Bharathidasan University; Jawaharlal Nehru University, New Delhi; University of Munster	Krishnan, M (corresponding author), Bharathidasan Univ, Dept Environm Biotechnol, Tiruchirappalli, Tamil Nadu, India.	profmkrish@gmail.com	König, Simone/B-6504-2008; KUMAR, DINESH/GRJ-5448-2022; Kirti, P.B./R-1504-2019; Mani, Kannan/AFT-0678-2022; Kumar, Dilip/GQB-0364-2022; Krishnan, Muthukalingan/AAA-5953-2021	König, Simone/0000-0003-0672-7246; KUMAR, DINESH/0000-0002-9641-6662; Mani, Kannan/0000-0002-0897-8842; Kumar, Dilip/0000-0003-3721-4718; Kumar, Dilip/0000-0003-4566-1446; Singh, Naveen Kumar/0000-0001-7673-0198; PRASAD, TULIKA/0000-0003-1617-8375; Kumar, Koppolu Raja Rajesh/0000-0001-5153-6671	Indo-German Academic Exchange Service PPP program; Department of Biotechnology; Department of Science and Technology; University Grant Commission (UGC); DST-FIST, New Delhi, India; BRNS Mumbai	Indo-German Academic Exchange Service PPP program; Department of Biotechnology; Department of Science and Technology(Department of Science & Technology (India)); University Grant Commission (UGC)(University Grants Commission, India); DST-FIST, New Delhi, India(Department of Science & Technology (India)); BRNS Mumbai(Department of Atomic Energy (DAE)Board of Research in Nuclear Sciences (BRNS))	This project was made possible by funding of the Indo-German Academic Exchange Service PPP program. The authors are highly thankful to Department of Biotechnology, Department of Science and Technology, University Grant Commission (UGC), DST-FIST, New Delhi, India, and BRNS Mumbai for providing the financial support to carry out this research work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiyodi KG, 2002, ENFIELD REPROD BIO A, P70; Almenara DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053460; Amdam GV, 2006, NATURE, V439, P76, DOI 10.1038/nature04340; Choi So Joung, 1997, Korean Journal of Entomology, V27, P53; CUTTING JA, 1973, ANAL BIOCHEM, V54, P386, DOI 10.1016/0003-2697(73)90367-9; Garcia J, 2010, FISH SHELLFISH IMMUN, V29, P293, DOI 10.1016/j.fsi.2010.04.010; HAGEDORN HH, 1979, ANNU REV ENTOMOL, V24, P475, DOI 10.1146/annurev.en.24.010179.002355; HARNISH DG, 1982, J EXP ZOOL, V220, P1, DOI 10.1002/jez.1402200102; HAUNERLAND NH, 1987, ANAL BIOCHEM, V161, P307, DOI 10.1016/0003-2697(87)90455-6; Havukainen H, 2011, J EXP BIOL, V214, P582, DOI 10.1242/jeb.048314; Hyrsl P, 2005, BIOLOGIA, V60, P207; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Khan MAS, 2000, J AGR FOOD CHEM, V48, P1503, DOI 10.1021/jf990700r; Krishnan M., 2010, MASS SPECTROM, V2, P179; Li AK, 2003, J BIOL CHEM, V278, P2799, DOI 10.1074/jbc.M205067200; Li ZJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001940; Liu Chao Liang, 2001, Journal of Insect Biotechnology and Sericology, V70, P95; Liu QH, 2009, IMMUNOBIOLOGY, V214, P257, DOI 10.1016/j.imbio.2008.10.003; Magalhaes I, 2004, J CHROMATOGR B, V799, P87, DOI 10.1016/j.jchromb.2003.10.026; Maltais D, 2009, FISH PHYSIOL BIOCHEM, V35, P241, DOI 10.1007/s10695-008-9205-6; Maruta K, 2002, ARCH INSECT BIOCHEM, V50, P97, DOI 10.1002/arch.10035; Meng Yan, 2008, Journal of Insect Biotechnology and Sericology, V77, P35; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; MUNDALL EC, 1979, COMP BIOCHEM PHYS B, V63, P459, DOI 10.1016/0305-0491(79)90047-6; Nakamura A, 1999, BIOCHEM BIOPH RES CO, V264, P580, DOI 10.1006/bbrc.1999.1549; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Pakkianathan BC, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-5; PAN ML, 1971, J INSECT PHYSIOL, V17, P677, DOI 10.1016/0022-1910(71)90116-8; PAN ML, 1969, SCIENCE, V165, P393, DOI 10.1126/science.165.3891.393; Rono MK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000434; Rosenberg IM, 1996, PROTEIN ANAL PURIFIC, P265; Sambook J, 1989, MOL CLONING LAB MANU; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Shi XD, 2006, FISH SHELLFISH IMMUN, V20, P769, DOI 10.1016/j.fsi.2005.09.005; Smolenaars MMW, 2007, J LIPID RES, V48, P489, DOI 10.1194/jlr.R600028-JLR200; STIFANI S, 1990, BIOCHIM BIOPHYS ACTA, V1045, P271, DOI 10.1016/0005-2760(90)90130-P; Tong Z, 2010, IMMUNOBIOLOGY, V215, P898, DOI 10.1016/j.imbio.2009.10.001; Tufail M, 2000, ARCH INSECT BIOCHEM, V45, P37, DOI 10.1002/1520-6327(200009)45:1&lt;37::AID-ARCH4&gt;3.0.CO;2-8; Vanishree V, 1998, THESIS BHARATHIDASAN; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang SH, 2011, J BIOL CHEM, V286, P22653, DOI 10.1074/jbc.M111.247635; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Warrier S, 2002, MOL REPROD DEV, V61, P536, DOI 10.1002/mrd.10106; WHEELER DE, 1990, ARCH INSECT BIOCHEM, V14, P253, DOI 10.1002/arch.940140405; YANO K, 1994, BBA-GENE STRUCT EXPR, V1218, P1, DOI 10.1016/0167-4781(94)90094-9; YANO K, 1994, FEBS LETT, V356, P207, DOI 10.1016/0014-5793(94)01265-2; ZACHARIUS RM, 1969, ANAL BIOCHEM, V30, P148, DOI 10.1016/0003-2697(69)90383-2; Zhang SC, 2005, FISH SHELLFISH IMMUN, V19, P93, DOI 10.1016/j.fsi.2004.10.008; Zhang SC, 2011, INT J BIOCHEM CELL B, V43, P303, DOI 10.1016/j.biocel.2010.11.003	50	79	97	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73005	10.1371/journal.pone.0073005	http://dx.doi.org/10.1371/journal.pone.0073005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24367621	Green Published, Green Submitted, gold			2022-12-25	WOS:000324408400013
J	Virgili, N; Mancera, P; Wappenhans, B; Sorrosal, G; Biber, K; Pugliese, M; Espinosa-Parrilla, JF				Virgili, Noemi; Mancera, Pilar; Wappenhans, Blanca; Sorrosal, Georgina; Biber, Knut; Pugliese, Marco; Espinosa-Parrilla, Juan F.			K-ATP Channel Opener Diazoxide Prevents Neurodegeneration: A New Mechanism of Action via Antioxidative Pathway Activation	PLOS ONE			English	Article							SENSITIVE POTASSIUM CHANNEL; FUMARIC-ACID ESTERS; MULTIPLE-SCLEROSIS; AUTOIMMUNE ENCEPHALOMYELITIS; DOPAMINE RELEASE; OXIDATIVE STRESS; ROS PRODUCTION; AMYLOID-BETA; CELL-DEATH; NEURONS	Pharmacological modulation of ATP-sensitive potassium channels has become a promising new therapeutic approach for the treatment of neurodegenerative diseases due to their role in mitochondrial and cellular protection. For instance, diazoxide, a well-known ATP-sensitive potassium channel activator with high affinity for mitochondrial component of the channel has been proved to be effective in animal models for different diseases such as Alzheimer's disease, stroke or multiple sclerosis. Here, we analyzed the ability of diazoxide for protecting neurons front different neurotoxic insults in vitro and ex vivo. Results showed that diazoxide effectively protects NSC-34 motoneurons from glutamatergic, oxidative and inflammatory damage. Moreover, diazoxide decreased neuronal death in organotypic hippocampal slice cultures after exicitotoxicity and preserved myelin sheath in organotypic cerebellar cultures exposed to pro-inflammatory demyelinating damage. In addition, we demonstrated that one of the mechanisms of actions implied in the neuroprotective role of diazoxide is mediated by the activation of Nrf2 expression and nuclear translocation. Nrf2 expression was increased in NSC-34 neurons in vitro as well as in the spinal cord of experimental autoimmune encephalomyelitis animals orally administered with diazoxide. Thus, diazoxide is a neuroprotective agent against oxidative stress-induced damage and cellular dysfunction that can be beneficial for diseases such as multiple sclerosis.	[Virgili, Noemi; Mancera, Pilar; Wappenhans, Blanca; Pugliese, Marco; Espinosa-Parrilla, Juan F.] Neurotec Pharma SL, Bioincubadora PCB Santander, Barcelona, Spain; [Sorrosal, Georgina] Advancell SA, Barcelona, Spain; [Biber, Knut] Univ Freiburg, Dept Psychiat & Psychotherapy, D-79106 Freiburg, Germany; [Pugliese, Marco] Univ Barcelona, Dept Ciencies Fisiol 1, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Pugliese, Marco] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona, Spain	University of Freiburg; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBERNED	Pugliese, M (corresponding author), Neurotec Pharma SL, Bioincubadora PCB Santander, Parc Cient Barcelona, Barcelona, Spain.	marcopugliese@neurotec-pharma.com		Espinosa-Parrilla, Juan Francisco/0000-0001-6631-3542	Ministerio de Economia y Competividad (INNPACTO Program); l'Agencia de Suport a l'Empresa Catalana (ACC1O) (Nuclis d'Innovacio Tecnologica program), Generalitat de Catalunya, Spain	Ministerio de Economia y Competividad (INNPACTO Program); l'Agencia de Suport a l'Empresa Catalana (ACC1O) (Nuclis d'Innovacio Tecnologica program), Generalitat de Catalunya, Spain	The study was supported by by Ministerio de Economia y Competividad (INNPACTO Program) and by l'Agencia de Suport a l'Empresa Catalana (ACC1O) (Nuclis d'Innovacio Tecnologica program), Generalitat de Catalunya, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe E, 2010, BRAIN RES, V1330, P151, DOI 10.1016/j.brainres.2010.02.074; Aktas O, 2004, J IMMUNOL, V173, P5794, DOI 10.4049/jimmunol.173.9.5794; AMOROSO S, 1990, SCIENCE, V247, P852, DOI 10.1126/science.2305257; ASHCROFT FM, 1988, J PHYSIOL-LONDON, V400, P501, DOI 10.1113/jphysiol.1988.sp017134; Ashcroft FM, 2006, BIOCHEM SOC T, V34, P243, DOI 10.1042/BST0340243; Bajgar R, 2001, J BIOL CHEM, V276, P33369, DOI 10.1074/jbc.M103320200; Birgbauer E, 2004, J NEUROSCI RES, V78, P157, DOI 10.1002/jnr.20248; Busija DW, 2008, ADV DRUG DELIVER REV, V60, P1471, DOI 10.1016/j.addr.2008.03.020; Calabrese V, 2007, NEUROCHEM RES, V32, P757, DOI 10.1007/s11064-006-9203-y; Cancherini DV, 2003, AM J PHYSIOL-RENAL, V285, pF1291, DOI 10.1152/ajprenal.00103.2003; Choi EM, 2009, EUR J PHARMACOL, V624, P45, DOI 10.1016/j.ejphar.2009.09.041; Correia SC, 2010, J ALZHEIMERS DIS, V20, pS475, DOI 10.3233/JAD-2010-100669; de Vries HE, 2008, FREE RADICAL BIO MED, V45, P1375, DOI 10.1016/j.freeradbiomed.2008.09.001; Debska G, 2002, BBA-BIOENERGETICS, V1556, P97, DOI 10.1016/S0005-2728(02)00340-7; di Penta A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054722; Eggett CJ, 2000, J NEUROCHEM, V74, P1895, DOI 10.1046/j.1471-4159.2000.0741895.x; Ejarque-Ortiz A, 2010, J NEUROSCI RES, V88, P1113, DOI 10.1002/jnr.22272; Ellrichmann G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016172; Facundo HTF, 2007, FREE RADICAL BIO MED, V42, P1039, DOI 10.1016/j.freeradbiomed.2007.01.001; Fogal B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010906; Fornazari M, 2008, J NEUROSCI RES, V86, P1548, DOI 10.1002/jnr.21614; Foster DB, 2012, CIRC RES, V111, P446, DOI 10.1161/CIRCRESAHA.112.266445; Garlid KD, 1997, CIRC RES, V81, P1072; Garlid KD, 1996, J BIOL CHEM, V271, P8796, DOI 10.1074/jbc.271.15.8796; Garlid KD, 2012, J MOL CELL CARDIOL, V52, P578, DOI 10.1016/j.yjmcc.2011.12.011; Goodman Y, 1996, BRAIN RES, V706, P328, DOI 10.1016/0006-8993(95)01367-9; HALESTRAP AP, 1989, BIOCHIM BIOPHYS ACTA, V973, P355, DOI 10.1016/S0005-2728(89)80378-0; INOUE I, 1991, NATURE, V352, P244, DOI 10.1038/352244a0; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kobayashi Akira, 2006, Tanpakushitsu Kakusan Koso, V51, P1304; Kong WM, 2011, BRAIN BEHAV IMMUN, V25, P872, DOI 10.1016/j.bbi.2010.09.012; Lee DH, 2012, INT J MOL SCI, V13, P11783, DOI 10.3390/ijms130911783; Levin BE, 2000, BRAIN RES, V874, P158, DOI 10.1016/S0006-8993(00)02573-7; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Liu D, 2010, J ALZHEIMERS DIS, V22, P443, DOI 10.3233/JAD-2010-101017; Liu JL, 1998, J NEUROSCI, V18, P7768; Maneuf YP, 1996, EXP NEUROL, V139, P12, DOI 10.1006/exnr.1996.0075; Miller DM, 2013, FREE RADICAL BIO MED, V57, P1, DOI 10.1016/j.freeradbiomed.2012.12.011; MIZUNO Y, 1984, BRAIN RES, V307, P109, DOI 10.1016/0006-8993(84)90466-9; Moharregh-Khiabani D, 2009, CURR NEUROPHARMACOL, V7, P60, DOI 10.2174/157015909787602788; Nagy K, 2004, J NEUROSCI RES, V76, P697, DOI 10.1002/jnr.20120; Nakagawa I, 2013, J CLIN NEUROSCI, V20, P144, DOI 10.1016/j.jocn.2012.03.027; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Ortega FJ, 2012, EXP NEUROL, V235, P282, DOI 10.1016/j.expneurol.2012.02.010; Ortega FJ, 2013, J CEREBR BLOOD F MET, V33, P356, DOI 10.1038/jcbfm.2012.166; Patel JC, 2011, J NEUROCHEM, V118, P721, DOI 10.1111/j.1471-4159.2011.07358.x; PAUCEK P, 1992, J BIOL CHEM, V267, P26062; Raval AP, 2007, BRAIN RES, V1184, P345, DOI 10.1016/j.brainres.2007.09.073; Roseborough G, 2006, AM J PATHOL, V168, P1443, DOI 10.2353/ajpath.2006.050569; Schreibelt G, 2007, BRAIN RES REV, V56, P322, DOI 10.1016/j.brainresrev.2007.07.005; Szewczyk A, 1993, Pol J Pharmacol, V45, P437; Tan SH, 2012, NEUROL RES, V34, P707, DOI 10.1179/1743132812Y.0000000069; Teshima Y, 2003, STROKE, V34, P1796, DOI 10.1161/01.STR.0000077017.60947.AE; Tufekci KU, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/314082; van Weering HRJ, 2011, HIPPOCAMPUS, V21, P220, DOI 10.1002/hipo.20742; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Vinet J, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-27; Virgili N, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-149; Wang JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056605; Wang L, 2011, NEUROSCI LETT, V491, P63, DOI 10.1016/j.neulet.2010.12.065; Wang ZY, 2005, BRAIN RES BULL, V64, P441, DOI 10.1016/j.brainresbull.2004.10.001; Xie J, 2010, J NEUROSCI RES, V88, P428, DOI 10.1002/jnr.22213; Yamauchi T, 2003, INVEST OPHTH VIS SCI, V44, P2750, DOI 10.1167/iovs.02-0815; Yang Y, 2006, INT J NEUROPSYCHOPH, V9, P51, DOI 10.1017/S1461145705005547; Yang YJ, 2009, INT J NEUROPSYCHOPH, V12, P317, DOI 10.1017/S1461145708009243; Zhang YKJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059122; Zhou F, 2008, J CELL MOL MED, V12, P1559, DOI 10.1111/j.1582-4934.2007.00144.x	68	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e75189	10.1371/journal.pone.0075189	http://dx.doi.org/10.1371/journal.pone.0075189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24040400	Green Published, gold, Green Submitted			2022-12-25	WOS:000326734500136
J	Zheng, SQ; Ding, AJ; Li, GP; Wu, GS; Luo, HR				Zheng, Shan-Qing; Ding, Ai-Jun; Li, Guo-Ping; Wu, Gui-Sheng; Luo, Huai-Rong			Drug Absorption Efficiency in Caenorhbditis elegans Delivered by Different Methods	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; LIFE-SPAN; CALORIC RESTRICTION; DIETARY RESTRICTION; SMALL MOLECULES; MODEL; IDENTIFICATION; INCREASE; WORM; BIOACTIVITY	Background: Caenorhbditis elegans has being vigorously used as a model organism in many research fields and often accompanied by administrating with various drugs. The methods of delivering drugs to worms are varied from one study to another, which make difficult in comparing results between studies. Methodology/Principal Findings: We evaluated the drug absorption efficiency in C. elegans using five frequently used methods with resveratrol with low aqueous solubility and water-soluble 5-Fluoro-2'-deoxyuridine (FUDR) as positive compounds. The drugs were either applied to the LB medium with bacteria OP50, before spreading onto Nematode Growth Medium (NGM) plates (LB medium method), or to the NGM with live (NGM live method) or dead bacteria (NGM dead method), or spotting the drug solution to the surface of plates directly (spot dead method), or growing the worms in liquid medium (liquid growing method). The concentration of resveratrol and FUDR increased gradually within C. elegans and reached the highest during 12 hours to one day and then decreased slowly. At the same time point, the higher the drug concentration, the higher the metabolism rate. The drug concentrations in worms fed with dead bacteria were higher than with live bacteria at the same time point. Consistently, the drug concentration in medium with live bacteria decreased much faster than in medium with dead bacteria, reach to about half of the original concentration within 12 hours. Conclusion: Resveratrol with low aqueous solubility and water-soluble FUDR have the same absorption and metabolism pattern. The drug metabolism rate in worms was both dosage and time dependent. NGM dead method and liquid growing method achieved the best absorption efficiency in worms. The drug concentration within worms was comparable with that in mice, providing a bridge for dose translation from worms to mammals.	[Zheng, Shan-Qing; Ding, Ai-Jun; Luo, Huai-Rong] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Yunnan, Peoples R China; [Zheng, Shan-Qing; Ding, Ai-Jun] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Guo-Ping] Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China; [Li, Guo-Ping] Beijing Inst Geriatr, Minist Hlth, Beijing, Peoples R China; [Wu, Gui-Sheng] Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Hospital; Chinese Academy of Sciences; Kunming Institute of Zoology	Luo, HR (corresponding author), Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Yunnan, Peoples R China.	luohuairong@mail.kib.ac.cn	Luo, Huai-Rong/ABE-7525-2021	Zheng, Shanqing/0000-0002-5039-0196	Yunnan provincial government [20080A007]; 100 Talents Program of the Chinese Academy of Sciences; State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany [P2008-ZZ21, T2009-KF05]	Yunnan provincial government; 100 Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany	This work was partially supported by the Yunnan provincial government (20080A007), the 100 Talents Program of the Chinese Academy of Sciences, and the State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany (P2008-ZZ21 and T2009-KF05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg AT, 2010, RAPID COMMUN MASS SP, V24, P1447, DOI 10.1002/rcm.4535; Ajmo JM, 2008, AM J PHYSIOL-GASTR L, V295, pG833, DOI 10.1152/ajpgi.90358.2008; Anastassopoulou CG, 2011, CURR PHARM DESIGN, V17, P1225, DOI 10.2174/138161211795703753; Artal-Sanz Marto, 2006, Biotechnology Journal, V1, P1405, DOI 10.1002/biot.200600176; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596; BRENNER S, 1974, GENETICS, V77, P71; Burns AR, 2006, NAT PROTOC, V1, P1906, DOI 10.1038/nprot.2006.283; Burns AR, 2010, NAT CHEM BIOL, V6, P549, DOI [10.1038/NCHEMBIO.380, 10.1038/nchembio.380]; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Desalermos A, 2011, EXPERT OPIN DRUG DIS, V6, P645, DOI 10.1517/17460441.2011.573781; Dexter PM, 2012, NEUROTHERAPEUTICS, V9, P393, DOI 10.1007/s13311-012-0109-x; Evason K, 2005, SCIENCE, V307, P258, DOI 10.1126/science.1105299; Evason K, 2008, AGING CELL, V7, P305, DOI 10.1111/j.1474-9726.2008.00375.x; Fonseca-Kelly Zoe, 2012, Front Neurol, V3, P84, DOI 10.3389/fneur.2012.00084; GANDHI S, 1980, MECH AGEING DEV, V12, P137, DOI 10.1016/0047-6374(80)90090-1; Guarente L, 2005, MECH AGEING DEV, V126, P923, DOI 10.1016/j.mad.2005.03.013; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; JOHNSON TE, 1982, P NATL ACAD SCI-BIOL, V79, P6603, DOI 10.1073/pnas.79.21.6603; Jones DL, 2011, NAT CELL BIOL, V13, P506, DOI 10.1038/ncb0511-506; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Keaney M, 2003, FREE RADICAL BIO MED, V34, P277, DOI 10.1016/S0891-5849(02)01290-X; Kim S, 2008, BIOCHEM BIOPH RES CO, V368, P588, DOI 10.1016/j.bbrc.2008.01.131; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; Kniazeva M, 2004, PLOS BIOL, V2, P1446, DOI 10.1371/journal.pbio.0020257; Kniazeva M, 2003, GENETICS, V163, P159; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; Liao VHC, 2011, MECH AGEING DEV, V132, P480, DOI 10.1016/j.mad.2011.07.008; Masuda M, 2004, ANAL CHEM, V76, P728, DOI 10.1021/ac034840i; McColl G, 2008, J BIOL CHEM, V283, P350, DOI 10.1074/jbc.M705028200; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; MITCHELL DH, 1979, J GERONTOL, V34, P28, DOI 10.1093/geronj/34.1.28; Moy TI, 2006, P NATL ACAD SCI USA, V103, P10414, DOI 10.1073/pnas.0604055103; Nass R, 2001, PARKINSONISM RELAT D, V7, P185, DOI 10.1016/S1353-8020(00)00056-0; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; Pungaliya C, 2009, P NATL ACAD SCI USA, V106, P7708, DOI 10.1073/pnas.0811918106; Sellers WR, 2011, CELL, V147, P26, DOI 10.1016/j.cell.2011.09.016; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Stiernagle Theresa, 2006, WormBook, P1; Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Wypijewska A, 2010, FEBS J, V277, P3003, DOI 10.1111/j.1742-4658.2010.07709.x; Zarse K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004062; Zheng J, 2012, INT J OBESITY, V36, P186, DOI 10.1038/ijo.2011.93	50	83	85	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56877	10.1371/journal.pone.0056877	http://dx.doi.org/10.1371/journal.pone.0056877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	24058503	gold, Green Submitted, Green Published			2022-12-25	WOS:000316849500039
J	Liang, HY; Hussey, SE; Sanchez-Avila, A; Tantiwong, P; Musi, N				Liang, Hanyu; Hussey, Sophie E.; Sanchez-Avila, Alicia; Tantiwong, Puntip; Musi, Nicolas			Effect of Lipopolysaccharide on Inflammation and Insulin Action in Human Muscle	PLOS ONE			English	Article							LPS-BINDING-PROTEIN; ENDOPLASMIC-RETICULUM STRESS; TYPE-2 DIABETIC SUBJECTS; HUMAN SKELETAL-MUSCLE; ADIPOSE-TISSUE; RESISTANCE; GLUCOSE; SENSITIVITY; ENDOTOXEMIA; OBESITY	Accumulating evidence from animal studies suggest that chronic elevation of circulating intestinal-generated lipopolysaccharide (LPS) (i.e., metabolic endotoxemia) could play a role in the pathogenesis of insulin resistance. However, the effect of LPS in human muscle is unclear. Moreover, it is unknown whether blockade/down regulation of toll-like receptor (TLR) 4 can prevent the effect of LPS on insulin action and glucose metabolism in human muscle cells. In the present study we compared plasma LPS concentration in insulin resistant [obese non-diabetic and obese type 2 diabetic (T2DM)] subjects versus lean individuals. In addition, we employed a primary human skeletal muscle cell culture system to investigate the effect of LPS on glucose metabolism and whether these effects are mediated via TLR4. Obese non-diabetic and T2DM subjects had significantly elevated plasma LPS and LPS binding protein (LBP) concentrations. Plasma LPS (r = -0.46, P = 0.005) and LBP (r = -0.49, P = 0.005) concentrations negatively correlated with muscle insulin sensitivity (M). In human myotubes, LPS increased JNK phosphorylation and MCP-1 and IL-6 gene expression. This inflammatory response led to reduced insulin-stimulated IRS-1, Akt and AS160 phosphorylation and impaired glucose transport. Both pharmacologic blockade of TLR4 with TAK-242, and TLR4 gene silencing, suppressed the inflammatory response and insulin resistance caused by LPS in human muscle cells. Taken together, these findings suggest that elevations in plasma LPS concentration found in obese and T2DM subjects could play a role in the pathogenesis of insulin resistance and that antagonists of TLR4 may improve insulin action in these individuals.	[Liang, Hanyu; Hussey, Sophie E.; Sanchez-Avila, Alicia; Tantiwong, Puntip; Musi, Nicolas] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Diabet Div, San Antonio, TX 78229 USA; [Liang, Hanyu; Hussey, Sophie E.; Tantiwong, Puntip; Musi, Nicolas] South Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Audie L Murphy Div, San Antonio, TX USA; [Liang, Hanyu; Hussey, Sophie E.; Tantiwong, Puntip; Musi, Nicolas] Texas Diabet Inst, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Musi, N (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Diabet Div, San Antonio, TX 78229 USA.	musi@uthscsa.edu		Liang, Huiying/0000-0002-9987-8002	National Institutes of Health [RO1-DK80157, RO1- DK089229, TR000149, 1F32DK095565-01A1]; American Diabetes Association; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000149, UL1TR001120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK095565, R01DK089229, R01DK080157] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (RO1-DK80157 and RO1- DK089229 to N.M., TR000149 to UTHSCSA, and 1F32DK095565-01A1 to S.H.) and the American Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Al-Attas OS, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-20; Alhusaini S, 2010, BIOCHEM BIOPH RES CO, V397, P472, DOI 10.1016/j.bbrc.2010.05.138; Andreasen AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023999; Bouzakri K, 2008, DIABETES, V57, P1508, DOI 10.2337/db07-0583; Brun P, 2007, AM J PHYSIOL-GASTR L, V292, pG518, DOI 10.1152/ajpgi.00024.2006; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Ciaraldi TP, 1995, J CLIN INVEST, V96, P2820, DOI 10.1172/JCI118352; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Frisard MI, 2010, AM J PHYSIOL-ENDOC M, V298, pE988, DOI 10.1152/ajpendo.00307.2009; Ghanim H, 2009, DIABETES CARE, V32, P2281, DOI 10.2337/dc09-0979; Gubern C, 2006, DIABETES, V55, P216, DOI 10.2337/diabetes.55.1.216; Harte AL, 2012, DIABETES CARE, V35, P375, DOI 10.2337/dc11-1593; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Hussey SE, 2013, BIOSCIENCE REP, V33, P37, DOI 10.1042/BSR20120098; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawamoto T, 2008, EUR J PHARMACOL, V584, P40, DOI 10.1016/j.ejphar.2008.01.026; Kitchens RL, 2005, J ENDOTOXIN RES, V11, P225, DOI 10.1179/096805105X46565; Lamping N, 1998, J CLIN INVEST, V101, P2065, DOI 10.1172/JCI2338; Laugerette F, 2011, BIOCHIMIE, V93, P39, DOI 10.1016/j.biochi.2010.04.016; LEE JD, 1992, J EXP MED, V175, P1697, DOI 10.1084/jem.175.6.1697; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Nieto-Vazquez I, 2008, DIABETES, V57, P3211, DOI 10.2337/db07-1062; Pilon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015912; Reyna SM, 2008, DIABETES, V57, P2595, DOI 10.2337/db08-0038; Sell H, 2006, ENDOCRINOLOGY, V147, P2458, DOI 10.1210/en.2005-0969; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Somwar R, 2001, BIOCHEM J, V359, P639, DOI 10.1042/0264-6021:3590639; Sun LA, 2010, DIABETES CARE, V33, P1925, DOI 10.2337/dc10-0340; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; van der Crabben SN, 2009, J CLIN ENDOCR METAB, V94, P463, DOI 10.1210/jc.2008-0761; WURFEL MM, 1995, J EXP MED, V181, P1743, DOI 10.1084/jem.181.5.1743; Zweigner J, 2001, BLOOD, V98, P3800, DOI 10.1182/blood.V98.13.3800; Zweigner J, 2006, MICROBES INFECT, V8, P946, DOI 10.1016/j.micinf.2005.10.006	39	113	119	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63983	10.1371/journal.pone.0063983	http://dx.doi.org/10.1371/journal.pone.0063983			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704966	gold, Green Published, Green Submitted			2022-12-25	WOS:000319330200098
J	Zeller, M; Muller, A; Gutberlet, M; Nichols, T; Hahn, D; Kostler, H; Bartsch, AJ				Zeller, Mario; Mueller, Alexander; Gutberlet, Marcel; Nichols, Thomas; Hahn, Dietbert; Koestler, Herbert; Bartsch, Andreas J.			Boosting BOLD fMRI by K-Space Density Weighted Echo Planar Imaging	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; TO-NOISE RATIO; PHYSIOLOGICAL NOISE; GEOMETRIC DISTORTION; BLOOD OXYGENATION; SIGNAL CHANGES; TIME-SERIES; HUMAN BRAIN; RESONANCE; ROBUST	Functional magnetic resonance imaging (fMRI) has become a powerful and influential method to non-invasively study neuronal brain activity. For this purpose, the blood oxygenation level-dependent (BOLD) effect is most widely used. T-2* weighted echo planar imaging (EPI) is BOLD sensitive and the prevailing fMRI acquisition technique. Here, we present an alternative to its standard Cartesian recordings, i.e. k-space density weighted EPI, which is expected to increase the signal-to-noise ratio in fMRI data. Based on in vitro and in vivo pilot measurements, we show that fMRI by k-space density weighted EPI is feasible and that this new acquisition technique in fact boosted spatial and temporal SNR as well as the detection of local fMRI activations. Spatial resolution, spatial response function and echo time were identical for density weighted and conventional Cartesian EPI. The signal-to-noise ratio gain of density weighting can improve activation detection and has the potential to further increase the sensitivity of fMRI investigations.	[Zeller, Mario; Mueller, Alexander; Hahn, Dietbert; Koestler, Herbert] Univ Wurzburg, Dept Radiol, Univ Clin, D-97070 Wurzburg, Germany; [Gutberlet, Marcel] Hannover Med Sch, Dept Radiol, Hannover, Germany; [Nichols, Thomas] Univ Warwick, Dept Stat, Warwick, England; [Nichols, Thomas; Bartsch, Andreas J.] Univ Oxford, John Radcliffe Hosp, Oxford Ctr Funct MRI Brain, Oxford OX3 9DU, England; [Koestler, Herbert] Univ Wurzburg, Comprehens Heart Failure Ctr, Bavaria, Germany; [Bartsch, Andreas J.] Heidelberg Univ, Dept Neuroradiol, Heidelberg, Germany	University of Wurzburg; Hannover Medical School; University of Warwick; University of Oxford; University of Wurzburg; Ruprecht Karls University Heidelberg	Zeller, M (corresponding author), Univ Wurzburg, Dept Radiol, Univ Clin, D-97070 Wurzburg, Germany.	zeller@roentgen.uni-wuerzburg.de	Goncalves, Gislene Lopes/D-3567-2013; Köstler, Herbert/B-2089-2010; Cordeiro-Estrela, Pedro/A-2913-2015; Freitas, Thales Renato Ochotorena de/G-1160-2012; Marinho, Jorge/AAC-1097-2019; Althoff, Sérgio Luiz/AAE-5820-2020; Nichols, Thomas E./N-9902-2017	Goncalves, Gislene Lopes/0000-0002-1459-4888; Köstler, Herbert/0000-0001-6207-9226; Freitas, Thales Renato Ochotorena de/0000-0002-1019-9303; Nichols, Thomas E./0000-0002-4516-5103; Althoff, Sergio Luiz/0000-0002-0877-5156; Testoni, Andre Filipe/0000-0002-4680-0092; Cordeiro-Estrela, Pedro/0000-0003-3383-571X	Deutsche Forschungsgemeinschaft (dfg.de) [DFG KO 2938/3-1]; German Research Foundation (DFG); University of Wuerzburg	Deutsche Forschungsgemeinschaft (dfg.de); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This work was supported by grant sponsor Deutsche Forschungsgemeinschaft (dfg.de), Grant number: DFG KO 2938/3-1. This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J.L.R, 2007, TR07JA2 FMRIB; Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Bartsch AJ, 2006, J MAGN RESON IMAGING, V23, P921, DOI 10.1002/jmri.20579; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Clare S, 2001, MAGNET RESON MED, V45, P930, DOI 10.1002/mrm.1124; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Deichmann R, 2002, NEUROIMAGE, V15, P120, DOI 10.1006/nimg.2001.0985; Duong TQ, 2003, MAGN RESON MED, V49, P1019, DOI 10.1002/mrm.10472; Feinberg DA, 2002, MAGN RESON MED, V48, P1, DOI 10.1002/mrm.10227; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fujita N, 2001, MAGN RESON MED, V46, P723, DOI 10.1002/mrm.1251; Geier OM, 2007, MAGN RESON MATER PHY, V20, P19, DOI 10.1007/s10334-006-0065-8; Greiser A, 2003, MAGN RESON MED, V50, P1266, DOI 10.1002/mrm.10647; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Gutberlet M, 2010, MAGN RESON IMAGING, V28, P341, DOI 10.1016/j.mri.2009.11.007; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; Kasper L, 2011, P INT SOC MAG RES ME, V19, P1634; Kriegeskorte N, 2010, J CEREBR BLOOD F MET, V30, P1551, DOI 10.1038/jcbfm.2010.86; Kruger G, 2001, MAGNET RESON MED, V46, P631, DOI 10.1002/mrm.1240; Man LC, 1997, MAGNET RESON MED, V37, P785, DOI 10.1002/mrm.1910370523; MARECI TH, 1984, J MAGN RESON, V57, P157, DOI 10.1016/0022-2364(84)90249-X; Murphy K, 2007, NEUROIMAGE, V34, P565, DOI 10.1016/j.neuroimage.2006.09.032; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; PARKER DL, 1987, MED PHYS, V14, P640, DOI 10.1118/1.596032; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Robson PM, 2008, MAGN RESON MED, V60, P895, DOI 10.1002/mrm.21728; ROEMER PB, 1990, MAGNET RESON MED, V16, P192, DOI 10.1002/mrm.1910160203; Schmithorst VJ, 2001, IEEE T MED IMAGING, V20, P535, DOI 10.1109/42.929619; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Triantafyllou C, 2005, NEUROIMAGE, V26, P243, DOI 10.1016/j.neuroimage.2005.01.007; Triantafyllou C, 2006, NEUROIMAGE, V32, P551, DOI 10.1016/j.neuroimage.2006.04.182; Uludag K, 2009, NEUROIMAGE, V48, P150, DOI 10.1016/j.neuroimage.2009.05.051; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Worsley KJ, 2001, FUNCTIONAL MRI INTRO; Wu GH, 2005, MAGN RESON MED, V53, P1046, DOI 10.1002/mrm.20451; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Zeller M, 2012, P ESMRMB 29 ANN M, P510; Zeller M, 2014, MAGN RESON MED, V71, P1117, DOI 10.1002/mrm.24737; Zeller M, 2013, J MAGN RESON IMAGING, V37, P965, DOI 10.1002/jmri.23872; Zellhuber M, 2012, PROCEEDINGS OF THE ASME TURBO EXPO 2012, VOL 2, PTS A AND B, P243	53	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2013	8	9							e74501	10.1371/journal.pone.0074501	http://dx.doi.org/10.1371/journal.pone.0074501			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PK	24040262	Green Published, gold, Green Submitted			2022-12-25	WOS:000327538600096
J	Ding, Y; Song, LR; Sedmak, B				Ding, Yi; Song, Lirong; Sedmak, Bojan			UVB Radiation as a Potential Selective Factor Favoring Microcystin Producing Bloom Forming Cyanobacteria	PLOS ONE			English	Article							ULTRAVIOLET-RADIATION; LIGHT; SOLAR; BIOSYNTHESIS; AERUGINOSA; EVOLUTION; GROWTH; DAMAGE; GENES	Due to the stratospheric ozone depletion, several organisms will become exposed to increased biologically active UVB (280-320nm) radiation, not only at polar but also at temperate and tropical latitudes. Bloom forming cyanobacteria are exposed to UVB radiation on a mass scale, particularly during the surface bloom and scum formation that can persist for long periods of time. All buoyant species of cyanobacteria are at least periodically exposed to higher irradiation during their vertical migration to the surface that usually occurs several times a day. The aim of this study is to assess the influence on cyanobacteria of UVB radiation at realistic environmental intensities. The effects of two UVB intensities of 0.5 and 0.99 W/m(2) in up to 0.5 cm water depth were studied in vitro on Microcystis aeruginosa strains, two microcystin producing and one non-producing. After UVB exposure their ability to proliferate was estimated by cell counting, while cell fitness and integrity were evaluated using light microscopy, autofluorescence and immunofluorescence. Gene damage was assessed by TUNEL assay and SYBR Green staining of the nucleoide area. We conclude that UVB exposure causes damage to the genetic material, cytoskeletal elements, higher sedimentation rates and consequent cell death. In contrast to microcystin producers (PCC7806 and FACHB905), the microcystin non-producing strain PCC7005 is more susceptible to the deleterious effects of radiation, with weak recovery ability. The ecological relevance of the results is discussed using data from eleven years' continuous UVB radiation measurements within the area of Ljubljana city (Slovenia, Central Europe). Our results suggest that increased solar radiation in temperate latitudes can have its strongest effect during cyanobacterial bloom formation in spring and early summer. UVB radiation in this period may significantly influence strain composition of cyanobacterial blooms in favor of microcystin producers.	[Ding, Yi; Song, Lirong] Chinese Acad Sci, Inst Hydrobiol, Key Lab Algal Biol, Wuhan, Peoples R China; [Ding, Yi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Sedmak, Bojan] Natl Inst Biol, Dept Genet Toxicol & Canc Biol, Ljubljana, Slovenia	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; National Institute of Biology - Slovenia	Sedmak, B (corresponding author), Natl Inst Biol, Dept Genet Toxicol & Canc Biol, Ljubljana, Slovenia.	bojan.sedmak@nib.si	Luo, Huai-Rong/ABE-7525-2021	Zheng, Shanqing/0000-0002-5039-0196	Slovenian Research Agency	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The work was supported by Slovenian Research Agency (http://www.arrs.gov.si/en/dobrodoslica.asp), Research Program P1-0245ARRS: Ecotoxicology, Toxicogenomics and Carcinogenesis - (BS salary, reagents, materials, analysis tools), and Ministry of Defence Administration for Civil Protection and Dosaster Relief (Contract No URSZR 4300-1117/2009-1) "Cyanobacterial toxins in surface waters,'' which co-financed the Laminar Flow Cabinet. Chinese grants from the Natural Science Foundation of China-Yunnan Project (U0833604) (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm) and '973' Program (2008CB418000) funded the nine-month stay of Ding Yi at the National Institute of Biology in Ljubljana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo SMFO, 2002, TOXICOLOGY, V181, P441, DOI 10.1016/S0300-483X(02)00491-2; Codd GA, 2000, ECOL ENG, V16, P51, DOI 10.1016/S0925-8574(00)00089-6; Ding Y, 2012, PHYCOLOGIA, V51, P567, DOI 10.2216/11-107.1; DONKOR V, 1991, FEMS MICROBIOL ECOL, V86, P159; Dziallas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025569; EKELUND NGA, 1991, J PLANT PHYSIOL, V138, P274, DOI 10.1016/S0176-1617(11)80287-7; Frangeul L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-274; Gan NQ, 2012, ENVIRON MICROBIOL, V14, P730, DOI 10.1111/j.1462-2920.2011.02624.x; Gumbo JR, 2011, AFR J BIOTECHNOL, V10, P8054; Hader DP, 2005, MUTAT RES-FUND MOL M, V571, P221, DOI 10.1016/j.mrfmmm.2004.11.017; Harel M, 2012, ENV MICROBIOL REP, V4, P342, DOI 10.1111/j.1758-2229.2012.00339.x; He YY, 2002, J PHOTOCH PHOTOBIO B, V66, P73, DOI 10.1016/S1011-1344(01)00278-0; Hessen DO, 2008, SOLAR RAD HUMAN HLTH, P123, DOI DOI 10.1038/NRG2897; Jungblut AD, 2006, ARCH MICROBIOL, V185, P107, DOI 10.1007/s00203-005-0073-5; Kaebernick M, 2000, APPL ENVIRON MICROB, V66, P3387, DOI 10.1128/AEM.66.8.3387-3392.2000; Kulandaivelu G, 1989, PHOTOSYNTHESIS MOL B, P305; Kurmayer R, 2003, APPL ENVIRON MICROB, V69, P787, DOI 10.1128/AEM.69.2.787-795.2003; Ma ZL, 2009, ENVIRON EXP BOT, V66, P265, DOI 10.1016/j.envexpbot.2009.02.006; Madronich S, 1998, J PHOTOCH PHOTOBIO B, V46, P5, DOI 10.1016/S1011-1344(98)00182-1; Morris DP, 1995, LIMNOL OCEANOGR, V40, P1381, DOI 10.4319/lo.1995.40.8.1381; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Pereira S, 2009, FEMS MICROBIOL REV, V33, P917, DOI 10.1111/j.1574-6976.2009.00183.x; Phelan RR, 2011, J PHYCOL, V47, P1241, DOI 10.1111/j.1529-8817.2011.01056.x; QUESADA A, 1995, J PHYCOL, V31, P242, DOI 10.1111/j.0022-3646.1995.00242.x; Rantala A, 2004, P NATL ACAD SCI USA, V101, P568, DOI 10.1073/pnas.0304489101; SCHERER S, 1988, PLANT PHYSIOL, V88, P1055, DOI 10.1104/pp.88.4.1055; Schopf JW., 2000, ECOLOGY CYANOBACTERI, P13; Sedmak B, 2005, MICROB ECOL, V50, P298, DOI 10.1007/s00248-004-0189-1; Sedmak B, 1998, J PLANKTON RES, V20, P691, DOI 10.1093/plankt/20.4.691; Sedmak B, 2009, J PLANKTON RES, V31, P1321, DOI 10.1093/plankt/fbp076; Shi L, 1999, J BIOL CHEM, V274, P10039, DOI 10.1074/jbc.274.15.10039; Sinha RP, 1998, J PHOTOCH PHOTOBIO B, V47, P83, DOI 10.1016/S1011-1344(98)00198-5; UTKILEN H, 1992, APPL ENVIRON MICROB, V58, P1321, DOI 10.1128/AEM.58.4.1321-1325.1992; WALSBY AE, 1987, CYANOBACTERIA, P377; Weatherhead EC, 2006, NATURE, V441, P39, DOI 10.1038/nature04746; Zilliges Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017615	36	83	85	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73919	10.1371/journal.pone.0073919	http://dx.doi.org/10.1371/journal.pone.0073919			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058503	Green Published, gold, Green Submitted			2022-12-25	WOS:000324408400043
J	Huang, ZB; Li, SZ; Song, W; Li, X; Li, QS; Zhang, ZY; Han, YQ; Zhang, XD; Miao, SY; Du, RL; Wang, LF				Huang, Zebin; Li, Shangze; Song, Wei; Li, Xin; Li, Qinshan; Zhang, Zeyan; Han, Yongqing; Zhang, Xiaodong; Miao, Shiying; Du, Runlei; Wang, Linfang			Lysine-Specific Demethylase 1 (LSD1/KDM1A) Contributes to Colorectal Tumorigenesis via Activation of the Wnt/B-Catenin Pathway by Down-Regulating Dickkopf-1 (DKK1)	PLOS ONE			English	Article							FREQUENT EPIGENETIC INACTIVATION; COLON-CANCER CELLS; BREAST-CANCER; CARCINOMA CELLS; SOMATIC-CELLS; LSD1; METHYLATION; GENE; PROLIFERATION; TRANSCRIPTION	We collected paired samples of tumor and adjacent normal colorectal tissues from 22 patients with colorectal carcinoma to compare the differences in the expression of lysine specific demethylase 1 (LSD1) in these two tissues. The results showed that in 19 paired samples (86.4%), LSD1 is more highly expressed in tumor tissue than in normal tissue. To explore the role of LSD1 in colorectal tumorigenesis, we used somatic cell gene targeting to generate an LSD1 knockout (KO) HCT 116 human colorectal cancer cell line as a research model. The analysis of phenotypic changes showed that LSD1 KO colorectal cancer cells are less tumorigenic, both in vivo and in vitro. The differential expression analysis of the cells by mRNA sequencing (RNA-Seq) yielded 2,663 differentially expressed genes, and 28 of these genes had highly significant differences (Q<0.01). We then selected the 4 colorectal cancer-related genes ADM, DKK1, HAS3 and SMURF2 for quantitative real-time PCR verification. The results showed that the differences in the expression of ADM, DKK1 and HAS3 were consistent with those measured using the RNA-Seq data. As DKK1 was the gene with the most significant differential expression, we analyzed the key proteins of the DKK1-related Wnt/beta-catenin signaling pathway and found that, after knocking out LSD1, the amount of free beta-catenin translocated to the nucleus was significantly reduced and that the transcription of the signaling pathway target gene c-Myc was down-regulated. Our studies show that LSD1 activates the Wnt/beta-catenin signaling pathway by down-regulating the pathway antagonist DKK1, which may be one of the mechanisms leading to colorectal tumorigenesis.	[Huang, Zebin; Song, Wei; Li, Qinshan; Han, Yongqing; Miao, Shiying; Wang, Linfang] Chinese Acad Med Sci, Tsinghua Univ, Peking Union Med Coll,Natl Lab Med Mol Biol, Dept Biochem & Mol Biol,Inst Basic Med Sci, Beijing 100084, Peoples R China; [Li, Shangze; Li, Xin; Zhang, Zeyan; Zhang, Xiaodong; Du, Runlei] Wuhan Univ, Coll Life Sci, Dept Cellular & Dev Biol, Wuhan 430072, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Tsinghua University; Wuhan University	Du, RL (corresponding author), Wuhan Univ, Coll Life Sci, Dept Cellular & Dev Biol, Wuhan 430072, Peoples R China.	runleidu@whu.edu.cn; wang.linfang@imicams.ac.cn	Zhang, Zeyan/GPT-3882-2022; Zhang, Ze-Yan/ABB-4948-2021; Li, Xin/L-2237-2019; li, shangze/AAW-6317-2021	Zhang, Zeyan/0000-0002-7896-3013; Li, Xin/0000-0002-3914-9377; 	National Basic Research Program of China [2011CB944302, 2011CB944404]; State Key Laboratory Special Fund [2060204]; National Natural Science Foundation of China [81270306, 30971499]	National Basic Research Program of China(National Basic Research Program of China); State Key Laboratory Special Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Basic Research Program of China (2011CB944302, 2011CB944404, http://www.973.gov.cn), the State Key Laboratory Special Fund (2060204, http://www.chinalab.gov.cn), and the National Natural Science Foundation of China (81270306, 30971499, http://www.nsfc.gov.cn). The experimental study was performed in compliance with the laws of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Cho HS, 2011, CANCER RES, V71, P655, DOI 10.1158/0008-5472.CAN-10-2446; Chosed R, 2007, MOL CELL, V26, P160, DOI 10.1016/j.molcel.2007.04.009; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Colnot S, 2004, P NATL ACAD SCI USA, V101, P17216, DOI 10.1073/pnas.0404761101; Dornhoff H, 2012, GASTROENTEROLOGY, V142, P1183, DOI 10.1053/j.gastro.2012.02.005; Foster CT, 2010, MOL CELL BIOL, V30, P4851, DOI 10.1128/MCB.00521-10; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Godmann M, 2007, BIOL REPROD, V77, P754, DOI 10.1095/biolreprod.107.062265; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hirata H, 2011, INT J CANCER, V128, P1793, DOI 10.1002/ijc.25507; Hirata R, 2002, NAT BIOTECHNOL, V20, P735, DOI 10.1038/nbt0702-735; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang Y, 2007, P NATL ACAD SCI USA, V104, P8023, DOI 10.1073/pnas.0700720104; Ilyas M, 2005, J PATHOL, V205, P130, DOI 10.1002/path.1692; Jin LH, 2013, BIOCHEM J, V449, P459, DOI 10.1042/BJ20121360; Kauffman EC, 2011, MOL CARCINOGEN, V50, P931, DOI 10.1002/mc.20758; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kocemba KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030359; Kohli M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh009; Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Li Y, 2012, ONCOGENE, V31, P5007, DOI 10.1038/onc.2012.8; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Lv SA, 2010, EUR J CELL BIOL, V89, P557, DOI 10.1016/j.ejcb.2010.01.004; Lv TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035065; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Mikheev AM, 2008, BREAST CANCER RES TR, V112, P263, DOI 10.1007/s10549-007-9867-2; Musri MM, 2010, J BIOL CHEM, V285, P30034, DOI 10.1074/jbc.M110.151209; Qi LS, 2012, CANCER SCI, V103, P828, DOI 10.1111/j.1349-7006.2012.02222.x; Qin XR, 2007, TRANSL RES, V150, P281, DOI 10.1016/j.trsl.2007.06.005; Rago C, 2007, NAT PROTOC, V2, P2734, DOI 10.1038/nprot.2007.408; Sato H, 2007, CARCINOGENESIS, V28, P2459, DOI 10.1093/carcin/bgm178; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Scoumanne A, 2007, J BIOL CHEM, V282, P15471, DOI 10.1074/jbc.M701023200; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259; Talero E, 2011, INFLAMM BOWEL DIS, V17, P696, DOI 10.1002/ibd.21420; Teng BP, 2011, ANTI-CANCER AGENT ME, V11, P620; Turashvili G, 2006, PATHOBIOLOGY, V73, P213, DOI 10.1159/000098207; van Noort M, 2002, DEV BIOL, V244, P1, DOI 10.1006/dbio.2001.0566; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Wu CY, 2012, INT J CANCER, V131, P1423, DOI 10.1002/ijc.27343; Yang P, 2011, STEM CELLS, V29, P791, DOI 10.1002/stem.634; Zhang P, 2011, MOL CANCER RES, V9, P1418, DOI 10.1158/1541-7786.MCR-11-0147; Zhang XD, 2008, NAT METHODS, V5, P163, DOI [10.1038/nmeth1170, 10.1038/NMETH1170]; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhou HY, 2010, J BIOL CHEM, V285, P29676, DOI 10.1074/jbc.C110.150599; Zhou XL, 2010, ACTA PHARMACOL SIN, V31, P202, DOI 10.1038/aps.2009.200	58	55	63	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70077	10.1371/journal.pone.0070077	http://dx.doi.org/10.1371/journal.pone.0070077			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922913	Green Published, gold, Green Submitted			2022-12-25	WOS:000322838900143
J	Hill, DK; Orton, MR; Mariotti, E; Boult, JKR; Panek, R; Jafar, M; Parkes, HG; Jamin, Y; Miniotis, MF; Al-Saffar, NMS; Beloueche-Babari, M; Robinson, SP; Leach, MO; Chung, YL; Eykyn, TR				Hill, Deborah K.; Orton, Matthew R.; Mariotti, Erika; Boult, Jessica K. R.; Panek, Rafal; Jafar, Maysam; Parkes, Harold G.; Jamin, Yann; Miniotis, Maria Falck; Al-Saffar, Nada M. S.; Beloueche-Babari, Mounia; Robinson, Simon P.; Leach, Martin O.; Chung, Yuen-Li; Eykyn, Thomas R.			Model Free Approach to Kinetic Analysis of Real-Time Hyperpolarized C-13 Magnetic Resonance Spectroscopy Data	PLOS ONE			English	Article							TO-NOISE RATIO; ANTICANCER AGENTS; BRAIN-TUMORS; CANCER; PYRUVATE; LACTATE; NMR; METABOLISM; EXCHANGE; INHIBITION	Real-time detection of the rates of metabolic flux, or exchange rates of endogenous enzymatic reactions, is now feasible in biological systems using Dynamic Nuclear Polarization Magnetic Resonance. Derivation of reaction rate kinetics from this technique typically requires multi-compartmental modeling of dynamic data, and results are therefore model-dependent and prone to misinterpretation. We present a model-free formulism based on the ratio of total areas under the curve (AUC) of the injected and product metabolite, for example pyruvate and lactate. A theoretical framework to support this novel analysis approach is described, and demonstrates that the AUC ratio is proportional to the forward rate constant k. We show that the model-free approach strongly correlates with k for whole cell in vitro experiments across a range of cancer cell lines, and detects response in cells treated with the pan-class I PI3K inhibitor GDC-0941 with comparable or greater sensitivity. The same result is seen in vivo with tumor xenograft-bearing mice, in control tumors and following drug treatment with dichloroacetate. An important finding is that the area under the curve is independent of both the input function and of any other metabolic pathways arising from the injected metabolite. This model-free approach provides a robust and clinically relevant alternative to kinetic model-based rate measurements in the clinical translation of hyperpolarized C-13 metabolic imaging in humans, where measurement of the input function can be problematic.	[Hill, Deborah K.; Orton, Matthew R.; Boult, Jessica K. R.; Panek, Rafal; Jafar, Maysam; Parkes, Harold G.; Jamin, Yann; Miniotis, Maria Falck; Al-Saffar, Nada M. S.; Beloueche-Babari, Mounia; Robinson, Simon P.; Leach, Martin O.; Chung, Yuen-Li; Eykyn, Thomas R.] Inst Canc Res, CR UK, Canc Imaging Ctr, Div Radiotherapy & Imaging, Sutton, Surrey, England; [Hill, Deborah K.; Orton, Matthew R.; Boult, Jessica K. R.; Panek, Rafal; Jafar, Maysam; Parkes, Harold G.; Jamin, Yann; Miniotis, Maria Falck; Al-Saffar, Nada M. S.; Beloueche-Babari, Mounia; Robinson, Simon P.; Leach, Martin O.; Chung, Yuen-Li; Eykyn, Thomas R.] Inst Canc Res, EPSRC, Canc Imaging Ctr, Div Radiotherapy & Imaging, Sutton, Surrey, England; [Hill, Deborah K.; Orton, Matthew R.; Boult, Jessica K. R.; Panek, Rafal; Jafar, Maysam; Parkes, Harold G.; Jamin, Yann; Miniotis, Maria Falck; Al-Saffar, Nada M. S.; Beloueche-Babari, Mounia; Robinson, Simon P.; Leach, Martin O.; Chung, Yuen-Li; Eykyn, Thomas R.] Royal Marsden NHS Trust, Sutton, Surrey, England; [Mariotti, Erika; Eykyn, Thomas R.] St Thomas Hosp, Div Imaging Sci & Biomed Engn, Kings Coll London, London, England	University of London; Institute of Cancer Research - UK; UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Leach, MO (corresponding author), Inst Canc Res, CR UK, Canc Imaging Ctr, Div Radiotherapy & Imaging, Sutton, Surrey, England.	martin.leach@icr.ac.uk; thomas.eykyn@icr.ac.uk	leach, martin o/C-2248-2008; Chung, Yuen-Li/K-2269-2019; Eykyn, Thomas/J-3284-2016; Parkes, Harold G/I-7412-2012	leach, martin o/0000-0002-0756-5368; Chung, Yuen-Li/0000-0003-0807-1658; Eykyn, Thomas/0000-0003-1768-3808; Robinson, Simon/0000-0003-4101-7274; Li Wai Suen, Connie/0000-0003-0529-0804; Hill, Danika/0000-0001-6284-7061; Panek, Rafal/0000-0002-9432-6698; Hill, Deborah/0000-0002-6441-5489; Chiu, Yu Ho Chris/0000-0002-5380-1114; Parkes, Harold/0000-0003-4981-864X; Jamin, yann/0000-0003-0350-3757; Eriksson, Emily/0000-0002-7851-973X	Cancer Research UK [C1060/A6916]; EPSRC Cancer Imaging Centre; NHS; Marie Curie Action: Early Stage Training [MEST-CT-2005 020718]; EPSRC platform [EP/H046526/1]; MRC; Department of Health (England) [C1060/A10334]; Cancer Research UK [16464] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H046526/1] Funding Source: researchfish; Medical Research Council [G0701533] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10162] Funding Source: researchfish; EPSRC [EP/H046526/1] Funding Source: UKRI; MRC [G0701533] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); EPSRC Cancer Imaging Centre(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NHS; Marie Curie Action: Early Stage Training; EPSRC platform(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health (England); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is supported by the Cancer Research UK and EPSRC Cancer Imaging Centre in association with the MRC and Department of Health (England) (refs C1060/A10334). The authors acknowledge NHS Funding to the NIHR Biomedical Research Centre. MFM and MBB acknowledge funding from Cancer Research UK (grant C1060/A6916), Marie Curie Action: Early Stage Training (grant MEST-CT-2005 020718), and EPSRC platform (grant EP/H046526/1). MOL is an NIHR Senior Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers MJ, 2008, CANCER RES, V68, P8607, DOI 10.1158/0008-5472.CAN-08-0749; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Beloueche-Babari M, 2011, CELL CYCLE, V10, P2883, DOI 10.4161/cc.10.17.17192; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Coen M, 2008, CHEM RES TOXICOL, V21, P9, DOI 10.1021/tx700335d; Day SE, 2007, NAT MED, V13, P1382, DOI 10.1038/nm1650; HaasKogan DA, 1996, INT J RADIAT ONCOL, V36, P95, DOI 10.1016/S0360-3016(96)00244-1; Harris T, 2009, P NATL ACAD SCI USA, V106, P18131, DOI 10.1073/pnas.0909049106; Harrison C, 2012, NMR BIOMED, V25, P1286, DOI 10.1002/nbm.2801; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Howe FA, 2003, MAGNET RESON MED, V49, P223, DOI 10.1002/mrm.10367; Kazan SM, 2012, MAGN RESON MED; Keshari KR, 2013, CANCER RES, V73, P529, DOI 10.1158/0008-5472.CAN-12-3461; Keshari KR, 2010, MAGN RESON MED, V63, P322, DOI 10.1002/mrm.22225; Kettunen MI, 2012, MAGN RESON MED; Koelsch BL, 2013, ANALYST, V138, P1011, DOI 10.1039/c2an36715g; Larson PEZ, 2012, J MAGN RESON, V225, P71, DOI 10.1016/j.jmr.2012.09.014; Lindon JC, 2001, PROG NUCL MAG RES SP, V39, P1, DOI 10.1016/S0079-6565(00)00036-4; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; Menichetti L, 2012, CONTRAST MEDIA MOL I, V7, P85, DOI 10.1002/cmmi.480; Morris ME, 2008, AAPS J, V10, P311, DOI 10.1208/s12248-008-9035-6; Park JM, 2012, MAGN RESON MED, V68, P1886, DOI 10.1002/mrm.24181; Peet AC, 2012, NAT REV CLIN ONCOL, V9, P700, DOI 10.1038/nrclinonc.2012.187; Santarelli MF, 2012, NMR BIOMED, V25, P925, DOI 10.1002/nbm.1813; Seth P, 2011, NEOPLASIA, V13, P60, DOI 10.1593/neo.101020; von Morze C, 2011, J MAGN RESON IMAGING, V33, P692, DOI 10.1002/jmri.22484; Ward CS, 2010, CANCER RES, V70, P1296, DOI 10.1158/0008-5472.CAN-09-2251; Witney TH, 2011, J BIOL CHEM, V286, P24572, DOI 10.1074/jbc.M111.237727; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zierhut ML, 2010, J MAGN RESON, V202, P85, DOI 10.1016/j.jmr.2009.10.003	31	133	133	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e71996	10.1371/journal.pone.0071996	http://dx.doi.org/10.1371/journal.pone.0071996			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023724	Green Published, Green Submitted, gold			2022-12-25	WOS:000324515600010
J	Wang, CH; Chang, CC; Liang, YM; Shih, CM; Chiu, WS; Tseng, P; Hung, DL; Tzeng, OJL; Muggleton, NG; Juan, CH				Wang, Chun-Hao; Chang, Che-Chien; Liang, Yen-Ming; Shih, Chun-Ming; Chiu, Wen-Sheng; Tseng, Philip; Hung, Daisy L.; Tzeng, Ovid J. L.; Muggleton, Neil G.; Juan, Chi-Hung			Open vs. Closed Skill Sports and the Modulation of Inhibitory Control	PLOS ONE			English	Article							MEDIAL FRONTAL-CORTEX; BASKETBALL PLAYERS; PHYSICAL-ACTIVITY; REACTION-TIME; BALL GAMES; EXPERTISE; COGNITION; BASEBALL; FITNESS; BRAIN	Background: Inhibitory control, or the ability to suppress planned but inappropriate prepotent actions in the current environment, plays an important role in the control of human performance. Evidence from empirical studies utilizing a sport-specific design has shown that athletes have superior inhibitory control. However, less is known about whether this superiority might (1) still be seen in a general cognitive task without a sport-related context; (2) be modulated differentially by different sporting expertise (e.g., tennis versus swimming). Methodology/Principal Findings: Here we compared inhibitory control across tennis players, swimmers and sedentary non-athletic controls using a stop-signal task without a sport-specific design. Our primary finding showed that tennis players had shorter stop-signal reaction times (SSRTs) when compared to swimmers and sedentary controls, whereas no difference was found between swimmers and sedentary controls. Importantly, this effect was further confirmed after considering potential confounding factors (e.g., BMI, training experience, estimated levels of physical activity and VO2max), indicative of better ability to inhibit unrequired responses in tennis players. Conclusions/Significance: This suggests that fundamental inhibitory control in athletes can benefit from open skill training. Sport with both physical and cognitive demands may provide a potential clinical intervention for those who have difficulties in inhibitory control.	[Wang, Chun-Hao; Hung, Daisy L.; Tzeng, Ovid J. L.] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Wang, Chun-Hao; Shih, Chun-Ming; Tseng, Philip; Hung, Daisy L.; Tzeng, Ovid J. L.; Muggleton, Neil G.; Juan, Chi-Hung] Natl Cent Univ, Inst Cognit Neurosci, Jhongli, Taiwan; [Chang, Che-Chien; Liang, Yen-Ming; Chiu, Wen-Sheng] Natl Cent Univ, Off Phys Educ, Jhongli, Taiwan; [Shih, Chun-Ming] Shu Te Univ, Grad Sch Human Sexual, Kaohsiung, Taiwan; [Hung, Daisy L.; Tzeng, Ovid J. L.; Muggleton, Neil G.; Juan, Chi-Hung] Natl Yang Ming Univ, Labs Cognit Neurosci, Taipei 112, Taiwan; [Tzeng, Ovid J. L.] Acad Sinica, Inst Linguist, Taipei 115, Taiwan; [Muggleton, Neil G.] UCL, Inst Cognit Neurosci, London, England	National Yang Ming Chiao Tung University; National Central University; National Central University; Shu-Te University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; University of London; University College London	Juan, CH (corresponding author), Natl Cent Univ, Inst Cognit Neurosci, Jhongli, Taiwan.	chijuan@cc.ncu.edu.tw	Muggleton, Neil/AAV-8929-2020; Tseng, Philip/AAG-4849-2021	Tseng, Philip/0000-0001-5120-5979; Tzeng, Ovid J. L./0000-0002-0844-7865; Wang, Chun-Hao/0000-0002-0180-7207	National Science Council, Taiwan [NSC-101-2628-H-008-001-MY4, NSC-101-2410-H-008-033-MY3, NSC-99-2410-H-008-022-MY3, NSC-100-2511-S-008-019, NSC-98-2410-H-008-010-MY3, NSC-98-2517-S-004-001-MY3, NSC-099-2811-H-008-005, NSC-100-2410-H-008-074-MY3]; UK Medical Research Council	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CHW, CMS, PT, DLH, OJT and CHJ were supported by the National Science Council, Taiwan (Grant numbers: NSC-101-2628-H-008-001-MY4, NSC-101-2410-H-008-033-MY3, NSC-99-2410-H-008-022-MY3, NSC-100-2511-S-008-019, NSC-98-2410-H-008-010-MY3, NSC-98-2517-S-004-001-MY3, NSC-099-2811-H-008-005). NGM was supported by the UK Medical Research Council and the National Science Council, Taiwan (Grant number: NSC-100-2410-H-008-074-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Batterink L, 2010, NEUROIMAGE, V52, P1696, DOI 10.1016/j.neuroimage.2010.05.059; Boehler CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026386; Bradshaw DI, 2005, RES Q EXERCISE SPORT, V76, P426; Chan JSY, 2011, PSYCHOL SPORT EXERC, V12, P509, DOI 10.1016/j.psychsport.2011.04.006; Chen CY, 2008, BEHAV BRAIN RES, V187, P483, DOI 10.1016/j.bbr.2007.10.011; Chen CY, 2009, NEUROIMAGE, V44, P537, DOI 10.1016/j.neuroimage.2008.09.005; Crevits L, 2000, NEURO-OPHTHALMOLOGY, V24, P331, DOI 10.1076/noph.24.2.331.7155; Dean AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025966; Di Russo F, 2003, VISION RES, V43, P1837, DOI 10.1016/S0042-6989(03)00299-2; Di Russo F, 2006, NEUROSCI LETT, V408, P113, DOI 10.1016/j.neulet.2006.08.085; Di Russo F, 2010, J NEUROTRAUM, V27, P2309, DOI 10.1089/neu.2010.1501; Everling S, 1998, NEUROPSYCHOLOGIA, V36, P885, DOI 10.1016/S0028-3932(98)00020-7; Fujiwara K, 2009, INT J SPORTS MED, V30, P647, DOI 10.1055/s-0029-1220732; Gauggel S, 2004, J NEUROL NEUROSUR PS, V75, P539; George JD, 1997, MED SCI SPORT EXER, V29, P415, DOI 10.1097/00005768-199703000-00019; Haggard P, 2005, TRENDS COGN SCI, V9, P290, DOI 10.1016/j.tics.2005.04.012; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hsu TY, 2011, NEUROIMAGE, V56, P2249, DOI 10.1016/j.neuroimage.2011.03.059; Kida N, 2005, COGNITIVE BRAIN RES, V22, P257, DOI 10.1016/j.cogbrainres.2004.09.003; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Lees A, 2003, J SPORT SCI, V21, P707, DOI 10.1080/0264041031000140275; Lenoir M, 2000, PERCEPT MOTOR SKILL, V91, P546, DOI 10.2466/pms.2000.91.2.546; Li CSR, 2006, NEUROIMAGE, V32, P1918, DOI 10.1016/j.neuroimage.2006.05.017; Li CSR, 2005, EXP BRAIN RES, V167, P305, DOI 10.1007/s00221-005-0110-2; Li RJ, 2009, NAT NEUROSCI, V12, P549, DOI 10.1038/nn.2296; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Logan Gordon D., 1994, P189; Mann DTY, 2007, J SPORT EXERCISE PSY, V29, P457, DOI 10.1123/jsep.29.4.457; Marinovic W, 2009, EXP BRAIN RES, V197, P311, DOI 10.1007/s00221-009-1916-0; Maximova K, 2009, AM J EPIDEMIOL, V170, P1084, DOI 10.1093/aje/kwp255; Muggleton NG, 2010, J COGNITIVE NEUROSCI, V22, P2804, DOI 10.1162/jocn.2010.21416; Nakamoto H, 2008, PERCEPT MOTOR SKILL, V106, P163, DOI 10.2466/PMS.106.1.163-170; Nakamoto H, 2008, BRAIN RES, V1189, P179, DOI 10.1016/j.brainres.2007.10.096; Nakata H, 2010, BRAIN RES REV, V62, P197, DOI 10.1016/j.brainresrev.2009.11.006; Overney LS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002380; Ozel S, 2004, J PSYCHOL, V138, P49, DOI 10.3200/JRLP.138.1.49-64; SALLIS JF, 1985, AM J EPIDEMIOL, V121, P91, DOI 10.1093/oxfordjournals.aje.a113987; Scisco JL, 2008, INT J PSYCHOPHYSIOL, V69, P52, DOI 10.1016/j.ijpsycho.2008.02.009; Senderecka M, 2012, INT J PSYCHOPHYSIOL, V85, P93, DOI 10.1016/j.ijpsycho.2011.05.007; Taddei F, 2012, MED SCI SPORT EXER, V44, P1057, DOI 10.1249/MSS.0b013e31824529c2; Tsai CL, 2009, RES DEV DISABIL, V30, P1268, DOI 10.1016/j.ridd.2009.05.001; Vestberg T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034731; Voss MW, 2010, APPL COGNITIVE PSYCH, V24, P812, DOI 10.1002/acp.1588; Williams BR, 1999, DEV PSYCHOL, V35, P205, DOI 10.1037/0012-1649.35.1.205; Yarrow K, 2009, NAT REV NEUROSCI, V10, P585, DOI 10.1038/nrn2672	46	194	198	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55773	10.1371/journal.pone.0055773	http://dx.doi.org/10.1371/journal.pone.0055773			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418458	Green Submitted, Green Published, gold			2022-12-25	WOS:000315970300049
J	Sun, ZZ; Dragon, S; Becker, A; Gounni, AS				Sun, Zhizhi; Dragon, Stephane; Becker, Allan; Gounni, Abdelilah S.			Leptin Inhibits Neutrophil Apoptosis in Children via ERK/NF-kappa B-Dependent Pathways	PLOS ONE			English	Article							PRO-INFLAMMATORY CYTOKINES; COLONY-STIMULATING FACTOR; HUMAN DENDRITIC CELLS; PROTEIN-KINASE; ADIPOSE-TISSUE; DEFICIENT MICE; SURVIVAL; ACTIVATION; RECEPTOR; OBESITY	Introduction and Rationale: Previous studies have shown that delayed neutrophil apoptosis is associated with chronic airway diseases. Leptin is an adipocyte-derived hormone that acts as a regulator of energy homeostasis and food intake. Emerging evidence suggests that leptin can regulate immune responses including the release of proinflammatory cytokines and protection of inflammatory cells from apoptosis. Serum leptin is increased during allergic reactions in the airways. However, the expression and function of leptin receptor in neutrophils isolated from children is not known. Methods: Flow cytometry was used to detect leptin receptor expression in neutrophils isolated from allergic asthmatic (n = 14), allergic non asthmatic (n = 21), non allergic asthmatic (n = 7) and healthy children (n = 23); confocal laser scanning microscopy combined with immunofluorescence was performed to detect intracellular pool of leptin receptor; Annexin-V/PI staining and caspase 3 activity was used to determine neutrophil survival. Pharmacological inhibitors were utilized to understand the role of MAPK and NF-kB pathway in leptin-induced neutrophil survival. Results and Conclusion: A heterogeneous leptin receptor expression was observed on neutrophils isolated from children. Neutrophils isolated from healthy children expressed more leptin receptor than those from allergic asthmatic (P<0.05) but not allergic non-asthmatic (P>0.05) or non-allergic asthmatic children (n = 7, P>0.05). Neutrophils isolated from children express an intracellular pool of leptin receptor that was mobilized to the cell surface upon GM-CSF stimulation. Finally, leptin exhibited anti-apoptotic properties on neutrophils via NF-kappa B and MEK1/2 MAPK pathway. Collectively, our data suggest that leptin may enhance airway inflammation by promoting neutrophil survival.	[Sun, Zhizhi; Dragon, Stephane; Becker, Allan; Gounni, Abdelilah S.] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Becker, Allan; Gounni, Abdelilah S.] Univ Manitoba, GREAT ICE, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Gounni, AS (corresponding author), Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada.	gounni@cc.umanitoba.ca	Gounni, Abdelilah Soussi/AAH-3456-2020	Kim, Do-Gyoon/0000-0001-7673-1254; Gounni, Abdelilah/0000-0003-1265-6560; DRAGON, Stephane/0000-0002-4999-5307; Soussi Gounni, Abdelilah/0000-0002-7282-0388	Canadian Institutes of Health Research (CIHR) [ROP:88714]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research (CIHR grant number ROP:88714). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado-Kristensson M, 2001, FASEB J, V15, P129, DOI 10.1096/fj.01-0817fje; Aoshiba K, 1999, J IMMUNOL, V162, P1692; Becker A, 2005, CAN MED ASSOC J, V173, pS3; Beuther DA, 2006, AM J RESP CRIT CARE, V174, P112, DOI 10.1164/rccm.200602-231PP; Bornstein SR, 1998, J CLIN ENDOCR METAB, V83, P280, DOI 10.1210/jc.83.1.280; BRACH MA, 1992, BLOOD, V80, P2920; Bruno A, 2005, EUR RESPIR J, V26, P398, DOI 10.1183/09031936.05.00092404; Bruno A, 2005, J IMMUNOL, V174, P8090, DOI 10.4049/jimmunol.174.12.8090; Bruno A, 2009, J ALLERGY CLIN IMMUN, V124, P230, DOI 10.1016/j.jaci.2009.04.032; Bruun JM, 2002, MOL CELL ENDOCRINOL, V190, P91, DOI 10.1016/S0303-7207(02)00007-2; Caldefie-Chezet F, 2003, FREE RADICAL RES, V37, P809, DOI 10.1080/1071576031000097526; Caldefie-Chezet F, 2001, J LEUKOCYTE BIOL, V69, P414; COLOTTA F, 1992, BLOOD, V80, P2012; Conus S, 2005, J ALLERGY CLIN IMMUN, V116, P1228, DOI 10.1016/j.jaci.2005.09.003; Coppack SW, 2001, P NUTR SOC, V60, P349, DOI 10.1079/PNS2001110; Cowburn AS, 2002, BLOOD, V100, P2607, DOI 10.1182/blood-2001-11-0122; Dibbert B, 1999, P NATL ACAD SCI USA, V96, P13330, DOI 10.1073/pnas.96.23.13330; El Kebir D, 2010, THESCIENTIFICWORLDJO, V10, P1731, DOI 10.1100/tsw.2010.169; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; Fernandez-Riejos P, 2008, CLIN EXP IMMUNOL, V151, P505, DOI 10.1111/j.1365-2249.2007.03563.x; Frasch SC, 1998, J BIOL CHEM, V273, P8389, DOI 10.1074/jbc.273.14.8389; Fujita Y, 2002, CLIN EXP IMMUNOL, V128, P21, DOI 10.1046/j.1365-2249.2002.01797.x; Gainsford T, 1996, P NATL ACAD SCI USA, V93, P14564, DOI 10.1073/pnas.93.25.14564; Girard D, 1997, BIOCHEM J, V325, P147, DOI 10.1042/bj3250147; Gorska E, 2010, EUR J MED RES, V15, P50; Houseknecht KL, 1998, J ANIM SCI, V76, P1405; KLEBANOFF SJ, 1992, BLOOD, V80, P225; Klein JB, 2000, J IMMUNOL, V164, P4286, DOI 10.4049/jimmunol.164.8.4286; Lam QLK, 2007, J BIOL CHEM, V282, P27587, DOI 10.1074/jbc.M704579200; Lappas M, 2005, ENDOCRINOLOGY, V146, P3334, DOI 10.1210/en.2005-0406; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Lo CKC, 2009, CELL MOL IMMUNOL, V6, P353, DOI 10.1038/cmi.2009.46; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; Mancuso P, 2002, J IMMUNOL, V168, P4018, DOI 10.4049/jimmunol.168.8.4018; Mancuso P, 2011, J IMMUNOL, V186, P1081, DOI 10.4049/jimmunol.1001470; Martin-Romero C, 2001, CELL IMMUNOL, V212, P83, DOI 10.1006/cimm.2001.1851; Matarese G, 2000, EUR CYTOKINE NETW, V11, P7; Mattioli B, 2005, J IMMUNOL, V174, P6820, DOI 10.4049/jimmunol.174.11.6820; Mattioli B, 2009, FEBS LETT, V583, P1102, DOI 10.1016/j.febslet.2009.02.029; Monteseirin J, 2009, J INVEST ALLERG CLIN, V19, P340; Moore SI, 2003, INFECT IMMUN, V71, P4182, DOI 10.1128/IAI.71.7.4182-4185.2003; Najib S, 2002, CELL IMMUNOL, V220, P143, DOI 10.1016/S0008-8749(03)00027-3; O'Donnell CP, 2000, RESP PHYSIOL, V119, P163, DOI 10.1016/S0034-5687(99)00111-5; Procaccini C, 2012, MOL ASPECTS MED, V33, P35, DOI 10.1016/j.mam.2011.10.012; Procaccini C, 2009, CURR SIGNAL TRANSD T, V4, P22, DOI 10.2174/157436209787048711; Raso GM, 2006, NEUROSCI LETT, V396, P121, DOI 10.1016/j.neulet.2005.11.022; Russo VC, 2004, ENDOCRINOLOGY, V145, P4103, DOI 10.1210/en.2003-1767; Saffar AS, 2008, J ALLERGY CLIN IMMUN, V121, P492, DOI 10.1016/j.jaci.2007.10.003; Saffar AS, 2007, J IMMUNOL, V178, P2535, DOI 10.4049/jimmunol.178.4.2535; Saxena NK, 2004, FASEB J, V18, P1612, DOI 10.1096/fj.04-1847fje; Shore SA, 2005, J ALLERGY CLIN IMMUN, V115, P103, DOI 10.1016/j.jaci.2004.10.007; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Suzukawa M, 2011, J IMMUNOL, V186, P5254, DOI 10.4049/jimmunol.1004054; Sweeney G, 2002, CELL SIGNAL, V14, P655, DOI 10.1016/S0898-6568(02)00006-2; THOMAS EL, 1988, REV INFECT DIS, V10, pS450; Tian ZG, 2002, BIOCHEM BIOPH RES CO, V298, P297, DOI 10.1016/S0006-291X(02)02462-2; Tschop J, 2010, J NEUROSCI, V30, P6036, DOI 10.1523/JNEUROSCI.4875-09.2010; Wong CK, 2007, EUR J IMMUNOL, V37, P2337, DOI 10.1002/eji.200636866	58	171	183	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55249	10.1371/journal.pone.0055249	http://dx.doi.org/10.1371/journal.pone.0055249			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383125	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600080
J	Sun, ZK; Fu, Q; Cao, LX; Jin, W; Cheng, LL; Li, ZL				Sun, Zikai; Fu, Qiang; Cao, Longxing; Jin, Wen; Cheng, LingLing; Li, Zhiliang			Intravenous N-Acetylcysteine for Prevention of Contrast-Induced Nephropathy: A Meta-Analysis of Randomized, Controlled Trials	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; RENAL-FUNCTION; SODIUM-BICARBONATE; SYSTEMATIC REVIEWS; REPERFUSION INJURY; CREATININE; CYSTEINE; PLASMA; CARE; PHARMACOKINETICS	Background: Contrast-induced nephropathy (CIN) is one of the common causes of acute renal insufficiency after contrast procedures. Whether intravenous N-acetylcysteine (NAC) is beneficial for the prevention of contrast-induced nephropathy is uncertain. In this meta-analysis of randomized controlled trials, we aimed to assess the efficacy of intravenous NAC for preventing CIN after administration of intravenous contrast media. Study Design: Relevant studies published up to September 2012 that investigated the efficacy of intravenous N-acetylcysteine for preventing CIN were collected from MEDLINE, OVID, EMBASE, Web of Science, Cochrane Central Register of Controlled Trials, and the conference proceedings from major cardiology and nephrology meetings. The primary outcome was CIN. Secondary outcomes included renal failure requiring dialysis, mortality, and length of hospitalization. Data were combined using random-effects models with the performance of standard tests to assess for heterogeneity and publication bias. Meta-regression analyses were also performed. Results: Ten trials involving 1916 patients met our inclusion criteria. Trials varied in patient demographic characteristics, inclusion criteria, dosing regimens, and trial quality. The summary risk ratio for contrast-induced nephropathy was 0.68 (95% CI, 0.46 to 1.02), a nonsignificant trend towards benefit in patients treated with intravenous NAC. There was evidence of significant heterogeneity in NAC effect across studies (Q = 17.42, P = 0.04; I-2 = 48%). Meta-regression revealed no significant relation between the relative risk of CIN and identified differences in participant or study characteristics. Conclusion: This meta-analysis showed that research on intravenous N-acetylcysteine and the incidence of CIN is too inconsistent at present to warrant a conclusion on efficacy. A large, well designed trial that incorporates the evaluation of clinically relevant outcomes in participants with different underlying risks of CIN is required to more adequately assess the role for intravenous NAC in CIN prevention.	[Sun, Zikai; Fu, Qiang; Cao, Longxing; Cheng, LingLing; Li, Zhiliang] Southern Med Univ, Zhujiang Hosp, Cardiovasc Dept, Guangzhou, Guangdong, Peoples R China; [Jin, Wen] Guangdong 2 Prov Peoples Hosp, Cardiovasc Dept, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Li, ZL (corresponding author), Southern Med Univ, Zhujiang Hosp, Cardiovasc Dept, Guangzhou, Guangdong, Peoples R China.	lizhiliang010@163.com	Gounni, Abdelilah Soussi/AAH-3456-2020	Kim, Do-Gyoon/0000-0001-7673-1254; Gounni, Abdelilah/0000-0003-1265-6560; DRAGON, Stephane/0000-0002-4999-5307; Soussi Gounni, Abdelilah/0000-0002-7282-0388				Ariarajah N, 2011, Rev Med Suisse, V7, P490; Aslanger E, 2012, CORONARY ARTERY DIS, V23, P265, DOI 10.1097/MCA.0b013e328351aacc; Baker CSR, 2003, J AM COLL CARDIOL, V41, P2114, DOI 10.1016/S0735-1097(03)00487-X; Baranska-Kosakowska A, 2007, TRANSPL P, V39, P2853, DOI 10.1016/j.transproceed.2007.08.057; BORGSTROM L, 1986, EUR J CLIN PHARMACOL, V31, P217, DOI 10.1007/BF00606662; Brautigam M, 2006, RADIOLOGY, V240, P615, DOI 10.1148/radiol.2402051532; Briguori C, 2004, EUR HEART J, V25, P206, DOI 10.1016/j.ehj.2003.11.016; Briguori C, 2002, J AM COLL CARDIOL, V40, P298, DOI 10.1016/S0735-1097(02)01958-7; Briguori C, 2007, CIRCULATION, V115, P1211, DOI 10.1161/CIRCULATIONAHA.106.687152; BURGUNDER JM, 1989, EUR J CLIN PHARMACOL, V36, P127, DOI 10.1007/BF00609183; Carbonell N, 2007, INT J CARDIOL, V115, P57, DOI 10.1016/j.ijcard.2006.04.023; Carbonell N, 2010, REV ESP CARDIOL, V63, P12, DOI 10.1016/S0300-8932(10)70004-X; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DiMari J, 1997, AM J PHYSIOL-RENAL, V272, pF292, DOI 10.1152/ajprenal.1997.272.3.F292; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Haase M, 2008, NEPHROL DIAL TRANSPL, V23, P1581, DOI 10.1093/ndt/gfm818; Hashimoto S, 2001, BRIT J PHARMACOL, V132, P270, DOI 10.1038/sj.bjp.0703787; Heyman SN, 2003, KIDNEY INT, V63, P634, DOI 10.1046/j.1523-1755.2003.00783.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoffmann U, 2004, J AM SOC NEPHROL, V15, P407, DOI 10.1097/01.ASN.0000106780.14856.55; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jaffery Z, 2012, CATHETER CARDIO INTE, V79, P921, DOI 10.1002/ccd.23157; Kefer JM, 2003, ACTA CARDIOL, V58, P555, DOI 10.2143/AC.58.6.2005321; Kiefer P, 2000, CRIT CARE MED, V28, P3935, DOI 10.1097/00003246-200012000-00037; Koc F, 2012, INT J CARDIOL, V155, P418, DOI 10.1016/j.ijcard.2010.10.041; Kotlyar Eugene, 2005, Heart Lung Circ, V14, P245, DOI 10.1016/j.hlc.2005.06.007; Marenzi G, 2006, NEW ENGL J MED, V354, P2773, DOI 10.1056/NEJMoa054209; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Moist L, 2010, AM J KIDNEY DIS, V56, P643, DOI 10.1053/j.ajkd.2010.03.028; Molitoris BA, 2007, NAT CLIN PRACT NEPHR, V3, P439, DOI 10.1038/ncpneph0551; Murphy SW, 2000, J AM SOC NEPHROL, V11, P177, DOI 10.1681/ASN.V111177; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; OLSSON B, 1988, EUR J CLIN PHARMACOL, V34, P77, DOI 10.1007/BF01061422; Parfrey P, 2005, CARDIOVASC INTER RAD, V28, pS3, DOI 10.1007/s00270-005-0196-8; Poletti PA, 2007, AM J ROENTGENOL, V189, P687, DOI 10.2214/AJR.07.2356; Quintavalle C, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.38; Rashid ST, 2004, J VASC SURG, V40, P1136, DOI 10.1016/j.jvs.2004.09.026; Ratcliffe JA, 2009, INT J ANGIOL, V18, P193, DOI 10.1055/s-0031-1278353; Recio-Mayoral A, 2007, J AM COLL CARDIOL, V49, P1283, DOI 10.1016/j.jacc.2006.11.034; Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33; Schmid CH, 2004, J CLIN EPIDEMIOL, V57, P683, DOI 10.1016/j.jclinepi.2003.12.001; Schultz MJ, 2006, CURR MED CHEM, V13, P2565, DOI 10.2174/092986706778201684; Shalansky SJ, 2005, PHARMACOTHERAPY, V25, P1095, DOI 10.1592/phco.2005.25.8.1095; Shalansky SJ, 2005, HEART, V91, P997, DOI 10.1136/hrt.2004.053579; Stacul F, 2011, EUR RADIOL, V21, P2527, DOI 10.1007/s00330-011-2225-0; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Tepel M, 2000, NEW ENGL J MED, V343, P180, DOI 10.1056/NEJM200007203430304; Thiele H, 2010, J AM COLL CARDIOL, V55, P2201, DOI 10.1016/j.jacc.2009.08.091; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Trivedi H, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2009.01.035; Tsikas D, 1998, J CHROMATOGR B, V708, P55, DOI 10.1016/S0378-4347(97)00670-1; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Walser M, 1998, AM J KIDNEY DIS, V32, P23, DOI 10.1053/ajkd.1998.v32.pm9669420; Webb JG, 2004, AM HEART J, V148, P422, DOI 10.1016/j.ahj.2004.03.041; Weinbroum AA, 2000, TRANSPLANTATION, V69, P853; Weisbord Steven D, 2005, J Intensive Care Med, V20, P63, DOI 10.1177/0885066604273503	57	171	183	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55124	10.1371/journal.pone.0055124	http://dx.doi.org/10.1371/journal.pone.0055124			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383125	gold, Green Submitted, Green Published			2022-12-25	WOS:000315563800113
J	Kim, J; Kim, G; An, S; Kwon, YK; Yoon, S				Kim, Jinkyu; Kim, Gunn; An, Sungbae; Kwon, Young-Kyun; Yoon, Sungroh			Entropy-Based Analysis and Bioinformatics-Inspired Integration of Global Economic Information Transfer	PLOS ONE			English	Article							FALSE DISCOVERY RATE; TIME-SERIES; STOCK-MARKET; NETWORK; MODEL; COINTEGRATION; RETURNS; GENES; FLOW	The assessment of information transfer in the global economic network helps to understand the current environment and the outlook of an economy. Most approaches on global networks extract information transfer based mainly on a single variable. This paper establishes an entirely new bioinformatics-inspired approach to integrating information transfer derived from multiple variables and develops an international economic network accordingly. In the proposed methodology, we first construct the transfer entropies (TEs) between various intra- and inter-country pairs of economic time series variables, test their significances, and then use a weighted sum approach to aggregate information captured in each TE. Through a simulation study, the new method is shown to deliver better information integration compared to existing integration methods in that it can be applied even when intra-country variables are correlated. Empirical investigation with the real world data reveals that Western countries are more influential in the global economic network and that Japan has become less influential following the Asian currency crisis.	[Kim, Jinkyu; Yoon, Sungroh] Seoul Natl Univ, Dept Elect & Comp Engn, Seoul, South Korea; [Kim, Gunn] Sejong Univ, Dept Phys, Seoul, South Korea; [An, Sungbae] Singapore Management Univ, Sch Econ, Singapore, Singapore; [Kwon, Young-Kyun] Kyung Hee Univ, Dept Phys, Seoul, South Korea; [Kwon, Young-Kyun] Kyung Hee Univ, Res Inst Basic Sci, Seoul, South Korea	Seoul National University (SNU); Sejong University; Singapore Management University; Kyung Hee University; Kyung Hee University	Yoon, S (corresponding author), Seoul Natl Univ, Dept Elect & Comp Engn, Seoul, South Korea.	sryoon@snu.ac.kr	Kwon, Young-Kyun/G-1833-2011; AN, Sungbae/D-1416-2009	Kwon, Young-Kyun/0000-0001-6027-8408; Kim, Joonyup/0000-0002-9950-6663; Binder, Brad/0000-0002-8172-2034; Dotson, Bradley/0000-0002-1003-3733	National Research Foundation of Korea; Ministry of Education, Science and Technology [2011-0009963, 2012R1A2A4A01008475]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (Grant No. 2011-0009963 to SY and Grant No. 2012R1A2A4A01008475 to SY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MACR DAT EM DEV MARK; Barnett L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238701; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanchard O., 1989, LECT MACROECONOMICS; Box G., 1970, TIME SERIES ANAL; Cao LY, 1997, PHYSICA D, V110, P43, DOI 10.1016/S0167-2789(97)00118-8; CARLSTEIN E, 1986, ANN STAT, V14, P1171, DOI 10.1214/aos/1176350057; Corsetti G, 1999, JPN WORLD ECON, V11, P305, DOI 10.1016/S0922-1425(99)00019-5; Dees S, 2007, J APPL ECONOMET, V22, P1, DOI 10.1002/jae.932; ENGLE RF, 1987, ECONOMETRICA, V55, P251, DOI 10.2307/1913236; Freeman C, 1987, TECHNOLOGY POLICY EC; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Granger CWJ, 2004, AM ECON REV, V94, P421, DOI 10.1257/0002828041464669; Hahs DW, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.128701; Hamilton J.D., 2020, TIME SERIES ANAL, DOI 10.2307/j.ctv14jx6sm; Kim K, 2004, PHYSICA A, V344, P272, DOI 10.1016/j.physa.2004.06.131; Kruskal J.B., 1956, P AM MATH SOC, V7, P48, DOI [10.1090/S0002-9939-1956-0078686-7, 10.2307/2033241, DOI 10.1090/S0002-9939-1956-0078686-7]; Kwon O, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/68003; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lee I, 2010, NAT BIOTECHNOL, V28, P149, DOI 10.1038/nbt.1603; Lindner M, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-119; Matia K, 2003, EUROPHYS LETT, V61, P422, DOI 10.1209/epl/i2003-00194-y; McCauley JL, 2003, PHYSICA A, V329, P178, DOI 10.1016/S0378-4371(03)00589-2; Park JB, 2007, PHYSICA A, V379, P179, DOI 10.1016/j.physa.2006.12.042; Peter FJ, 2011, THESIS EBERHARD KARL; Ragwitz M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.056201; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Silva AC, 2004, PHYSICA A, V344, P227, DOI 10.1016/j.physa.2004.06.122; Stanley HE, 2001, PHYSICA A, V299, P1, DOI 10.1016/S0378-4371(01)00351-X; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Thurow L., 1993, HEAD HEAD COMING EC; Vincente R, 2011, J COMPUT NEUROSCI, V30, P45; Vogel E. F., 1979, JAPAN NUMBER ONE LES; Yang JS, 2006, PHYSICA A, V363, P377, DOI 10.1016/j.physa.2005.12.039; Yook SH, 2001, PHYS REV LETT, V86, P5835, DOI 10.1103/PhysRevLett.86.5835	37	191	195	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e51986	10.1371/journal.pone.0051986	http://dx.doi.org/10.1371/journal.pone.0051986			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	067UP	23922872	Green Published, Green Submitted, gold			2022-12-25	WOS:000313320900015
J	Kim, JE; Ryu, HJ; Kang, TC				Kim, Ji-Eun; Ryu, Hea Jin; Kang, Tae-Cheon			Status Epilepticus Induces Vasogenic Edema via Tumor Necrosis Factor-alpha/Endothelin-1-Mediated Two Different Pathways	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; RAT PIRIFORM CORTEX; NADPH-OXIDASE; FACTOR-ALPHA; KAINIC ACID; NITRIC-OXIDE; RECEPTOR; PERMEABILITY; ENDOTHELIN; SEIZURE	Status epilepticus (SE) induces vasogenic edema in the piriform cortex with disruptions of the blood-brain barrier (BBB). However, the mechanisms of vasogenic edema formation following SE are still unknown. Here we investigated the endothelin B (ETB) receptor-mediated pathway of SE-induced vasogenic edema. Following SE, the release of tumor necrosis factor-alpha (TNF-alpha) stimulated endothelin-1 (ET-1) release and expression in neurons and endothelial cells. In addition, TNF-a-induced ET-1 increased BBB permeability via ETB receptor-mediated endothelial nitric oxide synthase (eNOS) activation in endothelial cells. ETB receptor activation also increased intracellular reactive oxygen species by NADPH oxidase production in astrocytes. These findings suggest that SE results in BBB dysfunctions via endothelial-astroglial interactions through the TNF-alpha-ET-1-eNOS/ NADPH oxidase pathway, and that these ETB receptor-mediated interactions may be an effective therapeutic strategy for vasogenic edema in various neurological diseases.	[Kim, Ji-Eun; Ryu, Hea Jin; Kang, Tae-Cheon] Hallym Univ, Coll Med, Dept Anat & Neurobiol, Chunchon, Kangwon Do, South Korea; [Kim, Ji-Eun; Ryu, Hea Jin; Kang, Tae-Cheon] Hallym Univ, Coll Med, Inst Epilepsy Res, Chunchon, Kangwon Do, South Korea	Hallym University; Hallym University	Kang, TC (corresponding author), Hallym Univ, Coll Med, Dept Anat & Neurobiol, Chunchon, Kangwon Do, South Korea.	tckang@hallym.ac.kr	Kwon, Young-Kyun/G-1833-2011; AN, Sungbae/D-1416-2009	Kwon, Young-Kyun/0000-0001-6027-8408; Kim, Joonyup/0000-0002-9950-6663; Binder, Brad/0000-0002-8172-2034; Dotson, Bradley/0000-0002-1003-3733	Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs [A111313]; National Research Foundation of Korea [2012R1A2A1A01001775]; Korean government	Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs; National Research Foundation of Korea(National Research Foundation of Korea); Korean government(Korean Government)	This study was supported by grants from the Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs (Grant number A111313) and the National Research Foundation of Korea (MEST No. 2012R1A2A1A01001775), funded by the Korean government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON BD, 1989, J INVEST DERMATOL, V93, P280, DOI 10.1111/1523-1747.ep12277592; BEDI KS, 1991, J COMP NEUROL, V311, P425, DOI 10.1002/cne.903110311; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; Bengtsson SH, 2003, CLIN EXP PHARMACOL P, V30, P849, DOI 10.1046/j.1440-1681.2003.03929.x; Covolan L, 2000, EPILEPSY RES, V39, P133, DOI 10.1016/S0920-1211(99)00119-9; Davenport AP, 2004, J CARDIOVASC PHARM, V44, pS276, DOI 10.1097/01.fjc.0000166284.08657.64; DELORENZO RJ, 1995, J CLIN NEUROPHYSIOL, V12, P316; Dong F, 2006, HYPERTENSION, V47, P222, DOI 10.1161/01.HYP.0000198555.51645.f1; El-Benna J, 2005, ARCH IMMUNOL THER EX, V53, P199; El-Benna J, 2009, EXP MOL MED, V41, P217, DOI 10.3858/emm.2009.41.4.058; Emerson MR, 1999, BRAIN RES, V825, P189, DOI 10.1016/S0006-8993(99)01195-6; Farkas G, 1998, NEUROSCI LETT, V242, P147, DOI 10.1016/S0304-3940(98)00060-3; Fotin-Mleczek M, 2002, J CELL SCI, V115, P2757; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Gursoy-Ozdemir Y, 2004, STROKE, V35, P1449, DOI 10.1161/01.STR.0000126044.83777.f4; Hartz AMS, 2006, MOL PHARMACOL, V69, P462, DOI 10.1124/mol.105.017954; Kang TC, 2006, GLIA, V54, P258, DOI 10.1002/glia.20380; Kim JE, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-6; Kim JE, 2011, J CLIN INVEST, V121, P2037, DOI 10.1172/JCI44818; Kim JE, 2010, J COMP NEUROL, V518, P4612, DOI 10.1002/cne.22482; Kleeberg J, 2004, AM J PHYSIOL-HEART C, V286, pH1339, DOI 10.1152/ajpheart.00227.2003; Lampl Y, 1997, STROKE, V28, P1951, DOI 10.1161/01.STR.28.10.1951; Luscher TF, 2000, CIRCULATION, V102, P2434, DOI 10.1161/01.CIR.102.19.2434; Lv S, 2010, LIVER INT, V30, P1198, DOI 10.1111/j.1478-3231.2010.02211.x; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; McCann SK, 2008, J NEUROSCI RES, V86, P2524, DOI 10.1002/jnr.21700; Miller AA, 2006, BRAIN RES, V1111, P111, DOI 10.1016/j.brainres.2006.06.082; Nico B, 2003, GLIA, V42, P235, DOI 10.1002/glia.10216; NITSCH C, 1985, J NEUROL SCI, V67, P67, DOI 10.1016/0022-510X(85)90023-1; Paravicini TM, 2003, CLIN EXP PHARMACOL P, V30, P855, DOI 10.1046/j.1440-1681.2003.03920.x; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Quintana A, 2005, J NEUROSCI RES, V82, P701, DOI 10.1002/jnr.20680; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Ryu HJ, 2010, NEUROSCIENCE, V170, P711, DOI 10.1016/j.neuroscience.2010.07.048; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Shapiro LA, 2008, EPILEPSIA, V49, P13, DOI 10.1111/j.1528-1167.2008.01633.x; Sharma HS, 2000, ACTA NEUROCHIR SUPPL, V76, P81; Sheen SH, 2011, BRAIN RES, V1369, P173, DOI 10.1016/j.brainres.2010.10.080; Skopal J, 1998, J CARDIOVASC PHARM, V31, pS370, DOI 10.1097/00005344-199800001-00104; SPERK G, 1994, PROG NEUROBIOL, V42, P1, DOI 10.1016/0301-0082(94)90019-1; Sriram K, 2007, J NEUROIMMUNE PHARM, V2, P140, DOI 10.1007/s11481-007-9070-6; Tack I, 1997, AM J PHYSIOL-RENAL, V272, pF31, DOI 10.1152/ajprenal.1997.272.1.F31; Toda N, 2009, PHARMACOL REV, V61, P62, DOI 10.1124/pr.108.000547; TSUKAHARA H, 1994, J BIOL CHEM, V269, P21778; Wui MZ, 2009, GLIA, V57, P1204, DOI 10.1002/glia.20842; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375	47	191	195	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74458	10.1371/journal.pone.0074458	http://dx.doi.org/10.1371/journal.pone.0074458			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	23922872	Green Submitted, gold, Green Published			2022-12-25	WOS:000324481600131
J	Lin, YL; Tsai, YJ; Liu, YF; Cheng, YC; Hung, CM; Lee, YJ; Pan, HC; Li, C				Lin, Yu-ling; Tsai, Yun-Jung; Liu, Yu-Fang; Cheng, Yi-Chuan; Hung, Chuan-Mao; Lee, Yi-Jen; Pan, Huichin; Li, Chuan			The Critical Role of Protein Arginine Methyltransferase prmt8 in Zebrafish Embryonic and Neural Development Is Non-Redundant with Its Paralogue prmt1	PLOS ONE			English	Article							METHYLATION; PROTEIN-ARGININE-METHYLTRANSFERASE-8; IDENTIFICATION; BINDING; FAMILY; DOMAIN; GENES; BRAIN; REST	Protein arginine methyltransferase (PRMT) 1 is the most conserved and widely distributed PRMT in eukaryotes. PRMT8 is a vertebrate-restricted paralogue of PRMT1 with an extra N-terminal sequence and brain-specific expression. We use zebrafish (Danio rerio) as a vertebrate model to study PRMT8 function and putative redundancy with PRMT1. The transcripts of zebrafish prmt8 were specifically expressed in adult zebrafish brain and ubiquitously expressed from zygotic to early segmentation stage before the neuronal development. Whole-mount in situ hybridization revealed ubiquitous prmt8 expression pattern during early embryonic stages, similar to that of prmt1. Knockdown of prmt8 with antisense morpholino oligonucleotide phenocopied prmt1-knockdown, with convergence/extension defects at gastrulation. Other abnormalities observed later include short body axis, curled tails, small and malformed brain and eyes. Catalytically inactive prmt8 failed to complement the morphants, indicating the importance of methyltransferase activity. Full-length prmt8 but not prmt1 cRNA can rescue the phenotypic changes. Nevertheless, cRNA encoding Prmt1 fused with the N-terminus of Prmt8 can rescue the prmt8 morphants. In contrast, N-terminus-deleted but not full-length prmt8 cRNA can rescue the prmt1 morphants as efficiently as prmt1 cRNA. Abnormal brain morphologies illustrated with brain markers and loss of fluorescent neurons in a transgenic fish upon prmt8 knockdown confirm the critical roles of prmt8 in neural development. In summery, our study is the first report showing the expression and function of prmt8 in early zebrafish embryogenesis. Our results indicate that prmt8 may play important roles non-overlapping with prmt1 in embryonic and neural development depending on its specific N-terminus.	[Lin, Yu-ling; Tsai, Yun-Jung; Liu, Yu-Fang; Hung, Chuan-Mao; Lee, Yi-Jen; Pan, Huichin; Li, Chuan] Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan; [Liu, Yu-Fang; Pan, Huichin; Li, Chuan] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Cheng, Yi-Chuan] Chang Gung Univ, Dept Biochem & Mol Biol, Tao Yuan, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chang Gung University	Li, C (corresponding author), Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan.	cli@csmu.edu.tw	Yuan, Lixing/I-2727-2012; Liu, Yuxuan/F-4226-2018; Liu, Ying/Q-6444-2017; Liu, Ying/GLN-6419-2022; van den Berg, Anke/H-1718-2011; Wu, Ping-Hsun/S-8746-2017; Chang, Chin-Kuo/E-4991-2010	Yuan, Lixing/0000-0003-0233-6184; Liu, Ying/0000-0001-5753-4247; Liu, Ying/0000-0001-5753-4247; van den Berg, Anke/0000-0002-8894-2638; Chen, Fanjun/0000-0001-8105-1683; Lin, Ming-Yen/0000-0002-8194-4833; Wu, Ping-Hsun/0000-0003-1021-8161; Liu, Yang/0000-0002-2362-9501; Chang, Chin-Kuo/0000-0002-8338-7196	National Science Council [95-2320-B-040-042, 96-2320-B-040-022-MY2, 98-2320-B-040-011-MY3]; Chung Shan Medical University [CSMU 94-OM-A-023, 97-OM-A-136, 98OM-A-060]	National Science Council(Ministry of Science and Technology, Taiwan); Chung Shan Medical University	The project was supported by 95-2320-B-040-042, 96-2320-B-040-022-MY2 and 98-2320-B-040-011-MY3 from National Science Council and CSMU 94-OM-A-023, 97-OM-A-136 and 98OM-A-060 from Chung Shan Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovich C, 1997, EMBO J, V16, P260, DOI 10.1093/emboj/16.2.260; Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Balint BL, 2005, MOL CELL BIOL, V25, P5648, DOI 10.1128/MCB.25.13.5648-5663.2005; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Batut J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025427; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bruce AW, 2009, GENOME RES, V19, P994, DOI 10.1101/gr.089086.108; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Gates KP, 2010, DEV BIOL, V340, P293, DOI 10.1016/j.ydbio.2010.01.029; Hung CJ, 2007, J BIOCHEM MOL BIOL, V40, P617; Hung CM, 2004, GENE, V340, P179, DOI 10.1016/j.gene.2004.07.039; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kousaka A, 2009, NEUROSCIENCE, V163, P1146, DOI 10.1016/j.neuroscience.2009.06.061; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Lin CH, 2002, J PROTEIN CHEM, V21, P447, DOI 10.1023/A:1021394903025; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Lu JG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-246; Nicholson TB, 2009, PHARMACOL RES, V60, P466, DOI 10.1016/j.phrs.2009.07.006; Pahlich S, 2008, PROTEINS, V72, P1125, DOI 10.1002/prot.22004; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Sayegh J, 2007, J BIOL CHEM, V282, P36444, DOI 10.1074/jbc.M704650200; Taneda T, 2007, BRAIN RES, V1155, P1, DOI 10.1016/j.brainres.2007.03.086; Tsai YJ, 2011, FEBS J, V278, P905, DOI 10.1111/j.1742-4658.2011.08006.x; Wang YC, 2012, FEBS J, V279, P932, DOI 10.1111/j.1742-4658.2012.08490.x; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	29	266	277	14	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e55221	10.1371/journal.pone.0055221	http://dx.doi.org/10.1371/journal.pone.0055221			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	24244618	gold, Green Submitted, Green Published			2022-12-25	WOS:000316252500001
J	Liu, Y; Zhang, AQ; Cao, L; Xia, HT; Ma, JJ				Liu, Yong; Zhang, An-Qiang; Cao, Lin; Xia, Hong-Tao; Ma, Jun-Jie			Taurolidine Lock Solutions for the Prevention of Catheter-Related Bloodstream Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Review							HOME PARENTERAL-NUTRITION; CENTRAL VENOUS CATHETERS; TARGETED USE; HEMODIALYSIS; BACTEREMIA; CITRATE; HEPARIN; SEPSIS; CANCER; TAUROLOCK(R)	Background: Catheter-related bloodstream infections (CRBSIs) are a significant cause of morbidity and mortality in critically ill patients, contributing to prolonged hospital stays and increased costs. Whether taurolidine lock solutions (TLS) are beneficial for the prevention of CRBSIs remains controversial. In this meta-analysis, we aim to assess the efficacy of TLS for preventing CRBSIs. Methods: We conducted a systematic search of PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials. Eligible studies included randomized controlled trials that reported on the effects of TLS for preventing CRBSIs. The primary outcome in these studies was catheter-related bloodstream infections, with microbial distribution of CRBSI and catheter-associated thrombosis as secondary outcomes. Data were combined using random-effects models owing to significant clinical heterogeneity. Results: Six randomized controlled trials (RCTs) conducted from 2004 through 2013 involving 431 patients and 86,078 catheter-days were included in the review. TLS were significantly associated with a lower incidence of CRBSIs when compared to heparin lock solutions (Risk Ratio [RR], 0.34; 95% Confidence Interval [CI], 0.21-0.55). Use of TLS significantly decreased the incidence of CRBSIs from gram-negative (G-) bacteria (P = 0.004; RR, 0.27; CI, 0.11-0.65), and was associated with a non-significant decrease in gram-positive (G+) bacterial infections (P = 0.07; RR, 0.41; CI, 0.15-1.09). No significant association was observed with TLS and catheter-associated thrombosis (RR, 1.99; CI, 0.75-5.28). Conclusions: The use of TLS reduced the incidence of CRBSIs without obvious adverse effects or bacterial resistance. However, the susceptibility of G+ and G- bacteria to taurolidine and the risk for catheter-associated thrombosis of TLS are indeterminate due to limited data. The results should be treated with caution due to the limited sample sizes and methodological deficiencies of included studies. Therefore, additional well-designed and adequately powered RCTs are needed to confirm these findings.	[Liu, Yong; Cao, Lin; Xia, Hong-Tao; Ma, Jun-Jie] Suining Cent Hosp, Intens Care Unit, Suining, Sichuan, Peoples R China; [Zhang, An-Qiang] Third Mil Med Univ, Daping Hosp, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China	Army Medical University	Liu, Y (corresponding author), Suining Cent Hosp, Intens Care Unit, Suining, Sichuan, Peoples R China.	616756156@qq.com	Yuan, Lixing/I-2727-2012; Liu, Yuxuan/F-4226-2018; Liu, Ying/Q-6444-2017; Liu, Ying/GLN-6419-2022; van den Berg, Anke/H-1718-2011; Wu, Ping-Hsun/S-8746-2017; Chang, Chin-Kuo/E-4991-2010	Yuan, Lixing/0000-0003-0233-6184; Liu, Ying/0000-0001-5753-4247; Liu, Ying/0000-0001-5753-4247; van den Berg, Anke/0000-0002-8894-2638; Chen, Fanjun/0000-0001-8105-1683; Lin, Ming-Yen/0000-0002-8194-4833; Wu, Ping-Hsun/0000-0003-1021-8161; Liu, Yang/0000-0002-2362-9501; Chang, Chin-Kuo/0000-0002-8338-7196				Akyuz C, 2010, PEDIATR BLOOD CANCER, V55, P949; Al-Amin A, 2012, BRIT J SURG, V99, P158; Allon M, 2003, CLIN INFECT DIS, V36, P1539, DOI 10.1086/375234; Betjes MGH, 2004, NEPHROL DIAL TRANSPL, V19, P1546, DOI 10.1093/ndt/gfh014; Bisseling TM, 2010, CLIN NUTR, V29, P464, DOI 10.1016/j.clnu.2009.12.005; Bradshaw JH, 2008, J PEDIATR GASTR NUTR, V47, P179, DOI 10.1097/MPG.0b013e318162c428; Branger B, 2008, ARTIF ORGANS, V32, P918, DOI 10.1111/j.1525-1594.2008.00684.x; Braumann C, 2005, J SURG RES, V129, P129, DOI 10.1016/j.jss.2005.03.012; Chu HP, 2012, J PEDIATR GASTR NUTR, V55, P403, DOI 10.1097/MPG.0b013e31825bb0ae; Dumichen MJ, 2012, J HOSP INFECT, V80, P304, DOI 10.1016/j.jhin.2012.01.003; Filiopoulos V, 2011, AM J NEPHROL, V33, P260, DOI 10.1159/000324685; Geron R, 2006, HAREFUAH, V145, P943; Geron Ronit, 2006, Harefuah, V145, P881; GORMAN SP, 1987, J APPL BACTERIOL, V62, P315, DOI 10.1111/j.1365-2672.1987.tb04926.x; Haag GM, 2011, J VASC ACCESS, V12, P244, DOI 10.5301/JVA.2011.6265; Handrup MM, 2012, APMIS, V120, P794, DOI 10.1111/j.1600-0463.2012.02910.x; Handrup MM, 2013, PEDIAT BLOOD CANC; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hill SM, 2011, J PEDIAT GASTROEN S1, V52, pE64; Jonkers C., 2012, CLIN NUTR S, V7, P203; Jurewitsch B, 2005, CLIN NUTR, V24, P462, DOI 10.1016/j.clnu.2005.02.001; Jurewitsch B, 1998, JPEN-PARENTER ENTER, V22, P242, DOI 10.1177/0148607198022004242; Labriola L, 2008, NEPHROL DIAL TRANSPL, V23, P1666, DOI 10.1093/ndt/gfm847; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Meyer B, 2010, J HOSP INFECT, V76, P200, DOI 10.1016/j.jhin.2010.05.020; Moher David, 2009, BMJ, V339, pb2535, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Novikov A, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-40; O'Grady NP, 2011, CLIN INFECT DIS, V52, P1087, DOI 10.1093/cid/cir138; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; O'Horo JC, 2011, AM J NEPHROL, V34, P415, DOI 10.1159/000331262; Oliveira C, 2012, PEDIATRICS, V129, P318, DOI 10.1542/peds.2011-1602; Olthof ED, 2012, CLIN NUTR; Olthof ED, 2012, CLIN NUTR S7, V7, P149; Rafferty GP, 2010, GUT, V59, pA35, DOI 10.1136/gut.2009.208991f; Rommes JH, 2001, CURR ANAESTH CRIT CA, V12, P25; Schiavone PA, 2010, PRACT GASTROENTEROL, V34, P22; Schiffer CA, 2013, J CLIN ONCOL; Shah CB, 2002, ANTIMICROB AGENTS CH, V46, P1674, DOI 10.1128/AAC.46.6.1674-1679.2002; Simon A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-102; Solomon LR, 2012, SEMIN DIALYSIS, V25, P233, DOI 10.1111/j.1525-139X.2011.00951.x; Solomon LR, 2010, AM J KIDNEY DIS, V55, P1060, DOI 10.1053/j.ajkd.2009.11.025; Sweet S, 2009, AM J KIDNEY DIS, V53, pA74; Tacconelli E, 2009, J HOSP INFECT, V72, P97, DOI 10.1016/j.jhin.2008.12.012; Taylor C, 2008, J REN CARE, V34, P116, DOI 10.1111/j.1755-6686.2008.00027.x; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Torres-Viera C, 2000, ANTIMICROB AGENTS CH, V44, P1720, DOI 10.1128/AAC.44.6.1720-1724.2000; Toure A, 2012, CLIN NUTR, V31, P567, DOI 10.1016/j.clnu.2012.01.001; van de Wetering MD, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003295.pub2; Vernon MA, 2006, SCOT MED J, V51, P54; Weber M, 2009, ZBL CHIR, V134, P350, DOI 10.1055/s-0028-1098929; Yahav D, 2008, CLIN INFECT DIS, V47, P83, DOI 10.1086/588667; Zwiech R, 2013, AM J THER	53	266	277	14	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e79417	10.1371/journal.pone.0079417	http://dx.doi.org/10.1371/journal.pone.0079417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24244618	Green Published, Green Submitted, gold			2022-12-25	WOS:000327539800007
J	Liu, Y; Lai, NW; Gao, K; Chen, FJ; Yuan, LX; Mi, GH				Liu, Ying; Lai, Ningwei; Gao, Kun; Chen, Fanjun; Yuan, Lixing; Mi, Guohua			Ammonium Inhibits Primary Root Growth by Reducing the Length of Meristem and Elongation Zone and Decreasing Elemental Expansion Rate in the Root Apex in Arabidopsis thaliana	PLOS ONE			English	Article							AUXIN TRANSPORT; GRAVITROPISM; STRESS; EFFLUX; NH4+; ORGANIZATION; SENSITIVITY; MUTATIONS; TOXICITY; NITROGEN	The inhibitory effect of ammonium on primary root growth has been well documented; however the underlying physiological and molecular mechanisms are still controversial. To avoid ammonium toxicity to shoot growth, we used a vertical two-layer split plate system, in which the upper layer contained nitrate and the lower layer contained ammonium. In this way, nitrogen status was maintained and only the apical part of the root system was exposed to ammonium. Using a kinematic approach, we show here that 1 mM ammonium reduces primary root growth, decreasing both elemental expansion and cell production. Ammonium inhibits the length of elongation zone and the maximum elemental expansion rate. Ammonium also decreases the apparent length of the meristem as well as the number of dividing cells without affecting cell division rate. Moreover, ammonium reduces the number of root cap cells but appears to affect neither the status of root stem cell niche nor the distal auxin maximum at the quiescent center. Ammonium also inhibits root gravitropism and concomitantly down-regulates the expression of two pivotal auxin transporters, AUX1 and PIN2. Insofar as ammonium inhibits root growth rate in AUX1 and PIN2 loss-of-function mutants almost as strongly as in wild type, we conclude that ammonium inhibits root growth and gravitropism by largely distinct pathways.	[Liu, Ying; Lai, Ningwei; Gao, Kun; Chen, Fanjun; Yuan, Lixing; Mi, Guohua] China Agr Univ, Coll Resources & Environm Sci, Key Lab Plant Soil Interact, MOE,Ctr Resources Environm & Food Secur, Beijing 100094, Peoples R China	China Agricultural University	Mi, GH (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Key Lab Plant Soil Interact, MOE,Ctr Resources Environm & Food Secur, Beijing 100094, Peoples R China.	miguohua@cau.edu.cn	Yuan, Lixing/I-2727-2012; Liu, Yuxuan/F-4226-2018; Liu, Ying/Q-6444-2017; Liu, Ying/GLN-6419-2022; van den Berg, Anke/H-1718-2011; Wu, Ping-Hsun/S-8746-2017; Chang, Chin-Kuo/E-4991-2010	Yuan, Lixing/0000-0003-0233-6184; Liu, Ying/0000-0001-5753-4247; Liu, Ying/0000-0001-5753-4247; van den Berg, Anke/0000-0002-8894-2638; Chen, Fanjun/0000-0001-8105-1683; Lin, Ming-Yen/0000-0002-8194-4833; Wu, Ping-Hsun/0000-0003-1021-8161; Liu, Yang/0000-0002-2362-9501; Chang, Chin-Kuo/0000-0002-8338-7196	NSFC [30771289, 31121062]	NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by NSFC (No.30771289), the innovative group grant of NSFC (No.31121062) [http://isisn.nsfc.gov.cn]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, SOIL SOLUTION CHEM A; Baskin TI, 2013, WIRES DEV BIOL, V2, P65, DOI 10.1002/wdev.94; Beemster GTS, 1998, PLANT PHYSIOL, V116, P1515, DOI 10.1104/pp.116.4.1515; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Britto DT, 2001, P NATL ACAD SCI USA, V98, P4255, DOI 10.1073/pnas.061034698; Britto DT, 2002, J PLANT PHYSIOL, V159, P567, DOI 10.1078/0176-1617-0774; CAO YW, 1993, PLANT PHYSIOL, V102, P983, DOI 10.1104/pp.102.3.983; Colon-Carmona A, 1999, PLANT J, V20, P503, DOI 10.1046/j.1365-313x.1999.00620.x; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Gazzarrini S, 1999, PLANT CELL, V11, P937, DOI 10.1105/tpc.11.5.937; Geisler M, 2002, PLANT PHYSIOL, V130, P1747, DOI 10.1104/pp.011197; Giehl RFH, 2012, PLANT CELL, V24, P33, DOI 10.1105/tpc.111.092973; Jiang K, 2005, ANNU REV CELL DEV BI, V21, P485, DOI 10.1146/annurev.cellbio.21.122303.114753; Kudoyarova GR, 1997, PLANT GROWTH REGUL, V23, P207, DOI 10.1023/A:1005990725068; Lewis DR, 2007, PLANT CELL, V19, P1838, DOI 10.1105/tpc.107.051599; Li Q, 2010, PLANT CELL ENVIRON, V33, P1529, DOI 10.1111/j.1365-3040.2010.02162.x; Ma Z, 2003, PLANT PHYSIOL, V131, P1381, DOI 10.1104/pp.012161; Malamy JE, 1997, DEVELOPMENT, V124, P33; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; MORRIS AK, 1992, B MATH BIOL, V54, P1069, DOI 10.1007/BF02460667; Mosier AR, 2004, AGR NITROGEN CYCLE A; Overvoorde P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001537; Perez-Torres CA, 2008, PLANT CELL, V20, P3258, DOI 10.1105/tpc.108.058719; Petrasek J, 2009, DEVELOPMENT, V136, P2675, DOI 10.1242/dev.030353; PICKETT FB, 1990, PLANT PHYSIOL, V94, P1462, DOI 10.1104/pp.94.3.1462; Qin C, 2008, P NATL ACAD SCI USA, V105, P18308, DOI 10.1073/pnas.0806168105; Remans T, 2006, P NATL ACAD SCI USA, V103, P19206, DOI 10.1073/pnas.0605275103; Robert HS, 2009, NAT CHEM BIOL, V5, P325, DOI 10.1038/nchembio.170; Rogato A, 2010, PLANT PHYSIOL, V154, P784, DOI 10.1104/pp.110.160309; ROMAN G, 1995, GENETICS, V139, P1393; SHARP RE, 1988, PLANT PHYSIOL, V87, P50, DOI 10.1104/pp.87.1.50; SILK WK, 1992, INT J PLANT SCI, V153, pS49, DOI 10.1086/297063; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Walch-Liu P, 2000, J EXP BOT, V51, P227, DOI 10.1093/jexbot/51.343.227; West G, 2004, PLANT PHYSIOL, V135, P1050, DOI 10.1104/pp.104.040022; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Yamaguchi M, 2010, PLANT CELL ENVIRON, V33, P223, DOI 10.1111/j.1365-3040.2009.02073.x; Yuan LX, 2007, PLANT CELL, V19, P2636, DOI 10.1105/tpc.107.052134; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407; Zou N, 2012, J EXP BOT, V63, P3777, DOI 10.1093/jxb/ers068	44	266	277	14	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61031	10.1371/journal.pone.0061031	http://dx.doi.org/10.1371/journal.pone.0061031			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	24244618	gold, Green Published, Green Submitted			2022-12-25	WOS:000317898000091
J	Liu, YX; van den Berg, A; Veenstra, R; Rutgers, B; Nolte, I; van Imhoff, G; Visser, L; Diepstra, A				Liu, Yuxuan; van den Berg, Anke; Veenstra, Rianne; Rutgers, Bea; Nolte, Ilja; van Imhoff, Gustaaf; Visser, Lydia; Diepstra, Arjan			PML Nuclear Bodies and SATB1 Are Associated with HLA Class I Expression in EBV plus Hodgkin Lymphoma	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; REED-STERNBERG CELLS; ARCHITECTURE; RESPONSES; CHROMATIN	Tumor cells of classical Hodgkin lymphoma (cHL) are characterized by a general loss of B cell phenotype, whereas antigen presenting properties are commonly retained. HLA class I is expressed in most EBV+ cHL cases, with an even enhanced expression in a proportion of the cases. Promyelocytic leukemia protein (PML) and special AT-rich region binding protein 1 (SATB1) are two global chromatin organizing proteins that have been shown to regulate HLA class I expression in Jurkat cells. We analyzed HLA class I, number of PML nuclear bodies (NBs) and SATB1 expression in tumor cells of 54 EBV+ cHL cases and used 27 EBV- cHL cases as controls. There was a significant difference in presence of HLA class I staining between EBV+ and EBV2 cases (p < 0.0001). We observed normal HLA class I expression in 35% of the EBV+ and in 19% of the EBV- cases. A stronger than normal HLA class I expression was observed in approximately 40% of EBV+ cHL and not in EBV- cHL cases. 36 EBV+ cHL cases contained less than 10 PML-NBs per tumor cell, whereas 16 cases contained more than 10 PMLNBs. The number of PML-NBs was positively correlated to the level of HLA class I expression (p < 0.01). The percentage of SATB1 positive cells varied between 0% to 100% in tumor cells and was inversely correlated with the level of HLA class I expression, but only between normal and strong expression (p < 0.05). Multivariable analysis indicated that the number of PML-NBs and the percentage of SATB1+ tumor cells are independent factors affecting HLA class I expression in EBV+ cHL. In conclusion, both PML and SATB1 are correlated to HLA class I expression levels in EBV+ cHL.	[Liu, Yuxuan; van den Berg, Anke; Veenstra, Rianne; Rutgers, Bea; Visser, Lydia; Diepstra, Arjan] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Nolte, Ilja] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [van Imhoff, Gustaaf] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Diepstra, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.	a.diepstra@umcg.nl	Yuan, Lixing/I-2727-2012; Liu, Yuxuan/F-4226-2018; Liu, Ying/Q-6444-2017; Liu, Ying/GLN-6419-2022; van den Berg, Anke/H-1718-2011; Wu, Ping-Hsun/S-8746-2017; Chang, Chin-Kuo/E-4991-2010	Yuan, Lixing/0000-0003-0233-6184; Liu, Ying/0000-0001-5753-4247; Liu, Ying/0000-0001-5753-4247; van den Berg, Anke/0000-0002-8894-2638; Chen, Fanjun/0000-0001-8105-1683; Lin, Ming-Yen/0000-0002-8194-4833; Wu, Ping-Hsun/0000-0003-1021-8161; Liu, Yang/0000-0002-2362-9501; Chang, Chin-Kuo/0000-0002-8338-7196	Abel Tasman Talent Program (ATTP), University Medical Center Groningen; Dutch Cancer Society (KWF) [RUG 2009-4313]	Abel Tasman Talent Program (ATTP), University Medical Center Groningen; Dutch Cancer Society (KWF)(KWF Kankerbestrijding)	This work was supported by grants from Abel Tasman Talent Program (ATTP), University Medical Center Groningen and the Dutch Cancer Society (KWF: RUG 2009-4313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JD, 2000, GENE DEV, V14, P521; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Chang SK, 2002, MOL CELLS, V14, P130; Condemine W, 2006, CANCER RES, V66, P6192, DOI 10.1158/0008-5472.CAN-05-3792; DELABIE J, 1995, LEUKEMIA LYMPHOMA, V18, P35, DOI 10.3109/10428199509064920; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Diepstra A, 2008, TISSUE ANTIGENS, V71, P219, DOI 10.1111/j.1399-0039.2008.01005.x; Diepstra A, 2005, LANCET, V365, P2216, DOI 10.1016/S0140-6736(05)66780-3; Diepstra A, 2009, J CLIN ONCOL, V27, P3815, DOI 10.1200/JCO.2008.20.5138; Hislop AD, 2007, J EXP MED, V204, P1863, DOI 10.1084/jem.20070256; Huang X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010865; Jarrett RF, 2002, ANN ONCOL, V13, P23, DOI 10.1093/annonc/13.S1.23; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Kuppers R, 2006, TRENDS IMMUNOL, V27, P203, DOI 10.1016/j.it.2006.03.001; Lallemand-Breitenbach V, COLD SPRING HARB PER, V2; Lee SP, 1997, J IMMUNOL, V158, P3325; Niens M, 2007, BLOOD, V110, P3310, DOI 10.1182/blood-2007-05-086934; Oudejans JJ, 1996, BLOOD, V87, P3844, DOI 10.1182/blood.V87.9.3844.bloodjournal8793844; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; ROWE M, 1995, EUR J IMMUNOL, V25, P1374, DOI 10.1002/eji.1830250536; Shiels C, 2001, J CELL SCI, V114, P3705; Sides MD, 2011, VIROLOGY, V416, P86, DOI 10.1016/j.virol.2011.04.005; Steidl C, 2012, BLOOD, V120, P3530, DOI 10.1182/blood-2012-06-439570; Stein H, 2008, WHO CLASSIFICATION T, V2, P321; Wang J, 2004, J CELL BIOL, V164, P515, DOI 10.1083/jcb.200305142; Woodberry T, 2005, J INFECT DIS, V192, P1513, DOI 10.1086/491741; Zuo J, 2008, J VIROL, V82, P2385, DOI 10.1128/JVI.01946-07; Zuo JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000255	29	266	277	14	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72930	10.1371/journal.pone.0072930	http://dx.doi.org/10.1371/journal.pone.0072930			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24244618	gold, Green Published, Green Submitted			2022-12-25	WOS:000323734600043
